Citrus Sinensis ID: 001902
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 998 | 2.2.26 [Sep-21-2011] | |||||||
| O48963 | 996 | Phototropin-1 OS=Arabidop | yes | no | 0.976 | 0.978 | 0.726 | 0.0 | |
| Q2QYY8 | 921 | Phototropin-1A OS=Oryza s | yes | no | 0.899 | 0.975 | 0.630 | 0.0 | |
| Q2RBR1 | 921 | Phototropin-1B OS=Oryza s | yes | no | 0.899 | 0.975 | 0.629 | 0.0 | |
| P93025 | 915 | Phototropin-2 OS=Arabidop | no | no | 0.841 | 0.918 | 0.609 | 0.0 | |
| Q9ST27 | 907 | Phototropin-2 OS=Oryza sa | no | no | 0.790 | 0.869 | 0.646 | 0.0 | |
| Q9LFA2 | 934 | Serine/threonine-protein | no | no | 0.331 | 0.354 | 0.457 | 7e-94 | |
| Q0DCT8 | 589 | Protein kinase G11A OS=Or | no | no | 0.379 | 0.643 | 0.428 | 9e-93 | |
| A2YBX5 | 589 | Protein kinase G11A OS=Or | N/A | no | 0.379 | 0.643 | 0.428 | 2e-92 | |
| P15792 | 609 | Protein kinase PVPK-1 OS= | N/A | no | 0.331 | 0.543 | 0.45 | 3e-91 | |
| Q05999 | 578 | Serine/threonine-protein | no | no | 0.339 | 0.586 | 0.435 | 5e-87 |
| >sp|O48963|PHOT1_ARATH Phototropin-1 OS=Arabidopsis thaliana GN=PHOT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1450 bits (3753), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 737/1014 (72%), Positives = 834/1014 (82%), Gaps = 39/1014 (3%)
Query: 5 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQP-TWQTWMEQRES---P 60
E + K S+K L RD+RGSLEVFNPST TRP NPVFRP+P WQ + R + P
Sbjct: 2 EPTEKPSTKPSSRTLPRDTRGSLEVFNPSTQLTRPDNPVFRPEPPAWQNLSDPRGTSPQP 61
Query: 61 EPEHAKLNSKSSRAEE----ITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGE 116
P+ S R+++ TSWMALKDP+P+ S +K+ ++
Sbjct: 62 RPQQEPAPSNPVRSDQEIAVTTSWMALKDPSPETIS------------KKTITAEKPQKS 109
Query: 117 AGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGG--DDPNGKPGTSRRNSNNSVRSSGEM 174
A AA QRAAEWGLVLKTDT+TGKPQ V R SGG +DPNGK TS+RNS NS RSSGEM
Sbjct: 110 AVAAEQRAAEWGLVLKTDTKTGKPQGVGVRNSGGTENDPNGKKTTSQRNSQNSCRSSGEM 169
Query: 175 SDEG--GKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV 232
SD G G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFF MTGYTSKEV
Sbjct: 170 SDGDVPGGRSGIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFNMTGYTSKEV 229
Query: 233 VGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGK 292
VGRNCRFLQG+GTD +++AKIRETL G +YCGR+LNYKKDGT FWNLLTIAPIKD+ GK
Sbjct: 230 VGRNCRFLQGSGTDADELAKIRETLAAGNNYCGRILNYKKDGTSFWNLLTIAPIKDESGK 289
Query: 293 VLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSL 352
VLKFIGMQVEVSKHTEGAK+K LRPNGLPESLIRYDARQK+MAT+SVTELV+A+K+PR+L
Sbjct: 290 VLKFIGMQVEVSKHTEGAKEKALRPNGLPESLIRYDARQKDMATNSVTELVEAVKRPRAL 349
Query: 353 SESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKK 412
SESTN P + KSE +E RR SENV P R + GGG R SMQRI+E+PEKK
Sbjct: 350 SESTNLHPFMTKSES---DELPKKPARRMSENVVPSGRRNSGGGRRNSMQRINEIPEKKS 406
Query: 413 QKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEG--DDDYESDDERPDSVDDKVRQKEMRK 470
+KS SFMG I +KS+S D+ S ++ I G DD+ DERP+SVDDKVRQKEMRK
Sbjct: 407 RKSSL-SFMG-IKKKSESLDE--SIDDGFIEYGEEDDEISDRDERPESVDDKVRQKEMRK 462
Query: 471 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDP 530
GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD
Sbjct: 463 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDL 522
Query: 531 ATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHL 586
TV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQK YFIGVQLDGS+H+
Sbjct: 523 TTVKKIRNAIDNQTEVTVQLINYTKSGKKFWNIFHLQPMRDQKGEVQYFIGVQLDGSKHV 582
Query: 587 EPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDS 646
EP+RN I E +E E LVK+TA N++EAV+ELPDAN+TPEDLWANHSKVVH KPHRKDS
Sbjct: 583 EPVRNVIEETAVKEGEDLVKKTAVNIDEAVRELPDANMTPEDLWANHSKVVHCKPHRKDS 642
Query: 647 PPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 706
PPW AIQK+L+SGE I L+HF+P+KPLGSGDTGSVHLVEL G+ Q FAMKAMDK VMLNR
Sbjct: 643 PPWIAIQKVLESGEPIGLKHFKPVKPLGSGDTGSVHLVELVGTDQLFAMKAMDKAVMLNR 702
Query: 707 NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 766
NKVHRA AEREILD+LDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQP KVLKE
Sbjct: 703 NKVHRARAEREILDLLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQPRKVLKE 762
Query: 767 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 826
DAVRFYAA+VVVALEYLHCQGIIYRDLKPENVL+QGNG +SL+DFDLSCLTSCKPQLL+P
Sbjct: 763 DAVRFYAAQVVVALEYLHCQGIIYRDLKPENVLIQGNGDISLSDFDLSCLTSCKPQLLIP 822
Query: 827 TTNE--KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 884
+ +E KK++ K QQ P+FMAEPMRASNSFVGTEEYIAPEII+GAGHTSAVDWWALGIL+
Sbjct: 823 SIDEKKKKKQQKSQQTPIFMAEPMRASNSFVGTEEYIAPEIISGAGHTSAVDWWALGILM 882
Query: 885 YEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944
YEMLYGYTPFRGKTRQKTF N+L KDLKFP+S P SL KQL++RLL RDPK RLG EG
Sbjct: 883 YEMLYGYTPFRGKTRQKTFTNVLQKDLKFPASIPASLQVKQLIFRLLQRDPKKRLGCFEG 942
Query: 945 ANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQNVF 998
ANE+K+H FFKG+NWAL+RC NPPEL+ P+F+ + E KVVDP ++DLQ NVF
Sbjct: 943 ANEVKQHSFFKGINWALIRCTNPPELETPIFSGEAENGEKVVDPELEDLQTNVF 996
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for photo-induced movements. Required for blue-light mediated mRNA destabilization. Mediates calcium spiking of extracellular origin in response to low rate of blue light. Mediates also rapid membrane depolarization and growth inhibition in response to blue light. Necessary for root phototropism. Involved in hypocotyl phototropism under low rate but not under high rate blue light. Contributes to the chloroplast accumulation but seems to be not required for chloroplast translocation. Regulates stomata opening and photomorphogenesis response of leaf tissue. Confers sensitivity to drought. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q2QYY8|PHT1A_ORYSJ Phototropin-1A OS=Oryza sativa subsp. japonica GN=PHOT1A PE=1 SV=2 | Back alignment and function description |
|---|
Score = 1246 bits (3224), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 629/998 (63%), Positives = 752/998 (75%), Gaps = 100/998 (10%)
Query: 5 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQRESPEPEH 64
E+ +Q + + P RDSRGSLEVFNPS+ S+ FR
Sbjct: 14 ERKEQQQQRGYQLP--RDSRGSLEVFNPSSASS------FR------------------- 46
Query: 65 AKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRA 124
+ ++ + + ++A+ D+E+ V Q QRA
Sbjct: 47 ----TAAAAPKSASPFLAIP------------------DREEDNVVAQ---------QRA 75
Query: 125 AEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKE-KG 183
AEWGLVL+TD TG PQ V AR S G S R+S E + + +
Sbjct: 76 AEWGLVLQTDHHTGLPQGVSARPSSG----------------SARTSSEDNPQQQQSAAA 119
Query: 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 243
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSAFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 244 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 304 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 363
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNN-TLKR 298
Query: 364 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 421
KS+ + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMTEVPSKRSSES--GSRRNSR-SGTRSSLQKINEVPDQGNRTRKSGLRAFM 355
Query: 422 GLIGRKSQSTDDHDSFENEIIMEGDDD--YESDDERPDSVDDKVRQKEMRKGIDLATTLE 479
G +G H S E ++ D+D +SDDERP+S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 539
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 540 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPLRNSIPE 595
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQK YFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 596 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 655
A+E LVK+TA+N++EA KELPDANL PEDLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPEDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 656 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 715
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 716 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 775
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 776 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895
K P+F AEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 822
Query: 896 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
GKTRQ+TFANILHKD++FP+S SL A+QLMYRLLHRDP +RLGS+EGANEIK HPFF+
Sbjct: 823 GKTRQRTFANILHKDIRFPASISVSLAARQLMYRLLHRDPANRLGSYEGANEIKGHPFFR 882
Query: 956 GVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDL 993
G+NW L+R PP+L+ PLF+ D ++ +V D+
Sbjct: 883 GINWPLIRATAPPKLEIPLFSKDDMEKKGLVTNNRTDM 920
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RBR1|PHT1B_ORYSJ Phototropin-1B OS=Oryza sativa subsp. japonica GN=PHOT1B PE=1 SV=2 | Back alignment and function description |
|---|
Score = 1245 bits (3222), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 628/998 (62%), Positives = 753/998 (75%), Gaps = 100/998 (10%)
Query: 5 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQRESPEPEH 64
E+ +Q + + P RDSRGSLEVFNPS+ S+ FR
Sbjct: 14 ERKEQQQQRGYQLP--RDSRGSLEVFNPSSASS------FR------------------- 46
Query: 65 AKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRA 124
+ ++ + + ++A+ D+E+ V Q QRA
Sbjct: 47 ----TAAAAPKSASPFLAIP------------------DREEDNVVAQ---------QRA 75
Query: 125 AEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKE-KG 183
AEWGLVL+TD TG PQ V AR S G S R+S E + + +
Sbjct: 76 AEWGLVLQTDHHTGLPQGVSARPSSG----------------SARTSSEDNPQQQQSAAA 119
Query: 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 243
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSVFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 244 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 304 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 363
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNN-TLKR 298
Query: 364 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 421
KS+ + + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMSEVPSKRSSES--GSRRNSR-SGTRSSLQKINEVPDQVNRTRKSGLRAFM 355
Query: 422 GLIGRKSQSTDDHDSFENEIIMEGDDD--YESDDERPDSVDDKVRQKEMRKGIDLATTLE 479
G +G H S E ++ D+D +SDDERP+S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 539
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 540 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPLRNSIPE 595
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQK YFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 596 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 655
A+E LVK+TA+N++EA KELPDANL P+DLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPKDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 656 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 715
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 716 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 775
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 776 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895
K P+F AEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 822
Query: 896 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
GKTRQ+TFANILHKD++FP+S SL A+QLMYRLLHRDP +RLGS+EGANEIK HPFF+
Sbjct: 823 GKTRQRTFANILHKDIRFPASISVSLAARQLMYRLLHRDPANRLGSYEGANEIKGHPFFR 882
Query: 956 GVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDL 993
G+NW L+R PP+L+ PLF+ D ++ +V D+
Sbjct: 883 GINWPLIRATAPPKLEIPLFSKDDMEKKGLVTNNRTDM 920
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93025|PHOT2_ARATH Phototropin-2 OS=Arabidopsis thaliana GN=PHOT2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 1075 bits (2779), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 547/897 (60%), Positives = 654/897 (72%), Gaps = 57/897 (6%)
Query: 116 EAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMS 175
++ +R AEWGL + V SG D + K + S N +
Sbjct: 62 DSAKITERTAEWGL------------SAVKPDSGDDGISFKLSSEVERSKN-MSRRSSEE 108
Query: 176 DEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR 235
+ PRVS +K ALST QQTFVVSDAT+P PI+YAS+GFF MTGY+SKE+VGR
Sbjct: 109 STSSESGAFPRVSQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGR 168
Query: 236 NCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLK 295
NCRFLQG TD +VAKIR+ ++NG+SYCGRLLNYKKDGTPFWNLLT+ PIKDD+G +K
Sbjct: 169 NCRFLQGPDTDKNEVAKIRDCVKNGKSYCGRLLNYKKDGTPFWNLLTVTPIKDDQGNTIK 228
Query: 296 FIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS-LSE 354
FIGMQVEVSK+TEG DK LRPNGL +SLIRYDARQKE A S+TE+VQ ++ +S + E
Sbjct: 229 FIGMQVEVSKYTEGVNDKALRPNGLSKSLIRYDARQKEKALDSITEVVQTIRHRKSQVQE 288
Query: 355 STNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQK 414
S + +++ S P P R + R S+ K +
Sbjct: 289 SVSNDTMVKPD----------------SSTTPTPGRQT----------RQSDEASKSFRT 322
Query: 415 SGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDD--ERPDSVDDKVRQKEMRKGI 472
GR S G K +S+++ E+ + ME ++ S + + DS D R++++R+GI
Sbjct: 323 PGRVS--TPTGSKLKSSNNR--HEDLLRMEPEELMLSTEVIGQRDSWDLSDRERDIRQGI 378
Query: 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPAT 532
DLATTLERIEKNFVI+DPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD AT
Sbjct: 379 DLATTLERIEKNFVISDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDQAT 438
Query: 533 VRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEP 588
V+KIR AI +Q ++TVQLINYTKSGKKFWNLFHLQPMRDQK YFIGVQLDGS+H+EP
Sbjct: 439 VQKIRDAIRDQREITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHVEP 498
Query: 589 LRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPP 648
L+N + E T +S KLVK TA NV+EAV+ELPDAN PEDLWA HSK V+P PH K+S
Sbjct: 499 LQNRLSERTEMQSSKLVKATATNVDEAVRELPDANTRPEDLWAAHSKPVYPLPHNKESTS 558
Query: 649 WKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK 708
WKAI+KI SGE + L HF+PIKPLGSGDTGSVHLVEL G+G+ +AMKAM+K +MLNRNK
Sbjct: 559 WKAIKKIQASGETVGLHHFKPIKPLGSGDTGSVHLVELKGTGELYAMKAMEKTMMLNRNK 618
Query: 709 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 768
HRAC EREI+ +LDHPF+P LYASFQT THVCLITD+CPGGELF LLDRQP K+L ED+
Sbjct: 619 AHRACIEREIISLLDHPFLPTLYASFQTSTHVCLITDFCPGGELFALLDRQPMKILTEDS 678
Query: 769 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 828
RFYAAEVV+ LEYLHC GI+YRDLKPEN+LL+ +GH+ L DFDLS +T+C PQL++P
Sbjct: 679 ARFYAAEVVIGLEYLHCLGIVYRDLKPENILLKKDGHIVLADFDLSFMTTCTPQLIIPAA 738
Query: 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 888
K+RR K Q P F+AEP SNSFVGTEEYIAPEII GAGHTSA+DWWALGILLYEML
Sbjct: 739 PSKRRRSKSQPLPTFVAEPSTQSNSFVGTEEYIAPEIITGAGHTSAIDWWALGILLYEML 798
Query: 889 YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948
YG TPFRGK RQKTFANILHKDL FPSS P SL +QL+ LL+RDP SRLGS GANEI
Sbjct: 799 YGRTPFRGKNRQKTFANILHKDLTFPSSIPVSLVGRQLINTLLNRDPSSRLGSKGGANEI 858
Query: 949 KKHPFFKGVNWALVRCMNPPELDAPLFATDTE---KEYKVVDPGM----QDLQQNVF 998
K+H FF+G+NW L+R M+PP LDAPL + + K+ K D G+ DL ++F
Sbjct: 859 KQHAFFRGINWPLIRGMSPPPLDAPLSIIEKDPNAKDIKWEDDGVLVNSTDLDIDLF 915
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for photo-induced movements. Mediates calcium spiking of extra- and intracellular origins in response to blue light. Involved in hypocotyl phototropism. Contributes to the chloroplast accumulation in low blue light and mediates their translocation (avoidance response) at high fluence. Regulates stomata opening and photomorphogenesis response of leaf tissue. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ST27|PHOT2_ORYSJ Phototropin-2 OS=Oryza sativa subsp. japonica GN=PHOT2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 1055 bits (2728), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 517/800 (64%), Positives = 612/800 (76%), Gaps = 11/800 (1%)
Query: 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 243
LPRVS +KDALS+ QQTFVVSDAT+PD PI+YAS GFF MTGY+ +EVVGRNCRFLQG
Sbjct: 86 LPRVSQELKDALSSLQQTFVVSDATRPDCPIIYASEGFFTMTGYSPREVVGRNCRFLQGP 145
Query: 244 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
TD +VAKIR+ +++G+S+CGRLLNY+KDG PFWNLLT+ PI+DD GKV+KFIGMQVEV
Sbjct: 146 DTDAAEVAKIRDAVKHGRSFCGRLLNYRKDGAPFWNLLTVTPIRDDNGKVIKFIGMQVEV 205
Query: 304 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTN----RP 359
SK+TEG DK +RPN LP SLIRYD RQK+ A SS+TE+VQ +K+PR + P
Sbjct: 206 SKYTEGLSDKRMRPNELPVSLIRYDERQKDKAMSSMTEVVQTVKQPRGARAPADAALLTP 265
Query: 360 PIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRS 419
P + ++ A G S + R+S + +K SGR S
Sbjct: 266 PKMSDADKMAAMSPVVAPGTPSGGGGGAGSFKSPLWDLKKEESRLSRLASGRK--SGRSS 323
Query: 420 FMGL-IGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTL 478
MG IG++S E ER DS + R+K++R+GIDLATTL
Sbjct: 324 LMGFKIGKRSSVGSREAPAVVEEPAPAPPPAPEVVERTDSWERAEREKDIRQGIDLATTL 383
Query: 479 ERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRA 538
ERIEKNFVITDPR+PDNPIIFASDSFLELTEY+REEILGRNCRFLQGPETD TV KIR
Sbjct: 384 ERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCRFLQGPETDQGTVDKIRE 443
Query: 539 AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPLRNSIP 594
AI Q ++TVQLINYTKSGKKFWNLFHLQPMRDQK YFIGVQLDGS+H+EPLRN +
Sbjct: 444 AIREQKEITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHVEPLRNRLS 503
Query: 595 EATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQK 654
E T +S KLVK TAENV++AV+ELPDANL PEDLWA HS V PKPH++++P W AI+K
Sbjct: 504 ENTEIQSAKLVKATAENVDDAVRELPDANLRPEDLWAIHSMRVSPKPHKRNNPSWIAIEK 563
Query: 655 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA 714
+ GE+I L+HF+P+KPLG GDTGSVHLVEL GSG+ FAMKAMDK VMLNRNKVHRAC
Sbjct: 564 ATNLGEKIGLKHFKPVKPLGCGDTGSVHLVELQGSGELFAMKAMDKSVMLNRNKVHRACI 623
Query: 715 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 774
EREI +LDHPF+P LY SFQT THVCLITD+CPGGELF +LDRQP K+ +E+ RFYAA
Sbjct: 624 EREIYALLDHPFLPTLYTSFQTPTHVCLITDFCPGGELFAVLDRQPMKIFREECARFYAA 683
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
EVV+ LEYLHC GIIYRDLKPEN+LLQ +GH+ LTDFDLS LT+ KP ++ +T+ K+RR
Sbjct: 684 EVVIGLEYLHCLGIIYRDLKPENILLQADGHIVLTDFDLSFLTTSKPHVIKNSTSLKRRR 743
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894
+ P F++EP SNSFVGTEEYIAPE+I GAGHTSA+DWWALGILLYEMLYG TPF
Sbjct: 744 SQEFLPPTFVSEPSTPSNSFVGTEEYIAPEVITGAGHTSAIDWWALGILLYEMLYGRTPF 803
Query: 895 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
RGK R+KTF NILHKDL FPSS P SL AKQL++ LL RDP +R+GS+ GAN+IK+H FF
Sbjct: 804 RGKNRKKTFYNILHKDLTFPSSIPVSLAAKQLIHGLLQRDPSNRIGSNAGANDIKQHSFF 863
Query: 955 KGVNWALVRCMNPPELDAPL 974
+ +NW L+RCM+PPELD PL
Sbjct: 864 QDINWPLIRCMSPPELDVPL 883
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFA2|KIPK_ARATH Serine/threonine-protein kinase KIPK OS=Arabidopsis thaliana GN=KIPK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 345 bits (886), Expect = 7e-94, Method: Compositional matrix adjust.
Identities = 176/385 (45%), Positives = 232/385 (60%), Gaps = 54/385 (14%)
Query: 640 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 699
KPH W+AI+ I + L+HF +K LG GD G+V+L EL G+ FA+K MD
Sbjct: 511 KPHMSMDVRWEAIKHIKVQYGSLGLRHFNLLKKLGCGDIGTVYLAELIGTNCLFAIKVMD 570
Query: 700 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 759
+ R K RA AEREIL MLDHPF+P LYA F + CL+ +YCPGG+L +L +Q
Sbjct: 571 NEFLARRKKSPRAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQ 630
Query: 760 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS----- 814
+ E A RFY AE+++ALEYLH GIIYRDLKPEN+L++ +GH+ LTDFDLS
Sbjct: 631 LGRCFPEPAARFYVAEILLALEYLHMLGIIYRDLKPENILVREDGHIMLTDFDLSLRCAV 690
Query: 815 -------------------------------CLT--SCKPQLLLP--TTNEKKRR----- 834
C+T SC+ P ++N+++ R
Sbjct: 691 NPTLVRSNSPPGKDPARISGPYNTSNCIQPFCITEPSCQVSCFSPRLSSNQQQGRKPKRG 750
Query: 835 --------HKGQQNPVFMAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 885
H + P +AEP A SNSFVGT EY+APEII G GH +AVDWW G+LLY
Sbjct: 751 DHLSKTQQHLSRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGVLLY 810
Query: 886 EMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945
E+LYG TPF+G +T AN++ ++LKFP S S AK L+ LL ++P++RLGS +G+
Sbjct: 811 ELLYGKTPFKGYNNDETLANVVLQNLKFPDSPLVSFQAKDLIRGLLVKEPENRLGSEKGS 870
Query: 946 NEIKKHPFFKGVNWALVRCMNPPEL 970
EIK+HPFF+G+NWAL+RC PPEL
Sbjct: 871 VEIKRHPFFEGLNWALIRCAIPPEL 895
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0DCT8|G11A_ORYSJ Protein kinase G11A OS=Oryza sativa subsp. japonica GN=Os06g0291600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 342 bits (877), Expect = 9e-93, Method: Compositional matrix adjust.
Identities = 185/432 (42%), Positives = 246/432 (56%), Gaps = 53/432 (12%)
Query: 596 ATAEESEKLV--KQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQ 653
A+A S +LV +T E + + P + D A S KPH+ + W+AIQ
Sbjct: 122 ASASGSARLVGRSETGERGFSSSRCRPSTSSDVSDESACSSISSVTKPHKANDSRWEAIQ 181
Query: 654 KILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC 713
I + L HF+ +K LG GD GSV+L EL G+ YFAMK MDK + +R K+ RA
Sbjct: 182 MIRTRDGILGLSHFKLLKKLGCGDIGSVYLSELSGTKSYFAMKVMDKASLASRKKLLRAQ 241
Query: 714 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 773
E+EIL LDHPF+P LY F+T CL+ ++CPGG+L L RQ K E AV+FY
Sbjct: 242 TEKEILQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYV 301
Query: 774 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL--------- 824
AE+++A+EYLH GIIYRDLKPENVL++ +GH+ L+DFDLS + P L+
Sbjct: 302 AEILLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEA 361
Query: 825 --------------------------LPTT---------NEKKRRHKGQQN------PVF 843
PTT ++K R+ K + P
Sbjct: 362 LRKNNQAYCVQPACVEPSCMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVVNQVSPWPEL 421
Query: 844 MAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
+AEP A S SFVGT EY+APEII G GH SAVDWW GI LYE+L+G TPF+G + T
Sbjct: 422 IAEPSDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 481
Query: 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962
N++ + L+FP S A+ L+ LL ++P+ RLG GA EIK+HPFF+GVNWAL+
Sbjct: 482 LFNVIGQPLRFPEYPVVSFSARDLIRGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWALI 541
Query: 963 RCMNPPELDAPL 974
RC +PPE+ P+
Sbjct: 542 RCASPPEVPRPV 553
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YBX5|G11A_ORYSI Protein kinase G11A OS=Oryza sativa subsp. indica GN=OsI_021818 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 341 bits (875), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 185/432 (42%), Positives = 246/432 (56%), Gaps = 53/432 (12%)
Query: 596 ATAEESEKLV--KQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQ 653
A+A S +LV +T E + + P + D A S KPH+ + W+AIQ
Sbjct: 122 ASASGSARLVGRSETGERGFSSSRCRPSTSSDVSDESACSSISSVTKPHKANDSRWEAIQ 181
Query: 654 KILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC 713
I + L HF+ +K LG GD GSV+L EL G+ YFAMK MDK + +R K+ RA
Sbjct: 182 MIRTRDGILGLSHFKLLKKLGCGDIGSVYLSELNGTKSYFAMKVMDKASLASRKKLLRAQ 241
Query: 714 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 773
E+EIL LDHPF+P LY F+T CL+ ++CPGG+L L RQ K E AV+FY
Sbjct: 242 TEKEILQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYV 301
Query: 774 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL--------- 824
AE+++A+EYLH GIIYRDLKPENVL++ +GH+ L+DFDLS + P L+
Sbjct: 302 AEILLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEA 361
Query: 825 --------------------------LPTT---------NEKKRRHKGQQN------PVF 843
PTT ++K R+ K + P
Sbjct: 362 LRKNNQAYCVQPACVEPSCMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVVNQVSPWPEL 421
Query: 844 MAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
+AEP A S SFVGT EY+APEII G GH SAVDWW GI LYE+L+G TPF+G + T
Sbjct: 422 IAEPSDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 481
Query: 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962
N++ + L+FP S A+ L+ LL ++P+ RLG GA EIK+HPFF+GVNWAL+
Sbjct: 482 LFNVIGQPLRFPEYPVVSFSARDLIRGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWALI 541
Query: 963 RCMNPPELDAPL 974
RC +PPE+ P+
Sbjct: 542 RCASPPEVPRPV 553
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15792|KPK1_PHAVU Protein kinase PVPK-1 OS=Phaseolus vulgaris PE=2 SV=1 | Back alignment and function description |
|---|
Score = 337 bits (864), Expect = 3e-91, Method: Compositional matrix adjust.
Identities = 171/380 (45%), Positives = 223/380 (58%), Gaps = 49/380 (12%)
Query: 640 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 699
KPH+ + W+AIQ + + ++HFR +K LG GD GSV+L EL G+ FAMK M+
Sbjct: 202 KPHKANDIRWEAIQAVRTRDGMLEMRHFRLLKKLGCGDIGSVYLAELSGTRTSFAMKVMN 261
Query: 700 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 759
K + NR K+ RA EREIL LDHPF+P LY F+T+ CL+ ++CPGG+L L RQ
Sbjct: 262 KTELANRKKLLRAQTEREILQSLDHPFLPTLYTHFETEIFSCLVMEFCPGGDLHALRQRQ 321
Query: 760 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819
P K E AVRFY AEV+++LEYLH GIIYRDLKPENVL++ +GH+ L+DFDLS S
Sbjct: 322 PGKYFSEHAVRFYVAEVLLSLEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCSV 381
Query: 820 KPQLLLPTTNEKKRRH-------------------------------------------- 835
P L+ + N + +
Sbjct: 382 SPTLVKSSNNLQTKSSGYCVQPSCIEPTCVMQPDCIKPSCFTPRFLSGKSKKDKKSKPKN 441
Query: 836 --KGQQNPV--FMAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 890
Q P+ +AEP A S SFVGT EY+APEII G GH SAVDWW GI LYE+L+G
Sbjct: 442 DMHNQVTPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG 501
Query: 891 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950
TPF+G + T N++ + L+FP S S A+ L+ LL ++P+ RL GA EIK+
Sbjct: 502 RTPFKGSANRATLFNVIGQPLRFPESPTVSFAARDLIRGLLVKEPQHRLAYRRGATEIKQ 561
Query: 951 HPFFKGVNWALVRCMNPPEL 970
HPFF+ VNWAL+RC PPE+
Sbjct: 562 HPFFQNVNWALIRCATPPEV 581
|
Phaseolus vulgaris (taxid: 3885) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05999|KPK7_ARATH Serine/threonine-protein kinase AtPK7 OS=Arabidopsis thaliana GN=PK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (827), Expect = 5e-87, Method: Compositional matrix adjust.
Identities = 169/388 (43%), Positives = 230/388 (59%), Gaps = 49/388 (12%)
Query: 640 KPHRKDSPP-WKAIQKILDS-GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 697
KPHR ++ W AIQ++ G + + F+ IK LG GD G+V+L EL G+G FA+K
Sbjct: 153 KPHRDNNDKRWVAIQEVRSRVGSSLEAKDFKLIKKLGGGDIGNVYLAELIGTGVSFAVKV 212
Query: 698 MDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD 757
M+K + R K+ RA E+EIL LDHPF+P LY+ F+T+ + CL+ ++CPGG+L L
Sbjct: 213 MEKAAIAARKKLVRAQTEKEILQSLDHPFLPTLYSHFETEMNSCLVMEFCPGGDLHSLRQ 272
Query: 758 RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817
+Q K E A RFY AEV++A+EYLH GIIYRDLKPENVL++ +GH+ L+DFDLS
Sbjct: 273 KQRGKYFPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 332
Query: 818 SCKPQL----------------LLPTTNEK---------------------KRRHKGQQN 840
+ P L + PT ++ K +H+ + N
Sbjct: 333 AVSPTLVRFAAITLESKSSSYCIQPTCVDQSSCIVQPDCIQPVCFTPRFLSKGKHRKKSN 392
Query: 841 ---------PVFMAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 890
P +AEP A S SFVGT EY+APEII G GH SAVDWW GI LYE+L+G
Sbjct: 393 DMSRQIRPLPELIAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG 452
Query: 891 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950
TPFRG + T N++ + L+FP S A+ L+ LL ++P+ RL GA EIK+
Sbjct: 453 ITPFRGGDNRATLFNVVGQPLRFPEHPNVSFAARDLIRGLLVKEPQHRLAYRRGATEIKQ 512
Query: 951 HPFFKGVNWALVRCMNPPELDAPLFATD 978
HPFF+ VNWAL+RC +PP++ P+ D
Sbjct: 513 HPFFQSVNWALIRCTSPPQIPQPVKPMD 540
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 998 | ||||||
| 225435157 | 1004 | PREDICTED: phototropin-1-like [Vitis vin | 0.986 | 0.981 | 0.795 | 0.0 | |
| 297746173 | 958 | unnamed protein product [Vitis vinifera] | 0.948 | 0.988 | 0.783 | 0.0 | |
| 224055599 | 977 | predicted protein [Populus trichocarpa] | 0.967 | 0.988 | 0.781 | 0.0 | |
| 401782496 | 1028 | phototropin 1 [Fragaria x ananassa] | 0.974 | 0.946 | 0.759 | 0.0 | |
| 255582071 | 1006 | serine/threonine protein kinase, putativ | 0.980 | 0.973 | 0.768 | 0.0 | |
| 350535803 | 1018 | phototropin-1 [Solanum lycopersicum] gi| | 0.972 | 0.953 | 0.734 | 0.0 | |
| 449460993 | 952 | PREDICTED: phototropin-1-like [Cucumis s | 0.878 | 0.921 | 0.802 | 0.0 | |
| 60099454 | 976 | phototropin [Phaseolus vulgaris] | 0.959 | 0.981 | 0.730 | 0.0 | |
| 356542583 | 977 | PREDICTED: phototropin-1-like [Glycine m | 0.960 | 0.981 | 0.734 | 0.0 | |
| 15231245 | 996 | non-specific serine/threonine protein ki | 0.976 | 0.978 | 0.726 | 0.0 |
| >gi|225435157|ref|XP_002281752.1| PREDICTED: phototropin-1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1619 bits (4193), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 805/1012 (79%), Positives = 887/1012 (87%), Gaps = 27/1012 (2%)
Query: 2 DQSEKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQRESPE 61
D S KSP + PL RDSRGSLEVFNPST+STRPTN FRPQPTW++W E R +PE
Sbjct: 5 DDSAKSP-----SLIPPLPRDSRGSLEVFNPSTYSTRPTNQAFRPQPTWKSWAEPRGTPE 59
Query: 62 PEHA-KLNSKSSR-AEEITSWMALKDPAPQ------KPSLPPLIQKMTNDQEKSTVTKQL 113
E + +L+SKS R A+EITSWMALK+P+P + S+ P + ++K T QL
Sbjct: 60 REGSPELSSKSGRSADEITSWMALKEPSPAPPLPLAQKSVSPAFNVQDDTRQKPTRKTQL 119
Query: 114 SGEAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGE 173
SGE AAQRAAEWGL+LKTDTETGKPQ V RTSGGD+PN K GTSRRNS NSVRSSGE
Sbjct: 120 SGEVDNAAQRAAEWGLMLKTDTETGKPQGVAVRTSGGDEPNYKTGTSRRNSGNSVRSSGE 179
Query: 174 MSDEGG--KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKE 231
MSDEGG K++ PRVS+ +KDALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGYTSKE
Sbjct: 180 MSDEGGAGKDRAFPRVSEDLKDALSTFQQTFVVSDATKPDYPILYASAGFFKMTGYTSKE 239
Query: 232 VVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEG 291
V+GRNCRFLQG+GTDPEDVAKIRE L G SYCGRLLNYKKDGTPFWNLLTI+PIKD+ G
Sbjct: 240 VIGRNCRFLQGSGTDPEDVAKIREALHAGNSYCGRLLNYKKDGTPFWNLLTISPIKDENG 299
Query: 292 KVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS 351
VLKFIGMQVEVSKHTEG+K+KM RPNGLPESLIRYDARQK+MAT+SV+ELVQA+KKPRS
Sbjct: 300 NVLKFIGMQVEVSKHTEGSKEKMTRPNGLPESLIRYDARQKDMATNSVSELVQAVKKPRS 359
Query: 352 LSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKK 411
LSES++RP +RKSE G E+ER A GRR SE+V PPRRNS G R SMQRISE+PEKK
Sbjct: 360 LSESSDRP-FMRKSEDG-EQERPEAPGRRNSESVAPPRRNSQSGR-RASMQRISELPEKK 416
Query: 412 KQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKG 471
+KS R SFM ++ RKSQ+ + F+ E++++ D DDERPDS+D+K RQ+EMR+G
Sbjct: 417 PRKSSRLSFMRIM-RKSQAHTEE--FDTEVLVD-DTSDSEDDERPDSIDNKTRQREMRRG 472
Query: 472 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPA 531
IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPA
Sbjct: 473 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPA 532
Query: 532 TVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLE 587
TVRKIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK YFIGVQLDGSEH+E
Sbjct: 533 TVRKIREAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHVE 592
Query: 588 PLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSP 647
PL N IPE+TA+ES KLVK+TAEN+++AV+ELPDANL PEDLW+NHSKVV PKPHRK+S
Sbjct: 593 PLHNCIPESTAKESAKLVKETAENIDDAVRELPDANLKPEDLWSNHSKVVLPKPHRKESS 652
Query: 648 PWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN 707
WKAIQKIL+ GEQI L+HFRP+KPLGSGDTGSVHLVELCG+G+YFAMKAMDK VMLNRN
Sbjct: 653 AWKAIQKILEDGEQIGLKHFRPVKPLGSGDTGSVHLVELCGTGEYFAMKAMDKNVMLNRN 712
Query: 708 KVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 767
KVHRACAEREILDMLDHPF+PALYASFQTKTH+CLITDYCPGGELFLLLDRQPTKVLKED
Sbjct: 713 KVHRACAEREILDMLDHPFLPALYASFQTKTHICLITDYCPGGELFLLLDRQPTKVLKED 772
Query: 768 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 827
AVRFYAAEVVVALEYLHCQG+IYRDLKPENVLLQ +GHV+LTDFDLSCLTSCKPQLL+P
Sbjct: 773 AVRFYAAEVVVALEYLHCQGVIYRDLKPENVLLQSSGHVALTDFDLSCLTSCKPQLLMPN 832
Query: 828 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 887
TNEKKR+HKGQQNP+FMAEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEM
Sbjct: 833 TNEKKRQHKGQQNPIFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEM 892
Query: 888 LYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947
LYGYTPFRGKTRQKTFANILHKDLKFPSS SL+AKQLMYRLLHRDPK+RLGS EGANE
Sbjct: 893 LYGYTPFRGKTRQKTFANILHKDLKFPSSISVSLNAKQLMYRLLHRDPKNRLGSREGANE 952
Query: 948 IKKHPFFKGVNWALVRCMNPPELDA-PLFATDTEKEYKVVDPGMQDLQQNVF 998
IK+HPFF+GVNWALVRCMNPPELDA PL TD EKE K VDP + DLQ N+F
Sbjct: 953 IKRHPFFRGVNWALVRCMNPPELDAPPLETTDAEKEVKSVDPELLDLQTNIF 1004
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297746173|emb|CBI16229.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1580 bits (4091), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 787/1004 (78%), Positives = 861/1004 (85%), Gaps = 57/1004 (5%)
Query: 2 DQSEKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQRESPE 61
D S KSP + PL RDSRGSLEVFNPST+STRPTN FRPQPTW++W E R S
Sbjct: 5 DDSAKSP-----SLIPPLPRDSRGSLEVFNPSTYSTRPTNQAFRPQPTWKSWAEPRRS-- 57
Query: 62 PEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAA 121
A+EITSWMALK+P+ +KS
Sbjct: 58 ------------ADEITSWMALKEPS---------PAPPLPLAQKS-------------- 82
Query: 122 QRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEG--G 179
RAAEWGL+LKTDTETGKPQ V RTSGGD+PN K GTSRRNS NSVRSSGEMSDEG G
Sbjct: 83 -RAAEWGLMLKTDTETGKPQGVAVRTSGGDEPNYKTGTSRRNSGNSVRSSGEMSDEGGAG 141
Query: 180 KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRF 239
K++ PRVS+ +KDALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGYTSKEV+GRNCRF
Sbjct: 142 KDRAFPRVSEDLKDALSTFQQTFVVSDATKPDYPILYASAGFFKMTGYTSKEVIGRNCRF 201
Query: 240 LQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGM 299
LQG+GTDPEDVAKIRE L G SYCGRLLNYKKDGTPFWNLLTI+PIKD+ G VLKFIGM
Sbjct: 202 LQGSGTDPEDVAKIREALHAGNSYCGRLLNYKKDGTPFWNLLTISPIKDENGNVLKFIGM 261
Query: 300 QVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRP 359
QVEVSKHTEG+K+KM RPNGLPESLIRYDARQK+MAT+SV+ELVQA+KKPRSLSES++R
Sbjct: 262 QVEVSKHTEGSKEKMTRPNGLPESLIRYDARQKDMATNSVSELVQAVKKPRSLSESSDR- 320
Query: 360 PIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRS 419
P +RKSE G E+ER A GRR SE+V PPRRNS G R SMQRISE+PEKK +KS R S
Sbjct: 321 PFMRKSEDG-EQERPEAPGRRNSESVAPPRRNSQSGR-RASMQRISELPEKKPRKSSRLS 378
Query: 420 FMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLE 479
FM ++ RKSQ+ + F+ E++++ D DDERPDS+D+K RQ+EMR+GIDLATTLE
Sbjct: 379 FMRIM-RKSQAHTEE--FDTEVLVD-DTSDSEDDERPDSIDNKTRQREMRRGIDLATTLE 434
Query: 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 539
RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR A
Sbjct: 435 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIREA 494
Query: 540 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPLRNSIPE 595
IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK YFIGVQLDGSEH+EPL N IPE
Sbjct: 495 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHVEPLHNCIPE 554
Query: 596 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 655
+TA+ES KLVK+TAEN+++AV+ELPDANL PEDLW+NHSKVV PKPHRK+S WKAIQKI
Sbjct: 555 STAKESAKLVKETAENIDDAVRELPDANLKPEDLWSNHSKVVLPKPHRKESSAWKAIQKI 614
Query: 656 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 715
L+ GEQI L+HFRP+KPLGSGDTGSVHLVELCG+G+YFAMKAMDK VMLNRNKVHRACAE
Sbjct: 615 LEDGEQIGLKHFRPVKPLGSGDTGSVHLVELCGTGEYFAMKAMDKNVMLNRNKVHRACAE 674
Query: 716 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 775
REILDMLDHPF+PALYASFQTKTH+CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE
Sbjct: 675 REILDMLDHPFLPALYASFQTKTHICLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 734
Query: 776 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
VVVALEYLHCQG+IYRDLKPENVLLQ +GHV+LTDFDLSCLTSCKPQLL+P TNEKKR+H
Sbjct: 735 VVVALEYLHCQGVIYRDLKPENVLLQSSGHVALTDFDLSCLTSCKPQLLMPNTNEKKRQH 794
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895
KGQQNP+FMAEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 795 KGQQNPIFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 854
Query: 896 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
GKTRQKTFANILHKDLKFPSS SL+AKQLMYRLLHRDPK+RLGS EGANEIK+HPFF+
Sbjct: 855 GKTRQKTFANILHKDLKFPSSISVSLNAKQLMYRLLHRDPKNRLGSREGANEIKRHPFFR 914
Query: 956 GVNWALVRCMNPPELDA-PLFATDTEKEYKVVDPGMQDLQQNVF 998
GVNWALVRCMNPPELDA PL TD EKE K VDP + DLQ N+F
Sbjct: 915 GVNWALVRCMNPPELDAPPLETTDAEKEVKSVDPELLDLQTNIF 958
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224055599|ref|XP_002298559.1| predicted protein [Populus trichocarpa] gi|222845817|gb|EEE83364.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1568 bits (4060), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 789/1009 (78%), Positives = 864/1009 (85%), Gaps = 43/1009 (4%)
Query: 1 MDQSEKSPKQSSKACESPLSRDSRGSLEVFNPST-FSTRPTNPVFRP-QPTWQTWMEQ-- 56
M+ ++KS KQSS PL RDSRGSLEVFNPS+ + RPTNP FR PTW++W++
Sbjct: 1 MEATDKSSKQSSGNV-PPLPRDSRGSLEVFNPSSAYLNRPTNPAFRSSNPTWKSWVDSSA 59
Query: 57 RESPEPEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGE 116
+ PEPE A + TSWMALKDP +KP +QLSGE
Sbjct: 60 KNEPEPEEAPIT---------TSWMALKDP--KKPK------------------QQLSGE 90
Query: 117 AGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSD 176
G A +RAAEWGLVLKTD ETGKPQ V RTSGGDDPN KPGTSRR+SNNSVR+SGE+SD
Sbjct: 91 IGVATKRAAEWGLVLKTDDETGKPQGVSVRTSGGDDPNAKPGTSRRDSNNSVRNSGELSD 150
Query: 177 EGG--KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVG 234
+GG +PRVS+ +++ALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGYTSKEV+G
Sbjct: 151 DGGTSNNSNIPRVSEDIRNALSTFQQTFVVSDATKPDYPILYASAGFFKMTGYTSKEVIG 210
Query: 235 RNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVL 294
RNCRFLQGAGTDPEDVAKIRE L+ +YCGRLLNYKKDG+PFWNLLTIAPIKDD GKVL
Sbjct: 211 RNCRFLQGAGTDPEDVAKIREALRGEGTYCGRLLNYKKDGSPFWNLLTIAPIKDDSGKVL 270
Query: 295 KFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSE 354
KFIGM VEVSKHTEG+KDK LRPNGLP SLIRYDARQKEMATSSVTELVQA+ +PR+LSE
Sbjct: 271 KFIGMLVEVSKHTEGSKDKTLRPNGLPGSLIRYDARQKEMATSSVTELVQAVNRPRALSE 330
Query: 355 STNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQK 414
STNRP ++RKSEGG E ER GA+GRR SENV P RRNS+ G R SMQRISE+PEKK +K
Sbjct: 331 STNRP-LMRKSEGGGEGERKGAIGRRNSENVAPNRRNSHRG-TRNSMQRISELPEKKPRK 388
Query: 415 SGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDL 474
S R SFMGL+ + + S D+ + + + D + DD R DS+DDKVR+KEMRKGIDL
Sbjct: 389 SSRLSFMGLMRKSTHSNDESFDVGITLDDDFESDDDDDDARLDSLDDKVRKKEMRKGIDL 448
Query: 475 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR 534
ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR
Sbjct: 449 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR 508
Query: 535 KIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPLR 590
KIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK YFIGVQLDGSEH+EP
Sbjct: 509 KIREAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHVEPRT 568
Query: 591 NSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWK 650
NSIPEATA ESE+LVKQTAENV++A +ELPDAN+ PEDLWANHSKVV+PKPHRKDSP WK
Sbjct: 569 NSIPEATAIESEQLVKQTAENVDDAARELPDANMRPEDLWANHSKVVYPKPHRKDSPSWK 628
Query: 651 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 710
AIQKIL+SGEQ+ L+HFRP+KPLGSGDTGSVHLVEL G+GQ+FAMK MDK MLNRNKVH
Sbjct: 629 AIQKILESGEQLGLKHFRPVKPLGSGDTGSVHLVELYGTGQFFAMKTMDKAAMLNRNKVH 688
Query: 711 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVR 770
RACAEREILDMLDHPF+PALYASFQTKTH+CLITDYCPGGELFLLLDRQP KVLKEDAVR
Sbjct: 689 RACAEREILDMLDHPFLPALYASFQTKTHICLITDYCPGGELFLLLDRQPKKVLKEDAVR 748
Query: 771 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830
FYAAEVV+ALEYLHCQGIIYRDLKPENVLLQ NGHV+LTDFDLSCLTSCKPQLL+P+TNE
Sbjct: 749 FYAAEVVIALEYLHCQGIIYRDLKPENVLLQSNGHVALTDFDLSCLTSCKPQLLIPSTNE 808
Query: 831 KKRRHKGQQN-PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 889
KKR K QQ PVFMAEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLY
Sbjct: 809 KKRHRKHQQAPPVFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLY 868
Query: 890 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949
GYTPFRGKTRQKTFANILHKDLKFP S P SL+AKQLMYRLLHRDPK+RLGS EGAN+IK
Sbjct: 869 GYTPFRGKTRQKTFANILHKDLKFPGSIPVSLNAKQLMYRLLHRDPKNRLGSREGANDIK 928
Query: 950 KHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQNVF 998
+HPFFKGVNWALVRC+NPPEL+AP + EKE KVVDPGMQDLQ N+F
Sbjct: 929 RHPFFKGVNWALVRCLNPPELEAPFLESGEEKEAKVVDPGMQDLQTNIF 977
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|401782496|dbj|BAM36551.1| phototropin 1 [Fragaria x ananassa] | Back alignment and taxonomy information |
|---|
Score = 1527 bits (3953), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 775/1021 (75%), Positives = 851/1021 (83%), Gaps = 48/1021 (4%)
Query: 18 PLSRDSRGSLEVFNPSTFSTRPTNPV-FRPQ--PTWQTWMEQRES-----PEPEHAKLNS 69
PL RDSRGSLE+FNPS STRP +P FR TW+TW++ R++ S
Sbjct: 16 PLPRDSRGSLEIFNPS--STRPASPPPFRQSKPATWKTWLDPRDTLNPKPDPSPPPIPAS 73
Query: 70 KSSRAE-EITSWMALKD----------PAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAG 118
KS R + ITSWMALKD P+ Q PP IQ+ + V + + E G
Sbjct: 74 KSGRDDGTITSWMALKDFPPTPPPPSKPSKQSQQAPPYIQQQQTIS--AAVNDKSTPEHG 131
Query: 119 AAAQRAAEWGLVLKTDTETGKPQAVVARTSGG-DDPNGKPGTSRRNSNNSVRSSGEMSDE 177
AAQRAAEWGLVLKTDTETGKPQ V R SGG +DP+ KPGTSRRNSNNSVRSSGE+SD+
Sbjct: 132 DAAQRAAEWGLVLKTDTETGKPQGVTTRNSGGPEDPSHKPGTSRRNSNNSVRSSGELSDD 191
Query: 178 GGKEKG----LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVV 233
GG G PRVS+ +K+ LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+
Sbjct: 192 GGGGGGIGKGFPRVSEDLKNVLSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVI 251
Query: 234 GRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKV 293
GRNCRFLQGA TDPEDVA++RE L SYCGRLLNYKKDGTPFWNLLTIAPIKD+ GKV
Sbjct: 252 GRNCRFLQGADTDPEDVAQLREALAKNTSYCGRLLNYKKDGTPFWNLLTIAPIKDETGKV 311
Query: 294 LKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLS 353
LKFIGMQVEVSKHTEG+KDKMLRPNGLPESLIRYDARQKE AT SVTELVQA+++PRSLS
Sbjct: 312 LKFIGMQVEVSKHTEGSKDKMLRPNGLPESLIRYDARQKEKATHSVTELVQAVRRPRSLS 371
Query: 354 ESTNRPPIIRKSEGGVEEER---------AGALGRRKSENVPPPRRNSYGGGCRTSMQRI 404
ESTNRP RKS GG E + +L RR SE+V PPRRNS G SM I
Sbjct: 372 ESTNRP--FRKSGGGGRGEEVIEAHARPSSESLPRRNSESVAPPRRNSLGDA-NFSMHSI 428
Query: 405 SEVPEKKKQKSGRRSFMGLIGRKSQSTD--DHDSFENEIIMEGDDDYESDDERPDSVDDK 462
EVPEKK++K RRSFMG++ +KSQ+ + D D+F+ E D +DERP S+DDK
Sbjct: 429 KEVPEKKQKKPRRRSFMGIM-KKSQTQNQLDDDTFDEFGASEDVRDDSDNDERPMSLDDK 487
Query: 463 VRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF 522
VR+KEMRKG+DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF
Sbjct: 488 VRKKEMRKGMDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF 547
Query: 523 LQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGV 578
LQGPETDPATV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQK YFIGV
Sbjct: 548 LQGPETDPATVKKIREAIDNQTEVTVQLINYTKSGKKFWNVFHLQPMRDQKGEVQYFIGV 607
Query: 579 QLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVH 638
QLDGS+H+EPL+NSIPE A+ESEKLVK+TA NV+EA +ELPDAN+ PEDLW NHSKVVH
Sbjct: 608 QLDGSQHIEPLQNSIPEVAAKESEKLVKETAVNVDEAARELPDANMKPEDLWMNHSKVVH 667
Query: 639 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 698
PKPHRKDSPPW AIQKILDSGEQI L+HF+PIKPLGSGDTGSVHLV+LCG+ QYFAMKAM
Sbjct: 668 PKPHRKDSPPWIAIQKILDSGEQIGLKHFKPIKPLGSGDTGSVHLVQLCGTDQYFAMKAM 727
Query: 699 DKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR 758
DK +MLNRNKVHRACAEREILDMLDHPF+PALYASFQTKTHVCLITDY PGGELFLLLD
Sbjct: 728 DKNIMLNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHVCLITDYYPGGELFLLLDT 787
Query: 759 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818
QPTKVLKE++VRFY AEVVVALEYLHCQGIIYRDLKPENVLLQ NGHV+LTDFDLSCLTS
Sbjct: 788 QPTKVLKENSVRFYVAEVVVALEYLHCQGIIYRDLKPENVLLQSNGHVTLTDFDLSCLTS 847
Query: 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 878
CKPQLLLPT NEKKR HK Q +P+FMAEPMRASNSFVGTEEYIAPEII GAGH+SAVDWW
Sbjct: 848 CKPQLLLPTINEKKRHHKRQHDPIFMAEPMRASNSFVGTEEYIAPEIITGAGHSSAVDWW 907
Query: 879 ALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
ALGIL+YEMLYGYTPFRGKTRQKTFANILHKDLKFP S P SL AKQLMYRLLHRDPK+R
Sbjct: 908 ALGILIYEMLYGYTPFRGKTRQKTFANILHKDLKFPGSIPASLQAKQLMYRLLHRDPKNR 967
Query: 939 LGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFA-TDTEKEYKVVDPGMQDLQQNV 997
LGS EGANEIK+HPFF+GVNWALVRCMNPP+LD+PLF T+ EK K+VDP MQDLQ N+
Sbjct: 968 LGSLEGANEIKRHPFFRGVNWALVRCMNPPQLDSPLFGTTEAEKGAKLVDPEMQDLQTNI 1027
Query: 998 F 998
F
Sbjct: 1028 F 1028
|
Source: Fragaria x ananassa Species: Fragaria x ananassa Genus: Fragaria Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255582071|ref|XP_002531832.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223528528|gb|EEF30552.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1513 bits (3916), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 782/1018 (76%), Positives = 868/1018 (85%), Gaps = 39/1018 (3%)
Query: 3 QSEKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPT-NPVFRPQPTWQTWMEQ-RESP 60
+S S KQS +PL RD RGSLEVFNPS+ S+ + N +RP W+TW+E+ + P
Sbjct: 6 RSSSSNKQSPPVI-TPLPRDPRGSLEVFNPSSTSSTRSTNLAYRPNTNWKTWVEKPHDGP 64
Query: 61 EPEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLI-----QKMTNDQEKSTVTKQLSG 115
+ KS RAEE T+WMA+KDPAP P+LP L Q + NDQ+K+ T +LSG
Sbjct: 65 NTQSP---PKSGRAEEATTWMAIKDPAPS-PTLPLLSSPSHSQLIGNDQDKNPAT-ELSG 119
Query: 116 EAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPN-GKPGTSRRNSNNSVRSSG-E 173
EA AA+RAAEWGLVLK +T+ GKPQ V R+SGGD+PN KPGTSRRNSNNSV+SSG +
Sbjct: 120 EAEMAARRAAEWGLVLKPETQEGKPQVGV-RSSGGDEPNSNKPGTSRRNSNNSVQSSGGD 178
Query: 174 MS-DEGGKE-KGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKE 231
+S D+GGKE KG+PRVS+ +K+ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKE
Sbjct: 179 LSEDDGGKENKGIPRVSEDIKNALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKE 238
Query: 232 VVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEG 291
V+GRNCRFLQGA TDPEDVAKIRE LQ+ SYCGRLLNYKKDGTPFWNLLTI+PIKD+ G
Sbjct: 239 VIGRNCRFLQGADTDPEDVAKIREALQSENSYCGRLLNYKKDGTPFWNLLTISPIKDESG 298
Query: 292 KVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS 351
KVLK+IGMQVEVSK TEG+KDKMLRPNGLPESLIRYDARQKEMATSSVTELVQA+K+PRS
Sbjct: 299 KVLKYIGMQVEVSKFTEGSKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAVKRPRS 358
Query: 352 LSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKK 411
LSE+T+RP ++RKSE G E+ER GALGRR SENVP RRNS GG R SMQ I+E+PEKK
Sbjct: 359 LSEATSRP-LMRKSESGGEDERKGALGRRNSENVPSNRRNSLGGA-RNSMQSINELPEKK 416
Query: 412 KQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDE------RPDSVDDKVRQ 465
+KS R SFMGL+ +KS + + DSF++ +I+ GDDD DDE RP+SVDDKVR+
Sbjct: 417 PRKSIRLSFMGLM-KKSSTQSNADSFDDALILNGDDDDVDDDEESEIDERPNSVDDKVRK 475
Query: 466 KEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQG 525
KEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQG
Sbjct: 476 KEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQG 535
Query: 526 PETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLD 581
PETDPATVRKIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK YFIGVQLD
Sbjct: 536 PETDPATVRKIREAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 595
Query: 582 GSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKP 641
GSEH+EP N IPE TA+ESEKLVKQTAENV+EAV+ELPDAN PEDLWANHSK VH KP
Sbjct: 596 GSEHVEPRSNCIPEETAQESEKLVKQTAENVDEAVRELPDANSKPEDLWANHSKAVHAKP 655
Query: 642 HRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 701
HRKD+P WKAIQKILD GE I L+HFRP+KPLGSGDTGSVHLVEL G+ +FAMKAMDK
Sbjct: 656 HRKDTPSWKAIQKILDDGEPIGLKHFRPVKPLGSGDTGSVHLVELSGTDHHFAMKAMDKN 715
Query: 702 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 761
VMLNRNKVHRACAEREILDMLDHPF+PALYASFQTKTH+CLITDYC GGELF+LLDRQPT
Sbjct: 716 VMLNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHICLITDYCSGGELFMLLDRQPT 775
Query: 762 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821
KVLKEDA RFYAAEVV+ALEYLHCQGIIYRDLKPENVLLQ +GHVSLTDFDLSCLTSCKP
Sbjct: 776 KVLKEDAARFYAAEVVIALEYLHCQGIIYRDLKPENVLLQSSGHVSLTDFDLSCLTSCKP 835
Query: 822 QLLLPTTNEKKR-RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 880
QLL+PT +EKK+ R QQ+P+FMAEPMRASNSFVGTEEYIAP +I +A
Sbjct: 836 QLLIPTVDEKKKHRKHHQQDPIFMAEPMRASNSFVGTEEYIAPVLIFHF-------IFAT 888
Query: 881 GILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG 940
GILLYEMLYGYTPFRGKTRQKTFAN+LHKDLKFP S SLHAKQLMYRLLHRDPK+RLG
Sbjct: 889 GILLYEMLYGYTPFRGKTRQKTFANVLHKDLKFPRSRQVSLHAKQLMYRLLHRDPKNRLG 948
Query: 941 SHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQNVF 998
SHEGANEIK+HPFFKGVNWALVRCMNPPELD P+F + EKE K++DP + DLQ NVF
Sbjct: 949 SHEGANEIKRHPFFKGVNWALVRCMNPPELDTPIFENEAEKEAKLIDPELLDLQNNVF 1006
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350535803|ref|NP_001234214.1| phototropin-1 [Solanum lycopersicum] gi|151176133|gb|ABN42185.2| phototropin-1 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 1482 bits (3837), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 746/1016 (73%), Positives = 833/1016 (81%), Gaps = 45/1016 (4%)
Query: 18 PLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWM-----------------EQRESP 60
PL RD RGSLEVFNPST+S+R TNPVFR QP+W+ W EQ P
Sbjct: 13 PLPRDPRGSLEVFNPSTYSSRSTNPVFRSQPSWKNWTAADPITRSTIPETEEKTEQIAIP 72
Query: 61 EPEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAA 120
+ K+N + W L+ Q+ L L++ + +K E GAA
Sbjct: 73 QIRVTKMNKSL-----LHGWQLLR---LQRNWLLRLLKNQLPVVRRFN-SKAAVDEVGAA 123
Query: 121 AQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEG-G 179
AQRAAEWGLVLKTD ETGK Q V RTSG DD NGK TSRR+S NS RSSGE SD+G G
Sbjct: 124 AQRAAEWGLVLKTDDETGKLQGVKVRTSG-DDTNGKTETSRRDSGNSGRSSGEFSDDGAG 182
Query: 180 KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRF 239
KE+G+PRVS+ ++DALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGYTSKEV+GRNCRF
Sbjct: 183 KERGIPRVSEDLRDALSTFQQTFVVSDATKPDYPILYASAGFFKMTGYTSKEVIGRNCRF 242
Query: 240 LQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGM 299
+QG+GTDPEDVA IRE LQ+G +YCGRLLNYKKDGTPFWNLLTIAPIKDD GKVLKFIGM
Sbjct: 243 MQGSGTDPEDVATIREALQSGSTYCGRLLNYKKDGTPFWNLLTIAPIKDDAGKVLKFIGM 302
Query: 300 QVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPR---SLSEST 356
QVEVSKHTEG+K+K +RPNGLPESLIRYD RQKEMA++SV EL++ +K PR +LSEST
Sbjct: 303 QVEVSKHTEGSKEKTVRPNGLPESLIRYDVRQKEMASNSVNELLEEIKNPRRARALSEST 362
Query: 357 N-RPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSM--QRISEVPEKKKQ 413
N RP +RKSEG E+ + N P RR+S+ G T+M ++I+EVPEKK +
Sbjct: 363 NNRPTFMRKSEGDQVEQDKQDTHKLNLVNKAPARRHSHAGTRTTTMKMEKINEVPEKKPK 422
Query: 414 KSGRRSFMGLIGRKSQSTDDHDS---FENEIIMEGDDDYESDDE---RPDSVDDKVRQKE 467
KS R SFMG++ +K ST FE + M+ DDD + + + RP SVDDKVR+KE
Sbjct: 423 KSARLSFMGIMKKKRSSTTMTTDDDDFEARMTMDNDDDDDDESDNDGRPVSVDDKVRKKE 482
Query: 468 MRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE 527
MRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE
Sbjct: 483 MRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE 542
Query: 528 TDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGS 583
TDPATV+KIR AIDNQTDVTVQLINYTK+GKKFWNLFHLQPMRDQK YFIGVQLDGS
Sbjct: 543 TDPATVKKIRQAIDNQTDVTVQLINYTKTGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 602
Query: 584 EHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHR 643
+H+EPL+NSIPE A ES KL+K+TA NV+EAV+ELPDAN PEDLW NHSKVV PKPHR
Sbjct: 603 QHVEPLQNSIPEDKATESAKLIKETAGNVDEAVRELPDANSKPEDLWRNHSKVVQPKPHR 662
Query: 644 KDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM 703
KDSP WKAIQKIL+SGE I L+HF+PIKPLGSGDTGSVHLVELCG+ Q+FAMKAMDK +M
Sbjct: 663 KDSPSWKAIQKILESGEPIGLKHFKPIKPLGSGDTGSVHLVELCGTDQHFAMKAMDKSIM 722
Query: 704 LNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 763
LNRNKVHRACAEREILDMLDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQ TKV
Sbjct: 723 LNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQQTKV 782
Query: 764 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823
LKEDA RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ GHVSLTDFDLSCLTSCKPQL
Sbjct: 783 LKEDAARFYAAEVVVALEYLHCQGIIYRDLKPENVLLQSGGHVSLTDFDLSCLTSCKPQL 842
Query: 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 883
L+P NEKK+ KGQ NP+FMAEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGIL
Sbjct: 843 LVPEINEKKKHQKGQHNPIFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGIL 902
Query: 884 LYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943
LYEMLYGYTPFRGKTRQKTF+NILHKDLKFP S +SLHAKQLMYRLLHRDPK+RLGS E
Sbjct: 903 LYEMLYGYTPFRGKTRQKTFSNILHKDLKFPGSIQSSLHAKQLMYRLLHRDPKNRLGSRE 962
Query: 944 GANEIKKHPFFKGVNWALVRCMNPPELD-APLFATDTEKEYKVVDPGMQDLQQNVF 998
GANEIK+HPFF+GVNWAL+RCMNPP+LD AP T++EKE K ++P M+DLQ NVF
Sbjct: 963 GANEIKQHPFFRGVNWALIRCMNPPKLDSAPFLGTESEKEGKDINPEMEDLQTNVF 1018
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460993|ref|XP_004148228.1| PREDICTED: phototropin-1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1463 bits (3787), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 730/910 (80%), Positives = 791/910 (86%), Gaps = 33/910 (3%)
Query: 116 EAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSG-EM 174
E G+AA RAAEWGLVLKTDTETGKPQ V RTSGGD+PN K SRR SNNSVRSSG EM
Sbjct: 49 EVGSAALRAAEWGLVLKTDTETGKPQGVGVRTSGGDEPNTKQENSRRTSNNSVRSSGDEM 108
Query: 175 SDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVG 234
S+EGG+E+G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+G
Sbjct: 109 SEEGGRERGIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVIG 168
Query: 235 RNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVL 294
RNCRFLQGA TDPEDVAKIRE LQ G SYCGRLLNYKKDGTPFWNLLTI+PIKDD+GKVL
Sbjct: 169 RNCRFLQGADTDPEDVAKIREALQAGTSYCGRLLNYKKDGTPFWNLLTISPIKDDDGKVL 228
Query: 295 KFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSE 354
K IGMQVEVSKHTEG KDKM+RPNGLPESLIRYDARQKEMATSSVTELVQA+K+PRSLSE
Sbjct: 229 KLIGMQVEVSKHTEGFKDKMVRPNGLPESLIRYDARQKEMATSSVTELVQAVKRPRSLSE 288
Query: 355 --------STNRPPIIRKSEGGVEEERAG----------ALGRRKSENVPPPRRNSYGGG 396
S NR + RKS GG G + RRKSE+ P GG
Sbjct: 289 YRPRALSESMNRR-LFRKSGGGGGGGEGGGKDEKDKLEPTMVRRKSESAAAPAGRRSQGG 347
Query: 397 CRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDE-- 454
R SMQRI+EVP+KK +KS RSFMG++ RKSQS + +SF+ I EG DD D+
Sbjct: 348 SRRSMQRINEVPDKKPKKSSHRSFMGIM-RKSQS-NVEESFD---IEEGSDDENESDDDV 402
Query: 455 RPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREE 514
RPDSVDDKVRQ+EMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREE
Sbjct: 403 RPDSVDDKVRQREMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREE 462
Query: 515 ILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK- 573
ILGRNCRFLQGPETD TV+KIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK
Sbjct: 463 ILGRNCRFLQGPETDRTTVKKIRDAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKG 522
Query: 574 ---YFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLW 630
YFIGVQLDGS+H+EPL N I E+TA+E EKL+K+TAENV+ A +ELPDANLTPEDLW
Sbjct: 523 EVQYFIGVQLDGSQHVEPLSNCIAESTAKEGEKLIKETAENVDLAARELPDANLTPEDLW 582
Query: 631 ANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSG 690
ANHSK+V PKPHRKDSP W+AIQKILD GEQI L+HF+P+KPLGSGDTGSVHLVELCG+
Sbjct: 583 ANHSKLVQPKPHRKDSPSWQAIQKILDGGEQIGLKHFKPVKPLGSGDTGSVHLVELCGTD 642
Query: 691 QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 750
QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF+PALYASFQTKTHVCLITDYCPGG
Sbjct: 643 QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHVCLITDYCPGG 702
Query: 751 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 810
ELFLLLDRQPTKV+KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ NGHV+LTD
Sbjct: 703 ELFLLLDRQPTKVIKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQSNGHVALTD 762
Query: 811 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 870
FDLSCLTSCKPQLLLP NEKK++ K QQ P+FMAEPMRASNSFVGTEEYIAPEII GAG
Sbjct: 763 FDLSCLTSCKPQLLLPAANEKKKQSKTQQTPIFMAEPMRASNSFVGTEEYIAPEIITGAG 822
Query: 871 HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRL 930
HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP S SL+AKQL++RL
Sbjct: 823 HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPRSISASLNAKQLIFRL 882
Query: 931 LHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLF-ATDTEKEY-KVVDP 988
LHRDPK+RLGS EGA+EIK+HPFF+GVNWALVRCMNPPEL+APLF TD EK+ K D
Sbjct: 883 LHRDPKNRLGSREGASEIKRHPFFRGVNWALVRCMNPPELEAPLFQTTDGEKDANKASDF 942
Query: 989 GMQDLQQNVF 998
++L+ +VF
Sbjct: 943 DPKELELSVF 952
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|60099454|dbj|BAD89966.1| phototropin [Phaseolus vulgaris] | Back alignment and taxonomy information |
|---|
Score = 1456 bits (3769), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 724/991 (73%), Positives = 814/991 (82%), Gaps = 33/991 (3%)
Query: 21 RDSRGSLEVFNPSTFSTRPTNPVFRP---QPTWQTWMEQRESPEPEHAKLNSKSSRAEEI 77
RD RGSLEVFNPS+ S PV P Q TW+TW++ R +PE + + +E+
Sbjct: 6 RDQRGSLEVFNPSSSSYSNEKPVISPLRTQSTWKTWVDSRVEEQPEKQQ---RGGGPDEV 62
Query: 78 T--SWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRAAEWGLVLKTDT 135
T SWMALKD P PS Q + V + E G AA+RAAEWGLVLKTDT
Sbjct: 63 TATSWMALKDSTPPPPS-----------QTLAAVLGEPPAEVGNAAKRAAEWGLVLKTDT 111
Query: 136 ETGKPQAVVARTSGGDDPNGK-PGTSRRNSNNSVRSSGEMSDEGGKEKG-LPRVSDIVKD 193
ETGKPQ V +TSGG++P K G SRR+S NSVRSSGE SD+G + +G +PRVS+ ++D
Sbjct: 112 ETGKPQGVAVQTSGGEEPGVKVTGGSRRDSGNSVRSSGESSDDGREYRGGIPRVSEDLRD 171
Query: 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 253
ALS FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+GRNCRF+QGA TDP+DVAKI
Sbjct: 172 ALSAFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVIGRNCRFMQGADTDPDDVAKI 231
Query: 254 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDK 313
RE LQ GQ+YCGRLLNYKKDGTPFWNLLTIAPIKD +G+VLKFIGMQVEVSKHTEG K+
Sbjct: 232 REALQTGQTYCGRLLNYKKDGTPFWNLLTIAPIKDHDGRVLKFIGMQVEVSKHTEGNKEN 291
Query: 314 MLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIRKSEGGVEEER 373
MLRPNGLPESLIRYDARQKE A SSV+EL+ A+++PR+LSES RP I + + G ++++
Sbjct: 292 MLRPNGLPESLIRYDARQKEKANSSVSELLLAVRRPRALSESGGRPLIRKSASGDDDQDK 351
Query: 374 AGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDD 433
RRKSE+V RR S+ G RTSM++I+E+PE K + S RRSFMG I RK+QS
Sbjct: 352 PEKSSRRKSESVASFRRKSHAGD-RTSMEKITEIPENKHKTSRRRSFMGFI-RKNQSK-- 407
Query: 434 HDSFENEIIMEGDDDYESDD-ERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRL 492
SF +E ++EG + +D ER S D KV++KE RKG+DLATTLERIEKNFVITDPRL
Sbjct: 408 FGSFNDEAVIEGSSESSDEDGERSGSFDGKVQRKEKRKGLDLATTLERIEKNFVITDPRL 467
Query: 493 PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552
PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR AID QTDVTVQLIN
Sbjct: 468 PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIREAIDTQTDVTVQLIN 527
Query: 553 YTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQT 608
YTK+GKKFWNLFHLQPMRDQK YFIGVQLDGS+H+EPL N I E TA+E EKLVK T
Sbjct: 528 YTKTGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSQHVEPLHNRIAENTAKEGEKLVKDT 587
Query: 609 AENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFR 668
AENV++A++ELPDANL PEDLW NHSKVVHPKPHR+D WKAIQKIL+SGEQI L HF+
Sbjct: 588 AENVDDALRELPDANLKPEDLWMNHSKVVHPKPHRRDEAAWKAIQKILESGEQIGLNHFK 647
Query: 669 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 728
P+KPLGSGDTGSV+LVEL +GQYFAMKAM+KG+MLNRNKVHRAC EREILDMLDHPF+P
Sbjct: 648 PVKPLGSGDTGSVYLVELGETGQYFAMKAMEKGIMLNRNKVHRACTEREILDMLDHPFLP 707
Query: 729 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 788
ALYASFQTKTHVCLITDYC GGELFLLLDRQP KVL+EDAVRFYAAEVVVALEYLHCQGI
Sbjct: 708 ALYASFQTKTHVCLITDYCSGGELFLLLDRQPAKVLREDAVRFYAAEVVVALEYLHCQGI 767
Query: 789 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 848
IYRDLKPENVLLQ +GHVSLTDFDLSCLTSCKPQLL+P+ NEKK+ KG Q P+FMAEPM
Sbjct: 768 IYRDLKPENVLLQSSGHVSLTDFDLSCLTSCKPQLLVPSINEKKKAQKGHQPPIFMAEPM 827
Query: 849 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 908
RASNSFVGTEEYIAPEII G+GH+SAVDWWALGILLYEM +GYTPFRGKTRQ+TF NILH
Sbjct: 828 RASNSFVGTEEYIAPEIITGSGHSSAVDWWALGILLYEMFFGYTPFRGKTRQRTFTNILH 887
Query: 909 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPP 968
KDLKFP S S AKQLMYRLL+RDPKSRLGS EGANEIK HPFF+GVNWALVRC PP
Sbjct: 888 KDLKFPKSKQVSFSAKQLMYRLLNRDPKSRLGSREGANEIKNHPFFRGVNWALVRCTKPP 947
Query: 969 ELDAPLF-ATDTEKEYKVVDPGMQDLQQNVF 998
ELDAPLF T EKE D +++ NVF
Sbjct: 948 ELDAPLFDTTRGEKEANFEDQVQEEM--NVF 976
|
Source: Phaseolus vulgaris Species: Phaseolus vulgaris Genus: Phaseolus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542583|ref|XP_003539746.1| PREDICTED: phototropin-1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1451 bits (3757), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 728/991 (73%), Positives = 824/991 (83%), Gaps = 32/991 (3%)
Query: 21 RDSRGSLEVFNPST-FST-RPTNPVFRPQPTWQTWMEQRESPEPEHAKLNSKSSRAEEIT 78
RD RGSLEVFNPS+ +ST + N R Q TW+TW++ E PE + + ++ T
Sbjct: 6 RDQRGSLEVFNPSSSYSTEKSVNSPVRVQSTWKTWID--ELPEQQQQQQCGGTNEVT-AT 62
Query: 79 SWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRAAEWGLVLKTDTETG 138
SWMALKD AP P+L ++ + + GE G AA+RAAEWGLVLKTDTETG
Sbjct: 63 SWMALKDSAPPPPTLAAVLGESLS---------AAVGEVGNAAKRAAEWGLVLKTDTETG 113
Query: 139 KPQAVVARTSGGDDPNGK-PGTSRRNSNNSVRSSGEMSDEGGKEKG-LPRVSDIVKDALS 196
KPQ V RTSGG++P+ K G SRR+S+NSVRSSGE SD+G + +G +PRVS+ ++DALS
Sbjct: 114 KPQGVKVRTSGGEEPSAKVTGGSRRDSSNSVRSSGESSDDGREYRGGIPRVSEDLRDALS 173
Query: 197 TFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRET 256
FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+GRNCRF+QGA TDP+DVAKIRE
Sbjct: 174 AFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVIGRNCRFMQGADTDPDDVAKIREA 233
Query: 257 LQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLR 316
LQ+G +YCGRLLNYKKDGTPFWNLLTIAPIKDD+G+VLKFIGMQVEVSKHTEGAK+KMLR
Sbjct: 234 LQSGSTYCGRLLNYKKDGTPFWNLLTIAPIKDDDGRVLKFIGMQVEVSKHTEGAKEKMLR 293
Query: 317 PNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIRKSEGG--VEEERA 374
PNGLPESLIRYDARQKE A S+V+EL+ A+++PR+LSES RP +I+KS G +++
Sbjct: 294 PNGLPESLIRYDARQKEKANSTVSELLLAVRRPRALSESAGRP-MIKKSASGDDAQDKPP 352
Query: 375 GALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDH 434
RRKSE+V RR S+ G R+SM+RI+E+PEKK + S RRSFMG I RKSQS +
Sbjct: 353 EKSSRRKSESVASFRRKSHAGD-RSSMERITELPEKKHKSSRRRSFMGFI-RKSQS--NF 408
Query: 435 DSFENEIIMEGDDDYESDDE-RPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLP 493
SF +E ++E + +D+ RP+S D KV++KE RKG+DLATTLERIEKNFVITDPRLP
Sbjct: 409 GSFNDEAVVENSSESSDEDDERPESFDGKVQKKEKRKGLDLATTLERIEKNFVITDPRLP 468
Query: 494 DNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553
DNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR AIDNQTDVTVQLINY
Sbjct: 469 DNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIREAIDNQTDVTVQLINY 528
Query: 554 TKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTA 609
TKSGKKFWNLFHLQPMRDQK YFIGVQLDGS+H+EPL N I + TA+E E+LVK TA
Sbjct: 529 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSQHVEPLHNRIADDTAKEGEQLVKDTA 588
Query: 610 ENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRP 669
ENV++A++ELPDAN+ PEDLW NHSKVVHPKPHR+D WKAIQ+IL+SGEQI L HFRP
Sbjct: 589 ENVDDALRELPDANMKPEDLWMNHSKVVHPKPHRRDEAAWKAIQQILNSGEQIGLNHFRP 648
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 729
+KPLGSGDTGSV+LVEL +G YFAMKAM+KGVMLNRNKVHRAC EREILDMLDHPF+PA
Sbjct: 649 VKPLGSGDTGSVYLVELGETGHYFAMKAMEKGVMLNRNKVHRACTEREILDMLDHPFLPA 708
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
LYASFQTKTHVCLITDYC GGELFLLLDRQP KVL+EDAVRFYAAEVVVALEYLHCQGII
Sbjct: 709 LYASFQTKTHVCLITDYCSGGELFLLLDRQPAKVLREDAVRFYAAEVVVALEYLHCQGII 768
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
YRDLKPENVLLQ +GHVSLTDFDLSCLTSCKPQLL+P NEKK+ KG P+FMAEPMR
Sbjct: 769 YRDLKPENVLLQSSGHVSLTDFDLSCLTSCKPQLLVPVINEKKKAQKGPHAPIFMAEPMR 828
Query: 850 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909
ASNSFVGTEEYIAPEII G+GHTSAVDWWALGILLYEM YGYTPFRGKTRQ+TF NILHK
Sbjct: 829 ASNSFVGTEEYIAPEIITGSGHTSAVDWWALGILLYEMFYGYTPFRGKTRQRTFTNILHK 888
Query: 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPE 969
DLKFP S S AKQLMYRLL+RDPKSRLGS EGANEIK HPFF+GVNWALVRC PPE
Sbjct: 889 DLKFPKSKQVSFSAKQLMYRLLNRDPKSRLGSREGANEIKNHPFFRGVNWALVRCTKPPE 948
Query: 970 LDAPLFATDT--EKEYKVVDPGMQDLQQNVF 998
LDAPL T EKE K + +D+ NVF
Sbjct: 949 LDAPLLETTEGGEKEAKFENQVQEDM--NVF 977
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15231245|ref|NP_190164.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] gi|79314333|ref|NP_001030814.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] gi|25090817|sp|O48963.1|PHOT1_ARATH RecName: Full=Phototropin-1; AltName: Full=Non-phototropic hypocotyl protein 1; AltName: Full=Root phototropism protein 1 gi|13430612|gb|AAK25928.1|AF360218_1 putative nonphototropic hypocotyl 1 protein [Arabidopsis thaliana] gi|2832241|gb|AAC01753.1| nonphototropic hypocotyl 1 [Arabidopsis thaliana] gi|7019644|emb|CAB75791.1| nonphototropic hypocotyl 1 [Arabidopsis thaliana] gi|14532876|gb|AAK64120.1| putative nonphototropic hypocotyl 1 protein [Arabidopsis thaliana] gi|332644551|gb|AEE78072.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] gi|332644552|gb|AEE78073.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1450 bits (3753), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 737/1014 (72%), Positives = 834/1014 (82%), Gaps = 39/1014 (3%)
Query: 5 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQP-TWQTWMEQRES---P 60
E + K S+K L RD+RGSLEVFNPST TRP NPVFRP+P WQ + R + P
Sbjct: 2 EPTEKPSTKPSSRTLPRDTRGSLEVFNPSTQLTRPDNPVFRPEPPAWQNLSDPRGTSPQP 61
Query: 61 EPEHAKLNSKSSRAEE----ITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGE 116
P+ S R+++ TSWMALKDP+P+ S +K+ ++
Sbjct: 62 RPQQEPAPSNPVRSDQEIAVTTSWMALKDPSPETIS------------KKTITAEKPQKS 109
Query: 117 AGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGG--DDPNGKPGTSRRNSNNSVRSSGEM 174
A AA QRAAEWGLVLKTDT+TGKPQ V R SGG +DPNGK TS+RNS NS RSSGEM
Sbjct: 110 AVAAEQRAAEWGLVLKTDTKTGKPQGVGVRNSGGTENDPNGKKTTSQRNSQNSCRSSGEM 169
Query: 175 SDEG--GKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV 232
SD G G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFF MTGYTSKEV
Sbjct: 170 SDGDVPGGRSGIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFNMTGYTSKEV 229
Query: 233 VGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGK 292
VGRNCRFLQG+GTD +++AKIRETL G +YCGR+LNYKKDGT FWNLLTIAPIKD+ GK
Sbjct: 230 VGRNCRFLQGSGTDADELAKIRETLAAGNNYCGRILNYKKDGTSFWNLLTIAPIKDESGK 289
Query: 293 VLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSL 352
VLKFIGMQVEVSKHTEGAK+K LRPNGLPESLIRYDARQK+MAT+SVTELV+A+K+PR+L
Sbjct: 290 VLKFIGMQVEVSKHTEGAKEKALRPNGLPESLIRYDARQKDMATNSVTELVEAVKRPRAL 349
Query: 353 SESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKK 412
SESTN P + KSE +E RR SENV P R + GGG R SMQRI+E+PEKK
Sbjct: 350 SESTNLHPFMTKSES---DELPKKPARRMSENVVPSGRRNSGGGRRNSMQRINEIPEKKS 406
Query: 413 QKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEG--DDDYESDDERPDSVDDKVRQKEMRK 470
+KS SFMG I +KS+S D+ S ++ I G DD+ DERP+SVDDKVRQKEMRK
Sbjct: 407 RKSSL-SFMG-IKKKSESLDE--SIDDGFIEYGEEDDEISDRDERPESVDDKVRQKEMRK 462
Query: 471 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDP 530
GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD
Sbjct: 463 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDL 522
Query: 531 ATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHL 586
TV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQK YFIGVQLDGS+H+
Sbjct: 523 TTVKKIRNAIDNQTEVTVQLINYTKSGKKFWNIFHLQPMRDQKGEVQYFIGVQLDGSKHV 582
Query: 587 EPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDS 646
EP+RN I E +E E LVK+TA N++EAV+ELPDAN+TPEDLWANHSKVVH KPHRKDS
Sbjct: 583 EPVRNVIEETAVKEGEDLVKKTAVNIDEAVRELPDANMTPEDLWANHSKVVHCKPHRKDS 642
Query: 647 PPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 706
PPW AIQK+L+SGE I L+HF+P+KPLGSGDTGSVHLVEL G+ Q FAMKAMDK VMLNR
Sbjct: 643 PPWIAIQKVLESGEPIGLKHFKPVKPLGSGDTGSVHLVELVGTDQLFAMKAMDKAVMLNR 702
Query: 707 NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 766
NKVHRA AEREILD+LDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQP KVLKE
Sbjct: 703 NKVHRARAEREILDLLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQPRKVLKE 762
Query: 767 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 826
DAVRFYAA+VVVALEYLHCQGIIYRDLKPENVL+QGNG +SL+DFDLSCLTSCKPQLL+P
Sbjct: 763 DAVRFYAAQVVVALEYLHCQGIIYRDLKPENVLIQGNGDISLSDFDLSCLTSCKPQLLIP 822
Query: 827 TTNE--KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 884
+ +E KK++ K QQ P+FMAEPMRASNSFVGTEEYIAPEII+GAGHTSAVDWWALGIL+
Sbjct: 823 SIDEKKKKKQQKSQQTPIFMAEPMRASNSFVGTEEYIAPEIISGAGHTSAVDWWALGILM 882
Query: 885 YEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944
YEMLYGYTPFRGKTRQKTF N+L KDLKFP+S P SL KQL++RLL RDPK RLG EG
Sbjct: 883 YEMLYGYTPFRGKTRQKTFTNVLQKDLKFPASIPASLQVKQLIFRLLQRDPKKRLGCFEG 942
Query: 945 ANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQNVF 998
ANE+K+H FFKG+NWAL+RC NPPEL+ P+F+ + E KVVDP ++DLQ NVF
Sbjct: 943 ANEVKQHSFFKGINWALIRCTNPPELETPIFSGEAENGEKVVDPELEDLQTNVF 996
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 998 | ||||||
| TAIR|locus:2102674 | 996 | PHOT1 "phototropin 1" [Arabido | 0.975 | 0.977 | 0.710 | 0.0 | |
| UNIPROTKB|Q8H935 | 963 | Vfphot1a "Phototropin" [Vicia | 0.942 | 0.977 | 0.671 | 0.0 | |
| UNIPROTKB|Q2QYY8 | 921 | PHOT1A "Phototropin-1A" [Oryza | 0.794 | 0.861 | 0.699 | 2.79999999871e-315 | |
| UNIPROTKB|Q2RBR1 | 921 | PHOT1B "Phototropin-1B" [Oryza | 0.794 | 0.861 | 0.698 | 5.7999999991e-315 | |
| TAIR|locus:2155821 | 915 | PHOT2 "phototropin 2" [Arabido | 0.631 | 0.688 | 0.630 | 4.3e-284 | |
| UNIPROTKB|Q9ST27 | 907 | PHOT2 "Phototropin-2" [Oryza s | 0.808 | 0.889 | 0.626 | 2.3e-275 | |
| UNIPROTKB|Q5I6E9 | 700 | Adi3 "AvrPto-dependent Pto-int | 0.212 | 0.302 | 0.483 | 1.3e-93 | |
| TAIR|locus:2055017 | 765 | AT2G44830 [Arabidopsis thalian | 0.250 | 0.326 | 0.434 | 5.5e-91 | |
| TAIR|locus:2133837 | 506 | D6PKL1 "D6 protein kinase like | 0.204 | 0.403 | 0.495 | 4.2e-89 | |
| TAIR|locus:2174885 | 499 | AT5G40030 [Arabidopsis thalian | 0.198 | 0.396 | 0.505 | 9.5e-89 |
| TAIR|locus:2102674 PHOT1 "phototropin 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3608 (1275.1 bits), Expect = 0., P = 0.
Identities = 721/1015 (71%), Positives = 811/1015 (79%)
Query: 5 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQP-TWQTWMEQRES---P 60
E + K S+K L RD+RGSLEVFNPST TRP NPVFRP+P WQ + R + P
Sbjct: 2 EPTEKPSTKPSSRTLPRDTRGSLEVFNPSTQLTRPDNPVFRPEPPAWQNLSDPRGTSPQP 61
Query: 61 EPEHAKLNSKSSRAE-EI---TSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSXX 116
P+ S R++ EI TSWMALKDP+P+ I K T EK Q S
Sbjct: 62 RPQQEPAPSNPVRSDQEIAVTTSWMALKDPSPET------ISKKTITAEKP----QKSAV 111
Query: 117 XXXXXXXXXXWGLVLKTDTETGKPQAVVARTSGG--DDPNGKPGTXXXXXXXXXXXXGEM 174
WGLVLKTDT+TGKPQ V R SGG +DPNGK T GEM
Sbjct: 112 AAEQRAAE--WGLVLKTDTKTGKPQGVGVRNSGGTENDPNGKKTTSQRNSQNSCRSSGEM 169
Query: 175 SD---EGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKE 231
SD GG+ G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFF MTGYTSKE
Sbjct: 170 SDGDVPGGRS-GIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFNMTGYTSKE 228
Query: 232 VVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEG 291
VVGRNCRFLQG+GTD +++AKIRETL G +YCGR+LNYKKDGT FWNLLTIAPIKD+ G
Sbjct: 229 VVGRNCRFLQGSGTDADELAKIRETLAAGNNYCGRILNYKKDGTSFWNLLTIAPIKDESG 288
Query: 292 KVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS 351
KVLKFIGMQVEVSKHTEGAK+K LRPNGLPESLIRYDARQK+MAT+SVTELV+A+K+PR+
Sbjct: 289 KVLKFIGMQVEVSKHTEGAKEKALRPNGLPESLIRYDARQKDMATNSVTELVEAVKRPRA 348
Query: 352 LSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKK 411
LSESTN P + KSE +E RR SENV P R + GGG R SMQRI+E+PEKK
Sbjct: 349 LSESTNLHPFMTKSES---DELPKKPARRMSENVVPSGRRNSGGGRRNSMQRINEIPEKK 405
Query: 412 KQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXX--SVDDKVRQKEMR 469
+KS SFMG I +KS+S D+ S ++ I SVDDKVRQKEMR
Sbjct: 406 SRKSSL-SFMG-IKKKSESLDE--SIDDGFIEYGEEDDEISDRDERPESVDDKVRQKEMR 461
Query: 470 KGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD 529
KGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD
Sbjct: 462 KGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD 521
Query: 530 PATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEH 585
TV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQK YFIGVQLDGS+H
Sbjct: 522 LTTVKKIRNAIDNQTEVTVQLINYTKSGKKFWNIFHLQPMRDQKGEVQYFIGVQLDGSKH 581
Query: 586 LEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKD 645
+EP+RN I E +E E LVK+TA N++EAV+ELPDAN+TPEDLWANHSKVVH KPHRKD
Sbjct: 582 VEPVRNVIEETAVKEGEDLVKKTAVNIDEAVRELPDANMTPEDLWANHSKVVHCKPHRKD 641
Query: 646 SPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN 705
SPPW AIQK+L+SGE I L+HF+P+KPLGSGDTGSVHLVEL G+ Q FAMKAMDK VMLN
Sbjct: 642 SPPWIAIQKVLESGEPIGLKHFKPVKPLGSGDTGSVHLVELVGTDQLFAMKAMDKAVMLN 701
Query: 706 RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLK 765
RNKVHRA AEREILD+LDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQP KVLK
Sbjct: 702 RNKVHRARAEREILDLLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQPRKVLK 761
Query: 766 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825
EDAVRFYAA+VVVALEYLHCQGIIYRDLKPENVL+QGNG +SL+DFDLSCLTSCKPQLL+
Sbjct: 762 EDAVRFYAAQVVVALEYLHCQGIIYRDLKPENVLIQGNGDISLSDFDLSCLTSCKPQLLI 821
Query: 826 PTTNEKKRR--HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 883
P+ +EKK++ K QQ P+FMAEPMRASNSFVGTEEYIAPEII+GAGHTSAVDWWALGIL
Sbjct: 822 PSIDEKKKKKQQKSQQTPIFMAEPMRASNSFVGTEEYIAPEIISGAGHTSAVDWWALGIL 881
Query: 884 LYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943
+YEMLYGYTPFRGKTRQKTF N+L KDLKFP+S P SL KQL++RLL RDPK RLG E
Sbjct: 882 MYEMLYGYTPFRGKTRQKTFTNVLQKDLKFPASIPASLQVKQLIFRLLQRDPKKRLGCFE 941
Query: 944 GANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQNVF 998
GANE+K+H FFKG+NWAL+RC NPPEL+ P+F+ + E KVVDP ++DLQ NVF
Sbjct: 942 GANEVKQHSFFKGINWALIRCTNPPELETPIFSGEAENGEKVVDPELEDLQTNVF 996
|
|
| UNIPROTKB|Q8H935 Vfphot1a "Phototropin" [Vicia faba (taxid:3906)] | Back alignment and assigned GO terms |
|---|
Score = 3261 (1153.0 bits), Expect = 0., Sum P(2) = 0.
Identities = 657/979 (67%), Positives = 740/979 (75%)
Query: 32 PSTFSTRPTNPVFRPQPTWQTWMEQ-RESPEPEHAKLNSKSSRAEEITSWM--ALKDPAP 88
P T R + VF P + +P P ++ SSR E + D P
Sbjct: 3 PFTRDHRGSLEVFNPSSSETNGTPNPNPNPNPSNSWNTGTSSRGTEAPPLRDSIISDEVP 62
Query: 89 QKPSLPPLIQKMTNDQEKSTVTKQLSXXXXXXXXXXXXWGLVLKTDTETGKPQAVVARTS 148
S L K T KS + ++ WGLVLKTD+ETGKPQ V R S
Sbjct: 63 TATSWMAL--KETTPSPKSGESGSVAEQRAAE------WGLVLKTDSETGKPQGVGVRGS 114
Query: 149 GGDDPNGKPGTXXXXXXXXXXXXGEMSDEGGKE-KGLPRVSDIVKDALSTFQQTFVVSDA 207
GG G GE SD+G + +G+PRVS+ ++DALS FQQTFVVSDA
Sbjct: 115 GGG------GGSRRDSNNSVRSSGESSDDGREGGRGIPRVSEDLRDALSAFQQTFVVSDA 168
Query: 208 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 267
TKPDYPIMYASAGFF MTGYTSKEV+GRNCRF+QGA TDP DVAKIRE L G SYCGRL
Sbjct: 169 TKPDYPIMYASAGFFSMTGYTSKEVIGRNCRFMQGADTDPNDVAKIREALAAGTSYCGRL 228
Query: 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRY 327
LNYKKDGT FWNLLTIAPIKD+ GK+LK IGMQVEVSKHTEG K+KMLRPNGLPESLIRY
Sbjct: 229 LNYKKDGTTFWNLLTIAPIKDEHGKILKLIGMQVEVSKHTEGTKEKMLRPNGLPESLIRY 288
Query: 328 DARQKEMATSSVTELVQAM-KKPRSLSESTNRPPIIRKSEGGVEEE----RAGALGRRKS 382
DARQKE A SSVTELV+A+ K+PRSLSES NR P +K G + + + R+
Sbjct: 289 DARQKEKANSSVTELVEAVSKRPRSLSESANRLPFNKKPTNGSNDHATPPNSESSSRKSG 348
Query: 383 ENVPPPRRNSYGG-GCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEI 441
+ RR S+ G G SM I+E+PE KS RRSFMG + RKS S ++ F +E
Sbjct: 349 STLRSFRRKSHSGAGNSNSMHPITELPENNN-KSRRRSFMGFM-RKSLSNNER--FNHEQ 404
Query: 442 IMXXXXXXXXXXXXXXSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFAS 501
++ + +++E RKG DLATTLERIEKNFVITDPRLPDNPIIFAS
Sbjct: 405 VIDRNSSEDEDRLDSFDEQNIAQKREKRKGFDLATTLERIEKNFVITDPRLPDNPIIFAS 464
Query: 502 DSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFW 561
DSFLELTEYSREEILGRNCRFLQGPETDPATV+KIR AIDNQT+VTVQLINYTK+GKKFW
Sbjct: 465 DSFLELTEYSREEILGRNCRFLQGPETDPATVKKIRYAIDNQTEVTVQLINYTKTGKKFW 524
Query: 562 NLFHLQPMRDQK----YFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVK 617
NLFHLQPMRDQK YFIGVQLDGS+H+EPL N I E TA+E E LVK+TAENV++A++
Sbjct: 525 NLFHLQPMRDQKGEVQYFIGVQLDGSQHVEPLHNGIAEDTAKEGENLVKKTAENVDDALR 584
Query: 618 ELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGD 677
ELPDAN+ PEDLW NHSKVVHPKPHR++ W+AIQKI++SGEQI L+HF+PIKPLGSGD
Sbjct: 585 ELPDANMKPEDLWMNHSKVVHPKPHRREDSAWRAIQKIMESGEQIGLKHFKPIKPLGSGD 644
Query: 678 TGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737
TGSVHLVELCG+ +FAMKAMDKGVM NRNKVHRAC EREILDMLDHPF+PALYASFQTK
Sbjct: 645 TGSVHLVELCGTDHHFAMKAMDKGVMPNRNKVHRACTEREILDMLDHPFLPALYASFQTK 704
Query: 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 797
TH+CLITDYCPGGELF+LLDRQP KVLKEDAVRFYA EVVVALEYLHCQGIIYRDLKPEN
Sbjct: 705 THICLITDYCPGGELFMLLDRQPAKVLKEDAVRFYATEVVVALEYLHCQGIIYRDLKPEN 764
Query: 798 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGT 857
VLLQ GHVSLTDFDLSCLTSCKP+L++P+TN+KK KGQ P+FMAEPMRASNSFVGT
Sbjct: 765 VLLQSTGHVSLTDFDLSCLTSCKPELIVPSTNDKK---KGQHGPIFMAEPMRASNSFVGT 821
Query: 858 EEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSST 917
EEYIAPEII G+GHT AVDWWALGILLYEM YGYTPFRGK RQ+TFANILHKDLK P S
Sbjct: 822 EEYIAPEIITGSGHTCAVDWWALGILLYEMFYGYTPFRGKNRQRTFANILHKDLKLPKSK 881
Query: 918 PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFAT 977
SL AKQL+Y LL RDP SRLGS GAN+IK H FFKG+NWALVRC PPELDAPLF T
Sbjct: 882 QVSLSAKQLIYHLLQRDPTSRLGSKGGANDIKHHSFFKGINWALVRCTKPPELDAPLFDT 941
Query: 978 ---DTEKEYKVVDPGMQDL 993
+ EK+ K VD G +D+
Sbjct: 942 NKEEKEKDDKYVDNGQEDM 960
|
|
| UNIPROTKB|Q2QYY8 PHOT1A "Phototropin-1A" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 2970 (1050.6 bits), Expect = 2.8e-315, Sum P(2) = 2.8e-315
Identities = 572/818 (69%), Positives = 671/818 (82%)
Query: 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 243
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSAFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 244 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 304 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 363
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNNT-LKR 298
Query: 364 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 421
KS+ + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMTEVPSKRSSES--GSRRNSRSG-TRSSLQKINEVPDQGNRTRKSGLRAFM 355
Query: 422 GLIGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXX--SVDDKVRQKEMRKGIDLATTLE 479
G +G H S E ++ S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 539
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 540 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPLRNSIPE 595
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQK YFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 596 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 655
A+E LVK+TA+N++EA KELPDANL PEDLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPEDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 656 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 715
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 716 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 775
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 776 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895
K P+F AEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 822
Query: 896 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
GKTRQ+TFANILHKD++FP+S SL A+QLMYRLLHRDP +RLGS+EGANEIK HPFF+
Sbjct: 823 GKTRQRTFANILHKDIRFPASISVSLAARQLMYRLLHRDPANRLGSYEGANEIKGHPFFR 882
Query: 956 GVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDL 993
G+NW L+R PP+L+ PLF+ D ++ +V D+
Sbjct: 883 GINWPLIRATAPPKLEIPLFSKDDMEKKGLVTNNRTDM 920
|
|
| UNIPROTKB|Q2RBR1 PHOT1B "Phototropin-1B" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 2967 (1049.5 bits), Expect = 5.8e-315, Sum P(2) = 5.8e-315
Identities = 571/818 (69%), Positives = 672/818 (82%)
Query: 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 243
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSVFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 244 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 304 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 363
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNNT-LKR 298
Query: 364 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 421
KS+ + + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMSEVPSKRSSES--GSRRNSRSG-TRSSLQKINEVPDQVNRTRKSGLRAFM 355
Query: 422 GLIGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXX--SVDDKVRQKEMRKGIDLATTLE 479
G +G H S E ++ S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 539
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 540 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPLRNSIPE 595
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQK YFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 596 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 655
A+E LVK+TA+N++EA KELPDANL P+DLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPKDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 656 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 715
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 716 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 775
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 776 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895
K P+F AEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 822
Query: 896 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
GKTRQ+TFANILHKD++FP+S SL A+QLMYRLLHRDP +RLGS+EGANEIK HPFF+
Sbjct: 823 GKTRQRTFANILHKDIRFPASISVSLAARQLMYRLLHRDPANRLGSYEGANEIKGHPFFR 882
Query: 956 GVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDL 993
G+NW L+R PP+L+ PLF+ D ++ +V D+
Sbjct: 883 GINWPLIRATAPPKLEIPLFSKDDMEKKGLVTNNRTDM 920
|
|
| TAIR|locus:2155821 PHOT2 "phototropin 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2067 (732.7 bits), Expect = 4.3e-284, Sum P(3) = 4.3e-284
Identities = 415/658 (63%), Positives = 490/658 (74%)
Query: 345 AMKKPRSLSESTNRPPIIRKSEGGVEEERAG-ALGRRKSENVPPPRRNSYGGGCRTSMQR 403
A +K ++L T IR + V+E + + + S P P R + R
Sbjct: 262 ARQKEKALDSITEVVQTIRHRKSQVQESVSNDTMVKPDSSTTPTPGRQT----------R 311
Query: 404 ISEVPEKKKQKSGRRSFMGLIGRKSQSTDD-HDSF---ENEIIMXXXXXXXXXXXXXXSV 459
S+ K + GR S G K +S+++ H+ E E +M S
Sbjct: 312 QSDEASKSFRTPGRVSTP--TGSKLKSSNNRHEDLLRMEPEELMLSTEVIGQRD----SW 365
Query: 460 DDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRN 519
D R++++R+GIDLATTLERIEKNFVI+DPRLPDNPIIFASDSFLELTEYSREEILGRN
Sbjct: 366 DLSDRERDIRQGIDLATTLERIEKNFVISDPRLPDNPIIFASDSFLELTEYSREEILGRN 425
Query: 520 CRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YF 575
CRFLQGPETD ATV+KIR AI +Q ++TVQLINYTKSGKKFWNLFHLQPMRDQK YF
Sbjct: 426 CRFLQGPETDQATVQKIRDAIRDQREITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYF 485
Query: 576 IGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSK 635
IGVQLDGS+H+EPL+N + E T +S KLVK TA NV+EAV+ELPDAN PEDLWA HSK
Sbjct: 486 IGVQLDGSDHVEPLQNRLSERTEMQSSKLVKATATNVDEAVRELPDANTRPEDLWAAHSK 545
Query: 636 VVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAM 695
V+P PH K+S WKAI+KI SGE + L HF+PIKPLGSGDTGSVHLVEL G+G+ +AM
Sbjct: 546 PVYPLPHNKESTSWKAIKKIQASGETVGLHHFKPIKPLGSGDTGSVHLVELKGTGELYAM 605
Query: 696 KAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 755
KAM+K +MLNRNK HRAC EREI+ +LDHPF+P LYASFQT THVCLITD+CPGGELF L
Sbjct: 606 KAMEKTMMLNRNKAHRACIEREIISLLDHPFLPTLYASFQTSTHVCLITDFCPGGELFAL 665
Query: 756 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815
LDRQP K+L ED+ RFYAAEVV+ LEYLHC GI+YRDLKPEN+LL+ +GH+ L DFDLS
Sbjct: 666 LDRQPMKILTEDSARFYAAEVVIGLEYLHCLGIVYRDLKPENILLKKDGHIVLADFDLSF 725
Query: 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 875
+T+C PQL++P K+RR K Q P F+AEP SNSFVGTEEYIAPEII GAGHTSA+
Sbjct: 726 MTTCTPQLIIPAAPSKRRRSKSQPLPTFVAEPSTQSNSFVGTEEYIAPEIITGAGHTSAI 785
Query: 876 DWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDP 935
DWWALGILLYEMLYG TPFRGK RQKTFANILHKDL FPSS P SL +QL+ LL+RDP
Sbjct: 786 DWWALGILLYEMLYGRTPFRGKNRQKTFANILHKDLTFPSSIPVSLVGRQLINTLLNRDP 845
Query: 936 KSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTE---KEYKVVDPGM 990
SRLGS GANEIK+H FF+G+NW L+R M+PP LDAPL + + K+ K D G+
Sbjct: 846 SSRLGSKGGANEIKQHAFFRGINWPLIRGMSPPPLDAPLSIIEKDPNAKDIKWEDDGV 903
|
|
| UNIPROTKB|Q9ST27 PHOT2 "Phototropin-2" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 2647 (936.8 bits), Expect = 2.3e-275, P = 2.3e-275
Identities = 520/830 (62%), Positives = 625/830 (75%)
Query: 172 GEMSDEGG----KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGY 227
G+ S +GG LPRVS +KDALS+ QQTFVVSDAT+PD PI+YAS GFF MTGY
Sbjct: 70 GKSSVDGGVGRASHDSLPRVSQELKDALSSLQQTFVVSDATRPDCPIIYASEGFFTMTGY 129
Query: 228 TSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIK 287
+ +EVVGRNCRFLQG TD +VAKIR+ +++G+S+CGRLLNY+KDG PFWNLLT+ PI+
Sbjct: 130 SPREVVGRNCRFLQGPDTDAAEVAKIRDAVKHGRSFCGRLLNYRKDGAPFWNLLTVTPIR 189
Query: 288 DDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMK 347
DD GKV+KFIGMQVEVSK+TEG DK +RPN LP SLIRYD RQK+ A SS+TE+VQ +K
Sbjct: 190 DDNGKVIKFIGMQVEVSKYTEGLSDKRMRPNELPVSLIRYDERQKDKAMSSMTEVVQTVK 249
Query: 348 KPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEV 407
+PR + + + ++ A+ S V P + GGG + + ++
Sbjct: 250 QPRGARAPADAALLTPPKMS--DADKMAAM----SPVVAPGTPSGGGGGAGSFKSPLWDL 303
Query: 408 PEKKKQ--------KSGRRSFMGL-IGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXXS 458
+++ + KSGR S MG IG++S E S
Sbjct: 304 KKEESRLSRLASGRKSGRSSLMGFKIGKRSSVGSREAPAVVEEPAPAPPPAPEVVERTDS 363
Query: 459 VDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGR 518
+ R+K++R+GIDLATTLERIEKNFVITDPR+PDNPIIFASDSFLELTEY+REEILGR
Sbjct: 364 WERAEREKDIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGR 423
Query: 519 NCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----Y 574
NCRFLQGPETD TV KIR AI Q ++TVQLINYTKSGKKFWNLFHLQPMRDQK Y
Sbjct: 424 NCRFLQGPETDQGTVDKIREAIREQKEITVQLINYTKSGKKFWNLFHLQPMRDQKGELQY 483
Query: 575 FIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHS 634
FIGVQLDGS+H+EPLRN + E T +S KLVK TAENV++AV+ELPDANL PEDLWA HS
Sbjct: 484 FIGVQLDGSDHVEPLRNRLSENTEIQSAKLVKATAENVDDAVRELPDANLRPEDLWAIHS 543
Query: 635 KVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFA 694
V PKPH++++P W AI+K + GE+I L+HF+P+KPLG GDTGSVHLVEL GSG+ FA
Sbjct: 544 MRVSPKPHKRNNPSWIAIEKATNLGEKIGLKHFKPVKPLGCGDTGSVHLVELQGSGELFA 603
Query: 695 MKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFL 754
MKAMDK VMLNRNKVHRAC EREI +LDHPF+P LY SFQT THVCLITD+CPGGELF
Sbjct: 604 MKAMDKSVMLNRNKVHRACIEREIYALLDHPFLPTLYTSFQTPTHVCLITDFCPGGELFA 663
Query: 755 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814
+LDRQP K+ +E+ RFYAAEVV+ LEYLHC GIIYRDLKPEN+LLQ +GH+ LTDFDLS
Sbjct: 664 VLDRQPMKIFREECARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQADGHIVLTDFDLS 723
Query: 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 874
LT+ KP ++ +T+ K+RR + P F++EP SNSFVGTEEYIAPE+I GAGHTSA
Sbjct: 724 FLTTSKPHVIKNSTSLKRRRSQEFLPPTFVSEPSTPSNSFVGTEEYIAPEVITGAGHTSA 783
Query: 875 VDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRD 934
+DWWALGILLYEMLYG TPFRGK R+KTF NILHKDL FPSS P SL AKQL++ LL RD
Sbjct: 784 IDWWALGILLYEMLYGRTPFRGKNRKKTFYNILHKDLTFPSSIPVSLAAKQLIHGLLQRD 843
Query: 935 PKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYK 984
P +R+GS+ GAN+IK+H FF+ +NW L+RCM+PPELD PL E + K
Sbjct: 844 PSNRIGSNAGANDIKQHSFFQDINWPLIRCMSPPELDVPLKLIGKETQPK 893
|
|
| UNIPROTKB|Q5I6E9 Adi3 "AvrPto-dependent Pto-interacting protein 3" [Solanum lycopersicum (taxid:4081)] | Back alignment and assigned GO terms |
|---|
Score = 533 (192.7 bits), Expect = 1.3e-93, Sum P(3) = 1.3e-93
Identities = 103/213 (48%), Positives = 142/213 (66%)
Query: 622 ANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSV 681
+ L+ + W+N + + KPH+ + P WKAI I + + HF+ +K LG GD GSV
Sbjct: 264 SGLSDDSNWSNITGSAN-KPHKGNDPRWKAILAIRARDGILGMSHFKLLKRLGCGDIGSV 322
Query: 682 HLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741
+L EL G+ YFAMK MDK + +R K+ RA EREIL +LDHPF+P LY F+T C
Sbjct: 323 YLSELSGTRCYFAMKVMDKASLASRKKLTRAQTEREILQLLDHPFLPTLYTHFETDRFSC 382
Query: 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ 801
L+ +YCPGG+L L RQP K E A RFYAAEV++ALEYLH G++YRDLKPENVL++
Sbjct: 383 LVMEYCPGGDLHTLRQRQPGKHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVR 442
Query: 802 GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
+GH+ L+DFDLS + P L+ ++++ +R
Sbjct: 443 DDGHIMLSDFDLSLRCAVSPTLIRISSDDPSKR 475
|
|
| TAIR|locus:2055017 AT2G44830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 537 (194.1 bits), Expect = 5.5e-91, Sum P(2) = 5.5e-91
Identities = 110/253 (43%), Positives = 156/253 (61%)
Query: 599 EESEKLVKQTAENVNEAVKELPDAN-LTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILD 657
+ S +V + E+ + D++ L+ E W+N + ++ KPH+ + P W AI I
Sbjct: 295 DRSISMVLDSFESTKTSASRASDSSGLSEESSWSNFTGSLN-KPHKGNDPWWNAILAIRT 353
Query: 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 717
+ + HF+ +K LG GD GSV+L EL G+ +FA+K MDK + +R K++RA ER+
Sbjct: 354 RDGILGMSHFKLLKRLGCGDIGSVYLAELSGTRCHFAVKVMDKASLEDRKKLNRAQTERD 413
Query: 718 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 777
IL +LDHPF+P LY F+T CL+ +YCPGG+L L RQP K E A RFYAAEV+
Sbjct: 414 ILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQPGKHFSEYAARFYAAEVL 473
Query: 778 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
+ALEYLH G++YRDLKPENVL++ +GH+ L+DFDLS + P L+ ++ RR
Sbjct: 474 LALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAVSPTLIKTFDSDPSRRGAF 533
Query: 838 QQNPVFMAEPMRA 850
P M EP A
Sbjct: 534 CVQPACM-EPTSA 545
|
|
| TAIR|locus:2133837 D6PKL1 "D6 protein kinase like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 528 (190.9 bits), Expect = 4.2e-89, Sum P(2) = 4.2e-89
Identities = 103/208 (49%), Positives = 138/208 (66%)
Query: 640 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 699
KPH+ + W+AIQ + + L HFR +K LG GD G+VHL EL G+ +FAMK MD
Sbjct: 96 KPHKANDVRWEAIQAVRTKHGVLGLNHFRLLKRLGCGDIGTVHLAELHGTRCFFAMKVMD 155
Query: 700 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 759
KG + +R K+ RA EREIL LDHPF+P LY+ F+T+ CL+ ++CPGG+L L RQ
Sbjct: 156 KGALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCPGGDLHTLRQRQ 215
Query: 760 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819
P K E A +FY AEV++A+EYLH GIIYRDLKPENVL++ +GHV L+DFDLS +
Sbjct: 216 PGKRFSEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVMLSDFDLSLRCTV 275
Query: 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEP 847
P ++ T + GQ+N + A+P
Sbjct: 276 SPTVVRSTVLASE----GQKNSGYCAQP 299
|
|
| TAIR|locus:2174885 AT5G40030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 520 (188.1 bits), Expect = 9.5e-89, Sum P(2) = 9.5e-89
Identities = 101/200 (50%), Positives = 138/200 (69%)
Query: 631 ANHSKVVHP-KPHRKDSPPWKAIQKILDS-GEQINLQHFRPIKPLGSGDTGSVHLVELCG 688
AN +V P KPH+ + W AIQ + S E + L HFR +K LG GD GSV+L EL
Sbjct: 76 ANFKRVFAPSKPHKGNDLRWDAIQNVKCSKNEDLGLGHFRLLKKLGCGDIGSVYLAELRE 135
Query: 689 SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 748
G +FAMK MDKG+++ R K+ RA EREIL +LDHPF+P LY+ F+T+ CL+ ++C
Sbjct: 136 MGCFFAMKVMDKGMLIGRKKLVRAQTEREILGLLDHPFLPTLYSHFETEKFSCLLMEFCS 195
Query: 749 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 808
GG+L +L +QP K E A RFYA+EV++ALEYLH G++YRDLKPENV+++ +GH+ L
Sbjct: 196 GGDLHILRQKQPGKHFSELAARFYASEVLLALEYLHMMGVVYRDLKPENVMVREDGHIML 255
Query: 809 TDFDLSCLTSCKPQLLLPTT 828
+DFDLS + P L+ T+
Sbjct: 256 SDFDLSLQSFVSPTLIQSTS 275
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q2QYY8 | PHT1A_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6302 | 0.8997 | 0.9750 | yes | no |
| Q2RBR1 | PHT1B_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6292 | 0.8997 | 0.9750 | yes | no |
| O48963 | PHOT1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7268 | 0.9769 | 0.9789 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| gw1.I.2683.1 | hypothetical protein (971 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 998 | |||
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-180 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-106 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-91 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-91 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-89 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-83 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-81 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-76 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-74 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-74 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-74 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-72 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-72 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-72 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-71 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-68 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-68 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-67 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-66 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-66 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-66 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-66 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-66 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-66 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-65 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-64 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-63 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-62 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-61 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-61 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-61 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-60 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-59 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-59 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-58 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-58 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-58 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-58 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-57 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-57 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-55 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-55 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-55 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-55 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-54 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-53 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-52 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-51 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-50 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-50 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-49 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-49 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-49 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-49 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-49 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-48 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-48 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-47 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-47 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-47 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-46 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-45 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-45 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-44 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-43 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-42 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-41 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-41 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-40 | |
| PRK13559 | 361 | PRK13559, PRK13559, hypothetical protein; Provisio | 2e-36 | |
| PRK13557 | 540 | PRK13557, PRK13557, histidine kinase; Provisional | 3e-36 | |
| PRK13559 | 361 | PRK13559, PRK13559, hypothetical protein; Provisio | 1e-35 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-33 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-31 | |
| PRK13558 | 665 | PRK13558, PRK13558, bacterio-opsin activator; Prov | 6e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-30 | |
| PRK13557 | 540 | PRK13557, PRK13557, histidine kinase; Provisional | 2e-30 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-29 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-28 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-28 | |
| PRK13558 | 665 | PRK13558, PRK13558, bacterio-opsin activator; Prov | 7e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-27 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-26 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-26 | |
| pfam13426 | 101 | pfam13426, PAS_9, PAS domain | 2e-26 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-26 | |
| pfam13426 | 101 | pfam13426, PAS_9, PAS domain | 8e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-24 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-24 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-23 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-22 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-22 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-21 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-18 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-12 | |
| TIGR02938 | 494 | TIGR02938, nifL_nitrog, nitrogen fixation negative | 1e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-09 | |
| cd00130 | 103 | cd00130, PAS, PAS domain; PAS motifs appear in arc | 6e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-09 | |
| cd00130 | 103 | cd00130, PAS, PAS domain; PAS motifs appear in arc | 1e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| pfam08447 | 90 | pfam08447, PAS_3, PAS fold | 2e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-07 | |
| TIGR00229 | 124 | TIGR00229, sensory_box, PAS domain S-box | 1e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-06 | |
| pfam00989 | 113 | pfam00989, PAS, PAS fold | 2e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-06 | |
| COG2202 | 232 | COG2202, AtoS, FOG: PAS/PAC domain [Signal transdu | 3e-06 | |
| TIGR00229 | 124 | TIGR00229, sensory_box, PAS domain S-box | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-05 | |
| COG2202 | 232 | COG2202, AtoS, FOG: PAS/PAC domain [Signal transdu | 2e-05 | |
| smart00086 | 43 | smart00086, PAC, Motif C-terminal to PAS motifs (l | 2e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-05 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-04 | |
| TIGR02938 | 494 | TIGR02938, nifL_nitrog, nitrogen fixation negative | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-04 | |
| smart00086 | 43 | smart00086, PAC, Motif C-terminal to PAS motifs (l | 0.001 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.001 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 0.001 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| smart00091 | 67 | smart00091, PAS, PAS domain | 0.002 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 0.002 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.004 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 525 bits (1354), Expect = e-180
Identities = 181/316 (57%), Positives = 223/316 (70%), Gaps = 2/316 (0%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
+HF+ IK LG GD G V LV L G+G+ FA+K +DK M+ RNKV R E+EIL LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
PF+P LYASFQT+T++CL+ DYCPGGELF LL RQP K L E+ RFYAAEV++ALEYLH
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 785 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT--TNEKKRRHKGQQNPV 842
GI+YRDLKPEN+LL +GH+ L+DFDLS + +P + ++ +
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
F EP SNSFVGTEEYIAPE+I+G GH SAVDWW LGILLYEMLYG TPF+G R +T
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240
Query: 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962
F+NIL K++ FP S P S A+ L+ +LL +DP RLGS GA EIK+HPFF+GVNWAL+
Sbjct: 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALI 300
Query: 963 RCMNPPELDAPLFATD 978
R PP + P D
Sbjct: 301 RHTTPPIIPRPDDGID 316
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 331 bits (851), Expect = e-106
Identities = 123/282 (43%), Positives = 164/282 (58%), Gaps = 32/282 (11%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
LG G G V LV +G+ +AMK + K ++ R +V ER IL ++HPF+ L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 733 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 792
+FQT+ + L+ +Y PGGELF L ++ E+ RFYAAE+V+ALEYLH GIIYRD
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRD 118
Query: 793 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 852
LKPEN+LL +GH+ LTDF L+ +E R N
Sbjct: 119 LKPENILLDADGHIKLTDFGLAK--------------------------ELSSEGSRT-N 151
Query: 853 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 912
+F GT EY+APE++ G G+ AVDWW+LG+LLYEML G PF + R++ + IL L+
Sbjct: 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR 211
Query: 913 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
FP S A+ L+ LL +DP RLGS GA EIK HPFF
Sbjct: 212 FPEF--LSPEARDLISGLLQKDPTKRLGSG-GAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 290 bits (744), Expect = 6e-91
Identities = 119/287 (41%), Positives = 169/287 (58%), Gaps = 22/287 (7%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
+ G G V L + +G +A+K + K M+ +N+V + ER+IL P+V LY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 733 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 792
SFQ K ++ L+ +Y PGG+L LL+ L ED R Y AE+V+ALEYLH GII+RD
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLEN--VGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118
Query: 793 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 852
LKP+N+L+ NGH+ LTDF LS + + Q+ L ++ +R
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR------------------ 160
Query: 853 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 912
VGT +YIAPE+I G GH+ VDWW+LG +LYE L G PF G+T ++ F NIL+ ++
Sbjct: 161 -IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE 219
Query: 913 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959
+P S A L+ +LL DP+ RLG+ + EIK HPFFKG++W
Sbjct: 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGA-KSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 290 bits (746), Expect = 6e-91
Identities = 121/296 (40%), Positives = 162/296 (54%), Gaps = 35/296 (11%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
F IK LG+G G V LV GSG+Y+A+K + K ++ +V E+ IL + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
PF+ LY SFQ +++ L+ +Y PGGELF L + + E RFYAA+VV+ALEYLH
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLH 118
Query: 785 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 844
I+YRDLKPEN+LL +G++ +TDF + KR
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFA-----------------KRVKGRTY----- 156
Query: 845 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904
+ GT EY+APEII G+ AVDWWALGIL+YEML GY PF + +
Sbjct: 157 --------TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE 208
Query: 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNW 959
IL ++FPS S AK L+ LL D RLG+ G N+IK HP+F G++W
Sbjct: 209 KILEGKVRFPS--FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 284 bits (730), Expect = 5e-89
Identities = 104/290 (35%), Positives = 150/290 (51%), Gaps = 38/290 (13%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
+ ++ LG G G V+L +G+ A+K + K + + R E +IL L HP
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
+ LY F+ + + L+ +YC GG+LF LL ++ L ED RFY +++ ALEYLH +
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSK 116
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
GI++RDLKPEN+LL +GHV L DF L+ +
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLAR---------------------------QLDP 149
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK-TRQKTFAN 905
+ +FVGT EY+APE++ G G+ AVD W+LG++LYE+L G PF G + F
Sbjct: 150 GEKL-TTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKK 208
Query: 906 ILHKDLKFPSSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
I FP S AK L+ +LL +DP+ RL A E +HPFF
Sbjct: 209 IGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL----TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 272 bits (697), Expect = 5e-83
Identities = 131/313 (41%), Positives = 180/313 (57%), Gaps = 24/313 (7%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
F IK +G G G V LV +GQ +AMK + K M+ RN++ AER+IL D P+
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
+ LY SFQ + H+ L+ +Y PGG+L LL R+ V E+ RFY AE+V+AL+ +H
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL 120
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLS---------CLTSCKPQLLLPTTNEKKRRHKG 837
G I+RD+KP+N+L+ +GH+ L DF L LL N RR
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897
+Q V +NS VGT +YIAPE++ G + DWW+LG++LYEMLYG+ PF
Sbjct: 181 KQRRVR-------ANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233
Query: 898 TRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
T Q+T+ I++ + L+FP P S A L+ RLL DP+ RLGS E EIK HPFFK
Sbjct: 234 TLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFE---EIKSHPFFK 289
Query: 956 GVNWALVRCMNPP 968
G++W +R PP
Sbjct: 290 GIDWENLRETKPP 302
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 265 bits (680), Expect = 2e-81
Identities = 108/292 (36%), Positives = 162/292 (55%), Gaps = 18/292 (6%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HP 725
F+ K +G G +V L + + + +A+K +DK ++ KV E+E+L L+ HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 726 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
+ LY +FQ + ++ + +Y P GEL + + + L E RFYAAE+++ALEYLH
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLHS 120
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCL---TSCKPQLLLPTTNEKKRRHKGQQNPV 842
+GII+RDLKPEN+LL + H+ +TDF + + S TN + K ++
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF- 179
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
SFVGT EY++PE++ + D WALG ++Y+ML G PFRG T
Sbjct: 180 ---------ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230
Query: 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
F IL + FP + P AK L+ +LL DP+ RLG +EG +E+K HPFF
Sbjct: 231 FQKILKLEYSFPPNFP--PDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 249 bits (638), Expect = 8e-76
Identities = 101/294 (34%), Positives = 145/294 (49%), Gaps = 40/294 (13%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
+ ++ LGSG G+V+ + G+G+ A+K + K K A E IL L HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPN 59
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
+ L +F+ K H+ L+ +YC GG+LF L R L ED + A +++ LEYLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLEYLHSN 117
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
GII+RDLKPEN+LL NG V + DF L+ L
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---------------------- 155
Query: 847 PMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR---QKT 902
+FVGT Y+APE++ G G+ VD W+LG++LYE+L G PF G+ +
Sbjct: 156 -----TTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQL 210
Query: 903 FANILHKDLKFPSSTPTSLH--AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
IL L+F +S AK L+ + L++DP R A EI +HP+F
Sbjct: 211 IRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP----TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 3e-74
Identities = 112/293 (38%), Positives = 164/293 (55%), Gaps = 39/293 (13%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
LG G G V LV++ + FA+K + K ++ + +E+EIL+ +HPF+ LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 733 SFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 791
+F+ K ++ ++ +YC GGEL+ +L DR + E RFY A VV+A EYLH +GIIYR
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDR---GLFDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 792 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 851
DLKPEN+LL NG+V L DF + K K +
Sbjct: 118 DLKPENLLLDSNGYVKLVDFG--------------FAKKLKSGQK--------------T 149
Query: 852 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG--KTRQKTFANILH- 908
+F GT EY+APEII G+ +VD+W+LGILLYE+L G PF + + + +IL
Sbjct: 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG 209
Query: 909 -KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNW 959
L+FP+ + AK L+ +LL R+P+ RLG+ + G +IKKH +F G +W
Sbjct: 210 NGKLEFPNYIDKA--AKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 244 bits (625), Expect = 4e-74
Identities = 113/293 (38%), Positives = 159/293 (54%), Gaps = 37/293 (12%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVP 728
+KP+ G GSV+L + +G YFA+K + K M+ +N+V AER I+ + P+V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 729 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 788
LY SFQ+K ++ L+ +Y GG+ L+ + L ED + Y AEVV+ +E LH +GI
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 789 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 848
I+RD+KPEN+L+ GH+ LTDF LS G +N
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLS--------------------RNGLENK------- 151
Query: 849 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 908
FVGT +Y+APE I G G DWW+LG +++E L+GY PF +T F NIL
Sbjct: 152 ----KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS 207
Query: 909 KDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959
+ + +P A L+ RLL DP RLG++ G EIK HPFFK +NW
Sbjct: 208 RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGAN-GYQEIKSHPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 9e-74
Identities = 121/343 (35%), Positives = 180/343 (52%), Gaps = 46/343 (13%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 729
K LG G G V L EL G+ + +A+K + K V+L + V E+ +L + HPF+
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
L++ FQTK + + +Y GG+L + R E RFYAAE+V+ L++LH +GII
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
YRDLK +NVLL GH+ + DF + CK +L T
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGM-----CKEGILGGVT--------------------- 152
Query: 850 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909
+++F GT +YIAPEI++ + AVDWWALG+LLYEML G +PF G + F +IL
Sbjct: 153 -TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED 211
Query: 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNW-ALVRC-MN 966
++++P S AK ++ L ++P+ RLG G +IK HPFF+ ++W L R +
Sbjct: 212 EVRYPRW--LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIK 269
Query: 967 PP-------ELDAPLFATDTEKEYKVVDPG----MQDLQQNVF 998
PP D F + KE V+ P ++++ Q F
Sbjct: 270 PPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDEAIIRNIDQEEF 312
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 241 bits (618), Expect = 3e-72
Identities = 114/307 (37%), Positives = 167/307 (54%), Gaps = 37/307 (12%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD--- 723
FR + LG G G V L E +G+ +A+KA+ KG ++ R++V E+ I + +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 783
HPF+ L+A FQT+ HVC + +Y GG+L + + V E FYAA VV+ L+YL
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYL 117
Query: 784 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 843
H I+YRDLK +N+LL G V + DF L CK
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGL-----CKEG--------------------- 151
Query: 844 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903
M R S +F GT E++APE++ +T AVDWW LG+L+YEML G +PF G ++ F
Sbjct: 152 MGFGDRTS-TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210
Query: 904 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNW-AL 961
+I++ ++++P A +M RLL R+P+ RLGS E A ++KK PFF+ +NW L
Sbjct: 211 DSIVNDEVRYPRFLSRE--AISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL 268
Query: 962 VRCMNPP 968
+ P
Sbjct: 269 LARKIKP 275
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 242 bits (620), Expect = 5e-72
Identities = 129/335 (38%), Positives = 184/335 (54%), Gaps = 35/335 (10%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
F IK +G G G V LV+ +G +AMK + K ML + +V AER+IL D+P+
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
V LY SFQ + ++ LI +Y PGG++ LL ++ T E+ RFY AE ++A++ +H
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKL 120
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR---HKGQQNPVF 843
G I+RD+KP+N+LL GH+ L+DF L C L E R F
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGL-----CTG-LKKSHRTEFYRILSHALPSNFLDF 174
Query: 844 MAEPM----RASN----------SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 889
+++PM +A S VGT +YIAPE+ G+ DWW+LG+++YEML
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 890 GYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947
GY PF Q+T+ I++ + L+FP P S AK L+ RL + + RLG++ G NE
Sbjct: 235 GYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNN-GVNE 292
Query: 948 IKKHPFFKGVNWALVRCMNP---PELDAPLFATDT 979
IK HPFFKGV+W +R PEL + TDT
Sbjct: 293 IKSHPFFKGVDWEHIRERPAPIIPELKSI---TDT 324
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 240 bits (615), Expect = 6e-72
Identities = 136/334 (40%), Positives = 184/334 (55%), Gaps = 47/334 (14%)
Query: 670 IKPLGSGDTGSVHLVE-LCGS--GQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDHP 725
+K LG G G V V + G+ G+ FAMK + K ++ N+ AER IL+ + HP
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 726 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
F+ L +FQT + LI +Y GGELF+ L+R+ + ED FY +E+ +ALE+LH
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQ 118
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
QGIIYRDLKPEN+LL GHV LTDF L CK + H+G
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGL-----CKESI-----------HEGT------- 155
Query: 846 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905
+++F GT EY+APEI+ +GH AVDWW+LG L+Y+ML G PF + R+KT
Sbjct: 156 ----VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211
Query: 906 ILHKDLKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEG-ANEIKKHPFFKGVNW--AL 961
IL L P TP A+ L+ +LL R+P SRLG+ G A E++ HPFF+ VNW L
Sbjct: 212 ILKGKLNLPPYLTP---EARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLL 268
Query: 962 VRCMNPP-------ELDAPLFATDTEKEYKVVDP 988
R + PP E D F + ++ V P
Sbjct: 269 ARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSP 302
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 1e-71
Identities = 122/305 (40%), Positives = 176/305 (57%), Gaps = 29/305 (9%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
F IK + +G G+V+LV + Q FAMK ++K ++ RN++ + ER+IL ++PF
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
V +++ SF+TK H+C++ +Y GG+ LL L D R Y AE V+ALEYLH
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA--LPVDMARMYFAETVLALEYLHNY 120
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN------EKKRRHKGQQN 840
GI++RDLKP+N+L+ GH+ LTDF LS K L+ TTN EK R
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLS-----KIGLMSLTTNLYEGHIEKDTRE----- 170
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
F+ GT EYIAPE+I G+ VDWWA+GI+LYE L G PF G T +
Sbjct: 171 --FL------DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 222
Query: 901 KTFANILHKDLKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959
+ F ++ D+++P A+ L+ RLL ++P RLG+ GA E+K+H FF G++W
Sbjct: 223 ELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTG-GAFEVKQHRFFLGLDW 281
Query: 960 -ALVR 963
L+R
Sbjct: 282 NGLLR 286
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 3e-68
Identities = 122/309 (39%), Positives = 170/309 (55%), Gaps = 44/309 (14%)
Query: 667 FRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKV-HRACAEREILDML 722
F ++ LG+G G V LV G +G+ +AMK + K ++ + K ER++L+ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 723 DH-PFVPALYASFQTKTHVCLITDYCPGGELFL-LLDRQPTKVLKEDAVRFYAAEVVVAL 780
PF+ L+ +FQT T + LI DY GGELF L R+ E VR Y AE+V+AL
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLAL 118
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
++LH GIIYRD+K EN+LL GHV LTDF LS
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS-------------------------- 152
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFR--- 895
F+AE + SF GT EY+APE+I G GH AVDWW+LG+L +E+L G +PF
Sbjct: 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212
Query: 896 GKTRQKTFAN-ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
+ Q + IL FP + S A+ + +LL +DPK RLG++ GA+EIK HPFF
Sbjct: 213 EQNSQSEISRRILKSKPPFPKT--MSAEARDFIQKLLEKDPKKRLGAN-GADEIKNHPFF 269
Query: 955 KGVNWALVR 963
+G++W +
Sbjct: 270 QGIDWDDLA 278
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 229 bits (585), Expect = 4e-68
Identities = 114/307 (37%), Positives = 160/307 (52%), Gaps = 37/307 (12%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
IK +G+G G VHLV S Y+A+K M ++ + E+ +L + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
PF+ L+ + + + ++ +Y PGGELF L + + FYA+E+V ALEYLH
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLH 118
Query: 785 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 844
+ I+YRDLKPEN+LL GH+ LTDF + KK R +
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFA----------------KKLRDR-------- 154
Query: 845 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904
+ + GT EY+APE+I GH AVDWWALGIL+YEML GY PF +
Sbjct: 155 ------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE 208
Query: 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALV- 962
IL L+FP L+AK L+ +LL D RLG+ + GA+++K H +FK V+W V
Sbjct: 209 KILAGKLEFPRH--LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVP 266
Query: 963 -RCMNPP 968
R + PP
Sbjct: 267 QRKLKPP 273
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 3e-67
Identities = 100/292 (34%), Positives = 155/292 (53%), Gaps = 37/292 (12%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 725
HF ++ +G G G V +V+ + + FAMK M+K + + V ER IL L+HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 726 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
F+ L+ SFQ + ++ L+ D GG+L L ++ E+ V+F+ E+V+ALEYLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS 118
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
+GII+RD+KP+N+LL GHV +TDF+++
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIAT----------------------------KV 150
Query: 846 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT--- 902
P + S GT Y+APE++ G++ AVDWW+LG+ YE L G P+RG +R
Sbjct: 151 TPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210
Query: 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
A D+ +P++ T A + +LL RDP+ RLG + ++K HP+F
Sbjct: 211 RAKQETADVLYPATWSTE--AIDAINKLLERDPQKRLGDN--LKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 226 bits (578), Expect = 1e-66
Identities = 114/301 (37%), Positives = 160/301 (53%), Gaps = 34/301 (11%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 729
K +G G G V L + G+++A+K + K +L + + AER +L + HPF+
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
L+ SFQT + + DY GGELF L R+ + E RFYAAE+ AL YLH II
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
YRDLKPEN+LL GHV LTDF L CK + E +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL-----CKEGI----------------------EHSK 151
Query: 850 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909
+++F GT EY+APE++ + VDWW LG +LYEMLYG PF + + + NIL+K
Sbjct: 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK 211
Query: 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA--LVRCMNP 967
L+ + S+ A+ L+ LL +D RLG+ + EIK H FF +NW + + + P
Sbjct: 212 PLRLKPN--ISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITP 269
Query: 968 P 968
P
Sbjct: 270 P 270
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 2e-66
Identities = 123/305 (40%), Positives = 177/305 (58%), Gaps = 38/305 (12%)
Query: 670 IKPLGSGDTGSVHLV-ELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
+K LG G G V LV ++ G +GQ +AMK + K + R++V R ER+IL ++HPF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV-RTKMERDILAEVNHPF 59
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
+ L+ +FQT+ + LI D+ GG+LF L ++ + E+ V+FY AE+ +AL++LH
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL 117
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
GIIYRDLKPEN+LL GH+ LTDF LS +EKK
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLS---------KESIDHEKK-------------- 154
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 906
+ SF GT EY+APE++ GHT + DWW+ G+L++EML G PF+GK R++T I
Sbjct: 155 ----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
Query: 907 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWALV--R 963
L L P S A+ L+ L R+P +RLG+ +G EIK+HPFF ++W + R
Sbjct: 211 LKAKLGMPQF--LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRR 268
Query: 964 CMNPP 968
+ PP
Sbjct: 269 EIKPP 273
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 3e-66
Identities = 120/315 (38%), Positives = 170/315 (53%), Gaps = 34/315 (10%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 730
K LG G G V LV +G+Y+AMK + K V++ +++V E +L HPF+ AL
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 731 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 790
SFQT +C + +Y GGELF L R+ +V ED RFY AE+V AL YLH ++Y
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 791 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 850
RDLK EN++L +GH+ +TDF L CK + T
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGL-----CKEGISDGAT---------------------- 151
Query: 851 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 910
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +K F IL ++
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211
Query: 911 LKFPSSTPTSLHAKQLMYRLLHRDPKSRL-GSHEGANEIKKHPFFKGVNW-ALVRCMNPP 968
++FP + S AK L+ LL +DPK RL G E A EI +H FF +NW +V+ P
Sbjct: 212 IRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEP 269
Query: 969 ELDAPLFATDTEKEY 983
P ++T+ Y
Sbjct: 270 PFK-PQVTSETDTRY 283
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 3e-66
Identities = 116/329 (35%), Positives = 162/329 (49%), Gaps = 50/329 (15%)
Query: 643 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV 702
+ D+ WK L F + LG+G G V + + G+G+Y+A+K + K
Sbjct: 9 KPDTSSWK-------------LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE 55
Query: 703 MLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK 762
+L +V E+ IL L HPF+ + SFQ + V + ++ GGELF L R+ +
Sbjct: 56 ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-RKAGR 114
Query: 763 VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822
D +FY AE+V+A EYLH + IIYRDLKPEN+LL GHV +TDF +
Sbjct: 115 -FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA-------- 165
Query: 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 882
KK + + + GT EY+APE+I GH AVDWW +G+
Sbjct: 166 --------KKVPDR--------------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGV 203
Query: 883 LLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS- 941
LLYE + GY PF T + + IL LKFP+ A+ L+ LL D RLG+
Sbjct: 204 LLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNW--FDGRARDLVKGLLQTDHTKRLGTL 261
Query: 942 HEGANEIKKHPFFKGVNW--ALVRCMNPP 968
G ++K HP+F G NW R P
Sbjct: 262 KGGVADVKNHPYFHGANWDKLYARYYPAP 290
|
Length = 329 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 5e-66
Identities = 113/301 (37%), Positives = 167/301 (55%), Gaps = 37/301 (12%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPA 729
K LG G G V L EL G+ ++FA+KA+ K V+L + V ER +L + +HPF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
L+ +FQTK H+ + +Y GG+L + Q + E RFYAAE++ L++LH +GII
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICGLQFLHKKGII 118
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
YRDLK +NVLL +GH+ + DF + CK +
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGM-----CKENMNGEGK--------------------- 152
Query: 850 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909
+++F GT +YIAPEI+ G + +VDWW+ G+LLYEML G +PF G+ + F +IL+
Sbjct: 153 -ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND 211
Query: 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV--RCMNP 967
FP S AK + +L RDP RLG +I++HPFF+G++W + R + P
Sbjct: 212 RPHFPRW--ISKEAKDCLSKLFERDPTKRLGV---DGDIRQHPFFRGIDWERLEKREIPP 266
Query: 968 P 968
P
Sbjct: 267 P 267
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 7e-66
Identities = 114/302 (37%), Positives = 171/302 (56%), Gaps = 36/302 (11%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL---DMLDHPFVPA 729
+G G G V+ V + + +AMK + K ++ + +V ER IL + + PF+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
L SFQT + + L+TDY GGELF L Q ED +FY AE+V+ALE+LH I+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
YRDLKPEN+LL GH++L DF LS K L T N+
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLS-----KANL---TDNK------------------- 151
Query: 850 ASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 908
+N+F GT EY+APE++ G+T VD+W+LG+L++EM G++PF + Q+ + NI
Sbjct: 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211
Query: 909 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV--RCMN 966
++FP + S +Q + LL+R+P+ RLG+H A E+K+HPFF ++W L+ + +
Sbjct: 212 GKVRFPKNV-LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQIT 270
Query: 967 PP 968
PP
Sbjct: 271 PP 272
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 6e-65
Identities = 126/356 (35%), Positives = 179/356 (50%), Gaps = 52/356 (14%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 725
F IK +G G G V LV + +AMK + K +L RN+ AER+IL D+
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61
Query: 726 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
+V LY SFQ K ++ + DY PGG++ LL R + +ED RFY AE+ A+E +H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHK 119
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDL------------------------------SC 815
G I+RD+KP+N+L+ +GH+ LTDF L S
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 875
+ C+ + L +RR K Q ++S VGT YIAPE++ G+T
Sbjct: 180 IDRCRLKPL-------ERRRKRQHQRC-------LAHSLVGTPNYIAPEVLLRTGYTQLC 225
Query: 876 DWWALGILLYEMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHR 933
DWW++G++LYEML G PF T +T +++ L PS S A L+ RL
Sbjct: 226 DWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-C 284
Query: 934 DPKSRLGSHEGANEIKKHPFFKGVNWA-LVRCMNPPELDAPLFATDTEKEYKVVDP 988
+ RLG + GA+EIK HPFFKG+++A L+R P + TDT + VDP
Sbjct: 285 GAEDRLGKN-GADEIKAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSN-FDPVDP 338
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 1e-64
Identities = 132/340 (38%), Positives = 193/340 (56%), Gaps = 50/340 (14%)
Query: 667 FRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNK-VHRACAEREILDML 722
F +K LG+G G V LV +G+ +AMK + K ++ + K V ER +L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 723 -DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 781
PF+ L+ +FQT+ + LI DY GGE+F L ++ ED VRFY+ E+++ALE
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALE 119
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
+LH GI+YRD+K EN+LL GHV LTDF LS
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLS--------------------------K 153
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
F++E + SF GT EY+APEII G GH AVDWW+LGIL++E+L G +PF + +
Sbjct: 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER 213
Query: 901 KTFANILHKDLKFPSSTPTSLH--AKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGV 957
T + + + LK P+ + A+ L+++LL +DPK RLG+ +GA+EIK+HPFFKG+
Sbjct: 214 NTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273
Query: 958 NWALV--RCMNPP-------ELDAPLFATDTEKEYKVVDP 988
+W + R +NPP ELD FA +E+ ++P
Sbjct: 274 DWEALALRKVNPPFRPSIRNELDVGNFA----EEFTNLEP 309
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 3e-63
Identities = 113/316 (35%), Positives = 173/316 (54%), Gaps = 36/316 (11%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 730
K LG G G V LV +G+Y+AMK + K V++ +++V E +L HPF+ AL
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 731 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 790
+FQT +C + +Y GGELF L R+ +V E+ RFY AE+V ALEYLH + ++Y
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVY 118
Query: 791 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 850
RD+K EN++L +GH+ +TDF L CK + ++ +
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGL-----CKEGI----SDGATMK---------------- 153
Query: 851 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 910
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + ++ F IL ++
Sbjct: 154 --TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211
Query: 911 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNW--ALVRCMNP 967
++FP + S AK L+ LL +DPK RLG A E+ +H FF +NW + + + P
Sbjct: 212 IRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP 269
Query: 968 PELDAPLFATDTEKEY 983
P P ++ + Y
Sbjct: 270 PF--KPQVTSEVDTRY 283
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 216 bits (551), Expect = 3e-62
Identities = 118/336 (35%), Positives = 181/336 (53%), Gaps = 28/336 (8%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
F +K +G G G V LV+ +G+ +AMK + K M ++++ AER++L D P+
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
V +LY SFQ ++ LI ++ PGG+L +L + T ED RFY AE V+A+E +H
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT--FSEDVTRFYMAECVLAIEAVHKL 120
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSC-----LTSCKPQLLLPTTNEKKRRHKGQQNP 841
G I+RD+KP+N+L+ GH+ L+DF LS S Q LL K R + +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL-QGKSNKNRIDNRNSV 179
Query: 842 VFMAEPMRASN----------------SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 885
+ + S+ S VGT +YIAPEI G+ DWW+LG +++
Sbjct: 180 AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239
Query: 886 EMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943
E L G+ PF + +T+ I++ + L FP S+ A+ L+ RL+ + ++RLG
Sbjct: 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI-TNAENRLGRG- 297
Query: 944 GANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDT 979
GA+EIK HPFF+GV+W +R + P + TDT
Sbjct: 298 GAHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDT 333
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 1e-61
Identities = 116/290 (40%), Positives = 154/290 (53%), Gaps = 32/290 (11%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 729
K +G G G V L + G ++A+K + K +L + + + AER +L L HPF+
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
L+ SFQT + + DY GGELF L R+ + E RFYAAEV A+ YLH II
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
YRDLKPEN+LL GHV LTDF L CK + EP
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL-----CKEGV----------------------EPEE 151
Query: 850 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909
+++F GT EY+APE++ + VDWW LG +LYEMLYG PF + + + NILHK
Sbjct: 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK 211
Query: 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959
L+ P + A L+ LLH+D + RLG+ EIK H FF +NW
Sbjct: 212 PLQLPGGKTVA--ACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 212 bits (540), Expect = 2e-61
Identities = 125/316 (39%), Positives = 174/316 (55%), Gaps = 36/316 (11%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 730
K LG G G V LV SG+Y+AMK + K V++ +++V E +L HPF+ +L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 731 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 790
SFQTK +C + +Y GGELF L R+ +V ED RFY AE+V AL+YLH I+Y
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVY 118
Query: 791 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 850
RDLK EN++L +GH+ +TDF L CK + T +
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGL-----CKEGITDAATMK-------------------- 153
Query: 851 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 910
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +K F IL +D
Sbjct: 154 --TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED 211
Query: 911 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV--RCMNP 967
+KFP + S AK L+ LL +DP RLG + A EI +H FF GVNW V + + P
Sbjct: 212 IKFPRT--LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVP 269
Query: 968 PELDAPLFATDTEKEY 983
P P ++T+ Y
Sbjct: 270 PF--KPQVTSETDTRY 283
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 2e-61
Identities = 113/330 (34%), Positives = 166/330 (50%), Gaps = 50/330 (15%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 725
F+ + +G G G V L + +G+ A+K M K ++ N+V ER+IL
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 726 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
++ L +FQ ++ L +Y PGG+ LL+ VL ED RFY AE+ A++ LH
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHE 119
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
G I+RDLKPEN L+ +GH+ LTDF LS
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLS------------------------------K 149
Query: 846 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905
+ +NS VG+ +Y+APE++ G G+ VD+W+LG +LYE L G+ PF G T +T+ N
Sbjct: 150 GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN 209
Query: 906 ILH--KDLKFPSSTPT----SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959
+ + + L+ P S A L+ +L++ DP R GS E +IK HPFFK V+W
Sbjct: 210 LKYWKETLQRPVYDDPRFNLSDEAWDLITKLIN-DPSRRFGSLE---DIKNHPFFKEVDW 265
Query: 960 ALVRCMNPP-------ELDAPLFATDTEKE 982
+R + PP E+D F D E E
Sbjct: 266 NELRELKPPFVPELESEIDTGYF-DDFENE 294
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 207 bits (527), Expect = 7e-60
Identities = 120/309 (38%), Positives = 167/309 (54%), Gaps = 34/309 (11%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
+G G G V V + + +A+K + K +++R++V AER +L ++ PF+ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 733 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 792
SFQ+ + L+ + GGELF L R+ RFY AE++ ALE LH +IYRD
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR--FDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 793 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 852
LKPEN+LL GH++L DF L CK L ++ K +N
Sbjct: 119 LKPENILLDYQGHIALCDFGL-----CK----LNMKDDDK------------------TN 151
Query: 853 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 912
+F GT EY+APE++ G G+T AVDWW LG+LLYEML G PF + + + IL + L+
Sbjct: 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR 211
Query: 913 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA--LVRCMNPPEL 970
FP AK L+ LL RDP RLG + GA EIK HPFF ++W L++ + PP
Sbjct: 212 FPDGFDRD--AKDLLIGLLSRDPTRRLGYN-GAQEIKNHPFFSQLSWKKLLMKGIQPPFK 268
Query: 971 DAPLFATDT 979
A A DT
Sbjct: 269 PAVSSAIDT 277
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 3e-59
Identities = 122/304 (40%), Positives = 173/304 (56%), Gaps = 38/304 (12%)
Query: 666 HFRPIKPLGSGDTGSVHLV-ELCG--SGQYFAMKAMDKGVMLNRNKV-HRACAEREILDM 721
+F +K LG+G G V LV ++ G SG+ +AMK + K ++ + K ER++L+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 722 LDH-PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
+ PF+ L+ +FQT T + LI DY GGELF L ++ + KE V+ Y+ E+V+AL
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLAL 118
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
E+LH GIIYRD+K EN+LL NGHV LTDF LS
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS-------------------------- 152
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKT 898
F + + + SF GT EY+AP+I+ G GH AVDWW++G+L+YE+L G +PF
Sbjct: 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212
Query: 899 RQKTFANILHKDLKFPSSTPTSLH--AKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFK 955
+ + A I + LK P + AK ++ RLL +DPK RLG A+EIKKHPFF+
Sbjct: 213 EKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272
Query: 956 GVNW 959
+NW
Sbjct: 273 KINW 276
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 205 bits (522), Expect = 5e-59
Identities = 121/317 (38%), Positives = 177/317 (55%), Gaps = 37/317 (11%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 730
K LG G G V LV+ +G+Y+AMK + K V++ +++V E +L HPF+ AL
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 731 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GII 789
SFQT +C + +Y GGELF L R+ +V ED RFY AE+V AL+YLH + ++
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVV 118
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
YRDLK EN++L +GH+ +TDF L CK +G ++ M
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGL-----CK---------------EGIKDGATM----- 153
Query: 850 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +K F IL +
Sbjct: 154 --KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211
Query: 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRL-GSHEGANEIKKHPFFKGVNWALV--RCMN 966
+++FP + S AK L+ LL +DPK RL G + A EI +H FF G+ W V + +
Sbjct: 212 EIRFPRT--LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLV 269
Query: 967 PPELDAPLFATDTEKEY 983
PP P ++T+ Y
Sbjct: 270 PPF--KPQVTSETDTRY 284
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 204 bits (519), Expect = 1e-58
Identities = 117/303 (38%), Positives = 161/303 (53%), Gaps = 33/303 (10%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 729
K +G G G V L + G+ +A+K + K ++LNR + AER +L + HPF+
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
L+ SFQT + + D+ GGELF L R+ + E RFYAAE+ AL YLH I+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSINIV 118
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
YRDLKPEN+LL GHV LTDF L CK + T
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL-----CKEGIAQSDT--------------------- 152
Query: 850 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909
+ +F GT EY+APE+I + + VDWW LG +LYEMLYG PF + + + NILHK
Sbjct: 153 -TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211
Query: 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA-LVRCMNPP 968
L SL A ++ LL +D + RLG+ E EI++HPFF+ ++W L + PP
Sbjct: 212 PLVLRPG--ASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPP 269
Query: 969 ELD 971
+
Sbjct: 270 PFN 272
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 2e-58
Identities = 118/323 (36%), Positives = 177/323 (54%), Gaps = 41/323 (12%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC--AEREILDMLDH 724
F +K +G G G V +V++ +GQ +AMK ++K ML R + AC ER++L D
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAET--ACFREERDVLVNGDR 60
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
++ L+ +FQ + ++ L+ DY GG+L LL + + L ED RFY AE+V+A++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVLAIDSVH 119
Query: 785 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 844
G ++RD+KP+NVLL NGH+ L DF SCL +
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFG-SCLR-------------------------LL 153
Query: 845 AEPMRASNSFVGTEEYIAPEIIA----GAGHTSA-VDWWALGILLYEMLYGYTPFRGKTR 899
A+ SN VGT +YI+PEI+ G G DWW+LG+ +YEMLYG TPF ++
Sbjct: 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 900 QKTFANIL-HKD-LKFPSSTP-TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
+T+ I+ HK+ +FP S AK L+ RL+ P++RLG + G + K HPFF+G
Sbjct: 214 VETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLGRN-GLQDFKDHPFFEG 271
Query: 957 VNWALVRCMNPPELDAPLFATDT 979
++W +R P + TDT
Sbjct: 272 IDWDNIRNSTAPYVPEVSSPTDT 294
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 7e-58
Identities = 108/319 (33%), Positives = 177/319 (55%), Gaps = 40/319 (12%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 729
K LG G G V L EL G+ Q+FA+KA+ K V+L + V E+ +L + +HPF+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
LY +FQTK ++ + +Y GG+L + Q FYAAE++ L++LH +GI+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
YRDLK +N+LL +GH+ + DF + CK +L + K
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGM-----CKENML----GDAK----------------- 152
Query: 850 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909
+ +F GT +YIAPEI+ G + ++VDWW+ G+LLYEML G +PF G ++ F +I
Sbjct: 153 -TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD 211
Query: 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV--RCMNP 967
+ +P + AK ++ +L R+P+ RLG +I++HPFF+ ++W+ + R + P
Sbjct: 212 NPCYPRW--LTREAKDILVKLFVREPERRLGVK---GDIRQHPFFREIDWSALEEREIEP 266
Query: 968 ---PELDAPLFATDTEKEY 983
P++ + ++ +KE+
Sbjct: 267 PFKPKVKSANDCSNFDKEF 285
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 9e-58
Identities = 119/331 (35%), Positives = 169/331 (51%), Gaps = 44/331 (13%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPA 729
K LG G G V L EL G+ + +A+K + K V+L + V E+ IL + HPF+ A
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
L+ FQTK + + +Y GG+L + Q ++ E RFYAAEV +AL +LH G+I
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
YRDLK +N+LL GH L DF + CK +L
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGM-----CKEGIL----------------------NGV 151
Query: 850 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909
+ +F GT +YIAPEI+ + +VDWWALG+L+YEM+ G PF F +ILH
Sbjct: 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211
Query: 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG---SHEGANEIKKHPFFKGVNWALV--RC 964
D+ +P S A ++ + ++P RLG S G + IK+HPFFK ++W L+ R
Sbjct: 212 DVLYP--VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRK 269
Query: 965 MNPP-------ELDAPLFATDTEKEYKVVDP 988
+ PP + D F D KE V+ P
Sbjct: 270 IKPPFKPKIKTKRDVNNFDQDFTKEEPVLTP 300
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 4e-57
Identities = 114/302 (37%), Positives = 167/302 (55%), Gaps = 39/302 (12%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 729
K LG G G V L EL G G+YFA+KA+ K V+L + V E+ +L + ++PF+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 730 LYASFQTKTHVCLITDYCPGGEL-FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 788
LY +FQTK H+ + ++ GG+L F + D+ + + FYAAE+V L++LH +GI
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYR---ATFYAAEIVCGLQFLHSKGI 117
Query: 789 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 848
IYRDLK +NV+L +GH+ + DF + CK + G
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGM-----CKENVF------------GDN--------- 151
Query: 849 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 908
RAS +F GT +YIAPEI+ G +T +VDWW+ G+LLYEML G +PF G + F +I
Sbjct: 152 RAS-TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV 210
Query: 909 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV--RCMN 966
+P + +K ++ +L RDP RLG I+ HPFFK +NW + R ++
Sbjct: 211 DTPHYPRW--ITKESKDILEKLFERDPTRRLGV---VGNIRGHPFFKTINWTALEKRELD 265
Query: 967 PP 968
PP
Sbjct: 266 PP 267
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 6e-57
Identities = 119/313 (38%), Positives = 177/313 (56%), Gaps = 26/313 (8%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
F +K +G G G V LV+ +G +AMK + K ML + +V AER+IL D +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
V ++ SFQ K ++ LI ++ PGG++ LL ++ T L E+A +FY AE V+A++ +H
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQL 120
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSC-------------LTSCKPQ-LLLPTTNEKK 832
G I+RD+KP+N+LL GHV L+DF L LT P N K+
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 833 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT 892
+ ++N +A S VGT +YIAPE+ G+ DWW+LG+++YEML GY
Sbjct: 181 KAETWKKNRRQLAY------STVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 893 PFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950
PF +T Q+T+ +++ + L FP P S AK L+ R D ++R+GS+ G EIK
Sbjct: 235 PFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSN-GVEEIKS 292
Query: 951 HPFFKGVNWALVR 963
HPFF+GV+W +R
Sbjct: 293 HPFFEGVDWGHIR 305
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 195 bits (496), Expect = 1e-55
Identities = 108/301 (35%), Positives = 158/301 (52%), Gaps = 36/301 (11%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 731
LG G G V L L SG+ +A+K + K V+L + V E+ IL + +HPF+ LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 732 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 791
FQT + + ++ GG+L + Q ++ E RFYAAE+ AL +LH +GIIYR
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 792 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 851
DLK +NVLL GH L DF + CK + G + +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGM-----CKEGI-----------FNG-----------KTT 153
Query: 852 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDL 911
++F GT +YIAPEI+ + +VDWWA+G+LLYEML G+ PF + F IL+ ++
Sbjct: 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 213
Query: 912 KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFFKGVNWALV--RCMNP 967
+P T S A ++ + ++P RLGS G I +HPFFK ++W + R + P
Sbjct: 214 VYP--TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEP 271
Query: 968 P 968
P
Sbjct: 272 P 272
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 3e-55
Identities = 96/302 (31%), Positives = 148/302 (49%), Gaps = 32/302 (10%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
LG G G V ++ +G+ +A K +DK + R A E++IL+ + F+ +L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 733 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 792
+F+TK +CL+ GG+L + E FYAA+++ LE+LH + I+YRD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 793 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 852
LKPENVLL +G+V ++D L+ KG +
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV------------------ELKGGKKI----------K 152
Query: 853 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 912
GT Y+APE++ G + +VDW+ALG LYEM+ G +PFR + + + + L+
Sbjct: 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212
Query: 913 FPSSTPTSL--HAKQLMYRLLHRDPKSRLGSHEG-ANEIKKHPFFKGVNWALVRC-MNPP 968
P AK L LL +DP+ RLG G A+E+++HP FK +NW + M P
Sbjct: 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEP 272
Query: 969 EL 970
Sbjct: 273 PF 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 4e-55
Identities = 106/304 (34%), Positives = 155/304 (50%), Gaps = 40/304 (13%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
+G G G V +V +G +AMK M K V+L + V ER+IL + + P++P L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 733 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 792
+FQ K ++ L+ +Y PGG+L LL+R + ED +FY AE+V+A+ +H G ++RD
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAIHSVHQMGYVHRD 127
Query: 793 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 852
+KPENVL+ GH+ L DF + + A M S
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLT--------------------------ANKMVNSK 161
Query: 853 SFVGTEEYIAPEII------AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 906
VGT +YIAPE++ + DWW+LG++ YEM+YG +PF T KT+ NI
Sbjct: 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221
Query: 907 L-HKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRC 964
+ + LKFP S L+ LL K RLG +EG + HPFF ++W +R
Sbjct: 222 MNFQRFLKFPEDPKVSSDFLDLIQSLL-CGQKERLG-YEG---LCCHPFFSKIDWNNIRN 276
Query: 965 MNPP 968
PP
Sbjct: 277 SLPP 280
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 4e-55
Identities = 100/295 (33%), Positives = 151/295 (51%), Gaps = 33/295 (11%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP- 725
F + LG G G V L E G+ + +A+K + K V++ + V E+ +L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 726 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
F+ L++ FQT + + +Y GG+L + Q KE FYAAE+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGKFKEPHAVFYAAEIAIGLFFLHS 119
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
+GIIYRDLK +NV+L GH+ + DF + CK + T
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGM-----CKENIFGGKT----------------- 157
Query: 846 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905
+ +F GT +YIAPEIIA + +VDWWA G+LLYEML G PF G+ + F +
Sbjct: 158 -----TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS 212
Query: 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNW 959
I+ ++ +P S S A + LL + P RLG G +I++H FF+ ++W
Sbjct: 213 IMEHNVSYPKS--LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 5e-54
Identities = 108/290 (37%), Positives = 151/290 (52%), Gaps = 32/290 (11%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 729
K +G G G V L +++A+K + K +L + + +ER +L + HPF+
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
L+ SFQT + + DY GGELF L R+ + E RFYAAE+ AL YLH I+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIV 118
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
YRDLKPEN+LL GH+ LTDF L CK + E
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGL-----CKENI----------------------EHNG 151
Query: 850 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909
+++F GT EY+APE++ + VDWW LG +LYEMLYG PF + + + NIL+K
Sbjct: 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 211
Query: 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959
L+ + S A+ L+ LL +D RLG+ + EIK H FF +NW
Sbjct: 212 PLQLKPNITNS--ARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 3e-53
Identities = 106/310 (34%), Positives = 167/310 (53%), Gaps = 45/310 (14%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 731
+G G V LVEL + + +AMK + K ++ + + E+ + + +HPF+ L+
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 732 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 791
+ FQT++ + + ++ GG+L + RQ + L E+ RFY+AE+ +AL +LH +GIIYR
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 792 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 851
DLK +NVLL GH+ LTD+ + CK + P +
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGM-----CKEGI----------------------RPGDTT 153
Query: 852 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF---------RGKTRQKT 902
++F GT YIAPEI+ G + +VDWWALG+L++EM+ G +PF T
Sbjct: 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213
Query: 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH--EGANEIKKHPFFKGVNWA 960
F IL K ++ P S S+ A ++ L++DPK RLG H G +IK HPFF+ ++W
Sbjct: 214 FQVILEKQIRIPRS--LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD 271
Query: 961 LV--RCMNPP 968
L+ + + PP
Sbjct: 272 LLEQKQVLPP 281
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 1e-52
Identities = 109/327 (33%), Positives = 164/327 (50%), Gaps = 41/327 (12%)
Query: 650 KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 709
KA +KI ++ + F IK +G G G V LV S Q +AMK + K M+ R+
Sbjct: 30 KAAEKITKL--RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDS 87
Query: 710 HRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV 769
ER+I+ + ++ L+ +FQ ++ ++ +Y PGG+L L+ + E
Sbjct: 88 AFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD---IPEKWA 144
Query: 770 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829
RFY AEVV+AL+ +H G I+RD+KP+N+LL +GH+ L DF +C+
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG-TCMK------------ 191
Query: 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS----AVDWWALGILLY 885
A M ++ VGT +YI+PE++ G DWW++G+ LY
Sbjct: 192 -------------MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238
Query: 886 EMLYGYTPFRGKTRQKTFANIL-HKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943
EML G TPF + T++ I+ HK+ L FP S AK L+ L D + RLG +
Sbjct: 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFL-TDREVRLGRN- 296
Query: 944 GANEIKKHPFFKG--VNWALVRCMNPP 968
G +EIK HPFFK + +R P
Sbjct: 297 GVDEIKSHPFFKNDQWTFDNIRETVAP 323
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 2e-52
Identities = 114/315 (36%), Positives = 174/315 (55%), Gaps = 26/315 (8%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
+ F +K +G G G V LV+ +G +AMK + K ML + +V AER+IL D
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
+V ++ SFQ K ++ LI ++ PGG++ LL ++ T L E+ +FY AE V+A++ +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIH 118
Query: 785 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSC-------------LTSCKPQ-LLLPTTNE 830
G I+RD+KP+N+LL GHV L+DF L L P N
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 890
K++ ++N +A S VGT +YIAPE+ G+ DWW+LG+++YEML G
Sbjct: 179 KRKAETWKRNRRQLA------FSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 891 YTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948
Y PF +T Q+T+ +++ + L FP P S AK L+ R + + R+G+ G EI
Sbjct: 233 YPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGA-PGVEEI 290
Query: 949 KKHPFFKGVNWALVR 963
K +PFF+GV+W +R
Sbjct: 291 KTNPFFEGVDWEHIR 305
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 1e-51
Identities = 84/282 (29%), Positives = 123/282 (43%), Gaps = 69/282 (24%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
LG G G+V+L +G+ A+K + K + + + E EIL L+HP + LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE--DSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 733 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 792
F+ + H+ L+ +YC GG L LL K L ED + +++ LEYLH GII+RD
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 793 LKPENVLLQ-GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 851
LKPEN+LL NG V L DF LS +
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSK---------------------------LLTSDKSLL 150
Query: 852 NSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 910
+ VGT Y+APE++ G G+ + D W+LG++LYE+
Sbjct: 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------- 187
Query: 911 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 952
K L+ ++L +DP+ R A EI +H
Sbjct: 188 ----------PELKDLIRKMLQKDPEKRP----SAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 3e-50
Identities = 108/310 (34%), Positives = 166/310 (53%), Gaps = 37/310 (11%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
F IK +G G G V +V++ + + +AMK ++K ML R + ER +L D +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
+ L+ +FQ + ++ L+ DY GG+L LL + + L ED RFY AE+V+A+ +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQL 121
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
++RD+KP+NVLL NGH+ L DF SCL +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFG-SCLK-------------------------MNQD 155
Query: 847 PMRASNSFVGTEEYIAPEIIA----GAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901
S+ VGT +YI+PEI+ G G + DWW+LG+ +YEMLYG TPF ++ +
Sbjct: 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
Query: 902 TFANILHKD--LKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958
T+ I++ + +FPS T S AK L+ RL+ + RLG + G + KKH FF+G++
Sbjct: 216 TYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRER-RLGQN-GIEDFKKHAFFEGID 273
Query: 959 WALVRCMNPP 968
W +R + P
Sbjct: 274 WENIRNLEAP 283
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 7e-50
Identities = 80/278 (28%), Positives = 132/278 (47%), Gaps = 37/278 (13%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLD 723
+ IK +G G G V+LV G+ + +K +D + N ++ R A E IL L+
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID---LSNMSEKEREDALNEVKILKKLN 57
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV--LKEDAVRFYAAEVVVALE 781
HP + Y SF+ K +C++ +Y GG+L + +Q + E+ + + ++ +AL+
Sbjct: 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
YLH + I++RD+KP+N+ L NG V L DF +S K +
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFGIS---------------------KVLSST 156
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901
V +A + VGT Y++PE+ + D W+LG +LYE+ PF G+ +
Sbjct: 157 VDLA------KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE 210
Query: 902 TFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSR 938
IL PS + L + L+ LL +DP+ R
Sbjct: 211 LALKILKGQYPPIPSQYSSEL--RNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 1e-49
Identities = 105/306 (34%), Positives = 159/306 (51%), Gaps = 35/306 (11%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP- 725
F + LG G G V L E G+ + +A+K + K V++ + V E+ +L + D P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 726 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
F+ L++ FQT + + +Y GG+L + Q KE FYAAE+ V L +LH
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGLFFLHR 119
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
+GIIYRDLK +NV+L GH+ + DF + CK ++ T
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKEHMVDGVT----------------- 157
Query: 846 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905
+ +F GT +YIAPEIIA + +VDWWA G+LLYEML G PF G+ + F +
Sbjct: 158 -----TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS 212
Query: 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG-SHEGANEIKKHPFFKGVNWALV-- 962
I+ ++ +P S S A + L+ + P RLG EG +I++H FF+ ++W +
Sbjct: 213 IMEHNVSYPKS--LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLEN 270
Query: 963 RCMNPP 968
R + PP
Sbjct: 271 REIQPP 276
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 1e-49
Identities = 127/353 (35%), Positives = 181/353 (51%), Gaps = 44/353 (12%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
F IK LG G G V L + +AMK + K +L RN+V AER+IL D+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
V LY SFQ K ++ + DY PGG++ LL R + ED RFY AE+ A+E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM 120
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG----QQNPV 842
G I+RD+KP+N+L+ +GH+ LTDF L C T++ K G Q +
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGL-CTG-------FRWTHDSKYYQSGDHVRQDSMD 172
Query: 843 FMAE--------------PM--RA--------SNSFVGTEEYIAPEIIAGAGHTSAVDWW 878
F E P+ RA ++S VGT YIAPE++ G+T DWW
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232
Query: 879 ALGILLYEMLYGYTPFRGKTRQKTFANIL--HKDLKFPSSTPTSLHAKQLMYRLLHRDPK 936
++G++LYEML G PF +T +T ++ L P S A L+ +L R P+
Sbjct: 233 SVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPE 291
Query: 937 SRLGSHEGANEIKKHPFFKGVNWAL-VRCMNPPELDAPLFATDTEKEYKVVDP 988
RLG + GA+EIK HPFFK ++++ +R + P + TDT + VDP
Sbjct: 292 DRLGKN-GADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSN-FDPVDP 342
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 5e-49
Identities = 105/302 (34%), Positives = 161/302 (53%), Gaps = 43/302 (14%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 731
+G G V LV L + + +AMK + K ++ + + E+ + + +HPF+ L+
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 732 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 791
+ FQT++ + + +Y GG+L + RQ + L E+ RFY+AE+ +AL YLH +GIIYR
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 792 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 851
DLK +NVLL GH+ LTD+ + CK L P +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGM-----CKEGL----------------------RPGDTT 153
Query: 852 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF---------RGKTRQKT 902
++F GT YIAPEI+ G + +VDWWALG+L++EM+ G +PF T
Sbjct: 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 213
Query: 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG--SHEGANEIKKHPFFKGVNWA 960
F IL K ++ P S S+ A ++ L++DPK RLG G +I+ HPFF+ V+W
Sbjct: 214 FQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 271
Query: 961 LV 962
L+
Sbjct: 272 LM 273
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 7e-49
Identities = 106/308 (34%), Positives = 164/308 (53%), Gaps = 43/308 (13%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALY 731
+G G V LV L + Q +AMK + K ++ + + E+ + + +PF+ L+
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 732 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 791
+ FQT + + L+ +Y GG+L + RQ + L E+ RFYAAE+ +AL +LH +GIIYR
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 792 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 851
DLK +NVLL +GH+ LTD+ + CK L P +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGM-----CKEGL----------------------GPGDTT 153
Query: 852 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF-------RGKTRQKTFA 904
++F GT YIAPEI+ G + +VDWWALG+L++EM+ G +PF T F
Sbjct: 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213
Query: 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS--HEGANEIKKHPFFKGVNWALV 962
IL K ++ P S+ A ++ L++DPK RLG G ++IK H FF+ ++W L+
Sbjct: 214 VILEKPIRIPRF--LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL 271
Query: 963 --RCMNPP 968
+ + PP
Sbjct: 272 EKKQVTPP 279
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 8e-49
Identities = 116/326 (35%), Positives = 180/326 (55%), Gaps = 43/326 (13%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
+ F +K +G G G V +V+L + + FAMK ++K ML R + ER++L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
++ L+ +FQ + ++ L+ DY GG+L LL + + L ED RFY AE+V+A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVH 119
Query: 785 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 844
++RD+KP+N+L+ NGH+ L DF SCL M
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFG-SCLK-------------------------LM 153
Query: 845 AEPMRASNSFVGTEEYIAPEIIA----GAG-HTSAVDWWALGILLYEMLYGYTPFRGKTR 899
+ S+ VGT +YI+PEI+ G G + DWW+LG+ +YEMLYG TPF ++
Sbjct: 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 900 QKTFANIL-HKD-LKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
+T+ I+ HK+ +FP+ T S AK L+ RL+ + RLG + G + K+HPFF G
Sbjct: 214 VETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLIC-SREHRLGQN-GIEDFKQHPFFTG 271
Query: 957 VNWALVR-CMNP--PELDAPLFATDT 979
++W +R C P PE+ +P TDT
Sbjct: 272 IDWDNIRNCEAPYIPEVSSP---TDT 294
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 4e-48
Identities = 105/310 (33%), Positives = 162/310 (52%), Gaps = 42/310 (13%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPA 729
+G G G V+ +G+ +AMK +DK + + A ER +L ++ D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
+ +F T + I D GG+L L + V E +RFYAAE+++ LE++H + ++
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
YRDLKP N+LL +GHV ++D L+C S KK+ H
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFS------------KKKPH-------------- 153
Query: 850 ASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRG-KTRQKTFAN-- 905
AS VGT Y+APE++ G + S+ DW++LG +L+++L G++PFR KT+ K +
Sbjct: 154 AS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210
Query: 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC 964
L ++ P S S + L+ LL RD RLG GA E+K+HPFF+ ++W +V
Sbjct: 211 TLTMAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFL 268
Query: 965 MN-PPELDAP 973
PP L P
Sbjct: 269 QKYPPPLIPP 278
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 9e-48
Identities = 101/295 (34%), Positives = 152/295 (51%), Gaps = 33/295 (11%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP- 725
F + LG G G V L E G+ + +A+K + K V++ + V E+ +L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 726 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
F+ L++ FQT + + +Y GG+L + Q KE FYAAE+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI--QQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
+GIIYRDLK +NV+L GH+ + DF + CK + T
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKENMWDGVT----------------- 157
Query: 846 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905
+ +F GT +YIAPEIIA + +VDWWA G+LLYEML G PF G+ + F +
Sbjct: 158 -----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 212
Query: 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG-SHEGANEIKKHPFFKGVNW 959
I+ ++ +P S S A + L+ + P RLG EG +IK+H FF+ ++W
Sbjct: 213 IMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 1e-47
Identities = 102/320 (31%), Positives = 158/320 (49%), Gaps = 42/320 (13%)
Query: 643 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY--FAMKAMDK 700
+KDS K ++ ++ + F I+ LG+G G V L + + A+K +K
Sbjct: 12 KKDSDSTKEPKR----KNKMKYEDFNFIRTLGTGSFGRVILATY-KNEDFPPVAIKRFEK 66
Query: 701 GVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP 760
++ + +V +ER+IL+ ++HPF LY SF+ ++++ L+ ++ GGE F L R
Sbjct: 67 SKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN- 125
Query: 761 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820
K D FYAA++V+ EYL I+YRDLKPEN+LL +G + +TDF + + +
Sbjct: 126 -KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184
Query: 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 880
+ + GT EYIAPEI+ GH A DWW L
Sbjct: 185 ------------------------------TYTLCGTPEYIAPEILLNVGHGKAADWWTL 214
Query: 881 GILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG 940
GI +YE+L G PF + IL + FP + K LM +LL D R G
Sbjct: 215 GIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNN--CKHLMKKLLSHDLTKRYG 272
Query: 941 S-HEGANEIKKHPFFKGVNW 959
+ +GA +K+HP+F ++W
Sbjct: 273 NLKKGAQNVKEHPWFGNIDW 292
|
Length = 340 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 174 bits (441), Expect = 2e-47
Identities = 111/326 (34%), Positives = 167/326 (51%), Gaps = 46/326 (14%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
F IK LG G G V L + +AMK + K +LNRN+V AER+IL D+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
V LY SFQ K ++ + DY PGG++ LL R +V E RFY AE+ +A+E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM 120
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSC------------------------------L 816
G I+RD+KP+N+L+ +GH+ LTDF L +
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 876
++C+ L T ++ + Q+ +A +S VGT YIAPE++ G+T D
Sbjct: 181 SNCRCGDRLKTLEQRATK----QHQRCLA------HSLVGTPNYIAPEVLLRKGYTQLCD 230
Query: 877 WWALGILLYEMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRD 934
WW++G++L+EML G PF T +T +++ L P S A L+ +L
Sbjct: 231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCC-S 289
Query: 935 PKSRLGSHEGANEIKKHPFFKGVNWA 960
+ RLG + GA++IK HPFF V+++
Sbjct: 290 AEERLGRN-GADDIKAHPFFSEVDFS 314
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 4e-47
Identities = 94/296 (31%), Positives = 147/296 (49%), Gaps = 31/296 (10%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
FR + LG G G V ++ +G+ +A K ++K + R A E++IL+ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
V +L +++TK +CL+ GG+L + E+ FYAAE+ LE LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
I+YRDLKPEN+LL GH+ ++D L+ + E
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAV-------------------------EIPEGE 156
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 906
+R VGT Y+APE++ +T + DWW LG L+YEM+ G +PFR + + +
Sbjct: 157 TIRGR---VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213
Query: 907 LHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNW 959
+ + S S A+ + +LL +DP RLG EGA E+K HPFF+ N+
Sbjct: 214 ERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 3e-46
Identities = 107/316 (33%), Positives = 166/316 (52%), Gaps = 39/316 (12%)
Query: 650 KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 709
K ++KI Q+ + + +K +G G G V LV S + +AMK + K M+ R+
Sbjct: 30 KIVRKI--RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87
Query: 710 HRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV 769
ER+I+ + P+V L+ +FQ ++ ++ +Y PGG+L L+ + E
Sbjct: 88 AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWA 144
Query: 770 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829
+FY AEVV+AL+ +H G+I+RD+KP+N+LL +GH+ L DF +C+
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG-TCM------------- 190
Query: 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLY 885
K G M ++ VGT +YI+PE++ G + DWW++G+ L+
Sbjct: 191 --KMDETG----------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 238
Query: 886 EMLYGYTPFRGKTRQKTFANIL-HKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943
EML G TPF + T++ I+ HK+ L FP S HAK L+ L D + RLG +
Sbjct: 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFL-TDREVRLGRN- 296
Query: 944 GANEIKKHPFFKGVNW 959
G EIK+HPFFK W
Sbjct: 297 GVEEIKQHPFFKNDQW 312
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 100/314 (31%), Positives = 161/314 (51%), Gaps = 37/314 (11%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
FR + LG G G V ++ +G+ +A K ++K + R A E++IL+ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
V L +++TK +CL+ GG+L + +E+ FYAAE++ LE LH +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
+YRDLKPEN+LL GH+ ++D L+ + +P + R
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA--------VKIPEGESIRGR------------ 161
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK----TRQKT 902
VGT Y+APE++ +T + D+W LG L+YEM+ G +PFRG+ R++
Sbjct: 162 --------VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213
Query: 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWAL 961
+L + + S S AK + LL +DPK RLG E GA E+K+HPFF+ +N+
Sbjct: 214 DRRVLETEEVY--SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR 271
Query: 962 VRC--MNPPELDAP 973
+ ++PP + P
Sbjct: 272 LEAGMLDPPFVPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 7e-45
Identities = 103/311 (33%), Positives = 158/311 (50%), Gaps = 41/311 (13%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPA 729
+G G G V+ +G+ +AMK +DK + + A ER +L ++ D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
+ +F T +C I D GG+L L + V E +RFYA E+++ LE++H + ++
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
YRDLKP N+LL +GHV ++D L+C S KK+ H
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFS------------KKKPHAS------------ 155
Query: 850 ASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLYGYTPFRG-KTRQKTFAN-- 905
VGT Y+APE++ G + S+ DW++LG +L+++L G++PFR KT+ K +
Sbjct: 156 -----VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210
Query: 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC 964
L +++ P S L K L+ LL RD RLG GA E+K+H FFKG++W V
Sbjct: 211 TLTVNVELPDSFSPEL--KSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYL 268
Query: 965 MNPPELDAPLF 975
P P
Sbjct: 269 QKYPPPLIPPR 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-44
Identities = 107/315 (33%), Positives = 163/315 (51%), Gaps = 39/315 (12%)
Query: 652 IQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR 711
I KI D ++ + + +K +G G G V LV + + +AMK + K M+ R+
Sbjct: 32 INKIRDL--RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF 89
Query: 712 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 771
ER+I+ + P+V L+ +FQ ++ ++ +Y PGG+L L+ + E RF
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARF 146
Query: 772 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 831
Y AEVV+AL+ +H G I+RD+KP+N+LL +GH+ L DF +C+ K
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG-TCMKMNK----------- 194
Query: 832 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEM 887
E M ++ VGT +YI+PE++ G + DWW++G+ LYEM
Sbjct: 195 --------------EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
Query: 888 LYGYTPFRGKTRQKTFANIL-HKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945
L G TPF + T++ I+ HK+ L FP S AK L+ L D + RLG + G
Sbjct: 241 LVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGRN-GV 298
Query: 946 NEIKKHPFFKGVNWA 960
EIK+H FFK WA
Sbjct: 299 EEIKRHLFFKNDQWA 313
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 4e-43
Identities = 101/296 (34%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
FR + LG G G V ++ +G+ +A K ++K + R A E++IL+ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
V +L +++TK +CL+ GG+L + +E FYAAE+ LE LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
I+YRDLKPEN+LL +GH+ ++D L+ + +P K R
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA--------VHVPEGQTIKGR------------ 161
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF--RGKTRQKTFA 904
VGT Y+APE++ +T + DWWALG LLYEM+ G +PF R K ++
Sbjct: 162 --------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213
Query: 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNW 959
L K+++ S S A+ L LL +DPK RLG GA E+K+HP FK +N+
Sbjct: 214 ERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 7e-43
Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 37/289 (12%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 725
F ++ +G G G V+ +G+ A+K + + K+ E +IL HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---EIQILKKCKHP 57
Query: 726 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
+ Y S+ K + ++ ++C GG L LL + L E + + E++ LEYLH
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS 116
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
GII+RD+K N+LL +G V L DF LS QL
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSA------QL---------------------- 148
Query: 846 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905
+A N+ VGT ++APE+I G + D W+LGI E+ G P+ K
Sbjct: 149 SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK 208
Query: 906 ILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
I + S K + + L ++P+ R A ++ KHPF
Sbjct: 209 IATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP----TAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 6e-42
Identities = 97/316 (30%), Positives = 150/316 (47%), Gaps = 42/316 (13%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 725
+R ++ LG G G V+L + A+K + K + +V R E +IL L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 726 -FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVALEYL 783
+ LY FQ + + L+ +Y GG L LL + K L E F A+++ ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 784 HCQGIIYRDLKPENVLLQGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
H +GII+RD+KPEN+LL +G V L DF L+ L +P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP---------------------DPG 156
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYEMLYGYTPFRGKTR 899
+ ++ VGT Y+APE++ G +S+ D W+LGI LYE+L G PF G+
Sbjct: 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
Query: 900 QKTFANILHKDLKFPSST-----------PTSLHAKQLMYRLLHRDPKSRLGSHEG-ANE 947
+ L L+ P+ + S A L+ +LL +DPK+RL S +++
Sbjct: 217 SSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 948 IKKHPFFKGVNWALVR 963
+ H K + + +
Sbjct: 277 LLAHLKLKESDLSDLL 292
|
Length = 384 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 92/306 (30%), Positives = 152/306 (49%), Gaps = 41/306 (13%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
LG G G V V++ +G+ +A K +DK + ++ A E+EIL+ ++ PF+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 733 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 792
+F++KTH+CL+ GG+L + + L+ + V Y+A++ + +LH I+YRD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 793 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 852
+KPENVLL G+ L+D L+ + L +R
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLA--------VELKDGKTITQR------------------ 154
Query: 853 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK----TRQKTFANILH 908
GT Y+APEI+ ++ VDW+A+G +YEM+ G TPF+ +++ L
Sbjct: 155 --AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212
Query: 909 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPP 968
++KF T +K + L + P+ RLGS E ++ +KH FFK +N+ P
Sbjct: 213 DEVKFEHQNFTE-ESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF--------P 263
Query: 969 ELDAPL 974
L+A L
Sbjct: 264 RLEAGL 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 81/297 (27%), Positives = 126/297 (42%), Gaps = 47/297 (15%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA---EREILDMLD 723
+ + LG G GSV+L +G+ A+K+++ L+ + A E IL L
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVE----LSGDSEEELEALEREIRILSSLQ 57
Query: 724 HPFVPALYASFQTKT--HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 781
HP + Y S + + + + +Y GG L LL + L E +R Y +++ L
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLA 115
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
YLH GI++RD+K N+L+ +G V L DF + KR +
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDGVVKLADFGCA-----------------KRLGDIETGE 158
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901
+ S GT ++APE+I G + A D W+LG + EM G P+ +
Sbjct: 159 --------GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW---SELG 207
Query: 902 TFANILHKDLKFPSSTP----TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
L+K S AK + + L RDPK R A+E+ +HPF
Sbjct: 208 NPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRP----TADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 2e-41
Identities = 95/315 (30%), Positives = 151/315 (47%), Gaps = 44/315 (13%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
LG G G V ++ +G+ +A K ++K + R A E+ IL + F+ +L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 733 SFQTKTHVCLITDYCPGGEL----FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 788
+FQTKT +CL+ GG+L + + + P E FY A+++ LE+LH + I
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG--FPEPRACFYTAQIISGLEHLHQRRI 118
Query: 789 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 848
IYRDLKPENVLL +G+V ++D L+ V + +
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLA---------------------------VELKDGQ 151
Query: 849 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG---KTRQKTFAN 905
+ + GT ++APE++ G + +VD++ALG+ LYEM+ PFR K K
Sbjct: 152 SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ 211
Query: 906 -ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA-NEIKKHPFFKGVNWALVR 963
IL+ + +P S +K LL +DP+ RLG +G + ++ HP F+ +NW +
Sbjct: 212 RILNDSVTYPDK--FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLE 269
Query: 964 CMNPPELDAPLFATD 978
P P F D
Sbjct: 270 AGMLP----PPFVPD 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 97/313 (30%), Positives = 152/313 (48%), Gaps = 35/313 (11%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
FR + LG G G V ++ +G+ +A K ++K + R A E+ IL+ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
V +L +++TK +CL+ GG+L + E FYAAE+ LE L +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
I+YRDLKPEN+LL GH+ ++D L+ + +P + R
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA--------VQIPEGETVRGR------------ 161
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 906
VGT Y+APE+I +T + DWW LG L+YEM+ G +PFR K +++
Sbjct: 162 --------VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR-KRKERVKREE 212
Query: 907 LHKDLKFPSSTPT---SLHAKQLMYRLLHRDPKSRLG-SHEGANEIKKHPFFKGVNWALV 962
+ + +K + S AK + LL ++PK RLG GA +K+HP FK +N+ +
Sbjct: 213 VDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL 272
Query: 963 RC--MNPPELDAP 973
+ PP P
Sbjct: 273 EANMLEPPFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|237427 PRK13559, PRK13559, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-36
Identities = 52/113 (46%), Positives = 72/113 (63%), Gaps = 3/113 (2%)
Query: 195 LSTFQQT---FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVA 251
+QT ++D +PD PI+ A+ F +TGY ++EVVGRNCRFLQGA TDP VA
Sbjct: 46 EQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVA 105
Query: 252 KIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
KIR + + LLNY+KDG PFWN L + P+ ++G++L F G Q +V+
Sbjct: 106 KIRAAIAAEREIVVELLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVT 158
|
Length = 361 |
| >gnl|CDD|237425 PRK13557, PRK13557, histidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 3e-36
Identities = 59/144 (40%), Positives = 81/144 (56%), Gaps = 7/144 (4%)
Query: 446 DDDYESDDERPDSVDD--KVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDS 503
R SVD+ + R I A +E ++TDP PDNPI+FA+ +
Sbjct: 3 SPPEPRPHGRAPSVDESAAGDVSDHRSDIFFAA-VETTRMPMIVTDPNQPDNPIVFANRA 61
Query: 504 FLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNL 563
FLE+T Y+ EEI+G NCRFLQGPETD ATV ++R AI + ++ +++NY K G FWN
Sbjct: 62 FLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERREIATEILNYRKDGSSFWNA 121
Query: 564 FHLQPMRDQ----KYFIGVQLDGS 583
+ P+ + YF G QLD S
Sbjct: 122 LFVSPVYNDAGDLVYFFGSQLDVS 145
|
Length = 540 |
| >gnl|CDD|237427 PRK13559, PRK13559, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 1e-35
Identities = 55/125 (44%), Positives = 74/125 (59%), Gaps = 4/125 (3%)
Query: 464 RQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFL 523
R G +E+ ITDP PD PI+ A+ +FL+LT Y+ EE++GRNCRFL
Sbjct: 35 RDFRGASGRLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFL 94
Query: 524 QGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQ----KYFIGVQ 579
QG TDP V KIRAAI + ++ V+L+NY K G+ FWN HL P+ + YF G Q
Sbjct: 95 QGAATDPIAVAKIRAAIAAEREIVVELLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQ 154
Query: 580 LDGSE 584
D ++
Sbjct: 155 WDVTD 159
|
Length = 361 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 87/289 (30%), Positives = 128/289 (44%), Gaps = 41/289 (14%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA-EREILDMLDHPFVPALY 731
+G G G V+ +G+ A+K + + N K + A E ++L++L HP + Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIR--IQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 732 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 791
+ V + +YC GG L LL+ ++L E +R Y +++ L YLH GI++R
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHR 123
Query: 792 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 851
D+KP N+ L NG + L DF C +L TT M E +
Sbjct: 124 DIKPANIFLDHNGVIKLGDF------GCAVKLKNNTTT--------------MGEEV--- 160
Query: 852 NSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 908
S GT Y+APE+I G GH A D W+LG ++ EM G P+ + F + H
Sbjct: 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFH 218
Query: 909 KDLKFPSSTPTSLHAKQLMYRLLHR----DPKSRLGSHEGANEIKKHPF 953
P SL L R DPK R A+E+ +HPF
Sbjct: 219 VGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP----TASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 76/277 (27%), Positives = 126/277 (45%), Gaps = 35/277 (12%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
F+ +K LG G GSV+ V+ Q++A+K +D G M ++ + A E IL ++HP
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPN 60
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT--KVLKEDAVRFYAAEVVVALEYLH 784
+ + +F +C++ +Y P G+L + ++ K++ E + +++ L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 785 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 844
Q I++RDLK N+LL N V + D +S + KK K Q
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVL-------------KKNMAKTQ------ 161
Query: 845 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904
+GT Y+APE+ G ++ D W+LG LLYEM PF ++ Q
Sbjct: 162 ----------IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY 211
Query: 905 NILHKDLKFPSSTPT-SLHAKQLMYRLLHRDPKSRLG 940
+ K+P P S + + +L PK R
Sbjct: 212 KVQRG--KYPPIPPIYSQDLQNFIRSMLQVKPKLRPN 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|237426 PRK13558, PRK13558, bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 6e-31
Identities = 48/106 (45%), Positives = 73/106 (68%)
Query: 203 VVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS 262
++DAT PD P++Y + F ++TGY+ EV+GRNCRFLQG T+ E VA++RE + +
Sbjct: 162 TIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERP 221
Query: 263 YCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308
L NY+KDG+ FWN + IAPI+D++G V ++G Q +V++ E
Sbjct: 222 TSVELRNYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKE 267
|
Length = 665 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 78/296 (26%), Positives = 131/296 (44%), Gaps = 41/296 (13%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 725
+K LG G +G V+ V +G+ +A+K + + + E + L + P
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI-HVDG-DEEFRKQLLRELKTLRSCESP 59
Query: 726 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
+V Y +F + + ++ +Y GG L LL + + E + + A +++ L+YLH
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYLHT 117
Query: 786 Q-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 844
+ II+RD+KP N+L+ G V + DF +S +L T ++
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISK--------VLENTLDQC------------ 157
Query: 845 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904
N+FVGT Y++PE I G ++ A D W+LG+ L E G PF Q +F
Sbjct: 158 -------NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFL-PPGQPSFF 209
Query: 905 NILHKDLKFPS----STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
++ P + S + + L +DPK R A E+ +HPF K
Sbjct: 210 ELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRP----SAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|237425 PRK13557, PRK13557, histidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-30
Identities = 49/118 (41%), Positives = 79/118 (66%)
Query: 188 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDP 247
SDI A+ T + +V+D +PD PI++A+ F +MTGY ++E++G NCRFLQG TD
Sbjct: 29 SDIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDR 88
Query: 248 EDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 305
VA++R+ + + +LNY+KDG+ FWN L ++P+ +D G ++ F G Q++VS+
Sbjct: 89 ATVAEVRDAIAERREIATEILNYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSR 146
|
Length = 540 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 75/247 (30%), Positives = 104/247 (42%), Gaps = 57/247 (23%)
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
M D+P LY S T LI DY G+LF LL ++ L E V+ ++V AL
Sbjct: 65 MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEAL 122
Query: 781 EYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
LH II+ D+K ENVL + + L D+ L CK G
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL-----CK--------------IIGTP 163
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG--- 896
+ + GT +Y +PE I G + + DWWA+G+L YE+L G PF+
Sbjct: 164 S------------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211
Query: 897 --------KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948
RQ K L F + S +A + +L + RL ++ NEI
Sbjct: 212 EELDLESLLKRQ-------QKKLPFIKN--VSKNANDFVQSMLKYNINYRLTNY---NEI 259
Query: 949 KKHPFFK 955
KHPF K
Sbjct: 260 IKHPFLK 266
|
Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 80/300 (26%), Positives = 121/300 (40%), Gaps = 45/300 (15%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LD 723
+ I+ +G G T V+ + + A+K +D L + + +E+ M +
Sbjct: 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRID----LEKCQTSVDELRKEVQAMSQCN 57
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEY 782
HP V Y SF + L+ Y GG L ++ P L E + EV+ LEY
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 783 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
LH G I+RD+K N+LL +G V + DF +S L +K R
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSAS------LADGGDRTRKVRK------- 164
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901
+FVGT ++APE++ G+ D W+ GI E+ G P+ K
Sbjct: 165 ----------TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214
Query: 902 TFANILHKDLKFPSSTPT-------SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
L D P S T S ++++ L +DP R A E+ KH FF
Sbjct: 215 VLMLTLQND---PPSLETGADYKKYSKSFRKMISLCLQKDPSKR----PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-29
Identities = 60/154 (38%), Positives = 92/154 (59%), Gaps = 2/154 (1%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
++ F +KP+ G G V+L + + +A+K + K M+N+N VH+ AER+ L +
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 783
PF+ LY S Q+ +V L+ +Y GG++ LL E+ Y +EV +AL+YL
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLL--HIYGYFDEEMAVKYISEVALALDYL 120
Query: 784 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817
H GII+RDLKP+N+L+ GH+ LTDF LS +T
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 7e-29
Identities = 84/308 (27%), Positives = 138/308 (44%), Gaps = 43/308 (13%)
Query: 651 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 710
A++ I+ G+ L ++ ++ +G G +G V+ +G+ A+K M L +
Sbjct: 7 ALKDIVSEGDPREL--YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKE 60
Query: 711 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVR 770
E I+ HP + Y S+ + ++ +Y GG L ++ + + + E +
Sbjct: 61 LIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIA 119
Query: 771 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830
+ EV+ LEYLH Q +I+RD+K +N+LL +G V L DF + QL T E
Sbjct: 120 YVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAA------QL----TKE 169
Query: 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 890
K +R NS VGT ++APE+I + VD W+LGI+ EM G
Sbjct: 170 KSKR-----------------NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
Query: 891 YTPFRGKTRQKTFANILHK---DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947
P+ + + I K LK P K + + L +DP+ R + E
Sbjct: 213 EPPYLREPPLRALFLITTKGIPPLKNPEKWSPEF--KDFLNKCLVKDPEKRPSAE----E 266
Query: 948 IKKHPFFK 955
+ +HPF K
Sbjct: 267 LLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 75/300 (25%), Positives = 122/300 (40%), Gaps = 42/300 (14%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
+ LG+G++G V V +G+ A+K + + K + E +IL +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK--QILRELDILHKCNS 58
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
P++ Y +F + + +Y GG L +L + E + A V+ L YLH
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEV-QGRIPERILGKIAVAVLKGLTYLH 117
Query: 785 CQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 843
+ II+RD+KP N+L+ G + L DF +S QL N
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS------GQL----VNSL------------ 155
Query: 844 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ-KT 902
+ +FVGT Y+APE I G ++ D W+LG+ L E+ G P+ +
Sbjct: 156 -------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208
Query: 903 FANILHKDLKFPS----STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958
+L + P S S + + L +DP+ R E+ +HPF K
Sbjct: 209 IFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRER----PSYKELLEHPFIKKYE 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 88/298 (29%), Positives = 127/298 (42%), Gaps = 54/298 (18%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 724
F ++ +G G G V+ + Q A+K +D L + ++EI L
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID----LEEAEDEIEDIQQEIQFLSQCRS 58
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
P++ Y SF + + +I +YC GG LL L E + F EV++ LEYLH
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGLEYLH 115
Query: 785 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 844
+G I+RD+K N+LL G V L DF +S QL T+ KR
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVS------GQL---TSTMSKR----------- 155
Query: 845 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904
N+FVGT ++APE+I +G+ D W+LGI E+ G P +
Sbjct: 156 -------NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF 208
Query: 905 NILHKDLKFPSSTPTSLHA-------KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
I P + P SL K + L++DPK R A E+ KH F K
Sbjct: 209 LI-------PKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERP----SAKELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|237426 PRK13558, PRK13558, bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 7e-28
Identities = 50/123 (40%), Positives = 71/123 (57%), Gaps = 9/123 (7%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 545
I D LPD P+I+ +D+F +T YS +E+LGRNCRFLQG +T+ V ++R AID +
Sbjct: 162 TIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERP 221
Query: 546 VTVQLINYTKSGKKFWNLFHLQPMRDQ----KYFIGVQLDGSEHLEPLRNSIPEATAEES 601
+V+L NY K G FWN + P+RD+ +++G Q D +E R A E
Sbjct: 222 TSVELRNYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTE-----RKEAELALQRER 276
Query: 602 EKL 604
KL
Sbjct: 277 RKL 279
|
Length = 665 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 85/299 (28%), Positives = 130/299 (43%), Gaps = 55/299 (18%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR--NKVHR-ACAEREILDML 722
H+ PI+ LG G G L K ++ L R K R A E IL +L
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN----LTRLSEKERRDALNEIVILSLL 56
Query: 723 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 782
HP + A Y F + + +Y GG L+ + RQ ++ +E+ V +Y ++V A+ Y
Sbjct: 57 QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 783 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
+H GI++RD+K N+ L G + L DF +S K +
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS---------------------KILGSEY 155
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
MAE + VGT Y++PE+ G + D WALG +LYE+L T ++T
Sbjct: 156 SMAE------TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL---------TLKRT 200
Query: 903 FA--NILHKDLKF------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
F N L+ +K P + S L++ LL +DP+ R A+E+ P
Sbjct: 201 FDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKR----PTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 79/291 (27%), Positives = 129/291 (44%), Gaps = 51/291 (17%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA---EREI--LDMLDHPFV 727
LGSG GSV+ G +FA+K + + + + + E+EI L L HP +
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVS---LADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 728 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 787
+ + + ++ + + PGG L LL + E +R Y ++++ LEYLH +
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRN 122
Query: 788 IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEP 847
++RD+K N+L+ NG V L DF ++ K+
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMA----------------KQ------------VVE 154
Query: 848 MRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 906
+ SF G+ ++APE+IA G + A D W+LG + EM G P+ ++ + A +
Sbjct: 155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAV 211
Query: 907 LH----KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
K+L P S AK + + L RDP R A E+ +HPF
Sbjct: 212 FKIGRSKELP-PIPDHLSDEAKDFILKCLQRDPSLRP----TAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 75/267 (28%), Positives = 119/267 (44%), Gaps = 31/267 (11%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
+G G G V V + +AMK +D M NR + A E +L LD ++ Y
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 733 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV-RFYAAEVVVALEYLHCQGIIYR 791
SF K + ++ +Y G+L LL Q + L ED V RF+ ++++ L +LH + I++R
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF-IQILLGLAHLHSKKILHR 125
Query: 792 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 851
D+K N+ L +V + D ++ +LL TN +
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVA-------KLLSDNTN--------------------FA 158
Query: 852 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDL 911
N+ VGT Y++PE+ + D WALG++LYE G PF + I+
Sbjct: 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF 218
Query: 912 KFPSSTPTSLHAKQLMYRLLHRDPKSR 938
P S S QL+ + L +D + R
Sbjct: 219 P-PVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-26
Identities = 83/288 (28%), Positives = 137/288 (47%), Gaps = 43/288 (14%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPAL 730
LG G G+V+LV+ + +K + + + LN N+ +A E ++L LDHP +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 731 YASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 788
+ASF + C+IT+YC G +L L+ + K L E+ V + ++++ + Y+H + I
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 789 IYRDLKPENVLLQGNGHVSLTDFDLSCLT--SCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
++RDLK +N+ L+ N + + DF +S L SC L TT
Sbjct: 128 LHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCD----LATT------------------ 164
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 906
F GT Y++PE + G+ S D W+LG +LYEM F G+ I
Sbjct: 165 -------FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI 217
Query: 907 LHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
+ P + L++ +M +L++DP R A EI ++PF
Sbjct: 218 VEGPTPSLPETYSRQLNS--IMQSMLNKDPSLRP----SAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 70/294 (23%), Positives = 128/294 (43%), Gaps = 44/294 (14%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 729
++ +G G G+V V G+ K +D G M + K + +E IL L HP +
Sbjct: 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHPNIVR 63
Query: 730 LYASF--QTKTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHC 785
Y ++ + ++ +YC GG+L L+ + + K ++E+ + ++++AL H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 786 QG-----IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
+ +++RDLKP N+ L N +V L DF L+ +L +
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA--------KILGHDS----------- 164
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
A ++VGT Y++PE + + D W+LG L+YE+ PF + +
Sbjct: 165 --SFA------KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL 216
Query: 901 KTFANILHKDLKFPSSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
+ + I K+ KF S +++ +L+ DP R E+ + P
Sbjct: 217 QLASKI--KEGKFRRIPYRYSSELNEVIKSMLNVDPDKR----PSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 32/223 (14%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC-AEREILDMLDHPFVPALY 731
+G G G V+ +G + A+K + + + + ++ E ++L L HP +
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQIS--LEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 732 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 791
S +T + +I +Y G L ++ + E V Y +V+ L YLH QG+I+R
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHR 123
Query: 792 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 851
D+K N+L +G V L DF ++ + + +
Sbjct: 124 DIKAANILTTKDGVVKLADFGVA---------------------------TKLNDVSKDD 156
Query: 852 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894
S VGT ++APE+I +G ++A D W+LG + E+L G P+
Sbjct: 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY 199
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 80/278 (28%), Positives = 123/278 (44%), Gaps = 53/278 (19%)
Query: 681 VHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTKT 738
V LV + Q F +K + K +R + L ++ H P + L+ ++
Sbjct: 9 VLLVMDTRTQQTFILKGLRKSSEYSRER----------LTIIPHCVPNMVCLHKYIVSED 58
Query: 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 798
V L+ + GG+L+ + + + E+ V+ +AAE+VVAL+ LH +GI+ RDL P N+
Sbjct: 59 SVFLVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116
Query: 799 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 858
LL GH+ LT F + + V E +
Sbjct: 117 LLDDRGHIQLTYF-------------------------SRWSEV---EDSCDGEAV--EN 146
Query: 859 EYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI-LHKDLKFPSST 917
Y APE+ + T A DWW+LG +L+E+L G T + I H L P
Sbjct: 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHP-----SGINTHTTLNIPEW- 200
Query: 918 PTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFF 954
S A+ L+ +LL +P RLG+ G +IK HPFF
Sbjct: 201 -VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|222120 pfam13426, PAS_9, PAS domain | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 37/104 (35%), Positives = 66/104 (63%), Gaps = 3/104 (2%)
Query: 202 FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ 261
+V D PD I+YA+ ++ GYT +E++G++ R L G G D E VA++RE L+NG
Sbjct: 1 ILVLD---PDGRIVYANDAALRLLGYTREELLGKSIRDLFGPGDDEEAVARLREALRNGG 57
Query: 262 SYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 305
L +KDG PF L++ +P++D++G+V+ +G+ ++++
Sbjct: 58 EVEVELELRRKDGEPFPVLVSASPVRDEDGEVVGIVGILRDITE 101
|
Length = 101 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 86/311 (27%), Positives = 138/311 (44%), Gaps = 50/311 (16%)
Query: 651 AIQKILDSGEQ-INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 709
A+Q ++D G+ L +F I G G TG V + +G+ A+K MD R +
Sbjct: 7 ALQLVVDPGDPRSYLDNFVKI---GEGSTGIVCIATDKSTGRQVAVKKMDL-----RKQQ 58
Query: 710 HRACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 767
R E++ M D HP + +Y+S+ + ++ ++ GG L D + E+
Sbjct: 59 RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEE 115
Query: 768 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 827
+ V+ AL +LH QG+I+RD+K +++LL +G V L+DF S
Sbjct: 116 QIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS--------- 166
Query: 828 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 887
E RR S VGT ++APE+I+ + + VD W+LGI++ EM
Sbjct: 167 -KEVPRR-----------------KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 208
Query: 888 LYGYTPFRGKTRQKTFANILHKDLKFPSSTPT---SLHAKQLMYRLLHRDPKSRLGSHEG 944
+ G P+ + + I +D P S + + R+L RDP R
Sbjct: 209 VDGEPPYFNEPPLQAMKRI--RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQR----AT 262
Query: 945 ANEIKKHPFFK 955
A E+ HPF
Sbjct: 263 AAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|222120 pfam13426, PAS_9, PAS domain | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-26
Identities = 36/104 (34%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 485 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 544
++ DP D I++A+D+ L L Y+REE+LG++ R L GP D V ++R A+ N
Sbjct: 1 ILVLDP---DGRIVYANDAALRLLGYTREELLGKSIRDLFGPGDDEEAVARLREALRNGG 57
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSE 584
+V V+L K G+ F L P+RD+ +G+ D +E
Sbjct: 58 EVEVELELRRKDGEPFPVLVSASPVRDEDGEVVGIVGILRDITE 101
|
Length = 101 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 74/316 (23%), Positives = 125/316 (39%), Gaps = 67/316 (21%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFV 727
+ +G G G V+ +G+ A+K + ++ A REI L L+HP +
Sbjct: 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLR---FESEGIPKTALREIKLLKELNHPNI 60
Query: 728 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 787
L F+ K + L+ ++ L+ DRQ + L E ++ Y +++ L + H G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 788 IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEP 847
I++RDLKPEN+L+ G + L DF L+ +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH--------------------- 157
Query: 848 MRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR------- 899
+V T Y APE++ G G+++ VD W++G + E+L F GK+
Sbjct: 158 ------YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211
Query: 900 ------------QKTFANILHKDLKFPSSTPTSLH---------AKQLMYRLLHRDPKSR 938
K + + FP L A L+ ++LH DP R
Sbjct: 212 FRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKR 271
Query: 939 LGSHEGANEIKKHPFF 954
+ + + HP+F
Sbjct: 272 ITAEQAL----AHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 72/273 (26%), Positives = 110/273 (40%), Gaps = 71/273 (26%)
Query: 716 REI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGE--LFLLLDRQPTKVLKEDAVRF 771
REI L L HP + L T+ + L+ +YC + L LD++P L + ++
Sbjct: 47 REISLLKELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGP-LSPNLIKS 102
Query: 772 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLPTTNE 830
+++ L Y H I++RDLKP+N+L+ +G + L DF L+
Sbjct: 103 IMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI------------ 150
Query: 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLY 889
P+R V T Y APEI+ G+ H ++AVD W++G + EM+
Sbjct: 151 ----------------PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT 194
Query: 890 GYTPFRGKTRQ----KTFANIL---------------HKDLKFPSSTPTSLH-------- 922
G F G + K F IL FP P L
Sbjct: 195 GKPLFPGDSEIDQLFKIF-QILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDP 253
Query: 923 -AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
L+ ++L +P R+ A E KHP+F
Sbjct: 254 EGIDLLSKMLQYNPAKRI----SAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 70/278 (25%), Positives = 117/278 (42%), Gaps = 42/278 (15%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVML-NRNKVHRACAEREILDMLDH 724
K LG G G V+ L G G A+K + + + R E I+ LDH
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLR---EARIMRKLDH 60
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEY 782
P + L + + ++ +Y PGG+L +L +P ++ D + F A ++ +EY
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSF-ALQIARGMEY 118
Query: 783 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
L + I+RDL N L+ N V ++DF LS ++ + KG + P+
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRD----------LYDDDYYKVKGGKLPI 168
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQK 901
++APE + TS D W+ G+LL+E+ G P+ G + +
Sbjct: 169 R----------------WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE 212
Query: 902 TFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ L P + P L+ +LM + DP+ R
Sbjct: 213 VLEYLKKGYRLPKPPNCPPELY--KLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 76/295 (25%), Positives = 129/295 (43%), Gaps = 51/295 (17%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
+ I+ +G G G VHL + +K + M +++ A E ++L +L HP
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPN 60
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
+ Y +F + ++ +Y PGG L + ++ +L ED + + ++++AL ++H +
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 787 GIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 843
I++RDLK +N+LL + H V + DF +S + S K
Sbjct: 121 LILHRDLKTQNILL--DKHKMVVKIGDFGISKILSSK----------------------- 155
Query: 844 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903
+ + VGT YI+PE+ G + D WALG +LYE+ F
Sbjct: 156 -----SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA------- 203
Query: 904 ANILHKDLKFPSST--PTSLH----AKQLMYRLLHRDPKSRLGSHEGANEIKKHP 952
AN+ LK S T P S +QL+ +L+ DP R ++I P
Sbjct: 204 ANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKR----PQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 33/230 (14%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
F ++ LG G GSV+ +GQ A+K V+ + E IL D P+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIK-----VVPVEEDLQEIIKEISILKQCDSPY 59
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
+ Y S+ T + ++ +YC G + ++ + K L E+ + + + LEYLH
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-KITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
I+RD+K N+LL G L DF +S GQ +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVS----------------------GQLT-----D 151
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896
M N+ +GT ++APE+I G+ + D W+LGI EM G P+
Sbjct: 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 67/270 (24%), Positives = 125/270 (46%), Gaps = 32/270 (11%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 729
++ +G G G LV+ S Q +AMK + + + + V + E +L + HP + A
Sbjct: 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIR--LPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
SF+ H+ ++ +YC GG+L + Q K+ ED + + ++ + ++++H + ++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVL 122
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
+RD+K +N+ L NG V L DF + L + P
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARL---------------------------LTSPGA 155
Query: 850 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909
+ ++VGT Y+ PEI + + D W+LG +LYE+ PF+ + + +
Sbjct: 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG 215
Query: 910 DLK-FPSSTPTSLHAKQLMYRLLHRDPKSR 938
K PS L + L+ ++ R+P+SR
Sbjct: 216 SYKPLPSHYSYELRS--LIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 72/302 (23%), Positives = 122/302 (40%), Gaps = 69/302 (22%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
LG G G V+ + +G + A K + + ++ E +IL HP + LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 733 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 792
++ + + ++ ++C GG L ++ + + L E +R+ +++ AL +LH +I+RD
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIML-ELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRD 128
Query: 793 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 852
LK N+LL +G V L DF +S + ++R
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAK----------NKSTLQKRD----------------- 161
Query: 853 SFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANIL 907
+F+GT ++APE++A + D W+LGI L E+ P
Sbjct: 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP-------------- 207
Query: 908 HKD-------LKFPSSTPTSLHA--------KQLMYRLLHRDPKSRLGSHEGANEIKKHP 952
H + LK S P +L + L +DP R A E+ KHP
Sbjct: 208 HHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP----TAAELLKHP 263
Query: 953 FF 954
F
Sbjct: 264 FV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 85/321 (26%), Positives = 147/321 (45%), Gaps = 48/321 (14%)
Query: 651 AIQKILDSGE-QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 709
A++ ++D G+ + L+++ I G G TG V + SG+ A+K MD R +
Sbjct: 9 ALRMVVDQGDPRSLLENYIKI---GEGSTGIVCIAREKHSGRQVAVKMMDL-----RKQQ 60
Query: 710 HRACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 767
R E++ M D H V +Y S+ + ++ ++ GG L ++ + L E+
Sbjct: 61 RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR---LNEE 117
Query: 768 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 827
+ V+ AL YLH QG+I+RD+K +++LL +G V L+DF S
Sbjct: 118 QIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS--------- 168
Query: 828 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 887
+ KR+ S VGT ++APE+I+ + + VD W+LGI++ EM
Sbjct: 169 KDVPKRK------------------SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210
Query: 888 LYGYTPFRGKTRQKTFANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946
+ G P+ + + + K ++ S + + R+L R+P+ R A
Sbjct: 211 VDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER----ATAQ 266
Query: 947 EIKKHPFFKGVNWALVRCMNP 967
E+ HPF + L C+ P
Sbjct: 267 ELLDHPFL--LQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 93/310 (30%), Positives = 138/310 (44%), Gaps = 50/310 (16%)
Query: 651 AIQKILDSGE-QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 709
A+Q ++D G+ + L +F I G G TG V + + SG+ A+K MD R +
Sbjct: 8 ALQMVVDPGDPRTYLDNFIKI---GEGSTGIVCIATVKSSGKLVAVKKMDL-----RKQQ 59
Query: 710 HRACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 767
R E++ M D H V +Y S+ + ++ ++ GG L D + E+
Sbjct: 60 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEE 116
Query: 768 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 827
+ V+ AL LH QG+I+RD+K +++LL +G V L+DF S
Sbjct: 117 QIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--------- 167
Query: 828 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 887
E RR S VGT ++APE+I+ + VD W+LGI++ EM
Sbjct: 168 -KEVPRR-----------------KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209
Query: 888 LYGYTPFRGKTRQKTFANI---LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944
+ G P+ + K I L LK SL K + RLL RDP R
Sbjct: 210 VDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSL--KGFLDRLLVRDPAQR----AT 263
Query: 945 ANEIKKHPFF 954
A E+ KHPF
Sbjct: 264 AAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 5e-23
Identities = 69/284 (24%), Positives = 129/284 (45%), Gaps = 33/284 (11%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 729
+K +G G G LV+ G+ + +K ++ M + + + E +L + HP +
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMKHPNIVQ 63
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
SF+ ++ ++ DYC GG+L+ ++ Q + ED + + ++ +AL+++H + I+
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
+RD+K +N+ L +G + L DF ++ +L +T E R
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIA--------RVLNSTVELAR---------------- 159
Query: 850 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909
+ +GT Y++PEI + + D WALG +LYEM F + I+
Sbjct: 160 ---TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG 216
Query: 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
P S+ S + L+ +L R+P+ R N I + F
Sbjct: 217 SYP-PVSSHYSYDLRNLVSQLFKRNPRDR----PSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 6e-23
Identities = 73/286 (25%), Positives = 127/286 (44%), Gaps = 46/286 (16%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-----LDM 721
++ ++ +G G G+V+ + +G+ A+K ++ L+ + +RE+ L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIIN----LDTPDDDVSDIQREVALLSQLRQ 58
Query: 722 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 781
P + Y S+ + +I +Y GG + L+ P + E + EV+VAL+
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP---IAEKYISVIIREVLVALK 115
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
Y+H G+I+RD+K N+L+ G+V L DF ++ L N KR
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL---------NQNSSKR-------- 158
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
++FVGT ++APE+I G + + D W+LGI +YEM G P+
Sbjct: 159 ----------STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF 208
Query: 901 KTFANILHKDLKFPSSTPTSLHAKQL---MYRLLHRDPKSRLGSHE 943
+ I P + ++K L + L +PK RL + E
Sbjct: 209 RAMMLIPKSK---PPRLEDNGYSKLLREFVAACLDEEPKERLSAEE 251
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 66/281 (23%), Positives = 111/281 (39%), Gaps = 48/281 (17%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV----MLNRNKVHRACAE--REILDM-- 721
K LG G G V+ G + L E E M
Sbjct: 4 GKKLGEGAFGEVYK------GTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKK 57
Query: 722 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 781
L HP + L + ++T+Y PGG+L L + K+ +D ++ A ++ +E
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQM-ALQIAKGME 116
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
YL + ++RDL N L+ N V ++DF LS + + +KR + P
Sbjct: 117 YLESKNFVHRDLAARNCLVTENLVVKISDFGLS-------RDIYEDDYYRKRGGG--KLP 167
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQ 900
+ ++APE + TS D W+ G+LL+E+ G P+ G + +
Sbjct: 168 IK----------------WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE 211
Query: 901 KTFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ + +D L P + P L+ +LM + DP+ R
Sbjct: 212 EVLELL--EDGYRLPRPENCPDELY--ELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 78/287 (27%), Positives = 124/287 (43%), Gaps = 34/287 (11%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMD-KGVMLNRNKVHRA---CAEREI--LDMLDHPF 726
+GSG GSV+L SG+ A+K ++ V + R+ REI L L H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
+ S H+ + +Y PGG + LL+ +E VR + +++ L YLH +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNR 125
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
GII+RD+K N+L+ G + ++DF +S +L + + K +
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGIS------KKLEANSLSTKTNGAR---------- 169
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 906
S G+ ++APE++ +T D W+LG L+ EML G PF T+ + I
Sbjct: 170 -----PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI 224
Query: 907 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
S +S A + + D R A E+ KHPF
Sbjct: 225 GENASPEIPSNISS-EAIDFLEKTFEIDHNKR----PTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 69/278 (24%), Positives = 116/278 (41%), Gaps = 43/278 (15%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVML-NRNKVHRACAEREILDMLDH 724
K LG G G V+ +L G G A+K + + + R E I+ LDH
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLR---EARIMRKLDH 60
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEY 782
P V L + + ++ +Y GG+L +L R+ L + +A ++ +EY
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEY 117
Query: 783 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
L + I+RDL N L+ N V ++DF LS ++ R +G + P+
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRD----------LYDDDYYRKRGGKLPI 167
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQK 901
++APE + TS D W+ G+LL+E+ G P+ G + ++
Sbjct: 168 R----------------WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 211
Query: 902 TFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ + L P + P L+ LM + DP+ R
Sbjct: 212 VLEYLKNGYRLPQPPNCPPELY--DLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 76/292 (26%), Positives = 124/292 (42%), Gaps = 34/292 (11%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
L +F+ K +G G V+ G+ A+K + M++ E ++L LD
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALE 781
HP V ASF + ++ + G+L ++ ++ +++ E + Y ++ ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
++H + I++RD+KP NV + G V L D L S K TT
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------TT------------- 161
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ- 900
A++S VGT Y++PE I G+ D W+LG LLYEM +PF G
Sbjct: 162 --------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213
Query: 901 -KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS---HEGANEI 948
I D + S + L+ R ++ DP+ R + A E+
Sbjct: 214 YSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-22
Identities = 51/126 (40%), Positives = 74/126 (58%), Gaps = 5/126 (3%)
Query: 855 VGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP 914
+GT +Y+APE++ G H AVDWWALG+ L+E L G PF +T Q+ F NIL++D+ +P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 915 SSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 973
S++A+ + LL DP R G E+K+HP F GV+W ++ P + P
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKR----AGLKELKQHPLFHGVDWENLQNQTMPFIPQP 656
Query: 974 LFATDT 979
TDT
Sbjct: 657 DDETDT 662
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 8e-22
Identities = 80/314 (25%), Positives = 124/314 (39%), Gaps = 68/314 (21%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
+G G G V + +G+ A+K + L ++A E + L HP+V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV-ALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 733 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 792
F + L+ +Y P +L D + + L E V+ Y ++ + Y+H GI++RD
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANGIMHRD 124
Query: 793 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 852
LKP N+L+ +G + + DF L+ L S E R +
Sbjct: 125 LKPANLLISADGVLKIADFGLARLFS--------------------------EEEPRLYS 158
Query: 853 SFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH--- 908
V T Y APE++ GA VD WA+G + E+L G F G+ + A +
Sbjct: 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLG 218
Query: 909 ----------KDL------------------KFPSSTPTSLHAKQLMYRLLHRDPKSRLG 940
L FP ++P +L L+ LL DP RL
Sbjct: 219 TPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALD---LLKGLLVYDPSKRL- 274
Query: 941 SHEGANEIKKHPFF 954
A E +HP+F
Sbjct: 275 ---SAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 65/231 (28%), Positives = 100/231 (43%), Gaps = 42/231 (18%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK--AMDKGVMLNRNKVHRACAEREILDM 721
+ + I+ +GSG G V+ +G+ A+K ++ G + E +L
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-----DDFEIIQQEISMLKE 56
Query: 722 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVA 779
HP + A + S+ + + ++ +YC GG L + R P L E + + E +
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKG 113
Query: 780 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
L YLH G I+RD+K N+LL +G V L DF +S QL T KR
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSA------QL---TATIAKR------ 158
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEM 887
SF+GT ++APE+ A G+ D WALGI E+
Sbjct: 159 ------------KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 71/291 (24%), Positives = 129/291 (44%), Gaps = 38/291 (13%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 724
+ IK +G G G ++L + ++ +K +D M + K +++E+ L + H
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK---EASKKEVILLAKMKH 58
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
P + +ASFQ + ++ +YC GG+L ++RQ + ED + + ++ + L+++H
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 785 CQGIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 843
+ I++RD+K +N+ L NG V+ L DF ++
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--------------------------- 151
Query: 844 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903
+ + M + + VGT Y++PEI + + D W+LG +LYE+ PF G +
Sbjct: 152 LNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV 211
Query: 904 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
I P S S + L+ +L P+ R I K PF
Sbjct: 212 LKICQGYFA-PISPNFSRDLRSLISQLFKVSPRDR----PSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 3e-21
Identities = 72/288 (25%), Positives = 125/288 (43%), Gaps = 49/288 (17%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
+ I LG+G+ GSV V+ +G A K + G + K + E +I+
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK--QILRELQIMHECRS 62
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV--LKEDAVRFYAAEVVVALEY 782
P++ + Y +F + ++C+ ++ G L DR K + + + A VV L Y
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSL----DRIYKKGGPIPVEILGKIAVAVVEGLTY 118
Query: 783 LH-CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
L+ I++RD+KP N+L+ G + L DF +S +L+ N
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS------GELI---------------NS 157
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF------- 894
+ +++FVGT Y++PE I G +T D W+LGI + E+ G PF
Sbjct: 158 I--------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDD 209
Query: 895 RGKTRQKTFANILHKDLKFPSST-PTSL---HAKQLMYRLLHRDPKSR 938
G+ ++L + ++ P P+S + + L +DP R
Sbjct: 210 DGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTER 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 3e-21
Identities = 87/322 (27%), Positives = 133/322 (41%), Gaps = 73/322 (22%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE---ILDMLD 723
++ IK LG G GSV+L +G+ A+K M K RE + + +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF----YSWEECMNLREVKSLRKLNE 56
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 783
HP + L F+ + + +Y G L+ L+ + K E +R +++ L ++
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 784 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 843
H G +RDLKPEN+L+ G V + DF L+ +P P T+
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP----PYTD-------------- 157
Query: 844 MAEPMRASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLYGYTP-FRGKTR-- 899
+V T Y APEI+ ++S VD WALG ++ E LY P F G +
Sbjct: 158 ----------YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAE-LYTLRPLFPGSSEID 206
Query: 900 --QKTFANIL----------HKDL------KFPSSTPTSLH---------AKQLMYRLLH 932
K + +L L +FP PTSLH A L+ +L
Sbjct: 207 QLYKICS-VLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLR 265
Query: 933 RDPKSRLGSHEGANEIKKHPFF 954
DPK R A++ +HP+F
Sbjct: 266 WDPKKRP----TASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 8e-21
Identities = 74/329 (22%), Positives = 125/329 (37%), Gaps = 83/329 (25%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA------CAEREI-- 718
+ I +G G G V+ +G+ A+K + ++ A REI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI---------RMENEKEGFPITAIREIKL 51
Query: 719 LDMLDHPFVPALY---ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 775
L L HP + L S + + ++ +Y +L LLD K E ++ Y +
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGS-IYMVFEYMDH-DLTGLLDSPEVK-FTESQIKCYMKQ 108
Query: 776 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
++ L+YLH GI++RD+K N+L+ +G + L DF L+ R +
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLA------------------RPY 150
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPF 894
+ + + + V T Y PE++ GA VD W++G +L E+ G F
Sbjct: 151 TKRNSADY--------TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202
Query: 895 RGKTRQKTFANILH-------------------KDLKFPSSTPTSL----------HAKQ 925
+G T + I ++LK L A
Sbjct: 203 QGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALD 262
Query: 926 LMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
L+ +LL DPK R+ + + H +F
Sbjct: 263 LLDKLLTLDPKKRISADQALQ----HEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 65/281 (23%), Positives = 116/281 (41%), Gaps = 43/281 (15%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 727
K LG G G V+ +L G A+K + + + + E ++ L HP V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKLGHPNV 58
Query: 728 PALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF-----YAAEVVVAL 780
L + + L+ +Y GG+L +L R ++ + +A ++ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
EYL + ++RDL N L+ + V ++DF LS + + +++ G+
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS--------RDVYDDDYYRKKTGGK-- 168
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 899
P+R ++APE + TS D W+ G+LL+E+ G TP+ G +
Sbjct: 169 -----LPIR----------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213
Query: 900 QKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
++ + K L P P L+ +LM DP+ R
Sbjct: 214 EEVLEYL-RKGYRLPKPEYCPDELY--ELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 71/325 (21%), Positives = 126/325 (38%), Gaps = 87/325 (26%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-----LDMLDHPFV 727
+G G G+V+ +G++ A+K + V L+ + + REI L+ +HP +
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVR--VPLSEEGIPLSTL-REIALLKQLESFEHPNI 63
Query: 728 PALYASFQTK-----THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 782
L + L+ ++ +L L + P L + ++ +++ +++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 783 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDL-------SCLTSCKPQLLLPTTNEKKRRH 835
LH I++RDLKP+N+L+ +G V + DF L LTS
Sbjct: 123 LHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSV---------------- 166
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP-F 894
V T Y APE++ + + + VD W++G + E+ + P F
Sbjct: 167 -------------------VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL-FRRRPLF 206
Query: 895 RGKTR----QKTF------------ANILHKDLKFPSSTPTSL---------HAKQLMYR 929
RG + K F N+ FPS TP S L+ +
Sbjct: 207 RGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKK 266
Query: 930 LLHRDPKSRLGSHEGANEIKKHPFF 954
+L +P R+ + E HP+F
Sbjct: 267 MLTFNPHKRISAFEALQ----HPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 68/248 (27%), Positives = 106/248 (42%), Gaps = 57/248 (22%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI---LDML- 722
F ++ +G G G V+ +GQ A+K MD E EI ++L
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----------IIEDEEEEIKEEYNILR 57
Query: 723 ---DHPFVPALYASFQTKTHVC------LITDYCPGGELFLLLD--RQPTKVLKEDAVRF 771
+HP + Y +F K L+ + C GG + L+ R+ K LKE+ + +
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117
Query: 772 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 831
E + L YLH +I+RD+K +N+LL N V L DF +S L +T +
Sbjct: 118 ILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--------QLDSTLGR 169
Query: 832 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYE 886
+ N+F+GT ++APE+IA A + + D W+LGI E
Sbjct: 170 R-------------------NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
Query: 887 MLYGYTPF 894
+ G P
Sbjct: 211 LADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 74/281 (26%), Positives = 114/281 (40%), Gaps = 65/281 (23%)
Query: 707 NKVHRACAEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVL 764
++ + A RE+ L L H + L +F+ K + L+ +Y L LL+ P L
Sbjct: 40 DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGG-L 97
Query: 765 KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824
DAVR Y +++ A+ Y H II+RD+KPEN+L+ +G + L DF + +P
Sbjct: 98 PPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155
Query: 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGIL 883
+V T Y APE++ G + VD WA+G +
Sbjct: 156 ------------------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCI 191
Query: 884 LYEMLYGYTPFRGKT------------------RQKTF-ANILHKDLKFPS-STPTSLHA 923
+ E+L G F G + Q+ F +N + FP S P SL
Sbjct: 192 MAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLER 251
Query: 924 K----------QLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
+ + L DPK RL E+ +HP+F
Sbjct: 252 RYPGKVSSPALDFLKACLRMDPKERLTCD----ELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 78/300 (26%), Positives = 126/300 (42%), Gaps = 51/300 (17%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 729
I LG G G V+ + +G A K ++ + ++ E EIL +HP++
Sbjct: 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVK 73
Query: 730 LYASFQTKTHVCLITDYCPGGE---LFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
L +F + ++ ++CPGG + L LDR L E ++ +++ AL+YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHSM 129
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
II+RDLK NVLL +G + L DF +S +RR
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSA----------KNVKTLQRR------------ 167
Query: 847 PMRASNSFVGTEEYIAPEII-----AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901
+SF+GT ++APE++ + D W+LGI L EM P +
Sbjct: 168 -----DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 222
Query: 902 TFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958
I + L PS S+ + + L + P++R A ++ +HPF V
Sbjct: 223 VLLKIAKSEPPTLSQPSK--WSMEFRDFLKTALDKHPETR----PSAAQLLEHPFVSSVT 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 66/235 (28%), Positives = 106/235 (45%), Gaps = 29/235 (12%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
L +FR K +G G V+ G A+K + +++ E ++L L+
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALE 781
HP V YASF + ++ + G+L ++ ++ +++ E V Y ++ ALE
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
++H + +++RD+KP NV + G V L D L S K TT
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------TT------------- 161
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896
A++S VGT Y++PE I G+ D W+LG LLYEM +PF G
Sbjct: 162 --------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 83/298 (27%), Positives = 129/298 (43%), Gaps = 55/298 (18%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
LG G+ GSV+ V +G AMK + + L+ +K ++ E +IL P++ Y
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIR--LELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 733 SFQTKTHVCLITDYCPGGELFLLLD-RQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIY 790
+F + V + +Y G L L T+ + ED +R VV L++L + II+
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126
Query: 791 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL--LPTTNEKKRRHKGQQNPVFMAEPM 848
RD+KP NVL+ GNG V L DF +S L+ L TN
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTN------------------- 161
Query: 849 RASNSFVGTEEYIAPEIIAGAG------HTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
+G + Y+APE I G +T D W+LG+ + EM G P+ +T
Sbjct: 162 ------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI 215
Query: 903 FAN---ILHKDLKFPSSTPT--SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
FA I+ D P + P+ S A+ + + L++ P R + HP+
Sbjct: 216 FAQLSAIVDGD---PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE----HPWLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 84/329 (25%), Positives = 139/329 (42%), Gaps = 56/329 (17%)
Query: 651 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 710
A+Q ++ G+ ++ +G G TG V + +G+ A+K MD R +
Sbjct: 10 ALQLVVSPGDP--REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQR 62
Query: 711 RACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 768
R E++ M D H V +Y S+ + ++ ++ GG L D + E+
Sbjct: 63 RELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEEQ 119
Query: 769 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 828
+ V+ AL YLH QG+I+RD+K +++LL +G + L+DF S
Sbjct: 120 IATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS---------- 169
Query: 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 888
E +R S VGT ++APE+I+ + + VD W+LGI++ EM+
Sbjct: 170 KEVPKR-----------------KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
Query: 889 YGYTPFRGKTRQKTFANI---LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945
G P+ + + I L +K + L + +L R+P R A
Sbjct: 213 DGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG--FLDLMLVREPSQR----ATA 266
Query: 946 NEIKKHPFFKGVNWALVRCMNPPELDAPL 974
E+ +HPF K PP PL
Sbjct: 267 QELLQHPFLK--------LAGPPSCIVPL 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 70/286 (24%), Positives = 114/286 (39%), Gaps = 32/286 (11%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLDHPFVP 728
K LG G G V+L +G+ A+K + D + +V+ E ++L L H +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 729 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 788
Y + + + +Y PGG + L + L E R Y +++ +EYLH I
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 789 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 848
++RD+K N+L G+V L DF S KR + M
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGAS-----------------KRLQTICSSGTGM---- 164
Query: 849 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 908
S GT +++PE+I+G G+ D W++G + EML P+ I
Sbjct: 165 ---KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT 221
Query: 909 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
+ + S A+ + R + K R A E+ +H F
Sbjct: 222 QPTNPQLPSHVSPDARNFLRRTFVENAKKR----PSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 70/272 (25%), Positives = 123/272 (45%), Gaps = 34/272 (12%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLDHPFV 727
++ +G G G V LV G+ + +K ++ + N ++ R AE+E +L L HP +
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLN---LRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 728 PALYASFQTKTHVCLIT-DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
A S++ + + I +C GG+L+ L Q K+L E+ V + ++ +AL+YLH +
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
I++RDLK +NV L + + D ++ + +N MA
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIA---------------------RVLENQCDMA- 159
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 906
++ +GT Y++PE+ + + D WALG +YEM F K I
Sbjct: 160 -----STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI 214
Query: 907 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ L P S +L+ +L + P+ R
Sbjct: 215 IEGKLP-PMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-18
Identities = 76/298 (25%), Positives = 126/298 (42%), Gaps = 58/298 (19%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKA--MDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 730
LG G+ G+V+ + + A+K +D V L + + +E EIL D P++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIM----SELEILYKCDSPYIIGF 64
Query: 731 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 790
Y +F + + + T++ GG L + + P VL AV VV L YL I++
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY-RKIPEHVLGRIAV-----AVVKGLTYLWSLKILH 118
Query: 791 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 850
RD+KP N+L+ G V L DF +S QL+ N +
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVS------TQLV---------------NSI-------- 149
Query: 851 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF------- 903
+ ++VGT Y+APE I+G + D W+LGI E+ G P+ + +
Sbjct: 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL 209
Query: 904 ANILHKDLKFPSSTPTSLHAKQLMY---RLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958
I+ +D P P +++ ++ + + + PK R + HPF N
Sbjct: 210 QCIVDED---PPVLPVGQFSEKFVHFITQCMRKQPKERP----APENLMDHPFIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 4e-18
Identities = 83/327 (25%), Positives = 129/327 (39%), Gaps = 80/327 (24%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-VHRACAEREI--LDMLD 723
+ K LG G V+ +G+ A+K + G ++ A REI L L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFT-ALREIKLLQELK 60
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV------- 776
HP + L F K+++ L+ ++ D + KV+K+ ++ A++
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-------DLE--KVIKDKSIVLTPADIKSYMLMT 111
Query: 777 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
+ LEYLH I++RDLKP N+L+ +G + L DF L+
Sbjct: 112 LRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR--------------------- 150
Query: 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPF- 894
P R V T Y APE++ GA H VD W++G + E+L PF
Sbjct: 151 ------SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR-VPFL 203
Query: 895 RGKT--RQ--KTFANI-------------LHKDLKFPSSTPTSLH---------AKQLMY 928
G + Q K F + L ++F PT L A L+
Sbjct: 204 PGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQ 263
Query: 929 RLLHRDPKSRLGSHEGANEIKKHPFFK 955
RLL +P R+ A + +HP+F
Sbjct: 264 RLLTLNPNKRI----TARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 70/236 (29%), Positives = 98/236 (41%), Gaps = 55/236 (23%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLDHPFVPAL 730
LG G GSV L +G FA+K + D L + + E EI P++
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR----ELEINKSCKSPYIVKY 64
Query: 731 YASF--QTKTHVCLITDYCPGGELFLLLDRQPTKVLK------EDAVRFYAAEVVVALEY 782
Y +F ++ + + + +YC GG L D KV K E + A V+ L Y
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSL----DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 783 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
LH + II+RD+KP N+LL G V L DF +S G+
Sbjct: 121 LHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS----------------------GE---- 154
Query: 843 FMAEPMRASNS----FVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894
NS F GT Y+APE I G ++ D W+LG+ L E+ PF
Sbjct: 155 -------LVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 4e-18
Identities = 74/296 (25%), Positives = 126/296 (42%), Gaps = 50/296 (16%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD------KGVMLNRNKVHRACAEREILD 720
+ + +G G +G+V+ +GQ A+K M+ K +++N V R I++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
LD S+ + ++ +Y GG L D + E + E + AL
Sbjct: 81 YLD---------SYLVGDELWVVMEYLAGGSL---TDVVTETCMDEGQIAAVCRECLQAL 128
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
E+LH +I+RD+K +N+LL +G V LTDF C T E+ +R
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF-CAQ---------ITPEQSKR------ 172
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
++ VGT ++APE++ + VD W+LGI+ EM+ G P+ +
Sbjct: 173 -----------STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
Query: 901 KTFANI-LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+ I + + + S + + R L D + R A E+ +HPF K
Sbjct: 222 RALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRG----SAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-18
Identities = 87/342 (25%), Positives = 152/342 (44%), Gaps = 50/342 (14%)
Query: 608 TAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRK--DSPPWKAIQKILDSGEQINLQ 665
+AE +N+ K P T E+ + + + P+ ++K D P + + + + E
Sbjct: 12 SAELLNQYAKYFPHVLFTSEEAFEKYCADLDPEAYKKCVDLPEGEEVPESNNPRE----- 66
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-VHRACAEREILDMLDH 724
H + L + + V GS K + K VMLN + A +E L DH
Sbjct: 67 HMYVLTTLVGRNPTTAAFVATRGSDP--KEKVVAKFVMLNDERQAAYARSELHCLAACDH 124
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED--------AVRFYAAEV 776
+ + F++ + LI +Y GG+L ++Q + LKE + FY ++
Sbjct: 125 FGIVKHFDDFKSDDKLLLIMEYGSGGDL----NKQIKQRLKEHLPFQEYEVGLLFY--QI 178
Query: 777 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
V+AL+ +H + +++RDLK N+ L G + L DF S K
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS---------------------K 217
Query: 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896
+ V + ++SF GT Y+APE+ ++ D W+LG++LYE+L + PF+G
Sbjct: 218 QYSDSV----SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
Query: 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
++++ +L+ P P S K L+ LL ++P R
Sbjct: 274 PSQREIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 5e-18
Identities = 79/334 (23%), Positives = 132/334 (39%), Gaps = 89/334 (26%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDML 722
++ + P+GSG G V +G+ A+K + + ++ +H R E +L +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---QSAIHAKRTYRELRLLKHM 71
Query: 723 DHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 774
DH F PA +S + V L+T G +L ++ Q L +D ++F
Sbjct: 72 DHENVIGLLDVFTPA--SSLEDFQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVY 125
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
+++ L+Y+H GII+RDLKP N+ + + + + DF L+ R
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-------------------R 166
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP 893
H + M +V T Y APEI+ H VD W++G ++ E+L G T
Sbjct: 167 HT--------DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTL 215
Query: 894 FRG------------------------------KTRQKTFANILHKDLK--FPSSTPTSL 921
F G + ++ + KD K F + P
Sbjct: 216 FPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPL-- 273
Query: 922 HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
A L+ ++L DP R+ A E HP+
Sbjct: 274 -AIDLLEKMLVLDPDKRI----TAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 76/298 (25%), Positives = 129/298 (43%), Gaps = 52/298 (17%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMK-------AMDKGVMLNRNKVHRACAEREILDMLDHP 725
+G G G V+L +G+ A+K + ++ V +E E L LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 726 FVPALYASFQTK-THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
+ Y F+T ++ + +Y PGG + L R + +E VRF+ +V+ L YLH
Sbjct: 69 NIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGR-FEEQLVRFFTEQVLEGLAYLH 125
Query: 785 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 844
+GI++RDLK +N+L+ +G ++DF +S K+ N
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGIS-----------------KKSDDIYDN---- 164
Query: 845 AEPMRASNSFVGTEEYIAPEII--AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
+ S G+ ++APE+I G+++ VD W+LG ++ EM G P+ + ++
Sbjct: 165 ----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW---SDEEA 217
Query: 903 FANI--LHKDLKFPSSTP-----TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
A + L P P S A + +P +R A E+ +HPF
Sbjct: 218 IAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNR----PTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-17
Identities = 65/232 (28%), Positives = 106/232 (45%), Gaps = 42/232 (18%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLDHP 725
F + LG+G+ G V V SG A K + + RN++ R E ++L + P
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIR---ELKVLHECNSP 59
Query: 726 FVPALYASFQTKTHVCLITDYCPGGELFLLLD---RQPTKVLKEDAVRFYAAEVVVALEY 782
++ Y +F + + + ++ GG L +L R P +L + ++ V+ L Y
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISI-----AVLRGLTY 114
Query: 783 LHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
L + I++RD+KP N+L+ G + L DF +S GQ
Sbjct: 115 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----------------------GQ--- 149
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 893
+ + M +NSFVGT Y++PE + G +T D W+LG+ L EM G P
Sbjct: 150 --LIDSM--ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-17
Identities = 78/293 (26%), Positives = 126/293 (43%), Gaps = 49/293 (16%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
F ++ +G G G V+ + + A+K +D + +++ E +L D P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
+ Y S+ T + +I +Y GG LL P L+E + E++ L+YLH +
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSE 120
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
I+RD+K NVLL G V L DF ++ QL T + KR
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVA------GQL---TDTQIKR------------- 158
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 906
N+FVGT ++APE+I + + D W+LGI E+ G P + I
Sbjct: 159 -----NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
Query: 907 LHKDLKFPSSTPTSLHA------KQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
P ++P +L K+ + L++DP+ R A E+ KH F
Sbjct: 214 -------PKNSPPTLEGQYSKPFKEFVEACLNKDPRFR----PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 7e-17
Identities = 72/245 (29%), Positives = 106/245 (43%), Gaps = 47/245 (19%)
Query: 715 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 774
E +L D P+V Y S+ T + +I +Y GG LL+ P L E +
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILR 108
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
E++ L+YLH + I+RD+K NVLL +G V L DF ++ QL T + KR
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA------GQL---TDTQIKR- 158
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894
N+FVGT ++APE+I + + S D W+LGI E+ G P
Sbjct: 159 -----------------NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPH 201
Query: 895 RGKTRQKTFANILHKDLKFPSSTPTSLHA------KQLMYRLLHRDPKSRLGSHEGANEI 948
K I P + P +L K+ + L+++P R A E+
Sbjct: 202 SELHPMKVLFLI-------PKNNPPTLEGNYSKPLKEFVEACLNKEPSFR----PTAKEL 250
Query: 949 KKHPF 953
KH F
Sbjct: 251 LKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 9e-17
Identities = 79/300 (26%), Positives = 128/300 (42%), Gaps = 52/300 (17%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD- 723
+ F I+ +GSG G V+ +G+ A+K V+ A ++EI+ M D
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIK-----VIKLEPGEDFAVVQQEIIMMKDC 63
Query: 724 -HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 782
H + A + S+ + + + ++C GG L + T L E + + + E + L Y
Sbjct: 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY--HVTGPLSESQIAYVSRETLQGLYY 121
Query: 783 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
LH +G ++RD+K N+LL NGHV L DF +S + T K++
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT--------ATIAKRK--------- 164
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEM------LYGYTP 893
SF+GT ++APE+ A G+ D WA+GI E+ ++ P
Sbjct: 165 ----------SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214
Query: 894 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
R T +N LK S H + L ++PK R A ++ +HPF
Sbjct: 215 MRALFLM-TKSNFQPPKLKDKMKWSNSFH--HFVKMALTKNPKKR----PTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 62/235 (26%), Positives = 104/235 (44%), Gaps = 29/235 (12%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
L +F+ K +G G V+ + A+K + M++ E ++L L+
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALE 781
HP V SF + ++ + G+L ++ ++ +++ E V Y ++ A+E
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
++H + +++RD+KP NV + G V L D L S K TT
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------TT------------- 161
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896
A++S VGT Y++PE I G+ D W+LG LLYEM +PF G
Sbjct: 162 --------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 76/326 (23%), Positives = 128/326 (39%), Gaps = 69/326 (21%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG--VMLNRNKVHRACAEREILDMLDH 724
++PI+ +GSG G V SG+ A+K + V + R E +IL H
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR---ELKILRHFKH 63
Query: 725 PFVPALYASFQTK----THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
+ A+ + V ++ D ++ QP L E+ +R++ +++ L
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQP---LTEEHIRYFLYQLLRGL 120
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
+Y+H +I+RDLKP N+L+ + + + DF ++ S P E K
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT-------EHKY------- 166
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899
FM E +V T Y APE++ + +T+A+D W++G + EML F GK
Sbjct: 167 --FMTE-------YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217
Query: 900 QKTFANIL-------HKDLK-------------FPSSTPTSLH---------AKQLMYRL 930
IL + L P P A L+ ++
Sbjct: 218 VHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQM 277
Query: 931 LHRDPKSRLGSHEGANEIKKHPFFKG 956
L DP+ R+ + +HPF
Sbjct: 278 LQFDPEERI----TVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 72/242 (29%), Positives = 102/242 (42%), Gaps = 41/242 (16%)
Query: 715 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 774
E +L D P+V Y S+ T + +I +Y GG LL P E +
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLK 108
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
E++ L+YLH + I+RD+K NVLL G V L DF ++ QL T + KR
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVA------GQL---TDTQIKR- 158
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894
N+FVGT ++APE+I + + S D W+LGI E+ G P
Sbjct: 159 -----------------NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPN 201
Query: 895 RGKTRQKTFANILHKDLKFPSSTPT---SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951
+ I K T T S K+ + L++DP R A E+ KH
Sbjct: 202 SDMHPMRVLFLI----PKNNPPTLTGEFSKPFKEFIDACLNKDPSFR----PTAKELLKH 253
Query: 952 PF 953
F
Sbjct: 254 KF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 66/240 (27%), Positives = 105/240 (43%), Gaps = 43/240 (17%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
F ++ +G+G G V+ +GQ A+K MD + ++ E +L H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73
Query: 727 -VPALYASFQTKT------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 779
+ Y +F K+ + L+ ++C G + L+ LKED + + E++
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 780 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
L +LH +I+RD+K +NVLL N V L DF +S QL R G++
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------QL---------DRTVGRR 178
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV-----DWWALGILLYEMLYGYTPF 894
N+F+GT ++APE+IA + A D W+LGI EM G P
Sbjct: 179 ------------NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 4e-16
Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 56/224 (25%)
Query: 762 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821
+L++ R+ +++ AL+Y+H +I+RDLKP N+LL + V L DF L+ S
Sbjct: 102 NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161
Query: 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWAL 880
+ +NPV + + +V T Y APEI+ G+ T VD W++
Sbjct: 162 E--------------NPENPV-LTD-------YVATRWYRAPEILLGSTRYTKGVDMWSV 199
Query: 881 GILLYEMLYGYTPFRGKTRQKTFANIL-------HKDL-------------KFPSSTPTS 920
G +L EML G F G + I+ +D+ PS
Sbjct: 200 GCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKP 259
Query: 921 LH---------AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
L A L+ +LL +P RL A E +HP+
Sbjct: 260 LDELLPKASDDALDLLKKLLVFNPNKRL----TAEEALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 5e-16
Identities = 75/291 (25%), Positives = 125/291 (42%), Gaps = 52/291 (17%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMD------KGVMLNRNKVHRACAEREILDMLDHPF 726
+G G +G+V+ +GQ A+K M+ K +++N V R I++ LD
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 83
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
S+ + ++ +Y GG L D + E + E + AL++LH
Sbjct: 84 ------SYLVGDELWVVMEYLAGGSL---TDVVTETCMDEGQIAAVCRECLQALDFLHSN 134
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
+I+RD+K +N+LL +G V LTDF T E+ +R
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCA----------QITPEQSKR------------ 172
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 906
++ VGT ++APE++ + VD W+LGI+ EM+ G P+ + + +
Sbjct: 173 -----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-L 226
Query: 907 LHKDLKFPSSTPTSLHA--KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+ + P L A + + R L D R GS A E+ +HPF K
Sbjct: 227 IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRR-GS---AKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 6e-16
Identities = 82/329 (24%), Positives = 137/329 (41%), Gaps = 60/329 (18%)
Query: 639 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 698
P P S + +L + +GSG G+V+ V +G+ +A+K +
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI 107
Query: 699 ----DKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFL 754
+ V R ++ C E EIL ++HP V + F + ++ ++ GG L
Sbjct: 108 YGNHEDTV---RRQI---CREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-- 159
Query: 755 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814
+ T + E + A +++ + YLH + I++RD+KP N+L+ +V + DF +S
Sbjct: 160 ----EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVS 215
Query: 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII-----AGA 869
+ +A+ M NS VGT Y++PE I GA
Sbjct: 216 RI---------------------------LAQTMDPCNSSVGTIAYMSPERINTDLNHGA 248
Query: 870 GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN----ILHKDLKFPSSTPT-SLHAK 924
A D W+LG+ + E G PF G RQ +A+ I P + T S +
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFPF-GVGRQGDWASLMCAICMSQP--PEAPATASREFR 305
Query: 925 QLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
+ L R+P R A ++ +HPF
Sbjct: 306 HFISCCLQREPAKRW----SAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 8e-16
Identities = 70/285 (24%), Positives = 114/285 (40%), Gaps = 32/285 (11%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMK--AMDKGVMLNRNKVHRACAER-EILDMLDHPFVPA 729
LG G G+V+ L GQ A+K +D +L K + E ++L L H +
Sbjct: 8 LGKGAYGTVYC-GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
+ + + ++ PGG + +L+R L E Y +++ + YLH ++
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
+RD+K NV+L NG + L DF C +L + M + M
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDF------GCARRLAWVGLHGTHSN---------MLKSMH 169
Query: 850 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR-QKTFANILH 908
GT ++APE+I +G+ D W++G ++EM G P R F H
Sbjct: 170 ------GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH 223
Query: 909 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
+ L S A + L RD R A ++ +H F
Sbjct: 224 RGLMPRLPDSFSAAAIDFVTSCLTRDQHER----PSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 80/319 (25%), Positives = 126/319 (39%), Gaps = 72/319 (22%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFV 727
+ +G G G V +GQ A+K K V + V + A REI L L HP +
Sbjct: 6 LSKIGEGSYGVVFKCRNRETGQIVAIK---KFVESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 728 PALYASFQTKTHVCLITDYCPGGELFLL--LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
L F+ K + L+ +YC + +L L++ P V E ++ + + A+ + H
Sbjct: 63 VNLIEVFRRKRKLHLVFEYC---DHTVLNELEKNPRGV-PEHLIKKIIWQTLQAVNFCHK 118
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
I+RD+KPEN+L+ G + L DF + ++L
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFA-------RILTG------------------- 152
Query: 846 EPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR----- 899
P +V T Y APE++ G + VD WA+G + E+L G + GK+
Sbjct: 153 -PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211
Query: 900 --QKTFANIL--H----------KDLKFPSSTP----------TSLHAKQLMYRLLHRDP 935
+KT +++ H K L P S A + L DP
Sbjct: 212 LIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDP 271
Query: 936 KSRLGSHEGANEIKKHPFF 954
RL E+ +HP+F
Sbjct: 272 TERLSC----EELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-16
Identities = 81/287 (28%), Positives = 127/287 (44%), Gaps = 53/287 (18%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
LGSG TG+V + G+ FA+K +D M + +RA AE L D + +
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 733 SFQTK--------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE-------VV 777
F K + L+ DY G+L RQ K + F E V+
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDL-----RQEIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 778 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
+A+ ++H + +I+RD+K N+LL NG V L DF S + + T ++ R
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA-------TVSDDVGR--- 203
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897
+F GT Y+APEI ++ D ++LG+LLYE+L PF G+
Sbjct: 204 ---------------TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248
Query: 898 TRQKTFANILHKDL--KF-PSSTPTSLHAKQLMYRLLHRDPKSRLGS 941
++ ++HK L ++ P S ++++ LL DPK R S
Sbjct: 249 NMEE----VMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSS 291
|
Length = 496 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 9e-16
Identities = 65/290 (22%), Positives = 116/290 (40%), Gaps = 36/290 (12%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMD--KGVMLNRNKVHRAC-AEREILDMLDHPFVPA 729
LG+G S + +G A+K + + + +V A E ++ L+HP +
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
+ + +H L ++ GG + LL + KE + Y +++ L YLH II
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQII 125
Query: 790 YRDLKPENVLLQGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 848
+RD+K N+L+ G + + DF + + L +GQ
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFG----AAAR----LAAKGTGAGEFQGQ---------- 167
Query: 849 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 908
+GT ++APE++ G + + D W++G ++ EM P+ + A I
Sbjct: 168 -----LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK 222
Query: 909 -KDLKFPSSTPTSLH--AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
S P L + + R L P+ R + E+ KHP F+
Sbjct: 223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDR----PPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 74/329 (22%), Positives = 126/329 (38%), Gaps = 88/329 (26%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---D 723
++ + +G G V + +G+Y+A+K M K + + + REI +
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD----------RQPTKVLKEDAVRFYA 773
HP + L + L +F L+D ++P L E V+ Y
Sbjct: 57 HPNILRLIEVLFDRKTGRLAL-------VFELMDMNLYELIKGRKRP---LPEKRVKSYM 106
Query: 774 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 833
+++ +L+++H GI +RD+KPEN+L++ + + L DF KP P T
Sbjct: 107 YQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKP----PYT----- 156
Query: 834 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYT 892
++ T Y APE + G + +D WA+G + +E+L +
Sbjct: 157 -------------------EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197
Query: 893 PFRGKTR------------------QKTFANILHKDLKFPSSTPTSL-----HAKQ---- 925
F G K F H + FPS T L +A
Sbjct: 198 LFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLD 257
Query: 926 LMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
L+ +LL DP R+ + + HP+F
Sbjct: 258 LLKKLLAYDPDERITAKQALR----HPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 84/356 (23%), Positives = 135/356 (37%), Gaps = 79/356 (22%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
P +P+G G G V V G+ A+K M V N R E ++L H
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPN-VFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 727 V--------PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 778
V P F+ + ++T+ +++ QP L D V+ + +++
Sbjct: 61 VLSALDILQPPHIDPFE---EIYVVTELMQSDLHKIIVSPQP---LSSDHVKVFLYQILR 114
Query: 779 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 838
L+YLH GI++RD+KP N+L+ N + + DF L+ + +H Q
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA-----------RVEEPDESKHMTQ 163
Query: 839 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR-- 895
+ V T+ Y APEI+ G+ H TSAVD W++G + E+L F+
Sbjct: 164 E---------------VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208
Query: 896 ---------------------GKTRQKTFANILHKDLKFPS-------STPTSLHAKQLM 927
+ A+IL K PS S+ + A L+
Sbjct: 209 SPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLL 268
Query: 928 YRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNP---PELDAPLFATDTE 980
R+L DP R+ A + HP+ CM ++ +D E
Sbjct: 269 CRMLVFDPDKRI----SAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFE 320
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 3e-15
Identities = 75/342 (21%), Positives = 131/342 (38%), Gaps = 97/342 (28%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDMLD 723
+ +KP+GSG G V +G+ A+K K + + + R E ++L L
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK---KISNVFDDLIDAKRILREIKLLRHLR 57
Query: 724 HP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLD-----RQPTKVLKEDAVR 770
H P F V ++T+ + D + P + L +D ++
Sbjct: 58 HENIIGLLDILRPPSPEDFND---VYIVTEL-------METDLHKVIKSP-QPLTDDHIQ 106
Query: 771 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830
++ +++ L+YLH +I+RDLKP N+L+ N + + DF L+
Sbjct: 107 YFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA---------------- 150
Query: 831 KKRRHKGQQ--NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEM 887
R F+ E +V T Y APE++ + T A+D W++G + E+
Sbjct: 151 ---RGVDPDEDEKGFLTE-------YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL 200
Query: 888 LYGYTPFRGKT-----------------------RQKTFANIL-------HKDL--KFPS 915
L F G+ + N L K L FP
Sbjct: 201 LTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPG 260
Query: 916 STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957
++P ++ L+ ++L DPK R+ A+E HP+ +
Sbjct: 261 ASPEAID---LLEKMLVFDPKKRI----TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 3e-15
Identities = 74/286 (25%), Positives = 122/286 (42%), Gaps = 42/286 (14%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
+G G +G+V +GQ A+K ++ + + K E ++ L +P +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 733 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 792
SF + ++ +Y GG L D + E + E + ALE+LH +I+RD
Sbjct: 84 SFLVGDELFVVMEYLAGGSL---TDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRD 140
Query: 793 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 852
+K +NVLL +G V LTDF T E+ +R +
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCA----------QITPEQSKR-----------------S 173
Query: 853 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK--- 909
+ VGT ++APE++ + VD W+LGI+ EM+ G P+ + + I
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP 233
Query: 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+L+ P + + R L D + R GS A E+ +HPF K
Sbjct: 234 ELQNPEKLSPIF--RDFLNRCLEMDVEKR-GS---AKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 3e-15
Identities = 74/291 (25%), Positives = 125/291 (42%), Gaps = 52/291 (17%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMD------KGVMLNRNKVHRACAEREILDMLDHPF 726
+G G +G+V+ +GQ A++ M+ K +++N V R I++ LD
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 84
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
S+ + ++ +Y GG L D + E + E + ALE+LH
Sbjct: 85 ------SYLVGDELWVVMEYLAGGSL---TDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
+I+RD+K +N+LL +G V LTDF T E+ +R
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA----------QITPEQSKR------------ 173
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 906
++ VGT ++APE++ + VD W+LGI+ EM+ G P+ + + +
Sbjct: 174 -----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-L 227
Query: 907 LHKDLKFPSSTPTSLHA--KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+ + P L A + + R L D + R GS A E+ +H F K
Sbjct: 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR-GS---AKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 74/302 (24%), Positives = 122/302 (40%), Gaps = 65/302 (21%)
Query: 666 HFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNR--NKVHRACAER 716
H + IK LG G G V ELC +G+ A+K LN + HR+ ER
Sbjct: 5 HLKFIKQLGEGHFGKV---ELCRYDPLGDNTGEQVAVK------SLNHSGEEQHRSDFER 55
Query: 717 EILDM--LDHPFVPAL--YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFY 772
EI + LDH + + LI +Y P G L L R ++ + + F
Sbjct: 56 EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF- 114
Query: 773 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 832
++++ ++YL Q I+RDL N+L++ V ++DF L+ +LP +
Sbjct: 115 SSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA--------KVLPEDKDYY 166
Query: 833 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG- 890
+ ++P+F + APE + + +SA D W+ G+ LYE+ YG
Sbjct: 167 YVKEPGESPIF----------------WYAPECLRTSKFSSASDVWSFGVTLYELFTYGD 210
Query: 891 ------------YTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPK 936
+G+ +L + L P S P ++ LM +P+
Sbjct: 211 PSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVY--DLMKLCWEAEPQ 268
Query: 937 SR 938
R
Sbjct: 269 DR 270
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-15
Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 36/229 (15%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLDHP 725
F I LG+G+ G V V+ SG A K + + RN++ R E ++L + P
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECNSP 63
Query: 726 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
++ Y +F + + + ++ GG L +L + K + E+ + + V+ L YL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 786 Q-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 844
+ I++RD+KP N+L+ G + L DF +S GQ +
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----------------------GQ-----L 154
Query: 845 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 893
+ M +NSFVGT Y++PE + G ++ D W++G+ L E+ G P
Sbjct: 155 IDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 63/235 (26%), Positives = 100/235 (42%), Gaps = 42/235 (17%)
Query: 673 LGSGDTGSVHLVELCGSGQ-YFAMK-------AMDKGVMLNRNKVHRACAEREIL-DMLD 723
LGSG G V+ V +GQ A+K A K + +E I+ + L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 724 HPFVPALYASFQTKTHVCLITDY---CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
HP + Y +F + ++ D P GE F L ++ + E+ + ++V+AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSL-KEKKQRFTEERIWNIFVQMVLAL 126
Query: 781 EYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
YLH + I++RDL P N++L + V++TDF L+ + K +
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA-------------------KQKQPE 167
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894
+ + S VGT Y PEI+ + D WA G +LY+M PF
Sbjct: 168 SKL---------TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 81/322 (25%), Positives = 133/322 (41%), Gaps = 69/322 (21%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH----RACAEREILDML 722
+ P+ +G G G+V+ SG + A+K++ V N + + R A + L+
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VQTNEDGLPLSTVREVALLKRLEAF 59
Query: 723 DHPFVPALY---ASFQT--KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 777
DHP + L A+ +T +T V L+ ++ +L LD+ P L + ++ + +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 778 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
L++LH I++RDLKPEN+L+ G V L DF L+ + SC+ L
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL-------------- 164
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897
PV V T Y APE++ + + + VD W++G + EM F G
Sbjct: 165 --TPV------------VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210
Query: 898 TRQ----KTFANI-LHKDLKFPSSTPTSLHA--------------------KQLMYRLLH 932
+ K F I L + +P A QL+ +L
Sbjct: 211 SEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLT 270
Query: 933 RDPKSRLGSHEGANEIKKHPFF 954
+P R+ A +HPFF
Sbjct: 271 FNPHKRI----SAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 58/224 (25%), Positives = 86/224 (38%), Gaps = 67/224 (29%)
Query: 764 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823
L E VR Y +++ +E+ H II+RD+KPEN+L+ +G V L DF +
Sbjct: 97 LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA--------- 147
Query: 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGI 882
+A P +V T Y APE++ G + AVD WA+G
Sbjct: 148 ------------------RTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGC 189
Query: 883 LLYEMLYGYTPFRGKT------------------------RQKTFANILHKDLK------ 912
L+ EML G F G + + FA + ++K
Sbjct: 190 LVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLE 249
Query: 913 --FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
FP + L L + L DP R S +++ H FF
Sbjct: 250 KRFPKLSGLVL---DLAKQCLRIDPDDRPSS----SQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 86/384 (22%), Positives = 144/384 (37%), Gaps = 108/384 (28%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGS--GQYFAMK----AMDKGVMLNRNKVHRACAEREIL 719
+ IK LG G G V + + A+K K ++ R A RE+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR-------ALREL- 52
Query: 720 DMLDHPFVPALYASFQTKTH---VCL----ITDYCPGGELFL---LLDRQPTKVLK---- 765
L F + H CL I EL+L L++ ++++
Sbjct: 53 -KLLRHF----------RGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQP 101
Query: 766 -EDA-VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823
DA + + +++ L+Y+H +++RDLKP N+L+ + + + DF L+ S P
Sbjct: 102 LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP-- 159
Query: 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEI-IAGAGHTSAVDWWALGI 882
+N FM E +V T Y APEI ++ +T A+D W++G
Sbjct: 160 --------------GENAGFMTE-------YVATRWYRAPEIMLSFQSYTKAIDVWSVGC 198
Query: 883 LLYEMLYGYTPFRGKTRQKTFANILH----------------------KDL------KFP 914
+L E+L F+GK IL + L F
Sbjct: 199 ILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFE 258
Query: 915 SSTPTSLH-AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 973
S P + A L+ +LL DP R+ E +HP+ L +P D P
Sbjct: 259 SIFPNANPLALDLLEKLLAFDPTKRISVEEAL----EHPY-------LAIWHDPD--DEP 305
Query: 974 LFATDTEKEYKVVDPGMQDLQQNV 997
+ + ++ D M++L+ +
Sbjct: 306 VCQKPFDFSFESED-SMEELRDMI 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 77/332 (23%), Positives = 124/332 (37%), Gaps = 66/332 (19%)
Query: 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LD 720
L+ + + LG G G V+ +G+ A+K K +M N A REI L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK---KILMHNEKDGFPITALREIKILK 62
Query: 721 MLDHPFVPAL------YASFQTKTHVC--LITDYCPGGELFLLLDRQPTKVLKEDAVRFY 772
L HP V L + ++T Y +L LL+ K L E ++ Y
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVK-LTESQIKCY 120
Query: 773 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL-TSCKPQLLLPTTNEK 831
+++ + YLH I++RD+K N+L+ G + + DF L+ P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP-------- 172
Query: 832 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG 890
+ R + V T Y PE++ G +T+AVD W +G + EM
Sbjct: 173 -------KGGGGGGT--RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
Query: 891 YTPFRGKT---------------RQKTFANI-----LHKDLKFPSSTPT--SLHAKQ--- 925
+GK+ ++T+ F + T K
Sbjct: 224 RPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE 283
Query: 926 ---LMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
L+ +LL DP RL A++ +HP+F
Sbjct: 284 GLDLLSKLLSLDPYKRL----TASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 73/279 (26%), Positives = 108/279 (38%), Gaps = 78/279 (27%)
Query: 716 REI--LDMLDHPFVPALYASFQTK--THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 771
REI L L HP + L K + L+ +YC +L LLD PT E V+
Sbjct: 55 REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTP-FSESQVKC 112
Query: 772 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 831
+++ L+YLH II+RDLK N+LL G + + DF L+ + + P
Sbjct: 113 LMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK---- 168
Query: 832 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG 890
V T Y APE++ G +T+A+D WA+G +L E+L
Sbjct: 169 -----------------------VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
Query: 891 YTPFRGKT----------------------------------RQKTFANILHKDLKFPSS 916
GK+ ++ + N+ H KFP
Sbjct: 206 KPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKH---KFPWL 262
Query: 917 TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+ L +L+ LL DPK R A E + +FK
Sbjct: 263 SEAGL---RLLNFLLMYDPKKRA----TAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
LG G G V+ + A+K + + +H E + L H +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSYLKHRNIVQYLG 72
Query: 733 SFQTKTHVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 790
S + + PGG L LL + P K E + FY +++ L+YLH I++
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKD-NEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 791 RDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
RD+K +NVL+ +G V ++DF S +R G NP
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTS------------------KRLAG-INPC------- 165
Query: 850 ASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFR--GKTRQKTFAN 905
+ +F GT +Y+APE+I G+ + D W+LG + EM G PF G+ + F
Sbjct: 166 -TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV 224
Query: 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943
+ K S AK + R DP R +H+
Sbjct: 225 GMFKIHP-EIPESLSAEAKNFILRCFEPDPDKRASAHD 261
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 71/291 (24%), Positives = 115/291 (39%), Gaps = 35/291 (12%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLDH 724
+R K LG G G V+L +G+ A K + D +V E ++L L H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 725 PFVPALYASFQTKTH--VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 782
+ Y + + + + +Y PGG + L + L E R Y +++ + Y
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSY 121
Query: 783 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
LH I++RD+K N+L G+V L DF S K Q
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGAS---------------------KRLQTIC 160
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
+R S GT +++PE+I+G G+ D W+LG + EML P+
Sbjct: 161 MSGTGIR---SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA 217
Query: 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
I + + S HA+ + + + + R A E+ +HPF
Sbjct: 218 IFKIATQPTNPQLPSHISEHARDFLGCIF-VEARHR----PSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 61/270 (22%), Positives = 114/270 (42%), Gaps = 34/270 (12%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 729
+K LGSG G VHL + G A+K + +G M + + A +++ L HP +
Sbjct: 9 LKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEA----KVMMKLSHPNLVQ 63
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
LY + + ++T+Y G L L + L + + ++V A+EYL G I
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
+RDL N L+ + V ++DF L+ + +L +++ +G + PV
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLA-------RYVL---DDQYTSSQGTKFPV------- 165
Query: 850 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILH 908
++ PE+ + +S D W+ G+L++E+ G P+ + + ++
Sbjct: 166 ---------KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV-S 215
Query: 909 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ +MY H P+ R
Sbjct: 216 AGYRLYRPKLAPTEVYTIMYSCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-14
Identities = 76/294 (25%), Positives = 125/294 (42%), Gaps = 31/294 (10%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
+Q + I+ +G G G V+L + A+K + + + N R E +I L
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAA------- 774
HP + +Y+ V Y G L LL Q + KE A +
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
++ +EY+H +G+++RDLKP+N+LL G V + D+ + + + LL ++
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE--- 177
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894
M VGT +Y+APE + G + + D +ALG++LY+ML P+
Sbjct: 178 ------RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
Query: 895 RGKTRQKTFANILHKD-LKFPSST------PTSLHAKQLMYRLLHRDPKSRLGS 941
R K +K I ++D + P P L Q+ + L DP R S
Sbjct: 232 RRKKGRK----ISYRDVILSPIEVAPYREIPPFL--SQIAMKALAVDPAERYSS 279
|
Length = 932 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 43/240 (17%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
F ++ +G+G G V+ +GQ A+K MD + ++ E +L H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 727 -VPALYASFQTKT------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 779
+ Y +F K + L+ ++C G + L+ LKE+ + + E++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 780 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
L +LH +I+RD+K +NVLL N V L DF +S + R G++
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---------------QLDRTVGRR 168
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPF 894
N+F+GT ++APE+IA A + D W+LGI EM G P
Sbjct: 169 ------------NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 74/295 (25%), Positives = 121/295 (41%), Gaps = 51/295 (17%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 729
I LG G G V+ + +G A K +D + ++ E +IL DHP +
Sbjct: 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVK 66
Query: 730 LYASFQTKTHVCLITDYCPGGEL---FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
L +F + ++ ++ ++C GG + L L+R L E +R + + AL YLH
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTEPQIRVVCKQTLEALNYLHEN 122
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
II+RDLK N+L +G + L DF +S T +RR
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSA----------KNTRTIQRR------------ 160
Query: 847 PMRASNSFVGTEEYIAPEII-----AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901
+SF+GT ++APE++ + D W+LGI L EM P +
Sbjct: 161 -----DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR 215
Query: 902 TFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
I + L PS + K + + L ++ +R ++ +HPF
Sbjct: 216 VLLKIAKSEPPTLAQPSRWSSEF--KDFLKKCLEKNVDARW----TTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 76/323 (23%), Positives = 126/323 (39%), Gaps = 75/323 (23%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI--L 719
F+ ++ +G G G V+ +G+ A+K + +GV + A REI L
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV--------PSTAIREISLL 53
Query: 720 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 779
L+HP + L T+ + L+ ++ +L +D P + ++ Y +++
Sbjct: 54 KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 780 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
L + H +++RDLKP+N+L+ G + L DF L+ R G
Sbjct: 113 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-------------------RAFGV- 152
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKT 898
P+R V T Y APEI+ G +++AVD W+LG + EM+ F G +
Sbjct: 153 -------PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205
Query: 899 RQKTFANILH----------------KDLK--FPSSTPTSLH---------AKQLMYRLL 931
I D K FP + L+ ++L
Sbjct: 206 EIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQML 265
Query: 932 HRDPKSRLGSHEGANEIKKHPFF 954
H DP R+ + HPFF
Sbjct: 266 HYDPNKRISAKAALA----HPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 69/262 (26%), Positives = 117/262 (44%), Gaps = 48/262 (18%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLDHP 725
F I LG+G+ G V V SG A K + + RN++ R E ++L + P
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECNSP 63
Query: 726 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ---PTKVLKEDAVRFYAAEVVVALEY 782
++ Y +F + + + ++ GG L +L + P ++L + ++ V+ L Y
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI-----AVIKGLTY 118
Query: 783 LHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
L + I++RD+KP N+L+ G + L DF +S GQ
Sbjct: 119 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----------------------GQ--- 153
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF---RGKT 898
+ + M +NSFVGT Y++PE + G ++ D W++G+ L EM G P K
Sbjct: 154 --LIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209
Query: 899 RQKTFANILHKDLKFPSSTPTS 920
+ F + D P+ + TS
Sbjct: 210 LELMFGCPVEGD---PAESETS 228
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 4e-13
Identities = 68/291 (23%), Positives = 112/291 (38%), Gaps = 42/291 (14%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
F ++ +G G G+V+ + + A+K M + K E + L + HP
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
+ + L+ +YC G LL + ++P + ++ A+ A + L YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ---GLAYLHS 143
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
+I+RD+K N+LL G V L DF + + S
Sbjct: 144 HNMIHRDIKAGNILLTEPGQVKLADFGSASIAS--------------------------- 176
Query: 846 EPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
+NSFVGT ++APE+I + VD W+LGI E+ P
Sbjct: 177 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 232
Query: 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
+I + S S + + + L + P+ R S E+ KH F
Sbjct: 233 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTS----EELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-13
Identities = 85/357 (23%), Positives = 144/357 (40%), Gaps = 93/357 (26%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
L+ ++ +KP+GSG G V G A+K + + N+ RA E +L ++
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVN 78
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFL---LLDRQPTKV----LKEDAVRFYAAEV 776
H + +L F + + D ++L L+D +V L + + + ++
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQD------VYLVMELMDANLCQVIHMELDHERMSYLLYQM 132
Query: 777 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
+ +++LH GII+RDLKP N++++ + + + DF L+ T+C TN
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAC--------TN------- 176
Query: 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896
FM P +V T Y APE+I G G+ VD W++G ++ E++ G F+G
Sbjct: 177 ------FMMTP------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224
Query: 897 KTR----------------------QKTFANI--------------LHKDLKFPSSTP-- 918
Q T N L D FPS +
Sbjct: 225 TDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERD 284
Query: 919 --TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 973
+ A+ L+ ++L DP R+ E HP+ W +P E +AP
Sbjct: 285 KLKTSQARDLLSKMLVIDPDKRISVDEALR----HPYIT--VW-----YDPAEAEAP 330
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 71/322 (22%), Positives = 137/322 (42%), Gaps = 73/322 (22%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDH 724
F+ ++ LG G +V+ +G+ A+K + L+ + + A REI M L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKE----IHLDAEEGTPSTAIREISLMKELKH 57
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLD-RQPTKVLKEDAVRFYAAEVVVALEYL 783
+ L+ T+ + L+ +Y +L +D L + V+ + +++ + +
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 784 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 843
H +++RDLKP+N+L+ G + L DF L+ R G
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLA-------------------RAFGI----- 152
Query: 844 MAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR--- 899
P+ ++ V T Y AP+++ G+ +++++D W++G ++ EM+ G F G
Sbjct: 153 ---PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ 209
Query: 900 -------------------------QKTFANILHKDLK--FPSSTPTSLHAKQLMYRLLH 932
+ TF +DL+ FP + P + L++RLL
Sbjct: 210 LLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGI---DLLHRLLQ 266
Query: 933 RDPKSRLGSHEGANEIKKHPFF 954
+P+ R+ +H+ HP+F
Sbjct: 267 LNPELRISAHDALQ----HPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 72/297 (24%), Positives = 119/297 (40%), Gaps = 51/297 (17%)
Query: 667 FRPIKPLGSGDTGSVH----LVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD-- 720
IK LGSG G+V+ + E A+K + R + A +EILD
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-------REETSPK-ANKEILDEA 60
Query: 721 ----MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAA 774
+DHP V L + LIT P G L LD R + + +
Sbjct: 61 YVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCL---LDYVRNHKDNIGSQYLLNWCV 116
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
++ + YL + +++RDL NVL++ HV +TDF L+ L +EK+
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD---------VDEKEYH 167
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTP 893
+G + P+ +++A E I +T D W+ G+ ++E M +G P
Sbjct: 168 AEGGKVPI----------------KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
Query: 894 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950
+ G ++L K + P ++ ++ + D +SR E NE K
Sbjct: 212 YEGI-PAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 72/293 (24%), Positives = 110/293 (37%), Gaps = 42/293 (14%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
+ F ++ +G G G+V+ + + A+K M + K E L L H
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYL 783
P + + L+ +YC G +L + ++P L+E + + L YL
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP---LQEVEIAAICHGALQGLAYL 131
Query: 784 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 843
H I+RD+K N+LL G V L DF + L S
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS------------------------- 166
Query: 844 MAEPMRASNSFVGTEEYIAPEIIAG--AGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
+NSFVGT ++APE+I G VD W+LGI E+ P
Sbjct: 167 ------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
Query: 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
+I D SS S + + + L + P+ R S E+ KH F
Sbjct: 221 SALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSE----ELLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|131984 TIGR02938, nifL_nitrog, nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-12
Identities = 31/92 (33%), Positives = 56/92 (60%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
I+YA+ F ++TGYT +E++G+N L T PE + +L + + G+LLN +KD
Sbjct: 26 ILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNRRKD 85
Query: 274 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 305
G + LT+AP+ ++ G+ F+GM ++++
Sbjct: 86 GELYLAELTVAPVLNEAGETTHFLGMHRDITE 117
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes [Central intermediary metabolism, Nitrogen fixation, Regulatory functions, Protein interactions]. Length = 494 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 70/279 (25%), Positives = 118/279 (42%), Gaps = 39/279 (13%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAEREILDML 722
F+ IK LGSG G+V+ G+ A+K + + NK E ++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 66
Query: 723 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVAL 780
D+P V L T T V LIT P G LLD R+ + + + ++ +
Sbjct: 67 DNPHVCRLLGICLTST-VQLITQLMPFG---CLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
YL + +++RDL NVL++ HV +TDF L+ L +EK+ +G +
Sbjct: 123 NYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---------GADEKEYHAEGGKV 173
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGKTR 899
P+ +++A E I +T D W+ G+ ++E M +G P+ G
Sbjct: 174 PI----------------KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IP 216
Query: 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
++IL K + P ++ +M + D SR
Sbjct: 217 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSR 255
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 25/138 (18%)
Query: 761 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820
T+ L D ++++ +++ L+Y+H +++RDLKP N+LL N + + DF L+ +
Sbjct: 100 TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD-- 157
Query: 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEI-IAGAGHTSAVDWWA 879
P + H G F+ E +V T Y APEI + G+T A+D W+
Sbjct: 158 -----PEHD-----HTG-----FLTE-------YVATRWYRAPEIMLNSKGYTKAIDIWS 195
Query: 880 LGILLYEMLYGYTPFRGK 897
+G +L EML F GK
Sbjct: 196 VGCILAEMLSNRPLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 82/310 (26%), Positives = 123/310 (39%), Gaps = 69/310 (22%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVP 728
I+ +G G G V+ V G A+K +D + AE IL L +HP V
Sbjct: 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDP----ISDVDEEIEAEYNILQSLPNHPNVV 82
Query: 729 ALYASFQTKTHVCLITDYCPGGELFLLLDR----QPTKVLK----------EDAVRFYAA 774
Y F D GG+L+L+L+ T+++K E + +
Sbjct: 83 KFYGMFYK-------ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
++ L++LH II+RD+K N+LL G V L DF +S QL T+ + RR
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA------QL----TSTRLRR 185
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLY 889
N+ VGT ++APE+IA + + D W+LGI E+
Sbjct: 186 -----------------NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD 228
Query: 890 GYTPFRGKTRQKTFANILHKDLKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHE---GA 945
G P KT K P + PT LH ++ H + + E
Sbjct: 229 GDPPLFDMHPVKTL-------FKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSV 281
Query: 946 NEIKKHPFFK 955
+ +HPF K
Sbjct: 282 THLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-12
Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 40/240 (16%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-- 721
L+ ++ +KP+GSG G V + A+K + + +N+ H A RE++ M
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVLMKC 79
Query: 722 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKEDAVRFYAAEVV 777
++H + L F + + D EL +D +V L + + + +++
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL---MDANLCQVIQMELDHERMSYLLYQML 136
Query: 778 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
+++LH GII+RDLKP N++++ + + + DF L+ R G
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-------------------RTAG 177
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897
FM P +V T Y APE+I G G+ VD W++G ++ EM+ G F G
Sbjct: 178 TS---FMMTP------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 6e-12
Identities = 85/356 (23%), Positives = 145/356 (40%), Gaps = 91/356 (25%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-- 721
L+ ++ +KP+GSG G V + A+K + + +N+ H A RE++ M
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKC 72
Query: 722 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKEDAVRFYAAEVV 777
++H + +L F + + D EL +D +V L + + + +++
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMEL---MDANLCQVIQMELDHERMSYLLYQML 129
Query: 778 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
+++LH GII+RDLKP N++++ + + + DF L+ R G
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-------------------RTAG 170
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG- 896
FM P +V T Y APE+I G G+ VD W++G ++ EM+ F G
Sbjct: 171 TS---FMMTP------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 897 ---------------------KTRQKTFANIL-----HKDLKFPSSTPTSL--------- 921
K Q T N + + L FP P SL
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281
Query: 922 ----HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 973
A+ L+ ++L DP R+ +E +HP+ W +P E++AP
Sbjct: 282 LKASQARDLLSKMLVIDPAKRI----SVDEALQHPYIN--VW-----YDPAEVEAP 326
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 7e-12
Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 61/215 (28%)
Query: 769 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-VSLTDFDLSCLTSCKPQLLLPT 827
V+ Y+ ++ AL Y+H + I +RDLKP+N+L+ N H + L DF
Sbjct: 172 VKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF---------------- 215
Query: 828 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYE 886
K GQ+ S S++ + Y APE++ GA +T+ +D W+LG ++ E
Sbjct: 216 -GSAKNLLAGQR-----------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAE 263
Query: 887 MLYGYTPFRGKTRQKTFANIL-----------------HKDLKFPSSTPTSLH------- 922
M+ GY F G++ I+ + D+KFP P L
Sbjct: 264 MILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGT 323
Query: 923 ---AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
A + + L +P RL E + PFF
Sbjct: 324 PDDAINFISQFLKYEPLKRLNPIEALAD----PFF 354
|
Length = 440 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 67/277 (24%), Positives = 106/277 (38%), Gaps = 47/277 (16%)
Query: 677 DTGSVHLVELCGSGQY-------------FAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
D S+ L+ G+GQ+ A+K + G M AE +I+ L
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR 59
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 783
HP + LYA + + ++T+ G L L + LK + AA+V + YL
Sbjct: 60 HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 784 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 843
Q I+RDL NVL+ N + DF L+ + + + R G + P+
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARVIK---------EDIYEARE-GAKFPI- 168
Query: 844 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKT 902
++ APE + D W+ GILL E++ YG P+ G T +
Sbjct: 169 ---------------KWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV 213
Query: 903 FANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ + P P L+ +M DP R
Sbjct: 214 LQQVDQGYRMPCPPGCPKELY--DIMLDCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 44/206 (21%)
Query: 759 QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817
+ ED + A +V ALEYLH + +I+RD+KP NVL+ NG V L DF +S
Sbjct: 95 DKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS--- 151
Query: 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV-- 875
L + +A+ + A G + Y+APE I +
Sbjct: 152 ---GYL----VDS-------------VAKTIDA-----GCKPYMAPERINPELNQKGYDV 186
Query: 876 --DWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSST----PTSLHAKQLMYR 929
D W+LGI + E+ G P+ KT L + ++ PS S + + +
Sbjct: 187 KSDVWSLGITMIELATGRFPY---DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNK 243
Query: 930 LLHRDPKSRLGSHEGANEIKKHPFFK 955
L ++ K R E+ +HPFF+
Sbjct: 244 CLKKNYKER----PNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 44/233 (18%)
Query: 663 NLQH-FRPIKPLGSGDTGSVHLVELCGSGQYFAMK--AMDKGVMLNRNKVHRACAEREIL 719
N QH + I+ +GSG G V+ +G+ A+K ++ G + ++EI
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF-------SLIQQEIF 58
Query: 720 DMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 777
+ + H + A + S+ ++ + + +YC GG L + T L E + + E +
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETL 116
Query: 778 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
L YLH +G ++RD+K N+LL NG V L DF ++ T KR+
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKI---------TATIAKRK--- 164
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEM 887
SF+GT ++APE+ A G+ D WA+GI E+
Sbjct: 165 ---------------SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 67/270 (24%), Positives = 112/270 (41%), Gaps = 62/270 (22%)
Query: 715 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 774
E ++L L + L +F+ + + L+ +Y + LL+ P V + VR Y
Sbjct: 50 ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPP-EKVRSYIY 107
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
+++ A+ + H I++RD+KPEN+L+ N + L DF + R
Sbjct: 108 QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFA-------------------R 148
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894
+ + + E +V T Y +PE++ GA + AVD W++G +L E+ G F
Sbjct: 149 NLSEGSNANYTE-------YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
Query: 895 RGK-------TRQKT------------FANILHKDLKFPSST-PTSLHAK---------- 924
G+ T QK ++N L+FP+ P SL +
Sbjct: 202 PGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLL 261
Query: 925 QLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
LM LL +P R + + N HP F
Sbjct: 262 DLMKNLLKLNPTDRYLTEQCLN----HPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 61/238 (25%), Positives = 100/238 (42%), Gaps = 30/238 (12%)
Query: 715 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 774
E EIL DHP + L K + ++ + PGG L L R+ L + +
Sbjct: 42 EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSL 100
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
+ +EYL + I+RDL N L+ N + ++DF +S + + T +
Sbjct: 101 DAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMS-----REEEGGIYTVSDGLK 155
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTP 893
Q P+ ++ APE + +TS D W+ GILL+E G TP
Sbjct: 156 ----QIPI----------------KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTP 195
Query: 894 FRGKTRQKTFANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950
+ G + Q+T I + P P ++ +LM + DP++R E NE++
Sbjct: 196 YPGMSNQQTRERIESGYRMPAPQLCPEEIY--RLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 63/269 (23%), Positives = 107/269 (39%), Gaps = 36/269 (13%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
LG G G V+ A+K + + M +V E ++ + HP + L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 733 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 792
+ +IT++ G L L + + + + A ++ A+EYL + I+RD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 793 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 852
L N L+ N V + DF LS L T + H G + P+
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRL----------MTGDTYTAHAGAKFPI---------- 169
Query: 853 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM-LYGYTPFRGKTRQKTFANILHKDL 911
++ APE +A + D WA G+LL+E+ YG +P+ G + + +L K
Sbjct: 170 ------KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKGY 222
Query: 912 KF--PSSTPTSLHAKQLMYRLLHRDPKSR 938
+ P P ++ +LM +P R
Sbjct: 223 RMERPEGCPPKVY--ELMRACWQWNPSDR 249
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 77/329 (23%), Positives = 130/329 (39%), Gaps = 71/329 (21%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDMLDH 724
++ + P+GSG GSV +G A+K + + ++ +H R E +L + H
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKH 75
Query: 725 P--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 776
F PA S + V L+T + G +L ++ Q L +D V+F ++
Sbjct: 76 ENVIGLLDVFTPA--RSLEEFNDVYLVT-HLMGADLNNIVKCQK---LTDDHVQFLIYQI 129
Query: 777 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
+ L+Y+H II+RDLKP N+ + + + + DF L+ RH
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA-------------------RHT 170
Query: 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR 895
+ +V T Y APEI+ H VD W++G ++ E+L G T F
Sbjct: 171 DDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219
Query: 896 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
G + L L+ + L ++ S N I+
Sbjct: 220 GTDH----IDQLKLILRLVGTPGAEL--------------LKKISSESARNYIQSLTQMP 261
Query: 956 GVNWALVRC-MNPPELD--APLFATDTEK 981
+N+A V NP +D + D++K
Sbjct: 262 KMNFANVFIGANPLAVDLLEKMLVLDSDK 290
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 64/274 (23%), Positives = 108/274 (39%), Gaps = 38/274 (13%)
Query: 671 KPLGSGDTGSVHL-VELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 727
K LG G+ GSV V L SG+ A+K + + + K E ++ LDHP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLDHPCI 58
Query: 728 PALYASFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
L + + + L+ + P G L L R+ V ++ A +V + + YL +
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSD---LKELAHQVAMGMAYLESK 114
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
++RDL NVLL ++DF +S L ++ R + P+
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMS--------RALGAGSDYYRATTAGRWPL---- 162
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFAN 905
++ APE I +S D W+ G+ L+E YG P+ + A
Sbjct: 163 ------------KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM 210
Query: 906 ILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ + L P P ++ +M P+ R
Sbjct: 211 LESGERLPRPEECPQEIY--SIMLSCWKYRPEDR 242
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 73/282 (25%), Positives = 121/282 (42%), Gaps = 45/282 (15%)
Query: 673 LGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 729
LG G+ GSV +L GS Q A+K M K + + + + E + DHP V
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVK-MLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 730 LYA-SFQTKTHVCL-----ITDYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEVVV 778
L S +++ L I + G+L FLL+ R +P + + VRF ++
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF-MIDIAS 124
Query: 779 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 838
+EYL + I+RDL N +L N V + DF LS KK
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS----------------KK------ 162
Query: 839 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGK 897
++ + R + +++A E +A +T+ D WA G+ ++E M G TP+ G
Sbjct: 163 ---IYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219
Query: 898 TRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ + ++ + LK P ++ +LM + +PK R
Sbjct: 220 ENSEIYNYLIKGNRLKQPPDCLEDVY--ELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 30/233 (12%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLD 723
++R K LG G G V+L +G+ A+K + D +V+ E ++L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 724 HPFVPALYASFQ--TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 781
H + Y + + + + +Y PGG + L + L E+ R Y +++ +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVS 120
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
YLH I++RD+K N+L G+V L DF S KR
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS-----------------KRIQT----- 158
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894
+ M+ S GT +++PE+I+G G+ D W++ + EML P+
Sbjct: 159 ICMSGT--GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 65/316 (20%), Positives = 115/316 (36%), Gaps = 59/316 (18%)
Query: 674 GSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS 733
D VHL + + A+K ++ ++ + E L HP + S
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 734 FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 793
F + + +++ G LL + L E A+ F +V+ AL+Y+H +G I+R +
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSV 127
Query: 794 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNS 853
K ++LL G+G V L+ S KR+ P + +
Sbjct: 128 KASHILLSGDGKVVLSGLRYSV----------SMIKHGKRQRVVHDFPKSSVKNL----- 172
Query: 854 FVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPF-------------RGKT 898
+++PE++ G+ D +++GI E+ G+ PF RG
Sbjct: 173 -----PWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTV 227
Query: 899 R----QKTF----ANILHKDLKFPSSTPT-----------SLHAKQLMYRLLHRDPKSRL 939
+ T+ ++ S H Q + L RDP+SR
Sbjct: 228 PCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR- 286
Query: 940 GSHEGANEIKKHPFFK 955
A+++ H FFK
Sbjct: 287 ---PSASQLLNHSFFK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 74/293 (25%), Positives = 117/293 (39%), Gaps = 48/293 (16%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPALY 731
+GSG G V+ + +G A+K M + N+ + R + +++ D P++ Y
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 732 ASFQTKTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYL-HCQGI 788
F T + V I L LL R P + ED + +V AL YL G+
Sbjct: 81 GYFITDSDV-FICMELMSTCLDKLLKRIQGP---IPEDILGKMTVAIVKALHYLKEKHGV 136
Query: 789 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 848
I+RD+KP N+LL +G+V L DF +S + +
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGISG---------------------------RLVDSK 169
Query: 849 RASNSFVGTEEYIAPEIIAGAGHTSA----VDWWALGILLYEMLYGYTPFRG-KTRQKTF 903
+ S G Y+APE I D W+LGI L E+ G P++ KT +
Sbjct: 170 AKTRS-AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL 228
Query: 904 ANILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
IL ++ P + S + L +D + R E+ +HPF +
Sbjct: 229 TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKR----PKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 75/308 (24%), Positives = 125/308 (40%), Gaps = 59/308 (19%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
+R +K +GSG G+V +G A+K + + + RA E +L + H
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHEN 75
Query: 727 VPALYASFQTKTHVCLITDY---CP--GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 781
V L F + D+ P G +L L+ + L ED ++F +++ L+
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK---LSEDRIQFLVYQMLKGLK 132
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
Y+H GII+RDLKP N+ + + + + DF L+ R +
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-------------------RQTDSE-- 171
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
+V T Y APE+I H T VD W++G ++ EML G F+G
Sbjct: 172 ---------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222
Query: 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 960
I+ + TP+ ++ +L S + N +KK P F+ ++
Sbjct: 223 DQLMEIMKV-----TGTPS-------------KEFVQKLQSEDAKNYVKKLPRFRKKDFR 264
Query: 961 -LVRCMNP 967
L+ NP
Sbjct: 265 SLLPNANP 272
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 58/245 (23%), Positives = 109/245 (44%), Gaps = 43/245 (17%)
Query: 665 QHFRPIKPLGSGDTGSVHLV-ELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI 718
Q + + +G G G V +L G++ A+K + ++G+ L+ R A
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS---TIREVAVLRH 57
Query: 719 LDMLDHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 773
L+ +HP V L+ + +T + L+ ++ +L LD+ P + + ++
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 116
Query: 774 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 833
+++ L++LH +++RDLKP+N+L+ +G + L DF L+ + S
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--------------- 161
Query: 834 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 893
F A S V T Y APE++ + + + VD W++G + EM
Sbjct: 162 ---------FQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 208
Query: 894 FRGKT 898
FRG +
Sbjct: 209 FRGSS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-11
Identities = 62/250 (24%), Positives = 100/250 (40%), Gaps = 54/250 (21%)
Query: 723 DHPFVPALYASFQTKTHVC-----------LITDYCPGGELFLLLDRQPTKVLKE----- 766
D P A F+ +T +C L + P G LF + + P + L+E
Sbjct: 14 DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAAD 73
Query: 767 ------DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCLT 817
+ R +V+ AL H QGI++RDLKP+N+++ G H + DF +
Sbjct: 74 GALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGT-- 130
Query: 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 877
LLP + + + +GT Y APE + G T D
Sbjct: 131 ------LLPGVRDADVAT------------LTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 878 WALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK-FPSSTPTSLHAK---QLMYRLLHR 933
+A G++ E L G +G + A IL++ L S P + Q++ + L++
Sbjct: 173 YAWGLIFLECLTGQRVVQG----ASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNK 228
Query: 934 DPKSRLGSHE 943
DP+ R S
Sbjct: 229 DPRQRAASAP 238
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-11
Identities = 67/286 (23%), Positives = 107/286 (37%), Gaps = 53/286 (18%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
+ IK L G G V + G +K KG L E +L ++HP
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL---------IEAMLLQNVNHPS 118
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
V + + + C++ + +L+ L ++ + + A+ ++ L YLH Q
Sbjct: 119 VIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ-ILEGLRYLHAQ 176
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
II+RD+K EN+ + V + D + Q PV
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDLGAA------------------------QFPV--VA 210
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGK-TRQKTFA 904
P GT E APE++A + S D W+ GI+L+EML Y T F + + +
Sbjct: 211 PAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYV 268
Query: 905 NILHKDL------------KFPSSTPTSLHAKQLMYRLLHRDPKSR 938
H L +FP + L + Y L R P +R
Sbjct: 269 KSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTR 314
|
Length = 357 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 73/274 (26%), Positives = 114/274 (41%), Gaps = 59/274 (21%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH----RACAEREILDML-DH 724
I+ +G G G V V +G A+K +D +H AE IL L DH
Sbjct: 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDP--------IHDIDEEIEAEYNILKALSDH 74
Query: 725 PFVPALYASFQTKT-----HVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVV 777
P V Y + K + L+ + C GG + L+ + + ++E + + E +
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 778 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
+ L++LH I+RD+K N+LL G V L DF +S QL T+ + RR
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA------QL----TSTRLRR--- 181
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYT 892
N+ VGT ++APE+IA + + + D W+LGI E+ G
Sbjct: 182 --------------NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
Query: 893 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQL 926
P + K P + P +LH +L
Sbjct: 228 PLADLHPMRAL-------FKIPRNPPPTLHQPEL 254
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 52/224 (23%), Positives = 81/224 (36%), Gaps = 77/224 (34%)
Query: 780 LEYLHCQGIIYRDLKPENVLLQGNGH----VSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
+ YLH +++RDLKP N+L+ G G V + D L+ L + + L
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA---------- 170
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPF 894
+PV V T Y APE++ GA H T A+D WA+G + E+L F
Sbjct: 171 --DLDPV------------VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216
Query: 895 RGKTRQKTFANILHKD-----------------------------------LKFPSS--- 916
+G+ + +N +D +PS+
Sbjct: 217 KGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLA 276
Query: 917 ------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
L+ +LL DP R+ + E HP+F
Sbjct: 277 KWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE----HPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 78/335 (23%), Positives = 133/335 (39%), Gaps = 94/335 (28%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
+ PIKP+G G G V + + + A+K + NR R E ++L LDH
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN-AFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 727 V--------PALYASFQTKTHVCLITDYCPGGELFLLLDR------QPTKVLKEDAVRFY 772
V P +F V ++ + L+D + ++ L +D +++
Sbjct: 66 VIAIKDIMPPPHREAFND---VYIVYE---------LMDTDLHQIIRSSQTLSDDHCQYF 113
Query: 773 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 832
+++ L+Y+H +++RDLKP N+LL N + + DF L+ TS K
Sbjct: 114 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD---------- 163
Query: 833 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPE-IIAGAGHTSAVDWWALGILLYEMLYGY 891
FM E +V T Y APE ++ + +T+A+D W++G + E+L
Sbjct: 164 ----------FMTE-------YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
Query: 892 TPFRGK---TRQKTFANIL----HKDL-------------------------KFPSSTPT 919
F GK + K +L +DL FP + P
Sbjct: 207 PLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPL 266
Query: 920 SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
++ L+ ++L DP R+ E HP+
Sbjct: 267 AI---DLLEKMLVFDPSKRITVEEALA----HPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 65/275 (23%), Positives = 112/275 (40%), Gaps = 65/275 (23%)
Query: 712 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 771
A E +L L H + L+ TK + L+ +Y +L +D L VR
Sbjct: 50 AIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG-GLSMHNVRL 107
Query: 772 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 831
+ +++ L Y H + +++RDLKP+N+L+ G + L DF L+
Sbjct: 108 FLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLA----------------- 150
Query: 832 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG 890
R K + P + ++ V T Y P+++ G+ +++++D W +G + YEM G
Sbjct: 151 --RAK--------SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
Query: 891 YTPFRGKT----------------RQKTFANILH----KDLKFPSSTPTSL--------- 921
F G T ++T+ + K FP P L
Sbjct: 201 RPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDR 260
Query: 922 --HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
H ++L + L +PK R+ + E KHP+F
Sbjct: 261 IPHGEELALKFLQYEPKKRISAAEAM----KHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 65/276 (23%), Positives = 103/276 (37%), Gaps = 38/276 (13%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
F ++ +G G G+V+ + + A+K M + K E L L HP
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
+ + L+ +YC G LL + ++P + ++ AV A + L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ---GLAYLHS 133
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
+I+RD+K N+LL G V L DF A
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFG-------------------------------SA 162
Query: 846 EPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
M +N FVGT ++APE+I + VD W+LGI E+ P
Sbjct: 163 SIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222
Query: 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+I + S S + + + L + P+ R
Sbjct: 223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 43/234 (18%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELC------GSGQYFAMKAMDKGVMLNRNKVHRACAEREI 718
++ + I+ LG G G V L C G+G+ A+K + + + + + ++EI
Sbjct: 4 RYLKKIRVLGEGHFGKVSL--YCYDPANDGTGEMVAVKTLKREC----GQQNTSGWKKEI 57
Query: 719 --LDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 774
L L H + S Q + LI +Y P G L D P L + +A
Sbjct: 58 NILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL---RDYLPKHKLNLAQLLLFAQ 114
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
++ + YLH Q I+RDL NVLL + V + DF L+ +P +E R
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA--------KAVPEGHEYYRV 166
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 888
+ +PVF + A E + + A D W+ G+ LYE+L
Sbjct: 167 REDGDSPVF----------------WYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 69/280 (24%), Positives = 122/280 (43%), Gaps = 38/280 (13%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRACAEREILD 720
IN +K LGSG G VHL + Q A+KA+++G M + + A +++
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKW--RAQIKVAIKAINEGAMSEEDFIEEA----KVMM 54
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
L HP + LY + + ++T++ G L L RQ L +D + +V +
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGM 113
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
EYL I+RDL N L+ G V ++DF ++ + +L +++ G +
Sbjct: 114 EYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMT-------RYVL---DDEYTSSSGAKF 163
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 899
PV ++ PE+ + ++S D W+ G+L++E+ G PF K+
Sbjct: 164 PV----------------KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN 207
Query: 900 QKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ I L P +++ ++MY H P+ R
Sbjct: 208 YEVVEMISRGFRLYRPKLASMTVY--EVMYSCWHEKPEGR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 59/245 (24%), Positives = 102/245 (41%), Gaps = 45/245 (18%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
+ ++PLG G G V + A+K K V+ + V A E +I+ LDH
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVK---KIVLTDPQSVKHALREIKIIRRLDHDN 63
Query: 727 VPALY-------------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 773
+ +Y T+ + I +L +L++ P L E+ R +
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP---LSEEHARLFM 120
Query: 774 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV-SLTDFDLSCLTSCKPQLLLPTTNEKK 832
+++ L+Y+H +++RDLKP NV + V + DF L+ + +
Sbjct: 121 YQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV------------DPH 168
Query: 833 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGY 891
HKG +++E + T+ Y +P ++ + T A+D WA G + EML G
Sbjct: 169 YSHKG-----YLSEGLV-------TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
Query: 892 TPFRG 896
F G
Sbjct: 217 PLFAG 221
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 39/230 (16%)
Query: 715 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 774
E + L L H + +L+A V +IT+ G L L +VL ++ A
Sbjct: 52 EVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMAC 111
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
+V + YL Q I+RDL N+L+ + + DF L+ L
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLI----------------- 154
Query: 835 HKGQQNPVFMAE----PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 889
+ V+++ P + + APE + ++ D W+ GILLYEM Y
Sbjct: 155 ----KEDVYLSSDKKIPYK----------WTAPEAASHGTFSTKSDVWSFGILLYEMFTY 200
Query: 890 GYTPFRGKTRQKTFANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
G P+ G + + I + P+ P ++ ++M +P+ R
Sbjct: 201 GQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIY--KIMLECWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 80/319 (25%), Positives = 122/319 (38%), Gaps = 72/319 (22%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 729
+K +GSG GSV +G+ A+K + + + RA E +L + H V
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIG 78
Query: 730 LYASFQTKTHVCLITD-YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 788
L F + D Y + L + L ED V++ +++ L+Y+H GI
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGI 138
Query: 789 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 848
I+RDLKP N+ + + + + DF L+ RH +
Sbjct: 139 IHRDLKPGNLAVNEDCELKILDFGLA-------------------RHADAE--------- 170
Query: 849 RASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANIL 907
+V T Y APE+I H VD W++G ++ EML G T F+GK IL
Sbjct: 171 --MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228
Query: 908 ------------------------------HKDLK--FPSSTPTSLHAKQLMYRLLHRDP 935
KD FP ++P A L+ ++L D
Sbjct: 229 KVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASP---QAVDLLEKMLELDV 285
Query: 936 KSRLGSHEGANEIKKHPFF 954
RL A E +HP+F
Sbjct: 286 DKRL----TATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 60/241 (24%), Positives = 102/241 (42%), Gaps = 58/241 (24%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAERE 717
+H + I+ LG G+ GSV ELC +G+ A+K + + R E E
Sbjct: 4 RHLKFIQQLGKGNFGSV---ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFER---EIE 57
Query: 718 ILDMLDHPFVPALYASFQTKTHVC---------LITDYCPGGELFLLLDRQPTKVLKEDA 768
IL L H + Y VC L+ +Y P G L L + ++ D
Sbjct: 58 ILKSLQHDNI-VKYKG------VCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL---DH 107
Query: 769 VRF--YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 826
+ YA+++ +EYL + ++RDL N+L++ V + DF L+ +LP
Sbjct: 108 RKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT--------KVLP 159
Query: 827 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 886
E + + ++P+F + APE + + + A D W+ G++LYE
Sbjct: 160 QDKEYYKVREPGESPIF----------------WYAPESLTESKFSVASDVWSFGVVLYE 203
Query: 887 M 887
+
Sbjct: 204 L 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 76/277 (27%), Positives = 111/277 (40%), Gaps = 42/277 (15%)
Query: 671 KPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRA-CAEREILDMLDHPF 726
K +G+G+ G V L G+ A+K + G K R +E I+ DHP
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT---EKQRRDFLSEASIMGQFDHPN 66
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLL---DRQPTKVLKEDAVRFYAAEVVVALEYL 783
+ L V ++T+Y G L L D Q T + +R A+ ++YL
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIAS----GMKYL 122
Query: 784 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 843
G ++RDL N+L+ N ++DF LS + P+ T K
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI----------- 171
Query: 844 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGKTRQKT 902
P+R + APE IA TSA D W+ GI+++E M YG P+ + Q
Sbjct: 172 ---PIR----------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV 218
Query: 903 FANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
I L P P +LH QLM +D R
Sbjct: 219 IKAIEEGYRLPAPMDCPAALH--QLMLDCWQKDRNER 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 9e-11
Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 56/248 (22%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-- 721
L+ ++ +KP+GSG G V +GQ A+K + + +N H A RE++ M
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKL 71
Query: 722 LDHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKEDAV 769
++H F P S + V L+ + L+D +V L + +
Sbjct: 72 VNHKNIIGLLNVFTPQ--KSLEEFQDVYLVME---------LMDANLCQVIQMDLDHERM 120
Query: 770 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829
+ +++ +++LH GII+RDLKP N++++ + + + DF L+
Sbjct: 121 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------- 165
Query: 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 889
R G FM P +V T Y APE+I G G+ VD W++G ++ EM+
Sbjct: 166 ----RTAGTS---FMMTP------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 212
Query: 890 GYTPFRGK 897
G F G
Sbjct: 213 GTVLFPGT 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 69/272 (25%), Positives = 113/272 (41%), Gaps = 38/272 (13%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 729
+K LG+G G V + A+K++ +G M AE ++ L HP +
Sbjct: 11 VKKLGAGQFGEVWM-GYYNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVR 65
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
LYA T+ + +IT+Y G L L L + + AA++ + ++ + I
Sbjct: 66 LYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
+RDL+ N+L+ + DF L+ L NE R +G + P+
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIE---------DNEYTAR-EGAKFPI------- 167
Query: 850 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH 908
++ APE I T D W+ GILL E++ YG P+ G T + N L
Sbjct: 168 ---------KWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-LE 217
Query: 909 KDLKF--PSSTPTSLHAKQLMYRLLHRDPKSR 938
+ + P + P L+ +LM P+ R
Sbjct: 218 RGYRMPRPDNCPEELY--ELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 75/336 (22%), Positives = 116/336 (34%), Gaps = 87/336 (25%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLDH 724
+ + +G G G V + Q A+K K +M N + A RE IL +L H
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALK---KVLMENEKEGFPITALREIKILQLLKH 70
Query: 725 PFVPALYASFQT--------KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 776
V L +T K L+ ++C + +L V+F +E+
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFC---------EHDLAGLLSNKNVKFTLSEI 121
Query: 777 -------VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829
+ L Y+H I++RD+K N+L+ +G + L DF L+ S N
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLS-------KN 174
Query: 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEML 888
K R+ + V T Y PE++ G +D W G ++ EM
Sbjct: 175 SKPNRYTNR----------------VVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218
Query: 889 YGYTPFRGKTRQKTFANI-------------------LHKDLKFPSSTP----------- 918
+G T Q I L K ++ P
Sbjct: 219 TRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYV 278
Query: 919 TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
HA L+ +LL DP R+ + N H FF
Sbjct: 279 KDPHALDLIDKLLVLDPAKRIDADTALN----HDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 72/272 (26%), Positives = 118/272 (43%), Gaps = 38/272 (13%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 729
IK LG+G G V + G+ + A+K + G M + + A +I+ L H +
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEA----QIMKKLRHDKLVQ 65
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
LYA ++ + ++T+Y G L L + LK + AA+V + Y+ I
Sbjct: 66 LYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124
Query: 790 YRDLKPENVLLQGNGHV-SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 848
+RDL+ N+L+ G+G V + DF L+ L NE R +G + P+
Sbjct: 125 HRDLRSANILV-GDGLVCKIADFGLARLIE---------DNEYTAR-QGAKFPI------ 167
Query: 849 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANIL 907
++ APE T D W+ GILL E++ G P+ G ++ +
Sbjct: 168 ----------KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 217
Query: 908 HK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ P P SLH +LM + +DP+ R
Sbjct: 218 RGYRMPCPQDCPISLH--ELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 67/229 (29%)
Query: 764 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823
L + +F+ +++ AL+Y+H + +RDLKP+N+L + + + DF L+ +
Sbjct: 100 LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-----RVAF 154
Query: 824 L-LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWAL 880
PT +F + +V T Y APE+ + +T A+D W++
Sbjct: 155 NDTPTA-------------IFWTD-------YVATRWYRAPELCGSFFSKYTPAIDIWSI 194
Query: 881 GILLYEMLYGYTPFRGKT--------------------------RQKTFANILHKDL--- 911
G + E+L G F GK + + + + + K
Sbjct: 195 GCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVP 254
Query: 912 ---KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957
KFP++ P +L +L+ RLL DPK R A E P+FKG+
Sbjct: 255 FSQKFPNADPLAL---RLLERLLAFDPKDR----PTAEEALADPYFKGL 296
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 53/231 (22%), Positives = 101/231 (43%), Gaps = 32/231 (13%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
+ ++ LG G +V+ + +G+ A+K + + A E +L L H
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR--LQEEEGTPFTAIREASLLKGLKHAN 64
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
+ L+ TK + L+ +Y +L +D+ P L + V+ + +++ L Y+H +
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGG-LHPENVKLFLFQLLRGLSYIHQR 122
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
I++RDLKP+N+L+ G + L DF L+ S
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSV--------------------------- 155
Query: 847 PMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRG 896
P ++ V T Y P+++ G+ +++ +D W +G + EM+ G F G
Sbjct: 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 66/281 (23%), Positives = 105/281 (37%), Gaps = 38/281 (13%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
F + +G G G+V+ + + A+K M K E + L L HP
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
+ + L+ +YC G LL + ++P + ++ A+ A + L YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ---GLAYLHS 139
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
+I+RD+K N+LL G V L DF + +S
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--------------------------- 172
Query: 846 EPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
+NSFVGT ++APE+I + VD W+LGI E+ P
Sbjct: 173 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 228
Query: 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943
+I D S + + + L + P+ R S E
Sbjct: 229 LYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAE 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 70/286 (24%), Positives = 113/286 (39%), Gaps = 59/286 (20%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 727
K LG G G V E SG A+K + + + E I+ LDH +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLK--EAAIMHSLDHENL 58
Query: 728 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF--------YAAEVVVA 779
LY T + ++T+ P G L LDR L++DA+ YA ++
Sbjct: 59 IRLYGVVLTHP-LMMVTELAPLGSL---LDR-----LRKDALGHFLISTLCDYAVQIANG 109
Query: 780 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
+ YL + I+RDL N+LL + V + DF L + + +
Sbjct: 110 MRYLESKRFIHRDLAARNILLASDDKVKIGDFGLM-----------------RALPQNED 152
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 898
+ V M E ++ + + APE + + A D W G+ L+EM YG P+ G +
Sbjct: 153 HYV-MEEHLKVPFA------WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS 205
Query: 899 RQKTFANILHK------DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ IL K L+ P + P ++ +M + +P R
Sbjct: 206 G----SQILKKIDKEGERLERPEACPQDIY--NVMLQCWAHNPADR 245
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 73/280 (26%), Positives = 115/280 (41%), Gaps = 50/280 (17%)
Query: 673 LGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 729
+G+G+ G V L G + A+K + G + + +E I+ DHP +
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMGQFDHPNIIH 69
Query: 730 LYASFQTKTHVCLITDYCPGGEL--FLLL-DRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
L V +IT++ G L FL D Q T + +R AA ++YL
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAA----GMKYLSEM 125
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
++RDL N+L+ N ++DF LS + +P + +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLS-----------------RFLEDDTSDPTYTSS 168
Query: 847 -----PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGKTRQ 900
P+R + APE IA TSA D W+ GI+++E M YG P+ + Q
Sbjct: 169 LGGKIPIR----------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218
Query: 901 KTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSR 938
N + +D + P PT+LH QLM +D +R
Sbjct: 219 DVI-NAIEQDYRLPPPMDCPTALH--QLMLDCWQKDRNAR 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 66/274 (24%), Positives = 108/274 (39%), Gaps = 47/274 (17%)
Query: 680 SVHLVELCGSGQY-------------FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
S+ L G+GQ+ A+K + G M E +I+ L H
Sbjct: 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDK 62
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
+ LYA + + ++T+Y G L L K L+ + AA++ + YL +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
I+RDL N+L+ N + DF L+ L +E R G + P+
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIE---------DDEYTARE-GAKFPI---- 168
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFAN 905
++ APE T D W+ GILL E++ YG P+ G T ++
Sbjct: 169 ------------KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ 216
Query: 906 I-LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ + P + P L+ LM + +DP+ R
Sbjct: 217 VERGYRMPRPPNCPEELY--DLMLQCWDKDPEER 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 78/291 (26%), Positives = 122/291 (41%), Gaps = 59/291 (20%)
Query: 671 KPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 727
K LG G+ GSV +L GS A+K M K + +++ +E + DHP V
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 728 PALY------ASFQTKTHVCLITDYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEV 776
L +S Q +I + G+L FLL R P K+ + ++F ++
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF-MVDI 122
Query: 777 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK---- 832
+ +EYL + I+RDL N +L+ + V + DF LS KK
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS----------------KKIYSG 166
Query: 833 ---RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 888
R+ + + PV ++IA E +A +TS D WA G+ ++E+
Sbjct: 167 DYYRQGRIAKMPV----------------KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
Query: 889 YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
G TP+ G + + + H + LK P L+ LMY DPK R
Sbjct: 211 RGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYD--LMYSCWRADPKDR 259
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 34/240 (14%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 720
+I + + +K LG+G G V + S + A+K + G M V E ++
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM----SVQAFLEEANLMK 56
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVA 779
L H + LYA + + +IT+Y G L L KVL + F +A++
Sbjct: 57 TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF-SAQIAEG 115
Query: 780 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
+ Y+ + I+RDL+ NVL+ + + DF L+ + NE R +G +
Sbjct: 116 MAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE---------DNEYTAR-EGAK 165
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 898
P+ ++ APE I T D W+ GILLYE++ YG P+ G +
Sbjct: 166 FPI----------------KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 44/230 (19%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMK-----AMDKGVMLNRNKVHRACAEREI--L 719
++ ++ +G G G V+ +G+ A+K D+GV + A REI L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGV--------PSTAIREISLL 52
Query: 720 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 779
L+HP + L ++ + L+ ++ +L +D P L ++ Y +++
Sbjct: 53 KELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111
Query: 780 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
+ Y H +++RDLKP+N+L+ G + L DF L+ R G
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLA-------------------RAFGV- 151
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEML 888
P+R V T Y APEI+ G+ S VD W++G + EM+
Sbjct: 152 -------PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-10
Identities = 50/183 (27%), Positives = 76/183 (41%), Gaps = 41/183 (22%)
Query: 715 EREILDMLDHPFVPALYASFQTKTHVCLI-----TD-YCPGGELFLLLDRQPTKVLKEDA 768
E IL ++HP + L +F CLI TD YC L ++ + A
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYC------YLAAKRNIAICDILA 186
Query: 769 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 828
+ V+ A++YLH II+RD+K EN+ + G V L DF +C P
Sbjct: 187 IE---RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAAC---------FPVD 234
Query: 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 888
+ + + GT APE++A + AVD W+ GI+L+EM
Sbjct: 235 INANKYY-----------------GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMA 277
Query: 889 YGY 891
+
Sbjct: 278 TCH 280
|
Length = 391 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 63/279 (22%), Positives = 110/279 (39%), Gaps = 76/279 (27%)
Query: 712 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE----- 766
A E +L L H + L+ T+ + L+ +Y LD+ + L +
Sbjct: 51 AIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY---------LDKDLKQYLDDCGNSI 101
Query: 767 --DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824
V+ + +++ L Y H + +++RDLKP+N+L+ G + L DF L+ S
Sbjct: 102 NMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI----- 156
Query: 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGIL 883
P + ++ V T Y P+I+ G+ +++ +D W +G +
Sbjct: 157 ----------------------PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCI 194
Query: 884 LYEMLYGYTPFRGKT---------------RQKTFANILH----KDLKFPSSTPTSLHAK 924
YEM G F G T ++T+ IL K +P LH
Sbjct: 195 FYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNH 254
Query: 925 ---------QLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
+L+ +LL + + R+ A E KHP+F
Sbjct: 255 APRLDSDGAELLSKLLQFEGRKRI----SAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 30/233 (12%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLD 723
++R K LG G G V+L +G+ A+K + D +V+ E ++L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 724 HPFVPALYASFQ--TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 781
H + Y + + + + ++ PGG + L + L E+ R Y +++ +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVS 120
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
YLH I++RD+K N+L G+V L DF S K Q
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGAS---------------------KRLQTI 159
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894
M+ S GT +++PE+I+G G+ D W++G + EML P+
Sbjct: 160 CLSGTGMK---SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-10
Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 31/174 (17%)
Query: 715 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPG--GELFLLLDRQPTKVLKEDAVRFY 772
E +L L HP V AL CL+ P +L+ L + + L V
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVL---PKYRSDLYTYLGARL-RPLGLAQVTAV 265
Query: 773 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 832
A +++ A++Y+H +GII+RD+K ENVL+ G + L DF +C
Sbjct: 266 ARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA--------------- 310
Query: 833 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 886
P GT + APE++AG +T +VD W+ G++++E
Sbjct: 311 --RGSWSTPFHYG--------IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 67/300 (22%), Positives = 114/300 (38%), Gaps = 52/300 (17%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLN-RNKVHRACA 714
+I L R ++ LG G G V+ EL G S A+K + + + + +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ--- 57
Query: 715 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLL------------DRQP 760
E E++ L HP + L + C++ +Y G+L FL+ D
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 761 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820
L A ++ +EYL ++RDL N L+ V ++DF LS
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD---- 173
Query: 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 880
++ A+ R + + ++ PE I T+ D W+
Sbjct: 174 ---------------------IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212
Query: 881 GILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
G++L+E+ YG P+ G + Q+ I + L P P ++A LM + P R
Sbjct: 213 GVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYA--LMIECWNEIPARR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 73/331 (22%), Positives = 119/331 (35%), Gaps = 61/331 (18%)
Query: 665 QHFRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRA----CA 714
+ + LG G G V +G+ A+K + V +R V
Sbjct: 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67
Query: 715 EREILDM--LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRF 771
RE+ M + H + L + + L+ D +L ++DR K+ L E V+
Sbjct: 68 LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDR---KIRLTESQVKC 123
Query: 772 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 831
+++ L LH ++RDL P N+ + G + DF L+ P T ++
Sbjct: 124 ILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPP--YSDTLSKD 181
Query: 832 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYG 890
+ + S V T Y APE++ GA + AVD W++G + E+L G
Sbjct: 182 ET-----------MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
Query: 891 YTPFRGKTRQKTFANILH-----------KDLKFPSSTPTSLHAKQ-------------- 925
F G+ I + K P T + +
Sbjct: 231 KPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAI 290
Query: 926 -LMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
L+ LL +P R+ A E KH +FK
Sbjct: 291 DLLQSLLKLNPLERI----SAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-10
Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 48/235 (20%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 727
+ L G G V + G Q +KA+ G R E +IL + H +
Sbjct: 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR--------EIDILKTISHRAI 148
Query: 728 PALYASFQTKTHVCLITDY--CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
L +++ K+ VC++ C +LF +DR L++ ++ AL YLH
Sbjct: 149 INLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQ--AITIQRRLLEALAYLHG 203
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDLSC-LTSC--KPQLLLPTTNEKKRRHKGQQNPV 842
+GII+RD+K EN+ L + L DF +C L + PQ
Sbjct: 204 RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ-------------------- 243
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897
+ GT E +PE++A + + D W+ G++L+EM GK
Sbjct: 244 --------CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290
|
Length = 392 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 78/324 (24%), Positives = 127/324 (39%), Gaps = 76/324 (23%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI--L 719
+ I+ +G G G V+ +GQ AMK + ++GV + A REI L
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGV--------PSTAIREISLL 53
Query: 720 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVV 778
L HP + L ++ + LI ++ +L LD P + + + V+ Y +++
Sbjct: 54 KELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQ 112
Query: 779 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 838
+ + H + +++RDLKP+N+L+ G + L DF L+ R G
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA-------------------RAFGI 153
Query: 839 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA-VDWWALGILLYEMLYGYTPFRGK 897
P+R V T Y APE++ G+ S VD W++G + EM F G
Sbjct: 154 --------PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205
Query: 898 TRQKTFANILH----------------KDLK--FPSSTPTSLHAK---------QLMYRL 930
+ I D K FP SL + L+ ++
Sbjct: 206 SEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKM 265
Query: 931 LHRDPKSRLGSHEGANEIKKHPFF 954
L DP R+ A + HP+F
Sbjct: 266 LIYDPAKRI----SAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 76/327 (23%), Positives = 126/327 (38%), Gaps = 87/327 (26%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAM----DKGVMLNRNKVHRACAEREILDMLDHP 725
++ LG G +V+ +GQ A+K + ++GV A E +L L H
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFT------AIREASLLKGLKHA 63
Query: 726 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
+ L+ TK + + +Y +L + + P L VR + +++ L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGG-LHPYNVRLFMFQLLRGLAYIHG 121
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
Q I++RDLKP+N+L+ G + L DF L+ R K +
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLA-------------------RAK--------S 154
Query: 846 EPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904
P + +S V T Y P+++ GA ++SA+D W G + EML G F G +
Sbjct: 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG------VS 208
Query: 905 NILHKDLK--------------------------FPSSTPTSLH-----------AKQLM 927
++ + K F P L A+ L
Sbjct: 209 DVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLA 268
Query: 928 YRLLHRDPKSRLGSHEGANEIKKHPFF 954
++L PK R+ A + HP+F
Sbjct: 269 SQMLMMFPKDRI----SAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 37/212 (17%)
Query: 712 ACAEREILDMLDHPFVPALYASF--QTKTHVCLITDYCPGGELFLLLDRQPTKV------ 763
AC E +L L HP V AL F + V L+ DY ++ + +K
Sbjct: 45 ACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQ 104
Query: 764 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDFDLSCLTSC 819
L V+ +++ + YLH +++RDLKP N+L+ G G V + D + L +
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN- 163
Query: 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWW 878
+P+ +P+ + V T Y APE++ GA H T A+D W
Sbjct: 164 --------------------SPL---KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 200
Query: 879 ALGILLYEMLYGYTPFRGKTRQKTFANILHKD 910
A+G + E+L F + +N H D
Sbjct: 201 AIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD 232
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 63/279 (22%), Positives = 113/279 (40%), Gaps = 36/279 (12%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRACAEREILD 720
I+ + +K LG+G G V + GQY A+K + +G M + A +++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKW--RGQYDVAIKMIKEGSMSEDEFIEEA----KVMM 54
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
L H + LY + + ++T+Y G L L R+ K + + +V +
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGM 113
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
YL + I+RDL N L+ G V ++DF LS + +L +++ G +
Sbjct: 114 AYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLS-------RYVL---DDEYTSSVGSKF 163
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 899
PV + PE++ + +S D WA G+L++E+ G P+
Sbjct: 164 PV----------------RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN 207
Query: 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+T + + L+ S +MY H + R
Sbjct: 208 SETVEKVS-QGLRLYRPHLASEKVYAIMYSCWHEKAEER 245
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 62/243 (25%), Positives = 103/243 (42%), Gaps = 50/243 (20%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDML 722
+ ++ + P+GSG GSV Q A+K + + ++ +H R E +L +
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---QSLIHARRTYRELRLLKHM 71
Query: 723 DHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 774
H F PA S + V L+T+ G +L ++ Q L ++ V+F
Sbjct: 72 KHENVIGLLDVFTPA--TSIENFNEVYLVTNLM-GADLNNIVKCQK---LSDEHVQFLIY 125
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
+++ L+Y+H GII+RDLKP NV + + + + DF L+
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD---------------- 169
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP 893
+ M +V T Y APEI+ H VD W++G ++ E+L G
Sbjct: 170 -----------DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKAL 215
Query: 894 FRG 896
F G
Sbjct: 216 FPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 74/319 (23%), Positives = 127/319 (39%), Gaps = 74/319 (23%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDK--GVMLNRNKVHRACAEREILDMLDHPFV 727
++P+G G G V +GQ A+K + K + + +R E ++L L H +
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR---ELKLLKHLRHENI 71
Query: 728 PALYASF-QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
+L F + +T+ G +L LL +P L++ ++++ +++ L+Y+H
Sbjct: 72 ISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRP---LEKQFIQYFLYQILRGLKYVHSA 127
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
G+++RDLKP N+L+ N + + DF L+ + PQ+
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARIQD--PQM----------------------- 162
Query: 847 PMRASNSFVGTEEYIAPEI-IAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905
+V T Y APEI + + VD W+ G + EML G F GK F+
Sbjct: 163 -----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI 217
Query: 906 IL----------------HKDLKFPSSTP-------------TSLHAKQLMYRLLHRDPK 936
I L+F S P A L+ ++L DP+
Sbjct: 218 ITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQ 277
Query: 937 SRLGSHEGANEIKKHPFFK 955
R+ + E HP+
Sbjct: 278 KRISAAEAL----AHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 56/207 (27%), Positives = 79/207 (38%), Gaps = 50/207 (24%)
Query: 762 KVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820
V+ E+ + A V AL YL + II+RD+KP N+LL NG++ L DF +S
Sbjct: 102 SVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS------ 155
Query: 821 PQLLLPTTNEKKRRHKGQ-QNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVD 876
GQ + + A G Y+APE I G+ D
Sbjct: 156 ----------------GQLVDSI-------AKTRDAGCRPYMAPERIDPSARDGYDVRSD 192
Query: 877 WWALGILLYEMLYGYTPFRG------KTRQ--KTFANILHKDLKFPSSTPTSLHAKQLMY 928
W+LGI LYE+ G P+ + Q K IL + S +
Sbjct: 193 VWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSF----VNFIN 248
Query: 929 RLLHRDPKSRLGSHEGANEIKKHPFFK 955
L +D R E+ +HPF K
Sbjct: 249 LCLIKDESKR----PKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|238075 cd00130, PAS, PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-09
Identities = 27/94 (28%), Positives = 55/94 (58%), Gaps = 8/94 (8%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQN----GQSYCGRLLN 269
I+YA+ ++ GY+ +E++G++ L PED ++RE L+N G+ +
Sbjct: 14 ILYANPAAEQLLGYSPEELIGKSLLDL----IHPEDREELRERLENLLSGGEPVTLEVRL 69
Query: 270 YKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
+KDG+ W L+++ PI+D+ G+V+ +G+ ++
Sbjct: 70 RRKDGSVIWVLVSLTPIRDEGGEVIGLLGVVRDI 103
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. Length = 103 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 52/234 (22%), Positives = 92/234 (39%), Gaps = 37/234 (15%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 721
IN + + +G G+ G V L + GQ A+K + + AE ++
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKD----DSTAAQAFLAEASVMTT 56
Query: 722 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 781
L HP + L + ++T+Y G L L + V+ +A +V +E
Sbjct: 57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGME 116
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
YL + ++RDL NVL+ + ++DF L+ E + + P
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA--------------KEASQGQDSGKLP 162
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 894
V ++ APE + ++ D W+ GILL+E+ +G P+
Sbjct: 163 V----------------KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|238075 cd00130, PAS, PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-08
Identities = 26/101 (25%), Positives = 46/101 (45%), Gaps = 7/101 (6%)
Query: 485 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 544
++ D D I++A+ + +L YS EE++G++ L PE ++ +
Sbjct: 5 VIVLDL---DGRILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGE 61
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLD 581
VT+++ K G W L L P+RD+ +GV D
Sbjct: 62 PVTLEVRLRRKDGSVIWVLVSLTPIRDEGGEVIGLLGVVRD 102
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. Length = 103 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 37/212 (17%)
Query: 712 ACAEREILDMLDHPFVPALYASF--QTKTHVCLITDYCPGGELFLLLDRQPTKV------ 763
AC E +L L HP V +L F V L+ DY ++ + +K
Sbjct: 45 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ 104
Query: 764 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDFDLSCLTSC 819
L V+ +++ + YLH +++RDLKP N+L+ G G V + D + L +
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN- 163
Query: 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWW 878
+P+ +P+ + V T Y APE++ GA H T A+D W
Sbjct: 164 --------------------SPL---KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 200
Query: 879 ALGILLYEMLYGYTPFRGKTRQKTFANILHKD 910
A+G + E+L F + +N H D
Sbjct: 201 AIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 232
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 64/268 (23%), Positives = 110/268 (41%), Gaps = 36/268 (13%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
LG G G V + G+ + A+K + G M + A +++ L H + LYA
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEA----QVMKKLRHEKLVQLYA 68
Query: 733 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 792
++ + ++T+Y G L L + K L+ + AA++ + Y+ ++RD
Sbjct: 69 VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 793 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 852
L+ N+L+ N + DF L+ L NE R +G + P+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIE---------DNEYTAR-QGAKFPI---------- 167
Query: 853 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHK-D 910
++ APE T D W+ GILL E+ G P+ G ++ +
Sbjct: 168 ------KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 221
Query: 911 LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ P P SLH LM + ++P+ R
Sbjct: 222 MPCPPECPESLH--DLMCQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 62/283 (21%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY---FAMKAMDKGVMLNRNKVHRACAEREI 718
I+ ++ +GSG G V L G A+K + +G M + + A ++
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWL----GYWLEKRKVAIKTIREGAMSEEDFIEEA----QV 52
Query: 719 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 778
+ L HP + LY ++ +CL+ ++ G L L Q K +E + +V
Sbjct: 53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQE-TLLGMCLDVCE 111
Query: 779 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 838
+ YL +I+RDL N L+ N V ++DF ++ + +L +++ G
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMT-------RFVL---DDQYTSSTGT 161
Query: 839 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 897
+ PV ++ +PE+ + + ++S D W+ G+L++E+ G TP+ +
Sbjct: 162 KFPV----------------KWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205
Query: 898 TRQKTFANIL--HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ + I + K P S++ +LM P+ R
Sbjct: 206 SNSEVVETINAGFRLYK-PRLASQSVY--ELMQHCWKERPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 60/275 (21%), Positives = 108/275 (39%), Gaps = 62/275 (22%)
Query: 712 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 771
A E +L L H + L+ T + L+ +Y +L +D ++ V+
Sbjct: 51 AIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMD-DCGNIMSMHNVKI 108
Query: 772 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 831
+ +++ L Y H + +++RDLKP+N+L+ G + L DF L+ S
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV------------ 156
Query: 832 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYG 890
P + ++ V T Y P+++ G+ +++ +D W +G + +EM G
Sbjct: 157 ---------------PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG 201
Query: 891 YTPFRGKTRQKTFANILH-------------------KDLKFPSSTPTSL--HAK----- 924
F G T + I K+ FP P L HA
Sbjct: 202 RPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTE 261
Query: 925 --QLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957
+L+ + L + K R+ A E KH +F+ +
Sbjct: 262 GIELLTKFLQYESKKRI----SAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|219844 pfam08447, PAS_3, PAS fold | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-08
Identities = 29/90 (32%), Positives = 43/90 (47%), Gaps = 7/90 (7%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ-----NGQSYCGRLL 268
I+Y S F ++ GYT +E+ +L PED ++R LQ G+ Y G
Sbjct: 1 IIYWSPRFEEILGYTPEELKSSYEGWLDL--VHPEDRERVRRALQEFSLKKGEPYSGEYR 58
Query: 269 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIG 298
+KDG W PI+D+ GK ++ IG
Sbjct: 59 IRRKDGEYRWVEARGRPIRDENGKPVRVIG 88
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 90 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 61/272 (22%), Positives = 108/272 (39%), Gaps = 62/272 (22%)
Query: 712 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 771
A E +L L H + L+ T+ + L+ +Y +L LD ++ V+
Sbjct: 50 AIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLD-NCGNLMSMHNVKI 107
Query: 772 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 831
+ +++ L Y H + I++RDLKP+N+L+ G + L DF L+ S
Sbjct: 108 FMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV------------ 155
Query: 832 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYG 890
P + ++ V T Y P+++ G+ +++ +D W +G +LYEM G
Sbjct: 156 ---------------PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200
Query: 891 YTPFRGKTRQKTF-------------------ANILHKDLKFPSSTPTSL--HAKQ---- 925
F G T ++ +N + FP L HA +
Sbjct: 201 RPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTD 260
Query: 926 ---LMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
L+ LL + KSR+ + +H +F
Sbjct: 261 GIDLLSSLLLYETKSRISAEAAL----RHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 42/189 (22%), Positives = 82/189 (43%), Gaps = 28/189 (14%)
Query: 714 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 773
+E IL DHP + L + + ++ + PGG+ L ++ ++ + V+F A
Sbjct: 41 SEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF-A 99
Query: 774 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 833
+ + YL + I+RDL N L+ N + ++DF +S
Sbjct: 100 LDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMS------------------- 140
Query: 834 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 892
+ + + ++ + ++ ++ APE + ++S D W+ GILL+E G
Sbjct: 141 --RQEDDGIYSSSGLKQI-----PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVC 193
Query: 893 PFRGKTRQK 901
P+ G T Q+
Sbjct: 194 PYPGMTNQQ 202
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 70/321 (21%), Positives = 125/321 (38%), Gaps = 77/321 (23%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI--LDML 722
++ +G G G+V + + + A+K + D+GV + A REI L L
Sbjct: 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS--------ALREICLLKEL 56
Query: 723 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 782
H + LY + + L+ +YC +L D + + V+ + +++ L +
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDI-DPEIVKSFMFQLLKGLAF 114
Query: 783 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
H +++RDLKP+N+L+ NG + L DF L+ R G
Sbjct: 115 CHSHNVLHRDLKPQNLLINKNGELKLADFGLA-------------------RAFGI---- 151
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP-FRGKTRQ 900
P+R ++ V T Y P+++ GA +++++D W+ G + E+ P F G
Sbjct: 152 ----PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 207
Query: 901 KTFANI-----------------LHKDLKFPSSTPTSLHA----------KQLMYRLLHR 933
I L +P T+ + L+ LL
Sbjct: 208 DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVC 267
Query: 934 DPKSRLGSHEGANEIKKHPFF 954
+P R+ A E +HP+F
Sbjct: 268 NPVQRI----SAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 67/268 (25%), Positives = 110/268 (41%), Gaps = 36/268 (13%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
LG G G V + G+ + A+K + G M+ + A +I+ L H + LYA
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEA----QIMKKLRHDKLVPLYA 68
Query: 733 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 792
++ + ++T++ G L L K LK + AA++ + Y+ I+RD
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 793 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 852
L+ N+L+ N + DF L+ L NE R +G + P+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIE---------DNEYTAR-QGAKFPI---------- 167
Query: 853 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHK-D 910
++ APE T D W+ GILL E++ G P+ G ++ +
Sbjct: 168 ------KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR 221
Query: 911 LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ P P SLH +LM +DP R
Sbjct: 222 MPCPQGCPESLH--ELMKLCWKKDPDER 247
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 63/286 (22%), Positives = 104/286 (36%), Gaps = 48/286 (16%)
Query: 671 KPLGSGDTGSVHLVE---LCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 725
+ LG G G V L E LC A+K + R HR E E+L L H
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR---EAELLTNLQHE 67
Query: 726 FVPALYASFQTKTHVCLITDYCPGGEL-----------FLLLDRQPTKVLKEDAVRFYAA 774
+ Y + ++ +Y G+L L+ + L + + A
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
++ + YL Q ++RDL N L+ N V + DF
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF----------------------- 164
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTP 893
G V+ + R + ++ PE I T+ D W+LG++L+E+ YG P
Sbjct: 165 --GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
Query: 894 FRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ + + I + L+ P + P ++ LM R+P R
Sbjct: 223 WYQLSNNEVIECITQGRVLQRPRTCPKEVY--DLMLGCWQREPHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 63/293 (21%), Positives = 114/293 (38%), Gaps = 55/293 (18%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM---LNRNKVHRACAE-REILDM 721
+ + I LG G+ G V L + G + + V+ L + K +E R LDM
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGI----EEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 722 ---LDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDR--------QPTKVLKEDA 768
L H V L + +I +Y G+L FL + P ++ A
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 769 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 828
+ ++ + +++L ++RDL N L+ V + S L+ K
Sbjct: 122 L---CTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV-----SLLSLSK-------D 166
Query: 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 888
+K + + P+R ++APE + ++ D W+ G+L++E+
Sbjct: 167 VYNSEYYKLRNALI----PLR----------WLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212
Query: 889 -YGYTPFRGKTRQKTFANILHKDLKF--PSSTPTSLHAKQLMYRLLHRDPKSR 938
G PF G + ++ + L+ P P+ L+ +LM R +PK R
Sbjct: 213 TQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY--KLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 58/233 (24%), Positives = 87/233 (37%), Gaps = 42/233 (18%)
Query: 714 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 773
E I+ DHP + L V +IT+Y G L L K V
Sbjct: 54 TEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGM-L 112
Query: 774 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 833
+ ++YL ++RDL N+L+ N ++DF LS
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS------------------- 153
Query: 834 RHKGQQNPVFMAE----PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-ML 888
R + + P+R + APE IA TSA D W+ GI+++E M
Sbjct: 154 RRLEDSEATYTTKGGKIPIR----------WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
Query: 889 YGYTPFRGKTRQKTFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
YG P+ + Q + +D L P P++L+ QLM +D R
Sbjct: 204 YGERPYWDMSNQDVIKAV--EDGYRLPPPMDCPSALY--QLMLDCWQKDRNER 252
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 32/227 (14%)
Query: 714 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 773
E I+ DHP + L T+ V ++ + P GEL L L ++ Y+
Sbjct: 56 QEAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYS 113
Query: 774 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 833
++ AL YL + ++RD+ NVL+ V L DF LS + L + K
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS-------RYLEDESYYKAS 166
Query: 834 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 892
+ K P++ ++APE I TSA D W G+ ++E+L G
Sbjct: 167 KGK---------LPIK----------WMAPESINFRRFTSASDVWMFGVCMWEILMLGVK 207
Query: 893 PFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
PF+G I + + L P + P +L++ LM + DP R
Sbjct: 208 PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS--LMTKCWAYDPSKR 252
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 55/248 (22%), Positives = 93/248 (37%), Gaps = 53/248 (21%)
Query: 715 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-----QPTKVLKEDAV 769
E ++ DHP + L +CL+ +Y G+L L Q + +
Sbjct: 58 EAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSA 117
Query: 770 RFY---------------AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814
R A +V + YL + ++RDL N L+ N V + DF LS
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 874
+N ++ A+ +AS + ++ PE I +T+
Sbjct: 178 ------------------------RN-IYSADYYKASENDAIPIRWMPPESIFYNRYTTE 212
Query: 875 VDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD---LKFPSSTPTSLHAKQLMYRL 930
D WA G++L+E+ YG P+ G ++ + +D L P + P L+ LM
Sbjct: 213 SDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV--RDGNVLSCPDNCPLELYN--LMRLC 268
Query: 931 LHRDPKSR 938
+ P R
Sbjct: 269 WSKLPSDR 276
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 65/281 (23%), Positives = 111/281 (39%), Gaps = 44/281 (15%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 721
+N++ + ++ +G G+ G V L G Y K K + N AE ++
Sbjct: 3 LNMKELKLLQTIGKGEFGDVML------GDYRGNKVAVKCIK-NDATAQAFLAEASVMTQ 55
Query: 722 LDHP-FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
L H V L + K + ++T+Y G L L + VL D + ++ +V A+
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
EYL ++RDL NVL+ + ++DF L T E +
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGL--------------TKEASSTQDTGKL 161
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 899
PV ++ APE + ++ D W+ GILL+E+ +G P+ +
Sbjct: 162 PV----------------KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP-RIP 204
Query: 900 QKTFANILHKDLKF--PSSTPTSLHAKQLMYRLLHRDPKSR 938
K + K K P P ++ +M + H D +R
Sbjct: 205 LKDVVPRVEKGYKMDAPDGCPPVVY--DVMKQCWHLDAATR 243
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 67/280 (23%), Positives = 114/280 (40%), Gaps = 44/280 (15%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA-----CAEREILDML-DH 724
K LG+G G V VE G + M V + + H + +E +I+ L +H
Sbjct: 41 KTLGAGAFGKV--VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
+ L + + +IT+YC G+L L R+ L + + ++ +V + +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 785 CQGIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 843
+ I+RDL NVLL +G + + DF L+ R N V
Sbjct: 159 SKNCIHRDLAARNVLLT-HGKIVKICDFGLA------------------RDIMNDSNYVV 199
Query: 844 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKT 902
N+ + +++APE I +T D W+ GILL+E+ G P+ G
Sbjct: 200 ------KGNARLPV-KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK 252
Query: 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHR----DPKSR 938
F ++ + + + P HA +Y ++ DP R
Sbjct: 253 FYKLIKEGYRM--AQPE--HAPAEIYDIMKTCWDADPLKR 288
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 69/315 (21%), Positives = 114/315 (36%), Gaps = 68/315 (21%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK---AMDKGVML-----------NRNKVH 710
H + LG G G VHL E+ ++ + KG L N+N +
Sbjct: 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN 64
Query: 711 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FL----LLDRQ----- 759
E +IL L P + L + +C+IT+Y G+L FL L D++
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 760 ------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 813
+ ++ A ++ ++YL ++RDL N L+ N + + DF
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADF-- 182
Query: 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 873
G ++ + R V ++A E I T+
Sbjct: 183 -----------------------GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT 219
Query: 874 AVDWWALGILLYEMLY--GYTPFRGKTRQKTFANI--LHKD------LKFPSSTPTSLHA 923
A D WA G+ L+E+L P+ T ++ N +D L P P L+
Sbjct: 220 ASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLY- 278
Query: 924 KQLMYRLLHRDPKSR 938
+LM + RD + R
Sbjct: 279 -ELMLQCWSRDCRER 292
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|232884 TIGR00229, sensory_box, PAS domain S-box | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-07
Identities = 21/95 (22%), Positives = 42/95 (44%), Gaps = 4/95 (4%)
Query: 497 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY-TK 555
I++ + +F E+ YS EE++GRN L E +I ++ + + + K
Sbjct: 25 ILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERRLEGEREPVSEERRVRRK 84
Query: 556 SGKKFWNLFHLQPMR---DQKYFIGVQLDGSEHLE 587
G + W + P+R + +G+ D +E +
Sbjct: 85 DGSEIWVEVSVSPIRTNGGELGVVGIVRDITERKQ 119
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator [Regulatory functions, Small molecule interactions]. Length = 124 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 41/294 (13%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDML 722
R +K LGSG G+VH G + K + R + L
Sbjct: 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL 66
Query: 723 DHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 777
DH ++ L AS Q L+T P G L + RQ L + + ++
Sbjct: 67 DHAYIVRLLGICPGASLQ------LVTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQIA 119
Query: 778 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
+ YL +++R+L N+LL+ + V + DF ++ LL P ++KK +
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA-------DLLYP--DDKKYFYSE 170
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRG 896
+ P+ +++A E I +T D W+ G+ ++EM+ YG P+ G
Sbjct: 171 HKTPI----------------KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214
Query: 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950
R ++L K + ++ +M + D R E ANE +
Sbjct: 215 -MRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 50/207 (24%), Positives = 77/207 (37%), Gaps = 62/207 (29%)
Query: 779 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 838
+ +LH I++RDLK N+LL G + + DF L+ R +
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLA------------------REY--- 156
Query: 839 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGK 897
P++ V T Y APE++ GA ++A+D W++G + E+L F GK
Sbjct: 157 ------GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210
Query: 898 ----TRQKTF--------------ANILH-KDLKFPSSTPTSLHAK-----------QLM 927
K F + + K F L K L+
Sbjct: 211 SEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLL 270
Query: 928 YRLLHRDPKSRLGSHEGANEIKKHPFF 954
RLL DP R+ + + KHP+F
Sbjct: 271 NRLLTYDPAKRISAEDAL----KHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 46/225 (20%), Positives = 84/225 (37%), Gaps = 59/225 (26%)
Query: 758 RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV-SLTDFDLSCL 816
R P + L ++ + +++ + + H G+++RDLKP+N+L+ + + D L
Sbjct: 101 RGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160
Query: 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAV 875
S P+++ + T Y APE++ G+ H ++ V
Sbjct: 161 FSI---------------------------PVKSYTHEIVTLWYRAPEVLLGSTHYSTPV 193
Query: 876 DWWALGILLYEMLYGYTPFRGKTRQKTFANILH-------------KDLK----FPSSTP 918
D W++G + EM F G + + +I L+ FP P
Sbjct: 194 DIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKP 253
Query: 919 TSL---------HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
L L+ ++L DP R+ A HP+F
Sbjct: 254 QDLSRAVPDLSPEGLDLLQKMLRYDPAKRI----SAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 71/283 (25%), Positives = 116/283 (40%), Gaps = 44/283 (15%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 728
K LG G+ GSV +L A+K M K + R+++ +E + DHP V
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 729 ALYA-SFQTKTH-----VCLITDYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEVV 777
L QT +I + G+L FLL R P + + V+F ++
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF-MTDIA 122
Query: 778 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
+EYL + I+RDL N +L N +V + DF LS + R+ +
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI---------YNGDYYRQGRI 173
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM-LYGYTPFRG 896
+ PV ++IA E +A +T+ D W+ G+ ++E+ G TP+ G
Sbjct: 174 AKMPV----------------KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217
Query: 897 KTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ + + + LK P L++ LM +PK R
Sbjct: 218 VENSEIYDYLRQGNRLKQPPDCLDGLYS--LMSSCWLLNPKDR 258
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 33/114 (28%), Positives = 57/114 (50%), Gaps = 26/114 (22%)
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
+++ A+EY+H + +I+RD+K EN+ L +G + L DF + +P E++
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA----------MPFEKEREAF 324
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 888
G +VGT +PEI+AG G+ D W+ G++L +ML
Sbjct: 325 DYG----------------WVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 67/290 (23%), Positives = 119/290 (41%), Gaps = 37/290 (12%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE----REILDML 722
+ +K LGSG G+V+ G+ + K +LN +A E I+ +
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIK--ILNETTGPKANVEFMDEALIMASM 66
Query: 723 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 782
DHP + L + T + L+T P G L + + + + + ++ + Y
Sbjct: 67 DHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN-WCVQIAKGMMY 124
Query: 783 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
L + +++RDL NVL++ HV +TDF L+ L +EK+ G + P+
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE---------GDEKEYNADGGKMPI 175
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRG-KTRQ 900
+++A E I T D W+ G+ ++E M +G P+ G TR+
Sbjct: 176 ----------------KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219
Query: 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950
++L K + P ++ +M + D SR E A E +
Sbjct: 220 --IPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 48/241 (19%), Positives = 90/241 (37%), Gaps = 44/241 (18%)
Query: 715 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKV--------- 763
E ++ L HP + L + VC++ +Y G+L FL++ + V
Sbjct: 57 EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116
Query: 764 ----LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819
L A ++ +EYL +++DL N+L+ HV ++D LS
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLS----- 171
Query: 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 879
++ A+ R + ++ PE I +S D W+
Sbjct: 172 --------------------REIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS 211
Query: 880 LGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKS 937
G++L+E+ +G P+ G + Q+ + + L P +++ LM P
Sbjct: 212 FGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYS--LMTECWQEGPSR 269
Query: 938 R 938
R
Sbjct: 270 R 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 67/290 (23%), Positives = 113/290 (38%), Gaps = 48/290 (16%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQY---FAMKAMDKGVMLNRNKVHRACAERE 717
+I+ H K +G+G+ G V L G+ A+K + G + +E
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEAS 58
Query: 718 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 777
I+ H + L +IT+Y G L K L++ F + ++V
Sbjct: 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGAL--------DKYLRDHDGEFSSYQLV 110
Query: 778 -------VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830
++YL ++RDL N+L+ N ++DF LS + P+ T+
Sbjct: 111 GMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGG 170
Query: 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLY 889
K P+R + APE IA TSA D W+ GI+++E M +
Sbjct: 171 KI--------------PIR----------WTAPEAIAYRKFTSASDVWSFGIVMWEVMSF 206
Query: 890 GYTPFRGKTRQKTFANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
G P+ + + I L P P++++ QLM + +D R
Sbjct: 207 GERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY--QLMLQCWQQDRARR 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 66/275 (24%), Positives = 112/275 (40%), Gaps = 46/275 (16%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 730
K LG+G G V + A+K M G M V AE ++ L H + L
Sbjct: 12 KKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL 66
Query: 731 YASFQTKTHVCLITDYCPGGELFLLL-----DRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
+A TK + +IT++ G L L +QP L + ++A++ + ++
Sbjct: 67 HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID-----FSAQIAEGMAFIEQ 120
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
+ I+RDL+ N+L+ + + DF L+ + NE R +G + P+
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIE---------DNEYTAR-EGAKFPI--- 167
Query: 846 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFA 904
++ APE I T D W+ GILL E++ YG P+ G + +
Sbjct: 168 -------------KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214
Query: 905 NILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ + P + P L+ +M R P+ R
Sbjct: 215 ALERGYRMPRPENCPEELY--NIMMRCWKNRPEER 247
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 68/293 (23%), Positives = 109/293 (37%), Gaps = 55/293 (18%)
Query: 670 IKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML 722
I+ LG G G V ELC +G+ A+K++ N + E EIL L
Sbjct: 9 IRDLGEGHFGKV---ELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL 63
Query: 723 DHPFVPALYASFQTK---THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 779
H + Y T+ + LI ++ P G L L R K+ + ++ YA ++
Sbjct: 64 YHENI-VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLK-YAVQICKG 121
Query: 780 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
++YL + ++RDL NVL++ V + DF L+ + T E
Sbjct: 122 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT--------KAIETDKEYYTVKDDLD 173
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY----GYTPF- 894
+PVF + APE + + A D W+ G+ LYE+L +P
Sbjct: 174 SPVF----------------WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217
Query: 895 ---------RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
G+ +L + + P QLM + P R
Sbjct: 218 LFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKR 270
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 58/239 (24%), Positives = 91/239 (38%), Gaps = 48/239 (20%)
Query: 673 LGSGDTGSVHLVELCGSGQY----FAMKAMDKGVMLNRNKVHRACA----------EREI 718
LG G G VHL E G ++ F++ +L K+ R A E +I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 719 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAV------- 769
+ L P + L A T +C+IT+Y G+L FL K D V
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 770 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829
F A ++ ++YL ++RDL N L+ N + + DF +S
Sbjct: 133 IFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS--------------- 177
Query: 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 888
++ + R V +++ E I T+A D WA G+ L+E+L
Sbjct: 178 ----------RNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 61/259 (23%), Positives = 110/259 (42%), Gaps = 40/259 (15%)
Query: 673 LGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRAC-----AEREILDMLDHPF 726
LGSG+ G V G Y K +D + + +N+ ++ E EI+ LD+P+
Sbjct: 3 LGSGNFGCVK------KGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPY 56
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
+ + + + + L+ + GG L L + ++ + V +V + ++YL +
Sbjct: 57 IVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMH-QVSMGMKYLEGK 114
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
++RDL NVLL + ++DF LS + L + K R G+
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLS-------KALGADDSYYKARSAGKW------- 160
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFAN 905
P++ + APE I +S D W+ GI ++E YG P++ + +
Sbjct: 161 PLK----------WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF 210
Query: 906 ILH-KDLKFPSSTPTSLHA 923
I K L P+ P ++A
Sbjct: 211 IEQGKRLDCPAECPPEMYA 229
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 64/279 (22%), Positives = 114/279 (40%), Gaps = 39/279 (13%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM----- 721
+ +K LGSG G+V+ G+ + K +L N +A +EILD
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIK--VLRENTSPKA--NKEILDEAYVMA 64
Query: 722 -LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
+ P+V L T T V L+T P G L + ++ +D + + ++ +
Sbjct: 65 GVGSPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLN-WCVQIAKGM 122
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
YL +++RDL NVL++ HV +TDF L+ L +E + G +
Sbjct: 123 SYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD---------IDETEYHADGGKV 173
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGKTR 899
P+ +++A E I T D W+ G+ ++E M +G P+ G
Sbjct: 174 PI----------------KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IP 216
Query: 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ ++L K + P ++ +M + D + R
Sbjct: 217 AREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECR 255
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 50/246 (20%), Positives = 91/246 (36%), Gaps = 47/246 (19%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA---MDKGVML---------NRNKVHRA 712
Q R + LG G G VHL E G ++ A + V++ + +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 713 CAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP--TKVLKEDAVR 770
E +I+ L +P + L + +C+IT+Y G+L L ++ + + +
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 771 --------FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822
+ A ++ ++YL ++RDL N L+ + + + DF
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADF----------- 173
Query: 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 882
G ++ + R V ++A E I T+A D WA G+
Sbjct: 174 --------------GMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 883 LLYEML 888
L+EM
Sbjct: 220 TLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|216228 pfam00989, PAS, PAS fold | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 23/87 (26%), Positives = 46/87 (52%), Gaps = 1/87 (1%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYK-K 272
I+Y +A ++ G + +EV+G++ L D E +R+ L G+ G ++++
Sbjct: 23 ILYVNAAAEELLGLSREEVIGKSLLDLIPEDDDAEVAELLRQALLQGEESRGFEVSFRVP 82
Query: 273 DGTPFWNLLTIAPIKDDEGKVLKFIGM 299
DG P + +P++D G+V F+G+
Sbjct: 83 DGRPRHVEVRASPVRDAGGEVRGFLGV 109
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 113 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 58/286 (20%), Positives = 109/286 (38%), Gaps = 46/286 (16%)
Query: 670 IKPLGSGDTGSVH--LVELCGSGQYF---AMKAM-DKGVMLNRNKVHRACAEREILDMLD 723
I+ LG G G V+ L + G+ A+K + + M R + E ++ +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEF---LNEASVMKEFN 67
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLL------DRQPTKVLKEDAVRFY--AAE 775
V L T ++ + G+L L + +F AAE
Sbjct: 68 CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 776 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
+ + YL + ++RDL N ++ + V + DF ++ + T+ ++
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT--------RDIYETDYYRKGG 179
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 894
KG P+R ++APE + T+ D W+ G++L+EM P+
Sbjct: 180 KG-------LLPVR----------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222
Query: 895 RGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRL 939
+G + ++ ++ L P + P L +LM +PK R
Sbjct: 223 QGLSNEEVLKFVIDGGHLDLPENCPDKLL--ELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 60/295 (20%), Positives = 108/295 (36%), Gaps = 61/295 (20%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-------- 722
KPLG G G V E + ++ + + E+++ D++
Sbjct: 18 KPLGEGAFGQVVKAE------AVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 723 --DHPFVPALYASFQTKTHVCLITDYCPGGEL--FL------------LLDRQPTKVLKE 766
H + L + + ++ +Y G L FL R P + L +
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 767 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV-SLTDFDLSCLTSCKPQLLL 825
+ +A +V +E+L + I+RDL NVL+ HV + DF L+
Sbjct: 132 KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV-TEDHVMKIADFGLARDIHH------ 184
Query: 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 885
+ R+ + PV +++APE + +T D W+ G+LL+
Sbjct: 185 ---IDYYRKTTNGRLPV----------------KWMAPEALFDRVYTHQSDVWSFGVLLW 225
Query: 886 E-MLYGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
E G +P+ G ++ F + ++ P + L+ LM H P R
Sbjct: 226 EIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYH--LMRDCWHEVPSQR 278
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|225112 COG2202, AtoS, FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 49.1 bits (115), Expect = 3e-06
Identities = 19/97 (19%), Positives = 41/97 (42%), Gaps = 2/97 (2%)
Query: 210 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ--NGQSYCGRL 267
D I+YA+ ++ GY+ +E +GR L + ++ L G
Sbjct: 130 EDGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERRELELARALAEGRGGPLEIEY 189
Query: 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+KDG +L+ D+G+++ +G+ +++
Sbjct: 190 RVRRKDGERVRWILSRISPVRDDGEIVGVVGIARDIT 226
|
Length = 232 |
| >gnl|CDD|232884 TIGR00229, sensory_box, PAS domain S-box | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 4e-06
Identities = 22/94 (23%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYK-K 272
I+Y + F ++ GY+++E++GRN L E +I L+ + + K
Sbjct: 25 ILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERRLEGEREPVSEERRVRRK 84
Query: 273 DGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306
DG+ W ++++PI G L +G+ ++++
Sbjct: 85 DGSEIWVEVSVSPI-RTNGGELGVVGIVRDITER 117
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator [Regulatory functions, Small molecule interactions]. Length = 124 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 41/168 (24%), Positives = 69/168 (41%), Gaps = 26/168 (15%)
Query: 772 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 831
Y+ +V +E+L + I+RDL N+LL N V + DF L+ P +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------- 236
Query: 832 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG 890
R + P+ +++APE I +T D W+ G+LL+E+ G
Sbjct: 237 --RKGDARLPL----------------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 278
Query: 891 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+P+ G + F L + + + T+ Q M H +P R
Sbjct: 279 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 67/308 (21%), Positives = 120/308 (38%), Gaps = 56/308 (18%)
Query: 671 KPLGSGDTGSV---HLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 725
K LG G+ G V L G Y A+K + + + +++ +E +L ++HP
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHP 63
Query: 726 FVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQ------------PTKVLKEDAVRF 771
V LY + + LI +Y G L FL R+ + L R
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 772 YAAEVVVALEYLHCQGIIY--------RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823
+++ + +G+ Y RDL NVL+ + ++DF LS +
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 883
+ +R KG+ PV +++A E + +T+ D W+ G+L
Sbjct: 184 V--------KRSKGRI-PV----------------KWMAIESLFDHIYTTQSDVWSFGVL 218
Query: 884 LYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH 942
L+E++ G P+ G ++ F N+L + S LM ++P R
Sbjct: 219 LWEIVTLGGNPYPGIAPERLF-NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFA 277
Query: 943 EGANEIKK 950
+ + E++K
Sbjct: 278 DISKELEK 285
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 6e-06
Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 40/288 (13%)
Query: 657 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER 716
D GE L + IK +G+G G V LV+ + ++F KA+ + R K + E
Sbjct: 6 DDGES-RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK-SQLVIEV 63
Query: 717 EILDMLDHPFVPALYASFQTKTH--VCLITDYCPGGELFLLLDRQPTKVLK------EDA 768
++ L H + F K + + ++ ++C G+ L R K K E A
Sbjct: 64 NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGD----LSRNIQKCYKMFGKIEEHA 119
Query: 769 VRFYAAEVVVALEYLH-------CQGIIYRDLKPENVLLQ-GNGHVSLTDFDLSCLTSCK 820
+ +++ AL Y H + +++RDLKP+N+ L G H+ + L +
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG-R 178
Query: 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII--AGAGHTSAVDWW 878
P + K E M ++S VGT Y +PE++ + D W
Sbjct: 179 PIAKIGDFGLSKN---------IGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMW 227
Query: 879 ALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQL 926
ALG ++YE+ G TPF + F+ ++ +LK P +K+L
Sbjct: 228 ALGCIIYELCSGKTPFH---KANNFSQLI-SELKRGPDLPIKGKSKEL 271
|
Length = 1021 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 40/168 (23%), Positives = 69/168 (41%), Gaps = 26/168 (15%)
Query: 772 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 831
Y+ +V +E+L + I+RDL N+LL N V + DF L+ P +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------- 231
Query: 832 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG 890
R + P+ +++APE I +T+ D W+ G+LL+E+ G
Sbjct: 232 --RKGSARLPL----------------KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 273
Query: 891 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+P+ G + F L + + + ++M DPK R
Sbjct: 274 ASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 64/294 (21%), Positives = 108/294 (36%), Gaps = 51/294 (17%)
Query: 671 KPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 725
+ LG G G V L E A+KA+ + R R E E+L L H
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQHE 67
Query: 726 FVPALYASFQTKTHVCLITDYCPGGEL-----------FLLLDRQPTKVLKE---DAVRF 771
+ Y + ++ +Y G+L +L+D QP + E +
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 772 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 831
A+++ + YL Q ++RDL N L+ N V + DF
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDF-------------------- 167
Query: 832 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG 890
G V+ + R + ++ PE I T+ D W+ G++L+E+ YG
Sbjct: 168 -----GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG 222
Query: 891 YTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943
P+ + + I + L+ P P ++ +M R+P+ RL E
Sbjct: 223 KQPWFQLSNTEVIECITQGRVLERPRVCPKEVY--DIMLGCWQREPQQRLNIKE 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|225112 COG2202, AtoS, FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 46.8 bits (109), Expect = 2e-05
Identities = 30/118 (25%), Positives = 47/118 (39%), Gaps = 9/118 (7%)
Query: 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPAT 532
L LE + D D I++A+ + EL YS EE LGR L PE +
Sbjct: 113 RLRALLEASPDGIWVLDE---DGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERR 169
Query: 533 VRK--IRAAIDNQTDVTVQLINYTKSGKK-FWNLFHLQPMRDQ---KYFIGVQLDGSE 584
+ A + ++ K G++ W L + P+RD +G+ D +E
Sbjct: 170 ELELARALAEGRGGPLEIEYRVRRKDGERVRWILSRISPVRDDGEIVGVVGIARDITE 227
|
Length = 232 |
| >gnl|CDD|197509 smart00086, PAC, Motif C-terminal to PAS motifs (likely to contribute to PAS structural domain) | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 2e-05
Identities = 11/36 (30%), Positives = 25/36 (69%)
Query: 269 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+KDG+ W L++ +PI+D++G+V +G+ +++
Sbjct: 6 LRRKDGSYIWVLVSASPIRDEDGEVEGILGVVRDIT 41
|
PAC motif occurs C-terminal to a subset of all known PAS motifs. It is proposed to contribute to the PAS domain fold. Length = 43 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 62/300 (20%), Positives = 112/300 (37%), Gaps = 52/300 (17%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAM-DKGVMLNRNKVHRACA 714
+INL R ++ LG G V+ L G+ Q A+K + DK R +
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 715 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLL------------DRQP 760
R L HP + L + + +I YC +L FL++ D+
Sbjct: 61 MRS---RLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 761 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820
L+ ++ +E+L ++++DL NVL+ +V ++D L
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLF------ 171
Query: 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 880
V+ A+ + + + +++PE I + D W+
Sbjct: 172 -------------------REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212
Query: 881 GILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
G++L+E+ YG P+ G + Q I ++ L P P ++ LM + P R
Sbjct: 213 GVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYT--LMLECWNEFPSRR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 52/226 (23%), Positives = 90/226 (39%), Gaps = 30/226 (13%)
Query: 715 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 774
E IL HP + L K + ++ + GG+ L + ++ ++ ++
Sbjct: 43 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM-VE 101
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
+EYL + I+RDL N L+ + ++DF +S + + +T K
Sbjct: 102 NAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMS---REEEDGVYASTGGMK-- 156
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTP 893
Q PV ++ APE + ++S D W+ GILL+E G P
Sbjct: 157 ----QIPV----------------KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVP 196
Query: 894 FRGKTRQKTFANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ + Q+T I L P P +++ +LM R DP R
Sbjct: 197 YANLSNQQTREAIEQGVRLPCPELCPDAVY--RLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 62/293 (21%), Positives = 113/293 (38%), Gaps = 46/293 (15%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 721
+NLQ + +G G+ G+V E +GQ A+K + V E ++
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVT-----AQAFLEETAVMTK 55
Query: 722 LDHP-FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
L H V L ++ + + G L L + ++ + ++ +V +
Sbjct: 56 LHHKNLVRLLGVILHNGLYI--VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
EYL + +++RDL N+L+ +G ++DF L+
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA-------------------------- 147
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 899
M NS + + + APE + +S D W+ G+LL+E+ YG P+ K
Sbjct: 148 ---RVGSMGVDNSKLPVK-WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYP-KMS 202
Query: 900 QKTFANILHKDLKF--PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950
K + K + P P ++ LM +PK R H+ +++K
Sbjct: 203 LKEVKECVEKGYRMEPPEGCPADVYV--LMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 29/122 (23%)
Query: 769 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPT 827
++ Y +++ + Y H +++RDLKP+N+L+ + + L DF L+
Sbjct: 104 IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA------------- 150
Query: 828 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA-VDWWALGILLYE 886
R G P+R V T Y APEI+ G+ H S VD W++G + E
Sbjct: 151 ------RAFGI--------PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAE 196
Query: 887 ML 888
M+
Sbjct: 197 MV 198
|
Length = 294 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 55/235 (23%), Positives = 99/235 (42%), Gaps = 43/235 (18%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN--RNKVHRACAEREIL------DML 722
LGSG+ G+V + MK +K V + +N + + E+L L
Sbjct: 1 GELGSGNFGTV-------KKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL 53
Query: 723 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 782
D+P++ + + ++ + L+ + G L L Q K + E + +V + ++Y
Sbjct: 54 DNPYIVRMIGICEAESWM-LVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKY 110
Query: 783 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
L ++RDL NVLL + ++DF LS + L N K + G+
Sbjct: 111 LEETNFVHRDLAARNVLLVTQHYAKISDFGLS-------KALGADENYYKAKTHGKW--- 160
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRG 896
P++ + APE + +S D W+ G+L++E YG P++G
Sbjct: 161 ----PVK----------WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 31/123 (25%), Positives = 54/123 (43%), Gaps = 27/123 (21%)
Query: 766 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825
ED ++ + +++ L Y H + ++RD+K N+LL G + L DF L+ L
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL--------- 165
Query: 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILL 884
+ +E R + V T Y PE++ G + A+D W+ G +L
Sbjct: 166 -----------------YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 208
Query: 885 YEM 887
E+
Sbjct: 209 GEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 62/290 (21%), Positives = 100/290 (34%), Gaps = 50/290 (17%)
Query: 670 IKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLN--RNKVHRACAEREILDML 722
+ LG G G V L E + A+K + K N R R E E+L
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFER---EAELLTNF 65
Query: 723 DHPFVPALYASFQTKTHVCLITDYCPGGEL------------FLLLDRQPTKVLKEDAVR 770
H + Y ++ +Y G+L FL P L +
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 771 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830
A ++ + YL Q ++RDL N L+ + V + DF +S
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS---------------- 169
Query: 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 889
V+ + R + ++ PE I T+ D W+ G++L+E+ Y
Sbjct: 170 ---------RDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTY 220
Query: 890 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRL 939
G P+ G + ++ I L T S +M RDP+ R+
Sbjct: 221 GKQPWYGLSNEEVIECITQGRLLQRPRTCPS-EVYDIMLGCWKRDPQQRI 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 49/208 (23%)
Query: 710 HRACA-EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 767
HR A E E+L L HP + L + + + ++ L +Y P G L L + ++VL+ D
Sbjct: 51 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK--SRVLETD 108
Query: 768 ----------------AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 811
+ +AA+V ++YL + I+RDL N+L+ N + DF
Sbjct: 109 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 168
Query: 812 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 871
LS +GQ+ V++ + M ++A E + + +
Sbjct: 169 GLS---------------------RGQE--VYVKKTMGRL-----PVRWMAIESLNYSVY 200
Query: 872 TSAVDWWALGILLYEML-YGYTPFRGKT 898
T+ D W+ G+LL+E++ G TP+ G T
Sbjct: 201 TTNSDVWSYGVLLWEIVSLGGTPYCGMT 228
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|131984 TIGR02938, nifL_nitrog, nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-04
Identities = 24/92 (26%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 497 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKS 556
I++A+D+F +T Y++EEI+G+N L T P + + ++ Q +L+N K
Sbjct: 26 ILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNRRKD 85
Query: 557 GKKFWNLFHLQPMRDQK----YFIGVQLDGSE 584
G+ + + P+ ++ +F+G+ D +E
Sbjct: 86 GELYLAELTVAPVLNEAGETTHFLGMHRDITE 117
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes [Central intermediary metabolism, Nitrogen fixation, Regulatory functions, Protein interactions]. Length = 494 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 53/244 (21%), Positives = 97/244 (39%), Gaps = 33/244 (13%)
Query: 680 SVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL--DMLDHPFVPALYASFQTK 737
SV+L +G ++ D + N + H + E++ HP + + F T
Sbjct: 15 SVYLARHTPTGTLVTVRITD---LENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG 71
Query: 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 797
+ + +I+ + G LL + + E + + L YLH G I+R++K +
Sbjct: 72 SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASH 131
Query: 798 VLLQGNGHVSLTDFD-LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG 856
+L+ G+G VSL+ L L GQ+ V P
Sbjct: 132 ILISGDGLVSLSGLSHLYSLV-----------------RNGQKAKVVYDFP----QFSTS 170
Query: 857 TEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP 914
+++PE++ G+ D +++GI E+ G PF+ R + +L + LK P
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ----MLLQKLKGP 226
Query: 915 SSTP 918
+P
Sbjct: 227 PYSP 230
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 30/149 (20%), Positives = 58/149 (38%), Gaps = 15/149 (10%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFV 727
IK L G T V+L+ + +K R E IL +L V
Sbjct: 3 IKLLKGGLTNRVYLLGTKDED--YVLK--INPSREKGADRER---EVAILQLLARKGLPV 55
Query: 728 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 787
P + AS ++ L+ ++ G L + + + + ++ AE++ L L
Sbjct: 56 PKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ------LAELLAKLHQLPLLV 109
Query: 788 IIYRDLKPENVLLQGNGHVSLTDFDLSCL 816
+ + DL P N+L+ + + D++ +
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 39/168 (23%), Positives = 70/168 (41%), Gaps = 26/168 (15%)
Query: 772 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 831
Y+ +V +E+L + I+RDL N+LL N V + DF L+ P +
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------- 230
Query: 832 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG 890
R + P+ +++APE I +T+ D W+ G+LL+E+ G
Sbjct: 231 --RKGDARLPL----------------KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 272
Query: 891 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+P+ G + F L + + + + +M H +P+ R
Sbjct: 273 ASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR 320
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 51/209 (24%)
Query: 710 HRACA-EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 767
HR A E E+L L HP + L + + + ++ + +Y P G L L + ++VL+ D
Sbjct: 46 HRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRK--SRVLETD 103
Query: 768 A-----------------VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 810
++F A++V ++YL + I+RDL NVL+ N + D
Sbjct: 104 PAFAKEHGTASTLTSQQLLQF-ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIAD 162
Query: 811 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 870
F LS +G++ V++ + M ++A E + +
Sbjct: 163 FGLS---------------------RGEE--VYVKKTMGRL-----PVRWMAIESLNYSV 194
Query: 871 HTSAVDWWALGILLYEML-YGYTPFRGKT 898
+T+ D W+ G+LL+E++ G TP+ G T
Sbjct: 195 YTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 46/213 (21%), Positives = 82/213 (38%), Gaps = 46/213 (21%)
Query: 731 YASFQTKTHVCLITDYCP----GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
YA ++ + Y P L++ P L + ++ +V +E+L +
Sbjct: 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESP--ALSYMDLVGFSYQVANGMEFLASK 258
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
++RDL NVL+ V + DF L+ +
Sbjct: 259 NCVHRDLAARNVLICEGKLVKICDFGLA------------------------------RD 288
Query: 847 PMRASN-----SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQ 900
MR SN S +++APE I +T+ D W+ GILL+E+ G TP+
Sbjct: 289 IMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348
Query: 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHR 933
+ F N + + + + P HA +Y ++ +
Sbjct: 349 EQFYNAIKRGYRM--AKPA--HASDEIYEIMQK 377
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 47/224 (20%), Positives = 95/224 (42%), Gaps = 23/224 (10%)
Query: 674 GSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS 733
G D +V+L +G+Y ++ ++ N V E + + +HP + A+
Sbjct: 9 GFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRAT 67
Query: 734 FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 793
F + ++T + G L+ + E A+ + V+ AL+Y+H G ++R +
Sbjct: 68 FIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSV 127
Query: 794 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNS 853
K ++L+ +G V L+ +N H GQ+ V P +
Sbjct: 128 KASHILISVDGKVYLSGL---------------RSNLSMINH-GQRLRVVHDFPKYS--- 168
Query: 854 FVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFR 895
V +++PE++ G+ + D +++GI E+ G+ PF+
Sbjct: 169 -VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 51/209 (24%)
Query: 710 HRACA-EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 767
HR A E E+L L HP + L + + + ++ L +Y P G L L + ++VL+ D
Sbjct: 39 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK--SRVLETD 96
Query: 768 A-----------------VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 810
+ F AA+V ++YL + I+RDL N+L+ N + D
Sbjct: 97 PAFAIANSTASTLSSQQLLHF-AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 155
Query: 811 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 870
F LS +GQ+ V++ + M ++A E + +
Sbjct: 156 FGLS---------------------RGQE--VYVKKTMGRL-----PVRWMAIESLNYSV 187
Query: 871 HTSAVDWWALGILLYEML-YGYTPFRGKT 898
+T+ D W+ G+LL+E++ G TP+ G T
Sbjct: 188 YTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 7e-04
Identities = 44/192 (22%), Positives = 78/192 (40%), Gaps = 26/192 (13%)
Query: 748 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 807
E+ LL ++ L + + +V +E+L + ++RDL NVLL V
Sbjct: 218 NDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVK 277
Query: 808 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA 867
+ DF L+ ++ KG F+ P++ ++APE I
Sbjct: 278 ICDFGLA----------RDIMHDSNYVSKGS---TFL--PVK----------WMAPESIF 312
Query: 868 GAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQL 926
+T+ D W+ GILL+E+ G TP+ G TF N + + + +
Sbjct: 313 DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDI 372
Query: 927 MYRLLHRDPKSR 938
M + + +P+ R
Sbjct: 373 MVKCWNSEPEKR 384
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 9e-04
Identities = 66/320 (20%), Positives = 109/320 (34%), Gaps = 78/320 (24%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQY----------------FAMKAMDKGVML 704
+ Q ++ LG G G VHL E G + A+K +
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-- 58
Query: 705 NRNKVHRACAERE--ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQP 760
+ R +E IL L P + L +C+I +Y G+L FL
Sbjct: 59 --SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAE 116
Query: 761 TKVLKEDA-------VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 813
T L ++ + + A ++ + YL ++RDL N L+ N + + DF +
Sbjct: 117 TSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 814 SCLTSCKPQLLLPTTNE--KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 871
S ++ Q P+R ++A E +
Sbjct: 177 S--------------RNLYSSDYYRVQGRAPL---PIR----------WMAWESVLLGKF 209
Query: 872 TSAVDWWALGILLYEMLYGYT-----PFRGKTRQKTFANILHKD--------LKFPSSTP 918
T+ D WA G+ L+E+ T P+ T Q+ N H L P + P
Sbjct: 210 TTKSDVWAFGVTLWEI---LTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCP 266
Query: 919 TSLHAKQLMYRLLHRDPKSR 938
++ +LM RD + R
Sbjct: 267 KDIY--ELMLECWRRDEEDR 284
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|197509 smart00086, PAC, Motif C-terminal to PAS motifs (likely to contribute to PAS structural domain) | Back alignment and domain information |
|---|
Score = 37.2 bits (87), Expect = 0.001
Identities = 13/42 (30%), Positives = 18/42 (42%), Gaps = 4/42 (9%)
Query: 547 TVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSE 584
TV+ K G W L P+RD+ +GV D +E
Sbjct: 1 TVEYRLRRKDGSYIWVLVSASPIRDEDGEVEGILGVVRDITE 42
|
PAC motif occurs C-terminal to a subset of all known PAS motifs. It is proposed to contribute to the PAS domain fold. Length = 43 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 64/295 (21%), Positives = 112/295 (37%), Gaps = 48/295 (16%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAE 715
++ ++ LG G G V+ G A+K + + + E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE--SCSEQDESDFLME 59
Query: 716 REILDMLDHP-FVPALYASFQTKTHVCLITDYCPGGEL--FLLLDR----QPTKVLKEDA 768
I+ +H V + SF+ L+ + GG+L FL +R +P+ + +D
Sbjct: 60 ALIMSKFNHQNIVRLIGVSFERLPRFILL-ELMAGGDLKSFLRENRPRPERPSSLTMKDL 118
Query: 769 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLL--QGNGHVS-LTDFDLSCLTSCKPQLLL 825
+ F A +V +YL I+RD+ N LL +G G V+ + DF
Sbjct: 119 L-FCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF-------------- 163
Query: 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 885
G ++ A R + +++ PE TS D W+ G+LL+
Sbjct: 164 -----------GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLW 212
Query: 886 EML-YGYTPFRGKTRQKTFANI-LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
E+ GY P+ G+T Q+ + L P P ++ ++M P+ R
Sbjct: 213 EIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVY--RIMTDCWQHTPEDR 265
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 50/184 (27%), Positives = 73/184 (39%), Gaps = 67/184 (36%)
Query: 778 VALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
VAL+Y H + +++ DLKPEN+L++ S T D P TN R
Sbjct: 242 VALDYFHTELHLMHTDLKPENILME----TSDTVVD-------------PVTN----RA- 279
Query: 837 GQQNPVFMAEPMR--------------ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 882
+P R + + V T Y +PE++ G G + D W++G
Sbjct: 280 ------LPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGC 333
Query: 883 LLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPK---SRL 939
++YE+ YT GK T N+ H LH LM + L R P R
Sbjct: 334 IIYEL---YT---GKLLYDTHDNLEH------------LH---LMEKTLGRLPSEWAGRC 372
Query: 940 GSHE 943
G+ E
Sbjct: 373 GTEE 376
|
Length = 467 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 60/287 (20%), Positives = 106/287 (36%), Gaps = 52/287 (18%)
Query: 673 LGSGDTGSVHLVELCGS------GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
LG G G V L E C + A+KA+ + R R E E+L +L H
Sbjct: 13 LGEGAFGKVFLAE-CHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTVLQHQH 68
Query: 727 VPALYASFQTKTHVCLITDYCPGGEL--FL--------LLDR---QPTKVLKEDAVRFYA 773
+ Y + ++ +Y G+L FL +L L + A
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 774 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 833
+++ + YL ++RDL N L+ V + DF
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDF---------------------- 166
Query: 834 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 892
G ++ + R + ++ PE I T+ D W+ G++L+E+ YG
Sbjct: 167 ---GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
Query: 893 PFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
P+ + + I ++L+ P + P ++A +M R+P+ R
Sbjct: 224 PWYQLSNTEAIECITQGRELERPRTCPPEVYA--IMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 17/37 (45%), Positives = 26/37 (70%)
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 811
+V+ L LH GI++RD+KPEN+L+ +G V + DF
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353
|
Length = 507 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 60/254 (23%), Positives = 101/254 (39%), Gaps = 46/254 (18%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACA----EREILDML-DH 724
KPLG G G V + E G + +A+ V ML + + + E E++ M+ H
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----------- 771
+ L + + +I +Y G L +L R P D R
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 772 -YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830
+V +EYL Q I+RDL NVL+ N + + DF L+ + +
Sbjct: 141 SCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA--------RDVNNIDY 192
Query: 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 889
K+ G+ PV +++APE + +T D W+ G+L++E+
Sbjct: 193 YKKTTNGRL-PV----------------KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235
Query: 890 GYTPFRGKTRQKTF 903
G +P+ G ++ F
Sbjct: 236 GGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 63/285 (22%), Positives = 109/285 (38%), Gaps = 47/285 (16%)
Query: 673 LGSGDTGSVH---LVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
LGSG G V+ ++ G G A+K + KG K E ++ +HP
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNHPN 60
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLL-----DRQPTKVLKEDAVRFYAAEVVVALE 781
+ L +I + GG+L L +R +L + +V
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 782 YLHCQGIIYRDLKPENVLLQGNGH-----VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
YL I+RDL N L+ G+ V + DF L+ + ++ ++ +
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA--------RDIYKSDYYRKEGE 172
Query: 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFR 895
G P+R ++APE + T+ D W+ G+L++E+L G P+
Sbjct: 173 GLL-------PVR----------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215
Query: 896 GKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRL 939
Q+ ++ L+ P + P ++ QLM +DP R
Sbjct: 216 ALNNQEVLQHVTAGGRLQKPENCPDKIY--QLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 25/96 (26%), Positives = 45/96 (46%), Gaps = 11/96 (11%)
Query: 722 LDHPFVPALYA--SFQTKT----HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 775
+DH +P Y SF+ + L E+F + + K++K +
Sbjct: 80 IDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMK-----D 134
Query: 776 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 811
++ LEY+H GI + D+KPEN+++ GN + D+
Sbjct: 135 MLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170
|
Length = 294 |
| >gnl|CDD|214512 smart00091, PAS, PAS domain | Back alignment and domain information |
|---|
Score = 37.0 bits (86), Expect = 0.002
Identities = 15/49 (30%), Positives = 28/49 (57%), Gaps = 4/49 (8%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS 262
I+YA+ ++ GY+ +E++G++ L PED +++E LQ S
Sbjct: 23 ILYANPAAEELLGYSPEELIGKSLLEL----IHPEDRERVQEALQRLLS 67
|
PAS motifs appear in archaea, eubacteria and eukarya. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. Length = 67 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 46/254 (18%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHR----ACAEREILDML-DH 724
KPLG G G V + E G + K + V ML + + +E E++ M+ H
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQP-------TKVLKEDAVRFY--- 772
+ L + + ++ +Y G L +L R P T L E+ + F
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 773 --AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830
A +V +EYL Q I+RDL NVL+ + + + DF L+ + +
Sbjct: 138 SCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA--------RDVHNIDY 189
Query: 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 889
K+ G+ PV +++APE + +T D W+ G+LL+E+
Sbjct: 190 YKKTTNGRL-PV----------------KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 232
Query: 890 GYTPFRGKTRQKTF 903
G +P+ G ++ F
Sbjct: 233 GGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 33/145 (22%), Positives = 60/145 (41%), Gaps = 45/145 (31%)
Query: 760 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS----- 814
P + + V A ++ + YLH +G+I++D+ N ++ V +TD LS
Sbjct: 111 PQALSTQQLVHM-AIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFP 169
Query: 815 ----CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 870
CL NE + P++ ++A E +
Sbjct: 170 MDYHCLGD----------NENR--------------PVK----------WMALESLVNKE 195
Query: 871 HTSAVDWWALGILLYEML-YGYTPF 894
++SA D W+ G+LL+E++ G TP+
Sbjct: 196 YSSASDVWSFGVLLWELMTLGQTPY 220
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 998 | |||
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| PF13426 | 104 | PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_ | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.58 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.58 | |
| PF13426 | 104 | PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_ | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.53 | |
| PF08448 | 110 | PAS_4: PAS fold; InterPro: IPR013656 The PAS fold | 99.5 | |
| PF00989 | 113 | PAS: PAS fold; InterPro: IPR013767 PAS domains are | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| PRK13557 | 540 | histidine kinase; Provisional | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| PRK11091 | 779 | aerobic respiration control sensor protein ArcB; P | 99.4 | |
| PF00989 | 113 | PAS: PAS fold; InterPro: IPR013767 PAS domains are | 99.4 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.4 | |
| PRK13559 | 361 | hypothetical protein; Provisional | 99.39 | |
| PF08448 | 110 | PAS_4: PAS fold; InterPro: IPR013656 The PAS fold | 99.38 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 99.36 | |
| PRK13559 | 361 | hypothetical protein; Provisional | 99.34 | |
| PRK11091 | 779 | aerobic respiration control sensor protein ArcB; P | 99.31 | |
| PRK13557 | 540 | histidine kinase; Provisional | 99.3 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.29 | |
| PRK10060 | 663 | RNase II stability modulator; Provisional | 99.29 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.28 | |
| PRK13558 | 665 | bacterio-opsin activator; Provisional | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.21 | |
| TIGR00229 | 124 | sensory_box PAS domain S-box. The PAS domain was p | 99.13 | |
| PRK13558 | 665 | bacterio-opsin activator; Provisional | 99.12 | |
| PRK10060 | 663 | RNase II stability modulator; Provisional | 99.12 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 99.07 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.01 | |
| PF08447 | 91 | PAS_3: PAS fold; InterPro: IPR013655 The PAS fold | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.89 | |
| TIGR00229 | 124 | sensory_box PAS domain S-box. The PAS domain was p | 98.89 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.85 | |
| PRK11073 | 348 | glnL nitrogen regulation protein NR(II); Provision | 98.83 | |
| PF08447 | 91 | PAS_3: PAS fold; InterPro: IPR013655 The PAS fold | 98.8 | |
| COG3829 | 560 | RocR Transcriptional regulator containing PAS, AAA | 98.78 | |
| cd00130 | 103 | PAS PAS domain; PAS motifs appear in archaea, euba | 98.78 | |
| PRK11360 | 607 | sensory histidine kinase AtoS; Provisional | 98.71 | |
| PRK11073 | 348 | glnL nitrogen regulation protein NR(II); Provision | 98.7 | |
| TIGR02966 | 333 | phoR_proteo phosphate regulon sensor kinase PhoR. | 98.68 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.68 | |
| TIGR02966 | 333 | phoR_proteo phosphate regulon sensor kinase PhoR. | 98.68 | |
| KOG0501 | 971 | consensus K+-channel KCNQ [Inorganic ion transport | 98.67 | |
| cd00130 | 103 | PAS PAS domain; PAS motifs appear in archaea, euba | 98.65 | |
| PF13596 | 106 | PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D. | 98.64 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.64 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.62 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.6 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.6 | |
| KOG0501 | 971 | consensus K+-channel KCNQ [Inorganic ion transport | 98.59 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.57 | |
| PF12860 | 115 | PAS_7: PAS fold | 98.56 | |
| PRK11388 | 638 | DNA-binding transcriptional regulator DhaR; Provis | 98.55 | |
| PRK11360 | 607 | sensory histidine kinase AtoS; Provisional | 98.53 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-54 Score=461.25 Aligned_cols=336 Identities=54% Similarity=0.973 Sum_probs=294.6
Q ss_pred CCCCCCCCCchhhHHhhh-ccccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHH
Q 001902 639 PKPHRKDSPPWKAIQKIL-DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 717 (998)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~ 717 (998)
.+|++....-|....... ..+..+..+.|++++.||.|.-|+||+|+...++..+|+|++.+..+..+....+.+.|.+
T Consensus 50 ~kph~~~d~~w~a~~~~~~~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~e 129 (459)
T KOG0610|consen 50 NKPHKGNDVRWEAISSIRNSKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTERE 129 (459)
T ss_pred CCCCCCCchhhhhhccccccCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHH
Confidence 456666666677666555 4667888999999999999999999999999999999999999998888899999999999
Q ss_pred HHHhCCCCCccceeEEEeeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 001902 718 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 797 (998)
Q Consensus 718 il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~N 797 (998)
||..++||.++.+|..|+.+++.|+|||||+||+|..+++++.++.+++..++.|+.+++-||+|||-.|||+|||||+|
T Consensus 130 IL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPEN 209 (459)
T KOG0610|consen 130 ILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPEN 209 (459)
T ss_pred HHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCccccCCCCCCCCCcc-----h------------------hhhhccc---CC--CCcccccccc-
Q 001902 798 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT-----N------------------EKKRRHK---GQ--QNPVFMAEPM- 848 (998)
Q Consensus 798 ILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~-----~------------------~~~~~~~---~~--~~~~~~~~~~- 848 (998)
|||.++|++.|+||.++......+....... . ..++..+ .. ..+....++.
T Consensus 210 ILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~ 289 (459)
T KOG0610|consen 210 ILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTG 289 (459)
T ss_pred eEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCC
Confidence 9999999999999999977654443322110 0 0000000 00 0011222333
Q ss_pred cccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHH
Q 001902 849 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMY 928 (998)
Q Consensus 849 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~ 928 (998)
-.+.+++||-.|+|||++.+..++.++|.|+||+++|||++|..||.|.+..+.+.+|+...+.+|.....+..++|||+
T Consensus 290 ~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr 369 (459)
T KOG0610|consen 290 ARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIR 369 (459)
T ss_pred ccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHH
Confidence 34578999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HccccCccCcCCChhcHHHHHcCCCccCCChhhhhcCCCCCCCCCC
Q 001902 929 RLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPL 974 (998)
Q Consensus 929 ~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~ 974 (998)
++|.+||.+|+..+.+|.+|.+||||++++|+.+++..||.++.|.
T Consensus 370 ~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~ 415 (459)
T KOG0610|consen 370 KLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPV 415 (459)
T ss_pred HHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCcc
Confidence 9999999999999999999999999999999999999999997665
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-53 Score=467.04 Aligned_cols=309 Identities=42% Similarity=0.717 Sum_probs=266.3
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+..++|+++..||+|+||.||+|+-+.||..||+|++++..+....++..+..|..||...++|+||++|..|++..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
||||||++||++..+|.+. +.|+++.++.|+.+++.|+..||+.|+|||||||+|+|||..|++||+|||+|......
T Consensus 217 YLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999999999885 56999999999999999999999999999999999999999999999999999655432
Q ss_pred CCCCCCc----chhhhhcccCCCCcc----------------cccccccccccccCCCCcccchhhcCCCCCChhHHHHH
Q 001902 821 PQLLLPT----TNEKKRRHKGQQNPV----------------FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 880 (998)
Q Consensus 821 ~~~~~~~----~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSl 880 (998)
....... .+...........+. ..........+.+|||.|||||++.+.+|+..+|.|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 2211100 000000000000000 00011123456799999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCChHHHHHHHHhCC--CCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 881 GILLYEMLYGYTPFRGKTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 881 G~il~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
|||+||||.|.+||.+.+..+.+.+|+... +.+|....++.+++|||.+||+ ||.+|+. ..+++||.+||||++++
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG-~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG-SKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC-cccHHHHhcCCccccCC
Confidence 999999999999999999999999999765 8889999999999999999999 9999999 66799999999999999
Q ss_pred hhhhhcCCCCCCCCC
Q 001902 959 WALVRCMNPPELDAP 973 (998)
Q Consensus 959 ~~~~~~~~~~~~~~p 973 (998)
|..++.+.||..|..
T Consensus 453 W~~l~~~~apfvP~v 467 (550)
T KOG0605|consen 453 WDHLREMPAPFVPQV 467 (550)
T ss_pred cchhhcCCCCCCCCC
Confidence 999999998887543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=446.25 Aligned_cols=282 Identities=45% Similarity=0.800 Sum_probs=254.9
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+..++|++++.||+|+||+||.|+.+.+++.||+|++++..+...........|..||..++||+||.++..|++.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 35568999999999999999999999999999999999999888888889999999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|||+||+.||.|+..|.++ +.+++..++.|+..|+.||.|||++|||||||||+|||++.+|+++|+|||+++..-
T Consensus 101 ylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~-- 176 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL-- 176 (357)
T ss_pred EEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc--
Confidence 9999999999999999876 559999999999999999999999999999999999999999999999999996421
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
.......++|||+.|||||++.+.+|+..+|.||||+++|+|++|.+||.+.+..
T Consensus 177 -------------------------~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~ 231 (357)
T KOG0598|consen 177 -------------------------KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK 231 (357)
T ss_pred -------------------------cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH
Confidence 1122345689999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhh--hcCCCCCCCC
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV--RCMNPPELDA 972 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~--~~~~~~~~~~ 972 (998)
..+++|.++....+.. .++.++++||+++|.+||.+|+.....+.+|.+||||.+++|..+ ..+.||..+.
T Consensus 232 ~~~~~I~~~k~~~~p~-~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~ 304 (357)
T KOG0598|consen 232 KMYDKILKGKLPLPPG-YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPN 304 (357)
T ss_pred HHHHHHhcCcCCCCCc-cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecC
Confidence 9999999987443332 368899999999999999999976667999999999999999977 5566655543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-52 Score=426.07 Aligned_cols=276 Identities=45% Similarity=0.832 Sum_probs=257.7
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
..+++|+.++.||.|+||.|.+++++.+|..||+|++.+..+....+++...+|..+|+.+.||+++++++.|.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 55789999999999999999999999999999999999998888888999999999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
|||||++||.|+.++++. +.+++..++.++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+...
T Consensus 121 mvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS--- 195 (355)
T ss_pred EEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence 999999999999999874 569999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
....+.||||.|+|||++...+|+.++|.||||+++|||+.|.+||...+...
T Consensus 196 ---------------------------~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~ 248 (355)
T KOG0616|consen 196 ---------------------------GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ 248 (355)
T ss_pred ---------------------------CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH
Confidence 22457899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhh--hcCCCCCCC
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV--RCMNPPELD 971 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~--~~~~~~~~~ 971 (998)
++.+|+.+++.+|.. .++++++||+++|+.|-.+|.... .+.++|.+||||++++|..+ +.++||..+
T Consensus 249 iY~KI~~~~v~fP~~--fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 249 IYEKILEGKVKFPSY--FSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred HHHHHHhCcccCCcc--cCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCC
Confidence 999999999999875 688999999999999999996654 48999999999999999877 677777765
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=453.89 Aligned_cols=288 Identities=39% Similarity=0.673 Sum_probs=260.6
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 740 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 740 (998)
....+|...+.||+|+|++|++|+++.+++.||||++.+..+.....++.+..|..+|.+| +||.|++||..|++...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3457899999999999999999999999999999999998887788888899999999999 899999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+|+||+++|+|.++|++. +.+++..++.++.+|+.||+|||++|||||||||+|||++.+|+++|.|||.|+.++..
T Consensus 150 YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999999999886 56999999999999999999999999999999999999999999999999999887643
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
.... ..+...........+++||..|.+||+|.....++.+|||+||||||+|+.|.+||.+.+..
T Consensus 228 ~~~~--------------~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney 293 (604)
T KOG0592|consen 228 QKSQ--------------ENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY 293 (604)
T ss_pred hccc--------------cCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH
Confidence 3221 01111111112246799999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhcCCCCCCC
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELD 971 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~ 971 (998)
.++++|+...+.||.. .+..+.+||+++|..||.+|+| +.+|.+||||.+++|..++...||++.
T Consensus 294 liFqkI~~l~y~fp~~--fp~~a~dLv~KLLv~dp~~Rlt----~~qIk~HpFF~~Vdw~nlw~~~PP~l~ 358 (604)
T KOG0592|consen 294 LIFQKIQALDYEFPEG--FPEDARDLIKKLLVRDPSDRLT----SQQIKAHPFFEGVDWENLWQQTPPKLQ 358 (604)
T ss_pred HHHHHHHHhcccCCCC--CCHHHHHHHHHHHccCcccccc----HHHHhhCcccccCChhhhhhcCCCccc
Confidence 9999999998888865 5689999999999999999999 999999999999999999999999985
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=429.93 Aligned_cols=263 Identities=28% Similarity=0.463 Sum_probs=236.0
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC-
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT- 738 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~- 738 (998)
..+..++.+.++.||+|+.|+||+|+|+.|++.+|+|++.. ..+....+++.+|++|++.++|||||.+|+.|..+.
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence 44666789999999999999999999999999999999953 346777889999999999999999999999999988
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
.++|+||||++|+|.+++... +.+++..+..++.++++||.|||. .+||||||||+|||+++.|.|||||||.|..+
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 599999999999999999875 559999999999999999999996 89999999999999999999999999999654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
.. ....+++||..|||||.+.+..|+.++||||||++++|+++|+.||...
T Consensus 230 vn-----------------------------S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 230 VN-----------------------------SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred hh-----------------------------hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 31 1456789999999999999999999999999999999999999999874
Q ss_pred -----ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 898 -----TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 898 -----~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
+..+.+..|+.+..+-.....+|+++++|+..||++||.+||+ +.||++|||+++...
T Consensus 281 ~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s----~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 281 NPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPS----AKQLLQHPFIKKFED 343 (364)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCC----HHHHhcCHHHhhccc
Confidence 6678888888865443333368999999999999999999999 999999999998544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-50 Score=450.21 Aligned_cols=256 Identities=33% Similarity=0.576 Sum_probs=241.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
.+|+..+.||+|||+.||.+++..+|..||+|++.+..+......+.+.+|++|.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 47999999999999999999999999999999999988888899999999999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
|+|..++|..++++. +.+++..++.+++||+.||.|||+++|||||||.+|+|++++.+|||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~---- 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD---- 171 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc----
Confidence 999999999999864 67999999999999999999999999999999999999999999999999999664311
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.....+.||||+|.|||++....++..+||||+||+||-|++|++||...+-.+.+.
T Consensus 172 -----------------------~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~ 228 (592)
T KOG0575|consen 172 -----------------------GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN 228 (592)
T ss_pred -----------------------ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH
Confidence 133467899999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 905 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
+|...+...|. .+|.++++||.+||+.||.+||| ++++|.|+||+
T Consensus 229 ~Ik~~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rps----l~~vL~h~Ff~ 273 (592)
T KOG0575|consen 229 KIKLNEYSMPS--HLSAEAKDLIRKLLRPNPSERPS----LDEVLDHPFFK 273 (592)
T ss_pred HHHhcCccccc--ccCHHHHHHHHHHhcCCcccCCC----HHHHhcCHhhh
Confidence 99999998888 57999999999999999999999 99999999994
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-51 Score=433.91 Aligned_cols=261 Identities=33% Similarity=0.507 Sum_probs=230.3
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccCh----hHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR----NKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
.+.|.+.+.||+|+||.|.+|.++.||+.||||++++...... .....+.+|++||++|+|||||+++++|...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 4678999999999999999999999999999999998755442 234456799999999999999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC---CcEEEEeccCccc
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSCL 816 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~---g~vkL~DFG~a~~ 816 (998)
.||||||+.||+|++.+-.+ +.+.+...+.+++||+.||.|||++||+||||||+|||+..+ -.+||+|||+|+.
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999999876 458999999999999999999999999999999999999876 6899999999976
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCC---CChhHHHHHHHHHHHHHcCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~~sDIwSlG~il~eLltG~~P 893 (998)
.+. .....++||||.|.|||++....+ ..++|||||||+||-+++|.+|
T Consensus 329 ~g~----------------------------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pP 380 (475)
T KOG0615|consen 329 SGE----------------------------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPP 380 (475)
T ss_pred ccc----------------------------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCC
Confidence 541 123467899999999999977543 3488999999999999999999
Q ss_pred CCCCChHH-HHHHHHhCCCCCC--CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 894 FRGKTRQK-TFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 894 f~~~~~~~-~~~~i~~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
|.+..... ..+.|.++.+.+. .+..+|.+..+||..||..||++||| +.++|+||||+...
T Consensus 381 FS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s----~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 381 FSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPS----ADEALNHPWFKDAP 444 (475)
T ss_pred cccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcC----HHHHhcChhhhccc
Confidence 99877665 7788888877654 55678999999999999999999999 99999999999764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=440.40 Aligned_cols=296 Identities=40% Similarity=0.778 Sum_probs=262.9
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCC
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 738 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 738 (998)
..+.+++|.+++.||+|+||+|+++..+.+++.||||+++++.+...+.++....|.+|+... +||+++.++.+|++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 478889999999999999999999999999999999999999999999999999999999988 5999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
++|+||||+.||++..+.+ ...+++..++.|+..|+.||+|||++||||||||.+|||+|.+|++||+|||+++..-
T Consensus 443 ~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred eEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999999999544433 3569999999999999999999999999999999999999999999999999996521
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
.....++++||||.|||||++.+..|+.++|.||||++||||+.|..||.+.+
T Consensus 520 ---------------------------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd 572 (694)
T KOG0694|consen 520 ---------------------------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD 572 (694)
T ss_pred ---------------------------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 01124678999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhh--hcCCCCCCCCCCC
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV--RCMNPPELDAPLF 975 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~--~~~~~~~~~~p~~ 975 (998)
..+.+..|+..+..+|.. +|.++.++|+++|.+||++|+.+- ..+.+|.+||||+.++|..+ +.+.||.. |..
T Consensus 573 Eee~FdsI~~d~~~yP~~--ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~--P~i 648 (694)
T KOG0694|consen 573 EEEVFDSIVNDEVRYPRF--LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFV--PTI 648 (694)
T ss_pred HHHHHHHHhcCCCCCCCc--ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCC--ccc
Confidence 999999999999988876 588999999999999999999974 34789999999999999988 55666555 544
Q ss_pred CCccccccccCCchhH
Q 001902 976 ATDTEKEYKVVDPGMQ 991 (998)
Q Consensus 976 ~~~~~~~~~~~~~~~~ 991 (998)
... -|++-++++|-
T Consensus 649 ~~~--~D~snFd~eFt 662 (694)
T KOG0694|consen 649 KGP--EDVSNFDEEFT 662 (694)
T ss_pred CCh--hhhcccchhhh
Confidence 332 34555555553
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=391.58 Aligned_cols=261 Identities=27% Similarity=0.463 Sum_probs=223.6
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
++.|+.+.++|+|+||.||+|+++.||+.||||.+... -.++...+-..+||++|++++|+|+|.++++|.....++||
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 35799999999999999999999999999999998754 33455566678999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
+||| ..++.+-+.+.+. .++.+.++++++|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+..
T Consensus 80 FE~~-dhTvL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~---- 153 (396)
T KOG0593|consen 80 FEYC-DHTVLHELERYPN-GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA---- 153 (396)
T ss_pred eeec-chHHHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC----
Confidence 9999 4555555666543 399999999999999999999999999999999999999999999999999976542
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
+....+.++.|.+|.|||.+.+ ..|++++||||+||++.||++|.+.|.+.+..++
T Consensus 154 -----------------------pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ 210 (396)
T KOG0593|consen 154 -----------------------PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ 210 (396)
T ss_pred -----------------------CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH
Confidence 2223456789999999999998 7899999999999999999999999999998888
Q ss_pred HHHHHhC-------------------CCCCCCC----------CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCC
Q 001902 903 FANILHK-------------------DLKFPSS----------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953 (998)
Q Consensus 903 ~~~i~~~-------------------~~~~~~~----------~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~ 953 (998)
+..|... .+.+|.. +..+.-+.+|+++||..||++|++ .+++|.|||
T Consensus 211 Ly~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s----c~qll~H~y 286 (396)
T KOG0593|consen 211 LYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS----CEQLLHHPY 286 (396)
T ss_pred HHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc----HHHHhcChH
Confidence 8777652 1122221 334556789999999999999999 999999999
Q ss_pred ccCCC
Q 001902 954 FKGVN 958 (998)
Q Consensus 954 f~~~~ 958 (998)
|.++.
T Consensus 287 Fd~~~ 291 (396)
T KOG0593|consen 287 FDGFI 291 (396)
T ss_pred HHHHH
Confidence 97643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=398.71 Aligned_cols=259 Identities=29% Similarity=0.507 Sum_probs=228.5
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|.+.+.||+|+||+||+|+++.++..||||.+.+... .....+.+..|+.||+.++|||||.+++++...+++|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999987644 556677888999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC------CcEEEEeccCcccc
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN------GHVSLTDFDLSCLT 817 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~------g~vkL~DFG~a~~~ 817 (998)
||||.||+|.+++++. +.+++..++.++.||+.||++||+++||||||||.|||++.. -.+||+|||+|+.+
T Consensus 88 MEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999999886 459999999999999999999999999999999999999865 46899999999765
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
. +.....+.||+|.|||||++....|+.|+|+||+|+|+|+|++|++||...
T Consensus 166 ~----------------------------~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 166 Q----------------------------PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred C----------------------------chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 3 223456789999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHhCCCCCCCC-CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 898 TRQKTFANILHKDLKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~~~~-~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
+..+.+..+.++.-..+.. ...+..+.+|+...|+.+|.+|.+ -.+-+.|+++..-
T Consensus 218 t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~----~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 218 TPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRIS----FEDFFDHPFLAAN 274 (429)
T ss_pred CHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCc----hHHhhhhhhcccC
Confidence 9998888777654333322 234556679999999999999999 7777888887763
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=386.05 Aligned_cols=251 Identities=29% Similarity=0.475 Sum_probs=223.0
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeE-EEeeCCe-E
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA-SFQTKTH-V 740 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~-~~~~~~~-~ 740 (998)
...+|++++.||.|+||.||+|.+..+|+.+|.|.+..+ ..+....+....|+.+|++|+|||||++++ .|..++. +
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 356899999999999999999999999999999999855 456677788999999999999999999998 5555444 8
Q ss_pred EEEEecCCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCcEEEecCCcEEEEeccCc
Q 001902 741 CLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHC--QG--IIYRDLKPENVLLQGNGHVSLTDFDLS 814 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH~--~~--IiHrDLkP~NILi~~~g~vkL~DFG~a 814 (998)
+||||||.+|+|..++++ +....+++..+++++.|++.||..+|+ .+ |+||||||.||+++.+|.+||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999999974 445679999999999999999999999 45 999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
+.+... .....+++|||+||+||.+.+.+|+.+|||||+||++|||+.-++||
T Consensus 176 r~l~s~---------------------------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF 228 (375)
T KOG0591|consen 176 RFLSSK---------------------------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPF 228 (375)
T ss_pred hHhcch---------------------------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCc
Confidence 765421 12345789999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCC
Q 001902 895 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS 941 (998)
Q Consensus 895 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~ 941 (998)
.+.+......+|.+++.+.-.....|..+..||..|+..||..||+.
T Consensus 229 ~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 229 YGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 99999999999999977633335678899999999999999999984
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=407.25 Aligned_cols=256 Identities=33% Similarity=0.542 Sum_probs=234.9
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|.+.+.||+|+||.||+++.+.+.+.||+|.+.+... .....+.+.+|++|++.++||||+.++++|+...++|+|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 579999999999999999999999999999999987543 3445678899999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
|||.| +|+.++... +.++++.++.++.+++.||.|||+.+|+|||+||.|||+..+|++|+||||+|+.++....
T Consensus 81 e~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~-- 155 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS-- 155 (808)
T ss_pred hhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCce--
Confidence 99965 999999875 5599999999999999999999999999999999999999999999999999988763222
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.-..+.|||.|||||.+.+.+|+..+|+||||||+|||++|++||.........+
T Consensus 156 -------------------------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~ 210 (808)
T KOG0597|consen 156 -------------------------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVK 210 (808)
T ss_pred -------------------------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHH
Confidence 2345679999999999999999999999999999999999999999999899999
Q ss_pred HHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 905 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.|...+.++|. ..|..+.+||+.+|.+||.+|++ ..+|+.|||.++.
T Consensus 211 ~I~~d~v~~p~--~~S~~f~nfl~gLL~kdP~~Rlt----W~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 211 SILKDPVKPPS--TASSSFVNFLQGLLIKDPAQRLT----WTDLLGHPFWKGK 257 (808)
T ss_pred HHhcCCCCCcc--cccHHHHHHHHHHhhcChhhccc----HHHHhcChHHhhh
Confidence 99999888887 46889999999999999999999 9999999999884
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=411.27 Aligned_cols=263 Identities=31% Similarity=0.539 Sum_probs=239.4
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.+.|++.+.||.|+.|.|-+|++..||+..|||++.+...........+.+||-||+.+.||||+++|+++.+..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 46799999999999999999999999999999999987666666778899999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
.||++||.|++++-++ +++++..+..+++||+.|+.|||..+|+||||||+|+|++..+++||+|||+|......
T Consensus 91 lEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--- 165 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--- 165 (786)
T ss_pred EEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC---
Confidence 9999999999999886 56999999999999999999999999999999999999999999999999999553211
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCC-ChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT-SAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
..-.+-||+|.|.|||++.|.+|. .++||||+|+|||.|++|++||.+.+-...
T Consensus 166 -------------------------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~L 220 (786)
T KOG0588|consen 166 -------------------------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVL 220 (786)
T ss_pred -------------------------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHH
Confidence 123456999999999999999885 599999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhh
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
+.++.++.+..| ..++.++++||.+||..||+.|+| .++|++|||+++..-.-.
T Consensus 221 LlKV~~G~f~MP--s~Is~eaQdLLr~ml~VDp~~RiT----~~eI~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 221 LLKVQRGVFEMP--SNISSEAQDLLRRMLDVDPSTRIT----TEEILKHPFLSGYTSLPS 274 (786)
T ss_pred HHHHHcCcccCC--CcCCHHHHHHHHHHhccCcccccc----HHHHhhCchhhcCCCCCh
Confidence 999999988877 457999999999999999999999 999999999999654433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=399.46 Aligned_cols=263 Identities=28% Similarity=0.455 Sum_probs=227.7
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEeeCC-e
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKT-H 739 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~-~ 739 (998)
+..++|.++++||.|+||.||+|..+.+|..||||.+++.... .+.+ .-++|+.-|++|+ ||||+++++++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 3467999999999999999999999999999999999876543 2222 2357999999998 999999999998877 9
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|+||||| ...|+++++.+ ...+++..++.|+.||++||+|+|++|+.||||||+|||+..+..+||+|||+|+....
T Consensus 85 L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999999 88999999887 67899999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
. ...+.++.|.+|+|||+|.. ..|+.+.||||+|||++|+++-++.|.|.+
T Consensus 163 k----------------------------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 163 K----------------------------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred C----------------------------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 2 23456789999999999865 568889999999999999999999999999
Q ss_pred hHHHHHHHHh--C-----------------CCCCCCC---------CCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 899 RQKTFANILH--K-----------------DLKFPSS---------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 899 ~~~~~~~i~~--~-----------------~~~~~~~---------~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
..+++.+|.. + ++.+|.. ...+.++.+||.+||.+||.+||| |.++|+
T Consensus 215 E~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT----A~~al~ 290 (538)
T KOG0661|consen 215 EIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT----ASQALQ 290 (538)
T ss_pred HHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc----HHHHhc
Confidence 9888887764 1 2233322 235778999999999999999999 999999
Q ss_pred CCCccCCChh
Q 001902 951 HPFFKGVNWA 960 (998)
Q Consensus 951 Hp~f~~~~~~ 960 (998)
||||+--...
T Consensus 291 ~pffq~~~~~ 300 (538)
T KOG0661|consen 291 HPFFQVGRAS 300 (538)
T ss_pred Cccccccccc
Confidence 9999985444
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=406.54 Aligned_cols=262 Identities=34% Similarity=0.615 Sum_probs=234.8
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccCh--hHHHHHHHHHHHHHhCC-CCCccceeEEEeeCC
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR--NKVHRACAEREILDMLD-HPFVPALYASFQTKT 738 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~--~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~ 738 (998)
...+.|.+.+.||+|+||+|++|.+..++..||+|++.+...... .....+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 446799999999999999999999999999999998876533211 23456668999999998 999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC-CcEEEEeccCcccc
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLT 817 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~-g~vkL~DFG~a~~~ 817 (998)
.+|+|||||.||+|++++... +.+.+..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999999883 569999999999999999999999999999999999999999 99999999999654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC-CC-ChhHHHHHHHHHHHHHcCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HT-SAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
. .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||.
T Consensus 172 ~---------------------------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~ 224 (370)
T KOG0583|consen 172 P---------------------------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFD 224 (370)
T ss_pred C---------------------------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 2 0112345679999999999999977 75 69999999999999999999999
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 896 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 896 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
..+....+..|..+.+.+|.... |.++++|+.+||..||.+|++ +.++++||||+..
T Consensus 225 d~~~~~l~~ki~~~~~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t----~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 225 DSNVPNLYRKIRKGEFKIPSYLL-SPEARSLIEKMLVPDPSTRIT----LLEILEHPWFQKE 281 (370)
T ss_pred CccHHHHHHHHhcCCccCCCCcC-CHHHHHHHHHHcCCCcccCCC----HHHHhhChhhccC
Confidence 99999999999999999998765 999999999999999999999 9999999999974
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=367.52 Aligned_cols=262 Identities=35% Similarity=0.588 Sum_probs=243.7
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
...+++|++.+.||.|.||.||+|+.++++-.||+|++.+..+......+++.+|++|...|+||||+++|++|.+...+
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 34567999999999999999999999999999999999987766666778899999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
||++||.++|+|+..|..+....+++.....++.|++.||.|+|.++||||||||+|+|++..|.+||+|||.+..
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~---- 173 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH---- 173 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee----
Confidence 9999999999999999976677899999999999999999999999999999999999999999999999999843
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
.++....+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||...+..
T Consensus 174 -------------------------~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~ 228 (281)
T KOG0580|consen 174 -------------------------APSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS 228 (281)
T ss_pred -------------------------cCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH
Confidence 2345567889999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
+.+.+|.+.++.+| ..++.++.+||.+||.++|.+|.. +.+++.|||+.+.
T Consensus 229 etYkrI~k~~~~~p--~~is~~a~dlI~~ll~~~p~~r~~----l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 229 ETYKRIRKVDLKFP--STISGGAADLISRLLVKNPIERLA----LTEVMDHPWIVAN 279 (281)
T ss_pred HHHHHHHHccccCC--cccChhHHHHHHHHhccCcccccc----HHHHhhhHHHHhc
Confidence 99999999998888 457899999999999999999999 9999999998753
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=374.47 Aligned_cols=288 Identities=41% Similarity=0.752 Sum_probs=261.6
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+-+++|..++.||+|.||+|-+|+.+.+++.||+|+++++.+...+.+.....|-++|+..+||.+..+...|+..+.+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 45578999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||++||.|+-.|.+. ..+++...+.+-..|+.||.|||+++||.||||.+|+|+|.+|++||.|||+++..-
T Consensus 244 CFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-- 319 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-- 319 (516)
T ss_pred EEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc--
Confidence 9999999999999988774 569999999999999999999999999999999999999999999999999985421
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
......+++||||.|+|||++....|+..+|.|.+|+++|||+||++||...+..
T Consensus 320 -------------------------~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~ 374 (516)
T KOG0690|consen 320 -------------------------KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE 374 (516)
T ss_pred -------------------------cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence 0112456889999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhh--hcCCCCCCCCCCCCC
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV--RCMNPPELDAPLFAT 977 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~--~~~~~~~~~~p~~~~ 977 (998)
..+.-|+.+++.+|.. ++++++.||..+|.+||.+|+..- +.+.++.+|+||..++|... ..+.||..+...-.|
T Consensus 375 kLFeLIl~ed~kFPr~--ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSet 452 (516)
T KOG0690|consen 375 KLFELILMEDLKFPRT--LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSET 452 (516)
T ss_pred HHHHHHHhhhccCCcc--CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCccccc
Confidence 9999999999999876 689999999999999999999864 46999999999999999876 667777776555444
Q ss_pred cc
Q 001902 978 DT 979 (998)
Q Consensus 978 ~~ 979 (998)
|+
T Consensus 453 DT 454 (516)
T KOG0690|consen 453 DT 454 (516)
T ss_pred ch
Confidence 44
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=369.56 Aligned_cols=261 Identities=30% Similarity=0.490 Sum_probs=232.7
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+..+.|.+...||+|.|+.||++.+..+|+.+|+|++........ ..+.+.+|+.|.+.|+||||+++++.+...+..|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 345789999999999999999999999999999999886655444 5678889999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC---CcEEEEeccCccccC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSCLTS 818 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~---g~vkL~DFG~a~~~~ 818 (998)
||+|+|.|++|..-+-.+ ..+++..+..+++||+++|.|+|.+|||||||||.|+|+.+. .-+||+|||+|...+
T Consensus 87 lvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999999987544332 458999999999999999999999999999999999999753 469999999996543
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
........+|||.|||||++...+|+..+|||+.|++||-|+.|++||.+.+
T Consensus 165 ----------------------------~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~ 216 (355)
T KOG0033|consen 165 ----------------------------DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 216 (355)
T ss_pred ----------------------------CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc
Confidence 1123456789999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCC--CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 899 RQKTFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
....+..|+++...++ .+..+++++++|+++||..||.+|+| +.++|+|||+...
T Consensus 217 ~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIt----a~EAL~HpWi~~r 273 (355)
T KOG0033|consen 217 QHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRIT----ADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhcc----HHHHhCCchhcch
Confidence 9999999999876654 57789999999999999999999999 9999999999873
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=393.57 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=224.7
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC--Ce
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--TH 739 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~ 739 (998)
...+.|+.+.+||+|.||.||+|++..+|+.||+|.+..+.. +.....-..+||.||++|+||||+++.+..... ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 345789999999999999999999999999999999987643 344556677899999999999999999988765 68
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|||+||| ..+|..++... +-.+++.+++.|+.||+.||+|||++||+|||||.+|||||.+|.+||+|||+|..+..
T Consensus 193 iYlVFeYM-dhDL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 193 IYLVFEYM-DHDLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEEEecc-cchhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99999999 77888888653 35699999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
... ...+..+.|++|.|||.|.|. .|+.++|+||+||||.||+.|++.|.+.+
T Consensus 271 ~~~--------------------------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 271 SGS--------------------------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred CCC--------------------------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 221 124566889999999999885 68999999999999999999999999999
Q ss_pred hHHHHHHHHhCC----------CCCCC-----------------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 899 RQKTFANILHKD----------LKFPS-----------------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 899 ~~~~~~~i~~~~----------~~~~~-----------------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
..+++..|.+-. ..+|. ...++..+.+|+..||+.||.+|.| |.++|+|
T Consensus 325 EveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t----A~~aL~s 400 (560)
T KOG0600|consen 325 EVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT----ASSALQS 400 (560)
T ss_pred HHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc----HHHHhcC
Confidence 999999887621 01110 1224667789999999999999999 9999999
Q ss_pred CCccC
Q 001902 952 PFFKG 956 (998)
Q Consensus 952 p~f~~ 956 (998)
+||..
T Consensus 401 eyF~t 405 (560)
T KOG0600|consen 401 EYFTT 405 (560)
T ss_pred ccccc
Confidence 99954
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=390.82 Aligned_cols=266 Identities=34% Similarity=0.560 Sum_probs=228.2
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccC-----------hhHHHHHHHHHHHHHhCCCCCccce
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-----------RNKVHRACAEREILDMLDHPFVPAL 730 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~-----------~~~~~~~~~E~~il~~l~h~nIv~l 730 (998)
..+++|++++.||+|.||.|.+|++..+++.||||++.+..... ....+...+||.||++|.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34579999999999999999999999999999999998643221 1234688899999999999999999
Q ss_pred eEEEee--CCeEEEEEecCCCCchhHHHhhCCCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEE
Q 001902 731 YASFQT--KTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 807 (998)
Q Consensus 731 ~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~-l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vk 807 (998)
+++..+ .+.+|||+|||..|.+...-.. +. +++.++++|+++++.||+|||.+|||||||||+|+|++++|+||
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d---~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD---KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCC---cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 999975 5789999999998887654332 33 99999999999999999999999999999999999999999999
Q ss_pred EEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC----CCChhHHHHHHHH
Q 001902 808 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGIL 883 (998)
Q Consensus 808 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDIwSlG~i 883 (998)
|+|||.+......... .. ...-...+|||.|+|||.+.+.. .+.+.||||+|++
T Consensus 251 IsDFGVs~~~~~~~~~---~~-------------------d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVT 308 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDE---GS-------------------DDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVT 308 (576)
T ss_pred eeccceeeecccCCcc---cc-------------------HHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhh
Confidence 9999999654322100 00 00112258999999999987732 3458999999999
Q ss_pred HHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 884 LYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 884 l~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
||.|+.|+.||.+....+.+.+|+...+.+|....+...+++||.+||++||++|++ +.+|..|||...
T Consensus 309 LYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~----l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 309 LYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRIT----LPDIKLHPWVTR 377 (576)
T ss_pred HHHhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheee----hhhheecceecc
Confidence 999999999999999999999999999999999888999999999999999999999 999999999886
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=395.01 Aligned_cols=267 Identities=40% Similarity=0.728 Sum_probs=234.9
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997654434445567888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~----- 153 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----- 153 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----
Confidence 999999999999765 4589999999999999999999999999999999999999999999999999854320
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+.
T Consensus 154 -------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~ 208 (291)
T cd05612 154 -------------------------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE 208 (291)
T ss_pred -------------------------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1123469999999999999999999999999999999999999999998888888
Q ss_pred HHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCC-hhcHHHHHcCCCccCCChhhhhcC
Q 001902 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWALVRCM 965 (998)
Q Consensus 905 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~-~~~a~elL~Hp~f~~~~~~~~~~~ 965 (998)
.+......++.. .+..+++||.+||..||.+||+. +..+.++++||||+.++|..+...
T Consensus 209 ~i~~~~~~~~~~--~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~ 268 (291)
T cd05612 209 KILAGKLEFPRH--LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQR 268 (291)
T ss_pred HHHhCCcCCCcc--CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcC
Confidence 888887766654 47889999999999999999952 234999999999999999877443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=383.65 Aligned_cols=273 Identities=26% Similarity=0.407 Sum_probs=238.2
Q ss_pred cccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 658 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
....++.+.|++...||.|..++||+|+...++.+||||++..+...+ ..+.+..|+..|..++||||++++..|..+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 345677889999999999999999999999999999999998765433 378899999999999999999999999999
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
+.+|+||.||.+|++.++++..-...+++..+..|++++++||.|||.+|-||||||+.||||+.+|.|||+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 99999999999999999998765556999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCccccccccccc-ccccCCCCcccchhhcC--CCCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS-NSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~--~~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
-.. + ..+... .+++||++|||||++.. .+|+.|+||||||++..||++|..||
T Consensus 177 ~~~----------------G--------~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf 232 (516)
T KOG0582|consen 177 FDS----------------G--------DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF 232 (516)
T ss_pred ccc----------------C--------ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc
Confidence 311 0 111222 67899999999999754 57899999999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCCCCCC--------CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChh
Q 001902 895 RGKTRQKTFANILHKDLKFPSS--------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 960 (998)
Q Consensus 895 ~~~~~~~~~~~i~~~~~~~~~~--------~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 960 (998)
....+...+..-+++..+.+.. ...+..++.++..||.+||.+||| +.++|+|+||+..+-.
T Consensus 233 ~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRpt----AskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 233 SKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPT----ASKLLKHAFFKKAKSK 302 (516)
T ss_pred ccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCC----HHHHhccHHHhhccch
Confidence 9999988887777777654432 334667889999999999999999 9999999999986543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=401.58 Aligned_cols=267 Identities=27% Similarity=0.456 Sum_probs=235.2
Q ss_pred HHhhhccccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCcccee
Q 001902 652 IQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALY 731 (998)
Q Consensus 652 ~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 731 (998)
++.+...+.+. ..|....+||+|+.|.||.|....+++.||+|.+..... ...+-+.+|+.+|+..+|+|||.++
T Consensus 262 l~~v~~~~dP~--~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl 336 (550)
T KOG0578|consen 262 LKRVVSQGDPR--SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFL 336 (550)
T ss_pred hheeccCCChh--hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHH
Confidence 33344445443 479999999999999999999999999999999986533 3346688999999999999999999
Q ss_pred EEEeeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEec
Q 001902 732 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 811 (998)
Q Consensus 732 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DF 811 (998)
+.|...+.+|+|||||+||+|.+++... .+++.++..|+++++.||+|||.+||||||||.+|||++.+|.+||+||
T Consensus 337 ~Sylv~deLWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDF 413 (550)
T KOG0578|consen 337 DSYLVGDELWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDF 413 (550)
T ss_pred HHhcccceeEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeee
Confidence 9999999999999999999999999763 4999999999999999999999999999999999999999999999999
Q ss_pred cCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCC
Q 001902 812 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 891 (998)
Q Consensus 812 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~ 891 (998)
|++..+... .....+.+|||+|||||++....|++++||||||++++||+-|+
T Consensus 414 GFcaqi~~~---------------------------~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGE 466 (550)
T KOG0578|consen 414 GFCAQISEE---------------------------QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGE 466 (550)
T ss_pred eeeeccccc---------------------------cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCC
Confidence 999654311 12456789999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHh-CCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 892 TPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 892 ~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
+||...++...+..|.. +...+.....+|+.+++||.+||+.|+.+|++ |.+||+||||+..
T Consensus 467 PPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~Ras----A~eLL~HpFl~~a 529 (550)
T KOG0578|consen 467 PPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRAS----AKELLEHPFLKMA 529 (550)
T ss_pred CCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCC----HHHHhcChhhhhc
Confidence 99998888777776664 55666677789999999999999999999999 9999999999643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=361.13 Aligned_cols=273 Identities=26% Similarity=0.448 Sum_probs=229.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
.+|..++.||+|.||.||+|++..+|+.||||.++.....+. ......+||++|+.++|+||+.++++|...+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 479999999999999999999999999999999987643332 2345678999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||| ..+|...++.. ...++..+++.|+.++++||+|||.+.|+||||||+|+||+++|.+||+|||+|+.++....
T Consensus 81 Efm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~-- 156 (318)
T KOG0659|consen 81 EFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR-- 156 (318)
T ss_pred Eec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc--
Confidence 999 77999998765 46799999999999999999999999999999999999999999999999999987653322
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
.....+-|.+|.|||.+.|. .|+..+||||.|||+.||+-|.+.|.|.+..+++
T Consensus 157 -------------------------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL 211 (318)
T KOG0659|consen 157 -------------------------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL 211 (318)
T ss_pred -------------------------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH
Confidence 22233789999999999885 6888999999999999999999999999999999
Q ss_pred HHHHhCC-----CCCCC---------------------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 904 ANILHKD-----LKFPS---------------------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 904 ~~i~~~~-----~~~~~---------------------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
..|.+-- -.+|+ ....+.++.+|+.+||..||.+|++ +.|+|+|+||+..
T Consensus 212 ~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit----a~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 212 SKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRIT----ASQALKHPYFKSL 287 (318)
T ss_pred HHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhccc----HHHHhcchhhhcC
Confidence 8887621 01111 1234667899999999999999999 9999999999974
Q ss_pred ChhhhhcCCCCCCCCCCC
Q 001902 958 NWALVRCMNPPELDAPLF 975 (998)
Q Consensus 958 ~~~~~~~~~~~~~~~p~~ 975 (998)
-. ...|.+++.|.-
T Consensus 288 P~----pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 288 PL----PTPPSKLPIPST 301 (318)
T ss_pred CC----CCChhhCcCCcc
Confidence 22 223445555543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=400.02 Aligned_cols=268 Identities=40% Similarity=0.768 Sum_probs=237.5
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
...++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999998764444455677889999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 95 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-- 170 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-- 170 (329)
T ss_pred EEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC--
Confidence 999999999999999765 4589999999999999999999999999999999999999999999999999854320
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 171 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 222 (329)
T PTZ00263 171 ----------------------------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR 222 (329)
T ss_pred ----------------------------CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH
Confidence 1123469999999999999999999999999999999999999999988888
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCC-hhcHHHHHcCCCccCCChhhhh
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~-~~~a~elL~Hp~f~~~~~~~~~ 963 (998)
.+..+..+...+|.. .+..+.+||.+||+.||.+||+. .+.+.+|++||||++.+|..+.
T Consensus 223 ~~~~i~~~~~~~p~~--~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~ 283 (329)
T PTZ00263 223 IYEKILAGRLKFPNW--FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLY 283 (329)
T ss_pred HHHHHhcCCcCCCCC--CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence 888888877666543 67889999999999999999974 2458999999999999998774
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=427.66 Aligned_cols=290 Identities=38% Similarity=0.672 Sum_probs=261.6
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+..++|.+++.||+|+||.|.+++++.+++.||+|++.+-.+..+.....|..|..||...+++-|+.++..|+++.++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 35678999999999999999999999999999999999987777777788899999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+|||||+||+|..+|.+.. .+++..+++|+..|+.||..||+.|.|||||||+|||+|..|++||+|||.+..+..+
T Consensus 151 YlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 99999999999999998863 6999999999999999999999999999999999999999999999999988665422
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc----C-CCCCChhHHHHHHHHHHHHHcCCCCCC
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA----G-AGHTSAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~~~~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
....+...+|||.|.|||+|. + +.|+..+|.||+|+++|||++|..||+
T Consensus 229 --------------------------G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 229 --------------------------GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred --------------------------CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 123456679999999999994 2 568889999999999999999999999
Q ss_pred CCChHHHHHHHHhC--CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhcCCCCCCCCC
Q 001902 896 GKTRQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 973 (998)
Q Consensus 896 ~~~~~~~~~~i~~~--~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p 973 (998)
..+-.+.|-+|+.- .+.||....+|.++++||.++++ +|..|++ +.++.++.+||||.+++|..++...||..|-.
T Consensus 283 adslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLg-rngiedik~HpFF~g~~W~~iR~~~pP~vPev 360 (1317)
T KOG0612|consen 283 ADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLG-RNGIEDIKNHPFFEGIDWDNIRESVPPVVPEV 360 (1317)
T ss_pred HHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-Chhhhcc-cccHHHHHhCccccCCChhhhhhcCCCCCCcC
Confidence 99999999999965 78899778899999999999999 8899998 67799999999999999999999999988655
Q ss_pred CCCCccc
Q 001902 974 LFATDTE 980 (998)
Q Consensus 974 ~~~~~~~ 980 (998)
.-.+|+-
T Consensus 361 ssd~DTs 367 (1317)
T KOG0612|consen 361 SSDDDTS 367 (1317)
T ss_pred CCCCccc
Confidence 5444443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=396.13 Aligned_cols=262 Identities=43% Similarity=0.780 Sum_probs=229.0
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 750 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 750 (998)
+.||+|+||.||+|.+..+|+.||+|++++...........+..|+.+++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999999999999999998765545555667888999999999999999999999999999999999999
Q ss_pred chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchh
Q 001902 751 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830 (998)
Q Consensus 751 sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 830 (998)
+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~---------- 148 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD---------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC----------
Confidence 999998764 45899999999999999999999999999999999999999999999999998532100
Q ss_pred hhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCC
Q 001902 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 910 (998)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~ 910 (998)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+....
T Consensus 149 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~ 211 (323)
T cd05571 149 -----------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211 (323)
T ss_pred -----------------CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 011234579999999999999999999999999999999999999999988888888777776
Q ss_pred CCCCCCCCCcHHHHHHHHHccccCccCcCCChh-cHHHHHcCCCccCCChhhhh
Q 001902 911 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 911 ~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~ 963 (998)
..+|. ..+.++.+||.+||..||.+||+..+ .+.++++||||++++|..+.
T Consensus 212 ~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~ 263 (323)
T cd05571 212 IRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVV 263 (323)
T ss_pred CCCCC--CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 66654 46889999999999999999993221 29999999999999998774
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=400.43 Aligned_cols=294 Identities=37% Similarity=0.652 Sum_probs=235.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++..++|+||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765444555667888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
|||+||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..........
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999999765 459999999999999999999999999999999999999999999999999986543211100
Q ss_pred CCcc-hhhhhcccC--CCCc-----ccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 825 LPTT-NEKKRRHKG--QQNP-----VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 825 ~~~~-~~~~~~~~~--~~~~-----~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.... ......... .... .............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 0000 000000000 0000 0000001112356899999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHHhC--CCCCCCCCCCcHHHHHHHHHccccCccCc---CCChhcHHHHHcCCCccCCChhhhhcC
Q 001902 897 KTRQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSR---LGSHEGANEIKKHPFFKGVNWALVRCM 965 (998)
Q Consensus 897 ~~~~~~~~~i~~~--~~~~~~~~~~s~~l~~Ll~~~L~~dP~~R---pt~~~~a~elL~Hp~f~~~~~~~~~~~ 965 (998)
.+....+..+... .+.+|.....+.++++||.+|++ +|.+| |+ +++|++||||++++|..+...
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~----~~ei~~hp~f~~~~~~~~~~~ 307 (363)
T cd05628 239 ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPG----VEEIKTNPFFEGVDWEHIRER 307 (363)
T ss_pred CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCC----HHHHhCCCCCCCCCHHHHHhC
Confidence 8888888888763 45566666788999999999876 55554 66 999999999999999988654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=396.99 Aligned_cols=271 Identities=37% Similarity=0.644 Sum_probs=236.9
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||+|.+..+++.||+|++++...........+.+|+.++..++||||+++++++...+.+||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765444455677889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 999999999999764 4589999999999999999999999999999999999999999999999999854221
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+.
T Consensus 154 -------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~ 208 (333)
T cd05600 154 -------------------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE 208 (333)
T ss_pred -------------------------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH
Confidence 1234579999999999999999999999999999999999999999988877777
Q ss_pred HHHhCC--CCCCCC----CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhcCCCCCCC
Q 001902 905 NILHKD--LKFPSS----TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELD 971 (998)
Q Consensus 905 ~i~~~~--~~~~~~----~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~ 971 (998)
.+.... +..+.. ..++.++.+||.+||..+|.+||+ +.++++||||+.++|..+....||..+
T Consensus 209 ~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s----~~~ll~h~~~~~~~~~~~~~~~~~~~~ 277 (333)
T cd05600 209 NLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGS----LEDIKNHPFFKEVDWNELRELKPPFVP 277 (333)
T ss_pred HHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCC----HHHHHhCcccCCCCHHHHhhCCCCCCC
Confidence 665432 222222 245889999999999999999999 999999999999999988877776653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=397.87 Aligned_cols=269 Identities=36% Similarity=0.720 Sum_probs=235.1
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCC-eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSG-QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
.+..++|.+.+.||+|+||.||+|.+..++ ..||+|++.+...........+.+|+.+++.++||||+++++++...+.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 355678999999999999999999976554 7899999986554445556778899999999999999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|+||||+++++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999775 4589999999999999999999999999999999999999999999999999854320
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.
T Consensus 184 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 184 ------------------------------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred ------------------------------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 11235699999999999998899999999999999999999999999888
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCC-hhcHHHHHcCCCccCCChhhhh
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~-~~~a~elL~Hp~f~~~~~~~~~ 963 (998)
...+..+..+...+|. ..+..+.+||.+||..||.+|++. .+.+.++++||||++++|....
T Consensus 234 ~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~ 296 (340)
T PTZ00426 234 LLIYQKILEGIIYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLL 296 (340)
T ss_pred HHHHHHHhcCCCCCCC--CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 8888888887766654 367889999999999999999632 1339999999999999998764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=385.67 Aligned_cols=263 Identities=32% Similarity=0.474 Sum_probs=220.3
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC--eEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT--HVCL 742 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~--~~~l 742 (998)
..+...+.||+|+||.||++.+..+|..+|+|.+... +....+.+.+|+.+|.+++|||||++++...... .++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~---~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE---DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecc---cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 4688889999999999999999999999999998765 2222677899999999999999999999755444 6999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec-CCcEEEEeccCccccCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~-~g~vkL~DFG~a~~~~~~~ 821 (998)
+|||+++|+|.+++.+.++ .+++..++.+.+||++||+|||++||||+||||+|||++. +|.+||+|||+++.....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~- 171 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK- 171 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccc-
Confidence 9999999999999998765 7999999999999999999999999999999999999999 799999999998654320
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCC-CCh
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRG-KTR 899 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~-~~~ 899 (998)
...........||+.|||||++... ...+++|||||||++.||+||+.||.. ...
T Consensus 172 -----------------------~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~ 228 (313)
T KOG0198|consen 172 -----------------------GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE 228 (313)
T ss_pred -----------------------cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch
Confidence 0111233457899999999999853 344599999999999999999999988 455
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
...+..+.......+-...+|.++++||.+||..||.+||| |.+||+|||.+...-
T Consensus 229 ~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpt----a~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 229 AEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPT----AEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcC----HHHHhhChhhhcccc
Confidence 55555555544222333447899999999999999999999 999999999987543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=363.46 Aligned_cols=270 Identities=31% Similarity=0.531 Sum_probs=234.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeeccccc-----ChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeC
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-----NRNKVHRACAEREILDML-DHPFVPALYASFQTK 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~-----~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 737 (998)
...|...+.||.|..++|.++.++.+|+.+|+|++...... .....+....|+.||+++ .||+|+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 35788889999999999999999999999999998643221 122345566799999998 799999999999999
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
..+++|+|.|+.|.|+|+|... -.+++...+.|++||++|+.|||.++||||||||+|||++++.++||+|||+|+.+
T Consensus 96 sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 9999999999999999999874 45999999999999999999999999999999999999999999999999999775
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC------CCCCChhHHHHHHHHHHHHHcCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG------AGHTSAVDWWALGILLYEMLYGY 891 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~sDIwSlG~il~eLltG~ 891 (998)
... ..-...||||+|+|||.+.. .+|+..+|+||+|+|+|-|+.|+
T Consensus 174 ~~G----------------------------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGc 225 (411)
T KOG0599|consen 174 EPG----------------------------EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGC 225 (411)
T ss_pred CCc----------------------------hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCC
Confidence 411 11235799999999999854 46788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCCCCC--CCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhcCCC
Q 001902 892 TPFRGKTRQKTFANILHKDLKF--PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNP 967 (998)
Q Consensus 892 ~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~ 967 (998)
+||.+....-++..|+.+...+ |.+...|...++||.+||+.||.+|+| ++++|.||||..+-....+.+.|
T Consensus 226 pPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Rit----ake~LaHpff~q~~~~~~r~msP 299 (411)
T KOG0599|consen 226 PPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRIT----AKEALAHPFFIQIAQQQARQMSP 299 (411)
T ss_pred CchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhccc----HHHHhcChHHHHHHHhcccccCC
Confidence 9999999999999999988765 566788999999999999999999999 99999999998765555554444
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=399.46 Aligned_cols=302 Identities=38% Similarity=0.692 Sum_probs=240.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||.|+||.||+|.+..+|+.||+|++.+...........+.+|+.++..++||||++++++|...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998654444555667888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
|||++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++..+.......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999999764 459999999999999999999999999999999999999999999999999986543211100
Q ss_pred -CCcchhhh----------hcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCC
Q 001902 825 -LPTTNEKK----------RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 825 -~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~P 893 (998)
........ ......................+||+.|+|||++.+..++.++|||||||++|+|++|.+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 00000000 0000000000000000012245799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHhC--CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhcCCCCCC
Q 001902 894 FRGKTRQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPEL 970 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~--~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~ 970 (998)
|.+.+....+..+... .+.++.....+..+.+||.+||. +|.+|++. ..+.++++||||++++|..+....+|..
T Consensus 239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~-~~~~~ll~h~~~~~~~~~~~~~~~~~~~ 315 (364)
T cd05599 239 FCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN-NGVNEIKSHPFFKGVDWEHIRERPAPII 315 (364)
T ss_pred CCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC-CCHHHHhcCCCcCCCCHHHHhhcCCCCC
Confidence 9998888877777654 34455555678999999999997 99999974 4599999999999999998876555543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=385.37 Aligned_cols=272 Identities=34% Similarity=0.573 Sum_probs=226.7
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37889999999999999999999999999999886544444444567789999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG----- 155 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-----
Confidence 999999998886554456899999999999999999999999999999999999999999999999998543210
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......
T Consensus 156 -----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05631 156 -----------------------ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE 212 (285)
T ss_pred -----------------------CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH
Confidence 011234689999999999999999999999999999999999999987654322222
Q ss_pred HHh--CCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh-cHHHHHcCCCccCCChhhhhcC
Q 001902 906 ILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVRCM 965 (998)
Q Consensus 906 i~~--~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~~~ 965 (998)
+.. ...........+.++.+||.+||+.||.+||+..+ .+.++++||||.+++|..+...
T Consensus 213 ~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~ 275 (285)
T cd05631 213 VDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEAN 275 (285)
T ss_pred HHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhC
Confidence 221 11112223346889999999999999999998553 4899999999999999988544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=401.98 Aligned_cols=300 Identities=36% Similarity=0.684 Sum_probs=239.0
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|.+++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||++++++|.+.+++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 37999999999999999999999999999999997654444455677888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999999764 458999999999999999999999999999999999999999999999999986432111000
Q ss_pred -C----Ccchhhhh---cccCCCCcc------------cccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHH
Q 001902 825 -L----PTTNEKKR---RHKGQQNPV------------FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 884 (998)
Q Consensus 825 -~----~~~~~~~~---~~~~~~~~~------------~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il 884 (998)
. ........ ......... ............+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 0 00000000 000000000 000000011246799999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHHHh--CCCCCCCCCCCcHHHHHHHHHccccCccCcC---CChhcHHHHHcCCCccCCCh
Q 001902 885 YEMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRL---GSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 885 ~eLltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rp---t~~~~a~elL~Hp~f~~~~~ 959 (998)
|+|++|.+||.+.+....+..+.. ..+.+|.....+.++.+||.+||. +|.+|+ + +.++++||||++++|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~----~~~~l~hp~~~~~~~ 313 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG----AHEIKSHPFFRGVDW 313 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC----HHHHhcCCCcCCCCH
Confidence 999999999998888777777765 345556666678999999999998 787765 6 999999999999999
Q ss_pred hhhhcCCCCCCC
Q 001902 960 ALVRCMNPPELD 971 (998)
Q Consensus 960 ~~~~~~~~~~~~ 971 (998)
..++...+|..+
T Consensus 314 ~~~~~~~~~~~~ 325 (377)
T cd05629 314 DTIRQIRAPFIP 325 (377)
T ss_pred HHHccCCCCccc
Confidence 999887777664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=366.47 Aligned_cols=260 Identities=23% Similarity=0.349 Sum_probs=222.9
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe--eCCeEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ--TKTHVC 741 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~--~~~~~~ 741 (998)
.+.|+.+++|++|+||.||+|+++.|++.||+|.++.+.-... ..-...+||.+|.+++|||||.+.++.. +-+.+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G-FPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG-FPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC-CcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 5689999999999999999999999999999999987642222 2234567999999999999999999876 446799
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
|||||| ..+|..++...+ .++...+++.++.|+++||+|||++.|+||||||+|+|++..|.+||+|||+|+.++..
T Consensus 154 ~VMe~~-EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp- 230 (419)
T KOG0663|consen 154 IVMEYV-EHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP- 230 (419)
T ss_pred eeHHHH-HhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence 999999 678999998764 56999999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
....+..+.|.+|.|||.+.+. .|++++|+||+|||+.||+++++.|.|....
T Consensus 231 --------------------------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~ 284 (419)
T KOG0663|consen 231 --------------------------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI 284 (419)
T ss_pred --------------------------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH
Confidence 1234567899999999999885 5899999999999999999999999999999
Q ss_pred HHHHHHHhCC-------------------CCCCCC-----------CCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 901 KTFANILHKD-------------------LKFPSS-----------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 901 ~~~~~i~~~~-------------------~~~~~~-----------~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
+++.+|.+.- +.++.. ..++....+|+..+|.+||.+|.| |.+.|+
T Consensus 285 dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t----A~~~L~ 360 (419)
T KOG0663|consen 285 DQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT----AEDGLK 360 (419)
T ss_pred HHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc----HHHhhc
Confidence 9999887620 111111 114567789999999999999999 999999
Q ss_pred CCCccCC
Q 001902 951 HPFFKGV 957 (998)
Q Consensus 951 Hp~f~~~ 957 (998)
|+||...
T Consensus 361 h~~F~e~ 367 (419)
T KOG0663|consen 361 HEYFRET 367 (419)
T ss_pred ccccccC
Confidence 9999984
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=395.74 Aligned_cols=297 Identities=37% Similarity=0.687 Sum_probs=237.5
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++..++|+||+++++.+...+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998654445556677888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
|||+|++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++..........
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999999764 458999999999999999999999999999999999999999999999999986543211100
Q ss_pred CCcc------hhhhhc--ccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 825 LPTT------NEKKRR--HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 825 ~~~~------~~~~~~--~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.... ...... ....................+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 0000 000000 00000000000001122356899999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHHhC--CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhcC
Q 001902 897 KTRQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCM 965 (998)
Q Consensus 897 ~~~~~~~~~i~~~--~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~ 965 (998)
.+....+..+... .+.+|.....+.++++||.+|+. ||.+|++. ..+.++++||||++++|..+...
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~-~~~~ei~~hp~f~~~~~~~~~~~ 307 (360)
T cd05627 239 ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGS-NGVEEIKSHPFFEGVDWGHIRER 307 (360)
T ss_pred CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCC-CCHHHHhcCCCCCCCCHHHHhcC
Confidence 8888888877753 34556555678999999999874 99999963 23899999999999999988654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=389.11 Aligned_cols=262 Identities=45% Similarity=0.805 Sum_probs=227.9
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 750 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 750 (998)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998765555556677888999999999999999999999999999999999999
Q ss_pred chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchh
Q 001902 751 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830 (998)
Q Consensus 751 sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 830 (998)
+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~---------- 148 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---------- 148 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc----------
Confidence 999988764 45899999999999999999999999999999999999999999999999998532100
Q ss_pred hhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCC
Q 001902 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 910 (998)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~ 910 (998)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 149 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 211 (328)
T cd05593 149 -----------------AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED 211 (328)
T ss_pred -----------------ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC
Confidence 011234579999999999999999999999999999999999999999888877777777666
Q ss_pred CCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhhh
Q 001902 911 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 911 ~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~ 963 (998)
..+|. .++.++.+||.+||..||.+|++.. +.+.++++||||.+.+|..+.
T Consensus 212 ~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~ 263 (328)
T cd05593 212 IKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVY 263 (328)
T ss_pred ccCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 66554 4688999999999999999998321 129999999999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=395.37 Aligned_cols=292 Identities=36% Similarity=0.578 Sum_probs=231.8
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
.|++++.||+|+||+||+|.+..+++.||+|++.+...........+..|+.+++.++|+||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999987655555666788899999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|++||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++...........
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99999999999765 4589999999999999999999999999999999999999999999999999854321110000
Q ss_pred CcchhhhhcccCC-------C-------------CcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHH
Q 001902 826 PTTNEKKRRHKGQ-------Q-------------NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 885 (998)
Q Consensus 826 ~~~~~~~~~~~~~-------~-------------~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~ 885 (998)
............. . ...............+||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 0000000000000 0 0000000011123568999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCChHHHHHHHHh--CCCCCCCCCCCcHHHHHHHHHcccc--CccCcCCChhcHHHHHcCCCccCCChhh
Q 001902 886 EMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHR--DPKSRLGSHEGANEIKKHPFFKGVNWAL 961 (998)
Q Consensus 886 eLltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~l~~Ll~~~L~~--dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 961 (998)
+|++|..||...+.......+.. ....++....++.++.+||.+||+. +|..|++ +.++++||||+.++|..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~----~~~~l~hp~f~~~~~~~ 315 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNG----ADDIKAHPFFSEVDFSS 315 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCC----HHHHhcCcccCCCChhH
Confidence 99999999998887776666664 3455666667899999999996654 5555999 99999999999999976
Q ss_pred hh
Q 001902 962 VR 963 (998)
Q Consensus 962 ~~ 963 (998)
..
T Consensus 316 ~~ 317 (381)
T cd05626 316 DI 317 (381)
T ss_pred Hh
Confidence 53
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=385.15 Aligned_cols=259 Identities=42% Similarity=0.754 Sum_probs=227.3
Q ss_pred cCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCCch
Q 001902 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 752 (998)
Q Consensus 673 LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 752 (998)
||+|+||.||+|.+..+++.||+|++.+...........+..|+.++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999865444555667788899999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhh
Q 001902 753 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 832 (998)
Q Consensus 753 ~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 832 (998)
.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------------ 146 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD------------ 146 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC------------
Confidence 9999764 45899999999999999999999999999999999999999999999999998532100
Q ss_pred hcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCC
Q 001902 833 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 912 (998)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~ 912 (998)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+......
T Consensus 147 ---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~ 211 (312)
T cd05585 147 ---------------DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR 211 (312)
T ss_pred ---------------CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCC
Confidence 01123457999999999999999999999999999999999999999998888888888877666
Q ss_pred CCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhh
Q 001902 913 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 913 ~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~ 963 (998)
++. ..+..+.+||.+||..||.+||++. .+.++|+||||...+|..+.
T Consensus 212 ~~~--~~~~~~~~li~~~L~~dp~~R~~~~-~~~e~l~hp~~~~~~~~~~~ 259 (312)
T cd05585 212 FPD--GFDRDAKDLLIGLLSRDPTRRLGYN-GAQEIKNHPFFSQLSWKKLL 259 (312)
T ss_pred CCC--cCCHHHHHHHHHHcCCCHHHcCCCC-CHHHHHcCCCcCCCCHHHHH
Confidence 554 4688999999999999999998642 28999999999999987663
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=397.14 Aligned_cols=299 Identities=37% Similarity=0.634 Sum_probs=235.1
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++|+||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 37999999999999999999999999999999997654444445567888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
|||++++|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999999774 458999999999999999999999999999999999999999999999999985432111000
Q ss_pred CCcchhhhhccc-------CCCC---------cccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHH
Q 001902 825 LPTTNEKKRRHK-------GQQN---------PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 888 (998)
Q Consensus 825 ~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLl 888 (998)
........+... .... ..............+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 000000000000 0000 000000011223568999999999999999999999999999999999
Q ss_pred cCCCCCCCCChHHHHHHHHhC--CCCCCCCCCCcHHHHHHHHHccccCccCcC---CChhcHHHHHcCCCccCCChhhh-
Q 001902 889 YGYTPFRGKTRQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRL---GSHEGANEIKKHPFFKGVNWALV- 962 (998)
Q Consensus 889 tG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rp---t~~~~a~elL~Hp~f~~~~~~~~- 962 (998)
+|..||.+.+..+....+... ....+....++..+.+||.+|+. +|.+|+ + +.++++||||++++|..+
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~-~p~~R~~~~t----~~ell~h~~~~~~~~~~~~ 313 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNG----ADEIKAHPFFKGIDFASLI 313 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC----HHHHhCCCCcCCCCHHHHh
Confidence 999999998877766666543 33444555678999999999874 999999 7 999999999999999877
Q ss_pred hcCCCCCC
Q 001902 963 RCMNPPEL 970 (998)
Q Consensus 963 ~~~~~~~~ 970 (998)
....+|..
T Consensus 314 ~~~~~~~~ 321 (376)
T cd05598 314 RRQKAPYI 321 (376)
T ss_pred hcCCCCCC
Confidence 44444443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=386.71 Aligned_cols=262 Identities=41% Similarity=0.783 Sum_probs=227.8
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 750 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 750 (998)
+.||+|+||.||++.+..+|+.||+|++.+...........+..|+.+++.++||||++++++|...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998765545555667788999999999999999999999999999999999999
Q ss_pred chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchh
Q 001902 751 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830 (998)
Q Consensus 751 sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 830 (998)
+|..++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~---------- 148 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC----------
Confidence 999988764 45899999999999999999999999999999999999999999999999987432100
Q ss_pred hhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCC
Q 001902 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 910 (998)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~ 910 (998)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+....
T Consensus 149 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~ 211 (323)
T cd05595 149 -----------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211 (323)
T ss_pred -----------------CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 011124579999999999999999999999999999999999999999988888888877776
Q ss_pred CCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhhh
Q 001902 911 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 911 ~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~ 963 (998)
..+|. .++.++.+||.+||..||.+|++.. ..+.++++||||.+.+|....
T Consensus 212 ~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 263 (323)
T cd05595 212 IRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 263 (323)
T ss_pred CCCCC--CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 66654 4688999999999999999998322 129999999999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=394.83 Aligned_cols=269 Identities=36% Similarity=0.632 Sum_probs=232.7
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+..++|++++.||+|+||.||+|.+..+++.||+|++.+...........+..|+.+++.++||||+++++++.+.+.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 35567999999999999999999999999999999999865444444556677899999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999998653 4889999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC----CCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA----GHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
. .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+
T Consensus 196 ~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 249 (370)
T cd05596 196 G--------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (370)
T ss_pred C--------------------------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence 0 0112345799999999998654 378899999999999999999999999
Q ss_pred CChHHHHHHHHhCC--CCCCCCCCCcHHHHHHHHHccccCccC--cCCChhcHHHHHcCCCccCCChhhh
Q 001902 897 KTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKS--RLGSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 897 ~~~~~~~~~i~~~~--~~~~~~~~~s~~l~~Ll~~~L~~dP~~--Rpt~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
.+....+..+.... +.+|.....|.++.+||.+||..+|.+ |++ +.++++||||+..+|...
T Consensus 250 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s----~~ell~h~~~~~~~~~~~ 315 (370)
T cd05596 250 DSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNG----VDEIKSHPFFKNDQWTFD 315 (370)
T ss_pred CCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCC----HHHHhcCcccCCCChhhH
Confidence 88888888887643 556666678999999999999999987 999 999999999999888654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=391.50 Aligned_cols=274 Identities=38% Similarity=0.679 Sum_probs=237.0
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|.+.+.||+|+||.||+|.+..+|+.||+|++++...........+..|+.+++.++|+||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36999999999999999999999999999999998765544556677888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-- 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-- 157 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc--
Confidence 9999999999997752 4599999999999999999999999999999999999999999999999999854321100
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc------CCCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA------GAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
.......||+.|+|||++. ...++.++|||||||++|+|++|..||...+
T Consensus 158 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 158 ------------------------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred ------------------------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 0112346899999999986 4567789999999999999999999999888
Q ss_pred hHHHHHHHHhCC--CCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhcCCCCCC
Q 001902 899 RQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPEL 970 (998)
Q Consensus 899 ~~~~~~~i~~~~--~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~ 970 (998)
....+..+.... ..+|.....+..+.+||.+||+ +|.+||+ +.++++||||+.++|..+....||..
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t----~~~l~~h~~~~~~~~~~~~~~~~~~~ 282 (330)
T cd05601 214 SAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLG----YEGLCCHPFFSKIDWNNIRNSLPPFV 282 (330)
T ss_pred HHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCC----HHHHhCCCCcCCCCHHHHhhCCCCcc
Confidence 877777776542 4556666678999999999998 9999999 99999999999999999877655544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=386.17 Aligned_cols=262 Identities=38% Similarity=0.744 Sum_probs=227.1
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEEEEecCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 749 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 749 (998)
+.||+|+||.||+|.++.+++.||+|++.+...........+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999999876544445566777888888877 799999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--------- 149 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--------- 149 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC---------
Confidence 9999988764 45999999999999999999999999999999999999999999999999997432100
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~ 909 (998)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~ 211 (320)
T cd05590 150 ------------------GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211 (320)
T ss_pred ------------------CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC
Confidence 01123457999999999999999999999999999999999999999999888888888877
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCccCcCCChh--cHHHHHcCCCccCCChhhhh
Q 001902 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 910 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~--~a~elL~Hp~f~~~~~~~~~ 963 (998)
...++. ..+.++.+||.+||+.||.+||++.+ ...++++||||+.++|..+.
T Consensus 212 ~~~~~~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~ 265 (320)
T cd05590 212 EVVYPT--WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLN 265 (320)
T ss_pred CCCCCC--CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 666554 36889999999999999999999432 23899999999999998773
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=380.98 Aligned_cols=312 Identities=58% Similarity=1.013 Sum_probs=257.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++.+.||+|++|.||+|.+..+++.||+|.+.+...........+..|+++++.++|+||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36999999999999999999999999999999998765544456677889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+.+++|.+++.......+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999987656679999999999999999999999999999999999999999999999999986543221111
Q ss_pred CCcchhhhhcc--cCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 825 LPTTNEKKRRH--KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 825 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
........... ....................|+..|+|||++.+..++.++|||||||++|+|++|..||.+.+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 00000000000 0000000001111223456799999999999998899999999999999999999999999888888
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhcCCCCCCCCCCCC
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFA 976 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~~~ 976 (998)
+..+......++.....+..+.+||.+||..||.+||+++..+.++|+||||++.+|+.++-..||..+.|.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (316)
T cd05574 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPDDG 314 (316)
T ss_pred HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCCCcccc
Confidence 88887777777666567899999999999999999999999999999999999999999999999999777654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=394.60 Aligned_cols=293 Identities=38% Similarity=0.635 Sum_probs=233.6
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
.|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++|+||+++++.+...+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58999999999999999999999999999999987554445566788899999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
||++|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...........
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 99999999999765 4589999999999999999999999999999999999999999999999999754321111000
Q ss_pred Ccchhhhh-----cccCCCCc---------------ccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHH
Q 001902 826 PTTNEKKR-----RHKGQQNP---------------VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 885 (998)
Q Consensus 826 ~~~~~~~~-----~~~~~~~~---------------~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~ 885 (998)
.......+ .......+ .............+||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 00000000 00000000 00000011123568999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCChHHHHHHHHhC--CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhh
Q 001902 886 EMLYGYTPFRGKTRQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 886 eLltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
+|++|.+||.+.+.......+... ....|.....+.++.+||.+|+ .+|.+|++ ...+.++++||||+.++|...
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~-~~~~~ei~~hp~f~~~~~~~~ 316 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLG-KNGADEIKAHPFFKTIDFSSD 316 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCC-CCCHHHHhcCCCcCCcChHHH
Confidence 999999999998887777777653 3455555667899999999986 59999997 345899999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=392.13 Aligned_cols=300 Identities=41% Similarity=0.720 Sum_probs=243.9
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|.+++.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765544456677888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999999875 569999999999999999999999999999999999999999999999999986654322100
Q ss_pred CCcchhhhhcc--cCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 825 LPTTNEKKRRH--KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 825 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
........... ....................||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 00000000000 0000000000011123456799999999999999999999999999999999999999999888888
Q ss_pred HHHHHh--CCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhcCCCCCC
Q 001902 903 FANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPEL 970 (998)
Q Consensus 903 ~~~i~~--~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~ 970 (998)
+..+.. ....+|....++..+.+||.+||. ||.+|++. +.++++||||++++|.......||..
T Consensus 239 ~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s---~~~ll~hp~~~~~~~~~~~~~~~~~~ 304 (350)
T cd05573 239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGS---FEEIKSHPFFKGIDWENLRETKPPFV 304 (350)
T ss_pred HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCC---HHHHhcCCCcCCCCHHHHhhCCCCcC
Confidence 888877 555666666679999999999998 99999984 78999999999999998876666654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=384.27 Aligned_cols=265 Identities=40% Similarity=0.753 Sum_probs=229.5
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEEEEecCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 749 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 749 (998)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4689999999999999999999999999876544555566777899998876 899999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--------- 149 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--------- 149 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC---------
Confidence 9999988764 45899999999999999999999999999999999999999999999999988532100
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~ 909 (998)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~ 211 (321)
T cd05591 150 ------------------GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211 (321)
T ss_pred ------------------CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 01123456999999999999999999999999999999999999999999988888888887
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCccCcCCChh---cHHHHHcCCCccCCChhhhhcCC
Q 001902 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE---GANEIKKHPFFKGVNWALVRCMN 966 (998)
Q Consensus 910 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~---~a~elL~Hp~f~~~~~~~~~~~~ 966 (998)
...+|. ..+.++.+||.+||..||.+||+..+ .+.++++||||..++|..+....
T Consensus 212 ~~~~p~--~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~ 269 (321)
T cd05591 212 DVLYPV--WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRK 269 (321)
T ss_pred CCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCC
Confidence 766554 36889999999999999999994333 39999999999999999875433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=393.41 Aligned_cols=268 Identities=35% Similarity=0.660 Sum_probs=228.6
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+..++|++++.||+|+||.||++.+..+++.||+|++.+...........+..|+.+++.++||||+++++++..++.+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999998654444445566788999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+|||||++|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 999999999999999653 48999999999999999999999999999999999999999999999999985432110
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC----CCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.
T Consensus 197 --------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 197 --------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred --------------------------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 01123457999999999997643 678999999999999999999999998
Q ss_pred ChHHHHHHHHhCC--CCCCCCCCCcHHHHHHHHHccccCccC--cCCChhcHHHHHcCCCccCCChhhh
Q 001902 898 TRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKS--RLGSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 898 ~~~~~~~~i~~~~--~~~~~~~~~s~~l~~Ll~~~L~~dP~~--Rpt~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
+....+..+.... +.+|.....+..+++|+.+||..++.. |++ +.++++||||+..+|...
T Consensus 251 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~----~~e~l~hp~~~~~~~~~~ 315 (370)
T cd05621 251 SLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNG----VEEIKQHPFFKNDQWNWD 315 (370)
T ss_pred CHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCC----HHHHhcCcccCCCCcChH
Confidence 8888888887643 556666667899999999999855543 778 999999999999766543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=384.84 Aligned_cols=268 Identities=35% Similarity=0.698 Sum_probs=232.3
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCC-CccceeEEEeeCCeEEEEE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP-FVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~-nIv~l~~~~~~~~~~~lV~ 744 (998)
+|++++.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..++|+ +|+.+++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 588999999999999999999999999999999876554555567788899999999764 6888999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~---- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG---- 154 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC----
Confidence 999999999998764 45899999999999999999999999999999999999999999999999987431100
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.
T Consensus 155 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~ 211 (324)
T cd05587 155 -----------------------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ 211 (324)
T ss_pred -----------------------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011234579999999999999999999999999999999999999999998888888
Q ss_pred HHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhhhc
Q 001902 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC 964 (998)
Q Consensus 905 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~ 964 (998)
.+......++. ..+.++.+|+.+||..||.+|++.. ....++++||||+.++|..+..
T Consensus 212 ~i~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~ 270 (324)
T cd05587 212 SIMEHNVSYPK--SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLER 270 (324)
T ss_pred HHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence 88877665554 4688999999999999999999853 3458999999999999987743
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=383.74 Aligned_cols=258 Identities=27% Similarity=0.436 Sum_probs=229.3
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
..|..+..||+|+||.||+|.+..+++.||+|++..+. .......+..|+.+|..++++||.++|+.|..+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 46888899999999999999999999999999998543 4456788899999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
|||.||++.++++.. ..+.+..+..++++++.||.|||..+.+|||||+.|||+..+|.+||+|||.+..+.
T Consensus 91 ey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~------ 162 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT------ 162 (467)
T ss_pred HHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee------
Confidence 999999999999763 446888899999999999999999999999999999999999999999999985532
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.......+++|||.|||||++.+..|+.++||||||++.|||++|.+||...++...+.
T Consensus 163 ---------------------~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf 221 (467)
T KOG0201|consen 163 ---------------------NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF 221 (467)
T ss_pred ---------------------chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE
Confidence 12223468899999999999999999999999999999999999999999988866666
Q ss_pred HHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 905 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
.|.+...+.... .+|.-+++|+..||.+||+.||+ |.+||+|+|++...
T Consensus 222 lIpk~~PP~L~~-~~S~~~kEFV~~CL~k~P~~Rps----A~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 222 LIPKSAPPRLDG-DFSPPFKEFVEACLDKNPEFRPS----AKELLKHKFIKRAK 270 (467)
T ss_pred eccCCCCCcccc-ccCHHHHHHHHHHhhcCcccCcC----HHHHhhhHHHHhcC
Confidence 666655544444 78889999999999999999999 99999999999844
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=383.71 Aligned_cols=262 Identities=42% Similarity=0.752 Sum_probs=226.1
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHH-HHHhCCCCCccceeEEEeeCCeEEEEEecCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTKTHVCLITDYCPG 749 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~-il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 749 (998)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999999999999999998654433344455555655 56789999999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
++|..++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~---------- 148 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE---------- 148 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc----------
Confidence 9999998764 4589999999999999999999999999999999999999999999999998843210
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~ 909 (998)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 149 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 211 (323)
T cd05575 149 -----------------HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK 211 (323)
T ss_pred -----------------CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 011223457999999999999999999999999999999999999999998888888888876
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhh
Q 001902 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 910 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~ 963 (998)
....+. ..+..+.+||.+||+.||.+||+.++.+.++++||||..++|..+.
T Consensus 212 ~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~ 263 (323)
T cd05575 212 PLRLKP--NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLV 263 (323)
T ss_pred CCCCCC--CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHh
Confidence 655443 4588999999999999999999988888999999999999998774
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=383.16 Aligned_cols=268 Identities=36% Similarity=0.693 Sum_probs=233.1
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEEEE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
+|.+++.||+|+||.||+|.+..+++.||+|++.+..............|..++..+ .|++|+.+++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999999999999999999876544444556677788888877 5899999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~---- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---- 154 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC----
Confidence 999999999998764 45899999999999999999999999999999999999999999999999998532100
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+.
T Consensus 155 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~ 211 (323)
T cd05616 155 -----------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 211 (323)
T ss_pred -----------------------CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011234579999999999999999999999999999999999999999998888888
Q ss_pred HHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhhhc
Q 001902 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC 964 (998)
Q Consensus 905 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~ 964 (998)
.+......+|. ..+.++.+|+.+||+.||.+|++.. +...++++||||+.++|..+..
T Consensus 212 ~i~~~~~~~p~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~ 270 (323)
T cd05616 212 SIMEHNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER 270 (323)
T ss_pred HHHhCCCCCCC--cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence 88887766664 4688999999999999999999854 3468999999999999988753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=382.77 Aligned_cols=264 Identities=41% Similarity=0.781 Sum_probs=228.4
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHH---HhCCCCCccceeEEEeeCCeEEEE
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL---DMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il---~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
|++++.||+|+||.||+|.+..+++.||+|++++...........+..|+.++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 77899999999999999999999999999999876444444556677776665 456899999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+++++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--- 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--- 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC---
Confidence 999999999988754 35899999999999999999999999999999999999999999999999987432100
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
.......+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+
T Consensus 155 ------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~ 210 (324)
T cd05589 155 ------------------------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210 (324)
T ss_pred ------------------------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 01123467999999999999999999999999999999999999999998888888
Q ss_pred HHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh-cHHHHHcCCCccCCChhhh
Q 001902 904 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 904 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~ 962 (998)
..+......+|. .++..+.+||.+||..||.+||++.+ .+.++++||||+.++|..+
T Consensus 211 ~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~ 268 (324)
T cd05589 211 DSIVNDEVRYPR--FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL 268 (324)
T ss_pred HHHHhCCCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHH
Confidence 888877666554 46888999999999999999996554 4999999999999999876
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=364.76 Aligned_cols=265 Identities=27% Similarity=0.399 Sum_probs=224.8
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee-----CCe
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-----KTH 739 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-----~~~ 739 (998)
..|..++.||.|+||.|+.+.++.+|+.||+|.+... .......++..+|+.+|+.++|+||+.+++.+.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4566689999999999999999999999999988743 3455667888999999999999999999999865 468
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|+|+|+| +.+|..+++.+ ..+++.+++.+++||+.||+|+|+.||+||||||+|+|++.+..+||+|||+|+....
T Consensus 101 vYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 99999999 88999999875 4499999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
. ......+.++.|.+|.|||.+.. ..|+...||||+|||+.||++|++.|.|.+
T Consensus 178 ~-------------------------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d 232 (359)
T KOG0660|consen 178 F-------------------------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD 232 (359)
T ss_pred c-------------------------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence 2 01122356789999999999754 679999999999999999999999999988
Q ss_pred hHHHHHHHHhCC-----------------------CCCC------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 899 RQKTFANILHKD-----------------------LKFP------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 899 ~~~~~~~i~~~~-----------------------~~~~------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
...++..|+.-. ...| .....++.+.+||.+||..||.+|+| ++++|
T Consensus 233 ~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit----a~eAL 308 (359)
T KOG0660|consen 233 YVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT----AEEAL 308 (359)
T ss_pred hHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC----HHHHh
Confidence 887777665411 1111 11346778999999999999999999 99999
Q ss_pred cCCCccCCChhhh
Q 001902 950 KHPFFKGVNWALV 962 (998)
Q Consensus 950 ~Hp~f~~~~~~~~ 962 (998)
.||||..+.-..-
T Consensus 309 ~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 309 AHPYLAPYHDPED 321 (359)
T ss_pred cChhhhhhcCCcc
Confidence 9999998654433
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=384.41 Aligned_cols=262 Identities=43% Similarity=0.791 Sum_probs=226.4
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 750 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 750 (998)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|+.++..++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999999999999999998765545555667788999999999999999999999999999999999999
Q ss_pred chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 751 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 751 sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
+|..++.+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--------- 149 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--------- 149 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC---------
Confidence 999988764 458999999999999999999997 79999999999999999999999999998432100
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~ 909 (998)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~ 211 (325)
T cd05594 150 ------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211 (325)
T ss_pred ------------------CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC
Confidence 01122456999999999999999999999999999999999999999998887777777776
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhhh
Q 001902 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 910 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~ 963 (998)
...+|. .++.++.+||.+||..||.+|++.. +.+.++++||||+++.|....
T Consensus 212 ~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~ 264 (325)
T cd05594 212 EIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVY 264 (325)
T ss_pred CCCCCC--CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 666554 3688999999999999999998321 129999999999999998663
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=381.93 Aligned_cols=264 Identities=38% Similarity=0.748 Sum_probs=223.2
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEEEEecCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 749 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 749 (998)
+.||+|+||.||+|.+..+++.||+|++++...........+..|..++..+ +||||+++++++...+.+|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999999999999999999876555555667788899999998 799999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---------- 148 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR---------- 148 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc----------
Confidence 9999988764 4599999999999999999999999999999999999999999999999999843110
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC---------hH
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT---------RQ 900 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~---------~~ 900 (998)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..
T Consensus 149 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~ 211 (329)
T cd05588 149 -----------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTED 211 (329)
T ss_pred -----------------CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchH
Confidence 0011234579999999999999999999999999999999999999996311 12
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh--hcHHHHHcCCCccCCChhhhhcC
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH--EGANEIKKHPFFKGVNWALVRCM 965 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~--~~a~elL~Hp~f~~~~~~~~~~~ 965 (998)
.....+......+|. .++..+.+||.+||+.||.+|++.. ..+.++++||||..++|..+...
T Consensus 212 ~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~ 276 (329)
T cd05588 212 YLFQVILEKQIRIPR--SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQK 276 (329)
T ss_pred HHHHHHHcCCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhC
Confidence 234445555555543 4688899999999999999999854 23789999999999999887543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=379.09 Aligned_cols=268 Identities=36% Similarity=0.696 Sum_probs=232.1
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEeeCCeEEEEE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lV~ 744 (998)
+|...+.||+|+||.||+|.+..+|+.||+|++.+...........+..|..++..+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788899999999999999999999999999998764444455567778899998885 577888999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~---- 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---- 154 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC----
Confidence 999999999998764 45999999999999999999999999999999999999999999999999998532100
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+.
T Consensus 155 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~ 211 (323)
T cd05615 155 -----------------------GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ 211 (323)
T ss_pred -----------------------CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011224569999999999999999999999999999999999999999998888888
Q ss_pred HHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhhhc
Q 001902 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC 964 (998)
Q Consensus 905 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~ 964 (998)
.+......+|. ..+..+.+|+.+||..+|.+|++.. +...++++||||+.++|..+..
T Consensus 212 ~i~~~~~~~p~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~ 270 (323)
T cd05615 212 SIMEHNVSYPK--SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLEN 270 (323)
T ss_pred HHHhCCCCCCc--cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhc
Confidence 88887766654 3678899999999999999999865 3578999999999999987744
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=382.40 Aligned_cols=259 Identities=33% Similarity=0.559 Sum_probs=235.9
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEeeCCeEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~l 742 (998)
...|++.+.||.|.||.||+|.++.+|+.+|+|++.+...........+.+|+.||+++. |||||.++++|.+.+.+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 467999999999999999999999999999999999887766666788999999999998 9999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC----CcEEEEeccCccccC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDFDLSCLTS 818 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~----g~vkL~DFG~a~~~~ 818 (998)
|||+|.||.|++.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+... +.+|++|||+|....
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999999999999876 39999999999999999999999999999999999999743 579999999996543
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
. .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+
T Consensus 191 ~----------------------------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 191 P----------------------------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred C----------------------------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 1 123456799999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCC--CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 899 RQKTFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.......+..+++.++ .+..+|..+++|+..||..||.+|+| +.++|+|||++..
T Consensus 243 ~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~t----a~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 243 EFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLT----AAQALQHPWIKSI 299 (382)
T ss_pred hhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCC----HHHHhcCccccCC
Confidence 9999999998877554 45677999999999999999999999 9999999998875
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=365.71 Aligned_cols=255 Identities=30% Similarity=0.555 Sum_probs=233.5
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
..+|++.+.||+|.||.|-+|.+...|+.||||.++++.+.+..+.-.+.+||+||..|+||||+++|++|++.+.++||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 36899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||.-+|.|++|+... +.|++..++.+++||+.|+.|+|+++++|||||.+|||+|.++++||.|||++..+...
T Consensus 132 MEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--- 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--- 206 (668)
T ss_pred EEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc---
Confidence 9999999999999875 56999999999999999999999999999999999999999999999999999654321
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCC-CChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
..-.++||+|.|.+||.+++.+| .+.+|.||||++||-|++|..||.+.+....
T Consensus 207 -------------------------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l 261 (668)
T KOG0611|consen 207 -------------------------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL 261 (668)
T ss_pred -------------------------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH
Confidence 12347899999999999999988 4689999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
+.+|..+.+.-|.. +..+..||+.||..||++|.| +.+|..|=|..
T Consensus 262 vrQIs~GaYrEP~~---PSdA~gLIRwmLmVNP~RRAT----ieDiAsHWWvN 307 (668)
T KOG0611|consen 262 VRQISRGAYREPET---PSDASGLIRWMLMVNPERRAT----IEDIASHWWVN 307 (668)
T ss_pred HHHhhcccccCCCC---CchHHHHHHHHHhcCcccchh----HHHHhhhheee
Confidence 99999887665544 345678999999999999999 99999997754
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=377.89 Aligned_cols=258 Identities=40% Similarity=0.782 Sum_probs=221.8
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEEEEecCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 749 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 749 (998)
+.||+|+||.||+|.+..+|+.||+|++++..............|..++..+ +||||+++++++...+++|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4689999999999999999999999999875443334455667788888765 899999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~---------- 148 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF---------- 148 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc----------
Confidence 9999998764 4589999999999999999999999999999999999999999999999998743110
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~ 909 (998)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 149 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~ 211 (316)
T cd05620 149 -----------------GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD 211 (316)
T ss_pred -----------------CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 001123457999999999999999999999999999999999999999988887777777666
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcH-HHHHcCCCccCCChhhhh
Q 001902 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA-NEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 910 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a-~elL~Hp~f~~~~~~~~~ 963 (998)
...++. ..+.++.+||.+||..||.+||+ + .++++||||+.++|..+.
T Consensus 212 ~~~~~~--~~~~~~~~li~~~l~~dP~~R~~----~~~~~~~h~~f~~~~~~~~~ 260 (316)
T cd05620 212 TPHYPR--WITKESKDILEKLFERDPTRRLG----VVGNIRGHPFFKTINWTALE 260 (316)
T ss_pred CCCCCC--CCCHHHHHHHHHHccCCHHHcCC----ChHHHHcCCCcCCCCHHHHH
Confidence 555544 36889999999999999999999 5 589999999999998763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=380.95 Aligned_cols=263 Identities=42% Similarity=0.744 Sum_probs=226.6
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHH-HHHhCCCCCccceeEEEeeCCeEEEEEecCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTKTHVCLITDYCPG 749 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~-il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 749 (998)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999999999999999998654444444455555654 56778999999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
++|..++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--------- 149 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--------- 149 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC---------
Confidence 9999888764 45899999999999999999999999999999999999999999999999998432100
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~ 909 (998)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+....+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~ 211 (325)
T cd05604 150 ------------------SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211 (325)
T ss_pred ------------------CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 01123457999999999999999999999999999999999999999998888888888776
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhc
Q 001902 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRC 964 (998)
Q Consensus 910 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~ 964 (998)
....+. ..+..+.++|.+||..+|.+||+.++.+.++++||||..++|..+..
T Consensus 212 ~~~~~~--~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~ 264 (325)
T cd05604 212 PLVLRP--GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQ 264 (325)
T ss_pred CccCCC--CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence 654433 46888999999999999999999888899999999999999987754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=377.83 Aligned_cols=261 Identities=41% Similarity=0.809 Sum_probs=222.9
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEEEEecCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 749 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 749 (998)
+.||+|+||.||+|.+..+++.||+|++++..............|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999999999999999999876544444555666777777654 899999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--------- 149 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC---------
Confidence 9999998764 45899999999999999999999999999999999999999999999999998542100
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~ 909 (998)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 211 (316)
T cd05592 150 ------------------EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND 211 (316)
T ss_pred ------------------CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 01123457999999999999999999999999999999999999999998888877777665
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhcC
Q 001902 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCM 965 (998)
Q Consensus 910 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~ 965 (998)
...++. .++.++.+||.+||..||.+||++ ..++++||||..++|..+...
T Consensus 212 ~~~~~~--~~~~~~~~ll~~~l~~~P~~R~~~---~~~l~~h~~~~~~~~~~~~~~ 262 (316)
T cd05592 212 RPHFPR--WISKEAKDCLSKLFERDPTKRLGV---DGDIRQHPFFRGIDWERLEKR 262 (316)
T ss_pred CCCCCC--CCCHHHHHHHHHHccCCHHHcCCC---hHHHHcCcccCCCCHHHHHhC
Confidence 544443 368889999999999999999982 358899999999999877543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=369.67 Aligned_cols=267 Identities=32% Similarity=0.569 Sum_probs=222.5
Q ss_pred cCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCCch
Q 001902 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 752 (998)
Q Consensus 673 LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 752 (998)
||+|+||.||++.+..+|+.||+|.+................|+++++.++||||+++++++....+.|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765443333344556799999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhh
Q 001902 753 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 832 (998)
Q Consensus 753 ~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 832 (998)
.+++.......++...+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~------------ 148 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG------------ 148 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC------------
Confidence 98887655556899999999999999999999999999999999999999999999999998543210
Q ss_pred hcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHh
Q 001902 833 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR----QKTFANILH 908 (998)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~----~~~~~~i~~ 908 (998)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||..... .........
T Consensus 149 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 212 (277)
T cd05607 149 ----------------KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212 (277)
T ss_pred ----------------ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc
Confidence 011234689999999999998899999999999999999999999976433 223333333
Q ss_pred CCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhcCCCC
Q 001902 909 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPP 968 (998)
Q Consensus 909 ~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~ 968 (998)
..+..+ ....+.++.+||.+||+.||.+||++++.+.++++||||+.++|..+..-..|
T Consensus 213 ~~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~ 271 (277)
T cd05607 213 DEVKFE-HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIP 271 (277)
T ss_pred cccccc-cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCC
Confidence 333332 23468899999999999999999998888899999999999999888654333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=376.55 Aligned_cols=260 Identities=38% Similarity=0.771 Sum_probs=222.2
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEEEEecCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 749 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 749 (998)
+.||+|+||.||+|.+..+++.||+|++++..............|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999999876443334445666788888764 999999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--------- 149 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC---------
Confidence 9999999764 45899999999999999999999999999999999999999999999999988432100
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~ 909 (998)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~ 211 (316)
T cd05619 150 ------------------DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD 211 (316)
T ss_pred ------------------CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 01122456999999999999999999999999999999999999999998887777777665
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHH-HHHcCCCccCCChhhhhcC
Q 001902 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN-EIKKHPFFKGVNWALVRCM 965 (998)
Q Consensus 910 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~-elL~Hp~f~~~~~~~~~~~ 965 (998)
...++. ..+.++.+||.+||+.||.+||+ +. ++++||||+.++|..+...
T Consensus 212 ~~~~~~--~~~~~~~~li~~~l~~~P~~R~~----~~~~l~~h~~~~~~~~~~~~~~ 262 (316)
T cd05619 212 NPCYPR--WLTREAKDILVKLFVREPERRLG----VKGDIRQHPFFREIDWSALEER 262 (316)
T ss_pred CCCCCc--cCCHHHHHHHHHHhccCHhhcCC----ChHHHHcCcccCCCCHHHHHhC
Confidence 544443 36788999999999999999999 64 8999999999999877443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=385.90 Aligned_cols=276 Identities=36% Similarity=0.653 Sum_probs=231.7
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+..++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45568999999999999999999999999999999999764444444556678899999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 9999999999999998653 4899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC----CCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
. .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+
T Consensus 196 ~--------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 196 G--------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred C--------------------------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 0 01123457999999999997643 77899999999999999999999999
Q ss_pred CChHHHHHHHHhCC--CCCCCCCCCcHHHHHHHHHccccCccC---cCCChhcHHHHHcCCCccCCChh--hhhcCCCCC
Q 001902 897 KTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKS---RLGSHEGANEIKKHPFFKGVNWA--LVRCMNPPE 969 (998)
Q Consensus 897 ~~~~~~~~~i~~~~--~~~~~~~~~s~~l~~Ll~~~L~~dP~~---Rpt~~~~a~elL~Hp~f~~~~~~--~~~~~~~~~ 969 (998)
.+....+..+.... +.+|.....+..+++||.+||. +|.. |++ +.++++||||++.+|. .++...+|.
T Consensus 250 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~----~~ei~~h~~~~~~~~~~~~~~~~~~~~ 324 (371)
T cd05622 250 DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT-DREVRLGRNG----VEEIKRHLFFKNDQWAWETLRDTVAPV 324 (371)
T ss_pred CCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcC-ChhhhcCCCC----HHHHhcCcccCCCChhHHhcCCCCCCC
Confidence 88888888887643 5566666789999999999998 5554 556 9999999999996664 444444443
Q ss_pred C
Q 001902 970 L 970 (998)
Q Consensus 970 ~ 970 (998)
.
T Consensus 325 ~ 325 (371)
T cd05622 325 V 325 (371)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=377.62 Aligned_cols=259 Identities=28% Similarity=0.435 Sum_probs=220.5
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeE-EEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~-valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
..+...++.+.+.||.|+||+||++.+. |.. +|+|++......... ...+.+|+.+|.+++|||||++++++....
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3455667777888999999999999984 445 999999876544443 778999999999999999999999999887
Q ss_pred -eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCcEEEecCC-cEEEEeccCcc
Q 001902 739 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG-IIYRDLKPENVLLQGNG-HVSLTDFDLSC 815 (998)
Q Consensus 739 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~-IiHrDLkP~NILi~~~g-~vkL~DFG~a~ 815 (998)
..+|||||+++|+|..++.+.....++...+..++.||++||.|||+++ ||||||||+|||++.++ ++||+|||+++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 7999999999999999998744467999999999999999999999999 99999999999999998 99999999996
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc--CCCCCChhHHHHHHHHHHHHHcCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA--GAGHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~sDIwSlG~il~eLltG~~P 893 (998)
...... ...+...||+.|||||++. ...|+.++||||||+++|||+||+.|
T Consensus 193 ~~~~~~---------------------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~P 245 (362)
T KOG0192|consen 193 EKVISK---------------------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIP 245 (362)
T ss_pred eecccc---------------------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCC
Confidence 543110 1223368999999999999 56999999999999999999999999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHH
Q 001902 894 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 948 (998)
|.+.........+.......+....++..+..|+..||..||..||++.+++..+
T Consensus 246 f~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l 300 (362)
T KOG0192|consen 246 FEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRL 300 (362)
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHH
Confidence 9999886666666655544444444788999999999999999999988765443
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=376.92 Aligned_cols=262 Identities=40% Similarity=0.772 Sum_probs=226.5
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEEEEecCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 749 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 749 (998)
+.||+|+||.||+|.+..+++.||+|++++...........+..|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999999876554555567778899999888 799999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
++|..++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--------- 149 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--------- 149 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC---------
Confidence 9999988765 45999999999999999999999999999999999999999999999999988431100
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~ 909 (998)
.......+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 150 ------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~ 211 (318)
T cd05570 150 ------------------GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED 211 (318)
T ss_pred ------------------CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 01122356999999999999999999999999999999999999999988888887777776
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhhh
Q 001902 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 910 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~ 963 (998)
...++. ..+..+.+||.+||..||.+||++. ..+.+++.||||+.++|....
T Consensus 212 ~~~~~~--~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~ 264 (318)
T cd05570 212 EVRYPR--WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLE 264 (318)
T ss_pred CCCCCC--cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 665553 4688999999999999999999931 123999999999999997664
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=370.92 Aligned_cols=270 Identities=34% Similarity=0.599 Sum_probs=224.9
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
.|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++|+||+++++++...+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999998999999999986544444444567789999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG----- 155 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-----
Confidence 999999998887654456999999999999999999999999999999999999999999999999998543210
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
......+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......
T Consensus 156 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05605 156 -----------------------ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE 212 (285)
T ss_pred -----------------------CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH
Confidence 011234689999999999988899999999999999999999999988665433322
Q ss_pred HH----hCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhhhcC
Q 001902 906 IL----HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCM 965 (998)
Q Consensus 906 i~----~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~ 965 (998)
+. .....+ ....+..+.+|+.+||..||.+||++. +.+.++++||||...+|..+...
T Consensus 213 ~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 275 (285)
T cd05605 213 VERRVKEDQEEY--SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAG 275 (285)
T ss_pred HHHHhhhccccc--CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhC
Confidence 22 222222 234688899999999999999999322 12999999999999999877443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=368.84 Aligned_cols=263 Identities=33% Similarity=0.604 Sum_probs=219.0
Q ss_pred cCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCCch
Q 001902 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 752 (998)
Q Consensus 673 LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 752 (998)
||+|+||+||++.+..+++.||+|.+.+...........+..|+.+++.++|+||+++++++...+..|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999865444444556678899999999999999999999999999999999999999
Q ss_pred hHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchh
Q 001902 753 FLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830 (998)
Q Consensus 753 ~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 830 (998)
.+++... ....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--------- 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--------- 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---------
Confidence 8887432 23468999999999999999999999999999999999999999999999999985432110
Q ss_pred hhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH----HHHHHH
Q 001902 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ----KTFANI 906 (998)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~----~~~~~i 906 (998)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+
T Consensus 152 ------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 213 (280)
T cd05608 152 ------------------SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI 213 (280)
T ss_pred ------------------ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh
Confidence 0112346899999999999999999999999999999999999999765432 222233
Q ss_pred HhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh-cHHHHHcCCCccCCChhhhhc
Q 001902 907 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVRC 964 (998)
Q Consensus 907 ~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~~ 964 (998)
......++ ...+..+.+|+.+||+.||.+||++.+ .++++++||||+.+.|..+..
T Consensus 214 ~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~ 270 (280)
T cd05608 214 LNDSVTYP--DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEA 270 (280)
T ss_pred cccCCCCc--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhh
Confidence 33322222 346889999999999999999996553 499999999999999987744
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=377.03 Aligned_cols=274 Identities=38% Similarity=0.671 Sum_probs=229.1
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||++.+..+++.||+|++.+...........+..|+.++..++|+||+.+++++...+++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654444455667888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||++|++|.+++.+. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--- 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC---
Confidence 999999999999764 2458999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-----CCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
........||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 157 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~ 213 (331)
T cd05597 157 -----------------------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred -----------------------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH
Confidence 001123469999999999963 4567899999999999999999999998887
Q ss_pred HHHHHHHHhCC--CCCCCC-CCCcHHHHHHHHHccccCccC--cCCChhcHHHHHcCCCccCCChhhhhcCCCCC
Q 001902 900 QKTFANILHKD--LKFPSS-TPTSLHAKQLMYRLLHRDPKS--RLGSHEGANEIKKHPFFKGVNWALVRCMNPPE 969 (998)
Q Consensus 900 ~~~~~~i~~~~--~~~~~~-~~~s~~l~~Ll~~~L~~dP~~--Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~ 969 (998)
.+.+..+.... ..++.. ...+..+++||.+||+.++.. |++ +.++++||||.+.+|..+....+|.
T Consensus 214 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~----~~~~l~hp~~~~~~~~~~~~~~~~~ 284 (331)
T cd05597 214 VETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNG----LQDFKDHPFFEGIDWDNIRNSTAPY 284 (331)
T ss_pred HHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCC----HHHHhcCCCCCCCCHHHHhhCCCCc
Confidence 77777776543 223322 346889999999999754433 667 9999999999999999887766653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=377.17 Aligned_cols=262 Identities=39% Similarity=0.748 Sum_probs=220.9
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEEEEecCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 749 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 749 (998)
+.||+|+||.||+|.+..+++.||+|++++...........+..|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999999876555555667788899988877 899999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--------- 149 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--------- 149 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC---------
Confidence 9999888764 45999999999999999999999999999999999999999999999999998432100
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC---------ChH
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK---------TRQ 900 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~---------~~~ 900 (998)
........||+.|+|||++.+..++.++|||||||++|+|++|..||... ...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~ 211 (329)
T cd05618 150 ------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 211 (329)
T ss_pred ------------------CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHH
Confidence 01123457999999999999999999999999999999999999999521 112
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh--hcHHHHHcCCCccCCChhhhh
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH--EGANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~--~~a~elL~Hp~f~~~~~~~~~ 963 (998)
.....+......+|. ..+..+.+||.+||..||.+||+.. ..+.++++||||+.++|..+.
T Consensus 212 ~~~~~i~~~~~~~p~--~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~ 274 (329)
T cd05618 212 YLFQVILEKQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLME 274 (329)
T ss_pred HHHHHHhcCCCCCCC--CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHH
Confidence 234445555555553 4678899999999999999999853 236899999999999998664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=369.70 Aligned_cols=285 Identities=36% Similarity=0.634 Sum_probs=248.1
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
.++..+.|..-+.||+||||.||-|.-+.||+.||+|.+.+..+..+.......+|..||.+++.++||.+-..|++.+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 45667889999999999999999999999999999999988777666677778899999999999999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|+||..|+||+|.-.|-..+...+++..++.|+.+|+.||.+||..+||+|||||+|||+|+.|+|+|+|+|+|+.+..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999999888877667799999999999999999999999999999999999999999999999999976541
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
. ......+||.+|||||++.+..|+...|.|||||+||+|+.|+.||.....
T Consensus 340 g----------------------------~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 340 G----------------------------KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred C----------------------------CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 1 122334899999999999999999999999999999999999999976443
Q ss_pred H----HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhh--hcCCCCCCCC
Q 001902 900 Q----KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV--RCMNPPELDA 972 (998)
Q Consensus 900 ~----~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~--~~~~~~~~~~ 972 (998)
. +.-..+......++ ...|.++++|...+|++||.+|+..+ +.+.++.+||||+.++|..+ ..+.||..|-
T Consensus 392 Kvk~eEvdrr~~~~~~ey~--~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPd 469 (591)
T KOG0986|consen 392 KVKREEVDRRTLEDPEEYS--DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPD 469 (591)
T ss_pred hhhHHHHHHHHhcchhhcc--cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCC
Confidence 2 33334444455555 56799999999999999999999998 78999999999999999987 4566666554
Q ss_pred CC
Q 001902 973 PL 974 (998)
Q Consensus 973 p~ 974 (998)
|.
T Consensus 470 p~ 471 (591)
T KOG0986|consen 470 PG 471 (591)
T ss_pred cc
Confidence 43
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=376.48 Aligned_cols=262 Identities=40% Similarity=0.716 Sum_probs=224.3
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHH-HHHHhCCCCCccceeEEEeeCCeEEEEEecCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER-EILDMLDHPFVPALYASFQTKTHVCLITDYCPG 749 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~-~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 749 (998)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|. .+++.++|+||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4689999999999999999999999999865433333333444444 456788999999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--------- 149 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--------- 149 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC---------
Confidence 9999999764 45889999999999999999999999999999999999999999999999998532100
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~ 909 (998)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+....+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 211 (325)
T cd05602 150 ------------------NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 211 (325)
T ss_pred ------------------CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC
Confidence 01123457999999999999999999999999999999999999999998888888888776
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhh
Q 001902 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 910 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~ 963 (998)
...++ ...+..+.++|.+||+.||.+|++..+.+.++++|+||..++|..+.
T Consensus 212 ~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~ 263 (325)
T cd05602 212 PLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLI 263 (325)
T ss_pred CcCCC--CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHH
Confidence 55443 34688999999999999999999988888999999999999998774
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=375.89 Aligned_cols=263 Identities=45% Similarity=0.802 Sum_probs=223.9
Q ss_pred ccccCCCCceeEEEEEEc---cCCeEEEEEEeeccccc-ChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 670 IKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~---~~~~~valK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
++.||+|+||.||+|.+. .+++.||+|++++.... .......+..|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999874 46899999999864322 22334567789999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+++++|.+++.+. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 153 (323)
T cd05584 81 YLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE----- 153 (323)
T ss_pred CCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-----
Confidence 99999999999765 45889999999999999999999999999999999999999999999999998432100
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..
T Consensus 154 ----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~ 211 (323)
T cd05584 154 ----------------------GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211 (323)
T ss_pred ----------------------CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 0112235799999999999998899999999999999999999999999888888888
Q ss_pred HHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhhh
Q 001902 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 906 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~ 963 (998)
+......++. ..+..+.+||.+||..||.+||+.. ..+.++++||||+...|..+.
T Consensus 212 ~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~ 268 (323)
T cd05584 212 ILKGKLNLPP--YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLL 268 (323)
T ss_pred HHcCCCCCCC--CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 8877665554 4678899999999999999999322 129999999999999997763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=380.80 Aligned_cols=262 Identities=41% Similarity=0.748 Sum_probs=224.4
Q ss_pred cCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC---CCCCccceeEEEeeCCeEEEEEecCCC
Q 001902 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQTKTHVCLITDYCPG 749 (998)
Q Consensus 673 LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l---~h~nIv~l~~~~~~~~~~~lV~E~~~g 749 (998)
||+|+||.||+|.+..+++.||+|++.+..............|..++..+ +||||+.++.++...+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765443334445556677777665 799999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
++|..++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--------- 149 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--------- 149 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC---------
Confidence 9999998764 45899999999999999999999999999999999999999999999999998532100
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 908 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~ 908 (998)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~ 211 (330)
T cd05586 150 ------------------NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211 (330)
T ss_pred ------------------CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc
Confidence 0112345799999999999764 478899999999999999999999999888888888877
Q ss_pred CCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhc
Q 001902 909 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRC 964 (998)
Q Consensus 909 ~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~ 964 (998)
+...++.. .++..+.+||.+||+.||.+||+..+.+.++++||||...+|..+..
T Consensus 212 ~~~~~~~~-~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~ 266 (330)
T cd05586 212 GKVRFPKN-VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSK 266 (330)
T ss_pred CCCCCCCc-cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHh
Confidence 76666543 36789999999999999999998777799999999999999987743
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=358.40 Aligned_cols=262 Identities=27% Similarity=0.452 Sum_probs=222.9
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCC-ccceeEEEeeCC----
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF-VPALYASFQTKT---- 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~~~---- 738 (998)
...|..+++||+|+||+||+|+++.+|+.||+|.+.-.... ........+|+.+++.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45688999999999999999999999999999999865321 223345678999999999999 999999998877
Q ss_pred --eEEEEEecCCCCchhHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCc
Q 001902 739 --HVCLITDYCPGGELFLLLDRQPT--KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814 (998)
Q Consensus 739 --~~~lV~E~~~ggsL~~~l~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a 814 (998)
.+++||||+ ..+|..++..... ..++...++.+++||+.||+|||+++|+||||||.||||+++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 8899999987542 35777999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~P 893 (998)
+... .+.+..+..++|.+|.|||++.+. .|+..+||||+|||++||+++++.
T Consensus 168 ra~~---------------------------ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~L 220 (323)
T KOG0594|consen 168 RAFS---------------------------IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPL 220 (323)
T ss_pred HHhc---------------------------CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCC
Confidence 6432 123345667899999999999987 789999999999999999999999
Q ss_pred CCCCChHHHHHHHHhC------------------CCCCCCC----------CCCcHHHHHHHHHccccCccCcCCChhcH
Q 001902 894 FRGKTRQKTFANILHK------------------DLKFPSS----------TPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~------------------~~~~~~~----------~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 945 (998)
|.+.....++.+|.+- ...++.. ...+....+++.+||+.+|.+|.+ +
T Consensus 221 FpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S----a 296 (323)
T KOG0594|consen 221 FPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS----A 296 (323)
T ss_pred CCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC----H
Confidence 9999998888888762 0111111 112347789999999999999999 9
Q ss_pred HHHHcCCCccCCC
Q 001902 946 NEIKKHPFFKGVN 958 (998)
Q Consensus 946 ~elL~Hp~f~~~~ 958 (998)
+.+|.||||....
T Consensus 297 ~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 297 KGALTHPYFSELP 309 (323)
T ss_pred HHHhcChhhcccc
Confidence 9999999999863
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=376.38 Aligned_cols=273 Identities=37% Similarity=0.689 Sum_probs=226.4
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEEEEecCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 749 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 749 (998)
+.||+|+||.||+|.+..+++.||+|++++...........+..|+.++.++ +||||+.+++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999999876555555667788899999888 699999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--------- 149 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--------- 149 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC---------
Confidence 9999988764 45999999999999999999999999999999999999999999999999988532100
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC------C-hHHH
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK------T-RQKT 902 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~------~-~~~~ 902 (998)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||... . ....
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~ 211 (327)
T cd05617 150 ------------------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL 211 (327)
T ss_pred ------------------CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH
Confidence 01123457999999999999999999999999999999999999999532 1 1233
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh--hcHHHHHcCCCccCCChhhhhcCCCCCCCCCC
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH--EGANEIKKHPFFKGVNWALVRCMNPPELDAPL 974 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~--~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~ 974 (998)
...+......+|. ..+..+.++|.+||..||.+|++.. ..+.++++||||+.++|..+.....+....|.
T Consensus 212 ~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~ 283 (327)
T cd05617 212 FQVILEKPIRIPR--FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQ 283 (327)
T ss_pred HHHHHhCCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCC
Confidence 3444444444443 4678899999999999999999853 34689999999999999988654444333344
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=375.20 Aligned_cols=262 Identities=43% Similarity=0.760 Sum_probs=224.6
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHH-HHHhCCCCCccceeEEEeeCCeEEEEEecCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTKTHVCLITDYCPG 749 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~-il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 749 (998)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999999999999999998654433334445555554 67889999999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--------- 149 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--------- 149 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC---------
Confidence 9999888764 45899999999999999999999999999999999999999999999999987432100
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~ 909 (998)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 211 (321)
T cd05603 150 ------------------EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK 211 (321)
T ss_pred ------------------CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC
Confidence 01123457999999999999989999999999999999999999999998888888888776
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhh
Q 001902 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 910 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~ 963 (998)
...++. ..+..+.++|.+||+.||.+||+....+.++++|+||..++|..+.
T Consensus 212 ~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T cd05603 212 PLQLPG--GKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLY 263 (321)
T ss_pred CCCCCC--CCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHh
Confidence 655543 4578899999999999999999977778899999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=378.16 Aligned_cols=278 Identities=37% Similarity=0.656 Sum_probs=232.3
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||++.+..+++.||+|++.+...........+..|+.++..++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998644434445566788999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||++||+|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-- 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-- 157 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc--
Confidence 9999999999997642 4589999999999999999999999999999999999999999999999999854321100
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-----CCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 158 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 213 (331)
T cd05624 158 ------------------------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred ------------------------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH
Confidence 01123569999999999876 4578899999999999999999999999888
Q ss_pred HHHHHHHHhCC--CCCCCC-CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhcCCCCCCC
Q 001902 900 QKTFANILHKD--LKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELD 971 (998)
Q Consensus 900 ~~~~~~i~~~~--~~~~~~-~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~ 971 (998)
...+..+.... +++|.. ..++..+.+||.+||+.++ +|+. ...++++++||||+.++|..++...+|..+
T Consensus 214 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~-~~~~-~~~~~~~~~h~~f~~~~~~~~~~~~~~~~p 286 (331)
T cd05624 214 VETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRE-RRLG-QNGIEDFKKHAFFEGIDWENIRNLEAPYIP 286 (331)
T ss_pred HHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCch-hhcC-CCCHHHHhcCCCcCCCCHHHHhhCCCCccC
Confidence 88787777643 333332 3468899999999999655 4432 123999999999999999999888777664
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=363.49 Aligned_cols=284 Identities=36% Similarity=0.682 Sum_probs=254.8
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeC
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK 737 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 737 (998)
...+...+|..+..||.|+||.|.++..+++.+.||||+++++++.....++....|.++|... +-|.+++++.+|++-
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 3456778999999999999999999999999999999999999998888888888999999887 578999999999999
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
+.+|+||||+.||+|.-.++.- +.+.+..+..++..|+-||-|||++|||+||||.+|||++.+|++||.|||+++.-
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred hheeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999999998888764 55889999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
. .......+++|||.|+|||.+...+|+..+|.||+|++||||+.|++||.+.
T Consensus 501 i---------------------------~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 501 I---------------------------FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred c---------------------------cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 1 1112456789999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhh--hcCCCCCCCCC
Q 001902 898 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV--RCMNPPELDAP 973 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~--~~~~~~~~~~p 973 (998)
+..+.+..|...+..+|.. +|.++.++.+.+|.+.|.+|+..- +.-.+|..||||+.++|..+ +.+.||..+-+
T Consensus 554 DE~elF~aI~ehnvsyPKs--lSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~ 630 (683)
T KOG0696|consen 554 DEDELFQAIMEHNVSYPKS--LSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKI 630 (683)
T ss_pred CHHHHHHHHHHccCcCccc--ccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCcc
Confidence 9999999999999988875 689999999999999999999865 34568999999999999988 45566666443
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=377.85 Aligned_cols=262 Identities=25% Similarity=0.445 Sum_probs=238.3
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe-EEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH-VCL 742 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~l 742 (998)
++.|.+++++|.|+||.+++++++..++.|++|.+.......+. .+...+|..+++++.|||||.+.+.|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 56899999999999999999999999999999999876554443 3477889999999999999999999998887 999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
||+||+||+|.+.+.++.+..++++.+..|+.||+.||.|||+++|+|||||+.|||++.++.|+|+|||+|+.+..+.
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999998765221
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
....+++||+.||+||.+.+.+|+.++|||||||++|||++-+++|.+.+-...
T Consensus 161 --------------------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L 214 (426)
T KOG0589|consen 161 --------------------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL 214 (426)
T ss_pred --------------------------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH
Confidence 234678999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
..+|.+.. -.|.....+.+++.+|..||..+|..||+ +.+||.+|.++..-
T Consensus 215 i~ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPs----a~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 215 ILKINRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPS----ALELLRRPHLLRYL 265 (426)
T ss_pred HHHHhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCC----HHHHhhChhhhhHH
Confidence 99998876 34555568999999999999999999999 99999999988643
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=376.56 Aligned_cols=276 Identities=36% Similarity=0.638 Sum_probs=231.0
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||++.+..+++.||+|++.+...........+..|+.++..++|+||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 37999999999999999999999999999999997644434444556788999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++|+|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~--- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--- 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC---
Confidence 9999999999997642 458999999999999999999999999999999999999999999999999985422100
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc-----CCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
.......+||+.|+|||++. ...++.++|||||||++|+|++|+.||.+.+.
T Consensus 157 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 157 -----------------------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred -----------------------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 01112347999999999986 34578899999999999999999999999888
Q ss_pred HHHHHHHHhCCC--CCCCC-CCCcHHHHHHHHHccccCccC--cCCChhcHHHHHcCCCccCCChhhhhcCCCCCCC
Q 001902 900 QKTFANILHKDL--KFPSS-TPTSLHAKQLMYRLLHRDPKS--RLGSHEGANEIKKHPFFKGVNWALVRCMNPPELD 971 (998)
Q Consensus 900 ~~~~~~i~~~~~--~~~~~-~~~s~~l~~Ll~~~L~~dP~~--Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~ 971 (998)
...+..+..... .+|.. ..++.++++||.+||+.++.. |++ +.++++||||++++|..+....+|..+
T Consensus 214 ~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~----~~~~~~h~~f~~~~~~~~~~~~~~~~~ 286 (332)
T cd05623 214 VETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNG----IEDFKQHPFFTGIDWDNIRNCEAPYIP 286 (332)
T ss_pred HHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCC----HHHHhCCCCcCCCCHHHHhhCCCCccC
Confidence 888888876542 33332 356889999999999765544 567 999999999999999988766665554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=379.60 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=228.5
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
+.|.++..||.|+||.||+|.++.++...|-|++.. ........+.-||+||..++||+||++++.|..++.+||+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 457899999999999999999999998889998863 35667788899999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
|||+||-+..++-.- +..|++.+++.+++|++.||.|||+++|||||||..|||++-+|.++|.|||.+....
T Consensus 109 EFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~------ 181 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK------ 181 (1187)
T ss_pred eecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch------
Confidence 999999888877654 4569999999999999999999999999999999999999999999999999984321
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-----CCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
.......+++|||+|||||+..+ .+|++++||||||++|.+|..+.+|-...+.
T Consensus 182 ---------------------~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp 240 (1187)
T KOG0579|consen 182 ---------------------STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP 240 (1187)
T ss_pred ---------------------hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence 01123467899999999999754 5789999999999999999999999999999
Q ss_pred HHHHHHHHhCCCC-CCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 900 QKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 900 ~~~~~~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
...+-+|.+...+ +......+..+.+||.+||.+||..||+ +.+||+||||+.+.-
T Consensus 241 MRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~----aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 241 MRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPP----AAQLLKHPFVQNAPS 297 (1187)
T ss_pred HHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCC----HHHHhhCcccccCCc
Confidence 9999998887654 3344556788999999999999999999 999999999997643
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=375.51 Aligned_cols=300 Identities=37% Similarity=0.635 Sum_probs=252.8
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+...-|..++.||-|+||.|.+++-..|...||+|.+.+..+..+..+.....|..||..-+++-||+||..|++++.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 44567999999999999999999999999999999999988888888899999999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC-
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK- 820 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~- 820 (998)
+||+|++||++..+|.+. +.++++.+++|+..+..|++++|+.|+|||||||+|||||.+|++||.|||++.-+...
T Consensus 706 FVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999999999886 56999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCCCCcchhhhhcccCCCCccccc--------------------ccccccccccCCCCcccchhhcCCCCCChhHHHHH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMA--------------------EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 880 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSl 880 (998)
+..++.. .. +..++..... ...-....++||+.|+|||++....|+..+|.||.
T Consensus 784 dskYYq~-gd-----H~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~ 857 (1034)
T KOG0608|consen 784 DSKYYQE-GD-----HHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV 857 (1034)
T ss_pred ccccccC-CC-----ccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence 2222221 11 1111110000 00112346799999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCChHHHHHHHHh--CCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 881 GILLYEMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 881 G~il~eLltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
|+|||+|+.|++||......+...+++. ..+.++....+|.++.+||.++++ +++.|+. +.+++++..||||+++|
T Consensus 858 gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLG-kng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLG-KNGADQVKAHPFFKGID 935 (1034)
T ss_pred hHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhhc-ccchhhhhcCccccccc
Confidence 9999999999999998887766666653 346677778899999999999887 8899998 66788999999999999
Q ss_pred hhhhhcCCCCCCC
Q 001902 959 WALVRCMNPPELD 971 (998)
Q Consensus 959 ~~~~~~~~~~~~~ 971 (998)
|+-++....|-.+
T Consensus 936 fsslRkq~ApYIP 948 (1034)
T KOG0608|consen 936 FSSLRKQRAPYIP 948 (1034)
T ss_pred hHhhhhccCCcCc
Confidence 9999887766443
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=367.79 Aligned_cols=257 Identities=26% Similarity=0.377 Sum_probs=212.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 379999999999999999999999999999999976432 2334566788999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||++++.+..+... ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 154 (287)
T cd07848 80 EYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS--- 154 (287)
T ss_pred ecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc---
Confidence 99988777655433 2458999999999999999999999999999999999999999999999999985532110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
........|++.|+|||++.+..++.++|||||||++|+|++|++||.+.+......
T Consensus 155 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~ 211 (287)
T cd07848 155 -----------------------NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211 (287)
T ss_pred -----------------------cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011123568999999999999889999999999999999999999998876655444
Q ss_pred HHHhCC-------------------CCCCC-----------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 905 NILHKD-------------------LKFPS-----------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 905 ~i~~~~-------------------~~~~~-----------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
.+.... ..++. ....|..+.+||.+||+.||.+||| +.++|+||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s----~~~~l~hp~f 287 (287)
T cd07848 212 TIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL----TEQCLNHPAF 287 (287)
T ss_pred HHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC----HHHHhcCCCC
Confidence 333211 01111 0125778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=367.74 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=212.9
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
+++|++++.||.|+||.||+|.+..+++.||+|+++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 468999999999999999999999999999999987542 122234567899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||++ ++|.+++... ...++...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--- 156 (288)
T cd07871 82 FEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--- 156 (288)
T ss_pred EeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC---
Confidence 99996 5899888654 245889999999999999999999999999999999999999999999999998542210
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
........|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 157 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~ 212 (288)
T cd07871 157 ------------------------TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE 212 (288)
T ss_pred ------------------------CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 011223468999999999876 5688999999999999999999999998877666
Q ss_pred HHHHHhCC-------------------CCCCC---------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 903 FANILHKD-------------------LKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 903 ~~~i~~~~-------------------~~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
+..+.... ..++. ....+.++++||.+||+.||.+||| +.++|+||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t----~~~~l~hp~f 288 (288)
T cd07871 213 LHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS----AEAALRHSYF 288 (288)
T ss_pred HHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC----HHHHhcCCCC
Confidence 65554311 00111 1235778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=373.80 Aligned_cols=268 Identities=44% Similarity=0.790 Sum_probs=220.0
Q ss_pred CcccccccCCCCceeEEEEEEc---cCCeEEEEEEeeccccc-ChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 740 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~valK~i~~~~~~-~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 740 (998)
+|++++.||+|+||.||+|++. .+++.||+|++.+.... .......+..|+.+++.+ +|+||+.+++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999999874 47899999999764332 223455677899999999 599999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999998764 45899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCC-
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKT- 898 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~- 898 (998)
. .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus 159 ~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 212 (332)
T cd05614 159 E--------------------------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE 212 (332)
T ss_pred C--------------------------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCC
Confidence 0 0112245799999999999875 47889999999999999999999996432
Q ss_pred ---hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhhh
Q 001902 899 ---RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 899 ---~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~ 963 (998)
.......+......++ ...+..+.+||.+||..||.+||++. +.+.++++||||+..+|..+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 279 (332)
T cd05614 213 RNTQSEVSRRILKCDPPFP--SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALA 279 (332)
T ss_pred CCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 2333444444444433 34688999999999999999999432 238999999999999997664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=364.65 Aligned_cols=261 Identities=31% Similarity=0.504 Sum_probs=234.6
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
+-|.+.+.||+|.|+.|.+|++.-+|..||||++.+..+ +......+.+|.++|+.+.|||||++|++......+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 569999999999999999999999999999999998755 3344567888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe-cCCcEEEEeccCccccCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-GNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~-~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|+-++|+|++|+.++.. .++++..++|+.||+.|+.|+|+..+|||||||+||.|- .-|-|||.|||++..+.
T Consensus 97 ELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~----- 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ----- 170 (864)
T ss_pred EecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC-----
Confidence 99999999999988754 499999999999999999999999999999999998765 57899999999984432
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCC-ChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT-SAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
+-..-.+.||++.|-|||.+.+..|+ +++||||||+|||-|+||++||...+..+.
T Consensus 171 -----------------------PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET 227 (864)
T KOG4717|consen 171 -----------------------PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET 227 (864)
T ss_pred -----------------------CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh
Confidence 11233567999999999999998886 589999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhh
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWAL 961 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 961 (998)
+..|+.+.+..|.. +|.++++||..||..||.+|.+ +++|..|+|+++.+-..
T Consensus 228 LTmImDCKYtvPsh--vS~eCrdLI~sMLvRdPkkRAs----lEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 228 LTMIMDCKYTVPSH--VSKECRDLIQSMLVRDPKKRAS----LEEIVSTSWLQAGDRGL 280 (864)
T ss_pred hhhhhcccccCchh--hhHHHHHHHHHHHhcCchhhcc----HHHHhccccccCCCCCc
Confidence 99999988777654 6899999999999999999999 99999999999986543
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=370.46 Aligned_cols=261 Identities=24% Similarity=0.391 Sum_probs=218.7
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+..++|++++.||+|+||.||++.+..++..+|+|++.... .......+.+|+++++.++||||+++++++...+.++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 45679999999999999999999999999999999987542 3344567889999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 156 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 156 (331)
T ss_pred EEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc-
Confidence 999999999999999764 3589999999999999999999986 699999999999999999999999998843210
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 157 ----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 208 (331)
T cd06649 157 ----------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208 (331)
T ss_pred ----------------------------cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0112346999999999999999999999999999999999999999776543
Q ss_pred HHHHHHH----------------------------------------------hCCCCCCCCCCCcHHHHHHHHHccccC
Q 001902 901 KTFANIL----------------------------------------------HKDLKFPSSTPTSLHAKQLMYRLLHRD 934 (998)
Q Consensus 901 ~~~~~i~----------------------------------------------~~~~~~~~~~~~s~~l~~Ll~~~L~~d 934 (998)
+....+. ....+.......+.++++||.+||.+|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~ 288 (331)
T cd06649 209 ELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKN 288 (331)
T ss_pred HHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCC
Confidence 3322111 111111111235778999999999999
Q ss_pred ccCcCCChhcHHHHHcCCCccCCCh
Q 001902 935 PKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 935 P~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
|++||| +.+|++||||+....
T Consensus 289 P~~Rpt----~~ell~h~~~~~~~~ 309 (331)
T cd06649 289 PAERAD----LKMLMNHTFIKRSEV 309 (331)
T ss_pred cccCCC----HHHHhcChHHhhccc
Confidence 999999 999999999987544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=373.65 Aligned_cols=263 Identities=43% Similarity=0.779 Sum_probs=226.4
Q ss_pred ccccCCCCceeEEEEEE---ccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEec
Q 001902 670 IKPLGSGDTGSVHLVEL---CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 746 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~---~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 746 (998)
++.||+|+||.||++.+ ..+|+.||+|++.+... .......+..|+.++++++||||+++++++...+.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 36799999999999987 35789999999986532 222345567899999999999999999999999999999999
Q ss_pred CCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCC
Q 001902 747 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 826 (998)
Q Consensus 747 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 826 (998)
+++++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~------ 151 (318)
T cd05582 80 LRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH------ 151 (318)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC------
Confidence 9999999999764 45899999999999999999999999999999999999999999999999998542210
Q ss_pred cchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 001902 827 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 906 (998)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i 906 (998)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+
T Consensus 152 ---------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i 210 (318)
T cd05582 152 ---------------------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210 (318)
T ss_pred ---------------------CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH
Confidence 01122457999999999999988999999999999999999999999998888888888
Q ss_pred HhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh-cHHHHHcCCCccCCChhhhhc
Q 001902 907 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVRC 964 (998)
Q Consensus 907 ~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~~ 964 (998)
......+|. .++..+.+||.+||+.||.+||++.+ .+.++++||||+.++|..+..
T Consensus 211 ~~~~~~~p~--~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T cd05582 211 LKAKLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYR 267 (318)
T ss_pred HcCCCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHh
Confidence 777665553 36889999999999999999999764 488999999999999987744
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=372.50 Aligned_cols=280 Identities=39% Similarity=0.684 Sum_probs=250.5
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
++.+.+++.+..||-|+||.|-++........+|+|++++..+.+..+.+.+..|..||..+++|+||++|-.|.+..++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 34567889999999999999999998666667999999998888888889999999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|++||-|-||.|+.+|..+ +.+.+...+.++..+++|++|||++|||+|||||+|+|++.+|.+||.|||+|+.+...
T Consensus 496 YmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999999999875 56999999999999999999999999999999999999999999999999999775421
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
....++||||.|.|||++.+..++.++|.||||+++|||++|.+||.+.++.
T Consensus 574 ----------------------------~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm 625 (732)
T KOG0614|consen 574 ----------------------------RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM 625 (732)
T ss_pred ----------------------------CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH
Confidence 2346789999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhh--hcCCCCCC
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV--RCMNPPEL 970 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~--~~~~~~~~ 970 (998)
..+..|+++--.+.-+..++..+.+||++++..+|.+|+... ..+.+|.+|.||.+++|.-+ +.+.||..
T Consensus 626 ktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~ 698 (732)
T KOG0614|consen 626 KTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPII 698 (732)
T ss_pred HHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCcc
Confidence 999999987433333345678889999999999999999854 57999999999999999877 44555544
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=368.27 Aligned_cols=261 Identities=25% Similarity=0.414 Sum_probs=210.6
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++++.||+|+||.||+|.+..+++.||+|++..... ........+|+.+++.++||||+++++++......|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 3689999999999999999999999999999999875422 22234567899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 156 (303)
T cd07869 82 FEYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--- 156 (303)
T ss_pred EECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC---
Confidence 9999 56788777654 245899999999999999999999999999999999999999999999999998532211
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCCh-HH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR-QK 901 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~-~~ 901 (998)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ..
T Consensus 157 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 212 (303)
T cd07869 157 ------------------------SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD 212 (303)
T ss_pred ------------------------CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH
Confidence 011123468999999999876 4578899999999999999999999987543 23
Q ss_pred HHHHHHhC--CC---CC------------------C-------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 902 TFANILHK--DL---KF------------------P-------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 902 ~~~~i~~~--~~---~~------------------~-------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
.+..+... .. .+ + .....+..+.+||.+||+.||.+||| +.++|+|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s----~~~~l~h 288 (303)
T cd07869 213 QLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS----AQAALSH 288 (303)
T ss_pred HHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC----HHHHhcC
Confidence 33333210 00 00 0 00123457889999999999999999 9999999
Q ss_pred CCccCCCh
Q 001902 952 PFFKGVNW 959 (998)
Q Consensus 952 p~f~~~~~ 959 (998)
|||+.+.+
T Consensus 289 ~~f~~~~~ 296 (303)
T cd07869 289 EYFSDLPP 296 (303)
T ss_pred cccccCCh
Confidence 99998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=367.75 Aligned_cols=261 Identities=26% Similarity=0.434 Sum_probs=215.6
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 739 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 739 (998)
.++...|+++++||+||.+.||+|..- ....||+|.+... ..+......+.+|+.+|.+| +|.+|+++++|-..+++
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 356788999999999999999999974 4556777665532 34667788999999999999 69999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+||||||- ..+|..+|.+.. ..++.-.++.|..|||.|+.++|..||||.||||.|+|+. .|.+||+|||+|..+..
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred EEEEeecc-cccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 99999987 889999998754 3355569999999999999999999999999999999999 78999999999977653
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC-----------CCChhHHHHHHHHHHHHH
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-----------HTSAVDWWALGILLYEML 888 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----------~~~~sDIwSlG~il~eLl 888 (998)
+...+ ...+-+||+.||+||.+.... .+.++||||||||||+|+
T Consensus 512 DTTsI-------------------------~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv 566 (677)
T KOG0596|consen 512 DTTSI-------------------------VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV 566 (677)
T ss_pred cccce-------------------------eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH
Confidence 33222 234568999999999996543 456899999999999999
Q ss_pred cCCCCCCCCC-hHHHHHHHHhC--CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 889 YGYTPFRGKT-RQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 889 tG~~Pf~~~~-~~~~~~~i~~~--~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
+|++||.... ....+..|... .+.||..... .++.++++.||.+||.+||+ +.+||+|||++.
T Consensus 567 YgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~-~~li~~mK~CL~rdPkkR~s----i~eLLqhpFl~~ 632 (677)
T KOG0596|consen 567 YGKTPFGQIINQIAKLHAITDPNHEIEFPDIPEN-DELIDVMKCCLARDPKKRWS----IPELLQHPFLQI 632 (677)
T ss_pred hcCCchHHHHHHHHHHHhhcCCCccccccCCCCc-hHHHHHHHHHHhcCcccCCC----cHHHhcCccccc
Confidence 9999998754 34444555544 3456655433 23999999999999999999 999999999987
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=355.80 Aligned_cols=256 Identities=26% Similarity=0.427 Sum_probs=225.9
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
-|.++.+||+|+||.||+|.++++|+.+|+|.+..+ ...+.+..|+.||.++++++||++|+.|.....+|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 488999999999999999999999999999987643 356788999999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
||..|++.++++-+ .+.+++..+..+++..++||+|||...-||||||..|||++.+|.+||.|||.|..+
T Consensus 109 YCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQL-------- 179 (502)
T KOG0574|consen 109 YCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQL-------- 179 (502)
T ss_pred hcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchh--------
Confidence 99999999998754 467999999999999999999999999999999999999999999999999998432
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
++.+-..++++|||.|||||++..-.|+.++||||||++..||..|++||....+...+..
T Consensus 180 -------------------TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM 240 (502)
T KOG0574|consen 180 -------------------TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM 240 (502)
T ss_pred -------------------hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe
Confidence 2333456788999999999999999999999999999999999999999998887655544
Q ss_pred HHhCC-CCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 906 ILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 906 i~~~~-~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
|-... ..|......|.++.+|+++||-++|++|-| +-+|++|||.+...
T Consensus 241 IPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~T----A~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 241 IPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKT----ALRLCEHTFIKNAP 290 (502)
T ss_pred ccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHH----HHHHhhhhhhcCCC
Confidence 43332 223344456889999999999999999999 99999999999843
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=378.19 Aligned_cols=254 Identities=29% Similarity=0.481 Sum_probs=220.4
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-C-----CCccceeEEEeeCCe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-H-----PFVPALYASFQTKTH 739 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h-----~nIv~l~~~~~~~~~ 739 (998)
+|.+++.||+|+||+|.+|.+.+|++.||||+++.. .....+...|+.||..|+ | -|||+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 799999999999999999999999999999999854 345667788999999996 4 489999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC--CcEEEEeccCcccc
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN--GHVSLTDFDLSCLT 817 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~--g~vkL~DFG~a~~~ 817 (998)
+|||+|.+ ..+|+++++.+....++...++.++.||+.||.+||+.||||+||||+|||+..- ..|||+|||.|+..
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999999 8999999999888889999999999999999999999999999999999999853 47999999999764
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
+. ....++-+..|.|||++.|.+|+.+.||||||||++||++|.+.|.|.
T Consensus 342 ~q------------------------------~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 342 SQ------------------------------RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred CC------------------------------cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 31 111557889999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHhCCC---------------------C-------------------------------CC-CCC-------
Q 001902 898 TRQKTFANILHKDL---------------------K-------------------------------FP-SST------- 917 (998)
Q Consensus 898 ~~~~~~~~i~~~~~---------------------~-------------------------------~~-~~~------- 917 (998)
+..+++..|+.-.- . .| ...
T Consensus 392 ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~ 471 (586)
T KOG0667|consen 392 NEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLP 471 (586)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcc
Confidence 99988888775100 0 01 000
Q ss_pred -CCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 918 -PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 918 -~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
.....+.+||.+||.+||.+|+| ..++|+||||++..
T Consensus 472 ~~~~~~F~dflk~~L~~dP~~R~t----p~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 472 KADDKLFIDFLKRCLEWDPAERIT----PAQALNHPFLTGTS 509 (586)
T ss_pred cccHHHHHHHHHHHhccCchhcCC----HHHHhcCccccccc
Confidence 11235689999999999999999 99999999999753
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=371.53 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=233.4
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
.|.-++.||.|+||.||-|++..+...||||.+....-...+...++..|+..|++++|||++.+.++|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 48888999999999999999999999999999987766677778899999999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|| -|+-.|++.-. .+++-+-.+..|+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|..+.
T Consensus 107 YC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------- 177 (948)
T KOG0577|consen 107 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------- 177 (948)
T ss_pred HH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-------
Confidence 99 78888888765 3569999999999999999999999999999999999999999999999999885532
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC---CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
+..+++|||+|||||++.. +.|+-++||||||++..+|.-.++|+...+....
T Consensus 178 ------------------------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA 233 (948)
T KOG0577|consen 178 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 233 (948)
T ss_pred ------------------------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH
Confidence 4567899999999999854 6788999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
+..|.+...+.......|..+.+|+..||++-|.+||| .+++|+|+|...
T Consensus 234 LYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRpt----se~ll~H~fv~R 283 (948)
T KOG0577|consen 234 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPT----SEELLKHRFVLR 283 (948)
T ss_pred HHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCc----HHHHhhcchhcc
Confidence 99999888777667778999999999999999999999 999999999875
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=359.37 Aligned_cols=277 Identities=34% Similarity=0.603 Sum_probs=229.0
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
.|+..+.||.|+||.||++.+..+++.||+|++.............+.+|+.+++.++|+||+.+++.+..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37788999999999999999999999999999976544444444567789999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG----- 155 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-----
Confidence 999999998887654456999999999999999999999999999999999999999999999999988543210
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
.......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........
T Consensus 156 -----------------------~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~ 212 (285)
T cd05632 156 -----------------------ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212 (285)
T ss_pred -----------------------CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 011234689999999999988999999999999999999999999988765444333
Q ss_pred HHhCC--CCCCCCCCCcHHHHHHHHHccccCccCcCCChh-cHHHHHcCCCccCCChhhh--hcCCCCCC
Q 001902 906 ILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALV--RCMNPPEL 970 (998)
Q Consensus 906 i~~~~--~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~--~~~~~~~~ 970 (998)
+.... .........+..+.+|+.+||..||.+||++.+ .+.++++|+||+.++|..+ ..+.||-.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 282 (285)
T cd05632 213 VDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFV 282 (285)
T ss_pred HHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCC
Confidence 32211 111122346788999999999999999999774 4889999999999999865 44444444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=359.71 Aligned_cols=277 Identities=35% Similarity=0.618 Sum_probs=227.1
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
.|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++|++|+.+++.+...+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 37788999999999999999999999999999886544444445567789999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG----- 155 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-----
Confidence 999999999987654456999999999999999999999999999999999999999999999999988442200
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH---HH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ---KT 902 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~---~~ 902 (998)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 156 -----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~ 212 (285)
T cd05630 156 -----------------------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212 (285)
T ss_pred -----------------------ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH
Confidence 0112346899999999999999999999999999999999999999875432 22
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhhhc--CCCCCCC
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC--MNPPELD 971 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~--~~~~~~~ 971 (998)
...+... .........+..+.+|+.+||+.||.+|||+. ..+.++++||||+.++|..++. .+||..+
T Consensus 213 ~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05630 213 VERLVKE-VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKP 283 (285)
T ss_pred HHhhhhh-hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCC
Confidence 2222221 11112234678899999999999999999843 1378999999999999987754 4454443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=369.34 Aligned_cols=263 Identities=25% Similarity=0.401 Sum_probs=211.2
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC-----CeE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----THV 740 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~~~ 740 (998)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999987432 2233445678899999999999999999987543 358
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||| +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 80 YVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999999 57899988764 35899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC--CCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
.. .........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+
T Consensus 157 ~~------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 157 TP------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred cC------------------------ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 00 0011234579999999999876 678899999999999999999999998766
Q ss_pred hHHHHHHHHh--------------------------CCCCCC---CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 899 RQKTFANILH--------------------------KDLKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 899 ~~~~~~~i~~--------------------------~~~~~~---~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
....+..+.. ...+.+ .....+..+.+||.+||+.||++||+ +.++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~e~l 288 (338)
T cd07859 213 VVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT----AEEAL 288 (338)
T ss_pred hHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC----HHHHh
Confidence 5433222111 000100 11235678899999999999999999 99999
Q ss_pred cCCCccCCChh
Q 001902 950 KHPFFKGVNWA 960 (998)
Q Consensus 950 ~Hp~f~~~~~~ 960 (998)
+||||+++...
T Consensus 289 ~hp~f~~~~~~ 299 (338)
T cd07859 289 ADPYFKGLAKV 299 (338)
T ss_pred cCchhhhcCcc
Confidence 99999987554
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=356.77 Aligned_cols=265 Identities=45% Similarity=0.816 Sum_probs=232.4
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|.+.+.||.|+||.||++.+..+++.+|+|++.............+.+|++++++++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36899999999999999999999999999999998765545556677889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|.+++.+. ..+++..+..++.||+.||.|||++||+|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 999999999999775 45899999999999999999999999999999999999999999999999998543210
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+......
T Consensus 155 --------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 208 (290)
T cd05580 155 --------------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE 208 (290)
T ss_pred --------------------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 123468999999999988888899999999999999999999999888777777
Q ss_pred HHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhhh
Q 001902 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 905 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~ 963 (998)
.+......++.. .+..+.++|.+||..||.+|++.. +.++++++||||+.++|..+.
T Consensus 209 ~~~~~~~~~~~~--~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 266 (290)
T cd05580 209 KILEGKVRFPSF--FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALL 266 (290)
T ss_pred HHhcCCccCCcc--CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHh
Confidence 777666555543 578999999999999999999322 349999999999999998774
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=373.64 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=207.5
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+...+|++++.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||++++++|......|
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 455789999999999999999999999999999996432 34678999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+|||++ +++|..++... ..++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 160 lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 999999 57888888664 358999999999999999999999999999999999999999999999999985321000
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC---
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT--- 898 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~--- 898 (998)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 237 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~ 290 (391)
T PHA03212 237 --------------------------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLD 290 (391)
T ss_pred --------------------------ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCccccc
Confidence 011234579999999999999999999999999999999999998875432
Q ss_pred ----hHHHHHHHHhC--------------------------CCCCCC-------CCCCcHHHHHHHHHccccCccCcCCC
Q 001902 899 ----RQKTFANILHK--------------------------DLKFPS-------STPTSLHAKQLMYRLLHRDPKSRLGS 941 (998)
Q Consensus 899 ----~~~~~~~i~~~--------------------------~~~~~~-------~~~~s~~l~~Ll~~~L~~dP~~Rpt~ 941 (998)
....+..++.. ....+. ....+.++.+||.+||+.||.+|||
T Consensus 291 ~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt- 369 (391)
T PHA03212 291 GDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS- 369 (391)
T ss_pred ccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC-
Confidence 11122222111 000000 0123557889999999999999999
Q ss_pred hhcHHHHHcCCCccCC
Q 001902 942 HEGANEIKKHPFFKGV 957 (998)
Q Consensus 942 ~~~a~elL~Hp~f~~~ 957 (998)
+.++|+||||+.+
T Consensus 370 ---a~elL~hp~f~~~ 382 (391)
T PHA03212 370 ---AEALLDFAAFQDI 382 (391)
T ss_pred ---HHHHhcChhhccC
Confidence 9999999999874
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=364.59 Aligned_cols=259 Identities=24% Similarity=0.400 Sum_probs=216.1
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+..++|++.+.||.|+||.||++.+..++..+|+|++.... .......+.+|+++++.++|+||++++++|...+.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 45679999999999999999999999999999999987542 3344567889999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+|+||||+|||++.+|.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~- 156 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 156 (333)
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh-
Confidence 999999999999999764 4589999999999999999999985 799999999999999999999999999843210
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 157 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 157 ----------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred ----------------------------hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 0112346899999999999988999999999999999999999999865543
Q ss_pred HHHHHH--------------------------------------------HhCCCCCCCCCCCcHHHHHHHHHccccCcc
Q 001902 901 KTFANI--------------------------------------------LHKDLKFPSSTPTSLHAKQLMYRLLHRDPK 936 (998)
Q Consensus 901 ~~~~~i--------------------------------------------~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~ 936 (998)
.....+ .....+.......+.++.+||.+||+.||+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 288 (333)
T cd06650 209 ELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPA 288 (333)
T ss_pred HHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcc
Confidence 322111 111111111123467889999999999999
Q ss_pred CcCCChhcHHHHHcCCCccCC
Q 001902 937 SRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 937 ~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
+||| +.++++||||+..
T Consensus 289 ~Rpt----~~ell~h~~~~~~ 305 (333)
T cd06650 289 ERAD----LKQLMVHAFIKRS 305 (333)
T ss_pred cCcC----HHHHhhCHHHhcC
Confidence 9999 9999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=357.98 Aligned_cols=256 Identities=26% Similarity=0.438 Sum_probs=209.2
Q ss_pred CCcccccccCCCCceeEEEEEEcc-CCeEEEEEEeecccccChhHHHHHHHHHHHHHhC---CCCCccceeEEEe-----
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCG-SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQ----- 735 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~-~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l---~h~nIv~l~~~~~----- 735 (998)
++|++++.||+|+||.||+|.+.. +++.||+|.++...... .......+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 379999999999999999999854 47889999987543222 2223455677777665 6999999999885
Q ss_pred eCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
....+++||||++ ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457899999995 689999877655668999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||.
T Consensus 159 ~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 159 IYSFQ----------------------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred eccCC----------------------------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 43211 11234568999999999998899999999999999999999999999
Q ss_pred CCChHHHHHHHHhCCC-C----CCC--------------------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 896 GKTRQKTFANILHKDL-K----FPS--------------------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 896 ~~~~~~~~~~i~~~~~-~----~~~--------------------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
+.+....+..+..... + ++. ....+..+.+|+.+||+.||++||| +.++|+
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~ 286 (290)
T cd07862 211 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALS 286 (290)
T ss_pred CCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC----HHHHhc
Confidence 9887777776654211 0 000 0235677899999999999999999 999999
Q ss_pred CCCc
Q 001902 951 HPFF 954 (998)
Q Consensus 951 Hp~f 954 (998)
||||
T Consensus 287 hp~f 290 (290)
T cd07862 287 HPYF 290 (290)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=378.29 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=207.9
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 737 (998)
..+|++++.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||++++++|...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 457999999999999999999999999999999886431 2234699999999999999999887432
Q ss_pred --CeEEEEEecCCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC-cEEEEecc
Q 001902 738 --THVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFD 812 (998)
Q Consensus 738 --~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g-~vkL~DFG 812 (998)
..+++||||++ ++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 25789999995 577776653 2345699999999999999999999999999999999999999665 79999999
Q ss_pred CccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCC
Q 001902 813 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGY 891 (998)
Q Consensus 813 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~ 891 (998)
+|...... .......||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 217 la~~~~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~ 268 (440)
T PTZ00036 217 SAKNLLAG----------------------------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY 268 (440)
T ss_pred cchhccCC----------------------------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 98543210 111235689999999998764 6899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhC-----------------CCCCCC----------CCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 892 TPFRGKTRQKTFANILHK-----------------DLKFPS----------STPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 892 ~Pf~~~~~~~~~~~i~~~-----------------~~~~~~----------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
+||.+.+....+..++.. .+.++. ....+.++.+||.+||.+||.+|||
T Consensus 269 ~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t---- 344 (440)
T PTZ00036 269 PIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN---- 344 (440)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC----
Confidence 999998777666665431 111111 1124678999999999999999999
Q ss_pred HHHHHcCCCccCCCh
Q 001902 945 ANEIKKHPFFKGVNW 959 (998)
Q Consensus 945 a~elL~Hp~f~~~~~ 959 (998)
+.++|+||||..+..
T Consensus 345 a~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 345 PIEALADPFFDDLRD 359 (440)
T ss_pred HHHHhCChhHHhhhc
Confidence 999999999987644
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=352.70 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=213.7
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC--C---eE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--T---HV 740 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~---~~ 740 (998)
.|...+.+|.|+||.||.+...++++.+|||.+-.+. +.-..|+.||+.++|||||++..+|... . +.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 5888899999999999999999999999999876542 2334699999999999999999888632 2 45
Q ss_pred EEEEecCCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC-CcEEEEeccCcccc
Q 001902 741 CLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLT 817 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~-g~vkL~DFG~a~~~ 817 (998)
.+||||| .-+|.++++. .....++.-.++.++.||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 98 nlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 6999999 6799988874 123558899999999999999999999999999999999999965 99999999999765
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.. .....++..|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.|
T Consensus 177 ~~----------------------------~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG 228 (364)
T KOG0658|consen 177 VK----------------------------GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG 228 (364)
T ss_pred cc----------------------------CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence 31 1223456789999999999885 688999999999999999999999999
Q ss_pred CChHHHHHHHHhC-----------------CCCCC----------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 897 KTRQKTFANILHK-----------------DLKFP----------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 897 ~~~~~~~~~i~~~-----------------~~~~~----------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
.+...++..|++- ..++| .....++++.+|+.++|.++|.+|.+ +.+++
T Consensus 229 ~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~----~~~~l 304 (364)
T KOG0658|consen 229 DSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS----ALEAL 304 (364)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC----HHHHh
Confidence 9998888877651 11111 12345778999999999999999999 99999
Q ss_pred cCCCccCCChh
Q 001902 950 KHPFFKGVNWA 960 (998)
Q Consensus 950 ~Hp~f~~~~~~ 960 (998)
.||||....-.
T Consensus 305 ~h~fFdelr~~ 315 (364)
T KOG0658|consen 305 AHPFFDELRDP 315 (364)
T ss_pred cchhhHHhhCc
Confidence 99999986444
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=365.95 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=209.5
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
....++|+.++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++|+||+++++++...+.+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 344678999999999999999999999999999999986532 334456788999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||+++++|.+. ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 148 ~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 148 QVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred EEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999999999998653 23567788899999999999999999999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-----CCCCChhHHHHHHHHHHHHHcCCCCCC
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
........||..|+|||++.. ...+.++|||||||++|+|++|+.||.
T Consensus 222 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 222 ---------------------------MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred ---------------------------cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 011234579999999998843 234568999999999999999999997
Q ss_pred CCChH---HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 896 GKTRQ---KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 896 ~~~~~---~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
..... .....+... .........+.++.+||.+||..||++||+ +.++++||||.+.
T Consensus 275 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt----~~ell~hp~~~~~ 334 (353)
T PLN00034 275 VGRQGDWASLMCAICMS-QPPEAPATASREFRHFISCCLQREPAKRWS----AMQLLQHPFILRA 334 (353)
T ss_pred CCCCccHHHHHHHHhcc-CCCCCCCccCHHHHHHHHHHccCChhhCcC----HHHHhcCcccccC
Confidence 43322 222222221 122223456889999999999999999999 9999999999985
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=355.20 Aligned_cols=302 Identities=38% Similarity=0.676 Sum_probs=242.8
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||.|+||.||++.+..+++.|++|.+.............+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999988664444455667889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999999999765 458999999999999999999999999999999999999999999999999885421110000
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.... . ..............|+..|+|||.+.+..++.++|||||||++|+|++|..||.+......+.
T Consensus 159 ~~~~----------~--~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~ 226 (305)
T cd05609 159 LYEG----------H--IEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226 (305)
T ss_pred cccc----------c--cccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 0000 0 000000011223568899999999988889999999999999999999999999888877777
Q ss_pred HHHhCCCCCCCCC-CCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhcCCCCCCCCCCCCCcccccc
Q 001902 905 NILHKDLKFPSST-PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEY 983 (998)
Q Consensus 905 ~i~~~~~~~~~~~-~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 983 (998)
.+.......+... ..+..+.+||.+||..||++||++. .+.++++||||...+|+......+ ..+|.+.-.....|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~-~~~~ll~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 303 (305)
T cd05609 227 QVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTG-GAFEVKQHRFFLGLDWNGLLRQKA--EFIPQLESEDDTSY 303 (305)
T ss_pred HHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCcc-CHHHHHhCccccCCCHHHHhhcCC--CCCCCCCCcccccc
Confidence 7776655554432 4688899999999999999999853 378999999999999998765433 33466644444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=363.03 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=218.6
Q ss_pred cccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 658 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
..+.+....+++++.||+|.||.||++.+.. ...+|+|.++...+. .+.+.+|+.+|++|+|++||++++++..+
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQ 273 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence 4456667789999999999999999999943 348999999875332 25677899999999999999999999998
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
+.+|||||||+.|+|.++|+...+..+...+...++.||++|++||+++++|||||-..||||++++.|||+|||+|+..
T Consensus 274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccccc
Confidence 89999999999999999999866778999999999999999999999999999999999999999999999999999743
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~ 896 (998)
..+.- ......--...|.|||.+....++.+|||||||++||||+| |+.||.+
T Consensus 354 ~d~~Y--------------------------~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ 407 (468)
T KOG0197|consen 354 GDDEY--------------------------TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG 407 (468)
T ss_pred CCCce--------------------------eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC
Confidence 21110 00111123457999999999999999999999999999997 9999999
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
.+..+.+..+.++ ...|....++.++.+++..||+.+|++||||..
T Consensus 408 msn~ev~~~le~G-yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~ 453 (468)
T KOG0197|consen 408 MSNEEVLELLERG-YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFET 453 (468)
T ss_pred CCHHHHHHHHhcc-CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHH
Confidence 9999998887765 455666678999999999999999999999764
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=364.89 Aligned_cols=255 Identities=25% Similarity=0.483 Sum_probs=207.9
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 737 (998)
.++|++++.||+|+||.||++.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 478999999999999999999999999999999987542 2334456777899999999999999999998644
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
..+|+||||++ ++|.+.+.. .++...+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 35799999995 566666643 3888999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 174 ~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 174 CTN----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccC----------------------------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 110 0112346899999999999999999999999999999999999999887
Q ss_pred ChHHHHHHHHh----------------------CCCCC--------------CC----CCCCcHHHHHHHHHccccCccC
Q 001902 898 TRQKTFANILH----------------------KDLKF--------------PS----STPTSLHAKQLMYRLLHRDPKS 937 (998)
Q Consensus 898 ~~~~~~~~i~~----------------------~~~~~--------------~~----~~~~s~~l~~Ll~~~L~~dP~~ 937 (998)
+....+..+.. ....+ +. ....+..+.+||.+||+.||.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 305 (359)
T cd07876 226 DHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDK 305 (359)
T ss_pred CHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCccc
Confidence 65443332221 11010 00 0123567899999999999999
Q ss_pred cCCChhcHHHHHcCCCccC
Q 001902 938 RLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 938 Rpt~~~~a~elL~Hp~f~~ 956 (998)
||| +.++|+||||+.
T Consensus 306 R~t----~~e~l~hp~~~~ 320 (359)
T cd07876 306 RIS----VDEALRHPYITV 320 (359)
T ss_pred CCC----HHHHhcCchhhh
Confidence 999 999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=336.08 Aligned_cols=293 Identities=36% Similarity=0.706 Sum_probs=250.6
Q ss_pred cccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEee
Q 001902 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT 736 (998)
Q Consensus 658 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 736 (998)
+.+.+.+++|.+++.||+|+|++|.++++++|.+.||+|++++....+.+.+.-.+.|..+..+. +||.+|-++.+|++
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 34567789999999999999999999999999999999999999888888888888999998887 79999999999999
Q ss_pred CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
+..+++|.||++||+|.-.++++ ..+++++++.+...|+.||.|||++|||.||||.+|+|++..|++||.|+|+++.
T Consensus 323 esrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred cceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999999998888776 4599999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.- .+-...++++|||.|.|||.+.+..|...+|.|+||++++||+.|+.||.-
T Consensus 401 ~l---------------------------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 401 GL---------------------------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CC---------------------------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 21 122456789999999999999999999999999999999999999999941
Q ss_pred -------CC-hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh--cHHHHHcCCCccCCChhhhhcCC
Q 001902 897 -------KT-RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFFKGVNWALVRCMN 966 (998)
Q Consensus 897 -------~~-~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~--~a~elL~Hp~f~~~~~~~~~~~~ 966 (998)
.+ ..-.+.-|+...+..|.. +|-.+-.+++..|++||.+|+..+. +..++..|+||+.++|.+++
T Consensus 454 vgm~n~d~ntedylfqvilekqiriprs--lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~le--- 528 (593)
T KOG0695|consen 454 VGMDNPDMNTEDYLFQVILEKQIRIPRS--LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLE--- 528 (593)
T ss_pred ecCCCcccchhHHHHHHHhhhcccccce--eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHh---
Confidence 12 223344556666666654 4556678999999999999998763 58899999999999999984
Q ss_pred CCCCCCCCCCCcccccccc
Q 001902 967 PPELDAPLFATDTEKEYKV 985 (998)
Q Consensus 967 ~~~~~~p~~~~~~~~~~~~ 985 (998)
.+..+|-|+..+..||..
T Consensus 529 -qk~v~ppf~p~i~~d~~l 546 (593)
T KOG0695|consen 529 -QKQVLPPFQPQITDDYGL 546 (593)
T ss_pred -hcccCCCCCCccccccCc
Confidence 344555555555555543
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=363.63 Aligned_cols=255 Identities=25% Similarity=0.460 Sum_probs=210.5
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 737 (998)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 578999999999999999999999999999999987543 2333456678899999999999999999987543
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
..+|+||||++ ++|.+.+.. .++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 36799999995 577777743 3888999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 177 ~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 177 GTS----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CCC----------------------------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 210 0112346899999999999999999999999999999999999999988
Q ss_pred ChHHHHHHHHhCCC----------------------C--------------CCC----CCCCcHHHHHHHHHccccCccC
Q 001902 898 TRQKTFANILHKDL----------------------K--------------FPS----STPTSLHAKQLMYRLLHRDPKS 937 (998)
Q Consensus 898 ~~~~~~~~i~~~~~----------------------~--------------~~~----~~~~s~~l~~Ll~~~L~~dP~~ 937 (998)
+....+..++.... . ++. ....+..+++||.+||+.||.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 308 (364)
T cd07875 229 DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 308 (364)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCccc
Confidence 77666655543100 0 000 0112457889999999999999
Q ss_pred cCCChhcHHHHHcCCCccC
Q 001902 938 RLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 938 Rpt~~~~a~elL~Hp~f~~ 956 (998)
||| +.++|+||||..
T Consensus 309 R~t----~~e~L~hp~~~~ 323 (364)
T cd07875 309 RIS----VDEALQHPYINV 323 (364)
T ss_pred CCC----HHHHhcCccccc
Confidence 999 999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=363.93 Aligned_cols=261 Identities=27% Similarity=0.416 Sum_probs=214.4
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC-----eE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-----HV 740 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-----~~ 740 (998)
+|++.+.||+|+||.||++.+..+|+.||+|.+... .........+.+|+.+++.++|+||+++++++...+ .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc-ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 488899999999999999999999999999998653 223344567889999999999999999999998776 89
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 99999994 6788877653 45999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
. ........+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.
T Consensus 157 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 210 (372)
T cd07853 157 E--------------------------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210 (372)
T ss_pred c--------------------------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH
Confidence 0 0111234689999999999874 478899999999999999999999998877
Q ss_pred HHHHHHHHhC-----------------------CCCCC-------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 900 QKTFANILHK-----------------------DLKFP-------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 900 ~~~~~~i~~~-----------------------~~~~~-------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
...+..+... ....+ .....+.++.+||.+||+.||.+||| +.++|
T Consensus 211 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l 286 (372)
T cd07853 211 IQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS----AADAL 286 (372)
T ss_pred HHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC----HHHHh
Confidence 6655544321 11111 11234778999999999999999999 99999
Q ss_pred cCCCccCCChh
Q 001902 950 KHPFFKGVNWA 960 (998)
Q Consensus 950 ~Hp~f~~~~~~ 960 (998)
+||||++..+.
T Consensus 287 ~hp~~~~~~~~ 297 (372)
T cd07853 287 AHPYLDEGRLR 297 (372)
T ss_pred cCHhhCCCcch
Confidence 99999986543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=333.79 Aligned_cols=265 Identities=30% Similarity=0.482 Sum_probs=222.4
Q ss_pred cccc-cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEEEE
Q 001902 667 FRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 667 y~~~-~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
|++. ..||+|+++.|-.+....+|..||||++.+. ......++.+|.+++.++ .|+||++++++|+++..+||||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 4433 5689999999999999999999999999876 344567888999999999 7999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC---cEEEEeccCccccCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g---~vkL~DFG~a~~~~~~~ 821 (998)
|.|.||+|...+.++ ..+++..+..++.+|+.||.|||.+||.||||||+|||..+.. -||||||.+..-+....
T Consensus 156 EKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred ecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 999999999999875 4599999999999999999999999999999999999998654 48999999874321111
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc-----CCCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
... ......-.+.+|+..|||||+.. ...|+.++|.||||+|||-|++|++||.+
T Consensus 234 ~~s--------------------pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 234 DCS--------------------PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred CCC--------------------CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 100 00011234568999999999863 34688899999999999999999999976
Q ss_pred CC---------------hHHHHHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 897 KT---------------RQKTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 897 ~~---------------~~~~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
.- ....+..|..+.+.||+ +..+|.+.++|+..+|..|+.+|.+ +.++++|||++...-
T Consensus 294 ~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rls----a~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 294 HCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS----AAQVLNHPWVQRCAP 369 (463)
T ss_pred ccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh----hhhccCCccccccch
Confidence 32 24667788888888875 5678999999999999999999999 999999999998755
Q ss_pred h
Q 001902 960 A 960 (998)
Q Consensus 960 ~ 960 (998)
.
T Consensus 370 e 370 (463)
T KOG0607|consen 370 E 370 (463)
T ss_pred h
Confidence 4
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=355.17 Aligned_cols=259 Identities=23% Similarity=0.418 Sum_probs=213.3
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|.+++.||+|+||.||++.+..+++.+|+|.++.... ......+.+|+.+++.++|+||+++++++..++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 4689999999999999999999999999999999875432 22234566799999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||++ ++|.+++... ...++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 158 (309)
T cd07872 83 FEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-- 158 (309)
T ss_pred EeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence 99995 5888887654 2458999999999999999999999999999999999999999999999999985422110
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.
T Consensus 159 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 213 (309)
T cd07872 159 -------------------------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213 (309)
T ss_pred -------------------------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 11123457899999999865 4678899999999999999999999988776555
Q ss_pred HHHHHhC-------------------CCCCCC---------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 903 FANILHK-------------------DLKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 903 ~~~i~~~-------------------~~~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
+..+... ...++. ...++.++.+||.+||+.||.+||| +.++|+||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~~ 289 (309)
T cd07872 214 LHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS----AEEAMKHAYF 289 (309)
T ss_pred HHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC----HHHHhcChhh
Confidence 5444321 011111 1235778999999999999999999 9999999999
Q ss_pred cCC
Q 001902 955 KGV 957 (998)
Q Consensus 955 ~~~ 957 (998)
+..
T Consensus 290 ~~~ 292 (309)
T cd07872 290 RSL 292 (309)
T ss_pred hhc
Confidence 975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=333.81 Aligned_cols=254 Identities=27% Similarity=0.441 Sum_probs=216.5
Q ss_pred cCCcccc-cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEee----C
Q 001902 664 LQHFRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT----K 737 (998)
Q Consensus 664 ~~~y~~~-~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~----~ 737 (998)
.++|.+- +.||-|-.|.|..|.++.|++.+|+|++... ....+|.++.-.. .|||||.++++|.+ .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 4667665 5699999999999999999999999987632 4455677765444 79999999999864 4
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec---CCcEEEEeccCc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLS 814 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~---~g~vkL~DFG~a 814 (998)
.++.+|||.|+||.|++.+..++...+++..+..|+.||+.|+.|||+.+|.||||||+|+|++. |..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 57889999999999999999988888999999999999999999999999999999999999985 457999999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
+.... ...-.+.+-||+|.|||++-..+|+..+|+||+|+++|-|++|.+||
T Consensus 212 K~t~~----------------------------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPF 263 (400)
T KOG0604|consen 212 KETQE----------------------------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263 (400)
T ss_pred cccCC----------------------------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcc
Confidence 65321 11224567899999999999999999999999999999999999999
Q ss_pred CCCCh----HHHHHHHHhCCCCCC--CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 895 RGKTR----QKTFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 895 ~~~~~----~~~~~~i~~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
..... ..+..+|..+.+.|| ++...|...+++|+++|..+|.+|+| +.+++.|||+.+.
T Consensus 264 YS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlT----I~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 264 YSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLT----IEEVMDHPWINQY 328 (400)
T ss_pred cccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhee----HHHhhcCchhccc
Confidence 87553 345566666665555 56678999999999999999999999 9999999999873
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=351.75 Aligned_cols=255 Identities=28% Similarity=0.465 Sum_probs=207.0
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC---CCCCccceeEEEee-----C
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQT-----K 737 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l---~h~nIv~l~~~~~~-----~ 737 (998)
+|++++.||+|+||.||+|.+..+++.||+|.++...... .......+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 5889999999999999999999999999999987543222 2223445567666655 79999999998864 3
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
..+++||||++ ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 56899999996 58988887655556899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.
T Consensus 159 ~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 159 SCQ----------------------------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cCc----------------------------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 211 0112346899999999999989999999999999999999999999887
Q ss_pred ChHHHHHHHHhCC-----CCCC--------------------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCC
Q 001902 898 TRQKTFANILHKD-----LKFP--------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 952 (998)
Q Consensus 898 ~~~~~~~~i~~~~-----~~~~--------------------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp 952 (998)
.....+..+.... ..++ ....++..+.+||.+||+.||.+||| +.+++.||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~~~l~hp 286 (288)
T cd07863 211 SEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS----AFRALQHP 286 (288)
T ss_pred CHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC----HHHHhcCC
Confidence 7766655554310 0000 01235667899999999999999999 99999999
Q ss_pred Cc
Q 001902 953 FF 954 (998)
Q Consensus 953 ~f 954 (998)
||
T Consensus 287 ~f 288 (288)
T cd07863 287 FF 288 (288)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=342.93 Aligned_cols=260 Identities=26% Similarity=0.382 Sum_probs=220.6
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeeccccc--ChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 742 (998)
+.|.+.+.||+|++|.||.|.+..+++.||+|.+...... .......+.+|+.++++++||||+++++++.....+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4689999999999999999999999999999998754322 12234577889999999999999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999999999765 4589999999999999999999999999999999999999999999999999854321000
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
.........|+..|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 160 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 215 (263)
T cd06625 160 ------------------------SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA 215 (263)
T ss_pred ------------------------ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH
Confidence 00011234688999999999998899999999999999999999999988777666
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
...+.............+..+.+||.+||..+|.+||| +.++++||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~ll~~~~~ 263 (263)
T cd06625 216 IFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPS----AEELLRHFFV 263 (263)
T ss_pred HHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCC----HHHHhhCCCC
Confidence 66665554443344457889999999999999999999 9999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=361.43 Aligned_cols=256 Identities=25% Similarity=0.465 Sum_probs=209.0
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 737 (998)
.++|++++.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 578999999999999999999999999999999987542 2333456677899999999999999999988643
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
..+|+||||++ ++|.+.+.. .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 35799999995 567666644 3889999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 170 ~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 170 GTS----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred CCc----------------------------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 211 0112346899999999999999999999999999999999999999887
Q ss_pred ChHHHHHHHHhC----------------------CCC-----CC-------------CCCCCcHHHHHHHHHccccCccC
Q 001902 898 TRQKTFANILHK----------------------DLK-----FP-------------SSTPTSLHAKQLMYRLLHRDPKS 937 (998)
Q Consensus 898 ~~~~~~~~i~~~----------------------~~~-----~~-------------~~~~~s~~l~~Ll~~~L~~dP~~ 937 (998)
+....+..++.. ... ++ .....+..+.+||.+||..||.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 301 (355)
T cd07874 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301 (355)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchh
Confidence 765544433221 000 00 00113457889999999999999
Q ss_pred cCCChhcHHHHHcCCCccCC
Q 001902 938 RLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 938 Rpt~~~~a~elL~Hp~f~~~ 957 (998)
||| +.++|+||||...
T Consensus 302 Rps----~~ell~hp~~~~~ 317 (355)
T cd07874 302 RIS----VDEALQHPYINVW 317 (355)
T ss_pred cCC----HHHHhcCcchhcc
Confidence 999 9999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=376.33 Aligned_cols=266 Identities=28% Similarity=0.412 Sum_probs=225.1
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC---
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT--- 738 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~--- 738 (998)
...++|.+.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.++..++|+||++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345799999999999999999999999999999999976533 3445567788999999999999999988775332
Q ss_pred -----eEEEEEecCCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEec
Q 001902 739 -----HVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 811 (998)
Q Consensus 739 -----~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DF 811 (998)
.+++||||+++|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 478999999999999998643 2346899999999999999999999999999999999999999999999999
Q ss_pred cCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCC
Q 001902 812 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 891 (998)
Q Consensus 812 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~ 891 (998)
|++........ .......+||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 188 Gls~~~~~~~~-------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~ 242 (496)
T PTZ00283 188 GFSKMYAATVS-------------------------DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242 (496)
T ss_pred ccCeecccccc-------------------------ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 99865321100 01123457999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 892 TPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 892 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
.||.+.+....+..+...... +....++.++.+|+.+||+.||.+||+ +.++++|||++..-
T Consensus 243 ~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~RPs----~~ell~~p~~~~~~ 304 (496)
T PTZ00283 243 RPFDGENMEEVMHKTLAGRYD-PLPPSISPEMQEIVTALLSSDPKRRPS----SSKLLNMPICKLFI 304 (496)
T ss_pred CCCCCCCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccChhhCcC----HHHHHhCHHHHHhh
Confidence 999998887777777665443 233457889999999999999999999 99999999998753
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=374.53 Aligned_cols=260 Identities=25% Similarity=0.399 Sum_probs=222.6
Q ss_pred CCcccccccCCCCceeEEEEEEccC-CeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGS-GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~-~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
..|.+.+.||+|+||.||+|.+..+ +..+|+|.+... .......+..|+.+++.++||||+++++++...+..|||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 4599999999999999999999877 788999976533 334445677899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 744 TDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
|||++|++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999999887542 23468999999999999999999999999999999999999999999999999986532110
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...
T Consensus 224 ~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~ 278 (478)
T PTZ00267 224 S-------------------------LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE 278 (478)
T ss_pred c-------------------------cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0 012235679999999999999999999999999999999999999999988888
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.+..+..+... +....++..+.+||.+||..||.+||+ +.+++.|+|++.+
T Consensus 279 ~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps----~~~~l~~~~~~~~ 329 (478)
T PTZ00267 279 IMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALRPT----TQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHhCCCC-CCCccCCHHHHHHHHHHhccChhhCcC----HHHHHhCHHHHHH
Confidence 88777766543 223457889999999999999999999 9999999999753
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=327.07 Aligned_cols=258 Identities=27% Similarity=0.432 Sum_probs=219.5
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~l 742 (998)
.++.+.+..||.|+.|.|++++.+.+|...|||.+.+. .+.+..++++..+.++.+. ++|+||+++++|..+..++|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 45667788899999999999999999999999999864 3566677888888777665 59999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
.||.| +..+..++++. .+++++..+-++..-++.||.||..+ ||||||+||+|||+|..|++||||||++..+..
T Consensus 169 cMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd-- 244 (391)
T KOG0983|consen 169 CMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD-- 244 (391)
T ss_pred HHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec--
Confidence 99999 77777777665 35699999999999999999999865 999999999999999999999999999855431
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc---CCCCCChhHHHHHHHHHHHHHcCCCCCCCC-
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGK- 897 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDIwSlG~il~eLltG~~Pf~~~- 897 (998)
+...+.-.|-+.|||||.+. ...|+.++||||||++++||.||..||.+.
T Consensus 245 --------------------------SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 245 --------------------------SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK 298 (391)
T ss_pred --------------------------ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence 12334456999999999985 457888999999999999999999999985
Q ss_pred ChHHHHHHHHhCCCC-CCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 898 TRQKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
...+.+.++++...+ ++.....|+.+.+|+..||++|+.+||. ..+||+|||+...
T Consensus 299 tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~----Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 299 TDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPK----YNKLLEHPFIKRY 355 (391)
T ss_pred ccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcc----hHHHhcCcceeec
Confidence 446677777765443 4445568999999999999999999999 9999999999874
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=361.84 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=210.6
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 737 (998)
.++|++++.||.|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3689999999999999999999999999999999875422 223345677899999999999999999887533
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
...|++|+++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 4579999999 8899888764 34999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus 169 ~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 169 DD------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred CC------------------------------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 21 1123468999999999977 5688899999999999999999999988
Q ss_pred CChHHHHHHHHhCCC----------------------C-CCC------CCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 897 KTRQKTFANILHKDL----------------------K-FPS------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~----------------------~-~~~------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
.+....+..+..... + .+. ....++.+.+||.+||..||.+||| +.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s----~~e 294 (343)
T cd07878 219 NDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS----ASE 294 (343)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC----HHH
Confidence 766555544432100 0 000 0124566889999999999999999 999
Q ss_pred HHcCCCccCCC
Q 001902 948 IKKHPFFKGVN 958 (998)
Q Consensus 948 lL~Hp~f~~~~ 958 (998)
+|+||||....
T Consensus 295 ll~hp~~~~~~ 305 (343)
T cd07878 295 ALAHPYFSQYH 305 (343)
T ss_pred HhcCcchhccC
Confidence 99999998753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=346.39 Aligned_cols=263 Identities=35% Similarity=0.603 Sum_probs=218.9
Q ss_pred cCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCCch
Q 001902 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 752 (998)
Q Consensus 673 LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 752 (998)
||+|+||.||+|.+..+|+.||+|++.+...........+..|+++++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999865443444455667899999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhh
Q 001902 753 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 832 (998)
Q Consensus 753 ~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 832 (998)
.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~------------ 148 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG------------ 148 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC------------
Confidence 99998765456999999999999999999999999999999999999999999999999987543210
Q ss_pred hcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCC-
Q 001902 833 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDL- 911 (998)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~- 911 (998)
.......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+.....
T Consensus 149 ----------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 212 (277)
T cd05577 149 ----------------KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212 (277)
T ss_pred ----------------CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc
Confidence 011233578899999999888899999999999999999999999977654222222222111
Q ss_pred -CCCCCCCCcHHHHHHHHHccccCccCcCCChh-cHHHHHcCCCccCCChhhhh
Q 001902 912 -KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 912 -~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~ 963 (998)
........+..+.++|.+||..||.+||++.+ .+.++++||||..++|..+.
T Consensus 213 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~ 266 (277)
T cd05577 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLE 266 (277)
T ss_pred ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhh
Confidence 11222346889999999999999999997776 79999999999999997773
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=373.31 Aligned_cols=254 Identities=23% Similarity=0.382 Sum_probs=203.5
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCC------CCccceeEEEee
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH------PFVPALYASFQT 736 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h------~nIv~l~~~~~~ 736 (998)
..++|++++.||+|+||.||+|.+..+++.||||+++... ........|+.+++.+.| .+++.++++|..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3578999999999999999999999999999999986421 122345567777777654 458888888875
Q ss_pred C-CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEecCC----------
Q 001902 737 K-THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNG---------- 804 (998)
Q Consensus 737 ~-~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkP~NILi~~~g---------- 804 (998)
. .++|+||+++ |++|.+++.+. ..+++..++.++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 4 5799999999 88898888764 459999999999999999999998 5999999999999998765
Q ss_pred ------cEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHH
Q 001902 805 ------HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 878 (998)
Q Consensus 805 ------~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIw 878 (998)
.+||+|||.+.... ......+||+.|+|||++.+..++.++|||
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~------------------------------~~~~~~~gt~~Y~APE~~~~~~~~~~~Diw 329 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER------------------------------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMW 329 (467)
T ss_pred cCCCCceEEECCCCccccCc------------------------------cccccccCCccccCcHHhhcCCCCcHHHHH
Confidence 49999999874211 112345799999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCC----------------------------------------CCC
Q 001902 879 ALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPS----------------------------------------STP 918 (998)
Q Consensus 879 SlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~----------------------------------------~~~ 918 (998)
||||++|+|++|++||.+.+..+.+..+......+|. ...
T Consensus 330 SlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (467)
T PTZ00284 330 SMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVI 409 (467)
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhh
Confidence 9999999999999999887765544433221100000 001
Q ss_pred CcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 919 TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 919 ~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.+..+.+||.+||++||.+||| +.++|+||||+..
T Consensus 410 ~~~~~~dli~~mL~~dP~~R~t----a~e~L~Hp~~~~~ 444 (467)
T PTZ00284 410 RDDLLCDLIYGLLHYDRQKRLN----ARQMTTHPYVLKY 444 (467)
T ss_pred chHHHHHHHHHhCCcChhhCCC----HHHHhcCcccccc
Confidence 1345779999999999999999 9999999999874
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=353.83 Aligned_cols=265 Identities=21% Similarity=0.344 Sum_probs=210.7
Q ss_pred cccccCCC--CceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEec
Q 001902 669 PIKPLGSG--DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 746 (998)
Q Consensus 669 ~~~~LG~G--~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 746 (998)
+++.||+| +|++||++.++.+|+.||+|.+..... .......+..|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 789999999999999999999875432 233455677899999999999999999999999999999999
Q ss_pred CCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCC
Q 001902 747 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 826 (998)
Q Consensus 747 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 826 (998)
+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~--- 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR--- 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc---
Confidence 99999999997654456899999999999999999999999999999999999999999999999865332110000
Q ss_pred cchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC--CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 827 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
. ...........++..|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 158 -------------~----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 220 (327)
T cd08227 158 -------------L----RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 220 (327)
T ss_pred -------------c----cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH
Confidence 0 000001123357788999999976 468899999999999999999999998765444333
Q ss_pred HHHhCCCCC--------------------------------------------CCCCCCcHHHHHHHHHccccCccCcCC
Q 001902 905 NILHKDLKF--------------------------------------------PSSTPTSLHAKQLMYRLLHRDPKSRLG 940 (998)
Q Consensus 905 ~i~~~~~~~--------------------------------------------~~~~~~s~~l~~Ll~~~L~~dP~~Rpt 940 (998)
.......+. +.....+..+.+||.+||+.||.+|||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 300 (327)
T cd08227 221 EKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS 300 (327)
T ss_pred HHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCC
Confidence 333221110 011124568899999999999999999
Q ss_pred ChhcHHHHHcCCCccCCC
Q 001902 941 SHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 941 ~~~~a~elL~Hp~f~~~~ 958 (998)
+.++++||||+.++
T Consensus 301 ----~~ell~~p~f~~~~ 314 (327)
T cd08227 301 ----ASTLLNHSFFKQIK 314 (327)
T ss_pred ----HHHHhcChhhhhcc
Confidence 99999999998864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=357.37 Aligned_cols=257 Identities=24% Similarity=0.347 Sum_probs=204.9
Q ss_pred ccccCCcccccccCCCCceeEEEEEEc-----cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASF 734 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~ 734 (998)
++..++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.++..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 455678999999999999999999852 345789999987532 233456788999999999 899999999988
Q ss_pred ee-CCeEEEEEecCCCCchhHHHhhCC-----------------------------------------------------
Q 001902 735 QT-KTHVCLITDYCPGGELFLLLDRQP----------------------------------------------------- 760 (998)
Q Consensus 735 ~~-~~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------- 760 (998)
.. .+.+++||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 65 456899999999999999987531
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhh
Q 001902 761 -------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 833 (998)
Q Consensus 761 -------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~ 833 (998)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~----------- 229 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----------- 229 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc-----------
Confidence 12477888999999999999999999999999999999999999999999999854321110
Q ss_pred cccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCC
Q 001902 834 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLK 912 (998)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~ 912 (998)
........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+......+...+.....
T Consensus 230 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 295 (338)
T cd05102 230 --------------YVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR 295 (338)
T ss_pred --------------hhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC
Confidence 011123356788999999999999999999999999999996 99999886654444444433323
Q ss_pred CCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 913 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 913 ~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
.......+..+.+|+.+||..||.+|||+.++
T Consensus 296 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el 327 (338)
T cd05102 296 MRAPENATPEIYRIMLACWQGDPKERPTFSAL 327 (338)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 33334568899999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.99 Aligned_cols=264 Identities=26% Similarity=0.447 Sum_probs=222.9
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.+.|++++.||.|+||.||++.+..+++.+++|++... +......+..|+.+++.++|+||+++++++..++.+|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 36799999999999999999999999999999998753 444567788899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+++++|..++.... ..+++..+..++.||+.+|.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 88 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--- 163 (292)
T cd06644 88 IEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--- 163 (292)
T ss_pred EecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc---
Confidence 99999999988876542 45899999999999999999999999999999999999999999999999987432100
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc-----CCCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
........+++.|+|||++. ...++.++|||||||++|+|++|.+||...+
T Consensus 164 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 164 ------------------------LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred ------------------------ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 01122446889999999985 3446779999999999999999999998877
Q ss_pred hHHHHHHHHhCCC-CCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhh
Q 001902 899 RQKTFANILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 899 ~~~~~~~i~~~~~-~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
....+..+..... ........+..+.+||.+||..||++||+ +.++++||||..+++...
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~~~~~~ 280 (292)
T cd06644 220 PMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPS----AAQLLEHPFVSSVTSNRP 280 (292)
T ss_pred HHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcC----HHHHhcCccccccccchh
Confidence 6666666554432 22233456788999999999999999999 999999999999888654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=340.63 Aligned_cols=258 Identities=41% Similarity=0.746 Sum_probs=221.2
Q ss_pred cCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCCch
Q 001902 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 752 (998)
Q Consensus 673 LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 752 (998)
||.|++|.||+|.+..+++.|++|++.+...........+.+|+.+++.++||||+++++.+..+..+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999988999999999876555555667889999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhh
Q 001902 753 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 832 (998)
Q Consensus 753 ~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 832 (998)
.+++.+. ..++...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----------- 147 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----------- 147 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----------
Confidence 9999775 348999999999999999999999999999999999999999999999999985432110
Q ss_pred hcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHHHhCC
Q 001902 833 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT--RQKTFANILHKD 910 (998)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~--~~~~~~~i~~~~ 910 (998)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ....+..+....
T Consensus 148 -----------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 210 (262)
T cd05572 148 -----------------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN 210 (262)
T ss_pred -----------------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC
Confidence 1123468899999999988889999999999999999999999998776 566666666432
Q ss_pred CCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChh
Q 001902 911 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWA 960 (998)
Q Consensus 911 ~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~ 960 (998)
.........+..+.+||.+||..+|.+||++. ..+.++++||||+.++|.
T Consensus 211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 22222233478999999999999999999943 458999999999999885
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=348.31 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=214.3
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|.+++.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 5689999999999999999999999999999999875422 22234567899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||++ ++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 83 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 83 FEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred Eeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 99995 6898888664 3458999999999999999999999999999999999999999999999999985422110
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
.......+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.
T Consensus 159 -------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~ 213 (301)
T cd07873 159 -------------------------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213 (301)
T ss_pred -------------------------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 111233578999999998764 578899999999999999999999998776655
Q ss_pred HHHHHhCC-------------------CCCCC---------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 903 FANILHKD-------------------LKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 903 ~~~i~~~~-------------------~~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
...+.... ..++. ...++..+.+||.+||+.||.+||| +.++|+||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~eil~h~~f 289 (301)
T cd07873 214 LHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS----AEEAMKHPYF 289 (301)
T ss_pred HHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC----HHHHhcCccc
Confidence 54433210 01111 1235778899999999999999999 9999999999
Q ss_pred cCCC
Q 001902 955 KGVN 958 (998)
Q Consensus 955 ~~~~ 958 (998)
+.+.
T Consensus 290 ~~~~ 293 (301)
T cd07873 290 HCLG 293 (301)
T ss_pred cccc
Confidence 8864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=336.60 Aligned_cols=256 Identities=25% Similarity=0.445 Sum_probs=218.6
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee-CCeEEEEE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KTHVCLIT 744 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-~~~~~lV~ 744 (998)
+|++++.||.|++|.||++.+..+++.||+|.+..... .......+.+|+.++++++|+|++++++.+.. ...+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999999875432 33345667889999999999999999998864 45789999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|.+++.......+++..++.++.+++.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--- 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--- 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC---
Confidence 99999999999987555668999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...+......
T Consensus 157 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~ 212 (257)
T cd08223 157 ------------------------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212 (257)
T ss_pred ------------------------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 11224468999999999999999999999999999999999999999887766666
Q ss_pred HHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 905 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
.+..+..+. .....+..+.+|+.+||+.||.+||+ +.++++||||
T Consensus 213 ~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~~l~~~~~ 257 (257)
T cd08223 213 RIIEGKLPP-MPKDYSPELGELIATMLSKRPEKRPS----VKSILRQPYI 257 (257)
T ss_pred HHHhcCCCC-CccccCHHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 666654422 22356789999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=336.49 Aligned_cols=256 Identities=28% Similarity=0.445 Sum_probs=221.6
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
+|.+.+.||+|++|.||+|.+..+++.|++|.+..... .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 47888999999999999999999999999999875433 34455678899999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+++++|.+++.......++...+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~---- 155 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT---- 155 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc----
Confidence 9999999999987655679999999999999999999999999999999999999999999999999885432110
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
.......|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......
T Consensus 156 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 212 (256)
T cd08529 156 -----------------------NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212 (256)
T ss_pred -----------------------chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 111234688999999999998899999999999999999999999998887777777
Q ss_pred HHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 906 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
+.....+.. ....+..+.+++.+||+.+|++||+ +.++++|||+
T Consensus 213 ~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~ll~~~~~ 256 (256)
T cd08529 213 IIRGVFPPV-SQMYSQQLAQLIDQCLTKDYRQRPD----TFQLLRNPSL 256 (256)
T ss_pred HHcCCCCCC-ccccCHHHHHHHHHHccCCcccCcC----HHHHhhCCCC
Confidence 666543322 2256788999999999999999999 9999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=341.77 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=210.6
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36889999999999999999999999999999987542 2334467888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|..+. .+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----- 147 (279)
T cd06619 79 EFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----- 147 (279)
T ss_pred ecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc-----
Confidence 999999986542 378889999999999999999999999999999999999999999999999854320
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh-----
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR----- 899 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~----- 899 (998)
.......|+..|+|||++.+..++.++|+|||||++|+|++|..||.....
T Consensus 148 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 203 (279)
T cd06619 148 ------------------------SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL 203 (279)
T ss_pred ------------------------ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc
Confidence 012235789999999999998899999999999999999999999965322
Q ss_pred --HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 900 --QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 900 --~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
......+.............+.++.+|+.+||+.+|.+||+ +.++++||||+..+
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~eil~~~~~~~~~ 260 (279)
T cd06619 204 MPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPA----PENLMDHPFIVQYN 260 (279)
T ss_pred chHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCC----HHHHhcCccccccc
Confidence 12222222222222222346778999999999999999999 99999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.64 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=213.4
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEee------C
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT------K 737 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~------~ 737 (998)
+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+.+|+.++..+ +|+||+++++++.. .
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 56999999999999999999999999999999987532 2235677899999998 79999999999865 3
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
..+|+||||+++++|.+++.......+++..+..++.|++.||+|||+++|+|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999999999999998755566899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc-----CCCCCChhHHHHHHHHHHHHHcCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYT 892 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDIwSlG~il~eLltG~~ 892 (998)
... ........|++.|+|||++. ...++.++|||||||++|+|++|..
T Consensus 162 ~~~---------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~ 214 (272)
T cd06637 162 DRT---------------------------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214 (272)
T ss_pred ccc---------------------------cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 210 01123456899999999986 3457889999999999999999999
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 893 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 893 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
||...........+.............+..+.+|+.+||..||.+||| +.++++||||
T Consensus 215 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~il~~~~~ 272 (272)
T cd06637 215 PLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPT----TEQLMKHPFI 272 (272)
T ss_pred CccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCC----HHHHhhCCCC
Confidence 998766655555444433333333456789999999999999999999 9999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=340.29 Aligned_cols=259 Identities=30% Similarity=0.464 Sum_probs=222.4
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++.+.||.|++|.||++.+..++..+|+|++.... .......+.+|+.+++.++|+||+++++++.....+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47899999999999999999999999999999987542 2334566788999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|.+++... .+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 152 (274)
T cd06609 79 EYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--- 152 (274)
T ss_pred EeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc---
Confidence 999999999998764 58999999999999999999999999999999999999999999999999986543110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...+......
T Consensus 153 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~ 208 (274)
T cd06609 153 ------------------------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF 208 (274)
T ss_pred ------------------------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence 11233468899999999999889999999999999999999999998877666655
Q ss_pred HHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 905 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
.+.....+.......+..+.+++.+||..+|++||| +.++++||||+...-
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt----~~~il~~~~~~~~~~ 259 (274)
T cd06609 209 LIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPS----AKELLKHKFIKKAKK 259 (274)
T ss_pred HhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcC----HHHHhhChhhcCCCc
Confidence 555543332222236788999999999999999999 999999999998644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=360.71 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=211.6
Q ss_pred cCCcccccccCCCCceeEEEEEEc--cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~--~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
..+|.+++.||+|+||.||+|... .+++.|++|.+... ....+|+.+++.++||||+++++++.....+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 457999999999999999999864 35688999987643 23457999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+|||++ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 163 lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 163 MVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999999 57888888543 569999999999999999999999999999999999999999999999999986533111
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh--
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR-- 899 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~-- 899 (998)
. ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 240 ~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~ 294 (392)
T PHA03207 240 D-------------------------TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294 (392)
T ss_pred c-------------------------cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC
Confidence 0 0112345799999999999999999999999999999999999999976532
Q ss_pred -HHHHHHHHhC----CCCC-------------------------CC---CCCCcHHHHHHHHHccccCccCcCCChhcHH
Q 001902 900 -QKTFANILHK----DLKF-------------------------PS---STPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946 (998)
Q Consensus 900 -~~~~~~i~~~----~~~~-------------------------~~---~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 946 (998)
...+..++.. ...+ +. ....+.++.+||.+||..||.+||+ +.
T Consensus 295 ~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps----a~ 370 (392)
T PHA03207 295 SSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS----AQ 370 (392)
T ss_pred cHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC----HH
Confidence 2222222211 0000 10 0123567889999999999999999 99
Q ss_pred HHHcCCCccCCChhhhh
Q 001902 947 EIKKHPFFKGVNWALVR 963 (998)
Q Consensus 947 elL~Hp~f~~~~~~~~~ 963 (998)
++|.||||+...|..+.
T Consensus 371 e~l~~p~f~~~~~~~~~ 387 (392)
T PHA03207 371 DILSLPLFTKEPINLLN 387 (392)
T ss_pred HHhhCchhhccchhhhc
Confidence 99999999998887764
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=342.45 Aligned_cols=254 Identities=39% Similarity=0.636 Sum_probs=211.5
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEec
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 746 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 746 (998)
|++++.||+|+||.||++.+..+++.||+|++....... ........|+.+++.++||||+++++++......++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhccccccccccccccccccccccccccccc
Confidence 788999999999999999999999999999998763322 2222345599999999999999999999999999999999
Q ss_pred CCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCC
Q 001902 747 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 826 (998)
Q Consensus 747 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 826 (998)
+++++|.+++... ..++...+..++.||+.||.+||++||+|+||||+||+++.++.++|+|||.+....
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-------- 149 (260)
T PF00069_consen 80 CPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-------- 149 (260)
T ss_dssp ETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--------
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------
Confidence 9999999999843 458999999999999999999999999999999999999999999999999985421
Q ss_pred cchhhhhcccCCCCcccccccccccccccCCCCcccchhhc-CCCCCChhHHHHHHHHHHHHHcCCCCCCCCC---hHHH
Q 001902 827 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKT---RQKT 902 (998)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~---~~~~ 902 (998)
..........+++.|+|||++. +..++.++||||||+++|+|++|..||.... ....
T Consensus 150 -------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~ 210 (260)
T PF00069_consen 150 -------------------ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI 210 (260)
T ss_dssp -------------------STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH
T ss_pred -------------------ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh
Confidence 0111233457899999999998 7888999999999999999999999999873 3333
Q ss_pred HHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 903 FANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 903 ~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
+............ ....+..+.+||.+||+.||++||+ +.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~----~~~l~~~~~~ 260 (260)
T PF00069_consen 211 IEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPS----AEELLKHPWF 260 (260)
T ss_dssp HHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTT----HHHHHTSGGG
T ss_pred hhhcccccccccccccchhHHHHHHHHHHHccCChhHCcC----HHHHhcCCCC
Confidence 3333332221111 1122478999999999999999999 9999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=342.01 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=209.5
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
+|++++.||+|++|.||+|.+..++..||+|.++.... .......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58899999999999999999999999999999875422 22334567789999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 746 YCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
|++ ++|.+++.... ...+++..++.++.||+.||.|||++||+|+||||+||+++.+|.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 154 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---- 154 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC----
Confidence 996 68888886533 256899999999999999999999999999999999999999999999999998543211
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
........+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.......
T Consensus 155 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~ 211 (285)
T cd07861 155 -----------------------VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL 211 (285)
T ss_pred -----------------------cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 0112233578999999998764 5788999999999999999999999887654443
Q ss_pred HHHHhCCC------------------CC---------CCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 904 ANILHKDL------------------KF---------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 904 ~~i~~~~~------------------~~---------~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
..+..... .+ .....++.++.+||.+||..||.+||| +.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~ll~~~~~ 285 (285)
T cd07861 212 FRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS----AKKALNHPYF 285 (285)
T ss_pred HHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC----HHHHhcCCCC
Confidence 33322100 00 011236788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=345.34 Aligned_cols=256 Identities=27% Similarity=0.421 Sum_probs=213.4
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++..++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 36999999999999999999999999999999987532 3344567888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
||+++++|.+++.+. ..+++..+..++.||+.||.|||+ .+++|+||||+|||++.++.++|+|||++.....
T Consensus 79 ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 152 (308)
T cd06615 79 EHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 152 (308)
T ss_pred eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----
Confidence 999999999999765 458999999999999999999997 5999999999999999999999999998743210
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.....
T Consensus 153 -------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 207 (308)
T cd06615 153 -------------------------SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE 207 (308)
T ss_pred -------------------------cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH
Confidence 0112356899999999998888999999999999999999999999765543322
Q ss_pred HHHHhCC------------------------------------CCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 904 ANILHKD------------------------------------LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 904 ~~i~~~~------------------------------------~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
..+.... .+.......+.++.+|+.+||..+|++||+ +.+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ 283 (308)
T cd06615 208 AMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERAD----LKE 283 (308)
T ss_pred HhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcC----HHH
Confidence 2221110 000001125678999999999999999999 999
Q ss_pred HHcCCCccCC
Q 001902 948 IKKHPFFKGV 957 (998)
Q Consensus 948 lL~Hp~f~~~ 957 (998)
+++||||.+.
T Consensus 284 ll~~~~~~~~ 293 (308)
T cd06615 284 LTKHPFIKRA 293 (308)
T ss_pred HhcChhhhhc
Confidence 9999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=337.20 Aligned_cols=256 Identities=43% Similarity=0.758 Sum_probs=215.6
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHH-HhCCCCCccceeEEEeeCCeEEEEEecCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPALYASFQTKTHVCLITDYCPG 749 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il-~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 749 (998)
+.||.|+||.||+|.+..+++.||+|++.+...........+..|..++ ...+|+||+++++++...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999998765333333334445555544 445899999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
++|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---------- 149 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---------- 149 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----------
Confidence 9999999764 4589999999999999999999999999999999999999999999999998743210
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~ 909 (998)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+....+..+...
T Consensus 150 ---------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 208 (260)
T cd05611 150 ---------------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR 208 (260)
T ss_pred ---------------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 12345888999999998888899999999999999999999999988887777777666
Q ss_pred CCCCCCC--CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChh
Q 001902 910 DLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 960 (998)
Q Consensus 910 ~~~~~~~--~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 960 (998)
...++.. ..++..+.+++.+||..+|++||++.. +.+++.||||+.++|.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~-~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 209 RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANG-YQEIKSHPFFKSINWD 260 (260)
T ss_pred ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCc-HHHHHcChHhhcCCCC
Confidence 5544432 246889999999999999999997322 6899999999999883
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=339.91 Aligned_cols=259 Identities=36% Similarity=0.654 Sum_probs=205.4
Q ss_pred ccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHH---hCCCCCccceeEEEeeCCeEEEEEecCC
Q 001902 672 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD---MLDHPFVPALYASFQTKTHVCLITDYCP 748 (998)
Q Consensus 672 ~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~---~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 748 (998)
.||+|+||.||++.+..+++.+|+|++.+.............+|..+++ ..+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997654433322233344544443 3479999999999999999999999999
Q ss_pred CCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcc
Q 001902 749 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 828 (998)
Q Consensus 749 ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~ 828 (998)
+++|.+++..+ ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-------- 150 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------- 150 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--------
Confidence 99999998765 45999999999999999999999999999999999999999999999999988432200
Q ss_pred hhhhhcccCCCCcccccccccccccccCCCCcccchhhc-CCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHH
Q 001902 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKTR--QKTFAN 905 (998)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~--~~~~~~ 905 (998)
......|++.|+|||.+. +..++.++|||||||++|+|++|..||..... ......
T Consensus 151 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 209 (279)
T cd05633 151 ---------------------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209 (279)
T ss_pred ---------------------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH
Confidence 011235899999999986 45688999999999999999999999976432 122222
Q ss_pred HHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhh
Q 001902 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 906 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~ 962 (998)
... ..........+..+.+||.+||..||.+||+.. ..+.++++||||++++|...
T Consensus 210 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 266 (279)
T cd05633 210 MTL-TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV 266 (279)
T ss_pred Hhh-cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence 111 112222234688999999999999999999311 22899999999999999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=341.31 Aligned_cols=260 Identities=27% Similarity=0.455 Sum_probs=221.4
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||.|+||.||++.+..++..+|+|++... .......+..|+.++++++|+||+++++++......|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 5799999999999999999999889999999998743 3445567888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~---- 156 (280)
T cd06611 82 EFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST---- 156 (280)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc----
Confidence 9999999999987642 45999999999999999999999999999999999999999999999999987442210
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc-----CCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
........|++.|+|||++. ...++.++|||||||++|+|++|.+||...+.
T Consensus 157 -----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~ 213 (280)
T cd06611 157 -----------------------LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213 (280)
T ss_pred -----------------------ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence 01122456899999999985 34467799999999999999999999998877
Q ss_pred HHHHHHHHhCCCC-CCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 900 QKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 900 ~~~~~~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
...+..+.....+ +......+..+.+||.+||+.+|.+||+ +.++++||||.....
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~~~~~~~ 270 (280)
T cd06611 214 MRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPT----AAELLKHPFVSDQSD 270 (280)
T ss_pred HHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcC----HHHHhcChhhcccch
Confidence 7766666654332 2233456789999999999999999999 999999999998644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=337.52 Aligned_cols=265 Identities=45% Similarity=0.827 Sum_probs=225.9
Q ss_pred cCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCCch
Q 001902 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 752 (998)
Q Consensus 673 LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 752 (998)
||.|+||.||++.+..+|+.+++|++.............+.+|+.++++++|+||+++++.+......|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999888999999999766544445667888999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhh
Q 001902 753 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 832 (998)
Q Consensus 753 ~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 832 (998)
.+++.+.. .+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~------- 151 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL------- 151 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc-------
Confidence 99998753 589999999999999999999999999999999999999999999999999854321111000
Q ss_pred hcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCC
Q 001902 833 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 912 (998)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~ 912 (998)
...........++..|+|||.+....++.++||||||+++|+|++|..||........+..+......
T Consensus 152 ------------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 219 (265)
T cd05579 152 ------------NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE 219 (265)
T ss_pred ------------ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcC
Confidence 00011223456888999999998888899999999999999999999999988888888787776666
Q ss_pred CCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 913 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 913 ~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
++.....+..+.+|+.+||+.+|.+|||+.. +.++|+||||+.++|
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~-~~~~l~~~~~~~~~~ 265 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKS-IEEIKNHPFFKGIDW 265 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCcc-HHHHhcCccccCCCC
Confidence 6665556889999999999999999999322 389999999999988
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=378.18 Aligned_cols=265 Identities=25% Similarity=0.388 Sum_probs=218.0
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee--CC
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KT 738 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~ 738 (998)
....++|++++.||.|+||.||+|.+..++..+|+|++..... .......+..|+.+++.++||||++++++|.. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3446799999999999999999999999999999999876533 33445678889999999999999999998854 46
Q ss_pred eEEEEEecCCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCcEEEec-------
Q 001902 739 HVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQ-------GIIYRDLKPENVLLQG------- 802 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~-------~IiHrDLkP~NILi~~------- 802 (998)
.+||||||+++++|.++|... ....+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 799999999999999998752 234699999999999999999999984 4999999999999964
Q ss_pred ----------CCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC--CC
Q 001902 803 ----------NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AG 870 (998)
Q Consensus 803 ----------~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~ 870 (998)
.+.+||+|||++...... ......+||+.|+|||++.+ ..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~----------------------------s~~~s~vGTp~YmAPEvL~ge~~~ 219 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIE----------------------------SMAHSCVGTPYYWSPELLLHETKS 219 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccc----------------------------ccccccCCCccccCHHHHhccCCC
Confidence 235899999998543211 01224579999999999865 45
Q ss_pred CCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 871 HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 871 ~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
++.++||||||||||+|++|..||...+....+...+.....++. ...+..+.+||..||..+|.+||+ +.++|.
T Consensus 220 ~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPS----a~QlL~ 294 (1021)
T PTZ00266 220 YDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPS----ALQCLG 294 (1021)
T ss_pred CCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcC----HHHHhc
Confidence 788999999999999999999999877665555555544333332 346789999999999999999999 999999
Q ss_pred CCCccCCCh
Q 001902 951 HPFFKGVNW 959 (998)
Q Consensus 951 Hp~f~~~~~ 959 (998)
||||+.+..
T Consensus 295 h~~ik~i~~ 303 (1021)
T PTZ00266 295 YQIIKNVGP 303 (1021)
T ss_pred cHHHhhcCC
Confidence 999986543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=342.95 Aligned_cols=245 Identities=18% Similarity=0.203 Sum_probs=208.0
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee----CCeEEEEEec
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----KTHVCLITDY 746 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~----~~~~~lV~E~ 746 (998)
..||+|++|.||++.. +|+.||+|.++............+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6789999999999998 789999999987544444446778899999999999999999999876 4578999999
Q ss_pred CCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 747 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 747 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
+++|+|.+++... ..++......++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----- 176 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----- 176 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----
Confidence 9999999999764 4588899999999999999999985 9999999999999999999999999998543211
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC--CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+
T Consensus 177 -------------------------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~ 231 (283)
T PHA02988 177 -------------------------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY 231 (283)
T ss_pred -------------------------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 112368899999999976 67899999999999999999999999998888888
Q ss_pred HHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 904 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 904 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
..+......++....++..+.+|+.+||+.||.+|||+.+++..+-
T Consensus 232 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~ 277 (283)
T PHA02988 232 DLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277 (283)
T ss_pred HHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 7777665555444467889999999999999999999555444433
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=361.46 Aligned_cols=254 Identities=27% Similarity=0.385 Sum_probs=205.1
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEE
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 742 (998)
...+|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.++++++|+||+++++++...+..|+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 35689999999999999999999999999999996432 235679999999999999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
|||++ .++|.+++.... ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.......
T Consensus 238 v~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 238 VLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 99999 578888886542 3599999999999999999999999999999999999999999999999999865321100
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh---
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR--- 899 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~--- 899 (998)
........||+.|+|||++.+..++.++|||||||+||+|++|..|+.....
T Consensus 316 -------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~ 370 (461)
T PHA03211 316 -------------------------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE 370 (461)
T ss_pred -------------------------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccc
Confidence 0111245799999999999999999999999999999999998766533211
Q ss_pred ----HHHHHHHHh-CCCC---CC-----------------------------CCCCCcHHHHHHHHHccccCccCcCCCh
Q 001902 900 ----QKTFANILH-KDLK---FP-----------------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSH 942 (998)
Q Consensus 900 ----~~~~~~i~~-~~~~---~~-----------------------------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~ 942 (998)
...+.+++. .... ++ .....+..+.+||.+||+.||.+|||
T Consensus 371 ~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs-- 448 (461)
T PHA03211 371 RRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS-- 448 (461)
T ss_pred cCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC--
Confidence 122222222 1110 11 11124557889999999999999999
Q ss_pred hcHHHHHcCCCccC
Q 001902 943 EGANEIKKHPFFKG 956 (998)
Q Consensus 943 ~~a~elL~Hp~f~~ 956 (998)
+.++|+||||+.
T Consensus 449 --a~elL~hp~f~~ 460 (461)
T PHA03211 449 --AAELLRLPLFQS 460 (461)
T ss_pred --HHHHhhCcccCC
Confidence 999999999975
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=339.19 Aligned_cols=256 Identities=26% Similarity=0.433 Sum_probs=217.0
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEec
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 746 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 746 (998)
|++++.||.|+||.||++.+..++..+++|.+... .......+.+|+.+++.++|+||+++++++...+..|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 68899999999999999999999999999998643 334556788899999999999999999999999999999999
Q ss_pred CCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCC
Q 001902 747 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 826 (998)
Q Consensus 747 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 826 (998)
+++++|..++.+. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~------ 156 (282)
T cd06643 84 CAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT------ 156 (282)
T ss_pred cCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc------
Confidence 9999999887653 245899999999999999999999999999999999999999999999999998542210
Q ss_pred cchhhhhcccCCCCcccccccccccccccCCCCcccchhhc-----CCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 827 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
........|++.|+|||++. +..++.++|||||||++|+|++|.+||...+...
T Consensus 157 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~ 215 (282)
T cd06643 157 ---------------------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR 215 (282)
T ss_pred ---------------------ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH
Confidence 01122346899999999984 3456789999999999999999999999887777
Q ss_pred HHHHHHhCCCC-CCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 902 TFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 902 ~~~~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
....+...... .+.....+..+.+||.+||..||.+||+ +.++++||||+..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~ 268 (282)
T cd06643 216 VLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWT----TTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcC----HHHHhcCCCEecc
Confidence 66666554322 2233446789999999999999999999 9999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=337.43 Aligned_cols=254 Identities=26% Similarity=0.438 Sum_probs=213.1
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|.+.+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE---PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 35899999999999999999999999999999998754 223345677899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+++++|.+++... +.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06645 85 MEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--- 159 (267)
T ss_pred EeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc---
Confidence 9999999999998764 45899999999999999999999999999999999999999999999999998543210
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc---CCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
........|++.|+|||++. ...++.++|+|||||++|+|++|..||......
T Consensus 160 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~ 215 (267)
T cd06645 160 ------------------------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred ------------------------ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch
Confidence 01122346899999999984 455788999999999999999999999776654
Q ss_pred HHHHHHHhCCCCCCC---CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCC
Q 001902 901 KTFANILHKDLKFPS---STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~---~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~ 953 (998)
.............+. ...++..+.+|+.+||..+|++||+ +.++++|||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~----~~~ll~~~~ 267 (267)
T cd06645 216 RALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPT----AEKLLQHPF 267 (267)
T ss_pred hhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcC----HHHHhcCCC
Confidence 444444433332222 2245778999999999999999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=338.03 Aligned_cols=260 Identities=35% Similarity=0.640 Sum_probs=209.8
Q ss_pred ccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHH---HHHHhCCCCCccceeEEEeeCCeEEEEEecCC
Q 001902 672 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER---EILDMLDHPFVPALYASFQTKTHVCLITDYCP 748 (998)
Q Consensus 672 ~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~---~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 748 (998)
.||+|+||.||+|.+..+++.||+|++.+..............|. .+++..+||+|+.+++++...+..|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 479999999999999999999999998865433222222233343 34455689999999999999999999999999
Q ss_pred CCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcc
Q 001902 749 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 828 (998)
Q Consensus 749 ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~ 828 (998)
|++|..++... ..+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-------- 150 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------- 150 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--------
Confidence 99999988764 45999999999999999999999999999999999999999999999999998532200
Q ss_pred hhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCC---hHHHHH
Q 001902 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT---RQKTFA 904 (998)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~---~~~~~~ 904 (998)
......|+..|+|||++.+ ..++.++||||+||++|+|++|..||.+.. ......
T Consensus 151 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~ 209 (278)
T cd05606 151 ---------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209 (278)
T ss_pred ---------------------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH
Confidence 1123368999999999975 468899999999999999999999998763 222222
Q ss_pred HHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcC-----CChhcHHHHHcCCCccCCChhhhhcCCCC
Q 001902 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRL-----GSHEGANEIKKHPFFKGVNWALVRCMNPP 968 (998)
Q Consensus 905 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rp-----t~~~~a~elL~Hp~f~~~~~~~~~~~~~~ 968 (998)
.+......++ ...+..+.+++.+||..+|.+|| + +.++++||||+..+|..+.....|
T Consensus 210 ~~~~~~~~~~--~~~s~~~~~li~~~l~~~p~~R~~~~~~~----~~~ll~~~~~~~~~~~~~~~~~~~ 272 (278)
T cd05606 210 MTLTMAVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRG----AQEVKEHPFFRSLDWQMVFLQKYP 272 (278)
T ss_pred HhhccCCCCC--CcCCHHHHHHHHHHhhcCHHhccCCCCCC----HHHHHhCccccCCCchHhhhcccC
Confidence 2222233333 23588999999999999999999 7 999999999999999988555444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=339.74 Aligned_cols=271 Identities=18% Similarity=0.262 Sum_probs=219.0
Q ss_pred ccccCCcccccccCCCCceeEEEEEEcc-----CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 735 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 735 (998)
.+..++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3456789999999999999999997642 35689999876432 2233445778999999999999999999999
Q ss_pred eCCeEEEEEecCCCCchhHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEE
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQP--------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 807 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vk 807 (998)
..+..|+||||+++++|.+++.+.. ...++...+..++.||+.||.|||++||+||||||+|||++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999999997532 12356678899999999999999999999999999999999999999
Q ss_pred EEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHH
Q 001902 808 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 887 (998)
Q Consensus 808 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eL 887 (998)
|+|||++........ ........++..|+|||.+.+..++.++|||||||++|+|
T Consensus 160 L~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el 214 (288)
T cd05061 160 IGDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214 (288)
T ss_pred ECcCCcccccccccc-------------------------ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHH
Confidence 999999854321100 0111223457789999999988899999999999999999
Q ss_pred Hc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc--CCCccCCCh
Q 001902 888 LY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK--HPFFKGVNW 959 (998)
Q Consensus 888 lt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~--Hp~f~~~~~ 959 (998)
++ |..||.+.........+...... +.....+..+.+++.+||+.||.+|||+.++++.+.+ ||||++++|
T Consensus 215 ~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 215 TSLAEQPYQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 98 89999888777766666554322 2223457889999999999999999996666655555 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=299.63 Aligned_cols=259 Identities=24% Similarity=0.428 Sum_probs=219.4
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
..|..+++||+|.||+||++++..+++.||+|.++.+.- +........+|+.+++.++|.|||+++++...+..+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 468888999999999999999999999999999986532 2333456788999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||| ..+|..+...-. +.+..+.++.++.|+++||.|+|++++.||||||.|+||+.+|.+||.|||+++.++.
T Consensus 81 e~c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi----- 153 (292)
T KOG0662|consen 81 EFC-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI----- 153 (292)
T ss_pred HHh-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC-----
Confidence 999 778888876643 4599999999999999999999999999999999999999999999999999976541
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC-CCChhHHHHHHHHHHHHH-cCCCCCCCCChHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEML-YGYTPFRGKTRQKT 902 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDIwSlG~il~eLl-tG~~Pf~~~~~~~~ 902 (998)
+.+-.+..+.|.+|.+|.++.+.+ |++..|+||.|||+.|+. .|.+.|.+.+..++
T Consensus 154 ----------------------pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq 211 (292)
T KOG0662|consen 154 ----------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_pred ----------------------ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH
Confidence 122334557899999999998865 788999999999999999 59999999999999
Q ss_pred HHHHHhCC-----CCCCCC----------------------CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 903 FANILHKD-----LKFPSS----------------------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 903 ~~~i~~~~-----~~~~~~----------------------~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
+++|..-- -.+|.. +.++...++|++++|.-+|.+|++ ++..++||||.
T Consensus 212 lkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qris----aeaalqhpyf~ 287 (292)
T KOG0662|consen 212 LKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS----AEAALQHPYFS 287 (292)
T ss_pred HHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccC----HHHHhcCcccc
Confidence 99887521 111111 112334579999999999999999 99999999998
Q ss_pred CC
Q 001902 956 GV 957 (998)
Q Consensus 956 ~~ 957 (998)
.+
T Consensus 288 d~ 289 (292)
T KOG0662|consen 288 DF 289 (292)
T ss_pred cc
Confidence 75
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=353.71 Aligned_cols=262 Identities=22% Similarity=0.289 Sum_probs=214.9
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
.+.|..+.+.+..+||+|.||+||++++-+ .||||++.... ..++..+.|.+|..++++.+|.||+-+.|++....
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~-pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDD-PTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCC-CCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 445666788899999999999999999955 59999998753 45568899999999999999999999999999888
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
. .||+.+|+|.+|+.+++... ..+.+...+.|++||++|+.|||.++|||||||..||++.++++|||+|||++..-.
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred e-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 7 99999999999999998764 569999999999999999999999999999999999999999999999999984321
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC---CCCCChhHHHHHHHHHHHHHcCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
+.. + ........|...|||||++.. .+|++.+|||||||++|||++|.+||.
T Consensus 540 --------------~w~-g----------~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 540 --------------RWS-G----------EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred --------------eec-c----------ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 110 0 111223358899999999964 578899999999999999999999999
Q ss_pred CCChHHHHHHHHhCCC---CCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 896 GKTRQKTFANILHKDL---KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 896 ~~~~~~~~~~i~~~~~---~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
..+...++..+-++-+ .......++.++++|+..||.+++++||.+.+++..|+.+
T Consensus 595 i~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 595 IQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred CCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 5554444443333311 1112244667899999999999999999988877666555
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=334.70 Aligned_cols=261 Identities=28% Similarity=0.428 Sum_probs=220.4
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++.+.||.|+||.||+|....++..+++|++....... ....+.+|+.+++.++|+||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999987543222 5577889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
||+++++|.+++..... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999976432 56899999999999999999999999999999999999999999999999998554311110
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
.........|+..|+|||++... .++.++|+|||||++|+|++|+.||...+....
T Consensus 159 -----------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~ 215 (267)
T cd06610 159 -----------------------TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV 215 (267)
T ss_pred -----------------------cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh
Confidence 00122345689999999999776 788899999999999999999999988877666
Q ss_pred HHHHHhCCCC-CCCC---CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 903 FANILHKDLK-FPSS---TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 903 ~~~i~~~~~~-~~~~---~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
+..+...... ++.. ...+..+.+|+.+||..||++||+ +.+|++||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~ll~~p~~ 267 (267)
T cd06610 216 LMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT----AEELLKHKFF 267 (267)
T ss_pred HHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcC----HHHHhhCCCC
Confidence 6666554322 1111 246788999999999999999999 9999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=354.59 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=201.0
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
..+|++++.||+|+||.||+|.+..+++.||+|+.... ....|+.+++.++|+||+++++++...+..|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 45799999999999999999999999999999985432 234589999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+ .++|.+++... ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||++......
T Consensus 136 ~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 210 (357)
T PHA03209 136 LPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--- 210 (357)
T ss_pred EEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence 9999 56888888654 346899999999999999999999999999999999999999999999999998432100
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCC-CCCCCChH--
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT-PFRGKTRQ-- 900 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~-Pf~~~~~~-- 900 (998)
.......||+.|+|||++.+..++.++|||||||++|+|+++.. +|......
T Consensus 211 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~ 265 (357)
T PHA03209 211 -------------------------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265 (357)
T ss_pred -------------------------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHH
Confidence 01123569999999999999999999999999999999997544 44332111
Q ss_pred -------HHHHHHHhC----CCCCC----------------------------CCCCCcHHHHHHHHHccccCccCcCCC
Q 001902 901 -------KTFANILHK----DLKFP----------------------------SSTPTSLHAKQLMYRLLHRDPKSRLGS 941 (998)
Q Consensus 901 -------~~~~~i~~~----~~~~~----------------------------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~ 941 (998)
..+..++.. ...++ .....+..+.+||.+||+.||.+|||
T Consensus 266 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpt- 344 (357)
T PHA03209 266 EYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPS- 344 (357)
T ss_pred HHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcC-
Confidence 111111111 00011 01123556778999999999999999
Q ss_pred hhcHHHHHcCCCccCC
Q 001902 942 HEGANEIKKHPFFKGV 957 (998)
Q Consensus 942 ~~~a~elL~Hp~f~~~ 957 (998)
+.++|+||||+.+
T Consensus 345 ---a~e~l~hp~f~~~ 357 (357)
T PHA03209 345 ---AEEILNYPMFAQL 357 (357)
T ss_pred ---HHHHhcCchhccC
Confidence 9999999999863
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=339.01 Aligned_cols=256 Identities=28% Similarity=0.406 Sum_probs=213.0
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEe------e
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ------T 736 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~------~ 736 (998)
.+.|++.+.||.|+||.||+|.+..+++.+|+|++... ......+..|+.+++++ +|+||+++++++. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 35899999999999999999999999999999998643 22345677899999998 7999999999985 3
Q ss_pred CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
.+.+|++|||+++++|.+++.......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 56889999999999999999876556689999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc-----CCCCCChhHHHHHHHHHHHHHcCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGY 891 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDIwSlG~il~eLltG~ 891 (998)
.... ........|++.|+|||.+. ...++.++|||||||++|+|++|.
T Consensus 171 ~~~~---------------------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~ 223 (282)
T cd06636 171 LDRT---------------------------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA 223 (282)
T ss_pred hhcc---------------------------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCC
Confidence 3200 01122356899999999986 346778999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 892 TPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 892 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
.||...........+.............+..+.+||.+||..||.+||+ +.+|++||||
T Consensus 224 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~ell~~~~~ 282 (282)
T cd06636 224 PPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPS----TEQLLKHPFI 282 (282)
T ss_pred CCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcC----HHHHhcCCCC
Confidence 9998776555554444333222233346789999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.34 Aligned_cols=261 Identities=28% Similarity=0.419 Sum_probs=216.3
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccCh------hHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR------NKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~------~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
+|.+...||.|++|.||+|.+..+++.+|+|.+........ .....+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 47788999999999999999988999999998875433221 234567889999999999999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999999765 4589999999999999999999999999999999999999999999999999865431
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
.... ...........|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+.
T Consensus 159 ~~~~---------------------~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 217 (267)
T cd06628 159 NSLS---------------------TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217 (267)
T ss_pred cccc---------------------CCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH
Confidence 1100 0001112235688999999999988899999999999999999999999988766
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
...+..+..... .......+..+.++|.+||+.||.+||+ +.++++||||
T Consensus 218 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~ 267 (267)
T cd06628 218 LQAIFKIGENAS-PEIPSNISSEAIDFLEKTFEIDHNKRPT----AAELLKHPFL 267 (267)
T ss_pred HHHHHHHhccCC-CcCCcccCHHHHHHHHHHccCCchhCcC----HHHHhhCCCC
Confidence 555555444221 1122346788999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.70 Aligned_cols=256 Identities=28% Similarity=0.477 Sum_probs=223.6
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
+|++++.||.|+||.||.+.+..+++.+++|.+..... .......+.+|+.++++++|+||+++++++...+.++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 48999999999999999999999999999999875432 23445677899999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+++++|.+++.+.....+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~---- 155 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY---- 155 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc----
Confidence 9999999999987655668999999999999999999999999999999999999999999999999985432111
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....
T Consensus 156 -----------------------~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08221 156 -----------------------SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK 212 (256)
T ss_pred -----------------------ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 012245689999999999888889999999999999999999999999888888877
Q ss_pred HHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 906 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
+..+.... .....+.++.+++.+||..+|.+||+ +.++++|||+
T Consensus 213 ~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~s----~~~ll~~~~l 256 (256)
T cd08221 213 IVQGNYTP-VVSVYSSELISLVHSLLQQDPEKRPT----ADEVLDQPLL 256 (256)
T ss_pred HHcCCCCC-CccccCHHHHHHHHHHcccCcccCCC----HHHHhhCcCC
Confidence 77665443 23456889999999999999999999 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=343.93 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=193.3
Q ss_pred ccccCCCCceeEEEEEEc--cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee--CCeEEEEEe
Q 001902 670 IKPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVCLITD 745 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~--~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~~lV~E 745 (998)
.++||+|+||.||+|.++ .+++.||+|.+.... ......+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 368999999999999975 467899999986532 12346789999999999999999998853 567899999
Q ss_pred cCCCCchhHHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe----cCCcEEEEeccCc
Q 001902 746 YCPGGELFLLLDRQ-------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLS 814 (998)
Q Consensus 746 ~~~ggsL~~~l~~~-------~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~----~~g~vkL~DFG~a 814 (998)
|+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 99 56888877532 123589999999999999999999999999999999999994 5678999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~P 893 (998)
........ .........||+.|+|||++.+. .++.++|||||||++|+|++|.+|
T Consensus 160 ~~~~~~~~------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 215 (317)
T cd07868 160 RLFNSPLK------------------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred eccCCCCc------------------------cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 65431100 01112345789999999999874 578899999999999999999999
Q ss_pred CCCCCh---------HHHHHHHHhCC-C----------CCC-------------------------CCCCCcHHHHHHHH
Q 001902 894 FRGKTR---------QKTFANILHKD-L----------KFP-------------------------SSTPTSLHAKQLMY 928 (998)
Q Consensus 894 f~~~~~---------~~~~~~i~~~~-~----------~~~-------------------------~~~~~s~~l~~Ll~ 928 (998)
|.+... ...+..+.... . ..+ .....+..+.+||.
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 295 (317)
T cd07868 216 FHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 295 (317)
T ss_pred ccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHH
Confidence 965332 11122221100 0 000 00123456889999
Q ss_pred HccccCccCcCCChhcHHHHHcCCCc
Q 001902 929 RLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 929 ~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
+||+.||.+||| ++++|+||||
T Consensus 296 ~mL~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07868 296 KLLTMDPIKRIT----SEQAMQDPYF 317 (317)
T ss_pred HHhccCcccCCC----HHHHhcCCCC
Confidence 999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=335.50 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=211.9
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++.+.||+|+||.||++.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 468999999999999999999999999999999987432 22345677899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06646 85 MEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--- 159 (267)
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc---
Confidence 9999999999998764 45899999999999999999999999999999999999999999999999998543210
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc---CCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
........|++.|+|||.+. ...++.++|+|||||++|+|++|..||......
T Consensus 160 ------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~ 215 (267)
T cd06646 160 ------------------------IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred ------------------------ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 01122346889999999984 345778999999999999999999999766554
Q ss_pred HHHHHHHhCCCCCC---CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCC
Q 001902 901 KTFANILHKDLKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953 (998)
Q Consensus 901 ~~~~~i~~~~~~~~---~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~ 953 (998)
.....+.......+ .....+..+.+||.+||+.+|++||+ ++++++|+|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~l~ 267 (267)
T cd06646 216 RALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPT----AERLLTHLF 267 (267)
T ss_pred hhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcC----HHHHhcCCC
Confidence 44433333333222 22345788999999999999999999 999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=341.65 Aligned_cols=256 Identities=25% Similarity=0.416 Sum_probs=215.9
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
.+|.+++.||+|+||.||++.+..+++.||+|.+..... .....+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 689999999999999999999999999999999875422 23456788999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--- 169 (297)
T cd06656 96 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (297)
T ss_pred cccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc---
Confidence 99999999999865 348899999999999999999999999999999999999999999999999885432110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+......
T Consensus 170 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~ 225 (297)
T cd06656 170 ------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (297)
T ss_pred ------------------------cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee
Confidence 01123468899999999999889999999999999999999999998766543333
Q ss_pred HHHhC-CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 905 NILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 905 ~i~~~-~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.+... ..........+..+.+|+.+||..+|.+||+ +.++++||||+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~~~~~ 275 (297)
T cd06656 226 LIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGS----AKELLQHPFLKLA 275 (297)
T ss_pred eeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcC----HHHHhcCchhccc
Confidence 22222 1222223446778899999999999999999 9999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=340.12 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=217.0
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
.+|++++.||+|+||.||++.+..+++.|++|.+..... .....+.+|+.+++.++|+||+++++.+......|+||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 589999999999999999999999999999999875432 23466788999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|.+++.. ..++...+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 97 e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--- 170 (296)
T cd06654 97 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 170 (296)
T ss_pred cccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc---
Confidence 99999999999865 347899999999999999999999999999999999999999999999999885432110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+......
T Consensus 171 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~ 226 (296)
T cd06654 171 ------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (296)
T ss_pred ------------------------cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH
Confidence 01123468899999999998888999999999999999999999998877654444
Q ss_pred HHHhCC-CCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 905 NILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 905 ~i~~~~-~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.+.... ...+.....+..+.+|+.+||..+|.+||+ +.++++||||...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~eil~~~~~~~~ 276 (296)
T cd06654 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS----AKELLQHQFLKIA 276 (296)
T ss_pred HHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcC----HHHHhhChhhhcc
Confidence 333322 222233446788999999999999999999 9999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.22 Aligned_cols=256 Identities=25% Similarity=0.490 Sum_probs=221.3
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
+|++++.||.|+||.||++.+..+|+.||+|.+..... .......+.+|+.++++++|+||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999875432 23344678889999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~----- 154 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST----- 154 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc-----
Confidence 999999999997654456899999999999999999999999999999999999999999999999988543210
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......
T Consensus 155 ----------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08218 155 ----------------------VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK 212 (256)
T ss_pred ----------------------hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH
Confidence 0011234588899999999988889999999999999999999999998888777777
Q ss_pred HHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 906 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
+..+... +.....+..+.++|.+||+.+|.+||+ +.++++||||
T Consensus 213 ~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~vl~~~~~ 256 (256)
T cd08218 213 IIRGSYP-PVSSHYSYDLRNLVSQLFKRNPRDRPS----VNSILEKNFI 256 (256)
T ss_pred HhcCCCC-CCcccCCHHHHHHHHHHhhCChhhCcC----HHHHhhCcCC
Confidence 7665543 223456788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.83 Aligned_cols=259 Identities=26% Similarity=0.393 Sum_probs=212.0
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeeccccc--ChhHHHHHHHHHHHHHhCCCCCccceeEEEee--CCeEE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVC 741 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~~ 741 (998)
.|++.+.||+|+||.||+|.+..+++.|++|.+...... .......+.+|+.+++.++||||+++++++.. ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 689999999999999999999999999999998754321 22345678889999999999999999998865 46789
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
++|||+++++|.+++... ..++...++.++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++.......
T Consensus 83 l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 999999999999999764 348999999999999999999999999999999999999999999999999985432100
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
. .........++..|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 161 ~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~ 216 (266)
T cd06651 161 M------------------------SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA 216 (266)
T ss_pred c------------------------cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH
Confidence 0 0001123458899999999998889999999999999999999999998876655
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
....+.............+..+.+|+ +||..+|.+||+ ++++++||||+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~----~~eil~hp~~~ 265 (266)
T cd06651 217 AIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPS----AEELLRHPFAQ 265 (266)
T ss_pred HHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcC----HHHHhcCcccc
Confidence 55544433222111233577888888 677789999999 99999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.41 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=215.2
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeeccccc---ChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML---NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 742 (998)
+|++.+.||.|+||.||+|.. .+++.+|+|.+...... .......+.+|+.+++.++|+||+++++++...+.+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 488899999999999999987 57889999988754221 22334668889999999999999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
||||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999999764 3589999999999999999999999999999999999999999999999998854321100
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
. ...........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+....
T Consensus 158 ~---------------------~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~ 216 (265)
T cd06631 158 H---------------------GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA 216 (265)
T ss_pred c---------------------ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH
Confidence 0 0001112345689999999999998899999999999999999999999988766555
Q ss_pred HHHHHhCCCC-CCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 903 FANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 903 ~~~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
...+...... .+.....+..+.+||.+||..+|.+||+ +.++++||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~~l~~~~~ 265 (265)
T cd06631 217 MFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPS----ALQLLRHDFL 265 (265)
T ss_pred HHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCC----HHHHhcCCCC
Confidence 4444433212 2233456888999999999999999999 9999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=336.14 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=210.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+.+++.++|+||+++++++.....+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999998999999999875421 2223345678999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|..++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (286)
T cd07847 80 EYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--- 154 (286)
T ss_pred eccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc---
Confidence 999998888877553 358999999999999999999999999999999999999999999999999985532110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
.......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+..
T Consensus 155 ------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~ 210 (286)
T cd07847 155 ------------------------DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL 210 (286)
T ss_pred ------------------------ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 01123457889999999876 45788999999999999999999999887765554
Q ss_pred HHHHhCC-------------------CCCCC----------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 904 ANILHKD-------------------LKFPS----------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 904 ~~i~~~~-------------------~~~~~----------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
..+.... ...+. ....+..+.+|+.+||+.+|++||+ +.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~eil~~~~f 286 (286)
T cd07847 211 YLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS----CEELLEHPYF 286 (286)
T ss_pred HHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCC----HHHHhcCCCC
Confidence 4433210 00111 1234678899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=338.44 Aligned_cols=256 Identities=26% Similarity=0.437 Sum_probs=219.3
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
.+|++.+.||.|++|.||++.+..+++.|++|.+.... ......+.+|+.+++.++|+||+++++++...+.+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 47999999999999999999999999999999987532 233467788999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|..++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 169 (296)
T cd06655 96 EYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--- 169 (296)
T ss_pred EecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc---
Confidence 999999999988653 48999999999999999999999999999999999999999999999999875432110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.......|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+......
T Consensus 170 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~ 225 (296)
T cd06655 170 ------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (296)
T ss_pred ------------------------ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 01123468899999999998889999999999999999999999999887766555
Q ss_pred HHHhCCC-CCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 905 NILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 905 ~i~~~~~-~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.+..... .+.....++..+.+||.+||..||.+||+ +.+++.||||+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt----~~~il~~~~~~~~ 275 (296)
T cd06655 226 LIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGS----AKELLQHPFLKLA 275 (296)
T ss_pred HHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCC----HHHHhhChHhhhc
Confidence 5543322 22233456888999999999999999999 9999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=334.86 Aligned_cols=255 Identities=38% Similarity=0.725 Sum_probs=217.7
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++++......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 48899999999999999999998999999999987655454567788999999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+.|++|.+++... ..+++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~----- 153 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD----- 153 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC-----
Confidence 99999999999775 46899999999999999999999999999999999999999999999999988543211
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh--HHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR--QKTF 903 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~--~~~~ 903 (998)
.......|+..|+|||++....++.++|+||||+++|+|++|..||...+. ...+
T Consensus 154 -----------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 210 (258)
T cd05578 154 -----------------------TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210 (258)
T ss_pred -----------------------ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH
Confidence 011234588899999999888899999999999999999999999988764 3333
Q ss_pred HHHHh-CCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 904 ANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 904 ~~i~~-~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
..... .....+ ...+..+.++|.+||..||.+||++. +.++++||||
T Consensus 211 ~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~--~~~l~~~~~~ 258 (258)
T cd05578 211 RAKQETADVLYP--ATWSTEAIDAINKLLERDPQKRLGDN--LKDLKNHPYF 258 (258)
T ss_pred HHHhccccccCc--ccCcHHHHHHHHHHccCChhHcCCcc--HHHHhcCCCC
Confidence 33333 222233 34678999999999999999999932 3999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=347.97 Aligned_cols=247 Identities=26% Similarity=0.427 Sum_probs=215.9
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
.+++..+....++.||+|+-|.||+++. .++.||||.++ +.-..+|+-|++|+|+||+.+.++|....
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~----------elkETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVR----------ELKETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHh----------hhhhhhHHHHHhccCcceeeEeeeecCCc
Confidence 3455556667788999999999999997 57899999765 22345788999999999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
.+|||||||..|.|+.+|+.. ..++...+..|..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||-++...
T Consensus 186 cyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred eeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence 999999999999999999764 568999999999999999999999999999999999999999999999999885533
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
. ....-+++||..|||||++...+.+.|+||||||++||||+||..||..-+
T Consensus 264 ~----------------------------~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 264 D----------------------------KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred h----------------------------hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 1 123346899999999999999999999999999999999999999999988
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
...++.-+-...+.+|-...++..++=||+.||.-.|.+||+ .++||.|
T Consensus 316 ssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPS----Frqil~H 364 (904)
T KOG4721|consen 316 SSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPS----FRQILLH 364 (904)
T ss_pred hheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCcc----HHHHHHH
Confidence 777766665666777777778888999999999999999999 6677777
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=351.99 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=212.2
Q ss_pred ccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCCc
Q 001902 672 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGE 751 (998)
Q Consensus 672 ~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggs 751 (998)
.||+|.||+||-+++..|...+|||.+... +....+-+..||.+.++|+|.|||++++.+..++++-|.||.++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 489999999999999999999999998743 34456678889999999999999999999999999999999999999
Q ss_pred hhHHHhhCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe-cCCcEEEEeccCccccCCCCCCCCCcc
Q 001902 752 LFLLLDRQPTKVL--KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-GNGHVSLTDFDLSCLTSCKPQLLLPTT 828 (998)
Q Consensus 752 L~~~l~~~~~~~l--~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~-~~g~vkL~DFG~a~~~~~~~~~~~~~~ 828 (998)
|.+++.... +++ ++..+..+.+||++||.|||.+.|||||||-+||||+ -.|.+||+|||-++.+.
T Consensus 659 LSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA---------- 727 (1226)
T KOG4279|consen 659 LSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA---------- 727 (1226)
T ss_pred HHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc----------
Confidence 999998764 445 8889999999999999999999999999999999998 47999999999886532
Q ss_pred hhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC--CCCChhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHH
Q 001902 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFRGKTR-QKTFAN 905 (998)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDIwSlG~il~eLltG~~Pf~~~~~-~~~~~~ 905 (998)
.-.....++.||..|||||++..+ +|+.++|||||||++.||.||++||..... ...+.+
T Consensus 728 -----------------ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk 790 (1226)
T KOG4279|consen 728 -----------------GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK 790 (1226)
T ss_pred -----------------cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh
Confidence 112234577899999999999765 588899999999999999999999976543 222222
Q ss_pred HHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 906 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
+--.....|-...+|.+++.||.+|+.++|..||+ |.+||..||++.-
T Consensus 791 VGmyKvHP~iPeelsaeak~FilrcFepd~~~R~s----A~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 791 VGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPS----AKDLLQDPFLQHN 838 (1226)
T ss_pred hcceecCCCCcHHHHHHHHHHHHHHcCCCcccCcc----HHHhccCcccccC
Confidence 22222333444457889999999999999999999 9999999999863
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=339.50 Aligned_cols=255 Identities=23% Similarity=0.422 Sum_probs=205.9
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
+|++++.||.|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++|+||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48899999999999999999999999999999875422 22233556789999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|++ ++|.+++... ...+++..++.++.||++||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~----- 152 (284)
T cd07839 80 YCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP----- 152 (284)
T ss_pred cCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC-----
Confidence 995 5788877654 245999999999999999999999999999999999999999999999999998543211
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCC-CCCChHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF-RGKTRQKTF 903 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf-~~~~~~~~~ 903 (998)
........+++.|+|||++.+. .++.++|||||||++|+|++|..|| .+.+....+
T Consensus 153 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~ 210 (284)
T cd07839 153 ----------------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 210 (284)
T ss_pred ----------------------CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH
Confidence 0111234578899999998774 4688999999999999999988885 444444444
Q ss_pred HHHHhCC--------------CC---CC----------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 904 ANILHKD--------------LK---FP----------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 904 ~~i~~~~--------------~~---~~----------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
..+.... .. ++ ....++.++.+||.+||..||.+||| +.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~il~h~~f 284 (284)
T cd07839 211 KRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS----AEEALQHPYF 284 (284)
T ss_pred HHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCC----HHHHhcCCCC
Confidence 4332210 00 00 11235778899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=333.28 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=216.6
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++.+.||.|++|.||+|.+..+++.+++|.+.... .......+.+|+.+++.++||||+++++.+...+.++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 36889999999999999999999999999999987653 2345567888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
||+++++|.+++.... ..+++..+..++.||+.||+|||+ .|++|+||||+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~--- 154 (265)
T cd06605 79 EYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--- 154 (265)
T ss_pred EecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH---
Confidence 9999999999997653 568999999999999999999999 99999999999999999999999999987432100
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC-----C
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK-----T 898 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~-----~ 898 (998)
......++..|+|||.+.+..++.++|||||||++|+|++|..||... .
T Consensus 155 --------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 208 (265)
T cd06605 155 --------------------------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208 (265)
T ss_pred --------------------------HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc
Confidence 001156888999999999999999999999999999999999999764 2
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.......+.....+.......+..+.+||.+||..||.+||| +.+++.||||+..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~ll~~~~~~~~ 263 (265)
T cd06605 209 IFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPS----YKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcC----HHHHhhCchhhcc
Confidence 233344444432221111226888999999999999999999 9999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=329.71 Aligned_cols=254 Identities=28% Similarity=0.452 Sum_probs=216.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++.+.||.|+||.||+|.+..+++.+++|++... .......+.+|+.+++.++||||+++++++...+.+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE---PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC---chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 5799999999999999999999889999999999754 2235577889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|.+++... ...+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~---- 154 (262)
T cd06613 80 EYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT---- 154 (262)
T ss_pred eCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh----
Confidence 999999999998764 245899999999999999999999999999999999999999999999999988543210
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC---CCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
........++..|+|||.+.+. .++.++|+|||||++|+|++|.+||.+.+...
T Consensus 155 -----------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~ 211 (262)
T cd06613 155 -----------------------IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR 211 (262)
T ss_pred -----------------------hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0112235688999999999776 78889999999999999999999999887666
Q ss_pred HHHHHHhCCCCCCC---CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCC
Q 001902 902 TFANILHKDLKFPS---STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953 (998)
Q Consensus 902 ~~~~i~~~~~~~~~---~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~ 953 (998)
....+....+..+. ....+.++.+|+.+||..+|..||| +.+++.|+|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~il~~~~ 262 (262)
T cd06613 212 ALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT----ATKLLQHPF 262 (262)
T ss_pred HHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCC----HHHHhcCCC
Confidence 66555554332221 2234678999999999999999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=334.27 Aligned_cols=257 Identities=30% Similarity=0.496 Sum_probs=214.0
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
+|++.+.||.|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++|+||+++++++......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58899999999999999999998999999999876532 23345678889999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--- 154 (286)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC---
Confidence 99 999999987643 5699999999999999999999999999999999999999999999999999855431110
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.......|+..|+|||++.+. .++.++|||||||++|+|++|.+||.+......+.
T Consensus 155 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~ 211 (286)
T cd07832 155 -----------------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA 211 (286)
T ss_pred -----------------------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH
Confidence 112234689999999998664 46889999999999999999999998877666555
Q ss_pred HHHhCC-------------------CCCCCC---------CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 905 NILHKD-------------------LKFPSS---------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 905 ~i~~~~-------------------~~~~~~---------~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
.+.... ..++.. ...+..+.+||.+||..+|.+||+ ++++++||||.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~----~~~~l~h~~~~ 286 (286)
T cd07832 212 IVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS----AAEALRHPYFT 286 (286)
T ss_pred HHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC----HHHHhhCcCcC
Confidence 544310 011111 234678899999999999999999 99999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=369.60 Aligned_cols=151 Identities=39% Similarity=0.653 Sum_probs=139.4
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
+++|.+++.||+|+||.||+|.+..+++.||||+++............+..|+.+++.++|+||++++.++...+++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 46899999999999999999999989999999999876555566667888999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
|||+.|++|.+++... ..+++..++.|+.||+.||.|||.+|||||||||+||||+.++.+||+|||+++.
T Consensus 83 mEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 83 MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999999764 4589999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=328.73 Aligned_cols=253 Identities=28% Similarity=0.451 Sum_probs=215.4
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++.+.||.|+||.||++.+..+++.|++|.+.... ....+.+|+.+++.++|+||+++++++.....+|++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 57999999999999999999998889999999987542 2577889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|.+++... ...+++..++.++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--- 153 (256)
T cd06612 78 EYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--- 153 (256)
T ss_pred ecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc---
Confidence 999999999998654 2458999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.......|+..|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 154 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~ 209 (256)
T cd06612 154 ------------------------AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF 209 (256)
T ss_pred ------------------------cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh
Confidence 01223458889999999999899999999999999999999999998776654443
Q ss_pred HHHhCCC-CCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 905 NILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 905 ~i~~~~~-~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
.+..... .+......+..+.+||.+||..||.+||| +.++|.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~~il~~~~~ 256 (256)
T cd06612 210 MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPS----AIQLLQHPFI 256 (256)
T ss_pred hhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcC----HHHHhcCCCC
Confidence 3332211 12222345678999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=327.74 Aligned_cols=255 Identities=28% Similarity=0.476 Sum_probs=219.2
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
+|++.+.||+|+||.||+|.+..+++.+|+|.+..... .......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 48899999999999999999999999999999876533 33446778899999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC-CcEEEEeccCccccCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~-g~vkL~DFG~a~~~~~~~~~~ 824 (998)
|+++++|.+++.......+++..+..++.+++.+|.|||++||+|+||+|+||+++.+ +.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---- 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---- 155 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC----
Confidence 9999999999987655668999999999999999999999999999999999999855 46899999998543211
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.......|+..|+|||.+.+..++.++||||||+++|+|++|..||.+.+......
T Consensus 156 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 211 (256)
T cd08220 156 ------------------------SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211 (256)
T ss_pred ------------------------ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence 01123468899999999998888999999999999999999999999887776666
Q ss_pred HHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 905 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
.+...... +.....+..+.+++.+||..+|.+||| +.++++||||
T Consensus 212 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~ll~~p~~ 256 (256)
T cd08220 212 KIMSGTFA-PISDRYSPDLRQLILSMLNLDPSKRPQ----LSQIMAQPIC 256 (256)
T ss_pred HHHhcCCC-CCCCCcCHHHHHHHHHHccCChhhCCC----HHHHhhCCCC
Confidence 66554332 223346889999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=331.04 Aligned_cols=252 Identities=18% Similarity=0.262 Sum_probs=208.8
Q ss_pred cccCCcccccccCCCCceeEEEEEEc---cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
+...+|++.+.||+|+||.||++.+. ..+..+|+|.++... .......+.+|+.++++++||||+++++++...+
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 34567999999999999999999875 446789999987542 2334567889999999999999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
..|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.++|+|||.+....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999999997653 458999999999999999999999999999999999999999999999999764321
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~ 897 (998)
... ........++..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 159 ~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 159 SEA--------------------------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred ccc--------------------------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 000 001112345678999999999999999999999999999775 99999988
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 898 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
+....+..+... ...+....++..+.+++.+||..+|.+||++.+
T Consensus 213 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~ 257 (266)
T cd05064 213 SGQDVIKAVEDG-FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQ 257 (266)
T ss_pred CHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence 877776666544 333444557888999999999999999999433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=329.47 Aligned_cols=260 Identities=25% Similarity=0.367 Sum_probs=213.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccc--cChhHHHHHHHHHHHHHhCCCCCccceeEEEee--CCeE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHV 740 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~ 740 (998)
.+|++.+.||+|+||.||++.+..+++.||+|.+..... ........+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 479999999999999999999999999999998864321 123345678889999999999999999998875 3578
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 8999999999999998764 34889999999999999999999999999999999999999999999999988543210
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
.. .........|+..|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 160 ~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 215 (265)
T cd06652 160 CL------------------------SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM 215 (265)
T ss_pred cc------------------------cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH
Confidence 00 001122346899999999998888999999999999999999999999887666
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
..+..+.............+..+.++|.+|+. +|.+||+ ++++++|||+.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~----~~~il~~~~~~ 265 (265)
T cd06652 216 AAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPS----ADELLRHTFVH 265 (265)
T ss_pred HHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCC----HHHHhcCcccC
Confidence 55555443322222223456788999999995 9999999 99999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=336.07 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=210.9
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
.|++++.||.|++|.||+|.+..+++.||+|.+..... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48899999999999999999999999999998875432 22234567889999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+. ++|..++.......+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~---- 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---- 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc----
Confidence 995 689988876655679999999999999999999999999999999999999999999999999885432110
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC-CCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+......
T Consensus 155 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~ 211 (284)
T cd07860 155 -----------------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 211 (284)
T ss_pred -----------------------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 0112335788999999987654 5789999999999999999999998876655444
Q ss_pred HHHhCCC------------------CCCC---------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 905 NILHKDL------------------KFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 905 ~i~~~~~------------------~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
++..... .++. ...++.++.++|.+||+.||.+||| +.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~f 284 (284)
T cd07860 212 RIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS----AKAALAHPFF 284 (284)
T ss_pred HHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCC----HHHHhcCCCC
Confidence 4332100 0010 1235778899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=338.13 Aligned_cols=255 Identities=27% Similarity=0.466 Sum_probs=215.5
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
.|.....||.|+||.||++.+..++..||+|.+... .......+.+|+.+++.++|+||+++++.+...+..|+|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 456667899999999999999889999999988643 23345667889999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 100 ~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----- 171 (292)
T cd06658 100 FLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE----- 171 (292)
T ss_pred CCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc-----
Confidence 9999999998854 34899999999999999999999999999999999999999999999999988432210
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
........|++.|+|||++.+..++.++||||||+++|+|++|+.||...+....+..
T Consensus 172 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~ 229 (292)
T cd06658 172 ----------------------VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR 229 (292)
T ss_pred ----------------------cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0111234689999999999888899999999999999999999999988776665555
Q ss_pred HHhC-CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 906 ILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 906 i~~~-~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
+... ....+.....+..+.+|+.+||..||.+||| +.++++||||...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~il~~~~~~~~ 278 (292)
T cd06658 230 IRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT----AQELLQHPFLKLA 278 (292)
T ss_pred HHhcCCCccccccccCHHHHHHHHHHccCChhHCcC----HHHHhhChhhhcc
Confidence 4432 1222333456788999999999999999999 9999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=335.01 Aligned_cols=259 Identities=25% Similarity=0.426 Sum_probs=216.8
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+..++|++++.||+|+||.||++.+..+|+.||+|++.... .......+.+|+++++.++||||+++++++...+.+|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 34578999999999999999999999899999999887542 2344577889999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
+||||+++++|.+++... +.+++..++.++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~- 156 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN- 156 (284)
T ss_pred EEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh-
Confidence 999999999999998764 458999999999999999999997 5999999999999999999999999998743210
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 157 ----------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 208 (284)
T cd06620 157 ----------------------------SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNID 208 (284)
T ss_pred ----------------------------hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchh
Confidence 0112346899999999998888999999999999999999999999865432
Q ss_pred -----------HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 901 -----------KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 901 -----------~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.....+.....+.......+.++.+|+.+||..||.+||+ +.++++|+||...
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt----~~e~~~~~~~~~~ 272 (284)
T cd06620 209 DDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPT----PQQLCAMPPFIQA 272 (284)
T ss_pred hhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcC----HHHHhcCcccccc
Confidence 2233333332222122236678999999999999999999 9999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=333.74 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=214.0
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCC-----eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 736 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-----~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 736 (998)
+..++|++++.||+|+||.||+|.+...+ ..+++|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 34568999999999999999999986554 789999887432 33445678899999999999999999999999
Q ss_pred CCeEEEEEecCCCCchhHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQPT--------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 802 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~ 802 (998)
....|++|||+++++|.+++..... ..++...+..++.||+.||.|||++|++|+||||+||+++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 9999999999999999999975421 45788999999999999999999999999999999999999
Q ss_pred CCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHH
Q 001902 803 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 882 (998)
Q Consensus 803 ~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~ 882 (998)
++.++|+|||++........ ........+++.|+|||.+.+..++.++|||||||
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~ 214 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADY-------------------------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGV 214 (283)
T ss_pred CCcEEECCCcceeecccccc-------------------------ccccCCCcccccccCHHHhccCcCchhhhHHHHHH
Confidence 99999999999854321100 01112335688999999998888999999999999
Q ss_pred HHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 883 LLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 883 il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
++|+|++ |..||.+.+..+....+..... .+....++.++.+|+.+||+.||.+||+ +.+++++
T Consensus 215 il~el~~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05048 215 VLWEIFSYGLQPYYGFSNQEVIEMIRSRQL-LPCPEDCPARVYALMIECWNEIPARRPR----FKDIHTR 279 (283)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-CCCcccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 9999997 9999999888777666655433 2334567899999999999999999999 6666654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=331.21 Aligned_cols=261 Identities=23% Similarity=0.382 Sum_probs=213.4
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccC---hhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN---RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 742 (998)
+|+..+.||+|++|.||++.+..+++.+|+|++....... ......+..|+.+++.++|+||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999999999999999987543211 2245678899999999999999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC-cEEEEeccCccccCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g-~vkL~DFG~a~~~~~~~ 821 (998)
||||+++++|.+++.+. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999999764 4589999999999999999999999999999999999998776 59999999985543110
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
...........|+..|+|||.+.+..++.++|+|||||++|+|++|..||.......
T Consensus 159 -----------------------~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 215 (268)
T cd06630 159 -----------------------TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215 (268)
T ss_pred -----------------------ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Confidence 000111234568999999999988889999999999999999999999997654332
Q ss_pred HHHHH---HhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 902 TFANI---LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 902 ~~~~i---~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
....+ .............+..+.+++.+||..+|.+||+ +.++++||||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~ll~~~~~~ 268 (268)
T cd06630 216 HLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPP----SRELLKHPVFR 268 (268)
T ss_pred hHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcC----HHHHhcCcccC
Confidence 22222 2222222222346788999999999999999999 99999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=350.29 Aligned_cols=256 Identities=22% Similarity=0.318 Sum_probs=207.6
Q ss_pred cccCCcccccccCCCCceeEEEEEEccC-----CeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEe
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ 735 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~ 735 (998)
+..++|++.+.||+|+||.||+|.+..+ +..||+|+++... .......+.+|+.+++.+ +|+||+++++++.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3456899999999999999999987544 3579999997543 223456678899999999 8999999999999
Q ss_pred eCCeEEEEEecCCCCchhHHHhhCC-------------------------------------------------------
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQP------------------------------------------------------- 760 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~~------------------------------------------------------- 760 (998)
..+.+|+|||||++|+|.+++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999999886421
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCc
Q 001902 761 -------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 827 (998)
Q Consensus 761 -------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~ 827 (998)
...++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~----- 267 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----- 267 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-----
Confidence 12478888999999999999999999999999999999999999999999999854321100
Q ss_pred chhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 001902 828 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANI 906 (998)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i 906 (998)
........+++.|||||++.+..++.++|||||||++|+|++ |..||........+..+
T Consensus 268 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~ 327 (374)
T cd05106 268 --------------------YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327 (374)
T ss_pred --------------------eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH
Confidence 011122345678999999998899999999999999999997 99999887665555555
Q ss_pred HhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 907 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 907 ~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
.......+.....+.++.+++.+||+.||.+||++.++
T Consensus 328 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l 365 (374)
T cd05106 328 VKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365 (374)
T ss_pred HHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 55544444444568899999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=362.60 Aligned_cols=262 Identities=29% Similarity=0.403 Sum_probs=215.4
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeE-EEee---
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYA-SFQT--- 736 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~-~~~~--- 736 (998)
+...++++.+.|.+|||+.||+|.+...|..||+|.+-. .+....+.+.+|+++|++|. |+|||.+++ ....
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 445678899999999999999999988889999998763 37777888999999999995 999999999 3321
Q ss_pred C---CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEecCCcEEEEec
Q 001902 737 K---THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDF 811 (998)
Q Consensus 737 ~---~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkP~NILi~~~g~vkL~DF 811 (998)
+ -.+.|+||||.||.|-++|..+....|++.++.+|+.++++||++||... |||||||-+||||+.+|+.|||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 1 25789999999999999998654555999999999999999999999997 999999999999999999999999
Q ss_pred cCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhh---cCCCCCChhHHHHHHHHHHHHH
Q 001902 812 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII---AGAGHTSAVDWWALGILLYEML 888 (998)
Q Consensus 812 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l---~~~~~~~~sDIwSlG~il~eLl 888 (998)
|.++.....+. ...+. .-........-|+.|+|||++ .+.+.+.|+|||+|||+||-|+
T Consensus 191 GSatt~~~~~~----~~~e~--------------~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLC 252 (738)
T KOG1989|consen 191 GSATTKILSPT----SAQEV--------------NYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLC 252 (738)
T ss_pred cccccccCCCc----cHHHH--------------HHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHH
Confidence 99854321110 00000 000111223579999999998 5678899999999999999999
Q ss_pred cCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHH
Q 001902 889 YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948 (998)
Q Consensus 889 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 948 (998)
+...||.+... -.|+.+.+.+|.....+..+.+||..||+.||.+||++-++..++
T Consensus 253 y~t~PFe~sg~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 253 YFTTPFEESGK----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred HhCCCcCcCcc----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 99999987643 357788999999999999999999999999999999965554443
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=327.00 Aligned_cols=252 Identities=26% Similarity=0.476 Sum_probs=216.1
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
+|++.+.||.|+||.||++.+..+++.||+|.+.... .....+.+.+|+.+++.++|+||+++++.+...+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5889999999999999999999999999999986432 23345677889999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+++++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~----- 153 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP----- 153 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-----
Confidence 999999999987655566899999999999999999999999999999999999999999999999988543211
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 154 ----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~ 211 (255)
T cd08219 154 ----------------------GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK 211 (255)
T ss_pred ----------------------ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH
Confidence 0112235689999999999998899999999999999999999999998887777766
Q ss_pred HHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 906 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
+....... .....+..+.+||.+||..||.+||+ +.+++.-
T Consensus 212 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~ 252 (255)
T cd08219 212 VCQGSYKP-LPSHYSYELRSLIKQMFKRNPRSRPS----ATTILSR 252 (255)
T ss_pred HhcCCCCC-CCcccCHHHHHHHHHHHhCCcccCCC----HHHHhhc
Confidence 66554332 23346788999999999999999999 7777653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=337.42 Aligned_cols=263 Identities=29% Similarity=0.388 Sum_probs=213.8
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC--CeE
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THV 740 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~ 740 (998)
..++|++.+.||.|+||.||+|.+..+|+.||+|.++..... ........+|+.++++++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 457899999999999999999999999999999998754321 12223456799999999999999999998754 578
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999995 58888887542 45899999999999999999999999999999999999999999999999998554311
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
. .......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+.
T Consensus 162 ~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 162 A---------------------------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred c---------------------------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 0 01112245788999999866 5578899999999999999999999998888
Q ss_pred HHHHHHHHhCC-------------------CCCCC---------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 900 QKTFANILHKD-------------------LKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 900 ~~~~~~i~~~~-------------------~~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
...+..+.... ...+. ....+..+.+||.+||+.||.+||| +.+++.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~~il~h 290 (309)
T cd07845 215 IEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT----AEEALES 290 (309)
T ss_pred HHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC----HHHHhcC
Confidence 77776665421 00110 0124778899999999999999999 9999999
Q ss_pred CCccCCCh
Q 001902 952 PFFKGVNW 959 (998)
Q Consensus 952 p~f~~~~~ 959 (998)
|||+....
T Consensus 291 ~~f~~~~~ 298 (309)
T cd07845 291 SYFKEKPL 298 (309)
T ss_pred hhhccCCC
Confidence 99986433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=334.13 Aligned_cols=258 Identities=29% Similarity=0.449 Sum_probs=213.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||++.+..+++.||+|.++.. ........+.+|+.++++++|+||+++++++...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 4689999999999999999999989999999988753 23344567889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 745 DYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 745 E~~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
||+++++|..++... ....+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 999999999988753 12368999999999999999999997 5999999999999999999999999998843210
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC------CCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA------GHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.......|++.|+|||.+.+. .++.++|||||||++|+|++|..||..
T Consensus 156 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 156 --------------------------SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred --------------------------CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 011234588899999998554 347799999999999999999999977
Q ss_pred CChHHHHHH---HHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 897 KTRQKTFAN---ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 897 ~~~~~~~~~---i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
......... +.... ........+.++.+||.+||..+|.+||+ +.++++||||....
T Consensus 210 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~l~~~~~~~~~~ 269 (286)
T cd06622 210 ETYANIFAQLSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPT----YAQLLEHPWLVKYK 269 (286)
T ss_pred cchhhHHHHHHHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCC----HHHHhcChhhhhcc
Confidence 655443332 22222 12222347889999999999999999999 99999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=348.83 Aligned_cols=258 Identities=22% Similarity=0.323 Sum_probs=208.0
Q ss_pred cccCCcccccccCCCCceeEEEEEE-----ccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEe
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ 735 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~ 735 (998)
+..++|++.+.||+|+||.||+|.+ ..++..||+|+++... .......+.+|+.+++.+ +||||+++++++.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 3456899999999999999999974 3457789999987542 223446788899999999 8999999999999
Q ss_pred eCCeEEEEEecCCCCchhHHHhhCC-------------------------------------------------------
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQP------------------------------------------------------- 760 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~~------------------------------------------------------- 760 (998)
..+..++|||||++|+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999999986431
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 761 ------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 761 ------------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 12477888999999999999999999999999999999999999999999999854321110
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHH
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK 901 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~ 901 (998)
........++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 270 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~ 324 (375)
T cd05104 270 -------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324 (375)
T ss_pred -------------------------ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH
Confidence 001122345678999999999999999999999999999997 999998776555
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
.+...+............+.++.+|+.+||+.||++||+ +.++++
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~eil~ 369 (375)
T cd05104 325 KFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPT----FKQIVQ 369 (375)
T ss_pred HHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcC----HHHHHH
Confidence 555555544333333445789999999999999999999 555543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=343.93 Aligned_cols=255 Identities=26% Similarity=0.489 Sum_probs=209.3
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 737 (998)
.++|++++.||+|+||.||+|.+..+++.||+|.+.+.. ........+.+|+.++++++|+||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 478999999999999999999999999999999986532 2333445677899999999999999999988643
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
..+|+||||+ +++|.+.+... ++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 94 ~~~~lv~e~~-~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred CcEEEEEecc-CCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 3579999999 56888887653 889999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
... .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 169 ~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 169 GTS----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred CCC----------------------------CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 211 0112345889999999999999999999999999999999999999887
Q ss_pred ChHHHHHHHHhCCC------------------------------------CCCC-----CCCCcHHHHHHHHHccccCcc
Q 001902 898 TRQKTFANILHKDL------------------------------------KFPS-----STPTSLHAKQLMYRLLHRDPK 936 (998)
Q Consensus 898 ~~~~~~~~i~~~~~------------------------------------~~~~-----~~~~s~~l~~Ll~~~L~~dP~ 936 (998)
+....+..+..... .++. ....+..+.+||.+||+.||+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 300 (353)
T cd07850 221 DHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPE 300 (353)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChh
Confidence 76554444432100 0000 112355688999999999999
Q ss_pred CcCCChhcHHHHHcCCCccC
Q 001902 937 SRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 937 ~Rpt~~~~a~elL~Hp~f~~ 956 (998)
+||| +.++|+||||+.
T Consensus 301 ~R~t----~~eiL~~~~~~~ 316 (353)
T cd07850 301 KRIS----VDDALQHPYINV 316 (353)
T ss_pred hCcC----HHHHhcChhHhh
Confidence 9999 999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=330.59 Aligned_cols=256 Identities=29% Similarity=0.438 Sum_probs=212.6
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCC----
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT---- 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~---- 738 (998)
.++|++.+.||.|++|.||+|.+..+++.+++|++.... .....+.+|+.+++++ +|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 468999999999999999999999899999999987542 2345688899999999 7999999999997544
Q ss_pred --eEEEEEecCCCCchhHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCc
Q 001902 739 --HVCLITDYCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814 (998)
Q Consensus 739 --~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a 814 (998)
.+|+||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 5899999999999999987532 456899999999999999999999999999999999999999999999999988
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-----CCCCChhHHHHHHHHHHHHHc
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLY 889 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDIwSlG~il~eLlt 889 (998)
...... ........|++.|+|||++.. ..++.++|||||||++|+|++
T Consensus 161 ~~~~~~---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~ 213 (275)
T cd06608 161 AQLDST---------------------------LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD 213 (275)
T ss_pred eecccc---------------------------hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHh
Confidence 543210 011223468999999999854 346778999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhCCCC-CCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 890 GYTPFRGKTRQKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 890 G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
|..||...........+...... .......+..+.+||.+||..||++||| +.++++|||+
T Consensus 214 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt----~~~ll~~~~~ 275 (275)
T cd06608 214 GKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPF----MEELLEHPFI 275 (275)
T ss_pred CCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcC----HHHHhcCCCC
Confidence 99999877666666665554322 2222235778999999999999999999 9999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=335.76 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=203.7
Q ss_pred cCCcccccccCCCCceeEEEEEEcc----------------CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCc
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCG----------------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 727 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~----------------~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nI 727 (998)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++.+++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 4689999999999999999998632 34579999987542 33445678899999999999999
Q ss_pred cceeEEEeeCCeEEEEEecCCCCchhHHHhhCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 001902 728 PALYASFQTKTHVCLITDYCPGGELFLLLDRQP-----------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIY 790 (998)
Q Consensus 728 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiH 790 (998)
+++++++...+..|+||||+++++|.+++.... ...++...+..++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999986531 123677889999999999999999999999
Q ss_pred ccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC
Q 001902 791 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 870 (998)
Q Consensus 791 rDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 870 (998)
|||||+|||++.++.+||+|||++....... .........++..|+|||++.+..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~ 216 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGD-------------------------YYRIQGRAVLPIRWMAWECILMGK 216 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCc-------------------------eeEecCcCCCCccccCHHHHhcCC
Confidence 9999999999999999999999985432110 001122345678999999999888
Q ss_pred CCChhHHHHHHHHHHHHHc--CCCCCCCCChHHHHHHHHh---C---CCCCCCCCCCcHHHHHHHHHccccCccCcCCCh
Q 001902 871 HTSAVDWWALGILLYEMLY--GYTPFRGKTRQKTFANILH---K---DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH 942 (998)
Q Consensus 871 ~~~~sDIwSlG~il~eLlt--G~~Pf~~~~~~~~~~~i~~---~---~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~ 942 (998)
++.++|||||||++|+|++ |..||.+.+....+..+.. . .........++..+.+|+.+||..||.+|||
T Consensus 217 ~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-- 294 (304)
T cd05096 217 FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPS-- 294 (304)
T ss_pred CCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcC--
Confidence 9999999999999999986 6788887766555544322 1 1111223456788999999999999999999
Q ss_pred hcHHHH
Q 001902 943 EGANEI 948 (998)
Q Consensus 943 ~~a~el 948 (998)
+.+|
T Consensus 295 --~~~i 298 (304)
T cd05096 295 --FSDI 298 (304)
T ss_pred --HHHH
Confidence 5555
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=326.72 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=211.1
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+...+|.+.+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++.++|+||+++++++...+.++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 4456799999999999999999999999999999998743 223467888999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+||||+++++|.+++.......++...++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999999976555568999999999999999999999999999999999999999999999999985432110
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 900 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~ 900 (998)
. .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 159 ~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 212 (263)
T cd05052 159 Y--------------------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 212 (263)
T ss_pred e--------------------------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 0 00112234668999999999999999999999999999998 99999988776
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
.....+... ...+.....+..+.+++.+||..||++||++.+
T Consensus 213 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 254 (263)
T cd05052 213 QVYELLEKG-YRMERPEGCPPKVYELMRACWQWNPSDRPSFAE 254 (263)
T ss_pred HHHHHHHCC-CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 666555443 333334557889999999999999999999444
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=327.28 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=210.8
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+..++|+++++||+|+||.||+|.+. ++..||+|.+.... .....+.+|+.+++.++|+||+++++++...+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 355678999999999999999999974 56789999876532 2346788899999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
+++|||+++++|.+++.......++...+..++.||+.||+|||+++++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 99999999999999998765667899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~ 899 (998)
.. .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 157 ~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 210 (261)
T cd05072 157 EY--------------------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210 (261)
T ss_pred ce--------------------------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence 00 01112345678999999988889999999999999999998 9999988877
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH 942 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~ 942 (998)
......+... ...+.....+.++.+|+.+||..+|++||++.
T Consensus 211 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 252 (261)
T cd05072 211 SDVMSALQRG-YRMPRMENCPDELYDIMKTCWKEKAEERPTFD 252 (261)
T ss_pred HHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHccCCcccCcCHH
Confidence 7666665543 34444556788999999999999999999933
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=334.36 Aligned_cols=256 Identities=28% Similarity=0.407 Sum_probs=210.8
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||+|.+..+++.||+|.+.+.... ......+.+|+++++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 3689999999999999999999889999999998764322 234456778999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|..+.... ..+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--- 154 (286)
T cd07846 80 EFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--- 154 (286)
T ss_pred ecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc---
Confidence 999999998877553 348999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
.......++..|+|||++.+ ..++.++|||||||++|+|++|.+||......+..
T Consensus 155 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~ 210 (286)
T cd07846 155 ------------------------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL 210 (286)
T ss_pred ------------------------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHH
Confidence 11123468899999999876 44678999999999999999999999876655444
Q ss_pred HHHHhC-------------------CCCCCC----------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 904 ANILHK-------------------DLKFPS----------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 904 ~~i~~~-------------------~~~~~~----------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
..+... ....+. ...++..+.+|+.+||..+|.+||+ +.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 286 (286)
T cd07846 211 YHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS----SSQLLHHEFF 286 (286)
T ss_pred HHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchh----HHHHhcCCCC
Confidence 443321 011111 1245778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=335.03 Aligned_cols=256 Identities=27% Similarity=0.389 Sum_probs=216.0
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
..|.+.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 46999999999999999999998899999999987554444555667889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||++ ++|.+++... ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 95 e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~------ 166 (307)
T cd06607 95 EYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS------ 166 (307)
T ss_pred HhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC------
Confidence 9995 6777776543 2458999999999999999999999999999999999999999999999999884421
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc---CCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
......|++.|+|||++. ...++.++||||||+++|+|++|.+||.+.+...
T Consensus 167 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~ 221 (307)
T cd06607 167 -------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (307)
T ss_pred -------------------------CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH
Confidence 112345788999999884 3567889999999999999999999998877766
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
....+.............+..+.+||.+||..+|.+||+ +.+++.||||...
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~ 273 (307)
T cd06607 222 ALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPS----SEELLKHRFVLRE 273 (307)
T ss_pred HHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcC----HHHHhcChhhccc
Confidence 655555443322222345778999999999999999999 9999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=328.21 Aligned_cols=258 Identities=26% Similarity=0.426 Sum_probs=212.2
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccC-------hhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-------RNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~-------~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.+....... ....+.+..|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4788899999999999999998899999999886422111 112356778999999999999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
..++||||+++++|.+++.+. ..++...++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999999775 468999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC--CCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.... ........|+..|+|||++.... ++.++|+||||+++|+|++|..||..
T Consensus 160 ~~~~-------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 160 DIYD-------------------------NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred cccc-------------------------ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 1000 00122345889999999987654 78899999999999999999999987
Q ss_pred CChHHHHHHHHhCC--CCCCCC--CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 897 KTRQKTFANILHKD--LKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 897 ~~~~~~~~~i~~~~--~~~~~~--~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
.........+.... ..++.. ..++..+.+||.+||..+|.+||+ +.++|+||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~~ 272 (272)
T cd06629 215 EEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT----ARELLQHPFI 272 (272)
T ss_pred cchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCC----HHHHhhCCCC
Confidence 66655544443322 122221 245788999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=329.33 Aligned_cols=258 Identities=28% Similarity=0.393 Sum_probs=218.2
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
..|+.++.||.|+||.||+|.+..++..+|+|++.... .......+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35888999999999999999998899999999987542 2344567888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06640 82 EYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc---
Confidence 99999999999865 348899999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.......++..|+|||++.+..++.++|+|||||++|+|++|..||...+......
T Consensus 156 ------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 211 (277)
T cd06640 156 ------------------------IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF 211 (277)
T ss_pred ------------------------cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh
Confidence 01123468889999999998889999999999999999999999998877665555
Q ss_pred HHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 905 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
.+..... .......+..+.+|+.+||..+|.+||+ +.++++||||.....
T Consensus 212 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~~~ 261 (277)
T cd06640 212 LIPKNNP-PTLTGEFSKPFKEFIDACLNKDPSFRPT----AKELLKHKFIVKNAK 261 (277)
T ss_pred hhhcCCC-CCCchhhhHHHHHHHHHHcccCcccCcC----HHHHHhChHhhhcch
Confidence 4433321 1122345678899999999999999999 999999999987544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=314.04 Aligned_cols=266 Identities=25% Similarity=0.346 Sum_probs=215.9
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe-----
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ----- 735 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~----- 735 (998)
.++..+|++.+.||+|||+.||++.+..+++.||+|.+... ..+..+...+|++..++++||||++++++..
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 46788999999999999999999999999999999998754 3566778889999999999999999988663
Q ss_pred eCCeEEEEEecCCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEecCCcEEEEec
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDF 811 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkP~NILi~~~g~vkL~DF 811 (998)
..+..||+++|...|+|.+.+... ++..+++.++..|+.+|++||++||... .+||||||.|||++..+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 345699999999999999998753 4456999999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC---CCCCChhHHHHHHHHHHHHH
Q 001902 812 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEML 888 (998)
Q Consensus 812 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDIwSlG~il~eLl 888 (998)
|.+......-. +... ...-........|..|.|||.+.- ...+.++|||||||+||.|+
T Consensus 174 GS~~~a~i~i~--------------~~~~----a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~m 235 (302)
T KOG2345|consen 174 GSATQAPIQIE--------------GSRQ----ALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMM 235 (302)
T ss_pred cCccccceEee--------------chHH----HHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHH
Confidence 99865431100 0000 000111223457899999999854 45677999999999999999
Q ss_pred cCCCCCCCCCh--HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 889 YGYTPFRGKTR--QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 889 tG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
+|..||..... ....-.+....+.+|...+.|..+.+||+.||+.||.+||+ +.+|+.+
T Consensus 236 f~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~----i~~ll~~ 296 (302)
T KOG2345|consen 236 FGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPT----IPELLSK 296 (302)
T ss_pred HcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCC----HHHHHHH
Confidence 99999964221 11222344567889999999999999999999999999999 7777654
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=332.43 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=213.0
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++.+.||.|++|.||++.+..+|+.||+|.+..... .......+.+|+.+++.++|+||+++++++......|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999865422 2233456778999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec-CCcEEEEeccCccccCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~-~g~vkL~DFG~a~~~~~~~~~ 823 (998)
||++ ++|.+++.......+++..++.++.||+.||.|||++||+|+||+|+||+++. ++.+||+|||++.......
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-- 157 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-- 157 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--
Confidence 9994 68888876655555788999999999999999999999999999999999985 5679999999985432110
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
.......+++.|+|||++.+. .++.++|||||||++|+|++|.+||........
T Consensus 158 -------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~ 212 (294)
T PLN00009 158 -------------------------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE 212 (294)
T ss_pred -------------------------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 111233578899999998764 578899999999999999999999988776665
Q ss_pred HHHHHhCCC---------------------CCC------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 903 FANILHKDL---------------------KFP------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 903 ~~~i~~~~~---------------------~~~------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
+..+..... .++ .....+.++.+++.+||+.+|.+||+ +.++++||||.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~~~l~~~~~~ 288 (294)
T PLN00009 213 LFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT----ARAALEHEYFK 288 (294)
T ss_pred HHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC----HHHHhcCchHh
Confidence 555432100 000 01235778899999999999999999 99999999999
Q ss_pred CCC
Q 001902 956 GVN 958 (998)
Q Consensus 956 ~~~ 958 (998)
.++
T Consensus 289 ~~~ 291 (294)
T PLN00009 289 DLG 291 (294)
T ss_pred HHh
Confidence 864
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=329.84 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=216.6
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
.|...+.||.|++|.||++.+..+++.+++|.+... .......+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 455567899999999999999889999999987633 23344567889999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+++++|.+++.. ..++...+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~----- 168 (285)
T cd06648 97 FLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----- 168 (285)
T ss_pred ccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC-----
Confidence 9999999999876 34899999999999999999999999999999999999999999999999987432210
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
........|++.|+|||.+.+..++.++|||||||++|+|++|..||...+....+..
T Consensus 169 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~ 226 (285)
T cd06648 169 ----------------------VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR 226 (285)
T ss_pred ----------------------CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH
Confidence 0112234689999999999888899999999999999999999999988777666666
Q ss_pred HHhCCCCCC-CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 906 ILHKDLKFP-SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 906 i~~~~~~~~-~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
+.....+.. .....+..+.+|+.+||+.+|.+||+ +.++++||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~il~~~~~~~~ 275 (285)
T cd06648 227 IRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT----AAELLNHPFLAKA 275 (285)
T ss_pred HHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcC----HHHHccCcccccC
Confidence 655432222 22236789999999999999999999 9999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=331.07 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=209.0
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHH-HHhCCCCCccceeEEEeeCCeEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-LDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~i-l~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
++|++++.||+|+||.||++.+..+|+.||+|.++..... .....+..|+.+ ++.++||||+++++++..++.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 4799999999999999999999999999999998765321 223345556654 6667999999999999999999999
Q ss_pred EecCCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 744 TDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|||++ ++|.+++... ....+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99995 7888777542 234689999999999999999999997 9999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC----CCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----AGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||..
T Consensus 158 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 158 ----------------------------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ----------------------------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 01122458889999999865 4567899999999999999999999975
Q ss_pred C-ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChh
Q 001902 897 K-TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 960 (998)
Q Consensus 897 ~-~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 960 (998)
. .....+..+............++.++.+||.+||..+|.+||+ +.++++||||+.....
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~~~~ 270 (283)
T cd06617 210 WKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPN----YPELLQHPFFELHLSK 270 (283)
T ss_pred cccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcC----HHHHhcCchhhhcccc
Confidence 3 2334444444432222122346789999999999999999999 9999999999986543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=333.73 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=213.3
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeeccccc--ChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
+|.+.+.||.|++|.||+|.+..+++.|++|.+...... .......+..|+.+++.++|+||+++++++...+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488889999999999999999989999999999865433 122345567899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+ +++|.+++.... ..+++..+..++.||++||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-- 156 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--
Confidence 9999 999999997653 369999999999999999999999999999999999999999999999999985543110
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
.......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....
T Consensus 157 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~ 211 (298)
T cd07841 157 -------------------------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ 211 (298)
T ss_pred -------------------------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH
Confidence 01122356888999999865 4578899999999999999999988987776555
Q ss_pred HHHHHhCCCC-----C------------------C---CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 903 FANILHKDLK-----F------------------P---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 903 ~~~i~~~~~~-----~------------------~---~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
+..+...... + + .....+..+.+||.+||..||.+||| +.++++||||++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~e~l~~~~~~~ 287 (298)
T cd07841 212 LGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT----ARQALEHPYFSN 287 (298)
T ss_pred HHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC----HHHHhhCccccC
Confidence 5554321000 0 0 01234678899999999999999999 999999999998
Q ss_pred C
Q 001902 957 V 957 (998)
Q Consensus 957 ~ 957 (998)
.
T Consensus 288 ~ 288 (298)
T cd07841 288 D 288 (298)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=332.23 Aligned_cols=256 Identities=27% Similarity=0.456 Sum_probs=205.8
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++.+.||+|++|.||++.+..+++.||+|.+...... .....+.+|+.+++.++|+||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 46899999999999999999999889999999998754321 1223456799999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||++ ++|.+++.+.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 156 (291)
T cd07844 82 FEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--- 156 (291)
T ss_pred EecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC---
Confidence 99996 58999887653 35899999999999999999999999999999999999999999999999987432100
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCC-hHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT-RQK 901 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~-~~~ 901 (998)
........++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ..+
T Consensus 157 ------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~ 212 (291)
T cd07844 157 ------------------------SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED 212 (291)
T ss_pred ------------------------CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH
Confidence 001122346889999999876 457889999999999999999999997665 233
Q ss_pred HHHHHHhC-------------------CCCCC---------CCCCCc--HHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 902 TFANILHK-------------------DLKFP---------SSTPTS--LHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 902 ~~~~i~~~-------------------~~~~~---------~~~~~s--~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
....+... ....+ .....+ .++.+++.+||+.+|.+||+ +.++++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps----~~e~l~~ 288 (291)
T cd07844 213 QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS----AAEAMKH 288 (291)
T ss_pred HHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC----HHHHhcC
Confidence 33222210 00000 001223 67889999999999999999 9999999
Q ss_pred CCc
Q 001902 952 PFF 954 (998)
Q Consensus 952 p~f 954 (998)
|||
T Consensus 289 ~~f 291 (291)
T cd07844 289 PYF 291 (291)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.73 Aligned_cols=255 Identities=30% Similarity=0.453 Sum_probs=214.4
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccc--cChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
+|+..+.||+|++|.||+|.+..++..|++|.+..... ........+.+|+.+++.++|+||+++++++.....+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47788999999999999999988999999999875322 1234456788999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+++++|.+++.+. ..+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 9999999999999765 358899999999999999999999999999999999999999999999999885432110
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC-CCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
......|+..|+|||.+.... ++.++|+|||||++|+|++|..||........
T Consensus 157 --------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~ 210 (258)
T cd06632 157 --------------------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA 210 (258)
T ss_pred --------------------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH
Confidence 112346889999999997766 88999999999999999999999987765555
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
...+.............+..+.+|+.+||..+|.+||+ +.+++.|||+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~~l~~~~~ 258 (258)
T cd06632 211 VFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPT----AAELLEHPFV 258 (258)
T ss_pred HHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcC----HHHHhcCCCC
Confidence 54444322111222346788999999999999999999 9999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=325.58 Aligned_cols=258 Identities=29% Similarity=0.471 Sum_probs=219.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++.+.||.|++|.||+|.+..+++.|++|++...... .....+.+|+.++..++|+||+++++++...+.+++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3688999999999999999999999999999998765321 44677889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
||+++++|.+++... ..+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~-- 154 (264)
T cd06623 79 EYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL-- 154 (264)
T ss_pred EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--
Confidence 999999999999765 558999999999999999999999 999999999999999999999999999885432111
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC---hH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT---RQ 900 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~---~~ 900 (998)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..
T Consensus 155 -------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~ 209 (264)
T cd06623 155 -------------------------DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF 209 (264)
T ss_pred -------------------------CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHH
Confidence 01123458889999999998889999999999999999999999998773 34
Q ss_pred HHHHHHHhCCCCCCCCCC-CcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 901 KTFANILHKDLKFPSSTP-TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~-~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
.....+..... ...... .+..+.++|.+||..+|++||+ +.++++||||+..+
T Consensus 210 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~----~~~ll~~~~~~~~~ 263 (264)
T cd06623 210 ELMQAICDGPP-PSLPAEEFSPEFRDFISACLQKDPKKRPS----AAELLQHPFIKKAD 263 (264)
T ss_pred HHHHHHhcCCC-CCCCcccCCHHHHHHHHHHccCChhhCCC----HHHHHhCHHHHhcc
Confidence 44444443332 222233 6788999999999999999999 99999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=344.74 Aligned_cols=262 Identities=29% Similarity=0.508 Sum_probs=232.5
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
..+...+.|.+.+.||+|.|+.|.++++.-++..||||++.+... +......+.+|+++|+.++|||||+++.+.....
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 344556789999999999999999999999999999999988654 4444455889999999999999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
.+|+||||+-+|.+++++.+++ .+.+..++.++.|++.|++|||+++|||||||++|||++.+.++||+|||++..+.
T Consensus 129 ~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999999998873 47779999999999999999999999999999999999999999999999996543
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCC-CChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
. .....+++|++.|.|||++.+..| .+.+|+||+|++||-|++|.+||.+.
T Consensus 207 ~----------------------------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 207 Y----------------------------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred c----------------------------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 1 123356799999999999999877 46999999999999999999999999
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 898 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
+-.+...+.+.+.+..|.. .+.++.+||+++|-.+|.+|++ ++++.+|.|..-.
T Consensus 259 ~lk~Lr~rvl~gk~rIp~~--ms~dce~lLrk~lvl~Pskr~~----~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 259 NLKELRPRVLRGKYRIPFY--MSCDCEDLLRKFLVLNPSKRGP----CDQIMKDRWRNDL 312 (596)
T ss_pred ccccccchheeeeecccce--eechhHHHHHHhhccCccccCC----HHHhhhhcccchh
Confidence 8888777777777666554 5678999999999999999999 9999999998863
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=363.78 Aligned_cols=270 Identities=25% Similarity=0.335 Sum_probs=210.5
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||+|.+..+|+.||+|++............++.+|+.+++.++||||+++++++...+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999998654444555677889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 745 DYCPGGELFLLLDRQP---------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~---------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
||++|++|.+++.... ...++...+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 9999999999986421 1235567788999999999999999999999999999999999999999999996
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
............ ..................+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 162 ~i~~~~~~~~~l---------~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~ 232 (932)
T PRK13184 162 FKKLEEEDLLDI---------DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232 (932)
T ss_pred eccccccccccc---------ccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 642111100000 00000000111122234679999999999999999999999999999999999999998
Q ss_pred CCChHHHHHHH-HhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 896 GKTRQKTFANI-LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 896 ~~~~~~~~~~i-~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
........... .............+..+.+++.+||..||.+|++..+
T Consensus 233 ~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~e 281 (932)
T PRK13184 233 RKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQ 281 (932)
T ss_pred CcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 76544333221 1111112222356788999999999999999998544
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=330.21 Aligned_cols=257 Identities=28% Similarity=0.388 Sum_probs=211.8
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeC-----
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK----- 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~----- 737 (998)
.++|.+.+.||+|+||.||+|.+..+++.+|+|++.... .....+..|+.+++++ +||||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 478999999999999999999999999999999986431 2234567789999998 899999999998643
Q ss_pred CeEEEEEecCCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 738 THVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
...|+||||+++++|.++++. .....+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 468999999999999998864 223568999999999999999999999999999999999999999999999999885
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-----CCCChhHHHHHHHHHHHHHcC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-----GHTSAVDWWALGILLYEMLYG 890 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDIwSlG~il~eLltG 890 (998)
...... .......|+..|+|||++... .++.++|||||||++|+|++|
T Consensus 177 ~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g 229 (291)
T cd06639 177 QLTSTR---------------------------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229 (291)
T ss_pred hccccc---------------------------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhC
Confidence 432110 011234688999999998643 357899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhCCCC-CCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 891 YTPFRGKTRQKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 891 ~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
++||...+....+..+...... .......+..+.+||.+||..+|++||+ +.++++||||+
T Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~il~~~~~~ 291 (291)
T cd06639 230 DPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPS----VTHLLEHPFIK 291 (291)
T ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcC----HHHHhcCcccC
Confidence 9999887766666665544321 2222345678999999999999999999 99999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=332.63 Aligned_cols=258 Identities=27% Similarity=0.396 Sum_probs=216.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
..|+.++.||.|+||.||++.+..++..||+|.+.... .......+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 35888899999999999999998899999999987542 2334567889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|.+++.. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06642 82 EYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred EccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc---
Confidence 99999999998864 358999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.......|+..|+|||++.+..++.++|+|||||++|+|++|..||..........
T Consensus 156 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 211 (277)
T cd06642 156 ------------------------IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF 211 (277)
T ss_pred ------------------------hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh
Confidence 01123468899999999999889999999999999999999999998766555444
Q ss_pred HHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 905 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
.+.....+ ......+..+.+|+.+||..+|++||+ +.++++||||....+
T Consensus 212 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~~~ 261 (277)
T cd06642 212 LIPKNSPP-TLEGQYSKPFKEFVEACLNKDPRFRPT----AKELLKHKFITRYTK 261 (277)
T ss_pred hhhcCCCC-CCCcccCHHHHHHHHHHccCCcccCcC----HHHHHHhHHHHHHhh
Confidence 43333221 112345778999999999999999999 999999999987543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=330.41 Aligned_cols=257 Identities=26% Similarity=0.376 Sum_probs=209.2
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEe-----e
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ-----T 736 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~-----~ 736 (998)
..++|++++.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +|+||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 3568999999999999999999999999999999876421 1234567899999999 7999999999873 4
Q ss_pred CCeEEEEEecCCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCc
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a 814 (998)
.+.+++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 56799999999999999987632 2345889999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-----CCCCChhHHHHHHHHHHHHHc
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLY 889 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDIwSlG~il~eLlt 889 (998)
....... .......|++.|+|||++.. ..++.++|||||||++|+|++
T Consensus 172 ~~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~ 224 (286)
T cd06638 172 AQLTSTR---------------------------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGD 224 (286)
T ss_pred eecccCC---------------------------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhc
Confidence 5432110 01123468999999999853 457889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhCCC-CCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 890 GYTPFRGKTRQKTFANILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 890 G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
|..||........+..+..... ........+..+.+||.+||+.||++||+ +.++++|+||
T Consensus 225 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~ell~~~~~ 286 (286)
T cd06638 225 GDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPT----VSDLLQHVFI 286 (286)
T ss_pred CCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCC----HHHHhhcccC
Confidence 9999988766555444333221 11122335678999999999999999999 9999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=324.03 Aligned_cols=256 Identities=27% Similarity=0.472 Sum_probs=217.6
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
+|.+.+.||.|+||.||++.+..+|..+|+|.+..... .......+.+|+.+++.++|+||+++++.+.....+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 48889999999999999999999999999999876432 22344567789999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc-EEEEeccCccccCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-VSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~-vkL~DFG~a~~~~~~~~~~ 824 (998)
|+++++|.+++.+.....+++..+..++.||+.||.|||+.+++|+||||+||+++.++. ++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--- 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc---
Confidence 999999999998765556899999999999999999999999999999999999998864 6999999885432110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+......
T Consensus 157 ------------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 212 (257)
T cd08225 157 ------------------------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212 (257)
T ss_pred ------------------------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 01122458999999999988889999999999999999999999998877766666
Q ss_pred HHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 905 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
.+...... +.....+..+.++|.+||..+|++||| +.++++||||
T Consensus 213 ~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt----~~~ll~~~~~ 257 (257)
T cd08225 213 KICQGYFA-PISPNFSRDLRSLISQLFKVSPRDRPS----ITSILKRPFL 257 (257)
T ss_pred HHhcccCC-CCCCCCCHHHHHHHHHHhccChhhCcC----HHHHhhCCCC
Confidence 55544332 223456788999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=328.44 Aligned_cols=260 Identities=28% Similarity=0.447 Sum_probs=212.8
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee--CCeEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVCL 742 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~~l 742 (998)
++|+..+.||.|++|.||+|.+..+++.+|+|.+.... .......+.+|+++++.++||||++++++|.. .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 46899999999999999999999999999999987542 22445678899999999999999999998864 347899
Q ss_pred EEecCCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 743 ITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
||||+++++|.+++.. .....++...+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999988754 22355899999999999999999999999999999999999999999999999997432100
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC---
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK--- 897 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~--- 897 (998)
......++..|+|||.+.+..++.++|||||||++|+|++|..||...
T Consensus 159 -----------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 209 (287)
T cd06621 159 -----------------------------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP 209 (287)
T ss_pred -----------------------------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC
Confidence 011335788999999999989999999999999999999999999865
Q ss_pred --ChHHHHHHHHhCCC-CCCCC----CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 898 --TRQKTFANILHKDL-KFPSS----TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 898 --~~~~~~~~i~~~~~-~~~~~----~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
...+....+..... ..+.. ...+..+.+||.+||..+|++||| +.++++||||+...-
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~eil~~~~~~~~~~ 274 (287)
T cd06621 210 PLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT----PWDMLEHPWIKAQMK 274 (287)
T ss_pred CCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCC----HHHHHhCcccccccc
Confidence 22333333333221 11111 224568899999999999999999 999999999987544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.90 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=211.6
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCC--C----CccceeEEEeeC
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--P----FVPALYASFQTK 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h--~----nIv~l~~~~~~~ 737 (998)
..+|.++..||+|.||.|-.+.+.+++..+|||+++.- ..-.+...-|+++|.++.+ | -+|++.+||...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 68999999999999999999999999999999998742 1233455668999999932 2 478889999999
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec---------------
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG--------------- 802 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~--------------- 802 (998)
++.|||+|.+ |.+++++|..+...+++..+++.++.||+++++|||+.+++|.||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999999 889999999988889999999999999999999999999999999999999953
Q ss_pred -----CCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHH
Q 001902 803 -----NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 877 (998)
Q Consensus 803 -----~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDI 877 (998)
+-.|+|+|||.|.... ..+..++.|..|.|||++.+-+++.++||
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~------------------------------e~hs~iVsTRHYRAPEViLgLGwS~pCDv 292 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDH------------------------------EHHSTIVSTRHYRAPEVILGLGWSQPCDV 292 (415)
T ss_pred eccCCCcceEEEecCCcceec------------------------------cCcceeeeccccCCchheeccCcCCccCc
Confidence 2348999999884321 12356789999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCChHH---HHHHHHh------------------CCCCCCCC--------------------
Q 001902 878 WALGILLYEMLYGYTPFRGKTRQK---TFANILH------------------KDLKFPSS-------------------- 916 (998)
Q Consensus 878 wSlG~il~eLltG~~Pf~~~~~~~---~~~~i~~------------------~~~~~~~~-------------------- 916 (998)
||+||||+||++|...|...++.+ ++..|+. +.+.++..
T Consensus 293 WSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~ 372 (415)
T KOG0671|consen 293 WSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYM 372 (415)
T ss_pred eeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHh
Confidence 999999999999999999887665 3333322 11111111
Q ss_pred ---CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 917 ---TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 917 ---~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
......+.+||++||..||.+|+| +.|+|.||||+..
T Consensus 373 ~~~d~e~~~LfDLl~~mL~fDP~~RiT----l~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 373 LQDDLEHVQLFDLLRRMLEFDPARRIT----LREALSHPFFARL 412 (415)
T ss_pred ccCcHHHhHHHHHHHHHHccCcccccc----HHHHhcCHHhhcC
Confidence 001125689999999999999999 9999999999874
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=331.16 Aligned_cols=258 Identities=22% Similarity=0.382 Sum_probs=208.4
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEeeCCe----
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTH---- 739 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~---- 739 (998)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 369999999999999999999999999999998875422 2223356778999999995 6999999999877665
Q ss_pred -EEEEEecCCCCchhHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec-CCcEEEEeccCc
Q 001902 740 -VCLITDYCPGGELFLLLDRQP---TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLS 814 (998)
Q Consensus 740 -~~lV~E~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~-~g~vkL~DFG~a 814 (998)
.|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999975 7888876532 245899999999999999999999999999999999999998 899999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~P 893 (998)
....... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..|
T Consensus 159 ~~~~~~~---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 211 (295)
T cd07837 159 RAFSIPV---------------------------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211 (295)
T ss_pred eecCCCc---------------------------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCC
Confidence 5432110 01122357889999999865 4578899999999999999999999
Q ss_pred CCCCChHHHHHHHHhCCC-----C------------CCC---------CCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 894 FRGKTRQKTFANILHKDL-----K------------FPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~~~-----~------------~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
|.+.+....+..+..... . ++. ....+..+.+||.+||..||.+||+ +.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~----~~e 287 (295)
T cd07837 212 FPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS----AKA 287 (295)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC----HHH
Confidence 998777666555443100 0 000 1236778999999999999999999 999
Q ss_pred HHcCCCcc
Q 001902 948 IKKHPFFK 955 (998)
Q Consensus 948 lL~Hp~f~ 955 (998)
++.||||+
T Consensus 288 il~~~~~~ 295 (295)
T cd07837 288 ALTHPYFD 295 (295)
T ss_pred HhcCCCcC
Confidence 99999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.02 Aligned_cols=258 Identities=29% Similarity=0.476 Sum_probs=220.8
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 750 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 750 (998)
+.||+|.||+||-+.++++|+.||||++.+....... ..++.+|..||..++||.||.+--.|++.+.+++|||.+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 6799999999999999999999999999987654443 37889999999999999999999999999999999999955
Q ss_pred chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC---CcEEEEeccCccccCCCCCCCCCc
Q 001902 751 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSCLTSCKPQLLLPT 827 (998)
Q Consensus 751 sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~---g~vkL~DFG~a~~~~~~~~~~~~~ 827 (998)
++.+++-....+.+++...+.++.||+.||.|||.+||+|+||||+|||+.+. -.+||||||+|+.++...
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks------ 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS------ 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh------
Confidence 54455444445679999999999999999999999999999999999999854 479999999998765221
Q ss_pred chhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 001902 828 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANIL 907 (998)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~ 907 (998)
...+++|||.|+|||++....|+..-|+||.|+|+|--++|..||.... ++-.+|.
T Consensus 722 ----------------------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQ 777 (888)
T KOG4236|consen 722 ----------------------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQ 777 (888)
T ss_pred ----------------------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhh
Confidence 2347899999999999999999999999999999999999999997653 3445555
Q ss_pred hCCCCCC--CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC-Chhhhhc
Q 001902 908 HKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV-NWALVRC 964 (998)
Q Consensus 908 ~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~-~~~~~~~ 964 (998)
...+-+| .+..++.++.+||..+|+..-.+|.+ +.+.|.|||+++. -|..++.
T Consensus 778 NAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRys----vdk~lsh~Wlq~yq~w~DLRe 833 (888)
T KOG4236|consen 778 NAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYS----VDKSLSHPWLQDYQTWLDLRE 833 (888)
T ss_pred ccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcc----hHhhccchhhhcchHHHHHHH
Confidence 5554444 34568999999999999999999999 9999999999984 3555543
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=328.32 Aligned_cols=255 Identities=21% Similarity=0.309 Sum_probs=212.5
Q ss_pred ccCCcccccccCCCCceeEEEEEEcc-----CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
..++|.+.+.||+|+||.||+|.+.. +++.||+|.++... .......+.+|+++++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35679999999999999999998743 46889999987542 233456888999999999999999999999999
Q ss_pred CeEEEEEecCCCCchhHHHhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc
Q 001902 738 THVCLITDYCPGGELFLLLDRQP------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 805 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~ 805 (998)
...|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999997542 234788999999999999999999999999999999999999999
Q ss_pred EEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHH
Q 001902 806 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 885 (998)
Q Consensus 806 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~ 885 (998)
++|+|||++........ ........+++.|+|||++.+..++.++|||||||++|
T Consensus 161 ~kl~d~g~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 215 (280)
T cd05049 161 VKIGDFGMSRDVYTTDY-------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLW 215 (280)
T ss_pred EEECCcccceecccCcc-------------------------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHH
Confidence 99999999854321100 01112334678899999999999999999999999999
Q ss_pred HHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 886 EMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 886 eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
+|++ |..||.+.+.......+..+....+ ....+..+.+|+.+||..||.+||+ +.+++
T Consensus 216 e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~----~~eil 275 (280)
T cd05049 216 EIFTYGKQPWYGLSNEEVIECITQGRLLQR-PRTCPSEVYDIMLGCWKRDPQQRIN----IKDIH 275 (280)
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHcCCcCCC-CCCCCHHHHHHHHHHcCCCcccCCC----HHHHH
Confidence 9998 9999998888777777766544332 3457889999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.10 Aligned_cols=259 Identities=29% Similarity=0.532 Sum_probs=215.9
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
+|.+.+.||+|+||.||++.+..+++.|++|.++.... .......+.+|+.+++.++|+||+++++++...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 58899999999999999999988999999999986533 24567788999999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+++++|.+++... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~- 156 (264)
T cd06626 80 YCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM- 156 (264)
T ss_pred cCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc-
Confidence 99999999999764 448899999999999999999999999999999999999999999999999986543211100
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC---CCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---HTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
........++..|+|||++.+.. ++.++||||||+++|+|++|..||........
T Consensus 157 ----------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~ 214 (264)
T cd06626 157 ----------------------GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ 214 (264)
T ss_pred ----------------------cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH
Confidence 00012346889999999998766 78899999999999999999999976643322
Q ss_pred HH-HHHh-CCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 903 FA-NILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 903 ~~-~i~~-~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
.. .+.. ....+|.....+..+.+||.+||+.+|.+||+ +.+++.|||+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~----~~~i~~~~~~ 264 (264)
T cd06626 215 IMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPT----ASELLQHPFV 264 (264)
T ss_pred HHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCC----HHHHhcCCCC
Confidence 22 2222 22334444455888999999999999999999 9999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=328.51 Aligned_cols=257 Identities=27% Similarity=0.458 Sum_probs=214.4
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC---CCCccceeEEEeeCCeEEE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD---HPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~l 742 (998)
.|++++.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++ ||||+++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4888999999999999999999999999999987542 2334567788999999996 9999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
||||+++++|.+++... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 99999999999998653 58999999999999999999999999999999999999999999999999885532110
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
.......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.....
T Consensus 156 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~ 209 (277)
T cd06917 156 --------------------------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209 (277)
T ss_pred --------------------------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 11223468999999999865 456889999999999999999999998876655
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
....+.....+.......+.++.+|+.+||..||.+||+ +.++++||||+...
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~il~~~~~~~~~ 262 (277)
T cd06917 210 AMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLS----AEELLKSKWIKAHS 262 (277)
T ss_pred hhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcC----HHHHhhChHhhccc
Confidence 444333322211112236778999999999999999999 99999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=359.16 Aligned_cols=268 Identities=24% Similarity=0.310 Sum_probs=199.9
Q ss_pred cCCcccccccCCCCceeEEEEEEccCC-eEEEEE--------------EeecccccChhHHHHHHHHHHHHHhCCCCCcc
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSG-QYFAMK--------------AMDKGVMLNRNKVHRACAEREILDMLDHPFVP 728 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~-~~valK--------------~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv 728 (998)
.++|++++.||+|+||.||+|..+... ...+.| .+.+...........+.+|+.+|++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 578999999999999999998764332 222222 11111112223445678999999999999999
Q ss_pred ceeEEEeeCCeEEEEEecCCCCchhHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc
Q 001902 729 ALYASFQTKTHVCLITDYCPGGELFLLLDRQP---TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 805 (998)
Q Consensus 729 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~ 805 (998)
++++++...+..|+||+++ +++|..++.... ........++.++.||+.||.|||++|||||||||+|||++.+|.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999999 567777765421 122446678889999999999999999999999999999999999
Q ss_pred EEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHH
Q 001902 806 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 885 (998)
Q Consensus 806 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~ 885 (998)
+||+|||++..+.... .......+||+.|+|||++.+..++.++|||||||++|
T Consensus 306 vkL~DFGla~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 359 (501)
T PHA03210 306 IVLGDFGTAMPFEKER--------------------------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILL 359 (501)
T ss_pred EEEEeCCCceecCccc--------------------------ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHH
Confidence 9999999986543110 01122457999999999999999999999999999999
Q ss_pred HHHcCCCCCC-CC--ChHHHHHHHHhCC----CCCC--------------------------CCCCCcHHHHHHHHHccc
Q 001902 886 EMLYGYTPFR-GK--TRQKTFANILHKD----LKFP--------------------------SSTPTSLHAKQLMYRLLH 932 (998)
Q Consensus 886 eLltG~~Pf~-~~--~~~~~~~~i~~~~----~~~~--------------------------~~~~~s~~l~~Ll~~~L~ 932 (998)
+|++|..++. .. .....+..++... ..++ .....+..+.++|.+||+
T Consensus 360 ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~ 439 (501)
T PHA03210 360 DMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLT 439 (501)
T ss_pred HHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhc
Confidence 9999876443 22 2222333222210 0011 011245567888999999
Q ss_pred cCccCcCCChhcHHHHHcCCCccCCChhhh
Q 001902 933 RDPKSRLGSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 933 ~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
+||.+||| +.++|.||||........
T Consensus 440 ~DP~~Rps----a~elL~hp~f~~~~~~~~ 465 (501)
T PHA03210 440 FDWHLRPG----AAELLALPLFSAEEEEEI 465 (501)
T ss_pred cCcccCcC----HHHHhhChhhhcCCchHH
Confidence 99999999 999999999998765544
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=339.66 Aligned_cols=260 Identities=24% Similarity=0.365 Sum_probs=208.3
Q ss_pred ccccCCcccccccCCCCceeEEEEEEcc-----CCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASF 734 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~ 734 (998)
++..++|++++.||.|+||.||+|.+.. +++.||+|++.... .......+..|+.++.++ +|+||+++++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 3445689999999999999999997543 45789999987432 223445677899999999 899999999987
Q ss_pred ee-CCeEEEEEecCCCCchhHHHhhCCC----------------------------------------------------
Q 001902 735 QT-KTHVCLITDYCPGGELFLLLDRQPT---------------------------------------------------- 761 (998)
Q Consensus 735 ~~-~~~~~lV~E~~~ggsL~~~l~~~~~---------------------------------------------------- 761 (998)
.. +..++++|||+++++|.+++.....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 5678999999999999999864321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhc
Q 001902 762 -------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834 (998)
Q Consensus 762 -------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~ 834 (998)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~------------ 228 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------------ 228 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc------------
Confidence 2578999999999999999999999999999999999999999999999999865321110
Q ss_pred ccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCC
Q 001902 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKF 913 (998)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~ 913 (998)
........++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+...+......
T Consensus 229 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 295 (337)
T cd05054 229 -------------YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295 (337)
T ss_pred -------------hhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC
Confidence 011123456778999999999999999999999999999997 999998765545454444443333
Q ss_pred CCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 914 PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 914 ~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
......+.++.+++.+||+.+|++||+ +.++++|
T Consensus 296 ~~~~~~~~~~~~l~~~cl~~~p~~RPs----~~ell~~ 329 (337)
T cd05054 296 RAPEYATPEIYSIMLDCWHNNPEDRPT----FSELVEI 329 (337)
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 333456788999999999999999999 7777664
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.12 Aligned_cols=255 Identities=26% Similarity=0.377 Sum_probs=209.9
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++.+.||+|+||.||+|.+..+++.||+|.+......+......+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999999999999999887644445556677889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 745 DYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 745 E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
||+++++|.+++... ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 999999999888632 23458999999999999999999999999999999999999999999999999885432110
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh--H
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR--Q 900 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~--~ 900 (998)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .
T Consensus 161 --------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~ 214 (267)
T cd08228 161 --------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF 214 (267)
T ss_pred --------------------------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH
Confidence 011234688999999999988899999999999999999999999976432 2
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
.....+.....+.......+..+.+|+.+||..+|++||+ +.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~vl~ 260 (267)
T cd08228 215 SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPD----IGYVHQ 260 (267)
T ss_pred HHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcC----HHHHHH
Confidence 3333333322221112245678999999999999999999 666654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=344.96 Aligned_cols=260 Identities=23% Similarity=0.305 Sum_probs=210.1
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccC-----CeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeE
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYA 732 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~ 732 (998)
...+..++|++.+.||+|+||.||+|.+... +..||+|++.... .......+.+|+.++++++ ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 3445567899999999999999999987433 3579999987542 2334567889999999996 999999999
Q ss_pred EEeeCCeEEEEEecCCCCchhHHHhhCC----------------------------------------------------
Q 001902 733 SFQTKTHVCLITDYCPGGELFLLLDRQP---------------------------------------------------- 760 (998)
Q Consensus 733 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------- 760 (998)
++...+.+|||||||++|+|.+++....
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 9999999999999999999999886431
Q ss_pred ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 001902 761 ------------------------------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 798 (998)
Q Consensus 761 ------------------------------------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NI 798 (998)
...+++..+..++.||+.||+|||+++|+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 12477888899999999999999999999999999999
Q ss_pred EEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHH
Q 001902 799 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 878 (998)
Q Consensus 799 Li~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIw 878 (998)
|++.++.+||+|||++........ ........+++.|+|||++.+..++.++|||
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 323 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSN-------------------------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVW 323 (400)
T ss_pred EEeCCCEEEEEeCCcceecccccc-------------------------ccccCCcCCCcceEChhhhcCCCCCchhhHH
Confidence 999999999999999854321100 0112234577899999999998999999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcH
Q 001902 879 ALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945 (998)
Q Consensus 879 SlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 945 (998)
||||++|+|++ |..||........+...+......+.....+..+.+++.+||..||++||++.+++
T Consensus 324 SlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~ 391 (400)
T cd05105 324 SYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS 391 (400)
T ss_pred HHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHH
Confidence 99999999996 99999876554444444444444444456788999999999999999999955543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=332.85 Aligned_cols=256 Identities=28% Similarity=0.465 Sum_probs=216.4
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
..|.....||.|+||.||++.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 35666778999999999999998899999999986532 223456788999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|..++.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 98 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~---- 170 (297)
T cd06659 98 EFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---- 170 (297)
T ss_pred ecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc----
Confidence 99999999998755 34899999999999999999999999999999999999999999999999988432210
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
........|+..|+|||++.+..++.++|||||||++|+|++|..||...+....+.
T Consensus 171 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 227 (297)
T cd06659 171 -----------------------VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 227 (297)
T ss_pred -----------------------cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011223568999999999998889999999999999999999999998877766665
Q ss_pred HHHhCCCC-CCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 905 NILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 905 ~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.+...... .......+..+.++|.+||+.+|.+||+ +.++++||||...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps----~~~ll~~~~~~~~ 277 (297)
T cd06659 228 RLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERAT----AQELLDHPFLLQT 277 (297)
T ss_pred HHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcC----HHHHhhChhhccC
Confidence 55443222 2223346788999999999999999999 9999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=329.56 Aligned_cols=279 Identities=37% Similarity=0.639 Sum_probs=227.4
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEeeCCeEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lV 743 (998)
++|.+.+.||.|+||.||++.+..+++.|++|++.+...........+..|..++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 37999999999999999999999999999999998755544555677888999999998 99999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+++++|.+++.+. ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999999999875 35999999999999999999999999999999999999999999999999998654322110
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
........ .................|+..|+|||++.+..++.++||||||++++++++|..||...+....+
T Consensus 159 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 231 (280)
T cd05581 159 ESNKGDAT-------NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231 (280)
T ss_pred ccCCCCCc-------cccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 00000000 00000011112334567899999999998888899999999999999999999999988876666
Q ss_pred HHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 904 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 904 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
..+......++. ..+..+.+||.+||+.+|.+||++.+...++++||||
T Consensus 232 ~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 232 QKILKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHhcCCCCCC--ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 776655544443 4578899999999999999999944444999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=345.87 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=215.2
Q ss_pred ccccccCCCCceeEEEEEEccCCeEEEEEEeecc-cccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC--eEEEEE
Q 001902 668 RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG-VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT--HVCLIT 744 (998)
Q Consensus 668 ~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~-~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~--~~~lV~ 744 (998)
+....||+|+|-+||+|.|..+|..||--.++.. ........+++..|+.+|+.|+|+||+++|.++.+.. .+-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4456799999999999999999988875544432 3345667789999999999999999999999997654 588999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCcEEEec-CCcEEEEeccCccccCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ--GIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--~IiHrDLkP~NILi~~-~g~vkL~DFG~a~~~~~~~ 821 (998)
|.+..|+|..|+++. +.++...++.|++||++||.|||++ .|||||||.+||+|+. .|.|||+|+|+|..+..
T Consensus 123 EL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~-- 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK-- 198 (632)
T ss_pred ecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc--
Confidence 999999999999886 4589999999999999999999998 5999999999999996 58999999999966431
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC-ChH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK-TRQ 900 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~-~~~ 900 (998)
.....++|||.|||||+.. ..|+..+||||||++++||+|+..||... +..
T Consensus 199 ---------------------------s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A 250 (632)
T KOG0584|consen 199 ---------------------------SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA 250 (632)
T ss_pred ---------------------------cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH
Confidence 1234579999999999987 77999999999999999999999999875 556
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.+|+++..+..+---..--.+++++||.+||.. .+.||| +.+||+||||..-
T Consensus 251 QIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~s----a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 251 QIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLS----AKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccC----HHHHhhChhhccc
Confidence 777787776544332333478999999999998 899999 9999999999984
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=322.42 Aligned_cols=256 Identities=25% Similarity=0.474 Sum_probs=216.5
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe--eCCeEEEE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ--TKTHVCLI 743 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~--~~~~~~lV 743 (998)
+|++++.||.|+||.||+|.+..++..+|+|.+..... .......+..|+.+++.++|+||+++++++. ....+|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 48899999999999999999999999999999876433 3445567888999999999999999999775 34678999
Q ss_pred EecCCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 744 TDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLH-----CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH-----~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
|||+++++|.+++... ....+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999998753 2356899999999999999999999 89999999999999999999999999999855
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
..... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||..
T Consensus 160 ~~~~~---------------------------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 160 LGHDS---------------------------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred ccCCc---------------------------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 32110 001234689999999999988899999999999999999999999998
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
.+.......+...... ......+..+.+++.+||..+|.+||+ +.++++|||+
T Consensus 213 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~l~~~p~~Rp~----~~~il~~~~~ 265 (265)
T cd08217 213 RNQLQLASKIKEGKFR-RIPYRYSSELNEVIKSMLNVDPDKRPS----TEELLQLPLI 265 (265)
T ss_pred cCHHHHHHHHhcCCCC-CCccccCHHHHHHHHHHccCCcccCCC----HHHHhhCCCC
Confidence 8766666655554332 222346788999999999999999999 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=330.32 Aligned_cols=256 Identities=26% Similarity=0.385 Sum_probs=217.0
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
-|...+.||+|+||.||+|.+..++..|++|++.............+.+|+.+++.++|+|++++++++...+..|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 37777889999999999999999999999999976544444555678889999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+. ++|.+++... ...+++..+..++.||+.+|.|||++||+|+||+|+||+++.++.++|+|||++....
T Consensus 102 ~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------- 172 (313)
T cd06633 102 YCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------- 172 (313)
T ss_pred cCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-------
Confidence 994 6777777654 2458999999999999999999999999999999999999999999999999873211
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc---CCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
......|+..|+|||++. ...++.++|||||||++|+|++|..||...+....
T Consensus 173 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~ 228 (313)
T cd06633 173 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 228 (313)
T ss_pred ------------------------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 112346889999999984 35678899999999999999999999988877666
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
...+.....+.......+..+.+|+.+||+.+|.+||+ +.+++.||||+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~----~~~~l~~~~~~~~~ 280 (313)
T cd06633 229 LYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPA----SAELLRHDFVRRDR 280 (313)
T ss_pred HHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcC----HHHHhcCcccCCCc
Confidence 66666554443334446778999999999999999999 99999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=324.44 Aligned_cols=249 Identities=24% Similarity=0.318 Sum_probs=212.1
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
.+|++++.||.|+||.||+|.+.. ++.+++|++.... ......+..|+.+++.++|+||+++++++......++||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 479999999999999999999977 8899999987542 223456788999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|.+++.......++...+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~--- 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--- 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc---
Confidence 99999999999987666679999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTF 903 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~ 903 (998)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+.+
T Consensus 159 ------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~ 214 (261)
T cd05148 159 ------------------------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY 214 (261)
T ss_pred ------------------------ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 00112335678999999988889999999999999999998 89999888877777
Q ss_pred HHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcH
Q 001902 904 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945 (998)
Q Consensus 904 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 945 (998)
..+... ...+....++..+.+++.+||+.||.+|||+.+++
T Consensus 215 ~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~ 255 (261)
T cd05148 215 DQITAG-YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALR 255 (261)
T ss_pred HHHHhC-CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 766643 34444556788999999999999999999954443
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=334.06 Aligned_cols=250 Identities=26% Similarity=0.428 Sum_probs=191.2
Q ss_pred cccCCCCceeEEEEEEcc--CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe--eCCeEEEEEec
Q 001902 671 KPLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ--TKTHVCLITDY 746 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~--~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~--~~~~~~lV~E~ 746 (998)
.+||+|+||.||+|.+.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++. ....+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999999753 56899999887532 1235678999999999999999999885 45688999999
Q ss_pred CCCCchhHHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----ecCCcEEEEeccCcc
Q 001902 747 CPGGELFLLLDRQ-------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL----QGNGHVSLTDFDLSC 815 (998)
Q Consensus 747 ~~ggsL~~~l~~~-------~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi----~~~g~vkL~DFG~a~ 815 (998)
+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 A-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred e-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 9 45787776521 12358899999999999999999999999999999999999 456799999999986
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
....... .........||+.|+|||++.+. .++.++|||||||++|+|++|.+||
T Consensus 161 ~~~~~~~------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f 216 (317)
T cd07867 161 LFNSPLK------------------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ccCCCcc------------------------cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence 5431110 00112345789999999999774 5788999999999999999999999
Q ss_pred CCCChH---------HHHHHHHhC--------------CCCC----------------------CCCCCCcHHHHHHHHH
Q 001902 895 RGKTRQ---------KTFANILHK--------------DLKF----------------------PSSTPTSLHAKQLMYR 929 (998)
Q Consensus 895 ~~~~~~---------~~~~~i~~~--------------~~~~----------------------~~~~~~s~~l~~Ll~~ 929 (998)
...... ..+..+... ...+ ......+..+.+||.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 296 (317)
T cd07867 217 HCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQK 296 (317)
T ss_pred ccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHH
Confidence 753321 111111110 0000 0011234568899999
Q ss_pred ccccCccCcCCChhcHHHHHcCCCc
Q 001902 930 LLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 930 ~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
||..||.+||| +.++|+||||
T Consensus 297 ~l~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07867 297 LLTMDPTKRIT----SEQALQDPYF 317 (317)
T ss_pred HhccCcccccC----HHHHhcCCCC
Confidence 99999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.87 Aligned_cols=248 Identities=31% Similarity=0.494 Sum_probs=200.7
Q ss_pred CCccccccc--CCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEE
Q 001902 665 QHFRPIKPL--GSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 665 ~~y~~~~~L--G~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~ 741 (998)
+.|.+.+.+ |.|+||.||++.++.++..+|+|.+....... .|+.+...+ +|+||++++++|...+..|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 466676666 99999999999999999999999987542211 122222222 7999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC-cEEEEeccCccccCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCK 820 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g-~vkL~DFG~a~~~~~~ 820 (998)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 999999999999999775 3699999999999999999999999999999999999999988 999999998854321
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 163 ------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 212 (267)
T PHA03390 163 ------------------------------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE 212 (267)
T ss_pred ------------------------------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 11235889999999999989999999999999999999999999865433
Q ss_pred HH-HHHHHhC-CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 901 KT-FANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 901 ~~-~~~i~~~-~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
.. ...+... ....+.....+..+.+||.+||+.+|.+||+. ++++|+||||+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~---~~~~l~h~~~~~ 267 (267)
T PHA03390 213 ELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTN---YNEIIKHPFLKI 267 (267)
T ss_pred hhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCch---HHHHhcCCcccC
Confidence 21 1111111 11222233578899999999999999999961 599999999973
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=321.81 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=208.0
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++.+.||+|+||.||++... .+..+|+|.+..... ....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 457999999999999999999874 456899998764422 235678899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-- 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc--
Confidence 99999999999987543 358999999999999999999999999999999999999999999999999885432100
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~ 902 (998)
........++..|+|||++.+..++.++||||||+++|+|++ |+.||...+....
T Consensus 155 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~ 210 (256)
T cd05114 155 ------------------------YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV 210 (256)
T ss_pred ------------------------eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 001112235678999999988889999999999999999999 9999998888777
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
+..+...... ......+..+.+|+.+||..+|.+||+ +.++++
T Consensus 211 ~~~i~~~~~~-~~~~~~~~~~~~li~~c~~~~p~~Rps----~~~l~~ 253 (256)
T cd05114 211 VEMISRGFRL-YRPKLASMTVYEVMYSCWHEKPEGRPT----FAELLR 253 (256)
T ss_pred HHHHHCCCCC-CCCCCCCHHHHHHHHHHccCCcccCcC----HHHHHH
Confidence 7777665432 223345778999999999999999999 666653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=331.16 Aligned_cols=257 Identities=24% Similarity=0.366 Sum_probs=210.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC--CeEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVC 741 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~~ 741 (998)
.++|++.+.||.|+||.||+|.+..+++.+++|.++..... ......+.+|+.++++++||||+++++++... +.+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35799999999999999999999989999999999754332 22334567899999999999999999998877 8999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+||||++ ++|.+++.... ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 83 lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999996 59999887643 358999999999999999999999999999999999999999999999999885533110
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC-CCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
.......+++.|+|||.+.+.. ++.++|||||||++|+|++|.+||......
T Consensus 161 ---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~ 213 (293)
T cd07843 161 ---------------------------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213 (293)
T ss_pred ---------------------------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 1112345788999999987644 688999999999999999999999887766
Q ss_pred HHHHHHHhCCC-------------C------C---------CCCCC--CcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 901 KTFANILHKDL-------------K------F---------PSSTP--TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 901 ~~~~~i~~~~~-------------~------~---------~~~~~--~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
..+.++..... + + ..... .+..+.+||.+||+.+|++||| +.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t----~~ell~ 289 (293)
T cd07843 214 DQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS----AEDALK 289 (293)
T ss_pred HHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCC----HHHHhc
Confidence 65555432110 0 0 00011 3677899999999999999999 999999
Q ss_pred CCCc
Q 001902 951 HPFF 954 (998)
Q Consensus 951 Hp~f 954 (998)
||||
T Consensus 290 ~~~f 293 (293)
T cd07843 290 HPYF 293 (293)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=324.43 Aligned_cols=252 Identities=29% Similarity=0.405 Sum_probs=208.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++.+.||.|+||.||++.+..+++.+++|.+.............+.+|+.+++.++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999999999999887654444555677889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 745 DYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 745 E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
||+++++|.+++... ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 999999999988642 23468999999999999999999999999999999999999999999999999875432110
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh--H
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR--Q 900 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~--~ 900 (998)
.......|+..|+|||++.+..++.++|+||||+++|+|++|..||.+... .
T Consensus 161 --------------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08229 161 --------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred --------------------------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH
Confidence 011234688999999999998899999999999999999999999976543 2
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
.....+.....+.......+..+.+|+.+||..||.+|||+.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 257 (267)
T cd08229 215 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITY 257 (267)
T ss_pred HHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHH
Confidence 3333333322222222346789999999999999999999443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=327.23 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=210.5
Q ss_pred cccCCcccccccCCCCceeEEEEEE-----ccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 736 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 736 (998)
++.++|.+.+.||+|+||.||++.. ..++..+|+|.+... .......+.+|+.++++++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 4457899999999999999999985 234677999988643 33455678899999999999999999999999
Q ss_pred CCeEEEEEecCCCCchhHHHhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQP-----------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 805 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~-----------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~ 805 (998)
.+.+++||||+++++|.+++.... ...+++..+..++.||+.||+|||++|++||||||+|||++.++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999999999999997532 134899999999999999999999999999999999999999999
Q ss_pred EEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHH
Q 001902 806 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 885 (998)
Q Consensus 806 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~ 885 (998)
++|+|||++........ ........++..|+|||++.+..++.++|||||||++|
T Consensus 159 ~kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~ 213 (288)
T cd05093 159 VKIGDFGMSRDVYSTDY-------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLW 213 (288)
T ss_pred EEeccCCccccccCCce-------------------------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHH
Confidence 99999999854321100 01112334678899999999888999999999999999
Q ss_pred HHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 886 EMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 886 eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
+|++ |.+||...........+..+... +.....+..+.+|+.+||+.||.+|||+.+
T Consensus 214 ~l~t~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 271 (288)
T cd05093 214 EIFTYGKQPWYQLSNNEVIECITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKE 271 (288)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9998 99999988887777777765432 223346789999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=329.70 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=217.9
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
.|...+.||+|+||.||++.+..++..+|+|.+.............+.+|+.+++.++|+|++++++++...+..|+|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 48899999999999999999988999999999876544444556678899999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|++ ++|.+++... ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++....
T Consensus 106 ~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~------- 176 (317)
T cd06635 106 YCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS------- 176 (317)
T ss_pred CCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-------
Confidence 996 5777777543 3458999999999999999999999999999999999999999999999999874321
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc---CCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
......|++.|+|||++. ...++.++|||||||++|+|++|..||...+....
T Consensus 177 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 232 (317)
T cd06635 177 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 232 (317)
T ss_pred ------------------------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 012335888999999984 45678899999999999999999999988877777
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
...+.............+..+.+|+.+||+.+|.+||+ +.++++|+|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~il~~~~~~~ 282 (317)
T cd06635 233 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPT----SEELLKHMFVLR 282 (317)
T ss_pred HHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcC----HHHHHhChhhhc
Confidence 77777665544444456788999999999999999999 999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=332.30 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=216.6
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++++.||+|+||.||++.+..+++.|++|.+... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 36899999999999999999999888999999998643 223346678899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+++++|.+++.+. .++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-- 169 (293)
T cd06647 95 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 169 (293)
T ss_pred EecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc--
Confidence 9999999999998753 47899999999999999999999999999999999999999999999999875432110
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.....
T Consensus 170 -------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~ 224 (293)
T cd06647 170 -------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224 (293)
T ss_pred -------------------------cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe
Confidence 1112346889999999998888899999999999999999999999877654444
Q ss_pred HHHHhC-CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 904 ANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 904 ~~i~~~-~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
..+... ...++.....+..+.+|+.+||..+|.+||+ +.+++.||||+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~----~~~il~h~~~~~~ 275 (293)
T cd06647 225 YLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS----AKELLQHPFLKIA 275 (293)
T ss_pred eehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcC----HHHHhcCHHHhcC
Confidence 333322 2223333345778999999999999999999 9999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=330.70 Aligned_cols=262 Identities=24% Similarity=0.354 Sum_probs=209.5
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEeeCCeEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~l 742 (998)
.++|...+.||+|+||.||++.+..+++.+|+|.+..... ......+.+|+.++.++. |+||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 3578888999999999999999999999999999875432 244567788999999995 9999999999999999999
Q ss_pred EEecCCCCchhHHH---hhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 743 ITDYCPGGELFLLL---DRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 743 V~E~~~ggsL~~~l---~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
+|||+. ++|.++. .......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 999994 4555443 223335699999999999999999999975 99999999999999999999999999985422
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC---CCCChhHHHHHHHHHHHHHcCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
.. .......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.
T Consensus 160 ~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 211 (288)
T cd06616 160 DS----------------------------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211 (288)
T ss_pred cC----------------------------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence 10 011223588899999999776 68889999999999999999999997
Q ss_pred CCCh-HHHHHHHHhCCCC-CC--CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChh
Q 001902 896 GKTR-QKTFANILHKDLK-FP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 960 (998)
Q Consensus 896 ~~~~-~~~~~~i~~~~~~-~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 960 (998)
.... ...+..+.....+ .+ .....+.++.+||.+||..+|.+||| +.++++||||+...+.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 212 KWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPK----YKELLEHPFIKDYEER 276 (288)
T ss_pred hcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcC----HHHHhcChhhhchhhc
Confidence 6542 1222333222211 11 12346889999999999999999999 9999999999875543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.24 Aligned_cols=257 Identities=29% Similarity=0.460 Sum_probs=211.3
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++.+.||+|+||.||+|.+..+++.|++|.++... ........+.+|+.+++.++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 36999999999999999999999999999999887542 23334567889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||++++.+..+..+. ..++...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-- 155 (288)
T cd07833 80 EYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155 (288)
T ss_pred ecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--
Confidence 999887776665443 4489999999999999999999999999999999999999999999999999855331110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
.......++..|+|||++.+. .++.++||||||+++|+|++|.+||.+......+
T Consensus 156 ------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 211 (288)
T cd07833 156 ------------------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL 211 (288)
T ss_pred ------------------------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 012235688999999999887 7889999999999999999999999877655444
Q ss_pred HHHHhCC-------------------CCCCC-----------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCC
Q 001902 904 ANILHKD-------------------LKFPS-----------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953 (998)
Q Consensus 904 ~~i~~~~-------------------~~~~~-----------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~ 953 (998)
..+.... ..++. ...++.++.+||.+||..+|++||+ +.++++|||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~ 287 (288)
T cd07833 212 YLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT----CDELLQHPY 287 (288)
T ss_pred HHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc----HHHHhcCCC
Confidence 3332100 00000 1123778999999999999999999 999999999
Q ss_pred c
Q 001902 954 F 954 (998)
Q Consensus 954 f 954 (998)
|
T Consensus 288 f 288 (288)
T cd07833 288 F 288 (288)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=327.48 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=210.3
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEec
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 746 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 746 (998)
|++++.||.|++|.||+|.+..+|+.||+|++..... .......+.+|+.+++.++|+|++++++++...+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999999875432 222335677899999999999999999999999999999999
Q ss_pred CCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCC
Q 001902 747 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 826 (998)
Q Consensus 747 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 826 (998)
+ +++|.+++.......+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~------ 152 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP------ 152 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC------
Confidence 9 568999987765456899999999999999999999999999999999999999999999999998543211
Q ss_pred cchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 827 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
........+++.|+|||++.+. .++.++||||||+++|+|++|.+||...+....+..
T Consensus 153 ---------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 211 (283)
T cd07835 153 ---------------------VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR 211 (283)
T ss_pred ---------------------ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0111223568899999988664 568899999999999999999999988776555444
Q ss_pred HHhCCC------------------CCC---------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 906 ILHKDL------------------KFP---------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 906 i~~~~~------------------~~~---------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
+..... .++ .....+..+.++|.+||+.+|.+||| +.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~il~~~~~ 283 (283)
T cd07835 212 IFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS----AKAALQHPYF 283 (283)
T ss_pred HHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcC----HHHHhcCCCC
Confidence 433100 000 12345678999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=333.36 Aligned_cols=255 Identities=24% Similarity=0.322 Sum_probs=207.4
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCe----EEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
+...+|++++.||+|+||.||+|.+..++. .||+|.++.. ........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 345689999999999999999999866655 4899988643 2334456788899999999999999999988764
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
..++|+||+++|+|.+++.... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 5789999999999999997653 35889999999999999999999999999999999999999999999999999654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~ 896 (998)
...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 160 ~~~~~~-------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 160 GADEKE-------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred cCCCcc-------------------------eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 311100 01112234678999999999999999999999999999997 9999988
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHH
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 946 (998)
...... ..+......++....++..+.+++.+||..+|.+||++.+++.
T Consensus 215 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~ 263 (316)
T cd05108 215 IPASEI-SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELII 263 (316)
T ss_pred CCHHHH-HHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 765544 3445554455555567889999999999999999999554433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=319.15 Aligned_cols=256 Identities=31% Similarity=0.538 Sum_probs=220.8
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
+|.+.+.||.|+||.||++.+..+++.+++|++..... .......+..|+++++.++|+|++++++.+......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 48899999999999999999988999999999875432 33455678889999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 746 YCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|+++++|.+++.... ...++...+..++.+|+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 999999999997643 4669999999999999999999999999999999999999999999999999885432110
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
.......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.....
T Consensus 158 -------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~ 212 (258)
T cd08215 158 -------------------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212 (258)
T ss_pred -------------------------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH
Confidence 1122346889999999998888999999999999999999999999888777766
Q ss_pred HHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 904 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 904 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
..+....... .....+..+.+++.+||..+|++||+ +.++|+||||
T Consensus 213 ~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~ll~~~~~ 258 (258)
T cd08215 213 LKILKGQYPP-IPSQYSSELRNLVSSLLQKDPEERPS----IAQILQSPFI 258 (258)
T ss_pred HHHhcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcC----HHHHhcCCCC
Confidence 6666554322 22356789999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=337.00 Aligned_cols=283 Identities=27% Similarity=0.427 Sum_probs=222.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC-----
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----- 738 (998)
.++|++++.||+|+||.||++.+..+|+.||+|.+.... ........+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467999999999999999999999999999999986532 23334456788999999999999999999987543
Q ss_pred -eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 739 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 739 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
..|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 468999999 8899888864 35899999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.. ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+
T Consensus 169 ~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 169 DS------------------------------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred cc------------------------------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 21 1123357889999999876 4578899999999999999999999988
Q ss_pred CChHHHHHHHHhCCCCCC-----------------------------CCCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 897 KTRQKTFANILHKDLKFP-----------------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~-----------------------------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
.+....+..+.......+ .....+..+.++|.+||+.||.+||| +.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t----~~~ 294 (343)
T cd07880 219 HDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT----AAE 294 (343)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC----HHH
Confidence 776555554433211100 01245678899999999999999999 999
Q ss_pred HHcCCCccCCChhhhhcCCCCCCCCCCCCCccccccccCCchhHHhhh
Q 001902 948 IKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQ 995 (998)
Q Consensus 948 lL~Hp~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 995 (998)
++.||||+...-. ++....|. -..+.+..+..++|.|-
T Consensus 295 ~l~~~~~~~~~~~------~~~~~~~~----~~~~~~~~~~~~~~~~~ 332 (343)
T cd07880 295 ALAHPYFEEFHDP------EDETEAPP----YDDSFDEVDQSLEEWKR 332 (343)
T ss_pred HhcCccHhhhcCc------ccccCCCC----ccccHHhhccchHHHHH
Confidence 9999999975211 11111222 23446666666666654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=336.95 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=207.9
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC-----C
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----T 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~ 738 (998)
.++|++.+.||+|+||.||++.+..+|+.||+|.+... ........+..|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 36899999999999999999999999999999998642 2233456677899999999999999999887543 4
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
.+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 82 DVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred eEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 6899999994 588887754 358999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
.... .........|++.|+|||.+.+ ..++.++|||||||++|+|++|++||.+.
T Consensus 158 ~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 158 PEHD------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred cccc------------------------ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1100 0011223568999999998755 56888999999999999999999999876
Q ss_pred ChHHHHHHHHhCC----------------------CCCC-------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHH
Q 001902 898 TRQKTFANILHKD----------------------LKFP-------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948 (998)
Q Consensus 898 ~~~~~~~~i~~~~----------------------~~~~-------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 948 (998)
+.......+.... .+.. .....+.++.+||.+||+.+|.+||| +.++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~e~ 289 (336)
T cd07849 214 DYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT----VEEA 289 (336)
T ss_pred CHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC----HHHH
Confidence 6543333222100 0000 01234678899999999999999999 9999
Q ss_pred HcCCCccCC
Q 001902 949 KKHPFFKGV 957 (998)
Q Consensus 949 L~Hp~f~~~ 957 (998)
++||||+..
T Consensus 290 l~hp~~~~~ 298 (336)
T cd07849 290 LAHPYLEQY 298 (336)
T ss_pred hcCcccccc
Confidence 999999976
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=327.13 Aligned_cols=270 Identities=41% Similarity=0.735 Sum_probs=217.7
Q ss_pred CcccccccCCCCceeEEEEEEc---cCCeEEEEEEeecccccC-hhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 740 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~valK~i~~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 740 (998)
+|++.+.||.|++|.||++.+. .+++.||+|++++..... ......+.+|+.++.++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788999999999999999864 457899999987543222 23345677899999999 699999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||+++++|.+++... ..+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999998764 45899999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC--CCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
. ........|+..|+|||.+.+.. .+.++||||||+++|+|++|..||....
T Consensus 159 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 212 (288)
T cd05583 159 E--------------------------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212 (288)
T ss_pred c--------------------------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 0 00112346889999999987654 6789999999999999999999996432
Q ss_pred h----HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhcCC
Q 001902 899 R----QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMN 966 (998)
Q Consensus 899 ~----~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~ 966 (998)
. ......+.....+. ....+..+.++|.+||..||++|||+.. +.++|+||||+.++|..+....
T Consensus 213 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~R~t~~~-~~~~l~~~~~~~~~~~~~~~~~ 281 (288)
T cd05583 213 EQNSQSEISRRILKSKPPF--PKTMSAEARDFIQKLLEKDPKKRLGANG-ADEIKNHPFFQGIDWDDLAAKR 281 (288)
T ss_pred ccchHHHHHHHHHccCCCC--CcccCHHHHHHHHHHhcCCHhhccCcch-HHHHhcCcccccCCHHHHhhhc
Confidence 2 22233333333332 3346788999999999999999999543 6789999999999998874433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=327.15 Aligned_cols=260 Identities=28% Similarity=0.451 Sum_probs=221.9
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.+.|++.+.||+|++|.||++.+..++..+++|++..... ....+.+|+.+++.++|+||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4579999999999999999999988899999999875422 456778899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+++++|.+++.... ..++...+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-- 170 (286)
T cd06614 94 MEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-- 170 (286)
T ss_pred EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch--
Confidence 99999999999998753 369999999999999999999999999999999999999999999999999874432110
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.....
T Consensus 171 -------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~ 225 (286)
T cd06614 171 -------------------------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225 (286)
T ss_pred -------------------------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0112345788999999998888999999999999999999999999887776655
Q ss_pred HHHHhCCCC-CCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 904 ANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 904 ~~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
..+...... ......++..+.+||.+||+.+|.+||+ +.++++||||+...|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~il~~~~~~~~~~ 278 (286)
T cd06614 226 FLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS----AEELLQHPFLKKACP 278 (286)
T ss_pred HHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcC----HHHHhhChHhhccCc
Confidence 555543332 2222336788999999999999999999 999999999999544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=325.59 Aligned_cols=258 Identities=17% Similarity=0.231 Sum_probs=209.3
Q ss_pred cccCCcccccccCCCCceeEEEEEEcc-----CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 736 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 736 (998)
+..++|++.+.||+|+||.||++.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 345689999999999999999998742 35789999886432 22334567889999999999999999999999
Q ss_pred CCeEEEEEecCCCCchhHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEE
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQP--------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 808 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL 808 (998)
....++||||+++++|.+++.... ...++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999999987532 123577889999999999999999999999999999999999999999
Q ss_pred EeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHH
Q 001902 809 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 888 (998)
Q Consensus 809 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLl 888 (998)
+|||++........ ........+++.|+|||++.+..++.++|||||||++|+|+
T Consensus 161 ~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 215 (277)
T cd05062 161 GDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 215 (277)
T ss_pred CCCCCccccCCcce-------------------------eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHH
Confidence 99999854321100 00111234678899999999888999999999999999999
Q ss_pred c-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 889 Y-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 889 t-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
+ |..||.+.+.......+...... +.....+..+.+|+.+||+.||.+||+ +.+++++
T Consensus 216 ~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps----~~e~l~~ 274 (277)
T cd05062 216 TLAEQPYQGMSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPS----FLEIISS 274 (277)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 8 79999988877777666655432 223446788999999999999999999 6666643
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=332.60 Aligned_cols=260 Identities=27% Similarity=0.441 Sum_probs=205.7
Q ss_pred CcccccccCCCCceeEEEEEEcc--CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC--CeEE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVC 741 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~--~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~~ 741 (998)
+|.+.+.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 8999999999875333333446677899999999999999999999988 8899
Q ss_pred EEEecCCCCchhHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec----CCcEEEEeccCc
Q 001902 742 LITDYCPGGELFLLLDRQ---PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG----NGHVSLTDFDLS 814 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~----~g~vkL~DFG~a 814 (998)
+||||++ ++|.+++... ....+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999995 5676666432 2236899999999999999999999999999999999999999 899999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~P 893 (998)
......... ........+++.|+|||++.+. .++.++|||||||++|+|++|.+|
T Consensus 160 ~~~~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~ 215 (316)
T cd07842 160 RLFNAPLKP------------------------LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215 (316)
T ss_pred cccCCCccc------------------------ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence 654311100 0112345689999999998764 578899999999999999999999
Q ss_pred CCCCChHH---------HHHHHHh--------------------------CCCCCCC---------CCCCcHHHHHHHHH
Q 001902 894 FRGKTRQK---------TFANILH--------------------------KDLKFPS---------STPTSLHAKQLMYR 929 (998)
Q Consensus 894 f~~~~~~~---------~~~~i~~--------------------------~~~~~~~---------~~~~s~~l~~Ll~~ 929 (998)
|.+..... .+..++. ....++. ....+..+.+++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 295 (316)
T cd07842 216 FKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295 (316)
T ss_pred CcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHH
Confidence 97654321 1111111 0001110 01456678999999
Q ss_pred ccccCccCcCCChhcHHHHHcCCCc
Q 001902 930 LLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 930 ~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
||..||.+||| +.++++||||
T Consensus 296 ~l~~~P~~Rps----~~eil~~~~f 316 (316)
T cd07842 296 LLEYDPTKRIT----AEEALEHPYF 316 (316)
T ss_pred HhcCCcccCcC----HHHHhcCCCC
Confidence 99999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=326.59 Aligned_cols=255 Identities=24% Similarity=0.425 Sum_probs=209.4
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
+|++++.||.|++|.||+|.+..+|..||+|++..... ......+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 48899999999999999999999999999999876432 2233556789999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 746 YCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
|++ ++|.+++.... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~---- 153 (284)
T cd07836 79 YMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---- 153 (284)
T ss_pred cCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC----
Confidence 996 48888876542 245899999999999999999999999999999999999999999999999988543211
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
........++..|++||++.+. .++.++|||||||++|+|++|..||.+.+..+.+
T Consensus 154 -----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 210 (284)
T cd07836 154 -----------------------VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL 210 (284)
T ss_pred -----------------------ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 0111233578899999998664 5688999999999999999999999988766655
Q ss_pred HHHHhCC------------------CCCCC---------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 904 ANILHKD------------------LKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 904 ~~i~~~~------------------~~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
..+.... ..++. ....+..+.++|.+||+.||.+||+ +.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~~l~~~~f 284 (284)
T cd07836 211 LKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS----AHDALQHPWF 284 (284)
T ss_pred HHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC----HHHHhcCCCC
Confidence 5543210 00000 0134678899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=327.73 Aligned_cols=255 Identities=27% Similarity=0.396 Sum_probs=203.3
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
.+|++++.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999875422 222335678999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+. ++|.+++.... ..++...++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--- 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC---
Confidence 9995 67776665442 347888899999999999999999999999999999999999999999999885422110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChH-HH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQ-KT 902 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~-~~ 902 (998)
.......+++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.. +.
T Consensus 158 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~ 213 (291)
T cd07870 158 ------------------------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ 213 (291)
T ss_pred ------------------------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH
Confidence 011223578999999998764 5788999999999999999999999865532 22
Q ss_pred HHHHHhC-C----------------------CCCC-------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCC
Q 001902 903 FANILHK-D----------------------LKFP-------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 952 (998)
Q Consensus 903 ~~~i~~~-~----------------------~~~~-------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp 952 (998)
+..+... . ...+ .....+..+.+|+.+||..||.+||| +.+++.||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t----~~~~l~h~ 289 (291)
T cd07870 214 LEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS----AQDALLHP 289 (291)
T ss_pred HHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcC----HHHHhcCC
Confidence 2222110 0 0000 00123567889999999999999999 99999999
Q ss_pred Cc
Q 001902 953 FF 954 (998)
Q Consensus 953 ~f 954 (998)
||
T Consensus 290 ~~ 291 (291)
T cd07870 290 YF 291 (291)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=321.11 Aligned_cols=250 Identities=25% Similarity=0.344 Sum_probs=208.8
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+..++|++.+.||+|++|.||+|.+. +++.||+|.++.... ....+.+|+.++++++|+||+++++++...+.+|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 44568999999999999999999974 467899999875422 2356778999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+||||+++++|.+++.......++...+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999999977655568999999999999999999999999999999999999999999999999986543110
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 900 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~ 900 (998)
. .......++..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..
T Consensus 158 ~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 211 (261)
T cd05068 158 Y--------------------------EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA 211 (261)
T ss_pred c--------------------------cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 0 00111223468999999998889999999999999999998 99999988777
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
..+..+... ...+.....+..+.+++.+||+.+|.+||++.+
T Consensus 212 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 253 (261)
T cd05068 212 EVLQQVDQG-YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFET 253 (261)
T ss_pred HHHHHHHcC-CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 666665443 333444557889999999999999999999433
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=324.87 Aligned_cols=255 Identities=28% Similarity=0.419 Sum_probs=216.2
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
-|++++.||.|+||.||++.+..++..+|+|++.... .......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 4788899999999999999998899999999886432 23345678889999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+++++|.+++.. ..++...+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~---- 155 (277)
T cd06641 83 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---- 155 (277)
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch----
Confidence 9999999999865 348999999999999999999999999999999999999999999999999885432110
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
.......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........
T Consensus 156 -----------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 212 (277)
T cd06641 156 -----------------------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL 212 (277)
T ss_pred -----------------------hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH
Confidence 011234688899999999888889999999999999999999999988776655555
Q ss_pred HHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 906 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
+.....+ ......+..+.+++.+||..+|.+||+ +.++++||||...
T Consensus 213 ~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~~l~~~~~~~~ 259 (277)
T cd06641 213 IPKNNPP-TLEGNYSKPLKEFVEACLNKEPSFRPT----AKELLKHKFIVRF 259 (277)
T ss_pred HhcCCCC-CCCcccCHHHHHHHHHHccCChhhCcC----HHHHHhCHHHhhh
Confidence 5433222 122346788999999999999999999 9999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=325.89 Aligned_cols=267 Identities=44% Similarity=0.773 Sum_probs=216.7
Q ss_pred CcccccccCCCCceeEEEEEEc---cCCeEEEEEEeecccccC-hhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 740 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~valK~i~~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 740 (998)
.|++.+.||.|+||.||+|.+. .+|+.||+|++....... ......+.+|+.+++.+ +|+||+.+++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4888999999999999999985 478999999987643322 23345677899999999 699999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.|++||||+|+|||++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999999764 45889999999999999999999999999999999999999999999999988543211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC--CCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
. ........|+..|+|||.+.+. .++.++||||||+++|+|++|..||....
T Consensus 159 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 212 (290)
T cd05613 159 E--------------------------VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212 (290)
T ss_pred c--------------------------ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC
Confidence 0 0111234689999999998653 46789999999999999999999997533
Q ss_pred h----HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhh
Q 001902 899 R----QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 899 ~----~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~ 962 (998)
. ......+.....+++ ...+..+.+|+.+||..||.+||+.. ..+.+++.||||+.++|..+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 279 (290)
T cd05613 213 EKNSQAEISRRILKSEPPYP--QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL 279 (290)
T ss_pred ccccHHHHHHHhhccCCCCC--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH
Confidence 2 233333333333333 34678899999999999999998432 34999999999999999765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=324.22 Aligned_cols=251 Identities=26% Similarity=0.456 Sum_probs=203.4
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeC--CeEEEE
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK--THVCLI 743 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~--~~~~lV 743 (998)
|++++.||+|+||.||++.+..+++.||+|.++.... .... .....|+.++.++ +|+||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6788999999999999999999999999999876422 2222 2345688888888 499999999999887 899999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||++ ++|.+.+.... ..+++..++.++.||+.||.|||++||+||||+|+||+++. +.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--- 152 (282)
T cd07831 79 FELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--- 152 (282)
T ss_pred EecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC---
Confidence 99996 57877776542 45899999999999999999999999999999999999999 99999999998543211
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
.......++..|+|||++.. ..++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 153 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~ 207 (282)
T cd07831 153 -------------------------PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ 207 (282)
T ss_pred -------------------------CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH
Confidence 01122457889999998754 4568899999999999999999999988776655
Q ss_pred HHHHHhC------------------CCCCCC---------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 903 FANILHK------------------DLKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 903 ~~~i~~~------------------~~~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
+..+... ...++. ....+..+.+||.+||..+|.+||+ +.++++||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~----~~~~l~~~~~ 282 (282)
T cd07831 208 IAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT----AKQALRHPYF 282 (282)
T ss_pred HHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC----HHHHhhCCCC
Confidence 5444321 111111 1235788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=329.87 Aligned_cols=261 Identities=25% Similarity=0.357 Sum_probs=205.9
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 737 (998)
.++|++++.||+|+||.||+|.+..+++.||+|.+..... .........+|+.++++++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4589999999999999999999999999999999875422 122233456799999999999999999988654
Q ss_pred --CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 738 --THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 738 --~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
...++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus 90 ~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 90 YKGSFYLVFEFC-EHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCceEEEEEcCC-CcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 3569999999 458888876542 358999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
........ .........++..|+|||.+.+. .++.++||||||+++|+|++|.+||
T Consensus 168 ~~~~~~~~-----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~ 224 (310)
T cd07865 168 AFSLSKNS-----------------------KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM 224 (310)
T ss_pred cccCCccc-----------------------CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC
Confidence 54311110 00112234678999999998764 4688999999999999999999999
Q ss_pred CCCChHHHHHHHHhC--CC-----------------CCCC-----------CCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 895 RGKTRQKTFANILHK--DL-----------------KFPS-----------STPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 895 ~~~~~~~~~~~i~~~--~~-----------------~~~~-----------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
.+.+.......+... .+ .++. ....+..+.+||.+||..||.+|||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t---- 300 (310)
T cd07865 225 QGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID---- 300 (310)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC----
Confidence 887765444333221 00 0110 0112456789999999999999999
Q ss_pred HHHHHcCCCc
Q 001902 945 ANEIKKHPFF 954 (998)
Q Consensus 945 a~elL~Hp~f 954 (998)
+.++|+||||
T Consensus 301 ~~e~l~h~~f 310 (310)
T cd07865 301 ADTALNHDFF 310 (310)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=328.59 Aligned_cols=256 Identities=22% Similarity=0.319 Sum_probs=210.8
Q ss_pred cccCCcccccccCCCCceeEEEEEEc-----cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEe
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ 735 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~ 735 (998)
+..++|.+.+.||+|+||.||++.+. .++..+|+|+++... .......+.+|+.+++++ +|+||+++++++.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 44568999999999999999999862 346689999887542 233456788999999999 7999999999999
Q ss_pred eCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
..+.+|+||||+++++|.+++.......+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++.
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999999999976544458999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPF 894 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf 894 (998)
....... ........++..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 190 ~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~ 244 (302)
T cd05055 190 DIMNDSN-------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244 (302)
T ss_pred cccCCCc-------------------------eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCc
Confidence 4321100 001123346789999999999999999999999999999998 99999
Q ss_pred CCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 895 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 895 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
........+..........+.....+..+.+|+.+||..+|++||++.++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~el 294 (302)
T cd05055 245 PGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294 (302)
T ss_pred CCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 88776655555555444444444567899999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=337.61 Aligned_cols=267 Identities=25% Similarity=0.401 Sum_probs=213.9
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe----eCCeE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ----TKTHV 740 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~----~~~~~ 740 (998)
++|++.+.||.|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 679999999999999999999999999999999875422 2234566778999999999999999999875 33578
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......
T Consensus 84 ~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLM-ESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehh-hhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999999 56898888654 44999999999999999999999999999999999999999999999999998553211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
... .........|+..|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+.
T Consensus 161 ~~~-----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 217 (334)
T cd07855 161 PTE-----------------------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217 (334)
T ss_pred CcC-----------------------CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh
Confidence 100 0111223478999999999866 4578899999999999999999999988765
Q ss_pred HHHHHHHHhCCC--------------------CCCC---------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 900 QKTFANILHKDL--------------------KFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 900 ~~~~~~i~~~~~--------------------~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
...+..+..... .++. ....+.++.++|.+||+.+|.+||+ +.+++.
T Consensus 218 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~ 293 (334)
T cd07855 218 VHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT----VEQALQ 293 (334)
T ss_pred HHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC----HHHHHh
Confidence 444333222100 0000 1235788999999999999999999 999999
Q ss_pred CCCccCCChhhh
Q 001902 951 HPFFKGVNWALV 962 (998)
Q Consensus 951 Hp~f~~~~~~~~ 962 (998)
||||.+......
T Consensus 294 ~~~~~~~~~~~~ 305 (334)
T cd07855 294 HPFLAQYHDPDD 305 (334)
T ss_pred ChhhhhccCCcc
Confidence 999997655444
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=325.21 Aligned_cols=257 Identities=22% Similarity=0.348 Sum_probs=209.2
Q ss_pred ccCCcccccccCCCCceeEEEEEEc----cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELC----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~----~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
..++|++.+.||+|+||.||+|.+. .++..+++|.+... ........+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 3568999999999999999999863 45678999998743 23344567888999999999999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC
Q 001902 739 HVCLITDYCPGGELFLLLDRQP---------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 803 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~---------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~ 803 (998)
..|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+|+||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 9999999999999999985321 1247888999999999999999999999999999999999999
Q ss_pred CcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHH
Q 001902 804 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 883 (998)
Q Consensus 804 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~i 883 (998)
+.+||+|||++........ ........++..|+|||++.+..++.++|||||||+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 215 (283)
T cd05090 161 LHVKISDLGLSREIYSADY-------------------------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVV 215 (283)
T ss_pred CcEEeccccccccccCCcc-------------------------eecccCCCccceecChHHhccCCCCchhhhHHHHHH
Confidence 9999999999855321100 001123345778999999988889999999999999
Q ss_pred HHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 884 LYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 884 l~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
+|+|++ |..||.+.........+.... ..+....++..+.+++.+||+.||.+||+ +.+|+++
T Consensus 216 l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05090 216 LWEIFSFGLQPYYGFSNQEVIEMVRKRQ-LLPCSEDCPPRMYSLMTECWQEGPSRRPR----FKDIHTR 279 (283)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcccCcccCcC----HHHHHHH
Confidence 999998 999998877655555544433 33444457889999999999999999999 5555543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=319.71 Aligned_cols=259 Identities=25% Similarity=0.364 Sum_probs=214.5
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeeccc--ccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC--CeE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV--MLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THV 740 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~--~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~ 740 (998)
.+|++.+.||+|+||.||++.+..+++.||+|.+.... .........+.+|+.+++.++|+||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 36999999999999999999999999999999875432 12234556788999999999999999999998653 568
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
+++|||+++++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 9999999999999998764 34889999999999999999999999999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
. ..........|+..|+|||++.+..++.++|+|||||++|+|++|..||......
T Consensus 160 ~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 215 (264)
T cd06653 160 C------------------------MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM 215 (264)
T ss_pred c------------------------ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH
Confidence 0 0001112356899999999999888899999999999999999999999887766
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
....++.............+..+.++|.+||. +|..||+ +.+++.|||.
T Consensus 216 ~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~----~~~~~~~~~~ 264 (264)
T cd06653 216 AAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPT----AEFLLRHPFV 264 (264)
T ss_pred HHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCcc----HHHHhcCCCC
Confidence 66665554333322334567889999999999 5799999 9999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=324.10 Aligned_cols=258 Identities=19% Similarity=0.248 Sum_probs=211.4
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccC-----CeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 735 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 735 (998)
.+..++|.+.+.||+|+||.||++.+... +..||+|.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 35567899999999999999999998643 4889999986442 2334456788999999999999999999999
Q ss_pred eCCeEEEEEecCCCCchhHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEE
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQP--------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 807 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vk 807 (998)
.....++||||+++++|.+++.... ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999999999999987532 22467889999999999999999999999999999999999999999
Q ss_pred EEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHH
Q 001902 808 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 887 (998)
Q Consensus 808 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eL 887 (998)
|+|||++........ ........++..|+|||.+.+..++.++|||||||++|+|
T Consensus 160 l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 214 (277)
T cd05032 160 IGDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214 (277)
T ss_pred ECCcccchhhccCcc-------------------------cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHh
Confidence 999999854321100 0111233567899999999888899999999999999999
Q ss_pred Hc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 888 LY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 888 lt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
++ |..||.+.+.......+.... ..+.....+..+.+|+.+||+.+|++||| +.+++.
T Consensus 215 ~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~l~~ 273 (277)
T cd05032 215 ATLAEQPYQGLSNEEVLKFVIDGG-HLDLPENCPDKLLELMRMCWQYNPKMRPT----FLEIVS 273 (277)
T ss_pred hccCCCCCccCCHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 98 999998888777666665432 22333446889999999999999999999 555543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=320.74 Aligned_cols=249 Identities=23% Similarity=0.351 Sum_probs=205.6
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+..++|++.+.||+|+||.||+|.+..+ ..+|+|+++.... ....+.+|+.+++.++|+||+++++.+. ....|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 4456899999999999999999998655 4699999875322 2346788999999999999999998875 45689
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+||||+++++|.+++.......++...+..++.|++.||+|||+++|+|+||||+||+++.++.++|+|||.+.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999999987555568999999999999999999999999999999999999999999999999985432110
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 900 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~ 900 (998)
........++..|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 157 --------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~ 210 (262)
T cd05071 157 --------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 210 (262)
T ss_pred --------------------------cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence 001122346778999999988889999999999999999999 89999888777
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
..+..+... ...+.....+..+.+|+.+||+.||.+||++.+
T Consensus 211 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 252 (262)
T cd05071 211 EVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEERPTFEY 252 (262)
T ss_pred HHHHHHhcC-CCCCCccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 666665443 233444567888999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=334.71 Aligned_cols=262 Identities=23% Similarity=0.320 Sum_probs=207.1
Q ss_pred cccCCC--CceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCC
Q 001902 671 KPLGSG--DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 748 (998)
Q Consensus 671 ~~LG~G--~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 748 (998)
..||.| +||+||++.+..+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|...+..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 999999999999999999999875432 23345778889999999999999999999999999999999999
Q ss_pred CCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcc
Q 001902 749 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 828 (998)
Q Consensus 749 ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~ 828 (998)
+++|.+++.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~----- 157 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK----- 157 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc-----
Confidence 999999998754456899999999999999999999999999999999999999999999999865322100000
Q ss_pred hhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC--CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 001902 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 906 (998)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i 906 (998)
... .........++..|+|||++.+. .++.++|||||||++|+|++|..||.+......+...
T Consensus 158 -----------~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 222 (328)
T cd08226 158 -----------AKV----VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK 222 (328)
T ss_pred -----------ccc----cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHH
Confidence 000 00001112356779999999764 4788999999999999999999999887665554443
Q ss_pred HhCCCC---------------------------------------------CCCCCCCcHHHHHHHHHccccCccCcCCC
Q 001902 907 LHKDLK---------------------------------------------FPSSTPTSLHAKQLMYRLLHRDPKSRLGS 941 (998)
Q Consensus 907 ~~~~~~---------------------------------------------~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~ 941 (998)
...... .+.....+..+.+||.+||+.||++|||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt- 301 (328)
T cd08226 223 LKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS- 301 (328)
T ss_pred hcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC-
Confidence 332111 1111234567899999999999999999
Q ss_pred hhcHHHHHcCCCccCC
Q 001902 942 HEGANEIKKHPFFKGV 957 (998)
Q Consensus 942 ~~~a~elL~Hp~f~~~ 957 (998)
+.++|+||||+.+
T Consensus 302 ---a~e~l~~~~~~~~ 314 (328)
T cd08226 302 ---ASSLLSHAFFKQV 314 (328)
T ss_pred ---HHHHhhCHHHHHH
Confidence 9999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=320.70 Aligned_cols=255 Identities=25% Similarity=0.382 Sum_probs=204.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
+.+.....||+|+||.||++.+..++..|++|.+... .......+.+|+.+++.++|+||+++++++...+..++||
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3444456799999999999999889999999988754 2334567889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec-CCcEEEEeccCccccCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVL--KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l--~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~-~g~vkL~DFG~a~~~~~~~ 821 (998)
||+++++|.+++.... ..+ +...+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||.+.......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 85 EQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 9999999999997642 234 88889999999999999999999999999999999986 6799999999885432100
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC--CCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
.......|++.|+|||++.+.. ++.++||||||+++|+|++|..||.....
T Consensus 164 ---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~ 216 (268)
T cd06624 164 ---------------------------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216 (268)
T ss_pred ---------------------------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC
Confidence 0112235789999999986643 78899999999999999999999976543
Q ss_pred HHH-HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 900 QKT-FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 900 ~~~-~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
... .................+.++.+|+.+||..+|.+||| +.+++.||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~ll~~~~~ 268 (268)
T cd06624 217 PQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRAS----AHDLLQDPFL 268 (268)
T ss_pred hhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCC----HHHHHhCCCC
Confidence 222 11111111111122346788999999999999999999 9999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=317.58 Aligned_cols=250 Identities=48% Similarity=0.864 Sum_probs=217.2
Q ss_pred cCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCCch
Q 001902 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 752 (998)
Q Consensus 673 LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 752 (998)
||.|+||.||++.+..+++.+++|++.+...........+..|+.+++.++|+||+++++.+..+..+|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999999877655555677888999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhh
Q 001902 753 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 832 (998)
Q Consensus 753 ~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 832 (998)
.+++... ..+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----------- 147 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----------- 147 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-----------
Confidence 9999775 358999999999999999999999999999999999999999999999999885432110
Q ss_pred hcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCC
Q 001902 833 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 912 (998)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~ 912 (998)
.......++..|+|||.+.+...+.++|+||||+++|+|++|..||...+.......+......
T Consensus 148 ----------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 211 (250)
T cd05123 148 ----------------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR 211 (250)
T ss_pred ----------------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 1123456889999999998888899999999999999999999999888776666776665444
Q ss_pred CCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 913 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 913 ~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
++. ..+..+.+||.+||..||++||++.. +.++++||||
T Consensus 212 ~~~--~~~~~l~~~i~~~l~~~p~~R~~~~~-~~~l~~~~~f 250 (250)
T cd05123 212 FPE--FLSPEARDLISGLLQKDPTKRLGSGG-AEEIKAHPFF 250 (250)
T ss_pred CCC--CCCHHHHHHHHHHhcCCHhhCCCccc-HHHHHhCCCC
Confidence 443 35788999999999999999999433 4999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=336.20 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=211.0
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC-----Ce
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----TH 739 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~~ 739 (998)
.+|++.+.||.|+||.||++.+..+++.||+|.+..... .......+..|+.+++.++|+||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 579999999999999999999999999999999875422 333345677899999999999999999987644 35
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|+||||+ +++|.+++... ..+++..+..++.||+.||.|||+++++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 89999999 57898888764 4599999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
.. .......++..|+|||.+.. ..++.++|||||||++|+|++|++||.+.+
T Consensus 161 ~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 161 KG---------------------------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred Cc---------------------------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 10 01123467889999999865 468889999999999999999999998765
Q ss_pred hHHHHHHHHhCC----------------------CC---C----CCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 899 RQKTFANILHKD----------------------LK---F----PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 899 ~~~~~~~i~~~~----------------------~~---~----~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
....+..+.... .. . ......+..+.+||.+||+.+|.+||| +.+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps----~~ell 289 (337)
T cd07858 214 YVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT----VEEAL 289 (337)
T ss_pred hHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC----HHHHH
Confidence 443333222100 00 0 011346788999999999999999999 99999
Q ss_pred cCCCccCCChh
Q 001902 950 KHPFFKGVNWA 960 (998)
Q Consensus 950 ~Hp~f~~~~~~ 960 (998)
+||||..+.-.
T Consensus 290 ~h~~~~~~~~~ 300 (337)
T cd07858 290 AHPYLASLHDP 300 (337)
T ss_pred cCcchhhhcCc
Confidence 99999876433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=330.00 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=206.8
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeE--EEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCC
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 738 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~--valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 738 (998)
+..++|++.+.||+|+||.||+|.+..++.. +++|.++.. ........+.+|+.++.++ +|+||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 4456899999999999999999999777764 466665532 2334456778899999999 8999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC
Q 001902 739 HVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 804 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g 804 (998)
.+|+||||+++++|.+++.+.. ...++...++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999997542 23578999999999999999999999999999999999999999
Q ss_pred cEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHH
Q 001902 805 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 884 (998)
Q Consensus 805 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il 884 (998)
.+||+|||++..... ........++..|+|||++.+..++.++|||||||++
T Consensus 162 ~~kl~dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 213 (303)
T cd05088 162 VAKIADFGLSRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213 (303)
T ss_pred cEEeCccccCcccch----------------------------hhhcccCCCcccccCHHHHhccCCcccccchhhhhHH
Confidence 999999998742110 0001112346689999999888899999999999999
Q ss_pred HHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 885 YEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 885 ~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
|+|++ |..||.+.+..+....+... .........+..+.+|+.+||..+|.+||+ +.+++.+
T Consensus 214 ~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~ 276 (303)
T cd05088 214 WEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 276 (303)
T ss_pred HHHHhcCCCCcccCChHHHHHHHhcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 99998 99999887776666555432 222233446788999999999999999999 5555544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=319.71 Aligned_cols=252 Identities=28% Similarity=0.405 Sum_probs=208.9
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.....+......+.+|+.++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999899999999987654445555678889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 745 DYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 745 E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
||+++++|..++... ....++...+..++.+|+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 999999999998642 23458999999999999999999999999999999999999999999999999875432110
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh--H
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR--Q 900 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~--~ 900 (998)
.......|++.|+|||.+.+..++.++|||||||++|+|++|..||..... .
T Consensus 161 --------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08224 161 --------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred --------------------------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH
Confidence 011234588899999999998899999999999999999999999965432 2
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
.....+..+..........+..+.++|.+||..+|++||++.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ 257 (267)
T cd08224 215 SLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISY 257 (267)
T ss_pred HHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 3333443332221112246778999999999999999999443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=319.59 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=205.9
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+..++|++++.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+.++++++|+||+++++++. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 45678999999999999999999874 566799999876432 2356788999999999999999999875 45689
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
++|||+++++|.+++.......+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999999999977555568999999999999999999999999999999999999999999999999985432110
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 900 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~ 900 (998)
........++..|+|||++.+..++.++||||||+++|+|++ |.+||.+.+..
T Consensus 157 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 210 (260)
T cd05070 157 --------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210 (260)
T ss_pred --------------------------cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 001112235678999999988889999999999999999999 99999888777
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH 942 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~ 942 (998)
+....+... ...+.....+..+.+|+.+||..+|.+|||+.
T Consensus 211 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 251 (260)
T cd05070 211 EVLEQVERG-YRMPCPQDCPISLHELMLQCWKKDPEERPTFE 251 (260)
T ss_pred HHHHHHHcC-CCCCCCCcCCHHHHHHHHHHcccCcccCcCHH
Confidence 777666543 33344445688999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=319.89 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=209.0
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++++.||+|+||.||++.+.. +..+|+|.+..... ....+.+|+.++++++||||+++++++.....+++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4579999999999999999998743 45699998875422 235678899999999999999999999988999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+.+++|.+++..... .+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||.+.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-- 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-- 154 (256)
T ss_pred EEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc--
Confidence 999999999999976433 58999999999999999999999999999999999999999999999999885432110
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~ 902 (998)
........++..|+|||++.+..++.++|||||||++|+|++ |..||...+....
T Consensus 155 ------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~ 210 (256)
T cd05113 155 ------------------------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET 210 (256)
T ss_pred ------------------------eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence 001112235678999999998889999999999999999998 9999988877777
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
...+...... +.....+..+.+++.+||..||.+||+ +.+|+.+
T Consensus 211 ~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~ll~~ 254 (256)
T cd05113 211 VEKVSQGLRL-YRPHLASEKVYAIMYSCWHEKAEERPT----FQQLLSS 254 (256)
T ss_pred HHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCCC----HHHHHHh
Confidence 7777665433 223346789999999999999999999 7777754
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=330.07 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=202.9
Q ss_pred CceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCCchhHHH
Q 001902 677 DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL 756 (998)
Q Consensus 677 ~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l 756 (998)
++|.||.+.+..+++.||+|++.... ........+..|+.+++.++|+||+++++++...+..+++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 44556666666799999999998652 23456678999999999999999999999999999999999999999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhccc
Q 001902 757 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836 (998)
Q Consensus 757 ~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~ 836 (998)
.......+++..+..++.||+.||.|||+++|+||||||+||+++.+|.++|+|||.+..........
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~------------ 158 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ------------ 158 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc------------
Confidence 87555568999999999999999999999999999999999999999999999999886542111000
Q ss_pred CCCCcccccccccccccccCCCCcccchhhcC--CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCC-
Q 001902 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKF- 913 (998)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~~- 913 (998)
...........++..|+|||++.. ..++.++|||||||++|+|++|..||........+.....+....
T Consensus 159 --------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (314)
T cd08216 159 --------RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCL 230 (314)
T ss_pred --------cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccc
Confidence 000111234467889999999976 357889999999999999999999998765544332222211100
Q ss_pred -------------------------------CCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 914 -------------------------------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 914 -------------------------------~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
+.....+.++.+|+.+||..||++||| +.++|+||||+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~p~~~~~~ 302 (314)
T cd08216 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS----ASQLLNHSFFKQCK 302 (314)
T ss_pred cccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC----HHHHhcCchHhhhc
Confidence 001112457889999999999999999 99999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=316.71 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=201.8
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 750 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 750 (998)
+.||+|+||.||+|.+..+++.+|+|.+.... .......+.+|+++++.++||||+++++++......|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999999999999999876432 3344567889999999999999999999999999999999999999
Q ss_pred chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchh
Q 001902 751 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830 (998)
Q Consensus 751 sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 830 (998)
+|.+++... ...+++..++.++.|++.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 79 ~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-------- 149 (252)
T cd05084 79 DFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-------- 149 (252)
T ss_pred cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc--------
Confidence 999998754 24589999999999999999999999999999999999999999999999999854221000
Q ss_pred hhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhC
Q 001902 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHK 909 (998)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~ 909 (998)
........++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+...
T Consensus 150 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~ 212 (252)
T cd05084 150 -----------------ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG 212 (252)
T ss_pred -----------------cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC
Confidence 000011123467999999999889999999999999999997 99999877766555554443
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 910 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
...+.....+..+.+|+.+||..+|++||+ +.+++
T Consensus 213 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~~ 247 (252)
T cd05084 213 -VRLPCPELCPDAVYRLMERCWEYDPGQRPS----FSTVH 247 (252)
T ss_pred -CCCCCcccCCHHHHHHHHHHcCCChhhCcC----HHHHH
Confidence 233334456889999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=322.31 Aligned_cols=257 Identities=20% Similarity=0.300 Sum_probs=209.7
Q ss_pred ccCCcccccccCCCCceeEEEEEEcc-----CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
..+.|.+.+.||+|++|.||+|.+.. ++..|++|.+.... .......+..|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34679999999999999999999977 77899999876432 233445688899999999999999999999988
Q ss_pred CeEEEEEecCCCCchhHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC---cEEEE
Q 001902 738 THVCLITDYCPGGELFLLLDRQPT-----KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLT 809 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g---~vkL~ 809 (998)
+..++||||+++++|.+++..... ..+++..+..++.||+.||.|||+++++|+||||+||+++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 999999999999999999976421 2588999999999999999999999999999999999998765 59999
Q ss_pred eccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc
Q 001902 810 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 889 (998)
Q Consensus 810 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt 889 (998)
|||++........ ........++..|+|||++.+..++.++|||||||++|+|++
T Consensus 162 dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 216 (277)
T cd05036 162 DFGMARDIYRASY-------------------------YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216 (277)
T ss_pred cCccccccCCccc-------------------------eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHc
Confidence 9999865321100 000112234568999999998899999999999999999996
Q ss_pred -CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 890 -GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 890 -G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
|..||.+.+.......+... .........+..+.+|+.+||+.+|++||+ +.++++|
T Consensus 217 ~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps----~~~vl~~ 274 (277)
T cd05036 217 LGYMPYPGRTNQEVMEFVTGG-GRLDPPKGCPGPVYRIMTDCWQHTPEDRPN----FATILER 274 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcC----HHHHHHH
Confidence 99999988776666555443 222333456788999999999999999999 7777765
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=325.13 Aligned_cols=254 Identities=30% Similarity=0.476 Sum_probs=213.4
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEec
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 746 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 746 (998)
|.....||+|+||.||++.+..++..+|+|.+... .......+.+|+.+++.++|+||+++++++...+..|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 34446799999999999999999999999987532 223456688899999999999999999999999999999999
Q ss_pred CCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCC
Q 001902 747 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 826 (998)
Q Consensus 747 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 826 (998)
+++++|.+++.. ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 99 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~------ 169 (292)
T cd06657 99 LEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------ 169 (292)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc------
Confidence 999999998754 34899999999999999999999999999999999999999999999999987433210
Q ss_pred cchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 001902 827 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 906 (998)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i 906 (998)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.........+
T Consensus 170 ---------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~ 228 (292)
T cd06657 170 ---------------------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228 (292)
T ss_pred ---------------------cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 01123356889999999998888899999999999999999999999887666555444
Q ss_pred HhCC-CCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 907 LHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 907 ~~~~-~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.... ..+......+..+.+++.+||..+|.+||+ +.++++||||...
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~----~~~ll~~~~~~~~ 276 (292)
T cd06657 229 RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT----AAELLKHPFLAKA 276 (292)
T ss_pred HhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcC----HHHHhcChHHhcc
Confidence 3321 122233456788999999999999999999 9999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=319.39 Aligned_cols=252 Identities=24% Similarity=0.371 Sum_probs=209.1
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+..++|+++++||+|+||.||+|.. .+++.||+|.+..... ....+.+|+.+++.++|+||+++++++. .+.+
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence 35567899999999999999999986 4578899999875432 2356788999999999999999998874 4678
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|++|||+++++|.+++.......++...+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999999999997766667999999999999999999999999999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~ 899 (998)
. ........++..|+|||++....++.++||||||+++|+|++ |.+||.+.+.
T Consensus 156 ~--------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 209 (260)
T cd05067 156 E--------------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209 (260)
T ss_pred C--------------------------cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence 0 001122346778999999998889999999999999999998 9999998877
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
......+... ...+.....+.++.+|+.+||..+|++||+ +++++
T Consensus 210 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~l~ 254 (260)
T cd05067 210 PEVIQNLERG-YRMPRPDNCPEELYELMRLCWKEKPEERPT----FEYLR 254 (260)
T ss_pred HHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHccCChhhCCC----HHHHH
Confidence 6666655443 333444556789999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=319.33 Aligned_cols=255 Identities=22% Similarity=0.282 Sum_probs=211.3
Q ss_pred cCCcccccccCCCCceeEEEEEEccC---CeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.++|++.+.||+|+||.||+|.+..+ ...+|+|.++... .......+..|+.+++.++|+||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 45799999999999999999998644 4589999887542 344456788899999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
++||||+++++|.+++.... ..++...+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999997653 36899999999999999999999999999999999999999999999999998654311
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~ 899 (998)
... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 160 ~~~-------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~ 214 (266)
T cd05033 160 EAT-------------------------YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214 (266)
T ss_pred ccc-------------------------eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH
Confidence 100 00112235678999999998889999999999999999997 9999988777
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
......+... ...+.....+..+.+|+.+||+.+|++||+ +.+++++
T Consensus 215 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~----~~ei~~~ 261 (266)
T cd05033 215 QDVIKAVEDG-YRLPPPMDCPSALYQLMLDCWQKDRNERPT----FSQIVST 261 (266)
T ss_pred HHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcC----HHHHHHH
Confidence 7666666543 233444557889999999999999999999 5555543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=333.83 Aligned_cols=262 Identities=25% Similarity=0.383 Sum_probs=216.7
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC-----eE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-----HV 740 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-----~~ 740 (998)
+|++.+.||.|++|.||+|.+..+++.||+|.+.... ........+..|+.+++.++|+||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5889999999999999999998889999999987542 22344567888999999999999999999987765 88
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||++ ++|.+++.+. ..+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 80 YIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999995 5898888764 36999999999999999999999999999999999999999999999999998654311
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
... ........+++.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+.
T Consensus 157 ~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~ 212 (330)
T cd07834 157 EDE------------------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY 212 (330)
T ss_pred ccc------------------------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH
Confidence 100 0112234688999999999887 788999999999999999999999998887
Q ss_pred HHHHHHHHhCCCCCC-----------------------------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 900 QKTFANILHKDLKFP-----------------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~-----------------------------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
.+.+..+.......+ .....+..+.+||.+||+.+|.+||+ +.++++
T Consensus 213 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~ 288 (330)
T cd07834 213 IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT----ADEALA 288 (330)
T ss_pred HHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC----HHHHHh
Confidence 666665554211000 01225678899999999999999999 999999
Q ss_pred CCCccCCCh
Q 001902 951 HPFFKGVNW 959 (998)
Q Consensus 951 Hp~f~~~~~ 959 (998)
||||+++.-
T Consensus 289 ~~~~~~~~~ 297 (330)
T cd07834 289 HPYLAQLHD 297 (330)
T ss_pred CccHHhhcc
Confidence 999998543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=312.33 Aligned_cols=264 Identities=28% Similarity=0.457 Sum_probs=209.6
Q ss_pred cCCcccccccCCCCceeEEEEEEccCC----eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee-CC
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSG----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KT 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~----~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-~~ 738 (998)
...|+++..||+|.||.||+|..+.++ +.||+|.++...-. ........+|+.+++.++||||+.+..+|.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 357999999999999999999765442 37999998754221 1223456789999999999999999999876 88
Q ss_pred eEEEEEecCCCCchhHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC----CcEEEEec
Q 001902 739 HVCLITDYCPGGELFLLLDRQ---PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDF 811 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~----g~vkL~DF 811 (998)
.+++++||. ..+|..+++.+ ....++...++.|+.||+.|+.|||++-|+||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999999 66888888742 33569999999999999999999999999999999999999987 89999999
Q ss_pred cCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcC
Q 001902 812 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG 890 (998)
Q Consensus 812 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG 890 (998)
|+++.+... ..+......++.|.+|.|||.+.+. .|+++.||||.|||+.||++-
T Consensus 181 GlaR~~~~p------------------------lkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl 236 (438)
T KOG0666|consen 181 GLARLFNNP------------------------LKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTL 236 (438)
T ss_pred cHHHHhhcc------------------------ccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHcc
Confidence 999775421 1223345567899999999999986 578899999999999999999
Q ss_pred CCCCCCCC---------hHHHHHHHHhC-----CCCCC------CC------------------------CCCcHHHHHH
Q 001902 891 YTPFRGKT---------RQKTFANILHK-----DLKFP------SS------------------------TPTSLHAKQL 926 (998)
Q Consensus 891 ~~Pf~~~~---------~~~~~~~i~~~-----~~~~~------~~------------------------~~~s~~l~~L 926 (998)
++.|.+.. ...++.+|..- .-.+| .. ..-++...+|
T Consensus 237 ~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~L 316 (438)
T KOG0666|consen 237 EPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDL 316 (438)
T ss_pred CccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHH
Confidence 99996532 23445555431 01111 10 1113336789
Q ss_pred HHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 927 MYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 927 l~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
|.+||..||-+|+| +.++|+|+||+.-
T Consensus 317 L~klL~yDP~kRIt----a~qAleh~yF~~d 343 (438)
T KOG0666|consen 317 LQKLLTYDPIKRIT----AEQALEHPYFTED 343 (438)
T ss_pred HHHHhccCchhhcc----HHHHhcccccccC
Confidence 99999999999999 9999999999974
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=323.62 Aligned_cols=257 Identities=21% Similarity=0.325 Sum_probs=211.1
Q ss_pred cccCCcccccccCCCCceeEEEEEEccC-----CeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 736 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 736 (998)
++..+|++++.||+|+||.||++.+..+ ++.+|+|+++... .......+..|+.++..++||||+++++++..
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3456799999999999999999987543 5789999987542 23345667889999999999999999999999
Q ss_pred CCeEEEEEecCCCCchhHHHhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQ--------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 802 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~ 802 (998)
.+..++++||+++++|.+++... ....++...+..++.|++.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 99999999999999999998531 1234788889999999999999999999999999999999999
Q ss_pred CCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHH
Q 001902 803 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 882 (998)
Q Consensus 803 ~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~ 882 (998)
++.+||+|||++........ ........+++.|+|||++.+..++.++|||||||
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 214 (283)
T cd05091 160 KLNVKISDLGLFREVYAADY-------------------------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGV 214 (283)
T ss_pred CCceEecccccccccccchh-------------------------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHH
Confidence 99999999999854321100 01112334678999999998888999999999999
Q ss_pred HHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 883 LLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 883 il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
++|+|++ |..||.+......+..+...... +....++..+.+|+.+||+.+|.+||+ +.+|+.
T Consensus 215 ~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~----~~~i~~ 278 (283)
T cd05091 215 VLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPR----FKDIHS 278 (283)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCC----HHHHHH
Confidence 9999998 89999988887777777665432 223457888999999999999999999 666554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=326.80 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=216.6
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
..|...+.||+|+||.||++.+..++..+++|.+.............+.+|+.+++.++|+|++++++++...+..++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45888999999999999999999999999999987543334445567788999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+. ++|.+++... ...+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++....
T Consensus 95 e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~------ 166 (308)
T cd06634 95 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------ 166 (308)
T ss_pred EccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec------
Confidence 9995 6787777543 2458999999999999999999999999999999999999999999999999874422
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc---CCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
......|++.|+|||.+. ...++.++|||||||++|+|++|..||...+...
T Consensus 167 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 221 (308)
T cd06634 167 -------------------------PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (308)
T ss_pred -------------------------CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH
Confidence 012345888999999985 3457889999999999999999999998877666
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
....+.....+.......+..+.+||.+||..+|.+||+ +.++++|||+...
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~----~~~ll~~~~~~~~ 273 (308)
T cd06634 222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT----SEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCC----HHHHhhCcccccc
Confidence 666665554444334457788999999999999999999 9999999999884
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=338.43 Aligned_cols=260 Identities=23% Similarity=0.351 Sum_probs=224.3
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCCe---E-EEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEE
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---Y-FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF 734 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~-valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 734 (998)
.+++..++..+.++||+|+||.||++..+..+. . ||+|..+............+.+|+++|++++|||||++||+.
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 456667777888999999999999999865422 3 899998865556778889999999999999999999999999
Q ss_pred eeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCc
Q 001902 735 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814 (998)
Q Consensus 735 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a 814 (998)
....-++||||+|.||+|.++|++.+. .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||++
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999999998753 5999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccc-cccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN-SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYT 892 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~ 892 (998)
.... .. .... ...-...|+|||.+....|++++|||||||++||+++ |..
T Consensus 310 ~~~~---~~-------------------------~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~ 361 (474)
T KOG0194|consen 310 RAGS---QY-------------------------VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAE 361 (474)
T ss_pred cCCc---ce-------------------------eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCC
Confidence 5432 00 0000 1124568999999999999999999999999999997 899
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 893 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 893 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
||.+........+|.......+.....+.++..++.+|+..+|++||++.+++..
T Consensus 362 Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~ 416 (474)
T KOG0194|consen 362 PYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKK 416 (474)
T ss_pred CCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHH
Confidence 9999999999999977776666666778899999999999999999997765443
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=318.20 Aligned_cols=250 Identities=23% Similarity=0.374 Sum_probs=206.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
..+|++.+.||+|+||.||++.+. ++..+|+|++..... ....+..|+.+++.++|+||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 346899999999999999999885 567899999875432 224577899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus 78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~- 155 (256)
T cd05059 78 TEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY- 155 (256)
T ss_pred EecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-
Confidence 99999999999997653 3589999999999999999999999999999999999999999999999998854321000
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~ 902 (998)
.......++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+....
T Consensus 156 -------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 210 (256)
T cd05059 156 -------------------------TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV 210 (256)
T ss_pred -------------------------cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH
Confidence 00111124567999999999899999999999999999998 8999988777666
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
...+... ...+.....+..+.+++.+||..+|.+||| +.++++
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt----~~~~l~ 253 (256)
T cd05059 211 VESVSAG-YRLYRPKLAPTEVYTIMYSCWHEKPEDRPA----FKKLLS 253 (256)
T ss_pred HHHHHcC-CcCCCCCCCCHHHHHHHHHHhcCChhhCcC----HHHHHH
Confidence 6665543 233334457889999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=317.69 Aligned_cols=247 Identities=22% Similarity=0.387 Sum_probs=205.7
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEE-eeCCe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF-QTKTH 739 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~-~~~~~ 739 (998)
.+...+|++.+.||+|+||.||++.. .|..+++|.++.. .....+.+|+.++++++|+|++++++++ ...+.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 74 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence 35667899999999999999999986 4778999988643 2345678899999999999999999975 45577
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
.++||||+++++|.+++.......+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 99999999999999999876555689999999999999999999999999999999999999999999999998843210
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~ 898 (998)
......++..|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 155 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 155 ------------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ------------------------------cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 0112234568999999998889999999999999999997 999998877
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
.......+... ........++..+.+++.+||+.+|.+||| +.+++
T Consensus 205 ~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~l~ 250 (256)
T cd05082 205 LKDVVPRVEKG-YKMDAPDGCPPVVYDVMKQCWHLDAATRPS----FLQLR 250 (256)
T ss_pred HHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHhcCChhhCcC----HHHHH
Confidence 66665555443 222333456889999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=324.50 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=209.6
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCC----------------eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCC
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSG----------------QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~----------------~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~n 726 (998)
..++|++++.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCC
Confidence 3568999999999999999999876543 568999987543 2345667889999999999999
Q ss_pred ccceeEEEeeCCeEEEEEecCCCCchhHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 001902 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQP---------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 797 (998)
Q Consensus 727 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~N 797 (998)
|+++++++..++..++||||+++++|.+++.... ...+++..++.++.|++.||.|||++||+|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999997643 1258999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHH
Q 001902 798 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 877 (998)
Q Consensus 798 ILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDI 877 (998)
|+++.++.++|+|||++....... .........+++.|+|||++.+..++.++||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSD-------------------------YYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215 (296)
T ss_pred eeecCCCceEEccccceeecccCc-------------------------ceeecCcCCCCceecCHHHhhcCCCCccchh
Confidence 999999999999999985432110 0111234456789999999988889999999
Q ss_pred HHHHHHHHHHHc--CCCCCCCCChHHHHHHHHhC------CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 878 WALGILLYEMLY--GYTPFRGKTRQKTFANILHK------DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 878 wSlG~il~eLlt--G~~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
|||||++|+|++ |..||...+....+..+... ....+.....+.++.+|+.+||+.||.+||| +.+|+
T Consensus 216 ~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt----~~el~ 291 (296)
T cd05051 216 WAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT----FREIH 291 (296)
T ss_pred hhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCC----HHHHH
Confidence 999999999997 78899887766666655432 1122333446789999999999999999999 66664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=368.62 Aligned_cols=259 Identities=28% Similarity=0.477 Sum_probs=218.6
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
++.....||.|.||.||.|.+..+|...|+|.++..... ......+.+|..++..++|||+|++|++-.+.+.++|.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 566778899999999999999999999999988765433 4556677889999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
||.+|+|.+++... ...++...+.+..|++.|+.|||+.|||||||||.||+++.+|.+|++|||.|..+.......
T Consensus 1315 yC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~- 1391 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM- 1391 (1509)
T ss_pred HhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC-
Confidence 99999999999763 557888888999999999999999999999999999999999999999999997654221110
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC---CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
...-....||+.|||||++.+. +..-+.|||||||++.||+||+.||...+....
T Consensus 1392 ----------------------~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a 1449 (1509)
T KOG4645|consen 1392 ----------------------PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA 1449 (1509)
T ss_pred ----------------------CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH
Confidence 0122356899999999999764 456799999999999999999999988776554
Q ss_pred HHHHH-hC-CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 903 FANIL-HK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 903 ~~~i~-~~-~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
+.-.+ .+ ..++|.. +|.+..+||..||..||.+|.+ +.|||.|.|-+.
T Consensus 1450 IMy~V~~gh~Pq~P~~--ls~~g~dFle~Cl~~dP~~Rw~----~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1450 IMYHVAAGHKPQIPER--LSSEGRDFLEHCLEQDPKMRWT----ASQLLEHAFGKS 1499 (1509)
T ss_pred HHhHHhccCCCCCchh--hhHhHHHHHHHHHhcCchhhhH----HHHHHHhhcccc
Confidence 44333 33 3344443 8999999999999999999999 999999988654
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=314.77 Aligned_cols=257 Identities=30% Similarity=0.437 Sum_probs=216.0
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC--CeEEEE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVCLI 743 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~~lV 743 (998)
+|.+.+.||+|++|.||+|.+..+++.+++|++..... .......+.+|+.++++++|+||+++++.+... ..+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 47888999999999999999998999999999876532 234567888999999999999999999999988 899999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999999998753 6999999999999999999999999999999999999999999999999998554311100
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC-hHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT-RQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~-~~~~ 902 (998)
.......++..|+|||.+.+...+.++||||||+++|+|++|..||.... ....
T Consensus 158 -------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 212 (260)
T cd06606 158 -------------------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA 212 (260)
T ss_pred -------------------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH
Confidence 01223468899999999988889999999999999999999999998876 2333
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
...+.............+..+.+|+.+||..||.+||+ +.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~----~~~ll~~~~~ 260 (260)
T cd06606 213 LYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT----ADELLQHPFL 260 (260)
T ss_pred HHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCC----HHHHhhCCCC
Confidence 33333222222223345789999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.58 Aligned_cols=252 Identities=31% Similarity=0.513 Sum_probs=214.9
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
+|.+.+.||.|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++|+||+++++++......+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48888999999999999999988999999999876432 355678889999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---- 152 (253)
T cd05122 78 FCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK---- 152 (253)
T ss_pred cCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc----
Confidence 999999999987753 468999999999999999999999999999999999999999999999999885432110
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 153 ------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 208 (253)
T cd05122 153 ------------------------ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK 208 (253)
T ss_pred ------------------------cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence 02344688999999999988889999999999999999999999988765554444
Q ss_pred HHhCCC-CCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCC
Q 001902 906 ILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953 (998)
Q Consensus 906 i~~~~~-~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~ 953 (998)
+..... ..+.....+..+.++|.+||..||.+||| +.++++|||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t----~~~~l~~~~ 253 (253)
T cd05122 209 IATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT----AEQLLKHPF 253 (253)
T ss_pred HHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCC----HHHHhcCCC
Confidence 443222 22222334788999999999999999999 999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=324.91 Aligned_cols=261 Identities=21% Similarity=0.340 Sum_probs=212.6
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccC-----CeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeE
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 732 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~ 732 (998)
...+..++|++.+.||+|+||.||++.+... ...+|+|.+.... .......+.+|+.+++++ +|+||+++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 4456667899999999999999999998643 3789999987542 233445688899999999 8999999999
Q ss_pred EEeeCCeEEEEEecCCCCchhHHHhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 001902 733 SFQTKTHVCLITDYCPGGELFLLLDRQ--------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 798 (998)
Q Consensus 733 ~~~~~~~~~lV~E~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NI 798 (998)
++...+.++++|||+++++|..++... ....+++..+..++.||+.||.|||++||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999998642 245689999999999999999999999999999999999
Q ss_pred EEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHH
Q 001902 799 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 878 (998)
Q Consensus 799 Li~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIw 878 (998)
|++.++.+||+|||++........ ........++..|+|||++.+..++.++|||
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 218 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDY-------------------------YRKTTNGRLPVKWMAPEALFDRVYTHQSDVW 218 (293)
T ss_pred EEcCCCeEEeCccccccccccccc-------------------------eeccCCCCCCccccCHHHhccCCcCccccee
Confidence 999999999999999865321100 0011122356789999999888899999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 879 ALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 879 SlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
||||++|+|++ |..||.+......+..+... .........+..+.+|+.+||..||.+||| +.+++++
T Consensus 219 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~eil~~ 287 (293)
T cd05053 219 SFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG-YRMEKPQNCTQELYHLMRDCWHEVPSQRPT----FKQLVED 287 (293)
T ss_pred ehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcccCcccCcC----HHHHHHH
Confidence 99999999997 99999888776666655443 233334456789999999999999999999 6665543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.64 Aligned_cols=249 Identities=20% Similarity=0.291 Sum_probs=202.2
Q ss_pred ccCCCCceeEEEEEE--ccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCC
Q 001902 672 PLGSGDTGSVHLVEL--CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 749 (998)
Q Consensus 672 ~LG~G~~g~Vy~a~~--~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 749 (998)
.||+|+||.||+|.+ ..++..+|+|+++... ........+.+|+.+++.++|+||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999965 4568899999987542 23445677889999999999999999999875 4567899999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~------ 151 (257)
T cd05116 80 GPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY------ 151 (257)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe------
Confidence 9999999764 45899999999999999999999999999999999999999999999999998654311100
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHh
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILH 908 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~ 908 (998)
........++..|+|||.+....++.++|||||||++|+|++ |..||...+.......+..
T Consensus 152 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~ 213 (257)
T cd05116 152 ------------------YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES 213 (257)
T ss_pred ------------------eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC
Confidence 001112235678999999988889999999999999999997 9999988777666666654
Q ss_pred CCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 909 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 909 ~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
+. ..+.....+.++.+||.+||+.||.+||++..+...|.
T Consensus 214 ~~-~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~ 253 (257)
T cd05116 214 GE-RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLR 253 (257)
T ss_pred CC-CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence 43 23333457889999999999999999999655544443
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=334.25 Aligned_cols=257 Identities=30% Similarity=0.467 Sum_probs=209.2
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC------C
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------T 738 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------~ 738 (998)
++|.+.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++|+||+++++++... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 589999999999999999999988999999999875422 223345677899999999999999999998654 3
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
..|+||||+. .+|..++. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++....
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 5699999994 57776652 248999999999999999999999999999999999999999999999999984321
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
. ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 169 ~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 169 A------------------------------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred C------------------------------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 0 1123467889999999876 46788999999999999999999999987
Q ss_pred ChHHHHHHHHhCC-----------------------CCCCC------CCCCcHHHHHHHHHccccCccCcCCChhcHHHH
Q 001902 898 TRQKTFANILHKD-----------------------LKFPS------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948 (998)
Q Consensus 898 ~~~~~~~~i~~~~-----------------------~~~~~------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 948 (998)
+....+..+.... ...+. ....+..+.+||.+||+.||.+||+ +.++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~----~~e~ 294 (342)
T cd07879 219 DYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT----ATEA 294 (342)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC----HHHH
Confidence 7655554443310 00000 1235678899999999999999999 9999
Q ss_pred HcCCCccCCChhh
Q 001902 949 KKHPFFKGVNWAL 961 (998)
Q Consensus 949 L~Hp~f~~~~~~~ 961 (998)
+.||||+.+....
T Consensus 295 l~h~~f~~~~~~~ 307 (342)
T cd07879 295 LEHPYFDSFRDAD 307 (342)
T ss_pred hcCcchhhccccc
Confidence 9999999986543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=331.67 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=207.4
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 737 (998)
.++|.+.+.||.|+||.||+|.+..+|+.||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 368999999999999999999999999999999986542 23456678899999999999999999876543
Q ss_pred --------CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec-CCcEEE
Q 001902 738 --------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSL 808 (998)
Q Consensus 738 --------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~-~g~vkL 808 (998)
...|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE
Confidence 36899999995 689888854 34899999999999999999999999999999999999984 567899
Q ss_pred EeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHH
Q 001902 809 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEM 887 (998)
Q Consensus 809 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eL 887 (998)
+|||++........ .........|+..|+|||.+.. ..++.++|||||||++|+|
T Consensus 157 ~dfg~~~~~~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 212 (342)
T cd07854 157 GDFGLARIVDPHYS------------------------HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 212 (342)
T ss_pred CCcccceecCCccc------------------------cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHH
Confidence 99999854321100 0011122357889999998754 5678899999999999999
Q ss_pred HcCCCCCCCCChHHHHHHHHhCCC----------------------CCC------CCCCCcHHHHHHHHHccccCccCcC
Q 001902 888 LYGYTPFRGKTRQKTFANILHKDL----------------------KFP------SSTPTSLHAKQLMYRLLHRDPKSRL 939 (998)
Q Consensus 888 ltG~~Pf~~~~~~~~~~~i~~~~~----------------------~~~------~~~~~s~~l~~Ll~~~L~~dP~~Rp 939 (998)
++|..||.+.+.......+..... ..+ .....+.++.+||.+||+.||.+||
T Consensus 213 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 292 (342)
T cd07854 213 LTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL 292 (342)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhcc
Confidence 999999988776555554433210 000 0123567889999999999999999
Q ss_pred CChhcHHHHHcCCCccCC
Q 001902 940 GSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 940 t~~~~a~elL~Hp~f~~~ 957 (998)
| +.++++||||+.+
T Consensus 293 t----~~ell~h~~~~~~ 306 (342)
T cd07854 293 T----AEEALMHPYMSCY 306 (342)
T ss_pred C----HHHHhCCCccccc
Confidence 9 9999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=323.00 Aligned_cols=255 Identities=21% Similarity=0.295 Sum_probs=209.6
Q ss_pred ccCCcccccccCCCCceeEEEEEEc-----cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
...+|.+.+.||+|+||.||+|.+. .++..+++|.+... .......+.+|+.++++++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 3457999999999999999999863 34567899987643 233345678899999999999999999999999
Q ss_pred CeEEEEEecCCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC
Q 001902 738 THVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 803 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~ 803 (998)
+..++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997542 2348899999999999999999999999999999999999999
Q ss_pred CcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHH
Q 001902 804 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 883 (998)
Q Consensus 804 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~i 883 (998)
+.++|+|||++........ ........++..|+|||++.+..++.++|||||||+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 214 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDY-------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 214 (291)
T ss_pred CcEEECCCCcccccCCCce-------------------------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHH
Confidence 9999999999854321100 011223457889999999999999999999999999
Q ss_pred HHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHH
Q 001902 884 LYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946 (998)
Q Consensus 884 l~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 946 (998)
+|+|++ |..||...+.......+..+.... .....+..+.+|+.+||..+|.+||++.++++
T Consensus 215 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 215 LWEIFTYGKQPWFQLSNTEVIECITQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHhCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 999998 999998888777766665544332 23346788999999999999999999555433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.44 Aligned_cols=253 Identities=20% Similarity=0.293 Sum_probs=208.5
Q ss_pred ccCCcccccccCCCCceeEEEEEEc-----cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
+..+|++.++||+|+||.||++... .++..+++|.+... .......+.+|+++++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4567899999999999999999742 35678999987643 334556788999999999999999999999999
Q ss_pred CeEEEEEecCCCCchhHHHhhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC
Q 001902 738 THVCLITDYCPGGELFLLLDRQPT-------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 804 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~-------------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g 804 (998)
+..+++|||+++++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 999999999999999999976421 3488899999999999999999999999999999999999999
Q ss_pred cEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHH
Q 001902 805 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 884 (998)
Q Consensus 805 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il 884 (998)
.++|+|||++........ ........+++.|+|||++.+..++.++|||||||++
T Consensus 160 ~~kL~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 214 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDY-------------------------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVL 214 (280)
T ss_pred CEEECCCCceeEcCCCce-------------------------eecCCCccccccccCHHHhccCCcCchhhHHHHHHHH
Confidence 999999999854321100 0011223457889999999999999999999999999
Q ss_pred HHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 885 YEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 885 ~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
|+|++ |.+||...........+.... .......++..+.+|+.+||+.||.+||++.++
T Consensus 215 ~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l 274 (280)
T cd05092 215 WEIFTYGKQPWYQLSNTEAIECITQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274 (280)
T ss_pred HHHHcCCCCCCccCCHHHHHHHHHcCc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 99998 999998877777666665543 223334578889999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=318.22 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=208.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCC---eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~---~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
..+|++.+.||+|+||.||+|.+..++ ..+|+|.++... .......+.+|+.+++.++||||+++++++..++.+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 467999999999999999999986444 379999887542 233456788899999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||+++++|.+++.... ..++...+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999997653 45899999999999999999999999999999999999999999999999998654311
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~ 899 (998)
... ........++..|+|||++.+..++.++|+|||||++|++++ |..||.....
T Consensus 160 ~~~------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~ 215 (267)
T cd05066 160 PEA------------------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215 (267)
T ss_pred cce------------------------eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH
Confidence 100 000111234568999999998889999999999999999886 9999988877
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
......+... ...+.....+..+.+++.+||+.+|.+||++.++
T Consensus 216 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 259 (267)
T cd05066 216 QDVIKAIEEG-YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQI 259 (267)
T ss_pred HHHHHHHhCC-CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHH
Confidence 6666666544 3445455678899999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.98 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=211.1
Q ss_pred cccCCCCceeEEEEEEccC---CeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecC
Q 001902 671 KPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYC 747 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~---~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 747 (998)
+.||+|+||.||+|.+... +..|++|.+....... ....+..|+.+++.++|+||+++++++.....+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4689999999999999765 8999999998653322 4678889999999999999999999999999999999999
Q ss_pred CCCchhHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 748 PGGELFLLLDRQP-------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 748 ~ggsL~~~l~~~~-------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
++++|.+++.... ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999997641 356999999999999999999999999999999999999999999999999998654311
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~ 899 (998)
.. ........+++.|+|||.+....++.++|||||||++|+|++ |..||.....
T Consensus 159 ~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 213 (262)
T cd00192 159 DY-------------------------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213 (262)
T ss_pred cc-------------------------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH
Confidence 10 011234457889999999988889999999999999999998 6999999877
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
......+... ...+.....+.++.+++.+||+.+|.+||+ +.++++|
T Consensus 214 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~l~~~ 260 (262)
T cd00192 214 EEVLEYLRKG-YRLPKPEYCPDELYELMLSCWQLDPEDRPT----FSELVER 260 (262)
T ss_pred HHHHHHHHcC-CCCCCCccCChHHHHHHHHHccCCcccCcC----HHHHHHh
Confidence 7777766653 233334456889999999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=320.89 Aligned_cols=254 Identities=24% Similarity=0.437 Sum_probs=208.2
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC---CCCCccceeEEEeeCCe----
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQTKTH---- 739 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l---~h~nIv~l~~~~~~~~~---- 739 (998)
|++.+.||.|+||.||++.+..+++.||+|.++.... .......+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6788999999999999999988899999999975432 222334566787777666 69999999999987776
Q ss_pred -EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 740 -VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 740 -~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
++++|||++ ++|.+++.......+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999995 589998877544568999999999999999999999999999999999999999999999999885432
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
... ......++..|+|||++.+..++.++|||||||++|+|++|.+||.+..
T Consensus 159 ~~~----------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 159 FEM----------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred CCc----------------------------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 110 0112347889999999999889999999999999999999999999888
Q ss_pred hHHHHHHHHhCC-----CCCC-----------C---------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCC
Q 001902 899 RQKTFANILHKD-----LKFP-----------S---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953 (998)
Q Consensus 899 ~~~~~~~i~~~~-----~~~~-----------~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~ 953 (998)
..+.+.++.... ..++ . ....+..+.+||.+||+.||.+||+ +.++++|||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~----~~~il~~~~ 286 (287)
T cd07838 211 EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS----AFEALQHPY 286 (287)
T ss_pred hHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC----HHHHhcCcC
Confidence 777666665421 0000 0 0123567789999999999999999 999999999
Q ss_pred c
Q 001902 954 F 954 (998)
Q Consensus 954 f 954 (998)
|
T Consensus 287 ~ 287 (287)
T cd07838 287 F 287 (287)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.84 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=205.6
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+..++|.+...||+|++|.||+|.+..+ ..+|+|.+.... .....+.+|+.+++.++|+|++++++++. .+..+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 3456799999999999999999998554 469999876532 12356778999999999999999998875 45689
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+||||+++++|.+++.......++...+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999999999977555568999999999999999999999999999999999999999999999999985432110
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 900 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~ 900 (998)
........++..|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus 157 --------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 210 (260)
T cd05069 157 --------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR 210 (260)
T ss_pred --------------------------ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 001112246778999999988889999999999999999999 99999988777
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
.....+... ...+.....+..+.+|+.+||..||.+||+ +++++
T Consensus 211 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~i~ 254 (260)
T cd05069 211 EVLEQVERG-YRMPCPQGCPESLHELMKLCWKKDPDERPT----FEYIQ 254 (260)
T ss_pred HHHHHHHcC-CCCCCCcccCHHHHHHHHHHccCCcccCcC----HHHHH
Confidence 766665543 333334456788999999999999999999 55544
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=331.87 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=208.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 737 (998)
.++|.+.+.||+|+||.||++.+..+++.||+|++.+... .......+.+|+.++++++|+||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 4789999999999999999999999999999999875422 223345677899999999999999999988543
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
...|++++++ +++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 4578999988 88998887653 4899999999999999999999999999999999999999999999999988432
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.. ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..
T Consensus 171 ~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 171 DD------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred cc------------------------------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 10 1123468899999999866 5678899999999999999999999987
Q ss_pred CChHHHHHHHHhCCC-----------------------CCCC------CCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 897 KTRQKTFANILHKDL-----------------------KFPS------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~-----------------------~~~~------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
.+....+..+..... ..+. ....+..+.+||.+||+.||.+||+ +.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e 296 (345)
T cd07877 221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQ 296 (345)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC----HHH
Confidence 766554444332110 0000 1134678899999999999999999 999
Q ss_pred HHcCCCccCC
Q 001902 948 IKKHPFFKGV 957 (998)
Q Consensus 948 lL~Hp~f~~~ 957 (998)
++.||||++.
T Consensus 297 ~l~h~~f~~~ 306 (345)
T cd07877 297 ALAHAYFAQY 306 (345)
T ss_pred HhcChhhhhc
Confidence 9999999974
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.65 Aligned_cols=253 Identities=24% Similarity=0.338 Sum_probs=205.4
Q ss_pred cccccccCCCCceeEEEEEEcc---CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC-----
Q 001902 667 FRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 738 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~---~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----- 738 (998)
|++.+.||+|+||.||+|.... ++..||+|.++.... .......+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 6788999999999999999754 347899999875422 3344567889999999999999999999886544
Q ss_pred -eEEEEEecCCCCchhHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccC
Q 001902 739 -HVCLITDYCPGGELFLLLDRQ----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 813 (998)
Q Consensus 739 -~~~lV~E~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~ 813 (998)
..++||||+++++|..++... ....+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 389999999999999888542 223589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCC
Q 001902 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYT 892 (998)
Q Consensus 814 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~ 892 (998)
+......... .......++..|+|||++.+..++.++|||||||++|+|++ |.+
T Consensus 160 ~~~~~~~~~~-------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~ 214 (273)
T cd05035 160 SKKIYSGDYY-------------------------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT 214 (273)
T ss_pred eeeccccccc-------------------------cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 8654211100 01112235678999999988889999999999999999998 999
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 893 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 893 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
||.+......+..+.... ........+..+.+++.+||..||.+||+ +.++++
T Consensus 215 p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~e~~~ 267 (273)
T cd05035 215 PYPGVENHEIYDYLRHGN-RLKQPEDCLDELYDLMYSCWRADPKDRPT----FTKLRE 267 (273)
T ss_pred CCCCCCHHHHHHHHHcCC-CCCCCcCCCHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 998888777776665543 23334457889999999999999999999 665554
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.94 Aligned_cols=254 Identities=28% Similarity=0.449 Sum_probs=217.9
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
+|++.+.||.|+||.||++.+..+++.+++|.+...... ......+..|+.+++.++|+||+++++++......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 488999999999999999999999999999998765432 3445677789999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 746 YCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 746 ~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|+++++|.+++.+. ....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 99999999998662 2345899999999999999999999999999999999999999999999999998553211
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.....
T Consensus 157 --------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~ 210 (256)
T cd08530 157 --------------------------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR 210 (256)
T ss_pred --------------------------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 111235788999999999988999999999999999999999999988876666
Q ss_pred HHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 904 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 904 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
..+....... .....+.++.+++.+||..+|.+||+ +.++++||++
T Consensus 211 ~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~~l~~p~~ 256 (256)
T cd08530 211 YKVQRGKYPP-IPPIYSQDLQNFIRSMLQVKPKLRPN----CDKILASPAV 256 (256)
T ss_pred HHHhcCCCCC-CchhhCHHHHHHHHHHcCCCcccCCC----HHHHhcCCCC
Confidence 6665544332 22356788999999999999999999 9999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=318.46 Aligned_cols=254 Identities=20% Similarity=0.309 Sum_probs=206.7
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCe----EEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
+...+|++++.||.|+||.||+|.+..++. .||+|++.... .......+.+|+.++..++|+||+++++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 456789999999999999999999877766 48999887532 33445678889999999999999999998875
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
...+++|||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 45789999999999999987642 45899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~ 896 (998)
...... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||..
T Consensus 160 ~~~~~~-------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 160 DIDETE-------------------------YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred ccccce-------------------------eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 311100 00111235678999999998889999999999999999998 9999987
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
.........+.. ....+.....+..+.+++.+||..||++||+ +.+++
T Consensus 215 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~----~~~l~ 262 (279)
T cd05109 215 IPAREIPDLLEK-GERLPQPPICTIDVYMIMVKCWMIDSECRPR----FRELV 262 (279)
T ss_pred CCHHHHHHHHHC-CCcCCCCccCCHHHHHHHHHHcCCChhhCcC----HHHHH
Confidence 766555444433 3333444567889999999999999999999 55555
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.62 Aligned_cols=245 Identities=22% Similarity=0.337 Sum_probs=207.3
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+...+|++.+.||.|+||.||+|.. .|+.+|+|.+..... ....+.+|+.+++.++|+||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 4567899999999999999999987 478999999875422 4567889999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~- 155 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG- 155 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc-
Confidence 9999999999999998765457999999999999999999999999999999999999999999999999998543100
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 900 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~ 900 (998)
.....++..|+|||++....++.++|||||||++|+|++ |..||......
T Consensus 156 -----------------------------~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 206 (256)
T cd05039 156 -----------------------------QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 206 (256)
T ss_pred -----------------------------cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 001234567999999988889999999999999999997 99999888766
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
.....+... .........+..+.+||.+||..+|.+||++.+
T Consensus 207 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 248 (256)
T cd05039 207 DVVPHVEKG-YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQ 248 (256)
T ss_pred HHHHHHhcC-CCCCCccCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 665555443 222333456789999999999999999999433
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=313.47 Aligned_cols=248 Identities=22% Similarity=0.339 Sum_probs=206.8
Q ss_pred cccCCCCceeEEEEEEcc-CC--eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecC
Q 001902 671 KPLGSGDTGSVHLVELCG-SG--QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYC 747 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~-~~--~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 747 (998)
+.||+|++|.||+|.+.. .+ ..+|+|.+...... ...+.+.+|+.++++++|+||+++++.+.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999855 33 36999999876433 556788899999999999999999999988 8999999999
Q ss_pred CCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCc
Q 001902 748 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 827 (998)
Q Consensus 748 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~ 827 (998)
++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---- 153 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH---- 153 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc----
Confidence 9999999998754356899999999999999999999999999999999999999999999999998654321100
Q ss_pred chhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 001902 828 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANI 906 (998)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i 906 (998)
........++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+
T Consensus 154 --------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 213 (257)
T cd05040 154 --------------------YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213 (257)
T ss_pred --------------------eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 011113457788999999999899999999999999999998 99999888877777776
Q ss_pred HhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 907 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 907 ~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
......++.....+..+.+++.+||+.+|.+||+ +.+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~~ 252 (257)
T cd05040 214 DKEGERLERPEACPQDIYNVMLQCWAHNPADRPT----FAALR 252 (257)
T ss_pred HhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCC----HHHHH
Confidence 6544444444456789999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=335.01 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=209.7
Q ss_pred cccccCCcccccccCCCCceeEEEEEEc-----cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEE
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYAS 733 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~ 733 (998)
+.+..++|.+.+.||+|+||.||+|.+. .+++.||+|+++... .......+.+|+.+|.++. ||||++++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 4556678999999999999999999964 346789999997542 2233456888999999997 9999999999
Q ss_pred EeeCCeEEEEEecCCCCchhHHHhhCCC----------------------------------------------------
Q 001902 734 FQTKTHVCLITDYCPGGELFLLLDRQPT---------------------------------------------------- 761 (998)
Q Consensus 734 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------------------------------------- 761 (998)
+...+.+++|||||++|+|.+++.+...
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 9999999999999999999999965321
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 001902 762 --------------------------------------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 797 (998)
Q Consensus 762 --------------------------------------------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~N 797 (998)
..++...+..++.||+.||+|||+++|+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 236677888999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHH
Q 001902 798 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 877 (998)
Q Consensus 798 ILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDI 877 (998)
||++.++.+||+|||++........ ........+++.|+|||++.+..++.++||
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 324 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSN-------------------------YISKGSTFLPLKWMAPESIFNNLYTTLSDV 324 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccc-------------------------cccCCCcCCCCceeChHHhcCCCCCcHhHH
Confidence 9999999999999999854321100 011123457889999999998889999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcH
Q 001902 878 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945 (998)
Q Consensus 878 wSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 945 (998)
|||||++|+|++ |..||......+.....+......+.....+.++.+|+.+||..+|.+||++.+++
T Consensus 325 wslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell 393 (401)
T cd05107 325 WSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393 (401)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 999999999998 89999876666655555554444444445788999999999999999999944443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.69 Aligned_cols=253 Identities=23% Similarity=0.295 Sum_probs=203.8
Q ss_pred cccccccCCCCceeEEEEEEccCCe--EEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee------CC
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------KT 738 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~--~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~------~~ 738 (998)
|.+.+.||+|+||.||+|.+..++. .+|+|.++... ........+..|+.+++.++|+||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567889999999999999877665 68999887542 244556778889999999999999999997642 23
Q ss_pred eEEEEEecCCCCchhHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCc
Q 001902 739 HVCLITDYCPGGELFLLLDRQ----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a 814 (998)
..++||||+++++|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 578999999999999887421 2234889999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTP 893 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~P 893 (998)
..+..... ........+++.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 160 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p 214 (272)
T cd05075 160 KKIYNGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214 (272)
T ss_pred cccCcccc-------------------------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 65421100 001122346778999999999999999999999999999998 8999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 894 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
|.+.........+..+.. .+.....+..+.++|.+||+.||.+||| +.+|++
T Consensus 215 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~l~~ 266 (272)
T cd05075 215 YPGVENSEIYDYLRQGNR-LKQPPDCLDGLYSLMSSCWLLNPKDRPS----FETLRC 266 (272)
T ss_pred CCCCCHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 988877777666665432 2333456788999999999999999999 555554
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.41 Aligned_cols=254 Identities=27% Similarity=0.462 Sum_probs=217.9
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
+|++.+.||+|++|.||++.+..+++.|++|.+..... .......+.+|++++++++|+|++++++++...+..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 48889999999999999999988999999999986533 23456788899999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (254)
T cd06627 80 YAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--- 154 (254)
T ss_pred cCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc---
Confidence 99999999999765 4699999999999999999999999999999999999999999999999999855321110
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
......++..|+|||.+.+..++.++||||||+++|+|++|..||...........
T Consensus 155 ------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~ 210 (254)
T cd06627 155 ------------------------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR 210 (254)
T ss_pred ------------------------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 01234688899999999888888999999999999999999999988776655555
Q ss_pred HHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 906 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
+...... +.....+..+.+++.+||..+|++||+ +.+++.||||
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~~l~~~~~ 254 (254)
T cd06627 211 IVQDDHP-PLPEGISPELKDFLMQCFQKDPNLRPT----AKQLLKHPWI 254 (254)
T ss_pred HhccCCC-CCCCCCCHHHHHHHHHHHhCChhhCcC----HHHHhcCCCC
Confidence 5433222 223346789999999999999999999 9999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=314.62 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=211.4
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+..++|.+.+.||.|+||.||+|.+. .++.+|+|.+..... ....+.+|+.+++.++|+||+++++++......+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 55678999999999999999999975 457899999875432 2356788999999999999999999999989999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+||||+++++|.+++.......++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999999987655679999999999999999999999999999999999999999999999999985432100
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 900 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~ 900 (998)
........++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.+..
T Consensus 158 --------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 211 (261)
T cd05034 158 --------------------------YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211 (261)
T ss_pred --------------------------hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 000112234568999999998889999999999999999998 99999988877
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
..+..+... ...+.....+..+.+++.+||..+|.+||+ +.+++
T Consensus 212 ~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~l~ 255 (261)
T cd05034 212 EVLEQVERG-YRMPRPPNCPEELYDLMLQCWDKDPEERPT----FEYLQ 255 (261)
T ss_pred HHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccCcccCCC----HHHHH
Confidence 777766543 333444445788999999999999999999 55544
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=324.36 Aligned_cols=257 Identities=21% Similarity=0.307 Sum_probs=206.7
Q ss_pred ccccCCcccccccCCCCceeEEEEEEcc-------CCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 732 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-------~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~ 732 (998)
.+..++|.+.+.||+|+||.||++.+.. +...+|+|.+.... .......+..|+.+++.+ +|+||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 4455789999999999999999998743 23579999987542 233456788899999999 7999999999
Q ss_pred EEeeCCeEEEEEecCCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 001902 733 SFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 798 (998)
Q Consensus 733 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NI 798 (998)
++...+..|+||||+++++|.+++.... ...++...+..++.||+.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999999999999997642 13488899999999999999999999999999999999
Q ss_pred EEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHH
Q 001902 799 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 878 (998)
Q Consensus 799 Li~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIw 878 (998)
|++.++.++|+|||.+........ ........+++.|+|||++.+..++.++|||
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 226 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDY-------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 226 (307)
T ss_pred EEcCCCcEEECCCcccccccccch-------------------------hhccccCCCccceeChHHhccCCCCcHHHHH
Confidence 999999999999999854321000 0001112345789999999988899999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcH
Q 001902 879 ALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945 (998)
Q Consensus 879 SlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 945 (998)
||||++|+|++ |..||.+.........+... ...+.....+.++.+|+.+||..+|.+||++.+++
T Consensus 227 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 293 (307)
T cd05098 227 SFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 293 (307)
T ss_pred HHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 99999999998 89999877665555554433 33333345688999999999999999999944443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=320.58 Aligned_cols=267 Identities=28% Similarity=0.468 Sum_probs=223.3
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccCh----hHHHHHHHHHHHHHhCCCCCccceeEEEe-eCC
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR----NKVHRACAEREILDMLDHPFVPALYASFQ-TKT 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~-~~~ 738 (998)
.++|-++..||+|||+.||+|.+....++||+|+-........ +..+...+|..|.+.|+||.||++|++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 4689999999999999999999999999999998764432222 22445678999999999999999999996 567
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCcEEEec---CCcEEEEeccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ--GIIYRDLKPENVLLQG---NGHVSLTDFDL 813 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--~IiHrDLkP~NILi~~---~g~vkL~DFG~ 813 (998)
.+|-|+|||+|.+|.-+|+.+ +.+++..++.|+.||+.||.||... .|||-||||.|||+.. -|.+||.|||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 899999999999999999875 5699999999999999999999976 6999999999999974 46799999999
Q ss_pred ccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC----CCCChhHHHHHHHHHHHHHc
Q 001902 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA----GHTSAVDWWALGILLYEMLY 889 (998)
Q Consensus 814 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~sDIwSlG~il~eLlt 889 (998)
++.+..+... ........+...||.+|++||.+.-+ +.+.++||||+|+|+|.+++
T Consensus 620 SKIMdddSy~--------------------~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY 679 (775)
T KOG1151|consen 620 SKIMDDDSYN--------------------SVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY 679 (775)
T ss_pred hhhccCCccC--------------------cccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc
Confidence 9998754321 11233455667899999999998543 46779999999999999999
Q ss_pred CCCCCCCCChH-HHH--HHHH-hCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 890 GYTPFRGKTRQ-KTF--ANIL-HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 890 G~~Pf~~~~~~-~~~--~~i~-~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
|+.||...... +++ ..|+ ...+.||..+-.+.++++||++||.+.-++|.. +.+|..||||..
T Consensus 680 GrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~D----V~qLA~dpyllP 746 (775)
T KOG1151|consen 680 GRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRID----VQQLACDPYLLP 746 (775)
T ss_pred cCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhh----HHHHccCccccc
Confidence 99999875432 222 2233 245788888889999999999999999999999 999999999987
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=321.39 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=204.1
Q ss_pred CCcccccccCCCCceeEEEEEEccCCe--EEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~--~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~ 741 (998)
++|++.+.||.|+||.||+|.+..++. .+++|.++.. ........+.+|+.++.++ +||||+++++++...+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877664 4688877632 2333456788899999999 7999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEE
Q 001902 742 LITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 807 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vk 807 (998)
+||||+++++|.+++.... ...++...++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997532 13488899999999999999999999999999999999999999999
Q ss_pred EEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHH
Q 001902 808 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 887 (998)
Q Consensus 808 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eL 887 (998)
|+|||++...... ........+..|+|||++.+..++.++|||||||++|+|
T Consensus 160 l~dfg~~~~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 211 (297)
T cd05089 160 IADFGLSRGEEVY----------------------------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211 (297)
T ss_pred ECCcCCCccccce----------------------------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHH
Confidence 9999987421100 001111235579999999988899999999999999999
Q ss_pred Hc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 888 LY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 888 lt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
++ |..||.+.........+... ...+....++..+.+|+.+||..+|.+||++.++
T Consensus 212 ~t~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 268 (297)
T cd05089 212 VSLGGTPYCGMTCAELYEKLPQG-YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268 (297)
T ss_pred HcCCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 97 99999988877777666554 2223334578899999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=322.08 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=203.2
Q ss_pred cCCcccccccCCCCceeEEEEEEccC--------------CeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccc
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGS--------------GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 729 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~--------------~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~ 729 (998)
.++|++.+.||+|+||.||+|.+..+ ...||+|.++... .......+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 46899999999999999999987543 3358999987542 2344567889999999999999999
Q ss_pred eeEEEeeCCeEEEEEecCCCCchhHHHhhCC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 001902 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQP----------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 799 (998)
Q Consensus 730 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NIL 799 (998)
+++++...+..|+||||+++++|.+++.... ...++...+..++.||+.||+|||++|++|+||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999986531 123678889999999999999999999999999999999
Q ss_pred EecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHH
Q 001902 800 LQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 879 (998)
Q Consensus 800 i~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwS 879 (998)
++.++.+||+|||++....... .........++..|+|||++.+..++.++||||
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS 216 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGD-------------------------YYRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216 (295)
T ss_pred EcCCCcEEecccccccccccCc-------------------------ceeccCcCcCceeecChhhhccCCcCchhhHHH
Confidence 9999999999999985432110 001112334678899999999888999999999
Q ss_pred HHHHHHHHHc--CCCCCCCCChHHHHHHHHh-----CC-CCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 880 LGILLYEMLY--GYTPFRGKTRQKTFANILH-----KD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 880 lG~il~eLlt--G~~Pf~~~~~~~~~~~i~~-----~~-~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
|||++|+|++ |..||...+.......+.. .. .........+..+.+|+.+||..||.+||++.++
T Consensus 217 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i 289 (295)
T cd05097 217 FGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI 289 (295)
T ss_pred HHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 9999999987 7789988766655544432 11 1122233467889999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.53 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=209.6
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC--CeEEEEE
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVCLIT 744 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~~lV~ 744 (998)
|++++.||.|++|.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|+|++++++++... ...++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678899999999999999999899999999998653 2333445677899999999999999999999887 8999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||++ ++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 80 EYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred cccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9996 58888886542 4699999999999999999999999999999999999999999999999999855331110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+....+
T Consensus 156 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~ 211 (287)
T cd07840 156 ------------------------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL 211 (287)
T ss_pred ------------------------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 01122356889999998765 45788999999999999999999999888776665
Q ss_pred HHHHhCCC-----CCCCC-----------------------CC-CcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 904 ANILHKDL-----KFPSS-----------------------TP-TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 904 ~~i~~~~~-----~~~~~-----------------------~~-~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
..+..... .++.. .. .+..+.+++.+||..+|.+||+ +.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~~~~ 287 (287)
T cd07840 212 EKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS----ADQALQHEYF 287 (287)
T ss_pred HHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC----HHHHhhCcCC
Confidence 55543110 00000 11 2778899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=329.65 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=204.9
Q ss_pred cccCCcccccccCCCCceeEEEEEE-----ccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEe
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ 735 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~ 735 (998)
+..++|++.+.||.|+||.||+|.+ ..+++.||+|+++... .......+.+|+.++..+ +|+||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 3456899999999999999999985 3467899999987542 233456788899999999 6899999999876
Q ss_pred e-CCeEEEEEecCCCCchhHHHhhCC------------------------------------------------------
Q 001902 736 T-KTHVCLITDYCPGGELFLLLDRQP------------------------------------------------------ 760 (998)
Q Consensus 736 ~-~~~~~lV~E~~~ggsL~~~l~~~~------------------------------------------------------ 760 (998)
. ...+++|||||++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 457899999999999999986431
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 761 -----------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 761 -----------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~------ 235 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------ 235 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch------
Confidence 123677888999999999999999999999999999999999999999999998543211100
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHh
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILH 908 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~ 908 (998)
.......+++.|+|||++.+..++.++|||||||++|+|++ |..||........+...+.
T Consensus 236 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 296 (343)
T cd05103 236 -------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 296 (343)
T ss_pred -------------------hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh
Confidence 01112345678999999988889999999999999999996 9999987654444444343
Q ss_pred CCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 909 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 909 ~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
.....+.....+..+.+++..||+.||.+||+ +.+|++|
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps----~~eil~~ 335 (343)
T cd05103 297 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 335 (343)
T ss_pred ccCCCCCCCCCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 33333333346778999999999999999999 7777765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=318.71 Aligned_cols=250 Identities=30% Similarity=0.448 Sum_probs=203.0
Q ss_pred ccccccCCCCceeEEEEEEc----cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 668 RPIKPLGSGDTGSVHLVELC----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 668 ~~~~~LG~G~~g~Vy~a~~~----~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.+.+.||.|.||.||+|.+. ..+..|+||.++.. ........+.+|++++++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 35678999999999999997 34678999999642 2344578889999999999999999999999988889999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+++|+|.+++.......++...+..++.||+.||.|||+++++|++|+|+|||++.++.+||+|||++........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~- 158 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK- 158 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 9999999999999886456699999999999999999999999999999999999999999999999999855421100
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~ 902 (998)
........+...|+|||.+....++.++||||||+++|||++ |..||...+....
T Consensus 159 ------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~ 214 (259)
T PF07714_consen 159 ------------------------YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI 214 (259)
T ss_dssp ------------------------EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH
T ss_pred ------------------------cccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 011223346788999999998889999999999999999999 7899999888887
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
...+.... ..+....++..+.++|..||..||.+||+ +.+|+
T Consensus 215 ~~~~~~~~-~~~~~~~~~~~~~~li~~C~~~~p~~RPs----~~~i~ 256 (259)
T PF07714_consen 215 IEKLKQGQ-RLPIPDNCPKDIYSLIQQCWSHDPEKRPS----FQEIL 256 (259)
T ss_dssp HHHHHTTE-ETTSBTTSBHHHHHHHHHHT-SSGGGS------HHHHH
T ss_pred cccccccc-cceeccchhHHHHHHHHHHcCCChhhCcC----HHHHH
Confidence 77774443 33344457889999999999999999999 55554
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=316.02 Aligned_cols=257 Identities=23% Similarity=0.324 Sum_probs=210.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCe---EEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
...|++.+.||+|+||.||+|.+..+++ .||+|++.... .......+..|+.+++.++||||+++++++..+...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4578999999999999999999877664 69999987532 344567788999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
++||||+++++|.+++.... ..++...++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 81 MIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999999987653 45899999999999999999999999999999999999999999999999998554211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~ 899 (998)
.... .........++..|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 160 ~~~~----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~ 217 (269)
T cd05065 160 TSDP----------------------TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217 (269)
T ss_pred cccc----------------------ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH
Confidence 1000 0000011112467999999998899999999999999999886 9999998877
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
......+.. ....+....++..+.+++.+||..+|.+||+ +.+++.
T Consensus 218 ~~~~~~i~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~i~~ 263 (269)
T cd05065 218 QDVINAIEQ-DYRLPPPMDCPTALHQLMLDCWQKDRNARPK----FGQIVS 263 (269)
T ss_pred HHHHHHHHc-CCcCCCcccCCHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 776666643 3444545567888999999999999999999 556553
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=330.97 Aligned_cols=255 Identities=27% Similarity=0.439 Sum_probs=212.0
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe----
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH---- 739 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~---- 739 (998)
.++|.+.+.||+|++|.||+|.+..+++.||+|++.... ........+.+|+.+++.++|+||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 468999999999999999999999999999999887542 223344667789999999999999999988866554
Q ss_pred --EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 740 --VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 740 --~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
.|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 7799998865 35899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.. ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 169 ~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 169 DD------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred cc------------------------------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 20 0123357889999999865 4678899999999999999999999988
Q ss_pred CChHHHHHHHHhCCCCCC-----------------------------CCCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 897 KTRQKTFANILHKDLKFP-----------------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~-----------------------------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
.+....+..+.......+ .....+..+.+||.+||..||.+||| +.+
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt----~~e 294 (343)
T cd07851 219 SDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT----AAE 294 (343)
T ss_pred CChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC----HHH
Confidence 777666655543211000 01234788999999999999999999 999
Q ss_pred HHcCCCccCC
Q 001902 948 IKKHPFFKGV 957 (998)
Q Consensus 948 lL~Hp~f~~~ 957 (998)
|++||||+..
T Consensus 295 ll~h~~~~~~ 304 (343)
T cd07851 295 ALAHPYLAEY 304 (343)
T ss_pred HhcCCCcccc
Confidence 9999999964
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=312.62 Aligned_cols=248 Identities=22% Similarity=0.324 Sum_probs=201.3
Q ss_pred cccCCCCceeEEEEEEccCC---eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecC
Q 001902 671 KPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYC 747 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~---~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 747 (998)
+.||+|+||.||+|.+..++ ..+|+|.+...... .....+.+|+.+++.++|+||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46899999999999875544 78999998865432 34567888999999999999999999776 45689999999
Q ss_pred CCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCc
Q 001902 748 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 827 (998)
Q Consensus 748 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~ 827 (998)
++++|.+++.... .+++..+..++.|++.||+|||..+++|+||||+|||++.++.+||+|||++.........
T Consensus 78 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~---- 151 (257)
T cd05060 78 PLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY---- 151 (257)
T ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc----
Confidence 9999999998753 5899999999999999999999999999999999999999999999999998654211100
Q ss_pred chhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 001902 828 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANI 906 (998)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i 906 (998)
........++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+.......+
T Consensus 152 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~ 211 (257)
T cd05060 152 --------------------YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML 211 (257)
T ss_pred --------------------cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 001111234568999999998899999999999999999997 99999888776666655
Q ss_pred HhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHH
Q 001902 907 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948 (998)
Q Consensus 907 ~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 948 (998)
.... ..+.....+..+.+|+.+||..+|.+||++.+++..+
T Consensus 212 ~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l 252 (257)
T cd05060 212 ESGE-RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252 (257)
T ss_pred HcCC-cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 4432 3344455778999999999999999999955544433
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=316.85 Aligned_cols=252 Identities=20% Similarity=0.293 Sum_probs=201.5
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCe----EEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
+..++|++++.||.|+||.||+|.+..++. .+++|.+... ........+..|+.+++.++||||+++++++. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 345689999999999999999999877776 4666766432 12234456777888999999999999999875 4
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
...+++|||+++++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 56789999999999999997643 45899999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~ 896 (998)
..... ........++..|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 160 ~~~~~-------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 214 (279)
T cd05111 160 YPDDK-------------------------KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214 (279)
T ss_pred cCCCc-------------------------ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 21110 001123457778999999998889999999999999999998 9999988
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
.........+..+ ...+....++..+.+++.+||..||.+||++.+
T Consensus 215 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~e 260 (279)
T cd05111 215 MRPHEVPDLLEKG-ERLAQPQICTIDVYMVMVKCWMIDENVRPTFKE 260 (279)
T ss_pred CCHHHHHHHHHCC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 7765544444333 333333446778899999999999999999443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=318.77 Aligned_cols=254 Identities=21% Similarity=0.296 Sum_probs=208.1
Q ss_pred ccCCcccccccCCCCceeEEEEEEcc-----CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
..++|++.+.||.|+||.||+|.+.. ++..+|+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 35689999999999999999999743 67899999987542 234456788899999999999999999999999
Q ss_pred CeEEEEEecCCCCchhHHHhhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 001902 738 THVCLITDYCPGGELFLLLDRQP--------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 797 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~--------------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~N 797 (998)
...|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999997431 1247788899999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHH
Q 001902 798 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 877 (998)
Q Consensus 798 ILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDI 877 (998)
|+++.++.++|+|||++........ ........++..|+|||++.+..++.++||
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY-------------------------YKASENDAIPIRWMPPESIFYNRYTTESDV 215 (288)
T ss_pred eEecCCCceEECccccceecccCcc-------------------------ccccCCCccChhhcCHHHHhcCCCCchhHH
Confidence 9999999999999998854321100 011112234667999999998899999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 878 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 878 wSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
|||||++|+|++ |..||.+.+..+....+...... +.....+..+.+|+.+||+.+|.+|||+.++
T Consensus 216 ~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el 282 (288)
T cd05050 216 WAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 999999999997 88999888777777666655432 2233467899999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=326.95 Aligned_cols=273 Identities=25% Similarity=0.333 Sum_probs=212.8
Q ss_pred CCccc-ccccCCCCceeEEEEEEccCCeEEEEEEeecccccChh-----------HHHHHHHHHHHHHhCCCCCccceeE
Q 001902 665 QHFRP-IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN-----------KVHRACAEREILDMLDHPFVPALYA 732 (998)
Q Consensus 665 ~~y~~-~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~-----------~~~~~~~E~~il~~l~h~nIv~l~~ 732 (998)
++|.. .+.||.|+||.||+|.+..+++.||+|+++........ ....+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 46654 47799999999999999999999999998754322210 0124678999999999999999999
Q ss_pred EEeeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEecc
Q 001902 733 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 812 (998)
Q Consensus 733 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG 812 (998)
++...+..|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9999999999999995 6899988764 458999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCC
Q 001902 813 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGY 891 (998)
Q Consensus 813 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~ 891 (998)
++.............. .. ............+++.|+|||.+.+. .++.++|||||||++|+|++|.
T Consensus 165 ~~~~~~~~~~~~~~~~---------~~----~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~ 231 (335)
T PTZ00024 165 LARRYGYPPYSDTLSK---------DE----TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231 (335)
T ss_pred ceeecccccccccccc---------cc----cccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9865432211100000 00 00001112234578899999998764 4688999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCCC-----CCCC---------------------CCCCcHHHHHHHHHccccCccCcCCChhcH
Q 001902 892 TPFRGKTRQKTFANILHKDL-----KFPS---------------------STPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945 (998)
Q Consensus 892 ~Pf~~~~~~~~~~~i~~~~~-----~~~~---------------------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 945 (998)
+||.+.+....+..+..... .++. ....+..+.+||.+||..+|++||+ +
T Consensus 232 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~ 307 (335)
T PTZ00024 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS----A 307 (335)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC----H
Confidence 99998887766655543110 0000 1234677899999999999999999 9
Q ss_pred HHHHcCCCccCC
Q 001902 946 NEIKKHPFFKGV 957 (998)
Q Consensus 946 ~elL~Hp~f~~~ 957 (998)
.++|.||||+..
T Consensus 308 ~~~l~~~~~~~~ 319 (335)
T PTZ00024 308 KEALKHEYFKSD 319 (335)
T ss_pred HHHhcCcccCCC
Confidence 999999999975
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.10 Aligned_cols=256 Identities=21% Similarity=0.315 Sum_probs=214.1
Q ss_pred cCCcccccccCCCCceeEEEEEEcc-----CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
..+|++++.||.|+||.||+|..+. +.+.+++|.+.... .......+.+|+.++++++|+||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4689999999999999999999753 35689999876431 2234567889999999999999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEec
Q 001902 739 HVCLITDYCPGGELFLLLDRQPT-------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 811 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~-------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DF 811 (998)
..|+||||+++++|.+++..... ..+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999999976531 15899999999999999999999999999999999999999999999999
Q ss_pred cCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-C
Q 001902 812 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-G 890 (998)
Q Consensus 812 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G 890 (998)
|++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 162 ~~~~~~~~~~--------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~ 215 (275)
T cd05046 162 SLSKDVYNSE--------------------------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215 (275)
T ss_pred ccccccCccc--------------------------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9874321000 011123356778999999988888999999999999999998 8
Q ss_pred CCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 891 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 891 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
..||........+..+......++.....+..+.+++.+||..+|.+||+ +.+++.+
T Consensus 216 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~----~~~~l~~ 272 (275)
T cd05046 216 ELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPS----FSELVSA 272 (275)
T ss_pred CCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCC----HHHHHHH
Confidence 89998877777777776666666666667889999999999999999999 7776653
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=321.14 Aligned_cols=257 Identities=21% Similarity=0.305 Sum_probs=208.8
Q ss_pred ccccCCcccccccCCCCceeEEEEEEc-------cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 732 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-------~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~ 732 (998)
.+..++|.+.+.||+|+||.||+|.+. ..+..+|+|.+.... .......+.+|+.+++.+ +||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 455678999999999999999999853 235589999887532 233456788999999999 8999999999
Q ss_pred EEeeCCeEEEEEecCCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 001902 733 SFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 798 (998)
Q Consensus 733 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NI 798 (998)
++...+.+|+||||+++++|.+++.... ...++...+..++.||+.||.|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 9999999999999999999999997642 13477888999999999999999999999999999999
Q ss_pred EEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHH
Q 001902 799 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 878 (998)
Q Consensus 799 Li~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIw 878 (998)
+++.++.+||+|||++........ ........+++.|+|||++.+..++.++|||
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 223 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDY-------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 223 (304)
T ss_pred EEcCCCcEEECCCccceecccccc-------------------------cccccCCCCCceeeCchhhccCCCCchhhHH
Confidence 999999999999999865431110 0011223456789999999988899999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcH
Q 001902 879 ALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945 (998)
Q Consensus 879 SlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 945 (998)
||||++|+|++ |..||.+.........+.... .......++..+.+|+.+||..+|.+||++.+++
T Consensus 224 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l 290 (304)
T cd05101 224 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLV 290 (304)
T ss_pred HHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence 99999999998 889998887777666654432 2233345788999999999999999999944443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=322.26 Aligned_cols=259 Identities=25% Similarity=0.351 Sum_probs=209.0
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC----
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT---- 738 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~---- 738 (998)
..++|++.+.||+|+||.||+|.+..+|+.||+|.++.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35689999999999999999999999999999999875432 2223346678999999999999999999887654
Q ss_pred ------eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEecc
Q 001902 739 ------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 812 (998)
Q Consensus 739 ------~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG 812 (998)
.+|+||||+++ +|..++... ...+++..++.++.||+.||+|||+.||+|+||||+||+++.++.+||+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 89999999965 777777654 3458999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCC
Q 001902 813 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGY 891 (998)
Q Consensus 813 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~ 891 (998)
++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|+
T Consensus 162 ~~~~~~~~~~--------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 162 LARLYNSEES--------------------------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred ccccccCCcc--------------------------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 9855321110 01122346788999998865 45688999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCC---CC--CC-----------------------CCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 892 TPFRGKTRQKTFANILHKD---LK--FP-----------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 892 ~Pf~~~~~~~~~~~i~~~~---~~--~~-----------------------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
+||...+....+..+.... .+ ++ .....+..+.+|+.+||..||.+||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~--- 292 (302)
T cd07864 216 PIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT--- 292 (302)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC---
Confidence 9998877666555544310 00 00 11235778999999999999999999
Q ss_pred cHHHHHcCCCc
Q 001902 944 GANEIKKHPFF 954 (998)
Q Consensus 944 ~a~elL~Hp~f 954 (998)
+.+++.||||
T Consensus 293 -~~~il~~~~~ 302 (302)
T cd07864 293 -AEEALNSPWL 302 (302)
T ss_pred -HHHHhcCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=323.69 Aligned_cols=268 Identities=26% Similarity=0.375 Sum_probs=208.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 737 (998)
.++|.+.+.||+|+||.||+|.+..+++.+|+|.+......+. ......+|+++++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 5789999999999999999999999999999999875432221 223556899999999999999999887433
Q ss_pred --CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 738 --THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 738 --~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
..+++||||+. ++|...+... ...+++..++.++.||++||.|||++||+|+||||+||+++.++.++|+|||++.
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 35799999995 5677766543 3469999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
.......... ..............|++.|+|||.+.+. .++.++|||||||++|+|++|.+||
T Consensus 164 ~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 164 PYDGPPPNPK----------------GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred hccCCCcccc----------------cCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 5432111000 0000011223456789999999998654 5788999999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCC-----------------------CC-----CCCCCcHHHHHHHHHccccCccCcCCChhcHH
Q 001902 895 RGKTRQKTFANILHKDLK-----------------------FP-----SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946 (998)
Q Consensus 895 ~~~~~~~~~~~i~~~~~~-----------------------~~-----~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 946 (998)
.+.+.......+...... .+ .....+..+.+||.+||..||.+||| +.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t----~~ 303 (311)
T cd07866 228 QGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT----AS 303 (311)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC----HH
Confidence 988776655554431000 00 00123457889999999999999999 99
Q ss_pred HHHcCCCc
Q 001902 947 EIKKHPFF 954 (998)
Q Consensus 947 elL~Hp~f 954 (998)
+++.||||
T Consensus 304 ell~~~~f 311 (311)
T cd07866 304 DALEHPYF 311 (311)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=319.58 Aligned_cols=254 Identities=28% Similarity=0.499 Sum_probs=210.9
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEec
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 746 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 746 (998)
|++.+.||.|++|.||+|.+..+++.+++|.+..... .......+..|+.+++.++|+||+++++++...+.+++||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6788999999999999999988999999999876432 223456778899999999999999999999999999999999
Q ss_pred CCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCC
Q 001902 747 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 826 (998)
Q Consensus 747 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 826 (998)
++ ++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~----- 152 (283)
T cd05118 80 MD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV----- 152 (283)
T ss_pred cC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-----
Confidence 96 48888876643 468999999999999999999999999999999999999999999999999885543111
Q ss_pred cchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 827 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+.+..
T Consensus 153 ----------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 210 (283)
T cd05118 153 ----------------------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK 210 (283)
T ss_pred ----------------------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 011234578899999999876 788999999999999999999999988877665555
Q ss_pred HHhCC-------------------CCCCC---------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 906 ILHKD-------------------LKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 906 i~~~~-------------------~~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
+.... ..++. ....+.++.+||.+||..||.+||+ +.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~ll~~~~~ 283 (283)
T cd05118 211 IFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT----AEQALAHPYF 283 (283)
T ss_pred HHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcC----HHHHhhCCCC
Confidence 43210 00000 1235678999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=314.05 Aligned_cols=254 Identities=22% Similarity=0.301 Sum_probs=208.8
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCe---EEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
..+.|...+.||+|+||.||+|.+..++. .+++|.+.... .......+.+|+++++.++|+||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 34678899999999999999999876554 79999886542 23345678889999999999999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
.|+||||+++++|.+++.... ..++...+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999997643 4589999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~ 898 (998)
.... .........+..|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 160 ~~~~------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 160 DPEG------------------------TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred cccc------------------------ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 1100 000111223567999999988889999999999999999997 999998877
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
.......+... ...+.....+..+.+|+.+||..+|.+||++.++
T Consensus 216 ~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i 260 (268)
T cd05063 216 NHEVMKAINDG-FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDI 260 (268)
T ss_pred HHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 76666666543 3445555678899999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=312.44 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=207.1
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+..++|++.+.||+|+||.||++.+. .+..+++|.+... ......+.+|+.+++.++|+||+++++++.. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 355689999999999999999999864 4567999988753 2234678889999999999999999999887 778
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
+++|||+++++|.+++.+.....++...+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 99999999999999998765566889999999999999999999999999999999999999999999999988543210
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~ 899 (998)
. ........++..|+|||++....++.++|+|||||++|++++ |..||.+.+.
T Consensus 156 ~--------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 156 E--------------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred C--------------------------cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 0 001112235678999999988889999999999999999998 9999998777
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
......+... ...+.....+.++.+++.+||+.+|++||++.+
T Consensus 210 ~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 252 (260)
T cd05073 210 PEVIRALERG-YRMPRPENCPEELYNIMMRCWKNRPEERPTFEY 252 (260)
T ss_pred HHHHHHHhCC-CCCCCcccCCHHHHHHHHHHcccCcccCcCHHH
Confidence 6666555443 334444567889999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=327.14 Aligned_cols=265 Identities=28% Similarity=0.422 Sum_probs=211.4
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeC--CeE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK--THV 740 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~--~~~ 740 (998)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+.... ........+..|+.+++++ +|+||+++++++... ...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 468999999999999999999998899999999886532 2233345677899999999 999999999988643 468
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||++ ++|..++... .+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 99999995 5999888653 5888999999999999999999999999999999999999999999999998654311
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
... ..........|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 161 ~~~----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~ 218 (337)
T cd07852 161 EEN----------------------PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218 (337)
T ss_pred ccc----------------------ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence 100 00112234568999999998865 4578899999999999999999999987665
Q ss_pred HHHHHHHHhCCCC----------------------------C-CCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 900 QKTFANILHKDLK----------------------------F-PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 900 ~~~~~~i~~~~~~----------------------------~-~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
......+...... . ......+.++.+||.+||+.||++||| +.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps----~~~il~ 294 (337)
T cd07852 219 LNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT----AEEALE 294 (337)
T ss_pred HHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccC----HHHHhh
Confidence 5444433221100 0 011225778999999999999999999 999999
Q ss_pred CCCccCCCh
Q 001902 951 HPFFKGVNW 959 (998)
Q Consensus 951 Hp~f~~~~~ 959 (998)
||||+.++-
T Consensus 295 ~~~~~~~~~ 303 (337)
T cd07852 295 HPYVAQFHN 303 (337)
T ss_pred Chhhhhhcc
Confidence 999998633
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=319.36 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=204.0
Q ss_pred cCCcccccccCCCCceeEEEEEEcc----------------CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCc
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCG----------------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 727 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~----------------~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nI 727 (998)
.++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3579999999999999999986532 35579999987542 33445678899999999999999
Q ss_pred cceeEEEeeCCeEEEEEecCCCCchhHHHhhCCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 001902 728 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPT---------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 798 (998)
Q Consensus 728 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NI 798 (998)
+++++++...+..|+||||+++++|.+++..... ..++...+..++.||+.||+|||++||+|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9999999999999999999999999999876421 2367788999999999999999999999999999999
Q ss_pred EEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHH
Q 001902 799 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 878 (998)
Q Consensus 799 Li~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIw 878 (998)
|++.++.++|+|||++..+..... ........++..|++||+..+..++.++|||
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Diw 216 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY-------------------------YRIQGRAVLPIRWMSWESILLGKFTTASDVW 216 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc-------------------------eeccCcCcCccccCCHHHHhcCCccchhhhh
Confidence 999999999999999854321100 0111223456789999999888899999999
Q ss_pred HHHHHHHHHHc--CCCCCCCCChHHHHHHHHh------CCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHH
Q 001902 879 ALGILLYEMLY--GYTPFRGKTRQKTFANILH------KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946 (998)
Q Consensus 879 SlG~il~eLlt--G~~Pf~~~~~~~~~~~i~~------~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 946 (998)
||||++|+|++ |..||...+..+.+..... .....+....++..+.+|+.+||..||.+||++.+++.
T Consensus 217 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 217 AFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999997 7899987766555443321 11223334456788999999999999999999555443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=316.99 Aligned_cols=251 Identities=21% Similarity=0.307 Sum_probs=204.1
Q ss_pred CcccccccCCCCceeEEEEEEcc-----CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47889999999999999998743 23578999887542 233456788999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 001902 741 CLITDYCPGGELFLLLDRQ----------------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 798 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~----------------------~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NI 798 (998)
++||||+++++|.+++... ....++...+..++.|++.||.|||+++|+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999988642 123478899999999999999999999999999999999
Q ss_pred EEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHH
Q 001902 799 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 878 (998)
Q Consensus 799 Li~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIw 878 (998)
|++.++.+||+|||++........ ........++..|+|||++.+..++.++|||
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 213 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDS-------------------------YVKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213 (290)
T ss_pred EEcCCCcEEeccccccccccCccc-------------------------hhcccCCCCCccccCHHHHccCCcchHhHHH
Confidence 999999999999999854321100 0011223456789999999888899999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 879 ALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 879 SlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
||||++|+|++ |..||.+.........+. .....+.....+..+.+|+.+||+.+|.+||++.++
T Consensus 214 slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i 279 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAPERLFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 99999999998 999998877666554443 333444445678899999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.79 Aligned_cols=256 Identities=29% Similarity=0.466 Sum_probs=211.9
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeeccccc--ChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
+|.+.+.||+|+||.||++.+..++..+++|+++..... .......+..|+.+++.++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 588999999999999999999887777878777643322 122334566789999999999999999999999999999
Q ss_pred EecCCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 744 TDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
|||+++++|.+++.. .....+++..++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~- 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS- 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC-
Confidence 999999999998864 23456999999999999999999999999999999999999984 67999999988543211
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......
T Consensus 159 --------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~ 212 (260)
T cd08222 159 --------------------------CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS 212 (260)
T ss_pred --------------------------cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 011223458889999999988888999999999999999999999998777666
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
....+.....+. .....+..+.++|.+||..+|++||+ +.++++||||
T Consensus 213 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~ 260 (260)
T cd08222 213 VVLRIVEGPTPS-LPETYSRQLNSIMQSMLNKDPSLRPS----AAEILRNPFI 260 (260)
T ss_pred HHHHHHcCCCCC-CcchhcHHHHHHHHHHhcCChhhCcC----HHHHhhCCCC
Confidence 666665543222 22356788999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=320.99 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=206.6
Q ss_pred ccccCCcccccccCCCCceeEEEEEEcc-------CCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 732 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-------~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~ 732 (998)
.+..++|.+.+.||+|+||.||+|.+.. .+..+|+|.++... .......+..|+.+++.+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3445689999999999999999998632 35679999987532 234456788899999999 6999999999
Q ss_pred EEeeCCeEEEEEecCCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 001902 733 SFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 798 (998)
Q Consensus 733 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NI 798 (998)
++...+.+|+||||+++++|.+++.... ...++...+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 9999999999999999999999997532 23588899999999999999999999999999999999
Q ss_pred EEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHH
Q 001902 799 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 878 (998)
Q Consensus 799 Li~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIw 878 (998)
|++.++.+||+|||++........ ........++..|+|||++.+..++.++|||
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 220 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDY-------------------------YKKTSNGRLPVKWMAPEALFDRVYTHQSDVW 220 (314)
T ss_pred EEcCCCcEEEcccccccccccccc-------------------------ccccccCCCCccccCHHHHccCCcCccchhh
Confidence 999999999999999854321100 0001112345689999999988899999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 879 ALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 879 SlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
||||++|+|++ |..||.+......+..+.... .......++..+.+|+.+||..+|.+||++.+
T Consensus 221 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 285 (314)
T cd05099 221 SFGILMWEIFTLGGSPYPGIPVEELFKLLREGH-RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQ 285 (314)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 99999999998 999998887777776665543 22223456778999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=324.21 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=207.6
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee-CCeEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KTHVCL 742 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-~~~~~l 742 (998)
.++|.+++.||.|+||.||+|.+..+++.||+|.+.+... .......+..|+.+++.++||||++++++|.. ...+|+
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 4689999999999999999999999999999998865422 23344667789999999999999999998865 568999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
||||+ +++|..++.. ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||.+.....
T Consensus 88 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--- 160 (328)
T cd07856 88 VTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--- 160 (328)
T ss_pred Eeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---
Confidence 99999 6789888864 3478889999999999999999999999999999999999999999999998843210
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.....
T Consensus 161 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~ 213 (328)
T cd07856 161 ---------------------------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213 (328)
T ss_pred ---------------------------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0122357889999998766 568899999999999999999999998766533
Q ss_pred HHHHHHhC--------------------------CCCCCC---CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCC
Q 001902 902 TFANILHK--------------------------DLKFPS---STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 952 (998)
Q Consensus 902 ~~~~i~~~--------------------------~~~~~~---~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp 952 (998)
....+... ....+. ....+..+.++|.+||+.+|.+||+ +.+++.||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~ell~~~ 289 (328)
T cd07856 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS----AAEALAHP 289 (328)
T ss_pred HHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCC
Confidence 32221110 001110 1235678999999999999999999 99999999
Q ss_pred CccCC
Q 001902 953 FFKGV 957 (998)
Q Consensus 953 ~f~~~ 957 (998)
||...
T Consensus 290 ~~~~~ 294 (328)
T cd07856 290 YLAPY 294 (328)
T ss_pred ccccc
Confidence 99754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=342.78 Aligned_cols=256 Identities=24% Similarity=0.360 Sum_probs=220.8
Q ss_pred ccccCCcccccccCCCCceeEEEEEEc-----cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 735 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 735 (998)
.+...+.+..+.||+|+||+||+++.. .....||||.++... +.....+|.+|++++..++|||||+++|++.
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 345667888999999999999999873 235689999998642 4446789999999999999999999999999
Q ss_pred eCCeEEEEEecCCCCchhHHHhhC--------C----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQ--------P----TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 803 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~--------~----~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~ 803 (998)
.++-.|+|+|||..|+|.++|... . ..+|+..+...|+.||+.||.||-++.+|||||-..|+||.++
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 999999999999999999999742 1 2238899999999999999999999999999999999999999
Q ss_pred CcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHH
Q 001902 804 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 883 (998)
Q Consensus 804 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~i 883 (998)
..|||+|||+++..-.. +|.+ ....-.-...|||||.+...+|+.+|||||+|++
T Consensus 640 l~VKIsDfGLsRdiYss------DYYk-------------------~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVv 694 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSS------DYYK-------------------VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVV 694 (774)
T ss_pred eEEEecccccchhhhhh------hhhc-------------------ccCCceeeeecCCHHHhhcCcccchhhhhhhhhh
Confidence 99999999999653211 1110 0111123568999999999999999999999999
Q ss_pred HHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 884 LYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 884 l~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
|||+++ |.-||.+..+.+.+..|..+.+ ++....++.++.+|+..||+.+|.+||+|+++
T Consensus 695 LWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 695 LWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred hhhhhccccCcccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 999995 9999999999999999999988 88888899999999999999999999998875
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=323.40 Aligned_cols=261 Identities=25% Similarity=0.375 Sum_probs=207.0
Q ss_pred CcccccccCCCCceeEEEEEEccC--CeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEee----CC
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGS--GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT----KT 738 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~--~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~----~~ 738 (998)
+|++.+.||+|+||.||++.+..+ +..||+|.+.... ........+.+|+.+++++ +|+||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488899999999999999999888 8999999987432 2233345677899999999 69999999986532 35
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
.+|++|+|+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 80 ~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 80 ELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred cEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 688999999 57899888654 458999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
..... .........|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus 157 ~~~~~-----------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 157 ENPGE-----------------------NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred ccccc-----------------------ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 11100 0011234578999999998765 56889999999999999999999999876
Q ss_pred ChHHHHHHHHhCC----------------------------CCCC-CCCCCcHHHHHHHHHccccCccCcCCChhcHHHH
Q 001902 898 TRQKTFANILHKD----------------------------LKFP-SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948 (998)
Q Consensus 898 ~~~~~~~~i~~~~----------------------------~~~~-~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 948 (998)
+....+..++... ..+. .....+..+.+|+.+||+.||.+||| +.++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~l 289 (332)
T cd07857 214 DYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS----VEEA 289 (332)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC----HHHH
Confidence 6544443332210 0011 11234678999999999999999999 9999
Q ss_pred HcCCCccCC
Q 001902 949 KKHPFFKGV 957 (998)
Q Consensus 949 L~Hp~f~~~ 957 (998)
+.||||+..
T Consensus 290 l~~~~~~~~ 298 (332)
T cd07857 290 LEHPYLAIW 298 (332)
T ss_pred hcChhhhhh
Confidence 999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=328.03 Aligned_cols=253 Identities=26% Similarity=0.326 Sum_probs=199.4
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC-eEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-HVCL 742 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-~~~l 742 (998)
.+.|..-+.||+|+||.||++... +|..||||.+....... ..++.+|+.++.+++|||+|+++|||.+.+ ..+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 367888899999999999999984 45899999877543221 355999999999999999999999999888 5999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ---GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
|+|||++|+|.+.|.......+++....+|+.++++||+|||.. .||||||||+|||+|++..+||+|||+|+..+.
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 99999999999999876432789999999999999999999985 399999999999999999999999999955431
Q ss_pred -CCCCCCCcchhhhhcccCCCCcccccccccccccc-cCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 820 -KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSF-VGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 820 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
... .... .||.+|+|||++..+..+.++||||||++|.||++|+.|....
T Consensus 230 ~~~~----------------------------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 230 GDTS----------------------------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred cccc----------------------------eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 110 0111 6999999999999989999999999999999999999888753
Q ss_pred C---hHHHH---HHHHhC-CC---CCCCC--CCCc-----HHHHHHHHHccccCccCcCCChhcHHHH
Q 001902 898 T---RQKTF---ANILHK-DL---KFPSS--TPTS-----LHAKQLMYRLLHRDPKSRLGSHEGANEI 948 (998)
Q Consensus 898 ~---~~~~~---~~i~~~-~~---~~~~~--~~~s-----~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 948 (998)
. ..... ...+.. .+ .-|.. ...+ ..+..+...|++.+|..||++.+++..+
T Consensus 282 ~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 282 RPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred CCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 2 11111 111111 11 00110 1112 1355788999999999999987765555
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=318.69 Aligned_cols=261 Identities=27% Similarity=0.425 Sum_probs=210.8
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 739 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 739 (998)
.+..++|++.+.||+|+||.||+|.+..+++.||+|.++... .......+..|+.++..+ +|+||+++++++.....
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 456789999999999999999999998889999999987542 222344556677766666 59999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
.|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.++|+|||++....
T Consensus 89 ~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 89 VFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred EEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99999999 557777776533 368999999999999999999997 599999999999999999999999999884432
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC----CCChhHHHHHHHHHHHHHcCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||
T Consensus 167 ~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 218 (296)
T cd06618 167 DSK----------------------------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY 218 (296)
T ss_pred CCC----------------------------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCC
Confidence 100 011224788999999987654 788999999999999999999999
Q ss_pred CCCCh-HHHHHHHHhCCCC-CCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 895 RGKTR-QKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 895 ~~~~~-~~~~~~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
..... .+.+..+.....+ .+.....+.++.+|+.+||..||.+||+ +.++++||||+..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~ 279 (296)
T cd06618 219 KNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPK----YRELLQHPFIRRY 279 (296)
T ss_pred CcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCC----HHHHhcChhhhcc
Confidence 76433 3444555544322 2333346788999999999999999999 9999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=348.93 Aligned_cols=273 Identities=28% Similarity=0.424 Sum_probs=209.6
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC-----
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK----- 737 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~----- 737 (998)
...+|+.+..||+||||.||+|+++-+|+.||||.+.... +......+.+|+.+|.+|+|||||++|..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 3568999999999999999999999999999999998654 556677889999999999999999988653110
Q ss_pred --------------------------------------------------------------------------------
Q 001902 738 -------------------------------------------------------------------------------- 737 (998)
Q Consensus 738 -------------------------------------------------------------------------------- 737 (998)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH
Q 001902 738 ----------------------------------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 783 (998)
Q Consensus 738 ----------------------------------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~L 783 (998)
..+||-||||+..+|.+++.++.... .....+.++++|++||+|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence 02789999999999999998764321 4678899999999999999
Q ss_pred HHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccc-cccccccccCCCCccc
Q 001902 784 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE-PMRASNSFVGTEEYIA 862 (998)
Q Consensus 784 H~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~a 862 (998)
|++|||||||||.||++++++.|||+|||+|+..-.... .............. .....+..+||..|+|
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~----------~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLE----------SIDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhh----------hHhhccCccccccCCCCcccccccceeeeec
Confidence 999999999999999999999999999999965210000 00000000011111 1224567899999999
Q ss_pred chhhcCCC---CCChhHHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHhCCCCCCCCC--CCcHHHHHHHHHccccCcc
Q 001902 863 PEIIAGAG---HTSAVDWWALGILLYEMLYGYTPFRGK-TRQKTFANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPK 936 (998)
Q Consensus 863 PE~l~~~~---~~~~sDIwSlG~il~eLltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~--~~s~~l~~Ll~~~L~~dP~ 936 (998)
||++.+.. |+.|+|+||||++|+||+. ||... .....+..+-.+.++.+... +--+.-..+|..||+.||+
T Consensus 784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~ 860 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPS 860 (1351)
T ss_pred HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCc
Confidence 99997754 9999999999999999995 46442 33344455555556655111 1123446899999999999
Q ss_pred CcCCChhcHHHHHcCCCcc
Q 001902 937 SRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 937 ~Rpt~~~~a~elL~Hp~f~ 955 (998)
+||| |.+||++.||.
T Consensus 861 kRPt----A~eLL~s~llp 875 (1351)
T KOG1035|consen 861 KRPT----ATELLNSELLP 875 (1351)
T ss_pred cCCC----HHHHhhccCCC
Confidence 9999 99999999988
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=323.22 Aligned_cols=262 Identities=21% Similarity=0.309 Sum_probs=209.7
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccC-------CeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccce
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGS-------GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPAL 730 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-------~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l 730 (998)
.+.+...+|++.+.||+|+||.||+|.+... +..+|+|.+... ........+.+|+.+++++ +|+||+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3445567899999999999999999986432 247899988743 2334456788999999999 89999999
Q ss_pred eEEEeeCCeEEEEEecCCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 001902 731 YASFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPE 796 (998)
Q Consensus 731 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~ 796 (998)
++++...+.++++|||+++++|.+++.+.. ...++...+..++.||+.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999997532 224778889999999999999999999999999999
Q ss_pred cEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhH
Q 001902 797 NVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 876 (998)
Q Consensus 797 NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sD 876 (998)
|||++.++.+||+|||++........ ........++..|+|||++.+..++.++|
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 218 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDY-------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSD 218 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccc-------------------------cccccCCCcCceEcCHHHhccCCcCchhh
Confidence 99999999999999999854321100 00111223456899999999999999999
Q ss_pred HHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHH
Q 001902 877 WWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948 (998)
Q Consensus 877 IwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 948 (998)
||||||++|+|++ |..||.+.+.......+.... ..+.....+.++.+|+.+||..+|.+||++.+++..+
T Consensus 219 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 219 VWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred hHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 9999999999998 899999887777666665432 2233345678899999999999999999944443333
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.43 Aligned_cols=246 Identities=21% Similarity=0.287 Sum_probs=198.5
Q ss_pred ccCCCCceeEEEEEEc--cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCC
Q 001902 672 PLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 749 (998)
Q Consensus 672 ~LG~G~~g~Vy~a~~~--~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 749 (998)
.||+|+||.||+|.+. ..+..+|+|++.... .......+.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999774 446679999987542 3344567889999999999999999999875 4578999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
++|.+++... ...+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..........
T Consensus 79 ~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~----- 152 (257)
T cd05115 79 GPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY----- 152 (257)
T ss_pred CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce-----
Confidence 9999998754 2458999999999999999999999999999999999999999999999999985432111100
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHh
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILH 908 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~ 908 (998)
.......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+..
T Consensus 153 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05115 153 -------------------KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213 (257)
T ss_pred -------------------eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC
Confidence 00111234678999999988889999999999999999996 9999998877776665555
Q ss_pred CCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHH
Q 001902 909 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946 (998)
Q Consensus 909 ~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 946 (998)
+. ..+.....+.++.+++.+||..+|.+||++.+++.
T Consensus 214 ~~-~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 214 GK-RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 43 22333456889999999999999999999655433
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=310.20 Aligned_cols=242 Identities=21% Similarity=0.351 Sum_probs=202.0
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEE
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 742 (998)
..++|++.+.||.|+||.||++.. +++.+|+|.++... ....+.+|+.+++.++||||+++++++..+ ..++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 346799999999999999999874 78899999886432 235678899999999999999999998764 4799
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
||||+++++|.+++.......++...+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~--- 152 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM--- 152 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc---
Confidence 99999999999999876555689999999999999999999999999999999999999999999999998843210
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHH
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK 901 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~ 901 (998)
.......+..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+...
T Consensus 153 ---------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 205 (254)
T cd05083 153 ---------------------------GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205 (254)
T ss_pred ---------------------------cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence 0011234567999999988889999999999999999997 999999887766
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
....+... ...+.....+..+.+|+.+||+.+|.+||++.+
T Consensus 206 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 246 (254)
T cd05083 206 VKECVEKG-YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHK 246 (254)
T ss_pred HHHHHhCC-CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 66555443 333333456789999999999999999999444
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=315.35 Aligned_cols=253 Identities=30% Similarity=0.473 Sum_probs=206.8
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEeeCCeEEEEEe
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lV~E 745 (998)
|.+.+.||.|++|.||+|.+..+++.+++|.+...... .......+|+..+++++ |+||+++++++..++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 67889999999999999999888999999998754321 12233456889999998 9999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+ +++|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~----- 152 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR----- 152 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-----
Confidence 99 889999887765456899999999999999999999999999999999999999999999999988543211
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.......++..|+|||++.. ..++.++|+||||+++|+|++|++||........+.
T Consensus 153 -----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~ 209 (283)
T cd07830 153 -----------------------PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY 209 (283)
T ss_pred -----------------------CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH
Confidence 01123458889999998854 457889999999999999999999998876655554
Q ss_pred HHHhCC-------------------CCCCC---------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 905 NILHKD-------------------LKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 905 ~i~~~~-------------------~~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
.+...- ..++. ....+..+.+||.+||..+|.+||| +.+++.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~~~~~ 283 (283)
T cd07830 210 KICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT----ASQALQHPYF 283 (283)
T ss_pred HHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC----HHHHhhCCCC
Confidence 433210 00000 0122567899999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=307.62 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=210.3
Q ss_pred cccccccCCCCceeEEEEEEccCC----eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEE
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSG----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~----~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 742 (998)
|++.+.||.|+||.||++.+...+ ..+|+|.+.... .......+..|+.+++.++|+||+++++++...+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 457789999999999999997766 899999987542 22256788899999999999999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
+|||+++++|.+++.......+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999999775433389999999999999999999999999999999999999999999999999855331100
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHH
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK 901 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~ 901 (998)
.......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...+...
T Consensus 159 --------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~ 212 (258)
T smart00219 159 --------------------------YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE 212 (258)
T ss_pred --------------------------cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 00001226789999999988889999999999999999998 899998887777
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
....+...... +.....+.++.+++.+||..||.+||| +.++++
T Consensus 213 ~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt----~~~ll~ 256 (258)
T smart00219 213 VLEYLKKGYRL-PKPENCPPEIYKLMLQCWAEDPEDRPT----FSELVE 256 (258)
T ss_pred HHHHHhcCCCC-CCCCcCCHHHHHHHHHHCcCChhhCcC----HHHHHh
Confidence 77766655432 233447889999999999999999999 777764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=315.05 Aligned_cols=254 Identities=28% Similarity=0.469 Sum_probs=210.7
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEec
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 746 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 746 (998)
|++.+.||+|++|.||+|.+..+++.|++|++.... ........+..|+.+++.++|+||+++++++...+..++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 667889999999999999999999999999998653 2233345677899999999999999999999999999999999
Q ss_pred CCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCC
Q 001902 747 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 826 (998)
Q Consensus 747 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 826 (998)
++ ++|.+++.+.. ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~----- 152 (282)
T cd07829 80 CD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL----- 152 (282)
T ss_pred cC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-----
Confidence 96 68999997753 359999999999999999999999999999999999999999999999999885432110
Q ss_pred cchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 827 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
.......++..|+|||.+.+. .++.++|||||||++|+|++|.+||.+.+....+..
T Consensus 153 ----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 210 (282)
T cd07829 153 ----------------------RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFK 210 (282)
T ss_pred ----------------------cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 011223467889999999776 788899999999999999999999988776666555
Q ss_pred HHhC------------------CCCCCC---------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 906 ILHK------------------DLKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 906 i~~~------------------~~~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
+... ...++. ....+..+.++|.+||..||.+||+ +.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~p~~ 282 (282)
T cd07829 211 IFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS----AKEALKHPYF 282 (282)
T ss_pred HHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCC----HHHHhhCcCC
Confidence 4431 000111 1123668999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=313.02 Aligned_cols=255 Identities=22% Similarity=0.372 Sum_probs=200.7
Q ss_pred cCCcccccccCCCCceeEEEEEE----ccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee--C
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVEL----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--K 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~----~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~ 737 (998)
..+|++++.||+|+||.||++.. ..+++.||+|.+... .......+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 35799999999999999999974 457889999998753 33445678899999999999999999997653 4
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
..+++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 57899999999999999997642 35899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
...... ........++..|+|||++.+..++.++|||||||++|+|++|..|+...
T Consensus 159 ~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 214 (284)
T cd05081 159 PQDKEY------------------------YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP 214 (284)
T ss_pred cCCCcc------------------------eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCc
Confidence 311100 00011123455699999999888999999999999999999988776433
Q ss_pred ChH---------------HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 898 TRQ---------------KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 898 ~~~---------------~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
... ..+..++.....++....++..+.+|+.+||..+|++||| +.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~ 278 (284)
T cd05081 215 PAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPS----FSELAL 278 (284)
T ss_pred chhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 211 1111233333344445567889999999999999999999 555543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=315.14 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=201.4
Q ss_pred CcccccccCCCCceeEEEEEE----ccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC--Ce
Q 001902 666 HFRPIKPLGSGDTGSVHLVEL----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--TH 739 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~----~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~ 739 (998)
-|++++.||+|+||.||+|.. ..+++.||+|.++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 479999999999999999984 4568899999987542 334456788999999999999999999988765 67
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
.++||||++|++|.+++.+.. ..++...+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 899999999999999987642 3589999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC-
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT- 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~- 898 (998)
.... ........++..|+|||++.+..++.++|||||||++|+|++++.|+....
T Consensus 162 ~~~~------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~ 217 (284)
T cd05079 162 DKEY------------------------YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217 (284)
T ss_pred Cccc------------------------eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc
Confidence 1100 011123457788999999988889999999999999999999877653211
Q ss_pred -------------hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 899 -------------RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 899 -------------~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
...............+.....+..+.+|+.+||+.||.+||+ +.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~il~ 278 (284)
T cd05079 218 LFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTT----FQNLIE 278 (284)
T ss_pred hhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcC----HHHHHH
Confidence 111111222223334444557889999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=308.34 Aligned_cols=250 Identities=21% Similarity=0.344 Sum_probs=206.8
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
..+|++.+.||.|+||.||++.+. .+..+|+|.+..... ....+.+|+++++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 457899999999999999999884 477899998875432 234677899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc--
Confidence 99999999999987643 358899999999999999999999999999999999999999999999999885432110
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~ 902 (998)
........++..|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 155 ------------------------~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 210 (256)
T cd05112 155 ------------------------YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210 (256)
T ss_pred ------------------------ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 001112235678999999998889999999999999999998 9999988877776
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
...+.... ........+..+.+|+.+||..+|.+||+ +.++++
T Consensus 211 ~~~~~~~~-~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~----~~~~l~ 253 (256)
T cd05112 211 VETINAGF-RLYKPRLASQSVYELMQHCWKERPEDRPS----FSLLLH 253 (256)
T ss_pred HHHHhCCC-CCCCCCCCCHHHHHHHHHHcccChhhCCC----HHHHHH
Confidence 66665432 22223346789999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.61 Aligned_cols=254 Identities=22% Similarity=0.298 Sum_probs=208.1
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCe----EEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
..++|++.+.||+|+||.||+|.+..+|. .+|+|.+.... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45689999999999999999999876654 68999877543 24455678889999999999999999999887 7
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
..++||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 8999999999999999997653 348999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~ 897 (998)
..... .......++..|+|||.+....++.++|+|||||++|+|++ |..||.+.
T Consensus 161 ~~~~~-------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 215 (279)
T cd05057 161 VDEKE-------------------------YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215 (279)
T ss_pred Ccccc-------------------------eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 11100 00011224568999999988889999999999999999998 99999988
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHH
Q 001902 898 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 946 (998)
...+....+... ...+.....+..+.+++.+||..||..||++.+++.
T Consensus 216 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 216 PAVEIPDLLEKG-ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CHHHHHHHHhCC-CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 776666555543 334444456788999999999999999999555433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.49 Aligned_cols=244 Identities=23% Similarity=0.349 Sum_probs=199.5
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 750 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 750 (998)
+.||+|+||.||++.. .++..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 3689999999999986 468899999987542 2333456788999999999999999999999999999999999999
Q ss_pred chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchh
Q 001902 751 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830 (998)
Q Consensus 751 sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 830 (998)
+|.+++.... ..+++..+..++.|++.+|.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--------- 147 (250)
T cd05085 78 DFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI--------- 147 (250)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc---------
Confidence 9999987643 458899999999999999999999999999999999999999999999999884321000
Q ss_pred hhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhC
Q 001902 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHK 909 (998)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~ 909 (998)
........++..|+|||++.+..++.++||||||+++|++++ |..||.+.........+...
T Consensus 148 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~ 210 (250)
T cd05085 148 -----------------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG 210 (250)
T ss_pred -----------------cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 000111234568999999998889999999999999999998 99999888776666655543
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcH
Q 001902 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945 (998)
Q Consensus 910 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 945 (998)
. ........+..+.+|+.+||..+|.+||++.+++
T Consensus 211 ~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~ 245 (250)
T cd05085 211 Y-RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQ 245 (250)
T ss_pred C-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 2 2223345678999999999999999999944433
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=303.63 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=214.5
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHH-HHhCCCCCccceeEEEeeCCeEE
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-LDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~i-l~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
.-+..+-+..||.|+||+|++..++.+|+..|||.++... ......++..|.+. ++.-++||||++|+....++..|
T Consensus 62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n--~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN--IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW 139 (361)
T ss_pred ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc--chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence 3456677888999999999999999999999999998653 33445667777765 44558999999999999999999
Q ss_pred EEEecCCCCchhHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 742 LITDYCPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~---~~~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
|.||+| ..||..+.+. .....+++..+..|....+.||.||-.. .|||||+||+|||++..|.+||||||++..+
T Consensus 140 iCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 140 ICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred eeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence 999999 7777655442 2234599999999999999999999865 8999999999999999999999999998443
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC--CCCCChhHHHHHHHHHHHHHcCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
. .+...+...|-..|||||.+.. ..|+.+||+||||++|||+.||..||.
T Consensus 219 v----------------------------~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr 270 (361)
T KOG1006|consen 219 V----------------------------DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR 270 (361)
T ss_pred H----------------------------HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc
Confidence 2 1122334578999999999954 468889999999999999999999998
Q ss_pred CCCh-HHHHHHHHhCCCCCCCC----CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 896 GKTR-QKTFANILHKDLKFPSS----TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 896 ~~~~-~~~~~~i~~~~~~~~~~----~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
+-+. .+++..++.++.+.... ...+..+..||.-||.+|-+.||. ..+|+++||++-...
T Consensus 271 ~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpk----y~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 271 KWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPK----YDDLKKFPFYRMYAV 335 (361)
T ss_pred hHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcc----hhhhhcCchhhhhhh
Confidence 8544 56777777776654322 346888999999999999999999 999999999987533
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=328.08 Aligned_cols=244 Identities=34% Similarity=0.520 Sum_probs=207.8
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEE
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~ 741 (998)
..+.|.+...+|.|+||.|-.+.+..+++.+++|++.+.. ....+|+.++... +||||+++++.+.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 3678999999999999999999999999999999998652 2334577666555 8999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE-ecCCcEEEEeccCccccCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi-~~~g~vkL~DFG~a~~~~~~ 820 (998)
+|||++.|+-|.+.+..++. +. ..+..|+.+|+.++.|||.+|||||||||+|||+ +..|+++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999999988877766432 33 6777899999999999999999999999999999 58999999999998654311
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
..+.+-|..|.|||++....|+.++|+||||++||+|++|+.||......
T Consensus 470 ------------------------------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 470 ------------------------------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred ------------------------------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 12346788999999999999999999999999999999999999876555
Q ss_pred -HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 901 -KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 901 -~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
+++.++...... ..+|..+++||+.||+.||.+||+ +.+++.||||
T Consensus 520 ~ei~~~i~~~~~s----~~vS~~AKdLl~~LL~~dP~~Rl~----~~~i~~h~w~ 566 (612)
T KOG0603|consen 520 IEIHTRIQMPKFS----ECVSDEAKDLLQQLLQVDPALRLG----ADEIGAHPWF 566 (612)
T ss_pred HHHHHhhcCCccc----cccCHHHHHHHHHhccCChhhCcC----hhhhccCcch
Confidence 444444443322 567999999999999999999999 9999999999
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=313.32 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=196.0
Q ss_pred Cc-ccccccCCCCceeEEEEEE----ccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee--CC
Q 001902 666 HF-RPIKPLGSGDTGSVHLVEL----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KT 738 (998)
Q Consensus 666 ~y-~~~~~LG~G~~g~Vy~a~~----~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~ 738 (998)
+| ++++.||+|+||+||++.. ..++..+|+|++.... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 45 8999999999999988653 3568899999987542 22344667789999999999999999998764 45
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
.+++||||+++++|.+++... .+++..++.++.|++.||.|||++||+|+||||+|||++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 689999999999999999763 48999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
..... ........++..|+|||.+.+..++.++|||||||++|+|++|..||....
T Consensus 159 ~~~~~------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 159 EGHEY------------------------YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred Ccchh------------------------hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence 11100 001122345677999999988889999999999999999999999986543
Q ss_pred hH--------------HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 899 RQ--------------KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 899 ~~--------------~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
.. .............+.....+..+.+|+.+||..+|++||++.++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i 274 (283)
T cd05080 215 KKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSL 274 (283)
T ss_pred chhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHH
Confidence 21 01111111122223334567899999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.91 Aligned_cols=246 Identities=26% Similarity=0.365 Sum_probs=202.9
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 750 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 750 (998)
+.||.|+||.||++.+.. ++.|++|.+..... ......+.+|+.++++++|+||+++++++......++||||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 468999999999999977 99999999876533 235567889999999999999999999999999999999999999
Q ss_pred chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchh
Q 001902 751 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830 (998)
Q Consensus 751 sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 830 (998)
+|.+++.... ..++...+..++.+++.+|.|||+++++||||||+|||++.++.++|+|||++.........
T Consensus 78 ~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~------- 149 (251)
T cd05041 78 SLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT------- 149 (251)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce-------
Confidence 9999987643 35889999999999999999999999999999999999999999999999998543210000
Q ss_pred hhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhC
Q 001902 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHK 909 (998)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~ 909 (998)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+...
T Consensus 150 ------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~ 211 (251)
T cd05041 150 ------------------VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG 211 (251)
T ss_pred ------------------eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC
Confidence 00011234567999999988889999999999999999998 89999887765555554433
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 910 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
...+.....+.++.+|+.+||..+|.+||+ +.++++
T Consensus 212 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~ell~ 247 (251)
T cd05041 212 -YRMPAPQLCPEEIYRLMLQCWAYDPENRPS----FSEIYN 247 (251)
T ss_pred -CCCCCCccCCHHHHHHHHHHhccChhhCcC----HHHHHH
Confidence 333334456789999999999999999999 777664
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.30 Aligned_cols=244 Identities=23% Similarity=0.331 Sum_probs=197.8
Q ss_pred cccCCCCceeEEEEEEccCCe--EEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEEEEecC
Q 001902 671 KPLGSGDTGSVHLVELCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYC 747 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~--~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~ 747 (998)
+.||+|+||.||++.+..++. .+++|.++.. ........+.+|+.++.++ +||||+++++++...+.+|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 358999999999999987775 4688877642 2334456788899999999 8999999999999999999999999
Q ss_pred CCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccC
Q 001902 748 PGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 813 (998)
Q Consensus 748 ~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~ 813 (998)
++++|.+++.... ...++...+..++.|++.||+|||++|++|+||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997532 12478999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCC
Q 001902 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYT 892 (998)
Q Consensus 814 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~ 892 (998)
+..... .........+..|+|||++....++.++|||||||++|+|++ |..
T Consensus 159 ~~~~~~----------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~ 210 (270)
T cd05047 159 SRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 210 (270)
T ss_pred ccccch----------------------------hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 732110 000111234567999999988889999999999999999996 999
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcH
Q 001902 893 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945 (998)
Q Consensus 893 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 945 (998)
||.+.+....+..+... ...+.....+..+.+|+.+||..||.+||++.+++
T Consensus 211 pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 262 (270)
T cd05047 211 PYCGMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 262 (270)
T ss_pred CccccCHHHHHHHHhCC-CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence 99887776666655443 22223344678899999999999999999944443
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=310.89 Aligned_cols=256 Identities=19% Similarity=0.212 Sum_probs=208.7
Q ss_pred cccCCcccccccCCCCceeEEEEEEcc----CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee-
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCG----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT- 736 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~----~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~- 736 (998)
+..++|++.+.||+|+||.||+|.+.. ++..+++|.+... ........+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 445789999999999999999999865 3688999988643 244456778899999999999999999998765
Q ss_pred CCeEEEEEecCCCCchhHHHhhCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEe
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQPT------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 810 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~~------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~D 810 (998)
....+++++|+++++|.+++..... ..+++..+..++.||+.||+|||+++++|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 5778999999999999999875322 4589999999999999999999999999999999999999999999999
Q ss_pred ccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-
Q 001902 811 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY- 889 (998)
Q Consensus 811 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt- 889 (998)
||+++.+...... .......++..|+|||++.+..++.++|||||||++|++++
T Consensus 161 ~g~~~~~~~~~~~-------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~ 215 (280)
T cd05043 161 NALSRDLFPMDYH-------------------------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTL 215 (280)
T ss_pred CCCcccccCCceE-------------------------EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcC
Confidence 9998654211100 00112245678999999998889999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcH
Q 001902 890 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945 (998)
Q Consensus 890 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 945 (998)
|..||...+.......+.. ...++....++..+.+++.+||..||++|||+.+++
T Consensus 216 g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~ 270 (280)
T cd05043 216 GQTPYVEIDPFEMAAYLKD-GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLV 270 (280)
T ss_pred CCCCcCcCCHHHHHHHHHc-CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 9999988776665544443 334444455688999999999999999999944433
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=311.12 Aligned_cols=238 Identities=20% Similarity=0.306 Sum_probs=191.3
Q ss_pred cccCCCCceeEEEEEEccCCe-------EEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 671 KPLGSGDTGSVHLVELCGSGQ-------YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~-------~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
+.||.|+||.||+|.+...+. .+++|.+... .....+.+..|..+++.++||||+++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999999865543 4888877543 233456678899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc--------EEEEeccCcc
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--------VSLTDFDLSC 815 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~--------vkL~DFG~a~ 815 (998)
|||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++. ++++|||++.
T Consensus 78 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999997653 35899999999999999999999999999999999999987764 6999999874
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcC-CCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYG-YTP 893 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG-~~P 893 (998)
... ......++..|+|||++.+ ..++.++|||||||++|+|++| .+|
T Consensus 157 ~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~ 205 (258)
T cd05078 157 TVL-------------------------------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP 205 (258)
T ss_pred ccC-------------------------------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 321 1123457889999999977 4578899999999999999998 566
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 894 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
|...+..... .+......+|. ..+.++.+|+.+||+.||++||| ++++++
T Consensus 206 ~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps----~~~il~ 255 (258)
T cd05078 206 LSALDSQKKL-QFYEDRHQLPA--PKWTELANLINQCMDYEPDFRPS----FRAIIR 255 (258)
T ss_pred hhhccHHHHH-HHHHccccCCC--CCcHHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 6665554433 23333333333 34678999999999999999999 666664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=307.89 Aligned_cols=233 Identities=32% Similarity=0.477 Sum_probs=190.6
Q ss_pred CCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCCchhHH
Q 001902 676 GDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 755 (998)
Q Consensus 676 G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~ 755 (998)
|.+|.||+|.+..+++.||+|.+.+.. ....|...+....||||+++++++...+..|+||||++|++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999987642 223344555566799999999999999999999999999999999
Q ss_pred HhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcc
Q 001902 756 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835 (998)
Q Consensus 756 l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~ 835 (998)
+.+. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.+.....
T Consensus 76 l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~---------------- 137 (237)
T cd05576 76 ISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED---------------- 137 (237)
T ss_pred HHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc----------------
Confidence 8765 3489999999999999999999999999999999999999999999999998743220
Q ss_pred cCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCC
Q 001902 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPS 915 (998)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 915 (998)
......++..|+|||.+.+..++.++|+||+||++|+|++|..||...... ......+..
T Consensus 138 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~ 197 (237)
T cd05576 138 --------------SCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNI 197 (237)
T ss_pred --------------ccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCC
Confidence 011224567899999998888999999999999999999999987643211 111111112
Q ss_pred CCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCc
Q 001902 916 STPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFF 954 (998)
Q Consensus 916 ~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f 954 (998)
....+..+.+||.+||+.||.+||++. ..+.++++||||
T Consensus 198 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 198 PEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 234678899999999999999999953 236999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.36 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=206.1
Q ss_pred ccCCcccccccCCCCceeEEEEEEccC---CeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
...+|.+.+.||.|+||.||+|.+... ...+++|...... .....+.+.+|+.+++.++|+||+++++++.. +.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 345789999999999999999987543 4578999876542 24455678899999999999999999998875 55
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
.|+||||+++++|.+++.... ..++...+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 789999999999999997643 3589999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~ 898 (998)
... .......++..|+|||.+....++.++|||||||++|+|++ |..||.+.+
T Consensus 160 ~~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 160 ESY--------------------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred ccc--------------------------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 100 00112235578999999988889999999999999999985 999999888
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
.......+.... ..+....++..+.+|+.+||..+|.+||| +.+++.
T Consensus 214 ~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~~~ 260 (270)
T cd05056 214 NNDVIGRIENGE-RLPMPPNCPPTLYSLMTKCWAYDPSKRPR----FTELKA 260 (270)
T ss_pred HHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 777666665543 22334456889999999999999999999 555543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=307.08 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=207.9
Q ss_pred CcccccccCCCCceeEEEEEEcc-CCeEEEEEEeecccc-------cChhHHHHHHHHHHHHHh-CCCCCccceeEEEee
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCG-SGQYFAMKAMDKGVM-------LNRNKVHRACAEREILDM-LDHPFVPALYASFQT 736 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~-~~~~valK~i~~~~~-------~~~~~~~~~~~E~~il~~-l~h~nIv~l~~~~~~ 736 (998)
.|++.+.||+|+||.||++.+.. +++.+|+|.+..... ........+..|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999977 688999998864321 123344567778888865 799999999999999
Q ss_pred CCeEEEEEecCCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEecCCcEEEEeccC
Q 001902 737 KTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDL 813 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkP~NILi~~~g~vkL~DFG~ 813 (998)
++..++||||+++++|.+++.. .....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988753 233568999999999999999999996 6899999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCC
Q 001902 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 814 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~P 893 (998)
+....... ......|+..|+|||++.+..++.++|+||||+++|+|++|.+|
T Consensus 161 ~~~~~~~~----------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p 212 (269)
T cd08528 161 AKQKQPES----------------------------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212 (269)
T ss_pred eeeccccc----------------------------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCc
Confidence 85432110 12234688999999999988899999999999999999999999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcH
Q 001902 894 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 945 (998)
|...+.......+.............+..+.+|+.+||..||++||++.+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~ 264 (269)
T cd08528 213 FYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264 (269)
T ss_pred ccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHH
Confidence 9887777666666655443333335678999999999999999999944433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=313.28 Aligned_cols=256 Identities=22% Similarity=0.333 Sum_probs=204.9
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCe----EEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
+...+|+.++.||+|+||.||++.+..++. .+|+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 345689999999999999999999877775 56888876432 233344678899999999999999999988754
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
..++++||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++...
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 4679999999999999987642 35889999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~ 896 (998)
...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 160 ~~~~~~-------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 160 EGDEKE-------------------------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred cCcccc-------------------------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 211100 01112345778999999998899999999999999999997 9999987
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
....... .++.....++.....+..+.+++.+||..+|++||++.+++..
T Consensus 215 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 215 IPTREIP-DLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCHHHHH-HHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7654443 3444444444445567889999999999999999995554443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=331.44 Aligned_cols=259 Identities=28% Similarity=0.417 Sum_probs=226.0
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEe-----eC
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ-----TK 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~-----~~ 737 (998)
.+.|++...||.|.+|.||++.++.+|+..|+|+....... -+.+..|.+|++.+ +|||++.+|++|. ..
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 46799999999999999999999999999999998865332 24566788999888 7999999999986 35
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
+.+|||||||.|||..|+++.-.+..+.++.+..|++.++.||.+||.+.+||||||-.|||++.+|.|||+|||.+...
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 78999999999999999999877788999999999999999999999999999999999999999999999999998554
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-----CCCChhHHHHHHHHHHHHHcCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-----GHTSAVDWWALGILLYEMLYGYT 892 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDIwSlG~il~eLltG~~ 892 (998)
. .......+.+|||.|||||++... .|+..+|+||||++..||.-|.+
T Consensus 174 d---------------------------sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~P 226 (953)
T KOG0587|consen 174 D---------------------------STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAP 226 (953)
T ss_pred e---------------------------cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCC
Confidence 3 223445678999999999999553 46779999999999999999999
Q ss_pred CCCCCChHHHHHHHHhCCCC-CCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 893 PFRGKTRQKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 893 Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
|+....+...+..|.+...+ +..+...+.++.+||..||.+|-.+||+ +.++|+|||++..
T Consensus 227 Pl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~----~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 227 PLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPS----TEELLKHPFITEQ 288 (953)
T ss_pred CccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcc----hhhhccCCccccc
Confidence 99999998888777765433 3334556889999999999999999999 9999999999954
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.93 Aligned_cols=245 Identities=22% Similarity=0.304 Sum_probs=198.7
Q ss_pred cccCCCCceeEEEEEEccCC------eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 671 KPLGSGDTGSVHLVELCGSG------QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~------~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
+.||.|+||.||++.+...+ +.+++|.+.... .......+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999986443 789999886542 2234567888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC-----cEEEEeccCc
Q 001902 745 DYCPGGELFLLLDRQ-----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-----HVSLTDFDLS 814 (998)
Q Consensus 745 E~~~ggsL~~~l~~~-----~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g-----~vkL~DFG~a 814 (998)
||+++++|.+++... ....+++..+..++.||+.||.|||+++++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999753 223478899999999999999999999999999999999999887 8999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTP 893 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~P 893 (998)
........ ........++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 159 ~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p 213 (269)
T cd05044 159 RDIYKSDY-------------------------YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213 (269)
T ss_pred cccccccc-------------------------cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCC
Confidence 54321100 001122345778999999999999999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 894 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
|...+.......+.... .+......+..+.+|+.+||..+|.+||++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 262 (269)
T cd05044 214 YPALNNQEVLQHVTAGG-RLQKPENCPDKIYQLMTNCWAQDPSERPTFDR 262 (269)
T ss_pred CcccCHHHHHHHHhcCC-ccCCcccchHHHHHHHHHHcCCCcccCCCHHH
Confidence 98877766655554332 22333446788999999999999999999444
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=305.51 Aligned_cols=245 Identities=21% Similarity=0.310 Sum_probs=190.6
Q ss_pred cccCCCCceeEEEEEEcc--CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCC
Q 001902 671 KPLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 748 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~--~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 748 (998)
+.||+|+||.||+|.... ....+++|.+.... .......+.+|+.+++.++|+||+++++.+......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999997532 34578888776432 23345567889999999999999999999999999999999999
Q ss_pred CCchhHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 749 GGELFLLLDRQPT---KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 749 ggsL~~~l~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
+++|.+++..... ...+...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--- 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh---
Confidence 9999999976432 2346778899999999999999999999999999999999999999999998843211000
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-------CCCCChhHHHHHHHHHHHHHc-CCCCCCCC
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-------AGHTSAVDWWALGILLYEMLY-GYTPFRGK 897 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~ 897 (998)
........+++.|+|||++.. ..++.++|||||||++|+|++ |..||...
T Consensus 156 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 156 ----------------------YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ----------------------eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 001123346778999999743 356779999999999999998 88999887
Q ss_pred ChHHHHHHHHhCC-CCCCC---CCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 898 TRQKTFANILHKD-LKFPS---STPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 898 ~~~~~~~~i~~~~-~~~~~---~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
.....+..+.... ..++. ....+..+.+++..|+ .||.+||++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~ 262 (269)
T cd05042 214 SDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEE 262 (269)
T ss_pred CHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHH
Confidence 7766666555432 22222 2346778889999998 59999999443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=343.50 Aligned_cols=257 Identities=21% Similarity=0.342 Sum_probs=216.6
Q ss_pred cCCcccccccCCCCceeEEEEEEccCC-----eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~-----~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
.....+.+.||+|+||.||.+...... ..||+|.+++ ..+......|.+|..+|+.++|||||++++++....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 345677789999999999999985442 3488888875 346778899999999999999999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQ-----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 813 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~-----~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~ 813 (998)
..+|++|||+||+|..+|+.. ....++...+..++.+|++|+.||+++++|||||...|+|++....|||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999999864 134599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCC
Q 001902 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYT 892 (998)
Q Consensus 814 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~ 892 (998)
|+.+....- . +......-...|||||.+....++.++||||||++|||+++ |..
T Consensus 849 ArDiy~~~y------y-------------------r~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~ 903 (1025)
T KOG1095|consen 849 ARDIYDKDY------Y-------------------RKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGAT 903 (1025)
T ss_pred hHhhhhchh------e-------------------eccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCC
Confidence 974321100 0 00001112357999999999999999999999999999998 999
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHH
Q 001902 893 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948 (998)
Q Consensus 893 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 948 (998)
||.+.++.+.+.....+. .++....++..+.++|..||+.+|++||+|..+++++
T Consensus 904 PY~~~~n~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~ 958 (1025)
T KOG1095|consen 904 PYPSRSNFEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQD 958 (1025)
T ss_pred CCCCcchHHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhh
Confidence 999999999988777665 5566667788899999999999999999977665543
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=305.68 Aligned_cols=239 Identities=21% Similarity=0.299 Sum_probs=190.0
Q ss_pred cccCCCCceeEEEEEEcc------------CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 671 KPLGSGDTGSVHLVELCG------------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~------------~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
+.||+|+||.||++.... ....+++|.+... .......+..|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999998532 2336888887643 2334456778899999999999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc-------EEEEec
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-------VSLTDF 811 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~-------vkL~DF 811 (998)
..++||||+++++|..++.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999998886543 45899999999999999999999999999999999999987664 899999
Q ss_pred cCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc-CCCCCChhHHHHHHHHHHHHH-c
Q 001902 812 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEML-Y 889 (998)
Q Consensus 812 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDIwSlG~il~eLl-t 889 (998)
|++.... ......|+..|+|||.+. +..++.++|||||||++|+|+ .
T Consensus 157 g~~~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (262)
T cd05077 157 GIPITVL-------------------------------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYN 205 (262)
T ss_pred CCCcccc-------------------------------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 9874321 112235788999999986 466888999999999999998 5
Q ss_pred CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 890 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 890 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
|..||......+.. .+...... ...+.+.++.+||.+||+.||.+||+ ..+|+++
T Consensus 206 ~~~p~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~----~~~il~~ 260 (262)
T cd05077 206 GEIPLKDKTLAEKE-RFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPF----FRAIMRD 260 (262)
T ss_pred CCCCCCCcchhHHH-HHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcC----HHHHHHh
Confidence 89998776543332 23333222 22334578899999999999999999 6666654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=286.57 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=210.7
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEee--CCe
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQT--KTH 739 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~--~~~ 739 (998)
+.++|++++++|+|.++.||.+.+..++..|++|++++ ...+.+.+|+.||..|. ||||+++++...+ ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 35789999999999999999999999999999999875 35678899999999995 9999999999875 456
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec-CCcEEEEeccCccccC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTS 818 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~-~g~vkL~DFG~a~~~~ 818 (998)
..||+||+++.++..+... ++.-.++.++.+|+.||.|||++||+|||+||.|++|+. ...++|+|+|+|....
T Consensus 110 paLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred chhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 7899999999888887644 888999999999999999999999999999999999995 4579999999995532
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCC-C
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFR-G 896 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~-~ 896 (998)
+....+-.+.+.+|--||.+.. ..|+..-|+|||||+|..|+..+.||. |
T Consensus 185 ----------------------------p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG 236 (338)
T KOG0668|consen 185 ----------------------------PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 236 (338)
T ss_pred ----------------------------CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC
Confidence 1222334467889999999966 567889999999999999999887764 5
Q ss_pred CChHHHHHHHHhC-------------CCCC---------------------CCC-CCCcHHHHHHHHHccccCccCcCCC
Q 001902 897 KTRQKTFANILHK-------------DLKF---------------------PSS-TPTSLHAKQLMYRLLHRDPKSRLGS 941 (998)
Q Consensus 897 ~~~~~~~~~i~~~-------------~~~~---------------------~~~-~~~s~~l~~Ll~~~L~~dP~~Rpt~ 941 (998)
.++.+++.+|.+- .+.+ +.. .-.++++.+||.++|..|..+|+|
T Consensus 237 ~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT- 315 (338)
T KOG0668|consen 237 HDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT- 315 (338)
T ss_pred CCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc-
Confidence 5666666655431 1111 111 224689999999999999999999
Q ss_pred hhcHHHHHcCCCccCCChh
Q 001902 942 HEGANEIKKHPFFKGVNWA 960 (998)
Q Consensus 942 ~~~a~elL~Hp~f~~~~~~ 960 (998)
|.+++.||||..+.-+
T Consensus 316 ---akEam~HpyF~~~~~~ 331 (338)
T KOG0668|consen 316 ---AKEAMAHPYFAPVREA 331 (338)
T ss_pred ---hHHHhcCchHHHHHHH
Confidence 9999999999986433
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=309.14 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=205.3
Q ss_pred CCcccccccCCCCceeEEEEEEc----cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee--CC
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELC----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KT 738 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~----~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~ 738 (998)
..|++.+.||+|+||.||++... .+++.+|+|++...... .....+.+|+.+++.++|+||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 57889999999999999999864 34889999999865322 356778899999999999999999998877 56
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
..++||||+++++|.+++.... ..++...+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||.+....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 8999999999999999997653 358999999999999999999999999999999999999999999999999985543
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
..... ........++..|+|||.+.+..++.++|||||||++|+|++|..||....
T Consensus 161 ~~~~~------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 161 EDKDY------------------------YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred cCCcc------------------------eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 11100 000111235567999999988889999999999999999999999986542
Q ss_pred hH--------------HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 899 RQ--------------KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 899 ~~--------------~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
.. ......+......+....++.++.+|+.+||..+|.+||++.+++..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05038 217 AEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI 279 (284)
T ss_pred chhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 21 22233344444445455567889999999999999999995544443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=302.91 Aligned_cols=249 Identities=19% Similarity=0.264 Sum_probs=196.2
Q ss_pred cccCCCCceeEEEEEEcc---CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe-eCCeEEEEEec
Q 001902 671 KPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ-TKTHVCLITDY 746 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~---~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~-~~~~~~lV~E~ 746 (998)
+.||+|+||.||+|.+.. .+..+|+|.+... ........+..|+.+++.++||||+++++++. .++..++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998743 3568999987532 23345567888999999999999999999765 46678999999
Q ss_pred CCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCC
Q 001902 747 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 826 (998)
Q Consensus 747 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 826 (998)
+.+++|.+++.+.. ..++...+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++........
T Consensus 79 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~---- 153 (262)
T cd05058 79 MKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY---- 153 (262)
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc----
Confidence 99999999997643 3467788889999999999999999999999999999999999999999999854321100
Q ss_pred cchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 001902 827 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFAN 905 (998)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~ 905 (998)
..........++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+.......
T Consensus 154 -------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~ 214 (262)
T cd05058 154 -------------------YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY 214 (262)
T ss_pred -------------------eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 00011123346778999999988889999999999999999999 5777877776666655
Q ss_pred HHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 906 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
+.... ..+.....+..+.+++.+||..+|++||+ +.++++
T Consensus 215 ~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~il~ 254 (262)
T cd05058 215 LLQGR-RLLQPEYCPDPLYEVMLSCWHPKPEMRPT----FSELVS 254 (262)
T ss_pred HhcCC-CCCCCCcCCHHHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 55442 22223345778999999999999999999 555543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=305.00 Aligned_cols=245 Identities=22% Similarity=0.313 Sum_probs=190.6
Q ss_pred cccCCCCceeEEEEEEc--cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCC
Q 001902 671 KPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 748 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~--~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 748 (998)
+.||+|+||.||+|... .++..+|+|.++... .......+.+|+.+++.++||||+++++++.....+++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999864 356789999887542 22334567889999999999999999999999999999999999
Q ss_pred CCchhHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 749 GGELFLLLDRQP---TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 749 ggsL~~~l~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
+++|.+++.... ...++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~--- 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY--- 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce---
Confidence 999999997532 22466778889999999999999999999999999999999999999999999854221100
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-------CCCChhHHHHHHHHHHHHHc-CCCCCCCC
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-------GHTSAVDWWALGILLYEMLY-GYTPFRGK 897 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~sDIwSlG~il~eLlt-G~~Pf~~~ 897 (998)
........|+..|+|||++.+. .++.++|||||||++|+|++ |..||...
T Consensus 156 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 156 ----------------------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred ----------------------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 0111234578899999998642 35779999999999999996 99999877
Q ss_pred ChHHHHHHHHhC-CCCCCCC---CCCcHHHHHHHHHccccCccCcCCChh
Q 001902 898 TRQKTFANILHK-DLKFPSS---TPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 898 ~~~~~~~~i~~~-~~~~~~~---~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
............ ....+.. ...+..+.+++.+|+ .+|++|||+.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~ 262 (269)
T cd05087 214 SDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEE 262 (269)
T ss_pred ChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHH
Confidence 665554433322 2222221 235678899999998 58999999433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=307.14 Aligned_cols=238 Identities=19% Similarity=0.297 Sum_probs=189.0
Q ss_pred ccCCCCceeEEEEEEccC------------------------CeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCc
Q 001902 672 PLGSGDTGSVHLVELCGS------------------------GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 727 (998)
Q Consensus 672 ~LG~G~~g~Vy~a~~~~~------------------------~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nI 727 (998)
.||+|+||.||++....+ ...+++|++... .......+..|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 689999999999975322 245888887643 22334567788999999999999
Q ss_pred cceeEEEeeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC---
Q 001902 728 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG--- 804 (998)
Q Consensus 728 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g--- 804 (998)
+++++++......++||||+++++|..++.+. ...+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999988654 34589999999999999999999999999999999999998644
Q ss_pred ----cEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHH
Q 001902 805 ----HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWA 879 (998)
Q Consensus 805 ----~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwS 879 (998)
.++|+|||.+.... ......++..|+|||.+.+ ..++.++||||
T Consensus 158 ~~~~~~kl~d~g~~~~~~-------------------------------~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~s 206 (274)
T cd05076 158 GTSPFIKLSDPGVSFTAL-------------------------------SREERVERIPWIAPECVPGGNSLSTAADKWS 206 (274)
T ss_pred CccceeeecCCccccccc-------------------------------cccccccCCcccCchhhcCCCCCCcHHHHHH
Confidence 48999999874321 0012247788999999866 56789999999
Q ss_pred HHHHHHHHH-cCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 880 LGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 880 lG~il~eLl-tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
|||++|+|+ +|..||.......... ........+. ..+..+.+||.+||+.+|.+||+ +.+++++
T Consensus 207 lG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps----~~~il~~ 272 (274)
T cd05076 207 FGTTLLEICFDGEVPLKERTPSEKER-FYEKKHRLPE--PSCKELATLISQCLTYEPTQRPS----FRTILRD 272 (274)
T ss_pred HHHHHHHHHhCCCCCccccChHHHHH-HHHhccCCCC--CCChHHHHHHHHHcccChhhCcC----HHHHHHh
Confidence 999999995 7999998766544332 2333223332 34568999999999999999999 6666654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=301.97 Aligned_cols=236 Identities=19% Similarity=0.261 Sum_probs=190.1
Q ss_pred cccCCCCceeEEEEEEccCC----------eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 671 KPLGSGDTGSVHLVELCGSG----------QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~----------~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
+.||+|+||.||++.+..++ ..+++|.+.... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999997766 357788766432 115677889999999999999999999888 778
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC-------cEEEEeccC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-------HVSLTDFDL 813 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g-------~vkL~DFG~ 813 (998)
++||||+++++|.+++..... .++...+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999999987532 589999999999999999999999999999999999999887 799999999
Q ss_pred ccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC--CCCChhHHHHHHHHHHHHHc-C
Q 001902 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLY-G 890 (998)
Q Consensus 814 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDIwSlG~il~eLlt-G 890 (998)
+..... .....++..|+|||++.+. .++.++|||||||++|+|++ |
T Consensus 155 a~~~~~-------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~ 203 (259)
T cd05037 155 PITVLS-------------------------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNG 203 (259)
T ss_pred cccccc-------------------------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCC
Confidence 854321 1123467789999999876 78899999999999999998 6
Q ss_pred CCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 891 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 891 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
..||...+.......... ....+ ......+.+|+.+||..+|.+||+ +.++++
T Consensus 204 ~~p~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt----~~~il~ 256 (259)
T cd05037 204 EEPLSTLSSSEKERFYQD-QHRLP--MPDCAELANLINQCWTYDPTKRPS----FRAILR 256 (259)
T ss_pred CCCcccCCchhHHHHHhc-CCCCC--CCCchHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 888877654333333222 11111 122368899999999999999999 555553
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=303.76 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=202.3
Q ss_pred cccccccCCCCceeEEEEEEc---cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC-----
Q 001902 667 FRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 738 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~---~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----- 738 (998)
|.+.+.||+|+||.||+|.+. .+++.+|+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 677889999999999999864 3578999999976532 3344667889999999999999999999886432
Q ss_pred -eEEEEEecCCCCchhHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccC
Q 001902 739 -HVCLITDYCPGGELFLLLDRQ----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 813 (998)
Q Consensus 739 -~~~lV~E~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~ 813 (998)
..+++++|+.+++|.+++... ....++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 357899999999998887532 122478899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCC
Q 001902 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYT 892 (998)
Q Consensus 814 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~ 892 (998)
+........ ........+++.|++||.+....++.++|||||||++|+|++ |.+
T Consensus 160 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~ 214 (273)
T cd05074 160 SKKIYSGDY-------------------------YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214 (273)
T ss_pred cccccCCcc-------------------------eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCC
Confidence 864321110 001112345678999999998889999999999999999998 999
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 893 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 893 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
||.+.+....+..+.... ........+..+.+++.+||..+|.+||+ +.+++.
T Consensus 215 p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~l~~~p~~Rps----~~~~~~ 267 (273)
T cd05074 215 PYAGVENSEIYNYLIKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPS----FQHLRD 267 (273)
T ss_pred CCCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 998887776666665543 22223346788999999999999999999 555543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=293.66 Aligned_cols=265 Identities=25% Similarity=0.372 Sum_probs=213.2
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee-----
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----- 736 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~----- 736 (998)
...+.|+-+.+||+|.||.||+|+.+.+|+.||+|.+-.+.. .........+|+.+|..|+|+|++.+++.+..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 345789999999999999999999999999999986643211 11223455779999999999999999887742
Q ss_pred ---CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccC
Q 001902 737 ---KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 813 (998)
Q Consensus 737 ---~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~ 813 (998)
...+|+||.+| ..+|..++... ...++...+++++.+++.||.|+|.+.|+|||+||.|+||+.+|.+||+|||+
T Consensus 93 ~r~r~t~ylVf~~c-ehDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 93 NRDRATFYLVFDFC-EHDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ccccceeeeeHHHh-hhhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 23589999999 67888888654 24599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCC
Q 001902 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYT 892 (998)
Q Consensus 814 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~ 892 (998)
++.++.......| ..+..+.|++|.+||.+.+. .|+++.|||..|||+.+|++|.+
T Consensus 171 ar~fs~~~n~~kp-----------------------rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrsp 227 (376)
T KOG0669|consen 171 ARAFSTSKNVVKP-----------------------RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSP 227 (376)
T ss_pred ccceecccccCCC-----------------------CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCc
Confidence 9776543332211 13455789999999999884 68899999999999999999999
Q ss_pred CCCCCChHHHHHHHHh--CCCC---CCC-----------------C-----------CCCcHHHHHHHHHccccCccCcC
Q 001902 893 PFRGKTRQKTFANILH--KDLK---FPS-----------------S-----------TPTSLHAKQLMYRLLHRDPKSRL 939 (998)
Q Consensus 893 Pf~~~~~~~~~~~i~~--~~~~---~~~-----------------~-----------~~~s~~l~~Ll~~~L~~dP~~Rp 939 (998)
-|.+.+....+..|.. +.+. ||. . -.-+.++.+|+.+||..||.+|+
T Consensus 228 imqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~ 307 (376)
T KOG0669|consen 228 IMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRI 307 (376)
T ss_pred cccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCc
Confidence 9999888777766643 1110 110 0 00133667999999999999999
Q ss_pred CChhcHHHHHcCCCccC
Q 001902 940 GSHEGANEIKKHPFFKG 956 (998)
Q Consensus 940 t~~~~a~elL~Hp~f~~ 956 (998)
+ +.++|+|.||..
T Consensus 308 ~----ad~alnh~~F~k 320 (376)
T KOG0669|consen 308 D----ADQALNHDFFWK 320 (376)
T ss_pred c----hHhhhchhhhhc
Confidence 9 999999999986
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=304.20 Aligned_cols=259 Identities=16% Similarity=0.170 Sum_probs=189.9
Q ss_pred cccCCcccccccCCCCceeEEEEEEccC---CeEEEEEEeecccccChhH--------HHHHHHHHHHHHhCCCCCccce
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNK--------VHRACAEREILDMLDHPFVPAL 730 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~valK~i~~~~~~~~~~--------~~~~~~E~~il~~l~h~nIv~l 730 (998)
+...+|++.+.||+|+||.||+|.+..+ +..+|+|+........... ......+...+..++|++|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4457899999999999999999998777 6778888644221110000 0111223344556789999999
Q ss_pred eEEEeeCC----eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcE
Q 001902 731 YASFQTKT----HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV 806 (998)
Q Consensus 731 ~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~v 806 (998)
++++.... ..+++|+++ ..++.+++... ...++..+..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 98765443 457889988 55777776653 236788899999999999999999999999999999999999999
Q ss_pred EEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHH
Q 001902 807 SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 886 (998)
Q Consensus 807 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~e 886 (998)
+|+|||+|.......... ...........||+.|+|||++.+..++.++|||||||++|+
T Consensus 166 ~l~DFGla~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~e 225 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHI--------------------EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225 (294)
T ss_pred EEEEcCCceeeccCCccc--------------------ccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 999999986543111100 000111233569999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCh-HH--------HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 887 MLYGYTPFRGKTR-QK--------TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 887 LltG~~Pf~~~~~-~~--------~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
|++|.+||.+... .. .+..+....... ...+..+.+++..|+..+|.+||+ ..+|++
T Consensus 226 l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~----~~~l~~ 291 (294)
T PHA02882 226 WAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPD----YDALIK 291 (294)
T ss_pred HHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCC----HHHHHH
Confidence 9999999987632 21 122222222222 234678999999999999999999 665543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=298.48 Aligned_cols=247 Identities=18% Similarity=0.298 Sum_probs=191.4
Q ss_pred cccCCCCceeEEEEEEccC--CeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCC
Q 001902 671 KPLGSGDTGSVHLVELCGS--GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 748 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~--~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 748 (998)
+.||+|+||.||++..... ...+++|.+.... .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3689999999999976433 3456677665432 23345678899999999999999999999999999999999999
Q ss_pred CCchhHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCC
Q 001902 749 GGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 826 (998)
Q Consensus 749 ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 826 (998)
+++|.+++.+.. ...++...++.++.||+.||+|||+++++||||||+|||++.++.++|+|||++........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 154 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---- 154 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence 999999997642 23467778889999999999999999999999999999999999999999998743211000
Q ss_pred cchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-------CCCCChhHHHHHHHHHHHHHc-CCCCCCCCC
Q 001902 827 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-------AGHTSAVDWWALGILLYEMLY-GYTPFRGKT 898 (998)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~ 898 (998)
........|+..|+|||++.. ..++.++|||||||++|+|++ |..||....
T Consensus 155 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 155 ---------------------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred ---------------------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 011124568899999999743 245679999999999999996 678998877
Q ss_pred hHHHHHHHHhCC-CCCC---CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 899 RQKTFANILHKD-LKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 899 ~~~~~~~i~~~~-~~~~---~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
..+.+..+.... ...+ .....+..+.+++..|+ .+|.+||+ +.+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~----~~~i~ 263 (268)
T cd05086 214 DREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRAT----AEEVH 263 (268)
T ss_pred HHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCC----HHHHH
Confidence 777776665442 2211 12346778899999999 68999999 55554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=303.17 Aligned_cols=142 Identities=29% Similarity=0.435 Sum_probs=124.5
Q ss_pred hhccccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-----C---CC
Q 001902 655 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-----H---PF 726 (998)
Q Consensus 655 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-----h---~n 726 (998)
.+..|+.++.++|.+.++||+|.|++||+|.|..+.+.||+|+++.. ..-.+....||++|++++ | ..
T Consensus 68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~ 143 (590)
T KOG1290|consen 68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKC 143 (590)
T ss_pred eeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence 34557778889999999999999999999999999999999998853 334456778999999983 2 47
Q ss_pred ccceeEEEe----eCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEe
Q 001902 727 VPALYASFQ----TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQ 801 (998)
Q Consensus 727 Iv~l~~~~~----~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkP~NILi~ 801 (998)
||++++.|. ++.++|+|+|++ |..|..++.......++...++.|++|||.||.|||.. ||||-||||+|||+.
T Consensus 144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 999999996 456999999999 99999999887777899999999999999999999975 999999999999995
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=314.14 Aligned_cols=257 Identities=21% Similarity=0.295 Sum_probs=220.1
Q ss_pred cCCcccccccCCCCceeEEEEEEccC-C--eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGS-G--QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-~--~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
..+.++.+.||+|.||.|+.+.+... | ..||||+++.+.... ....|.+|..+|.+|+|+|++++|++..+ ...
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 45677889999999999999998543 3 468999998765433 67899999999999999999999999988 678
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
.+|||++++|+|.+.|++.....|....+..|+.||+.||.||..+++|||||-..|+|+-....|||+|||+.+.++..
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 89999999999999999866778999999999999999999999999999999999999999999999999999876533
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~ 899 (998)
...+ ......--...|+|||.|....++.++|||+||++||||++ |+.||.+...
T Consensus 266 ed~Y------------------------vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g 321 (1039)
T KOG0199|consen 266 EDMY------------------------VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG 321 (1039)
T ss_pred Ccce------------------------EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH
Confidence 3221 11112234567999999999999999999999999999996 9999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHH
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 948 (998)
..++.+|- ..-.++....++..+.+++..||..+|.+||||..+.++.
T Consensus 322 ~qIL~~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 322 IQILKNID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHHhcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 99999887 4445667777899999999999999999999966544333
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=329.23 Aligned_cols=263 Identities=17% Similarity=0.216 Sum_probs=182.0
Q ss_pred cccCCcccccccCCCCceeEEEEEEccC----CeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEE----
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGS----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS---- 733 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~----~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~---- 733 (998)
+..++|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .....++ .++...+.++..+...
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 3467899999999999999999999888 89999998764211 1111111 1122222222222211
Q ss_pred --EeeCCeEEEEEecCCCCchhHHHhhCCCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 001902 734 --FQTKTHVCLITDYCPGGELFLLLDRQPTK------------------VLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 793 (998)
Q Consensus 734 --~~~~~~~~lV~E~~~ggsL~~~l~~~~~~------------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDL 793 (998)
.......+|||||+++++|.+++...... ......+..++.||+.||.|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 23566899999999999999998753211 1123456789999999999999999999999
Q ss_pred CCCcEEEec-CCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC--
Q 001902 794 KPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-- 870 (998)
Q Consensus 794 kP~NILi~~-~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-- 870 (998)
||+|||++. ++.+||+|||+|+.+.... .......+|++.|||||.+....
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~--------------------------~~~~~~~~~t~~Y~APE~~~~~~~~ 335 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI--------------------------NYIPKEFLLDPRYAAPEQYIMSTQT 335 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccc--------------------------ccCCcccccCCCccChHHhhccCCC
Confidence 999999996 5899999999996432110 01123457899999999764332
Q ss_pred --------------------CCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh-CCCCC----------------
Q 001902 871 --------------------HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH-KDLKF---------------- 913 (998)
Q Consensus 871 --------------------~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~-~~~~~---------------- 913 (998)
++.++|||||||+||+|+++..|+.. ....+...+. ....+
T Consensus 336 ~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 413 (566)
T PLN03225 336 PSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLR 413 (566)
T ss_pred CCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhh
Confidence 33456999999999999997766543 2222222211 11100
Q ss_pred ---CCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhh
Q 001902 914 ---PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 914 ---~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~ 963 (998)
......+..+.+||.+||+.||.+||| +.++|+||||++..+..+.
T Consensus 414 ~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t----a~e~L~Hpff~~~~~~~~~ 462 (566)
T PLN03225 414 RGFEVLDLDGGAGWELLKSMMRFKGRQRIS----AKAALAHPYFDREGLLGLS 462 (566)
T ss_pred hhhhhccccchHHHHHHHHHccCCcccCCC----HHHHhCCcCcCCCCccccc
Confidence 000112234568999999999999999 9999999999998776543
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=316.94 Aligned_cols=244 Identities=31% Similarity=0.447 Sum_probs=195.9
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC------Ce
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------TH 739 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------~~ 739 (998)
-+..-+.||+|+||.||+++++.+|+.+|+|.+.+.. .....+....|+++|++++|+|||+++++-.+. ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 4566688999999999999999999999999998654 445567888999999999999999999876543 36
Q ss_pred EEEEEecCCCCchhHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec--CC--cEEEEeccCc
Q 001902 740 VCLITDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG--NG--HVSLTDFDLS 814 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~--~g--~vkL~DFG~a 814 (998)
..+|||||.||+|..+|.+- ....|++..+..++.++..||.|||.+|||||||||.||++-. +| ..||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 78999999999999999752 2345999999999999999999999999999999999999863 34 4799999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~P 893 (998)
+..+.. ....+++||+.|++||++.. ..|+..+|.|||||++|+++||..|
T Consensus 172 rel~d~----------------------------s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lP 223 (732)
T KOG4250|consen 172 RELDDN----------------------------SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELP 223 (732)
T ss_pred ccCCCC----------------------------CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCC
Confidence 765422 23457899999999999985 7888899999999999999999999
Q ss_pred CCCCCh----HHHHHHHHhCC-------------------CCCCCCCCCcH----HHHHHHHHccccCccCcC
Q 001902 894 FRGKTR----QKTFANILHKD-------------------LKFPSSTPTSL----HAKQLMYRLLHRDPKSRL 939 (998)
Q Consensus 894 f~~~~~----~~~~~~i~~~~-------------------~~~~~~~~~s~----~l~~Ll~~~L~~dP~~Rp 939 (998)
|-.... .+....+..++ ..+|....++. -+...|..+|..+|.+|.
T Consensus 224 F~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 224 FIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 965332 23333333221 11222222333 235688899999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=309.45 Aligned_cols=257 Identities=27% Similarity=0.408 Sum_probs=212.8
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC------CCCccceeEEEe
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD------HPFVPALYASFQ 735 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~------h~nIv~l~~~~~ 735 (998)
+...+|.+....|.|-||+|..|.+..-|..||||+|..+.+ -.+.-+.|++||++|+ --++++++..|.
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 345889999999999999999999998899999999986532 2344567999999995 348999999999
Q ss_pred eCCeEEEEEecCCCCchhHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC-CcEEEEeccC
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDL 813 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~-g~vkL~DFG~ 813 (998)
..+++|||||-+ ...|.++|++-+ .-.|....++.|+.||.-||..|-..||+|.||||+|||++++ ..+||||||.
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 999999999998 889999998742 2248889999999999999999999999999999999999965 5789999999
Q ss_pred ccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCC
Q 001902 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 814 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~P 893 (998)
|...+.. .-+.+..+..|.|||.+.|.+|++..|+||.||+||||+||+..
T Consensus 584 A~~~~en-----------------------------eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl 634 (752)
T KOG0670|consen 584 ASFASEN-----------------------------EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL 634 (752)
T ss_pred ccccccc-----------------------------cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeecccee
Confidence 8543311 11233456789999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHhCCCCCCC----------------------------------------C-----------CCC---
Q 001902 894 FRGKTRQKTFANILHKDLKFPS----------------------------------------S-----------TPT--- 919 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~~~~~~~----------------------------------------~-----------~~~--- 919 (998)
|.|.++..++.-.+...-++|. + ..+
T Consensus 635 FpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~de 714 (752)
T KOG0670|consen 635 FPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDE 714 (752)
T ss_pred cCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCch
Confidence 9999888887766543222220 0 000
Q ss_pred ----cHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 920 ----SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 920 ----s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
-..+.+||.+||..||++|.| +.++|+||||++
T Consensus 715 q~~~~~~~rdLLdkml~LdP~KRit----~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 715 QPKIVQQLRDLLDKMLILDPEKRIT----VNQALKHPFITE 751 (752)
T ss_pred hHHHHHHHHHHHHHHhccChhhcCC----HHHHhcCCcccC
Confidence 114679999999999999999 999999999985
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=290.84 Aligned_cols=253 Identities=26% Similarity=0.471 Sum_probs=210.6
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 737 (998)
..+|.-++.+|.|+- .|..|.|.-.++++|+|.+.... .......+..+|..++..+.|+||++++.+|...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 357888999999998 78889998899999999887653 3333446778899999999999999999999643
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
..+|+||||| ..+|...+.- .+....+..+..|++.|++|||+.||+||||||+||++..++.+||.|||+|...
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 4689999999 8889888863 2788899999999999999999999999999999999999999999999999542
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
... -..+.++.|..|.|||++.+..+...+||||+||++.||++|+..|.|.
T Consensus 169 ~~~----------------------------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 169 DTD----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred Ccc----------------------------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 211 1234568999999999999999999999999999999999999999988
Q ss_pred ChHHHHHHHHhC------------------------------------CCCCCCC----CCCcHHHHHHHHHccccCccC
Q 001902 898 TRQKTFANILHK------------------------------------DLKFPSS----TPTSLHAKQLMYRLLHRDPKS 937 (998)
Q Consensus 898 ~~~~~~~~i~~~------------------------------------~~~~~~~----~~~s~~l~~Ll~~~L~~dP~~ 937 (998)
+..+++.++... +..|+.. ...+..+++|+.+||-.||++
T Consensus 221 d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~ 300 (369)
T KOG0665|consen 221 DHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEK 300 (369)
T ss_pred hHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhh
Confidence 877776666541 0011111 112345789999999999999
Q ss_pred cCCChhcHHHHHcCCCcc
Q 001902 938 RLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 938 Rpt~~~~a~elL~Hp~f~ 955 (998)
|.+ ++++|+||||+
T Consensus 301 Ris----v~daL~HPY~~ 314 (369)
T KOG0665|consen 301 RIS----VDDALRHPYIK 314 (369)
T ss_pred ccc----HHHHhcCCeee
Confidence 999 99999999999
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=304.59 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=218.7
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
.+.+...+..+..+||.|.||.||.+.+++....||||.++.+.+ .++.|+.|..+|+.++|||+|+++++|..+.
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 445555667778999999999999999999999999999987544 5788999999999999999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
-+|||+|||..|.|.+||.......++.-.+..++.||..|+.||..+++|||||-..|+|+.++..||+.|||+++.|.
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999999999987655667777888899999999999999999999999999999999999999999998875
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~ 897 (998)
.+.- ..+...--...|.|||.|-...++.++|||+||++|||+.| |-.||.+.
T Consensus 417 gDTY--------------------------TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi 470 (1157)
T KOG4278|consen 417 GDTY--------------------------TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI 470 (1157)
T ss_pred CCce--------------------------ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence 3321 11112223567999999999999999999999999999996 99999999
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 898 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
+....|.-+ ...+.-.....|++....|+..||++.|.+||+|++
T Consensus 471 dlSqVY~LL-EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFae 515 (1157)
T KOG4278|consen 471 DLSQVYGLL-EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAE 515 (1157)
T ss_pred cHHHHHHHH-hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHH
Confidence 887776544 444444455678899999999999999999999876
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=305.77 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=209.7
Q ss_pred CCcccccccCCCCceeEEEEEEccC----CeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGS----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~----~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
....+.+.||.|.||.||++..... .--||||.-+.+. +....+.|..|..+|+.++||||++++|++.+ ...
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 3455667899999999999997432 3358889887654 34457889999999999999999999999876 558
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|||||+++-|.|..+++.+. ..++...+..++.||+.||+|||++++|||||-..|||+.+..-|||+|||+++.+..+
T Consensus 466 WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999999999998764 56999999999999999999999999999999999999999999999999999776522
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~ 899 (998)
.- ...+...-...|||||.++-..++.++|||-||+++||++. |..||.+-.+
T Consensus 545 ~y--------------------------YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN 598 (974)
T KOG4257|consen 545 AY--------------------------YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN 598 (974)
T ss_pred ch--------------------------hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc
Confidence 11 11122223557999999999999999999999999999985 9999999888
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
.+.+-.+.++. .+|....+++.+..|+.+||.++|.+||++.++
T Consensus 599 sDVI~~iEnGe-RlP~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 599 SDVIGHIENGE-RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred cceEEEecCCC-CCCCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 77777666654 445566788999999999999999999998763
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-33 Score=315.71 Aligned_cols=267 Identities=23% Similarity=0.328 Sum_probs=228.2
Q ss_pred cccccccCCcccccccCCCCceeEEEEEEccCC---eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEE
Q 001902 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF 734 (998)
Q Consensus 658 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~---~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 734 (998)
-...|.....++.+.||.|.||.||.++.+..| ..||||.++... .......|+.|+.||-+++||||++|-++.
T Consensus 622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred hhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 344566777889999999999999999998776 469999998653 445677899999999999999999999999
Q ss_pred eeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCc
Q 001902 735 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814 (998)
Q Consensus 735 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a 814 (998)
....-+.||+|||++|+|..+|+.+. +.++..++.-+++.|+.|++||-++|.|||||-..|||++++-.+|++|||++
T Consensus 700 Tks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccce
Confidence 99999999999999999999998775 45999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHH-cCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTP 893 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLl-tG~~P 893 (998)
+.+..++...+. ...---...|.|||.+...+++.+|||||+|++|||.+ +|..|
T Consensus 779 Rvledd~~~~yt------------------------t~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERP 834 (996)
T KOG0196|consen 779 RVLEDDPEAAYT------------------------TLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 834 (996)
T ss_pred eecccCCCcccc------------------------ccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCc
Confidence 876544321111 01111246799999999999999999999999999988 59999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc---HHHHHcCC
Q 001902 894 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG---ANEIKKHP 952 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~---a~elL~Hp 952 (998)
|...++++.++.|.++ +.+|....++..+.+|+..||++|-..||.|.++ ++.++..|
T Consensus 835 YWdmSNQdVIkaIe~g-yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 835 YWDMSNQDVIKAIEQG-YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ccccchHHHHHHHHhc-cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 9999999999887664 6677777889999999999999999999998765 34455554
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=300.61 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=209.5
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+.-+...++++||+|.||.|.+|.- ..+..||+|.++... .......+..|+++|.+|+||||+.++++|..++.+|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 3345678889999999999999997 447999999998764 3445688999999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+|+|||++|+|.+++..+....+.......|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++.+-..+
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999999999988744434556677799999999999999999999999999999999999999999996432110
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHH--cCCCCCCCCCh
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML--YGYTPFRGKTR 899 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLl--tG~~Pf~~~~~ 899 (998)
- .+.....+-...|||||.+..++++.++|+|+||+++||++ +...||...+.
T Consensus 692 y-------------------------y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 692 Y-------------------------YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred c-------------------------eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 0 01223345567899999999999999999999999999987 58889988877
Q ss_pred HHHHHHHHhC------CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 900 QKTFANILHK------DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 900 ~~~~~~i~~~------~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
....+..-.- ..-++...-++..+.++|..||+.+-.+||++.++
T Consensus 747 e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l 797 (807)
T KOG1094|consen 747 EQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL 797 (807)
T ss_pred HHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence 6666554321 11123344577889999999999999999995543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-31 Score=282.99 Aligned_cols=242 Identities=43% Similarity=0.719 Sum_probs=204.4
Q ss_pred CceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCCchhHHH
Q 001902 677 DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL 756 (998)
Q Consensus 677 ~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l 756 (998)
+||.||++.+..+++.+++|++........ ...+.+|+.++++++|+||+++++++......+++|||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999988899999999876533221 578889999999999999999999999999999999999999999998
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhccc
Q 001902 757 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836 (998)
Q Consensus 757 ~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~ 836 (998)
..... ++...+..++.+++.+|.|||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------------- 141 (244)
T smart00220 79 KKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------------- 141 (244)
T ss_pred HhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---------------
Confidence 76532 8999999999999999999999999999999999999999999999999985543111
Q ss_pred CCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHhCCCCCCC
Q 001902 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG-KTRQKTFANILHKDLKFPS 915 (998)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~-~~~~~~~~~i~~~~~~~~~ 915 (998)
......++..|++||.+.+..++.++||||||+++|+|++|..||.. .+.......+.........
T Consensus 142 -------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 208 (244)
T smart00220 142 -------------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP 208 (244)
T ss_pred -------------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc
Confidence 12234688899999999988889999999999999999999999988 4444444444444333322
Q ss_pred CCC-CcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 916 STP-TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 916 ~~~-~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
... .+..+.+++.+||..+|++||+ +.++++||||
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~~~~~~~~ 244 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLT----AEEALQHPFF 244 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccC----HHHHhhCCCC
Confidence 222 6788999999999999999999 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=310.20 Aligned_cols=266 Identities=18% Similarity=0.204 Sum_probs=191.7
Q ss_pred ccccCCcccccccCCCCceeEEEEEEc----------------cCCeEEEEEEeecccccChh-----------HHHHHH
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELC----------------GSGQYFAMKAMDKGVMLNRN-----------KVHRAC 713 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~----------------~~~~~valK~i~~~~~~~~~-----------~~~~~~ 713 (998)
.+..++|++.++||+|+||.||++.+. ..++.||||.+......... ..+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 355789999999999999999999752 34568999998643211000 112233
Q ss_pred HHHHHHHhCCCCCc-----cceeEEEee--------CCeEEEEEecCCCCchhHHHhhCCC-------------------
Q 001902 714 AEREILDMLDHPFV-----PALYASFQT--------KTHVCLITDYCPGGELFLLLDRQPT------------------- 761 (998)
Q Consensus 714 ~E~~il~~l~h~nI-----v~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~~------------------- 761 (998)
.|+.++.+++|.++ +.++++|.. .+..||||||+++++|.+++.....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46677777766544 666666642 3568999999999999999864211
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCC
Q 001902 762 ---KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 838 (998)
Q Consensus 762 ---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~ 838 (998)
..++...++.++.|++.+|.|||+++|+||||||+|||++.++.+||+|||++..+.....
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~---------------- 364 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN---------------- 364 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc----------------
Confidence 1235677889999999999999999999999999999999999999999999854321100
Q ss_pred CCcccccccccccccccCCCCcccchhhcCCCC----------------------CChhHHHHHHHHHHHHHcCCC-CCC
Q 001902 839 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH----------------------TSAVDWWALGILLYEMLYGYT-PFR 895 (998)
Q Consensus 839 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~----------------------~~~sDIwSlG~il~eLltG~~-Pf~ 895 (998)
.......+|+.|+|||.+..... ..+.||||+||++|+|++|.. ||.
T Consensus 365 ----------~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 365 ----------FNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred ----------cCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 00112235889999999854321 124799999999999999886 775
Q ss_pred CCChH-----------HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCc---cCcCCChhcHHHHHcCCCccC
Q 001902 896 GKTRQ-----------KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDP---KSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 896 ~~~~~-----------~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP---~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
+.... .....+......++.....+..+++|+.+||..+| .+|+| +.++|+||||..
T Consensus 435 ~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlS----a~eaL~Hp~f~~ 505 (507)
T PLN03224 435 NIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLS----VGQALSHRFFLP 505 (507)
T ss_pred chhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCC----HHHHhCCCCcCC
Confidence 42211 11112223344555556678899999999999876 68999 999999999964
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=266.82 Aligned_cols=223 Identities=26% Similarity=0.394 Sum_probs=185.4
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCC
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 738 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 738 (998)
..+..++...+..||+|++|.|-+.++..+|...|+|.+.... .....+++.+|+.+..+. ++|++|.+|+.+....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 3455567777889999999999999999999999999998542 344556778888876665 8999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 739 HVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
.+||.||.| ..||..+.++ ..++.+++..+-+|+..++.||.|||++ .+||||+||+||||+.+|++|+||||++-
T Consensus 119 dvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999999 7788766543 3457799999999999999999999987 99999999999999999999999999985
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC----CCCCChhHHHHHHHHHHHHHcCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----AGHTSAVDWWALGILLYEMLYGY 891 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~sDIwSlG~il~eLltG~ 891 (998)
.+.. +...+...|-..|||||.+.. ..|+.++||||||+++.||.+++
T Consensus 198 ~L~d----------------------------SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr 249 (282)
T KOG0984|consen 198 YLVD----------------------------SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILR 249 (282)
T ss_pred eehh----------------------------hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcc
Confidence 4321 111223468889999999843 47888999999999999999999
Q ss_pred CCCCC-CChHHHHHHHHhCCCCC
Q 001902 892 TPFRG-KTRQKTFANILHKDLKF 913 (998)
Q Consensus 892 ~Pf~~-~~~~~~~~~i~~~~~~~ 913 (998)
.||.. .++.++++.++....+.
T Consensus 250 ~PY~~w~tpF~qLkqvVeep~P~ 272 (282)
T KOG0984|consen 250 FPYESWGTPFQQLKQVVEEPSPQ 272 (282)
T ss_pred ccccccCCHHHHHHHHhcCCCCC
Confidence 99975 56778888888765443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-33 Score=283.46 Aligned_cols=262 Identities=27% Similarity=0.432 Sum_probs=213.5
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC-----e
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-----H 739 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-----~ 739 (998)
.+.+.-+.||.|+||.||.+.|..+|+.||+|.+.. ........+++.+|+.+|..++|.||+..++..+..+ .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 456677999999999999999999999999998864 3445556788999999999999999999998876543 4
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|+|+|+| ..+|..++-. ...++.+.++-+++||++||+|||+.||.||||||.|+|+++|..+||||||+++.-..
T Consensus 132 iYV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 132 LYVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence 68899998 6778777754 35699999999999999999999999999999999999999999999999999965331
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
+. ....+..+.|.+|.|||.+++. .|+.++||||.|||+.||+..+..|...+
T Consensus 209 d~--------------------------~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~ 262 (449)
T KOG0664|consen 209 RD--------------------------RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG 262 (449)
T ss_pred hh--------------------------hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence 11 1122334678999999999986 57889999999999999999999999888
Q ss_pred hHHHHHHHHh-----------------------CCCCCCCC---------CCCcHHHHHHHHHccccCccCcCCChhcHH
Q 001902 899 RQKTFANILH-----------------------KDLKFPSS---------TPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946 (998)
Q Consensus 899 ~~~~~~~i~~-----------------------~~~~~~~~---------~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 946 (998)
+.+++..|.. +..+.|+. .....+...++.+||..||++|.+ ..
T Consensus 263 PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris----~~ 338 (449)
T KOG0664|consen 263 PIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS----VE 338 (449)
T ss_pred hHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc----Hh
Confidence 7776665543 12222221 112236678999999999999999 99
Q ss_pred HHHcCCCccCCChh
Q 001902 947 EIKKHPFFKGVNWA 960 (998)
Q Consensus 947 elL~Hp~f~~~~~~ 960 (998)
+.+.|+|.....+.
T Consensus 339 ~A~~~~~~~e~R~r 352 (449)
T KOG0664|consen 339 EALQHRYLEEGRLR 352 (449)
T ss_pred hhccccccccccee
Confidence 99999999886654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=305.63 Aligned_cols=285 Identities=26% Similarity=0.399 Sum_probs=237.3
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|+++.++|+|.+|.||+++++.+++..|+|+++... .....-+++|+-+++.++||||+.+++.|...+.+||+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 468999999999999999999999999999999998653 34456677899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
||||.||+|.+..+. .+++++.++..+++..++||+|||+.|-+|||||-.|||++..|.+||.|||.+..+.
T Consensus 91 MEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit----- 163 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT----- 163 (829)
T ss_pred EEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh-----
Confidence 999999999998765 3679999999999999999999999999999999999999999999999999985543
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhh---cCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII---AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l---~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
.....+.++.||++|||||+. ....|...+|||++|++..||.--++|.....+.
T Consensus 164 ----------------------ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 164 ----------------------ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred ----------------------hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 112234678999999999986 4577899999999999999999999998887777
Q ss_pred HHHHHHHhCCCCCC---CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC-----hhhhhcCCCCCCCC
Q 001902 901 KTFANILHKDLKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN-----WALVRCMNPPELDA 972 (998)
Q Consensus 901 ~~~~~i~~~~~~~~---~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~-----~~~~~~~~~~~~~~ 972 (998)
..+.-..+..++.| +....+..+-+|++.+|.++|.+||+ ++.+|.|||....- -.+|-.++-|..++
T Consensus 222 r~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRpt----aeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v 297 (829)
T KOG0576|consen 222 RALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPT----AEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVV 297 (829)
T ss_pred HHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCC----hhhheeceeeccchhhHHHHHHHHHccCCCCcc
Confidence 77766666655444 34556788999999999999999999 99999999998741 12344444444445
Q ss_pred CCCCCccccccc
Q 001902 973 PLFATDTEKEYK 984 (998)
Q Consensus 973 p~~~~~~~~~~~ 984 (998)
..+--+...+|-
T Consensus 298 ~~~~d~~~E~~~ 309 (829)
T KOG0576|consen 298 RYLEDYDGEDYL 309 (829)
T ss_pred cccccCCccccc
Confidence 554444444443
|
|
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=324.89 Aligned_cols=406 Identities=11% Similarity=0.065 Sum_probs=301.3
Q ss_pred cccccccccccccccccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCC
Q 001902 167 SVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTD 246 (998)
Q Consensus 167 ~~~~~~dit~~~~~e~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~ 246 (998)
......|||++++++++|+++++.|+.++++++++++++|. +|+|+++|+++++++||+.+|++|+++..+.++...
T Consensus 182 ~~g~~~DIT~rk~ae~~l~~~~~~l~~l~e~~~~~i~~~d~---~g~i~~~N~~~~~~~G~~~~e~~g~~~~~~~~~~~~ 258 (807)
T PRK13560 182 VDGFAEDITERKRAEERIDEALHFLQQLLDNIADPAFWKDE---DAKVFGCNDAACLACGFRREEIIGMSIHDFAPAQPA 258 (807)
T ss_pred EEEEEEccchHHHHHHHHHHHHHHHHHHHhhCCCeEEEEcC---CCCEEEEhHHHHHHhCCCHHHHcCCcchhcCCcchh
Confidence 34456999999999999999999999999999999999998 788999999999999999999999999888776654
Q ss_pred hHHHHHHHHHHHcCCcEEEEEEEEecCCCEEEEEeee--eEEeCCCCCEEEEEEEEecchhhhHHHHHhhcCCCCCchhh
Q 001902 247 PEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTI--APIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESL 324 (998)
Q Consensus 247 ~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~--spi~d~~G~v~~~v~i~~DITerk~~E~~l~~~~~~L~~~l 324 (998)
..........+..++....+.+++++||+.+|+++.+ .|+.+.+|.+.+++++++|||++|++|++++.+.+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~~~~~g~~~g~~~~~~DITerk~~e~~L~~se~------ 332 (807)
T PRK13560 259 DDYQEADAAKFDADGSQIIEAEFQNKDGRTRPVDVIFNHAEFDDKENHCAGLVGAITDISGRRAAERELLEKED------ 332 (807)
T ss_pred HHHHHHHHHHhccCCceEEEEEEEcCCCCEEEEEEEecceEEEcCCCCEEEEEEEEEechHHHHHHHHHHHHHH------
Confidence 4444445556667777788889999999999776654 55678999999999999999999999998765311
Q ss_pred hhHHHHHHHHhHhhHHHHHHHcc-CCCCccccCCCCcc-cccCCCCchhhhcccccCCCCCCCCCCCCCC----------
Q 001902 325 IRYDARQKEMATSSVTELVQAMK-KPRSLSESTNRPPI-IRKSEGGVEEERAGALGRRKSENVPPPRRNS---------- 392 (998)
Q Consensus 325 ~~~d~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~e~~g~~~~~~~~~~~~~~---------- 392 (998)
.+..+..... .....+..+.+++. +..+...+||+.++++|+....+.|.....-
T Consensus 333 -------------~l~~l~~~~~~~i~~~d~~g~i~~~nn~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~ 399 (807)
T PRK13560 333 -------------MLRAIIEAAPIAAIGLDADGNICFVNNNAAERMLGWSAAEVMGKPLPGMDPELNEEFWCGDFQEWYP 399 (807)
T ss_pred -------------HHHHHHHhCcccEEEEcCCCCEEEecCHHHHHHhCCCHHHHcCCCccccChhhhhhhhhchhhhcCC
Confidence 1122222222 22334444555554 4456668999999999998777665321110
Q ss_pred ----CCC------CcccccccccccchhhccccCCccccccccccccCCCCCCCccccccccCCCCCCCCCCCCCchhhH
Q 001902 393 ----YGG------GCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDK 462 (998)
Q Consensus 393 ----~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~di~er~ 462 (998)
... .....+......+.....++|...|+.....+..+.+|.......+ ..||++|+
T Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~p~~d~~g~~~~~~~~-------------~~DITerk 466 (807)
T PRK13560 400 DGRPMAFDACPMAKTIKGGKIFDGQEVLIEREDDGPADCSAYAEPLHDADGNIIGAIAL-------------LVDITERK 466 (807)
T ss_pred cCCcchhhhhhHHHHHhcCCcccCceEEEEcCCCCeEEEEEEEeeeECCCCCEEEEEEE-------------eehhhhHH
Confidence 000 0011112223334455677888999999888888877766544444 78999999
Q ss_pred HHHHhhhccccHHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCC--CccccCCCCCHHHHHHHHHHH
Q 001902 463 VRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRN--CRFLQGPETDPATVRKIRAAI 540 (998)
Q Consensus 463 ~~e~e~r~~~~l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~--~~~l~~p~~~~~~~~~i~~~l 540 (998)
..|++++. .+.++++++++++.++..+ +..+.+|.....++||+++|+++.. +..+.+|++.......+...+
T Consensus 467 ~~E~~L~~---~~~~~e~~~~~i~~~~~~~--~~~~~~~~~~~~~~G~~~~e~~~~~~~~~~~~~p~d~~~~~~~~~~~~ 541 (807)
T PRK13560 467 QVEEQLLL---ANLIVENSPLVLFRWKAEE--GWPVELVSKNITQFGYEPDEFISGKRMFAAIIHPADLEQVAAEVAEFA 541 (807)
T ss_pred HHHHHHHH---HHHHHhcCCceEEEEecCC--CceEEEecchhhhcCCCHHHhhcccchHhhhcChhhHHHHHHHHHHHH
Confidence 99999987 6789999999999887652 2355666667788999999998633 456778888777777777777
Q ss_pred hcC-CcEEEEEEEEecCCcEEEEEEEEeeeccCC----EEEEEEecCCccccccccCcchhhhhHHHHHHHHhhhhhhhh
Q 001902 541 DNQ-TDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEA 615 (998)
Q Consensus 541 ~~g-~~~~~e~~~~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~~~~~~~~e~~~~~~~~~~k~~~~~v~e~ 615 (998)
..+ ..+..+++..++||..+|+..+..|++|.+ +++|+++|||+||+. |+.+++..+....++.++.|.
T Consensus 542 ~~g~~~~~~e~r~~~~dG~~~w~~~~~~~~~d~~G~~~~~~g~~~DITerK~a------E~~L~~a~~~~~~~l~~isHe 615 (807)
T PRK13560 542 AQGVDRFEQEYRILGKGGAVCWIDDQSAAERDEEGQISHFEGIVIDISERKHA------EEKIKAALTEKEVLLKEIHHR 615 (807)
T ss_pred hcCCccceeEEEEEcCCCCEEEEEecceeeeCCCCCEEEEEEEEechHHHHHH------HHHHHHHHHHHHHHHHHhHHH
Confidence 665 447889999999999999999999999886 899999999999973 333333333344445555544
Q ss_pred hcc
Q 001902 616 VKE 618 (998)
Q Consensus 616 ~~e 618 (998)
++.
T Consensus 616 lrn 618 (807)
T PRK13560 616 VKN 618 (807)
T ss_pred HhC
Confidence 443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=284.90 Aligned_cols=291 Identities=23% Similarity=0.334 Sum_probs=210.7
Q ss_pred hhhccccccccCCcccccccCCCCceeEEEEEEcc---CCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccc
Q 001902 654 KILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 729 (998)
Q Consensus 654 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~---~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~ 729 (998)
++.++...+ ...|.++++||+|.|++||++.+.. ..+.||+|.+.... ...++.+|+++|..+ .+.||+.
T Consensus 26 ~l~q~~p~~-~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~ 99 (418)
T KOG1167|consen 26 QLRQDIPFI-SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIK 99 (418)
T ss_pred HHHhhhhhh-hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhc
Confidence 333433333 3579999999999999999999977 78899999886432 345788999999999 6999999
Q ss_pred eeEEEeeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec-CCcEEE
Q 001902 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSL 808 (998)
Q Consensus 730 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~-~g~vkL 808 (998)
+.+++..++.+++||||++..+..++... ++...++.+++.++.||.++|++|||||||||+|||++. .+.-.|
T Consensus 100 ~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~L 174 (418)
T KOG1167|consen 100 LNGCFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVL 174 (418)
T ss_pred chhhhccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceE
Confidence 99999999999999999999999998865 788999999999999999999999999999999999984 577899
Q ss_pred EeccCccccCCCC-----------CCCC-CcchhhhhcccCCCCc-ccc----cccccccccccCCCCcccchhhcC-CC
Q 001902 809 TDFDLSCLTSCKP-----------QLLL-PTTNEKKRRHKGQQNP-VFM----AEPMRASNSFVGTEEYIAPEIIAG-AG 870 (998)
Q Consensus 809 ~DFG~a~~~~~~~-----------~~~~-~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~gt~~y~aPE~l~~-~~ 870 (998)
+|||+|....... .... ...........+...+ ... ...........||++|.|||++.. ..
T Consensus 175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~ 254 (418)
T KOG1167|consen 175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR 254 (418)
T ss_pred EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence 9999996211000 0000 0000000000000000 000 111123345689999999999966 56
Q ss_pred CCChhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHh--------------CC---------------------C---
Q 001902 871 HTSAVDWWALGILLYEMLYGYTPFRGKTR-QKTFANILH--------------KD---------------------L--- 911 (998)
Q Consensus 871 ~~~~sDIwSlG~il~eLltG~~Pf~~~~~-~~~~~~i~~--------------~~---------------------~--- 911 (998)
.++++||||.|+|+..++++..||..... ...+..|.. +. +
T Consensus 255 QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~ 334 (418)
T KOG1167|consen 255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIE 334 (418)
T ss_pred cCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChh
Confidence 78899999999999999999999853211 111111100 01 0
Q ss_pred -CCC----------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 912 -KFP----------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 912 -~~~----------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
..+ .....+..+.+|+.+||..||.+|+| ++++|+||||...+-
T Consensus 335 ~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRit----AEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 335 SIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRIT----AEDALKHPFFDEADR 389 (418)
T ss_pred hcccccccceeeccccccccHHHHHHHHHHccCChhhccc----HHHHhcCcCCcchhh
Confidence 000 01123447889999999999999999 999999999996543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=307.34 Aligned_cols=251 Identities=28% Similarity=0.399 Sum_probs=200.1
Q ss_pred cccccccCCCCcee-EEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEEEE
Q 001902 667 FRPIKPLGSGDTGS-VHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 667 y~~~~~LG~G~~g~-Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
|.-.+.+|.|+.|+ ||++.. .|+.||||.+-.+ ...-..+|+.+|+.- +||||+++|+.-.+....||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 45557789999986 699987 6889999987644 345677899999988 6999999999999999999999
Q ss_pred ecCCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec---C--CcEEEEeccCcccc
Q 001902 745 DYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---N--GHVSLTDFDLSCLT 817 (998)
Q Consensus 745 E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~---~--g~vkL~DFG~a~~~ 817 (998)
|.| ..+|.+++... ..........+.++.|+++||++||+.+||||||||.||||+. + ..++|+|||+++..
T Consensus 583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999 88999999873 1111222456788999999999999999999999999999986 3 46899999999876
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~ 896 (998)
....... .......||.+|+|||++.....+.++|||||||++|+.++ |..||..
T Consensus 662 ~~~~sS~------------------------~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 662 AGGKSSF------------------------SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred CCCcchh------------------------hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 5333221 22456679999999999999888889999999999999998 5899976
Q ss_pred CChHHHHHHHHhCCCCCCCCCCC-cHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 897 KTRQKTFANILHKDLKFPSSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~-s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
.. +.-.+|+.++..+-..... ..++.+||.+||+.+|..||+ |.++|.||||=.
T Consensus 718 ~~--~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPs----a~~VL~HPlFW~ 772 (903)
T KOG1027|consen 718 SL--ERQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPS----ATDVLNHPLFWD 772 (903)
T ss_pred hH--HhhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCC----HHHHhCCCccCC
Confidence 43 3334566655433222111 128899999999999999999 999999999954
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=289.73 Aligned_cols=253 Identities=22% Similarity=0.281 Sum_probs=211.8
Q ss_pred CcccccccCCCCceeEEEEEEccCCe----EEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~----~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
..+..++||+|+||+||++.+...|+ +||+|++... ........+..|+-+|.+++|||++++++++.... +.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 35667889999999999999865544 6788887653 23445678899999999999999999999998766 88
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
||++|+++|+|.++++.++ ..+.......|+.||++||.|||.+++|||||-..|||+.+-..+||.|||+++....+.
T Consensus 774 lvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999999998754 568889999999999999999999999999999999999999999999999997765332
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 900 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~ 900 (998)
..+ ......-.+.|||-|.+....|+.++||||||+++|||+| |..||.+....
T Consensus 853 ~ey-------------------------~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~ 907 (1177)
T KOG1025|consen 853 KEY-------------------------SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE 907 (1177)
T ss_pred ccc-------------------------cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH
Confidence 211 1112234567999999999999999999999999999997 99999998776
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHH
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 948 (998)
++-+.+..++ .++....++.++..++.+||..|+..||++++.+.+.
T Consensus 908 eI~dlle~ge-RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~f 954 (1177)
T KOG1025|consen 908 EIPDLLEKGE-RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEF 954 (1177)
T ss_pred HhhHHHhccc-cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHH
Confidence 6655554444 4777778899999999999999999999988765554
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=283.11 Aligned_cols=202 Identities=32% Similarity=0.502 Sum_probs=177.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHH-----HHHHHHHHHHHhCC---CCCccceeEEEe
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV-----HRACAEREILDMLD---HPFVPALYASFQ 735 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~-----~~~~~E~~il~~l~---h~nIv~l~~~~~ 735 (998)
..+|..++.||+|+||.|++|.++++...|++|.+.++.+.-...+ ..+-.||.||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 4579999999999999999999999999999999988655433222 23446999999997 999999999999
Q ss_pred eCCeEEEEEecC-CCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCc
Q 001902 736 TKTHVCLITDYC-PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814 (998)
Q Consensus 736 ~~~~~~lV~E~~-~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a 814 (998)
+++++||+||-. +|.+|++++..+ ..+++..++.|++|++.|+++||+.||||||||-+|+.++++|.+||+|||.|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 999999999987 466899999886 44999999999999999999999999999999999999999999999999988
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCC-CChhHHHHHHHHHHHHHcCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDIwSlG~il~eLltG~~P 893 (998)
.... +.+...++||..|.|||++.|.+| ...-|||+||++||-+++...|
T Consensus 718 a~~k-----------------------------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenp 768 (772)
T KOG1152|consen 718 AYTK-----------------------------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENP 768 (772)
T ss_pred hhhc-----------------------------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCC
Confidence 4422 234567899999999999999877 5678999999999999999999
Q ss_pred CCC
Q 001902 894 FRG 896 (998)
Q Consensus 894 f~~ 896 (998)
|..
T Consensus 769 yyn 771 (772)
T KOG1152|consen 769 YYN 771 (772)
T ss_pred CcC
Confidence 975
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=322.43 Aligned_cols=238 Identities=20% Similarity=0.306 Sum_probs=184.2
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
.|...+.||+|+||.||+|.+..++..||+|.+..... ....|+.++++++||||+++++++...+..|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 46677889999999999999988999999998864321 11245888999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH---CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH---~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
|+++|+|.++++. +++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||.+....
T Consensus 764 y~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~---- 833 (968)
T PLN00113 764 YIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC---- 833 (968)
T ss_pred CCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc----
Confidence 9999999999953 788999999999999999999 6699999999999999988887775 66542211
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH-H
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ-K 901 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~-~ 901 (998)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus 834 ---------------------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~ 886 (968)
T PLN00113 834 ---------------------------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG 886 (968)
T ss_pred ---------------------------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCC
Confidence 011236889999999999999999999999999999999999998542210 0
Q ss_pred HHHHHHh---CC--------CCCCCC----CCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 902 TFANILH---KD--------LKFPSS----TPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 902 ~~~~i~~---~~--------~~~~~~----~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
......+ .. ...... .....++.+++.+||+.||++||++.+++..
T Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0111110 00 000000 1112356789999999999999995554433
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=296.05 Aligned_cols=263 Identities=25% Similarity=0.365 Sum_probs=212.8
Q ss_pred cccccCCcccccccCCCCceeEEEEEEcc-------CCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCcccee
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 731 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-------~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~ 731 (998)
+.+......+.+.||+|.||.|+++.... ....||+|.++.... ......+..|+++|+.+ .|+||+.++
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 33444555666799999999999998531 146799999886533 36778899999999999 699999999
Q ss_pred EEEeeCCeEEEEEecCCCCchhHHHhhCC-------C-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 001902 732 ASFQTKTHVCLITDYCPGGELFLLLDRQP-------T-------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 797 (998)
Q Consensus 732 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------~-------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~N 797 (998)
+++...+.+++|+||+..|+|..++.... . ..++...+..++.||+.|++||+++++|||||-..|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999998754 0 238889999999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccC--CCCcccchhhcCCCCCChh
Q 001902 798 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG--TEEYIAPEIIAGAGHTSAV 875 (998)
Q Consensus 798 ILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~s 875 (998)
||+..+..+||+|||+|+....... .....-.| ...|||||.+....|+.++
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~--------------------------y~~~~~~~~LP~kWmApEsl~~~~ft~kS 502 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDY--------------------------YRTKSSAGTLPVKWMAPESLFDRVFTSKS 502 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCc--------------------------eEecCCCCccceeecCHHHhccCcccccc
Confidence 9999999999999999964321110 00011112 3359999999999999999
Q ss_pred HHHHHHHHHHHHHc-CCCCCCCCC-hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 876 DWWALGILLYEMLY-GYTPFRGKT-RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 876 DIwSlG~il~eLlt-G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
||||||++|||+++ |..||.+.. ..+.+. .++..........++.++.++++.||+.+|.+||++.+....+-.|
T Consensus 503 DVWSfGI~L~EifsLG~~PYp~~~~~~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 503 DVWSFGILLWEIFTLGGTPYPGIPPTEELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred hhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 99999999999997 999999865 444444 4444444445556789999999999999999999999877766665
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=265.45 Aligned_cols=244 Identities=23% Similarity=0.347 Sum_probs=189.3
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC--CCCCccceeEEEeeCC--
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML--DHPFVPALYASFQTKT-- 738 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l--~h~nIv~l~~~~~~~~-- 738 (998)
+....+++..||+|.||.||+|.. +++.||||++... ....+.+|.+|++.. .|+||+++++.-....
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 356778889999999999999998 5699999998753 457788898888764 8999999998776544
Q ss_pred --eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCcEEEecCCcEE
Q 001902 739 --HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ---------GIIYRDLKPENVLLQGNGHVS 807 (998)
Q Consensus 739 --~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---------~IiHrDLkP~NILi~~~g~vk 807 (998)
.++||++|.+.|+|.++|+.+ .+++.....++..|++||+|||.- .|+|||||..||||..|+++.
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 899999999999999999885 489999999999999999999952 599999999999999999999
Q ss_pred EEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC-CC-----ChhHHHHHH
Q 001902 808 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HT-----SAVDWWALG 881 (998)
Q Consensus 808 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-----~~sDIwSlG 881 (998)
|+|||+|..+.. ..+......-+||..|||||+|.+.- +. .+.||||+|
T Consensus 357 IaDFGLAl~~~p-------------------------~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamg 411 (534)
T KOG3653|consen 357 IADFGLALRLEP-------------------------GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMG 411 (534)
T ss_pred eeccceeEEecC-------------------------CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHH
Confidence 999999966431 11122334478999999999997642 22 278999999
Q ss_pred HHHHHHHcCCCC------------CC-----CCChHHHHHHHHhC--CCCCCCCCC---CcHHHHHHHHHccccCccCcC
Q 001902 882 ILLYEMLYGYTP------------FR-----GKTRQKTFANILHK--DLKFPSSTP---TSLHAKQLMYRLLHRDPKSRL 939 (998)
Q Consensus 882 ~il~eLltG~~P------------f~-----~~~~~~~~~~i~~~--~~~~~~~~~---~s~~l~~Ll~~~L~~dP~~Rp 939 (998)
.+||||++.... |. .....++...+++. ...+|+... .-.-+.+.+.-||..||+.|+
T Consensus 412 LVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARL 491 (534)
T KOG3653|consen 412 LVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARL 491 (534)
T ss_pred HHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhh
Confidence 999999964432 22 12222333333332 333443321 123467899999999999999
Q ss_pred CCh
Q 001902 940 GSH 942 (998)
Q Consensus 940 t~~ 942 (998)
|+.
T Consensus 492 TA~ 494 (534)
T KOG3653|consen 492 TAG 494 (534)
T ss_pred hhH
Confidence 954
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=259.64 Aligned_cols=243 Identities=23% Similarity=0.356 Sum_probs=184.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHh--CCCCCccceeEEEeeC----C
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDHPFVPALYASFQTK----T 738 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~--l~h~nIv~l~~~~~~~----~ 738 (998)
.+..+.+.||+|.||.||++.+ -|..||||++... +.....+|.+|+.. |+|+||+.+++.-..+ .
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeeccc--cCCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 4577889999999999999998 5789999999743 22456677777765 5999999998865433 3
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEEEecCCcEEEEe
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLTD 810 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--------~IiHrDLkP~NILi~~~g~vkL~D 810 (998)
.+|||++|.+.|||+|+|.+. .++.+...+++..++.||++||-. .|.|||||..|||+.++|.+-|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 689999999999999999884 489999999999999999999953 499999999999999999999999
Q ss_pred ccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCC------CChhHHHHHHHHH
Q 001902 811 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH------TSAVDWWALGILL 884 (998)
Q Consensus 811 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~------~~~sDIwSlG~il 884 (998)
+|+|.......... .-..+..+||..|||||+|...-. ...+||||||.++
T Consensus 360 LGLAv~h~~~t~~i-----------------------di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVl 416 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTI-----------------------DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVL 416 (513)
T ss_pred ceeeEEecccCCcc-----------------------cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHH
Confidence 99996544321110 112345689999999999965421 2379999999999
Q ss_pred HHHHc----------CCCCCCCC----ChHHHHHHHHh---CCCCCCCCCCCcH---HHHHHHHHccccCccCcCCC
Q 001902 885 YEMLY----------GYTPFRGK----TRQKTFANILH---KDLKFPSSTPTSL---HAKQLMYRLLHRDPKSRLGS 941 (998)
Q Consensus 885 ~eLlt----------G~~Pf~~~----~~~~~~~~i~~---~~~~~~~~~~~s~---~l~~Ll~~~L~~dP~~Rpt~ 941 (998)
||++. -++||.+- .+.+.+.+++- -....|......+ .+-+|++-||..||..|.|+
T Consensus 417 WEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 417 WEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred HHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence 99983 24688542 22344444432 2223333333333 34578999999999999993
|
|
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=312.84 Aligned_cols=372 Identities=14% Similarity=0.138 Sum_probs=275.2
Q ss_pred ccccccccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHH
Q 001902 176 DEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRE 255 (998)
Q Consensus 176 ~~~~~e~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~ 255 (998)
..++.++.+++++++|+.++++++++|+++|. +|+|+++|+++++++||+.+|++|+++..+.++++.......+..
T Consensus 270 ~~r~~~~~l~~~e~r~~~l~e~~~~~i~~~d~---dG~i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~d~~~~~~~~~~ 346 (1092)
T PRK09776 270 AFRAERKHISESETRFRNAMEYSAIGMALVGT---EGQWLQVNKALCQFLGYSQEELRGLTFQQLTWPEDLNKDLQQVEK 346 (1092)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhCCceEEEEcC---CCcEEehhHHHHHHhCCCHHHHccCCceeccCcchhHhHHHHHHH
Confidence 34555677899999999999999999999998 888999999999999999999999998888887776655555555
Q ss_pred HHHcC-CcEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhcCCCCCchhhhhHHHHHHHH
Q 001902 256 TLQNG-QSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEM 334 (998)
Q Consensus 256 ~l~~g-~~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~~~~~L~~~l~~~d~~~~~~ 334 (998)
.+..+ ..+..+.+..++||+.+|+..+.+++.+.+|.+.+++++++|||++|++|++++...+.
T Consensus 347 ~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~~~g~~~~~i~~~~DITerk~~e~~l~~~~~~--------------- 411 (1092)
T PRK09776 347 LLSGEINSYSMEKRYYRRDGEVVWALLAVSLVRDTDGTPLYFIAQIEDINELKRTEQVNERLMER--------------- 411 (1092)
T ss_pred HHcCCccceeeeeEEEcCCCCEEEEEEEEEEEECCCCCEeeehhhHHhhHHHHHHHHHHHHHHHH---------------
Confidence 54443 34678899999999999999999999999999999999999999999999886542111
Q ss_pred hHhhHHHHHHHcc-CCCCccccCCCCcccccCCCCchhhhcccccCCC--CCCCCCCCCCCCCCC--cccccccccccch
Q 001902 335 ATSSVTELVQAMK-KPRSLSESTNRPPIIRKSEGGVEEERAGALGRRK--SENVPPPRRNSYGGG--CRTSMQRISEVPE 409 (998)
Q Consensus 335 ~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~g~~~--~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 409 (998)
+..+.++.. ..+..+..+..+..+......+||+.++..+... ..+.|++ +...... ........-..+.
T Consensus 412 ----~~~~~~~~~~~i~~~d~~~~~~~~n~~~~~l~G~~~~~~~~~~~~~~~~~p~d-~~~~~~~~~~~~~~~~~~~~e~ 486 (1092)
T PRK09776 412 ----ITLANEAGGIGIWEWDLKPNIISWDKRMFELYEIPPHIKPTWQVWYACLHPED-RQRVEKEIRDALQGRSPFKLEF 486 (1092)
T ss_pred ----HHHHHHhcCceEEEEecCCCeEeeCHHHHHHhCCCcccCCCHHHHHHhcCHhH-HHHHHHHHHHHHhcCCCeeEEE
Confidence 111111211 2344555566677788888888888877433211 1112211 1000000 0001112234556
Q ss_pred hhccccCCccccccccccccCCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhccc-cHHHHHhhcCceEEEE
Q 001902 410 KKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGI-DLATTLERIEKNFVIT 488 (998)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~di~er~~~e~e~r~~~-~l~~i~e~~~d~i~i~ 488 (998)
+...++| ..|+...+.+..+.+|.......+ .+||++|++.++++++.. .++.++++++++|+++
T Consensus 487 r~~~~dG-~~w~~~~~~~~~d~~G~~~~~ig~-------------~~DITerk~~e~~L~~~~~~l~~~l~~~~~~i~~~ 552 (1092)
T PRK09776 487 RIVVKDG-VRHIRALANRVLNKDGEVERLLGI-------------NMDMTEVRQLNEALFQEKERLHITLDSIGEAVVCT 552 (1092)
T ss_pred EEEcCCc-eEEEEEeeEEEECCCCCEEEEEee-------------eeehhHHHHHHHHHHHHHHHHHHHHhccccEEEEE
Confidence 6678899 999998887777777765543333 789999999888887643 5889999999999999
Q ss_pred cCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCC--CCHHHHHHHHHHHhcCCc--EEEEEEEEecCCcEEEEEE
Q 001902 489 DPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE--TDPATVRKIRAAIDNQTD--VTVQLINYTKSGKKFWNLF 564 (998)
Q Consensus 489 D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~--~~~~~~~~i~~~l~~g~~--~~~e~~~~rkdG~~~wv~~ 564 (998)
|.+|+ |+++|+++++++||+.+|++|++...+.+.. ........+......... +..+....++||+.+|+.+
T Consensus 553 D~~g~---i~~~N~a~~~l~G~~~~e~iG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~~~~~~~ 629 (1092)
T PRK09776 553 DMAMK---VTFMNPVAEKMTGWTQEEALGVPLLTVLHITFGDNGPLMENIYSCLTSRSAAYLEQDVVLHCRSGGSYDVHY 629 (1092)
T ss_pred CCCCe---EEEEcHHHHHHhCCCHHHHcCCCHHHHcccccCCcchhhHHHHHHHhcCCCccccceEEEEeCCCcEEEEEE
Confidence 99887 9999999999999999999999966554322 222222334444444443 5567788999999999999
Q ss_pred EEeeeccCC----EEEEEEecCCcccc
Q 001902 565 HLQPMRDQK----YFIGVQLDGSEHLE 587 (998)
Q Consensus 565 ~~spi~d~~----~~vgi~rDITerk~ 587 (998)
+.+|+.+.+ +++++++|||++|+
T Consensus 630 ~~~pi~~~~g~~~g~v~~~~DITe~k~ 656 (1092)
T PRK09776 630 SITPLSTLDGENIGSVLVIQDVTESRK 656 (1092)
T ss_pred EeeeeecCCCCEEEEEEEEEecchHHH
Confidence 999999776 78999999999986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-26 Score=239.04 Aligned_cols=213 Identities=39% Similarity=0.646 Sum_probs=185.0
Q ss_pred cCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCCCCch
Q 001902 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 752 (998)
Q Consensus 673 LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 752 (998)
||+|++|.||++.+..+++.+++|++....... ....+.+|+.+++.+.|++|+++++++......+++|||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999988653211 346788999999999999999999999999999999999998999
Q ss_pred hHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec-CCcEEEEeccCccccCCCCCCCCCcchhh
Q 001902 753 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEK 831 (998)
Q Consensus 753 ~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~-~g~vkL~DFG~a~~~~~~~~~~~~~~~~~ 831 (998)
.+++.... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 79 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--------- 148 (215)
T cd00180 79 KDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--------- 148 (215)
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---------
Confidence 99987642 35899999999999999999999999999999999999998 89999999999854321110
Q ss_pred hhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCC
Q 001902 832 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 910 (998)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~ 910 (998)
......+...|++||.+... .++.+.|+|++|+++++|
T Consensus 149 ------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------- 187 (215)
T cd00180 149 ------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------- 187 (215)
T ss_pred ------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------
Confidence 12234578899999999887 788899999999999999
Q ss_pred CCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCC
Q 001902 911 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 952 (998)
Q Consensus 911 ~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp 952 (998)
..+.+++.+|+..+|.+||+ +.++++|+
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~----~~~l~~~~ 215 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPS----AKEILEHL 215 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcC----HHHHhhCC
Confidence 46889999999999999999 89998875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=275.64 Aligned_cols=357 Identities=13% Similarity=0.036 Sum_probs=230.8
Q ss_pred HHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCC-cEEEEEEEEecC
Q 001902 195 LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ-SYCGRLLNYKKD 273 (998)
Q Consensus 195 ld~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~-~~~~e~~~~~kd 273 (998)
++.++|+++++|. +|+|++||.++++++||+.+|++|+++..+++++........+...+..+. .+..+.....++
T Consensus 2 ~~~~~d~~~~~d~---~g~i~~~n~~~~~~~g~~~~el~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 78 (442)
T TIGR02040 2 LATAADVTLLLDA---EGVVREVAANPHHPSFEQLSEWEGRRWEEIVTAESVEKFELRLSEALRTGRGAVRVELNHIDPS 78 (442)
T ss_pred CcccCcEEEEECC---CCcEEEEEECCCcccccccccCCCCcHhHhhCcchHHHHHHHHHHHhccCCCcceEeeccCCCC
Confidence 5778999999999 777999999999999999999999999988887765555555556666654 455666656677
Q ss_pred CCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhcCCCCCchhhhhHHHHHHHHhHhhHHHHHHHcc-CCCCc
Q 001902 274 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMK-KPRSL 352 (998)
Q Consensus 274 G~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~~~~~L~~~l~~~d~~~~~~~~~~~~~~~~~l~-~~~~~ 352 (998)
|..+|+.++..++.+ + .+++++.+|||++++.+.++......+.+ +.....-....+..+..... .....
T Consensus 79 g~~~~~~~~~~~~~~--~--~~~~~i~rDi~~~~~~~~~l~~~~~~~e~-----~~~~l~~~e~r~~~l~e~~~~~i~~~ 149 (442)
T TIGR02040 79 SFELPMRFILVRLGA--D--RGVLALGRDLRAVAELQQQLVAAQQAMER-----DYWTLREMETRYRVVLEVSSDAVLLV 149 (442)
T ss_pred CCccCeEEEEEEeCC--C--CeEEEEecccHHHHHHHHHHHHHHHHHHH-----HHHHHHHHHHHHHHHHhhCCceEEEE
Confidence 777777777666643 2 26688999999988876554221111110 00000111122233333333 23444
Q ss_pred cc-cCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCC---cccccccccccchhhccccCCccccccccccc
Q 001902 353 SE-STNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGG---CRTSMQRISEVPEKKKQKSGRRSFMGLIGRKS 428 (998)
Q Consensus 353 ~~-~~~~~~~~~~~~~~~~~~~~e~~g~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 428 (998)
+. .+.+++.|..+...+||+++|++|++..++++.+........ ....+. ....... .+.+...| .+..+..
T Consensus 150 d~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~~~~~~~~~~~~~~l~~~~~~g~-~~~~~~~--~~~~~~~~-~~~~~~~ 225 (442)
T TIGR02040 150 DMSTGRIVEANSAAAALLGGVGQSLVGRAFPQEFEGRRREELMLTLRNVRATGS-AAPVRIL--LRRSQKRL-LVVVSVF 225 (442)
T ss_pred ECCCCEEEEEcHHHHHHhCcCHHHHcCCCHHHhCCHHHHHHHHHHHHHHHhcCC-CcceEEE--EcCCCeEE-EEEEEEE
Confidence 43 466778999999999999999999998888765322111100 011111 1111111 11121222 1111111
Q ss_pred cCCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhccccHHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHc
Q 001902 429 QSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELT 508 (998)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~di~er~~~e~e~r~~~~l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~ 508 (998)
.. ++...+. ....||++++..+.++++ .|+.++++++++|+++|.+|+ |++||++|++++
T Consensus 226 ~~-~~~~~~l--------------~~~~dit~~~~~e~~~~~--~~~~l~e~~~d~I~v~D~~G~---I~~~N~a~~~l~ 285 (442)
T TIGR02040 226 RQ-DGESLFL--------------CQLSPAGATQPVGDELSE--NLARLYHEAPDAIVFSDADGT---IRGANEAFLELT 285 (442)
T ss_pred Ee-CCceEEE--------------EEEcccchhhhhhHHHHH--HHHHHHHhCCceEEEEcCCCc---EEehhHHHHHHh
Confidence 11 1111111 124567777665554431 388999999999999999888 999999999999
Q ss_pred CCC-hhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEeeeccCC--EEEEEEecCCcc
Q 001902 509 EYS-REEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK--YFIGVQLDGSEH 585 (998)
Q Consensus 509 Gy~-~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rkdG~~~wv~~~~spi~d~~--~~vgi~rDITer 585 (998)
||+ .++++|++...+.++.... ....+......|.....+..+.++||+.+|++++++|+.+.+ .++++++|||+|
T Consensus 286 G~~~~~~l~G~~~~~~~~~~~~~-~~~~~~~~~~~g~~~~~~~~~~~~~G~~~~ve~s~~~i~~~~~~~~~~v~rDITeR 364 (442)
T TIGR02040 286 DSSSLEAVRGRTLDRWLGRGGVD-LRVLLSNVRRTGQVRLYATTLTGEFGAQTEVEISAAWVDQGERPLIVLVIRDISRR 364 (442)
T ss_pred CCCChHHHcCCCHHHHhCCCccc-HHHHHHHHhhcCceEEEEEEEEcCCCCEEEEEEEEEEeccCCceEEEEEEecchhh
Confidence 997 6789999976555533221 222233333445455677788999999999999999998776 899999999999
Q ss_pred ccc
Q 001902 586 LEP 588 (998)
Q Consensus 586 k~~ 588 (998)
|+.
T Consensus 365 ~~~ 367 (442)
T TIGR02040 365 LTM 367 (442)
T ss_pred ccC
Confidence 974
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-26 Score=239.74 Aligned_cols=215 Identities=37% Similarity=0.610 Sum_probs=180.5
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEec
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 746 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 746 (998)
|.+.+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+..++.++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56778999999999999999888999999998865322 2457788899999999999999999999999999999999
Q ss_pred CCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCC
Q 001902 747 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 826 (998)
Q Consensus 747 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 826 (998)
+++++|.+++...... ++...+..++.+++.+|.+||+++++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~----- 152 (225)
T smart00221 79 CEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL----- 152 (225)
T ss_pred cCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-----
Confidence 9999999999875321 7899999999999999999999999999999999999999999999999885543111
Q ss_pred cchhhhhcccCCCCcccccccccccccccCCCCcccchhh-cCCCCCChhHHHHHHHHHHHHHcCCCCCCC-CChH-HHH
Q 001902 827 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLYGYTPFRG-KTRQ-KTF 903 (998)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~~~~sDIwSlG~il~eLltG~~Pf~~-~~~~-~~~ 903 (998)
........++..|++||.+ ....++.++|+|+||+++|+|++|+.||.. .+.. ...
T Consensus 153 ---------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~ 211 (225)
T smart00221 153 ---------------------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLS 211 (225)
T ss_pred ---------------------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHH
Confidence 0011234678899999998 667778899999999999999999999988 5555 455
Q ss_pred HHHHhCC
Q 001902 904 ANILHKD 910 (998)
Q Consensus 904 ~~i~~~~ 910 (998)
+.+..+.
T Consensus 212 ~~~~~~~ 218 (225)
T smart00221 212 DVWSFGV 218 (225)
T ss_pred HHHhcCC
Confidence 5555443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=240.27 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=193.4
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEE-EeeCCeEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS-FQTKTHVC 741 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~-~~~~~~~~ 741 (998)
.+.|.+.+.||+|-||.+.+|+++.++..+++|.+.+... ....+.+|...--.| .|.||+.-|++ |+..+..+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 4679999999999999999999999999999999876432 346677777654445 58999988774 67788899
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec--CCcEEEEeccCccccCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG--NGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~--~g~vkL~DFG~a~~~~~ 819 (998)
++|||++-|+|.+-+... .+.+...+.++.|+++||.|||++++||||||.+||||-. ...|||||||.+...+.
T Consensus 99 F~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred EeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999999999887653 3889999999999999999999999999999999999953 45899999999855331
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-----CCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-----GHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
. -...-.+..|.+||..... ...+.+|||.||+++|.+++|++||
T Consensus 176 t------------------------------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PW 225 (378)
T KOG1345|consen 176 T------------------------------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPW 225 (378)
T ss_pred e------------------------------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcc
Confidence 1 0112245678999987432 2467899999999999999999999
Q ss_pred CCCCh----HHHHHHHHhC-CCCCCC-CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 895 RGKTR----QKTFANILHK-DLKFPS-STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 895 ~~~~~----~~~~~~i~~~-~~~~~~-~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
..... .-.+.+...+ ....|. ....+..+..+.++-|..++.+|-...+ +....+..|.
T Consensus 226 Qka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~-~kk~rk~~w~ 290 (378)
T KOG1345|consen 226 QKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWT-AKKMRKCLWK 290 (378)
T ss_pred hhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHH-HHHHHHHHHH
Confidence 74322 2233334433 334443 3457889999999999999999933222 4445555444
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=287.51 Aligned_cols=227 Identities=19% Similarity=0.262 Sum_probs=155.0
Q ss_pred CCC-CCccceeEEE-------eeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 001902 722 LDH-PFVPALYASF-------QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 793 (998)
Q Consensus 722 l~h-~nIv~l~~~~-------~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDL 793 (998)
+.| .||..++++| .....++++|||+ +++|.+++... ...++...++.++.||++||.|||++|||||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 344 5777777776 2334678889988 77999999753 345999999999999999999999999999999
Q ss_pred CCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchh-hhhcccCCC-C-----ccccccc-ccccccccCCCCcccchh
Q 001902 794 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE-KKRRHKGQQ-N-----PVFMAEP-MRASNSFVGTEEYIAPEI 865 (998)
Q Consensus 794 kP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~-~~~~~~~~~-~-----~~~~~~~-~~~~~~~~gt~~y~aPE~ 865 (998)
||+||||+..|.+|++|||++..............+- ..+...... . ......+ .......+||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999887888888887765432211100000000 000000000 0 0000000 011223579999999999
Q ss_pred hcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcH
Q 001902 866 IAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945 (998)
Q Consensus 866 l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 945 (998)
+.+..++.++|||||||+||||++|.+|+.... ..+..+.....+ +..........+++.+||+.+|.+||+ +
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~L~~~P~~Rps----~ 259 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLP-PQILLNWPKEASFCLWLLHPEPSCRPS----M 259 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcC-hhhhhcCHHHHHHHHHhCCCChhhCcC----h
Confidence 999999999999999999999999998876432 122222222111 111123456678999999999999999 9
Q ss_pred HHHHcCCCccCC
Q 001902 946 NEIKKHPFFKGV 957 (998)
Q Consensus 946 ~elL~Hp~f~~~ 957 (998)
.++|+||||...
T Consensus 260 ~eil~h~~~~~~ 271 (793)
T PLN00181 260 SELLQSEFINEP 271 (793)
T ss_pred HHHhhchhhhhh
Confidence 999999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-26 Score=260.86 Aligned_cols=261 Identities=41% Similarity=0.705 Sum_probs=221.2
Q ss_pred ccCCCCceeEEEEEEc---cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEeeCCeEEEEEecC
Q 001902 672 PLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLITDYC 747 (998)
Q Consensus 672 ~LG~G~~g~Vy~a~~~---~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lV~E~~ 747 (998)
.+|.|+||.|++++-. ..|..||+|+.++......... ....|..++..++ ||++++++..|+.+...+++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 3799999999988752 3478899999987655544444 5667888998886 999999999999999999999999
Q ss_pred CCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCc
Q 001902 748 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 827 (998)
Q Consensus 748 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~ 827 (998)
.||.|...+... ..+.+...+.+...++-+++++|+.+|+|||+|++||+++.+|++++.|||+++....
T Consensus 80 rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~-------- 149 (612)
T KOG0603|consen 80 RGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK-------- 149 (612)
T ss_pred ccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh--------
Confidence 999999888664 4488889999999999999999999999999999999999999999999999865321
Q ss_pred chhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 001902 828 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANIL 907 (998)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~ 907 (998)
....|||..|||||++. .+...+|.||||+++++|++|..||.+ +....|.
T Consensus 150 -----------------------~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il 200 (612)
T KOG0603|consen 150 -----------------------EKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL 200 (612)
T ss_pred -----------------------hhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh
Confidence 11128999999999998 677899999999999999999999988 6777777
Q ss_pred hCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhhhcCCCCCCCCCC
Q 001902 908 HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPPELDAPL 974 (998)
Q Consensus 908 ~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~ 974 (998)
+..+..|. ..+..+++++..++..+|.+|.... +++.++++|+||+.++|..+....++....|.
T Consensus 201 ~~~~~~p~--~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~ 266 (612)
T KOG0603|consen 201 KAELEMPR--ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPG 266 (612)
T ss_pred hhccCCch--hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCc
Confidence 76655554 4688999999999999999999875 67999999999999999988665555554444
|
|
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=274.92 Aligned_cols=373 Identities=10% Similarity=0.037 Sum_probs=263.3
Q ss_pred ccccccccccchHHHH-HHHHHhcCCcEEEEecCCCCCce--EEccHHHHHHcCCChhhhcCCC--CCcccCCCCChHHH
Q 001902 176 DEGGKEKGLPRVSDIV-KDALSTFQQTFVVSDATKPDYPI--MYASAGFFKMTGYTSKEVVGRN--CRFLQGAGTDPEDV 250 (998)
Q Consensus 176 ~~~~~e~~l~~~~~~l-~~ild~~~d~i~i~D~~g~dG~I--~~vN~a~~~l~Gys~eEliG~~--~~~l~~~~~~~~~~ 250 (998)
.++.++++++++++.+ +.+++++|+++++.+..+ +|.+ .|++++...++||...++++.. +..+++|++.....
T Consensus 54 ~r~~~~~~l~~~~e~~~r~l~~~~p~~i~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~p~d~~~~~ 132 (807)
T PRK13560 54 ARAIAEAEAQDCREQCERNLKANIPGGMFLFALDG-DGTFSFPSLLDANGELAAIAKHDLMADKGLLAMLIGGDDGDFFF 132 (807)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhcCCceEEEEEEcC-ccccccceeeccchhHHHhcCcccCCccchhhhhcCCCcchhhh
Confidence 3556778888888888 999999999999988732 3443 3478888888888888877543 33566666654433
Q ss_pred -------HHHHHHHHcCCcEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhcCCCCCchh
Q 001902 251 -------AKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPES 323 (998)
Q Consensus 251 -------~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~~~~~L~~~ 323 (998)
+.+..++..+.....+++++++||+ |+.....|..+.+|.+ .+.|+++|||++|++|++++.+
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~e~r~~~~dg~--~~~~~~~~~~~~~g~~-~~~g~~~DIT~rk~ae~~l~~~------- 202 (807)
T PRK13560 133 ANPFRSAETIAMALQSDDWQEEEGHFRCGDGR--FIDCCLRFERHAHADD-QVDGFAEDITERKRAEERIDEA------- 202 (807)
T ss_pred hChhhHHHHHHHHhccCcccceEEEEEeCCcc--EEEEEeeeeecCCCce-EEEEEEEccchHHHHHHHHHHH-------
Confidence 2333344455556788899999996 6667788888888875 6899999999999999886642
Q ss_pred hhhHHHHHHHHhHhhHHHHHHHcc-CCCCccccCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCC--cccc
Q 001902 324 LIRYDARQKEMATSSVTELVQAMK-KPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGG--CRTS 400 (998)
Q Consensus 324 l~~~d~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~g~~~~~~~~~~~~~~~~~~--~~~~ 400 (998)
...+..+..... .....+..+.+++.|..+...+||+++|++|+...++.|......+... ....
T Consensus 203 ------------~~~l~~l~e~~~~~i~~~d~~g~i~~~N~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~ 270 (807)
T PRK13560 203 ------------LHFLQQLLDNIADPAFWKDEDAKVFGCNDAACLACGFRREEIIGMSIHDFAPAQPADDYQEADAAKFD 270 (807)
T ss_pred ------------HHHHHHHHhhCCCeEEEEcCCCCEEEEhHHHHHHhCCCHHHHcCCcchhcCCcchhHHHHHHHHHHhc
Confidence 111222333333 3345566678889999999999999999999999999876432222100 0011
Q ss_pred cccccccchhhccccCCccccccccc--cccCCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhccc-cHHHH
Q 001902 401 MQRISEVPEKKKQKSGRRSFMGLIGR--KSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGI-DLATT 477 (998)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~di~er~~~e~e~r~~~-~l~~i 477 (998)
.......+..+..++|...|+.+..+ +..+..+....... ..+||++|++.|++++... .|+.+
T Consensus 271 ~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~~~~~g~~~g~~~-------------~~~DITerk~~e~~L~~se~~l~~l 337 (807)
T PRK13560 271 ADGSQIIEAEFQNKDGRTRPVDVIFNHAEFDDKENHCAGLVG-------------AITDISGRRAAERELLEKEDMLRAI 337 (807)
T ss_pred cCCceEEEEEEEcCCCCEEEEEEEecceEEEcCCCCEEEEEE-------------EEEechHHHHHHHHHHHHHHHHHHH
Confidence 11223345566788999886655432 33344444333332 3689999999999887644 58999
Q ss_pred HhhcCceEEEEcCCCCCCCEEEc-CHHHHHHcCCChhhhcCCCCccccCCCCCHHH-----------------HHHHHHH
Q 001902 478 LERIEKNFVITDPRLPDNPIIFA-SDSFLELTEYSREEILGRNCRFLQGPETDPAT-----------------VRKIRAA 539 (998)
Q Consensus 478 ~e~~~d~i~i~D~~G~d~~I~~v-N~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~-----------------~~~i~~~ 539 (998)
+++++++|+++|.+|. ++++ |+++++++||+.+|++|++...+.+....... ...+...
T Consensus 338 ~~~~~~~i~~~d~~g~---i~~~nn~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (807)
T PRK13560 338 IEAAPIAAIGLDADGN---ICFVNNNAAERMLGWSAAEVMGKPLPGMDPELNEEFWCGDFQEWYPDGRPMAFDACPMAKT 414 (807)
T ss_pred HHhCcccEEEEcCCCC---EEEecCHHHHHHhCCCHHHHcCCCccccChhhhhhhhhchhhhcCCcCCcchhhhhhHHHH
Confidence 9999999999999877 9987 67888899999999999986544332211110 0112334
Q ss_pred HhcCCcE-EEEEEEEecCCcEEEEEEEEeeeccCC----EEEEEEecCCcccc
Q 001902 540 IDNQTDV-TVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLE 587 (998)
Q Consensus 540 l~~g~~~-~~e~~~~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~ 587 (998)
+..+..+ ..++...++||..+|+.++..|+.+.+ +++++++|||+||+
T Consensus 415 ~~~~~~~~~~e~~~~~~~g~~~~~~~~~~p~~d~~g~~~~~~~~~~DITerk~ 467 (807)
T PRK13560 415 IKGGKIFDGQEVLIEREDDGPADCSAYAEPLHDADGNIIGAIALLVDITERKQ 467 (807)
T ss_pred HhcCCcccCceEEEEcCCCCeEEEEEEEeeeECCCCCEEEEEEEeehhhhHHH
Confidence 5555543 357888999999999999999999876 78999999999996
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=229.11 Aligned_cols=255 Identities=17% Similarity=0.162 Sum_probs=203.1
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCC-----eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe-
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ- 735 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-----~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~- 735 (998)
+...+++....+-+|.||.||.+.+.+.. +.+-+|.++.. ...-++..+..|..++..+.|||+.++.++..
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 44567888899999999999999775432 34556665533 23445678888999999999999999999875
Q ss_pred eCCeEEEEEecCCCCchhHHHhh------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEE
Q 001902 736 TKTHVCLITDYCPGGELFLLLDR------QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLT 809 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~------~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~ 809 (998)
+....++++.++.-|.|..++.. .....++..++..++.|++.|++|||+.||||.||-..|.+|++.-.+||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 45678899999988999999972 223347777888899999999999999999999999999999999999999
Q ss_pred eccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc
Q 001902 810 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 889 (998)
Q Consensus 810 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt 889 (998)
|=.+++..= +.+++ + .....-....||+||.+....|+.++|+||||++||||+|
T Consensus 439 DsaLSRDLF------P~DYh------------------c-LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmt 493 (563)
T KOG1024|consen 439 DSALSRDLF------PGDYH------------------C-LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMT 493 (563)
T ss_pred cchhccccC------ccccc------------------c-cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHh
Confidence 999885421 11110 0 0011124567999999999999999999999999999997
Q ss_pred -CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 890 -GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 890 -G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
|+.||...++.++..-+.. ...+.....++.++..++..||...|++||++.+.
T Consensus 494 lg~~PyaeIDPfEm~~ylkd-GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Ql 548 (563)
T KOG1024|consen 494 LGKLPYAEIDPFEMEHYLKD-GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQL 548 (563)
T ss_pred cCCCCccccCHHHHHHHHhc-cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHH
Confidence 9999999998887665544 44555566789999999999999999999996553
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=218.56 Aligned_cols=161 Identities=25% Similarity=0.262 Sum_probs=128.7
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcch
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 829 (998)
|+|.+++... +..+++..++.++.||+.||.|||+++ ||+|||++.++.+++ ||++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~---------- 61 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP---------- 61 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc----------
Confidence 6899999764 345999999999999999999999998 999999999999999 998854320
Q ss_pred hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHh
Q 001902 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ-KTFANILH 908 (998)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~-~~~~~i~~ 908 (998)
....||+.|||||++.+..++.++|||||||++|+|++|..||...... ..+..+..
T Consensus 62 ----------------------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 119 (176)
T smart00750 62 ----------------------EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN 119 (176)
T ss_pred ----------------------ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH
Confidence 1125899999999999999999999999999999999999999765432 33333333
Q ss_pred CCCCC-C----CCCCCcH--HHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 909 KDLKF-P----SSTPTSL--HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 909 ~~~~~-~----~~~~~s~--~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
..... + .....+. .+.+|+.+||..||.+||+ +.++++|+|+.
T Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~----~~~ll~~~~~~ 169 (176)
T smart00750 120 GMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREA----ANHYLAHCRAL 169 (176)
T ss_pred HhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccC----HHHHHHHHHHH
Confidence 22111 0 1111222 5899999999999999999 99999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=211.46 Aligned_cols=275 Identities=19% Similarity=0.248 Sum_probs=216.7
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEeeCCe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTH 739 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~ 739 (998)
.+..+.|+++++||+|+||.+|++....+|..||+|+-+...- .-++..|..+.+.|. ...|+.+..++.+.++
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 4557899999999999999999999999999999998765432 235667889999995 4789999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec---CCcEEEEeccCccc
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCL 816 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~---~g~vkL~DFG~a~~ 816 (998)
-.+||+.+ |.+|.+++.-- ...++...+..++-|++.-++|+|.+++|||||||+|+|+.- ...+.|+|||+|+.
T Consensus 86 nvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 99999999 99999998743 234999999999999999999999999999999999999974 35789999999976
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
+-.... ..+.+.+......||..|.+-....+...+...|+=|+|.+|.++..|.+||.+
T Consensus 164 y~d~~t--------------------~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQg 223 (341)
T KOG1163|consen 164 YRDIRT--------------------RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQG 223 (341)
T ss_pred hccccc--------------------cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccc
Confidence 532111 123344566778999999999888888889999999999999999999999988
Q ss_pred CC---hHHHHHHHHhCCCCCCCC---CCCcHHHHHHHHHccccCccCcCCChhcHHHH-------HcCCCccCCChhhhh
Q 001902 897 KT---RQKTFANILHKDLKFPSS---TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI-------KKHPFFKGVNWALVR 963 (998)
Q Consensus 897 ~~---~~~~~~~i~~~~~~~~~~---~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el-------L~Hp~f~~~~~~~~~ 963 (998)
.. ....+++|....+..+.. ...+.++...|..|-..--.+-|.... +.++ |+|.+=--.||..+.
T Consensus 224 lka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~y-lrqlFriLfr~ln~~~d~iyDW~~lk 302 (341)
T KOG1163|consen 224 LKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMY-LRQLFRILFRTLNHQYDYIYDWTMLK 302 (341)
T ss_pred cchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHH-HHHHHHHHHhhccccCCeEeeHHHHH
Confidence 54 345667777766555432 456778888888886665556666432 2333 344444447887774
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=254.07 Aligned_cols=242 Identities=38% Similarity=0.634 Sum_probs=188.5
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
.+|..++.|..|++|.||+++|+.+.+.+|+|+=+...+ +.+ |+....+|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li--------lRn---ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI--------LRN---ILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccchh--------hhc---cccccCCccee----------------
Confidence 579999999999999999999999999999964332211 011 44455566555
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
|+-..+++.. +.++.+. +.+++|||+.||+|||+||+|.+|+.-|++|+.|||+++...-.....
T Consensus 136 -----gDc~tllk~~--g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -----GDCATLLKNI--GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -----chhhhhcccC--CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 4444445443 2344332 779999999999999999999999999999999999987642111110
Q ss_pred -CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 825 -LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 825 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
+.... +.. ...-....++|||.|.|||++....|...+|.|+||+|+|+++.|+.||.+.+..+.+
T Consensus 201 l~eg~I--~k~-----------t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf 267 (1205)
T KOG0606|consen 201 LKEGHI--EKD-----------THEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF 267 (1205)
T ss_pred hhhcch--HHH-----------HHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH
Confidence 00000 000 0011345679999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCC-CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhh
Q 001902 904 ANILHKDLKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 904 ~~i~~~~~~~~~~-~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
..++...+.+|+. ....+++++++.++|+.+|..|.... .+-++.+|+||+.+||.-|
T Consensus 268 g~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~-ga~evk~h~ff~~LDw~~l 326 (1205)
T KOG0606|consen 268 GQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG-GALEVKQHGFFQLLDWKSL 326 (1205)
T ss_pred hhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccc-hhhhhhhccceeecccchh
Confidence 9999988888765 45678999999999999999998744 7889999999999999844
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=216.89 Aligned_cols=223 Identities=24% Similarity=0.334 Sum_probs=187.0
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeC
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK 737 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 737 (998)
+-.+..-.|++.++||+|+||.++++.+.-++++||||.-... ...-++..|....+.| ..++|+.+|.+....
T Consensus 22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 22 GVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred CceEecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 3345567899999999999999999999999999999965432 2234667788888888 579999999988999
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC-----CcEEEEecc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-----GHVSLTDFD 812 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~-----g~vkL~DFG 812 (998)
-+-.||||++ |.+|.|++.-. +..++...+..++.|++.-++|+|++.+|.|||||+|+||..- ..+.|+|||
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEecc
Confidence 9999999999 99999998754 2459999999999999999999999999999999999999743 358999999
Q ss_pred CccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCC
Q 001902 813 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT 892 (998)
Q Consensus 813 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~ 892 (998)
+|+.+...... .+.+.+.+.+..||..||+-....+...+.+.|+=|||-++++++.|.+
T Consensus 175 mAK~YrDp~Tk--------------------qHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsL 234 (449)
T KOG1165|consen 175 MAKEYRDPKTK--------------------QHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL 234 (449)
T ss_pred chhhhcCcccc--------------------ccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCC
Confidence 99876432221 1345567888999999999999999999999999999999999999999
Q ss_pred CCCC---CChHHHHHHHHh
Q 001902 893 PFRG---KTRQKTFANILH 908 (998)
Q Consensus 893 Pf~~---~~~~~~~~~i~~ 908 (998)
||.+ .+..+.+.+|-.
T Consensus 235 PWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 235 PWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred ccccccCcchHHHHHHhcc
Confidence 9977 345566666643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-24 Score=255.97 Aligned_cols=261 Identities=24% Similarity=0.395 Sum_probs=200.6
Q ss_pred ccccccCCCCceeEEEEEEccCCeEEEEEEeecc---cccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 668 RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG---VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 668 ~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~---~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
.....+|.|++|.|+.+......+.++.|.+... ..........+..|..+-..+.|+|++..+..+.......-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4557799999999999888777777777765421 1111222223666788888899999987777766665555559
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
|||++ +|+.++... ..++...+..++.||+.||+|||+.||.||||||+|++++.+|.+||+|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~--- 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW--- 474 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc---
Confidence 99999 999999875 458899999999999999999999999999999999999999999999999985532111
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCC-hhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~-~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
.........++|+..|+|||++.+..|++ ..||||.|++++.|++|+.||......+..
T Consensus 475 --------------------e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~ 534 (601)
T KOG0590|consen 475 --------------------EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS 534 (601)
T ss_pred --------------------chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc
Confidence 11123456778999999999999999987 799999999999999999999765443322
Q ss_pred -HHHHhC---CC---CCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 904 -ANILHK---DL---KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 904 -~~i~~~---~~---~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
...... .. +......++.+.+.+|.+||+.||.+|.| +++|++.+||+.++
T Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~t----i~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 535 FKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRIT----IEQILNDEWIRSIE 592 (601)
T ss_pred hhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheec----HHHHhhChHhhhcc
Confidence 111110 00 11112335667889999999999999999 99999999999863
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-22 Score=223.58 Aligned_cols=253 Identities=23% Similarity=0.222 Sum_probs=194.9
Q ss_pred CcccccccCCCCceeEEEEEEccCC-eEEEEEEeecccccChhHHHHHHHHHHHHHhCC----CCCccceeEEE-eeCCe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSG-QYFAMKAMDKGVMLNRNKVHRACAEREILDMLD----HPFVPALYASF-QTKTH 739 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~-~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~----h~nIv~l~~~~-~~~~~ 739 (998)
.|++.+.||+|+||.||+|.+..++ ..+|+|+......... ..+..|..++..+. ..++..+++.+ ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999997764 6899998775422111 15666888888886 36999999999 57889
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC-----CcEEEEeccCc
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-----GHVSLTDFDLS 814 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~-----g~vkL~DFG~a 814 (998)
.||||+.+ |.+|.++........++...+..++.|++.+|.+||+.|++||||||+|+++... ..+.|+|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 9999999877666779999999999999999999999999999999999999854 36999999999
Q ss_pred c--ccCCCCCCCCCcchhhhhcccCCCCcccccccccc-cccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCC
Q 001902 815 C--LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 891 (998)
Q Consensus 815 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~ 891 (998)
+ ......... ..+.+. ...+.||..|.++.+..+...+.+.|+||++.++.+++.|.
T Consensus 175 r~~~~~~~~~~~--------------------~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~ 234 (322)
T KOG1164|consen 175 RRFKYVGDSGGN--------------------LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGS 234 (322)
T ss_pred ccccccCCCCcc--------------------cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCC
Confidence 7 321111100 001111 24567999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHh---CCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh
Q 001902 892 TPFRGKTRQKTFANILH---KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH 942 (998)
Q Consensus 892 ~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~ 942 (998)
.||.+.........+.. ...........+.++.+++..+-..+...+|...
T Consensus 235 LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~ 288 (322)
T KOG1164|consen 235 LPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYE 288 (322)
T ss_pred CCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHH
Confidence 99977654333332222 1111111222346777888877778999999944
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-21 Score=215.60 Aligned_cols=263 Identities=36% Similarity=0.558 Sum_probs=208.0
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCC-CccceeEEEeeCCeEEEEEe
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP-FVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~-nIv~l~~~~~~~~~~~lV~E 745 (998)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|+.+++.+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 778899999999999999986 78999999876554444567888999999999988 79999999988778899999
Q ss_pred cCCCCchhHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC-cEEEEeccCccccCCCCCC
Q 001902 746 YCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g-~vkL~DFG~a~~~~~~~~~ 823 (998)
|+.++++.+++..... ..++......++.|++.++.|+|..+++|||+||+||+++..+ .++++|||.+.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999977765421 2689999999999999999999999999999999999999988 7999999998643211100
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC---CCCCChhHHHHHHHHHHHHHcCCCCCCCCCh-
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTR- 899 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~- 899 (998)
. ..........|+..|++||.+.+ ..+....|+||+|++++++++|..||.....
T Consensus 159 ~---------------------~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~ 217 (384)
T COG0515 159 S---------------------SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS 217 (384)
T ss_pred c---------------------cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 0 00012356789999999999988 5788899999999999999999999887763
Q ss_pred ---HHHHHHHHhCCCC-CCCCCCCc------HHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 900 ---QKTFANILHKDLK-FPSSTPTS------LHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 900 ---~~~~~~i~~~~~~-~~~~~~~s------~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
......+.....+ ........ ..+.+++.+|+..+|..|.+ ......++|....
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~----~~~~~~~~~~~~~ 281 (384)
T COG0515 218 SATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS----SSSDLSHDLLAHL 281 (384)
T ss_pred ccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCC----HHHHhhchHhhCc
Confidence 3444444443322 22222111 46889999999999999999 6666666555543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=228.70 Aligned_cols=178 Identities=20% Similarity=0.163 Sum_probs=132.7
Q ss_pred cccccCCcccccccCCCCceeEEEEEEcc-CCeEEEEEEeecccc--cChhHHHHHHHHHHHHHhCCCCCccceeEEEee
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCG-SGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPALYASFQT 736 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-~~~~valK~i~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 736 (998)
.....++|.+.+.||+|+||+||+|.+.. +++.+|+|++..... ........+.+|+++|++++|+|++..+..
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 34456789999999999999999999876 688889998753321 123345678899999999999999853322
Q ss_pred CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEEEecCCcEEEEeccCcc
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL-KPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDL-kP~NILi~~~g~vkL~DFG~a~ 815 (998)
.+..|||||||+|++|... .. .. ...++.|++++|.|||++||+|||| ||+|||++.++.+||+|||+|.
T Consensus 90 ~~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred cCCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 2457999999999999732 11 11 1467889999999999999999999 9999999999999999999997
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG 868 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 868 (998)
........ .. ......-....+++.|+|||++..
T Consensus 161 ~~~~~~~~----------------~~---~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGAL----------------YR---IAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcch----------------hh---hhhhhhhhhhhccCccCCcccCCh
Confidence 65311100 00 000011135678999999999854
|
|
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-19 Score=230.27 Aligned_cols=236 Identities=19% Similarity=0.311 Sum_probs=192.2
Q ss_pred chHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCC----
Q 001902 186 RVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ---- 261 (998)
Q Consensus 186 ~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~---- 261 (998)
..+..+..+++.++++++++|. +|+|+++|++|++++||+.+|++|+++..+.+++........+......+.
T Consensus 9 ~~~~~~~~~le~~~~~i~~~d~---~g~i~~~N~~~~~l~G~s~eeliG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (799)
T PRK11359 9 AADGIFFPALEQNMMGAVLINE---NDEVLFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVE 85 (799)
T ss_pred hhhhhHHHHHHhhcCcEEEEcC---CCeEEEEcHHHHHHhCCCHHHHcCCCHHHhcCccccccchHHHhhhhccCCcccc
Confidence 4556778899999999999998 777999999999999999999999998888777665544444544444433
Q ss_pred cEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhcCCCCCchhhhhHHHHHHHHhHhhHHH
Q 001902 262 SYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTE 341 (998)
Q Consensus 262 ~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~~~~~L~~~l~~~d~~~~~~~~~~~~~ 341 (998)
.+..+++.+++||..+|+.++..++. .+|. .+++++.+|||++++.+++++.
T Consensus 86 ~~~~e~~~~~~dG~~~~v~~~~~~~~-~~g~-~~~~~~~~DiT~~~~~~~~~~~-------------------------- 137 (799)
T PRK11359 86 GMSRELQLEKKDGSKIWTRFALSKVS-AEGK-VYYLALVRDASVEMAQKEQTRQ-------------------------- 137 (799)
T ss_pred ccceeeEEecCCcCEEEEEEEeeeec-cCCc-eEEEEEEeeccchhhhHHHHHH--------------------------
Confidence 24458888999999999999998873 4454 5678999999987765544211
Q ss_pred HHHHccCCCCccccCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCCcccccccccccchhhccccCCcccc
Q 001902 342 LVQAMKKPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFM 421 (998)
Q Consensus 342 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (998)
T Consensus 138 -------------------------------------------------------------------------------- 137 (799)
T PRK11359 138 -------------------------------------------------------------------------------- 137 (799)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccccCCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhccccHHHHHhhcCceEEEEcCCCCCCCEEEcC
Q 001902 422 GLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFAS 501 (998)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~di~er~~~e~e~r~~~~l~~i~e~~~d~i~i~D~~G~d~~I~~vN 501 (998)
+..++++++++++++|.+|. ++++|
T Consensus 138 ----------------------------------------------------~~~~~~~~~~~i~~~d~~g~---i~~~N 162 (799)
T PRK11359 138 ----------------------------------------------------LIIAVDHLDRPVIVLDPERR---IVQCN 162 (799)
T ss_pred ----------------------------------------------------HHHHHhcCCCcEEEEcCCCc---EEEEC
Confidence 35578999999999999777 99999
Q ss_pred HHHHHHcCCChhhhcCCCCcccc-CCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEeeeccCC----EEE
Q 001902 502 DSFLELTEYSREEILGRNCRFLQ-GPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFI 576 (998)
Q Consensus 502 ~a~~~l~Gy~~eEliG~~~~~l~-~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rkdG~~~wv~~~~spi~d~~----~~v 576 (998)
+++++++||+.+|++|++...+. ++.........+...+..+..+..+.+..++||..+|+.++..|+.+.+ +++
T Consensus 163 ~~~~~l~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~v~d~~g~~~~~~ 242 (799)
T PRK11359 163 RAFTEMFGYCISEASGMQPDTLLNIPEFPADNRIRLQQLLWKTARDQDEFLLLTRTGEKIWIKASISPVYDVLAHLQNLV 242 (799)
T ss_pred hhhHhhhCCCHHHHCCCChHHhcCCCCCcHHHHHHHHHhhccCCCCcceeEEeCCCCCEEEEEeeeeeeecCCCceeEEE
Confidence 99999999999999999876554 4555555666677777777778888999999999999999999998765 789
Q ss_pred EEEecCCcccc
Q 001902 577 GVQLDGSEHLE 587 (998)
Q Consensus 577 gi~rDITerk~ 587 (998)
++++|||+||+
T Consensus 243 ~~~~DITerk~ 253 (799)
T PRK11359 243 MTFSDITEERQ 253 (799)
T ss_pred EEeehhhhHHH
Confidence 99999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.7e-21 Score=199.04 Aligned_cols=176 Identities=16% Similarity=0.146 Sum_probs=136.5
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHH------HHHHHHHHHhCCCCCccceeEEE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR------ACAEREILDMLDHPFVPALYASF 734 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~------~~~E~~il~~l~h~nIv~l~~~~ 734 (998)
.+..++|++++.||.|+||.||++.+ ++..+|+|++............. +.+|+..+.++.|++|..+..++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 34468999999999999999999765 46689999998765444444333 57899999999999999999886
Q ss_pred eeC--------CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcE
Q 001902 735 QTK--------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV 806 (998)
Q Consensus 735 ~~~--------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~v 806 (998)
... +..+|||||++|.+|.++.. +++ ....+++.+|..||..|++|||+||+||+++.+| +
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-E
Confidence 533 35789999999999988732 333 2456999999999999999999999999999988 9
Q ss_pred EEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHH
Q 001902 807 SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 886 (998)
Q Consensus 807 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~e 886 (998)
+|+|||.+........ ..-++....+..++|+||||+++..
T Consensus 174 ~liDfg~~~~~~e~~a---------------------------------------~d~~vler~y~~~~di~~lg~~~~~ 214 (232)
T PRK10359 174 RIIDLSGKRCTAQRKA---------------------------------------KDRIDLERHYGIKNEIKDLGYYLLI 214 (232)
T ss_pred EEEECCCcccccchhh---------------------------------------HHHHHHHhHhcccccccceeEeehH
Confidence 9999998743210000 0013344456678999999999887
Q ss_pred HH
Q 001902 887 ML 888 (998)
Q Consensus 887 Ll 888 (998)
+.
T Consensus 215 ~~ 216 (232)
T PRK10359 215 YK 216 (232)
T ss_pred HH
Confidence 65
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=193.44 Aligned_cols=141 Identities=16% Similarity=0.170 Sum_probs=110.7
Q ss_pred ccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhH-----------------------HHHHHHHHHHHHhCCCCC
Q 001902 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-----------------------VHRACAEREILDMLDHPF 726 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~-----------------------~~~~~~E~~il~~l~h~n 726 (998)
...||+|+||.||+|.+. +|+.||+|+++......... ......|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999996 89999999998653211110 112345999999998888
Q ss_pred ccceeEEEeeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcEEEecCCc
Q 001902 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL-HCQGIIYRDLKPENVLLQGNGH 805 (998)
Q Consensus 727 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~L-H~~~IiHrDLkP~NILi~~~g~ 805 (998)
+.....+.... .+|||||++|+++...+... ..++...+..++.|++.+|.+| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 75544433322 38999999888776553332 4588999999999999999999 699999999999999999 578
Q ss_pred EEEEeccCccc
Q 001902 806 VSLTDFDLSCL 816 (998)
Q Consensus 806 vkL~DFG~a~~ 816 (998)
++|+|||+|..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-20 Score=221.81 Aligned_cols=238 Identities=20% Similarity=0.315 Sum_probs=186.8
Q ss_pred HHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEE
Q 001902 188 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 267 (998)
Q Consensus 188 ~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 267 (998)
.+.|+.+++.++++++++|. +|+++|+|+++++++||+.++++|++...+.++.........+...+..+..+..++
T Consensus 3 ~~~~~~i~~~~~~~i~~~d~---~g~~~~~N~~~~~~~G~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (494)
T TIGR02938 3 PEAYRQTVDQAPLAISITDL---KANILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKL 79 (494)
T ss_pred hHHHHHHHHhCCceEEEECC---CCcEEEEchhheeecCCCHHHHhCCCchhhcCCCCCHHHHHHHHHHHHhCCccccee
Confidence 46899999999999999999 777999999999999999999999987767666666667777788888888888888
Q ss_pred EEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhcCCCCCchhhhhHHHHHHHHhHhhHHHHHHHcc
Q 001902 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMK 347 (998)
Q Consensus 268 ~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~~~~~L~~~l~~~d~~~~~~~~~~~~~~~~~l~ 347 (998)
..++++|..+|+..++.|+.+.+|.+.+++++++|||++|+++++++..
T Consensus 80 ~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIt~~k~~e~~l~~~------------------------------- 128 (494)
T TIGR02938 80 LNRRKDGELYLAELTVAPVLNEAGETTHFLGMHRDITELHRLEQVVANQ------------------------------- 128 (494)
T ss_pred eccCCCccchhhheeeEEEECCCCCEEEEEEehhhhhHHHHHHHHHHHH-------------------------------
Confidence 8899999999999999999999999999999999999999988774321
Q ss_pred CCCCccccCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCCcccccccccccchhhccccCCcccccccccc
Q 001902 348 KPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRK 427 (998)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (998)
T Consensus 129 -------------------------------------------------------------------------------- 128 (494)
T TIGR02938 129 -------------------------------------------------------------------------------- 128 (494)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhccccHHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHH
Q 001902 428 SQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLEL 507 (998)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~di~er~~~e~e~r~~~~l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l 507 (998)
+.+ |+.++++++++|+++|.+|. ++++|++|+++
T Consensus 129 ---------------------------------------~~~----~~~~~~~~~~~i~~~d~~~~---i~~~N~~~~~~ 162 (494)
T TIGR02938 129 ---------------------------------------KLL----IESVVDAAPVAFVLLDPTGR---VILDNQEYKKL 162 (494)
T ss_pred ---------------------------------------HHH----HHHHHhcccceEEEEcCCCC---EEEechhHHHh
Confidence 111 67899999999999999777 99999999999
Q ss_pred cCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcE-EEEEEEEecCCc-EEEEEEEEeeeccCC------------
Q 001902 508 TEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDV-TVQLINYTKSGK-KFWNLFHLQPMRDQK------------ 573 (998)
Q Consensus 508 ~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~-~~e~~~~rkdG~-~~wv~~~~spi~d~~------------ 573 (998)
+|+...+..+.....+.+++.... +......+..+ ..+....+++|. .+|+.....++.+..
T Consensus 163 ~g~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (494)
T TIGR02938 163 ATDLRVKEPAHTVLDLLREAWREA----LAENWPQQLAFSNREARFDRGGGRPARWLSCTGSVIGMESDCADSFFCAAEQ 238 (494)
T ss_pred hchhhhhHHHHHHHHHhhHHhhhh----hhhcchhhhccccceeeeccCCCceeeEEEecCceEEeecchhhheeccCCC
Confidence 999998888766444444432222 11111112222 233444555555 789988887776543
Q ss_pred -EEEEEEecCCcccccc
Q 001902 574 -YFIGVQLDGSEHLEPL 589 (998)
Q Consensus 574 -~~vgi~rDITerk~~~ 589 (998)
+++++++|||++|+.+
T Consensus 239 ~~~~~~~~DITe~k~~e 255 (494)
T TIGR02938 239 PYLLLTIADISNLREEQ 255 (494)
T ss_pred chheehHHHHHHHHHHH
Confidence 4567889999999744
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-20 Score=201.69 Aligned_cols=236 Identities=23% Similarity=0.284 Sum_probs=152.5
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC----------CCCccceeEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD----------HPFVPALYASFQ 735 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~----------h~nIv~l~~~~~ 735 (998)
.+...+.||.|+++.||.|.+..||+.+|+|++...........+.+.+|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3566788999999999999999999999999987654334445666666654443322 223333333332
Q ss_pred ---------eC---C-----eEEEEEecCCCCchhHHHhh----CCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 001902 736 ---------TK---T-----HVCLITDYCPGGELFLLLDR----QPT-KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 793 (998)
Q Consensus 736 ---------~~---~-----~~~lV~E~~~ggsL~~~l~~----~~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDL 793 (998)
.. . ..+++|+-+ .++|.+++.- ... ..+.......+..|+++.+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 236788888 7788877542 111 12333344556689999999999999999999
Q ss_pred CCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-----
Q 001902 794 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----- 868 (998)
Q Consensus 794 kP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----- 868 (998)
+|+||+++.+|.++|+||+.....+.. ......+..|.+||....
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~------------------------------~~~~~~~~~~~PPe~~~~~~~~~ 221 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR------------------------------YRCSEFPVAFTPPELESCAGQFG 221 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE------------------------------EEGGGS-TTTS-HHHHHHHTSCH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce------------------------------eeccCCCcccCChhhhhhhcccC
Confidence 999999999999999999876432200 000234578999998744
Q ss_pred ---CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCc
Q 001902 869 ---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938 (998)
Q Consensus 869 ---~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~R 938 (998)
..++.+.|.|+||+++|.|+||..||........... .+......+..++.||..||++||.+|
T Consensus 222 ~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 222 QNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 2467899999999999999999999986543221111 222333567789999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-21 Score=229.22 Aligned_cols=273 Identities=21% Similarity=0.266 Sum_probs=192.1
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeeccc-ccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~-~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
.|...+.||++.|=+|.+|++.+ | .+++|++-+.. ...-....+...|++ ...+++||++.+.-+...+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 68888999999999999999843 4 49999987653 333344555555666 67779999999988888888899999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
+|+ ..+|+|.+..++ .+...+.+-|+.||+.||..+|..||+|||||.+||||++.+-+.|.||..-+.. +
T Consensus 101 qyv-khnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt------Y 171 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPT------Y 171 (1431)
T ss_pred HHH-hhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCc------c
Confidence 999 789999998764 4888889999999999999999999999999999999999999999999865432 1
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC-----------CCChhHHHHHHHHHHHHHc-CCC
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-----------HTSAVDWWALGILLYEMLY-GYT 892 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----------~~~~sDIwSlG~il~eLlt-G~~ 892 (998)
+|.. +|..+..- ..+-..-.+|.|||.+.... .+++-||||+||++.||++ |++
T Consensus 172 LPeD-----------NPadf~fF---FDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~P 237 (1431)
T KOG1240|consen 172 LPED-----------NPADFTFF---FDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRP 237 (1431)
T ss_pred CCCC-----------CcccceEE---EecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCC
Confidence 1111 11101000 01112345899999985421 5678999999999999997 899
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC-------CCccCCChhhhhcC
Q 001902 893 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH-------PFFKGVNWALVRCM 965 (998)
Q Consensus 893 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H-------p~f~~~~~~~~~~~ 965 (998)
||.-. +...|+..-.......-....+..+++||..|++.||++|++ |++.|+- .||-.+=+.-+.+.
T Consensus 238 lF~LS-QL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlS----AedyL~~yrG~~FP~yFy~FL~~Y~~~~ 312 (1431)
T KOG1240|consen 238 LFTLS-QLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLS----AEDYLQKYRGLVFPEYFYSFLYDYLDRF 312 (1431)
T ss_pred cccHH-HHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccC----HHHHHHhhhccccHHHHHHHHHHHHHhc
Confidence 98421 001111000000000000011335789999999999999999 8888876 23333333444555
Q ss_pred CCCC
Q 001902 966 NPPE 969 (998)
Q Consensus 966 ~~~~ 969 (998)
.|+.
T Consensus 313 ~~~~ 316 (1431)
T KOG1240|consen 313 VPLT 316 (1431)
T ss_pred CCcc
Confidence 5555
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-20 Score=190.75 Aligned_cols=247 Identities=19% Similarity=0.282 Sum_probs=201.0
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+...+..++.+|.+...|..|++++. |..++.|++...... ......+..|.-.|+-+.||||+.+++.+....++
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNL 262 (448)
T ss_pred CcchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence 355667788899999999999999995 456778877654332 22345677788888889999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEecCCcEEEE--eccCccc
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLT--DFDLSCL 816 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkP~NILi~~~g~vkL~--DFG~a~~ 816 (998)
.++..||+-|+|+.+++.+........++.+++.+|++|++|||+.. |.---|....++||++.+.+|. |--++..
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq 342 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ 342 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee
Confidence 99999999999999999987778888999999999999999999974 4445688889999998876653 4333311
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCC---ChhHHHHHHHHHHHHHcCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT---SAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~---~~sDIwSlG~il~eLltG~~P 893 (998)
. ....-.|.||+||.+...+-+ .++|+|||++++|||.|...|
T Consensus 343 e----------------------------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevp 388 (448)
T KOG0195|consen 343 E----------------------------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVP 388 (448)
T ss_pred c----------------------------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccc
Confidence 1 011346889999999887654 389999999999999999999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 894 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
|..-.+.+.-.+|.-..+.....+..+..+..|+.-|+..||.+||.+..+
T Consensus 389 fadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 389 FADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred cccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 999998888888877666666667789999999999999999999996543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.1e-19 Score=184.36 Aligned_cols=141 Identities=18% Similarity=0.167 Sum_probs=112.1
Q ss_pred ccccCCCCceeEEEEEEccCCeEEEEEEeecccccChh-----------------------HHHHHHHHHHHHHhCCCCC
Q 001902 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN-----------------------KVHRACAEREILDMLDHPF 726 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~-----------------------~~~~~~~E~~il~~l~h~n 726 (998)
.+.||+|++|.||+|.+. +|+.||+|++......... .......|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999986 8999999999875321000 0122357899999999998
Q ss_pred ccceeEEEeeCCeEEEEEecCCCCchhHH-HhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEecCC
Q 001902 727 VPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNG 804 (998)
Q Consensus 727 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~-l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkP~NILi~~~g 804 (998)
|.....+.... .||||||++|+++... +.. ..++...+..++.|++.+|.+||+ +||+||||||+|||++ ++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 86555544333 4899999988765433 332 347888999999999999999999 9999999999999999 89
Q ss_pred cEEEEeccCcccc
Q 001902 805 HVSLTDFDLSCLT 817 (998)
Q Consensus 805 ~vkL~DFG~a~~~ 817 (998)
.++|+|||++...
T Consensus 155 ~~~liDFG~a~~~ 167 (190)
T cd05145 155 KPYIIDVSQAVEL 167 (190)
T ss_pred CEEEEEcccceec
Confidence 9999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-18 Score=176.30 Aligned_cols=203 Identities=20% Similarity=0.191 Sum_probs=141.9
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeecccccCh-hHHHHHHHHHHHHHhCC-CCCccceeEEEeeCCeEEEEE
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-NKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~-~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lV~ 744 (998)
+.+...|++|+||+||++.. .+.+++.+.+........ -....+.+|+++|++|. |++|++++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 44568899999999998775 677888777665432211 11235778999999995 5889999886 4469999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL-KPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDL-kP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
||+.|.+|...+.. . ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 78 eyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 78 SYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99999998754321 1 1346789999999999999999999 799999999999999999999643211100
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCC-ChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHT-SAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~-~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
. ..- .+++. ... ...-...++.|++|+....- ..+ ...+.++.|+-+|.++|+..|+.+.+
T Consensus 149 ~--r~L--~~rDl---------~~l-lk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 M--RLL--AREDL---------RHL-LKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred H--HHH--HHHHH---------HHH-HHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 000 00000 000 00012367888888754322 233 57788999999999999999987654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.6e-19 Score=189.59 Aligned_cols=208 Identities=24% Similarity=0.332 Sum_probs=148.2
Q ss_pred CCCCccceeEEEeeC---------------------------CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHH
Q 001902 723 DHPFVPALYASFQTK---------------------------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 775 (998)
Q Consensus 723 ~h~nIv~l~~~~~~~---------------------------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~q 775 (998)
+|||||.++.+|.+. ..+|+||... ..+|..++-.+. .+....+.++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 599999999887432 2589999999 789999997643 677788889999
Q ss_pred HHHHHHHHHHCCceeccCCCCcEEEe--cCC--cEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCccccccccccc
Q 001902 776 VVVALEYLHCQGIIYRDLKPENVLLQ--GNG--HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 851 (998)
Q Consensus 776 il~aL~~LH~~~IiHrDLkP~NILi~--~~g--~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (998)
+++|+.|||++||.|||||.+|||+. .++ .+.|.|||++.... ......|. ....
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~-~hGlqlpy--------------------~S~~ 408 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADD-NHGLQLPY--------------------ESDE 408 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeecc-cccccccc--------------------cccc
Confidence 99999999999999999999999996 333 58899999874321 11111110 0011
Q ss_pred ccccCCCCcccchhhcCCCC------CChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH-HHHhCCCCCCCCCCCcHHHH
Q 001902 852 NSFVGTEEYIAPEIIAGAGH------TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA-NILHKDLKFPSSTPTSLHAK 924 (998)
Q Consensus 852 ~~~~gt~~y~aPE~l~~~~~------~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~-~i~~~~~~~~~~~~~s~~l~ 924 (998)
-..-|...-||||+....+- ..++|.|+.|.+.||+++...||.+......-. ...+..+ .+-...+++.++
T Consensus 409 Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL-Palp~~vpp~~r 487 (598)
T KOG4158|consen 409 VDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL-PALPSRVPPVAR 487 (598)
T ss_pred ccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC-CCCcccCChHHH
Confidence 23357888999999865431 238999999999999999999998844321111 1112222 122345788999
Q ss_pred HHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 925 QLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 925 ~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
+++..+|+.||++|++.. ++..+|+-.-|..-
T Consensus 488 qlV~~lL~r~pskRvsp~-iAANvl~LsLw~~~ 519 (598)
T KOG4158|consen 488 QLVFDLLKRDPSKRVSPN-IAANVLNLSLWRMG 519 (598)
T ss_pred HHHHHHhcCCccccCCcc-HHHhHHHHHHhcCc
Confidence 999999999999999944 45556554444433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.9e-18 Score=210.11 Aligned_cols=197 Identities=24% Similarity=0.354 Sum_probs=160.5
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC---CCCccceeEEEeeC
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD---HPFVPALYASFQTK 737 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~ 737 (998)
++....|.|-+.||+|+||+||+|.+.. |+.+|||+-+.........+.+ ++.+|+ -+.|..+...+...
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q------~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQ------VMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHH------HHHhhchhhhcchHHHHHHHccC
Confidence 4556789999999999999999999965 9999999887765544444443 344444 23455556666677
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec-------CCcEEEEe
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-------NGHVSLTD 810 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~-------~g~vkL~D 810 (998)
+..+||+||.+.|||.+++.. .+.+++..+..++.|++..|+.||..+|||+||||+|+||.. +--++|+|
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred CcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 788999999999999999974 466999999999999999999999999999999999999962 33589999
Q ss_pred ccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcC
Q 001902 811 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 890 (998)
Q Consensus 811 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG 890 (998)
||.|..+.-- .+.......++|-.|-.+|+..|.++++..|.|.|+.+++-|+.|
T Consensus 845 fG~siDm~lf-------------------------p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG 899 (974)
T KOG1166|consen 845 FGRSIDMKLF-------------------------PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFG 899 (974)
T ss_pred cccceeeeEc-------------------------CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHH
Confidence 9998654311 111234567899999999999999999999999999999999988
Q ss_pred C
Q 001902 891 Y 891 (998)
Q Consensus 891 ~ 891 (998)
+
T Consensus 900 ~ 900 (974)
T KOG1166|consen 900 K 900 (974)
T ss_pred H
Confidence 5
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-17 Score=175.09 Aligned_cols=135 Identities=22% Similarity=0.226 Sum_probs=106.9
Q ss_pred cccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-----CCCCccceeEEEeeCC---eE
Q 001902 669 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-----DHPFVPALYASFQTKT---HV 740 (998)
Q Consensus 669 ~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-----~h~nIv~l~~~~~~~~---~~ 740 (998)
-...||+|+||.||. +..++.. +||++.... ......+.+|+.+++.+ +||||+++++++.++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 346799999999995 7667666 699886532 22346788999999999 6799999999998874 43
Q ss_pred E-EEEec--CCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCcEEEec----CCcEEEEecc
Q 001902 741 C-LITDY--CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL-EYLHCQGIIYRDLKPENVLLQG----NGHVSLTDFD 812 (998)
Q Consensus 741 ~-lV~E~--~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL-~~LH~~~IiHrDLkP~NILi~~----~g~vkL~DFG 812 (998)
+ +|||| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 4 78999 5579999999663 25555 35678888888 9999999999999999999984 3479999954
Q ss_pred Cc
Q 001902 813 LS 814 (998)
Q Consensus 813 ~a 814 (998)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.3e-17 Score=175.48 Aligned_cols=144 Identities=20% Similarity=0.154 Sum_probs=113.0
Q ss_pred CcccccccCCCCceeEEEEE-EccCCeEEEEEEeecccccC-------------------hh--HHHHHHHHHHHHHhCC
Q 001902 666 HFRPIKPLGSGDTGSVHLVE-LCGSGQYFAMKAMDKGVMLN-------------------RN--KVHRACAEREILDMLD 723 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~-~~~~~~~valK~i~~~~~~~-------------------~~--~~~~~~~E~~il~~l~ 723 (998)
.|.+.+.||.|+||.||+|. +..+|+.||+|++....... .. ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 66789999999997542110 00 1123567999999997
Q ss_pred CC--CccceeEEEeeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCcEEE
Q 001902 724 HP--FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG-IIYRDLKPENVLL 800 (998)
Q Consensus 724 h~--nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~-IiHrDLkP~NILi 800 (998)
+. .+++++.+ . ..+|||||++|.+|....... ..+....+..++.||+.+|.+||+.| |+||||||+||++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 53 34444432 2 348999999998887655332 33666677899999999999999999 9999999999999
Q ss_pred ecCCcEEEEeccCccc
Q 001902 801 QGNGHVSLTDFDLSCL 816 (998)
Q Consensus 801 ~~~g~vkL~DFG~a~~ 816 (998)
+ ++.++|+|||.+..
T Consensus 183 ~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 183 H-DGKVVIIDVSQSVE 197 (237)
T ss_pred E-CCCEEEEEChhhhc
Confidence 9 88999999999854
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-18 Score=190.77 Aligned_cols=185 Identities=26% Similarity=0.368 Sum_probs=138.4
Q ss_pred CeEEEEEecCCCCchhHHHhh-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 738 THVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
.++||.|++|.-.+|.+++.+ ......+......++.|++.|++| +|.+|+|+||.||++..+..+||+|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 468999999999999999974 344557788899999999999999 9999999999999999999999999999855
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 895 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~ 895 (998)
+..... .....-.++..+||..||+||.+.+..|+.++||||||++|+||++ -..+|.
T Consensus 406 ~~~~~~---------------------~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e 464 (516)
T KOG1033|consen 406 QDKDET---------------------VAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE 464 (516)
T ss_pred cccCCc---------------------ccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH
Confidence 432221 0111223455689999999999999999999999999999999996 222221
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 896 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 896 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
....+..+-.+.++. ......+.-..|+..||...|.+||+ +.+.--|+|.
T Consensus 465 ---r~~t~~d~r~g~ip~-~~~~d~p~e~~ll~~lls~~p~~RP~----~~~~~~~~~~ 515 (516)
T KOG1033|consen 465 ---RIATLTDIRDGIIPP-EFLQDYPEEYTLLQQLLSPSPEERPS----AIEVALHEFL 515 (516)
T ss_pred ---HHHhhhhhhcCCCCh-HHhhcCcHHHHHHHHhcCCCcccCch----HHHHhhhhhc
Confidence 122233333333331 22222334468999999999999997 5555556654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.6e-16 Score=166.15 Aligned_cols=138 Identities=21% Similarity=0.237 Sum_probs=115.6
Q ss_pred ccccCCCCceeEEEEEEccCCeEEEEEEeecccccCh-----hHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-----NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~-----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++.||+|++|.||++.+ .|..+++|+......... .....+.+|+.++..+.|++|+.+..++...+..++||
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999987 677899998664332221 12345778999999999999988887777778889999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
||++|++|.+++... .. ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999998653 12 7788899999999999999999999999999999 88999999998843
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.3e-16 Score=162.92 Aligned_cols=133 Identities=18% Similarity=0.197 Sum_probs=108.5
Q ss_pred ccCCCCceeEEEEEEccCCeEEEEEEeecccccC-----hhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEec
Q 001902 672 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-----RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 746 (998)
Q Consensus 672 ~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~-----~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 746 (998)
.||+|+||.||++.. ++..+++|......... ......+.+|+.++..+.|+++..+..++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999985 67889999865432211 11235677899999999988776666666667778999999
Q ss_pred CCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 747 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 747 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
++|++|.+++.... . .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999875521 1 7789999999999999999999999999999 89999999998844
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3e-17 Score=195.14 Aligned_cols=297 Identities=33% Similarity=0.539 Sum_probs=227.3
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEE
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 742 (998)
..+.+.+++.+-+|.++.++.+.-..+|...+.|+...........+.....+-.++-.-.+|.++.....+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 45678888999999999999999888887777777665433333333444444444444456777766555666778899
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
+|+|..+++|...++.-+ ..+.+-.+.++..+..+++|||...++|+|++|.|+++..+|+.++.|||.....+.-+.
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 999999999999998753 477778888999999999999999999999999999999999999999995433222111
Q ss_pred CCCCc--ch--hhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 823 LLLPT--TN--EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 823 ~~~~~--~~--~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
..-.. .. .-.+..+....+.......+......||+.|.+||.+.+......+|.|++|+++++.++|.+||....
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 10000 00 000111111112222223455667899999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCCCC-CCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhh
Q 001902 899 RQKTFANILHKDLKFPSST-PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~-~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
....+..|..+.+++|... ..+.++++++..+|..+|.+|..+. ++.++..|+||+.++|.-+
T Consensus 1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~-~~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK-GAAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc-cccccccCCccCCCCcccc
Confidence 9999999999999988653 4578899999999999999999943 2448899999999999866
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=8e-16 Score=160.86 Aligned_cols=138 Identities=21% Similarity=0.154 Sum_probs=108.2
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeecccccCh-------------------hHHHHHHHHHHHHHhCCCCC-
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-------------------NKVHRACAEREILDMLDHPF- 726 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~-------------------~~~~~~~~E~~il~~l~h~n- 726 (998)
|.+.+.||.|+||.||++.+. +|+.+|+|++........ ........|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 788899999999999999874 799999998765321000 01123567888999997774
Q ss_pred -ccceeEEEeeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc
Q 001902 727 -VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 805 (998)
Q Consensus 727 -Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~ 805 (998)
++.+++ ....++||||++|++|..+... .....++.+++.++.++|+.||+|+||||+||+++.++.
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 444443 2345899999999998765421 335678899999999999999999999999999999999
Q ss_pred EEEEeccCcccc
Q 001902 806 VSLTDFDLSCLT 817 (998)
Q Consensus 806 vkL~DFG~a~~~ 817 (998)
++|+|||++...
T Consensus 164 ~~liDfg~~~~~ 175 (198)
T cd05144 164 IYIIDWPQMVST 175 (198)
T ss_pred EEEEECCccccC
Confidence 999999998544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PF13426 PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_B 3P7N_B 1LL8_A 3MJQ_A 3BWL_A 4EET_B 4EEP_A | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.5e-15 Score=137.61 Aligned_cols=104 Identities=26% Similarity=0.564 Sum_probs=96.4
Q ss_pred CCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCCEEE
Q 001902 199 QQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFW 278 (998)
Q Consensus 199 ~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w 278 (998)
|+|++++|. +|+|+++|++|++++||+.++++|+++..++++.........+.+++..+..+..++.+++++|+.+|
T Consensus 1 p~~i~i~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~ 77 (104)
T PF13426_consen 1 PDGIFILDP---DGRILYVNPAFERLFGYSREELIGKSISDFFPEEDRPEFEEQIERALEEGGSWSGEVRLRRKDGETFW 77 (104)
T ss_dssp -SEEEEEET---TSBEEEE-HHHHHHHTS-HHHHTTSBGGGGCSTTSCHHHHHHHHHHHHHTSSEEEEEEEEETTSEEEE
T ss_pred CEEEEEECC---cCcEEehhHHHHHHHCcCHHHHcCCCcccccCcccchhhHHHHHHHHhcCCceeEEEEEEcCCCCEEE
Confidence 689999999 78899999999999999999999999998888888888889999999999999999999999999999
Q ss_pred EEeeeeEEeCCCCCEEEEEEEEecchh
Q 001902 279 NLLTIAPIKDDEGKVLKFIGMQVEVSK 305 (998)
Q Consensus 279 ~~~~~spi~d~~G~v~~~v~i~~DITe 305 (998)
+.++++|+.+++|++.+++++++||||
T Consensus 78 ~~~~~~~i~~~~g~~~~~i~~~~DiTe 104 (104)
T PF13426_consen 78 VEVSASPIRDEDGEITGIIGIFRDITE 104 (104)
T ss_dssp EEEEEEEEEETTSSEEEEEEEEEEEHH
T ss_pred EEEEEEEEECCCCCEEEEEEEEEECCC
Confidence 999999999999999999999999996
|
... |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.2e-17 Score=196.44 Aligned_cols=263 Identities=24% Similarity=0.358 Sum_probs=206.3
Q ss_pred CCcccccccCCCCceeEEEEEEcc-CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEeeCCeEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCG-SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~-~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~l 742 (998)
..|.+.+.||+|+|+.|-.+.... +...+|.|.+.... ........+..|..+-+.+. |.|++.+++.....+..++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 468888999999999999888743 34566777665432 23444455666788878886 9999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEEecCC-cEEEEeccCccccCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH-CQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCK 820 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~~IiHrDLkP~NILi~~~g-~vkL~DFG~a~~~~~~ 820 (998)
+++|..|+++++.+........+......++.|+..++.|+| ..++.|+|+||+|.+++..+ .+++.|||+|......
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999999883222225777888899999999999999 99999999999999999999 9999999999654321
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccC-CCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG-TEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
. .........+| ++.|+|||.+.+. ...+..|+||+|+++.-+++|..||....
T Consensus 179 ~------------------------g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 179 N------------------------GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred C------------------------CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 0 11122344567 9999999999884 45678999999999999999999997755
Q ss_pred hHHHH-HHHHhC--CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 899 RQKTF-ANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 899 ~~~~~-~~i~~~--~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
..... ...... ......+...+....+++.+++..+|..|.+ ++++..+||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s----~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 235 RKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLS----IEELKLDNWLSS 291 (601)
T ss_pred cccccceeecccccccccCccccCChhhhhcccccccCCchhccc----cccccccccccc
Confidence 43322 222222 1123444556778889999999999999999 999999999998
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.6e-15 Score=180.65 Aligned_cols=138 Identities=21% Similarity=0.224 Sum_probs=111.3
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeeccccc-----ChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-----NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~-----~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.|...+.||+|+||.||++.+... .+++|........ .......+.+|+.+++.++|++++.+..++......
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 456778999999999999987443 4444433221111 112345678899999999999999888777777778
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
++||||++|++|.+++. ....++.+++.+|.+||+.||+||||||+|||+ .++.++|+|||++..
T Consensus 412 ~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999885 346789999999999999999999999999999 578999999999854
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.1e-15 Score=153.14 Aligned_cols=138 Identities=20% Similarity=0.216 Sum_probs=99.8
Q ss_pred ccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHH---------------------HHHHHHHHHHhCCCCC--
Q 001902 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH---------------------RACAEREILDMLDHPF-- 726 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~---------------------~~~~E~~il~~l~h~n-- 726 (998)
.+.||+|+||.||+|.+. +++.||+|++............ ....|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999986 7999999998764322111111 1134666666664443
Q ss_pred ccceeEEEeeCCeEEEEEecCCCCchhH-HHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEecCC
Q 001902 727 VPALYASFQTKTHVCLITDYCPGGELFL-LLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNG 804 (998)
Q Consensus 727 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkP~NILi~~~g 804 (998)
+++++.+ ...++||||++++++.. .+.... . ...+..++.+++.++.++|. .||+|+||||+||+++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 4555543 23589999998854321 121110 1 16678899999999999999 9999999999999999 89
Q ss_pred cEEEEeccCcccc
Q 001902 805 HVSLTDFDLSCLT 817 (998)
Q Consensus 805 ~vkL~DFG~a~~~ 817 (998)
.++|+|||.+...
T Consensus 152 ~~~liDfg~a~~~ 164 (187)
T cd05119 152 KVYIIDVPQAVEI 164 (187)
T ss_pred cEEEEECcccccc
Confidence 9999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.9e-15 Score=169.07 Aligned_cols=199 Identities=24% Similarity=0.320 Sum_probs=152.8
Q ss_pred HHhCCCCCccceeEEEeeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCCc
Q 001902 719 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI-IYRDLKPEN 797 (998)
Q Consensus 719 l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~I-iHrDLkP~N 797 (998)
|+.+.|.|+.++++.+.+....++|.+||..|+|.+.+... ...++.-....++++|+.||.|||...| .|+.|+++|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 35688999999999999999999999999999999999874 3558888889999999999999998865 999999999
Q ss_pred EEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC-------
Q 001902 798 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG------- 870 (998)
Q Consensus 798 ILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~------- 870 (998)
.+++....+||.|||+........ .........-...|.|||.+....
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~-------------------------~~~~~~~~~~~~lw~aPellr~~~~~~~~~~ 134 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETA-------------------------EPEAHHPIRKALLWTAPELLRGALSQSLESA 134 (484)
T ss_pred ceeeeeEEEEechhhhcccccccc-------------------------cccccchhHHHHhccCHHHhccccccccccc
Confidence 999999999999999985542100 000111112456799999997641
Q ss_pred CCChhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHh-CCC-CCCCC---CCCcHHHHHHHHHccccCccCcCCC
Q 001902 871 HTSAVDWWALGILLYEMLYGYTPFRGKTR----QKTFANILH-KDL-KFPSS---TPTSLHAKQLMYRLLHRDPKSRLGS 941 (998)
Q Consensus 871 ~~~~sDIwSlG~il~eLltG~~Pf~~~~~----~~~~~~i~~-~~~-~~~~~---~~~s~~l~~Ll~~~L~~dP~~Rpt~ 941 (998)
.+.+.||||||+++||+++..-||..... .+.+..+.. +.. ..|.. .....++..++..||..+|..||++
T Consensus 135 ~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 135 LTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI 214 (484)
T ss_pred ccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence 35679999999999999999999976332 234444444 211 11111 1234468899999999999999995
Q ss_pred hh
Q 001902 942 HE 943 (998)
Q Consensus 942 ~~ 943 (998)
.+
T Consensus 215 ~~ 216 (484)
T KOG1023|consen 215 EQ 216 (484)
T ss_pred HH
Confidence 54
|
|
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.2e-15 Score=197.83 Aligned_cols=268 Identities=9% Similarity=-0.004 Sum_probs=201.4
Q ss_pred cccccccccccccccccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCC-CCcccCCCC
Q 001902 167 SVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRN-CRFLQGAGT 245 (998)
Q Consensus 167 ~~~~~~dit~~~~~e~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~-~~~l~~~~~ 245 (998)
.+....|||+++++|+++++++++++.+++..+++++.+|. +|+++++|+++++++||+.++..+.. +..+.++++
T Consensus 388 ~i~~~~DITerk~~e~~l~~~~~~~~~~~~~~~~~i~~~d~---~~~~~~~n~~~~~l~G~~~~~~~~~~~~~~~~~p~d 464 (1092)
T PRK09776 388 FIAQIEDINELKRTEQVNERLMERITLANEAGGIGIWEWDL---KPNIISWDKRMFELYEIPPHIKPTWQVWYACLHPED 464 (1092)
T ss_pred ehhhHHhhHHHHHHHHHHHHHHHHHHHHHHhcCceEEEEec---CCCeEeeCHHHHHHhCCCcccCCCHHHHHHhcCHhH
Confidence 34456899999999999999999999999999999999999 67799999999999999998854432 224456666
Q ss_pred ChHHHHHHHHHHHcCCcEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhcCCCCCchhhh
Q 001902 246 DPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLI 325 (998)
Q Consensus 246 ~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~~~~~L~~~l~ 325 (998)
.......+...+..+..+..+++.+++|| .+|+.....++.|.+|++.+++++.+|||++|+++++++...++
T Consensus 465 ~~~~~~~~~~~~~~~~~~~~e~r~~~~dG-~~w~~~~~~~~~d~~G~~~~~ig~~~DITerk~~e~~L~~~~~~------ 537 (1092)
T PRK09776 465 RQRVEKEIRDALQGRSPFKLEFRIVVKDG-VRHIRALANRVLNKDGEVERLLGINMDMTEVRQLNEALFQEKER------ 537 (1092)
T ss_pred HHHHHHHHHHHHhcCCCeeEEEEEEcCCc-eEEEEEeeEEEECCCCCEEEEEeeeeehhHHHHHHHHHHHHHHH------
Confidence 66667778888888889999999999999 99999999999999999999999999999999999886642111
Q ss_pred hHHHHHHHHhHhhHHHHHHHcc-CCCCccccCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCC--CCCCccccc-
Q 001902 326 RYDARQKEMATSSVTELVQAMK-KPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNS--YGGGCRTSM- 401 (998)
Q Consensus 326 ~~d~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~g~~~~~~~~~~~~~~--~~~~~~~~~- 401 (998)
+..+..... .....+..+.+.+.|..+...+||+.+|++|+...++++...... .........
T Consensus 538 -------------l~~~l~~~~~~i~~~D~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (1092)
T PRK09776 538 -------------LHITLDSIGEAVVCTDMAMKVTFMNPVAEKMTGWTQEEALGVPLLTVLHITFGDNGPLMENIYSCLT 604 (1092)
T ss_pred -------------HHHHHhccccEEEEECCCCeEEEEcHHHHHHhCCCHHHHcCCCHHHHcccccCCcchhhHHHHHHHh
Confidence 111222222 223445556777899999999999999999998877764321111 000000000
Q ss_pred ---ccccccchhhccccCCccccccccccccCCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhc
Q 001902 402 ---QRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRK 470 (998)
Q Consensus 402 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~di~er~~~e~e~r~ 470 (998)
......+.....++|...|+.....+..+.+|...+...+ .+||+++++.+++++.
T Consensus 605 ~~~~~~~~~~~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~-------------~~DITe~k~~e~~L~~ 663 (1092)
T PRK09776 605 SRSAAYLEQDVVLHCRSGGSYDVHYSITPLSTLDGENIGSVLV-------------IQDVTESRKMLRQLSY 663 (1092)
T ss_pred cCCCccccceEEEEeCCCcEEEEEEEeeeeecCCCCEEEEEEE-------------EEecchHHHHHHHHHh
Confidence 0112223344578999999999888888877776654444 6799999998888754
|
|
| >PF13426 PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_B 3P7N_B 1LL8_A 3MJQ_A 3BWL_A 4EET_B 4EEP_A | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.8e-14 Score=132.83 Aligned_cols=100 Identities=27% Similarity=0.434 Sum_probs=91.5
Q ss_pred CceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEE
Q 001902 482 EKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFW 561 (998)
Q Consensus 482 ~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rkdG~~~w 561 (998)
|+||+++|.+|. |+++|++|++++||+++|++|+++..+.+++......+.+.+.+.++..+..+..++++||+.+|
T Consensus 1 p~~i~i~d~~g~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~ 77 (104)
T PF13426_consen 1 PDGIFILDPDGR---ILYVNPAFERLFGYSREELIGKSISDFFPEEDRPEFEEQIERALEEGGSWSGEVRLRRKDGETFW 77 (104)
T ss_dssp -SEEEEEETTSB---EEEE-HHHHHHHTS-HHHHTTSBGGGGCSTTSCHHHHHHHHHHHHHTSSEEEEEEEEETTSEEEE
T ss_pred CEEEEEECCcCc---EEehhHHHHHHHCcCHHHHcCCCcccccCcccchhhHHHHHHHHhcCCceeEEEEEEcCCCCEEE
Confidence 689999999777 99999999999999999999999999999888888899999999999889999999999999999
Q ss_pred EEEEEeeeccCC----EEEEEEecCCc
Q 001902 562 NLFHLQPMRDQK----YFIGVQLDGSE 584 (998)
Q Consensus 562 v~~~~spi~d~~----~~vgi~rDITe 584 (998)
++++++|+.+++ +++++++||||
T Consensus 78 ~~~~~~~i~~~~g~~~~~i~~~~DiTe 104 (104)
T PF13426_consen 78 VEVSASPIRDEDGEITGIIGIFRDITE 104 (104)
T ss_dssp EEEEEEEEEETTSSEEEEEEEEEEEHH
T ss_pred EEEEEEEEECCCCCEEEEEEEEEECCC
Confidence 999999999865 89999999996
|
... |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.7e-14 Score=153.27 Aligned_cols=137 Identities=23% Similarity=0.351 Sum_probs=105.2
Q ss_pred cccC-CCCceeEEEEEEccCCeEEEEEEeecccc----------cChhHHHHHHHHHHHHHhCCCCCc--cceeEEEeeC
Q 001902 671 KPLG-SGDTGSVHLVELCGSGQYFAMKAMDKGVM----------LNRNKVHRACAEREILDMLDHPFV--PALYASFQTK 737 (998)
Q Consensus 671 ~~LG-~G~~g~Vy~a~~~~~~~~valK~i~~~~~----------~~~~~~~~~~~E~~il~~l~h~nI--v~l~~~~~~~ 737 (998)
..|| .||.|+||.+.. .+..++||.+..... .+........+|+.++..|.|++| +.++++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4567 889999999887 477899998864211 011234567789999999998775 6677664332
Q ss_pred -C---eEEEEEecCCC-CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEecc
Q 001902 738 -T---HVCLITDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 812 (998)
Q Consensus 738 -~---~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG 812 (998)
. ..++||||++| .+|.+++... .++... +.+|+.+|.+||++||+||||||.|||++.++.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 2 23599999997 6898888652 355543 5689999999999999999999999999999999999999
Q ss_pred Cccc
Q 001902 813 LSCL 816 (998)
Q Consensus 813 ~a~~ 816 (998)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8844
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.9e-14 Score=138.62 Aligned_cols=132 Identities=23% Similarity=0.245 Sum_probs=111.9
Q ss_pred cccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCC--CCccceeEEEeeCCeEEEEEec
Q 001902 669 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTKTHVCLITDY 746 (998)
Q Consensus 669 ~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h--~nIv~l~~~~~~~~~~~lV~E~ 746 (998)
+++.||.|.++.||++... +..+++|.+..... ...+..|+.+++.+.+ .++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4578999999999999984 37899999875422 3567889999999976 5899999988888899999999
Q ss_pred CCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 747 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ---GIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 747 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
++|..+..+ +......++.+++.+|++||.. +++|+|++|+||+++..+.++++|||.+..
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 988877654 4456677889999999999985 799999999999999989999999998854
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF08448 PAS_4: PAS fold; InterPro: IPR013656 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-13 Score=127.97 Aligned_cols=110 Identities=24% Similarity=0.365 Sum_probs=99.7
Q ss_pred HHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCC
Q 001902 195 LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDG 274 (998)
Q Consensus 195 ld~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG 274 (998)
|++++++++++|. +|+|+++|+++++++|++.++++|+++..++++.........+.+++.++.....+..... +|
T Consensus 1 l~~~p~~i~v~D~---~~~i~~~N~~~~~~~~~~~~~~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 76 (110)
T PF08448_consen 1 LDSSPDGIFVIDP---DGRIVYANQAAAELFGVSPEELIGRSLFDLLPPEDREEFQAALRRALAGGEPVFFEEILLR-DG 76 (110)
T ss_dssp HHHCSSEEEEEET---TSBEEEE-HHHHHHHTSTHHHHTTSBHHHHSCCGCHHHHHHHHHHHHHHTSEEEEEEEECT-TS
T ss_pred CCCCCceeEEECC---CCEEEEEHHHHHHHhCCCHHHHhhccchhccccchhhhhHHHHHHhhccCceEEEEEEEee-cC
Confidence 6899999999999 8889999999999999999999999999888888778888889999999888776666544 99
Q ss_pred CEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhH
Q 001902 275 TPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308 (998)
Q Consensus 275 ~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~ 308 (998)
...|+.++++|+.|.+|++.|++++++|||++|+
T Consensus 77 ~~~~~~~~~~Pi~~~~g~~~g~~~~~~DiT~~rr 110 (110)
T PF08448_consen 77 EERWFEVSISPIFDEDGEVVGVLVIIRDITERRR 110 (110)
T ss_dssp CEEEEEEEEEEEECTTTCEEEEEEEEEEECCHHH
T ss_pred CcEEEEEEEEEeEcCCCCEEEEEEEEEECchhhC
Confidence 9999999999999999999999999999999985
|
The PAS fold appears in archaea, eubacteria and eukarya. ; PDB: 3K3D_A 3K3C_B 3KX0_X 3FC7_B 3LUQ_D 3MXQ_A 3BWL_C 3FG8_A. |
| >PF00989 PAS: PAS fold; InterPro: IPR013767 PAS domains are involved in many signalling proteins where they are used as a signal sensor domain [] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.9e-13 Score=128.17 Aligned_cols=112 Identities=21% Similarity=0.369 Sum_probs=96.3
Q ss_pred HHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEE-EEE
Q 001902 189 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYC-GRL 267 (998)
Q Consensus 189 ~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~-~e~ 267 (998)
++|++++++++++++++|. +|+|+|+|++++++|||+.++++|+++..+++++........+.+.+..+.... .+.
T Consensus 1 e~~~~i~~~~~~~i~~~d~---~g~I~~~N~a~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (113)
T PF00989_consen 1 ERYRAILENSPDGIFVIDE---DGRILYVNQAAEELLGYSREELIGKSLFDLIHPEDRRELRERLRQALSQGESGESFEV 77 (113)
T ss_dssp HHHHHHHHCSSSEEEEEET---TSBEEEECHHHHHHHSS-HHHHTTSBGGGGCSGGGHHHHHHHHHHHHHHCCHECEEEE
T ss_pred CHHHHHHhcCCceEEEEeC---cCeEEEECHHHHHHHccCHHHHcCCcHHHhcCchhhHHHHHHHHHHHHcCCCceeEEE
Confidence 5789999999999999998 788999999999999999999999999988887665567778888887777644 344
Q ss_pred EEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecc
Q 001902 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303 (998)
Q Consensus 268 ~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DI 303 (998)
....++|..+|+.+..+|+.+.+|++.|++++++||
T Consensus 78 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~DI 113 (113)
T PF00989_consen 78 RFRLRDGRPRWVEVRASPVRDEDGQIIGILVIFRDI 113 (113)
T ss_dssp EEEETTSCEEEEEEEEEEEEETTEEEEEEEEEEEE-
T ss_pred EEEecCCcEEEEEEEEEEEEeCCCCEEEEEEEEEeC
Confidence 444579999999999999999999999999999997
|
PAS domains appear in archaea, bacteria and eukaryotes. Several PAS-domain proteins are known to detect their signal by way of an associated cofactor. Haeme, flavin, and a 4-hydroxycinnamyl chromophore are used in different proteins. The PAS domain was named after three proteins that it occurs in: Per- period circadian protein Arnt- Ah receptor nuclear translocator protein Sim- single-minded protein. PAS domains are often associated with PAC domains IPR001610 from INTERPRO. It appears that these domains are directly linked, and that together they form the conserved 3D PAS fold. The division between the PAS and PAC domains is caused by major differences in sequences in the region connecting these two motifs []. In human PAS kinase, this region has been shown to be very flexible, and adopts different conformations depending on the bound ligand []. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels [].; GO: 0006355 regulation of transcription, DNA-dependent; PDB: 2GJ3_A 4F3L_B 1XFN_A 1OTD_A 2PYR_A 1KOU_A 1XFQ_A 2ZOI_A 2ZOH_A 1OTA_A .... |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=5.5e-13 Score=155.43 Aligned_cols=188 Identities=21% Similarity=0.247 Sum_probs=119.7
Q ss_pred CCCchhhhccCCcccCCCCCCCCCCchhhHHhhhccccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeeccc
Q 001902 623 NLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV 702 (998)
Q Consensus 623 ~l~p~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~ 702 (998)
.+-|..+...-+++....|+.........+.+-+.....-....|. .+.||.|++|+||+|.. .+|+.||||+.+++.
T Consensus 76 dllp~~~~~~L~~Lqd~v~p~~~~~~~~~l~~elg~~~~~~F~~fd-~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i 153 (437)
T TIGR01982 76 DLLPADIAEELSLLQDRVPPFDFKVARKVIEAALGGPLEELFAEFE-EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGI 153 (437)
T ss_pred ccCCHHHHHHHHHHhcCCCCCCHHHHHHHHHHHhCcCHHHHHhhCC-CcceeeeehhheEEEEe-cCCCEEEEEeeCCCc
Confidence 3457777777777777776554322222222222211111122333 36799999999999997 479999999987652
Q ss_pred ccChh---------------------------H----H------HHHHHHHHHHHhC-----CCCCc--cceeEEEeeCC
Q 001902 703 MLNRN---------------------------K----V------HRACAEREILDML-----DHPFV--PALYASFQTKT 738 (998)
Q Consensus 703 ~~~~~---------------------------~----~------~~~~~E~~il~~l-----~h~nI--v~l~~~~~~~~ 738 (998)
...-. . . -.+.+|...+.++ ++++| ++++. ....
T Consensus 154 ~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~ 231 (437)
T TIGR01982 154 EKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYW--DRTS 231 (437)
T ss_pred HHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEeh--hhcC
Confidence 11100 0 0 0233455555444 23433 33332 2334
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHH-HHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV-ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~-aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
..+|||||++|++|.++....... . ....++..++. .+..+|..|++|+|+||.||+++.+|.++|+|||++..+
T Consensus 232 ~~vLvmE~i~G~~L~~~~~~~~~~-~---~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 232 ERVLTMEWIDGIPLSDIAALDEAG-L---DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CceEEEEeECCcccccHHHHHhcC-C---CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 568999999999998876532111 2 23445666665 478899999999999999999999999999999998665
Q ss_pred C
Q 001902 818 S 818 (998)
Q Consensus 818 ~ 818 (998)
+
T Consensus 308 ~ 308 (437)
T TIGR01982 308 S 308 (437)
T ss_pred C
Confidence 4
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK13557 histidine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.7e-12 Score=155.22 Aligned_cols=134 Identities=37% Similarity=0.726 Sum_probs=121.7
Q ss_pred ccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCC
Q 001902 182 KGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ 261 (998)
Q Consensus 182 ~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~ 261 (998)
+.....+..|+.+++.++++|+++|..+.+|+|+|+|++|++++||+.+|++|+++..+.+++........++..+..+.
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~i~v~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~ 102 (540)
T PRK13557 23 DVSDHRSDIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERR 102 (540)
T ss_pred hhhhhhhHHHHHHHHhCcCcEEEEcCCCCCCCEEEEcHHHHHHhCCCHHHhcCCChHhhcCCCCCHHHHHHHHHHHHcCC
Confidence 44556689999999999999999998777899999999999999999999999999988888777778888888899888
Q ss_pred cEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhc
Q 001902 262 SYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 315 (998)
Q Consensus 262 ~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~ 315 (998)
.+..+++.++++|+.+|+.+++.|+.+.+|.+.+++++.+|||+++++++++..
T Consensus 103 ~~~~~~~~~~~~G~~~~~~~~~~~i~~~~g~~~~~~~~~~dit~~~~~e~~l~~ 156 (540)
T PRK13557 103 EIATEILNYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSRRRDAEDALRQ 156 (540)
T ss_pred CceEEEEEEeCCCCEEEEEEEEEEeECCCCCEEEEEEEecChHHHHHHHHHHHH
Confidence 888888889999999999999999999999999999999999999999877543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.2e-13 Score=156.08 Aligned_cols=262 Identities=21% Similarity=0.208 Sum_probs=197.2
Q ss_pred ccCCcccccccCC--CCceeEEEEEE--ccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeC
Q 001902 663 NLQHFRPIKPLGS--GDTGSVHLVEL--CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK 737 (998)
Q Consensus 663 ~~~~y~~~~~LG~--G~~g~Vy~a~~--~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 737 (998)
....|.+...+|. |.+|.||.+.. ..++..+|+|.-+.-. ........-.+|......+ .|++.++.+..+...
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccC
Confidence 3456778889999 99999999998 8889999999743221 1122223334556555566 589999989999999
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCcEEEecC-CcEEEEecc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV----ALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFD 812 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~----aL~~LH~~~IiHrDLkP~NILi~~~-g~vkL~DFG 812 (998)
+..++-+|+| +.+|..+.... ...+++..++.+..+... ||..+|..+|+|-|+||.||++..+ ..++++|||
T Consensus 191 ~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 191 GILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred Ccceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 9999999999 68888776543 455899999999999999 9999999999999999999999999 889999999
Q ss_pred CccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCC
Q 001902 813 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT 892 (998)
Q Consensus 813 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~ 892 (998)
+...++...... -........|...|++||.+.+. ++...|||+||.++.+..+|..
T Consensus 269 ~v~~i~~~~~~~----------------------~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~ 325 (524)
T KOG0601|consen 269 LVSKISDGNFSS----------------------VFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSH 325 (524)
T ss_pred eeEEccCCcccc----------------------ceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcc
Confidence 987665333211 01111233578899999987554 6789999999999999988776
Q ss_pred CCCCC--ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 893 PFRGK--TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 893 Pf~~~--~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
+.... +....+..+ -++.......+..+...+..|++.+|-.|++ ++.+++|++....
T Consensus 326 ~~~~g~~~~W~~~r~~---~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~----~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 326 LPSVGKNSSWSQLRQG---YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLT----AQILTALNVIHSK 385 (524)
T ss_pred cccCCCCCCccccccc---cCchhhhcCcchhhhhHHHHhcCcchhhhhH----HHHHhccccccch
Confidence 66543 222222211 1222223345666777999999999999999 9999999998854
|
|
| >PRK11091 aerobic respiration control sensor protein ArcB; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=8.8e-13 Score=166.79 Aligned_cols=142 Identities=13% Similarity=0.120 Sum_probs=129.3
Q ss_pred cccccccccccccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHH
Q 001902 171 SGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDV 250 (998)
Q Consensus 171 ~~dit~~~~~e~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~ 250 (998)
..+|+++++++++++++++.++.++++++++|+++|. +|+|+++|++|++++||+.++++|+++..+++++......
T Consensus 137 ~~~i~~r~~~~~~l~~~~~~l~~il~~~~~~i~~~D~---~g~i~~~N~a~~~l~G~~~~eliG~~~~~l~~~~~~~~~~ 213 (779)
T PRK11091 137 KNEIKEREETQIELEQQSSLLRSFLDASPDLVYYRNE---DGEFSGCNRAMELLTGKSEKQLIGLTPKDVYSPEAAEKVI 213 (779)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhcCcceEEEECC---CCcEEeEcHHHHHHhCcCHHHHcCCChHHhCCHHHHHHHH
Confidence 4788999999999999999999999999999999998 7889999999999999999999999998888776655666
Q ss_pred HHHHHHHHcCCcEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhc
Q 001902 251 AKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 315 (998)
Q Consensus 251 ~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~ 315 (998)
......+..+..+..+.+..++||..+|+.++..|+.+.+|.+.|++++++|||++|+++++++.
T Consensus 214 ~~~~~~~~~~~~~~~e~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~e~~l~~ 278 (779)
T PRK11091 214 ETDEKVFRHNVSLTYEQWLDYPDGRKACFELRKVPFYDRVGKRHGLMGFGRDITERKRYQDALEK 278 (779)
T ss_pred HHHHHHHhcCCCeEEEEEEEcCCCCEEEEEEEeeeEEcCCCCEEEEEEEEeehhHHHHHHHHHHH
Confidence 66677778888888899999999999999999999999999999999999999999999988654
|
|
| >PF00989 PAS: PAS fold; InterPro: IPR013767 PAS domains are involved in many signalling proteins where they are used as a signal sensor domain [] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.6e-12 Score=121.70 Aligned_cols=106 Identities=22% Similarity=0.317 Sum_probs=91.2
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEE-EEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVT-VQLIN 552 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~-~e~~~ 552 (998)
|++++++++++++++|.+|+ |+++|++|+++|||+.++++|+++..+.++++.......+.+.+..+.... .+...
T Consensus 3 ~~~i~~~~~~~i~~~d~~g~---I~~~N~a~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (113)
T PF00989_consen 3 YRAILENSPDGIFVIDEDGR---ILYVNQAAEELLGYSREELIGKSLFDLIHPEDRRELRERLRQALSQGESGESFEVRF 79 (113)
T ss_dssp HHHHHHCSSSEEEEEETTSB---EEEECHHHHHHHSS-HHHHTTSBGGGGCSGGGHHHHHHHHHHHHHHCCHECEEEEEE
T ss_pred HHHHHhcCCceEEEEeCcCe---EEEECHHHHHHHccCHHHHcCCcHHHhcCchhhHHHHHHHHHHHHcCCCceeEEEEE
Confidence 78999999999999999888 999999999999999999999999988888766667788888887777643 44445
Q ss_pred EecCCcEEEEEEEEeeeccCC----EEEEEEecC
Q 001902 553 YTKSGKKFWNLFHLQPMRDQK----YFIGVQLDG 582 (998)
Q Consensus 553 ~rkdG~~~wv~~~~spi~d~~----~~vgi~rDI 582 (998)
..++|+.+|+.++.+|+.+.+ +++++++||
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~DI 113 (113)
T PF00989_consen 80 RLRDGRPRWVEVRASPVRDEDGQIIGILVIFRDI 113 (113)
T ss_dssp EETTSCEEEEEEEEEEEEETTEEEEEEEEEEEE-
T ss_pred EecCCcEEEEEEEEEEEEeCCCCEEEEEEEEEeC
Confidence 557999999999999999887 889999997
|
PAS domains appear in archaea, bacteria and eukaryotes. Several PAS-domain proteins are known to detect their signal by way of an associated cofactor. Haeme, flavin, and a 4-hydroxycinnamyl chromophore are used in different proteins. The PAS domain was named after three proteins that it occurs in: Per- period circadian protein Arnt- Ah receptor nuclear translocator protein Sim- single-minded protein. PAS domains are often associated with PAC domains IPR001610 from INTERPRO. It appears that these domains are directly linked, and that together they form the conserved 3D PAS fold. The division between the PAS and PAC domains is caused by major differences in sequences in the region connecting these two motifs []. In human PAS kinase, this region has been shown to be very flexible, and adopts different conformations depending on the bound ligand []. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels [].; GO: 0006355 regulation of transcription, DNA-dependent; PDB: 2GJ3_A 4F3L_B 1XFN_A 1OTD_A 2PYR_A 1KOU_A 1XFQ_A 2ZOI_A 2ZOH_A 1OTA_A .... |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.9e-13 Score=160.81 Aligned_cols=187 Identities=17% Similarity=0.206 Sum_probs=115.6
Q ss_pred CCchhhhccCCcccCCCCCCCCCCchhhHHhhhccccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccc
Q 001902 624 LTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM 703 (998)
Q Consensus 624 l~p~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~ 703 (998)
+-|..+...-+++....|+.........+.+-+.....-....|.. +.||+|++|+||+|..+.+|+.||||+.+++..
T Consensus 79 llP~~~~~eL~~Lqd~vpp~~~~~~~~~ie~elG~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~ 157 (537)
T PRK04750 79 LFPPDIADELALLQDRVPPFDGALARAIIEKALGGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDIL 157 (537)
T ss_pred cCCHHHHHHHHHHHcCCCCCCHHHHHHHHHHHhCCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchH
Confidence 4577777777777777665543222222222222221112356777 899999999999999988899999999986521
Q ss_pred cC---------------------------h----hHHHHH------HHHHHHHHhC----CCCCccceeEEEe-eCCeEE
Q 001902 704 LN---------------------------R----NKVHRA------CAEREILDML----DHPFVPALYASFQ-TKTHVC 741 (998)
Q Consensus 704 ~~---------------------------~----~~~~~~------~~E~~il~~l----~h~nIv~l~~~~~-~~~~~~ 741 (998)
.. . +..+.+ .+|...+.++ .+...+.+-.+|. .....+
T Consensus 158 ~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~V 237 (537)
T PRK04750 158 PVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETV 237 (537)
T ss_pred HHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCce
Confidence 10 0 111122 2333333333 2333333333332 245578
Q ss_pred EEEecCCCCchhHHH--hhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC----cEEEEeccC
Q 001902 742 LITDYCPGGELFLLL--DRQPT--KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG----HVSLTDFDL 813 (998)
Q Consensus 742 lV~E~~~ggsL~~~l--~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g----~vkL~DFG~ 813 (998)
|||||++|+++.++. ...+. ..+....+..++.| ++..|++|+|+||.||+++.+| .++++|||+
T Consensus 238 LvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGi 310 (537)
T PRK04750 238 MVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGI 310 (537)
T ss_pred EEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecce
Confidence 999999999998753 22210 02333334444444 4468999999999999999888 999999999
Q ss_pred ccccC
Q 001902 814 SCLTS 818 (998)
Q Consensus 814 a~~~~ 818 (998)
+...+
T Consensus 311 vg~l~ 315 (537)
T PRK04750 311 VGSLN 315 (537)
T ss_pred EEECC
Confidence 86654
|
|
| >PRK13559 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=7e-12 Score=143.81 Aligned_cols=128 Identities=40% Similarity=0.755 Sum_probs=114.5
Q ss_pred chHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEE
Q 001902 186 RVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG 265 (998)
Q Consensus 186 ~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 265 (998)
.+.+.|+.+++.++++|+++|..+.+|+|+++|++|++++||+.+|++|+++..+.++.........+...+..+..+..
T Consensus 40 ~~~~~~~~~~e~~~~~i~i~D~~~~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (361)
T PRK13559 40 ASGRLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVAKIRAAIAAEREIVV 119 (361)
T ss_pred hhhhHHHHHHHhCCCcEEEecCCCCCCcEEEEchHHHHHhCCCHHHHcCCChhhhcCCCCCHHHHHHHHHHhccCCceEE
Confidence 55678999999999999999986667889999999999999999999999988777766666667778888888888888
Q ss_pred EEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHh
Q 001902 266 RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDK 313 (998)
Q Consensus 266 e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l 313 (998)
+...+++||..+|+.++..|+++.+|.+.+++++++|||++|+++++.
T Consensus 120 e~~~~~~dG~~~~~~~~~~~i~d~~G~~~~~v~~~~DITerk~~e~~~ 167 (361)
T PRK13559 120 ELLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVTDIRAVRALE 167 (361)
T ss_pred EEEEEcCCCCEEEEEEEEEEEEcCCCCEEEeeeeeeehhcchhhHHHH
Confidence 999999999999999999999999999999999999999999887553
|
|
| >PF08448 PAS_4: PAS fold; InterPro: IPR013656 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.6e-12 Score=121.13 Aligned_cols=106 Identities=24% Similarity=0.309 Sum_probs=94.6
Q ss_pred HhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCC
Q 001902 478 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSG 557 (998)
Q Consensus 478 ~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rkdG 557 (998)
|++++++|+++|.+|+ |+++|+++++++|++.++++|+++..+.++.........+.+++.++.....+..... +|
T Consensus 1 l~~~p~~i~v~D~~~~---i~~~N~~~~~~~~~~~~~~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 76 (110)
T PF08448_consen 1 LDSSPDGIFVIDPDGR---IVYANQAAAELFGVSPEELIGRSLFDLLPPEDREEFQAALRRALAGGEPVFFEEILLR-DG 76 (110)
T ss_dssp HHHCSSEEEEEETTSB---EEEE-HHHHHHHTSTHHHHTTSBHHHHSCCGCHHHHHHHHHHHHHHTSEEEEEEEECT-TS
T ss_pred CCCCCceeEEECCCCE---EEEEHHHHHHHhCCCHHHHhhccchhccccchhhhhHHHHHHhhccCceEEEEEEEee-cC
Confidence 6899999999999777 9999999999999999999999998888888888888889999999888776666655 99
Q ss_pred cEEEEEEEEeeeccCC----EEEEEEecCCcccc
Q 001902 558 KKFWNLFHLQPMRDQK----YFIGVQLDGSEHLE 587 (998)
Q Consensus 558 ~~~wv~~~~spi~d~~----~~vgi~rDITerk~ 587 (998)
..+|+.++++|+.+.. +++++++|||++|+
T Consensus 77 ~~~~~~~~~~Pi~~~~g~~~g~~~~~~DiT~~rr 110 (110)
T PF08448_consen 77 EERWFEVSISPIFDEDGEVVGVLVIIRDITERRR 110 (110)
T ss_dssp CEEEEEEEEEEEECTTTCEEEEEEEEEEECCHHH
T ss_pred CcEEEEEEEEEeEcCCCCEEEEEEEEEECchhhC
Confidence 9999999999998765 89999999999984
|
The PAS fold appears in archaea, eubacteria and eukarya. ; PDB: 3K3D_A 3K3C_B 3KX0_X 3FC7_B 3LUQ_D 3MXQ_A 3BWL_C 3FG8_A. |
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=99.36 E-value=2e-12 Score=152.46 Aligned_cols=214 Identities=13% Similarity=0.037 Sum_probs=145.6
Q ss_pred CccccCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCC---cccccccccccchhhccccCCcccccccccc
Q 001902 351 SLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGG---CRTSMQRISEVPEKKKQKSGRRSFMGLIGRK 427 (998)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~e~~g~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (998)
-++..+.+.++|..+...+||+.+|++|++..+++++..+...... ....+....+++..+..++|...|+.+...+
T Consensus 11 ~~d~~g~i~~~n~~~~~~~g~~~~el~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~~ 90 (442)
T TIGR02040 11 LLDAEGVVREVAANPHHPSFEQLSEWEGRRWEEIVTAESVEKFELRLSEALRTGRGAVRVELNHIDPSSFELPMRFILVR 90 (442)
T ss_pred EECCCCcEEEEEECCCcccccccccCCCCcHhHhhCcchHHHHHHHHHHHhccCCCcceEeeccCCCCCCccCeEEEEEE
Confidence 3455677888999999999999999999999999976432221111 1111111223344455677777777776544
Q ss_pred ccCCCCCCCccccccccCCCCCCCCCCCCCchhhHHH-----------HH---hhhcc-ccHHHHHhhcCceEEEEcC-C
Q 001902 428 SQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVR-----------QK---EMRKG-IDLATTLERIEKNFVITDP-R 491 (998)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~di~er~~~-----------e~---e~r~~-~~l~~i~e~~~d~i~i~D~-~ 491 (998)
..+..+. -...+|+++++.. |+ ++++. ..|+.++++++++|+++|. +
T Consensus 91 ~~~~~~~-----------------~~i~rDi~~~~~~~~~l~~~~~~~e~~~~~l~~~e~r~~~l~e~~~~~i~~~d~~~ 153 (442)
T TIGR02040 91 LGADRGV-----------------LALGRDLRAVAELQQQLVAAQQAMERDYWTLREMETRYRVVLEVSSDAVLLVDMST 153 (442)
T ss_pred eCCCCeE-----------------EEEecccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCCceEEEEECCC
Confidence 3332111 1225677654433 22 22221 2488999999999999997 6
Q ss_pred CCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEeeecc
Q 001902 492 LPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRD 571 (998)
Q Consensus 492 G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rkdG~~~wv~~~~spi~d 571 (998)
|. |+++|++|++|+||+.+|++|+++..+.++++.......+......+.....++. .++|...| .+.++++..
T Consensus 154 g~---i~~~N~a~~~l~G~~~~el~g~~~~~~~~~~~~~~~~~~l~~~~~~g~~~~~~~~--~~~~~~~~-~~~~~~~~~ 227 (442)
T TIGR02040 154 GR---IVEANSAAAALLGGVGQSLVGRAFPQEFEGRRREELMLTLRNVRATGSAAPVRIL--LRRSQKRL-LVVVSVFRQ 227 (442)
T ss_pred CE---EEEEcHHHHHHhCcCHHHHcCCCHHHhCCHHHHHHHHHHHHHHHhcCCCcceEEE--EcCCCeEE-EEEEEEEEe
Confidence 77 9999999999999999999999988888887777677777777777765544444 34444444 445667765
Q ss_pred CC--EEEEEEecCCcccc
Q 001902 572 QK--YFIGVQLDGSEHLE 587 (998)
Q Consensus 572 ~~--~~vgi~rDITerk~ 587 (998)
++ .+++.++|||++++
T Consensus 228 ~~~~~~l~~~~dit~~~~ 245 (442)
T TIGR02040 228 DGESLFLCQLSPAGATQP 245 (442)
T ss_pred CCceEEEEEEcccchhhh
Confidence 54 78888999999975
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >PRK13559 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-11 Score=141.10 Aligned_cols=114 Identities=46% Similarity=0.874 Sum_probs=101.8
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~ 553 (998)
|+.++++++++|+++|.+|.++.|+++|++|++++||+.+|++|+++..+.++.........+...+..+..+..+...+
T Consensus 45 ~~~~~e~~~~~i~i~D~~~~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 124 (361)
T PRK13559 45 FEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVAKIRAAIAAEREIVVELLNY 124 (361)
T ss_pred HHHHHHhCCCcEEEecCCCCCCcEEEEchHHHHHhCCCHHHHcCCChhhhcCCCCCHHHHHHHHHHhccCCceEEEEEEE
Confidence 68899999999999998655566999999999999999999999998877777777777777888888888888899999
Q ss_pred ecCCcEEEEEEEEeeeccCC----EEEEEEecCCcccc
Q 001902 554 TKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLE 587 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~ 587 (998)
++||+.+|+.++..|+++.+ +++++++|||++|+
T Consensus 125 ~~dG~~~~~~~~~~~i~d~~G~~~~~v~~~~DITerk~ 162 (361)
T PRK13559 125 RKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVTDIRA 162 (361)
T ss_pred cCCCCEEEEEEEEEEEEcCCCCEEEeeeeeeehhcchh
Confidence 99999999999999998776 78899999999996
|
|
| >PRK11091 aerobic respiration control sensor protein ArcB; Provisional | Back alignment and domain information |
|---|
Probab=99.31 E-value=8.4e-12 Score=157.92 Aligned_cols=155 Identities=12% Similarity=0.105 Sum_probs=125.8
Q ss_pred CCCchhhHHHHHhhhccc-cHHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHH
Q 001902 455 RPDSVDDKVRQKEMRKGI-DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATV 533 (998)
Q Consensus 455 ~~di~er~~~e~e~r~~~-~l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~ 533 (998)
..++.+|++.+++++... .|+.++++++++|+++|.+|+ |+++|++|++++||+.+|++|+++..+.+++......
T Consensus 137 ~~~i~~r~~~~~~l~~~~~~l~~il~~~~~~i~~~D~~g~---i~~~N~a~~~l~G~~~~eliG~~~~~l~~~~~~~~~~ 213 (779)
T PRK11091 137 KNEIKEREETQIELEQQSSLLRSFLDASPDLVYYRNEDGE---FSGCNRAMELLTGKSEKQLIGLTPKDVYSPEAAEKVI 213 (779)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhcCcceEEEECCCCc---EEeEcHHHHHHhCcCHHHHcCCChHHhCCHHHHHHHH
Confidence 346677776666665433 488999999999999999877 9999999999999999999999988888887766676
Q ss_pred HHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEeeeccCC----EEEEEEecCCccccccccCcchhhhhHHHHHHHHhh
Q 001902 534 RKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTA 609 (998)
Q Consensus 534 ~~i~~~l~~g~~~~~e~~~~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~~~~~~~~e~~~~~~~~~~k~~~ 609 (998)
......+..+..+..+.+..++||..+|+.++..|+.+.+ +++++++|||++|+ .++.+++.++....+.
T Consensus 214 ~~~~~~~~~~~~~~~e~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~------~e~~l~~a~~~~~~~~ 287 (779)
T PRK11091 214 ETDEKVFRHNVSLTYEQWLDYPDGRKACFELRKVPFYDRVGKRHGLMGFGRDITERKR------YQDALEKASRDKTTFI 287 (779)
T ss_pred HHHHHHHhcCCCeEEEEEEEcCCCCEEEEEEEeeeEEcCCCCEEEEEEEEeehhHHHH------HHHHHHHHHHHHHHHH
Confidence 7777788888888999999999999999999999998765 88999999999996 3334444444455666
Q ss_pred hhhhhhhcc
Q 001902 610 ENVNEAVKE 618 (998)
Q Consensus 610 ~~v~e~~~e 618 (998)
.++.+.++.
T Consensus 288 a~isHelrt 296 (779)
T PRK11091 288 STISHELRT 296 (779)
T ss_pred HHhhHhhcC
Confidence 666666554
|
|
| >PRK13557 histidine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.30 E-value=1e-11 Score=150.10 Aligned_cols=115 Identities=45% Similarity=0.882 Sum_probs=104.5
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~ 553 (998)
|+.++++++++|+++|.++.+++|+|+|++|++++||+.+|++|+++..+.+|+........++..+..+..+..+.+.+
T Consensus 32 ~~~~~~~~~~~i~v~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (540)
T PRK13557 32 FFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERREIATEILNY 111 (540)
T ss_pred HHHHHHhCcCcEEEEcCCCCCCCEEEEcHHHHHHhCCCHHHhcCCChHhhcCCCCCHHHHHHHHHHHHcCCCceEEEEEE
Confidence 89999999999999997555666999999999999999999999999888888888888888899998888888899999
Q ss_pred ecCCcEEEEEEEEeeeccCC----EEEEEEecCCccccc
Q 001902 554 TKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEP 588 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~~ 588 (998)
++||+.+|+.+++.|+.+.+ +++++.+|||++++.
T Consensus 112 ~~~G~~~~~~~~~~~i~~~~g~~~~~~~~~~dit~~~~~ 150 (540)
T PRK13557 112 RKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSRRRDA 150 (540)
T ss_pred eCCCCEEEEEEEEEEeECCCCCEEEEEEEecChHHHHHH
Confidence 99999999999999999875 788999999999863
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.1e-12 Score=134.14 Aligned_cols=211 Identities=21% Similarity=0.259 Sum_probs=148.1
Q ss_pred HHHhCCCCCccceeEEEeeC-----CeEEEEEecCCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC--Cc
Q 001902 718 ILDMLDHPFVPALYASFQTK-----THVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQ--GI 788 (998)
Q Consensus 718 il~~l~h~nIv~l~~~~~~~-----~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~--~I 788 (998)
-|-++.|.|+|+++.|+.+. ..+.++.|||..|+|..+|++. -...+.....++|+.||+.||.|||+. -|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 34556799999999988644 4588999999999999999853 234588889999999999999999998 59
Q ss_pred eeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC
Q 001902 789 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG 868 (998)
Q Consensus 789 iHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 868 (998)
+|+++..+-|++..+|-+|++--.-... .+..... .........+-++|.+||.=..
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~---h~s~~~~--------------------~~~Ek~~~~~~~g~~a~~sg~~ 256 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDST---HPSVNST--------------------REAEKSVNTSLPGFSAPESGTT 256 (458)
T ss_pred ccCCcchhheeecCCceEEecccCcccc---chhhhhh--------------------hHhhhhccccCCccccCCcCcc
Confidence 9999999999999998888753322211 1110000 0011223356789999997555
Q ss_pred CCCCChhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 869 AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ-KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 869 ~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
...+.++|||+||....+|..|..--...... ..-..+..-.+.+. .. --.+++.+||.-.|..||+ ++.
T Consensus 257 tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le--n~---lqr~~i~kcl~~eP~~rp~----ar~ 327 (458)
T KOG1266|consen 257 TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE--NG---LQRGSITKCLEGEPNGRPD----ARL 327 (458)
T ss_pred cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc--Cc---cccCcCcccccCCCCCCcc----hhh
Confidence 56667999999999999999876543222211 11111211111111 11 1246899999999999999 999
Q ss_pred HHcCCCccCCChh
Q 001902 948 IKKHPFFKGVNWA 960 (998)
Q Consensus 948 lL~Hp~f~~~~~~ 960 (998)
+|-||-+-.+.-.
T Consensus 328 llfHpllfeVhsl 340 (458)
T KOG1266|consen 328 LLFHPLLFEVHSL 340 (458)
T ss_pred hhcCceeeecchH
Confidence 9999998886543
|
|
| >PRK10060 RNase II stability modulator; Provisional | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.6e-11 Score=151.73 Aligned_cols=158 Identities=14% Similarity=0.173 Sum_probs=124.2
Q ss_pred ccccccccccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCccc-CCCCChHHHHH
Q 001902 174 MSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQ-GAGTDPEDVAK 252 (998)
Q Consensus 174 it~~~~~e~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~-~~~~~~~~~~~ 252 (998)
+++.....+.+......++.+++.++++|+++|. +|+|+++|++|++++||+.+|++|+++..++ ++.........
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~v~~~~~~gI~i~D~---~g~I~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~ 172 (663)
T PRK10060 96 WHDTPSVARDLSHGLSFAEQVVSEANSVIVILDS---RGNIQRFNRLCEEYTGLKEHDVIGQSVFKLFMSRREAAASRRN 172 (663)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhCCceEEEEeC---CCCEEEEcHHHHHHHCcCHHHHcCCCHHHHhCChhhHHHHHHH
Confidence 3344444555667778889999999999999999 7779999999999999999999999986444 44444555667
Q ss_pred HHHHHHcCCcEEEEEEEEecCCCEEEEEeeeeEEeCCCC-CEEEEEEEEecchhhhHHHHHhhcCCCCCchhhhhHHHHH
Q 001902 253 IRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEG-KVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQ 331 (998)
Q Consensus 253 i~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~spi~d~~G-~v~~~v~i~~DITerk~~E~~l~~~~~~L~~~l~~~d~~~ 331 (998)
+...+..+..+.++.+.++++|..+|+..... +.+..| ...+++++.+|||++++++++++. ++.+|.++
T Consensus 173 ~~~~~~~~~~~~~e~~~~~~~G~~~~~~~~~~-~~~~~g~~~~~~i~~~~DITe~k~~e~~l~~--------~a~~D~LT 243 (663)
T PRK10060 173 IRGFFRSGNAYEVERWIKTRKGQRLFLFRNKF-VHSGSGKNEIFLICSGTDITEERRAQERLRI--------LANTDSIT 243 (663)
T ss_pred HHHHHhcCCceEEEEEEEeCCCCEEEEEeeeE-EEcCCCCceEEEEEEEEechHHHHHHHHHHH--------HhhcCccC
Confidence 77778888889999999999999998866544 444444 456788999999999999988664 56677777
Q ss_pred HHHhHhhHHHHH
Q 001902 332 KEMATSSVTELV 343 (998)
Q Consensus 332 ~~~~~~~~~~~~ 343 (998)
...++..+.+..
T Consensus 244 GL~NR~~f~~~l 255 (663)
T PRK10060 244 GLPNRNAIQELI 255 (663)
T ss_pred CCcCHHHHHHHH
Confidence 777777777643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.5e-11 Score=136.91 Aligned_cols=237 Identities=17% Similarity=0.173 Sum_probs=156.2
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
.|.+ ...+-++.+..-.+.-+.++.+|.+..++... ........+-++-|+.++||||++++..+..++.+|||+|
T Consensus 14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTE 89 (690)
T KOG1243|consen 14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTE 89 (690)
T ss_pred Cccc-ccccCCCcccccccceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEee
Confidence 3555 33333333322234556778899998887542 2344566777888999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH-CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
.+ ..|..+++. ++...+.--+.||+.||.||| +++++|++|.-+.|+|+..|..||++|.++........
T Consensus 90 rV--~Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-- 160 (690)
T KOG1243|consen 90 RV--RPLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-- 160 (690)
T ss_pred cc--ccHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--
Confidence 98 557777766 346666777899999999998 56899999999999999999999999998744321110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
......---.|..|+.+.... -..|.|-|||++++++.|..+ .......
T Consensus 161 -------------------------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~~--~~~~~~~-- 209 (690)
T KOG1243|consen 161 -------------------------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSLL--TKTDLSN-- 209 (690)
T ss_pred -------------------------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcccC--cchhhhc--
Confidence 001111122355665443322 346999999999999998332 2211100
Q ss_pred HHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc-CCCccCC
Q 001902 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK-HPFFKGV 957 (998)
Q Consensus 905 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~-Hp~f~~~ 957 (998)
+ ..++.....+..+-+.-.+..||.....+..++. |+||+.-
T Consensus 210 ---------~--~~ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~~~~~gff~n~ 252 (690)
T KOG1243|consen 210 ---------T--GKIPKALIELYCKKLGATELKRPNKLRFILECRLLGGFFRND 252 (690)
T ss_pred ---------c--CccchhHHHHHHHHhccccccccchhhHHHHHHhccccccch
Confidence 0 0112223334444455566677763334444444 8898874
|
|
| >PRK13558 bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=5e-11 Score=148.15 Aligned_cols=128 Identities=39% Similarity=0.742 Sum_probs=115.0
Q ss_pred HHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEE
Q 001902 189 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLL 268 (998)
Q Consensus 189 ~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 268 (998)
+.++.+++.+++++++.|..+.+|+|+|+|+++++++||+.++++|+++..+.++.........+...+..+..+..+++
T Consensus 148 r~~~~~~~~~~~gi~~~d~~~~dg~i~~~N~~~~~l~G~~~eel~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 227 (665)
T PRK13558 148 RLKERALDEAPVGITIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERPTSVELR 227 (665)
T ss_pred HHHHHHHhcCCccEEEEcCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHHHhcCCCccHHHHHHHHHHHhcCCCeEEEEE
Confidence 45678999999999999865668889999999999999999999999988887777666667778888888888899999
Q ss_pred EEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhcC
Q 001902 269 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLR 316 (998)
Q Consensus 269 ~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~~ 316 (998)
.+++||..+|+.++..|+.+.+|.+.+++++++|||++|++|++++..
T Consensus 228 ~~~~dG~~~~~~~~~~pi~d~~G~~~~~vgi~~DITerk~~E~~L~~~ 275 (665)
T PRK13558 228 NYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKEAELALQRE 275 (665)
T ss_pred EECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeCcHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999999987653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.1e-11 Score=122.01 Aligned_cols=139 Identities=15% Similarity=0.123 Sum_probs=101.5
Q ss_pred ccccCCCCceeEEEEEEcc------CCeEEEEEEeeccccc-------------------ChhHHHHHH----HHHHHHH
Q 001902 670 IKPLGSGDTGSVHLVELCG------SGQYFAMKAMDKGVML-------------------NRNKVHRAC----AEREILD 720 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~~------~~~~valK~i~~~~~~-------------------~~~~~~~~~----~E~~il~ 720 (998)
...||.|--+.||.|.... .+..+|+|+++..... ..+....+. .|...|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998643 3579999988742110 011223333 7899999
Q ss_pred hCCC--CCccceeEEEeeCCeEEEEEecCCCCchhH-HHhhCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCC
Q 001902 721 MLDH--PFVPALYASFQTKTHVCLITDYCPGGELFL-LLDRQPTKVLKEDAVRFYAAEVVVALEYL-HCQGIIYRDLKPE 796 (998)
Q Consensus 721 ~l~h--~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~~l~~~~~~~i~~qil~aL~~L-H~~~IiHrDLkP~ 796 (998)
++.. -+++.++.+ ..-+|||||+.++.+.. .++. ..++...+..+..+++.+|..| |+.||||+||+|.
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 9854 566777754 44579999996654422 2322 2355667778889999999999 8999999999999
Q ss_pred cEEEecCCcEEEEeccCccc
Q 001902 797 NVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 797 NILi~~~g~vkL~DFG~a~~ 816 (998)
|||++ ++.+.|+|||.+..
T Consensus 155 NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred HEEEE-CCcEEEEECCCcee
Confidence 99997 57899999998854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.1e-11 Score=123.74 Aligned_cols=127 Identities=24% Similarity=0.305 Sum_probs=95.9
Q ss_pred ccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCc-cceeEEEeeCCeEEEEEecCC
Q 001902 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV-PALYASFQTKTHVCLITDYCP 748 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~lV~E~~~ 748 (998)
++.|+.|.++.||++.. .+..|++|+...... ....+..|..+++.+.+.++ ++++.+.. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 46789999999999987 478899998765421 12245678889988865444 45555433 33579999999
Q ss_pred CCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 749 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI-----IYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 749 ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~I-----iHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
|.++.... .. ...++.+++++|+.||..++ +|+|++|+||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~~-------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTED-------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCcccccc-------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 98876430 11 13456799999999999985 9999999999999 6789999999884
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.3e-11 Score=117.69 Aligned_cols=145 Identities=19% Similarity=0.198 Sum_probs=113.4
Q ss_pred cccccCCCCceeEEEEEEccCCeEEEEEEee-----cccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 669 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMD-----KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 669 ~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~-----~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.+..|-+|+-+.|+++.+ .|+.+.||.=. .......-...+..+|+++|.++.--.|.-..-+|.+...-+|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567788999999999987 78888888432 22223334466788899999999766666555567777777899
Q ss_pred EecCCC-CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC---cEEEEeccCcc
Q 001902 744 TDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSC 815 (998)
Q Consensus 744 ~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g---~vkL~DFG~a~ 815 (998)
|||++| .++.+++...-...........++..|-+.+.-||.++|||+||..+||++.++| .+.|+|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 999977 4788888765444455555588999999999999999999999999999998765 35899999984
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=9e-12 Score=143.02 Aligned_cols=254 Identities=21% Similarity=0.267 Sum_probs=186.7
Q ss_pred cccccCCcccccccCCCCceeEEEEEEc-cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeC
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELC-GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK 737 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 737 (998)
......+|..+..||.|.|+.|+.+.-. .++..|++|.+.........+... ..|..+...+ -|.+++..+..+...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCcccc
Confidence 3455788999999999999999998865 678999999988776555444333 3455555555 688999988888888
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC-CcEEEEeccCccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCL 816 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~-g~vkL~DFG~a~~ 816 (998)
...||--|||+++++...... ...+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..+++|||.+..
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred ccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence 888899999999987655532 2347788889999999999999999999999999999999976 7889999998743
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcc--cchhhcCCCCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYI--APEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
+.... ....+...++ ++.......+..+.|++|||..+++.++|.+.-
T Consensus 417 ~~~~~------------------------------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls 466 (524)
T KOG0601|consen 417 LAFSS------------------------------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS 466 (524)
T ss_pred cceec------------------------------ccccccccccccchhhccccccccccccccccccccccccCcccC
Confidence 21111 1112333444 444445567888999999999999999987654
Q ss_pred CCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 895 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 895 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
....... .|..+.. +........++.+.+.++..++..|+. +.++..|.=|-
T Consensus 467 ~~~~~~~---~i~~~~~--p~~~~~~~~~q~~~kv~~~~~~~~~~l----~~~l~~~~~~~ 518 (524)
T KOG0601|consen 467 ESGVQSL---TIRSGDT--PNLPGLKLQLQVLLKVMINPDRKRRPS----AVELSLHSEFY 518 (524)
T ss_pred cccccce---eeecccc--cCCCchHHhhhhhhhhhcCCccccchh----hhhhcccchhh
Confidence 4333211 2223322 222223467888999999999999999 77777776543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.6e-10 Score=114.60 Aligned_cols=134 Identities=21% Similarity=0.210 Sum_probs=103.8
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccC-----hhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-----RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~-----~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
..+++|+-+.+|.+.. -|..+++|.=.+..+-. .-...+..+|..++.++.--.|....=++.+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4578999999999966 45567787544332222 2224566789999999977677666666667777789999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
|++|..|.+++... .-.++..+-.-+.-||..||||+||.++||++..++ +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888663 145677888889999999999999999999999654 89999999843
|
|
| >TIGR00229 sensory_box PAS domain S-box | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.7e-10 Score=100.93 Aligned_cols=121 Identities=20% Similarity=0.406 Sum_probs=98.0
Q ss_pred HHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcC-CcEEEE
Q 001902 188 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNG-QSYCGR 266 (998)
Q Consensus 188 ~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g-~~~~~e 266 (998)
++.++.+++.++++++++|. +|+|+++|+++++++|++.++++|+++..+.++.........+...+..+ .....+
T Consensus 2 ~~~~~~~~~~~~~~~~~~d~---~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (124)
T TIGR00229 2 EERYRAIFESSPDAIIVIDL---EGNILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERLLEGEREPVSEE 78 (124)
T ss_pred chHHHHHHhhCCceEEEEcC---CCcEEEEchHHHHHhCCChHHhcCcchhhhcChhhhHHHHHHHHHHHcCCCCCcceE
Confidence 35778899999999999998 77799999999999999999999999887666655555555555555533 223445
Q ss_pred EEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHH
Q 001902 267 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKD 312 (998)
Q Consensus 267 ~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~ 312 (998)
.....++|..+|+.....|+. .+|...++++++.|||++++++++
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dit~~~~~~~~ 123 (124)
T TIGR00229 79 RRVRRKDGSEIWVEVSVSPIR-TNGGELGVVGIVRDITERKQAEEA 123 (124)
T ss_pred eeeEcCCCCEEEEEEEEeehh-hCCCeeEEEEEeeehhHHHHHHhc
Confidence 555688999999999999998 778899999999999999988764
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. |
| >PRK13558 bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.5e-10 Score=139.63 Aligned_cols=114 Identities=41% Similarity=0.791 Sum_probs=100.6
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~ 553 (998)
++.+++.+++++++.|..+.++.|+++|++|++++||+.+|++|+++..+.++.........+...+..+..+..+.+.+
T Consensus 150 ~~~~~~~~~~gi~~~d~~~~dg~i~~~N~~~~~l~G~~~eel~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 229 (665)
T PRK13558 150 KERALDEAPVGITIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERPTSVELRNY 229 (665)
T ss_pred HHHHHhcCCccEEEEcCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHHHhcCCCccHHHHHHHHHHHhcCCCeEEEEEEE
Confidence 46789999999999986433455999999999999999999999998888887777777777888888888889999999
Q ss_pred ecCCcEEEEEEEEeeeccCC----EEEEEEecCCcccc
Q 001902 554 TKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLE 587 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~ 587 (998)
++||+.+|+.++..|+.+.+ +++++++|||+||+
T Consensus 230 ~~dG~~~~~~~~~~pi~d~~G~~~~~vgi~~DITerk~ 267 (665)
T PRK13558 230 RKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKE 267 (665)
T ss_pred CCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeCcHHHH
Confidence 99999999999999998765 78999999999997
|
|
| >PRK10060 RNase II stability modulator; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.1e-10 Score=138.40 Aligned_cols=111 Identities=17% Similarity=0.158 Sum_probs=93.0
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccc-cCCCCCHHHHHHHHHHHhcCCcEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFL-QGPETDPATVRKIRAAIDNQTDVTVQLIN 552 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l-~~p~~~~~~~~~i~~~l~~g~~~~~e~~~ 552 (998)
++.+++.++++|+++|.+|+ |+++|++|++++||+.+|++|+++..+ .+++........++..+..+..+..|.+.
T Consensus 113 ~~~v~~~~~~gI~i~D~~g~---I~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 189 (663)
T PRK10060 113 AEQVVSEANSVIVILDSRGN---IQRFNRLCEEYTGLKEHDVIGQSVFKLFMSRREAAASRRNIRGFFRSGNAYEVERWI 189 (663)
T ss_pred HHHHHhhCCceEEEEeCCCC---EEEEcHHHHHHHCcCHHHHcCCCHHHHhCChhhHHHHHHHHHHHHhcCCceEEEEEE
Confidence 57799999999999999888 999999999999999999999996544 45555555667778888888889999999
Q ss_pred EecCCcEEEEEEEEeeeccCC----EEEEEEecCCcccc
Q 001902 553 YTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLE 587 (998)
Q Consensus 553 ~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~ 587 (998)
.+++|+.+|+.....+..+.+ +++++.+|||++|+
T Consensus 190 ~~~~G~~~~~~~~~~~~~~~g~~~~~~i~~~~DITe~k~ 228 (663)
T PRK10060 190 KTRKGQRLFLFRNKFVHSGSGKNEIFLICSGTDITEERR 228 (663)
T ss_pred EeCCCCEEEEEeeeEEEcCCCCceEEEEEEEEechHHHH
Confidence 999999999876655444333 67899999999985
|
|
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=7.6e-10 Score=140.72 Aligned_cols=140 Identities=14% Similarity=0.202 Sum_probs=117.2
Q ss_pred cccccccccccccccccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccC-CCC
Q 001902 167 SVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQG-AGT 245 (998)
Q Consensus 167 ~~~~~~dit~~~~~e~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~-~~~ 245 (998)
.+.+.+|||++++.+ +.++.+..+++.++++++++|. +|+|+++|+++++++||+.++++|+++..+.+ +..
T Consensus 118 ~~~~~~DiT~~~~~~----~~~~~~~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~l~G~~~~e~~g~~~~~~~~~~~~ 190 (799)
T PRK11359 118 YLALVRDASVEMAQK----EQTRQLIIAVDHLDRPVIVLDP---ERRIVQCNRAFTEMFGYCISEASGMQPDTLLNIPEF 190 (799)
T ss_pred EEEEEeeccchhhhH----HHHHHHHHHHhcCCCcEEEEcC---CCcEEEEChhhHhhhCCCHHHHCCCChHHhcCCCCC
Confidence 455668999866544 4456777899999999999998 77799999999999999999999999875543 444
Q ss_pred ChHHHHHHHHHHHcCCcEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHh
Q 001902 246 DPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDK 313 (998)
Q Consensus 246 ~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l 313 (998)
.......+...+..+..+..+++..+++|..+|+.++..|+.+.+|.+.+++++.+|||+++++++..
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~v~d~~g~~~~~~~~~~DITerk~~e~~~ 258 (799)
T PRK11359 191 PADNRIRLQQLLWKTARDQDEFLLLTRTGEKIWIKASISPVYDVLAHLQNLVMTFSDITEERQIRQLE 258 (799)
T ss_pred cHHHHHHHHHhhccCCCCcceeEEeCCCCCEEEEEeeeeeeecCCCceeEEEEEeehhhhHHHHHHHH
Confidence 55556667777777777888888999999999999999999999999999999999999999887653
|
|
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.4e-10 Score=134.91 Aligned_cols=111 Identities=25% Similarity=0.447 Sum_probs=99.6
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~ 553 (998)
|+.++++++++++++|.+|+ ++++|++|++++||++++++|++...+.++.........+...+..+..+..+...+
T Consensus 6 ~~~i~~~~~~~i~~~d~~g~---~~~~N~~~~~~~G~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (494)
T TIGR02938 6 YRQTVDQAPLAISITDLKAN---ILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNR 82 (494)
T ss_pred HHHHHHhCCceEEEECCCCc---EEEEchhheeecCCCHHHHhCCCchhhcCCCCCHHHHHHHHHHHHhCCcccceeecc
Confidence 78899999999999999888 999999999999999999999987777777666777777888888888888888889
Q ss_pred ecCCcEEEEEEEEeeeccCC----EEEEEEecCCcccc
Q 001902 554 TKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLE 587 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~ 587 (998)
+++|+.+|+.+++.|+.+.+ +++++++|||++|+
T Consensus 83 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIt~~k~ 120 (494)
T TIGR02938 83 RKDGELYLAELTVAPVLNEAGETTHFLGMHRDITELHR 120 (494)
T ss_pred CCCccchhhheeeEEEECCCCCEEEEEEehhhhhHHHH
Confidence 99999999999999998765 88999999999986
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.7e-09 Score=114.64 Aligned_cols=140 Identities=23% Similarity=0.305 Sum_probs=107.3
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCC--CCccceeEEEeeC---CeEEEEEe
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTK---THVCLITD 745 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h--~nIv~l~~~~~~~---~~~~lV~E 745 (998)
+.|+.|.++.||++... +|+.+++|+....... .....+..|..+++.+.+ ..+++++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 56899999999999874 3689999987654221 134567889999999965 4467777776653 36789999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC---------------------------------------- 785 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~---------------------------------------- 785 (998)
|++|.++.+.+.. ..++......++.++++.|.+||+
T Consensus 81 ~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 81 RVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9999988776532 236777777788888888888883
Q ss_pred ----------------CCceeccCCCCcEEEec--CCcEEEEeccCccc
Q 001902 786 ----------------QGIIYRDLKPENVLLQG--NGHVSLTDFDLSCL 816 (998)
Q Consensus 786 ----------------~~IiHrDLkP~NILi~~--~g~vkL~DFG~a~~ 816 (998)
..++|+|++|+||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 66789999998843
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1e-08 Score=115.09 Aligned_cols=214 Identities=16% Similarity=0.208 Sum_probs=150.3
Q ss_pred ceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe----eCCeEEEEEecCCC-Cch
Q 001902 678 TGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ----TKTHVCLITDYCPG-GEL 752 (998)
Q Consensus 678 ~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~----~~~~~~lV~E~~~g-gsL 752 (998)
..+.|+|....+|..|++|.++........ ....-.++++++.|.|||++.++|. .+..+++|++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 357899999999999999999543222221 1223467899999999999999886 34578999999986 467
Q ss_pred hHHHhhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 753 FLLLDRQ-------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 753 ~~~l~~~-------------~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
.++.-.. .+...++..+|.++.||..||.++|+.|+..+-|.|.+||++.+.+++|...|+......
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 7654321 233578899999999999999999999999999999999999988999988887643321
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC-
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT- 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~- 898 (998)
++ . +.+.+ -.+-|.=.||.++..|.||..--...+
T Consensus 446 d~---------------------------------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~ 481 (655)
T KOG3741|consen 446 DP---------------------------------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDS 481 (655)
T ss_pred CC---------------------------------------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccc
Confidence 11 0 11111 235789999999999999964422211
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
........+. ...|.+++++|..+...++++ -+ +.+++.|
T Consensus 482 ~~~s~~~~I~--------~~yS~D~rn~v~yl~s~~~~~-ks----I~~llp~ 521 (655)
T KOG3741|consen 482 TQSSHLTRIT--------TTYSTDLRNVVEYLESLNFRE-KS----IQDLLPM 521 (655)
T ss_pred hHHHHHHHhh--------hhhhHHHHHHHHHHHhcCccc-cc----HHHHHHH
Confidence 1122111111 125677888888888888874 33 5555543
|
|
| >PF08447 PAS_3: PAS fold; InterPro: IPR013655 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.9e-09 Score=95.94 Aligned_cols=86 Identities=28% Similarity=0.453 Sum_probs=73.7
Q ss_pred eEEccHHHHHHcCCChhhhcCCC----CCcccCCCCChHHHHHHHH-HHHcCCcEEEEEEEEecCCCEEEEEeeeeEEeC
Q 001902 214 IMYASAGFFKMTGYTSKEVVGRN----CRFLQGAGTDPEDVAKIRE-TLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKD 288 (998)
Q Consensus 214 I~~vN~a~~~l~Gys~eEliG~~----~~~l~~~~~~~~~~~~i~~-~l~~g~~~~~e~~~~~kdG~~~w~~~~~spi~d 288 (998)
|+|+|+++++++||+++++ |.. +..+++|++.......+.. .+..+..+..+++++++||+.+|++.+..+++|
T Consensus 1 ~i~~s~~~~~i~G~~~~~~-~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~~~e~R~~~~~G~~~wi~~~~~~~~d 79 (91)
T PF08447_consen 1 IIYWSDNFYEIFGYSPEEI-GKPDFEEWLERIHPDDRERVRQAIQQAALQNGEPFEIEYRIRRKDGEYRWIEVRGRPIFD 79 (91)
T ss_dssp -EEE-THHHHHHTS-HHHH-TCBEHHHHHHHB-TTTHHHHHHHHHHHHHHTT-EEEEEEEEEGTTSTEEEEEEEEEEEET
T ss_pred CEEEeHHHHHHhCCCHHHh-ccCCHHHHHhhcCHHHHHHHHHHHHHHhhccCcceEEEEEEECCCCCEEEEEEEEEEEEC
Confidence 6899999999999999999 766 5678899999888899988 788888999999999999999999999999999
Q ss_pred CCCCEEEEEEEE
Q 001902 289 DEGKVLKFIGMQ 300 (998)
Q Consensus 289 ~~G~v~~~v~i~ 300 (998)
++|++..++|++
T Consensus 80 ~~g~~~~~~Gv~ 91 (91)
T PF08447_consen 80 ENGKPIRIIGVI 91 (91)
T ss_dssp TTS-EEEEEEEE
T ss_pred CCCCEEEEEEEC
Confidence 999999999874
|
The PAS fold appears in archaea, eubacteria and eukarya. The PAS domain contains a sensory box, or S-box domain that occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include haem in the oxygen sensor FixL [], FAD in the redox potential sensor NifL [], and a 4-hydroxycinnamyl chromophore in photoactive yellow protein []. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. This domain has been found in the gene product of the madA gene of the filamentous zygomycete fungus Phycomyces blakesleeanus. It has been shown that MadA encodes a blue-light photoreceptor for phototropism and other light responses. The gene is involved in the phototropic responses associated with sporangiophore growth; they exhibit phototropism by bending toward near-UV and blue wavelengths and away from far-UV wavelengths in a manner that is physiologically similar to plant phototropic responses [].; GO: 0005515 protein binding; PDB: 3NJA_D 3H9W_A 3GDI_B 3ICY_A 3EEH_A 3MR0_B. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.4e-08 Score=108.64 Aligned_cols=134 Identities=19% Similarity=0.064 Sum_probs=96.1
Q ss_pred eEEEEEEccCCeEEEEEEeecccccC--------hhHHHHHHHHHHHHHhCCCCCc--cceeEEEee-----CCeEEEEE
Q 001902 680 SVHLVELCGSGQYFAMKAMDKGVMLN--------RNKVHRACAEREILDMLDHPFV--PALYASFQT-----KTHVCLIT 744 (998)
Q Consensus 680 ~Vy~a~~~~~~~~valK~i~~~~~~~--------~~~~~~~~~E~~il~~l~h~nI--v~l~~~~~~-----~~~~~lV~ 744 (998)
.|+.+.. .|+.|.+|......... ........+|...+.+|..-+| +.+..++.. ....+|||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 4666654 57789999764322100 0111246788888888854444 344555542 23578999
Q ss_pred ecCCCC-chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec-------CCcEEEEeccCcc
Q 001902 745 DYCPGG-ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-------NGHVSLTDFDLSC 815 (998)
Q Consensus 745 E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~-------~g~vkL~DFG~a~ 815 (998)
|++++. +|.+++........+......++.+++..+.-||.+||+|+|++++|||++. ++.+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999876 8999886432234566778899999999999999999999999999999985 4689999999874
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.9e-08 Score=103.29 Aligned_cols=127 Identities=24% Similarity=0.202 Sum_probs=83.3
Q ss_pred eEEEEEEccCCeEEEEEEeeccccc----------------------C-hhHHHHHHHHHHHHHhCCCC--CccceeEEE
Q 001902 680 SVHLVELCGSGQYFAMKAMDKGVML----------------------N-RNKVHRACAEREILDMLDHP--FVPALYASF 734 (998)
Q Consensus 680 ~Vy~a~~~~~~~~valK~i~~~~~~----------------------~-~~~~~~~~~E~~il~~l~h~--nIv~l~~~~ 734 (998)
.||.|.. ..|..+|+|+.+..... . ........+|.+.|.++..- ++++++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888887 56889999988742110 0 11133456799999999765 567776442
Q ss_pred eeCCeEEEEEecCC--CCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCcEEEecCCcEEEEec
Q 001902 735 QTKTHVCLITDYCP--GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY-LHCQGIIYRDLKPENVLLQGNGHVSLTDF 811 (998)
Q Consensus 735 ~~~~~~~lV~E~~~--ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~-LH~~~IiHrDLkP~NILi~~~g~vkL~DF 811 (998)
. -+|||||++ |..+..+.... ++......++.+++..+.. +|..||||+||.+.|||++.+ .+.|+||
T Consensus 80 --~--~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 --R--NVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp --T--TEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred --C--CEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 2 369999998 65665544332 2245567778888885555 579999999999999999976 9999999
Q ss_pred cCccc
Q 001902 812 DLSCL 816 (998)
Q Consensus 812 G~a~~ 816 (998)
|.+..
T Consensus 151 ~qav~ 155 (188)
T PF01163_consen 151 GQAVD 155 (188)
T ss_dssp TTEEE
T ss_pred Cccee
Confidence 98844
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >TIGR00229 sensory_box PAS domain S-box | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.5e-08 Score=91.95 Aligned_cols=111 Identities=22% Similarity=0.354 Sum_probs=90.0
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcC-CcEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ-TDVTVQLIN 552 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g-~~~~~e~~~ 552 (998)
++.+++.++++++++|.+|. ++++|+++++++|++.++++|++...+.++.........+...+..+ .....+...
T Consensus 5 ~~~~~~~~~~~~~~~d~~~~---i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (124)
T TIGR00229 5 YRAIFESSPDAIIVIDLEGN---ILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERLLEGEREPVSEERRV 81 (124)
T ss_pred HHHHHhhCCceEEEEcCCCc---EEEEchHHHHHhCCChHHhcCcchhhhcChhhhHHHHHHHHHHHcCCCCCcceEeee
Confidence 67899999999999999777 99999999999999999999999777777766665555566665533 224445555
Q ss_pred EecCCcEEEEEEEEeeec-cCC--EEEEEEecCCcccc
Q 001902 553 YTKSGKKFWNLFHLQPMR-DQK--YFIGVQLDGSEHLE 587 (998)
Q Consensus 553 ~rkdG~~~wv~~~~spi~-d~~--~~vgi~rDITerk~ 587 (998)
..++|..+|+.++..|+. +.. ++++++.|||++++
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dit~~~~ 119 (124)
T TIGR00229 82 RRKDGSEIWVEVSVSPIRTNGGELGVVGIVRDITERKQ 119 (124)
T ss_pred EcCCCCEEEEEEEEeehhhCCCeeEEEEEeeehhHHHH
Confidence 689999999999999988 233 88899999999986
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.5e-09 Score=126.40 Aligned_cols=171 Identities=19% Similarity=0.323 Sum_probs=125.9
Q ss_pred HHHHHHHHHHHHC-CceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccc
Q 001902 774 AEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 852 (998)
Q Consensus 774 ~qil~aL~~LH~~-~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (998)
.+.+.||.|+|.. ++||+.|.|++|.++.+|..||+.|+++........ +|- .........
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~--~p~----------------~~yd~~lp~ 167 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE--YPF----------------SEYDPPLPL 167 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc--ccc----------------ccCCCCCCh
Confidence 4555999999965 999999999999999999999999998754332111 110 011112223
Q ss_pred cccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHH-cCCCCCCCCChHHHHHHHHh-CC-CCCCCCCCCcHHHHHHHHH
Q 001902 853 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH-KD-LKFPSSTPTSLHAKQLMYR 929 (998)
Q Consensus 853 ~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLl-tG~~Pf~~~~~~~~~~~i~~-~~-~~~~~~~~~s~~l~~Ll~~ 929 (998)
...-...|.|||++.....+.++|+||+||++|.+. .|+.-+........+..-.. .+ -.+.....++.++++=|.+
T Consensus 168 ~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 168 LLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKK 247 (700)
T ss_pred hhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHH
Confidence 345677899999999988899999999999999999 56666655443333322111 11 1222335678899999999
Q ss_pred ccccCccCcCCChhcHHHHHcCCCccCCChhhhhcCC
Q 001902 930 LLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMN 966 (998)
Q Consensus 930 ~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~ 966 (998)
+|..++.-||+ +..++..|||....-..++.++
T Consensus 248 ~l~~~~~~rp~----~~~l~~~~ff~D~~~~aLrfLD 280 (700)
T KOG2137|consen 248 LLNGDSAVRPT----LDLLLSIPFFSDPGLKALRFLD 280 (700)
T ss_pred HhcCCcccCcc----hhhhhcccccCCchhhhhhhcc
Confidence 99999999999 9999999999998888887754
|
|
| >PRK11073 glnL nitrogen regulation protein NR(II); Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.3e-08 Score=116.20 Aligned_cols=108 Identities=12% Similarity=0.131 Sum_probs=88.7
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~ 553 (998)
++.+++++++|++++|.+|. |+++|++|++++||+.++++|+++..+.+... .....+...+..+..+..+....
T Consensus 9 ~~~il~~~~~gi~~~d~~~~---i~~~N~a~~~~~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 83 (348)
T PRK11073 9 AGQILNSLINSILLLDDDLA---IHYANPAAQQLLAQSSRKLFGTPLPELLSYFS--LNIELMRESLQAGQGFTDNEVTL 83 (348)
T ss_pred HHHHHhcCcCeEEEECCCCe---EeeEcHHHHHHhCCCHHHHcCCCHHHHcCcch--hhHHHHHHHHHcCCcccccceEE
Confidence 68899999999999999777 99999999999999999999999877765432 22344556666666655555666
Q ss_pred ecCCcEEEEEEEEeeeccCCEEEEEEecCCcccc
Q 001902 554 TKSGKKFWNLFHLQPMRDQKYFIGVQLDGSEHLE 587 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~~~vgi~rDITerk~ 587 (998)
.+||+.+|+.++.+|+. ..+++..++|||++++
T Consensus 84 ~~~g~~~~~~~~~~~~~-~~~~~~~~~dit~~~~ 116 (348)
T PRK11073 84 VIDGRSHILSLTAQRLP-EGMILLEMAPMDNQRR 116 (348)
T ss_pred EECCceEEEEEEEEEcc-CceeEEEEechhHHHH
Confidence 78999999999999998 3477888999999885
|
|
| >PF08447 PAS_3: PAS fold; InterPro: IPR013655 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.9e-08 Score=90.52 Aligned_cols=82 Identities=29% Similarity=0.411 Sum_probs=69.4
Q ss_pred EEEcCHHHHHHcCCChhhhcCCC----CccccCCCCCHHHHHHHHH-HHhcCCcEEEEEEEEecCCcEEEEEEEEeeecc
Q 001902 497 IIFASDSFLELTEYSREEILGRN----CRFLQGPETDPATVRKIRA-AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRD 571 (998)
Q Consensus 497 I~~vN~a~~~l~Gy~~eEliG~~----~~~l~~p~~~~~~~~~i~~-~l~~g~~~~~e~~~~rkdG~~~wv~~~~spi~d 571 (998)
|+|||++|++|+||+++++ |.. +..++||++...+.+.+.. .+..+..+..+++++++||+.+|++.+..++.|
T Consensus 1 ~i~~s~~~~~i~G~~~~~~-~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~~~e~R~~~~~G~~~wi~~~~~~~~d 79 (91)
T PF08447_consen 1 IIYWSDNFYEIFGYSPEEI-GKPDFEEWLERIHPDDRERVRQAIQQAALQNGEPFEIEYRIRRKDGEYRWIEVRGRPIFD 79 (91)
T ss_dssp -EEE-THHHHHHTS-HHHH-TCBEHHHHHHHB-TTTHHHHHHHHHHHHHHTT-EEEEEEEEEGTTSTEEEEEEEEEEEET
T ss_pred CEEEeHHHHHHhCCCHHHh-ccCCHHHHHhhcCHHHHHHHHHHHHHHhhccCcceEEEEEEECCCCCEEEEEEEEEEEEC
Confidence 6899999999999999999 766 6778899999999999999 788888999999999999999999999999997
Q ss_pred CC----EEEEEE
Q 001902 572 QK----YFIGVQ 579 (998)
Q Consensus 572 ~~----~~vgi~ 579 (998)
.+ .++|+.
T Consensus 80 ~~g~~~~~~Gv~ 91 (91)
T PF08447_consen 80 ENGKPIRIIGVI 91 (91)
T ss_dssp TTS-EEEEEEEE
T ss_pred CCCCEEEEEEEC
Confidence 76 667663
|
The PAS fold appears in archaea, eubacteria and eukarya. The PAS domain contains a sensory box, or S-box domain that occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include haem in the oxygen sensor FixL [], FAD in the redox potential sensor NifL [], and a 4-hydroxycinnamyl chromophore in photoactive yellow protein []. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. This domain has been found in the gene product of the madA gene of the filamentous zygomycete fungus Phycomyces blakesleeanus. It has been shown that MadA encodes a blue-light photoreceptor for phototropism and other light responses. The gene is involved in the phototropic responses associated with sporangiophore growth; they exhibit phototropism by bending toward near-UV and blue wavelengths and away from far-UV wavelengths in a manner that is physiologically similar to plant phototropic responses [].; GO: 0005515 protein binding; PDB: 3NJA_D 3H9W_A 3GDI_B 3ICY_A 3EEH_A 3MR0_B. |
| >COG3829 RocR Transcriptional regulator containing PAS, AAA-type ATPase, and DNA-binding domains [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=6.4e-08 Score=110.42 Aligned_cols=218 Identities=17% Similarity=0.162 Sum_probs=150.4
Q ss_pred HHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEe
Q 001902 192 KDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYK 271 (998)
Q Consensus 192 ~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~ 271 (998)
+.+++++.++++++|. ...|.++|..+..+++-....++|+++..+.+...-+.. . .+..+........
T Consensus 4 ~~~l~~~~~~~~vi~~---~~~~~~~~~~a~~~~~~~~~~~i~~~~~~i~~~~~~~~v-------~-~~~~~~~~~~~~~ 72 (560)
T COG3829 4 EGILKSILDGPVVIDK---NTGIDVANALALAKRQKNAEAVIGRPLREILETLGMERV-------E-QSRDKELTERLKL 72 (560)
T ss_pred hhhhhhcccceEEEEc---CCceeeechHHHHhhhcceEEEecccceeeccccCccee-------e-ccCccceeeeeec
Confidence 4489999999999998 445999999999999999999999998877665433211 1 2222222233333
Q ss_pred cCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhcCCCCCchhhhhHHHHHHHHhHhhHHHHHHHccCCCC
Q 001902 272 KDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS 351 (998)
Q Consensus 272 kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~~~~~L~~~l~~~d~~~~~~~~~~~~~~~~~l~~~~~ 351 (998)
+ + ...+ +..-++.++.|+++|++.++.|+++..+.-++.
T Consensus 73 ~-~-~~~~-~~~~~~~~~~~~~~g~~~~~~~~~e~~~~~~~~-------------------------------------- 111 (560)
T COG3829 73 K-V-KRIV-VVGKTPVDEQGRVVGVLEVFLDISEALELIEEN-------------------------------------- 111 (560)
T ss_pred c-c-eeEE-EcCCceeecCCceeeeehhhhhhHHHHHHHHHH--------------------------------------
Confidence 3 3 2223 334445677889999999999999854433321
Q ss_pred ccccCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCCcccccccccccchhhccccCCccccccccccccCC
Q 001902 352 LSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQST 431 (998)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (998)
T Consensus 112 -------------------------------------------------------------------------------- 111 (560)
T COG3829 112 -------------------------------------------------------------------------------- 111 (560)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhccccHHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCC
Q 001902 432 DDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYS 511 (998)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~~~di~er~~~e~e~r~~~~l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~ 511 (998)
+...++. |+.+++.+.++++++|.+|+ ++++|++...++|++
T Consensus 112 ------------------------------l~~~~~~-----l~~il~~~~~~l~vvD~~G~---~i~~N~~~~~~~gl~ 153 (560)
T COG3829 112 ------------------------------LRQLRQR-----LEAILDSIDDGLLVVDEDGI---IIYYNKAYAKLLGLS 153 (560)
T ss_pred ------------------------------HHHHHHH-----HHHHHhhccCceEEEcCCCc---EEEEcHHHHHHhCCC
Confidence 0001111 78899999999999999888 999999999999999
Q ss_pred hhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEeeeccCC---EEEEEEecCCcccc
Q 001902 512 REEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK---YFIGVQLDGSEHLE 587 (998)
Q Consensus 512 ~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rkdG~~~wv~~~~spi~d~~---~~vgi~rDITerk~ 587 (998)
.++++|++..++.....+ ....+.+..+++.......+..++. -.+..|+..++ +.+++++|+++-+.
T Consensus 154 ~e~~~gk~~~~v~~~~~~----s~~l~vl~~~kp~~~~~~~~~~~~~----i~~~~pv~~~g~l~G~v~~~~~~~~l~~ 224 (560)
T COG3829 154 PEEVLGKHLLDVVSAGED----STLLEVLRTGKPIRDVVQTYNGNKI----IVNVAPVYADGQLIGVVGISKDVSELER 224 (560)
T ss_pred HHHHcCCcHHHHHhccCC----ceehhhhhcCCcceeeeeeecCCce----eEeeccEecCCcEEEEEEeecchHHHHH
Confidence 999999997666511111 1234567777765444433333332 34566777665 88999999988763
|
|
| >cd00130 PAS PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.4e-07 Score=81.10 Aligned_cols=103 Identities=24% Similarity=0.479 Sum_probs=87.1
Q ss_pred cCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCCEE
Q 001902 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 277 (998)
Q Consensus 198 ~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 277 (998)
++++++++|. +|.++++|+++++++|++.++++|+++..+.++.........+...+..+.....++.....+|...
T Consensus 1 ~~~~i~~~d~---~~~~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (103)
T cd00130 1 LPDGVIVLDL---DGRILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGEPVTLEVRLRRKDGSVI 77 (103)
T ss_pred CCceEEEECC---CCcEEEECHHHHHHhCCCHHHHcCccHHHhcCCccchHHHHHHHHHHhcCcCeEEEEEEEccCCCEE
Confidence 3678999998 7779999999999999999999999987777776666666666666666666778888888899999
Q ss_pred EEEeeeeEEeCCCCCEEEEEEEEecc
Q 001902 278 WNLLTIAPIKDDEGKVLKFIGMQVEV 303 (998)
Q Consensus 278 w~~~~~spi~d~~G~v~~~v~i~~DI 303 (998)
|+.....++.+..|...+++++.+||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~di 103 (103)
T cd00130 78 WVLVSLTPIRDEGGEVIGLLGVVRDI 103 (103)
T ss_pred EEEEEEEEEecCCCCEEEEEEEEecC
Confidence 99999999998888999999999886
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. |
| >PRK11360 sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.9e-07 Score=114.23 Aligned_cols=128 Identities=13% Similarity=0.124 Sum_probs=106.2
Q ss_pred ccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCC
Q 001902 182 KGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ 261 (998)
Q Consensus 182 ~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~ 261 (998)
..+..++..++.+++.++++++++|. +|+|+++|+++++++||+.++++|+++..++++.. .....+...+..+.
T Consensus 255 ~~l~~~~~~~~~i~~~~~~~i~~~d~---~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~ 329 (607)
T PRK11360 255 QALRETRSLNELILESIADGVIAIDR---QGKITTMNPAAEVITGLQRHELVGKPYSELFPPNT--PFASPLLDTLEHGT 329 (607)
T ss_pred HHHHHHHHHHHHHHHhccCeEEEEcC---CCCEEEECHHHHHHhCCChHHhcCCcHHHHcCCch--hHHHHHHHHHhcCC
Confidence 45667778899999999999999998 77799999999999999999999999887776542 23345555666554
Q ss_pred c-EEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhc
Q 001902 262 S-YCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 315 (998)
Q Consensus 262 ~-~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~ 315 (998)
. ...+....+++|... +.++..|+.+.+|.+.+++++++|||+++++|++++.
T Consensus 330 ~~~~~~~~~~~~~~~~~-~~~~~~~i~~~~g~~~~~i~~~~Dite~~~~e~~l~~ 383 (607)
T PRK11360 330 EHVDLEISFPGRDRTIE-LSVSTSLLHNTHGEMIGALVIFSDLTERKRLQRRVAR 383 (607)
T ss_pred CccceEEEEEcCCCcEE-EEEEEeeEEcCCCCEEEEEEEEeechHHHHHHHHHHH
Confidence 4 335667778888876 8899999999999999999999999999999988654
|
|
| >PRK11073 glnL nitrogen regulation protein NR(II); Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.2e-07 Score=108.12 Aligned_cols=118 Identities=17% Similarity=0.212 Sum_probs=93.1
Q ss_pred hHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEE
Q 001902 187 VSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGR 266 (998)
Q Consensus 187 ~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e 266 (998)
+...++.+++++++|++++|. +|+|+++|+++++++||+.++++|+++..+.+... .....+...+..+..+...
T Consensus 5 ~~~~~~~il~~~~~gi~~~d~---~~~i~~~N~a~~~~~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 79 (348)
T PRK11073 5 TLPDAGQILNSLINSILLLDD---DLAIHYANPAAQQLLAQSSRKLFGTPLPELLSYFS--LNIELMRESLQAGQGFTDN 79 (348)
T ss_pred CcchHHHHHhcCcCeEEEECC---CCeEeeEcHHHHHHhCCCHHHHcCCCHHHHcCcch--hhHHHHHHHHHcCCccccc
Confidence 345678999999999999998 77899999999999999999999999887765432 2234455666666655544
Q ss_pred EEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhh
Q 001902 267 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (998)
Q Consensus 267 ~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~ 314 (998)
...+.+||..+|+.++.+|+. . .+++..++|||+++++++++.
T Consensus 80 ~~~~~~~g~~~~~~~~~~~~~--~---~~~~~~~~dit~~~~~~~~~~ 122 (348)
T PRK11073 80 EVTLVIDGRSHILSLTAQRLP--E---GMILLEMAPMDNQRRLSQEQL 122 (348)
T ss_pred ceEEEECCceEEEEEEEEEcc--C---ceeEEEEechhHHHHHHHHHH
Confidence 455678999999999999986 2 246778999999998877654
|
|
| >TIGR02966 phoR_proteo phosphate regulon sensor kinase PhoR | Back alignment and domain information |
|---|
Probab=98.68 E-value=1e-07 Score=107.36 Aligned_cols=113 Identities=14% Similarity=0.114 Sum_probs=88.7
Q ss_pred cchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEE
Q 001902 185 PRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYC 264 (998)
Q Consensus 185 ~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~ 264 (998)
....+.|+.+++++++||+++|. +|+|+++|++|++++||+.++++|+++..+..+. .+...+..+.. .
T Consensus 2 ~~~~~~l~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~-------~~~~~l~~~~~-~ 70 (333)
T TIGR02966 2 SALLSRFRAAAQALPDAVVVLDE---EGQIEWCNPAAERLLGLRWPDDLGQRITNLIRHP-------EFVEYLAAGRF-S 70 (333)
T ss_pred hhHHHHHHHHHHhCcCcEEEECC---CCcEEEEcHHHHHHhCCChHHHcCCcHHHHccCH-------HHHHHHHhccc-C
Confidence 45668899999999999999999 7779999999999999999999999987665431 23333443332 2
Q ss_pred EEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHh
Q 001902 265 GRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDK 313 (998)
Q Consensus 265 ~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l 313 (998)
.......++|..+|+.+.+.|+.+.+ ++++++|||++++.++..
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~dit~~~~~~~~~ 114 (333)
T TIGR02966 71 EPLELPSPINSERVLEIRIAPYGEEQ-----KLLVARDVTRLRRLEQMR 114 (333)
T ss_pred CCeEeecCCCCceEEEEEEEEcCCCc-----eEEEEeCchHHHHHHHHH
Confidence 23455568899999999999987542 678899999999887653
|
Members of this protein family are the regulatory histidine kinase PhoR associated with the phosphate ABC transporter in most Proteobacteria. Related proteins from Gram-positive organisms are not included in this model. The phoR gene usually is adjacent to the response regulator phoB gene (TIGR02154). |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.1e-07 Score=100.05 Aligned_cols=136 Identities=21% Similarity=0.186 Sum_probs=101.5
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeecccccC-------------------hhHHHHHHHHHHHHHhCCCC--
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-------------------RNKVHRACAEREILDMLDHP-- 725 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~-------------------~~~~~~~~~E~~il~~l~h~-- 725 (998)
+.+..+||-|.-|.||.|.+. .|.++|+|.-+.....- ........+|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 345578999999999999984 68999999765321100 11133456789999999665
Q ss_pred CccceeEEEeeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc
Q 001902 726 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 805 (998)
Q Consensus 726 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~ 805 (998)
.|++.+++ +.-++||||++|-.|...- +.......++..|+.-+.-+-..||||+|+.+=||+++++|.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 77777754 3457999999887776543 234445566666777666666899999999999999999999
Q ss_pred EEEEeccCc
Q 001902 806 VSLTDFDLS 814 (998)
Q Consensus 806 vkL~DFG~a 814 (998)
+.++||--+
T Consensus 241 ~~vIDwPQ~ 249 (304)
T COG0478 241 IVVIDWPQA 249 (304)
T ss_pred EEEEeCccc
Confidence 999999866
|
|
| >TIGR02966 phoR_proteo phosphate regulon sensor kinase PhoR | Back alignment and domain information |
|---|
Probab=98.68 E-value=1e-07 Score=107.39 Aligned_cols=102 Identities=11% Similarity=0.031 Sum_probs=82.5
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~ 553 (998)
|+.+++++++||+++|.+|. |+++|++|+++|||++++++|++...+..++ .++..+..+.. .......
T Consensus 8 l~~~~~~~~~~i~~~d~~g~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~-------~~~~~l~~~~~-~~~~~~~ 76 (333)
T TIGR02966 8 FRAAAQALPDAVVVLDEEGQ---IEWCNPAAERLLGLRWPDDLGQRITNLIRHP-------EFVEYLAAGRF-SEPLELP 76 (333)
T ss_pred HHHHHHhCcCcEEEECCCCc---EEEEcHHHHHHhCCChHHHcCCcHHHHccCH-------HHHHHHHhccc-CCCeEee
Confidence 78899999999999999888 9999999999999999999999977665532 23333433332 2335566
Q ss_pred ecCCcEEEEEEEEeeeccCCEEEEEEecCCcccc
Q 001902 554 TKSGKKFWNLFHLQPMRDQKYFIGVQLDGSEHLE 587 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~~~vgi~rDITerk~ 587 (998)
.++|..+|+.++++|+.+.+ ++++++|||++++
T Consensus 77 ~~~~~~~~~~~~~~p~~~~~-~~~~~~dit~~~~ 109 (333)
T TIGR02966 77 SPINSERVLEIRIAPYGEEQ-KLLVARDVTRLRR 109 (333)
T ss_pred cCCCCceEEEEEEEEcCCCc-eEEEEeCchHHHH
Confidence 68999999999999998765 8888999999875
|
Members of this protein family are the regulatory histidine kinase PhoR associated with the phosphate ABC transporter in most Proteobacteria. Related proteins from Gram-positive organisms are not included in this model. The phoR gene usually is adjacent to the response regulator phoB gene (TIGR02154). |
| >KOG0501 consensus K+-channel KCNQ [Inorganic ion transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.3e-07 Score=105.99 Aligned_cols=119 Identities=26% Similarity=0.606 Sum_probs=101.9
Q ss_pred HHHHHhhcC--c-eEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCC--CccccCCCCCHHHHHHHHHHHhcCCcEEE
Q 001902 474 LATTLERIE--K-NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRN--CRFLQGPETDPATVRKIRAAIDNQTDVTV 548 (998)
Q Consensus 474 l~~i~e~~~--d-~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~--~~~l~~p~~~~~~~~~i~~~l~~g~~~~~ 548 (998)
|+.++..+. | .+++.+++-.|..|+|+|+.||++.||.+.|++.++ +.+.++...+......+++++++.+.-++
T Consensus 16 LENiiRRsn~~dtsFlL~NAQiVD~PiVY~NdgFcKlsGY~RAevMQKs~tc~FMyGEltdk~ti~k~~~t~eN~~~~qf 95 (971)
T KOG0501|consen 16 LENIIRRSNNADTSFLLANAQIVDWPIVYCNDGFCKLSGYHRAEVMQKSCTCSFMYGELTDKGTIEKVRQTLENYETNQF 95 (971)
T ss_pred HHHHHhhccCCCcceeeccceeeccceEEecCcchhccCccHHHHhcccceeeeeeccccchhhHHHHHHHHHhhhhcce
Confidence 556665444 3 455556666688899999999999999999999988 56677778888899999999999999999
Q ss_pred EEEEEecCCcEEEEEEEEeeeccCC----EEEEEEecCCccccccccC
Q 001902 549 QLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPLRNS 592 (998)
Q Consensus 549 e~~~~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~~~~~~ 592 (998)
|+.++.|+.+.+|..+.+.||+++. .|+..++|||.-||+...+
T Consensus 96 EillyKKN~TPvW~~vqiAPIrNe~d~VVLfLctFkDIT~~KQPidde 143 (971)
T KOG0501|consen 96 EILLYKKNRTPVWLLVQIAPIRNEKDKVVLFLCTFKDITALKQPIDDE 143 (971)
T ss_pred eeEeeecCCCceEEEEEeecccCCCceEEEEEeecccchhhcCCCccc
Confidence 9999999999999999999999987 7888999999999975444
|
|
| >cd00130 PAS PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.2e-07 Score=77.57 Aligned_cols=99 Identities=25% Similarity=0.399 Sum_probs=83.3
Q ss_pred cCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 001902 481 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 560 (998)
Q Consensus 481 ~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rkdG~~~ 560 (998)
++++++++|.+|. ++++|+++++++|++.++++|++...+.++.........+...+..+.....+......+|...
T Consensus 1 ~~~~i~~~d~~~~---~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (103)
T cd00130 1 LPDGVIVLDLDGR---ILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGEPVTLEVRLRRKDGSVI 77 (103)
T ss_pred CCceEEEECCCCc---EEEECHHHHHHhCCCHHHHcCccHHHhcCCccchHHHHHHHHHHhcCcCeEEEEEEEccCCCEE
Confidence 3678999999777 9999999999999999999999977777777766666667666666666778888888999999
Q ss_pred EEEEEEeeeccCC----EEEEEEecC
Q 001902 561 WNLFHLQPMRDQK----YFIGVQLDG 582 (998)
Q Consensus 561 wv~~~~spi~d~~----~~vgi~rDI 582 (998)
|+.+...++.+.+ +++++++||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~di 103 (103)
T cd00130 78 WVLVSLTPIRDEGGEVIGLLGVVRDI 103 (103)
T ss_pred EEEEEEEEEecCCCCEEEEEEEEecC
Confidence 9999999988763 788888886
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. |
| >PF13596 PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.3e-07 Score=88.17 Aligned_cols=106 Identities=16% Similarity=0.279 Sum_probs=73.9
Q ss_pred HHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEE
Q 001902 191 VKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNY 270 (998)
Q Consensus 191 l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 270 (998)
++.++++++.+++++|. +++|.|.|+++.++++.. ...+|+++..+.++...... ..+.+.+..|+....+...
T Consensus 1 L~~il~s~~~~i~~vD~---~~~I~~~n~~a~~~f~~~-~~~iGr~l~~~~~~~~~~~l-~~~i~~~~~~~~~~~~~~~- 74 (106)
T PF13596_consen 1 LNNILDSMPIGIIFVDR---NLRIRYFNPAAARLFNLS-PSDIGRPLFDIHPPLSYPNL-KKIIEQVRSGKEEEFEIVI- 74 (106)
T ss_dssp HHHHHHHSSSEEEEEET---TSBEEEE-SCGC-SS----GGGTTSBCCCSS-HHHHHHH-HHHHHHHHTTSBSEEEEEE-
T ss_pred ChHHHhcCCCCEEEEcC---CCeEEEeChhHhhhcCCC-hHHCCCCHHHcCCccchHHH-HHHHHHHHcCCCceEEEEe-
Confidence 46789999999999999 777999999999999976 45689999988766333333 3444555666653333332
Q ss_pred ecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecch
Q 001902 271 KKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (998)
Q Consensus 271 ~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DIT 304 (998)
..+|. |+.+.+.|+++.+|+..|++.++.|||
T Consensus 75 ~~~~~--~~~~~~~P~~~~~g~~~G~v~~~~DIT 106 (106)
T PF13596_consen 75 PNGGR--WYLVRYRPYRDEDGEYAGAVITFQDIT 106 (106)
T ss_dssp EETTE--EEEEEEEEEE-TTS-EEEEEEEEEE-G
T ss_pred cCCCE--EEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 35554 667899999999999999999999998
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.4e-07 Score=93.73 Aligned_cols=140 Identities=14% Similarity=0.143 Sum_probs=103.7
Q ss_pred CCCCceeEEEEEEccCCeEEEEEEeecccccC---hhHHHHHHHHHHHHHhCCCCC--ccceeEEEee----CCeEEEEE
Q 001902 674 GSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN---RNKVHRACAEREILDMLDHPF--VPALYASFQT----KTHVCLIT 744 (998)
Q Consensus 674 G~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~---~~~~~~~~~E~~il~~l~h~n--Iv~l~~~~~~----~~~~~lV~ 744 (998)
|+||.|.|+.... .|+.|-+|.-....... +.....+.+|...+.+|..-+ ++++...-.. .-..+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 6799999999876 34468888665221111 335567888999888885332 5555522111 22467999
Q ss_pred ecCCC-CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc--EEEEeccCcc
Q 001902 745 DYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--VSLTDFDLSC 815 (998)
Q Consensus 745 E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~--vkL~DFG~a~ 815 (998)
|-++| .+|.+++....-...+......++.+++.++.-||+.|+.|+|+.+.|||++.+|. +.++||.-+.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98854 58988886644345678888899999999999999999999999999999987777 9999999764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.9e-07 Score=100.13 Aligned_cols=238 Identities=19% Similarity=0.253 Sum_probs=157.2
Q ss_pred ccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEE------EeeCC-e
Q 001902 668 RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS------FQTKT-H 739 (998)
Q Consensus 668 ~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~------~~~~~-~ 739 (998)
...+.||+|+.+.+|..... .-.+-|++.+..... + ......|... .||-+..-+.| .-+.. .
T Consensus 14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~-----~-aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAA-----Q-AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchh---hchhheeecCCCchH-----H-HHHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 34578999999999987653 346678877532111 1 1122333333 56654331111 11222 3
Q ss_pred EEEEEecCCCCc-hhHHHh----hCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCc
Q 001902 740 VCLITDYCPGGE-LFLLLD----RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814 (998)
Q Consensus 740 ~~lV~E~~~ggs-L~~~l~----~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a 814 (998)
+.++|..+.|.. +..++. ++......+..+..+++.|+.+.+.||..|.+-+|+.++|||+..++.|.|+|-...
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 778999987652 333332 355667888999999999999999999999999999999999999999999987643
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc-----CCCCCChhHHHHHHHHHHHHHc
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLY 889 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDIwSlG~il~eLlt 889 (998)
.. ........+.+|.+.|.+||... +..-+...|.|.||+++++|+.
T Consensus 165 qi----------------------------~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ 216 (637)
T COG4248 165 QI----------------------------NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLF 216 (637)
T ss_pred ee----------------------------ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHh
Confidence 21 11223345678999999999865 3344568999999999999997
Q ss_pred C-CCCCCCCChH----HHHH-HHHhCC-----------CCCCCC---CCCcHHHHHHHHHcccc--CccCcCCCh
Q 001902 890 G-YTPFRGKTRQ----KTFA-NILHKD-----------LKFPSS---TPTSLHAKQLMYRLLHR--DPKSRLGSH 942 (998)
Q Consensus 890 G-~~Pf~~~~~~----~~~~-~i~~~~-----------~~~~~~---~~~s~~l~~Ll~~~L~~--dP~~Rpt~~ 942 (998)
| +.||.+.... .-++ .|..+. .+.|.. .-+++.++.|..+|+.. ++.-|||.+
T Consensus 217 ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 217 GGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred cCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 5 9999763211 1111 222221 112222 23567888999999874 355799965
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=8.2e-08 Score=112.75 Aligned_cols=189 Identities=21% Similarity=0.233 Sum_probs=113.5
Q ss_pred CCchhhhccCCcccCCCCCCCCCCchhhHHhhhccccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccc
Q 001902 624 LTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM 703 (998)
Q Consensus 624 l~p~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~ 703 (998)
+-|..+...-+++....|+........-+.+-+.....-....|.. ..|+.++-|+||+|+.. +|+.||||+.+++..
T Consensus 85 l~p~e~~~eL~~LQD~vpp~~~~~~~~iie~eLG~~iee~F~eF~~-~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~ 162 (517)
T COG0661 85 LVPPEYAEELAKLQDRVPPFPFEEAERIIEEELGRPIEELFSEFEP-EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIR 162 (517)
T ss_pred ccCHHHHHHHHHhhcCCCCCCHHHHHHHHHHHhCCCHHHHHHHcCC-CchhhhhHhhheeEEec-CCCEEEEEecCCChH
Confidence 4677777777777777765533222222222222111111223333 67999999999999984 599999999876422
Q ss_pred cCh---------------------------hH----HH------HHHHHHHHHHhC-----CCCCccceeEEEeeCCeEE
Q 001902 704 LNR---------------------------NK----VH------RACAEREILDML-----DHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 704 ~~~---------------------------~~----~~------~~~~E~~il~~l-----~h~nIv~l~~~~~~~~~~~ 741 (998)
..- .. .+ ++..|..-+.++ +.++|.-..=+....+.-+
T Consensus 163 ~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~V 242 (517)
T COG0661 163 ERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRV 242 (517)
T ss_pred HHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcE
Confidence 110 00 01 112344444443 2444433332334445668
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHH-HHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA-LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~a-L~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
|+|||++|..+.+...... ...+ .+.++..++.+ +..+-..|+.|.|.+|.||+++.+|.+.+.|||+....+
T Consensus 243 LtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 243 LTMEWIDGIKISDIAALKS-AGID---RKELAELLVRAFLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred EEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999988843221 1234 23333333333 344445899999999999999999999999999985543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=5.6e-07 Score=94.64 Aligned_cols=126 Identities=25% Similarity=0.259 Sum_probs=92.2
Q ss_pred CCeEEEEEEeecccccC----hhHHHHHHHHHHHHHhCCCC--CccceeEEEeeC----CeEEEEEecCCCC-chhHHHh
Q 001902 689 SGQYFAMKAMDKGVMLN----RNKVHRACAEREILDMLDHP--FVPALYASFQTK----THVCLITDYCPGG-ELFLLLD 757 (998)
Q Consensus 689 ~~~~valK~i~~~~~~~----~~~~~~~~~E~~il~~l~h~--nIv~l~~~~~~~----~~~~lV~E~~~gg-sL~~~l~ 757 (998)
.++.|-+|........+ .-......+|...+..|..- .++.++.+.... ...+||+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 45666666543221111 12234567788887777433 345666666542 2458999999885 7999987
Q ss_pred hCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC---cEEEEeccCccc
Q 001902 758 RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCL 816 (998)
Q Consensus 758 ~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g---~vkL~DFG~a~~ 816 (998)
.... ++......++.+++..++-||.+||+|+|++|.|||++.++ .+.|+||+-+..
T Consensus 111 ~~~~--~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 111 QWEQ--LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hhcc--cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 6422 66777889999999999999999999999999999999887 899999998744
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0501 consensus K+-channel KCNQ [Inorganic ion transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.6e-07 Score=105.29 Aligned_cols=109 Identities=35% Similarity=0.683 Sum_probs=98.5
Q ss_pred cEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCC--cccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCCEEE
Q 001902 201 TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCR--FLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFW 278 (998)
Q Consensus 201 ~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~--~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w 278 (998)
.+++-++.-.|..|+|+|..||++.||.+.|+.-+++. +++.+..+....+.+++.+...+.-.+|+..++|+...+|
T Consensus 29 sFlL~NAQiVD~PiVY~NdgFcKlsGY~RAevMQKs~tc~FMyGEltdk~ti~k~~~t~eN~~~~qfEillyKKN~TPvW 108 (971)
T KOG0501|consen 29 SFLLANAQIVDWPIVYCNDGFCKLSGYHRAEVMQKSCTCSFMYGELTDKGTIEKVRQTLENYETNQFEILLYKKNRTPVW 108 (971)
T ss_pred ceeeccceeeccceEEecCcchhccCccHHHHhcccceeeeeeccccchhhHHHHHHHHHhhhhcceeeEeeecCCCceE
Confidence 44555555558899999999999999999999998865 7788888899999999999999998999999999999999
Q ss_pred EEeeeeEEeCCCCCEEEEEEEEecchhhhHH
Q 001902 279 NLLTIAPIKDDEGKVLKFIGMQVEVSKHTEG 309 (998)
Q Consensus 279 ~~~~~spi~d~~G~v~~~v~i~~DITerk~~ 309 (998)
+.+.+.||+++...++-|++.++|||..|+-
T Consensus 109 ~~vqiAPIrNe~d~VVLfLctFkDIT~~KQP 139 (971)
T KOG0501|consen 109 LLVQIAPIRNEKDKVVLFLCTFKDITALKQP 139 (971)
T ss_pred EEEEeecccCCCceEEEEEeecccchhhcCC
Confidence 9999999999999999999999999999874
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.57 E-value=8e-07 Score=92.09 Aligned_cols=142 Identities=21% Similarity=0.266 Sum_probs=95.2
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHH------HHHHHHHHHHhC---CCCCccce
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH------RACAEREILDML---DHPFVPAL 730 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~------~~~~E~~il~~l---~h~nIv~l 730 (998)
..+....|++++.+-......|.+..- +|+.+++|..+....-...... ...+.+..+.++ .......+
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 345567899999999999999988876 6789999988754211111111 112233333333 22333333
Q ss_pred eEEEe-----eCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc
Q 001902 731 YASFQ-----TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 805 (998)
Q Consensus 731 ~~~~~-----~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~ 805 (998)
+-+.. .....+|||||++|..|.++.. +++ .+...|.+++.-||+.|+.|+|.+|+|++++.+ .
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-c
Confidence 33322 2245678999999988877642 222 244567788999999999999999999999954 5
Q ss_pred EEEEeccCc
Q 001902 806 VSLTDFDLS 814 (998)
Q Consensus 806 vkL~DFG~a 814 (998)
++++||+..
T Consensus 173 i~iID~~~k 181 (229)
T PF06176_consen 173 IRIIDTQGK 181 (229)
T ss_pred EEEEECccc
Confidence 999999865
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12860 PAS_7: PAS fold | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.2e-07 Score=87.90 Aligned_cols=105 Identities=20% Similarity=0.275 Sum_probs=74.7
Q ss_pred HHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhh-cCCCCCccc---------CCCCChHHHHHHHHHHHcCCcEE
Q 001902 195 LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV-VGRNCRFLQ---------GAGTDPEDVAKIRETLQNGQSYC 264 (998)
Q Consensus 195 ld~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEl-iG~~~~~l~---------~~~~~~~~~~~i~~~l~~g~~~~ 264 (998)
|+++++||++.|. +|+++++|++|.+++|++.+.+ .|.++..+. .+.....................
T Consensus 1 Ld~l~~Gv~v~D~---~~rl~~~N~~~~~l~~~~~~~~~~G~~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (115)
T PF12860_consen 1 LDSLPQGVAVFDS---DGRLVFWNQRFRELFGLPPEMLRPGASFRDLLRRLAERGEFPPGDPEAWVRQRLARLRRRQPRS 77 (115)
T ss_pred CCCcCceEEEEcC---CCeEEeEcHHHHHHhCCCHHHhcCCCCHHHHHHHHHHcCCCCCCCHHHHHHHHHHHHhcCCCce
Confidence 4789999999999 7889999999999999999998 788865332 11222223333333334444333
Q ss_pred EEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHH
Q 001902 265 GRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAK 311 (998)
Q Consensus 265 ~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~ 311 (998)
.+ ....||. |++++..|+ ++| |+|.++.|||+++++|+
T Consensus 78 ~~--~~~~dgr--~l~~~~~~~--~~G---g~v~~~~DVT~~~~~E~ 115 (115)
T PF12860_consen 78 FE--LRLPDGR--WLEVRAQPL--PDG---GFVLTFTDVTERRRAEE 115 (115)
T ss_pred eE--EECCCCE--EEEEEeEEC--CCC---CEEEEEEeCCHHHHhcC
Confidence 33 3468886 677888888 445 67789999999999874
|
|
| >PRK11388 DNA-binding transcriptional regulator DhaR; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.2e-06 Score=104.34 Aligned_cols=103 Identities=16% Similarity=0.182 Sum_probs=76.5
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~ 553 (998)
+..+++++.+||+++|.+|+ |+++|+++++++|++.++++|++...+.+.. ..+...+..+..+.......
T Consensus 205 ~~~il~~~~~gVl~vD~~G~---I~~~N~aa~~llg~s~~~l~G~~i~~l~~~~------~~l~~vl~~~~~~~~~~~~l 275 (638)
T PRK11388 205 LNALLESMDDGVIAWDEQGN---LQFLNAQAARLLRLDATASQGRAITELLTLP------AVLQQAIKQAHPLKHVEVTF 275 (638)
T ss_pred HHHHHhccCCcEEEECCCCe---EehhhHHHHHHhCcCHHHHCCCcHHHHhccc------hHHHHHHhcCCceeeEEEEE
Confidence 46689999999999999888 9999999999999999999999977665321 12344556665544333334
Q ss_pred ecCCcEEEEEEEEeeeccCC--EEEEEEecCCcc
Q 001902 554 TKSGKKFWNLFHLQPMRDQK--YFIGVQLDGSEH 585 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~--~~vgi~rDITer 585 (998)
..+|..+++.+++.|+.+.. +++.+.+|++..
T Consensus 276 ~~~g~~~~~~v~~~Pi~~~~g~~~v~~l~~~~~~ 309 (638)
T PRK11388 276 ESQGQFIDAVITLKPIIEGQGTSFILLLHPVEQM 309 (638)
T ss_pred ecCCceEEEEEEEEeecccCceEEEEEehhhHHH
Confidence 55788888999999997543 566666776554
|
|
| >PRK11360 sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=5e-07 Score=110.59 Aligned_cols=109 Identities=15% Similarity=0.107 Sum_probs=88.6
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCc-EEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD-VTVQLIN 552 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~-~~~e~~~ 552 (998)
++.++++++++++++|.+|. |+++|+++++++||+.++++|++...+.++.. .....+...+..+.. ...+...
T Consensus 264 ~~~i~~~~~~~i~~~d~~g~---i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 338 (607)
T PRK11360 264 NELILESIADGVIAIDRQGK---ITTMNPAAEVITGLQRHELVGKPYSELFPPNT--PFASPLLDTLEHGTEHVDLEISF 338 (607)
T ss_pred HHHHHHhccCeEEEEcCCCC---EEEECHHHHHHhCCChHHhcCCcHHHHcCCch--hHHHHHHHHHhcCCCccceEEEE
Confidence 67899999999999999777 99999999999999999999999877776542 233445555555544 4456677
Q ss_pred EecCCcEEEEEEEEeeeccCC----EEEEEEecCCccccc
Q 001902 553 YTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEP 588 (998)
Q Consensus 553 ~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~~ 588 (998)
.+++|..+ +.++.+|+.+.+ +++++++|||++|+.
T Consensus 339 ~~~~~~~~-~~~~~~~i~~~~g~~~~~i~~~~Dite~~~~ 377 (607)
T PRK11360 339 PGRDRTIE-LSVSTSLLHNTHGEMIGALVIFSDLTERKRL 377 (607)
T ss_pred EcCCCcEE-EEEEEeeEEcCCCCEEEEEEEEeechHHHHH
Confidence 88888877 889999999765 889999999999963
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 998 | ||||
| 2v0u_A | 146 | N- And C-terminal Helices Of Oat Lov2 (404-546) Are | 1e-63 | ||
| 2v1a_A | 144 | N- And C-Terminal Helices Of Oat Lov2 (404-546) Are | 1e-63 | ||
| 2z6c_A | 129 | Crystal Structure Of Lov1 Domain Of Phototropin1 Fr | 2e-63 | ||
| 2z6c_A | 129 | Crystal Structure Of Lov1 Domain Of Phototropin1 Fr | 2e-22 | ||
| 2wkp_A | 332 | Structure Of A Photoactivatable Rac1 Containing Lov | 4e-63 | ||
| 2wkq_A | 332 | Structure Of A Photoactivatable Rac1 Containing The | 5e-62 | ||
| 2wkr_A | 332 | Structure Of A Photoactivatable Rac1 Containing The | 6e-62 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-55 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-55 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-55 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-55 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-55 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-55 | ||
| 2z6d_A | 130 | Crystal Structure Of Lov1 Domain Of Phototropin2 Fr | 7e-55 | ||
| 2z6d_A | 130 | Crystal Structure Of Lov1 Domain Of Phototropin2 Fr | 5e-24 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-55 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-55 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-54 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-54 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-54 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-54 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-54 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-54 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-53 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-53 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-53 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-53 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-53 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-51 | ||
| 4eep_A | 115 | Crystal Structure Of Lov2 Domain Of Arabidopsis Tha | 5e-51 | ||
| 4eer_A | 115 | Crystal Structure Of Lov2 Domain Of Arabidopsis Tha | 4e-50 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-48 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-48 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-48 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-48 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-48 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-48 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-48 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-48 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-48 | ||
| 4ees_A | 115 | Crystal Structure Of Ilov Length = 115 | 3e-48 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-48 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-48 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-48 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-48 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-48 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-48 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-48 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-48 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-48 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-48 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-48 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-48 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-48 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-48 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-48 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-48 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-48 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-48 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-48 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-48 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-48 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-48 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-48 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-47 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-47 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-47 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-47 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-47 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-47 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-47 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-47 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-47 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-47 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-47 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-47 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-47 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-47 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-47 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-47 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-47 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-47 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-47 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-47 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-47 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-47 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-47 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-47 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-46 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-46 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-46 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-46 | ||
| 4eeu_A | 118 | Crystal Structure Of Philov2.1 Length = 118 | 6e-45 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-44 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-44 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-44 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-44 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-43 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-43 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-43 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-43 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-43 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-43 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-43 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-42 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-42 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-42 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-42 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-42 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-42 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-42 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-42 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-42 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-42 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-42 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-42 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-42 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-42 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-42 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-42 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-42 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-42 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-42 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-41 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-41 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-39 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-38 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-38 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-37 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-37 | ||
| 1g28_A | 104 | Structure Of A Flavin-Binding Domain, Lov2, From Th | 5e-37 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-36 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-36 | ||
| 1n9l_A | 109 | Crystal Structure Of The Phot-lov1 Domain From Chla | 2e-35 | ||
| 1n9l_A | 109 | Crystal Structure Of The Phot-lov1 Domain From Chla | 1e-21 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-31 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-31 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-31 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-31 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-31 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-31 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-30 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-30 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-30 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-30 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-30 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-30 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-30 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-30 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-30 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-30 | ||
| 3ulf_A | 170 | The Light State Structure Of The Blue-light Photore | 6e-30 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-30 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-30 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-30 | ||
| 3ue6_A | 166 | The Dark Structure Of The Blue-light Photoreceptor | 6e-30 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-30 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-30 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-30 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-30 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-30 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-30 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-30 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-29 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-29 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-29 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-29 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-29 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-29 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-29 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-29 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-29 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-29 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-28 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-28 | ||
| 2pr5_A | 132 | Structural Basis For Light-dependent Signaling In T | 5e-27 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-26 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-26 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-26 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-26 | ||
| 3t50_A | 128 | X-Ray Structure Of The Lov Domain From The Lov-Hk S | 4e-26 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-25 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-25 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-25 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-24 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-24 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-24 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-24 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-24 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-24 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-24 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-24 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-24 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-24 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-24 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-24 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-24 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-23 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-23 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-23 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-23 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-23 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-23 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-23 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-23 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-23 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-23 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-23 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-23 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-23 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-23 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-23 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-23 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-23 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-23 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-23 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-23 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-23 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-23 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-23 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-23 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-23 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-23 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-22 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-22 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-22 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-22 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-22 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-22 | ||
| 3p7n_A | 258 | Crystal Structure Of Light Activated Transcription | 5e-22 | ||
| 3p7n_A | 258 | Crystal Structure Of Light Activated Transcription | 6e-18 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-22 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-22 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-22 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-22 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-22 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-21 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-21 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-21 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-21 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-21 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-21 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-21 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-21 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-21 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-21 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-21 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-21 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-21 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-21 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-21 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-21 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-20 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-20 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-20 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-20 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-20 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-20 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-20 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-20 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-20 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-20 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-20 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-19 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-19 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-19 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-19 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-19 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-19 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-19 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-19 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-19 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-18 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-18 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-18 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-18 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-18 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-18 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-18 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-18 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-18 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-18 | ||
| 3hjk_A | 154 | 2.0 Angstrom Structure Of The Ile74val Variant Of V | 8e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-18 | ||
| 3rh8_B | 148 | Crystal Structure Of The Light-State Dimer Of Funga | 9e-18 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-18 | ||
| 3is2_B | 154 | 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic | 1e-17 | ||
| 3hji_A | 154 | 1.8 Angstrom Crystal Structure Of The I74v:i85v Var | 1e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-17 | ||
| 3is2_A | 154 | 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic | 1e-17 | ||
| 2pd8_A | 149 | 1.8 Angstrom Crystal Structure Of The Cys71ser Muta | 2e-17 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-17 | ||
| 2pd7_A | 149 | 2.0 Angstrom Crystal Structure Of The Fungal Blue-L | 2e-17 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-17 | ||
| 3d72_A | 149 | 1.65 Angstrom Crystal Structure Of The Cys71val Var | 2e-17 | ||
| 3sw1_A | 162 | Structure Of A Full-Length Bacterial Lov Protein Le | 2e-17 | ||
| 3sw1_A | 162 | Structure Of A Full-Length Bacterial Lov Protein Le | 5e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-16 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-13 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-13 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 4hia_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-11 | ||
| 4hia_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 1e-09 | ||
| 4hj3_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-11 | ||
| 4hj3_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-11 | ||
| 4hj6_A | 178 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 3e-11 | ||
| 4hj6_A | 178 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-11 | ||
| 4hj4_A | 177 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 3e-11 | ||
| 4hj4_A | 177 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2gj3_A | 120 | Crystal Structure Of The Fad-Containing Pas Domain | 1e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-07 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-07 | ||
| 2l1m_A | 150 | Solution Structure Of The Eag Domain Of The Herg (K | 4e-07 | ||
| 2l1m_A | 150 | Solution Structure Of The Eag Domain Of The Herg (K | 4e-06 | ||
| 2l4r_A | 135 | Nmr Solution Structure Of The N-Terminal Pas Domain | 4e-07 | ||
| 2l4r_A | 135 | Nmr Solution Structure Of The N-Terminal Pas Domain | 4e-06 | ||
| 2l0w_A | 138 | Solution Nmr Structure Of The N-Terminal Pas Domain | 4e-07 | ||
| 2l0w_A | 138 | Solution Nmr Structure Of The N-Terminal Pas Domain | 4e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-07 | ||
| 1byw_A | 110 | Structure Of The N-Terminal Domain Of The Human-Erg | 5e-07 | ||
| 1byw_A | 110 | Structure Of The N-Terminal Domain Of The Human-Erg | 2e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-07 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-07 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-07 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 7e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 7e-07 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 7e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 7e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-07 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 7e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 3ewk_A | 227 | Structure Of The Redox Sensor Domain Of Methylococc | 1e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-06 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-06 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 1e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 2e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-05 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-05 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 |
| >pdb|2V0U|A Chain A, N- And C-terminal Helices Of Oat Lov2 (404-546) Are Involved In Light-induced Signal Transduction (cryo Dark Structure Of Lov2 (404-546)) Length = 146 | Back alignment and structure |
|
| >pdb|2V1A|A Chain A, N- And C-Terminal Helices Of Oat Lov2 (404-546) Are Involved In Light-Induced Signal Transduction (Room Temperature (293k) Dark Structure Of Lov2 (404-546)) Length = 144 | Back alignment and structure |
|
| >pdb|2Z6C|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin1 From Arabidopsis Thaliana Length = 129 | Back alignment and structure |
|
| >pdb|2Z6C|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin1 From Arabidopsis Thaliana Length = 129 | Back alignment and structure |
|
| >pdb|2WKP|A Chain A, Structure Of A Photoactivatable Rac1 Containing Lov2 Wildtype Length = 332 | Back alignment and structure |
|
| >pdb|2WKQ|A Chain A, Structure Of A Photoactivatable Rac1 Containing The Lov2 C450a Mutant Length = 332 | Back alignment and structure |
|
| >pdb|2WKR|A Chain A, Structure Of A Photoactivatable Rac1 Containing The Lov2 C450m Mutant Length = 332 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Z6D|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin2 From Arabidopsis Thaliana Length = 130 | Back alignment and structure |
|
| >pdb|2Z6D|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin2 From Arabidopsis Thaliana Length = 130 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EEP|A Chain A, Crystal Structure Of Lov2 Domain Of Arabidopsis Thaliana Phototropin 2 Length = 115 | Back alignment and structure |
|
| >pdb|4EER|A Chain A, Crystal Structure Of Lov2 Domain Of Arabidopsis Thaliana Phototropin 2 C426a Mutant Length = 115 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4EES|A Chain A, Crystal Structure Of Ilov Length = 115 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EEU|A Chain A, Crystal Structure Of Philov2.1 Length = 118 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1G28|A Chain A, Structure Of A Flavin-Binding Domain, Lov2, From The Chimeric PhytochromePHOTOTROPIN PHOTORECEPTOR PHY3 Length = 104 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1N9L|A Chain A, Crystal Structure Of The Phot-lov1 Domain From Chlamydomonas Reinhardtii In The Dark State. Length = 109 | Back alignment and structure |
|
| >pdb|1N9L|A Chain A, Crystal Structure Of The Phot-lov1 Domain From Chlamydomonas Reinhardtii In The Dark State. Length = 109 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3ULF|A Chain A, The Light State Structure Of The Blue-light Photoreceptor Aureochrome1 Lov Length = 170 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3UE6|A Chain A, The Dark Structure Of The Blue-light Photoreceptor Aureochrome1 Lov Length = 166 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2PR5|A Chain A, Structural Basis For Light-dependent Signaling In The Dimeric Lov Photosensor Ytva (dark Structure) Length = 132 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3T50|A Chain A, X-Ray Structure Of The Lov Domain From The Lov-Hk Sensory Protein From Brucella Abortus (Dark State). Length = 128 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3P7N|A Chain A, Crystal Structure Of Light Activated Transcription Factor El222 From Erythrobacter Litoralis Length = 258 | Back alignment and structure |
|
| >pdb|3P7N|A Chain A, Crystal Structure Of Light Activated Transcription Factor El222 From Erythrobacter Litoralis Length = 258 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3HJK|A Chain A, 2.0 Angstrom Structure Of The Ile74val Variant Of Vivid (Vvd). Length = 154 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3RH8|B Chain B, Crystal Structure Of The Light-State Dimer Of Fungal Blue-Light Photoreceptor Vivid Length = 148 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3IS2|B Chain B, 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic Acid Form Of Vivid Length = 154 | Back alignment and structure |
|
| >pdb|3HJI|A Chain A, 1.8 Angstrom Crystal Structure Of The I74v:i85v Variant Of Vivid (Vvd). Length = 154 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3IS2|A Chain A, 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic Acid Form Of Vivid Length = 154 | Back alignment and structure |
|
| >pdb|2PD8|A Chain A, 1.8 Angstrom Crystal Structure Of The Cys71ser Mutant Of Vivid Length = 149 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2PD7|A Chain A, 2.0 Angstrom Crystal Structure Of The Fungal Blue-Light Photoreceptor Vivid Length = 149 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3D72|A Chain A, 1.65 Angstrom Crystal Structure Of The Cys71val Variant In The Fungal Photoreceptor Vvd Length = 149 | Back alignment and structure |
|
| >pdb|3SW1|A Chain A, Structure Of A Full-Length Bacterial Lov Protein Length = 162 | Back alignment and structure |
|
| >pdb|3SW1|A Chain A, Structure Of A Full-Length Bacterial Lov Protein Length = 162 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4HIA|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|4HIA|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|4HJ3|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|4HJ3|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4HJ6|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 178 | Back alignment and structure |
|
| >pdb|4HJ6|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 178 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4HJ4|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 177 | Back alignment and structure |
|
| >pdb|4HJ4|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 177 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GJ3|A Chain A, Crystal Structure Of The Fad-Containing Pas Domain Of The Protein Nifl From Azotobacter Vinelandii. Length = 120 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2L1M|A Chain A, Solution Structure Of The Eag Domain Of The Herg (Kv11.1) K+ Channel Length = 150 | Back alignment and structure |
|
| >pdb|2L1M|A Chain A, Solution Structure Of The Eag Domain Of The Herg (Kv11.1) K+ Channel Length = 150 | Back alignment and structure |
|
| >pdb|2L4R|A Chain A, Nmr Solution Structure Of The N-Terminal Pas Domain Of Herg Length = 135 | Back alignment and structure |
|
| >pdb|2L4R|A Chain A, Nmr Solution Structure Of The N-Terminal Pas Domain Of Herg Length = 135 | Back alignment and structure |
|
| >pdb|2L0W|A Chain A, Solution Nmr Structure Of The N-Terminal Pas Domain Of Herg Potassium Channel Length = 138 | Back alignment and structure |
|
| >pdb|2L0W|A Chain A, Solution Nmr Structure Of The N-Terminal Pas Domain Of Herg Potassium Channel Length = 138 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1BYW|A Chain A, Structure Of The N-Terminal Domain Of The Human-Erg Potassium Channel Length = 110 | Back alignment and structure |
|
| >pdb|1BYW|A Chain A, Structure Of The N-Terminal Domain Of The Human-Erg Potassium Channel Length = 110 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3EWK|A Chain A, Structure Of The Redox Sensor Domain Of Methylococcus Capsulatus (Bath) Mmos Length = 227 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 998 | |||
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-119 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-113 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-112 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-112 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-112 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-112 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-112 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-110 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-109 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-109 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-108 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-108 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-108 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-106 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-106 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-106 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-105 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-105 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-103 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-103 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-103 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-99 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-86 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-85 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-73 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-71 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 9e-69 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-68 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 5e-67 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-66 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-62 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 3e-62 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 7e-53 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 7e-62 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 3e-40 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 9e-61 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 4e-54 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-59 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 6e-59 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-58 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-58 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 4e-58 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 5e-58 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 8e-52 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 5e-58 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-57 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-57 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-57 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-57 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 4e-57 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 6e-57 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 7e-57 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 9e-57 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-56 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-56 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-56 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-56 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-56 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-56 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-56 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-56 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 6e-56 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 7e-56 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-56 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-55 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 1e-55 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 9e-55 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-55 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-55 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 5e-55 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 3e-54 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-55 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 6e-55 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 7e-55 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 9e-55 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-54 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-54 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-54 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 4e-54 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 8e-52 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 5e-54 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-53 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-53 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 2e-53 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 1e-49 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 6e-53 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 9e-53 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 3e-51 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-52 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 1e-52 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 2e-49 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-52 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-52 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-52 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-52 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 3e-52 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 6e-51 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-52 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 4e-52 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 3e-50 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 9e-52 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-50 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-50 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-50 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-50 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-50 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 6e-50 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-49 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-49 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 4e-49 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 6e-48 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 6e-49 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-48 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-48 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-47 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-47 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 6e-47 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-46 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-46 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-06 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-46 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 6e-44 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 4e-43 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 5e-41 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 6e-41 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 4e-36 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-35 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-35 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-35 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-35 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-35 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 5e-35 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 7e-35 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-34 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-34 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-34 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 5e-34 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 9e-34 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-33 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-33 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-33 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 5e-33 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 9e-33 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-32 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-32 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-31 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-31 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-31 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-30 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-30 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-26 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 4e-26 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 8e-26 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-25 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-25 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-24 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-24 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-23 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 3e-23 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 3e-22 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 2e-19 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 1e-15 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 5e-23 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 8e-23 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-22 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-22 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-22 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-22 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-22 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-22 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 5e-22 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 7e-22 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-21 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-21 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-21 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-21 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 7e-21 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 8e-21 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 5e-12 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-20 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-20 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-20 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-20 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 6e-20 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 7e-20 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 9e-20 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-19 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-19 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-19 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-19 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-19 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-19 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-19 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-19 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-19 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-19 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 3e-19 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 3e-13 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 3e-19 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 4e-19 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 5e-19 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 5e-19 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 7e-19 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 9e-19 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-18 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-18 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-18 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-18 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-18 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-18 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 5e-18 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 8e-18 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 8e-18 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 9e-18 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-17 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-17 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-17 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-17 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-17 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 4e-17 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-17 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-17 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 5e-17 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 7e-17 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 7e-17 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-16 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-16 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-16 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-16 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-16 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-08 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-16 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 6e-16 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 7e-16 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 8e-16 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-15 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-15 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-15 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-15 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 5e-15 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-14 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-14 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 5e-14 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 7e-14 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 9e-14 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 6e-13 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-12 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-12 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-12 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-12 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-12 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 4e-12 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 5e-09 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 8e-12 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-11 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-11 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 4e-11 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 6e-11 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 7e-11 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 8e-11 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 9e-11 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 4e-10 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 5e-10 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 7e-10 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 8e-10 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-09 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-09 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-08 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 7e-08 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 1e-07 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 1e-07 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 1e-07 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 2e-04 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-07 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 3e-07 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 7e-07 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 5e-07 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 5e-07 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 1e-06 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 2e-05 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 8e-06 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 9e-06 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 3e-05 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-05 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-05 | |
| 3eeh_A | 125 | Putative light and redox sensing histidine kinase; | 3e-05 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 6e-05 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 7e-05 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 9e-04 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 2e-04 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 3e-04 |
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 366 bits (943), Expect = e-119
Identities = 104/315 (33%), Positives = 155/315 (49%), Gaps = 31/315 (9%)
Query: 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 719
+ + F+ K LG G +V L + + +A+K ++K ++ NKV ER+++
Sbjct: 25 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 84
Query: 720 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 779
LDHPF LY +FQ + Y GEL + + E RFY AE+V A
Sbjct: 85 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSA 142
Query: 780 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
LEYLH +GII+RDLKPEN+LL + H+ +TDF K +L +++ R
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT-----AK---VLSPESKQAR------ 188
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899
+NSFVGT +Y++PE++ + D WALG ++Y+++ G PFR
Sbjct: 189 -----------ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237
Query: 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS--HEGANEIKKHPFFKGV 957
F I+ + FP A+ L+ +LL D RLG EG +K HPFF+ V
Sbjct: 238 YLIFQKIIKLEYDFPEK--FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295
Query: 958 NWALVRCMNPPELDA 972
W + PP+L A
Sbjct: 296 TWENLHQQTPPKLTA 310
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 350 bits (900), Expect = e-113
Identities = 118/322 (36%), Positives = 176/322 (54%), Gaps = 38/322 (11%)
Query: 653 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKV 709
+ + E+ + F +K LG G G V LV+ + Q +AMK + K + R++V
Sbjct: 12 HHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV 71
Query: 710 HRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV 769
ER+IL ++HPF+ L+ +FQT+ + LI D+ GG+LF L ++ + E+ V
Sbjct: 72 R-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDV 128
Query: 770 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829
+FY AE+ +AL++LH GIIYRDLKPEN+LL GH+ LTDF L K +
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL-----SKESIDHEKK- 182
Query: 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 889
+ SF GT EY+APE++ GHT + DWW+ G+L++EML
Sbjct: 183 ---------------------AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221
Query: 890 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEI 948
G PF+GK R++T IL L P S A+ L+ L R+P +RLG+ +G EI
Sbjct: 222 GTLPFQGKDRKETMTMILKAKLGMPQF--LSPEAQSLLRMLFKRNPANRLGAGPDGVEEI 279
Query: 949 KKHPFFKGVNWALV--RCMNPP 968
K+H FF ++W + R ++PP
Sbjct: 280 KRHSFFSTIDWNKLYRREIHPP 301
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 348 bits (896), Expect = e-112
Identities = 123/323 (38%), Positives = 174/323 (53%), Gaps = 38/323 (11%)
Query: 653 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNK- 708
+ E+I + F ++ LG G G V V +G+ FAMK + K +++ K
Sbjct: 5 TSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD 64
Query: 709 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 768
AER IL+ + HPF+ L +FQT + LI +Y GGELF+ L+R+ + ED
Sbjct: 65 TAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDT 122
Query: 769 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 828
FY AE+ +AL +LH +GIIYRDLKPEN++L GHV LTDF L CK
Sbjct: 123 ACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL-----CK-------- 169
Query: 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 888
+ + ++F GT EY+APEI+ +GH AVDWW+LG L+Y+ML
Sbjct: 170 -------------ESIHDGTVT-HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDML 215
Query: 889 YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANE 947
G PF G+ R+KT IL L P + A+ L+ +LL R+ SRLG+ A E
Sbjct: 216 TGAPPFTGENRKKTIDKILKCKLNLPPY--LTQEARDLLKKLLKRNAASRLGAGPGDAGE 273
Query: 948 IKKHPFFKGVNWALV--RCMNPP 968
++ HPFF+ +NW + R + PP
Sbjct: 274 VQAHPFFRHINWEELLARKVEPP 296
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 347 bits (894), Expect = e-112
Identities = 120/349 (34%), Positives = 182/349 (52%), Gaps = 46/349 (13%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 720
+ +LQ F+ ++ LG+G G VHL+ +G+Y+AMK + K +++ +V ER +L
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
++ HPF+ ++ +FQ + +I DY GGELF LL + + +FYAAEV +AL
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLAL 119
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
EYLH + IIYRDLKPEN+LL NGH+ +TDF K
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGF-----AK-------------------- 154
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
+ + GT +YIAPE+++ + ++DWW+ GIL+YEML GYTPF
Sbjct: 155 -----YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 209
Query: 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNW 959
KT+ IL+ +L+FP + K L+ RL+ RD RLG+ G ++K HP+FK V W
Sbjct: 210 KTYEKILNAELRFPPF--FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267
Query: 960 ALV--RCMNPP--------ELDAPLFATDTEKEYKVVDPGMQDLQQNVF 998
+ R + P + D F E++ G +D ++F
Sbjct: 268 EKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDINYGVQG-EDPYADLF 315
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 349 bits (897), Expect = e-112
Identities = 113/329 (34%), Positives = 162/329 (49%), Gaps = 34/329 (10%)
Query: 643 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV 702
P + I S F +K +G G G V L ++A+K + K
Sbjct: 16 APPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKA 75
Query: 703 MLNRNKVHRACAEREILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 761
+L + + +ER +L + HPF+ L+ SFQT + + DY GGELF L R+
Sbjct: 76 ILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-- 133
Query: 762 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821
+ E RFYAAE+ AL YLH I+YRDLKPEN+LL GH+ LTDF L CK
Sbjct: 134 RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL-----CKE 188
Query: 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 881
+ +T +++F GT EY+APE++ + VDWW LG
Sbjct: 189 NIEHNST----------------------TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLG 226
Query: 882 ILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS 941
+LYEMLYG PF + + + NIL+K L+ + + A+ L+ LL +D RLG+
Sbjct: 227 AVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN--ITNSARHLLEGLLQKDRTKRLGA 284
Query: 942 HEGANEIKKHPFFKGVNWALV--RCMNPP 968
+ EIK H FF +NW + + + PP
Sbjct: 285 KDDFMEIKSHVFFSLINWDDLINKKITPP 313
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 350 bits (900), Expect = e-112
Identities = 108/356 (30%), Positives = 167/356 (46%), Gaps = 49/356 (13%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 720
++ + + +K +G G G V LV + + +AMK + K M+ R+ ER+I+
Sbjct: 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
+ P+V L+ +FQ ++ ++ +Y PGG+L L+ + E RFY AEVV+AL
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLAL 181
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
+ +H G I+RD+KP+N+LL +GH+ L DF K +G
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC----------------MKMNKEGMVR 225
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEMLYGYTPFRG 896
++ VGT +YI+PE++ G + DWW++G+ LYEML G TPF
Sbjct: 226 ----------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275
Query: 897 KTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
+ T++ I++ L FP S AK L+ L D + RLG + G EIK+H FF
Sbjct: 276 DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGRN-GVEEIKRHLFF 333
Query: 955 KGVNWA--LVRCMNPP-------ELDAPLF---ATDTEKEYKVVDPGMQDLQQNVF 998
K WA +R P ++D F D +E P Q F
Sbjct: 334 KNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPF 389
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 347 bits (893), Expect = e-112
Identities = 113/311 (36%), Positives = 170/311 (54%), Gaps = 34/311 (10%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 720
++ + F +K LG G G V LV +G+Y+AMK + K V++ +++V E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
HPF+ AL +FQT +C + +Y GGELF L R+ +V E+ RFY AE+V AL
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSAL 118
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
EYLH + ++YRD+K EN++L +GH+ +TDF L CK +
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL-----CKEGI----------------- 156
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +
Sbjct: 157 -----SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211
Query: 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNW 959
+ F IL ++++FP + S AK L+ LL +DPK RLG A E+ +H FF +NW
Sbjct: 212 RLFELILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269
Query: 960 ALV--RCMNPP 968
V + + PP
Sbjct: 270 QDVVQKKLLPP 280
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 347 bits (893), Expect = e-110
Identities = 102/318 (32%), Positives = 159/318 (50%), Gaps = 39/318 (12%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 720
++ F +K +G G V +V++ +GQ +AMK M+K ML R +V ER++L
Sbjct: 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV 116
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
D ++ L+ +FQ + ++ L+ +Y GG+L LL + + + + RFY AE+V+A+
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAI 175
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
+ +H G ++RD+KP+N+LL GH+ L DF K R G
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC----------------LKLRADGTVR 219
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAG-------HTSAVDWWALGILLYEMLYGYTP 893
S VGT +Y++PEI+ G + DWWALG+ YEM YG TP
Sbjct: 220 ----------SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
Query: 894 FRGKTRQKTFANILHKD--LKFPSSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950
F + +T+ I+H L P A+ + RLL P++RLG GA + +
Sbjct: 270 FYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGRG-GAGDFRT 327
Query: 951 HPFFKGVNWALVRCMNPP 968
HPFF G++W +R PP
Sbjct: 328 HPFFFGLDWDGLRDSVPP 345
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 342 bits (879), Expect = e-109
Identities = 101/315 (32%), Positives = 160/315 (50%), Gaps = 35/315 (11%)
Query: 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 717
+ +++ L F + LG G G V L E G+ + +A+K + K V++ + V E+
Sbjct: 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 718 ILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 776
+L + PF+ L++ FQT + + +Y GG+L + + KE FYAAE+
Sbjct: 73 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEI 130
Query: 777 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
+ L +L +GIIYRDLK +NV+L GH+ + DF + CK + T
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKENIWDGVT-------- 177
Query: 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896
+ +F GT +YIAPEIIA + +VDWWA G+LLYEML G PF G
Sbjct: 178 --------------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223
Query: 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFK 955
+ + F +I+ ++ +P S S A + L+ + P RLG G +IK+H FF+
Sbjct: 224 EDEDELFQSIMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281
Query: 956 GVNWALV--RCMNPP 968
++W + + + PP
Sbjct: 282 YIDWEKLERKEIQPP 296
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 344 bits (883), Expect = e-109
Identities = 102/317 (32%), Positives = 165/317 (52%), Gaps = 37/317 (11%)
Query: 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 719
+++ + F +K +G G G V +V+L + + FAMK ++K ML R + ER++L
Sbjct: 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL 128
Query: 720 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 779
D ++ L+ +FQ ++ L+ DY GG+L LL + + L E+ RFY AE+V+A
Sbjct: 129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIA 187
Query: 780 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
++ +H ++RD+KP+N+L+ NGH+ L DF C
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS-----CLK------------------ 224
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPF 894
M + S+ VGT +YI+PEI+ + DWW+LG+ +YEMLYG TPF
Sbjct: 225 ---LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281
Query: 895 RGKTRQKTFANILHK--DLKFPSSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951
++ +T+ I++ +FP+ S +AK L+ RL+ RLG + G + KKH
Sbjct: 282 YAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREH-RLGQN-GIEDFKKH 339
Query: 952 PFFKGVNWALVRCMNPP 968
PFF G++W +R P
Sbjct: 340 PFFSGIDWDNIRNCEAP 356
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 339 bits (872), Expect = e-108
Identities = 107/316 (33%), Positives = 163/316 (51%), Gaps = 36/316 (11%)
Query: 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 717
S ++ + +F I+ LG G G V L + +G +A+K + K V+L + V E+
Sbjct: 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 718 IL-DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 776
IL +HPF+ L+ FQT + + ++ GG+L + + + E RFYAAE+
Sbjct: 76 ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEI 133
Query: 777 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
+ AL +LH +GIIYRDLK +NVLL GH L DF + CK + T
Sbjct: 134 ISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM-----CKEGICNGVT-------- 180
Query: 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896
+ +F GT +YIAPEI+ + AVDWWA+G+LLYEML G+ PF
Sbjct: 181 --------------TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226
Query: 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFF 954
+ F IL+ ++ +P+ A ++ + ++P RLGS G + I +HPFF
Sbjct: 227 ENEDDLFEAILNDEVVYPTW--LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
Query: 955 KGVNWALV--RCMNPP 968
K ++WA + R + PP
Sbjct: 285 KEIDWAQLNHRQIEPP 300
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 339 bits (871), Expect = e-108
Identities = 102/314 (32%), Positives = 168/314 (53%), Gaps = 37/314 (11%)
Query: 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 717
++ ++ F K LG G G V L E + Q+FA+KA+ K V+L + V E+
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 718 ILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 776
+L + +HPF+ ++ +FQTK ++ + +Y GG+L + FYAAE+
Sbjct: 70 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEI 127
Query: 777 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
++ L++LH +GI+YRDLK +N+LL +GH+ + DF + CK +L
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGM-----CKENMLGDAK-------- 174
Query: 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896
+N+F GT +YIAPEI+ G + +VDWW+ G+LLYEML G +PF G
Sbjct: 175 --------------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
Query: 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
+ ++ F +I + +P AK L+ +L R+P+ RLG +I++HP F+
Sbjct: 221 QDEEELFHSIRMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGVRG---DIRQHPLFRE 275
Query: 957 VNWALV--RCMNPP 968
+NW + + ++PP
Sbjct: 276 INWEELERKEIDPP 289
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 337 bits (867), Expect = e-108
Identities = 111/351 (31%), Positives = 163/351 (46%), Gaps = 47/351 (13%)
Query: 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 717
S L F IK LG+G G V LV+ SG ++AMK +DK ++ ++ E+
Sbjct: 34 SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 718 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 777
IL ++ PF+ L SF+ +++ ++ +Y GGE+F L R E RFYAA++V
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIV 151
Query: 778 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
+ EYLH +IYRDLKPEN+L+ G++ +TDF K
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF-----AK----------------- 189
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897
+ + GT E +APEII G+ AVDWWALG+L+YEM GY PF
Sbjct: 190 --------RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241
Query: 898 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKG 956
+ + I+ ++FPS S K L+ LL D R G+ G N+IK H +F
Sbjct: 242 QPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
Query: 957 VNWALV--RCMNPP-------ELDAPLFATDTEKEYKVVDPGMQDLQQNVF 998
+W + R + P D F E+E + + + F
Sbjct: 300 TDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEE---IRVSINEKCGKEF 347
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 338 bits (868), Expect = e-106
Identities = 123/366 (33%), Positives = 184/366 (50%), Gaps = 36/366 (9%)
Query: 607 QTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQH 666
+T E E + + A P +S + + ++ +
Sbjct: 91 ETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSP-SDNSGAEEMEVSLAKPKHRVTMNE 149
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
F +K LG G G V LV+ +G+Y+AMK + K V++ +++V E +L HPF
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
+ AL SFQT +C + +Y GGELF L R+ +V ED RFY AE+V AL+YLH +
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSE 267
Query: 787 -GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
++YRDLK EN++L +GH+ +TDF L CK + T
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGL-----CKEGIKDGAT----------------- 305
Query: 846 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +K F
Sbjct: 306 -----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 360
Query: 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALV-- 962
IL ++++FP + AK L+ LL +DPK RLG A EI +H FF G+ W V
Sbjct: 361 ILMEEIRFPRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYE 418
Query: 963 RCMNPP 968
+ ++PP
Sbjct: 419 KKLSPP 424
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-106
Identities = 110/325 (33%), Positives = 174/325 (53%), Gaps = 45/325 (13%)
Query: 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 717
+ + + LQ F ++ +G G V LV L + + +AMK + K ++ + + E+
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 718 ILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 776
+ + +HPF+ L++ FQT++ + + +Y GG+L + RQ + L E+ RFY+AE+
Sbjct: 62 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEI 119
Query: 777 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
+AL YLH +GIIYRDLK +NVLL GH+ LTD+ + CK L
Sbjct: 120 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM-----CKEGL------------- 161
Query: 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF-- 894
P +++F GT YIAPEI+ G + +VDWWALG+L++EM+ G +PF
Sbjct: 162 ---------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212
Query: 895 -------RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GA 945
T F IL K ++ P S S+ A ++ L++DPK RLG H G
Sbjct: 213 VGSSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGF 270
Query: 946 NEIKKHPFFKGVNWALV--RCMNPP 968
+I+ HPFF+ V+W ++ + + PP
Sbjct: 271 ADIQGHPFFRNVDWDMMEQKQVVPP 295
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-106
Identities = 120/325 (36%), Positives = 177/325 (54%), Gaps = 44/325 (13%)
Query: 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNK-VHRAC 713
E++ +++F +K LG+G G V LV +G+ +AMK + K ++ + K
Sbjct: 47 HAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 106
Query: 714 AEREILDMLDH-PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFY 772
ER++L+ + PF+ L+ +FQT+T + LI DY GGELF L ++ + E V+ Y
Sbjct: 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIY 164
Query: 773 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 832
E+V+ALE+LH GIIYRD+K EN+LL NGHV LTDF L K
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL-----SK------------ 207
Query: 833 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYG 890
F+A+ + F GT EY+AP+I+ G GH AVDWW+LG+L+YE+L G
Sbjct: 208 ---------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
Query: 891 YTPF----RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGA 945
+PF ++ + IL + +P S AK L+ RLL +DPK RLG A
Sbjct: 259 ASPFTVDGEKNSQAEISRRILKSEPPYPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDA 316
Query: 946 NEIKKHPFFKGVNWALV--RCMNPP 968
+EIK+H FF+ +NW + + + P
Sbjct: 317 DEIKEHLFFQKINWDDLAAKKVPAP 341
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 333 bits (856), Expect = e-105
Identities = 93/322 (28%), Positives = 160/322 (49%), Gaps = 43/322 (13%)
Query: 655 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA 714
+ D E +N HF ++ +G G G V +V+ + + +AMK M+K + RN+V
Sbjct: 5 VFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 715 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 774
E +I+ L+HPF+ L+ SFQ + + ++ D GG+L L + KE+ V+ +
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFIC 122
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
E+V+AL+YL Q II+RD+KP+N+LL +GHV +TDF++
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNI-----AA-------------- 163
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGY 891
M + GT+ Y+APE+ + GAG++ AVDWW+LG+ YE+L G
Sbjct: 164 ---------MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
Query: 892 TPFRGKT---RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948
P+ ++ ++ + +PS+ S L+ +LL +P R +++
Sbjct: 215 RPYHIRSSTSSKEIVHTFETTVVTYPSA--WSQEMVSLLKKLLEPNPDQRFS---QLSDV 269
Query: 949 KKHPFFKGVNWALV--RCMNPP 968
+ P+ +NW V + + P
Sbjct: 270 QNFPYMNDINWDAVFQKRLIPG 291
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 331 bits (851), Expect = e-105
Identities = 110/363 (30%), Positives = 178/363 (49%), Gaps = 45/363 (12%)
Query: 620 PDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTG 679
+ N ++ ++ + + LQ F ++ +G G
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYA 66
Query: 680 SVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPALYASFQTKT 738
V LV L + + +AM+ + K ++ + + E+ + +HPF+ L++ FQT++
Sbjct: 67 KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126
Query: 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 798
+ + +Y GG+L + RQ + L E+ RFY+AE+ +AL YLH +GIIYRDLK +NV
Sbjct: 127 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184
Query: 799 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 858
LL GH+ LTD+ + CK L P +++F GT
Sbjct: 185 LLDSEGHIKLTDYGM-----CKEGL----------------------RPGDTTSTFCGTP 217
Query: 859 EYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF---------RGKTRQKTFANILHK 909
YIAPEI+ G + +VDWWALG+L++EM+ G +PF T F IL K
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277
Query: 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFFKGVNWALV--RCM 965
++ P S S+ A ++ L++DPK RLG H G +I+ HPFF+ V+W ++ + +
Sbjct: 278 QIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQV 335
Query: 966 NPP 968
PP
Sbjct: 336 VPP 338
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 334 bits (857), Expect = e-103
Identities = 96/422 (22%), Positives = 170/422 (40%), Gaps = 49/422 (11%)
Query: 591 NSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWK 650
+ + V + + + + P L + + WK
Sbjct: 117 PQAQLFCSFLDAETVARARAGAGDGLFQ-PLLRAVLAHLGQAPFQEFLDSLYFLRFLQWK 175
Query: 651 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 710
++ + + F + LG G G V ++ +G+ +A K ++K + R
Sbjct: 176 WLEA-----QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ 230
Query: 711 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF--LLLDRQPTKVLKEDA 768
A E++IL + F+ +L +F+TKT +CL+ GG++ + + +E
Sbjct: 231 GAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR 290
Query: 769 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 828
FY A++V LE+LH + IIYRDLKPENVLL +G+V ++D L+
Sbjct: 291 AIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE------------ 338
Query: 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 888
A + + GT ++APE++ G + +VD++ALG+ LYEM+
Sbjct: 339 --------------LKAGQTKT-KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
Query: 889 YGYTPFRGK----TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE- 943
PFR + ++ +L + + +P S +K LL +DP+ RLG +
Sbjct: 384 AARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPASKDFCEALLQKDPEKRLGFRDG 441
Query: 944 GANEIKKHPFFKGVNW-ALVRCMNPPELDAPLFA------TDTEKEYKVVDPGMQDLQQN 996
+ ++ HP F+ ++W L M P D V +
Sbjct: 442 SCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFSTVKGVAFEKADTE 501
Query: 997 VF 998
F
Sbjct: 502 FF 503
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-103
Identities = 114/431 (26%), Positives = 187/431 (43%), Gaps = 58/431 (13%)
Query: 589 LRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKV-VHPKPHRKDSP 647
+N + + ++ +Q N + +++ P +L E H + V P DS
Sbjct: 106 TQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSI 165
Query: 648 ------PWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 701
WK +++ + + FR + LG G G V ++ +G+ +A K ++K
Sbjct: 166 YFNRFLQWKWLER-----QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK 220
Query: 702 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 761
+ R A E++IL+ ++ FV +L +++TK +CL+ GG+L +
Sbjct: 221 RIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ 280
Query: 762 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821
E FYAAE+ LE LH + I+YRDLKPEN+LL +GH+ ++D L
Sbjct: 281 AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL-----AVH 335
Query: 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 881
+ E VGT Y+APE++ +T + DWWALG
Sbjct: 336 ----------------------VPEGQTI-KGRVGTVGYMAPEVVKNERYTFSPDWWALG 372
Query: 882 ILLYEMLYGYTPFRGK----TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKS 937
LLYEM+ G +PF+ + R++ + ++ S A+ L +LL +DP
Sbjct: 373 CLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQARSLCSQLLCKDPAE 430
Query: 938 RLGSHE-GANEIKKHPFFKGVNW-ALVRCMNPP----------ELDAPLFATDTEKEYKV 985
RLG A E+K+HP FK +N+ L M P D + +
Sbjct: 431 RLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVE 490
Query: 986 VDPGMQDLQQN 996
++P QD Q
Sbjct: 491 LEPTDQDFYQK 501
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 336 bits (864), Expect = e-103
Identities = 104/355 (29%), Positives = 168/355 (47%), Gaps = 35/355 (9%)
Query: 618 ELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGD 677
E + N + K + + + + +++ L F + LG G
Sbjct: 294 EGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGS 353
Query: 678 TGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPALYASFQT 736
G V L E G+ + +A+K + K V++ + V E+ +L + PF+ L++ FQT
Sbjct: 354 FGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 413
Query: 737 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPE 796
+ + +Y GG+L + + KE FYAAE+ + L +L +GIIYRDLK +
Sbjct: 414 MDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 471
Query: 797 NVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG 856
NV+L GH+ + DF + CK + T + +F G
Sbjct: 472 NVMLDSEGHIKIADFGM-----CKENIWDGVT----------------------TKTFCG 504
Query: 857 TEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSS 916
T +YIAPEIIA + +VDWWA G+LLYEML G PF G+ + F +I+ ++ +P S
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS 564
Query: 917 TPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALV--RCMNPP 968
S A + L+ + P RLG G +IK+H FF+ ++W + + + PP
Sbjct: 565 --MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP 617
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 326 bits (838), Expect = 3e-99
Identities = 105/387 (27%), Positives = 181/387 (46%), Gaps = 47/387 (12%)
Query: 594 PEATAEESEKLVKQTAENVNEAVKELPDANLTP--EDLWANHSKVVHPKPHRKDSPPWKA 651
+ S+ ++ ++ + K++P P E++ N V K D
Sbjct: 118 LACSHPFSKSAIEHVQGHLVK--KQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFC 175
Query: 652 IQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR 711
K ++ + + F + +G G G V+ +G+ +AMK +DK + +
Sbjct: 176 QWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL 235
Query: 712 ACAEREILDML---DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 768
A ER +L ++ D PF+ + +F T + I D GG+L L + V E
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEAD 293
Query: 769 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 828
+RFYAAE+++ LE++H + ++YRDLKP N+LL +GHV ++D L+
Sbjct: 294 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-------------- 339
Query: 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEM 887
K + ++ VGT Y+APE++ G + S+ DW++LG +L+++
Sbjct: 340 ---CDFSKKK------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384
Query: 888 LYGYTPFRG---KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-E 943
L G++PFR K + + L ++ P S S + L+ LL RD RLG
Sbjct: 385 LRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGR 442
Query: 944 GANEIKKHPFFKGVNWALV--RCMNPP 968
GA E+K+ PFF+ ++W +V + PP
Sbjct: 443 GAQEVKESPFFRSLDWQMVFLQKYPPP 469
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 277 bits (712), Expect = 2e-86
Identities = 92/306 (30%), Positives = 129/306 (42%), Gaps = 37/306 (12%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 720
Q L+ F +PLG G G+V+L S A+K + K + H+ E EI
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
L HP + LY F T V LI +Y P G ++ L + E Y E+ AL
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANAL 122
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
Y H + +I+RD+KPEN+LL G + + DF S RR
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA------------PSSRRT----- 165
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
GT +Y+ PE+I G H VD W+LG+L YE L G PF T Q
Sbjct: 166 ------------DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213
Query: 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 960
+T+ I + FP + A+ L+ RLL +P R E+ +HP+ +
Sbjct: 214 ETYKRISRVEFTFPDF--VTEGARDLISRLLKHNPSQRPMLR----EVLEHPWITANSSK 267
Query: 961 LVRCMN 966
C N
Sbjct: 268 PSNCQN 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 1e-85
Identities = 83/295 (28%), Positives = 127/295 (43%), Gaps = 37/295 (12%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 720
+ + F +PLG G G+V+L + A+K + K + H+ E EI
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
L HP + +Y F + + L+ ++ P GEL+ L + E + E+ AL
Sbjct: 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADAL 127
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
Y H + +I+RD+KPEN+L+ G + + DF S RR
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA------------PSLRRR----- 170
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
+ GT +Y+ PE+I G H VD W G+L YE L G PF +
Sbjct: 171 ------------TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 218
Query: 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+T I++ DLKFP S +K L+ +LL P RL + +HP+ K
Sbjct: 219 ETHRRIVNVDLKFPPF--LSDGSKDLISKLLRYHPPQRL----PLKGVMEHPWVK 267
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 2e-73
Identities = 71/378 (18%), Positives = 137/378 (36%), Gaps = 90/378 (23%)
Query: 627 EDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVEL 686
+D+ +N+S +++ + K+ + + +R I+ L G + L E
Sbjct: 7 KDILSNYSNLIYLNKYVKE--------------KDKYINDYRIIRTLNQGKFNKIILCE- 51
Query: 687 CGSGQYFAMKAMDKGVMLNRNKVHRACA--------------EREILDMLDHPFVPALYA 732
+++A+K +K ++ + ++ E +I+ + + +
Sbjct: 52 -KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110
Query: 733 SFQTKTHVCLITDYCPGGELF------LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
V +I +Y + +LD+ T + ++ V+ + Y+H +
Sbjct: 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170
Query: 787 -GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
I +RD+KP N+L+ NG V L+DF S K+
Sbjct: 171 KNICHRDVKPSNILMDKNGRVKLSDFGESEYM------------VDKKIK---------- 208
Query: 846 EPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRGK-TRQKT 902
GT E++ PE + + + VD W+LGI LY M Y PF K + +
Sbjct: 209 -------GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261
Query: 903 FANILHKDLKFPSSTPT-----------------SLHAKQLMYRLLHRDPKSRLGSHEGA 945
F NI K++++P S + L ++P R+ S
Sbjct: 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE--- 318
Query: 946 NEIKKHPFFKGVNWALVR 963
+ KH + N +R
Sbjct: 319 -DALKHEWLADTNIEDLR 335
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 2e-71
Identities = 71/308 (23%), Positives = 124/308 (40%), Gaps = 40/308 (12%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
F I LG G G V +Y+A+K + K+ +E +L L+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLN 60
Query: 724 HPFVPALYASFQ-------------TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVR 770
H +V YA++ K+ + + +YC G L+ L+ + + D
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQRDEYW 119
Query: 771 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830
+++ AL Y+H QGII+RDLKP N+ + + +V + DF L+ N
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA-------------KNV 166
Query: 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLY 889
+ + + + S +GT Y+A E++ G GH +D ++LGI+ +EM+Y
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
Query: 890 GYTPFRGKTRQKTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947
G R + ++FP K+++ L+ DP R GA
Sbjct: 227 P--FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP----GART 280
Query: 948 IKKHPFFK 955
+ +
Sbjct: 281 LLNSGWLP 288
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 9e-69
Identities = 72/338 (21%), Positives = 124/338 (36%), Gaps = 45/338 (13%)
Query: 623 NLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKIL---DSGEQINLQHFRPIKPLGSGDTG 679
+L E+L+ + P+ + +Q E Q F+ + LG G G
Sbjct: 12 DLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYG 71
Query: 680 SVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPALYASFQTKT 738
V V G+ +A+K +++ AE + HP L +++
Sbjct: 72 EVFKVRSKEDGRLYAVKRSMSPFRGPKDRAR-KLAEVGSHEKVGQHPCCVRLEQAWEEGG 130
Query: 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 798
+ L T+ C G L + L E V Y + ++AL +LH QG+++ D+KP N+
Sbjct: 131 ILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANI 188
Query: 799 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 858
L G L DF L V + G
Sbjct: 189 FLGPRGRCKLGDFGLL---------------------------VELGTAGAG-EVQEGDP 220
Query: 859 EYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT-PFRGKTRQKTFANILHKDLKFPSST 917
Y+APE++ G + +A D ++LG+ + E+ P G+ Q+ L +F +
Sbjct: 221 RYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP--PEFTAG- 276
Query: 918 PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
S + ++ +L DPK R A + P +
Sbjct: 277 -LSSELRSVLVMMLEPDPKLRA----TAEALLALPVLR 309
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 1e-68
Identities = 80/292 (27%), Positives = 125/292 (42%), Gaps = 34/292 (11%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
++ F+ LG G V+ E +G A+K +DK M V R E +I L
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 783
HP + LY F+ +V L+ + C GE+ L + K E+ R + +++ + YL
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYL 128
Query: 784 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 843
H GI++RDL N+LL N ++ + DF L+ +
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH------------------- 169
Query: 844 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903
+ GT YI+PEI + H D W+LG + Y +L G PF T + T
Sbjct: 170 --------YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL 221
Query: 904 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
++ D + PS AK L+++LL R+P RL + + HPF
Sbjct: 222 NKVVLADYEMPSFLSIE--AKDLIHQLLRRNPADRL----SLSSVLDHPFMS 267
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 5e-67
Identities = 78/331 (23%), Positives = 130/331 (39%), Gaps = 37/331 (11%)
Query: 625 TPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLV 684
P D V +PP K I ++L + + + + LG G +
Sbjct: 3 APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPR--SRRRYVRGRFLGKGGFAKCFEI 60
Query: 685 ELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744
+ + FA K + K ++L ++ + E I L H V + F+ V ++
Sbjct: 61 SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120
Query: 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 804
+ C L L R+ K L E R+Y ++V+ +YLH +I+RDLK N+ L +
Sbjct: 121 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 178
Query: 805 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPE 864
V + DF L+ + GT YIAPE
Sbjct: 179 EVKIGDFGLATKVEYDGERK---------------------------KVLCGTPNYIAPE 211
Query: 865 IIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAK 924
+++ GH+ VD W++G ++Y +L G PF ++T+ I + P A
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV--AA 269
Query: 925 QLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
L+ ++L DP +R NE+ FF
Sbjct: 270 SLIQKMLQTDPTARP----TINELLNDEFFT 296
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 1e-66
Identities = 70/293 (23%), Positives = 119/293 (40%), Gaps = 35/293 (11%)
Query: 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML 722
+ + + + LG G + + + FA K + K ++L ++ + E I L
Sbjct: 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 72
Query: 723 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 782
H V + F+ V ++ + C L L R+ K L E R+Y ++V+ +Y
Sbjct: 73 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQY 130
Query: 783 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
LH +I+RDLK N+ L + V + DF L+ +
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KV-------------- 174
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
GT YIAPE+++ GH+ VD W++G ++Y +L G PF ++T
Sbjct: 175 -----------LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223
Query: 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+ I + P A L+ ++L DP +R NE+ FF
Sbjct: 224 YLRIKKNEYSIPKHINPV--AASLIQKMLQTDPTARP----TINELLNDEFFT 270
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-62
Identities = 68/319 (21%), Positives = 138/319 (43%), Gaps = 38/319 (11%)
Query: 637 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 696
+H H + ++ +++ + ++ +G G G LV+ G+ + +K
Sbjct: 1 MHHHHHHS-----SGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIK 55
Query: 697 AMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL 756
++ M ++ + + E +L + HP + SF+ + ++ DYC GG+LF +
Sbjct: 56 EINISRMSSKER-EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI 114
Query: 757 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816
+ Q + +ED + + ++ +AL+++H + I++RD+K +N+ L +G V L DF ++ +
Sbjct: 115 NAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174
Query: 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 876
+ +L + +GT Y++PEI + + D
Sbjct: 175 LNSTVELA---------------------------RACIGTPYYLSPEICENKPYNNKSD 207
Query: 877 WWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPK 936
WALG +LYE+ F + + I+ P S S + L+ +L R+P+
Sbjct: 208 IWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQLFKRNPR 266
Query: 937 SRLGSHEGANEIKKHPFFK 955
R N I + F
Sbjct: 267 DRP----SVNSILEKGFIA 281
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* Length = 130 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-62
Identities = 97/130 (74%), Positives = 112/130 (86%)
Query: 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 243
PRVS +K ALST QQTFVVSDAT+P PI+YAS+GFF MTGY+SKE+VGRNCRFLQG
Sbjct: 1 FPRVSQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGP 60
Query: 244 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
TD +VAKIR+ ++NG+SYCGRLLNYKKDGTPFWNLLT+ PIKDD+G +KFIGMQVEV
Sbjct: 61 DTDKNEVAKIRDCVKNGKSYCGRLLNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEV 120
Query: 304 SKHTEGAKDK 313
SK+TEG DK
Sbjct: 121 SKYTEGVNDK 130
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* Length = 130 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 7e-53
Identities = 52/127 (40%), Positives = 78/127 (61%), Gaps = 4/127 (3%)
Query: 469 RKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPET 528
R +L T L +++ FV++D P PI++AS F +T YS +EI+GRNCRFLQGP+T
Sbjct: 3 RVSQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGPDT 62
Query: 529 DPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSE 584
D V KIR + N +L+NY K G FWNL + P++D + FIG+Q++ S+
Sbjct: 63 DKNEVAKIRDCVKNGKSYCGRLLNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEVSK 122
Query: 585 HLEPLRN 591
+ E + +
Sbjct: 123 YTEGVND 129
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* Length = 332 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 7e-62
Identities = 117/236 (49%), Positives = 146/236 (61%), Gaps = 19/236 (8%)
Query: 465 QKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQ 524
LATTLERIEKNFVITDPRLPDNPIIFASDSFL+LTEYSREEILGRN RFLQ
Sbjct: 4 SHHHHHHGSLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARFLQ 63
Query: 525 GPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQL 580
GPETD ATVRKIR AIDNQT+VTVQLINYTKSGKKFWNLFHLQPMRDQK YFIGVQL
Sbjct: 64 GPETDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQL 123
Query: 581 DGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPK 640
DG+EH+ +++ + + + A+ + + + D + L +++ P
Sbjct: 124 DGTEHVRDAAEREGVMLIKKTAENIDEAAKELIK-CVVVGDGAVGKTCLLISYTTNAFPG 182
Query: 641 PHRKDSPPW-KAIQKILDSGEQINLQ--------HFRPIKPLGSGDTGSVHLVELC 687
+ + ++ G+ +NL + ++PL T + +C
Sbjct: 183 EYI--PTVFDNYSANVMVDGKPVNLGLWDTAGLEDYDRLRPLSYPQT---DVFLIC 233
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* Length = 332 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 48/130 (36%), Positives = 76/130 (58%)
Query: 185 PRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAG 244
+ L ++ FV++D PD PI++AS F ++T Y+ +E++GRN RFLQG
Sbjct: 7 HHHHGSLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARFLQGPE 66
Query: 245 TDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
TD V KIR+ + N +L+NY K G FWNL + P++D +G V FIG+Q++ +
Sbjct: 67 TDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGT 126
Query: 305 KHTEGAKDKM 314
+H A ++
Sbjct: 127 EHVRDAAERE 136
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* Length = 146 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 9e-61
Identities = 120/150 (80%), Positives = 129/150 (86%), Gaps = 11/150 (7%)
Query: 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATV 533
LATTLERIEKNFVITDPRLPDNPIIFASDSFL+LTEYSREEILGRNCRFLQGPETD ATV
Sbjct: 4 LATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATV 63
Query: 534 RKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPL 589
RKIR AIDNQT+VTVQLINYTKSGKKFWNLFHLQPMRDQK YFIGVQLDG+EH+
Sbjct: 64 RKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVR-- 121
Query: 590 RNSIPEATAEESEKLVKQTAENVNEAVKEL 619
+A E L+K+TAEN++EA KEL
Sbjct: 122 -----DAAEREGVMLIKKTAENIDEAAKEL 146
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* Length = 146 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 4e-54
Identities = 53/154 (34%), Positives = 85/154 (55%), Gaps = 9/154 (5%)
Query: 189 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPE 248
+ + L ++ FV++D PD PI++AS F ++T Y+ +E++GRNCRFLQG TD
Sbjct: 2 EFLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRA 61
Query: 249 DVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308
V KIR+ + N +L+NY K G FWNL + P++D +G V FIG+Q++ ++H
Sbjct: 62 TVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVR 121
Query: 309 GAKDKMLRPNGLPESLIRYDARQKEMATSSVTEL 342
A ++ E ++ E + EL
Sbjct: 122 DAAER--------EGVMLIKKTA-ENIDEAAKEL 146
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 4e-59
Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 47/304 (15%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDML 722
+ + +G G V +GQ FA+K +D + + +RE I ML
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 723 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-----QPTKVLKEDAVRFYAAEVV 777
HP + L ++ + + ++ ++ G +L V E Y +++
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLC---FEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 778 VALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
AL Y H II+RD+KP VLL + V L F ++
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA-------------------- 180
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894
+ + E + VGT ++APE++ + VD W G++L+ +L G PF
Sbjct: 181 -------IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233
Query: 895 RGKTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 952
G T+++ F I+ K + S AK L+ R+L DP R+ E HP
Sbjct: 234 YG-TKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERI----TVYEALNHP 288
Query: 953 FFKG 956
+ K
Sbjct: 289 WLKE 292
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 6e-59
Identities = 79/310 (25%), Positives = 138/310 (44%), Gaps = 44/310 (14%)
Query: 653 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG-VMLNRNKVHR 711
++ L I+ F + LGSG G VHLVE SG +K ++K + ++
Sbjct: 11 RENLYFQGTID-DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA 69
Query: 712 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF--LLLDRQPTKVLKEDAV 769
E E+L LDHP + ++ F+ ++ ++ + C GGEL ++ + K L E V
Sbjct: 70 ---EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYV 126
Query: 770 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLP 826
+++ AL Y H Q ++++DLKPEN+L Q + + + DF L+
Sbjct: 127 AELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA------------ 174
Query: 827 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 886
+ S + GT Y+APE+ T D W+ G+++Y
Sbjct: 175 ---------------ELF-KSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYF 217
Query: 887 MLYGYTPFRGKTRQKTFANILHKDLKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945
+L G PF G + ++ +K+ + P + A L+ ++L +DP+ R A
Sbjct: 218 LLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP----SA 273
Query: 946 NEIKKHPFFK 955
++ H +FK
Sbjct: 274 AQVLHHEWFK 283
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-58
Identities = 78/365 (21%), Positives = 129/365 (35%), Gaps = 76/365 (20%)
Query: 637 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 696
+H H + + S ++ + + +G G G V + + A+K
Sbjct: 1 MHHHHHHSSGR--ENLYFQGGSLLELQ-KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIK 57
Query: 697 AMDKGVMLNRNKVHRACAERE--ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF- 753
M+K + N + E ++ L HP + LY ++ + ++CL+ + C GG L
Sbjct: 58 IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLD 117
Query: 754 -------------------------------------LLLDRQPTKVLKEDAVRFYAAEV 776
V +E + ++
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177
Query: 777 VVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
AL YLH QGI +RD+KPEN L + + L DF LS K+
Sbjct: 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLS----------------KEFY 221
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH--TSAVDWWALGILLYEMLYGYT 892
M GT ++APE++ D W+ G+LL+ +L G
Sbjct: 222 KLNNGEYYGMTT-------KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274
Query: 893 PFRGKTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950
PF G T + +L+K L F + S A+ L+ LL+R+ R A +
Sbjct: 275 PFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF----DAMRALQ 330
Query: 951 HPFFK 955
HP+
Sbjct: 331 HPWIS 335
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 4e-58
Identities = 88/337 (26%), Positives = 133/337 (39%), Gaps = 58/337 (17%)
Query: 643 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV 702
R + P S +++ P + LG G + V + + +A+K +D
Sbjct: 2 RDAALPGS------HSTHGFY-ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTG 54
Query: 703 MLNRNKVH----RACAERE--ILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLL 755
+ + R +E IL + HP + L +++T T L+ D GELF
Sbjct: 55 GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-- 112
Query: 756 LDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814
D KV L E R ++ + LH I++RDLKPEN+LL + ++ LTDF S
Sbjct: 113 -DYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA----- 869
C P L GT Y+APEII +
Sbjct: 172 CQ--LDPGEKLREV--------------------------CGTPSYLAPEIIECSMNDNH 203
Query: 870 -GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSS--TPTSLHAKQL 926
G+ VD W+ G+++Y +L G PF + + I+ + +F S S K L
Sbjct: 204 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDL 263
Query: 927 MYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVR 963
+ R L P+ R A E HPFF+ VR
Sbjct: 264 VSRFLVVQPQKRY----TAEEALAHPFFQQYVVEEVR 296
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 4e-58
Identities = 78/298 (26%), Positives = 129/298 (43%), Gaps = 45/298 (15%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
Q++ +G G G V + G+ A K + K + + ++ + E EI+ LDH
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ---EIEIMKSLDH 65
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYL 783
P + LY +F+ T + L+ + C GGELF +R K +E +V+ A+ Y
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELF---ERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 784 HCQGIIYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
H + +RDLKPEN L + S L DF L+
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA-------------------------- 156
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
+P + + VGT Y++P+++ G + D W+ G+++Y +L GY PF T
Sbjct: 157 -ARF-KPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS 213
Query: 901 KTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
+ I FP S A+ L+ RLL + PK R+ + + +H +F+
Sbjct: 214 EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI----TSLQALEHEWFEK 267
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* Length = 109 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 5e-58
Identities = 65/107 (60%), Positives = 86/107 (80%)
Query: 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETL 257
+ TFVV+DAT PD P++YAS GF+ MTGY EV+G NCRFLQG GTDP++V KIR+ +
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 258 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+ G++ RLLNY+KDGTPFWNLLT+ PIK +G+V KF+G+QV+V+
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVDVT 108
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* Length = 109 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 8e-52
Identities = 47/102 (46%), Positives = 64/102 (62%), Gaps = 4/102 (3%)
Query: 484 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ 543
FV+ D LPD P+++AS+ F +T Y +E+LG NCRFLQG TDP V+KIR AI
Sbjct: 5 TFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKG 64
Query: 544 TDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLD 581
+V+L+NY K G FWNL + P++ F+GVQ+D
Sbjct: 65 EACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVD 106
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 5e-58
Identities = 87/296 (29%), Positives = 133/296 (44%), Gaps = 45/296 (15%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAERE--ILDMLDHPFV 727
+ LGSG V G+G+ +A K + K + + R V R ERE IL + HP +
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 728 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVALEYLHCQ 786
L+ F+ KT V LI + GGELF D K L ED + +++ + YLH +
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELF---DFLAEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 787 GIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
I + DLKPEN++L N + L DF ++ +
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA--HKIEAG-------------------- 165
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
+ + GT E++APEI+ D W++G++ Y +L G +PF G+T+Q+T
Sbjct: 166 ---NEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET 219
Query: 903 FANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
NI + F TS AK + RLL +DPK R+ + +H + K
Sbjct: 220 LTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRM----TIAQSLEHSWIKA 271
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-57
Identities = 76/300 (25%), Positives = 121/300 (40%), Gaps = 42/300 (14%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
++ + LG G G V L + +GQ A+K + K + + E ++L LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYL 783
P + LY F+ K + L+ + GGELF D K E +V+ + Y+
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELF---DEIISRKRFSEVDAARIIRQVLSGITYM 142
Query: 784 HCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
H I++RDLKPEN+LL+ + ++ + DF LS
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST------------------------- 177
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
E + +GT YIAPE++ G + D W+ G++LY +L G PF G
Sbjct: 178 ---HFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEY 233
Query: 901 KTFANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958
+ F S AK L+ ++L P R+ A + H + +
Sbjct: 234 DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI----SARDALDHEWIQTYT 289
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-57
Identities = 70/304 (23%), Positives = 119/304 (39%), Gaps = 35/304 (11%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 720
I+ +H+ I+ LG G V LVE G ++A+K + +R + R E ++
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQR---EADMHR 81
Query: 721 MLDHPFVPALYASFQTKT----HVCLITDYCPGGELFLLLDRQPTKV--LKEDAVRFYAA 774
+ +HP + L A + L+ + G L+ ++R K L ED + +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
+ LE +H +G +RDLKP N+LL G L D S + + +
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG-----SMNQACIHVEGSRQ--- 193
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYEMLYGY 891
A ++ + T Y APE+ + H D W+LG +LY M++G
Sbjct: 194 ----------ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
Query: 892 TPFRGKTRQ-KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950
P+ ++ + A + L P S S QL+ ++ DP R +
Sbjct: 244 GPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRP----HIPLLLS 299
Query: 951 HPFF 954
Sbjct: 300 QLEA 303
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-57
Identities = 81/332 (24%), Positives = 136/332 (40%), Gaps = 43/332 (12%)
Query: 637 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 696
+H H S E N + K LG G V +GQ +A K
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK 60
Query: 697 AMDKGVMLNRNKVHRACAERE--ILDMLDH-PFVPALYASFQTKTHVCLITDYCPGGELF 753
+ K R + RA E +L++ P V L+ ++ + + LI +Y GGE+F
Sbjct: 61 FLKKR---RRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIF 117
Query: 754 LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---GNGHVSLTD 810
L + +++ E+ V +++ + YLH I++ DLKP+N+LL G + + D
Sbjct: 118 SLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 811 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 870
F +S +R +GT EY+APEI+
Sbjct: 178 FGMS--RKIGHA-----------------------CELR---EIMGTPEYLAPEILNYDP 209
Query: 871 HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSST--PTSLHAKQLMY 928
T+A D W +GI+ Y +L +PF G+ Q+T+ NI ++ + T S A +
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQ 269
Query: 929 RLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 960
LL ++P+ R A H + + ++
Sbjct: 270 SLLVKNPEKRP----TAEICLSHSWLQQWDFE 297
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 4e-57
Identities = 81/302 (26%), Positives = 126/302 (41%), Gaps = 45/302 (14%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH-RACAERE--ILDM 721
+ + LGSG V +G +A K + K + R ERE IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 722 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVAL 780
+ H V L+ ++ +T V LI + GGELF D K L E+ + +++ +
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELF---DFLAQKESLSEEEATSFIKQILDGV 128
Query: 781 EYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
YLH + I + DLKPEN++L H+ L DF L+ +
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDG-------------- 172
Query: 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896
+ + GT E++APEI+ D W++G++ Y +L G +PF G
Sbjct: 173 ---------VEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 897 KTRQKTFANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
T+Q+T ANI F TS AK + +LL ++ + RL E +HP+
Sbjct: 221 DTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRL----TIQEALRHPWI 276
Query: 955 KG 956
Sbjct: 277 TP 278
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 4e-57
Identities = 70/333 (21%), Positives = 124/333 (37%), Gaps = 50/333 (15%)
Query: 637 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 696
+H H S + + + +K +GSG + V V L Q +A+K
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQS-MSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIK 58
Query: 697 AMDKGVMLNRNKVHRACAEREILDMLDHP--FVPALYASFQTKTHVCLITDYCPGGELFL 754
++ + + E L+ L + LY T ++ ++ + +L
Sbjct: 59 YVNLE-EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNS 116
Query: 755 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814
L ++ K + + Y ++ A+ +H GI++ DLKP N L+ +G + L DF ++
Sbjct: 117 WLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 173
Query: 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---- 870
+ P T + +S VGT Y+ PE I
Sbjct: 174 -------NQMQPDTTSVVK------------------DSQVGTVNYMPPEAIKDMSSSRE 208
Query: 871 -------HTSAVDWWALGILLYEMLYGYTPFRGKTRQ-KTFANILHKDLKFPSSTPTSLH 922
+ D W+LG +LY M YG TPF+ Q I+ + +
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKD 268
Query: 923 AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+ ++ L RDPK R+ E+ HP+ +
Sbjct: 269 LQDVLKCCLKRDPKQRI----SIPELLAHPYVQ 297
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 6e-57
Identities = 87/298 (29%), Positives = 133/298 (44%), Gaps = 45/298 (15%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
+ F ++ LGSG V LV+ +G+ FA+K + K + + E +L + H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKH 65
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYL 783
+ L +++ TH L+ GGELF DR + E +V+ A++YL
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELF---DRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 784 HCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
H GI++RDLKPEN+L N + +TDF LS K +QN
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLS---------------------KMEQN 161
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
+ + GT Y+APE++A ++ AVD W++G++ Y +L GY PF +T
Sbjct: 162 GIMS--------TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES 213
Query: 901 KTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
K F I +F S S AK + LL +DP R + HP+ G
Sbjct: 214 KLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERY----TCEKALSHPWIDG 267
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 7e-57
Identities = 85/296 (28%), Positives = 129/296 (43%), Gaps = 45/296 (15%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAERE--ILDMLDHPFV 727
+ LGSG V +G +A K + K + R V R ERE IL + HP V
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 728 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVALEYLHCQ 786
L+ ++ KT V LI + GGELF D K L E+ + +++ + YLH
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 787 GIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
I + DLKPEN++L + + DF L+
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFG-------------------- 171
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
+ + GT E++APEI+ D W++G++ Y +L G +PF G T+Q+T
Sbjct: 172 ---NEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225
Query: 903 FANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
AN+ + +F TS AK + RLL +DPK R+ + +HP+ K
Sbjct: 226 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM----TIQDSLQHPWIKP 277
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 9e-57
Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 46/300 (15%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN--KVHRACAEREILDML 722
++ + LG G V +G FA K ++ + R+ K+ R E I L
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKL 62
Query: 723 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALE 781
HP + L+ S Q ++ L+ D GGELF + + E +++ ++
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELF---EDIVAREFYSEADASHCIQQILESIA 119
Query: 782 YLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 838
Y H GI++R+LKPEN+LL V L DF L+
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA------------------------ 155
Query: 839 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898
+ + A + F GT Y++PE++ ++ VD WA G++LY +L GY PF +
Sbjct: 156 ---IEV-NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211
Query: 899 RQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
+ + +A I +PS + AK L+ +L +PK R+ A++ K P+
Sbjct: 212 QHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI----TADQALKVPWICN 267
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-56
Identities = 78/292 (26%), Positives = 126/292 (43%), Gaps = 44/292 (15%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 730
+ LGSG G VH +G+ F K ++ L++ V E I++ L HP + L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHHPKLINL 113
Query: 731 YASFQTKTHVCLITDYCPGGELFLLLDRQPTK--VLKEDAVRFYAAEVVVALEYLHCQGI 788
+ +F+ K + LI ++ GGELF DR + + E V Y + L+++H I
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELF---DRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170
Query: 789 IYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
++ D+KPEN++ + V + DF L+
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLAT----------------------------KLN 202
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 906
P T E+ APEI+ D WA+G+L Y +L G +PF G+ +T N+
Sbjct: 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 262
Query: 907 LHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
D +F S AK + LL ++P+ RL ++ +HP+ KG
Sbjct: 263 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL----TVHDALEHPWLKG 310
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-56
Identities = 85/327 (25%), Positives = 136/327 (41%), Gaps = 62/327 (18%)
Query: 657 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA-- 714
SG+ + L + +G G G V L Y+AMK + K ++ + R
Sbjct: 5 SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPR 64
Query: 715 -------------------EREI--LDMLDHPFVPALY--ASFQTKTHVCLITDYCPGGE 751
+EI L LDHP V L + H+ ++ + G
Sbjct: 65 GTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP 124
Query: 752 LFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 811
+ + +P L ED RFY +++ +EYLH Q II+RD+KP N+L+ +GH+ + DF
Sbjct: 125 VMEVPTLKP---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 812 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 871
+S LL T VGT ++APE ++
Sbjct: 182 GVSNEFK-GSDALLSNT--------------------------VGTPAFMAPESLSETRK 214
Query: 872 T---SAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMY 928
A+D WA+G+ LY ++G PF + + I + L+FP + K L+
Sbjct: 215 IFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLIT 274
Query: 929 RLLHRDPKSRLGSHEGANEIKKHPFFK 955
R+L ++P+SR+ EIK HP+
Sbjct: 275 RMLDKNPESRI----VVPEIKLHPWVT 297
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-56
Identities = 66/337 (19%), Positives = 116/337 (34%), Gaps = 76/337 (22%)
Query: 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 719
+ + + LG G T +V +G FA+K + L V E E+L
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVL 61
Query: 720 DMLDHPFVPALYASFQTKT--HVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEV 776
L+H + L+A + T H LI ++CP G L+ +L + L E +V
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 777 VVALEYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 832
V + +L GI++R++KP N++ G LTDF +
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA------------------ 163
Query: 833 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--------GHTSAVDWWALGILL 884
+ ++ S GTEEY+ P++ A + + VD W++G+
Sbjct: 164 ---RELEDDEQFV-------SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
Query: 885 YEMLYGYTPFRGKTRQKTFANILHK-------------------DLKFPSSTPTSLH--- 922
Y G PFR + +++K + + P S
Sbjct: 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSR 273
Query: 923 -----AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
++ +L D + G ++
Sbjct: 274 GLQVLLTPVLANILEADQEKCW----GFDQFFAETSD 306
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-56
Identities = 83/302 (27%), Positives = 129/302 (42%), Gaps = 45/302 (14%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDK-GVMLNRNKVHRACAERE--ILDM 721
+ + LGSG V +G +A K + K +R V R ERE IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 722 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVAL 780
+ HP + L+ ++ +T V LI + GGELF D K L E+ + +++ +
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELF---DFLAQKESLSEEEATSFIKQILDGV 128
Query: 781 EYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
YLH + I + DLKPEN++L H+ L DF L+ +
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDG-------------- 172
Query: 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896
+ + GT E++APEI+ D W++G++ Y +L G +PF G
Sbjct: 173 ---------VEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 897 KTRQKTFANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
T+Q+T ANI F TS AK + +LL ++ + RL E +HP+
Sbjct: 221 DTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRL----TIQEALRHPWI 276
Query: 955 KG 956
Sbjct: 277 TP 278
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-56
Identities = 61/308 (19%), Positives = 111/308 (36%), Gaps = 61/308 (19%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
F+ I+ +GSG G V + G+ + +K + N K R E + L LD
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAER---EVKALAKLD 62
Query: 724 HPFVPALYASFQ----------------TKTHVCLITDYCPGGELFLLLDRQPTKVLKED 767
H + + + + ++C G L ++++ + L +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 768 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 827
++ ++Y+H + +I RDLKP N+ L V + DF L L
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT--------SLKN 174
Query: 828 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 887
++ GT Y++PE I+ + VD +ALG++L E+
Sbjct: 175 DGKRT--------------------RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214
Query: 888 LYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947
L+ K F ++ +D K L+ +LL + P+ R +E
Sbjct: 215 LHV--CDTAFETSKFFTDL--RDGIISDI--FDKKEKTLLQKLLSKKPEDRP----NTSE 264
Query: 948 IKKHPFFK 955
I +
Sbjct: 265 ILRTLTVW 272
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-56
Identities = 67/301 (22%), Positives = 119/301 (39%), Gaps = 42/301 (13%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
+ + + +G+G G + G+ K +D G M K +E +L L
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELK 63
Query: 724 HPFVPALYASFQTKT--HVCLITDYCPGGELFLLLDRQPTK--VLKEDAVRFYAAEVVVA 779
HP + Y +T + ++ +YC GG+L ++ + + L E+ V ++ +A
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 780 LEYLH-----CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
L+ H +++RDLKP NV L G +V L DF L+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA-------------------- 163
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894
+ + A +FVGT Y++PE + + D W+LG LLYE+ PF
Sbjct: 164 -RILNHDTSFA------KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216
Query: 895 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
++++ I + S +++ R+L+ R EI ++P
Sbjct: 217 TAFSQKELAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRP----SVEEILENPLI 271
Query: 955 K 955
Sbjct: 272 L 272
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 4e-56
Identities = 87/383 (22%), Positives = 153/383 (39%), Gaps = 53/383 (13%)
Query: 582 GSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKP 641
G+E+L S + + + + +P + L + P
Sbjct: 15 GTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFD 74
Query: 642 HRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 701
HR + A+ + + LG G G VH E +G A K +
Sbjct: 75 HRIVTAKQGAVNSFYTVSKT---------EILGGGRFGQVHKCEETATGLKLAAKIIKTR 125
Query: 702 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 761
M ++ +V E +++ LDH + LY +F++K + L+ +Y GGELF DR
Sbjct: 126 GMKDKEEVKN---EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF---DRIID 179
Query: 762 K--VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL--QGNGHVSLTDFDLSCLT 817
+ L E + ++ + ++H I++ DLKPEN+L + + + DF L+
Sbjct: 180 ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLA--- 236
Query: 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 877
RR+K + E ++ GT E++APE++ + D
Sbjct: 237 ---------------RRYKPR-------EKLK---VNFGTPEFLAPEVVNYDFVSFPTDM 271
Query: 878 WALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSST--PTSLHAKQLMYRLLHRDP 935
W++G++ Y +L G +PF G +T NIL S AK+ + +LL ++
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331
Query: 936 KSRLGSHEGANEIKKHPFFKGVN 958
R+ A+E KHP+
Sbjct: 332 SWRI----SASEALKHPWLSDHK 350
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 4e-56
Identities = 73/292 (25%), Positives = 128/292 (43%), Gaps = 45/292 (15%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 730
+ LG G+ G VH S + + K + ++ V + E IL++ H + L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKK---EISILNIARHRNILHL 66
Query: 731 YASFQTKTHVCLITDYCPGGELFLLLDRQPTK--VLKEDAVRFYAAEVVVALEYLHCQGI 788
+ SF++ + +I ++ G ++F +R T L E + Y +V AL++LH I
Sbjct: 67 HESFESMEELVMIFEFISGLDIF---ERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 789 IYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
+ D++PEN++ Q + + + +F + KP +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPG-----------------------D 158
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 906
R EY APE+ ++A D W+LG L+Y +L G PF +T Q+ NI
Sbjct: 159 NFR---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215
Query: 907 LHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
++ + F S+ A + RLL ++ KSR+ A+E +HP+ K
Sbjct: 216 MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM----TASEALQHPWLKQ 263
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 6e-56
Identities = 78/327 (23%), Positives = 136/327 (41%), Gaps = 47/327 (14%)
Query: 638 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 697
H + + ++++ + + ++ + LG G V +G FA K
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFS-DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 698 MDKGVMLNR--NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 755
++ + R K+ R E I L HP + L+ S Q ++ L+ D GGELF
Sbjct: 62 INTKKLSARDFQKLER---EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF-- 116
Query: 756 LDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDF 811
+ + E +++ ++ Y H GI++R+LKPEN+LL V L DF
Sbjct: 117 -EDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 175
Query: 812 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 871
L+ + + A + F GT Y++PE++ +
Sbjct: 176 GLA---------------------------IEV-NDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 872 TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYR 929
+ VD WA G++LY +L GY PF + + + +A I +PS + AK L+
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267
Query: 930 LLHRDPKSRLGSHEGANEIKKHPFFKG 956
+L +PK R+ A++ K P+
Sbjct: 268 MLTVNPKKRI----TADQALKVPWICN 290
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 7e-56
Identities = 87/352 (24%), Positives = 143/352 (40%), Gaps = 55/352 (15%)
Query: 637 VHPKPHRKDSPPWKAIQKILDSGEQINL--------QHFRPIKPLGSGDTGSVHLVELCG 688
+H H Q L + + + + ++ +K LGSG G V L
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 689 SGQYFAMKAMDKGVMLNRN--KVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 746
+ A+K + K + + K+ E +L +LDHP + LY F+ K + L+ +
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLE---EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117
Query: 747 CPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---G 802
GGELF D E +V+ + YLH I++RDLKPEN+LL+
Sbjct: 118 YKGGELF---DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEK 174
Query: 803 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 862
+ + + DF LS + E + +GT YIA
Sbjct: 175 DALIKIVDFGLSA----------------------------VFENQKKMKERLGTAYYIA 206
Query: 863 PEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSST--PTS 920
PE++ + D W++G++L+ +L GY PF G+T Q+ + F S S
Sbjct: 207 PEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265
Query: 921 LHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDA 972
AK L+ ++L D + R+ A + +HP+ K + + P L
Sbjct: 266 EGAKDLIKQMLQFDSQRRI----SAQQALEHPWIKEMCSKKESGIELPSLAN 313
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 7e-56
Identities = 76/316 (24%), Positives = 128/316 (40%), Gaps = 47/316 (14%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN--KVHRACAEREILDML 722
+ + + LG G G V + + Q +A+K ++K N++ + R E E+L L
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKL 78
Query: 723 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALE 781
DHP + L+ + + ++ + GGELF D K E +V +
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELF---DEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 782 YLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 838
Y+H I++RDLKPEN+LL+ + + + DF LS
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--------------------- 174
Query: 839 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898
+ +GT YIAPE++ G + D W+ G++LY +L G PF GK
Sbjct: 175 -------QQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN 226
Query: 899 RQKTFANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
+ F S AK L+ ++L P R+ A + +HP+ +
Sbjct: 227 EYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI----TATQCLEHPWIQK 282
Query: 957 VNWALVRCMNPPELDA 972
+ + P L++
Sbjct: 283 YSSETPTISDLPSLES 298
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-55
Identities = 66/309 (21%), Positives = 119/309 (38%), Gaps = 49/309 (15%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 720
+ + + +K +GSG + V V L Q +A+K ++ + + E L+
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLE-EADNQTLDSYRNEIAYLN 62
Query: 721 MLDHP--FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 778
L + LY T ++ ++ + +L L ++ K + + Y ++
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKSYWKNMLE 119
Query: 779 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 838
A+ +H GI++ DLKP N L+ +G + L DF ++ + +
Sbjct: 120 AVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA------------------NQMQPD 160
Query: 839 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-----------HTSAVDWWALGILLYEM 887
V +S VGT Y+ PE I + D W+LG +LY M
Sbjct: 161 TTSVVK-------DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 213
Query: 888 LYGYTPFRGKTRQ-KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946
YG TPF+ Q I+ + + + ++ L RDPK R+
Sbjct: 214 TYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI----SIP 269
Query: 947 EIKKHPFFK 955
E+ HP+ +
Sbjct: 270 ELLAHPYVQ 278
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* Length = 115 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-55
Identities = 93/113 (82%), Positives = 99/113 (87%), Gaps = 4/113 (3%)
Query: 478 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 537
E IEKNFVITDPRLPDNPIIFASD FLELTEYSREEILGRN RFLQGPETD ATV+KIR
Sbjct: 3 PEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKIR 62
Query: 538 AAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHL 586
AI +Q + TVQLINYTKSGKKFWNL HLQP+RDQK YFIGVQLDGS+H+
Sbjct: 63 DAIRDQRETTVQLINYTKSGKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDHV 115
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* Length = 115 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 9e-55
Identities = 47/113 (41%), Positives = 76/113 (67%)
Query: 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 253
+ ++ FV++D PD PI++AS GF ++T Y+ +E++GRN RFLQG TD V KI
Sbjct: 2 SPEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKI 61
Query: 254 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306
R+ +++ + +L+NY K G FWNLL + P++D +G++ FIG+Q++ S H
Sbjct: 62 RDAIRDQRETTVQLINYTKSGKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDH 114
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 3e-55
Identities = 73/298 (24%), Positives = 120/298 (40%), Gaps = 43/298 (14%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
+ + + LG G G V + + Q +A+K ++K N++ E E+L LDH
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDH 80
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYL 783
P + L+ + + ++ + GGELF D K E +V + Y+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELF---DEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 784 HCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
H I++RDLKPEN+LL+ + + + DF LS
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-------------------------- 171
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
+ +GT YIAPE++ G + D W+ G++LY +L G PF GK
Sbjct: 172 -TCF-QQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY 228
Query: 901 KTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
+ F S AK L+ ++L P R+ A + +HP+ +
Sbjct: 229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI----TATQCLEHPWIQK 282
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 4e-55
Identities = 76/300 (25%), Positives = 115/300 (38%), Gaps = 54/300 (18%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPA 729
KPLG G S Q FA+K + K E L + + HP +
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVK 70
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGI 788
L+ F + H L+ + GGELF +R + K E + ++V A+ ++H G+
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELF---ERIKKKKHFSETEASYIMRKLVSAVSHMHDVGV 127
Query: 789 IYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
++RDLKPEN+L + DF + R K N
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFA-------------------RLKPPDNQPLK- 167
Query: 846 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT--- 902
+ T Y APE++ G+ + D W+LG++LY ML G PF+ R T
Sbjct: 168 -------TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220
Query: 903 ----FANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
I D F S AK L+ LL DP RL + ++ + + +
Sbjct: 221 AVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL----KMSGLRYNEWLQD 276
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* Length = 166 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 5e-55
Identities = 66/155 (42%), Positives = 89/155 (57%), Gaps = 7/155 (4%)
Query: 440 EIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIF 499
+I + + ++ S +++ + L L+ ++NFVITD LPDNPI++
Sbjct: 6 SLIAQCSPEADTLLTDNPSKANRILEDPDYS---LVKALQMAQQNFVITDASLPDNPIVY 62
Query: 500 ASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKK 559
AS FL LT YS ++ILGRNCRFLQGPETDP V KIR AI D +V L+NY + G
Sbjct: 63 ASRGFLTLTGYSLDQILGRNCRFLQGPETDPRAVDKIRNAITKGVDTSVCLLNYRQDGTT 122
Query: 560 FWNLFHLQPMRDQK----YFIGVQLDGSEHLEPLR 590
FWNLF + +RD K ++GVQ SE L
Sbjct: 123 FWNLFFVAGLRDSKGNIVNYVGVQSKVSEDYAKLL 157
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* Length = 166 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-54
Identities = 56/143 (39%), Positives = 84/143 (58%)
Query: 166 NSVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMT 225
+ + + + L + AL QQ FV++DA+ PD PI+YAS GF +T
Sbjct: 12 SPEADTLLTDNPSKANRILEDPDYSLVKALQMAQQNFVITDASLPDNPIVYASRGFLTLT 71
Query: 226 GYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAP 285
GY+ +++GRNCRFLQG TDP V KIR + G LLNY++DGT FWNL +A
Sbjct: 72 GYSLDQILGRNCRFLQGPETDPRAVDKIRNAITKGVDTSVCLLNYRQDGTTFWNLFFVAG 131
Query: 286 IKDDEGKVLKFIGMQVEVSKHTE 308
++D +G ++ ++G+Q +VS+
Sbjct: 132 LRDSKGNIVNYVGVQSKVSEDYA 154
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 6e-55
Identities = 77/343 (22%), Positives = 122/343 (35%), Gaps = 59/343 (17%)
Query: 637 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPI-------KPLGSGDTGSVHLVELCGS 689
+H H Q I + + I + LGSG G V L +
Sbjct: 1 MHHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNG 60
Query: 690 GQYFAMKAMDKGVMLNRNKVHRACA----------EREILDMLDHPFVPALYASFQTKTH 739
A+K + K E +L LDHP + L+ F+ K +
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 740 VCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 798
L+T++ GGELF ++ E +++ + YLH I++RD+KPEN+
Sbjct: 121 FYLVTEFYEGGELF---EQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENI 177
Query: 799 LLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFV 855
LL+ ++ + DF LS +
Sbjct: 178 LLENKNSLLNIKIVDFGLSS----------------------------FFSKDYKLRDRL 209
Query: 856 GTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPS 915
GT YIAPE++ + D W+ G+++Y +L GY PF G+ Q + F
Sbjct: 210 GTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268
Query: 916 ST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
+ S AK+L+ +L D R A E + K
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNKRC----TAEEALNSRWIKK 307
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 200 bits (509), Expect = 6e-55
Identities = 80/378 (21%), Positives = 146/378 (38%), Gaps = 57/378 (15%)
Query: 587 EPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDS 646
+P + P + K ++ +V+E K + + + +
Sbjct: 92 KPCEPTAPVLIPGDERK--RRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 647 PPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 706
+ D E+ LG+G G VH V +G FA K + ++
Sbjct: 150 IKHDHVLDHYDIHEE-----------LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK 198
Query: 707 NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK--VL 764
V + E + + +L HP + L+ +F+ + +I ++ GGELF ++ + +
Sbjct: 199 ETVRK---EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF---EKVADEHNKM 252
Query: 765 KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQ 822
ED Y +V L ++H ++ DLKPEN++ + + L DF L+
Sbjct: 253 SEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA------- 305
Query: 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 882
+P ++ GT E+ APE+ G D W++G+
Sbjct: 306 ---------------------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
Query: 883 LLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLG 940
L Y +L G +PF G+ +T N+ D S + S K + +LL DP +R+
Sbjct: 345 LSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM- 403
Query: 941 SHEGANEIKKHPFFKGVN 958
++ +HP+ N
Sbjct: 404 ---TIHQALEHPWLTPGN 418
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 7e-55
Identities = 75/298 (25%), Positives = 124/298 (41%), Gaps = 41/298 (13%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
+ ++ + LG G V +GQ +A ++ L+ + E I +L H
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINT-KKLSARDHQKLEREARICRLLKH 69
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYL 783
P + L+ S + H LI D GGELF + + E +++ A+ +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELF---EDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 784 HCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
H G+++R+LKPEN+LL V L DF L+
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA-------------------------- 160
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
+ + +A F GT Y++PE++ + VD WA G++LY +L GY PF + +
Sbjct: 161 -IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH 219
Query: 901 KTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
+ + I FPS + AK L+ ++L +P R+ A E KHP+
Sbjct: 220 RLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRI----TAAEALKHPWISH 273
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 9e-55
Identities = 73/311 (23%), Positives = 131/311 (42%), Gaps = 43/311 (13%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM-LNRNKVHRACAEREILDML 722
L F PI+ LG G G V + +A+K + L R KV R E + L L
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR---EVKALAKL 60
Query: 723 DHPFVPALYASFQTKT------------HVCLITDYCPGGELFLLLDRQPTKVLKEDA-V 769
+HP + + ++ K ++ + C L ++ + T +E +
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 770 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829
++ A+E+LH +G+++RDLKP N+ + V + DF L +
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT--------AMDQDE 172
Query: 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 889
E++ VGT+ Y++PE I G ++ VD ++LG++L+E+LY
Sbjct: 173 EEQTVLTPMPAYARH-------TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
Query: 890 GYTPFRGKT-RQKTFANILHKDLKFPS-STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947
PF + R +T ++ ++LKFP T ++ +L P R A
Sbjct: 226 ---PFSTQMERVRTLTDV--RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERP----EAIN 276
Query: 948 IKKHPFFKGVN 958
I ++ F+ ++
Sbjct: 277 IIENAVFEDLD 287
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 2e-54
Identities = 95/384 (24%), Positives = 151/384 (39%), Gaps = 54/384 (14%)
Query: 591 NSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWK 650
N E L E ++ L D +L A K+ +P ++ ++
Sbjct: 16 NKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQ 75
Query: 651 AIQKILDSGEQINLQHFRPI----KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 706
++ + + + F +G G + V +G FA+K M+
Sbjct: 76 SMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS 135
Query: 707 NKVHRACAER-----EILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP 760
+ E IL + HP + L S+++ + + L+ D GELF D
Sbjct: 136 PEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF---DYLT 192
Query: 761 TKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819
KV L E R ++ A+ +LH I++RDLKPEN+LL N + L+DF SC
Sbjct: 193 EKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH--L 250
Query: 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA------GHTS 873
+P L GT Y+APEI+ + G+
Sbjct: 251 EPGEKLRE--------------------------LCGTPGYLAPEILKCSMDETHPGYGK 284
Query: 874 AVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLL 931
VD WA G++L+ +L G PF + + I+ +F S S K L+ RLL
Sbjct: 285 EVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLL 344
Query: 932 HRDPKSRLGSHEGANEIKKHPFFK 955
DP++RL A + +HPFF+
Sbjct: 345 QVDPEARL----TAEQALQHPFFE 364
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-54
Identities = 67/343 (19%), Positives = 118/343 (34%), Gaps = 72/343 (20%)
Query: 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 717
+ + + LG G T +V +G FA+K + L V E E
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFE 59
Query: 718 ILDMLDHPFVPALYASFQTKT--HVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAA 774
+L L+H + L+A + T H LI ++CP G L+ +L + L E
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830
+VV + +L GI++R++KP N++ G LTDF +
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA---------------- 163
Query: 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--------GHTSAVDWWALGI 882
+ ++ S GTEEY+ P++ A + + VD W++G+
Sbjct: 164 -----RELEDDEQF-------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211
Query: 883 LLYEMLYGYTPFRGKTRQKTFANILHK-------------------DLKFPSSTPTSLH- 922
Y G PFR + +++K + + P S
Sbjct: 212 TFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSL 271
Query: 923 -------AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958
++ +L D + G + E ++
Sbjct: 272 SRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIH 314
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 4e-54
Identities = 76/319 (23%), Positives = 124/319 (38%), Gaps = 38/319 (11%)
Query: 639 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 698
P P KA++ + L +FR K +G G V+ G A+K +
Sbjct: 9 QGPPVPQFQPQKALRPDMGYNT---LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65
Query: 699 DKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL-- 756
+++ E ++L L+HP V YASF + ++ + G+L ++
Sbjct: 66 QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH 125
Query: 757 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816
++ +++ E V Y ++ ALE++H + +++RD+KP NV + G V L D L
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185
Query: 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 876
S K +S VGT Y++PE I G+ D
Sbjct: 186 FSSKTTAA---------------------------HSLVGTPYYMSPERIHENGYNFKSD 218
Query: 877 WWALGILLYEMLYGYTPFRGKTRQKT--FANILHKDLKFPSSTPTSLHAKQLMYRLLHRD 934
W+LG LLYEM +PF G I D S S +QL+ ++ D
Sbjct: 219 IWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPD 278
Query: 935 PKSRLGSHEGANEIKKHPF 953
P+ R +
Sbjct: 279 PEKRP----DVTYVYDVAK 293
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} Length = 258 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 4e-54
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 144 VARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFV 203
+ R DD P T ++ + D + + V D + V
Sbjct: 21 MGRDLYDDDDKDHPFTMGQDRPIDGSGAPGADDT---RVEVQPPAQWVLDLIEASPIASV 77
Query: 204 VSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSY 263
VSD D P++ + F +TGY+ +E VGRNCRFL G+GT+P KIR+ ++ +
Sbjct: 78 VSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREHKPV 137
Query: 264 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLP-- 321
+LNYKKDGTPF N + +API DD+ ++L F+G QVEV
Sbjct: 138 LVEILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPNMGMARRERAAEMLK 197
Query: 322 ---------ESLIRYDARQKEMA 335
+L+ R KE+A
Sbjct: 198 TLSPRQLEVTTLVASGLRNKEVA 220
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} Length = 258 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 8e-52
Identities = 65/238 (27%), Positives = 99/238 (41%), Gaps = 25/238 (10%)
Query: 424 IGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEK 483
+GR DD D G D P + D +V + + + +E
Sbjct: 21 MGRDLYDDDDKDHP----FTMGQDRPIDGSGAPGADDTRVEVQPPAQ--WVLDLIEASPI 74
Query: 484 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ 543
V++DPRL DNP+I + +F +LT YS EE +GRNCRFL G T+P KIR +
Sbjct: 75 ASVVSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREH 134
Query: 544 TDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPLRNSIPEATAE 599
V V+++NY K G F N + P+ D YF+G Q++ + +
Sbjct: 135 KPVLVEILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPNM-----GMARR 189
Query: 600 ESEKLVKQTAENVNEAVKELPDANLTPEDLWAN----------HSKVVHPKPHRKDSP 647
E + +T V L + L +++ A H +V K + K S
Sbjct: 190 ERAAEMLKTLSPRQLEVTTLVASGLRNKEVAARLGLSEKTVKMHRGLVMEKLNLKTSA 247
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 5e-54
Identities = 82/333 (24%), Positives = 140/333 (42%), Gaps = 49/333 (14%)
Query: 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAE 715
+ EQ ++ ++R +K +G G+ V L +G+ A+K +DK + + K+ R E
Sbjct: 8 ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR---E 64
Query: 716 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 775
I+ +L+HP + L+ +T+ + LI +Y GGE+F L +KE R +
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQ 122
Query: 776 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
+V A++Y H + I++RDLK EN+LL + ++ + DF S L
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDA-------- 172
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT-SAVDWWALGILLYEMLYGYTPF 894
F G Y APE+ G + VD W+LG++LY ++ G PF
Sbjct: 173 ------------------FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214
Query: 895 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
G+ ++ +L + P S + L+ R L +P R +I K +
Sbjct: 215 DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKRFLVLNPIKRG----TLEQIMKDRWI 268
Query: 955 KGVNWALVRCMNPPELDAPLFATDTEKEYKVVD 987
EL + + K +D
Sbjct: 269 N-------AGHEEDELKPFVEPELDISDQKRID 294
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-53
Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 47/295 (15%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 730
LG G T V+ + G+ + +A+K + K E +L L HP + L
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 731 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGII 789
F+T T + L+ + GGELF DR K E +++ A+ YLH GI+
Sbjct: 114 KEIFETPTEISLVLELVTGGELF---DRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 790 YRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
+RDLKPEN+L + + + DF LS + + Q+L+ T
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKT------------------- 209
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK-TFAN 905
GT Y APEI+ G + VD W++GI+ Y +L G+ PF + + F
Sbjct: 210 -------VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR 262
Query: 906 ILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958
IL+ + F S SL+AK L+ +L+ DPK RL + +HP+ G
Sbjct: 263 ILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL----TTFQALQHPWVTGKA 313
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-53
Identities = 79/322 (24%), Positives = 125/322 (38%), Gaps = 52/322 (16%)
Query: 646 SPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN 705
+ +I + L + + +G G + FA+K +DK +
Sbjct: 3 TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK----S 58
Query: 706 RNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKV 763
+ E EIL HP + L + +V ++T+ GGEL D+ K
Sbjct: 59 KRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELL---DKILRQKF 112
Query: 764 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSC 819
E + +EYLH QG+++RDLKP N+L + + DF +
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA----- 167
Query: 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 879
K+ R + + P T ++APE++ G+ +A D W+
Sbjct: 168 -----------KQLRAENG----LLMTP-------CYTANFVAPEVLERQGYDAACDIWS 205
Query: 880 LGILLYEMLYGYTPFRGK---TRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRD 934
LG+LLY ML GYTPF T ++ A I S AK L+ ++LH D
Sbjct: 206 LGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVD 265
Query: 935 PKSRLGSHEGANEIKKHPFFKG 956
P RL A + +HP+
Sbjct: 266 PHQRL----TAALVLRHPWIVH 283
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} Length = 162 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-53
Identities = 42/115 (36%), Positives = 66/115 (57%)
Query: 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 253
+ VV++ D ++Y +A F +TGY+ E++ ++CRFLQG D A+I
Sbjct: 30 MVDASNDGIVVAEKEGDDTILIYVNAAFEYLTGYSRDEILYQDCRFLQGDDRDQLGRARI 89
Query: 254 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308
R+ + G+ L NY+KDG+ FWN L+I P+K D + FIG+Q +VS+ E
Sbjct: 90 RKAMAEGRPCREVLRNYRKDGSAFWNELSITPVKSDFDQRTYFIGIQKDVSRQVE 144
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} Length = 162 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-49
Identities = 41/135 (30%), Positives = 62/135 (45%), Gaps = 7/135 (5%)
Query: 457 DSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEIL 516
V + L + ++ V+ + D +I+ + +F LT YSR+EIL
Sbjct: 13 GLVPRGSHMINAQL---LQSMVDASNDGIVVAEKEGDDTILIYVNAAFEYLTGYSRDEIL 69
Query: 517 GRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK--- 573
++CRFLQG + D +IR A+ L NY K G FWN + P++
Sbjct: 70 YQDCRFLQGDDRDQLGRARIRKAMAEGRPCREVLRNYRKDGSAFWNELSITPVKSDFDQR 129
Query: 574 -YFIGVQLDGSEHLE 587
YFIG+Q D S +E
Sbjct: 130 TYFIGIQKDVSRQVE 144
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 6e-53
Identities = 87/307 (28%), Positives = 128/307 (41%), Gaps = 51/307 (16%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER-----EIL 719
+ K LGSG G V L + + A+K + K + A EIL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 720 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVV 778
L+HP + + F + ++ + GGELF D+ LKE + Y ++++
Sbjct: 70 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLL 125
Query: 779 ALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
A++YLH GII+RDLKPENVLL + + +TDF S
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS--------------------- 164
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYT 892
K M + GT Y+APE++ AG+ AVD W+LG++L+ L GY
Sbjct: 165 KILGETSLM-------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
Query: 893 PFRGKTRQKT-FANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949
PF Q + I F S A L+ +LL DPK+R E
Sbjct: 218 PFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF----TTEEAL 273
Query: 950 KHPFFKG 956
+HP+ +
Sbjct: 274 RHPWLQD 280
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} Length = 128 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 9e-53
Identities = 43/113 (38%), Positives = 67/113 (59%)
Query: 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 253
A ++++ PD PI++A+ F K+TGY + EV+GRNCRFLQG GTDP V I
Sbjct: 2 ASEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAI 61
Query: 254 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306
+ + + ++NYKK G FWN L I+P+ + G++ F+ Q++V+
Sbjct: 62 KSAIAAEKPIDIDIINYKKSGEAFWNRLHISPVHNANGRLQHFVSSQLDVTLE 114
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} Length = 128 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-51
Identities = 52/114 (45%), Positives = 74/114 (64%), Gaps = 4/114 (3%)
Query: 478 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 537
E +IT+P LPDNPI+FA+ +FL+LT Y +E++GRNCRFLQG TDPA VR I+
Sbjct: 3 SEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAIK 62
Query: 538 AAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLE 587
+AI + + + +INY KSG+ FWN H+ P+ + +F+ QLD + L
Sbjct: 63 SAIAAEKPIDIDIINYKKSGEAFWNRLHISPVHNANGRLQHFVSSQLDVTLELV 116
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-52
Identities = 46/329 (13%), Positives = 89/329 (27%), Gaps = 83/329 (25%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL----------- 719
LG D + +G+ F + N + + E L
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 720 -----------DMLDHPFVPALYASFQTKTHVCLITDY-------CPGGELFLLLDRQPT 761
D++ P + + + +++ + +L +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 762 --KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819
K L A +V+ L LH G+++ L+P +++L G V LT F+
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG- 257
Query: 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--------- 870
A + + PE+ A
Sbjct: 258 ------------------------------ARVVSSVSRGFEPPELEARRATISYHRDRR 287
Query: 871 --HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMY 928
T + D WALG+++Y + P I P + L+
Sbjct: 288 TLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQP------VRALLE 341
Query: 929 RLLHRDPKSRLGSHEGANEIKKHPFFKGV 957
L + RL + + P ++ +
Sbjct: 342 GFLRYPKEDRL----LPLQAMETPEYEQL 366
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 Length = 110 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-52
Identities = 31/107 (28%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 200 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR--NCRFLQGAGTDPEDVAKIRETL 257
+ F++++A + ++Y + GF ++ GY+ EV+ R C FL G T A+I + L
Sbjct: 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQAL 61
Query: 258 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+ + Y+KDG+ F L+ + P+K+++G V+ FI V
Sbjct: 62 LGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVM 108
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 Length = 110 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-49
Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 6/107 (5%)
Query: 484 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGR--NCRFLQGPETDPATVRKIRAAID 541
F+I + R+ + +I+ +D F EL YSR E++ R C FL GP T +I A+
Sbjct: 3 KFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALL 62
Query: 542 NQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSE 584
+ V++ Y K G F L + P++++ FI E
Sbjct: 63 GAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVME 109
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-52
Identities = 72/353 (20%), Positives = 129/353 (36%), Gaps = 50/353 (14%)
Query: 617 KELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSG 676
+P + E A + P KA + + + + +K +GSG
Sbjct: 9 GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANEC-ISVKGRIYSILKQIGSG 67
Query: 677 DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP--FVPALYASF 734
+ V V L Q +A+K ++ + + E L+ L + LY
Sbjct: 68 GSSKVFQV-LNEKKQIYAIKYVNLE-EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 735 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLK 794
T ++ ++ + +L L ++ K + + Y ++ A+ +H GI++ DLK
Sbjct: 126 ITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 182
Query: 795 PENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSF 854
P N L+ +G + L DF ++ + P T + +S
Sbjct: 183 PANFLIV-DGMLKLIDFGIA-------NQMQPDTTSVVK------------------DSQ 216
Query: 855 VGTEEYIAPEIIAGAG-----------HTSAVDWWALGILLYEMLYGYTPFRGKTRQ-KT 902
VG Y+ PE I + D W+LG +LY M YG TPF+ Q
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
I+ + + + ++ L RDPK R+ E+ HP+ +
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI----SIPELLAHPYVQ 325
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-52
Identities = 76/297 (25%), Positives = 126/297 (42%), Gaps = 37/297 (12%)
Query: 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 719
++ + H+ LG G G V + E +G A+K +++ + + + V + E + L
Sbjct: 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 720 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 779
+ HP + LY T T ++ +Y GGELF + + ++E R +++ A
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSA 123
Query: 780 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
++Y H +++RDLKPENVLL + + + DF LS + L T
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRT------------ 169
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKT 898
G+ Y APE+I+G VD W+ G++LY +L G PF +
Sbjct: 170 --------------SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215
Query: 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
F I P S L+ +L DP R +I++H +FK
Sbjct: 216 VPTLFKKIRGGVFYIPEYLNRS--VATLLMHMLQVDPLKRATIK----DIREHEWFK 266
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-52
Identities = 71/359 (19%), Positives = 131/359 (36%), Gaps = 56/359 (15%)
Query: 645 DSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML 704
+ PP + L + E Q + + PLGSG G V + +K + K +L
Sbjct: 4 EEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVL 63
Query: 705 NRNKVHRACAER-----EILDMLDHPFVPALYASFQTKTHVCLITD-YCPGGELFLLLDR 758
+ + IL ++H + + F+ + L+ + + G +LF +DR
Sbjct: 64 EDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR 123
Query: 759 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818
P L E + ++V A+ YL + II+RD+K EN+++ + + L DF +
Sbjct: 124 HPR--LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL- 180
Query: 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT-SAVDW 877
+ L T F GT EY APE++ G + ++
Sbjct: 181 -ERGKLFYT--------------------------FCGTIEYCAPEVLMGNPYRGPELEM 213
Query: 878 WALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKS 937
W+LG+ LY +++ PF + + P S L+ LL P+
Sbjct: 214 WSLGVTLYTLVFEENPFCE------LEETVEAAIHPPY--LVSKELMSLVSGLLQPVPER 265
Query: 938 RLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQN 996
R ++ P+ + +N + + E V+ ++
Sbjct: 266 RT----TLEKLVTDPWVT-------QPVNLADYTWEEVFRVNKPESGVLSAASLEMGNR 313
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-52
Identities = 87/307 (28%), Positives = 129/307 (42%), Gaps = 51/307 (16%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER-----EIL 719
+ K LGSG G V L + + A++ + K + A EIL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 720 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVV 778
L+HP + + F + ++ + GGELF D+ K LKE + Y ++++
Sbjct: 195 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLL 250
Query: 779 ALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
A++YLH GII+RDLKPENVLL + + +TDF S
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS--------------------- 289
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYT 892
K M + GT Y+APE++ AG+ AVD W+LG++L+ L GY
Sbjct: 290 KILGETSLM-------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342
Query: 893 PFRGKTRQKT-FANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949
PF Q + I F S A L+ +LL DPK+R E
Sbjct: 343 PFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF----TTEEAL 398
Query: 950 KHPFFKG 956
+HP+ +
Sbjct: 399 RHPWLQD 405
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A Length = 138 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-52
Identities = 32/118 (27%), Positives = 59/118 (50%), Gaps = 2/118 (1%)
Query: 189 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR--NCRFLQGAGTD 246
D + + F++++A + ++Y + GF ++ GY+ EV+ R C FL G T
Sbjct: 19 DTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQ 78
Query: 247 PEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
A+I + L + + Y+KDG+ F L+ + P+K+++G V+ FI V
Sbjct: 79 RRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVM 136
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A Length = 138 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 6e-51
Identities = 35/130 (26%), Positives = 57/130 (43%), Gaps = 9/130 (6%)
Query: 464 RQKEMRKGIDLATTLERIEK---NFVITDPRLPDNPIIFASDSFLELTEYSREEILGR-- 518
R + L T + + E F+I + R+ + +I+ +D F EL YSR E++ R
Sbjct: 8 RGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPC 67
Query: 519 NCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----Y 574
C FL GP T +I A+ + V++ Y K G F L + P++++
Sbjct: 68 TCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIM 127
Query: 575 FIGVQLDGSE 584
FI E
Sbjct: 128 FILNFEVVME 137
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-52
Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 41/297 (13%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDML 722
++ + ++ LG G G V L + + A+K +D ++ + + E I ML
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKML 62
Query: 723 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALE 781
+H V Y + L +YC GGELF DR + + E + + +++ +
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL-LLPTTNEKKRRHKGQQN 840
YLH GI +RD+KPEN+LL ++ ++DF L+ + + LL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM------------ 167
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTR 899
GT Y+APE++ H VD W+ GI+L ML G P+ +
Sbjct: 168 --------------CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213
Query: 900 -QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+ +++ K L++++L +P +R+ +IKK ++
Sbjct: 214 SCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI----TIPDIKKDRWYN 266
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* Length = 132 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-52
Identities = 58/126 (46%), Positives = 80/126 (63%), Gaps = 5/126 (3%)
Query: 478 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 537
L+ + VITDP L DNPI++ + F+++T Y EEILG+NCRFLQG TDPA V IR
Sbjct: 5 LDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNIR 64
Query: 538 AAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK--YFIGVQLDGSEHL---EPLRNS 592
A+ N+ VTVQ+ NY K G FWN ++ PM + YF+G+Q D ++ + L +S
Sbjct: 65 TALQNKEPVTVQIQNYKKDGTMFWNELNIDPMEIEDKTYFVGIQNDITKQKEYEKLLEDS 124
Query: 593 IPEATA 598
+ E TA
Sbjct: 125 LTEITA 130
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* Length = 132 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-50
Identities = 49/115 (42%), Positives = 73/115 (63%), Gaps = 2/115 (1%)
Query: 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 253
L + V++D D PI+Y + GF +MTGY ++E++G+NCRFLQG TDP +V I
Sbjct: 4 MLDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNI 63
Query: 254 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308
R LQN + ++ NYKKDGT FWN L I P++ ++ F+G+Q +++K E
Sbjct: 64 RTALQNKEPVTVQIQNYKKDGTMFWNELNIDPMEIEDKTY--FVGIQNDITKQKE 116
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 9e-52
Identities = 80/313 (25%), Positives = 124/313 (39%), Gaps = 57/313 (18%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 729
LG G V + Q +A+K ++K R++V R E E+L H V
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQGHRNVLE 75
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGI 788
L F+ + L+ + GG + + E +V AL++LH +GI
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSIL---SHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 789 IYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
+RDLKPEN+L + VS + DFDL
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLG-----------------SGIKLNGDCSPIST 175
Query: 846 EPMRASNSFVGTEEYIAPEIIAGAGHTS-----AVDWWALGILLYEMLYGYTPFRGK--- 897
+ + G+ EY+APE++ + D W+LG++LY +L GY PF G+
Sbjct: 176 PELL---TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS 232
Query: 898 ------------TRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHE 943
+ F +I +FP S AK L+ +LL RD K RL
Sbjct: 233 DCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL---- 288
Query: 944 GANEIKKHPFFKG 956
A ++ +HP+ +G
Sbjct: 289 SAAQVLQHPWVQG 301
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-50
Identities = 69/296 (23%), Positives = 124/296 (41%), Gaps = 39/296 (13%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDML 722
++ + ++ LG G G V L + + A+K +D ++ + + E I ML
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKML 62
Query: 723 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALE 781
+H V Y + L +YC GGELF DR + + E + + +++ +
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
YLH GI +RD+KPEN+LL ++ ++DF L+ + + L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------------- 166
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTR- 899
GT Y+APE++ H VD W+ GI+L ML G P+ +
Sbjct: 167 ------------MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214
Query: 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+ +++ K L++++L +P +R+ +IKK ++
Sbjct: 215 CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI----TIPDIKKDRWYN 266
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-50
Identities = 81/310 (26%), Positives = 119/310 (38%), Gaps = 45/310 (14%)
Query: 653 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA 712
LD + + +K +GSG+ G L+ + + A+K +++G V R
Sbjct: 8 TGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQR- 65
Query: 713 CAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFY 772
E L HP + T TH+ +I +Y GGEL+ + ED RF+
Sbjct: 66 --EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFF 121
Query: 773 AAEVVVALEYLHCQGIIYRDLKPENVLLQGN--GHVSLTDFDLSCLTSCKPQLLLPTTNE 830
+++ + Y H I +RDLK EN LL G+ + + DF S S +T
Sbjct: 122 FQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS--KSSVLHSQPKST-- 177
Query: 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLY 889
VGT YIAPE++ D W+ G+ LY ML
Sbjct: 178 ------------------------VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV 213
Query: 890 GYTPFRGKTR----QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945
G PF +KT IL P S L+ R+ DP +R+
Sbjct: 214 GAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRI----SI 269
Query: 946 NEIKKHPFFK 955
EIK H +F
Sbjct: 270 PEIKTHSWFL 279
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-50
Identities = 73/313 (23%), Positives = 112/313 (35%), Gaps = 50/313 (15%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN----KVHRACAEREILDMLDHPF 726
LG G G V V + A+K + K + V + E ++L L H
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK---EIQLLRRLRHKN 67
Query: 727 VPALY--ASFQTKTHVCLITDYCPGG--ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 782
V L + K + ++ +YC G E+ D P K Y +++ LEY
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 783 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC-KPQLLLPTTNEKKRRHKGQQNP 841
LH QGI+++D+KP N+LL G + ++ ++ T+
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS------------- 171
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRGKTR 899
G+ + PEI G VD W+ G+ LY + G PF G
Sbjct: 172 -------------QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI 218
Query: 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF-KGVN 958
K F NI P L+ +L +P R +I++H +F K
Sbjct: 219 YKLFENIGKGSYAIPGDCGPP--LSDLLKGMLEYEPAKRFSIR----QIRQHSWFRKKHP 272
Query: 959 WALVRCMNPPELD 971
A PP D
Sbjct: 273 PAEAPVPIPPSPD 285
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-50
Identities = 52/357 (14%), Positives = 107/357 (29%), Gaps = 68/357 (19%)
Query: 634 SKVVHPKPHRKDSPPWKAIQKILDSGEQINL--QHFRPIKPLGSGDTGSVHLVE-----L 686
S + P ++ W+ + + L + LG G V+
Sbjct: 32 SGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLND 91
Query: 687 CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 746
+ Q F +K N + + E L Y++ + L+ +
Sbjct: 92 AKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGEL 148
Query: 747 CPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG- 802
G L ++ P KV+ + V +A ++ +E +H II+ D+KP+N +L
Sbjct: 149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG 208
Query: 803 ----------NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 852
+ ++L D S P+ +F
Sbjct: 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPK-----------------GTIF--------T 243
Query: 853 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP--------------FRGKT 898
+ T + E+++ +D++ + +Y ML+G FR
Sbjct: 244 AKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP 303
Query: 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+ H L P L + L+ + L + + + ++
Sbjct: 304 HLDMWNEFFHVMLNIPD--CHHLPSLDLLRQKLKKVFQQHYTNK---IRALRNRLIV 355
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 6e-50
Identities = 68/305 (22%), Positives = 112/305 (36%), Gaps = 65/305 (21%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFV 727
+ LG G G V +GQ A+K + A +E+ P +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYD----------SPKARQEVDHHWQASGGPHI 84
Query: 728 PALYASFQTKTH----VCLITDYCPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVAL 780
+ ++ H + +I + GGELF R + + E ++ A+
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELF---SRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
++LH I +RD+KPEN+L + LTDF + K
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA---------------------KE 180
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897
+ T Y+APE++ + + D W+LG+++Y +L G+ PF
Sbjct: 181 TTQNALQ--------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232
Query: 898 TRQKTFANILHK----DLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951
T Q + + FP+ + S AKQL+ LL DP RL + H
Sbjct: 233 TGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL----TITQFMNH 288
Query: 952 PFFKG 956
P+
Sbjct: 289 PWINQ 293
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-49
Identities = 79/330 (23%), Positives = 132/330 (40%), Gaps = 49/330 (14%)
Query: 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 719
++ + H+ LG G G V + + +G A+K +++ + + + V + E + L
Sbjct: 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL 70
Query: 720 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 779
+ HP + LY T + + ++ +Y GGELF + + L E R +++
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSG 128
Query: 780 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
++Y H +++RDLKPENVLL + + + DF LS + L T
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRT------------ 174
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKT 898
G+ Y APE+I+G VD W+ G++LY +L G PF
Sbjct: 175 --------------SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220
Query: 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958
F I P S L+ +L DP R +I++H +FK
Sbjct: 221 VPTLFKKICDGIFYTPQYLNPS--VISLLKHMLQVDPMKRATIK----DIREHEWFK--- 271
Query: 959 WALVRCMNPPELDAPLFATDTEKEYKVVDP 988
+L LF D ++D
Sbjct: 272 ---------QDLPKYLFPEDPSYSSTMIDD 292
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 3e-49
Identities = 62/410 (15%), Positives = 117/410 (28%), Gaps = 94/410 (22%)
Query: 585 HLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRK 644
H+E + + + E E + E + E + +W +++ +
Sbjct: 3 HMEAGDSFMRDLLKREEELIGYCREEALKEPAAMV---EAVTATVWPQNAETTVDSLLSQ 59
Query: 645 DSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML 704
+ + ++PL GD V LV + FA+K G
Sbjct: 60 GE------------------RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN 101
Query: 705 NRNKVHRACAEREILDMLDHPFVPALYASFQ--------------------------TKT 738
+R+++ R L +
Sbjct: 102 SRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVA 161
Query: 739 HVCLITDYCPG--GELFLLLDRQPTK--VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLK 794
+ L+ LF LD A+ A+++ L +G+++
Sbjct: 162 NYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221
Query: 795 PENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSF 854
P+N+ + +G + L D + +
Sbjct: 222 PDNLFIMPDGRLMLGDVSAL------------------------------WKVGTRGPAS 251
Query: 855 VGTEEYIAPEII--AGAGHTSAVDWWALGILLYEMLYGYTPFRGKT-------RQKTFAN 905
Y E + + A T A++ W LG+ +Y + + PF T ++ +
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311
Query: 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
L F S TP K L+ R L+ D + RL E + P F
Sbjct: 312 PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL----LPLEAMETPEFL 357
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* Length = 149 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 4e-49
Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 11/112 (9%)
Query: 202 FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAG-----------TDPEDV 250
++ D + D PI+YAS F MTGY++ EV+GRNCRFLQ D +
Sbjct: 38 LILCDLKQKDTPIVYASEAFLYMTGYSNAEVLGRNCRFLQSPDGMVKPKSTRKYVDSNTI 97
Query: 251 AKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVE 302
+R+ + ++N+KK+G F N LT+ P++D+ G+ +G Q E
Sbjct: 98 NTMRKAIDRNAEVQVEVVNFKKNGQRFVNFLTMIPVRDETGEYRYSMGFQCE 149
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* Length = 149 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-48
Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 30/141 (21%)
Query: 471 GIDLATTLERI--EKN-------------FVITDPRLPDNPIIFASDSFLELTEYSREEI 515
G D+ L +I N ++ D + D PI++AS++FL +T YS E+
Sbjct: 9 GYDIMGYLIQIMNRPNPQVELGPVDTSVALILCDLKQKDTPIVYASEAFLYMTGYSNAEV 68
Query: 516 LGRNCRFLQGPE-----------TDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLF 564
LGRNCRFLQ P+ D T+ +R AID +V V+++N+ K+G++F N
Sbjct: 69 LGRNCRFLQSPDGMVKPKSTRKYVDSNTINTMRKAIDRNAEVQVEVVNFKKNGQRFVNFL 128
Query: 565 HLQPMRDQK----YFIGVQLD 581
+ P+RD+ Y +G Q +
Sbjct: 129 TMIPVRDETGEYRYSMGFQCE 149
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 6e-49
Identities = 48/339 (14%), Positives = 91/339 (26%), Gaps = 72/339 (21%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL----------- 719
LG D + +G+ F + N + + E L
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 720 -----------DMLDHPFVPALYASFQTKTHVCLITDY-------CPGGELFLLLDRQPT 761
D++ P + + + +++ + +L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 762 --KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819
K L A +V+ L LH G+++ L+P +++L G V LT F+
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---- 259
Query: 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-----TSA 874
A + E A ++ H T A
Sbjct: 260 ----------------------RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFA 297
Query: 875 VDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRD 934
D W LG+ +Y + P I P + L+ L
Sbjct: 298 FDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQP------VRALLEGFLRYP 351
Query: 935 PKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 973
+ RL + + P ++ + L + + D
Sbjct: 352 KEDRL----LPLQAMETPEYEQLRTELSAALPLYQTDGE 386
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-48
Identities = 85/301 (28%), Positives = 132/301 (43%), Gaps = 42/301 (13%)
Query: 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 717
+ + ++ + + LG G G V L + Q A+K + + ++ + R ERE
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRV--ERE 59
Query: 718 I--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 775
I L +L HP + LY T T + ++ +Y GGELF + + K + ED R + +
Sbjct: 60 ISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQ 116
Query: 776 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
++ A+EY H I++RDLKPEN+LL N +V + DF LS + L T
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKT-------- 166
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPF 894
G+ Y APE+I G VD W+ GI+LY ML G PF
Sbjct: 167 ------------------SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208
Query: 895 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
+ F + P A+ L+ R++ DP R+ EI++ P+F
Sbjct: 209 DDEFIPNLFKKVNSCVYVMPDFLSPG--AQSLIRRMIVADPMQRI----TIQEIRRDPWF 262
Query: 955 K 955
Sbjct: 263 N 263
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 7e-48
Identities = 69/338 (20%), Positives = 118/338 (34%), Gaps = 64/338 (18%)
Query: 638 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 697
P P + P + + I + + LG G G V + + + FA+K
Sbjct: 35 PPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM 94
Query: 698 MDKGVMLNRNKVHRACAEREI---LDMLDHPFVPALYASFQT----KTHVCLITDYCPGG 750
+ A RE+ P + + ++ + + ++ + GG
Sbjct: 95 LQD----------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 144
Query: 751 ELFLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 807
ELF R + + E + A++YLH I +RD+KPEN+L +
Sbjct: 145 ELF---SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 201
Query: 808 ---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPE 864
LTDF + T+ L + T Y+APE
Sbjct: 202 ILKLTDFGFAKETTSHNSL----------------------------TTPCYTPYYVAPE 233
Query: 865 IIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT----FANILHKDLKFPSS--TP 918
++ + + D W+LG+++Y +L GY PF I +FP+ +
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293
Query: 919 TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
S K L+ LL +P R+ E HP+
Sbjct: 294 VSEEVKMLIRNLLKTEPTQRM----TITEFMNHPWIMQ 327
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-47
Identities = 70/343 (20%), Positives = 116/343 (33%), Gaps = 44/343 (12%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 720
++ R + L G V+ + GSG+ +A+K + + + E +
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---EVCFMK 80
Query: 721 ML-DHPFVPALYASFQTKTH--------VCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 771
L HP + ++ L+T+ C G + L + L D V
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 772 YAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829
+ A++++H Q II+RDLK EN+LL G + L DF + S P
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYE 886
+ +N T Y PEII + D WALG +LY
Sbjct: 201 RALVEEEITRN---------------TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245
Query: 887 MLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946
+ + PF + + I++ P L+ +L +P+ RL
Sbjct: 246 LCFRQHPFEDGAKLR----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL----SIA 297
Query: 947 EIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPG 989
E+ A R +NP L + + G
Sbjct: 298 EVVHQLQ----EIAAARNVNPKSPITELLEQNGGYGSATLSRG 336
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 179 bits (454), Expect = 4e-47
Identities = 73/325 (22%), Positives = 122/325 (37%), Gaps = 66/325 (20%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 725
+ + LG+G G V +G+ A+K + L+ R C E +I+ L+HP
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ--ELSPKNRERWCLEIQIMKKLNHP 72
Query: 726 FVPALYASFQTKTHV------CLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVV 778
V + + L +YC GG+L L + LKE +R +++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 779 ALEYLHCQGIIYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
AL YLH II+RDLKPEN++LQ + D + L
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA--KELDQGELCTE-------- 182
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895
FVGT +Y+APE++ +T VD+W+ G L +E + G+ PF
Sbjct: 183 ------------------FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224
Query: 896 GKTRQKTFANILHK--------------DLKFPSSTPTSLH--------AKQLMYRLLHR 933
+ + + + +KF S PT H ++ + +L
Sbjct: 225 PNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW 284
Query: 934 DPKSRLGSHEGANEIKKHPFFKGVN 958
+ R + F+ ++
Sbjct: 285 HQRQRGTDP----QNPNVGCFQALD 305
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 6e-47
Identities = 76/327 (23%), Positives = 118/327 (36%), Gaps = 53/327 (16%)
Query: 639 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 698
+PP + +R LG G G+V A+K +
Sbjct: 5 KPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI 64
Query: 699 DKGVMLNRNKVHRACA-EREI--LDMLD----HPFVPALYASFQTKTHVCLITDY-CPGG 750
+ +L + + + E+ L + HP V L F+T+ L+ + P
Sbjct: 65 PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ 124
Query: 751 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLT 809
+LF + + L E R + +VV A+++ H +G+++RD+K EN+L+ G L
Sbjct: 125 DLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI 182
Query: 810 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA 869
DF L + F GT Y PE I+
Sbjct: 183 DFGSGALL--HDEPY---------------------------TDFDGTRVYSPPEWISRH 213
Query: 870 G-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMY 928
H W+LGILLY+M+ G PF IL +L FP+ S L+
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFPAH--VSPDCCALIR 265
Query: 929 RLLHRDPKSRLGSHEGANEIKKHPFFK 955
R L P SR EI P+ +
Sbjct: 266 RCLAPKPSSRP----SLEEILLDPWMQ 288
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-46
Identities = 62/311 (19%), Positives = 113/311 (36%), Gaps = 48/311 (15%)
Query: 657 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER 716
S + F P LG G G++ + + A+K + A E
Sbjct: 16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILP------ECFSFADREV 68
Query: 717 EILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 775
++L D HP V + + + + + + C L ++ Q +
Sbjct: 69 QLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVE-QKDFAHLGLEPITLLQQ 126
Query: 776 VVVALEYLHCQGIIYRDLKPENVLLQGNGH-----VSLTDFDLSCLTSCKPQLLLPTTNE 830
L +LH I++RDLKP N+L+ ++DF L
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC---------------- 170
Query: 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEM 887
K+ G+ + + GTE +IAPE+++ T VD ++ G + Y +
Sbjct: 171 -KKLAVGRHSFSRR-------SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 888 L-YGYTPFRGKTRQKTFANILHKDLKFPSSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGA 945
+ G PF +++ + L + A++L+ +++ DP+ R A
Sbjct: 223 ISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP----SA 278
Query: 946 NEIKKHPFFKG 956
+ KHPFF
Sbjct: 279 KHVLKHPFFWS 289
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-46
Identities = 52/296 (17%), Positives = 114/296 (38%), Gaps = 26/296 (8%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
L+H ++ + + + ++ D + + + + + +D
Sbjct: 61 LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLS-SPSPMDAPSVKIRRMDPFS 119
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEY 782
K ++ + C L ++R+ + + ++ A+E+
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 783 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
LH +G+++RDLKP N+ + V + DF L + E++
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT--------AMDQDEEEQTVLTPM---- 227
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
VGT+ Y++PE I G ++ VD ++LG++L+E+LY ++ R +
Sbjct: 228 ---PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST--QMERVRI 282
Query: 903 FANILHKDLKFPS-STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957
++ ++LKFP T ++ +L P R A +I ++ F+ +
Sbjct: 283 ITDV--RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP----EATDIIENAIFENL 332
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 20/85 (23%), Positives = 33/85 (38%), Gaps = 4/85 (4%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM-LNRNKVHRACAEREILDML 722
L F PI+ +G G G V + +A+K + L R KV R E + L L
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR---EVKALAKL 61
Query: 723 DHPFVPALYASFQTKTHVCLITDYC 747
+HP + + ++ +
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMD 86
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-46
Identities = 74/333 (22%), Positives = 123/333 (36%), Gaps = 51/333 (15%)
Query: 634 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 693
S +V H A + ++ ++ LGSG GSV+
Sbjct: 12 SGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 71
Query: 694 AMKAMDKGVMLNRNKV-HRACAEREI--LDMLDH--PFVPALYASFQTKTHVCLITDYC- 747
A+K ++K + + ++ + E+ L + V L F+ LI +
Sbjct: 72 AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 131
Query: 748 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHV 806
P +LF + + L+E+ R + +V+ A+ + H G+++RD+K EN+L+ N G +
Sbjct: 132 PVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 189
Query: 807 SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII 866
L DF L K + F GT Y PE I
Sbjct: 190 KLIDFGSGALL--KDTVY---------------------------TDFDGTRVYSPPEWI 220
Query: 867 AGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQ 925
H + W+LGILLY+M+ G PF I+ + F + +
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQRVSSE--CQH 272
Query: 926 LMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958
L+ L P R EI+ HP+ + V
Sbjct: 273 LIRWCLALRPSDRPTFE----EIQNHPWMQDVL 301
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-44
Identities = 72/335 (21%), Positives = 126/335 (37%), Gaps = 69/335 (20%)
Query: 656 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 715
+ + EQ K LG G +G+V G+ A+K M + A E
Sbjct: 6 IPNFEQSLKNLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLI------DFCDIALME 58
Query: 716 REILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-----QPTKVLKEDAV 769
++L D HP V Y S T + + + C L L++ + K+ KE
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 770 RFYAAEVVVALEYLHCQGIIYRDLKPENVLL-------------QGNGHVSLTDFDLSCL 816
++ + +LH II+RDLKP+N+L+ N + ++DF L
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC-- 175
Query: 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH----- 871
K+ GQ + N+ GT + APE++ + +
Sbjct: 176 ---------------KKLDSGQSS------FRTNLNNPSGTSGWRAPELLEESNNLQTKR 214
Query: 872 --TSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPT-----SLHA 923
T ++D +++G + Y +L G PF K ++ +NI+ A
Sbjct: 215 RLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEA 272
Query: 924 KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958
L+ +++ DP R A ++ +HP F +
Sbjct: 273 TDLISQMIDHDPLKRP----TAMKVLRHPLFWPKS 303
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-43
Identities = 55/303 (18%), Positives = 105/303 (34%), Gaps = 39/303 (12%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI---LD 720
F ++ +GSG+ GSV G +A+K K + V A RE+
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA---GSVDEQNALREVYAHAV 66
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVV 778
+ H V ++++ H+ + +YC GG L + + KE ++ +V
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 779 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK-- 836
L Y+H +++ D+KP N+ + + + +++ K
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF----------KIG 176
Query: 837 --GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTP 893
G + + G ++A E++ H D +AL + +
Sbjct: 177 DLG------HVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
Query: 894 FRGKTRQKTFANILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 952
R + I L + P S +L+ ++H DP+ R A + KH
Sbjct: 231 PRNG---DQWHEIRQGRLPRIPQV--LSQEFTELLKVMIHPDPERRP----SAMALVKHS 281
Query: 953 FFK 955
Sbjct: 282 VLL 284
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-41
Identities = 65/328 (19%), Positives = 118/328 (35%), Gaps = 38/328 (11%)
Query: 630 WANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGS 689
+ + + P+ + K +D + + +G G G VH ++ +
Sbjct: 23 GSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQT 82
Query: 690 GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 749
G A+K + V E L P + LY + + V + + G
Sbjct: 83 GFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134
Query: 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSL 808
G L L+ + L ED +Y + + LEYLH + I++ D+K +NVLL +G +L
Sbjct: 135 GSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAAL 192
Query: 809 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG 868
DF + P + + + + GTE ++APE++ G
Sbjct: 193 CDFGHA----------------------LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 869 AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLM 927
+ VD W+ ++ ML G P+ R I + + Q +
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290
Query: 928 YRLLHRDPKSRLGSHEGANEIKKHPFFK 955
L ++P R A E+++
Sbjct: 291 QEGLRKEPVHRA----SAMELRRKVGKA 314
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-41
Identities = 61/305 (20%), Positives = 100/305 (32%), Gaps = 85/305 (27%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI---LDMLDHPFV 727
+ LG G G V + + + FA+K + A RE+ P +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----------CPKARREVELHWRASQCPHI 73
Query: 728 PALYASFQT----KTHVCLITDYCPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVAL 780
+ ++ + + ++ + GGELF R + + E + A+
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELF---SRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 781 EYLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
+YLH I +RD+KPEN+L N + LTDF
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------------------ 166
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897
A E + + D W+LG+++Y +L GY PF
Sbjct: 167 ------------------------AKETTGE-KYDKSCDMWSLGVIMYILLCGYPPFYSN 201
Query: 898 TRQKT----FANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951
I +FP+ + S K L+ LL +P R+ E H
Sbjct: 202 HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM----TITEFMNH 257
Query: 952 PFFKG 956
P+
Sbjct: 258 PWIMQ 262
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 62/280 (22%), Positives = 107/280 (38%), Gaps = 22/280 (7%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 721
+ LG G G V +G+ MK + + + + E +++
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKVMRC 63
Query: 722 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 781
L+HP V + IT+Y GG L ++ ++ V F A ++ +
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSF-AKDIASGMA 122
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
YLH II+RDL N L++ N +V + DF L+ L+ + + + P
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVADFGLAR--------LMVDEKTQPEGLRSLKKP 174
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT-RQ 900
+ + VG ++APE+I G + VD ++ GI+L E++ R
Sbjct: 175 DR-----KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229
Query: 901 KTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
F + D P + P S + R DP+ R
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSFF--PITVRCCDLDPEKR 267
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 61/289 (21%), Positives = 110/289 (38%), Gaps = 49/289 (16%)
Query: 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 717
S I+ + + +G G G V + + A+K + + ++ E
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRA--KDVAIK-----QIESESERKAFIVELR 53
Query: 718 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEV 776
L ++HP + LY + VCL+ +Y GG L+ +L +P + +
Sbjct: 54 QLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 777 VVALEYLHC---QGIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLPTTNEKK 832
+ YLH + +I+RDLKP N+LL G V + DF +C
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----------------- 154
Query: 833 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT 892
+ M + G+ ++APE+ G+ ++ D ++ GI+L+E++
Sbjct: 155 ----------DIQTHM---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
Query: 893 PFRG-KTRQKTFANILHKDL--KFPSSTPTSLHAKQLMYRLLHRDPKSR 938
PF +H + P + + LM R +DP R
Sbjct: 202 PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI--ESLMTRCWSKDPSQR 248
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 78/312 (25%), Positives = 124/312 (39%), Gaps = 49/312 (15%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 721
IN + + +GSG T V + A+K ++ L + + +EI M
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN----LEKCQTSMDELLKEIQAM 67
Query: 722 --LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL------DRQPTKVLKEDAVRFYA 773
HP + + Y SF K + L+ GG + ++ + VL E +
Sbjct: 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 774 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLPTTNEKK 832
EV+ LEYLH G I+RD+K N+LL +G V + DF +S L + T K
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG-----GDITRNKV 182
Query: 833 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGY 891
R +FVGT ++APE++ G+ D W+ GI E+ G
Sbjct: 183 R------------------KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
Query: 892 TPFRGKTRQKTFANILHKD---LKFPSSTPTSLHA-----KQLMYRLLHRDPKSRLGSHE 943
P+ K L D L+ L ++++ L +DP+ R
Sbjct: 225 APYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP---- 280
Query: 944 GANEIKKHPFFK 955
A E+ +H FF+
Sbjct: 281 TAAELLRHKFFQ 292
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 70/288 (24%), Positives = 110/288 (38%), Gaps = 39/288 (13%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
LG G G V+ + A+K + + E + L H +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIP---ERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 733 SFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYR 791
SF + + + PGG L LL + + E + FY +++ L+YLH I++R
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 792 DLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 850
D+K +NVL+ +G + ++DF S KR +A
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTS-----------------KR----------LAGINPC 179
Query: 851 SNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFRG-KTRQKTFANIL 907
+ +F GT +Y+APEII G+ A D W+LG + EM G PF Q +
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG 239
Query: 908 HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+ S AK + + DP R AN++ F K
Sbjct: 240 MFKVHPEIPESMSAEAKAFILKCFEPDPDKRA----CANDLLVDEFLK 283
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 65/300 (21%), Positives = 118/300 (39%), Gaps = 37/300 (12%)
Query: 645 DSPPWKAIQKILDSGE---QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 701
D K ++ L + ++ F I LG+G+ G V V SG A K +
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-- 67
Query: 702 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 761
+ + ++ E ++L + P++ Y +F + + + ++ GG L +L +
Sbjct: 68 LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--A 125
Query: 762 KVLKEDAVRFYAAEVVVALEYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820
+ E + + V+ L YL + I++RD+KP N+L+ G + L DF +S
Sbjct: 126 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS------ 179
Query: 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 880
GQ + + M NSFVGT Y++PE + G ++ D W++
Sbjct: 180 ----------------GQ-----LIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSM 216
Query: 881 GILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG 940
G+ L EM G P ++ + + TP D + +
Sbjct: 217 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMA 276
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 63/313 (20%), Positives = 113/313 (36%), Gaps = 39/313 (12%)
Query: 633 HSKVVHPKPHRKDSPPWKAIQKILDSGEQ--INLQHFRPIKPLGSGDTGSVHLVELCGSG 690
H HP + G+ I + +G+G G+VH E G
Sbjct: 3 HHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG-- 60
Query: 691 QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 750
A+K + + +V+ E I+ L HP + + ++ ++T+Y G
Sbjct: 61 SDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 751 ELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVS 807
L+ LL + L E A +V + YLH + I++R+LK N+L+ V
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVK 179
Query: 808 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA 867
+ DF LS A +S S GT E++APE++
Sbjct: 180 VCDFGLSR---------------------------LKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 868 GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK--FPSSTPTSLHAKQ 925
D ++ G++L+E+ P+ + A + K + P + +
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV--AA 270
Query: 926 LMYRLLHRDPKSR 938
++ +P R
Sbjct: 271 IIEGCWTNEPWKR 283
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 62/292 (21%), Positives = 116/292 (39%), Gaps = 47/292 (16%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 732
+G G +V+ + A + L +++ R E E+L L HP + Y
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDR-KLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 733 SF----QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG- 787
S+ + K + L+T+ G L L R KV+K +R + +++ L++LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 788 -IIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
II+RDLK +N+ + G G V + D L+ L
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS------------------------- 185
Query: 846 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905
+ + +GT E++APE+ + +VD +A G+ + EM P+
Sbjct: 186 ----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 240
Query: 906 ILHKDLKFPSSTP--TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+ +K P+S K+++ + ++ R ++ H FF+
Sbjct: 241 RVTSGVK-PASFDKVAIPEVKEIIEGCIRQNKDERY----SIKDLLNHAFFQ 287
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 79/298 (26%), Positives = 125/298 (41%), Gaps = 51/298 (17%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--L 722
+ F ++ +G G G V + + A+K +D L + ++EI +
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID----LEEAEDEIEDIQQEITVLSQC 77
Query: 723 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 782
D P+V Y S+ T + +I +Y GG LL+ L E + E++ L+Y
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDY 134
Query: 783 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
LH + I+RD+K NVLL +G V L DF ++ QL T+ + +R
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG------QL----TDTQIKR-------- 176
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
N+FVGT ++APE+I + + S D W+LGI E+ G P K
Sbjct: 177 ---------NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV 227
Query: 903 FANILHKDLKFPSSTPT-----SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
I + PT S K+ + L+++P R A E+ KH F
Sbjct: 228 LFLIPKNN------PPTLEGNYSKPLKEFVEACLNKEPSFRP----TAKELLKHKFIL 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 76/294 (25%), Positives = 128/294 (43%), Gaps = 42/294 (14%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
+G G TG V L SG+ A+K MD + + + E I+ H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQH 101
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
V +Y S+ + ++ ++ GG L ++ + L E+ + V+ AL YLH
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLH 158
Query: 785 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 844
QG+I+RD+K +++LL +G V L+DF Q+ + + +R
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCA------QI----SKDVPKR---------- 198
Query: 845 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904
S VGT ++APE+I+ + + + VD W+LGI++ EM+ G P+ + +
Sbjct: 199 -------KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251
Query: 905 NILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+ LK L + + R+L RDP+ R A E+ HPF
Sbjct: 252 RLRDSPPPKLKNSHKVSPVL--RDFLERMLVRDPQER----ATAQELLDHPFLL 299
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 71/316 (22%), Positives = 117/316 (37%), Gaps = 54/316 (17%)
Query: 655 ILDSGEQ---INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR 711
L G Q + + +GSG G V + +G A+K M + NK
Sbjct: 12 YLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR----RSGNKEEN 67
Query: 712 ACAEREI---LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 768
++ L D P++ + +F T T V + + L ++ + E
Sbjct: 68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTC--AEKLKKRMQGPIPERI 125
Query: 769 VRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLP 826
+ +V AL YL + G+I+RD+KP N+LL G + L DF +S L
Sbjct: 126 LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-------- 177
Query: 827 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII-----AGAGHTSAVDWWALG 881
+A + G Y+APE I + D W+LG
Sbjct: 178 ---------------------DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 216
Query: 882 ILLYEMLYGYTPFRG-KTRQKTFANILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRL 939
I L E+ G P++ KT + +L ++ P S + + L +D + R
Sbjct: 217 ISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP 276
Query: 940 GSHEGANEIKKHPFFK 955
N++ +H F K
Sbjct: 277 ----KYNKLLEHSFIK 288
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 68/294 (23%), Positives = 124/294 (42%), Gaps = 42/294 (14%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
+ + + +G G +G+V+ +GQ A++ M+ + + K E ++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKN 76
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
P + S+ + ++ +Y GG L ++ + E + E + ALE+LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH 133
Query: 785 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 844
+I+RD+K +N+LL +G V LTDF Q+ T E+ +R
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA------QI----TPEQSKR---------- 173
Query: 845 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904
++ VGT ++APE++ + VD W+LGI+ EM+ G P+ + +
Sbjct: 174 -------STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
Query: 905 NILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
I L+ P + + R L D + R A E+ +H F K
Sbjct: 227 LIATNGTPELQNPEKLSAIF--RDFLNRCLEMDVEKR----GSAKELLQHQFLK 274
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 60/294 (20%), Positives = 107/294 (36%), Gaps = 52/294 (17%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE--RE-- 717
+ K +G G G VH L A+K++ G ++ E RE
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 718 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 777
I+ L+HP + LY ++ ++ P G+L+ L + + +R ++
Sbjct: 76 IMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRL-MLDIA 132
Query: 778 VALEYLHCQG--IIYRDLKPENVLL-----QGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830
+ +EY+ Q I++RDL+ N+ L + DF LS +
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV------------ 180
Query: 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEML 888
+ + +G +++APE I +T D ++ ++LY +L
Sbjct: 181 ------------------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222
Query: 889 YGYTPFRGKTRQK--TFANILHKDL--KFPSSTPTSLHAKQLMYRLLHRDPKSR 938
G PF + K I + L P P L + ++ DPK R
Sbjct: 223 TGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRL--RNVIELCWSGDPKKR 274
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 69/303 (22%), Positives = 119/303 (39%), Gaps = 42/303 (13%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-L 719
++ PI LG G G V + SGQ A+K + +N + R + +I +
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR--ATVNSQEQKRLLMDLDISM 60
Query: 720 DMLDHPFVPALYASFQTKTHVCLITDYCPGG-ELFLLLDRQPTKVLKEDAVRFYAAEVVV 778
+D PF Y + + V + + + F + + ED + A +V
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 779 ALEYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
ALE+LH + +I+RD+KP NVL+ G V + DF +S G
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS----------------------G 158
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----AGHTSAVDWWALGILLYEMLYGYTP 893
+ + + A + G + Y+APE I G++ D W+LGI + E+ P
Sbjct: 159 Y-----LVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
Query: 894 FRG-KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 952
+ T + ++ + + S + L ++ K R E+ +HP
Sbjct: 213 YDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERP----TYPELMQHP 268
Query: 953 FFK 955
FF
Sbjct: 269 FFT 271
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 77/317 (24%), Positives = 131/317 (41%), Gaps = 43/317 (13%)
Query: 643 RKDSPPWKAIQKILDSGEQIN-LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 701
+ +PP + ++K+ + + F ++ LG G GSV+ +GQ A+K +
Sbjct: 6 QLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-- 63
Query: 702 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 761
+ + E I+ D P V Y S+ T + ++ +YC G + ++ +
Sbjct: 64 ---VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN- 119
Query: 762 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821
K L ED + + LEYLH I+RD+K N+LL GH L DF ++
Sbjct: 120 KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG------ 173
Query: 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 881
QL T+ +R N+ +GT ++APE+I G+ D W+LG
Sbjct: 174 QL----TDTMAKR-----------------NTVIGTPFWMAPEVIQEIGYNCVADIWSLG 212
Query: 882 ILLYEMLYGYTPFRGKTRQKTFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
I EM G P+ + I + P S + + + L + P+ R
Sbjct: 213 ITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL--WSDNFTDFVKQCLVKSPEQR 270
Query: 939 LGSHEGANEIKKHPFFK 955
A ++ +HPF +
Sbjct: 271 A----TATQLLQHPFVR 283
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 62/308 (20%), Positives = 109/308 (35%), Gaps = 49/308 (15%)
Query: 643 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMD 699
+ + D E I + +GSG G+V+ G++ A+K ++
Sbjct: 3 KGHHHHHHGSRDAADDWE-IPDGQITVGQRIGSGSFGTVYK------GKWHGDVAVKMLN 55
Query: 700 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 759
++ E +L H + T + ++T +C G L+ L
Sbjct: 56 VTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHAS 113
Query: 760 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819
TK + + A + ++YLH + II+RDLK N+ L + V + DF L+ S
Sbjct: 114 ETKFEMKKLIDI-ARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS- 171
Query: 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVD 876
G+ ++APE+I + D
Sbjct: 172 ------------------------RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 877 WWALGILLYEMLYGYTPFRGKT-RQKTFANILHKDLK-----FPSSTPTSLHAKQLMYRL 930
+A GI+LYE++ G P+ R + + L S+ P + K+LM
Sbjct: 208 VYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM--KRLMAEC 265
Query: 931 LHRDPKSR 938
L + R
Sbjct: 266 LKKKRDER 273
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-33
Identities = 59/368 (16%), Positives = 124/368 (33%), Gaps = 82/368 (22%)
Query: 638 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSG--DTGSVHLVELCGSGQYFAM 695
H H ++ ++ + L G + + +G G D +V+L +G+Y +
Sbjct: 3 HHHHHHMENLYFQGMSSFLPEGG-----CYELLTVIGKGFEDLMTVNLARYKPTGEYVTV 57
Query: 696 KAMDKGVMLNRNKVHRACAEREILDM--LDHPFVPALYASFQTKTHVCLITDYCPGGELF 753
+ ++ + + + E+ +HP + A+F + ++T + G
Sbjct: 58 RRIN---LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 114
Query: 754 LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 813
L+ + E A+ + V+ AL+Y+H G ++R +K ++L+ +G V L+
Sbjct: 115 DLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 174
Query: 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA--GAGH 871
+ + + +R+ P V +++PE++ G+
Sbjct: 175 NL------SM----ISHGQRQRVVHDFP----------KYSVKVLPWLSPEVLQQNLQGY 214
Query: 872 TSAVDWWALGILLYEMLYGYTPF------------------------------------- 894
+ D +++GI E+ G+ PF
Sbjct: 215 DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSR 274
Query: 895 -------RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947
T P S H + + L R+P +R A+
Sbjct: 275 SVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP----SAST 330
Query: 948 IKKHPFFK 955
+ H FFK
Sbjct: 331 LLNHSFFK 338
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 68/292 (23%), Positives = 114/292 (39%), Gaps = 50/292 (17%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA-CAEREIL 719
+I+ + +G G G V+ G A+KA + ++ E ++
Sbjct: 3 EIDFAELTLEEIIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 720 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 779
ML HP + AL + ++CL+ ++ GG L +L + + D + +A ++
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARG 117
Query: 780 LEYLHCQG---IIYRDLKPENVLL--------QGNGHVSLTDFDLSCLTSCKPQLLLPTT 828
+ YLH + II+RDLK N+L+ N + +TDF L+
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-------- 169
Query: 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 888
S G ++APE+I + + D W+ G+LL+E+L
Sbjct: 170 ---------------------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL 208
Query: 889 YGYTPFRGKTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
G PFRG + L PS+ P +LM + DP SR
Sbjct: 209 TGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPF--AKLMEDCWNPDPHSR 258
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 70/301 (23%), Positives = 128/301 (42%), Gaps = 45/301 (14%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
+ + + LG G G V+ + +G A K ++ + ++ E EIL DH
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCDH 75
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
P++ L ++ + ++ ++CPGG + ++ + L E ++ +++ AL +LH
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLH 134
Query: 785 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 844
+ II+RDLK NVL+ G + L DF +S + ++R
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSA------KN----LKTLQKR---------- 174
Query: 845 AEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899
+SF+GT ++APE++ + D W+LGI L EM P
Sbjct: 175 -------DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227
Query: 900 QKTFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
+ I D L PS S+ + + L ++P++R A ++ +HPF
Sbjct: 228 MRVLLKIAKSDPPTLLTPSK--WSVEFRDFLKIALDKNPETRP----SAAQLLEHPFVSS 281
Query: 957 V 957
+
Sbjct: 282 I 282
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 63/309 (20%), Positives = 107/309 (34%), Gaps = 50/309 (16%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-- 718
+ + + +G G GSV+ + SGQ A+K + ++ + ++
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR----STVDEKEQKQLLMDLDV 73
Query: 719 -LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAE 775
+ D P++ Y + + + + V+ E+ +
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 776 VVVALEYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
V AL +L II+RD+KP N+LL +G++ L DF +S QL + +
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS------GQL----VDSIAKT 183
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----AGHTSAVDWWALGILLYEMLYG 890
G Y+APE I G+ D W+LGI LYE+ G
Sbjct: 184 R------------------DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225
Query: 891 YTPFRG-KTRQKTFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946
P+ + ++ D L S + L +D R
Sbjct: 226 RFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP----KYK 281
Query: 947 EIKKHPFFK 955
E+ KHPF
Sbjct: 282 ELLKHPFIL 290
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 75/310 (24%), Positives = 121/310 (39%), Gaps = 61/310 (19%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLD 723
F ++ +G+G G V+ +GQ A+K MD + ++ E +L
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 724 HPFVPALYASFQTKTHVC------LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 777
H + Y +F K L+ ++C G + L+ LKE+ + + E++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 778 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
L +LH +I+RD+K +NVLL N V L DF +S QL RR
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------QL----DRTVGRR--- 186
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYT 892
N+F+GT ++APE+IA A + D W+LGI EM G
Sbjct: 187 --------------NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 893 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQL-------MYRLLHRDPKSRLGSHEGA 945
P + I P + L +K+ + L ++ R
Sbjct: 233 PLCDMHPMRALFLI-------PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRP----AT 281
Query: 946 NEIKKHPFFK 955
++ KHPF +
Sbjct: 282 EQLMKHPFIR 291
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 58/292 (19%), Positives = 106/292 (36%), Gaps = 49/292 (16%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAEREI 718
I + + +G G G V+ G++ A++ +D N +++ E
Sbjct: 30 IPFEQLEIGELIGKGRFGQVY------HGRWHGEVAIRLIDIERD-NEDQLKAFKREVMA 82
Query: 719 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 778
H V + + H+ +IT C G L+ ++ R VL + R A E+V
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVK 141
Query: 779 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 838
+ YLH +GI+++DLK +NV NG V +TDF L + +
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSI---------------SGVLQAG 185
Query: 839 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---------HTSAVDWWALGILLYEMLY 889
+ + G ++APEII + D +ALG + YE+
Sbjct: 186 RREDKLRIQ-------NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238
Query: 890 GYTPFRGKTRQKTFANILHKDLKF---PSSTPTSLHAKQLMYRLLHRDPKSR 938
PF+ + + + +K + ++ + + R
Sbjct: 239 REWPFKTQPAEAIIWQM-GTGMKPNLSQIGMGKEI--SDILLFCWAFEQEER 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 45/292 (15%), Positives = 95/292 (32%), Gaps = 46/292 (15%)
Query: 656 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 715
++ I+ + + L +G + G +K + + K E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQG--NDIVVKVLKVR-DWSTRKSRDFNEE 57
Query: 716 REILDMLDHPFVPALYASFQT--KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 773
L + HP V + + Q+ H LIT + P G L+ +L V+ + +A
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 774 AEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 831
++ + +LH I L +V++ + ++ D+
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP----------- 166
Query: 832 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---HTSAVDWWALGILLYEML 888
+ ++APE + + + D W+ +LL+E++
Sbjct: 167 ---------------------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV 205
Query: 889 YGYTPFRGKTRQKTFANILHKDL--KFPSSTPTSLHAKQLMYRLLHRDPKSR 938
PF + + + + L P + +LM ++ DP R
Sbjct: 206 TREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV--SKLMKICMNEDPAKR 255
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 68/328 (20%), Positives = 111/328 (33%), Gaps = 56/328 (17%)
Query: 638 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 697
P R S + ++ + + F ++ +G G G+V+ + + A+K
Sbjct: 29 MPAGGRAGSLKDPDVAELFFKDD--PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKK 86
Query: 698 MDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD 757
M + K E L L HP + + L+ +YC G LL
Sbjct: 87 MSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV 146
Query: 758 RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817
+ K L+E + + L YLH +I+RD+K N+LL G V L DF +
Sbjct: 147 HK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS-- 202
Query: 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSA 874
+ NSFVGT ++APE+I +
Sbjct: 203 ----IM-------APA------------------NSFVGTPYWMAPEVILAMDEGQYDGK 233
Query: 875 VDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQL-------M 927
VD W+LGI E+ P +I + +L + +
Sbjct: 234 VDVWSLGITCIELAERKPPLFNMNAMSALYHI-------AQNESPALQSGHWSEYFRNFV 286
Query: 928 YRLLHRDPKSRLGSHEGANEIKKHPFFK 955
L + P+ R + + KH F
Sbjct: 287 DSCLQKIPQDRP----TSEVLLKHRFVL 310
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 4e-26
Identities = 55/285 (19%), Positives = 102/285 (35%), Gaps = 44/285 (15%)
Query: 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR--ACAER 716
G+ N + I+ LG G +V L ++ AMK ++ + + A E
Sbjct: 32 GDLFN-GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK------VVKSAEHYTETALDEI 84
Query: 717 EILDML-----DHP---FVPALYASFQTK----THVCLITDYCPGGE-LFLLLDRQPTKV 763
+L + + P V L F+ TH+C++ + G L + + +
Sbjct: 85 RLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQG 142
Query: 764 LKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822
L V+ +V+ L+YLH + II+ D+KPEN+LL N +
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRAS-------------------NSFVGTEEYIAP 863
+ V EP A + T +Y +
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSL 262
Query: 864 EIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 908
E++ G+G+ + D W+ + +E+ G F + ++ + H
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-26
Identities = 51/238 (21%), Positives = 82/238 (34%), Gaps = 50/238 (21%)
Query: 709 VHRACAEREILDMLDHPFVPALYASFQTKTHVC-----LITDYCPGGELFLLLDRQPTKV 763
A AER+ L + HP + ++ + ++ +Y G L ++
Sbjct: 123 QAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---- 178
Query: 764 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823
L Y E++ AL YLH G++Y DLKPEN++L + L D
Sbjct: 179 LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGA---------- 227
Query: 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 883
+ + GT + APEI+ G T A D + +G
Sbjct: 228 ---------------------VSRINSFGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRT 265
Query: 884 LYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS 941
L + G+ L +D T S L+ R + DP+ R +
Sbjct: 266 LAALTLDLPTRNGRYVDG-----LPEDDPVL-KTYDSYGR--LLRRAIDPDPRQRFTT 315
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 67/321 (20%), Positives = 118/321 (36%), Gaps = 78/321 (24%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFV 727
+ +G G G V + G + A+K + + + E EI ML H +
Sbjct: 47 QESIGKGRFGEVWRGKWRG--EEVAVK------IFSSREERSWFREAEIYQTVMLRHENI 98
Query: 728 PALYAS----FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 783
A+ T T + L++DY G LF L+R V E ++ A L +L
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV--EGMIKL-ALSTASGLAHL 155
Query: 784 HCQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
H + I +RDLK +N+L++ NG + D L+ RH
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA------------------VRH 197
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS------AVDWWALGILLYEMLY 889
+ + + A N VGT+ Y+APE++ + + D +A+G++ +E+
Sbjct: 198 DSATDTIDI-----APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252
Query: 890 GYT----------PFRGKT-RQKTFANI----LHKDL--KFPS---STPTSLHAKQLMYR 929
+ P+ + + + L P+ S ++M
Sbjct: 253 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE 312
Query: 930 LLHRDPKSRLGSHEGANEIKK 950
+ + +RL A IKK
Sbjct: 313 CWYANGAARL----TALRIKK 329
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 72/334 (21%), Positives = 115/334 (34%), Gaps = 89/334 (26%)
Query: 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI- 718
I L + +G G G V G + A+K + + E E+
Sbjct: 8 RDITLL-----ECVGKGRYGEVWRGSWQG--ENVAVK------IFSSRDEKSWFRETELY 54
Query: 719 -LDMLDHP----FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 773
ML H F+ + S + T + LIT Y G L+ L +R
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDT--VSCLRI-V 111
Query: 774 AEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCL-TSCKPQLL 824
+ L +LH + I +RDLK +N+L++ NG + D L+ + + QL
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA------VDWW 878
+ VGT+ Y+APE++ VD W
Sbjct: 172 VGNNPR------------------------VGTKRYMAPEVLDETIQVDCFDSYKRVDIW 207
Query: 879 ALGILLYEMLYGYT----------PFRGKT-RQKTFANI----LHKDL--KFPSS----- 916
A G++L+E+ PF +F ++ P+
Sbjct: 208 AFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDP 267
Query: 917 TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950
T TSL +LM +++P +RL A IKK
Sbjct: 268 TLTSL--AKLMKECWYQNPSARL----TALRIKK 295
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 64/331 (19%), Positives = 120/331 (36%), Gaps = 74/331 (22%)
Query: 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI- 718
++ + + +K +G G G V + + G + A+K V + E EI
Sbjct: 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWRG--EKVAVK-----VFFTTEE-ASWFRETEIY 83
Query: 719 -LDMLDHPFVPALYAS----FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 773
++ H + A+ + T + LITDY G L+ L + + ++ A
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKL-A 140
Query: 774 AEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825
V L +LH + I +RDLK +N+L++ NG + D L+
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA----------- 189
Query: 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS------AVDWWA 879
+ N V + N+ VGT+ Y+ PE++ + + + D ++
Sbjct: 190 -------VKFISDTNEVDI-----PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237
Query: 880 LGILLYEMLYGYT----------PFRGKT-RQKTFANI----LHKDL-----KFPSSTPT 919
G++L+E+ P+ ++ ++ K L SS
Sbjct: 238 FGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDEC 297
Query: 920 SLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950
+LM +P SRL + + K
Sbjct: 298 LRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 57/257 (22%), Positives = 95/257 (36%), Gaps = 53/257 (20%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--L 719
++L + + ++ +G G G+V+ L + A+K NR E+ I +
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFA---NRQNFIN---EKNIYRV 61
Query: 720 DMLDHPFVPALYA-----SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 774
+++H + + + L+ +Y P G L L + A
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAH 118
Query: 775 EVVVALEYLHCQ---------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825
V L YLH + I +RDL NVL++ +G ++DF LS
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR--------- 169
Query: 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-------GHTSAVDWW 878
V E A+ S VGT Y+APE++ GA VD +
Sbjct: 170 ----------LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219
Query: 879 ALGILLYEMLYGYTPFR 895
ALG++ +E+ T
Sbjct: 220 ALGLIYWEIFMRCTDLF 236
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 62/326 (19%), Positives = 121/326 (37%), Gaps = 59/326 (18%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
++ + LG G +V+L E A+KA+ + R E L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 727 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
+ ++ + L+ +Y G L ++ L D + +++ +++ H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM 130
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
I++RD+KP+N+L+ N + + DF ++ S
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--------------------------ET 164
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT------RQ 900
+ +N +GT +Y +PE G D +++GI+LYEML G PF G+T +
Sbjct: 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH 224
Query: 901 KTFANILHKDLKFPSST-----PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+ + ++ P SL ++ R +D +R + E+K
Sbjct: 225 ------IQDSVPNVTTDVRKDIPQSLSN--VILRATEKDKANRYKT---IQEMKD----- 268
Query: 956 GVNWALVRCMNPPELDAPLFATDTEK 981
L ++ + ++ D K
Sbjct: 269 ----DLSSVLHENRANEDVYELDKMK 290
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 27/101 (26%), Positives = 51/101 (50%)
Query: 208 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 267
T I+YA+ F ++ Y +E+VG++ R + + + T+ G + G
Sbjct: 5 TDLQGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNIWQGEF 64
Query: 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308
N +KDGT +W TI P+ D+ GK ++I ++ +++ E
Sbjct: 65 CNRRKDGTRYWVDSTIVPLMDNAGKPRQYISIRRDITAQKE 105
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-22
Identities = 27/99 (27%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 208 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 267
T I+YA+ + +G E++G++ L D E +A ++E LQ GQ + GRL
Sbjct: 127 TDRAGRIIYANPALCRFSGMAEGELLGQSPSILDSPLADQETLAAMQEALQAGQPWSGRL 186
Query: 268 LNYKK------DGTPFWNLLTIAPIKDDEGKVLKFIGMQ 300
LN ++ D +W ++ PI D ++ ++ +Q
Sbjct: 187 LNRRRTGPAPHDAEDYWAEISTTPIHTDGNGLVGYVQIQ 225
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 36/186 (19%), Positives = 72/186 (38%), Gaps = 19/186 (10%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 545
ITD I++A+D+F ++ Y REE++G++ R + A +R + I
Sbjct: 3 SITDL---QGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNI 59
Query: 546 VTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSE------HLEPLRNSIPE 595
+ N K G ++W + P+ D +I ++ D + L L+ ++
Sbjct: 60 WQGEFCNRRKDGTRYWVDSTIVPLMDNAGKPRQYISIRRDITAQKEAEAQLARLKQAMDA 119
Query: 596 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLW-ANHSKVVHPKPHRKDSPPWKAIQK 654
+ N A+ + + +L + S + P D A+Q+
Sbjct: 120 NSEMILLTDRAGRIIYANPALCRF--SGMAEGELLGQSPSILDSP---LADQETLAAMQE 174
Query: 655 ILDSGE 660
L +G+
Sbjct: 175 ALQAGQ 180
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 21/128 (16%), Positives = 52/128 (40%), Gaps = 13/128 (10%)
Query: 464 RQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFL 523
+++ + L ++ + ++TD II+A+ + + + E+LG++ L
Sbjct: 103 QKEAEAQLARLKQAMDANSEMILLTDR---AGRIIYANPALCRFSGMAEGELLGQSPSIL 159
Query: 524 QGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKK------FWNLFHLQPMRDQK---- 573
P D T+ ++ A+ + +L+N ++G +W P+
Sbjct: 160 DSPLADQETLAAMQEALQAGQPWSGRLLNRRRTGPAPHDAEDYWAEISTTPIHTDGNGLV 219
Query: 574 YFIGVQLD 581
++ +Q D
Sbjct: 220 GYVQIQHD 227
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 5e-23
Identities = 76/324 (23%), Positives = 120/324 (37%), Gaps = 68/324 (20%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 724
+ I +G G G V +GQ A+K K + + V + A REI L L H
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
P + L F+ K + L+ +YC + LDR + + E V+ + + A+ + H
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH 119
Query: 785 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 844
I+RD+KPEN+L+ + + L DF + R + +
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFA-------------------RLLTGPSDYYD 160
Query: 845 AEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTR---- 899
E V T Y +PE++ G VD WA+G + E+L G + GK+
Sbjct: 161 DE--------VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL 212
Query: 900 QKTF---------------ANILHKDLKFPSSTPT----------SLHAKQLMYRLLHRD 934
N +K P S A L+ LH D
Sbjct: 213 YLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMD 272
Query: 935 PKSRLGSHEGANEIKKHPFFKGVN 958
P RL ++ HP+F+ +
Sbjct: 273 PTERL----TCEQLLHHPYFENIR 292
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 8e-23
Identities = 50/222 (22%), Positives = 92/222 (41%), Gaps = 31/222 (13%)
Query: 722 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 781
L P V ++ + + + G +L +L RQ + AV ++ AL+
Sbjct: 91 LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVA-IVRQIGSALD 148
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
H G +RD+KPEN+L+ + L DF ++ T+
Sbjct: 149 AAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT----------------------- 185
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901
E + + VGT Y+APE + + T D +AL +LYE L G P++G
Sbjct: 186 ---DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV 242
Query: 902 TFANILHKDLKFPSSTPTSLHAK--QLMYRLLHRDPKSRLGS 941
A+ +++ + PS+ + ++ R + ++P+ R +
Sbjct: 243 MGAH-INQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVT 283
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 56/321 (17%), Positives = 103/321 (32%), Gaps = 78/321 (24%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-- 718
+ ++ G G V +L +Y A+K ++ E E+
Sbjct: 20 YFQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQ---DKQSWQN---EYEVYS 71
Query: 719 LDMLDHP----FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 774
L + H F+ A + LIT + G L L + + + A
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAE 128
Query: 775 EVVVALEYLHCQ----------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824
+ L YLH I +RD+K +NVLL+ N + DF L+
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA---------- 178
Query: 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA-----VDWWA 879
+ + ++ + VGT Y+APE++ GA + +D +A
Sbjct: 179 --------LKFEAGKSAGDT-------HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223
Query: 880 LGILLYEMLYGYTPFRGKT------------RQKTFANIL------HKDLKFPSSTPTSL 921
+G++L+E+ T G + + ++ K
Sbjct: 224 MGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHA 283
Query: 922 HAK---QLMYRLLHRDPKSRL 939
+ + D ++RL
Sbjct: 284 GMAMLCETIEECWDHDAEARL 304
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 76/369 (20%), Positives = 138/369 (37%), Gaps = 84/369 (22%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK--AMDK--GVMLNRNKVHRACAEREI- 718
++ + + LG G +V+ + + A+K ++ G A RE+
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT--------AIREVS 52
Query: 719 -LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 777
L L H + L+ T+ + L+ +Y +L LD + V+ + +++
Sbjct: 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI-INMHNVKLFLFQLL 110
Query: 778 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
L Y H Q +++RDLKP+N+L+ G + L DF L+ R K
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA-------------------RAKS 151
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRG 896
P + ++ V T Y P+I+ G+ ++ +D W +G + YEM G F G
Sbjct: 152 --------IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203
Query: 897 KTR----QKTFANIL----------------HKDLKFPSSTPTSL---------HAKQLM 927
T F IL K +P +L L+
Sbjct: 204 STVEEQLHFIF-RILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLL 262
Query: 928 YRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVD 987
+LL + ++R+ A + KHPFF +L ++ +FA + K +
Sbjct: 263 TKLLQFEGRNRI----SAEDAMKHPFF----LSLGERIHKLPDTTSIFALKEIQLQK--E 312
Query: 988 PGMQDLQQN 996
++ +
Sbjct: 313 ASLRSAHHH 321
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 62/367 (16%), Positives = 116/367 (31%), Gaps = 109/367 (29%)
Query: 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-ACAERE 717
GE + ++ LG G +V L + + + AMK ++ A E +
Sbjct: 13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIK 67
Query: 718 ILDML-----------DHPFVPALYASFQTK----THVCLITDYCPGGELFLLLDRQPTK 762
+L + + L F K HV ++ + G L L+ + +
Sbjct: 68 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR 126
Query: 763 VLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLL------QGNGHVSLTDFDLSC 815
+ V+ + ++++ L+Y+H + GII+ D+KPENVL+ + + + D +C
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 875
+ + + T EY +PE++ GA
Sbjct: 187 WYD--------------EHY----------------TNSIQTREYRSPEVLLGAPWGCGA 216
Query: 876 DWWALGILLYEMLYGYTPFRGKTRQKTFANILH--------------------------- 908
D W+ L++E++ G F + H
Sbjct: 217 DIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFN 276
Query: 909 ---KDLKFPSSTPTSLH-------------AKQ---LMYRLLHRDPKSRLGSHEGANEIK 949
L AK+ + +L DP+ R A +
Sbjct: 277 SRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA----DAGGLV 332
Query: 950 KHPFFKG 956
HP+ K
Sbjct: 333 NHPWLKD 339
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 61/274 (22%), Positives = 110/274 (40%), Gaps = 60/274 (21%)
Query: 722 LDHPFVPALY----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 777
L+HP + A+Y A ++ +Y G L ++ + + A+
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADAC 126
Query: 778 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
AL + H GII+RD+KP N+++ V + DF ++ R
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA-------------------RAIA 167
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897
+ + + +GT +Y++PE G + D ++LG +LYE+L G PF G
Sbjct: 168 DS-----GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222
Query: 898 T------RQKTFANILHKDLKFPSST----PTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947
+ + + +D PS+ L A ++ + L ++P++R + A E
Sbjct: 223 SPVSVAYQH------VREDPIPPSARHEGLSADLDA--VVLKALAKNPENRYQT---AAE 271
Query: 948 IKKHPFFKGVNWALVRCMNPPELDAPLFATDTEK 981
++ LVR N +AP TD E+
Sbjct: 272 MRA---------DLVRVHNGEPPEAPKVLTDAER 296
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 76/340 (22%), Positives = 121/340 (35%), Gaps = 71/340 (20%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 724
+ + +G G G V +G+ A+K K + + +K+ + A REI L L H
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
+ L + K L+ ++ + L+ P L V+ Y +++ + + H
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG-LDYQVVQKYLFQIINGIGFCH 141
Query: 785 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 844
II+RD+KPEN+L+ +G V L DF + R V+
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFA-------------------RTLAAPGEVYD 182
Query: 845 AEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903
E V T Y APE++ G AVD WA+G L+ EM G F G +
Sbjct: 183 DE--------VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL 234
Query: 904 ANILH-------------------KDLKFPSSTPT----------SLHAKQLMYRLLHRD 934
+I+ ++ P S L + LH D
Sbjct: 235 YHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHID 294
Query: 935 PKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPL 974
P R E+ H FF+ + EL +
Sbjct: 295 PDKRP----FCAELLHHDFFQMDGF---AERFSQELQLKV 327
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-22
Identities = 60/316 (18%), Positives = 116/316 (36%), Gaps = 35/316 (11%)
Query: 625 TPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLV 684
+ L + P + +A+ K D +N + + +G G+ G V
Sbjct: 77 SIPLLIDHLLSTQQPLTKKSGVVLHRAVPK--DKWV-LNHEDLVLGEQIGRGNFGEVFSG 133
Query: 685 ELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744
L A+K+ + + + + E IL HP + L K + ++
Sbjct: 134 RLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191
Query: 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 804
+ GG+ L + ++ + ++ + +EYL + I+RDL N L+
Sbjct: 192 ELVQGGDFLTFLRTEGARLRVKTLLQM-VGDAAAGMEYLESKCCIHRDLAARNCLVTEKN 250
Query: 805 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPE 864
+ ++DF +S + +Q PV ++ APE
Sbjct: 251 VLKISDFGMSREEA---------DGVYAASGGLRQVPV----------------KWTAPE 285
Query: 865 IIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLH 922
+ ++S D W+ GILL+E G +P+ + Q+T + L P P ++
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVF 345
Query: 923 AKQLMYRLLHRDPKSR 938
+LM + +P R
Sbjct: 346 --RLMEQCWAYEPGQR 359
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 7e-22
Identities = 84/361 (23%), Positives = 138/361 (38%), Gaps = 80/361 (22%)
Query: 635 KVVHPKPHRKDSPPWKAIQKILDSGEQINLQ---HFRPIKPLGSGDTGSVHLVELCGSGQ 691
+D K + G+ + + K +G+G G V+ +LC SG+
Sbjct: 21 SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 80
Query: 692 YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT------HVCLITD 745
A+K K V+ ++ +R E +I+ LDH + L F + ++ L+ D
Sbjct: 81 LVAIK---K-VLQDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133
Query: 746 YCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 803
Y P ++ + + L V+ Y ++ +L Y+H GI +RD+KP+N+LL +
Sbjct: 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD 192
Query: 804 -GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 862
+ L DF + + L+ EP S++ + Y A
Sbjct: 193 TAVLKLCDFGSA-------KQLVRG------------------EPNV---SYICSRYYRA 224
Query: 863 PEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANIL-------------- 907
PE+I GA TS++D W+ G +L E+L G F G + I+
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284
Query: 908 ---HKDLKFPSSTPTSLH----------AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
+ + KFP A L RLL P +RL E H FF
Sbjct: 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL----TPLEACAHSFF 340
Query: 955 K 955
Sbjct: 341 D 341
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 62/276 (22%), Positives = 108/276 (39%), Gaps = 65/276 (23%)
Query: 714 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 771
REI L L H + LY TK + L+ ++ +L LLD L+ +
Sbjct: 47 TIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKS 104
Query: 772 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 831
+ +++ + Y H + +++RDLKP+N+L+ G + + DF L+
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA----------------- 147
Query: 832 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYG 890
R G P+R + T Y AP+++ G+ ++ +D W++G + EM+ G
Sbjct: 148 --RAFG--------IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197
Query: 891 YTPFRGKTR----QKTFANIL----------HKDL-----KFPSSTPTSL---------H 922
F G + + F IL +L F P
Sbjct: 198 TPLFPGVSEADQLMRIF-RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDES 256
Query: 923 AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958
L+ ++L DP R+ A + +H +FK N
Sbjct: 257 GIDLLSKMLKLDPNQRI----TAKQALEHAYFKENN 288
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 3e-21
Identities = 65/275 (23%), Positives = 113/275 (41%), Gaps = 66/275 (24%)
Query: 716 REI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 773
REI L L HP + +L ++ + L+ ++ +L +LD T L++ ++ Y
Sbjct: 68 REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYL 125
Query: 774 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 833
+++ + + H I++RDLKP+N+L+ +G + L DF L+
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA------------------- 166
Query: 834 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYT 892
R G P+R+ V T Y AP+++ G+ +++VD W++G + EM+ G
Sbjct: 167 RAFG--------IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218
Query: 893 PFRGKTR----QKTFANIL----------------HKDLKFPSSTPTSL---------HA 923
F G T K F +IL K F
Sbjct: 219 LFPGVTDDDQLPKIF-SILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEG 277
Query: 924 KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958
L+ +L DP R+ A + HP+FK ++
Sbjct: 278 IDLLSNMLCFDPNKRI----SARDAMNHPYFKDLD 308
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 66/362 (18%), Positives = 122/362 (33%), Gaps = 86/362 (23%)
Query: 638 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 697
H H + + + + + + +G G G V + A+K
Sbjct: 1 HHHHHHMAAAAAAGPEMVRGQVFDV-GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK 59
Query: 698 MDKGVMLNRNKVHRACAEREI--LDMLDHP--------FVPALYASFQTKTHVCLITDYC 747
+ ++ + REI L H + V ++ D
Sbjct: 60 ISP----FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLM 112
Query: 748 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 807
+L+ LL Q L D + ++ +++ L+Y+H +++RDLKP N+LL +
Sbjct: 113 -ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 168
Query: 808 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA 867
+ DF L+ + + F+ E +V T Y APEI+
Sbjct: 169 ICDFGLARVAD-----------------PDHDHTGFLTE-------YVATRWYRAPEIML 204
Query: 868 GAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH------------------ 908
+ T ++D W++G +L EML F GK +IL
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 909 ------------KDLK--FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
FP++ +L L+ ++L +P R+ + HP+
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALD---LLDKMLTFNPHKRI----EVEQALAHPYL 317
Query: 955 KG 956
+
Sbjct: 318 EQ 319
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-21
Identities = 88/373 (23%), Positives = 149/373 (39%), Gaps = 80/373 (21%)
Query: 640 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 699
P + K + +GEQ + + K +G+G G V +L S + A+K
Sbjct: 16 NPLDDPNKVIKVLASDGKTGEQREIA-YTNCKVIGNGSFGVVFQAKLVESDE-VAIK--- 70
Query: 700 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH------VCLITDYCPGGELF 753
K V+ ++ +R E +I+ ++ HP V L A F + + L+ +Y P ++
Sbjct: 71 K-VLQDKRFKNR---ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVY 125
Query: 754 LLLD--RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTD 810
+ + + ++ Y +++ +L Y+H GI +RD+KP+N+LL G + L D
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID 185
Query: 811 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 870
F + + + S++ + Y APE+I GA
Sbjct: 186 FGSA-------------------KI---------LIAGEPNVSYICSRYYRAPELIFGAT 217
Query: 871 H-TSAVDWWALGILLYEMLYGYTPFRGKT-----------------RQKTFANILHKDLK 912
+ T+ +D W+ G ++ E++ G F G++ Q N + + K
Sbjct: 218 NYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHK 277
Query: 913 FPSSTPTSLH----------AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962
FP P A L+ RLL P +RL A E HPFF +
Sbjct: 278 FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL----TAIEALCHPFFDELRTGEA 333
Query: 963 RCMNPPELDAPLF 975
R N EL PLF
Sbjct: 334 RMPNGRELP-PLF 345
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 59/275 (21%), Positives = 98/275 (35%), Gaps = 68/275 (24%)
Query: 716 REI-----LDMLDHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLK 765
RE+ L+ +HP V L + + V L+ ++ +L LD+ P L
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118
Query: 766 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825
+ ++ + + L++LH I++RDLKPEN+L+ G V L DF L+
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA----------- 167
Query: 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 885
R M + V T Y APE++ + + + VD W++G +
Sbjct: 168 --------RIYS--------YQMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFA 210
Query: 886 EMLYGYTPFRGKTRQKTFANILH----------------KDLKFPSSTPTSL-------- 921
EM F G + I FP P +
Sbjct: 211 EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEME 270
Query: 922 -HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
QL+ +L +P R+ A +H +
Sbjct: 271 ESGAQLLLEMLTFNPHKRI----SAFRALQHSYLH 301
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} Length = 120 | Back alignment and structure |
|---|
Score = 87.9 bits (219), Expect = 8e-21
Identities = 29/92 (31%), Positives = 51/92 (55%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
I+YA+ F +TGY S+EV+G+N L T + L + + G L+N +KD
Sbjct: 27 ILYANRAFRTITGYGSEEVLGKNESILSNGTTPRLVYQALWGRLAQKKPWSGVLVNRRKD 86
Query: 274 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 305
T + LT+AP+ ++ G+ + ++GM + S+
Sbjct: 87 KTLYLAELTVAPVLNEAGETIYYLGMHRDTSE 118
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} Length = 120 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 5e-12
Identities = 27/116 (23%), Positives = 48/116 (41%), Gaps = 9/116 (7%)
Query: 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATV 533
T+E ITD I++A+ +F +T Y EE+LG+N L T
Sbjct: 7 FRQTVEHAPIAISITDL---KANILYANRAFRTITGYGSEEVLGKNESILSNGTTPRLVY 63
Query: 534 RKIRAAIDNQTDV-TVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSE 584
+ + + Q + L+N K + + P+ ++ Y++G+ D SE
Sbjct: 64 QALWGRL-AQKKPWSGVLVNRRKDKTLYLAELTVAPVLNEAGETIYYLGMHRDTSE 118
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 75/332 (22%), Positives = 123/332 (37%), Gaps = 85/332 (25%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDML 722
+ ++ + P+GSG GSV +G A+K K ++ +H RE+ L +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 723 DHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 776
H V L S + V L+T G +L ++ Q L +D V+F ++
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK---LTDDHVQFLIYQI 141
Query: 777 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
+ L+Y+H II+RDLKP N+ + + + + DF L+ RH
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA-------------------RHT 182
Query: 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR 895
M +V T Y APEI+ H VD W++G ++ E+L G T F
Sbjct: 183 AD----EMTG-------YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231
Query: 896 GKTRQKTFANILH------------------------------KDLK--FPSSTPTSLHA 923
G IL + F + P ++
Sbjct: 232 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD- 290
Query: 924 KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
L+ ++L D R+ A + H +F
Sbjct: 291 --LLEKMLVLDSDKRI----TAAQALAHAYFA 316
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-20
Identities = 69/337 (20%), Positives = 118/337 (35%), Gaps = 79/337 (23%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 721
F+ LG G G V +G+ A+K ++ + REI L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--PF--DKPLFALRTLREIKILKH 65
Query: 722 LDHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 773
H P + +F V +I + +L ++ Q L +D ++++
Sbjct: 66 FKHENIITIFNIQRPDSFENFN---EVYIIQELM-QTDLHRVISTQM---LSDDHIQYFI 118
Query: 774 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 833
+ + A++ LH +I+RDLKP N+L+ N + + DF L+ +
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID----------ESAAD 168
Query: 834 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYT 892
+ M E FV T Y APE++ + + A+D W+ G +L E+
Sbjct: 169 NSEPTGQQSGMVE-------FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
Query: 893 PFRGK----------------TRQKTFANIL---------------HKDLK--FPSSTPT 919
F G+ I L+ FP P
Sbjct: 222 IFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPK 281
Query: 920 SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
+ L+ R+L DP R+ A E +HP+ +
Sbjct: 282 GID---LLQRMLVFDPAKRI----TAKEALEHPYLQT 311
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 62/303 (20%), Positives = 114/303 (37%), Gaps = 74/303 (24%)
Query: 716 REI-----LDMLDHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLK 765
RE+ L+ +HP V L+ + +T + L+ ++ +L LD+ P +
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 118
Query: 766 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825
+ ++ +++ L++LH +++RDLKP+N+L+ +G + L DF L+
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA----------- 167
Query: 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 885
R M ++ V T Y APE++ + + + VD W++G +
Sbjct: 168 --------RIYS--------FQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFA 210
Query: 886 EMLYGYTPFRGKTRQKTFANILH----------------KDLKFPSSTPTSL-------- 921
EM FRG + IL F S + +
Sbjct: 211 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID 270
Query: 922 -HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTE 980
K L+ + L +P R+ A HP+F+ + LD+ L +
Sbjct: 271 ELGKDLLLKCLTFNPAKRI----SAYSALSHPYFQDLE------RCKENLDSHLPPSQNT 320
Query: 981 KEY 983
E
Sbjct: 321 SEL 323
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 4e-20
Identities = 64/302 (21%), Positives = 113/302 (37%), Gaps = 36/302 (11%)
Query: 640 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 699
P K + P ++ LG G G V+ A+K +
Sbjct: 195 YPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK 254
Query: 700 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF-LLLDR 758
+ M +V E ++ + HP + L + +IT++ G L L +
Sbjct: 255 EDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 310
Query: 759 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818
+V + A ++ A+EYL + I+R+L N L+ N V + DF LS
Sbjct: 311 NRQEVSAVVLLYM-ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS---- 365
Query: 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 878
+L+ T + H G + P+ + APE +A + D W
Sbjct: 366 ---RLM---TGDTYTAHAGAKFPIK----------------WTAPESLAYNKFSIKSDVW 403
Query: 879 ALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPK 936
A G+LL+E+ YG +P+ G + + + ++ P P ++ +LM +P
Sbjct: 404 AFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY--ELMRACWQWNPS 461
Query: 937 SR 938
R
Sbjct: 462 DR 463
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 6e-20
Identities = 65/322 (20%), Positives = 124/322 (38%), Gaps = 62/322 (19%)
Query: 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAE 715
+ F+ IK LGSG G+V+ G+ A+K + + E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDE 67
Query: 716 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 773
++ +D+P V L + V LIT P G L ++ R+ + + +
Sbjct: 68 AYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWC 123
Query: 774 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 833
++ + YL + +++RDL NVL++ HV +TDF L+ +LL EK+
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA-------KLL--GAEEKEY 174
Query: 834 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 892
+G + P+ +++A E I +T D W+ G+ ++E++ +G
Sbjct: 175 HAEGGKVPI----------------KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 893 PFRGKTRQKTFANI-----LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947
P+ G + + + L + P ++ +M + D SR
Sbjct: 219 PYDGIPASEISSILEKGERLPQ----PPICTIDVY--MIMRKCWMIDADSR--------- 263
Query: 948 IKKHPFFKGVNWALVRCMNPPE 969
P F+ + + P+
Sbjct: 264 ----PKFRELIIEFSKMARDPQ 281
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 7e-20
Identities = 61/281 (21%), Positives = 110/281 (39%), Gaps = 71/281 (25%)
Query: 714 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKED 767
A REI + L H + LY T+ + L+ ++ +L +D + L+ +
Sbjct: 50 AIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELN 108
Query: 768 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 827
V+++ +++ L + H I++RDLKP+N+L+ G + L DF L+
Sbjct: 109 LVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA------------- 155
Query: 828 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYE 886
R G P+ +S V T Y AP+++ G+ ++++D W+ G +L E
Sbjct: 156 ------RAFG--------IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAE 201
Query: 887 MLYGYTPFRGKT--------------------------------RQKTFANILHKDLKFP 914
M+ G F G Q+ L + L+
Sbjct: 202 MITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPH 261
Query: 915 SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+ P + ++ LL +P RL A + HP+F
Sbjct: 262 TKEPLDGNLMDFLHGLLQLNPDMRL----SAKQALHHPWFA 298
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 9e-20
Identities = 69/318 (21%), Positives = 121/318 (38%), Gaps = 41/318 (12%)
Query: 627 EDLWANHSKVVHPKPHRKDSPPW---KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHL 683
+ L A +SK HR + Q + +I + R LG G G V +
Sbjct: 143 QQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWM 202
Query: 684 VELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743
G+ + A+K + G M E +++ L H + LYA ++ + ++
Sbjct: 203 GTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 256
Query: 744 TDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 802
T+Y G L L + V AA++ + Y+ ++RDL+ N+L+
Sbjct: 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYVERMNYVHRDLRAANILVGE 315
Query: 803 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 862
N + DF L+ +L+ + + +G + P+ + A
Sbjct: 316 NLVCKVADFGLA-------RLI---EDNEYTARQGAKFPIK----------------WTA 349
Query: 863 PEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTS 920
PE T D W+ GILL E+ G P+ G ++ + + P P S
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 409
Query: 921 LHAKQLMYRLLHRDPKSR 938
LH LM + ++P+ R
Sbjct: 410 LH--DLMCQCWRKEPEER 425
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 68/333 (20%), Positives = 117/333 (35%), Gaps = 58/333 (17%)
Query: 648 PWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVML 704
P +++ ++ + + L ++ LG G G V E A+K + V+
Sbjct: 7 PLQSLTCLIGE-KDLRL-----LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS 60
Query: 705 NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTK 762
+ E + LDH + LY + ++T+ P G L L R+
Sbjct: 61 QPEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRL---RKHQG 116
Query: 763 VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822
+ YA +V + YL + I+RDL N+LL V + DF L
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM-------- 168
Query: 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 882
LP ++ + ++ P + APE + + A D W G+
Sbjct: 169 RALPQNDDHYVMQEHRKVPF----------------AWCAPESLKTRTFSHASDTWMFGV 212
Query: 883 LLYEML-YGYTPFRGKTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSRL 939
L+EM YG P+ G + I + L P P ++ +M + P+ R
Sbjct: 213 TLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY--NVMVQCWAHKPEDR- 269
Query: 940 GSHEGANEIKKHPFFKGVNWALVRCMNPPELDA 972
P F + L+ P ++ A
Sbjct: 270 ------------PTFVALRDFLLE-AQPTDMRA 289
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 63/342 (18%), Positives = 117/342 (34%), Gaps = 91/342 (26%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN------RNKVHRACAEREI 718
+ + + SG G+V + G A+K + V + REI
Sbjct: 22 SPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 719 --LDMLDHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 768
L+ HP FV + + L+T+ +L ++ V+
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMH---KLYLVTELM-RTDLAQVI-HDQRIVISPQH 135
Query: 769 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 828
++++ +++ L LH G+++RDL P N+LL N +++ DF+L+
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA-------------- 181
Query: 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEM 887
R +V Y APE++ T VD W+ G ++ EM
Sbjct: 182 -----REDTADA--NKTH-------YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
Query: 888 LYGYTPFRGKTRQKTFANILH-------------------------------KDLK--FP 914
FRG T I+ + P
Sbjct: 228 FNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVP 287
Query: 915 SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
++ P +L L+ ++L +P+ R+ + +HP+F+
Sbjct: 288 TADPVALD---LIAKMLEFNPQRRI----STEQALRHPYFES 322
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 78/363 (21%), Positives = 122/363 (33%), Gaps = 90/363 (24%)
Query: 655 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-AC 713
G +N F I+ +G G G V L + + +Y+A+K V+ N K R A
Sbjct: 26 SWKKGMLLN-NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVK-----VVRNIKKYTRSAK 79
Query: 714 AEREILDML------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 767
E +IL + ++ V + F H+CLI + G L+ ++ R +
Sbjct: 80 IEADILKKIQNDDINNNNIV-KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIE 137
Query: 768 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 827
++ Y E++ AL YL + + DLKPEN+LL K Q+
Sbjct: 138 DIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 828 TNEKK-----------RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 876
+ K H S + T +Y APE+I G + D
Sbjct: 198 STGIKLIDFGCATFKSDYH----------------GSIINTRQYRAPEVILNLGWDVSSD 241
Query: 877 WWALGILLYEMLYGYTPFRG--------------------------KTRQKTFANILHKD 910
W+ G +L E+ G FR KT + N
Sbjct: 242 MWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELK 301
Query: 911 LKFPSSTPTSLHAKQ------------------LMYRLLHRDPKSRLGSHEGANEIKKHP 952
L +P + + K +Y +L DP R E+ KH
Sbjct: 302 LAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP----SPAELLKHK 357
Query: 953 FFK 955
F +
Sbjct: 358 FLE 360
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 60/277 (21%), Positives = 109/277 (39%), Gaps = 66/277 (23%)
Query: 714 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 771
A REI L L H + L+ + + L+ ++C +L D L + V+
Sbjct: 48 ALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKS 105
Query: 772 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 831
+ +++ L + H + +++RDLKP+N+L+ NG + L +F L+
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA----------------- 148
Query: 832 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYG 890
R G P+R ++ V T Y P+++ GA ++++D W+ G + E+
Sbjct: 149 --RAFGI--------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198
Query: 891 YTP-FRGKTR----QKTFANIL----------HKDL----KFPSSTPT----------SL 921
P F G ++ F +L L +P T +
Sbjct: 199 GRPLFPGNDVDDQLKRIF-RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA 257
Query: 922 HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958
+ L+ LL +P R+ A E +HP+F
Sbjct: 258 TGRDLLQNLLKCNPVQRI----SAEEALQHPYFSDFC 290
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 74/333 (22%), Positives = 130/333 (39%), Gaps = 85/333 (25%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDML 722
+R ++P+GSG G+V +G A+K + + ++++ A RE+ L +
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---PFQSELFAKRAYRELRLLKHM 81
Query: 723 DHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 776
H V L + T L+ + G +L L+ + L ED ++F ++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK---LGEDRIQFLVYQM 137
Query: 777 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
+ L Y+H GII+RDLKP N+ + + + + DF L+ R
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-------------------RQA 178
Query: 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR 895
M +V T Y APE+I T VD W++G ++ EM+ G T F+
Sbjct: 179 DS----EMTG-------YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227
Query: 896 GKTRQKTFANILH------------------------------KDLK--FPSSTPTSLHA 923
G I+ KD +++P +++
Sbjct: 228 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVN- 286
Query: 924 KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
L+ ++L D + R+ A E HP+F+
Sbjct: 287 --LLEKMLVLDAEQRV----TAGEALAHPYFES 313
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 74/333 (22%), Positives = 128/333 (38%), Gaps = 86/333 (25%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDML 722
+ + +GSG GSV SG+ A+K + + ++++ A RE+ L +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---PFQSEIFAKRAYRELLLLKHM 80
Query: 723 DHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 776
H V L +S + L+ + +L ++ E+ +++ ++
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM-GLK---FSEEKIQYLVYQM 135
Query: 777 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
+ L+Y+H G+++RDLKP N+ + + + + DF L+ RH
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA-------------------RHA 176
Query: 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR 895
+ M +V T Y APE+I H VD W++G ++ EML G T F+
Sbjct: 177 DAE----MTG-------YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225
Query: 896 GKTRQKTFANILH------------------------------KDLK--FPSSTPTSLHA 923
GK IL KD FP ++P +
Sbjct: 226 GKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAAD- 284
Query: 924 KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
L+ ++L D RL A + HPFF+
Sbjct: 285 --LLEKMLELDVDKRL----TAAQALTHPFFEP 311
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-19
Identities = 76/299 (25%), Positives = 111/299 (37%), Gaps = 68/299 (22%)
Query: 714 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 771
A REI L L HP + L +F K+++ L+ D+ +L +++ L ++
Sbjct: 59 ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV-LTPSHIKA 116
Query: 772 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 831
Y + LEYLH I++RDLKP N+LL NG + L DF L+
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA----------------- 159
Query: 832 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYG 890
+ G P RA V T Y APE++ GA VD WA+G +L E+L
Sbjct: 160 --KSFG--------SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209
Query: 891 YTPFRGKTR----QKTFANIL----------HKDL----KFPSSTPTSLHAK-------- 924
G + + F L L F S LH
Sbjct: 210 VPFLPGDSDLDQLTRIF-ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDL 268
Query: 925 -QLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKE 982
L+ L +P +R+ A + K +F +L P +T KE
Sbjct: 269 LDLIQGLFLFNPCARI----TATQALKMKYF----SNRPGPTPGCQLPRPNCPVETLKE 319
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 60/307 (19%), Positives = 114/307 (37%), Gaps = 65/307 (21%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCG----SGQYFAMKAMDKGVMLNRNKVHRACAER 716
Q +H + ++ LG G+ GSV + +G+ A+K + + R E
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER---EI 62
Query: 717 EILDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFY 772
EIL L H + + ++ LI +Y P G L +L ++ + + + Y
Sbjct: 63 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQY 119
Query: 773 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 832
+++ +EYL + I+RDL N+L++ V + DF L+ +LP E
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT--------KVLPQDKEFF 171
Query: 833 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML---- 888
+ + ++P+F + APE + + + A D W+ G++LYE+
Sbjct: 172 KVKEPGESPIF----------------WYAPESLTESKFSVASDVWSFGVVLYELFTYIE 215
Query: 889 ------------YGYTPFRGKTRQKTFANI-----LHKDLKFPSSTPTSLHAKQLMYRLL 931
G + L + P P ++ +M
Sbjct: 216 KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR----PDGCPDEIY--MIMTECW 269
Query: 932 HRDPKSR 938
+ + R
Sbjct: 270 NNNVNQR 276
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 46/309 (14%), Positives = 82/309 (26%), Gaps = 73/309 (23%)
Query: 639 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHL---VELCGSGQYFAM 695
+P R+ S P +Q L G +I +R + G L + A+
Sbjct: 7 REPDRESSAPPDDVQ--LVPGARIANGRYRLLIFHGGVPPLQFWQALDTAL---DRQVAL 61
Query: 696 KAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 755
+D +L + + + L +D P V + T+ ++ ++ GG L +
Sbjct: 62 TFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEV 121
Query: 756 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815
D P+ A+R + A + H G+ P V + +G V L
Sbjct: 122 ADTSPSP---VGAIR-AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP---- 173
Query: 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 875
+
Sbjct: 174 -------------------------------------------ATMPDA-------NPQD 183
Query: 876 DWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAK------QLMYR 929
D +G LY +L P + A +D P + + R
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRSGLA-PAERDTAGQPIEPADIDRDIPFQISAVAAR 242
Query: 930 LLHRDPKSR 938
+ D R
Sbjct: 243 SVQGDGGIR 251
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-19
Identities = 69/318 (21%), Positives = 121/318 (38%), Gaps = 41/318 (12%)
Query: 627 EDLWANHSKVVHPKPHRKDSPPWK---AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHL 683
+ L A +SK HR + Q + +I + R LG G G V +
Sbjct: 226 QQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWM 285
Query: 684 VELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743
G+ + A+K + G M E +++ L H + LYA ++ + ++
Sbjct: 286 GTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 339
Query: 744 TDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 802
T+Y G L L + V AA++ + Y+ ++RDL+ N+L+
Sbjct: 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYVERMNYVHRDLRAANILVGE 398
Query: 803 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 862
N + DF L+ +L+ + + +G + P+ + A
Sbjct: 399 NLVCKVADFGLA-------RLI---EDNEYTARQGAKFPIK----------------WTA 432
Query: 863 PEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTS 920
PE T D W+ GILL E+ G P+ G ++ + + P P S
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 492
Query: 921 LHAKQLMYRLLHRDPKSR 938
LH LM + ++P+ R
Sbjct: 493 LH--DLMCQCWRKEPEER 508
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} Length = 124 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 3e-19
Identities = 16/86 (18%), Positives = 37/86 (43%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
I+ + G + GY+ ++ +G+ L G +++ ++N + G + KD
Sbjct: 29 IIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSEVISAVENQGKWTGEIRMLHKD 88
Query: 274 GTPFWNLLTIAPIKDDEGKVLKFIGM 299
G W PI + +++ +G+
Sbjct: 89 GHIGWIESMCVPIYGENYQMVGALGI 114
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} Length = 124 | Back alignment and structure |
|---|
Score = 66.7 bits (164), Expect = 3e-13
Identities = 22/103 (21%), Positives = 41/103 (39%), Gaps = 7/103 (6%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 545
V+TD II + L YS+E+ +G+ L P ++ +A++NQ
Sbjct: 21 VVTDL---QGFIIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSEVISAVENQGK 77
Query: 546 VTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSE 584
T ++ K G W P+ + +G+ D ++
Sbjct: 78 WTGEIRMLHKDGHIGWIESMCVPIYGENYQMVGALGINRDITK 120
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 61/336 (18%), Positives = 121/336 (36%), Gaps = 66/336 (19%)
Query: 632 NHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCG--- 688
+H + + + + D + +H + ++ LG G+ GSV +
Sbjct: 9 HHDYDIPTTENLYFQGAMGSAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQD 67
Query: 689 -SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA--SFQTKTHVCLITD 745
+G+ A+K + + R E EIL L H + + ++ LI +
Sbjct: 68 NTGEVVAVKKLQHSTEEHLRDFER---EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124
Query: 746 YCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 803
Y P G L +L ++ + + + Y +++ +EYL + I+RDL N+L++
Sbjct: 125 YLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 181
Query: 804 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 863
V + DF L+ +LP E + + ++P+F + AP
Sbjct: 182 NRVKIGDFGLT--------KVLPQDKEYYKVKEPGESPIF----------------WYAP 217
Query: 864 EIIAGAGHTSAVDWWALGILLYEML----------------YGYTPFRGKTRQKTFANI- 906
E + + + A D W+ G++LYE+ G +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
Query: 907 ----LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
L + P P ++ +M + + R
Sbjct: 278 NNGRLPR----PDGCPDEIY--MIMTECWNNNVNQR 307
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-19
Identities = 58/256 (22%), Positives = 101/256 (39%), Gaps = 50/256 (19%)
Query: 655 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-AC 713
I+ +GE+ + +G G G V ++ A+K ++ N+ A
Sbjct: 45 IVKNGEKWM-DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-----IIKNKKAFLNQAQ 98
Query: 714 AEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 766
E +L+++ + V L F + H+CL+ + L+ LL + +
Sbjct: 99 IEVRLLELMNKHDTEMKYYIVH-LKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSL 156
Query: 767 DAVRFYAAEVVVALEYLHCQ--GIIYRDLKPENVLL--QGNGHVSLTDFDLSCLTSCKPQ 822
+ R +A ++ AL +L II+ DLKPEN+LL + + DF SC
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC------- 209
Query: 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 882
GQ+ ++ + Y +PE++ G + A+D W+LG
Sbjct: 210 ------------QLGQR-----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGC 246
Query: 883 LLYEMLYGYTPFRGKT 898
+L EM G F G
Sbjct: 247 ILVEMHTGEPLFSGAN 262
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 5e-19
Identities = 68/341 (19%), Positives = 127/341 (37%), Gaps = 88/341 (25%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 721
L+ ++ +KP+GSG G V + A+K K +N+ H A RE+ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKC 117
Query: 722 LDHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 775
++H + +L + + V L+ + L ++ + L + + + +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-QME---LDHERMSYLLYQ 172
Query: 776 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
++ +++LH GII+RDLKP N++++ + + + DF L+
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------------- 211
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895
+ M +V T Y APE+I G G+ VD W++G ++ EM+ F
Sbjct: 212 RTAGTSFMMTP-------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264
Query: 896 GK-------------------------------------TRQKTFANILHKDLKFPSSTP 918
G+ TF + L S
Sbjct: 265 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324
Query: 919 TSLHAKQ---LMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
L A Q L+ ++L DP R+ ++ +HP+
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRI----SVDDALQHPYINV 361
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 64/301 (21%), Positives = 108/301 (35%), Gaps = 56/301 (18%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAERE 717
+H + I LG G+ GSV L G A+K + + R E +
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR---EIQ 76
Query: 718 ILDMLDHPFVPALYA-SFQTKTH-VCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 773
IL L F+ S+ + L+ +Y P G L FL ++ L + Y+
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYS 133
Query: 774 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 833
+++ +EYL + ++RDL N+L++ HV + DF L+ LLP +
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA--------KLLPLDKDYYV 185
Query: 834 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 892
+ Q+P+F + APE ++ + D W+ G++LYE+ Y
Sbjct: 186 VREPGQSPIF----------------WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK 229
Query: 893 PFRGKTRQKTFANILHKDLKF---------------PSSTPTSLHAKQLMYRLLHRDPKS 937
P + P +H +LM P+
Sbjct: 230 SCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVH--ELMKLCWAPSPQD 287
Query: 938 R 938
R
Sbjct: 288 R 288
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 7e-19
Identities = 60/254 (23%), Positives = 105/254 (41%), Gaps = 48/254 (18%)
Query: 655 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-AC 713
+ + + + + +K +G G G V Q+ A+K ++ N + HR A
Sbjct: 88 VQVPHDHVAYR-YEVLKVIGKGSFGQVVKAYDHKVHQHVALK-----MVRNEKRFHRQAA 141
Query: 714 AEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 766
E IL+ L + + +F + H+C+ + L+ L+ + +
Sbjct: 142 EEIRILEHLRKQDKDNTMNVIH-MLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSL 199
Query: 767 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--VSLTDFDLSCLTSCKPQLL 824
VR +A ++ L+ LH II+ DLKPEN+LL+ G + + DF SC
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH------ 253
Query: 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 884
V+ +++ + Y APE+I GA + +D W+LG +L
Sbjct: 254 ---------------QRVY---------TYIQSRFYRAPEVILGARYGMPIDMWSLGCIL 289
Query: 885 YEMLYGYTPFRGKT 898
E+L GY G+
Sbjct: 290 AELLTGYPLLPGED 303
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 9e-19
Identities = 74/369 (20%), Positives = 115/369 (31%), Gaps = 104/369 (28%)
Query: 655 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVE---LCGSGQYFAMKAMDKGVMLNRNKVHR 711
+ G+ + + + + LG G G V VE A+K ++ N K
Sbjct: 10 VCRIGDWLQ-ERYEIVGNLGEGTFGKV--VECLDHARGKSQVALK-----IIRNVGKYRE 61
Query: 712 -ACAEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 763
A E +L + V + F H+C+ + G F L +
Sbjct: 62 AARLEINVLKKIKEKDKENKFLCV-LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQP 119
Query: 764 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823
VR A ++ AL +LH + + DLKPEN+L +
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILF------------------VNSEF 161
Query: 824 LLPTTNEKKRRHKGQQNPV----------FMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 873
K K +N F E + V T Y PE+I G
Sbjct: 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH---TTIVATRHYRPPEVILELGWAQ 218
Query: 874 AVDWWALGILLYEMLYGYTPFRGKT------------------------RQKTFANILHK 909
D W++G +L+E G+T F+ +QK F
Sbjct: 219 PCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFY---KG 275
Query: 910 DLKFPSSTPTSLHAKQ---------------------LMYRLLHRDPKSRLGSHEGANEI 948
L + ++ + K+ LM R+L DP R+ E
Sbjct: 276 GLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI----TLAEA 331
Query: 949 KKHPFFKGV 957
HPFF G+
Sbjct: 332 LLHPFFAGL 340
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-18
Identities = 68/308 (22%), Positives = 124/308 (40%), Gaps = 44/308 (14%)
Query: 634 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 693
K+ P K PW+ +I + + K LG+G G V + +
Sbjct: 163 QKLSVPCMSSKPQKPWEKDAW------EIPRESLKLEKKLGAGQFGEVWMATYNKHTK-V 215
Query: 694 AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF 753
A+K M G M V AE ++ L H + L+A TK + +IT++ G L
Sbjct: 216 AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLL 270
Query: 754 -LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 812
L + +K + F +A++ + ++ + I+RDL+ N+L+ + + DF
Sbjct: 271 DFLKSDEGSKQPLPKLIDF-SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG 329
Query: 813 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT 872
L+ +++ + + +G + P+ ++ APE I T
Sbjct: 330 LA-------RVI---EDNEYTAREGAKFPI----------------KWTAPEAINFGSFT 363
Query: 873 SAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRL 930
D W+ GILL E++ YG P+ G + + + + P + P L+ +M R
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY--NIMMRC 421
Query: 931 LHRDPKSR 938
P+ R
Sbjct: 422 WKNRPEER 429
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 68/341 (19%), Positives = 125/341 (36%), Gaps = 88/341 (25%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 721
L+ ++ +KP+GSG G V + A+K K +N+ H A RE+ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKC 80
Query: 722 LDHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 775
++H + L S + V ++ + L ++ + L + + + +
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-QME---LDHERMSYLLYQ 135
Query: 776 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
++ +++LH GII+RDLKP N++++ + + + DF L+
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------------- 174
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895
+ M +V T Y APE+I G G+ VD W++G ++ EM+ G F
Sbjct: 175 RTAGTSFMMTP-------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 227
Query: 896 GK-------------------------------------TRQKTFANILHKDLKFPSSTP 918
G +F + L S
Sbjct: 228 GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 287
Query: 919 TSLHAKQ---LMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
L A Q L+ ++L D R+ +E +HP+
Sbjct: 288 NKLKASQARDLLSKMLVIDASKRI----SVDEALQHPYINV 324
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 70/338 (20%), Positives = 120/338 (35%), Gaps = 92/338 (27%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-D 723
++ ++ LG G V + + +K +L K + E +IL+ L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKKKIKREIKILENLRG 89
Query: 724 HPFVPALYA---SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
P + L ++T L+ ++ + L L + +RFY E++ AL
Sbjct: 90 GPNIITLADIVKDPVSRTPA-LVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKAL 143
Query: 781 EYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
+Y H GI++RD+KP NV++ + + L D+ L
Sbjct: 144 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL-------------------------- 177
Query: 840 NPVFMAE---PMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP-F 894
AE P + N V + + PE++ ++D W+LG +L M++ P F
Sbjct: 178 -----AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232
Query: 895 RGK---------------------------TRQKTFANIL----HKDLK--FPSSTPTSL 921
G F +IL K + S +
Sbjct: 233 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV 292
Query: 922 H--AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957
A + +LL D +SRL A E +HP+F V
Sbjct: 293 SPEALDFLDKLLRYDHQSRL----TAREAMEHPYFYTV 326
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-18
Identities = 70/342 (20%), Positives = 120/342 (35%), Gaps = 94/342 (27%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV--HRACAEREI--- 718
+ F+ + G G G+V L + +G A+K KV RE+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK-----------KVIQDPRFRNRELQIM 70
Query: 719 --LDMLDHPFVPALYASFQTKTH-------VCLITDYCPGGELFLLLDRQPTK--VLKED 767
L +L HP + L + F T + ++ +Y P L +
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPI 129
Query: 768 AVRFYAAEVVVALEYLHCQ--GIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLL 824
++ + +++ ++ LH + +RD+KP NVL+ + +G + L DF +
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA---------- 179
Query: 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGIL 883
+ P + +++ + Y APE+I G H T+AVD W++G +
Sbjct: 180 --------K----------KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCI 221
Query: 884 LYEMLYGYTPFRGKT-----------------RQKTFANILHKDLKFPSSTPTSLH---- 922
EM+ G FRG N H D+ +S
Sbjct: 222 FAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFS 281
Query: 923 ---------AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
A L+ LL P+ R+ E HP+F
Sbjct: 282 DHSLKDAKEAYDLLSALLQYLPEERM----KPYEALCHPYFD 319
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 3e-18
Identities = 68/367 (18%), Positives = 125/367 (34%), Gaps = 43/367 (11%)
Query: 634 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 693
S+ + + S A S QI + +G+G G V +
Sbjct: 23 SQQEGQQRKQHHSSKPTASMPRPHSDWQI-PDRYEIRHLIGTGSYGHVCEAYDKLEKRVV 81
Query: 694 AMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGE 751
A+K + + + + + REI L+ L+H V + + + D E
Sbjct: 82 AIKKILR---VFEDLIDCKRILREIAILNRLNHDHVVKVL-------DIVIPKDVEKFDE 131
Query: 752 LFLLLDRQPT---------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 802
L+++L+ + L E ++ ++V ++Y+H GI++RDLKP N L+
Sbjct: 132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ 191
Query: 803 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 862
+ V + DF L+ + R V T Y A
Sbjct: 192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRA 251
Query: 863 PEIIAGAGH-TSAVDWWALGILLYEMLYGYTP-----------FRGKTRQKTFANILHKD 910
PE+I + T A+D W++G + E+L F G + F +
Sbjct: 252 PELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS---CFPLSPDQK 308
Query: 911 LKFPSSTPTSLHAKQL--MYRLL---HRDPKSRLGSHEGANEIKKHPFFKGVNWA-LVRC 964
T + QL ++ +L + L + I+ P +G + A
Sbjct: 309 AGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368
Query: 965 MNPPELD 971
+ +
Sbjct: 369 SSADAIH 375
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 73/366 (19%), Positives = 127/366 (34%), Gaps = 98/366 (26%)
Query: 655 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVE---LCGSGQYFAMKAMDKGVMLNRNKVHR 711
I SG+ ++ + + LG G G V VE G++ A+K ++ N ++
Sbjct: 5 ICQSGDVLS-ARYEIVDTLGEGAFGKV--VECIDHKAGGRHVAVK-----IVKNVDRYCE 56
Query: 712 -ACAEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 763
A +E ++L+ L V + F+ H+C++ + G + +
Sbjct: 57 AARSEIQVLEHLNTTDPNSTFRCV-QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLP 114
Query: 764 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823
+ D +R A ++ ++ +LH + + DLKPEN+L +
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILF------------------VQSDY 156
Query: 824 LLPTTNEKKRRHKGQQNPV----------FMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 873
+ KR + NP + E ++ V T Y APE+I G +
Sbjct: 157 TEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH---STLVSTRHYRAPEVILALGWSQ 213
Query: 874 AVDWWALGILLYEMLYGYTPFRGKT------------------------RQKTFANIL-- 907
D W++G +L E G+T F ++K F +
Sbjct: 214 PCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLD 273
Query: 908 --------------HKDLK--FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951
K LK S L+ ++L DP R+ E KH
Sbjct: 274 WDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI----TLREALKH 329
Query: 952 PFFKGV 957
PFF +
Sbjct: 330 PFFDLL 335
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 72/364 (19%), Positives = 131/364 (35%), Gaps = 107/364 (29%)
Query: 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 718
G + + + + K LG+G G V V SG+ FA+K K V+ + +R E +I
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK---K-VLQDPRYKNR---ELDI 53
Query: 719 LDMLDHPFVPALYASFQTKTHVCLITDYCPGG--------------------------EL 752
+ +LDH + L F T P L
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 753 FLLLDRQPT-------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 799
++++ P + + + + Y ++ A+ ++H GI +RD+KP+N+L
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL 173
Query: 800 LQGN-GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 858
+ + L DF + + P S +++ +
Sbjct: 174 VNSKDNTLKLCDFGSA-------------------KK---------LIPSEPSVAYICSR 205
Query: 859 EYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTR-----------------Q 900
Y APE++ GA T ++D W++G + E++ G F G+T Q
Sbjct: 206 FYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQ 265
Query: 901 KTFANILHKDLKFPSSTPTSLH----------AKQLMYRLLHRDPKSRLGSHEGANEIKK 950
N + +++FP+ A L+ ++L +P R+ E
Sbjct: 266 MIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI----NPYEAMA 321
Query: 951 HPFF 954
HPFF
Sbjct: 322 HPFF 325
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-18
Identities = 61/281 (21%), Positives = 108/281 (38%), Gaps = 36/281 (12%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 720
++ LG G G V+ A+K + + M +V E ++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 64
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVA 779
+ HP + L + +IT++ G L L + +V + A ++ A
Sbjct: 65 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM-ATQISSA 123
Query: 780 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
+EYL + I+RDL N L+ N V + DF LS L + + H G +
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT----------GDTYTAHAGAK 173
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 898
P+ ++ APE +A + D WA G+LL+E+ YG +P+ G
Sbjct: 174 FPI----------------KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217
Query: 899 RQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ + + ++ P P ++ +LM +P R
Sbjct: 218 LSQVYELLEKDYRMERPEGCPEKVY--ELMRACWQWNPSDR 256
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 74/315 (23%), Positives = 119/315 (37%), Gaps = 42/315 (13%)
Query: 633 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 692
K+ P+ + + + + +I K +GSGD+G V L GQ
Sbjct: 17 QGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQR 76
Query: 693 F---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 749
A+KA+ G + + +E I+ DHP + L ++T+Y
Sbjct: 77 DVPVAIKALKAGYTERQRR--DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMEN 134
Query: 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLT 809
G L L + V V + YL G ++RDL NVL+ N ++
Sbjct: 135 GSLDTFLRTHDGQFTIMQLVGM-LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVS 193
Query: 810 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA 869
DF LS +L + G + P+ + APE IA
Sbjct: 194 DFGLSR--------VLEDDPDAAYTTTGGKIPI----------------RWTAPEAIAFR 229
Query: 870 GHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANI-----LHKDLKFPSSTPTSLHA 923
+SA D W+ G++++E+L YG P+ T + +++ L P P +LH
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA----PMGCPHALH- 284
Query: 924 KQLMYRLLHRDPKSR 938
QLM H+D R
Sbjct: 285 -QLMLDCWHKDRAQR 298
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 9e-18
Identities = 59/241 (24%), Positives = 103/241 (42%), Gaps = 21/241 (8%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL---D 720
L+ + +K LG G G V +G+ A+K K +N REI+ +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIMILTE 64
Query: 721 MLDHPFVPALYASFQTKT--HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 778
+ H + L + V L+ DY +L ++ L+ ++ +++
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANI---LEPVHKQYVVYQLIK 120
Query: 779 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLPTTNEKKRRHKG 837
++YLH G+++RD+KP N+LL HV + DF LS + + + +
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRG 896
+ + + +V T Y APEI+ G+ T +D W+LG +L E+L G F G
Sbjct: 181 DDDQPILTD-------YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233
Query: 897 K 897
Sbjct: 234 S 234
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 62/287 (21%), Positives = 117/287 (40%), Gaps = 41/287 (14%)
Query: 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAE 715
+ F+ IK LGSG G+V+ G+ A+K + + E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDE 67
Query: 716 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 773
++ +D+P V L + V LIT P G L ++ R+ + + +
Sbjct: 68 AYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWC 123
Query: 774 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 833
++ + YL + +++RDL NVL++ HV +TDF L+ +LL EK+
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA-------KLL--GAEEKEY 174
Query: 834 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 892
+G + P+ +++A E I +T D W+ G+ ++E++ +G
Sbjct: 175 HAEGGKVPI----------------KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 893 PFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
P+ G + + + + L P ++ +M + D SR
Sbjct: 219 PYDGIPASEISSILEKGERLPQPPICTIDVY--MIMVKCWMIDADSR 263
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 63/338 (18%), Positives = 116/338 (34%), Gaps = 81/338 (23%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 721
+ +KPLG G G V + A+K K ++ + A REI +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---K--IVLTDPQSVKHALREIKIIRR 64
Query: 722 LDHPFVPALYASF--QTKTHVCLITDYCPGGELFLLLDRQPT--------KVLKEDAVRF 771
LDH + ++ + ++++ + T L E+ R
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL 124
Query: 772 YAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830
+ +++ L+Y+H +++RDLKP N+ + + + + DF L+ +
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD------------ 172
Query: 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLY 889
+ ++E + T+ Y +P ++ + T A+D WA G + EML
Sbjct: 173 -----PHYSHKGHLSE-------GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220
Query: 890 GYTPFRGKTRQKTFANILH-----------------------------KDLK--FPSSTP 918
G T F G + IL K L P +
Sbjct: 221 GKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR 280
Query: 919 TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
++ + ++L P RL A E HP+
Sbjct: 281 EAVD---FLEQILTFSPMDRL----TAEEALSHPYMSI 311
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 60/279 (21%), Positives = 103/279 (36%), Gaps = 72/279 (25%)
Query: 714 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 771
A RE+ L L H + L + + LI +Y +L +D+ P + ++
Sbjct: 80 AIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP--DVSMRVIKS 136
Query: 772 YAAEVVVALEYLHCQGIIYRDLKPENVLL-----QGNGHVSLTDFDLSCLTSCKPQLLLP 826
+ +++ + + H + ++RDLKP+N+LL + + DF L+
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA------------ 184
Query: 827 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLY 885
R G P+R + T Y PEI+ G+ H +++VD W++ +
Sbjct: 185 -------RAFG--------IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWA 229
Query: 886 EMLYGYTPFRGKTR----QKTFANIL----------HKDL-----KFPSSTPTSL----- 921
EML F G + K F +L L FP +L
Sbjct: 230 EMLMKTPLFPGDSEIDQLFKIF-EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLG 288
Query: 922 -----HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
L+ +L DP R+ A +HP+F
Sbjct: 289 ALLDDEGLDLLTAMLEMDPVKRI----SAKNALEHPYFS 323
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 61/274 (22%), Positives = 109/274 (39%), Gaps = 38/274 (13%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 728
K LGSG+ G+V A+K + + AE ++ LD+P++
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIV 81
Query: 729 ALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 786
+ L+ + G L +L +R +K+ + +V + ++YL
Sbjct: 82 RMIG-ICEAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES 136
Query: 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 846
++RDL NVLL + ++DF LS + L N K + G+
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLS-------KALRADENYYKAQTHGKW------- 182
Query: 847 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFAN 905
P++ + APE I +S D W+ G+L++E YG P+RG + A
Sbjct: 183 PVK----------WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 232
Query: 906 ILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ + + P+ P ++ LM D ++R
Sbjct: 233 LEKGERMGCPAGCPREMY--DLMNLCWTYDVENR 264
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 60/341 (17%), Positives = 122/341 (35%), Gaps = 58/341 (17%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 721
++ +G G G V+L + + A+K +++ + + + REI L+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITILNR 81
Query: 722 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT---------KVLKEDAVRFY 772
L ++ LY + + D EL+++L+ + L E+ ++
Sbjct: 82 LKSDYIIRLY-------DLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTI 134
Query: 773 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL--SCLTSCKPQLLLPTTNE 830
+++ ++H GII+RDLKP N LL + V + DF L + + ++
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLY 889
++ + + V T Y APE+I + T ++D W+ G + E+L
Sbjct: 195 EEPGPHNKNLKKQLTS-------HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247
Query: 890 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPK------------- 936
+ L FP S+ L + ++ + +
Sbjct: 248 MLQSHINDPTNR-------FPL-FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTP 299
Query: 937 -----SRLGSHEGANEIKKHPFFKGVNWA-LVRCMNPPELD 971
+ E IK P K +N ++ ++
Sbjct: 300 TEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 61/305 (20%), Positives = 104/305 (34%), Gaps = 61/305 (20%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAM--DKGVMLNRNKVHRACA 714
+ + I+ LG G G V L G A+K++ + G +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK----K 72
Query: 715 EREILDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 770
E EIL L H + + + LI ++ P G L +L + +
Sbjct: 73 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQL 129
Query: 771 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830
YA ++ ++YL + ++RDL NVL++ V + DF L+ + T E
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT--------KAIETDKE 181
Query: 831 KKRRHKGQQNPVF-MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 888
+ +PVF APE + + A D W+ G+ L+E+L
Sbjct: 182 YYTVKDDRDSPVFWY-----------------APECLMQSKFYIASDVWSFGVTLHELLT 224
Query: 889 YGYTPFRGKTRQKTFANILHKDLKF---------------PSSTPTSLHAKQLMYRLLHR 933
Y + H + P + P ++ QLM +
Sbjct: 225 YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVY--QLMRKCWEF 282
Query: 934 DPKSR 938
P +R
Sbjct: 283 QPSNR 287
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 68/343 (19%), Positives = 124/343 (36%), Gaps = 52/343 (15%)
Query: 633 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 692
++ ++ + P Q +L +I+ K +G+G+ G V+ L S
Sbjct: 16 TTENLYFQGAMGSDPN----QAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGK 71
Query: 693 F----AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 748
A+K + G + E I+ H + L + +IT+Y
Sbjct: 72 KEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME 129
Query: 749 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 808
G L L + + V + ++YL ++RDL N+L+ N +
Sbjct: 130 NGALDKFLREKDGEFSVLQLVGM-LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKV 188
Query: 809 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG 868
+DF LS +L E G + P+ + APE I+
Sbjct: 189 SDFGLSR--------VLEDDPEATYTTSGGKIPI----------------RWTAPEAISY 224
Query: 869 AGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQL 926
TSA D W+ GI+++E++ YG P+ + + I L P P++++ QL
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY--QL 282
Query: 927 MYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPE 969
M + ++ R P F + L + + P+
Sbjct: 283 MMQCWQQERARR-------------PKFADIVSILDKLIRAPD 312
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-17
Identities = 63/310 (20%), Positives = 121/310 (39%), Gaps = 51/310 (16%)
Query: 635 KVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFA 694
+++ PK + SG +N++ + ++ +G G+ G V L G Y
Sbjct: 166 RLIKPKVMEGTVAAQDEFYR---SGWALNMKELKLLQTIGKGEFGDVML------GDYRG 216
Query: 695 MKAMDKGVMLNRNKVHRA-CAEREILDMLDHPFVPALYA-SFQTKTHVCLITDYCPGGEL 752
K K + + +A AE ++ L H + L + K + ++T+Y G L
Sbjct: 217 NKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274
Query: 753 --FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 810
+L R + + + ++F + +V A+EYL ++RDL NVL+ + ++D
Sbjct: 275 VDYLR-SRGRSVLGGDCLLKF-SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 332
Query: 811 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 870
F L+ E + PV ++ APE +
Sbjct: 333 FGLTK--------------EASSTQDTGKLPV----------------KWTAPEALREKK 362
Query: 871 HTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMY 928
++ D W+ GILL+E+ +G P+ + + + P P +++ +M
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY--DVMK 420
Query: 929 RLLHRDPKSR 938
H D +R
Sbjct: 421 NCWHLDAATR 430
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 75/363 (20%), Positives = 131/363 (36%), Gaps = 61/363 (16%)
Query: 640 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMK 696
PH + P Q + + ++++ + K +G+G+ G V L + A+K
Sbjct: 24 DPHTFEDP----TQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 697 AMDKGVML-NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 755
+ G R E I+ DHP + L V ++T+Y G L
Sbjct: 80 TLKVGYTEKQRRDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 756 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815
L + + V + ++YL G ++RDL N+L+ N ++DF L
Sbjct: 137 LRKHDAQFTVIQLVGM-LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGR 195
Query: 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 875
+L E +G + P+ + +PE IA TSA
Sbjct: 196 --------VLEDDPEAAYTTRGGKIPI----------------RWTSPEAIAYRKFTSAS 231
Query: 876 DWWALGILLYEML-YGYTPFRGKTRQKTFANI-----LHKDLKFPSSTPTSLHAKQLMYR 929
D W+ GI+L+E++ YG P+ + Q + L P P +L+ QLM
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP----PMDCPAALY--QLMLD 285
Query: 930 LLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPG 989
+D +R P F+ + L + + P + + ++D
Sbjct: 286 CWQKDRNNR-------------PKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQS 332
Query: 990 MQD 992
D
Sbjct: 333 NVD 335
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 7e-17
Identities = 64/318 (20%), Positives = 117/318 (36%), Gaps = 35/318 (11%)
Query: 626 PEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKP-LGSGDTGSVHLV 684
P + + P P+ +++ D + + LG G+ GSV
Sbjct: 296 PARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQG 355
Query: 685 ELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 742
+ A+K + +G + E +I+ LD+P++ L + L
Sbjct: 356 VYRMRKKQIDVAIKVLKQGTEKADTE--EMMREAQIMHQLDNPYIVRLIG-VCQAEALML 412
Query: 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 802
+ + GG L L + + V +V + ++YL + ++R+L NVLL
Sbjct: 413 VMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN 471
Query: 803 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 862
+ ++DF LS + L + R G+ P++ + A
Sbjct: 472 RHYAKISDFGLS-------KALGADDSYYTARSAGKW-------PLK----------WYA 507
Query: 863 PEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTS 920
PE I +S D W+ G+ ++E L YG P++ + A I K ++ P P
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 567
Query: 921 LHAKQLMYRLLHRDPKSR 938
L+ LM + R
Sbjct: 568 LY--ALMSDCWIYKWEDR 583
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 7e-17
Identities = 61/284 (21%), Positives = 115/284 (40%), Gaps = 44/284 (15%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 720
I+ ++ +GSG G VHL + A+K + +G M E E++
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAM----SEEDFIEEAEVMM 58
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
L HP + LY + +CL+T++ G L L Q E + +V +
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM-CLDVCEGM 117
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
YL +I+RDL N L+ N + ++DF ++ +++ G +
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF----------VLDDQYTSSTGTKF 167
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 899
PV ++ +PE+ + + ++S D W+ G+L++E+ G P+ ++
Sbjct: 168 PV----------------KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211
Query: 900 QKTFANI-----LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ +I L+K P T ++ Q+M P+ R
Sbjct: 212 SEVVEDISTGFRLYK----PRLASTHVY--QIMNHCWRERPEDR 249
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 70/340 (20%), Positives = 110/340 (32%), Gaps = 76/340 (22%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAM--DKGVMLNRNKVHRACA 714
+ ++ + I+ LG G G V L + A+KA+ D G
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK----Q 82
Query: 715 EREILDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 770
E +IL L H + + L+ +Y P G L +L L
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL---- 138
Query: 771 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830
+A ++ + YLH Q I+RDL NVLL + V + DF L+ +P +E
Sbjct: 139 -FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA--------KAVPEGHE 189
Query: 831 KKRRHKGQQNPVF-MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 888
R + +PVF APE + A D W+ G+ LYE+L
Sbjct: 190 YYRVREDGDSPVFWY-----------------APECLKEYKFYYASDVWSFGVTLYELLT 232
Query: 889 YGYTPFRGKTRQKTFANILHKDLKF---------------PSSTPTSLHAKQLMYRLLHR 933
+ + T+ I + P P ++ LM
Sbjct: 233 HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVY--HLMKNCWET 290
Query: 934 DPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 973
+ R P F+ + L + AP
Sbjct: 291 EASFR-------------PTFENLIPILKTVHEKYQGQAP 317
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 68/302 (22%), Positives = 122/302 (40%), Gaps = 51/302 (16%)
Query: 640 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 699
KP +D W ++ + + ++ LG+G G V + G + A+K++
Sbjct: 1 KPWWEDE--W-----------EVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLK 46
Query: 700 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL-DR 758
+G M + AE ++ L H + LYA T+ + +IT+Y G L L
Sbjct: 47 QGSMSPDAFL----AEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTP 101
Query: 759 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818
K+ + AA++ + ++ + I+RDL+ N+L+ + DF L+
Sbjct: 102 SGIKLTINKLLDM-AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA---- 156
Query: 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 878
+L+ +G + P+ ++ APE I T D W
Sbjct: 157 ---RLIEDNEYT---AREGAKFPI----------------KWTAPEAINYGTFTIKSDVW 194
Query: 879 ALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPK 936
+ GILL E++ +G P+ G T + N+ + P + P L+ QLM P+
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY--QLMRLCWKERPE 252
Query: 937 SR 938
R
Sbjct: 253 DR 254
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 56/287 (19%), Positives = 106/287 (36%), Gaps = 45/287 (15%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAM--DKGVMLNRNKVHRACAE 715
R +K LGSG G+VH G+ +K + G +
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT----DH 65
Query: 716 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 773
+ LDH + L + + L+T Y P G L + RQ L + +
Sbjct: 66 MLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHV---RQHRGALGPQLLLNWG 121
Query: 774 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 833
++ + YL G+++R+L NVLL+ V + DF ++ L ++K+
Sbjct: 122 VQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP---------PDDKQL 172
Query: 834 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 892
+ + P+ +++A E I +T D W+ G+ ++E++ +G
Sbjct: 173 LYSEAKTPI----------------KWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
Query: 893 PFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
P+ G + + + L P ++ +M + D R
Sbjct: 217 PYAGLRLAEVPDLLEKGERLAQPQICTIDVY--MVMVKCWMIDENIR 261
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 74/316 (23%), Positives = 120/316 (37%), Gaps = 54/316 (17%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAERE 717
+I + + +G G G VH A+K + + + E
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE--KFLQEAL 68
Query: 718 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAE 775
+ DHP + L T+ V +I + C GEL FL + L ++ YA +
Sbjct: 69 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQ 124
Query: 776 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
+ AL YL + ++RD+ NVL+ N V L DF LS + + +T K +
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS-------RYMEDSTYYKASKG 177
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 894
K P++ ++APE I TSA D W G+ ++E+L +G PF
Sbjct: 178 K---------LPIK----------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218
Query: 895 RGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
+G I + + L P + P +L+ LM + DP R P
Sbjct: 219 QGVKNNDVIGRIENGERLPMPPNCPPTLY--SLMTKCWAYDPSRR-------------PR 263
Query: 954 FKGVNWALVRCMNPPE 969
F + L + +
Sbjct: 264 FTELKAQLSTILEEEK 279
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 83.0 bits (204), Expect = 3e-16
Identities = 114/680 (16%), Positives = 190/680 (27%), Gaps = 214/680 (31%)
Query: 192 KDALSTFQQTFV-------VSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAG 244
KD LS F+ FV V D K I+ + +E+
Sbjct: 19 KDILSVFEDAFVDNFDCKDVQDMPKS---IL------------SKEEI------------ 51
Query: 245 TDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+ + ++ + + RL FW LL+ K +E V KF+
Sbjct: 52 ---DHIIMSKDAVS--GTL--RL---------FWTLLS----KQEEM-VQKFVE------ 84
Query: 305 KHTEGAKDKMLRPN-GLPESLIRYDARQKEMATSSVTELVQAMKK-PRSLSE-STNRPPI 361
++LR N S I+ + RQ M T E + + ++ + +R
Sbjct: 85 --------EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP 136
Query: 362 IRKSEGGVEEERA-------GALGRRKS-------ENVPPPRRNSYG------GGCRTSM 401
K + E R G LG K+ + + + C +
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPE 196
Query: 402 QRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDS---FENEIIMEGDDDYESDDERPDS 458
+ + QK + I S DH S I +
Sbjct: 197 TVL-----EMLQK-----LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246
Query: 459 ---VDDKVRQKEMRKGID-----LATTLERIEKNFVITDPRLPDNPIIFASDSFLE-LTE 509
+ + V+ + + L TT + +TD + D LT
Sbjct: 247 LLVLLN-VQNAKAWNAFNLSCKILLTT-----RFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 510 YSREEILGR--NCRFLQGPE----TDPATVRKIRAAIDNQTDV-----TVQLINYTKSGK 558
+ +L + +CR P T+P + I +I + V T +
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIE 360
Query: 559 KFWNLFHLQPMRDQKYFIGVQLDGSEHLEPLRNS--IPEAT---------AEESE----K 603
N L+P +K F + L S IP + K
Sbjct: 361 SSLN--VLEPAEYRKMF--------DRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK 410
Query: 604 LVKQT--AENVNEAVKELPDANL----TPEDLWANHSKVVHPKPHRKDSPPWKAIQKILD 657
L K + + E+ +P L E+ +A H +V K I LD
Sbjct: 411 LHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD 470
Query: 658 SGEQIN--LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN----RNKVHR 711
H +G HL + + M V L+ K+
Sbjct: 471 -----QYFYSH------IGH------HLKN-IEHPERMTLFRM---VFLDFRFLEQKIRH 509
Query: 712 A----CAEREILDML-DHPFVPALYASFQTKTH------VCLITDYCPGGELFLLLDR-- 758
A IL+ L F Y + V I D+ P E L+ +
Sbjct: 510 DSTAWNASGSILNTLQQLKF----YKPYICDNDPKYERLVNAILDFLPKIEENLICSKYT 565
Query: 759 --------QPTKVLKEDAVR 770
+ + E+A +
Sbjct: 566 DLLRIALMAEDEAIFEEAHK 585
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 8e-08
Identities = 64/485 (13%), Positives = 136/485 (28%), Gaps = 141/485 (29%)
Query: 560 FWNLFHLQPMRDQKYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKEL 619
FW + + F+ E L + E +Q + +++
Sbjct: 68 FW-TLLSKQEEMVQKFVE------EVLRINYKFLMSPIKTEQ----RQPSMMTRMYIEQR 116
Query: 620 PDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPL---GSG 676
+ L+ N ++V K + P+ +++ L RP K + G
Sbjct: 117 -------DRLY-NDNQVF-AKYNVSRLQPYLKLRQ--------ALLELRPAKNVLIDGVL 159
Query: 677 DTG-SVHLVELCGSGQYFAMKAMDKGVM-LNRNKVHRACAEREILDMLDHPFVPALYASF 734
+G + +++C S Y MD + LN + +L+ML L
Sbjct: 160 GSGKTWVALDVCLS--YKVQCKMDFKIFWLNLKNCNS---PETVLEMLQ-----KLLYQI 209
Query: 735 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLK 794
++ + + + ++ + R ++ Y +C ++ +++
Sbjct: 210 DP--------NWTSRSDHSSNI-KLRIHSIQAELRRLLKSK-----PYENCL-LVLLNVQ 254
Query: 795 PENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK---------KRRHK--GQQNPVF 843
F+LSC ++LL TT K H +
Sbjct: 255 NAKAW---------NAFNLSC------KILL-TTRFKQVTDFLSAATTTHISLDHHSMTL 298
Query: 844 M-AEPMRASNSFVGTEEY--------IAPEIIAGAG-----HTSAVDWW------ALGIL 883
E ++ P ++ + D W L +
Sbjct: 299 TPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTI 358
Query: 884 L---YEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSL-----------HAKQLM-Y 928
+ +L P + + + P+ + + +L Y
Sbjct: 359 IESSLNVL---EPAEYRKMFDRLS-VFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKY 414
Query: 929 RLLHRDPK-SRLGSH--------EGANEIKKHPFFKGVNWALVRCMNPPE-LDAPLFATD 978
L+ + PK S + + NE H ++V N P+ D+
Sbjct: 415 SLVEKQPKESTISIPSIYLELKVKLENEYALHR-------SIVDHYNIPKTFDSDDLIPP 467
Query: 979 TEKEY 983
+Y
Sbjct: 468 YLDQY 472
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 4e-16
Identities = 75/317 (23%), Positives = 121/317 (38%), Gaps = 54/317 (17%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAERE 717
+I + + +G G G VH A+K + + + E
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE--KFLQEAL 443
Query: 718 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAE 775
+ DHP + L T+ V +I + C GEL FL + L ++ YA +
Sbjct: 444 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQ 499
Query: 776 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
+ AL YL + ++RD+ NVL+ N V L DF LS + + +T K +
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS-------RYMEDSTYYKASKG 552
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 894
K P++ ++APE I TSA D W G+ ++E+L +G PF
Sbjct: 553 K---------LPIK----------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593
Query: 895 RGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
+G I + + L P + P +L+ LM + DP R P
Sbjct: 594 QGVKNNDVIGRIENGERLPMPPNCPPTLY--SLMTKCWAYDPSRR-------------PR 638
Query: 954 FKGVNWALVRCMNPPEL 970
F + L + +L
Sbjct: 639 FTELKAQLSTILEEEKL 655
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 6e-16
Identities = 59/280 (21%), Positives = 107/280 (38%), Gaps = 36/280 (12%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 720
++ + +K LGSG G V L + G A+K + +G M E + +
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSM----SEDEFFQEAQTMM 58
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
L HP + Y + + ++T+Y G L L + + +V +
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM-CYDVCEGM 117
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
+L I+RDL N L+ + V ++DF ++ +++ G +
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY----------VLDDQYVSSVGTKF 167
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 899
PV ++ APE+ ++S D WA GIL++E+ G P+ T
Sbjct: 168 PV----------------KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211
Query: 900 QKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ + L P +++ Q+MY H P+ R
Sbjct: 212 SEVVLKVSQGHRLYRPHLASDTIY--QIMYSCWHELPEKR 249
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 58/281 (20%), Positives = 107/281 (38%), Gaps = 46/281 (16%)
Query: 670 IKPLGSGDTGSVH---LVELCGSGQYFAMKAMDKGVMLNRNKVHRACA----EREILDML 722
+ +G G G V+ L++ G + A+K LNR + E I+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK------SLNRITDIGEVSQFLTEGIIMKDF 83
Query: 723 DHPFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVA 779
HP V +L +++ ++ Y G+L F+ + V +D + F +V
Sbjct: 84 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGF-GLQVAKG 140
Query: 780 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
++YL + ++RDL N +L V + DF L+ + + G +
Sbjct: 141 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA-------RDMYDKEYYSVHNKTGAK 193
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 898
PV +++A E + T+ D W+ G+LL+E++ G P+
Sbjct: 194 LPV----------------KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237
Query: 899 RQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+L L P P L+ ++M + H + R
Sbjct: 238 TFDITVYLLQGRRLLQPEYCPDPLY--EVMLKCWHPKAEMR 276
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 60/271 (22%), Positives = 106/271 (39%), Gaps = 36/271 (13%)
Query: 673 LGSGDTGSVHLVELCGSGQYF--AMKAMDKGVMLNRNKVHRA-CAEREILDMLDHPFVPA 729
LG G+ GSV + A+K + +G E +I+ LD+P++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPYIVR 74
Query: 730 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 789
L Q + + L+ + GG L L + ++ + +V + ++YL + +
Sbjct: 75 LIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL-LHQVSMGMKYLEEKNFV 132
Query: 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 849
+RDL NVLL + ++DF LS + L + R G+ P++
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLS-------KALGADDSYYTARSAGKW-------PLK 178
Query: 850 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH 908
+ APE I +S D W+ G+ ++E L YG P++ + A I
Sbjct: 179 ----------WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228
Query: 909 KD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
++ P P L+ LM + R
Sbjct: 229 GKRMECPPECPPELY--ALMSDCWIYKWEDR 257
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-15
Identities = 63/284 (22%), Positives = 99/284 (34%), Gaps = 72/284 (25%)
Query: 714 AEREI--LDMLDHPFVPALY--------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 763
A REI L +L H V L + K + L+ D+C +L LL K
Sbjct: 63 ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVK- 120
Query: 764 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQ 822
++ ++ L Y+H I++RD+K NVL+ +G + L DF L+ + K
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALG 881
TN V T Y PE++ G +D W G
Sbjct: 181 QPNRYTNR------------------------VVTLWYRPPELLLGERDYGPPIDLWGAG 216
Query: 882 ILLYEMLYGYTPFRGKTRQKTFANI-------------------LHKDLKFPSSTPTSL- 921
++ EM +G T Q A I L++ L+ +
Sbjct: 217 CIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK 276
Query: 922 ----------HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+A L+ +LL DP R+ +++ H FF
Sbjct: 277 DRLKAYVRDPYALDLIDKLLVLDPAQRI----DSDDALNHDFFW 316
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 57/281 (20%), Positives = 108/281 (38%), Gaps = 46/281 (16%)
Query: 670 IKPLGSGDTGSVH---LVELCGSGQYFAMKAMDKGVMLNRNKVHRACA----EREILDML 722
+ +G G G V+ L++ G + A+K LNR + E I+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK------SLNRITDIGEVSQFLTEGIIMKDF 147
Query: 723 DHPFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVA 779
HP V +L +++ ++ Y G+L F+ + V +D + F +V
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGF-GLQVAKG 204
Query: 780 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
+++L + ++RDL N +L V + DF L+ + + + G +
Sbjct: 205 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA-------RDMYDKEFDSVHNKTGAK 257
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 898
PV +++A E + T+ D W+ G+LL+E++ G P+
Sbjct: 258 LPV----------------KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301
Query: 899 RQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+L L P P L+ ++M + H + R
Sbjct: 302 TFDITVYLLQGRRLLQPEYCPDPLY--EVMLKCWHPKAEMR 340
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 62/293 (21%), Positives = 116/293 (39%), Gaps = 44/293 (15%)
Query: 650 KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 709
A + SG +N++ + ++ +G G+ G V L + G A+K + +
Sbjct: 6 AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVK------CIKNDAT 57
Query: 710 HRA-CAEREILDMLDHPFVPALYAS-FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 767
+A AE ++ L H + L + K + ++T+Y G L L + VL D
Sbjct: 58 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 117
Query: 768 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 827
+ ++ +V A+EYL ++RDL NVL+ + ++DF L+
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT------------- 164
Query: 828 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 887
E + PV ++ APE + ++ D W+ GILL+E+
Sbjct: 165 -KEASSTQDTGKLPV----------------KWTAPEALREKKFSTKSDVWSFGILLWEI 207
Query: 888 L-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+G P+ + + + P P +++ ++M H D R
Sbjct: 208 YSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY--EVMKNCWHLDAAMR 258
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 69/306 (22%), Positives = 119/306 (38%), Gaps = 49/306 (16%)
Query: 645 DSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKG 701
DS ++ +L E++ + +G G G V+ E Q A+K
Sbjct: 4 DSALLAEVKDVLIPHERVVTHS---DRVIGKGHFGVVYHGEYIDQAQNRIQCAIK----- 55
Query: 702 VMLNRNKVHRACA----EREILDMLDHPFVPALYA-SFQTKTHVCLITDYCPGGEL--FL 754
L+R + E ++ L+HP V AL + ++ Y G+L F+
Sbjct: 56 -SLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI 114
Query: 755 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814
++ V +D + F +V +EYL Q ++RDL N +L + V + DF L+
Sbjct: 115 RSPQRNPTV--KDLISF-GLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
Query: 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 874
+ +L ++H+ + PV ++ A E + T+
Sbjct: 172 -------RDILDREYYSVQQHRHARLPV----------------KWTALESLQTYRFTTK 208
Query: 875 VDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLH 932
D W+ G+LL+E+L G P+R + L P P SL+ Q+M +
Sbjct: 209 SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY--QVMQQCWE 266
Query: 933 RDPKSR 938
DP R
Sbjct: 267 ADPAVR 272
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 63/280 (22%), Positives = 109/280 (38%), Gaps = 36/280 (12%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 720
+I+ + +K LG+G G V + G A+K + +G M E +++
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMM 74
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
L H + LY + + +IT+Y G L L + + + +V A+
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAM 133
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
EYL + ++RDL N L+ G V ++DF LS + +L G +
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS-------RYVLDDEYT---SSVGSKF 183
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 899
PV + PE++ + +S D WA G+L++E+ G P+ T
Sbjct: 184 PV----------------RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227
Query: 900 QKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+T +I L P ++ +MY H R
Sbjct: 228 SETAEHIAQGLRLYRPHLASEKVY--TIMYSCWHEKADER 265
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 67/298 (22%), Positives = 101/298 (33%), Gaps = 67/298 (22%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVML-NRNKVHRACAER 716
I + + LG G G V+ A+K K L N+ K E
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---EA 64
Query: 717 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAA 774
I+ LDHP + L + +I + P GEL +L + LK + Y+
Sbjct: 65 VIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSL 120
Query: 775 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
++ A+ YL ++RD+ N+L+ V L DF LS
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS-------------------- 160
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYI------------APEIIAGAGHTSAVDWWALGI 882
R + E+Y +PE I T+A D W +
Sbjct: 161 --------------RY----IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAV 202
Query: 883 LLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
++E+L +G PF + + D L P P L+ LM R DP R
Sbjct: 203 CMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLY--TLMTRCWDYDPSDR 258
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 49/324 (15%), Positives = 95/324 (29%), Gaps = 68/324 (20%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF-------AMKAMDKGVMLNRNKVHRAC 713
+I + + LG G + G Y +K +DK
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE-- 61
Query: 714 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 773
++ L H + Y L+ ++ G L L + + + A
Sbjct: 62 -AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV-A 119
Query: 774 AEVVVALEYLHCQGIIYRDLKPENVLLQG--------NGHVSLTDFDLSCLTSCKPQLLL 825
++ A+ +L +I+ ++ +N+LL + L+D +S +L
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------ITVL 172
Query: 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILL 884
P ++ + ++ PE I + A D W+ G L
Sbjct: 173 PKDILQE--------------RIP----------WVPPECIENPKNLNLATDKWSFGTTL 208
Query: 885 YEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943
+E+ G P Q+ + P+ L L+ + +P R
Sbjct: 209 WEICSGGDKPLSALDSQRKLQFY-EDRHQLPAPKAAELA--NLINNCMDYEPDHR----- 260
Query: 944 GANEIKKHPFFKGVNWALVRCMNP 967
P F+ + L P
Sbjct: 261 --------PSFRAIIRDLNSLFTP 276
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 67/295 (22%), Positives = 118/295 (40%), Gaps = 50/295 (16%)
Query: 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAER 716
+Q L + LG G+ GSV +L F A+K + ++ + + E
Sbjct: 23 QQFTL-----GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREA 76
Query: 717 EILDMLDHPFVPALYA------SFQTKTHVCLITDYCPGGEL--FLLLDR---QPTKVLK 765
+ DHP V L + +I + G+L FLL R P +
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 766 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825
+ VRF ++ +EYL + I+RDL N +L + V + DF LS +
Sbjct: 137 QTLVRF-MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS--------RKI 187
Query: 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 885
+ + ++ + P++ ++A E +A +T D WA G+ ++
Sbjct: 188 YSGDYYRQGCASKL-------PVK----------WLALESLADNLYTVHSDVWAFGVTMW 230
Query: 886 EML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
E++ G TP+ G + + ++ + LK P ++ LMY+ DPK R
Sbjct: 231 EIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVY--DLMYQCWSADPKQR 283
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 7e-14
Identities = 70/354 (19%), Positives = 119/354 (33%), Gaps = 93/354 (26%)
Query: 688 GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH--VCLITD 745
+ +A+K ++ + AC E +L L HP V +L F + V L+ D
Sbjct: 46 KDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100
Query: 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEV-------VVALEYLHCQGIIYRDLKPENV 798
Y +L+ ++ + V+ V + + YLH +++RDLKP N+
Sbjct: 101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANI 159
Query: 799 LLQG----NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSF 854
L+ G G V + D + R +P+ +P+ +
Sbjct: 160 LVMGEGPERGRVKIADMGFA-------------------RLFN--SPL---KPLADLDPV 195
Query: 855 VGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKT--------------- 898
V T Y APE++ GA H T A+D WA+G + E+L F +
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255
Query: 899 ------------------------------RQKTFANILHKDLKFPSSTPTSLHAKQLMY 928
R+ T+ N A L+
Sbjct: 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 315
Query: 929 RLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKE 982
+LL DP R+ + + + P+F ++ P TE+E
Sbjct: 316 KLLTMDPIKRI----TSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEE 365
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 54/260 (20%), Positives = 103/260 (39%), Gaps = 42/260 (16%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 724
+R + +GSG G ++L +G+ A+K + K + E +I M+
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGG 64
Query: 725 PFVPALYASFQTKTHVCLITDYCPGG----ELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
+P + + ++ + G +LF R+ + LK V A +++ +
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFS--LK--TVLLLADQMISRI 118
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
EY+H + I+RD+KP+N L+ V + DF L+ + + +H
Sbjct: 119 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK----------KYRDARTHQHI- 167
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG- 896
P R + + GT Y + G + D +LG +L G P++G
Sbjct: 168 ---------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
Query: 897 --KTRQKTFANILHKDLKFP 914
T+++ + I K + P
Sbjct: 219 KAATKRQKYERISEKKMSTP 238
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 55/263 (20%), Positives = 101/263 (38%), Gaps = 46/263 (17%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 724
H++ + +G G G + + Q A+K + R+ + E +L
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGC 65
Query: 725 PFVPALYASFQTKTHVCLITDYCPG---GELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 781
+P +Y Q H L+ D G +L L R+ + +K V A +++ ++
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFS--VK--TVAMAAKQMLARVQ 120
Query: 782 YLHCQGIIYRDLKPENVLL-QGNGH----VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
+H + ++YRD+KP+N L+ + N + + DF + K R
Sbjct: 121 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV----------------KFYRDP 164
Query: 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV--DWWALGILLYEMLYGYTPF 894
+ + P R + GT Y++ I G + D ALG + L G P+
Sbjct: 165 VTKQHI----PYREKKNLSGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218
Query: 895 RG---KTRQKTFANILHKDLKFP 914
+G T ++ + I K P
Sbjct: 219 QGLKAATNKQKYERIGEKKQSTP 241
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 65/321 (20%), Positives = 113/321 (35%), Gaps = 65/321 (20%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
LG G G V L E A+KA+ + R R E E+L ML H
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTMLQH 102
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGEL--FL------------LLDRQPTKVLKEDAVR 770
+ + + ++ +Y G+L FL D P + +
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 771 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 830
A++V + YL ++RDL N L+ V + DF +S + +T+
Sbjct: 163 V-ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS--------RDIYSTDY 213
Query: 831 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 889
+ + P+R ++ PE I T+ D W+ G++L+E+ Y
Sbjct: 214 YRVGGRTML-------PIR----------WMPPESILYRKFTTESDVWSFGVVLWEIFTY 256
Query: 890 GYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948
G P+ + + I ++L+ P + P ++ +M R+P+ R
Sbjct: 257 GKQPWYQLSNTEAIDCITQGRELERPRACPPEVY--AIMRGCWQREPQQR---------- 304
Query: 949 KKHPFFKGVNWALVRCMNPPE 969
K V+ L P
Sbjct: 305 ---HSIKDVHARLQALAQAPP 322
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 69/321 (21%), Positives = 123/321 (38%), Gaps = 49/321 (15%)
Query: 633 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 692
H R ++ ++ + L K LG G+ GSV L
Sbjct: 7 HHHHSSGLVPRGSEELQNKLEDVVIDRNLLIL-----GKILGEGEFGSVMEGNLKQEDGT 61
Query: 693 F---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA-----SFQTKTHVCLIT 744
A+K M ++ ++ +E + HP V L S Q +I
Sbjct: 62 SLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120
Query: 745 DYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 799
+ G+L +LL R P + + ++F ++ + +EYL + ++RDL N +
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF-MVDIALGMEYLSNRNFLHRDLAARNCM 179
Query: 800 LQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEE 859
L+ + V + DF LS + + + ++ + P++
Sbjct: 180 LRDDMTVCVADFGLS--------KKIYSGDYYRQGRIAKM-------PVK---------- 214
Query: 860 YIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSST 917
+IA E +A +TS D WA G+ ++E+ G TP+ G + + +LH LK P
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDC 274
Query: 918 PTSLHAKQLMYRLLHRDPKSR 938
L+ ++MY DP R
Sbjct: 275 LDELY--EIMYSCWRTDPLDR 293
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 58/328 (17%), Positives = 117/328 (35%), Gaps = 59/328 (17%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 723
+ LG G G V+ G + A+K +++ + R + E ++ +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN---EASVMKEFN 86
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR------FYAAE 775
V L +I + G+L +L R A A E
Sbjct: 87 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 776 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
+ + YL+ ++RDL N ++ + V + DF ++ + T+ ++
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT--------RDIYETDYYRKGG 198
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 894
KG P+R +++PE + T+ D W+ G++L+E+ P+
Sbjct: 199 KGLL-------PVR----------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241
Query: 895 RGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
+G + ++ ++ L P + P L +LM +PK R P
Sbjct: 242 QGLSNEQVLRFVMEGGLLDKPDNCPDMLF--ELMRMCWQYNPKMR-------------PS 286
Query: 954 FKGVNWALVRCMNPPELDAPLFATDTEK 981
F + ++ M P + + ++ K
Sbjct: 287 FLEIISSIKEEMEPGFREVSFYYSEENK 314
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 61/324 (18%), Positives = 116/324 (35%), Gaps = 64/324 (19%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 723
I+ LG G G V+ ++ G A+K + + E I+ +
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM---EALIISKFN 91
Query: 724 HPFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDR----QPTKVLKEDAVRFYAAEV 776
H + S Q+ ++ + GG+L FL R QP+ + D + A ++
Sbjct: 92 HQNIVRCIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV-ARDI 149
Query: 777 VVALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKR 833
+YL I+RD+ N LL G + DF ++ + + ++
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA--------RDIYRASYYRK 201
Query: 834 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 892
P++ ++ PE TS D W+ G+LL+E+ GY
Sbjct: 202 GGCAML-------PVK----------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244
Query: 893 PFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951
P+ K+ Q+ + + P + P ++ ++M + P+ R
Sbjct: 245 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY--RIMTQCWQHQPEDR------------- 289
Query: 952 PFFKGVNWALVRCM-NPPELDAPL 974
P F + + C +P ++ L
Sbjct: 290 PNFAIILERIEYCTQDPDVINTAL 313
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 62/291 (21%), Positives = 107/291 (36%), Gaps = 53/291 (18%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
+ LG G G V L E A+KA+ + R R E E+L L H
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQH 76
Query: 725 PFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR----------- 770
+ Y + ++ +Y G+L FL +L + R
Sbjct: 77 EHIVKFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 771 -FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829
A+++ + YL Q ++RDL N L+ N V + DF +S + +T+
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS--------RDVYSTD 187
Query: 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 888
+ P+R ++ PE I T+ D W+ G++L+E+
Sbjct: 188 YYRVGGHTML-------PIR----------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230
Query: 889 YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
YG P+ + + I + L+ P P ++ +M R+P+ R
Sbjct: 231 YGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVY--DVMLGCWQREPQQR 279
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A Length = 120 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-12
Identities = 13/87 (14%), Positives = 30/87 (34%), Gaps = 2/87 (2%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAK-IRETLQNGQSYCGRLLNYKK 272
I + + +++GR+ L + + E + + I + SY + +
Sbjct: 24 IEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDRIMKRA 83
Query: 273 DGTPFWNLLTIAPIKDDEGKVLKFIGM 299
G FW +T + D + +
Sbjct: 84 GGELFWCHVTGRAL-DRTAPLAAGVWT 109
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A Length = 120 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 5e-09
Identities = 13/94 (13%), Positives = 27/94 (28%), Gaps = 4/94 (4%)
Query: 492 LPDNPIIFASDSFLELTEYSREEILGRNCRFLQ-GPETDPATVRKIRAAIDNQTDVTVQL 550
D I +D + +R +++GR+ L + +I +
Sbjct: 19 SRDRVIEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDR 78
Query: 551 INYTKSGKKFWNLFHLQPMR---DQKYFIGVQLD 581
I G+ FW + + + D
Sbjct: 79 IMKRAGGELFWCHVTGRALDRTAPLAAGVWTFED 112
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 59/323 (18%), Positives = 112/323 (34%), Gaps = 62/323 (19%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 723
I+ LG G G V+ ++ G A+K + + E I+ +
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM---EALIISKFN 132
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDR----QPTKVLKEDAVRFYAAEVV 777
H + ++ + GG+L FL R QP+ + D + A ++
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV-ARDIA 191
Query: 778 VALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
+YL I+RD+ N LL G + DF ++ + ++
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA--------RDIYRAGYYRKG 243
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTP 893
P++ ++ PE TS D W+ G+LL+E+ GY P
Sbjct: 244 GCAML-------PVK----------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
Query: 894 FRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 952
+ K+ Q+ + + P + P ++ ++M + P+ R P
Sbjct: 287 YPSKSNQEVLEFVTSGGRMDPPKNCPGPVY--RIMTQCWQHQPEDR-------------P 331
Query: 953 FFKGVNWALVRCM-NPPELDAPL 974
F + + C +P ++ L
Sbjct: 332 NFAIILERIEYCTQDPDVINTAL 354
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 62/291 (21%), Positives = 104/291 (35%), Gaps = 52/291 (17%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 723
++ LG G V+ L G A+K + R + E + L
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH---EAMLRARLQ 70
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF---------- 771
HP V L + +I YC G+L FL++ + V D R
Sbjct: 71 HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 772 --YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 829
A++ +EYL ++++DL NVL+ +V ++D L + +
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF--------REVYAAD 182
Query: 830 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 888
K P+R ++APE I + D W+ G++L+E+
Sbjct: 183 YYKLLGNSLL-------PIR----------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
Query: 889 YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
YG P+ G + Q I + + L P P ++ LM + P R
Sbjct: 226 YGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVY--ALMIECWNEFPSRR 274
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 49/286 (17%), Positives = 97/286 (33%), Gaps = 42/286 (14%)
Query: 632 NHSKVVHPKPHRKDSPPWKAIQKILDSGEQ---INLQHFRPIKPLGSGDTGSVHLVELCG 688
+HS V + L +G + + ++ + G ++
Sbjct: 6 HHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTS 65
Query: 689 SG--------QYFAMK--AMDKGVMLNRNKVHRACAEREI-----LDMLDHPFVPALYAS 733
+ Q F++K A D + +N RA ++ L +P
Sbjct: 66 TLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGF 125
Query: 734 -FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 792
+ L+ G L LD P VL E +V A ++ ALE+LH ++ +
Sbjct: 126 GVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGN 184
Query: 793 LKPENVLL--QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 850
+ EN+ + + V+L + + + G+ +
Sbjct: 185 VTAENIFVDPEDQSQVTLAGYGFA----------------FRYCPSGKHVA----YVEGS 224
Query: 851 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896
+ G E+I+ ++ G G + D +LG + + LYG+ P+
Sbjct: 225 RSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 59/262 (22%), Positives = 105/262 (40%), Gaps = 44/262 (16%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 724
+FR K +G G+ G + L + + +Y A+K + +++ + E L
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSG 64
Query: 725 PFVPALYASFQTKTHVCLITDYCPGG----ELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
+P +Y + ++ + G +LF L DR + LK V A +++ +
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFS--LK--TVLMIAIQLISRM 118
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGH-----VSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
EY+H + +IYRD+KPEN L+ G+ + + DF L+ K+
Sbjct: 119 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA----------------KEYID 162
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895
+ + P R S GT Y++ G + D ALG + L G P++
Sbjct: 163 PETKKHI----PYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQ 218
Query: 896 G---KTRQKTFANILHKDLKFP 914
G T ++ + I P
Sbjct: 219 GLKADTLKERYQKIGDTKRATP 240
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 6e-11
Identities = 48/235 (20%), Positives = 92/235 (39%), Gaps = 31/235 (13%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DH 724
FR + +GSG G ++L + + A+K + + K + E +I +L
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKIYRILQGG 62
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
+P + + L+ D G L L + K+ + + A +++ +E++H
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML-ADQMINRVEFVH 120
Query: 785 CQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
+ ++RD+KP+N L+ V + DF L+ + +H
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK----------KYRDTSTHQHI----- 165
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896
P R + + GT Y + G + D +LG +L L G P++G
Sbjct: 166 -----PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 50/285 (17%), Positives = 92/285 (32%), Gaps = 44/285 (15%)
Query: 638 HPKPHRKDSPPWKAIQKI-LDSGEQINL---QHFRPIKPLGSGDTGSVHLVELCGSGQYF 693
H Q + G+ ++ + K +GSG G ++L +
Sbjct: 6 HHSSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKD 65
Query: 694 AMKAM-----DKGVMLNRNKV-HRACAEREILDM-----LDHPFVPALYAS----FQTKT 738
A + + G + + K R + I LD+ +P Y S F+ ++
Sbjct: 66 ARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRS 125
Query: 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 798
+ ++ + G +L + + T V ++ LEY+H ++ D+K N+
Sbjct: 126 YRFMVMERL-GIDLQKISGQNGTFKKS--TVLQLGIRMLDVLEYIHENEYVHGDIKAANL 182
Query: 799 LL-QGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG 856
LL N V L D+ LS + G G
Sbjct: 183 LLGYKNPDQVYLADYGLS----------------YRYCPNGNHKQY----QENPRKGHNG 222
Query: 857 TEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901
T E+ + + G + D LG + L G P+ +
Sbjct: 223 TIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 73/322 (22%), Positives = 122/322 (37%), Gaps = 61/322 (18%)
Query: 638 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF--AM 695
H H + P I +LD I Q +G G+ G V + G A+
Sbjct: 4 HHHHHHGKNNPDPTIYPVLDW-NDIKFQ-----DVIGEGNFGQVLKARIKKDGLRMDAAI 57
Query: 696 KAMDKGVMLNRNKVHRA-CAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGEL- 752
K M + HR E E+L L HP + L + + + ++ L +Y P G L
Sbjct: 58 KRMKEYAS---KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 114
Query: 753 -FLLLDRQPTKVLK-------------EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 798
FL R + + F AA+V ++YL + I+RDL N+
Sbjct: 115 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHF-AADVARGMDYLSQKQFIHRDLAARNI 173
Query: 799 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 858
L+ N + DF LS ++ G+ P+R
Sbjct: 174 LVGENYVAKIADFGLS-----------RGQEVYVKKTMGRL-------PVR--------- 206
Query: 859 EYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSS 916
++A E + + +T+ D W+ G+LL+E++ G TP+ G T + + + L+ P +
Sbjct: 207 -WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 265
Query: 917 TPTSLHAKQLMYRLLHRDPKSR 938
++ LM + P R
Sbjct: 266 CDDEVY--DLMRQCWREKPYER 285
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 52/284 (18%), Positives = 99/284 (34%), Gaps = 44/284 (15%)
Query: 640 KPHRKDSPPWKAIQKILDSGEQINL---QHFRPIKPLGSGDTGSVHLVEL-----CGSGQ 691
+ S + + + GE I ++ P+G G G ++L ++ GS
Sbjct: 7 AQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDA 66
Query: 692 YFAMKAM--DKGVMLNRNKVHRACAEREILDM------LDHPFVPALYAS----FQTKTH 739
+K D G + K ++ A+ E + L + VP + S K++
Sbjct: 67 PCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSY 126
Query: 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 799
+I D G +L + + + V + ++ LEY+H ++ D+K N+L
Sbjct: 127 RFMIMDRF-GSDLQKIYEANAKR-FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL 184
Query: 800 L-QGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGT 857
L N V L D+ L+ + +G GT
Sbjct: 185 LNYKNPDQVYLVDYGLA----------------YRYCPEGVHKAY----AADPKRCHDGT 224
Query: 858 EEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901
E+ + + G + D LG + + L G+ P+ +
Sbjct: 225 IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 48/248 (19%), Positives = 98/248 (39%), Gaps = 51/248 (20%)
Query: 715 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF- 771
E +L ++HP V LY + + LI +Y G L FL R+
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 772 -------------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 812
+A ++ ++YL +++RDL N+L+ + ++DF
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 813 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT 872
LS + + +R +G+ P++ ++A E + +T
Sbjct: 196 LS--------RDVYEEDSYVKRSQGR-------IPVK----------WMAIESLFDHIYT 230
Query: 873 SAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRL 930
+ D W+ G+LL+E++ G P+ G ++ F + ++ P + ++ +LM +
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMY--RLMLQC 288
Query: 931 LHRDPKSR 938
++P R
Sbjct: 289 WKQEPDKR 296
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 63/296 (21%), Positives = 112/296 (37%), Gaps = 59/296 (19%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDML------ 722
KPLG G G V + E G + +A+ V ML + E+++ D++
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-----ATEKDLSDLVSEMEMM 94
Query: 723 ----DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----- 771
H + L + + +I +Y G L +L R P D R
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 772 -------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824
++ +EYL Q I+RDL NVL+ N + + DF L+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA--------RD 206
Query: 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 884
+ + K+ G+ P++ ++APE + +T D W+ G+L+
Sbjct: 207 INNIDYYKKTTNGR-------LPVK----------WMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 885 YEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+E+ G +P+ G ++ F + + P++ L+ +M H P R
Sbjct: 250 WEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY--MMMRDCWHAVPSQR 303
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 66/330 (20%), Positives = 111/330 (33%), Gaps = 73/330 (22%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 723
++ +G G G V G Y A+K + + + + R E ++ D
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---EAALMAEFD 108
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFY--------- 772
+P + L +CL+ +Y G+L FL T +
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 773 -----------AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821
A +V + YL + ++RDL N L+ N V + DF LS
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------- 221
Query: 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 881
+ + + K P+R ++ PE I +T+ D WA G
Sbjct: 222 -RNIYSADYYKADGNDAI-------PIR----------WMPPESIFYNRYTTESDVWAYG 263
Query: 882 ILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRL 939
++L+E+ YG P+ G ++ + L P + P L+ LM + P R
Sbjct: 264 VVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELY--NLMRLCWSKLPADR- 320
Query: 940 GSHEGANEIKKHPFFKGVNWALVRCMNPPE 969
P F ++ L R E
Sbjct: 321 ------------PSFCSIHRILQRMCERAE 338
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 71/355 (20%), Positives = 122/355 (34%), Gaps = 75/355 (21%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDML------ 722
KPLG G G V L E G + + V ML + E+++ D++
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----ATEKDLSDLISEMEMM 128
Query: 723 ----DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----- 771
H + L + + +I +Y G L +L R P +
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 772 -------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824
A +V +EYL + I+RDL NVL+ + + + DF L+
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH------ 242
Query: 825 LPTTNEKKRRHKGQQNPV-FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 883
+ ++ + PV +M APE + +T D W+ G+L
Sbjct: 243 ---HIDYYKKTTNGRLPVKWM-----------------APEALFDRIYTHQSDVWSFGVL 282
Query: 884 LYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS 941
L+E+ G +P+ G ++ F + + PS+ L+ +M H P R
Sbjct: 283 LWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELY--MMMRDCWHAVPSQR--- 337
Query: 942 HEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQN 996
P FK + L R + + + + P ++L N
Sbjct: 338 ----------PTFKQLVEDLDRIVALTS-NQEMGYYHHHHHHDYDIPTTENLYFN 381
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 54/243 (22%), Positives = 93/243 (38%), Gaps = 46/243 (18%)
Query: 715 EREILDMLD-HPFVPALY-ASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 770
E +IL + H V L A + + +I ++C G L +L R K
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 771 F------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818
Y+ +V +E+L + I+RDL N+LL V + DF L+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---- 195
Query: 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 878
+ + R+ + P++ ++APE I +T D W
Sbjct: 196 ----RDIYKDPDYVRKGDAR-------LPLK----------WMAPETIFDRVYTIQSDVW 234
Query: 879 ALGILLYEML-YGYTPFRGKTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDP 935
+ G+LL+E+ G +P+ G + F L + ++ P T ++ Q M H +P
Sbjct: 235 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY--QTMLDCWHGEP 292
Query: 936 KSR 938
R
Sbjct: 293 SQR 295
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 63/296 (21%), Positives = 112/296 (37%), Gaps = 59/296 (19%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDML------ 722
KPLG G G V + E G + +A+ V ML + E+++ D++
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-----ATEKDLSDLVSEMEMM 140
Query: 723 ----DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----- 771
H + L + + +I +Y G L +L R P D R
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 772 -------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824
++ +EYL Q I+RDL NVL+ N + + DF L+
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA--------RD 252
Query: 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 884
+ + K+ G+ P++ ++APE + +T D W+ G+L+
Sbjct: 253 INNIDYYKKTTNGR-------LPVK----------WMAPEALFDRVYTHQSDVWSFGVLM 295
Query: 885 YEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+E+ G +P+ G ++ F + + P++ L+ +M H P R
Sbjct: 296 WEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY--MMMRDCWHAVPSQR 349
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-08
Identities = 49/226 (21%), Positives = 86/226 (38%), Gaps = 42/226 (18%)
Query: 673 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA-CAEREILDMLDHPFVPALY 731
+G G G V+ + + A+K + V + ++ + E +++ H + L
Sbjct: 39 MGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 732 ASFQTKTHVCLITDYCPGGEL-FLLLDRQPTKVLKED-AVRFY----AAEVVVALEYLHC 785
+CL+ Y P G L L T L +R AA + +LH
Sbjct: 97 GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL--SWHMRCKIAQGAAN---GINFLHE 151
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
I+RD+K N+LL ++DF L+ + Q +
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLA-----R---ASEK---------FAQTVM--- 191
Query: 846 EPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYG 890
++ VGT Y+APE + G T D ++ G++L E++ G
Sbjct: 192 -----TSRIVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITG 230
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 48/263 (18%), Positives = 94/263 (35%), Gaps = 34/263 (12%)
Query: 683 LVELCGSG--QYFAMKAMDKGVMLNRNKVHRACAER--EILDMLDHPFVPALYASFQTKT 738
+VE C G + ++ V + + + + ++ +S + +
Sbjct: 105 IVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS 164
Query: 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 798
+ E + L + + Y+ +V +E+L + I+RDL N+
Sbjct: 165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 224
Query: 799 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 858
LL V + DF L+ + R + P+
Sbjct: 225 LLSEKNVVKICDFGLARDI---------YKDPDYVRKGDARLPL---------------- 259
Query: 859 EYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD--LKFPS 915
+++APE I +T D W+ G+LL+E+ G +P+ G + F L + ++ P
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 319
Query: 916 STPTSLHAKQLMYRLLHRDPKSR 938
T ++ Q M H +P R
Sbjct: 320 YTTPEMY--QTMLDCWHGEPSQR 340
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} Length = 117 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 1e-07
Identities = 10/82 (12%), Positives = 28/82 (34%), Gaps = 2/82 (2%)
Query: 497 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKS 556
+ + + Y+R+E L + L + + + + + +T++
Sbjct: 33 YLDVNPAICSAIGYTRDEFLALDWGVLSRGVDSGWAAASLARIVGGEP-LREERTVWTRN 91
Query: 557 GKKFWNLFHLQPMRDQKYFIGV 578
G + + D K +G+
Sbjct: 92 GDQLTVELSAHLLPDGK-ILGI 112
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} Length = 117 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-07
Identities = 13/93 (13%), Positives = 28/93 (30%), Gaps = 12/93 (12%)
Query: 210 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ---NGQSYCGR 266
+ + + GYT E + + L + D +L G+
Sbjct: 29 AEGHYLDVNPAICSAIGYTRDEFLALDWGVL----SRGVDSGWAAASLARIVGGEPLREE 84
Query: 267 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGM 299
+ ++G L+ + D K +G+
Sbjct: 85 RTVWTRNGDQLTVELSAHLLPDG-----KILGI 112
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} Length = 115 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-07
Identities = 20/81 (24%), Positives = 37/81 (45%), Gaps = 2/81 (2%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
I YA+ + ++K +V ++ Q D+A + + LQ+GQS + + D
Sbjct: 29 IRYANPAAELLFSQSAKRIVEQSLS--QLIQHASLDLALLTQPLQSGQSITDSDVTFVVD 86
Query: 274 GTPFWNLLTIAPIKDDEGKVL 294
G P +T++PI +L
Sbjct: 87 GRPLMLEVTVSPITWQRQLML 107
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} Length = 115 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 14/89 (15%), Positives = 34/89 (38%), Gaps = 7/89 (7%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNC-RFLQGPETDPATVRKIRAAIDNQT 544
+I D I +A+ + L S + I+ ++ + +Q D A + + +
Sbjct: 21 LILDD---GLAIRYANPAAELLFSQSAKRIVEQSLSQLIQHASLDLAL---LTQPLQSGQ 74
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMRDQK 573
+T + + G+ + P+ Q+
Sbjct: 75 SITDSDVTFVVDGRPLMLEVTVSPITWQR 103
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 52/246 (21%), Positives = 87/246 (35%), Gaps = 49/246 (19%)
Query: 714 AEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 770
+E ++L L +H + L + +IT+YC G+L FL R K
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 771 F--------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816
++ +V + +L + I+RDL N+LL + DF L+
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA-- 192
Query: 817 TSCKPQLLLPTTNEKKRRHKGQQNPV-FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 875
+ + + + PV +M APE I +T
Sbjct: 193 ------RDIKNDSNYVVKGNA-RLPVKWM-----------------APESIFNCVYTFES 228
Query: 876 DWWALGILLYEML-YGYTPFRG-KTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLH 932
D W+ GI L+E+ G +P+ G K + I + P P ++ +M
Sbjct: 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY--DIMKTCWD 286
Query: 933 RDPKSR 938
DP R
Sbjct: 287 ADPLKR 292
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} Length = 126 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 3e-07
Identities = 15/96 (15%), Positives = 27/96 (28%), Gaps = 6/96 (6%)
Query: 485 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 544
+ D D I + F Y E+LGR+ D V+ +
Sbjct: 30 IDVLDA---DGTICEVNQRFCAELGYDESEVLGRSIWEF-DLMFDAEDVQTQLSGFSVDE 85
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMR--DQKYFIGV 578
+ + + G HL + F+ +
Sbjct: 86 RRKFEGLYERRDGSTMSVEVHLLRFNLEGEDRFLAI 121
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} Length = 126 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 7e-07
Identities = 15/81 (18%), Positives = 25/81 (30%), Gaps = 1/81 (1%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
I + F GY EV+GR+ D EDV + L ++D
Sbjct: 39 ICEVNQRFCAELGYDESEVLGRSIWEF-DLMFDAEDVQTQLSGFSVDERRKFEGLYERRD 97
Query: 274 GTPFWNLLTIAPIKDDEGKVL 294
G+ + + +
Sbjct: 98 GSTMSVEVHLLRFNLEGEDRF 118
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} Length = 111 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-07
Identities = 19/99 (19%), Positives = 35/99 (35%), Gaps = 9/99 (9%)
Query: 210 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG---R 266
+ I+Y SA GY E++G + ED + N R
Sbjct: 17 SNGRIIYISANSKLHLGYLQGEMIGSFLKTF----LHEEDQFLVESYFYNEHHLMPCTFR 72
Query: 267 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 305
+ KKD T W + + + + I ++++V +
Sbjct: 73 FI--KKDHTIVWVEAAVEIVTTRAERTEREIILKMKVLE 109
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 52/242 (21%), Positives = 91/242 (37%), Gaps = 47/242 (19%)
Query: 715 EREILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLK------ 765
E +I+ L H + L + V +IT+YC G+L FL + +
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 766 -----EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820
D + F +++V + +L + I+RD+ NVLL + DF L+
Sbjct: 159 STASTRDLLHF-SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA------ 211
Query: 821 PQLLLPTTNEKKRRHKGQQNPV-FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 879
+ + + + PV +M APE I +T D W+
Sbjct: 212 --RDIMNDSNYIVKGNARL-PVKWM-----------------APESIFDCVYTVQSDVWS 251
Query: 880 LGILLYEML-YGYTPFRG-KTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPK 936
GILL+E+ G P+ G K + + + P+ P +++ +M +P
Sbjct: 252 YGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIY--SIMQACWALEPT 309
Query: 937 SR 938
R
Sbjct: 310 HR 311
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} Length = 126 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-06
Identities = 12/96 (12%), Positives = 34/96 (35%), Gaps = 6/96 (6%)
Query: 485 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 544
+I + + +++A+ + + Y+ EE++ + + A KI A +
Sbjct: 12 ILIINR---EGRLLYANTAVPKKLGYTHEELMSMHILTIT-SAGKMAEGEKILAELFAGK 67
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMR--DQKYFIGV 578
++ L K G + + ++ +
Sbjct: 68 KESLPLSLEKKEGTSIPAKARIWQGKWHNEPCLFAI 103
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} Length = 126 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 2e-05
Identities = 19/81 (23%), Positives = 31/81 (38%), Gaps = 1/81 (1%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
++YA+ K GYT +E++ + + + + KI L G+ L KK+
Sbjct: 21 LLYANTAVPKKLGYTHEELMSMHILTIT-SAGKMAEGEKILAELFAGKKESLPLSLEKKE 79
Query: 274 GTPFWNLLTIAPIKDDEGKVL 294
GT I K L
Sbjct: 80 GTSIPAKARIWQGKWHNEPCL 100
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 8e-06
Identities = 56/241 (23%), Positives = 85/241 (35%), Gaps = 50/241 (20%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA----CAEREILDML 722
F LG G G V+ L G A+K L + E E++ M
Sbjct: 32 FSNKNILGRGGFGKVYKGRL-ADGTLVAVK------RLKEERTQGGELQFQTEVEMISMA 84
Query: 723 DHPFVPALYASFQTKTHVCLITDYCPGGEL-FLLLDRQPTKVLKEDAVRFY----AAEVV 777
H + L T T L+ Y G + L +R ++ + R +A
Sbjct: 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR-- 142
Query: 778 VALEYLHCQG---IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 834
L YLH II+RD+K N+LL + DF L+ K L+ +
Sbjct: 143 -GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-----K---LMDYKDT---- 189
Query: 835 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP 893
H + + GT +IAPE G + D + G++L E++ G
Sbjct: 190 H--------------VTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRA 234
Query: 894 F 894
F
Sbjct: 235 F 235
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} Length = 118 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 9e-06
Identities = 16/96 (16%), Positives = 37/96 (38%), Gaps = 10/96 (10%)
Query: 485 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 544
+ ++ +D+ +TEYSRE++L N + + D I +
Sbjct: 26 SFCLGD---NWQFLYVNDATCRMTEYSREQLLSMNLQDI-----DVDFALHDWEEIRQKN 77
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMR--DQKYFIGV 578
+ T + ++SG+ F L + ++++
Sbjct: 78 NYTFKTRYRSQSGRIFLVEMSLTFLEDQERRFSCVF 113
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} Length = 118 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 12/81 (14%), Positives = 34/81 (41%), Gaps = 5/81 (6%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
+Y + +MT Y+ ++++ N + + D + E ++ +Y + +
Sbjct: 35 FLYVNDATCRMTEYSREQLLSMNLQDI-----DVDFALHDWEEIRQKNNYTFKTRYRSQS 89
Query: 274 GTPFWNLLTIAPIKDDEGKVL 294
G F +++ ++D E +
Sbjct: 90 GRIFLVEMSLTFLEDQERRFS 110
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 17/35 (48%), Positives = 23/35 (65%)
Query: 780 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814
L YLH + II+RD+K N+LL N +TDF +S
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 47/249 (18%), Positives = 90/249 (36%), Gaps = 52/249 (20%)
Query: 715 EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF 771
E +++ L H + L + + LI +YC G+L +L R+ + +
Sbjct: 98 ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 772 -------------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 812
+A +V +E+L + ++RDL NVL+ V + DF
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 813 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT 872
L+ + + + R + P++ ++APE + +T
Sbjct: 218 LA--------RDIMSDSNYVVRGNAR-------LPVK----------WMAPESLFEGIYT 252
Query: 873 SAVDWWALGILLYEML-YGYTPFRG-KTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYR 929
D W+ GILL+E+ G P+ G + I + + P ++ +M
Sbjct: 253 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIY--IIMQS 310
Query: 930 LLHRDPKSR 938
D + R
Sbjct: 311 CWAFDSRKR 319
|
| >3eeh_A Putative light and redox sensing histidine kinase; structural genomic MCSG, protein structure initiative, midwest center for STRU genomics; HET: PG5; 1.95A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 3e-05
Identities = 18/90 (20%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ---NGQSYCG--RLL 268
++ ++ + + G + ++ FL G PED +++T+Q +G+S R+
Sbjct: 34 VLVINSAYEDIWGRSVAKLRENPHDFLNG--IHPEDRELMKDTMQSLMDGESADVECRVN 91
Query: 269 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIG 298
+ W + PI +D G+ ++ G
Sbjct: 92 A--TEEYQRWVWIQGEPITNDAGETVRVAG 119
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 6e-05
Identities = 27/225 (12%), Positives = 64/225 (28%), Gaps = 23/225 (10%)
Query: 733 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYR 791
F + ++ ++ GG L++ TK+ + ++ +L +R
Sbjct: 130 DFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHR 186
Query: 792 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV--FMAEPMR 849
DL NVLL+ L G Q + + +
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNG--------------KSSTIPSCGLQVSIIDYTLSRLE 232
Query: 850 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 909
V + + ++ G G + + Y P+ + + K
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLK 292
Query: 910 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954
+ F + T + + R + ++ + + A ++
Sbjct: 293 QMTFKTKCNTPAMKQ--IKRKI-QEFHRTMLNFSSATDLLCQHSL 334
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} Length = 114 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 7e-05
Identities = 13/93 (13%), Positives = 27/93 (29%), Gaps = 17/93 (18%)
Query: 215 MYASAGFFKMTGYTSKEVVGRNCRFLQGAGTD----PEDVAKIRET----LQNGQSYCGR 266
+ S + + G +++G + PE + + L
Sbjct: 26 LAVSRRWREDYGLGDGDILGM---------SHYDIFPEIGEEWKSVHRRGLAGEVIRVEE 76
Query: 267 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGM 299
+ DG W + P + EG+V +
Sbjct: 77 DCFVRADGRTQWLRWEVRPWYEGEGRVGGVVIF 109
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} Length = 114 | Back alignment and structure |
|---|
Score = 39.1 bits (92), Expect = 9e-04
Identities = 12/88 (13%), Positives = 27/88 (30%), Gaps = 5/88 (5%)
Query: 498 IFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSG 557
+ S + E +ILG + + PE R + + + G
Sbjct: 26 LAVSRRWREDYGLGDGDILGMSHYDI-FPEIGEEWKSVHRRGLAGEVIRVEEDCFVRADG 84
Query: 558 KKFWNLFHLQPMRDQK----YFIGVQLD 581
+ W + ++P + + + D
Sbjct: 85 RTQWLRWEVRPWYEGEGRVGGVVIFTED 112
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} Length = 118 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 12/95 (12%), Positives = 21/95 (22%), Gaps = 12/95 (12%)
Query: 210 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ----NGQSYCG 265
I + F K N + +D + S
Sbjct: 24 GQATIRFRPPAFLKTLVSEHAGTTRLNTL----SMIHHDDRHMLSNAYSKLREAKHSLTL 79
Query: 266 --RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIG 298
R++ +G W + D+G G
Sbjct: 80 VYRIVT--PEGKLHWIEDHMRSSFSDDGLFSGIDG 112
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 12/86 (13%), Positives = 27/86 (31%), Gaps = 6/86 (6%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
I+ + G +VG+ + + + + + ++NG +
Sbjct: 41 ILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLEAGKSAVENGTA---TRSEDAVG 97
Query: 274 GTPFWNLLTIAPIKDDEGKVLKFIGM 299
G + N P+ D K F +
Sbjct: 98 GRHYHN--QYIPV-DSHRKSDTFQLV 120
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 998 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 4f3l_A | 361 | Mclock, circadian locomoter output cycles protein | 99.78 | |
| 4f3l_B | 387 | BMAL1B; BHLH, PAS, circadian rhythm proteins, tran | 99.77 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 99.75 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 99.74 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 99.73 | |
| 4hia_A | 176 | LOV protein; PAS, HTH, signaling protein; HET: FMN | 99.73 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 99.73 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 99.71 | |
| 3rty_A | 339 | Period circadian protein; PAS domain, signalling, | 99.7 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 99.69 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 99.68 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 99.68 | |
| 3mr0_A | 142 | Sensory box histidine kinase/response regulator; P | 99.67 | |
| 4hia_A | 176 | LOV protein; PAS, HTH, signaling protein; HET: FMN | 99.65 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 99.65 | |
| 1d06_A | 130 | Nitrogen fixation regulatory protein FIXL; oxygen | 99.65 | |
| 3f1p_B | 121 | ARYL hydrocarbon receptor nuclear translocator; PA | 99.65 | |
| 3f1p_B | 121 | ARYL hydrocarbon receptor nuclear translocator; PA | 99.65 | |
| 1d06_A | 130 | Nitrogen fixation regulatory protein FIXL; oxygen | 99.63 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 99.62 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 99.62 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 99.62 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 99.62 | |
| 2vv6_A | 119 | FIXL, sensor protein FIXL; signaling protein, tran | 99.61 | |
| 3f1p_A | 117 | Endothelial PAS domain-containing protein 1; PAS d | 99.61 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 99.6 | |
| 3f1p_A | 117 | Endothelial PAS domain-containing protein 1; PAS d | 99.6 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 99.6 | |
| 3nja_A | 125 | Probable ggdef family protein; structural genomics | 99.6 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 99.59 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 99.58 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 99.58 | |
| 2vv6_A | 119 | FIXL, sensor protein FIXL; signaling protein, tran | 99.58 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 99.57 | |
| 3k3c_A | 158 | Protein RV1364C/MT1410; sensor, PAS, signal transd | 99.57 | |
| 3mr0_A | 142 | Sensory box histidine kinase/response regulator; P | 99.57 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 99.57 | |
| 3mxq_A | 152 | Sensor protein; PSI2, MCSG, structural genomics, p | 99.56 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 99.56 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 99.55 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 99.54 | |
| 3kx0_X | 185 | Uncharacterized protein RV1364C/MT1410; PAS domain | 99.54 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 99.52 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 99.52 | |
| 3nja_A | 125 | Probable ggdef family protein; structural genomics | 99.51 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 99.5 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 99.5 | |
| 3h9w_A | 115 | Diguanylate cyclase with PAS/PAC sensor; alpha-bet | 99.49 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 99.49 | |
| 3eeh_A | 125 | Putative light and redox sensing histidine kinase; | 99.48 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 99.48 | |
| 2kdk_A | 121 | ARYL hydrocarbon receptor nuclear translocator-LI | 99.48 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 99.46 | |
| 3mfx_A | 129 | Sensory BOX/ggdef family protein; alpha-beta prote | 99.46 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 99.45 | |
| 4dj3_A | 317 | Period circadian protein homolog 3; PAS domain, ci | 99.45 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 99.45 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 99.44 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 99.44 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 99.44 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 99.44 | |
| 1v9y_A | 167 | Heme PAS sensor protein; signaling protein; HET: H | 99.43 | |
| 2kdk_A | 121 | ARYL hydrocarbon receptor nuclear translocator-LI | 99.43 | |
| 3k3c_A | 158 | Protein RV1364C/MT1410; sensor, PAS, signal transd | 99.43 | |
| 3h9w_A | 115 | Diguanylate cyclase with PAS/PAC sensor; alpha-bet | 99.41 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 99.41 | |
| 3gdi_A | 309 | Period circadian protein homolog 2; tandem PAS dom | 99.4 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 99.4 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 99.4 | |
| 3kx0_X | 185 | Uncharacterized protein RV1364C/MT1410; PAS domain | 99.39 | |
| 4dj2_A | 320 | Period circadian protein homolog 1; PAS domains, c | 99.38 | |
| 3mxq_A | 152 | Sensor protein; PSI2, MCSG, structural genomics, p | 99.37 | |
| 3mfx_A | 129 | Sensory BOX/ggdef family protein; alpha-beta prote | 99.36 | |
| 3vol_A | 233 | Aerotaxis transducer AER2; heme, oxygen sensor pro | 99.36 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 99.34 | |
| 1v9y_A | 167 | Heme PAS sensor protein; signaling protein; HET: H | 99.32 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 99.32 | |
| 3eeh_A | 125 | Putative light and redox sensing histidine kinase; | 99.32 | |
| 4eho_A | 635 | Bacteriophytochrome, PAS/PAC sensor; photoreceptor | 99.31 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 99.3 | |
| 4eho_A | 635 | Bacteriophytochrome, PAS/PAC sensor; photoreceptor | 99.28 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 99.27 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 4hi4_A | 121 | Aerotaxis transducer AER2; PAS domain, diatomic GA | 99.24 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 99.24 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 99.23 | |
| 2qkp_A | 151 | Uncharacterized protein; structural genomics, unkn | 99.22 | |
| 3fg8_A | 118 | Uncharacterized protein RHA05790; PAS domain, stru | 99.21 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 99.19 | |
| 1ll8_A | 114 | PAS kinase; PAS domain, ligand binding, ligand scr | 99.18 | |
| 4f3l_A | 361 | Mclock, circadian locomoter output cycles protein | 99.18 | |
| 3fg8_A | 118 | Uncharacterized protein RHA05790; PAS domain, stru | 99.17 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 99.16 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 99.16 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 99.1 | |
| 4f3l_B | 387 | BMAL1B; BHLH, PAS, circadian rhythm proteins, tran | 99.09 | |
| 1ll8_A | 114 | PAS kinase; PAS domain, ligand binding, ligand scr | 99.06 | |
| 4hi4_A | 121 | Aerotaxis transducer AER2; PAS domain, diatomic GA | 99.06 | |
| 3vol_A | 233 | Aerotaxis transducer AER2; heme, oxygen sensor pro | 99.05 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 3a0r_A | 349 | Sensor protein; four helix bundle, PAS fold, kinas | 99.0 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 2w0n_A | 118 | Sensor protein DCUS; signal transduction, two-comp | 98.97 | |
| 3a0r_A | 349 | Sensor protein; four helix bundle, PAS fold, kinas | 98.97 | |
| 3cax_A | 369 | Uncharacterized protein PF0695; structural genomic | 98.96 | |
| 2qkp_A | 151 | Uncharacterized protein; structural genomics, unkn | 98.94 | |
| 3a0s_A | 96 | Sensor protein; PAS-fold, kinase, phosphoprotein, | 98.91 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.89 | |
| 2ykf_A | 305 | Pdtas, probable sensor histidine kinase pdtas; tra | 98.37 | |
| 1nwz_A | 125 | PYP, photoactive yellow protein; PAS, LOV, GAF, do | 98.84 | |
| 1mzu_A | 129 | PPR; photoactive yellow protein, PAS, PYP, signali | 98.81 | |
| 1nwz_A | 125 | PYP, photoactive yellow protein; PAS, LOV, GAF, do | 98.81 | |
| 2jhe_A | 190 | Transcription regulator TYRR; aromatic hydrocarbon | 98.78 | |
| 1mzu_A | 129 | PPR; photoactive yellow protein, PAS, PYP, signali | 98.77 | |
| 2ykf_A | 305 | Pdtas, probable sensor histidine kinase pdtas; tra | 98.24 | |
| 2w0n_A | 118 | Sensor protein DCUS; signal transduction, two-comp | 98.75 | |
| 3rty_A | 339 | Period circadian protein; PAS domain, signalling, | 98.75 | |
| 3a0s_A | 96 | Sensor protein; PAS-fold, kinase, phosphoprotein, | 98.74 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.65 | |
| 3cax_A | 369 | Uncharacterized protein PF0695; structural genomic | 98.65 | |
| 4dj3_A | 317 | Period circadian protein homolog 3; PAS domain, ci | 98.57 | |
| 2jhe_A | 190 | Transcription regulator TYRR; aromatic hydrocarbon | 98.54 | |
| 3gdi_A | 309 | Period circadian protein homolog 2; tandem PAS dom | 98.53 | |
| 4dj2_A | 320 | Period circadian protein homolog 1; PAS domains, c | 98.48 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.46 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.45 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.3 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.06 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.98 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.92 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.89 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.62 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.47 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.33 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.16 | |
| 1oj5_A | 132 | Steroid receptor coactivator 1A; transcriptional c | 97.15 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.11 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.1 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.09 | |
| 1oj5_A | 132 | Steroid receptor coactivator 1A; transcriptional c | 97.08 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.97 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.9 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.89 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.85 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.83 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.82 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.44 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.9 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.11 | |
| 2ool_A | 337 | Sensor protein; bacteriophytochrome, photoconversi | 86.76 | |
| 2ool_A | 337 | Sensor protein; bacteriophytochrome, photoconversi | 84.31 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-58 Score=511.69 Aligned_cols=278 Identities=36% Similarity=0.646 Sum_probs=251.4
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++++.||+|+||+||+|+++.+|+.||+|++.+....+......+.+|+.+|++++|||||+++++|.+++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999999999999999999876555556678899999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
||||+||+|.+++.+. +.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+.....
T Consensus 111 mEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~- 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK- 187 (311)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT-
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC-
Confidence 9999999999999875 4599999999999999999999999999999999999999999999999999976431111
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
.....+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+....+
T Consensus 188 ------------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~ 243 (311)
T 4aw0_A 188 ------------------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF 243 (311)
T ss_dssp ------------------------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ------------------------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 11234678999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc--HHHHHcCCCccCCChhhhhcCCCCCC
Q 001902 904 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG--ANEIKKHPFFKGVNWALVRCMNPPEL 970 (998)
Q Consensus 904 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~--a~elL~Hp~f~~~~~~~~~~~~~~~~ 970 (998)
.+|....+.+|. .+|.++++||.+||.+||.+|||+.++ ...|++||||++++|..++...||.+
T Consensus 244 ~~i~~~~~~~p~--~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l 310 (311)
T 4aw0_A 244 AKIIKLEYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310 (311)
T ss_dssp HHHHHTCCCCCT--TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred HHHHcCCCCCCc--ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence 999999888775 478999999999999999999997653 45689999999999999998888865
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-56 Score=491.45 Aligned_cols=276 Identities=42% Similarity=0.753 Sum_probs=236.6
Q ss_pred cccCCcccccccCCCCceeEEEEEEc---cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
+..++|++++.||+|+||+||+|++. .+++.||+|++++...... ....+.+|+.+|++++|||||+++++|.+++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 44568999999999999999999984 4688999999987544322 2346778999999999999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
.+|||||||+||+|.+++.+. +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999999999875 459999999999999999999999999999999999999999999999999996432
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
.. .....+.+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+
T Consensus 178 ~~---------------------------~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 178 DH---------------------------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp ------------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CC---------------------------CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 11 112345789999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhhh--cCCCCC
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVR--CMNPPE 969 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~--~~~~~~ 969 (998)
..+.+..+.+..+.+|. .+|.++++||.+||+.||.+|||+. ..++++++||||++++|..+. .+.||.
T Consensus 231 ~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~ 302 (304)
T 3ubd_A 231 RKETMTMILKAKLGMPQ--FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPF 302 (304)
T ss_dssp HHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSS
T ss_pred HHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCc
Confidence 99999999998877765 4789999999999999999999964 357899999999999999883 445554
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-55 Score=493.55 Aligned_cols=260 Identities=25% Similarity=0.485 Sum_probs=229.3
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
+++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|++|+|||||+++++|.+++.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 5799999999999999999999999999999999987643 344567889999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
||||+||+|.+++..+....+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~---- 177 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS---- 177 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH----
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC----
Confidence 9999999999999877667789999999999999999999999999999999999999999999999999965320
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
........+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+....+
T Consensus 178 -----------------------~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 234 (350)
T 4b9d_A 178 -----------------------TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV 234 (350)
T ss_dssp -----------------------HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred -----------------------CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 001223568999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 904 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 904 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
.++..+..+ +....+|.++++||.+||+.||.+||| +.++|+||||+.
T Consensus 235 ~~i~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s----~~e~l~hp~~~~ 282 (350)
T 4b9d_A 235 LKIISGSFP-PVSLHYSYDLRSLVSQLFKRNPRDRPS----VNSILEKGFIAK 282 (350)
T ss_dssp HHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSHHHHT
T ss_pred HHHHcCCCC-CCCccCCHHHHHHHHHHccCChhHCcC----HHHHhcCHHhhc
Confidence 999988754 234467999999999999999999999 999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=486.22 Aligned_cols=256 Identities=29% Similarity=0.461 Sum_probs=228.8
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
..|+++++||+|+||.||+|.++.+|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999999765332 2345778999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
|||+||+|.+++.+. .+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 151 Ey~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~---- 223 (346)
T 4fih_A 151 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE---- 223 (346)
T ss_dssp CCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS----
T ss_pred eCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC----
Confidence 999999999999763 4999999999999999999999999999999999999999999999999999654311
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.....+.+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+....+.
T Consensus 224 -----------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~ 280 (346)
T 4fih_A 224 -----------------------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK 280 (346)
T ss_dssp -----------------------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred -----------------------CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence 112346789999999999999999999999999999999999999999999888888
Q ss_pred HHHhCCC-CCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 905 NILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 905 ~i~~~~~-~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.+..... .++....+|.++++||.+||..||.+||| +.++|+||||+..
T Consensus 281 ~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t----a~e~l~Hp~~~~~ 330 (346)
T 4fih_A 281 MIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT----AAELLKHPFLAKA 330 (346)
T ss_dssp HHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCC----HHHHTTCGGGGGC
T ss_pred HHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcC----HHHHhcCHhhcCC
Confidence 8876543 33444568999999999999999999999 9999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=470.37 Aligned_cols=260 Identities=32% Similarity=0.522 Sum_probs=217.3
Q ss_pred cccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 658 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
.|..+ ++|++++.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.+|++++|||||+++++|.+.
T Consensus 8 ~G~~i--g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 85 (275)
T 3hyh_A 8 DGAHI--GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK 85 (275)
T ss_dssp --------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCCEe--eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 34444 5899999999999999999999999999999999887666666677899999999999999999999999999
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
+.+||||||| +|+|.+++.++ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 86 ~~~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 86 DEIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp SEEEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred CEEEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeec
Confidence 9999999999 78999999875 45999999999999999999999999999999999999999999999999999653
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCC-CChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
... ....+.+||+.|||||++.+..| +.++|||||||++|+|++|++||.+
T Consensus 163 ~~~----------------------------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~ 214 (275)
T 3hyh_A 163 TDG----------------------------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214 (275)
T ss_dssp ----------------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCC----------------------------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence 211 12235689999999999998876 5799999999999999999999999
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
.+....+..+..+...+|. .+|.++++||.+||+.||.+||| +.++|+||||+.
T Consensus 215 ~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~s----~~eil~hpw~k~ 268 (275)
T 3hyh_A 215 ESIPVLFKNISNGVYTLPK--FLSPGAAGLIKRMLIVNPLNRIS----IHEIMQDDWFKV 268 (275)
T ss_dssp SSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHSCSSGGGSCC----HHHHHHCHHHHT
T ss_pred CCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccCChhHCcC----HHHHHcCccccc
Confidence 9988889999888877764 47899999999999999999999 999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=487.36 Aligned_cols=256 Identities=29% Similarity=0.461 Sum_probs=229.4
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
..|+++++||+|+||.||+|.++.+|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999999765332 2356788999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
|||+||+|.+++... .+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 228 Ey~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~---- 300 (423)
T 4fie_A 228 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE---- 300 (423)
T ss_dssp ECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS----
T ss_pred eCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC----
Confidence 999999999999763 4999999999999999999999999999999999999999999999999999654311
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.....+.+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+....+.
T Consensus 301 -----------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~ 357 (423)
T 4fie_A 301 -----------------------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK 357 (423)
T ss_dssp -----------------------CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred -----------------------CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence 112346789999999999999999999999999999999999999999999988888
Q ss_pred HHHhCCC-CCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 905 NILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 905 ~i~~~~~-~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.|..... .++....+|.++++||.+||..||.+||| +.+||+||||+..
T Consensus 358 ~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t----a~ell~Hp~~~~~ 407 (423)
T 4fie_A 358 MIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT----AAELLKHPFLAKA 407 (423)
T ss_dssp HHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCC----HHHHTTCGGGGGC
T ss_pred HHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcC----HHHHhcCHHhcCC
Confidence 8876543 34445678999999999999999999999 9999999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=459.93 Aligned_cols=255 Identities=23% Similarity=0.379 Sum_probs=216.6
Q ss_pred CCc-ccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee----CCe
Q 001902 665 QHF-RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----KTH 739 (998)
Q Consensus 665 ~~y-~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~----~~~ 739 (998)
++| ++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+|++++|||||+++++|.. .+.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 344 777889999999999999999999999999986543 44456788999999999999999999999865 457
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEec-CCcEEEEeccCccc
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQG-NGHVSLTDFDLSCL 816 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkP~NILi~~-~g~vkL~DFG~a~~ 816 (998)
+|||||||+||+|.+++.+. ..+++..++.|+.||+.||+|||++| ||||||||+|||++. +|.+||+|||+|+.
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 89999999999999999875 46999999999999999999999998 999999999999984 79999999999954
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.. .....+.+||+.|||||++.+ .|+.++|||||||++|+|+||++||.+
T Consensus 182 ~~-----------------------------~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 182 KR-----------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp CC-----------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC-----------------------------CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 21 012245689999999999875 599999999999999999999999987
Q ss_pred CChHHHH-HHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 897 KTRQKTF-ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 897 ~~~~~~~-~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
.+....+ ..+..+..+.......++++++||.+||..||.+||| +.++|+||||+.
T Consensus 232 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s----~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 232 CQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS----IKDLLNHAFFQE 288 (290)
T ss_dssp CSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGC-
T ss_pred CCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcC----HHHHhcCccccC
Confidence 6655444 4444443333333456789999999999999999999 999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=469.02 Aligned_cols=262 Identities=24% Similarity=0.348 Sum_probs=222.1
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.+.|++.++||+|+||.||+|+++.+|+.||||+++.... ..+|+.+|+.++|||||+++++|.+.+.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4678999999999999999999999999999999986532 23699999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC-cEEEEeccCccccCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g-~vkL~DFG~a~~~~~~~~ 822 (998)
||||+||+|.+++++. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.......
T Consensus 129 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp ECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999999999875 4599999999999999999999999999999999999999988 699999999976431110
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
.........++||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+....
T Consensus 207 ----------------------~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 264 (336)
T 4g3f_A 207 ----------------------GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL 264 (336)
T ss_dssp -----------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC
T ss_pred ----------------------ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence 0011123456899999999999999999999999999999999999999999888788
Q ss_pred HHHHHhCCCCCC-CCCCCcHHHHHHHHHccccCccCcCCChhcHHHH---------HcCCCccCC
Q 001902 903 FANILHKDLKFP-SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI---------KKHPFFKGV 957 (998)
Q Consensus 903 ~~~i~~~~~~~~-~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el---------L~Hp~f~~~ 957 (998)
+..+.....+++ ....++..+.+||.+||++||.+|||+.++++.+ |+|||++..
T Consensus 265 ~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 265 CLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 888888765443 2345789999999999999999999933332221 679998875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=492.95 Aligned_cols=283 Identities=32% Similarity=0.604 Sum_probs=240.3
Q ss_pred hccccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHH---HHHHHhCCCCCccceeE
Q 001902 656 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE---REILDMLDHPFVPALYA 732 (998)
Q Consensus 656 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E---~~il~~l~h~nIv~l~~ 732 (998)
.....++.+++|++++.||+|+||.||+|+++.+|+.||||++.+.............+| +.+++.++|||||++++
T Consensus 180 ~e~~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~ 259 (689)
T 3v5w_A 180 VELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 259 (689)
T ss_dssp HHTTCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred cccCCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEE
Confidence 334456778899999999999999999999999999999999987654433333444444 55666779999999999
Q ss_pred EEeeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEecc
Q 001902 733 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 812 (998)
Q Consensus 733 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG 812 (998)
+|.+.+.+|||||||+||+|.+++.+. +.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||
T Consensus 260 ~f~~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFG 337 (689)
T 3v5w_A 260 AFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337 (689)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccc
Confidence 999999999999999999999999875 459999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCC
Q 001902 813 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGY 891 (998)
Q Consensus 813 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~ 891 (998)
+|+.... ....+.+||+.|||||++.+ ..|+.++|||||||+||+|++|.
T Consensus 338 lA~~~~~-----------------------------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~ 388 (689)
T 3v5w_A 338 LACDFSK-----------------------------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388 (689)
T ss_dssp TCEECSS-----------------------------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred eeeecCC-----------------------------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9965431 11235689999999999964 67999999999999999999999
Q ss_pred CCCCCC---ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhhh--cC
Q 001902 892 TPFRGK---TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVR--CM 965 (998)
Q Consensus 892 ~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~--~~ 965 (998)
+||.+. +.......+....+.+|. .+|.++++||.+||+.||.+|++.. ..+.+|++||||++++|..+. .+
T Consensus 389 ~PF~~~~~~~~~~i~~~i~~~~~~~p~--~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~ 466 (689)
T 3v5w_A 389 SPFRQHKTKDKHEIDRMTLTMAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY 466 (689)
T ss_dssp CTTCGGGCCCHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCS
T ss_pred CCCCCCChHHHHHHHHhhcCCCCCCCc--cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCC
Confidence 999764 334556667777766664 4799999999999999999999853 468999999999999999884 45
Q ss_pred CCCCCC
Q 001902 966 NPPELD 971 (998)
Q Consensus 966 ~~~~~~ 971 (998)
.||..|
T Consensus 467 ~pP~~P 472 (689)
T 3v5w_A 467 PPPLIP 472 (689)
T ss_dssp CCSCCC
T ss_pred CcCccC
Confidence 566554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=463.56 Aligned_cols=266 Identities=24% Similarity=0.367 Sum_probs=224.3
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee------CC
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------KT 738 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~------~~ 738 (998)
++|++++.||+|+||+||+|.++.+|+.||||++++.. ........+.+|+.+|+.++|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 57999999999999999999999999999999997643 234456778899999999999999999998764 36
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
.+||||||| +|+|.+++.+. +.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 133 ~~~ivmE~~-~g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLM-ESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECC-SEEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEEeCC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 899999999 57899999764 569999999999999999999999999999999999999999999999999996543
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
.... .......+.+||+.|||||++.+. .++.++||||+||++|+|++|++||.+.
T Consensus 210 ~~~~-----------------------~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 210 TSPA-----------------------EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp -----------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred cCcc-----------------------ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 2111 011233567899999999999875 5689999999999999999999999999
Q ss_pred ChHHHHHHHHhCCCCCC--------------------C---------CCCCcHHHHHHHHHccccCccCcCCChhcHHHH
Q 001902 898 TRQKTFANILHKDLKFP--------------------S---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~~--------------------~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 948 (998)
+....+..|.......+ . ....|.++++||.+||..||.+||| +.++
T Consensus 267 ~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~ 342 (398)
T 4b99_A 267 NYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS----AAAA 342 (398)
T ss_dssp SHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC----HHHH
T ss_pred CHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC----HHHH
Confidence 99888888765321111 0 1235789999999999999999999 9999
Q ss_pred HcCCCccCCChhh
Q 001902 949 KKHPFFKGVNWAL 961 (998)
Q Consensus 949 L~Hp~f~~~~~~~ 961 (998)
|+||||+......
T Consensus 343 L~Hp~f~~~~~p~ 355 (398)
T 4b99_A 343 LRHPFLAKYHDPD 355 (398)
T ss_dssp TTSGGGTTTCCGG
T ss_pred hcCHhhCcCCCCc
Confidence 9999999865443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-51 Score=449.84 Aligned_cols=272 Identities=22% Similarity=0.356 Sum_probs=203.9
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC------
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT------ 738 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~------ 738 (998)
++|++++.||+|+||.||+|+++.+|+.||||+++... .....+.+.+|+.+|++++|||||+++++|...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 46999999999999999999999999999999997542 3445577889999999999999999999987544
Q ss_pred ------eEEEEEecCCCCchhHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEec
Q 001902 739 ------HVCLITDYCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 811 (998)
Q Consensus 739 ------~~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DF 811 (998)
++|||||||+||+|.+++..... ...+...++.|+.||+.||+|||++|||||||||+|||++.+|.+||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 47999999999999999986532 23456678999999999999999999999999999999999999999999
Q ss_pred cCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCC
Q 001902 812 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 891 (998)
Q Consensus 812 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~ 891 (998)
|+|+........... .............+||+.|||||++.+..|+.++|||||||++|+|++
T Consensus 163 Gla~~~~~~~~~~~~---------------~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~-- 225 (299)
T 4g31_A 163 GLVTAMDQDEEEQTV---------------LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-- 225 (299)
T ss_dssp CCC-----------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS--
T ss_pred ccceecCCCcccccc---------------ccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc--
Confidence 999765422111000 000011123346789999999999999999999999999999999996
Q ss_pred CCCCCCCh-HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhh
Q 001902 892 TPFRGKTR-QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWAL 961 (998)
Q Consensus 892 ~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 961 (998)
||.+... ...+..+.....+ +.....++.+.+||.+||+.||.+||| +.++|+||||++++|..
T Consensus 226 -Pf~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps----~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 226 -PFSTQMERVRTLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPE----AINIIENAVFEDLDFPG 290 (299)
T ss_dssp -CCSSHHHHHHHHHHHHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGCCC----
T ss_pred -CCCCccHHHHHHHHHhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcC----HHHHhcCHhhCCCCCCC
Confidence 7865332 2223333333221 111234567789999999999999999 99999999999998853
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=437.88 Aligned_cols=264 Identities=20% Similarity=0.270 Sum_probs=216.6
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
.+.+..++|++.++||+|+||+||+|.+. ..+|||+++... ......+.+.+|+.+|++++|||||++++++.. +
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 45678889999999999999999999863 359999987542 345567889999999999999999999998754 5
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
.+|||||||+||+|.+++.... ..+++..+..|+.||+.||+|||+++||||||||+|||++.++.+||+|||+|+...
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred eEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 6899999999999999997653 459999999999999999999999999999999999999999999999999996543
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC---CCCCChhHHHHHHHHHHHHHcCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
... ........+||+.|||||++.+ ..|+.++|||||||+||||+||+.||.
T Consensus 184 ~~~-------------------------~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~ 238 (307)
T 3omv_A 184 RWS-------------------------GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS 238 (307)
T ss_dssp -----------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCC-------------------------cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC
Confidence 110 0112345689999999999964 358899999999999999999999999
Q ss_pred CCChHHHHHHHHhCCCCCCC----CCCCcHHHHHHHHHccccCccCcCCChhcHH--HHHcCCC
Q 001902 896 GKTRQKTFANILHKDLKFPS----STPTSLHAKQLMYRLLHRDPKSRLGSHEGAN--EIKKHPF 953 (998)
Q Consensus 896 ~~~~~~~~~~i~~~~~~~~~----~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~--elL~Hp~ 953 (998)
+.+....+..++......|. ...++..+.+|+.+||+.||.+|||+.+++. ++|+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 239 HINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred CCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 88777666666655443332 2457889999999999999999999766554 3467775
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=446.52 Aligned_cols=281 Identities=26% Similarity=0.367 Sum_probs=211.7
Q ss_pred cCCcccccccCCCCceeEEEEEEc---cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCe
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 739 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 739 (998)
.+.|++++.||+|+||+||+|.++ .+++.||+|.+.+.. ...++.+|+.+|+.+ +||||++++++|.+.++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 368999999999999999999985 468899999886542 235678899999998 69999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC-CcEEEEeccCccccC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLTS 818 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~-g~vkL~DFG~a~~~~ 818 (998)
+|||||||+|++|.+++. .+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...
T Consensus 95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 999999999999999984 38999999999999999999999999999999999999977 899999999997654
Q ss_pred CCCCCCCCcchhhhhc-ccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRR-HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
................ ....................+||+.|||||++.+. .|+.++||||+||++|+|++|+.||.+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 2221100000000000 00000000001112234567899999999999876 588999999999999999999999965
Q ss_pred C-ChHHHHHHHHhC--------------------------------------C--------------CCCCCCCCCcHHH
Q 001902 897 K-TRQKTFANILHK--------------------------------------D--------------LKFPSSTPTSLHA 923 (998)
Q Consensus 897 ~-~~~~~~~~i~~~--------------------------------------~--------------~~~~~~~~~s~~l 923 (998)
. +....+..|..- . ...+.....|.++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 4 444444443220 0 0111234578899
Q ss_pred HHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 924 KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 924 ~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
++||.+||..||.+||| ++|+|+||||+++.
T Consensus 330 ~DLl~~lL~~dP~~R~t----a~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRIT----AEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHHTCSCTTTSCC----HHHHHTSGGGTTC-
T ss_pred HHHHHHHCcCChhHCcC----HHHHhcCcccCCCC
Confidence 99999999999999999 99999999999863
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=435.75 Aligned_cols=260 Identities=22% Similarity=0.349 Sum_probs=220.3
Q ss_pred ccccCCcccccccCCCCceeEEEEEEc-----cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 735 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 735 (998)
.|..++|.+.+.||+|+||.||+|.+. .++..||||+++.. .....+.+.+|+.+|++++|||||++++++.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 466678999999999999999999874 35889999999753 3455678999999999999999999999999
Q ss_pred eCCeEEEEEecCCCCchhHHHhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQ-----------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 804 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~-----------~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g 804 (998)
+.+.+|||||||++|+|.+++... ....+++..+..|+.||+.||.|||+++||||||||+|||++.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999763 234699999999999999999999999999999999999999999
Q ss_pred cEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHH
Q 001902 805 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 884 (998)
Q Consensus 805 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il 884 (998)
.+||+|||+|+...... .........||+.|||||++.+..|+.++|||||||++
T Consensus 166 ~~Ki~DFGla~~~~~~~-------------------------~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl 220 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 220 (299)
T ss_dssp CEEECCCSCHHHHTGGG-------------------------CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cEEECCcccceecCCCC-------------------------ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHH
Confidence 99999999996532110 01122345799999999999999999999999999999
Q ss_pred HHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 885 YEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 885 ~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
|||+| |+.||.+.+..+.+..+..+... +....++.++.+|+.+||+.||++||| +.+| |+|++
T Consensus 221 ~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs----~~~i--~~~L~ 285 (299)
T 4asz_A 221 WEIFTYGKQPWYQLSNNEVIECITQGRVL-QRPRTCPQEVYELMLGCWQREPHMRKN----IKGI--HTLLQ 285 (299)
T ss_dssp HHHHTTTCCTTTTSCHHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHH--HHHHH
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHcCCCC-CCCccchHHHHHHHHHHcCCChhHCcC----HHHH--HHHHH
Confidence 99998 99999999998888888876532 233457899999999999999999999 6666 34544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=436.25 Aligned_cols=257 Identities=20% Similarity=0.300 Sum_probs=214.2
Q ss_pred ccccCCcccccccCCCCceeEEEEEEc-----cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 735 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 735 (998)
.+...+|.+.++||+|+||.||+|.+. .+++.||||+++.. .....+.+.+|+.+|++++|||||++++++.
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 455678999999999999999999874 36889999999753 4455678999999999999999999999999
Q ss_pred eCCeEEEEEecCCCCchhHHHhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQP-------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 802 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~~-------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~ 802 (998)
+.+.+|||||||++|+|.+++.... ...+++..+..|+.||+.||.|||+++||||||||+|||++.
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 9999999999999999999997642 245999999999999999999999999999999999999999
Q ss_pred CCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHH
Q 001902 803 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 882 (998)
Q Consensus 803 ~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~ 882 (998)
++.+||+|||+|+...... ........+||+.|||||++.+..|+.++|||||||
T Consensus 194 ~~~~Ki~DFGla~~~~~~~-------------------------~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gv 248 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTD-------------------------YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGV 248 (329)
T ss_dssp TTEEEECCCC-----------------------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHH
T ss_pred CCcEEEcccccceeccCCC-------------------------cceecCcccccccccChhhhcCCCCCccccccchHH
Confidence 9999999999996542111 011223467999999999999999999999999999
Q ss_pred HHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 883 LLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 883 il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
+||||+| |+.||.+.+..+.+..+..+. ..+....++.++.+|+.+||+.||++||| +.+|++
T Consensus 249 vl~Ellt~G~~Pf~~~~~~~~~~~i~~g~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs----~~ei~~ 312 (329)
T 4aoj_A 249 VLWEIFTYGKQPWYQLSNTEAIDCITQGR-ELERPRACPPEVYAIMRGCWQREPQQRHS----IKDVHA 312 (329)
T ss_dssp HHHHHHTTSCCTTCSSCHHHHHHHHHHTC-CCCCCTTCCHHHHHHHHHHCCSSTTTSCC----HHHHHH
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCcccccHHHHHHHHHHcCcChhHCcC----HHHHHH
Confidence 9999998 999999999888888887753 22333457899999999999999999999 555554
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=470.31 Aligned_cols=262 Identities=28% Similarity=0.466 Sum_probs=234.8
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
+++|++++.||+|+||.||+|.++.+|+.||+|++... .......+.+|+.+|+.++|||||+++++|.+.+.+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999764 234456788999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC--CcEEEEeccCccccCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN--GHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~--g~vkL~DFG~a~~~~~~~ 821 (998)
||||+||+|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+.+...
T Consensus 233 ~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 233 YEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp EECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred EeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999999999999654 3459999999999999999999999999999999999999854 89999999999664311
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
......+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..+
T Consensus 311 ---------------------------~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~ 363 (573)
T 3uto_A 311 ---------------------------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 363 (573)
T ss_dssp ---------------------------SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred ---------------------------CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 12234689999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCC--CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhh
Q 001902 902 TFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWAL 961 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 961 (998)
.+..|......++.. ..+|.++++||.+||+.||.+||| +.++|+||||+...|..
T Consensus 364 ~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t----~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 364 TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT----IHQALEHPWLTPGNAPG 421 (573)
T ss_dssp HHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCC----HHHHHHSTTTSCCCCTT
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC----HHHHhcCcCcCCCCCCC
Confidence 999999887665543 567999999999999999999999 99999999999987754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=431.44 Aligned_cols=259 Identities=21% Similarity=0.317 Sum_probs=218.3
Q ss_pred ccccCCcccccccCCCCceeEEEEEEc-----cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 735 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 735 (998)
.+...+++++++||+|+||.||+|... .+++.||||+++... .....+.+.+|+.++++++|||||++++++.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 455678899999999999999999863 467899999997542 3344578899999999999999999999999
Q ss_pred eCCeEEEEEecCCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ 801 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~ 801 (998)
..+.+|||||||++|+|.++|.... ...+++..+..|+.||+.||.|||+++||||||||+|||++
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 9999999999999999999996532 23589999999999999999999999999999999999999
Q ss_pred cCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHH
Q 001902 802 GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 881 (998)
Q Consensus 802 ~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG 881 (998)
.++.+||+|||+|+...... ........+||+.|||||++.+..|+.++||||||
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~-------------------------~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfG 234 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAAD-------------------------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYG 234 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGG-------------------------CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred CCCCEEECCcccceeccCCC-------------------------ceeEecccccCCcccCHHHHhCCCCCccchhhhHH
Confidence 99999999999996543111 11123456799999999999999999999999999
Q ss_pred HHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 882 ILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 882 ~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
|+||||+| |..||.+.+..+.+..+..+.. .+....++.++.+|+.+||+.||.+|||+.+++..
T Consensus 235 vvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~-~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 235 VVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV-LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHTTTCCTTTTCCHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999998 9999999998888887776543 33445678999999999999999999995554433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=434.71 Aligned_cols=282 Identities=37% Similarity=0.741 Sum_probs=241.1
Q ss_pred cccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEee
Q 001902 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT 736 (998)
Q Consensus 658 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 736 (998)
+...+..++|++++.||+|+||.||+|+++.+|+.||+|++++...........+..|..++..+ +||||+++++++..
T Consensus 16 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~ 95 (353)
T 3txo_A 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT 95 (353)
T ss_dssp -------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CcCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe
Confidence 34456778999999999999999999999999999999999876554555667788999999998 79999999999999
Q ss_pred CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
.+.+|+|||||+|++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999999999775 4599999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.... .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+
T Consensus 174 ~~~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 226 (353)
T 3txo_A 174 GICN---------------------------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226 (353)
T ss_dssp SCC------------------------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccC---------------------------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC
Confidence 2110 1123456899999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh--hcHHHHHcCCCccCCChhhh--hcCCCCCC
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH--EGANEIKKHPFFKGVNWALV--RCMNPPEL 970 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~--~~a~elL~Hp~f~~~~~~~~--~~~~~~~~ 970 (998)
.+....+..+......+|.. .+..+.+||.+||+.||.+||++. ..+.++++||||++++|..+ +.+.||..
T Consensus 227 ~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~ 302 (353)
T 3txo_A 227 ENEDDLFEAILNDEVVYPTW--LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFR 302 (353)
T ss_dssp SSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred CCHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCcc
Confidence 99999999999988877754 688999999999999999999952 33489999999999999987 44555554
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=428.01 Aligned_cols=279 Identities=40% Similarity=0.764 Sum_probs=244.3
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+..++|++++.||+|+||.||+|.+..+|+.||+|++++...........+.+|+.+++.++||||+++++++...+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 34678999999999999999999999999999999998765444455677889999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+||||++|++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 82 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 158 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 999999999999999764 45999999999999999999999999999999999999999999999999998542110
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 159 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 212 (337)
T 1o6l_A 159 --------------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212 (337)
T ss_dssp --------------------------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred --------------------------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH
Confidence 112345689999999999999999999999999999999999999999999888
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhh--hcCCCCCCC
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV--RCMNPPELD 971 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~--~~~~~~~~~ 971 (998)
.+..+......+|. .++.++.+||.+||..||.+||+.. ..+.++++||||++++|..+ ..+.||..+
T Consensus 213 ~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p 283 (337)
T 1o6l_A 213 LFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP 283 (337)
T ss_dssp HHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCC
Confidence 88888888777664 4689999999999999999999321 12999999999999999877 445566554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=432.50 Aligned_cols=261 Identities=24% Similarity=0.360 Sum_probs=218.4
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccC-----CeEEEEEEeecccccChhHHHHHHHHHHHHHhCCC-CCccceeEE
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH-PFVPALYAS 733 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~l~~~ 733 (998)
+++..++|++.+.||+|+||.||+|.+..+ ++.||+|.+.... .......+.+|+.+|.+++| ||||+++++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 456678999999999999999999998654 4689999997643 33456778999999999965 899999999
Q ss_pred Eee-CCeEEEEEecCCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 001902 734 FQT-KTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 798 (998)
Q Consensus 734 ~~~-~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NI 798 (998)
|.. ++.+|||||||++|+|.++|+... ...+++..+..++.||+.||.|||+++||||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 865 467899999999999999997532 23589999999999999999999999999999999999
Q ss_pred EEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHH
Q 001902 799 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 878 (998)
Q Consensus 799 Li~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIw 878 (998)
|++.++.+||+|||+|+....... .......+||+.|||||++.+..|+.++|||
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~-------------------------~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVw 271 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPD-------------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVW 271 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT-------------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred eeCCCCCEEECcchhhhhcccCCC-------------------------ceeeccccccccccCHHHHhcCCCCCcccEe
Confidence 999999999999999965431111 1123456799999999999999999999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 879 ALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 879 SlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
||||+||||+| |..||.+.+....+..++......+....++.++.+||.+||+.||.+||| +.+|++|
T Consensus 272 S~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt----~~eil~~ 341 (353)
T 4ase_A 272 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 341 (353)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred ehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcC----HHHHHHH
Confidence 99999999998 999999877655555555444444444567899999999999999999999 7777766
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=421.35 Aligned_cols=275 Identities=41% Similarity=0.796 Sum_probs=242.8
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+..++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 34578999999999999999999999999999999998764444445677888999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred EEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 999999999999999875 4599999999999999999999999999999999999999999999999999854320
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 159 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 210 (318)
T 1fot_A 159 ----------------------------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210 (318)
T ss_dssp ----------------------------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ----------------------------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 1234579999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh-cHHHHHcCCCccCCChhhhh--cCCCCCC
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVR--CMNPPEL 970 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~--~~~~~~~ 970 (998)
.+..+......+|. ..+.++.+||.+||..||.+||+..+ .++++++||||++++|..+. .+.||..
T Consensus 211 ~~~~i~~~~~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~ 280 (318)
T 1fot_A 211 TYEKILNAELRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYE 280 (318)
T ss_dssp HHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCC
T ss_pred HHHHHHhCCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCC
Confidence 99999988777664 46889999999999999999994332 39999999999999998873 3444443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=431.92 Aligned_cols=280 Identities=38% Similarity=0.691 Sum_probs=238.1
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHH-HHhCCCCCccceeEEEeeCCe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-LDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~i-l~~l~h~nIv~l~~~~~~~~~ 739 (998)
.+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+..|..+ ++.++||||+++++++...+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 4556799999999999999999999999999999999988766555556667777776 567899999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|+||||++|++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999999999874 4589999999999999999999999999999999999999999999999999854211
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 192 ~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 244 (373)
T 2r5t_A 192 H---------------------------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 244 (373)
T ss_dssp C---------------------------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH
T ss_pred C---------------------------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH
Confidence 0 1123456899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhh--hcCCCCCCC
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV--RCMNPPELD 971 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~--~~~~~~~~~ 971 (998)
...+..+......++. .++..+.+||.+||+.||.+||++.+.+.++++||||++++|..+ +.+.||..+
T Consensus 245 ~~~~~~i~~~~~~~~~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p 316 (373)
T 2r5t_A 245 AEMYDNILNKPLQLKP--NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNP 316 (373)
T ss_dssp HHHHHHHHHSCCCCCS--SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHHHHHhcccCCCC--CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCC
Confidence 9999999988776654 478899999999999999999998888899999999999999988 445565543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=431.31 Aligned_cols=280 Identities=38% Similarity=0.739 Sum_probs=239.4
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 739 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 739 (998)
.+..++|++++.||+|+||.||+|+++.+++.||+|++++...........+..|..++.++ +||||++++++|...+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45677999999999999999999999999999999999987665555666788899999887 89999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|+|||||+||+|..++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999999875 4599999999999999999999999999999999999999999999999999854210
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC--
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK-- 897 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~-- 897 (998)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 206 ---------------------------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~ 258 (396)
T 4dc2_A 206 ---------------------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258 (396)
T ss_dssp ---------------------------TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC
T ss_pred ---------------------------CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 111234568999999999999999999999999999999999999999642
Q ss_pred -------ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh--hcHHHHHcCCCccCCChhhhh--cCC
Q 001902 898 -------TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH--EGANEIKKHPFFKGVNWALVR--CMN 966 (998)
Q Consensus 898 -------~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~--~~a~elL~Hp~f~~~~~~~~~--~~~ 966 (998)
........+....+.+|.. ++.++.+||.+||+.||.+||++. ..+.++++||||++++|..+. .+.
T Consensus 259 ~~~~~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~ 336 (396)
T 4dc2_A 259 SDNPDQNTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVV 336 (396)
T ss_dssp ------CCHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSC
T ss_pred ccccchhhHHHHHHHHhccccCCCCc--CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCC
Confidence 2334566777777776654 789999999999999999999964 347899999999999999884 445
Q ss_pred CCCCC
Q 001902 967 PPELD 971 (998)
Q Consensus 967 ~~~~~ 971 (998)
||..+
T Consensus 337 pp~~p 341 (396)
T 4dc2_A 337 PPFKP 341 (396)
T ss_dssp CSCCC
T ss_pred CCCcC
Confidence 66553
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=419.92 Aligned_cols=279 Identities=38% Similarity=0.734 Sum_probs=241.5
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 739 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 739 (998)
.+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+..|+.++.++ +||||+++++++...+.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 45567999999999999999999999999999999999987666667778888999999988 89999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|+||||++|++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999999999764 4599999999999999999999999999999999999999999999999999854210
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCC---
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG--- 896 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~--- 896 (998)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 163 ~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 215 (345)
T 3a8x_A 163 P---------------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 215 (345)
T ss_dssp T---------------------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC
T ss_pred C---------------------------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccc
Confidence 0 1123456899999999999999999999999999999999999999975
Q ss_pred ------CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh--hcHHHHHcCCCccCCChhhhh--cCC
Q 001902 897 ------KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH--EGANEIKKHPFFKGVNWALVR--CMN 966 (998)
Q Consensus 897 ------~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~--~~a~elL~Hp~f~~~~~~~~~--~~~ 966 (998)
......+..+......+|. ..+..+.+||.+||..||.+||++. ..+.++++||||++++|..+. .+.
T Consensus 216 ~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~ 293 (345)
T 3a8x_A 216 SDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVV 293 (345)
T ss_dssp -------CHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred ccccccccHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCC
Confidence 2334556667777666664 4788999999999999999999963 346899999999999998873 445
Q ss_pred CCCC
Q 001902 967 PPEL 970 (998)
Q Consensus 967 ~~~~ 970 (998)
||..
T Consensus 294 ~p~~ 297 (345)
T 3a8x_A 294 PPFK 297 (345)
T ss_dssp CSCC
T ss_pred CCcC
Confidence 5543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=436.32 Aligned_cols=278 Identities=35% Similarity=0.635 Sum_probs=242.2
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+..++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||++++++|.+.+.+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 35567999999999999999999999999999999999864333333344577899999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|||||||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 145 ~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 9999999999999999763 4899999999999999999999999999999999999999999999999999654311
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC----CCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
. .......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+
T Consensus 222 ~--------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 275 (410)
T 3v8s_A 222 G--------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275 (410)
T ss_dssp S--------------------------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred C--------------------------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC
Confidence 0 11234568999999999998765 78899999999999999999999999
Q ss_pred CChHHHHHHHHhC--CCCCCCCCCCcHHHHHHHHHccccCccC--cCCChhcHHHHHcCCCccCCChhhh--hcCCCCCC
Q 001902 897 KTRQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKS--RLGSHEGANEIKKHPFFKGVNWALV--RCMNPPEL 970 (998)
Q Consensus 897 ~~~~~~~~~i~~~--~~~~~~~~~~s~~l~~Ll~~~L~~dP~~--Rpt~~~~a~elL~Hp~f~~~~~~~~--~~~~~~~~ 970 (998)
.+....+..+... .+.+|....++.++++||.+||+.+|.+ |++ +.+|++||||++++|..+ +.+.||..
T Consensus 276 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~----~~ei~~Hp~f~~~~w~~~~~~~~~~p~~ 351 (410)
T 3v8s_A 276 DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNG----VEEIKRHLFFKNDQWAWETLRDTVAPVV 351 (410)
T ss_dssp SSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSC----HHHHHTSGGGCCSSCCSTTGGGSCCSCC
T ss_pred CChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCC----HHHHhcCccccCCCHHHHhhcccCCCCC
Confidence 9999999888864 3567776778999999999999988888 999 999999999999988644 67777766
Q ss_pred C
Q 001902 971 D 971 (998)
Q Consensus 971 ~ 971 (998)
+
T Consensus 352 p 352 (410)
T 3v8s_A 352 P 352 (410)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=425.21 Aligned_cols=280 Identities=35% Similarity=0.682 Sum_probs=245.2
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 739 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 739 (998)
.+..++|++++.||+|+||.||+|.+..+|+.||+|++++...........+..|..++..+ +||||+++++++...+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 45678999999999999999999999999999999999876544445567788899999988 89999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999999864 3599999999999999999999999999999999999999999999999999854210
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 174 ~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 226 (353)
T 2i0e_A 174 D---------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226 (353)
T ss_dssp T---------------------------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred C---------------------------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH
Confidence 0 1123456899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhh--hcCCCCCCC
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV--RCMNPPELD 971 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~--~~~~~~~~~ 971 (998)
...+..+....+.+|. ..+.++.+||.+||..||.+||++. ..+.++++||||++++|..+ +.+.||..+
T Consensus 227 ~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p 299 (353)
T 2i0e_A 227 DELFQSIMEHNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKP 299 (353)
T ss_dssp HHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCC
Confidence 9999999998877765 4789999999999999999999753 35899999999999999988 455566553
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=423.04 Aligned_cols=275 Identities=38% Similarity=0.696 Sum_probs=245.1
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
...++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 45679999999999999999999999999999999998765444455677889999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+||||++|++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-- 193 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC--
Confidence 999999999999999875 3599999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 194 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 245 (350)
T 1rdq_E 194 ----------------------------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245 (350)
T ss_dssp ----------------------------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ----------------------------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH
Confidence 1234579999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhh--hcCCCCCC
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV--RCMNPPEL 970 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~--~~~~~~~~ 970 (998)
.+..+..+...+|. .++..+.+||.+||+.||.+||+.. +.+.+|++||||++++|..+ +.+.||..
T Consensus 246 ~~~~i~~~~~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~ 315 (350)
T 1rdq_E 246 IYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFI 315 (350)
T ss_dssp HHHHHHHCCCCCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred HHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCC
Confidence 99999988777664 4689999999999999999999843 45899999999999999877 45555554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=424.32 Aligned_cols=275 Identities=36% Similarity=0.742 Sum_probs=238.9
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 739 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 739 (998)
.+..++|++++.||+|+||.||+|.++.+|+.||+|++++...........+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 35678999999999999999999999999999999999876443344556778899999877 99999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999999864 4599999999999999999999999999999999999999999999999999854210
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 171 ~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (345)
T 1xjd_A 171 G---------------------------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223 (345)
T ss_dssp T---------------------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred C---------------------------CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH
Confidence 0 0123456899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHH-HHHcCCCccCCChhhhh--cCCCCCC
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN-EIKKHPFFKGVNWALVR--CMNPPEL 970 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~-elL~Hp~f~~~~~~~~~--~~~~~~~ 970 (998)
...+..+......+|. ..+.++.+||.+||..||.+||+ +. ++++||||++++|..+. .+.||..
T Consensus 224 ~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dp~~R~~----~~~~i~~hp~f~~~~w~~l~~~~~~~p~~ 291 (345)
T 1xjd_A 224 EELFHSIRMDNPFYPR--WLEKEAKDLLVKLFVREPEKRLG----VRGDIRQHPLFREINWEELERKEIDPPFR 291 (345)
T ss_dssp HHHHHHHHHCCCCCCT--TSCHHHHHHHHHHSCSSGGGSBT----TBSCGGGSGGGTTCCHHHHHTTCSCC---
T ss_pred HHHHHHHHhCCCCCCc--ccCHHHHHHHHHHhcCCHhHcCC----ChHHHHcCccccCCCHHHHhhCCCCCCcC
Confidence 9999999888776664 36889999999999999999999 55 89999999999999884 4455544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=437.15 Aligned_cols=281 Identities=35% Similarity=0.634 Sum_probs=243.5
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+..++|++++.||+|+||.||+|.++.+++.||+|++.+...........+..|+.++..++||||++++++|.+.+.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 45568999999999999999999999999999999999864333333344578899999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|||||||+||+|.+++.+. ...+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 9999999999999999764 245999999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc-----CCCCCChhHHHHHHHHHHHHHcCCCCCC
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
. .......+||+.|+|||++. ...++.++|||||||++|+|++|++||.
T Consensus 229 ~--------------------------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~ 282 (437)
T 4aw2_A 229 G--------------------------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282 (437)
T ss_dssp S--------------------------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred C--------------------------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC
Confidence 1 11223468999999999997 5678999999999999999999999999
Q ss_pred CCChHHHHHHHHhC--CCCCCCC-CCCcHHHHHHHHHccccCccC--cCCChhcHHHHHcCCCccCCChhhhhcCCCCCC
Q 001902 896 GKTRQKTFANILHK--DLKFPSS-TPTSLHAKQLMYRLLHRDPKS--RLGSHEGANEIKKHPFFKGVNWALVRCMNPPEL 970 (998)
Q Consensus 896 ~~~~~~~~~~i~~~--~~~~~~~-~~~s~~l~~Ll~~~L~~dP~~--Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~ 970 (998)
+.+..+.+..++.. .+.+|.. ..++.++++||.+||+.+|.+ |++ +.++++||||++++|..++...||..
T Consensus 283 ~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~----~~eil~Hpff~~i~w~~l~~~~~p~~ 358 (437)
T 4aw2_A 283 AESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNG----IEDFKKHPFFSGIDWDNIRNCEAPYI 358 (437)
T ss_dssp CSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTT----THHHHTSGGGTTCCTTTGGGSCCSCC
T ss_pred CCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCC----HHHHhCCCccCCCCHHHHhhCCCCCC
Confidence 99998888888753 3455544 457999999999999998888 888 99999999999999999998888876
Q ss_pred CC
Q 001902 971 DA 972 (998)
Q Consensus 971 ~~ 972 (998)
+.
T Consensus 359 P~ 360 (437)
T 4aw2_A 359 PE 360 (437)
T ss_dssp CC
T ss_pred Cc
Confidence 43
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=432.26 Aligned_cols=282 Identities=35% Similarity=0.635 Sum_probs=240.8
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+..++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+..|+.++..++||||++++++|.+.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 45568999999999999999999999999999999999865443444445678899999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|||||||+||+|.+++.+.. ..+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+++.....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 99999999999999997642 35999999999999999999999999999999999999999999999999998654311
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc-------CCCCCChhHHHHHHHHHHHHHcCCCC
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-------GAGHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~~~~sDIwSlG~il~eLltG~~P 893 (998)
. .......+||+.|+|||++. ...++.++|||||||++|+|++|+.|
T Consensus 216 ~--------------------------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P 269 (412)
T 2vd5_A 216 G--------------------------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269 (412)
T ss_dssp S--------------------------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred C--------------------------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCC
Confidence 0 01123468999999999997 45689999999999999999999999
Q ss_pred CCCCChHHHHHHHHhC--CCCCCC-CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhcCCCCCC
Q 001902 894 FRGKTRQKTFANILHK--DLKFPS-STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPEL 970 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~--~~~~~~-~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~ 970 (998)
|.+.+....+..+... ...+|. ...++.++++||.+||+ +|.+|++ +..++++++||||++++|..++...||..
T Consensus 270 f~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlg-r~~~~ei~~Hpff~~i~w~~l~~~~~p~~ 347 (412)
T 2vd5_A 270 FYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLG-RGGAGDFRTHPFFFGLDWDGLRDSVPPFT 347 (412)
T ss_dssp TCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTT-TTTHHHHHTSGGGTTCCSTTSTTSCCSCC
T ss_pred CCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCC-CCCHHHHhcCCCcCCCCHHHHhhcCCCCC
Confidence 9999998888888753 234443 24578999999999999 9999963 12399999999999999999988777766
Q ss_pred C
Q 001902 971 D 971 (998)
Q Consensus 971 ~ 971 (998)
+
T Consensus 348 p 348 (412)
T 2vd5_A 348 P 348 (412)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=419.27 Aligned_cols=281 Identities=32% Similarity=0.653 Sum_probs=240.5
Q ss_pred hccccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe
Q 001902 656 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 735 (998)
Q Consensus 656 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 735 (998)
+..+..+..++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||++++++|.
T Consensus 6 ~~~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 6 FDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp --CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cCCCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 34456778899999999999999999999999999999999998765545556678889999999999999999999999
Q ss_pred eCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
+.+.+|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA 163 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceee
Confidence 999999999999999999999874 459999999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC---CCCCChhHHHHHHHHHHHHHcCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYT 892 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDIwSlG~il~eLltG~~ 892 (998)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 164 ~~~~~----------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~ 215 (384)
T 4fr4_A 164 MLPRE----------------------------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215 (384)
T ss_dssp ECCTT----------------------------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred eccCC----------------------------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCC
Confidence 53211 12245679999999999964 458899999999999999999999
Q ss_pred CCCCC---ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhh--hcCCC
Q 001902 893 PFRGK---TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV--RCMNP 967 (998)
Q Consensus 893 Pf~~~---~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~--~~~~~ 967 (998)
||... .....+..+......+|. .++..+.+||.+||..||.+||+. +.++++||||++++|..+ ..+.|
T Consensus 216 Pf~~~~~~~~~~~~~~~~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~s~---~~~l~~hp~f~~~~w~~~~~~~~~p 290 (384)
T 4fr4_A 216 PYHIRSSTSSKEIVHTFETTVVTYPS--AWSQEMVSLLKKLLEPNPDQRFSQ---LSDVQNFPYMNDINWDAVFQKRLIP 290 (384)
T ss_dssp SSCCCTTSCHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHSCSSGGGSCCS---HHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred CCCCCCCccHHHHHHHHhhcccCCCC--cCCHHHHHHHHHHhcCCHhHhccc---HHHHHcChhhhcCCHHHHHhCCCCC
Confidence 99753 334555556666555554 468899999999999999999983 789999999999999877 44555
Q ss_pred CCCC
Q 001902 968 PELD 971 (998)
Q Consensus 968 ~~~~ 971 (998)
|..+
T Consensus 291 ~~~p 294 (384)
T 4fr4_A 291 GFIP 294 (384)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 5554
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=409.18 Aligned_cols=262 Identities=29% Similarity=0.501 Sum_probs=233.7
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
+...++|++++.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 4456799999999999999999999999999999999986533 445567788999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 9999999999999999765 45999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCC-ChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT-SAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.
T Consensus 168 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 219 (328)
T 3fe3_A 168 ----------------------------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219 (328)
T ss_dssp ----------------------------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ----------------------------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH
Confidence 112345799999999999988775 799999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
......+..+....|. ..+.++.+||.+||..||.+||| +.++++||||+....
T Consensus 220 ~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~t----~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 220 KELRERVLRGKYRIPF--YMSTDCENLLKRFLVLNPIKRGT----LEQIMKDRWINAGHE 273 (328)
T ss_dssp HHHHHHHHHCCCCCCT--TSCHHHHHHHHHHCCSSTTTSCC----HHHHTTCTTTTTTCT
T ss_pred HHHHHHHHhCCCCCCC--CCCHHHHHHHHHHCCCChhHCcC----HHHHhcCHhhcCCCc
Confidence 9999999888776664 36889999999999999999999 999999999997543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=432.62 Aligned_cols=283 Identities=30% Similarity=0.589 Sum_probs=244.7
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+..++|++++.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 45668999999999999999999999999999999999876544445567788999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 741 CLITDYCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
|+||||++|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999999987643 3469999999999999999999999999999999999999999999999999996532
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC-
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK- 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~- 897 (998)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.
T Consensus 341 ~~---------------------------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 341 AG---------------------------QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp TT---------------------------CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CC---------------------------CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 11 01123458999999999999999999999999999999999999999875
Q ss_pred ---ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh-cHHHHHcCCCccCCChhhhh--cCCCCCCC
Q 001902 898 ---TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVR--CMNPPELD 971 (998)
Q Consensus 898 ---~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~--~~~~~~~~ 971 (998)
........+......+| ..++.++.+||.+||..||.+||++.+ .+.+|++||||++++|..+. .+.||..+
T Consensus 394 ~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P 471 (543)
T 3c4z_A 394 EKVENKELKQRVLEQAVTYP--DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVP 471 (543)
T ss_dssp CCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred cchhHHHHHHHHhhcccCCC--cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCC
Confidence 34566677777766665 357899999999999999999998764 57999999999999999885 45566554
Q ss_pred C
Q 001902 972 A 972 (998)
Q Consensus 972 ~ 972 (998)
.
T Consensus 472 ~ 472 (543)
T 3c4z_A 472 D 472 (543)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=429.37 Aligned_cols=280 Identities=41% Similarity=0.779 Sum_probs=232.9
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
..+..++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 34556789999999999999999999999999999999987655555566777889999999999999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
+|||||||++++|.+++.+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999999999775 459999999999999999999998 999999999999999999999999999985422
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 301 ~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 301 KD---------------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp C--------------------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CC---------------------------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 11 112235689999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhh--hcCCCCCC
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV--RCMNPPEL 970 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~--~~~~~~~~ 970 (998)
....+..+......+|. .++.++.+||.+||..||.+||+.. +.+.++++||||++++|..+ ..+.||..
T Consensus 354 ~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~ 426 (446)
T 4ejn_A 354 HEKLFELILMEEIRFPR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFK 426 (446)
T ss_dssp HHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred HHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCcc
Confidence 98888888888777664 3688999999999999999999111 12999999999999999877 44444444
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=413.53 Aligned_cols=265 Identities=29% Similarity=0.452 Sum_probs=234.6
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccCh---hHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR---NKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+.|++.+.||+|+||.||+|.+..+|+.||+|++.+...... .....+.+|+.+++.++||||++++++|...+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 4679999999999999999999999999999999986543221 2356788999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC----cEEEEeccCccc
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCL 816 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g----~vkL~DFG~a~~ 816 (998)
|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999999764 4699999999999999999999999999999999999998777 799999999865
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+
T Consensus 169 ~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~ 220 (361)
T 2yab_A 169 IEDG----------------------------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (361)
T ss_dssp CCTT----------------------------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cCCC----------------------------CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 3211 112345799999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHHhCCCCCCCC--CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhh
Q 001902 897 KTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
.+....+..+......++.. ...+..+++||.+||..||.+||| +.++|+||||+..+|...
T Consensus 221 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----~~e~l~hp~~~~~~~~~~ 284 (361)
T 2yab_A 221 DTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLT----IQEALRHPWITPVDTQQA 284 (361)
T ss_dssp SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHTSTTTSCSSHHHH
T ss_pred CCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcC----HHHHhcCcCcCCCchhhh
Confidence 99999999988877666532 457889999999999999999999 999999999999988654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=405.98 Aligned_cols=279 Identities=43% Similarity=0.765 Sum_probs=231.9
Q ss_pred ccccCCcccccccCCCCceeEEEEEEc---cCCeEEEEEEeeccccc-ChhHHHHHHHHHHHHHhCCCCCccceeEEEee
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDHPFVPALYASFQT 736 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~valK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 736 (998)
.+..++|++++.||+|+||.||+|.+. .+|+.||+|++++.... .......+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 456679999999999999999999985 68999999999865332 22344567789999999999999999999999
Q ss_pred CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
.+.+|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred CCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999999764 4589999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 171 ~~~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 171 SIHD---------------------------GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223 (327)
T ss_dssp -----------------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccC---------------------------CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence 2200 0112345799999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhhh--cCCCCCC
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVR--CMNPPEL 970 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~--~~~~~~~ 970 (998)
.+....+..+......+|. .++..+.+||.+||..||.+||++. ..+.++++||||+.++|..+. ...||..
T Consensus 224 ~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~ 298 (327)
T 3a62_A 224 ENRKKTIDKILKCKLNLPP--YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFK 298 (327)
T ss_dssp SSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCC
T ss_pred CCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCC
Confidence 9998888888888776654 4688999999999999999999543 249999999999999998773 4445444
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=431.60 Aligned_cols=283 Identities=34% Similarity=0.591 Sum_probs=242.2
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+..++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 46678899999999999999999999999999999999876444444556788999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||++||+|.+++.......+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||++......
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999999998765556999999999999999999999999999999999999999999999999999653211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC--
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT-- 898 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~-- 898 (998)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 340 ----------------------------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~ 391 (576)
T 2acx_A 340 ----------------------------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391 (576)
T ss_dssp ----------------------------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC
T ss_pred ----------------------------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc
Confidence 11224579999999999999999999999999999999999999998753
Q ss_pred --hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh-cHHHHHcCCCccCCChhhhh--cCCCCCCCCC
Q 001902 899 --RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVR--CMNPPELDAP 973 (998)
Q Consensus 899 --~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~--~~~~~~~~~p 973 (998)
.......+......++ ..++.++.+||.+||+.||.+||++.. .+.++++||||++++|..+. .+.||..+.|
T Consensus 392 ~~~~~i~~~i~~~~~~~p--~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~ 469 (576)
T 2acx_A 392 IKREEVERLVKEVPEEYS--ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDP 469 (576)
T ss_dssp CCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred hhHHHHHHHhhcccccCC--ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCc
Confidence 3445555555555554 457899999999999999999995432 38999999999999999885 4556655443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=442.79 Aligned_cols=282 Identities=35% Similarity=0.680 Sum_probs=247.0
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCC
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 738 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 738 (998)
..+..++|++++.||+|+||.||+|.+..+++.||||++++...........+..|..++..+ +||+|+.++++|.+.+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 345678999999999999999999999999999999999876544445567788899999987 7999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
.+||||||++||+|.+++... ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+++...
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999999875 459999999999999999999999999999999999999999999999999986422
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
.. .......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+
T Consensus 494 ~~---------------------------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 494 WD---------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp CT---------------------------TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cC---------------------------CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 11 112345689999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCC-hhcHHHHHcCCCccCCChhhh--hcCCCCCCCC
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWALV--RCMNPPELDA 972 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~-~~~a~elL~Hp~f~~~~~~~~--~~~~~~~~~~ 972 (998)
..+.+..|....+.+|. .++.++.+||.+||..||.+||++ .+.+.+|++||||+.++|..+ +.+.||..+.
T Consensus 547 ~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~ 621 (674)
T 3pfq_A 547 EDELFQSIMEHNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPK 621 (674)
T ss_dssp HHHHHHHHHSSCCCCCT--TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCB
T ss_pred HHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCc
Confidence 99999999998887775 478999999999999999999995 245699999999999999988 4556665543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=394.39 Aligned_cols=257 Identities=25% Similarity=0.407 Sum_probs=225.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 4689999999999999999999999999999999875432 2345678899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 170 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (297)
T ss_dssp EECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred EECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--
Confidence 9999999999999774 48999999999999999999999999999999999999999999999999986543111
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.....
T Consensus 171 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 225 (297)
T 3fxz_A 171 -------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225 (297)
T ss_dssp -------------------------CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred -------------------------cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 1223457999999999999999999999999999999999999999998887776
Q ss_pred HHHHhCC-CCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 904 ANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 904 ~~i~~~~-~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
..+.... ..+.....++..+.+||.+||..||.+||| +.++++||||+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~ell~h~~~~~~ 276 (297)
T 3fxz_A 226 YLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS----AKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCC----HHHHTTCGGGGGC
T ss_pred HHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcC----HHHHhhChhhccc
Confidence 6665433 334444567889999999999999999999 9999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=395.53 Aligned_cols=264 Identities=31% Similarity=0.552 Sum_probs=222.9
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccC-----------------------hhHHHHHHHH
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-----------------------RNKVHRACAE 715 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~-----------------------~~~~~~~~~E 715 (998)
+..+..++|++.+.||+|+||.||+|.+..+++.||+|++....... ......+.+|
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 86 (298)
T 2zv2_A 7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86 (298)
T ss_dssp ---CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred CCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence 44566789999999999999999999999999999999997653221 1224567889
Q ss_pred HHHHHhCCCCCccceeEEEee--CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 001902 716 REILDMLDHPFVPALYASFQT--KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 793 (998)
Q Consensus 716 ~~il~~l~h~nIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDL 793 (998)
+.+++.++||||+++++++.. ...+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||
T Consensus 87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 163 (298)
T 2zv2_A 87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI 163 (298)
T ss_dssp HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 999999999999999999986 6789999999999999887643 45999999999999999999999999999999
Q ss_pred CCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC---
Q 001902 794 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--- 870 (998)
Q Consensus 794 kP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--- 870 (998)
||+|||++.++.+||+|||++....... .......||+.|+|||++.+..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 216 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSD---------------------------ALLSNTVGTPAFMAPESLSETRKIF 216 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSS---------------------------CEECCCCSCGGGCCGGGCCTTCCCE
T ss_pred CHHHEEECCCCCEEEecCCCcccccccc---------------------------ccccCCcCCccccChhhhccCCCCC
Confidence 9999999999999999999986543111 1123457999999999997765
Q ss_pred CCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 871 HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 871 ~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
++.++|||||||++|+|++|..||.+.........+......++....++..+.+||.+||..||.+||| +.++++
T Consensus 217 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s----~~e~l~ 292 (298)
T 2zv2_A 217 SGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIV----VPEIKL 292 (298)
T ss_dssp ESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC----HHHHTT
T ss_pred CCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCC----HHHHhc
Confidence 3678999999999999999999999988888788888877777777778999999999999999999999 999999
Q ss_pred CCCccC
Q 001902 951 HPFFKG 956 (998)
Q Consensus 951 Hp~f~~ 956 (998)
||||+.
T Consensus 293 hp~~~~ 298 (298)
T 2zv2_A 293 HPWVTR 298 (298)
T ss_dssp CHHHHC
T ss_pred CccccC
Confidence 999963
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=398.10 Aligned_cols=264 Identities=30% Similarity=0.470 Sum_probs=231.9
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccC---hhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN---RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+.|++.+.||+|+||.||+|.+..+|+.||+|++....... ......+.+|+.+++.++||||+++++++...+.+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 57999999999999999999999999999999998653322 123567889999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC----cEEEEeccCcccc
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCLT 817 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g----~vkL~DFG~a~~~ 817 (998)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999999764 4599999999999999999999999999999999999999887 8999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 169 ~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 220 (326)
T 2y0a_A 169 DFG----------------------------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220 (326)
T ss_dssp CTT----------------------------SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCC----------------------------CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 211 1123457999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHhCCCCCCCC--CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhh
Q 001902 898 TRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
+....+..+......++.. ...+..+.+||.+||..||.+||| +.++|+||||+..++...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~~~~~~~~ 283 (326)
T 2y0a_A 221 TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT----IQDSLQHPWIKPKDTQQA 283 (326)
T ss_dssp SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHHSTTTSCCSHHHH
T ss_pred CHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCC----HHHHhcCCCccCCcchhh
Confidence 8888888887766555432 456889999999999999999999 999999999999887544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=412.30 Aligned_cols=259 Identities=29% Similarity=0.470 Sum_probs=228.6
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3579999999999999999999999999999999986543 334456788999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe---cCCcEEEEeccCccccCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~---~~g~vkL~DFG~a~~~~~~ 820 (998)
||||+|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 89 ~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp ECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999999999999875 4599999999999999999999999999999999999998 4678999999999554311
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..
T Consensus 167 ~---------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~ 219 (444)
T 3soa_A 167 Q---------------------------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH 219 (444)
T ss_dssp C---------------------------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred C---------------------------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH
Confidence 1 1123467999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 901 KTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
..+..+..+...++. ...++.++.+||.+||..||.+||| +.++|+||||+.
T Consensus 220 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----a~e~L~hp~~~~ 273 (444)
T 3soa_A 220 RLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT----AAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHHSCTTHH
T ss_pred HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCC----HHHHhcCccccC
Confidence 999999888765554 3567999999999999999999999 999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=407.57 Aligned_cols=275 Identities=20% Similarity=0.330 Sum_probs=224.5
Q ss_pred cccCCcccccccCCC--CceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 662 INLQHFRPIKPLGSG--DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G--~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
...++|++++.||+| +||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 346789999999999 999999999999999999999986533 34566778889999999999999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|+|||||++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999999876556799999999999999999999999999999999999999999999999998854321
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC--CCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
.... ...........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 181 ~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 181 HGQR--------------------QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp TTEE--------------------CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccc--------------------ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 1000 0001112234579999999999987 57899999999999999999999999886
Q ss_pred ChHHHHHHHHhCCCC--------------------------------------------CCCCCCCcHHHHHHHHHcccc
Q 001902 898 TRQKTFANILHKDLK--------------------------------------------FPSSTPTSLHAKQLMYRLLHR 933 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~--------------------------------------------~~~~~~~s~~l~~Ll~~~L~~ 933 (998)
+....+..+.....+ .+.....+..+.+||.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 320 (389)
T 3gni_B 241 PATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320 (389)
T ss_dssp CSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHTCS
T ss_pred CHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhc
Confidence 665555443332211 012234678899999999999
Q ss_pred CccCcCCChhcHHHHHcCCCccCCChhh
Q 001902 934 DPKSRLGSHEGANEIKKHPFFKGVNWAL 961 (998)
Q Consensus 934 dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 961 (998)
||.+||| +.++|+||||+.+.+..
T Consensus 321 dP~~Rpt----a~ell~hp~f~~~~~~~ 344 (389)
T 3gni_B 321 NPDARPS----ASTLLNHSFFKQIKRRA 344 (389)
T ss_dssp CTTTSCC----HHHHTTSGGGGGC---C
T ss_pred CcccCCC----HHHHhcCHHHHHHhhcc
Confidence 9999999 99999999999987753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=397.73 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=228.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 46899999999999999999999999999999998743 23445678999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec--CCcEEEEeccCccccCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG--NGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~--~g~vkL~DFG~a~~~~~~~ 821 (998)
||||+|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 80 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 80 FEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp ECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999999999999764 245999999999999999999999999999999999999997 789999999998653211
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 158 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 210 (321)
T 1tki_A 158 ---------------------------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp ---------------------------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ---------------------------CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH
Confidence 11234579999999999999889999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 902 TFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 902 ~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.+..+......++. ...++.++.+||.+||..||.+||| +.++|+||||+..
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~~~~~ 264 (321)
T 1tki_A 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT----ASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC----HHHHHHSHHHHSC
T ss_pred HHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcC----HHHHhcChhhccC
Confidence 99999888766553 2457889999999999999999999 9999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=401.99 Aligned_cols=258 Identities=29% Similarity=0.488 Sum_probs=229.0
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3579999999999999999999999999999999986533 344567788999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC---CcEEEEeccCccccCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~---g~vkL~DFG~a~~~~~~ 820 (998)
||||+|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 107 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp ECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999999999998764 459999999999999999999999999999999999999865 45999999998553211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..
T Consensus 185 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~ 236 (362)
T 2bdw_A 185 ----------------------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 236 (362)
T ss_dssp ----------------------------CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ----------------------------cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 1123457999999999999999999999999999999999999999999988
Q ss_pred HHHHHHHhCCCCCCCC--CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 901 KTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
..+..+..+...++.. ..++.++.+||.+||..||.+||+ +.++|+||||+.
T Consensus 237 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~~~~ 290 (362)
T 2bdw_A 237 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT----ADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCC----HHHHTTSHHHHT
T ss_pred HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcC----HHHHhcCcccCC
Confidence 8888888877665543 457899999999999999999999 999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=396.63 Aligned_cols=248 Identities=22% Similarity=0.284 Sum_probs=187.6
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC----eE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----HV 740 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----~~ 740 (998)
.+|.+.+.||+|+||.||+|.+ +|+.||||+++... ........|+..+.+++|||||++++++...+ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 3688889999999999999997 68999999987532 11122334566667889999999999997653 68
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEEEecCCcEEEEecc
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLTDFD 812 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--------~IiHrDLkP~NILi~~~g~vkL~DFG 812 (998)
|||||||++|+|.++++.. .+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 9999999999999999874 489999999999999999999987 99999999999999999999999999
Q ss_pred CccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC------CCCChhHHHHHHHHHHH
Q 001902 813 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA------GHTSAVDWWALGILLYE 886 (998)
Q Consensus 813 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~sDIwSlG~il~e 886 (998)
+|+........ ........+||+.|||||++.+. .++.++|||||||+|||
T Consensus 154 la~~~~~~~~~-----------------------~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~E 210 (303)
T 3hmm_A 154 LAVRHDSATDT-----------------------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 210 (303)
T ss_dssp TCEEEETTTTE-----------------------ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHH
T ss_pred CCccccCCCCc-----------------------eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHH
Confidence 99654321110 01122346899999999999765 35679999999999999
Q ss_pred HHcCCCCCCCC---------------ChHHHHHHHHhCCC--CCCCC---CCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 887 MLYGYTPFRGK---------------TRQKTFANILHKDL--KFPSS---TPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 887 LltG~~Pf~~~---------------~~~~~~~~i~~~~~--~~~~~---~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
|+||.+||... ........+..... .+|.. ...+..+.+|+.+||+.||.+|||+.++
T Consensus 211 l~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei 288 (303)
T 3hmm_A 211 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288 (303)
T ss_dssp HHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred HHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence 99998766321 11223333333332 22221 1123467899999999999999995444
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=385.73 Aligned_cols=259 Identities=22% Similarity=0.399 Sum_probs=216.0
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++||||+++++++...+.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 589999999999999999999999999999999986542 3445577889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 154 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP---- 154 (292)
T ss_dssp ECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC----
T ss_pred ecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc----
Confidence 99965 666655543 245999999999999999999999999999999999999999999999999998654211
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC-CCChhHHHHHHHHHHHHHcCCCC-CCCCChHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTP-FRGKTRQKT 902 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDIwSlG~il~eLltG~~P-f~~~~~~~~ 902 (998)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+....
T Consensus 155 -----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~ 211 (292)
T 3o0g_A 155 -----------------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_dssp -----------------------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH
T ss_pred -----------------------cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence 11223457899999999998766 79999999999999999987777 556666666
Q ss_pred HHHHHhCCCC-----C----------------------CCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 903 FANILHKDLK-----F----------------------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 903 ~~~i~~~~~~-----~----------------------~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
+..+...... + ......+..+.+||.+||+.||.+||| +.++|+||||+
T Consensus 212 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~ 287 (292)
T 3o0g_A 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS----AEEALQHPYFS 287 (292)
T ss_dssp HHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGT
T ss_pred HHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCC----HHHHhcCcccc
Confidence 6665441100 0 011246788999999999999999999 99999999999
Q ss_pred CC
Q 001902 956 GV 957 (998)
Q Consensus 956 ~~ 957 (998)
.+
T Consensus 288 ~~ 289 (292)
T 3o0g_A 288 DF 289 (292)
T ss_dssp TC
T ss_pred cC
Confidence 74
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=390.92 Aligned_cols=265 Identities=24% Similarity=0.403 Sum_probs=217.7
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
+-..++|++++.||+|+||.||+|.+. +|+.||+|++.... ........+.+|+.+++.++||||+++++++...+.+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence 344689999999999999999999994 58999999997543 2333456788999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||++ ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 95 TLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99999996 58888876643 45999999999999999999999999999999999999999999999999998654311
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.
T Consensus 173 ---------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (311)
T 3niz_A 173 ---------------------------VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225 (311)
T ss_dssp ---------------------------CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST
T ss_pred ---------------------------cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh
Confidence 112234578999999999977 5689999999999999999999999998777
Q ss_pred HHHHHHHHhC--CCCCC--------------------------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 900 QKTFANILHK--DLKFP--------------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 900 ~~~~~~i~~~--~~~~~--------------------------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
...+..+... ..... .....+.++.+||.+||+.||.+||| +.++|+|
T Consensus 226 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~h 301 (311)
T 3niz_A 226 DDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS----ARDAMNH 301 (311)
T ss_dssp TTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC----HHHHHTS
T ss_pred HHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC----HHHHhcC
Confidence 6666655431 10000 01235678999999999999999999 9999999
Q ss_pred CCccCCChh
Q 001902 952 PFFKGVNWA 960 (998)
Q Consensus 952 p~f~~~~~~ 960 (998)
|||+.+++.
T Consensus 302 p~f~~~~~~ 310 (311)
T 3niz_A 302 PYFKDLDPQ 310 (311)
T ss_dssp GGGTTSCTT
T ss_pred cccccCCcc
Confidence 999997653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=402.33 Aligned_cols=283 Identities=27% Similarity=0.417 Sum_probs=215.2
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEeeCC--eE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKT--HV 740 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~--~~ 740 (998)
.++|++++.||+|+||.||+|.+..+|+.||+|++... .........+.+|+.+++.+. ||||+++++++...+ .+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 47899999999999999999999999999999998754 334455677889999999997 999999999997544 79
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+|||||+ ++|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 99999995 6899998763 5899999999999999999999999999999999999999999999999999765321
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
........ .. ..................+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.
T Consensus 163 ~~~~~~~~-----~~-~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 163 RRVTNNIP-----LS-INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp CCCCCCGG-----GC-CC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccc-----cc-ccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 11100000 00 00000000111223455789999999999987 6789999999999999999999999999988
Q ss_pred HHHHHHHHhCCCCCC----------------------------------------------CCCCCcHHHHHHHHHcccc
Q 001902 900 QKTFANILHKDLKFP----------------------------------------------SSTPTSLHAKQLMYRLLHR 933 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~----------------------------------------------~~~~~s~~l~~Ll~~~L~~ 933 (998)
...+..++... ..| .....+.++.+||.+||..
T Consensus 237 ~~~~~~i~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 237 MNQLERIIGVI-DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHHHHHH-CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHhc-CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 88877775311 111 1124678999999999999
Q ss_pred CccCcCCChhcHHHHHcCCCccCCChhhh
Q 001902 934 DPKSRLGSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 934 dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
||.+||| +.++|+||||+.+....-
T Consensus 316 dP~~R~t----~~e~l~Hp~~~~~~~~~~ 340 (388)
T 3oz6_A 316 NPNKRIS----ANDALKHPFVSIFHNPNE 340 (388)
T ss_dssp SGGGSCC----HHHHTTSTTTTTTCCGGG
T ss_pred CcccCCC----HHHHhCCHHHHHhcCCcc
Confidence 9999999 999999999998755443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=386.74 Aligned_cols=261 Identities=34% Similarity=0.558 Sum_probs=230.0
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
++..++|++++.||+|+||.||+|.+..++..||+|++.............+.+|+.+++.++||||+++++++...+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 45678999999999999999999999999999999999765444444456788999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~- 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence 9999999999999999764 4599999999999999999999999999999999999999999999999998844221
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 162 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 213 (279)
T 3fdn_A 162 ----------------------------SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213 (279)
T ss_dssp ----------------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ----------------------------ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH
Confidence 1122456899999999999999999999999999999999999999999988
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
.....+......++. ..+..+.+||.+||..||.+||| +.++++||||+...
T Consensus 214 ~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps----~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 214 ETYKRISRVEFTFPD--FVTEGARDLISRLLKHNPSQRPM----LREVLEHPWITANS 265 (279)
T ss_dssp HHHHHHHHTCCCCCT--TSCHHHHHHHHHHCCSSGGGSCC----HHHHHHCHHHHHHC
T ss_pred HHHHHHHhCCCCCCC--cCCHHHHHHHHHHhccChhhCCC----HHHHhhCccccCCc
Confidence 888888877666654 36889999999999999999999 99999999998743
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=410.96 Aligned_cols=302 Identities=23% Similarity=0.283 Sum_probs=211.2
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee-----CC
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-----KT 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-----~~ 738 (998)
.++|++++.||+|+||.||+|.+..+++.||||++... .........+.+|+.+|+.++||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 47899999999999999999999999999999998754 3345566788999999999999999999999843 35
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
.+|+||||+ +++|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+...
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred eEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 799999998 78999999764 459999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhh-cCCCCCChhHHHHHHHHHHHHHc--------
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLY-------- 889 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~~~~sDIwSlG~il~eLlt-------- 889 (998)
....................................+||+.|+|||++ .+..++.++|||||||++|+|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 222110000000000000000000000011234566899999999987 45679999999999999999998
Q ss_pred ---CCCCCCCCCh--------------------HHHHHHHHh--C--------------------CCCC-------CCCC
Q 001902 890 ---GYTPFRGKTR--------------------QKTFANILH--K--------------------DLKF-------PSST 917 (998)
Q Consensus 890 ---G~~Pf~~~~~--------------------~~~~~~i~~--~--------------------~~~~-------~~~~ 917 (998)
|.++|.+.+. ...+..+.. + .++. ....
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 7777866541 122222211 0 0000 0113
Q ss_pred CCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhcCCCCCCCCC
Q 001902 918 PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 973 (998)
Q Consensus 918 ~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p 973 (998)
..+.++.+||.+||..||.+||| +.++|+||||+.+.|...+.....+...|
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t----~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~ 419 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRIT----INECLAHPFFKEVRIAEVETNATEKVRLP 419 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGTTTCCGGGCCCCSSCCCCS
T ss_pred CCCHHHHHHHHHHhccCccccCC----HHHHhcCHhhhhcCCCccCCCCCCCCCCC
Confidence 45889999999999999999999 99999999999999988755444444334
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=397.15 Aligned_cols=257 Identities=30% Similarity=0.470 Sum_probs=215.5
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
...++|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+|+.+++.++||||+++++++...+.+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 3457899999999999999999999999999999999764322 245778999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc--EEEEeccCccccCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--VSLTDFDLSCLTSC 819 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~--vkL~DFG~a~~~~~ 819 (998)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 93 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 93 IIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999999999764 45999999999999999999999999999999999999987765 99999999853210
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCCh-hHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA-VDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+..
T Consensus 171 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 171 ----------------------------HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp --------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred ----------------------------cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 011234579999999999988887765 899999999999999999998744
Q ss_pred h----HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 899 R----QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 899 ~----~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
. ...+..+......++....++..+.+||.+||..||.+||| +.++++||||..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps----~~ell~hp~f~~ 280 (361)
T 3uc3_A 223 EPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRIS----IPEIKTHSWFLK 280 (361)
T ss_dssp -CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCC----HHHHHTSHHHHT
T ss_pred cHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcC----HHHHHhCcchhc
Confidence 3 45556666777777777778999999999999999999999 999999999965
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=400.87 Aligned_cols=256 Identities=32% Similarity=0.516 Sum_probs=219.5
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 57899999999999999999999999999999999865443333445788999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+ +|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--- 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--- 161 (336)
T ss_dssp ECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS---
T ss_pred EECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC---
Confidence 9999 78999988764 45999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCC-CChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+......
T Consensus 162 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~ 216 (336)
T 3h4j_B 162 -------------------------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL 216 (336)
T ss_dssp -------------------------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC
T ss_pred -------------------------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH
Confidence 11234579999999999988776 6799999999999999999999987654443
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
...+.......| ...+..+.+||.+||..||.+||| +.++++||||+.
T Consensus 217 ~~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~Rpt----~~eil~hp~~~~ 264 (336)
T 3h4j_B 217 FKKVNSCVYVMP--DFLSPGAQSLIRRMIVADPMQRIT----IQEIRRDPWFNV 264 (336)
T ss_dssp BCCCCSSCCCCC--TTSCHHHHHHHHTTSCSSGGGSCC----HHHHTTCHHHHT
T ss_pred HHHHHcCCCCCc--ccCCHHHHHHHHHHcCCChhHCcC----HHHHHhChhhcc
Confidence 333333333333 346889999999999999999999 999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=393.31 Aligned_cols=261 Identities=26% Similarity=0.421 Sum_probs=220.6
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999875422 22335678899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 159 (323)
T 3tki_A 84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 159 (323)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred EEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC--
Confidence 9999999999999764 459999999999999999999999999999999999999999999999999986532110
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCC-CChhHHHHHHHHHHHHHcCCCCCCCCChH-H
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQ-K 901 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDIwSlG~il~eLltG~~Pf~~~~~~-~ 901 (998)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.... .
T Consensus 160 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 216 (323)
T 3tki_A 160 -----------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216 (323)
T ss_dssp -----------------------EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH
T ss_pred -----------------------cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 0112235679999999999988765 67899999999999999999999876553 3
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.+..+.......+....++..+.+||.+||..||.+||| +.++++||||+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~eil~h~~~~~~ 268 (323)
T 3tki_A 217 EYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT----IPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC----HHHHTTCTTTTCC
T ss_pred HHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcC----HHHHhhChhhccc
Confidence 444444444444445667899999999999999999999 9999999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=397.29 Aligned_cols=260 Identities=28% Similarity=0.455 Sum_probs=228.4
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.+.|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.....+|+|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999987542 33445788999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec--CCcEEEEeccCccccCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG--NGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~--~g~vkL~DFG~a~~~~~~~ 821 (998)
||||+|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 127 ~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 127 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 9999999999999764 345999999999999999999999999999999999999984 478999999998654211
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 205 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 257 (387)
T 1kob_A 205 ---------------------------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 257 (387)
T ss_dssp ---------------------------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred ---------------------------cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH
Confidence 11123469999999999999999999999999999999999999999998888
Q ss_pred HHHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 902 TFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 902 ~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
.+..+......++. ...++.++.+||.+||..||.+||| +.++|+||||++..+
T Consensus 258 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 258 TLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT----VHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC----HHHHHTSTTTSSCCT
T ss_pred HHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC----HHHHhhCccccCCcc
Confidence 88888877655443 3457899999999999999999999 999999999998544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=379.16 Aligned_cols=265 Identities=28% Similarity=0.466 Sum_probs=233.3
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.++++++||||+++++++...+..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4789999999999999999999999999999999986543 444567788999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc---EEEEeccCccccCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCK 820 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~---vkL~DFG~a~~~~~~ 820 (998)
|||+++++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++......
T Consensus 84 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999999999888765 45999999999999999999999999999999999999987655 999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 162 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 213 (284)
T 3kk8_A 162 ----------------------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 213 (284)
T ss_dssp ----------------------------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ----------------------------ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh
Confidence 1123457999999999999999999999999999999999999999999988
Q ss_pred HHHHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhh
Q 001902 901 KTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~ 963 (998)
.....+......++. ....+.++.+||.+||..||.+||| +.++|+||||+..++....
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~~l~h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 214 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT----ADQALKVPWICNRERVASA 274 (284)
T ss_dssp HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC----HHHHTTSHHHHSCCCGGGS
T ss_pred HHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCC----HHHHhcCccccCChhHHhH
Confidence 888888877655543 3467899999999999999999999 9999999999997765553
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=398.09 Aligned_cols=266 Identities=26% Similarity=0.430 Sum_probs=225.2
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccC--hhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN--RNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
+..+.|++.+.||+|+||.||+|.+..+|+.||+|++....... ......+.+|+.+++.++||||+++++++...+.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 33468999999999999999999999999999999997543221 1235678899999999999999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc---EEEEeccCc
Q 001902 740 VCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLS 814 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~---vkL~DFG~a 814 (998)
+|+|||||+|++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999998887642 2345899999999999999999999999999999999999987654 999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
....... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 181 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 233 (351)
T 3c0i_A 181 IQLGESG---------------------------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233 (351)
T ss_dssp EECCTTS---------------------------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred eEecCCC---------------------------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCC
Confidence 6543110 1123457999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 895 RGKTRQKTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 895 ~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
.+. ....+..+......++. ...++..+.+||.+||..||.+||| +.++|+||||+..++
T Consensus 234 ~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s----~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 234 YGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERIT----VYEALNHPWLKERDR 295 (351)
T ss_dssp CSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHTHHH
T ss_pred CCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcC----HHHHhcChhhcCCcc
Confidence 875 45566677766554432 2457889999999999999999999 999999999997543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=386.43 Aligned_cols=263 Identities=25% Similarity=0.392 Sum_probs=214.8
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeeccccc--ChhHHHHHHHHHHHHHhC---CCCCccceeEEEee
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDML---DHPFVPALYASFQT 736 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~--~~~~~~~~~~E~~il~~l---~h~nIv~l~~~~~~ 736 (998)
+..++|++++.||+|+||.||+|.+..+++.||+|++...... .........+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4467999999999999999999999999999999998753221 111123455677776666 59999999999976
Q ss_pred CC-----eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEec
Q 001902 737 KT-----HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 811 (998)
Q Consensus 737 ~~-----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DF 811 (998)
.. .+++||||++ ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 54 6899999995 69999998876566999999999999999999999999999999999999999999999999
Q ss_pred cCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCC
Q 001902 812 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 891 (998)
Q Consensus 812 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~ 891 (998)
|++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 165 g~a~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 216 (308)
T 3g33_A 165 GLARIYSYQ----------------------------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216 (308)
T ss_dssp SCTTTSTTC----------------------------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSS
T ss_pred ccccccCCC----------------------------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCC
Confidence 998543211 1123457999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCCCC-----CCC--------------------CCCCcHHHHHHHHHccccCccCcCCChhcHH
Q 001902 892 TPFRGKTRQKTFANILHKDLK-----FPS--------------------STPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946 (998)
Q Consensus 892 ~Pf~~~~~~~~~~~i~~~~~~-----~~~--------------------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 946 (998)
+||.+.+....+..+...... ++. ....+..+.+||.+||+.||.+||| +.
T Consensus 217 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~ 292 (308)
T 3g33_A 217 PLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS----AF 292 (308)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC----HH
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC----HH
Confidence 999999888887777642110 100 1246788999999999999999999 99
Q ss_pred HHHcCCCccCC
Q 001902 947 EIKKHPFFKGV 957 (998)
Q Consensus 947 elL~Hp~f~~~ 957 (998)
++|+||||+..
T Consensus 293 e~l~h~~~~~~ 303 (308)
T 3g33_A 293 RALQHSYLHKD 303 (308)
T ss_dssp HHHTSTTC---
T ss_pred HHhcCccccCC
Confidence 99999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=399.90 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=222.0
Q ss_pred Cccc--ccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 666 HFRP--IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 666 ~y~~--~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.|.+ .+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.++++++||||+++++++...+.+|||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3444 578999999999999999999999999998642 24456788999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE--ecCCcEEEEeccCccccCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL--QGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi--~~~g~vkL~DFG~a~~~~~~~ 821 (998)
|||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 165 ~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~- 242 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR- 242 (373)
T ss_dssp EECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-
T ss_pred EeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-
Confidence 9999999999988764 2459999999999999999999999999999999999999 45678999999998654211
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 243 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 295 (373)
T 2x4f_A 243 ---------------------------EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE 295 (373)
T ss_dssp ---------------------------CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ---------------------------cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 11223469999999999999999999999999999999999999999999988
Q ss_pred HHHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhh
Q 001902 902 TFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWAL 961 (998)
Q Consensus 902 ~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 961 (998)
.+..+......++. ...++.++.+||.+||..||.+||| +.++|+||||+..++..
T Consensus 296 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps----~~e~l~hp~~~~~~~~~ 353 (373)
T 2x4f_A 296 TLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRIS----ASEALKHPWLSDHKLHS 353 (373)
T ss_dssp HHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCC----HHHHHHSHHHHCHHHHH
T ss_pred HHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCC----HHHHhcCcCcCCCchhh
Confidence 88888887665543 2457899999999999999999999 99999999999977643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=390.65 Aligned_cols=265 Identities=24% Similarity=0.396 Sum_probs=207.4
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++++.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 358999999999999999999999999999999997543 222345677899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 744 TDYCPGGELFLLLDRQ----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
|||++ ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99996 6999988653 123589999999999999999999999999999999999999999999999999865421
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
. ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus 161 ~---------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 161 P---------------------------VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp C---------------------------CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred C---------------------------cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 111234578999999999977 468999999999999999999999999988
Q ss_pred hHHHHHHHHhCCCC------------------C--------------CCCCCCcHHHHHHHHHccccCccCcCCChhcHH
Q 001902 899 RQKTFANILHKDLK------------------F--------------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946 (998)
Q Consensus 899 ~~~~~~~i~~~~~~------------------~--------------~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 946 (998)
....+..+...... . ......+.++.+||.+||+.||.+||| +.
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~ 289 (317)
T 2pmi_A 214 DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS----AK 289 (317)
T ss_dssp HHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC----HH
T ss_pred hHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC----HH
Confidence 87777766541000 0 001246788999999999999999999 99
Q ss_pred HHHcCCCccCCChhhh
Q 001902 947 EIKKHPFFKGVNWALV 962 (998)
Q Consensus 947 elL~Hp~f~~~~~~~~ 962 (998)
++|+||||+...+...
T Consensus 290 e~l~hp~f~~~~~~~~ 305 (317)
T 2pmi_A 290 QALHHPWFAEYYHHAS 305 (317)
T ss_dssp HHTTSGGGGGGCC---
T ss_pred HHhCChhhhcccchhh
Confidence 9999999998766544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=410.29 Aligned_cols=261 Identities=28% Similarity=0.471 Sum_probs=231.3
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
..+..++|.+.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34567899999999999999999999999999999999986544334456678899999999999999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999999999764 4599999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCC-CChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+
T Consensus 169 ~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 169 G----------------------------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp T----------------------------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c----------------------------ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 1 11234579999999999988765 679999999999999999999999988
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
....+..+..+....|. .++..+.+||.+||..||.+||| +.++++||||+.
T Consensus 221 ~~~~~~~i~~~~~~~p~--~~s~~~~~Li~~~L~~dP~~Rpt----~~eil~hp~~~~ 272 (476)
T 2y94_A 221 VPTLFKKICDGIFYTPQ--YLNPSVISLLKHMLQVDPMKRAT----IKDIREHEWFKQ 272 (476)
T ss_dssp SHHHHHHHHTTCCCCCT--TCCHHHHHHHHHHTCSSTTTSCC----HHHHHTCHHHHT
T ss_pred HHHHHHHHhcCCcCCCc--cCCHHHHHHHHHHcCCCchhCcC----HHHHHhCHHhhh
Confidence 88888888887655543 46889999999999999999999 999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=388.49 Aligned_cols=265 Identities=29% Similarity=0.445 Sum_probs=232.5
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccCh---hHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR---NKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+.|++.+.||+|+||.||+|.+..+|+.||+|++........ .....+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3579999999999999999999999999999999986533221 1356788999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC----cEEEEeccCccc
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCL 816 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g----~vkL~DFG~a~~ 816 (998)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999999764 4589999999999999999999999999999999999999887 799999999855
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 169 ~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 220 (321)
T 2a2a_A 169 IEDG----------------------------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (321)
T ss_dssp CCTT----------------------------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cCcc----------------------------ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence 3211 112345699999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHHhCCCCCCCC--CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhh
Q 001902 897 KTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
.+....+..+......++.. ...+..+.+||.+||..||.+||| +.++++||||+.+++...
T Consensus 221 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~e~l~hp~~~~~~~~~~ 284 (321)
T 2a2a_A 221 DTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLT----IQEALRHPWITPVDNQQA 284 (321)
T ss_dssp SSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCC----HHHHHHSTTTSCSSHHHH
T ss_pred CCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcC----HHHHhcCccccCCCcccc
Confidence 98888888887766554432 456889999999999999999999 999999999999988655
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=382.67 Aligned_cols=260 Identities=31% Similarity=0.544 Sum_probs=230.2
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+..++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 35567999999999999999999999999999999999765433333456788999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~- 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS- 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS-
T ss_pred EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc-
Confidence 9999999999999999765 3589999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 167 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 218 (284)
T 2vgo_A 167 ----------------------------LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 218 (284)
T ss_dssp ----------------------------SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ----------------------------cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh
Confidence 0122457999999999999999999999999999999999999999998888
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.....+......++. ..+..+.+||.+||..||.+||+ +.++++||||+..
T Consensus 219 ~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps----~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 219 ETHRRIVNVDLKFPP--FLSDGSKDLISKLLRYHPPQRLP----LKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHHHHTTCCCCCT--TSCHHHHHHHHHHSCSSGGGSCC----HHHHHTCHHHHHH
T ss_pred HHHHHHhccccCCCC--cCCHHHHHHHHHHhhcCHhhCCC----HHHHhhCHHHHhh
Confidence 888888877666553 46889999999999999999999 9999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=392.73 Aligned_cols=264 Identities=22% Similarity=0.334 Sum_probs=214.2
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
...++|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345789999999999999999999999999999999976532 2333456778999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe-----cCCcEEEEeccCccc
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-----GNGHVSLTDFDLSCL 816 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~-----~~g~vkL~DFG~a~~ 816 (998)
+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 110 lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999996 5999999875 3499999999999999999999999999999999999995 455699999999865
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.
T Consensus 187 ~~~~---------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 239 (329)
T 3gbz_A 187 FGIP---------------------------IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239 (329)
T ss_dssp HC--------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCc---------------------------ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 3211 1112344689999999999875 48999999999999999999999999
Q ss_pred CCChHHHHHHHHhCCCCC------------------CCC----------CCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 896 GKTRQKTFANILHKDLKF------------------PSS----------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 896 ~~~~~~~~~~i~~~~~~~------------------~~~----------~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
+.+....+..+....... +.. ...+.++.+||.+||..||.+||| +.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e 315 (329)
T 3gbz_A 240 GDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS----AKN 315 (329)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC----HHH
T ss_pred CCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC----HHH
Confidence 988887777766421100 000 015678999999999999999999 999
Q ss_pred HHcCCCccCCChh
Q 001902 948 IKKHPFFKGVNWA 960 (998)
Q Consensus 948 lL~Hp~f~~~~~~ 960 (998)
+|+||||++.+|.
T Consensus 316 ~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 316 ALEHPYFSHNDFD 328 (329)
T ss_dssp HHTSGGGSSSCSC
T ss_pred HhCCcccCCCCCC
Confidence 9999999999884
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=393.56 Aligned_cols=256 Identities=26% Similarity=0.439 Sum_probs=219.5
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-----CCCccceeEEEe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-----HPFVPALYASFQ 735 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-----h~nIv~l~~~~~ 735 (998)
.+..++|++++.||+|+||.||+|.+..+++.||+|++... .........|+.+++.+. ||||+++++++.
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 34468999999999999999999999999999999998742 334456778999999996 999999999999
Q ss_pred eCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec-------------
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG------------- 802 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~------------- 802 (998)
..+..|+||||+ +++|.+++.......++...++.++.||+.||+|||++||+||||||+|||++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence 999999999999 999999998876667999999999999999999999999999999999999975
Q ss_pred ------------CCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC
Q 001902 803 ------------NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 870 (998)
Q Consensus 803 ------------~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 870 (998)
++.+||+|||++.... .......||+.|+|||++.+..
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~ 235 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKS------------------------------DYHGSIINTRQYRAPEVILNLG 235 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETT------------------------------SCCCSCCSCGGGCCHHHHTTCC
T ss_pred cccccccccccCCCCEEEEeccCceecC------------------------------CCCcCccCcccccCcHHHcCCC
Confidence 7899999999985422 1123457999999999999999
Q ss_pred CCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCC--------------------------CCC-------
Q 001902 871 HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP--------------------------SST------- 917 (998)
Q Consensus 871 ~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~------- 917 (998)
++.++|||||||++|+|++|+.||.+.+....+..+.....+.| ...
T Consensus 236 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 315 (360)
T 3llt_A 236 WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIK 315 (360)
T ss_dssp CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHH
T ss_pred CCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhh
Confidence 99999999999999999999999999887777666554322222 110
Q ss_pred -----------CCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 918 -----------PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 918 -----------~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
..+..+.+||.+||+.||.+||| +.++|+||||+
T Consensus 316 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----a~elL~hp~f~ 360 (360)
T 3llt_A 316 HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS----PAELLKHKFLE 360 (360)
T ss_dssp HHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC----HHHHTTSGGGC
T ss_pred hhhhcccccccchHHHHHHHHHHHhcCChhhCCC----HHHHhcCcccC
Confidence 11356779999999999999999 99999999996
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=390.58 Aligned_cols=256 Identities=26% Similarity=0.372 Sum_probs=225.6
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
..|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999998654444555678889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+. |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~------ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------ 205 (348)
T ss_dssp ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS------
T ss_pred ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC------
Confidence 9995 6888887643 2459999999999999999999999999999999999999999999999999985432
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc---CCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
.....+||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+...
T Consensus 206 -------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 260 (348)
T 1u5q_A 206 -------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 260 (348)
T ss_dssp -------------------------SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred -------------------------CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 112357999999999985 5678899999999999999999999999988888
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.+..+.....+.......+..+.+||.+||..||.+||| +.++++||||...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 261 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT----SEVLLKHRFVLRE 312 (348)
T ss_dssp HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHTTCHHHHSC
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcC----HHHHhhChhhhcc
Confidence 887777766555555567899999999999999999999 9999999999764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=401.48 Aligned_cols=254 Identities=25% Similarity=0.436 Sum_probs=209.6
Q ss_pred cCCcccc-cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHH-HhCCCCCccceeEEEee----C
Q 001902 664 LQHFRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPALYASFQT----K 737 (998)
Q Consensus 664 ~~~y~~~-~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il-~~l~h~nIv~l~~~~~~----~ 737 (998)
.++|.+. +.||+|+||.||+|.+..+|+.||||++... ..+.+|+.++ +..+||||++++++|.. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 4678887 6899999999999999999999999998643 3456788887 45589999999999875 6
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec---CCcEEEEeccCc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLS 814 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~---~g~vkL~DFG~a 814 (998)
.++|||||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 78999999999999999998765556999999999999999999999999999999999999997 789999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 212 ~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 263 (400)
T 1nxk_A 212 KETTSH----------------------------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263 (400)
T ss_dssp EECC---------------------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccCCC----------------------------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCC
Confidence 643211 1123457999999999999999999999999999999999999999
Q ss_pred CCCChHH----HHHHHHhCCCCCC--CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 895 RGKTRQK----TFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 895 ~~~~~~~----~~~~i~~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.+.+... ....+..+...++ ....++.++.+||.+||..||.+||| +.++++||||...
T Consensus 264 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----~~eil~hp~~~~~ 328 (400)
T 1nxk_A 264 YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQS 328 (400)
T ss_dssp CCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC----HHHHHHSHHHHTT
T ss_pred CCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcC----HHHHhcCccccCC
Confidence 8765322 3445555555444 34568899999999999999999999 9999999999863
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=382.80 Aligned_cols=258 Identities=24% Similarity=0.406 Sum_probs=213.8
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||+|.+ .+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 5899999999999999999999 6799999999975432 2223456778999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||++ ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 153 (288)
T 1ob3_A 80 EHLD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP---- 153 (288)
T ss_dssp ECCS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EecC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc----
Confidence 9995 59999887643 45999999999999999999999999999999999999999999999999998543211
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+
T Consensus 154 -----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 210 (288)
T 1ob3_A 154 -----------------------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210 (288)
T ss_dssp -------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred -----------------------ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0112234689999999999764 5899999999999999999999999998887777
Q ss_pred HHHHhC--CCC---CC----------------------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 904 ANILHK--DLK---FP----------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 904 ~~i~~~--~~~---~~----------------------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
..+... ... ++ .....+..+.+||.+||..||.+||| +.++|+||||+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~ 286 (288)
T 1ob3_A 211 MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT----AKQALEHAYFKE 286 (288)
T ss_dssp HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGGC
T ss_pred HHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC----HHHHhcCcchhh
Confidence 666541 000 00 01236788999999999999999999 999999999986
Q ss_pred C
Q 001902 957 V 957 (998)
Q Consensus 957 ~ 957 (998)
.
T Consensus 287 ~ 287 (288)
T 1ob3_A 287 N 287 (288)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=390.88 Aligned_cols=258 Identities=32% Similarity=0.497 Sum_probs=210.9
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
...+.|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.++++++||||+++++++...+.+|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 33578999999999999999999999999999999987542 2356778999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec---CCcEEEEeccCccccC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTS 818 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~---~g~vkL~DFG~a~~~~ 818 (998)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 125 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999999999764 45999999999999999999999999999999999999975 8899999999985432
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 203 ~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 203 HQ----------------------------VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp --------------------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred cc----------------------------cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 10 11234579999999999999999999999999999999999999998766
Q ss_pred hHH-HHHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 899 RQK-TFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 899 ~~~-~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
... .+..+......++. ....+..+.+||.+||..||.+||| +.++|+||||++..
T Consensus 255 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 255 GDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLT----TFQALQHPWVTGKA 313 (349)
T ss_dssp CHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC----HHHHHHSTTTTSTT
T ss_pred ccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcC----HHHHhcCcccCCCc
Confidence 544 55666665544432 3567889999999999999999999 99999999999754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=396.36 Aligned_cols=257 Identities=30% Similarity=0.475 Sum_probs=220.4
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~l 742 (998)
.++|++++.||+|+||.||+|.++.+|+.||+|++.+... ...+|+.++.++ +||||+++++++.+.+.+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 4679999999999999999999999999999999986532 234578888887 79999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC----CcEEEEeccCccccC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDFDLSCLTS 818 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~----g~vkL~DFG~a~~~~ 818 (998)
|||||+|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..+ +.+||+|||++....
T Consensus 94 v~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999999765 459999999999999999999999999999999999998543 359999999986532
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCC--
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG-- 896 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~-- 896 (998)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 172 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 224 (342)
T 2qr7_A 172 AEN---------------------------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224 (342)
T ss_dssp CTT---------------------------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST
T ss_pred CCC---------------------------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC
Confidence 111 112345799999999999888889999999999999999999999986
Q ss_pred -CChHHHHHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhh
Q 001902 897 -KTRQKTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 897 -~~~~~~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
.+....+..+..+...++. ...++..+.+||.+||..||.+||| +.++++||||.. |..+
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----~~~il~hp~~~~--~~~~ 287 (342)
T 2qr7_A 225 DDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT----AALVLRHPWIVH--WDQL 287 (342)
T ss_dssp TSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCC----HHHHTTSHHHHT--GGGS
T ss_pred cCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcC----HHHHhcCCeecC--cccc
Confidence 3556677777777766553 3467899999999999999999999 999999999965 5544
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=407.31 Aligned_cols=256 Identities=24% Similarity=0.439 Sum_probs=212.5
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 737 (998)
.++|++++.||+|+||.||+|.+..+++.||+|++... .........+.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 57899999999999999999999999999999999865 33455567888999999999999999999999654
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
..+||||||++ ++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 140 ~~~~lv~E~~~-~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 140 QDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp CEEEEEEECCS-EEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred CeEEEEEeCCC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 46899999995 457666643 3899999999999999999999999999999999999999999999999999543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.
T Consensus 215 ~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 215 GTS----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp --C----------------------------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCC----------------------------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 211 1223468999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHhCCCC-------------------CCCCCC---------------------CcHHHHHHHHHccccCccC
Q 001902 898 TRQKTFANILHKDLK-------------------FPSSTP---------------------TSLHAKQLMYRLLHRDPKS 937 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~-------------------~~~~~~---------------------~s~~l~~Ll~~~L~~dP~~ 937 (998)
+....+..++..... .+.... .+.++.+||.+||..||.+
T Consensus 267 ~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 346 (464)
T 3ttj_A 267 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346 (464)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhh
Confidence 888777776542100 000000 0457899999999999999
Q ss_pred cCCChhcHHHHHcCCCccCC
Q 001902 938 RLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 938 Rpt~~~~a~elL~Hp~f~~~ 957 (998)
||| +.++|+||||+..
T Consensus 347 R~t----a~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 347 RIS----VDDALQHPYINVW 362 (464)
T ss_dssp SCC----HHHHHTSTTTGGG
T ss_pred CCC----HHHHhcChhhhhc
Confidence 999 9999999999963
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=383.96 Aligned_cols=264 Identities=27% Similarity=0.405 Sum_probs=217.5
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++++.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.++++++||||+++++++...+..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 468999999999999999999999999999999987642 3344556778999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 155 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--- 155 (311)
T ss_dssp EECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc---
Confidence 9999999999988764 45999999999999999999999999999999999999999999999999998653311
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....
T Consensus 156 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 211 (311)
T 4agu_A 156 ------------------------SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ 211 (311)
T ss_dssp ----------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 111234478999999999976 6679999999999999999999999999887766
Q ss_pred HHHHHhC-------------------CCCCCC----------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCC
Q 001902 903 FANILHK-------------------DLKFPS----------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953 (998)
Q Consensus 903 ~~~i~~~-------------------~~~~~~----------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~ 953 (998)
...+... ....+. ....+..+.+||.+||+.||.+||| +.++|+|||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~ 287 (311)
T 4agu_A 212 LYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT----CEQLLHHPY 287 (311)
T ss_dssp HHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC----HHHHHTSGG
T ss_pred HHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCC----HHHHhcChH
Confidence 6554321 111111 1346778999999999999999999 999999999
Q ss_pred ccCCChhh
Q 001902 954 FKGVNWAL 961 (998)
Q Consensus 954 f~~~~~~~ 961 (998)
|+++.+..
T Consensus 288 f~~~~~~~ 295 (311)
T 4agu_A 288 FENIREIE 295 (311)
T ss_dssp GTTCC---
T ss_pred HHhccCHH
Confidence 99987653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=386.52 Aligned_cols=266 Identities=27% Similarity=0.433 Sum_probs=230.0
Q ss_pred CCcccc-cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEE
Q 001902 665 QHFRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 665 ~~y~~~-~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~l 742 (998)
+.|.+. +.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++..+ .||||+++++++...+.+|+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 567777 889999999999999999999999999986532 233456788899999999 56999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec---CCcEEEEeccCccccCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~---~g~vkL~DFG~a~~~~~ 819 (998)
||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 999999999999997665567999999999999999999999999999999999999997 78999999999865421
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 187 ~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 238 (327)
T 3lm5_A 187 A----------------------------CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238 (327)
T ss_dssp -----------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred c----------------------------cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 1 112235799999999999999999999999999999999999999999998
Q ss_pred HHHHHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhh
Q 001902 900 QKTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~ 963 (998)
...+..+......++. ...++..+.+||.+||..||.+||| +.++|+||||+..+|..+.
T Consensus 239 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 239 QETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPT----AEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC----HHHHTTCGGGCCCCTTCC-
T ss_pred hHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcC----HHHHhCCHhhccccccccc
Confidence 8888888776554443 3467889999999999999999999 9999999999999998763
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=392.46 Aligned_cols=285 Identities=41% Similarity=0.728 Sum_probs=229.6
Q ss_pred ccccCCcccccccCCCCceeEEEEEEc---cCCeEEEEEEeeccccc-ChhHHHHHHHHHHHHHhC-CCCCccceeEEEe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDML-DHPFVPALYASFQ 735 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~valK~i~~~~~~-~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~ 735 (998)
.+..++|++++.||+|+||.||+|.+. .+++.||+|++++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 445679999999999999999999984 58999999999764321 122334566799999999 7999999999999
Q ss_pred eCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
..+.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999999999764 359999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC--CCCCChhHHHHHHHHHHHHHcCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDIwSlG~il~eLltG~~P 893 (998)
..... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 208 ~~~~~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~p 261 (355)
T 1vzo_A 208 EFVAD--------------------------ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261 (355)
T ss_dssp ECCGG--------------------------GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred ecccC--------------------------CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 43211 0111234579999999999986 3478899999999999999999999
Q ss_pred CCCCC----hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhhhcCCCC
Q 001902 894 FRGKT----RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPP 968 (998)
Q Consensus 894 f~~~~----~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~~~~ 968 (998)
|.... .......+......++ ..++..+.+||.+||..||.+||++. +.+.++++||||+.++|..+.....|
T Consensus 262 f~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~ 339 (355)
T 1vzo_A 262 FTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 339 (355)
T ss_dssp TSCTTSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred CccCCccchHHHHHHHHhccCCCCC--cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCC
Confidence 97532 3444455555544444 34688999999999999999999221 12999999999999999988655544
Q ss_pred CCCCCCC
Q 001902 969 ELDAPLF 975 (998)
Q Consensus 969 ~~~~p~~ 975 (998)
....|.+
T Consensus 340 ~p~~p~~ 346 (355)
T 1vzo_A 340 APFKPVI 346 (355)
T ss_dssp CSCCCCC
T ss_pred CCCCCcc
Confidence 4444544
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=392.14 Aligned_cols=270 Identities=29% Similarity=0.448 Sum_probs=225.8
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeeccccc--ChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
.++|++++.||+|+||.||+|.+..+++.||+|++.+.... .......+.+|+.+++.++||||+++++++...+..|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 36899999999999999999999999999999999765322 2345678889999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhC--------------------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 001902 742 LITDYCPGGELFLLLDRQ--------------------------------------PTKVLKEDAVRFYAAEVVVALEYL 783 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~qil~aL~~L 783 (998)
+|||||+|++|.+++... ....+++..++.++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998521 012246788899999999999999
Q ss_pred HHCCceeccCCCCcEEEecCC--cEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcc
Q 001902 784 HCQGIIYRDLKPENVLLQGNG--HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYI 861 (998)
Q Consensus 784 H~~~IiHrDLkP~NILi~~~g--~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 861 (998)
|++||+||||||+|||++.++ .+||+|||++......... .........||+.|+
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~-----------------------~~~~~~~~~gt~~y~ 241 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG-----------------------EYYGMTTKAGTPYFV 241 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-------------------------------CCCGGGC
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCcc-----------------------ccccccccCCCcccc
Confidence 999999999999999998776 8999999998654211100 011223457999999
Q ss_pred cchhhcC--CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCC--CCCcHHHHHHHHHccccCccC
Q 001902 862 APEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKS 937 (998)
Q Consensus 862 aPE~l~~--~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~~L~~dP~~ 937 (998)
|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......++.. ...+..+.+||.+||..||.+
T Consensus 242 aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 242 APEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp CHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred CchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence 9999975 678899999999999999999999999999988888888876655433 347889999999999999999
Q ss_pred cCCChhcHHHHHcCCCccCCChh
Q 001902 938 RLGSHEGANEIKKHPFFKGVNWA 960 (998)
Q Consensus 938 Rpt~~~~a~elL~Hp~f~~~~~~ 960 (998)
||+ +.++|+||||+.+.+.
T Consensus 322 Rps----~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 322 RFD----AMRALQHPWISQFSDK 340 (345)
T ss_dssp SCC----HHHHHHSHHHHTTSSC
T ss_pred CCC----HHHHhcChhhccChHh
Confidence 999 9999999999987653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=397.59 Aligned_cols=296 Identities=22% Similarity=0.331 Sum_probs=219.3
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC-----C
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----T 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~ 738 (998)
.++|++++.||+|+||.||+|.+..+++.||||++... .........+.+|+.+|+.++||||+++++++... +
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 47899999999999999999999999999999999754 33455667889999999999999999999999766 6
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
.+|+||||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 104 ELYIVLEIA-DSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CEEEEEECC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred eEEEEEecC-CcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 799999999 56999999764 459999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCCCCcchhhhhcccCCCCccc-ccccccccccccCCCCcccchhh-cCCCCCChhHHHHHHHHHHHHHc-------
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVF-MAEPMRASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLY------- 889 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~gt~~y~aPE~l-~~~~~~~~sDIwSlG~il~eLlt------- 889 (998)
............ ....+.. ...........+||+.|+|||++ ....++.++|||||||++|+|++
T Consensus 181 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 181 SEKDTNIVNDLE------ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp ------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred cccccccccccc------ccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 221110000000 0000000 00001123567899999999986 55679999999999999999998
Q ss_pred ----CCCCCCCCC-----------------hHHHHHHHHh------------------------CCCCCCC-----CCCC
Q 001902 890 ----GYTPFRGKT-----------------RQKTFANILH------------------------KDLKFPS-----STPT 919 (998)
Q Consensus 890 ----G~~Pf~~~~-----------------~~~~~~~i~~------------------------~~~~~~~-----~~~~ 919 (998)
|.++|.+.+ ....+..+.. .....+. ....
T Consensus 255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (432)
T 3n9x_A 255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSI 334 (432)
T ss_dssp SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence 444554433 1122222211 0111110 1346
Q ss_pred cHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhcCCCCCCCCC
Q 001902 920 SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 973 (998)
Q Consensus 920 s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p 973 (998)
+.++.+||.+||..||.+||| +.++|+||||+.+.|...+...+++...|
T Consensus 335 s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~~~~~~e~~~~~~~~~~ 384 (432)
T 3n9x_A 335 SDDGINLLESMLKFNPNKRIT----IDQALDHPYLKDVRKKKLENFSTKKIILP 384 (432)
T ss_dssp CHHHHHHHHHHSCSSTTTSCC----HHHHHTCGGGTTTCCTTTC---CCCCCCS
T ss_pred CHHHHHHHHHHhcCCcccCCC----HHHHhcChhhhhccCcccCcCCCCCCCCC
Confidence 889999999999999999999 99999999999999988765444444333
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=382.81 Aligned_cols=256 Identities=29% Similarity=0.467 Sum_probs=223.5
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
.|...+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4777789999999999999999899999999997543 2334667889999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
|+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 123 ~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----- 194 (321)
T 2c30_A 123 FLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----- 194 (321)
T ss_dssp CCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-----
T ss_pred cCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC-----
Confidence 9999999999865 34999999999999999999999999999999999999999999999999998553311
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..
T Consensus 195 ----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~ 252 (321)
T 2c30_A 195 ----------------------VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252 (321)
T ss_dssp ----------------------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred ----------------------ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0112345799999999999999999999999999999999999999999888877777
Q ss_pred HHhCCCC-CCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 906 ILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 906 i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
+.....+ +......+..+.+||.+||..||.+||| +.++++||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~hp~~~~~~ 302 (321)
T 2c30_A 253 LRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT----AQELLDHPFLLQTG 302 (321)
T ss_dssp HHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGGGCC
T ss_pred HhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcC----HHHHhcChhhccCC
Confidence 7665432 2333457889999999999999999999 99999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=382.37 Aligned_cols=268 Identities=29% Similarity=0.455 Sum_probs=214.9
Q ss_pred cCCcccc-cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEE
Q 001902 664 LQHFRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 664 ~~~y~~~-~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~ 741 (998)
.+.|++. +.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++.++ +||||+++++++...+.+|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4678885 78999999999999999999999999997642 23356788899999985 7999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc---EEEEeccCccccC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTS 818 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~---vkL~DFG~a~~~~ 818 (998)
+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++....
T Consensus 88 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 999999999999999775 45999999999999999999999999999999999999998775 9999999986532
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-----CCCCChhHHHHHHHHHHHHHcCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDIwSlG~il~eLltG~~P 893 (998)
...... ..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 166 ~~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~p 225 (316)
T 2ac3_A 166 LNGDCS--------------------PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225 (316)
T ss_dssp ------------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCS
T ss_pred cCCccc--------------------cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCC
Confidence 111000 000111234579999999999975 4578899999999999999999999
Q ss_pred CCCCCh---------------HHHHHHHHhCCCCCCCC--CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 894 FRGKTR---------------QKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 894 f~~~~~---------------~~~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
|.+... ...+..+......++.. ...+..+.+||.+||..||.+||| +.++|+||||++
T Consensus 226 f~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~e~l~hp~~~~ 301 (316)
T 2ac3_A 226 FVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS----AAQVLQHPWVQG 301 (316)
T ss_dssp CCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHHSTTCC-
T ss_pred CcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCC----HHHHhcChhhcC
Confidence 987542 33455666666655532 457889999999999999999999 999999999998
Q ss_pred CChh
Q 001902 957 VNWA 960 (998)
Q Consensus 957 ~~~~ 960 (998)
..+.
T Consensus 302 ~~~~ 305 (316)
T 2ac3_A 302 CAPE 305 (316)
T ss_dssp ----
T ss_pred CCCc
Confidence 6553
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=391.96 Aligned_cols=258 Identities=32% Similarity=0.532 Sum_probs=223.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeeccccc-C----hhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCC
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-N----RNKVHRACAEREILDML-DHPFVPALYASFQTKT 738 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~-~----~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 738 (998)
++|++.+.||+|+||.||+|.+..+|+.||||++...... . ......+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999999989999999999764321 1 12245678899999999 8999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
..|+||||++|++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.+|.+||+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999999999764 459999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC------CCCCChhHHHHHHHHHHHHHcCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG------AGHTSAVDWWALGILLYEMLYGYT 892 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~sDIwSlG~il~eLltG~~ 892 (998)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 252 ~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~ 303 (365)
T 2y7j_A 252 PG----------------------------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303 (365)
T ss_dssp TT----------------------------CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred CC----------------------------cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCC
Confidence 11 11234579999999999863 357889999999999999999999
Q ss_pred CCCCCChHHHHHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 893 PFRGKTRQKTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 893 Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
||.+.+....+..+......++. ....+..+.+||.+||..||.+||| +.++|+||||+.
T Consensus 304 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~ell~hp~f~r 365 (365)
T 2y7j_A 304 PFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT----AEQALQHPFFER 365 (365)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGCC
T ss_pred CCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcC----HHHHhcCcccCC
Confidence 99998888888888777655432 2457888999999999999999999 999999999974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=411.88 Aligned_cols=263 Identities=29% Similarity=0.456 Sum_probs=232.0
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+..++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.++++++||||+++++++...+.+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 33468999999999999999999999999999999998765544556678899999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---ecCCcEEEEeccCccccC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi---~~~g~vkL~DFG~a~~~~ 818 (998)
+|||||.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 103 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999999999999765 459999999999999999999999999999999999999 467899999999985532
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
.. ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+
T Consensus 181 ~~----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 181 AS----------------------------KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp CC----------------------------CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc----------------------------cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 11 11233479999999999977 68999999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCC--CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 899 RQKTFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
....+..+..+...++ ....++..+++||.+||..||.+||| +.++|+||||+...+
T Consensus 232 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s----~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 232 EYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRIS----ARDALDHEWIQTYTK 290 (484)
T ss_dssp HHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSHHHHHHTC
T ss_pred HHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcC----HHHHhhChhhccccc
Confidence 9999999888765543 34567899999999999999999999 999999999987543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=378.21 Aligned_cols=260 Identities=31% Similarity=0.538 Sum_probs=200.8
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35899999999999999999999999999999999765433334457788999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-- 166 (278)
T ss_dssp EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--
Confidence 9999999999999764 3569999999999999999999999999999999999999999999999999985532110
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
.......||+.|+|||.+.+..++.++|||||||++|+|++|..||........+
T Consensus 167 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 221 (278)
T 3cok_A 167 -------------------------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL 221 (278)
T ss_dssp --------------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---
T ss_pred -------------------------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH
Confidence 1122356899999999999988999999999999999999999999887665555
Q ss_pred HHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 904 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 904 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
..+.......+ ...+.++.+||.+||..||.+||+ +.++++||||+..
T Consensus 222 ~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps----~~~~l~h~~~~~~ 269 (278)
T 3cok_A 222 NKVVLADYEMP--SFLSIEAKDLIHQLLRRNPADRLS----LSSVLDHPFMSRN 269 (278)
T ss_dssp --CCSSCCCCC--TTSCHHHHHHHHHHSCSSGGGSCC----HHHHTTSTTTC--
T ss_pred HHHhhcccCCc--cccCHHHHHHHHHHcccCHhhCCC----HHHHhcCccccCC
Confidence 55544443333 346889999999999999999999 9999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=390.67 Aligned_cols=260 Identities=28% Similarity=0.426 Sum_probs=214.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 737 (998)
.++|++++.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 478999999999999999999999999999999986542 3445567788999999999999999999999765
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 3569999999 8999999976 34899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+
T Consensus 179 ~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 179 DS------------------------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp CS------------------------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cc------------------------------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 21 1234578999999999987 6789999999999999999999999999
Q ss_pred CChHHHHHHHHhCCCCC-----------------------C------CCCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 897 KTRQKTFANILHKDLKF-----------------------P------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~-----------------------~------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
.+....+..+....... + .....+..+.+||.+||..||.+||| +.+
T Consensus 229 ~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t----~~e 304 (367)
T 1cm8_A 229 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT----AGE 304 (367)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHH
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCC----HHH
Confidence 88877777665421100 0 11345789999999999999999999 999
Q ss_pred HHcCCCccCCChhhh
Q 001902 948 IKKHPFFKGVNWALV 962 (998)
Q Consensus 948 lL~Hp~f~~~~~~~~ 962 (998)
+|+||||+.+.....
T Consensus 305 ~l~hp~f~~~~~~~~ 319 (367)
T 1cm8_A 305 ALAHPYFESLHDTED 319 (367)
T ss_dssp HHHSGGGTTTC----
T ss_pred HhcChHHHhhcCCcc
Confidence 999999998766543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=389.14 Aligned_cols=263 Identities=24% Similarity=0.397 Sum_probs=214.2
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 589999999999999999999999999999999875421 111123446999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~---- 153 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---- 153 (324)
T ss_dssp ECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC----
Confidence 9995 6999988765 345999999999999999999999999999999999999999999999999998543211
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+
T Consensus 154 -----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 210 (324)
T 3mtl_A 154 -----------------------TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL 210 (324)
T ss_dssp --------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred -----------------------ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 111234468999999999977 56899999999999999999999999998887777
Q ss_pred HHHHhCCCC-----CC-----------------------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 904 ANILHKDLK-----FP-----------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 904 ~~i~~~~~~-----~~-----------------------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
..+...... ++ ....++..+.+||.+||..||.+||| +.++|+||||+
T Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~ 286 (324)
T 3mtl_A 211 HFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS----AEDAMKHPFFL 286 (324)
T ss_dssp HHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGG
T ss_pred HHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC----HHHHhcChhhh
Confidence 766542110 00 01235778999999999999999999 99999999999
Q ss_pred CCChhhh
Q 001902 956 GVNWALV 962 (998)
Q Consensus 956 ~~~~~~~ 962 (998)
.+.....
T Consensus 287 ~~~~~~~ 293 (324)
T 3mtl_A 287 SLGERIH 293 (324)
T ss_dssp GGCSTTS
T ss_pred hcccccc
Confidence 8755443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=375.14 Aligned_cols=267 Identities=30% Similarity=0.443 Sum_probs=227.8
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeeccccc------ChhHHHHHHHHHHHHHhCC-CCCccceeEEEee
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML------NRNKVHRACAEREILDMLD-HPFVPALYASFQT 736 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~------~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~ 736 (998)
.++|++.+.||+|+||.||+|.+..+|+.||+|++...... .......+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 57899999999999999999999999999999999754211 1233566788999999995 9999999999999
Q ss_pred CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
.+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999999764 4599999999999999999999999999999999999999999999999999855
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc------CCCCCChhHHHHHHHHHHHHHcC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA------GAGHTSAVDWWALGILLYEMLYG 890 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~sDIwSlG~il~eLltG 890 (998)
.... .......|++.|+|||++. ...++.++|||||||++|+|++|
T Consensus 174 ~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g 225 (298)
T 1phk_A 174 LDPG----------------------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225 (298)
T ss_dssp CCTT----------------------------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred cCCC----------------------------cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHC
Confidence 3211 1123456899999999985 45678899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhCCCCCCCC--CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhc
Q 001902 891 YTPFRGKTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRC 964 (998)
Q Consensus 891 ~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~ 964 (998)
..||.+.+.......+......++.. ...+..+.+||.+||..||.+||| +.++++||||+...+..++.
T Consensus 226 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~~~~ 297 (298)
T 1phk_A 226 SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT----AEEALAHPFFQQYVVEEVRH 297 (298)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC----HHHHTTSGGGCTTC------
T ss_pred CCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCC----HHHHHhChHhhhccchhhcc
Confidence 99999988888888888776655433 457889999999999999999999 99999999999988876653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=375.19 Aligned_cols=257 Identities=30% Similarity=0.514 Sum_probs=219.0
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|.+.+.||+|+||.||+|.+..++..+|+|++.... .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 57999999999999999999999999999999998653 2234567889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---ecCCcEEEEeccCccccCC
Q 001902 745 DYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 745 E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi---~~~g~vkL~DFG~a~~~~~ 819 (998)
||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999999999988542 23569999999999999999999999999999999999999 4568899999999854321
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
. .......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.
T Consensus 180 ~----------------------------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~ 230 (285)
T 3is5_A 180 D----------------------------EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230 (285)
T ss_dssp -----------------------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred c----------------------------ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH
Confidence 1 1123456999999999986 4678999999999999999999999999888
Q ss_pred HHHHHHHHhCCCCCCC-CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 900 QKTFANILHKDLKFPS-STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~-~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
......+......++. ....+..+.+||.+||..||.+||| +.++|+||||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~e~l~hp~f~~ 284 (285)
T 3is5_A 231 EEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPS----AAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCC----HHHHHTSGGGGC
T ss_pred HHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcC----HHHHhcCHHhhc
Confidence 7777777665544433 2447889999999999999999999 999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=374.86 Aligned_cols=254 Identities=30% Similarity=0.530 Sum_probs=225.2
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++.+.||+|+||.||+|.+..++..+|+|.+..... .....+.+|+.+++.++||||+++++++...+..|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999986533 23467888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---ecCCcEEEEeccCccccCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi---~~~g~vkL~DFG~a~~~~~~~ 821 (998)
||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 86 ELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred eccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 999999999998764 458999999999999999999999999999999999999 77899999999998553211
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
.......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+...
T Consensus 163 ---------------------------~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 214 (277)
T 3f3z_A 163 ---------------------------KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE 214 (277)
T ss_dssp ---------------------------SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ---------------------------cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH
Confidence 112345699999999998765 8899999999999999999999999999888
Q ss_pred HHHHHHhCCCCCCCC--CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 902 TFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
....+......++.. ...+..+.+||.+||+.||.+||| +.++|+||||+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s----~~~~l~h~~~~~ 267 (277)
T 3f3z_A 215 VMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRIT----SLQALEHEWFEK 267 (277)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC----HHHHTTSHHHHH
T ss_pred HHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcC----HHHHhcCHHHhc
Confidence 888888877666543 357889999999999999999999 999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=383.28 Aligned_cols=260 Identities=27% Similarity=0.477 Sum_probs=232.4
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEE
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 742 (998)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++++...+.+|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 35689999999999999999999999999999999987766666677888999999999999999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 119 v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 195 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 195 (335)
T ss_dssp EECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-
Confidence 99999999999998764 459999999999999999999999999999999999999999999999999986532110
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 196 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 249 (335)
T 2owb_A 196 --------------------------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 249 (335)
T ss_dssp --------------------------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred --------------------------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence 112345799999999999999999999999999999999999999999888888
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
+..+......++. .++..+.+||.+||+.||.+||+ +.++++||||+..
T Consensus 250 ~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps----~~ell~~~~~~~~ 298 (335)
T 2owb_A 250 YLRIKKNEYSIPK--HINPVAASLIQKMLQTDPTARPT----INELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHTCCCCCT--TSCHHHHHHHHHHTCSSGGGSCC----GGGGGGSHHHHTS
T ss_pred HHHHhcCCCCCCc--cCCHHHHHHHHHHccCChhHCcC----HHHHhcCccccCC
Confidence 8888777665554 46889999999999999999999 9999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=374.40 Aligned_cols=260 Identities=27% Similarity=0.474 Sum_probs=231.8
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEE
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 742 (998)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34689999999999999999999999999999999987766666677888999999999999999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 168 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-- 168 (294)
T ss_dssp EEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC--
Confidence 99999999999998764 45999999999999999999999999999999999999999999999999998553211
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
........||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 169 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 223 (294)
T 2rku_A 169 -------------------------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223 (294)
T ss_dssp -------------------------TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred -------------------------ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0112345799999999999998899999999999999999999999999888888
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
+..+......++. ..+..+.+||.+||+.||.+||| +.++++||||+..
T Consensus 224 ~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps----~~~ll~~~~~~~~ 272 (294)
T 2rku_A 224 YLRIKKNEYSIPK--HINPVAASLIQKMLQTDPTARPT----INELLNDEFFTSG 272 (294)
T ss_dssp HHHHHTTCCCCCT--TSCHHHHHHHHHHTCSSGGGSCC----GGGGGGSHHHHTS
T ss_pred HHHHhhccCCCcc--ccCHHHHHHHHHHcccChhhCcC----HHHHhhChheecC
Confidence 8877777665554 46889999999999999999999 9999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=389.69 Aligned_cols=271 Identities=23% Similarity=0.412 Sum_probs=217.0
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC-----
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----- 738 (998)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 578999999999999999999999999999999997642 34455677889999999999999999999997654
Q ss_pred -eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 739 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 739 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
.+|+||||++ ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred cceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 7899999995 578888853 3899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 178 ~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 178 GTS----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp ----------------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccc----------------------------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 210 1123457999999999999999999999999999999999999999998
Q ss_pred ChHHHHHHHHhCCCCC-------------------CCCC---------------------CCcHHHHHHHHHccccCccC
Q 001902 898 TRQKTFANILHKDLKF-------------------PSST---------------------PTSLHAKQLMYRLLHRDPKS 937 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~-------------------~~~~---------------------~~s~~l~~Ll~~~L~~dP~~ 937 (998)
+....+..+....... +... ..+..+.+||.+||..||.+
T Consensus 230 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 309 (371)
T 2xrw_A 230 DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 309 (371)
T ss_dssp SHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGG
T ss_pred CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhh
Confidence 8877777766431110 0000 01457899999999999999
Q ss_pred cCCChhcHHHHHcCCCccCCChhhhhcCCCCCCCC
Q 001902 938 RLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDA 972 (998)
Q Consensus 938 Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~ 972 (998)
||| +.++|+||||+...........||..+.
T Consensus 310 R~t----~~e~l~hp~~~~~~~~~~~~~~~~~~~~ 340 (371)
T 2xrw_A 310 RIS----VDEALQHPYINVWYDPSEAEAPPPKIPD 340 (371)
T ss_dssp SCC----HHHHHHSHHHHTTCCHHHHTCCCCCCCT
T ss_pred CCC----HHHHhCCcchhhhcCccccCCCCCCCCC
Confidence 999 9999999999975444444444445433
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=385.86 Aligned_cols=253 Identities=29% Similarity=0.480 Sum_probs=198.9
Q ss_pred Ccccc---cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEeeCCeEE
Q 001902 666 HFRPI---KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVC 741 (998)
Q Consensus 666 ~y~~~---~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~ 741 (998)
+|++. +.||+|+||.||+|.+..+++.||+|++.+. ......+|+.+++.+. ||||+++++++.+....|
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 45554 7899999999999999999999999998754 2356778999999996 999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC---cEEEEeccCccccC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCLTS 818 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g---~vkL~DFG~a~~~~ 818 (998)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999999999999875 4599999999999999999999999999999999999998766 89999999986432
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 161 ~~---------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 161 PD---------------------------NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp C-------------------------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred CC---------------------------CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 11 111234568999999999999999999999999999999999999998644
Q ss_pred h-------HHHHHHHHhCCCCCCCC--CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 899 R-------QKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 899 ~-------~~~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
. ...+..+..+...++.. ..++.++.+||.+||..||.+||| +.++++||||+..
T Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----~~ell~h~w~~~~ 277 (325)
T 3kn6_A 214 RSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK----MSGLRYNEWLQDG 277 (325)
T ss_dssp ----CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCC----TTTSTTCGGGCTT
T ss_pred cccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCC----HHHHhcChhhccC
Confidence 3 45566666666554432 347889999999999999999999 8899999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=386.99 Aligned_cols=266 Identities=25% Similarity=0.418 Sum_probs=218.4
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccCh-----hHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-----NKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~-----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
.++|++++.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 3689999999999999999999999999999999986543221 13345667999999999999999999999999
Q ss_pred eEEEEEecCCCC-chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 739 HVCLITDYCPGG-ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 739 ~~~lV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
.+++||||+.+| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 999999999766 999999775 45999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCC-CChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus 181 ~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 181 ERG----------------------------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp CTT----------------------------CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred CCC----------------------------CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 211 11234579999999999988776 7799999999999999999999976
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC------CChhhhhcCCCCCC
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG------VNWALVRCMNPPEL 970 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~------~~~~~~~~~~~~~~ 970 (998)
... ...... .....++.++.+||.+||..||.+||| +.++++||||+. ..|..+.....|..
T Consensus 233 ~~~------~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps----~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~ 300 (335)
T 3dls_A 233 LEE------TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTT----LEKLVTDPWVTQPVNLADYTWEEVFRVNKPES 300 (335)
T ss_dssp GGG------GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCC----HHHHHHCTTTTCCCCGGGCCHHHHC-------
T ss_pred HHH------HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcC----HHHHhcCccccCCccccccCHHHHhhhcCCCC
Confidence 322 122222 223346889999999999999999999 999999999976 66776666555554
Q ss_pred C
Q 001902 971 D 971 (998)
Q Consensus 971 ~ 971 (998)
.
T Consensus 301 ~ 301 (335)
T 3dls_A 301 G 301 (335)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=390.67 Aligned_cols=265 Identities=25% Similarity=0.406 Sum_probs=224.7
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+..++|++++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++...+..
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 455689999999999999999999999999999999998642 445567788999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 107 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999999999875 3599999999999999999999996 999999999999999999999999999844210
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 185 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 185 -----------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp -----------------------------HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred -----------------------------ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 112345799999999999999999999999999999999999999987665
Q ss_pred HHHH------------------------------------------HHHHhCCCCCCCCCCCcHHHHHHHHHccccCccC
Q 001902 900 QKTF------------------------------------------ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKS 937 (998)
Q Consensus 900 ~~~~------------------------------------------~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~ 937 (998)
.... ..+............++.++.+||.+||..||.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 315 (360)
T 3eqc_A 236 KELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315 (360)
T ss_dssp HHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTT
T ss_pred HHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhh
Confidence 4332 2222232222223346889999999999999999
Q ss_pred cCCChhcHHHHHcCCCccCCChhhh
Q 001902 938 RLGSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 938 Rpt~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
||| +.++|+||||+...+..+
T Consensus 316 Rpt----~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 316 RAD----LKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp SCC----HHHHHTSHHHHHHHHSCC
T ss_pred CCC----HHHHhhChHhhcchHhhh
Confidence 999 999999999998766543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=372.41 Aligned_cols=261 Identities=28% Similarity=0.479 Sum_probs=221.1
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
..+..++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 34567899999999999999999999998999999999986543334445678899999999999999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
.|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999999999765 3589999999999999999999999999999999999999999999999999855321
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCC-CChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
. .......||+.|+|||.+.+..+ +.++|||||||++|+|++|..||...+
T Consensus 164 ~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 164 G----------------------------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp -----------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C----------------------------cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 1 01123468999999999988765 579999999999999999999999988
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
....+..+......++. ..+..+.+||.+||+.||.+||| +.++++||||+.
T Consensus 216 ~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps----~~~~l~h~~~~~ 267 (276)
T 2h6d_A 216 VPTLFKKIRGGVFYIPE--YLNRSVATLLMHMLQVDPLKRAT----IKDIREHEWFKQ 267 (276)
T ss_dssp HHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSGGGSCC----HHHHHHSHHHHT
T ss_pred HHHHHHHhhcCcccCch--hcCHHHHHHHHHHccCChhhCCC----HHHHHhChhhcc
Confidence 88888877776655543 46789999999999999999999 999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=404.62 Aligned_cols=258 Identities=30% Similarity=0.502 Sum_probs=221.5
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||+|.+..++..||+|++.+..... .....+.+|+.+++.++||||+++++++.....+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999999999999999998654322 23467888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC---CcEEEEeccCccccCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~---g~vkL~DFG~a~~~~~~~ 821 (998)
|||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++......
T Consensus 116 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~- 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192 (494)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence 999999999988764 459999999999999999999999999999999999999764 45999999998654311
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
......+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+...
T Consensus 193 ---------------------------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 244 (494)
T 3lij_A 193 ---------------------------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244 (494)
T ss_dssp ---------------------------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ---------------------------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1123457999999999986 468999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 902 TFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 902 ~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
.+..+......++. ...++..+++||.+||..||.+||| +.++|+||||+...
T Consensus 245 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s----~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 245 ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRIS----AQQALEHPWIKEMC 299 (494)
T ss_dssp HHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCC----HHHHHTCHHHHHHH
T ss_pred HHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCcc----HHHHhcCcccccCc
Confidence 99988887665543 3567899999999999999999999 99999999998753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=386.62 Aligned_cols=268 Identities=25% Similarity=0.445 Sum_probs=231.0
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChh--------------HHHHHHHHHHHHHhCCCCC
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN--------------KVHRACAEREILDMLDHPF 726 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~--------------~~~~~~~E~~il~~l~h~n 726 (998)
.+..++|++++.||+|+||.||+|.+ +|+.||+|++......... ....+.+|+.+++.++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 34568999999999999999999999 8999999999865332221 1277889999999999999
Q ss_pred ccceeEEEeeCCeEEEEEecCCCCchhHH------HhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEE
Q 001902 727 VPALYASFQTKTHVCLITDYCPGGELFLL------LDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVL 799 (998)
Q Consensus 727 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~------l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkP~NIL 799 (998)
|+++++++...+.+|+||||+++++|.++ +.......+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999999999999999999999999998 665445679999999999999999999999 99999999999999
Q ss_pred EecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCC-hhHH
Q 001902 800 LQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTS-AVDW 877 (998)
Q Consensus 800 i~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-~sDI 877 (998)
++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di 235 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK-----------------------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDI 235 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT-----------------------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHH
T ss_pred EcCCCcEEEeccccccccccc-----------------------------cccCCCCCcCccCchhhcCCCCCCcchhhH
Confidence 999999999999998543211 12345699999999999887 5666 9999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHhCCCCCCCC-----------------CCCcHHHHHHHHHccccCccCcC
Q 001902 878 WALGILLYEMLYGYTPFRGKTR-QKTFANILHKDLKFPSS-----------------TPTSLHAKQLMYRLLHRDPKSRL 939 (998)
Q Consensus 878 wSlG~il~eLltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~-----------------~~~s~~l~~Ll~~~L~~dP~~Rp 939 (998)
|||||++|+|++|..||..... ......+......++.. ...+..+.+||.+||+.||.+||
T Consensus 236 ~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 315 (348)
T 2pml_X 236 WSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315 (348)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCC
Confidence 9999999999999999998777 67777777766665532 45788999999999999999999
Q ss_pred CChhcHHHHHcCCCccCCChhhhh
Q 001902 940 GSHEGANEIKKHPFFKGVNWALVR 963 (998)
Q Consensus 940 t~~~~a~elL~Hp~f~~~~~~~~~ 963 (998)
| +.++++||||+..+|..+.
T Consensus 316 s----~~e~l~hp~f~~~~~~~~~ 335 (348)
T 2pml_X 316 T----SEDALKHEWLADTNIEDLR 335 (348)
T ss_dssp C----HHHHHTSGGGTTCCHHHHH
T ss_pred C----HHHHhcCccccCCCHHHHH
Confidence 9 9999999999999987664
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=404.99 Aligned_cols=257 Identities=28% Similarity=0.463 Sum_probs=225.1
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||+|.+..+++.||+|++.+.... ......+.+|+.++++++||||+++++++.....+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 5799999999999999999999999999999999764332 223567889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe---cCCcEEEEeccCccccCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~---~~g~vkL~DFG~a~~~~~~~ 821 (998)
|||.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (486)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence 999999999988764 4599999999999999999999999999999999999995 4567999999998653211
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+...
T Consensus 178 ---------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 229 (486)
T 3mwu_A 178 ---------------------------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD 229 (486)
T ss_dssp -------------------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ---------------------------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 11234579999999999976 48999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCC--CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 902 TFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 902 ~~~~i~~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.+..+..+...++ ....+|..+++||.+||..||.+||| +.++|+||||+..
T Consensus 230 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t----~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 230 ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT----ATQCLEHPWIQKY 283 (486)
T ss_dssp HHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCC----HHHHHHCHHHHHT
T ss_pred HHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcC----HHHHhcCHhhccC
Confidence 9988888765543 44567899999999999999999999 9999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=375.23 Aligned_cols=265 Identities=31% Similarity=0.493 Sum_probs=227.6
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccCh---hHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR---NKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.++|++++.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3579999999999999999999999999999999986543221 2356788999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC----cEEEEeccCccc
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCL 816 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g----~vkL~DFG~a~~ 816 (998)
++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 84 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999999764 4599999999999999999999999999999999999999877 899999999855
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 162 ~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 213 (283)
T 3bhy_A 162 IEAG----------------------------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213 (283)
T ss_dssp CC------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccCC----------------------------CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence 3211 111234689999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhh
Q 001902 897 KTRQKTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
.+.......+......++. ....+..+.+||.+||..||.+||+ +.++++||||+.+.+...
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~~l~h~~~~~~~~~~~ 277 (283)
T 3bhy_A 214 ETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMT----IAQSLEHSWIKAIRRRNV 277 (283)
T ss_dssp SSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCC----HHHHHHCHHHHHHHHCCC
T ss_pred cchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcC----HHHHHhCHHHHHHHHHhh
Confidence 9888888877766554432 2456888999999999999999999 999999999998755443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=404.63 Aligned_cols=259 Identities=28% Similarity=0.439 Sum_probs=224.1
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccCh----------hHHHHHHHHHHHHHhCCCCCccceeEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR----------NKVHRACAEREILDMLDHPFVPALYAS 733 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~----------~~~~~~~~E~~il~~l~h~nIv~l~~~ 733 (998)
.++|++++.||+|+||.||+|.+..+++.||+|++.+...... .....+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4789999999999999999999999999999999986543221 235678899999999999999999999
Q ss_pred EeeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC---cEEEEe
Q 001902 734 FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTD 810 (998)
Q Consensus 734 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g---~vkL~D 810 (998)
+.....+|+|||||+|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999998764 4599999999999999999999999999999999999999776 699999
Q ss_pred ccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcC
Q 001902 811 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 890 (998)
Q Consensus 811 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG 890 (998)
||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|
T Consensus 193 fg~a~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g 243 (504)
T 3q5i_A 193 FGLSSFFSKD----------------------------YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG 243 (504)
T ss_dssp CTTCEECCTT----------------------------SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHS
T ss_pred CCCCEEcCCC----------------------------CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhC
Confidence 9998654311 11234579999999999874 589999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 891 YTPFRGKTRQKTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 891 ~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.+||.+.+....+..+..+...++. ...++.++++||.+||..||.+||| +.++|+||||+..
T Consensus 244 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t----~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 244 YPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCT----AEEALNSRWIKKY 308 (504)
T ss_dssp SCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCC----HHHHhcCHhhhhc
Confidence 9999999999999999887765542 3567899999999999999999999 9999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=378.72 Aligned_cols=264 Identities=26% Similarity=0.386 Sum_probs=222.3
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEee----
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT---- 736 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~---- 736 (998)
...++|++++.||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34578999999999999999999999999999999987542 2235678899999999 89999999999976
Q ss_pred --CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCc
Q 001902 737 --KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814 (998)
Q Consensus 737 --~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a 814 (998)
.+.+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 568999999999999999998765567999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc-----CCCCCChhHHHHHHHHHHHHHc
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLY 889 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDIwSlG~il~eLlt 889 (998)
...... ........||+.|+|||++. +..++.++|||||||++|+|++
T Consensus 177 ~~~~~~---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~ 229 (326)
T 2x7f_A 177 AQLDRT---------------------------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229 (326)
T ss_dssp C----------------------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHH
T ss_pred eecCcC---------------------------ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHh
Confidence 543211 01123457999999999997 5678899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChh
Q 001902 890 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 960 (998)
Q Consensus 890 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 960 (998)
|..||.+.+....+..+.....+......++..+.+||.+||..||.+||+ +.++++||||+...+.
T Consensus 230 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~hp~~~~~~~~ 296 (326)
T 2x7f_A 230 GAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPA----TEQLMKHPFIRDQPNE 296 (326)
T ss_dssp SSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCC----HHHHHTSHHHHCCTTH
T ss_pred CCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCC----HHHHhhChHHhhCccc
Confidence 999999988877777777665554445567899999999999999999999 9999999999987554
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=385.69 Aligned_cols=266 Identities=27% Similarity=0.380 Sum_probs=216.4
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccC--hhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN--RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
.++|++++.||+|+||.||+|.+..+|+.||+|++....... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 468999999999999999999999999999999997543221 112246778999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+||||+++ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 89 lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~- 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP- 165 (346)
T ss_dssp EEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-
T ss_pred EEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC-
Confidence 99999965 898888764 346899999999999999999999999999999999999999999999999998654211
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..
T Consensus 166 --------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~ 219 (346)
T 1ua2_A 166 --------------------------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 219 (346)
T ss_dssp --------------------------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred --------------------------cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence 1122345789999999999764 5788999999999999999999999999888
Q ss_pred HHHHHHHhCCC-----CCCC---------------------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 901 KTFANILHKDL-----KFPS---------------------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 901 ~~~~~i~~~~~-----~~~~---------------------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
..+..+..... .++. ....+..+.+||.+||..||.+||| +.++|+||||
T Consensus 220 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~h~~f 295 (346)
T 1ua2_A 220 DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT----ATQALKMKYF 295 (346)
T ss_dssp HHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGG
T ss_pred HHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCC----HHHHhcChhh
Confidence 88777765210 1110 0334678999999999999999999 9999999999
Q ss_pred cCCChhhh
Q 001902 955 KGVNWALV 962 (998)
Q Consensus 955 ~~~~~~~~ 962 (998)
+...+...
T Consensus 296 ~~~~~~~~ 303 (346)
T 1ua2_A 296 SNRPGPTP 303 (346)
T ss_dssp TSSSCCCC
T ss_pred hcCCCCCC
Confidence 98766544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=388.15 Aligned_cols=260 Identities=27% Similarity=0.404 Sum_probs=205.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 737 (998)
.++|++++.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 378999999999999999999999999999999987542 3445567788999999999999999999998654
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred CeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 5689999999 8999999865 35999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+
T Consensus 183 ~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 183 AD------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp --------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cc------------------------------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 20 1224579999999999987 6789999999999999999999999999
Q ss_pred CChHHHHHHHHhCC-----------------------CCCCC------CCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 897 KTRQKTFANILHKD-----------------------LKFPS------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 897 ~~~~~~~~~i~~~~-----------------------~~~~~------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
.+....+..+.... ...+. ....+..+.+||.+||..||.+||| +.+
T Consensus 233 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t----~~e 308 (367)
T 2fst_X 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQ 308 (367)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC----HHH
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC----HHH
Confidence 88877776665410 00010 1235778999999999999999999 999
Q ss_pred HHcCCCccCCChhhh
Q 001902 948 IKKHPFFKGVNWALV 962 (998)
Q Consensus 948 lL~Hp~f~~~~~~~~ 962 (998)
+|+||||+......-
T Consensus 309 ~L~hp~~~~~~~~~~ 323 (367)
T 2fst_X 309 ALAHAYFAQYHDPDD 323 (367)
T ss_dssp HHTSGGGTTTCCGGG
T ss_pred HhcChhhhhccCCCC
Confidence 999999998765443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=376.63 Aligned_cols=255 Identities=33% Similarity=0.532 Sum_probs=223.1
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|.+.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++...+..|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 579999999999999999999999999999999985422 22356778999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---ecCCcEEEEeccCccccCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi---~~~g~vkL~DFG~a~~~~~~~ 821 (998)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 86 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-- 161 (304)
T 2jam_A 86 QLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-- 161 (304)
T ss_dssp CCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--
T ss_pred EcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--
Confidence 999999999998764 458999999999999999999999999999999999999 7789999999999854210
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 162 ---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 214 (304)
T 2jam_A 162 ---------------------------GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK 214 (304)
T ss_dssp ---------------------------BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred ---------------------------CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 01123468999999999999999999999999999999999999999998888
Q ss_pred HHHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 902 TFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 902 ~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
....+......++. ...++..+.+||.+||..||.+||+ +.++++||||++.
T Consensus 215 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~~l~h~~~~~~ 268 (304)
T 2jam_A 215 LFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYT----CEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCC----HHHHHTSHHHHSS
T ss_pred HHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC----HHHHhcCccccCC
Confidence 88888877655443 3567899999999999999999999 9999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=369.13 Aligned_cols=260 Identities=26% Similarity=0.420 Sum_probs=221.4
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 579999999999999999999999999999999975432 234567889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--- 159 (276)
T 2yex_A 85 EYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN--- 159 (276)
T ss_dssp ECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT---
T ss_pred EecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc---
Confidence 999999999998754 459999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCC-CChhHHHHHHHHHHHHHcCCCCCCCCChH-HH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQ-KT 902 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDIwSlG~il~eLltG~~Pf~~~~~~-~~ 902 (998)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.... ..
T Consensus 160 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 217 (276)
T 2yex_A 160 ----------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217 (276)
T ss_dssp ----------------------EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH
T ss_pred ----------------------chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH
Confidence 0011234579999999999987665 67999999999999999999999876543 33
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
+..+.......+.....+..+.+||.+||..||.+||| +.++++||||+..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~~~~~ 268 (276)
T 2yex_A 218 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT----IPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC----HHHHTTCTTTTCC
T ss_pred HHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCC----HHHHhcCccccCh
Confidence 44444444444444567889999999999999999999 9999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=378.97 Aligned_cols=254 Identities=25% Similarity=0.356 Sum_probs=207.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~l 742 (998)
.++|++++.||+|+||+||+|.+..+|+.||||++..... ..........|+..+..+ +|+||+++++++...+.+|+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 4689999999999999999999999999999999875433 233334445555555544 99999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 135 v~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-- 210 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-- 210 (311)
T ss_dssp EEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC--
Confidence 99999 779988887653 45999999999999999999999999999999999999999999999999998553211
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. .
T Consensus 211 --------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~ 260 (311)
T 3p1a_A 211 --------------------------GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---G 260 (311)
T ss_dssp ------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---H
T ss_pred --------------------------CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---H
Confidence 11234469999999999876 68999999999999999999977776532 2
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
...+.....+......++..+.+||.+||+.||.+||| +.++|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~ell~hp~~~~ 310 (311)
T 3p1a_A 261 WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRAT----AEALLALPVLRQ 310 (311)
T ss_dssp HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGSC
T ss_pred HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcC----HHHHHhCccccC
Confidence 33333333222223456889999999999999999999 999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=371.87 Aligned_cols=253 Identities=22% Similarity=0.326 Sum_probs=215.9
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+..++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+.+|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 34578999999999999999999999999999999997665556667788999999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 88 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 999999999999999875 459999999999999999999999999999999999999999999999999986542110
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 166 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~ 219 (294)
T 4eqm_A 166 --------------------------LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS 219 (294)
T ss_dssp -----------------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH
T ss_pred --------------------------ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 112234579999999999999999999999999999999999999999988877
Q ss_pred HHHHHHhCCCCCC---CCCCCcHHHHHHHHHccccCccCcCCCh
Q 001902 902 TFANILHKDLKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSH 942 (998)
Q Consensus 902 ~~~~i~~~~~~~~---~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~ 942 (998)
..........+.. ....++..+.++|.+||..||.+||+..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~ 263 (294)
T 4eqm_A 220 IAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTI 263 (294)
T ss_dssp HHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSH
T ss_pred HHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccH
Confidence 7766666543321 2345788999999999999999999743
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=387.39 Aligned_cols=258 Identities=27% Similarity=0.456 Sum_probs=212.7
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee-----
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----- 736 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~----- 736 (998)
...++|++++.||+|+||.||+|.+..+|+.||+|++..... ...+|+.+++.++||||++++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 345789999999999999999999999999999999875421 22369999999999999999999843
Q ss_pred ---------------------------------CCeEEEEEecCCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHH
Q 001902 737 ---------------------------------KTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALE 781 (998)
Q Consensus 737 ---------------------------------~~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~ 781 (998)
..++++||||++ ++|.+.+.. .....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 345899999996 588777653 23456999999999999999999
Q ss_pred HHHHCCceeccCCCCcEEEe-cCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCc
Q 001902 782 YLHCQGIIYRDLKPENVLLQ-GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEY 860 (998)
Q Consensus 782 ~LH~~~IiHrDLkP~NILi~-~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 860 (998)
|||++||+||||||+|||++ .++.+||+|||++...... .......||+.|
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~----------------------------~~~~~~~~t~~y 207 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS----------------------------EPSVAYICSRFY 207 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT----------------------------SCCCCCCCCSSC
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC----------------------------CCCcCcccCCCc
Confidence 99999999999999999998 6899999999999653211 122345789999
Q ss_pred ccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC-----------------CCCCCC-------
Q 001902 861 IAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK-----------------DLKFPS------- 915 (998)
Q Consensus 861 ~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~-----------------~~~~~~------- 915 (998)
+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..++.. ...++.
T Consensus 208 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (383)
T 3eb0_A 208 RAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR 287 (383)
T ss_dssp CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHH
T ss_pred cCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHH
Confidence 999999875 4899999999999999999999999999888877777641 111111
Q ss_pred ---CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 916 ---STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 916 ---~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
....+..+.+||.+||..||.+||| +.++|+||||+.+..
T Consensus 288 ~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 288 KILPEGTPSLAIDLLEQILRYEPDLRIN----PYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHSCTTCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSGGGHHHHH
T ss_pred hhCCCCCCHHHHHHHHHHccCChhhCCC----HHHHhcCHHHHHHHh
Confidence 1236788999999999999999999 999999999997644
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=370.02 Aligned_cols=257 Identities=22% Similarity=0.355 Sum_probs=216.7
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee----CC
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----KT 738 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~----~~ 738 (998)
....|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 34568999999999999999999999999999999986533 44556788899999999999999999998865 46
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEe-cCCcEEEEeccCcc
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQ-GNGHVSLTDFDLSC 815 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkP~NILi~-~~g~vkL~DFG~a~ 815 (998)
.+|+||||+++++|.+++... ..++...++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 789999999999999999874 45899999999999999999999999 99999999999998 78999999999985
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 181 ~~~~-----------------------------~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~ 230 (290)
T 1t4h_A 181 LKRA-----------------------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp GCCT-----------------------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccc-----------------------------cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCC
Confidence 4221 11234569999999998875 58999999999999999999999998
Q ss_pred CCChHHHHHHHH-hCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 896 GKTRQKTFANIL-HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 896 ~~~~~~~~~~i~-~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
+........... ....+.......+..+.+||.+||..||.+||| +.++++||||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~h~~f~~ 288 (290)
T 1t4h_A 231 ECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS----IKDLLNHAFFQE 288 (290)
T ss_dssp TCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGC-
T ss_pred CcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCC----HHHHhhCccccc
Confidence 865544444443 333332233445788999999999999999999 999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=381.24 Aligned_cols=265 Identities=25% Similarity=0.320 Sum_probs=217.4
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee-------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------- 736 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~------- 736 (998)
.++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4689999999999999999999999999999999876532 22234567789999999999999999999976
Q ss_pred -CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 737 -KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 737 -~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
.+.+|+||||++ ++|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 95 CKGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp --CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 457899999995 57777776542 459999999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
........ .........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||
T Consensus 173 ~~~~~~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 229 (351)
T 3mi9_A 173 AFSLAKNS-----------------------QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229 (351)
T ss_dssp ECCCCSSS-----------------------SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccc-----------------------cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 54311110 0112244578999999999976 45799999999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCCCCC--CCC----------------------------CcHHHHHHHHHccccCccCcCCChhc
Q 001902 895 RGKTRQKTFANILHKDLKFPS--STP----------------------------TSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 895 ~~~~~~~~~~~i~~~~~~~~~--~~~----------------------------~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
.+.+.......+.......+. ... .+..+.+||.+||..||.+|||
T Consensus 230 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---- 305 (351)
T 3mi9_A 230 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID---- 305 (351)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC----
T ss_pred CCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC----
Confidence 998887777766542111111 100 2567899999999999999999
Q ss_pred HHHHHcCCCccCCC
Q 001902 945 ANEIKKHPFFKGVN 958 (998)
Q Consensus 945 a~elL~Hp~f~~~~ 958 (998)
+.++|+||||+...
T Consensus 306 ~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 306 SDDALNHDFFWSDP 319 (351)
T ss_dssp HHHHHTSGGGGSSS
T ss_pred HHHHhCCCCcCCCC
Confidence 99999999998743
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=374.35 Aligned_cols=266 Identities=25% Similarity=0.385 Sum_probs=223.6
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeeccccc-ChhHHHHHHHHHHHHHhCCCCCccceeEEEe--eCCeE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDHPFVPALYASFQ--TKTHV 740 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~--~~~~~ 740 (998)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.++||||+++++++. ..+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999999999999999999764322 1344577889999999999999999999984 45689
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||++++ |.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999665 778877665667999999999999999999999999999999999999999999999999998654211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCC--CChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH--TSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
.. ........||+.|+|||++.+... +.++|||||||++|+|++|..||.+.+
T Consensus 163 ~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 163 AA-------------------------DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp CS-------------------------SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cc-------------------------ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 00 011234569999999999977543 679999999999999999999999998
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhh
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWAL 961 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 961 (998)
.......+......++. .++..+.+||.+||..||.+||| +.++++||||+......
T Consensus 218 ~~~~~~~i~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps----~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 218 IYKLFENIGKGSYAIPG--DCGPPLSDLLKGMLEYEPAKRFS----IRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp HHHHHHHHHHCCCCCCS--SSCHHHHHHHHHHTCSSTTTSCC----HHHHHHSHHHHSCCCC-
T ss_pred HHHHHHHHhcCCCCCCC--ccCHHHHHHHHHHccCChhhCCC----HHHHhcCcccccCCCCc
Confidence 88888888877665543 46889999999999999999999 99999999999865543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=392.96 Aligned_cols=256 Identities=25% Similarity=0.422 Sum_probs=217.2
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC------CCCCccceeEEEee
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML------DHPFVPALYASFQT 736 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l------~h~nIv~l~~~~~~ 736 (998)
...+|++++.||+|+||.||+|.+..+++.||+|++... ......+..|+.+++.+ +|+||+++++++..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 346899999999999999999999999999999998753 23445677788888877 57799999999999
Q ss_pred CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc--EEEEeccCc
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--VSLTDFDLS 814 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~--vkL~DFG~a 814 (998)
.+.+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++|||||||||+|||++.++. +||+|||++
T Consensus 171 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999999999 579999998776566999999999999999999999999999999999999999887 999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
+... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||
T Consensus 250 ~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf 299 (429)
T 3kvw_A 250 CYEH------------------------------QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLL 299 (429)
T ss_dssp EETT------------------------------CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred eecC------------------------------CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCC
Confidence 5422 1122457999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCC--------------------CC-----------------------------C--------CC
Q 001902 895 RGKTRQKTFANILHKDLK--------------------FP-----------------------------S--------ST 917 (998)
Q Consensus 895 ~~~~~~~~~~~i~~~~~~--------------------~~-----------------------------~--------~~ 917 (998)
.+.+....+..+...... ++ . ..
T Consensus 300 ~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 379 (429)
T 3kvw_A 300 PGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379 (429)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTT
T ss_pred CCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccc
Confidence 998887777666531000 00 0 01
Q ss_pred CCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 918 PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 918 ~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
..+..+.+||.+||+.||.+||| +.++|+||||+..
T Consensus 380 ~~~~~~~dli~~~L~~dP~~Rpt----a~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 380 CDDPLFLDFLKQCLEWDPAVRMT----PGQALRHPWLRRR 415 (429)
T ss_dssp CCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSTTTC--
T ss_pred cchHHHHHHHHHHCCCChhhCCC----HHHHhCChhhccC
Confidence 23678899999999999999999 9999999999973
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=383.62 Aligned_cols=263 Identities=22% Similarity=0.346 Sum_probs=221.0
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC----e
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----H 739 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----~ 739 (998)
.++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 578999999999999999999999999999999998766556666778899999999999999999999987543 4
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
.|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 59999999999999999764 4599999999999999999999999999999999999999999999999999865431
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
... .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 169 ~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 169 SGN------------------------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp -------------------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccc------------------------ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 110 01122345799999999999999999999999999999999999999999888
Q ss_pred HHHHHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 900 QKTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
......+.......+. ...++.++.+||.+||..||.+||+ ..+++.|+|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~----~~~~l~~~l~~~ 279 (311)
T 3ork_A 225 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ----TAAEMRADLVRV 279 (311)
T ss_dssp HHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCS----SHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChh----hHHHHHHHHHHH
Confidence 8777777766543332 2447889999999999999999999 888899998764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=383.01 Aligned_cols=265 Identities=26% Similarity=0.353 Sum_probs=220.9
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEE
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 742 (998)
..++|++++.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++...+..|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 3578999999999999999999999999999999987542 334445667889999999999999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 102 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp EEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence 99999999998887654 359999999999999999999999999999999999999999999999999985532110
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+...
T Consensus 179 --------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 232 (331)
T 4aaa_A 179 --------------------------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID 232 (331)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred --------------------------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 112345689999999999875 78899999999999999999999999988777
Q ss_pred HHHHHHhC-------------------CCCCCC----------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCC
Q 001902 902 TFANILHK-------------------DLKFPS----------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 952 (998)
Q Consensus 902 ~~~~i~~~-------------------~~~~~~----------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp 952 (998)
.+..+... ....+. ...++..+.+||.+||..||.+||| +.++|+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~ell~hp 308 (331)
T 4aaa_A 233 QLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF----CAELLHHD 308 (331)
T ss_dssp HHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC----GGGGGGSH
T ss_pred HHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCC----HHHHhcCc
Confidence 66655431 111111 1246788999999999999999999 89999999
Q ss_pred CccCCChhh
Q 001902 953 FFKGVNWAL 961 (998)
Q Consensus 953 ~f~~~~~~~ 961 (998)
||+...+..
T Consensus 309 ~f~~~~~~~ 317 (331)
T 4aaa_A 309 FFQMDGFAE 317 (331)
T ss_dssp HHHGGGHHH
T ss_pred hhccCChhh
Confidence 999876643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=374.18 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=211.9
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEee--CCe
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQT--KTH 739 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~--~~~ 739 (998)
+.++|++++.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.++ ||||+++++++.. ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 457899999999999999999999999999999998743 2366888999999996 9999999999987 678
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC-cEEEEeccCccccC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTS 818 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g-~vkL~DFG~a~~~~ 818 (998)
.++||||+++++|.+++.. +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 108 ~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999999999854 89999999999999999999999999999999999999777 89999999986532
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 183 ~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 183 PG----------------------------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp TT----------------------------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CC----------------------------CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 11 11234578999999999987 67899999999999999999999999543
Q ss_pred -ChHHHHHHHHh-------------CCCCC----------------------CCCCCCcHHHHHHHHHccccCccCcCCC
Q 001902 898 -TRQKTFANILH-------------KDLKF----------------------PSSTPTSLHAKQLMYRLLHRDPKSRLGS 941 (998)
Q Consensus 898 -~~~~~~~~i~~-------------~~~~~----------------------~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~ 941 (998)
+....+..+.. ..... ......+.++.+||.+||+.||.+|||
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt- 313 (330)
T 3nsz_A 235 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT- 313 (330)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC-
T ss_pred CchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCC-
Confidence 33332222211 11111 111226889999999999999999999
Q ss_pred hhcHHHHHcCCCccCCChh
Q 001902 942 HEGANEIKKHPFFKGVNWA 960 (998)
Q Consensus 942 ~~~a~elL~Hp~f~~~~~~ 960 (998)
+.++|+||||+.+.+.
T Consensus 314 ---a~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 314 ---AREAMEHPYFYTVVKD 329 (330)
T ss_dssp ---HHHHHTSGGGTTCC--
T ss_pred ---HHHHhcCccHhhhccC
Confidence 9999999999997653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=380.55 Aligned_cols=260 Identities=24% Similarity=0.377 Sum_probs=214.4
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCC--CCccceeEEEeeCCe
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTKTH 739 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h--~nIv~l~~~~~~~~~ 739 (998)
+..+.|++++.||+|+||.||+|.+ .+++.||+|++.... ........+.+|+.+++.++| +||+++++++...+.
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 4567899999999999999999998 568999999997653 244556788899999999976 999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|+|||+ .+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9999995 488999999875 4599999999999999999999999999999999999997 78999999999965431
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-----------CCCCChhHHHHHHHHHHHHH
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----------AGHTSAVDWWALGILLYEML 888 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~sDIwSlG~il~eLl 888 (998)
... .......+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 160 ~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell 214 (343)
T 3dbq_A 160 DTT-------------------------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 214 (343)
T ss_dssp -----------------------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHH
T ss_pred ccc-------------------------cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHH
Confidence 110 012234579999999999965 67888999999999999999
Q ss_pred cCCCCCCCCCh-HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 889 YGYTPFRGKTR-QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 889 tG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
+|..||.+... ...+..+.............+..+.+||.+||..||.+||| +.++|+||||+.
T Consensus 215 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt----~~e~l~hp~~~~ 279 (343)
T 3dbq_A 215 YGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS----IPELLAHPYVQI 279 (343)
T ss_dssp HSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHS
T ss_pred hCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCC----HHHHHhCccccc
Confidence 99999987543 34455555544444444456788999999999999999999 999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=373.54 Aligned_cols=263 Identities=25% Similarity=0.447 Sum_probs=222.0
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.+.|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 46899999999999999999999999999999998754 233456788899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 95 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~----- 168 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL----- 168 (302)
T ss_dssp EECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH-----
T ss_pred EEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccc-----
Confidence 9999999999988753 2459999999999999999999999999999999999999999999999999874311
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhh-----cCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII-----AGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l-----~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
..........||+.|+|||++ .+..++.++|||||||++|+|++|..||...+
T Consensus 169 ----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 169 ----------------------KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp ----------------------HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ----------------------ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 000112345799999999998 36678899999999999999999999999988
Q ss_pred hHHHHHHHHhCCCCC-CCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhh
Q 001902 899 RQKTFANILHKDLKF-PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWAL 961 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~-~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 961 (998)
....+..+.....+. .....++..+.+||.+||..||.+||| +.++++||||+.+.+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~ 286 (302)
T 2j7t_A 227 PMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPS----AAQLLEHPFVSSITSNK 286 (302)
T ss_dssp HHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCC----HHHHTTSTTTTTCCCCH
T ss_pred HHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCC----HHHHhcChHHhhhccch
Confidence 887777777664432 233456889999999999999999999 99999999999987753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=380.44 Aligned_cols=270 Identities=21% Similarity=0.357 Sum_probs=210.0
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC-----
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----- 738 (998)
.++|++++.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 357999999999999999999999999999999997542 3445677899999999999999999999985533
Q ss_pred ----------------------------------------------------eEEEEEecCCCCchhHHHhhCCC-CCCC
Q 001902 739 ----------------------------------------------------HVCLITDYCPGGELFLLLDRQPT-KVLK 765 (998)
Q Consensus 739 ----------------------------------------------------~~~lV~E~~~ggsL~~~l~~~~~-~~l~ 765 (998)
++++|||||++++|.+++..... ...+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 48999999999999999986432 2356
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCccccc
Q 001902 766 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845 (998)
Q Consensus 766 ~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (998)
...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++............ ....
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~---------------~~~~ 227 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV---------------LTPM 227 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------------------------
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc---------------cccc
Confidence 6678999999999999999999999999999999999999999999999765422111000 0000
Q ss_pred ccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHH
Q 001902 846 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQ 925 (998)
Q Consensus 846 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 925 (998)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..|+.. .......+.....+. .....+..+.+
T Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~ 304 (332)
T 3qd2_B 228 PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPL-LFTQKYPQEHM 304 (332)
T ss_dssp ----CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCH-HHHHHCHHHHH
T ss_pred cccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCc-ccccCChhHHH
Confidence 011233456799999999999999999999999999999999998776532 122222232222111 11224567899
Q ss_pred HHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 926 LMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 926 Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
||.+||..||.+||| +.++++||||+++
T Consensus 305 li~~~l~~~p~~Rps----~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 305 MVQDMLSPSPTERPE----ATDIIENAIFENL 332 (332)
T ss_dssp HHHHHHCSSGGGSCC----HHHHHHSTTCCCC
T ss_pred HHHHHccCCCCcCCC----HHHHhhchhhhcC
Confidence 999999999999999 9999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=383.90 Aligned_cols=260 Identities=26% Similarity=0.401 Sum_probs=218.9
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE---
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV--- 740 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~--- 740 (998)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 378999999999999999999999999999999997643 3444567788999999999999999999999876654
Q ss_pred ---EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 741 ---CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 741 ---~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999995 788888743 3999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus 195 ~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 195 DA------------------------------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp -----------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cc------------------------------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 21 1224578999999999987 6789999999999999999999999999
Q ss_pred CChHHHHHHHHhCCCC-----------------------CCC------CCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 897 KTRQKTFANILHKDLK-----------------------FPS------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~-----------------------~~~------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
.+....+..+...... .+. ....+..+.+||.+||+.||.+||| +.+
T Consensus 245 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e 320 (371)
T 4exu_A 245 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT----AAQ 320 (371)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC----HHH
T ss_pred CChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCC----HHH
Confidence 8877777666541100 000 1245789999999999999999999 999
Q ss_pred HHcCCCccCCChhhhh
Q 001902 948 IKKHPFFKGVNWALVR 963 (998)
Q Consensus 948 lL~Hp~f~~~~~~~~~ 963 (998)
+|+||||+.+......
T Consensus 321 ll~hp~f~~~~~~~~~ 336 (371)
T 4exu_A 321 ALTHPFFEPFRDPEEE 336 (371)
T ss_dssp HHTSGGGTTTCCGGGC
T ss_pred HhcCcccccCCCcccc
Confidence 9999999987665543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=371.31 Aligned_cols=262 Identities=25% Similarity=0.377 Sum_probs=208.0
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
++..++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+..+...++.++||||+++++++...+..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 3556899999999999999999999999999999999975422 222333344455567888999999999999999999
Q ss_pred EEEEecCCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 741 CLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
|+||||++ ++|.+++.. .....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999995 588777754 2345699999999999999999999998 9999999999999999999999999998553
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhh----cCCCCCChhHHHHHHHHHHHHHcCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII----AGAGHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~sDIwSlG~il~eLltG~~P 893 (998)
... .......||+.|+|||++ .+..++.++|||||||++|+|++|..|
T Consensus 161 ~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 212 (290)
T 3fme_A 161 VDD----------------------------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212 (290)
T ss_dssp -------------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCS
T ss_pred ccc----------------------------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 211 111234699999999996 456788899999999999999999999
Q ss_pred CCC-CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 894 FRG-KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 894 f~~-~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
|.. ......+................+..+.+||.+||..||.+||| +.++++||||+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~e~l~hp~f~~ 272 (290)
T 3fme_A 213 YDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPT----YPELMQHPFFTL 272 (290)
T ss_dssp SCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCC----HHHHTTSHHHHH
T ss_pred ccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcC----HHHHHhCccccc
Confidence 986 44455555566555444444567899999999999999999999 999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=381.34 Aligned_cols=260 Identities=23% Similarity=0.364 Sum_probs=217.8
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC-----C
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----T 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~ 738 (998)
.++|++++.||+|+||.||+|.+..+++.||+|++... ........+.+|+.++++++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 36899999999999999999999999999999998753 2344557788999999999999999999999754 4
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
..|+||||++ ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 7899999995 6999998763 49999999999999999999999999999999999999999999999999996543
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
.... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus 180 ~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 235 (364)
T 3qyz_A 180 PDHD------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 235 (364)
T ss_dssp GGGC------------------------BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCC------------------------ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence 1110 0111234579999999998755 55899999999999999999999999998
Q ss_pred ChHHHHHHHHhCCC----------------------CCCC-------CCCCcHHHHHHHHHccccCccCcCCChhcHHHH
Q 001902 898 TRQKTFANILHKDL----------------------KFPS-------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948 (998)
Q Consensus 898 ~~~~~~~~i~~~~~----------------------~~~~-------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 948 (998)
+....+..+..... +.+. ....+..+.+||.+||..||.+||| +.++
T Consensus 236 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~ 311 (364)
T 3qyz_A 236 HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE----VEQA 311 (364)
T ss_dssp SGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC----HHHH
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC----HHHH
Confidence 87776666543100 0000 1345788999999999999999999 9999
Q ss_pred HcCCCccCC
Q 001902 949 KKHPFFKGV 957 (998)
Q Consensus 949 L~Hp~f~~~ 957 (998)
|+||||+..
T Consensus 312 l~hp~~~~~ 320 (364)
T 3qyz_A 312 LAHPYLEQY 320 (364)
T ss_dssp HTSGGGTTT
T ss_pred hcCcchhhc
Confidence 999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=394.05 Aligned_cols=263 Identities=32% Similarity=0.499 Sum_probs=211.3
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccC-----hhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-----RNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~-----~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.+..... ......+.+|+.+|++++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 468999999999999999999999999999999998654321 1223357789999999999999999999854 5
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC---cEEEEeccCcc
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSC 815 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g---~vkL~DFG~a~ 815 (998)
..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 579999999999999998764 4599999999999999999999999999999999999997544 59999999996
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC---CCCCChhHHHHHHHHHHHHHcCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYT 892 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDIwSlG~il~eLltG~~ 892 (998)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+
T Consensus 291 ~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~ 342 (419)
T 3i6u_A 291 ILGET----------------------------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342 (419)
T ss_dssp SCC---------------------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCC----------------------------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 54311 11234579999999999864 567789999999999999999999
Q ss_pred CCCCCChH-HHHHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhh
Q 001902 893 PFRGKTRQ-KTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWAL 961 (998)
Q Consensus 893 Pf~~~~~~-~~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 961 (998)
||.+.... .....+......++. ....+..+.+||.+||..||.+||| +.++|+||||+..++..
T Consensus 343 pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~e~l~hp~~~~~~~~~ 410 (419)
T 3i6u_A 343 PFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT----TEEALRHPWLQDEDMKR 410 (419)
T ss_dssp SSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGCCHHHHH
T ss_pred CCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcC----HHHHhCCcccCChhHHH
Confidence 99875443 333444444443322 2456889999999999999999999 99999999999877654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=385.03 Aligned_cols=262 Identities=24% Similarity=0.382 Sum_probs=216.6
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC--CCCccceeEEEeeCCe
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD--HPFVPALYASFQTKTH 739 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~--h~nIv~l~~~~~~~~~ 739 (998)
+....|++++.||+|+||.||+|.+.. ++.||+|++..... .......+.+|+.+++.+. ||||+++++++...+.
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 344579999999999999999999854 89999999976532 4456678899999999996 5999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+||||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 999999 5589999999875 4689999999999999999999999999999999999996 68999999999965431
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-----------CCCCChhHHHHHHHHHHHHH
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----------AGHTSAVDWWALGILLYEML 888 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~sDIwSlG~il~eLl 888 (998)
... .......+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 207 ~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell 261 (390)
T 2zmd_A 207 DTT-------------------------SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 261 (390)
T ss_dssp --------------------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHH
T ss_pred CCc-------------------------cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHH
Confidence 100 011234579999999999975 36888999999999999999
Q ss_pred cCCCCCCCCC-hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 889 YGYTPFRGKT-RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 889 tG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
+|..||.+.. ....+..+.......+.....+..+.+||.+||..||.+||+ +.++|+||||+...
T Consensus 262 ~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 262 YGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS----IPELLAHPYVQIQT 328 (390)
T ss_dssp HSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHSCC
T ss_pred HCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCC----HHHHhhCcCccccC
Confidence 9999998754 345556666555444444445789999999999999999999 99999999998643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=374.74 Aligned_cols=274 Identities=25% Similarity=0.404 Sum_probs=201.5
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
..+..++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 34667899999999999999999999988999999998875421 2335667889999999999999999999999999
Q ss_pred EEEEEecCCCCchhHHHhh------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccC
Q 001902 740 VCLITDYCPGGELFLLLDR------QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 813 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~------~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~ 813 (998)
.++||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999874 1235699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCC
Q 001902 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYT 892 (998)
Q Consensus 814 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~ 892 (998)
+......... ..........||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 168 ~~~~~~~~~~----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 225 (303)
T 2vwi_A 168 SAFLATGGDI----------------------TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225 (303)
T ss_dssp HHHCC-------------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred hheeccCCCc----------------------cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 8654311100 00112234579999999999876 568899999999999999999999
Q ss_pred CCCCCChHHHHHHHHhCCCCCC--------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhh
Q 001902 893 PFRGKTRQKTFANILHKDLKFP--------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWAL 961 (998)
Q Consensus 893 Pf~~~~~~~~~~~i~~~~~~~~--------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 961 (998)
||.................... .....+..+.+||.+||..||.+||+ +.++++||||+...+..
T Consensus 226 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~ 298 (303)
T 2vwi_A 226 PYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT----AAELLRHKFFQKAKNKE 298 (303)
T ss_dssp TTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSTTC-------
T ss_pred CCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcC----HHHHhhChhhhcCCCCc
Confidence 9998877666655554432211 12346788999999999999999999 99999999999876543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=390.01 Aligned_cols=259 Identities=30% Similarity=0.456 Sum_probs=211.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee------C
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------K 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~------~ 737 (998)
..+|++++.||+|+||.||+|.+..+|+.||||++..... ...+|+.+++.++||||++++++|.. .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 3479999999999999999999999999999999875421 22369999999999999999998853 2
Q ss_pred CeEEEEEecCCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC-CcEEEEeccCc
Q 001902 738 THVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLS 814 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~-g~vkL~DFG~a 814 (998)
.++++||||+++ +|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 347899999964 66666542 223569999999999999999999999999999999999999965 67899999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~P 893 (998)
+..... ......+||+.|+|||++.+. .++.++|||||||++|+|++|++|
T Consensus 205 ~~~~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~p 256 (420)
T 1j1b_A 205 KQLVRG----------------------------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 256 (420)
T ss_dssp EECCTT----------------------------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred hhcccC----------------------------CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 653211 112345789999999999775 789999999999999999999999
Q ss_pred CCCCChHHHHHHHHhC-----------------CCCCCC----------CCCCcHHHHHHHHHccccCccCcCCChhcHH
Q 001902 894 FRGKTRQKTFANILHK-----------------DLKFPS----------STPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~-----------------~~~~~~----------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 946 (998)
|.+.+....+..++.. .+.++. ....+.++.+||.+||..||.+||| +.
T Consensus 257 f~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t----~~ 332 (420)
T 1j1b_A 257 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PL 332 (420)
T ss_dssp SCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC----HH
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC----HH
Confidence 9998887777666541 122221 1235789999999999999999999 99
Q ss_pred HHHcCCCccCCChhhh
Q 001902 947 EIKKHPFFKGVNWALV 962 (998)
Q Consensus 947 elL~Hp~f~~~~~~~~ 962 (998)
++++||||+.+.+...
T Consensus 333 e~l~hp~f~~~~~~~~ 348 (420)
T 1j1b_A 333 EACAHSFFDELRDPNV 348 (420)
T ss_dssp HHHTSGGGGGGGCTTC
T ss_pred HHhCCHhhcccccccc
Confidence 9999999998765543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=376.80 Aligned_cols=272 Identities=23% Similarity=0.346 Sum_probs=219.5
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC-----C
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----T 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~ 738 (998)
.++|++.+.||+|+||.||+|.+..+|+.||+|++... ........+.+|+.+++.++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 47899999999999999999999999999999998643 2344556778999999999999999999988654 6
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
..|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 8999999995 699999876 349999999999999999999999999999999999999999999999999996653
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
........ ...........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus 164 ~~~~~~~~-----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 164 ESAADNSE-----------------PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp ---------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccC-----------------ccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22111000 0000112234679999999998865 67889999999999999999999999998
Q ss_pred ChHHHHHHHHhC--C----------------------CCCCC------CCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 898 TRQKTFANILHK--D----------------------LKFPS------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 898 ~~~~~~~~i~~~--~----------------------~~~~~------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
+....+..+... . ...+. ....+..+.+||.+||..||.+||| +.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e 302 (353)
T 2b9h_A 227 DYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT----AKE 302 (353)
T ss_dssp SHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC----HHH
T ss_pred CcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC----HHH
Confidence 876665544321 0 00010 1246788999999999999999999 999
Q ss_pred HHcCCCccCCChhhh
Q 001902 948 IKKHPFFKGVNWALV 962 (998)
Q Consensus 948 lL~Hp~f~~~~~~~~ 962 (998)
+|+||||+...+...
T Consensus 303 ll~hp~~~~~~~~~~ 317 (353)
T 2b9h_A 303 ALEHPYLQTYHDPND 317 (353)
T ss_dssp HHTSGGGTTTCCTTS
T ss_pred HhcCccccccCCccc
Confidence 999999999877543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=370.00 Aligned_cols=257 Identities=23% Similarity=0.359 Sum_probs=214.0
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
..+..++|++.+.||+|+||.||+|.+ +|+.||+|++..... .......+.+|+.++++++||||+++++++...+.
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 356678999999999999999999987 688999999876532 44556778899999999999999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 740 VCLITDYCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
+++||||+++++|.+++..... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999999999976421 23899999999999999999999999 99999999999999999999999999854
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 189 ~~~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~ 241 (309)
T 3p86_A 189 KAST---------------------------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241 (309)
T ss_dssp ----------------------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred cccc---------------------------ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2211 1112345799999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
.+.......+............++..+.+||.+||..||.+||| +.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~~ll~ 291 (309)
T 3p86_A 242 LNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPS----FATIMD 291 (309)
T ss_dssp SCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcC----HHHHHH
Confidence 88888777776554444555567899999999999999999999 666654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=375.70 Aligned_cols=259 Identities=26% Similarity=0.405 Sum_probs=217.0
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe----
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH---- 739 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~---- 739 (998)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 368999999999999999999999999999999997642 344456778899999999999999999999987653
Q ss_pred --EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 740 --VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 740 --~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
+|+||||++ ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 599999995 688887743 3999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus 177 ~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 226 (353)
T 3coi_A 177 DA------------------------------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226 (353)
T ss_dssp -------------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred CC------------------------------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 20 1123468999999999987 6788999999999999999999999999
Q ss_pred CChHHHHHHHHhCC----------------------------CCCC-CCCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 897 KTRQKTFANILHKD----------------------------LKFP-SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 897 ~~~~~~~~~i~~~~----------------------------~~~~-~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
.+....+..+.... ..+. .....+..+.+||.+||..||.+||| +.+
T Consensus 227 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt----~~e 302 (353)
T 3coi_A 227 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT----AAQ 302 (353)
T ss_dssp SCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCC----HHH
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCC----HHH
Confidence 88776666554310 0011 12346889999999999999999999 999
Q ss_pred HHcCCCccCCChhhh
Q 001902 948 IKKHPFFKGVNWALV 962 (998)
Q Consensus 948 lL~Hp~f~~~~~~~~ 962 (998)
+|+||||+.+.....
T Consensus 303 ~l~hp~f~~~~~~~~ 317 (353)
T 3coi_A 303 ALTHPFFEPFRDPEE 317 (353)
T ss_dssp HHTSGGGTTTCCGGG
T ss_pred HhcCcchhhccCccc
Confidence 999999998766544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=372.37 Aligned_cols=264 Identities=25% Similarity=0.423 Sum_probs=219.4
Q ss_pred ccCCcccccccCCCCceeEEEEEEc-cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC---CCCCccceeEEEe---
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELC-GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQ--- 735 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l---~h~nIv~l~~~~~--- 735 (998)
..++|++++.||+|+||.||+|.+. .+|+.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3478999999999999999999995 678999999997543221 1122445677666665 8999999999987
Q ss_pred --eCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccC
Q 001902 736 --TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 813 (998)
Q Consensus 736 --~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~ 813 (998)
.....++||||++ ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5678999999996 6999999876656699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCC
Q 001902 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 814 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~P 893 (998)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 167 ~~~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 218 (326)
T 1blx_A 167 ARIYSFQ----------------------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 218 (326)
T ss_dssp CCCCCGG----------------------------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccCC----------------------------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCC
Confidence 8543210 112345789999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHhCCC-----CCC--------------------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHH
Q 001902 894 FRGKTRQKTFANILHKDL-----KFP--------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~~~-----~~~--------------------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 948 (998)
|.+.+....+..+..... .++ ....++..+.+||.+||..||.+||| +.++
T Consensus 219 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~ 294 (326)
T 1blx_A 219 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSA 294 (326)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHH
T ss_pred CCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC----HHHH
Confidence 999888777777664100 000 11346788999999999999999999 9999
Q ss_pred HcCCCccCCChh
Q 001902 949 KKHPFFKGVNWA 960 (998)
Q Consensus 949 L~Hp~f~~~~~~ 960 (998)
++||||+.+.+.
T Consensus 295 l~hp~~~~~~~~ 306 (326)
T 1blx_A 295 LSHPYFQDLERC 306 (326)
T ss_dssp HTSGGGTTCCCC
T ss_pred hcCccccccchh
Confidence 999999998764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=379.50 Aligned_cols=263 Identities=24% Similarity=0.355 Sum_probs=203.3
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC----
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT---- 738 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~---- 738 (998)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......++..++.++||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 35799999999999999999999999999999999865422 2234566788888999999999999986533
Q ss_pred ---eEEEEEecCCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCcEEEec-CCcEEEEe
Q 001902 739 ---HVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLH--CQGIIYRDLKPENVLLQG-NGHVSLTD 810 (998)
Q Consensus 739 ---~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH--~~~IiHrDLkP~NILi~~-~g~vkL~D 810 (998)
.+++||||+++ +|...+.. .....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||+|
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 38999999966 54443332 23456899999999999999999999 999999999999999997 89999999
Q ss_pred ccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC-CCChhHHHHHHHHHHHHHc
Q 001902 811 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLY 889 (998)
Q Consensus 811 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDIwSlG~il~eLlt 889 (998)
||++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 176 fg~a~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~ 227 (360)
T 3e3p_A 176 FGSAKKLSPS----------------------------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227 (360)
T ss_dssp CTTCBCCCTT----------------------------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CCCceecCCC----------------------------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 9998654311 1123456899999999997654 8999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhCCCCC------------------------------CCCCCCcHHHHHHHHHccccCccCcC
Q 001902 890 GYTPFRGKTRQKTFANILHKDLKF------------------------------PSSTPTSLHAKQLMYRLLHRDPKSRL 939 (998)
Q Consensus 890 G~~Pf~~~~~~~~~~~i~~~~~~~------------------------------~~~~~~s~~l~~Ll~~~L~~dP~~Rp 939 (998)
|..||.+.+....+..+....... ......+.++.+||.+||+.||.+||
T Consensus 228 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 307 (360)
T 3e3p_A 228 GEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307 (360)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccC
Confidence 999999988887777765421000 01122467899999999999999999
Q ss_pred CChhcHHHHHcCCCccCCChhhh
Q 001902 940 GSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 940 t~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
| +.++|+||||+.+.....
T Consensus 308 t----~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 308 K----PYEALCHPYFDELHDPAT 326 (360)
T ss_dssp C----HHHHTTSGGGGGGGCTTC
T ss_pred C----HHHHhcCccccccCCccc
Confidence 9 999999999998755444
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=369.46 Aligned_cols=261 Identities=27% Similarity=0.432 Sum_probs=219.9
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEE
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 742 (998)
..+.|++++.||+|+||.||+|.+..+|+.||+|++.... ....+.+|+.+++.++||||+++++++...+.+|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3578999999999999999999999999999999987542 23567889999999999999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
||||+++++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 102 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-- 178 (314)
T ss_dssp EEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred EeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence 99999999999999743 245999999999999999999999999999999999999999999999999998553211
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...+....
T Consensus 179 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 233 (314)
T 3com_A 179 -------------------------MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA 233 (314)
T ss_dssp -------------------------BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred -------------------------ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 0112345799999999999999999999999999999999999999998887766
Q ss_pred HHHHHhCCC-CCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChh
Q 001902 903 FANILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 960 (998)
Q Consensus 903 ~~~i~~~~~-~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 960 (998)
...+..... .+......+..+.+||.+||..||.+||| +.++++||||+...+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt----~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 234 IFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRAT----ATQLLQHPFVRSAKGV 288 (314)
T ss_dssp HHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCC----HHHHTTSHHHHTCCCG
T ss_pred HHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcC----HHHHHhCHHHhcCCcc
Confidence 665555432 22333446889999999999999999999 9999999999987654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=364.29 Aligned_cols=254 Identities=21% Similarity=0.307 Sum_probs=211.0
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~l 742 (998)
.++|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++..+ +||||+++++++...+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3579999999999999999999999999999999986533 333456778899999999 99999999999999999999
Q ss_pred EEecCCCCchhHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC-----------------
Q 001902 743 ITDYCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----------------- 803 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~----------------- 803 (998)
||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 999999999999997631 2458999999999999999999999999999999999999844
Q ss_pred --CcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHH
Q 001902 804 --GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWAL 880 (998)
Q Consensus 804 --g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSl 880 (998)
..+||+|||.+..... .....||+.|+|||++.+. .++.++|||||
T Consensus 169 ~~~~~kl~Dfg~~~~~~~-------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 217 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISS-------------------------------PQVEEGDSRFLANEVLQENYTHLPKADIFAL 217 (289)
T ss_dssp -CCCEEECCCTTCEETTC-------------------------------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHH
T ss_pred CceEEEEcccccccccCC-------------------------------ccccCCCccccChhHhcCCCCCCchhhHHHH
Confidence 4799999999854321 1123589999999999876 56679999999
Q ss_pred HHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 881 GILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 881 G~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
||++|+|++|.+|+.... ....+.....+ .....++..+.+||.+||..||.+||| +.++++||||+..
T Consensus 218 G~il~~l~~~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 218 ALTVVCAAGAEPLPRNGD---QWHEIRQGRLP-RIPQVLSQEFTELLKVMIHPDPERRPS----AMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHHHTTCCCCCSSSH---HHHHHHTTCCC-CCSSCCCHHHHHHHHHHTCSSGGGSCC----HHHHHTCTTC---
T ss_pred HHHHHHHhcCCCCCcchh---HHHHHHcCCCC-CCCcccCHHHHHHHHHHhCCCcccCCC----HHHHhhChHhhhh
Confidence 999999999998876543 23344444332 222357889999999999999999999 9999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=374.48 Aligned_cols=258 Identities=24% Similarity=0.404 Sum_probs=216.7
Q ss_pred cccCCcccccccCCCCceeEEEEEE-ccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCC------CccceeEEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVEL-CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP------FVPALYASF 734 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~------nIv~l~~~~ 734 (998)
+..++|++++.||+|+||.||+|.+ ..+++.||+|++... ......+.+|+.+++.++|+ +|+++++++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 3357999999999999999999998 567999999998743 23456778899999988665 499999999
Q ss_pred eeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec------------
Q 001902 735 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG------------ 802 (998)
Q Consensus 735 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~------------ 802 (998)
...+.+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999999999 999999998876567999999999999999999999999999999999999987
Q ss_pred -------CCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChh
Q 001902 803 -------NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 875 (998)
Q Consensus 803 -------~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~s 875 (998)
++.+||+|||++.... .......||+.|+|||++.+..++.++
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 215 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDD------------------------------EHHSTLVSTRHYRAPEVILALGWSQPC 215 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETT------------------------------SCCCSSCSCGGGCCHHHHTTSCCCTHH
T ss_pred cccccccCCCceEeeCcccccCc------------------------------cccccccCCccccChHHhhCCCCCcch
Confidence 6689999999985422 112345799999999999999999999
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCC-----------------------------------------
Q 001902 876 DWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP----------------------------------------- 914 (998)
Q Consensus 876 DIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~----------------------------------------- 914 (998)
|||||||++|+|++|..||...+.......+.....++|
T Consensus 216 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (339)
T 1z57_A 216 DVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFM 295 (339)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGC
T ss_pred hhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhc
Confidence 999999999999999999998887665554432111111
Q ss_pred -CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 915 -SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 915 -~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
.....+..+.+||.+||..||.+||| +.++++||||+.++
T Consensus 296 ~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~ 336 (339)
T 1z57_A 296 LSQDVEHERLFDLIQKMLEYDPAKRIT----LREALKHPFFDLLK 336 (339)
T ss_dssp SCCSHHHHHHHHHHHHHTCSSTTTSCC----HHHHTTSGGGGGGG
T ss_pred ccchhhHHHHHHHHHHHhCcCcccccC----HHHHhcCHHHHHHh
Confidence 01112457889999999999999999 99999999999753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=382.42 Aligned_cols=260 Identities=28% Similarity=0.445 Sum_probs=210.2
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC-----
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----- 738 (998)
..+|++++.||+|+||.||+|.+..++. +|+|.+..... ...+|+.+++.++||||++++++|...+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 4679999999999999999999977666 77777654321 1235999999999999999999995433
Q ss_pred -eEEEEEecCCCCchhHHHh-hCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe-cCCcEEEEeccCcc
Q 001902 739 -HVCLITDYCPGGELFLLLD-RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-GNGHVSLTDFDLSC 815 (998)
Q Consensus 739 -~~~lV~E~~~ggsL~~~l~-~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~-~~g~vkL~DFG~a~ 815 (998)
.+|+||||++++.+..+.. ......+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 4889999996654433332 11235699999999999999999999999999999999999999 79999999999986
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
..... ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 191 ~~~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 242 (394)
T 4e7w_A 191 ILIAG----------------------------EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242 (394)
T ss_dssp ECCTT----------------------------CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cccCC----------------------------CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 53211 112345789999999999775 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHhC-----------------CCCCCC----------CCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 895 RGKTRQKTFANILHK-----------------DLKFPS----------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 895 ~~~~~~~~~~~i~~~-----------------~~~~~~----------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
.+.+....+..+... ...++. ....+.++.+||.+||..||.+||| +.+
T Consensus 243 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e 318 (394)
T 4e7w_A 243 PGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT----AIE 318 (394)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC----HHH
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC----HHH
Confidence 999887777766541 011111 1236789999999999999999999 999
Q ss_pred HHcCCCccCCChhhhh
Q 001902 948 IKKHPFFKGVNWALVR 963 (998)
Q Consensus 948 lL~Hp~f~~~~~~~~~ 963 (998)
+++||||+.+.+....
T Consensus 319 ~l~hp~f~~~~~~~~~ 334 (394)
T 4e7w_A 319 ALCHPFFDELRTGEAR 334 (394)
T ss_dssp HHTSGGGSTTTSSCCC
T ss_pred HhcChhhhhhcccccc
Confidence 9999999998886553
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=369.71 Aligned_cols=264 Identities=24% Similarity=0.374 Sum_probs=213.1
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe--------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ-------- 735 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~-------- 735 (998)
.++|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 47899999999999999999999999999999998753 4456678889999999999999999999873
Q ss_pred ------eCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe-cCCcEEE
Q 001902 736 ------TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-GNGHVSL 808 (998)
Q Consensus 736 ------~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~-~~g~vkL 808 (998)
.....|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 4478999999996 699999865 4589999999999999999999999999999999999998 5679999
Q ss_pred EeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHH
Q 001902 809 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEM 887 (998)
Q Consensus 809 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eL 887 (998)
+|||++........ .........||+.|+|||.+.+ ..++.++|||||||++|+|
T Consensus 163 ~Dfg~~~~~~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el 218 (320)
T 2i6l_A 163 GDFGLARIMDPHYS------------------------HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218 (320)
T ss_dssp CCCTTCBCC--------------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHH
T ss_pred ccCccccccCCCcc------------------------cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHH
Confidence 99999865431100 0011233468999999999866 6788999999999999999
Q ss_pred HcCCCCCCCCChHHHHHHHHhCCCCC----------------------C------CCCCCcHHHHHHHHHccccCccCcC
Q 001902 888 LYGYTPFRGKTRQKTFANILHKDLKF----------------------P------SSTPTSLHAKQLMYRLLHRDPKSRL 939 (998)
Q Consensus 888 ltG~~Pf~~~~~~~~~~~i~~~~~~~----------------------~------~~~~~s~~l~~Ll~~~L~~dP~~Rp 939 (998)
++|+.||.+.+....+..+....... + ....++..+.+||.+||..||.+||
T Consensus 219 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 298 (320)
T 2i6l_A 219 LTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298 (320)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSC
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccC
Confidence 99999999988877766665432110 0 0134688999999999999999999
Q ss_pred CChhcHHHHHcCCCccCCChhhh
Q 001902 940 GSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 940 t~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
| +.++|+||||+...|...
T Consensus 299 t----~~ell~hp~~~~~~~p~~ 317 (320)
T 2i6l_A 299 T----AEEALSHPYMSIYSFPMD 317 (320)
T ss_dssp C----HHHHHTSHHHHTTCC---
T ss_pred C----HHHHhCCcccccccCccC
Confidence 9 999999999998877643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=385.44 Aligned_cols=266 Identities=25% Similarity=0.382 Sum_probs=197.3
Q ss_pred CCccc-ccccCCCCceeEEEEEEc--cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe--eCCe
Q 001902 665 QHFRP-IKPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ--TKTH 739 (998)
Q Consensus 665 ~~y~~-~~~LG~G~~g~Vy~a~~~--~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~--~~~~ 739 (998)
+.|.+ .++||+|+||.||+|.+. .+++.||+|++..... ...+.+|+.+|+.++||||+++++++. ....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 45776 457999999999999975 5689999999875422 245778999999999999999999995 4778
Q ss_pred EEEEEecCCCCchhHHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----ecCCcEEE
Q 001902 740 VCLITDYCPGGELFLLLDRQ-------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL----QGNGHVSL 808 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~-------~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi----~~~g~vkL 808 (998)
+|+||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 95 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECC-SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCC-CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 99999999 56888877631 12249999999999999999999999999999999999999 67789999
Q ss_pred EeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHH
Q 001902 809 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEM 887 (998)
Q Consensus 809 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eL 887 (998)
+|||++........ ........+||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 174 ~Dfg~a~~~~~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 229 (405)
T 3rgf_A 174 ADMGFARLFNSPLK------------------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 229 (405)
T ss_dssp CCTTCCC----------------------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHH
T ss_pred EECCCceecCCCCc------------------------ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHH
Confidence 99999965431100 01123356799999999999874 589999999999999999
Q ss_pred HcCCCCCCCCChH---------HHHHHHHhC--CCCCCC----------------------------------CCCCcHH
Q 001902 888 LYGYTPFRGKTRQ---------KTFANILHK--DLKFPS----------------------------------STPTSLH 922 (998)
Q Consensus 888 ltG~~Pf~~~~~~---------~~~~~i~~~--~~~~~~----------------------------------~~~~s~~ 922 (998)
++|.+||.+.... ..+..+... ...... ....+..
T Consensus 230 l~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (405)
T 3rgf_A 230 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309 (405)
T ss_dssp HHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSH
T ss_pred HhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHH
Confidence 9999999765442 333333321 000000 0112567
Q ss_pred HHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhhhc
Q 001902 923 AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRC 964 (998)
Q Consensus 923 l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~ 964 (998)
+.+||.+||..||.+||| +.++|+||||+...+.....
T Consensus 310 ~~~Ll~~~L~~dP~~R~t----a~e~L~hp~f~~~~~~~~~~ 347 (405)
T 3rgf_A 310 AFHLLQKLLTMDPIKRIT----SEQAMQDPYFLEDPLPTSDV 347 (405)
T ss_dssp HHHHHHHHSCSSGGGSCC----HHHHHTSGGGTSSSCCCSST
T ss_pred HHHHHHHHccCCcccCCC----HHHHhcChhhccCCCCcccc
Confidence 899999999999999999 99999999999876654433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=372.34 Aligned_cols=257 Identities=25% Similarity=0.333 Sum_probs=216.4
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCC---eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 736 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~---~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 736 (998)
..+..++|++.+.||+|+||.||+|.+..++ ..||+|+++... .......+.+|+.+++.++||||+++++++..
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 3566789999999999999999999997554 459999997542 34456778899999999999999999999999
Q ss_pred CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
.+..|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred CCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999999999754 34599999999999999999999999999999999999999999999999999966
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 895 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~ 895 (998)
....... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 201 ~~~~~~~------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 256 (325)
T 3kul_A 201 LEDDPDA------------------------AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW 256 (325)
T ss_dssp CC----C------------------------CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccCccc------------------------eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 4321110 011223356889999999998999999999999999999998 999999
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 896 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 896 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
+.........+... ...+....++..+.+||.+||..||.+|||+.++
T Consensus 257 ~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ei 304 (325)
T 3kul_A 257 NMTNRDVISSVEEG-YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQI 304 (325)
T ss_dssp TSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCCHHHHHHHHHcC-CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHH
Confidence 98888877776655 3444555688999999999999999999994443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=365.43 Aligned_cols=256 Identities=28% Similarity=0.415 Sum_probs=224.0
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.+.|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.....+|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 3579999999999999999999999999999999976532 23457788999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+++++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 99 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 173 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 173 (303)
T ss_dssp EECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred EEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence 999999999999865 459999999999999999999999999999999999999999999999999985532110
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 174 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 228 (303)
T 3a7i_A 174 -------------------------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL 228 (303)
T ss_dssp -------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred -------------------------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH
Confidence 1123457999999999999999999999999999999999999999988877777
Q ss_pred HHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 904 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 904 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
..+...... .....++..+.+||.+||..||.+||| +.++++||||..
T Consensus 229 ~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~~~~~~~ 276 (303)
T 3a7i_A 229 FLIPKNNPP-TLEGNYSKPLKEFVEACLNKEPSFRPT----AKELLKHKFILR 276 (303)
T ss_dssp HHHHHSCCC-CCCSSCCHHHHHHHHHHCCSSGGGSCC----HHHHTTCHHHHH
T ss_pred HHhhcCCCC-CCccccCHHHHHHHHHHcCCChhhCcC----HHHHhhChhhhc
Confidence 666654432 223457889999999999999999999 999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=377.26 Aligned_cols=259 Identities=24% Similarity=0.414 Sum_probs=209.9
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccc--------cChhHHHHHHHHHHHHHhCCCCCccceeEEEe
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--------LNRNKVHRACAEREILDMLDHPFVPALYASFQ 735 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~--------~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 735 (998)
.++|++++.||+|+||.||+|.+.. |+.||+|++..... .+......+.+|+.++++++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 4789999999999999999999854 99999999865322 22334578899999999999999999999984
Q ss_pred e-----CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEe
Q 001902 736 T-----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 810 (998)
Q Consensus 736 ~-----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~D 810 (998)
. ...+|+||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 3 347899999995 6888888754 34699999999999999999999999999999999999999999999999
Q ss_pred ccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHc
Q 001902 811 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLY 889 (998)
Q Consensus 811 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLlt 889 (998)
||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 178 fg~~~~~~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 229 (362)
T 3pg1_A 178 FNLAREDTAD----------------------------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229 (362)
T ss_dssp TTC-------------------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH
T ss_pred cCcccccccc----------------------------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHh
Confidence 9998542211 11234578999999999987 678999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhCCC------------------------CCCC------CCCCcHHHHHHHHHccccCccCcC
Q 001902 890 GYTPFRGKTRQKTFANILHKDL------------------------KFPS------STPTSLHAKQLMYRLLHRDPKSRL 939 (998)
Q Consensus 890 G~~Pf~~~~~~~~~~~i~~~~~------------------------~~~~------~~~~s~~l~~Ll~~~L~~dP~~Rp 939 (998)
|..||.+.+....+..+..... ..+. ....+..+.+||.+||..||.+||
T Consensus 230 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 309 (362)
T 3pg1_A 230 RKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI 309 (362)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCC
Confidence 9999999887777666643100 0010 123577899999999999999999
Q ss_pred CChhcHHHHHcCCCccCC
Q 001902 940 GSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 940 t~~~~a~elL~Hp~f~~~ 957 (998)
| +.++|+||||+.+
T Consensus 310 t----~~ell~hp~f~~~ 323 (362)
T 3pg1_A 310 S----TEQALRHPYFESL 323 (362)
T ss_dssp C----HHHHHTSGGGTTT
T ss_pred C----HHHHHcCchhhhc
Confidence 9 9999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=375.87 Aligned_cols=258 Identities=20% Similarity=0.312 Sum_probs=217.2
Q ss_pred ccccCCcccccccCCCCceeEEEEEEc-------cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 732 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-------~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~ 732 (998)
.+..++|++.+.||+|+||.||+|.+. .++..||+|+++... .......+.+|+.+++.+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 455678999999999999999999975 346689999997642 345567889999999999 8999999999
Q ss_pred EEeeCCeEEEEEecCCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 001902 733 SFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 798 (998)
Q Consensus 733 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NI 798 (998)
++...+.+|+||||+++++|.+++.... ...++...+..++.||+.||.|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999998643 23488999999999999999999999999999999999
Q ss_pred EEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHH
Q 001902 799 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 878 (998)
Q Consensus 799 Li~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIw 878 (998)
|++.+|.+||+|||++........ ........||+.|+|||++.+..++.++|||
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~-------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvw 289 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDY-------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 289 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCT-------------------------TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHH
T ss_pred EECCCCCEEEccccCCcccCcccc-------------------------eecccCCCcccceECHhHhcCCCCCcHHHHH
Confidence 999999999999999865431110 0112234578899999999999999999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 879 ALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 879 SlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
||||++|+|++ |..||.+......+..+..+. ..+....++.++.+||.+||..||.+||+ +.++++
T Consensus 290 slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt----~~ell~ 357 (370)
T 2psq_A 290 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPT----FKQLVE 357 (370)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 99999999998 999999988777776665543 23334457889999999999999999999 555554
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=366.94 Aligned_cols=260 Identities=27% Similarity=0.459 Sum_probs=225.0
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++||||+++++++...+..|+|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 4689999999999999999999999999999999976533 233456788999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC---CcEEEEeccCccccCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~---g~vkL~DFG~a~~~~~~ 820 (998)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.+||+|||++......
T Consensus 100 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 100 GELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 9999999999988764 359999999999999999999999999999999999999764 47999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
.......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..
T Consensus 178 ----------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (287)
T 2wei_A 178 ----------------------------TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY 228 (287)
T ss_dssp ----------------------------SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ----------------------------CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence 011233588999999998764 889999999999999999999999999888
Q ss_pred HHHHHHHhCCCCCC--CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 901 KTFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 901 ~~~~~i~~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
.....+..+...++ ....++..+.+||.+||..||.+||| +.++++||||+...+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT----ATQCLEHPWIQKYSS 285 (287)
T ss_dssp HHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHSHHHHHHCC
T ss_pred HHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcC----HHHHhcCHHHhcccc
Confidence 88888877765443 33567899999999999999999999 999999999987654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=384.39 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=208.1
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC--------CCCccceeEEEe
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD--------HPFVPALYASFQ 735 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~--------h~nIv~l~~~~~ 735 (998)
.++|++++.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.+. |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 57899999999999999999999999999999998743 334567788999999985 788999999987
Q ss_pred ----eCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEecCC------
Q 001902 736 ----TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNG------ 804 (998)
Q Consensus 736 ----~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkP~NILi~~~g------ 804 (998)
....+|+||||+ +++|.+.+.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence 566899999999 66776666665456699999999999999999999998 999999999999999775
Q ss_pred -------------------------------------------cEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCc
Q 001902 805 -------------------------------------------HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841 (998)
Q Consensus 805 -------------------------------------------~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 841 (998)
.+||+|||++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~---------------------- 248 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---------------------- 248 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB----------------------
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc----------------------
Confidence 799999999855321
Q ss_pred ccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh------HHHHHHHHh--CCCC-
Q 001902 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR------QKTFANILH--KDLK- 912 (998)
Q Consensus 842 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~------~~~~~~i~~--~~~~- 912 (998)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+. ...+..+.. +..+
T Consensus 249 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~ 320 (397)
T 1wak_A 249 --------HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPR 320 (397)
T ss_dssp --------CSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCH
T ss_pred --------cCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCCh
Confidence 12234799999999999999999999999999999999999999986542 222222221 1100
Q ss_pred ---------------------C----------------CCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 913 ---------------------F----------------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 913 ---------------------~----------------~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
. ......+..+.+||.+||+.||.+||| +.++|+||||+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~ 396 (397)
T 1wak_A 321 KLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT----AAECLRHPWLN 396 (397)
T ss_dssp HHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCC----HHHHHTSGGGG
T ss_pred HHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCC----HHHHhhCcccc
Confidence 0 001112456889999999999999999 99999999997
Q ss_pred C
Q 001902 956 G 956 (998)
Q Consensus 956 ~ 956 (998)
.
T Consensus 397 ~ 397 (397)
T 1wak_A 397 S 397 (397)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=391.32 Aligned_cols=262 Identities=21% Similarity=0.268 Sum_probs=201.5
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC--CCCCcccee-------EEEe
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML--DHPFVPALY-------ASFQ 735 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l--~h~nIv~l~-------~~~~ 735 (998)
..|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4599999999999999999999999999999999986554556667778886555555 699988755 4443
Q ss_pred eC-----------------CeEEEEEecCCCCchhHHHhhCCCCCCCHHHH------HHHHHHHHHHHHHHHHCCceecc
Q 001902 736 TK-----------------THVCLITDYCPGGELFLLLDRQPTKVLKEDAV------RFYAAEVVVALEYLHCQGIIYRD 792 (998)
Q Consensus 736 ~~-----------------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~------~~i~~qil~aL~~LH~~~IiHrD 792 (998)
.. ..+|||||||+ ++|.+++.... ..++.... ..++.||+.||+|||++||+|||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 32 34899999997 89999998642 23455555 57779999999999999999999
Q ss_pred CCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC--CC
Q 001902 793 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AG 870 (998)
Q Consensus 793 LkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~ 870 (998)
|||+|||++.+|.+||+|||++..... ......||+.|+|||++.+ ..
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~ 269 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT------------------------------RGPASSVPVTYAPREFLNASTAT 269 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC------------------------------EEEGGGSCGGGCCHHHHTCSEEE
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC------------------------------CccCccCCcCCcChhhccCCCCC
Confidence 999999999999999999999854320 0113357799999999987 67
Q ss_pred CCChhHHHHHHHHHHHHHcCCCCCCCCChHHH--HH-----HHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 871 HTSAVDWWALGILLYEMLYGYTPFRGKTRQKT--FA-----NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 871 ~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~--~~-----~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
++.++|||||||++|+|++|+.||.+...... +. ........++....++..+.+||.+||+.||.+|||
T Consensus 270 ~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt--- 346 (371)
T 3q60_A 270 FTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL--- 346 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCC---
T ss_pred cCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCC---
Confidence 89999999999999999999999987643210 00 001123334444567899999999999999999999
Q ss_pred cHHHHHcCCCccCCChhhh
Q 001902 944 GANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 944 ~a~elL~Hp~f~~~~~~~~ 962 (998)
+.++|+||||+.+.|...
T Consensus 347 -~~e~l~hp~f~~~~~~~~ 364 (371)
T 3q60_A 347 -PLEAMETPEFLQLQNEIS 364 (371)
T ss_dssp -HHHHTTSHHHHHHHHHHH
T ss_pred -HHHHhcCHHHHHHHHHHh
Confidence 999999999999877644
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=393.61 Aligned_cols=253 Identities=18% Similarity=0.163 Sum_probs=204.5
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHH---HHHhCCCCCcccee-------EE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE---ILDMLDHPFVPALY-------AS 733 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~---il~~l~h~nIv~l~-------~~ 733 (998)
.++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 468999999999999999999998999999999998665555666788889995 45555899999998 66
Q ss_pred EeeCC-----------------eEEEEEecCCCCchhHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 001902 734 FQTKT-----------------HVCLITDYCPGGELFLLLDRQPT-----KVLKEDAVRFYAAEVVVALEYLHCQGIIYR 791 (998)
Q Consensus 734 ~~~~~-----------------~~~lV~E~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHr 791 (998)
+...+ ..||||||+ +|+|.+++..... ..+++..+..++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 66553 389999999 7899999986411 123348888899999999999999999999
Q ss_pred cCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC--
Q 001902 792 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-- 869 (998)
Q Consensus 792 DLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-- 869 (998)
||||+|||++.+|.+||+|||++.... ......+| +.|+|||++.+.
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~------------------------------~~~~~~~g-~~y~aPE~~~~~~~ 279 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDG------------------------------ARVVSSVS-RGFEPPELEARRAT 279 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT------------------------------CEEECCCC-TTCCCHHHHHHHTS
T ss_pred CCCHHHEEEcCCCCEEEEechhheecC------------------------------CcccCCCC-cCccChhhhccccc
Confidence 999999999999999999999985421 01234467 999999999887
Q ss_pred ---------CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCC
Q 001902 870 ---------GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG 940 (998)
Q Consensus 870 ---------~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt 940 (998)
.++.++|||||||++|+|++|+.||.+.+.......+.. ....++..+.+||.+||..||.+|||
T Consensus 280 ~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp THHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred ccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCC
Confidence 899999999999999999999999987654333322222 22456889999999999999999999
Q ss_pred ChhcHHHHHcCCCccCCC
Q 001902 941 SHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 941 ~~~~a~elL~Hp~f~~~~ 958 (998)
+.++++||||+.++
T Consensus 354 ----~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 354 ----PLQAMETPEYEQLR 367 (377)
T ss_dssp ----HHHHHTSHHHHHHH
T ss_pred ----HHHHhhChHHHHHH
Confidence 99999999998753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=374.21 Aligned_cols=261 Identities=33% Similarity=0.516 Sum_probs=213.1
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeeccccc-----ChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-----NRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~-----~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
++|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.++||||+++++++...+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999999999999999999764321 1223345778999999999999999999987665
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc---EEEEeccCccc
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCL 816 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~---vkL~DFG~a~~ 816 (998)
.|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 89999999999999998764 45999999999999999999999999999999999999987664 99999999855
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc---CCCCCChhHHHHHHHHHHHHHcCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDIwSlG~il~eLltG~~P 893 (998)
.... .......||+.|+|||++. ...++.++|||||||++|+|++|..|
T Consensus 167 ~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 218 (322)
T 2ycf_A 167 LGET----------------------------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218 (322)
T ss_dssp CCCC----------------------------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccc----------------------------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 3210 0112346999999999974 46788999999999999999999999
Q ss_pred CCCCChH-HHHHHHHhCCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChh
Q 001902 894 FRGKTRQ-KTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 960 (998)
Q Consensus 894 f~~~~~~-~~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 960 (998)
|...... .....+......+.. ....+..+.+||.+||..||.+||+ +.++|+||||+..++.
T Consensus 219 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps----~~~~l~h~~~~~~~~~ 284 (322)
T 2ycf_A 219 FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT----TEEALRHPWLQDEDMK 284 (322)
T ss_dssp SCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGCCHHHH
T ss_pred CcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCC----HHHHhhCcCcCCHHHH
Confidence 9875543 333344444433321 2346889999999999999999999 9999999999987664
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=362.81 Aligned_cols=260 Identities=25% Similarity=0.452 Sum_probs=222.5
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe--eCCeEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ--TKTHVC 741 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~--~~~~~~ 741 (998)
.++|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++||||+++++++. ....+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4689999999999999999999999999999999986533 3455678889999999999999999999875 467899
Q ss_pred EEEecCCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCcEEEecCCcEEEEeccCc
Q 001902 742 LITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQG-----IIYRDLKPENVLLQGNGHVSLTDFDLS 814 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~~-----IiHrDLkP~NILi~~~g~vkL~DFG~a 814 (998)
+||||+++++|.+++... ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999999753 2345999999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 164 ~~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 216 (279)
T 2w5a_A 164 RILNHDT---------------------------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216 (279)
T ss_dssp HHC---C---------------------------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred eeecccc---------------------------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 5432110 0112346899999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 895 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 895 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
...+.......+..+... +.....+..+.+||.+||..||.+||+ +.++++|+|+.+
T Consensus 217 ~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~ll~~~~~~~ 273 (279)
T 2w5a_A 217 TAFSQKELAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPS----VEEILENPLILE 273 (279)
T ss_dssp CCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSTTCCG
T ss_pred cccCHHHHHHHHhhcccc-cCCcccCHHHHHHHHHHcCCCcccCCC----HHHHHhChhhhh
Confidence 998887777777776542 222357889999999999999999999 999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=374.09 Aligned_cols=261 Identities=24% Similarity=0.372 Sum_probs=217.9
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCC-eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCC------ccceeEEEe
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSG-QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF------VPALYASFQ 735 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~n------Iv~l~~~~~ 735 (998)
..++|++++.||+|+||.||+|.+..++ +.||+|+++.. ......+..|+.+++.+.|++ ++.+++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 3579999999999999999999998776 79999998743 234567778999999987655 899999999
Q ss_pred eCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---------------
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL--------------- 800 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi--------------- 800 (998)
..+..|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 999999999999 7777777776655679999999999999999999999999999999999999
Q ss_pred ----ecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhH
Q 001902 801 ----QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 876 (998)
Q Consensus 801 ----~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sD 876 (998)
+.++.+||+|||++.... .......||+.|+|||++.+..++.++|
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D 221 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDH------------------------------EHHTTIVATRHYRPPEVILELGWAQPCD 221 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETT------------------------------SCCCSSCSCGGGCCHHHHTTCCCCTHHH
T ss_pred cccccCCCcEEEeecCcccccc------------------------------ccccCCcCCCcccCCeeeecCCCCCccc
Confidence 668899999999985422 1123457999999999999999999999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCC------------------------------------------
Q 001902 877 WWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP------------------------------------------ 914 (998)
Q Consensus 877 IwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------------------------------ 914 (998)
||||||++|+|++|..||.+.+....+..+.......|
T Consensus 222 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (355)
T 2eu9_A 222 VWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301 (355)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCS
T ss_pred hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccccccc
Confidence 99999999999999999998877665554433211111
Q ss_pred CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhh
Q 001902 915 SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 915 ~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
.....+..+.+||.+||..||.+||| +.++|+||||+++++...
T Consensus 302 ~~~~~~~~l~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~~ 345 (355)
T 2eu9_A 302 QDSLEHVQLFDLMRRMLEFDPAQRIT----LAEALLHPFFAGLTPEER 345 (355)
T ss_dssp CCSHHHHHHHHHHHHHTCSSTTTSCC----HHHHTTSGGGGGCCHHHH
T ss_pred ccchhHHHHHHHHHHHhcCChhhCcC----HHHHhcChhhcCCChhhc
Confidence 01112447889999999999999999 999999999999988655
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=371.25 Aligned_cols=275 Identities=22% Similarity=0.303 Sum_probs=206.0
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCe---EEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
.+..++|++.+.||+|+||.||+|.+..++. .||+|++..... .......+.+|+.++++++||||+++++++...
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 3556789999999999999999999877665 899999976533 334567889999999999999999999999876
Q ss_pred CeE------EEEEecCCCCchhHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEE
Q 001902 738 THV------CLITDYCPGGELFLLLDRQP----TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 807 (998)
Q Consensus 738 ~~~------~lV~E~~~ggsL~~~l~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vk 807 (998)
... ++||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 654 99999999999999986431 22589999999999999999999999999999999999999999999
Q ss_pred EEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHH
Q 001902 808 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 887 (998)
Q Consensus 808 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eL 887 (998)
|+|||++........ ........+++.|+|||.+.+..++.++|||||||++|+|
T Consensus 178 l~Dfg~a~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 232 (323)
T 3qup_A 178 VADFGLSRKIYSGDY-------------------------YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232 (323)
T ss_dssp ECCCCC------------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred Eeecccccccccccc-------------------------ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHH
Confidence 999999865431110 0112233578899999999999999999999999999999
Q ss_pred Hc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh---cHHHHHcCCCccCCChhhh
Q 001902 888 LY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE---GANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 888 lt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~---~a~elL~Hp~f~~~~~~~~ 962 (998)
++ |..||.+.+.......+.... ..+.....+..+.+||.+||..||.+|||+.+ .++++++|||+....+.-+
T Consensus 233 l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 233 MTRGQTPYAGIENAEIYNYLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp HTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred HhCCCCCccccChHHHHHHHhcCC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 99 999999988888877776654 23334567889999999999999999999775 4678899999998765544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=378.34 Aligned_cols=271 Identities=18% Similarity=0.235 Sum_probs=224.1
Q ss_pred cccccCCcccccccCCCCceeEEEEE-----EccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEE
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVE-----LCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF 734 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~-----~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 734 (998)
..+..++|++++.||+|+||.||+|. +..+++.||+|++... ........+.+|+.++++++||||+++++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34556789999999999999999999 4557889999998743 2344556788899999999999999999999
Q ss_pred eeCCeEEEEEecCCCCchhHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC---cE
Q 001902 735 QTKTHVCLITDYCPGGELFLLLDRQP-----TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HV 806 (998)
Q Consensus 735 ~~~~~~~lV~E~~~ggsL~~~l~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g---~v 806 (998)
......|+|||||++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+| .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999999997642 23589999999999999999999999999999999999999555 59
Q ss_pred EEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHH
Q 001902 807 SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 886 (998)
Q Consensus 807 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~e 886 (998)
||+|||++....... .........||+.|+|||++.+..++.++|||||||++|+
T Consensus 224 kL~DFG~a~~~~~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~e 278 (367)
T 3l9p_A 224 KIGDFGMARDIYRAG-------------------------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 278 (367)
T ss_dssp EECCCHHHHHHHHHS-------------------------SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred EECCCcccccccccc-------------------------ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHH
Confidence 999999985432100 0112234568999999999999999999999999999999
Q ss_pred HHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhh
Q 001902 887 MLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 887 Llt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
|++ |..||.+.+....+..+..... .+....++..+.+||.+||+.||.+||+ +.++++|.++-..+....
T Consensus 279 llt~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~eil~~l~~~~~~~~~~ 350 (367)
T 3l9p_A 279 IFSLGYMPYPSKSNQEVLEFVTSGGR-MDPPKNCPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYCTQDPDVI 350 (367)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHHHHHCHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCccCCHHHHHHHHHHcCCCHhHCcC----HHHHHHHHHHHhhChhhc
Confidence 998 9999999988888777776543 2333457889999999999999999999 889998877665444333
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=357.63 Aligned_cols=255 Identities=22% Similarity=0.355 Sum_probs=217.8
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
+.+..++|++++.||+|+||.||+|.+. +++.||+|++..... ....+.+|+.++++++||||+++++++...+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 3456679999999999999999999985 577899999986532 23568889999999999999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
.|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred eEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999999999999997643 4599999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~ 898 (998)
.. ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 159 ~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 159 DQ--------------------------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp HH--------------------------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cc--------------------------cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 10 011223457889999999999999999999999999999999 999999988
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
.......+.... ........+..+.+|+.+||..||.+||+ +.++++|
T Consensus 213 ~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~ll~~ 260 (269)
T 4hcu_A 213 NSEVVEDISTGF-RLYKPRLASTHVYQIMNHCWRERPEDRPA----FSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHTTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHhcCc-cCCCCCcCCHHHHHHHHHHccCCcccCcC----HHHHHHH
Confidence 888877776653 33334456889999999999999999999 6776665
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=379.37 Aligned_cols=256 Identities=26% Similarity=0.424 Sum_probs=213.9
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CC-----CccceeEEEeeC
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HP-----FVPALYASFQTK 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~-----nIv~l~~~~~~~ 737 (998)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ......+..|+.+++.++ |+ +|+.+++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 57999999999999999999999999999999998743 234566777888888884 44 499999999999
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCcEEEe--cCCcEEEEeccC
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH--CQGIIYRDLKPENVLLQ--GNGHVSLTDFDL 813 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH--~~~IiHrDLkP~NILi~--~~g~vkL~DFG~ 813 (998)
+.+|+||||++ ++|.+++.......+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 99999999994 69999998765566999999999999999999999 57999999999999995 478899999999
Q ss_pred ccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCC
Q 001902 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 814 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~P 893 (998)
++.... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+|
T Consensus 208 a~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 257 (382)
T 2vx3_A 208 SCQLGQ------------------------------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPL 257 (382)
T ss_dssp CEETTC------------------------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ceeccc------------------------------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 865321 11245799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHhCCCCCC------------------C-------------------CCC------------------
Q 001902 894 FRGKTRQKTFANILHKDLKFP------------------S-------------------STP------------------ 918 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~~~~~~------------------~-------------------~~~------------------ 918 (998)
|.+.+....+..+.......+ . ...
T Consensus 258 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 337 (382)
T 2vx3_A 258 FSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG 337 (382)
T ss_dssp SCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTT
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccc
Confidence 999888877776654211000 0 000
Q ss_pred -------CcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 919 -------TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 919 -------~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
.+..+.+||.+||+.||.+||| +.++|+||||+...
T Consensus 338 ~~~~~~~~~~~~~dli~~mL~~dP~~Rpt----a~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 338 ESGHTVADYLKFKDLILRMLDYDPKTRIQ----PYYALQHSFFKKTA 380 (382)
T ss_dssp CTTCCHHHHHHHHHHHHHHTCSCTTTSCC----HHHHTTSGGGCC--
T ss_pred cccccchhhHHHHHHHHHhcCCChhhCCC----HHHHhcCcccccCC
Confidence 0136889999999999999999 99999999999754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=377.00 Aligned_cols=261 Identities=24% Similarity=0.357 Sum_probs=217.5
Q ss_pred cccccCCcccccccCCCCceeEEEEE-----EccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEE
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVE-----LCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS 733 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~-----~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~ 733 (998)
+.+..++|++.+.||+|+||.||+|. +..+++.||+|+++... .......+.+|+.++.++ +||||++++++
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 34667899999999999999999999 45567999999997542 344557789999999999 78999999999
Q ss_pred EeeCC-eEEEEEecCCCCchhHHHhhCCC---------------------------------------------------
Q 001902 734 FQTKT-HVCLITDYCPGGELFLLLDRQPT--------------------------------------------------- 761 (998)
Q Consensus 734 ~~~~~-~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------- 761 (998)
+...+ .+++|||||++++|.+++.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 88754 58999999999999999976432
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcc
Q 001902 762 -------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 828 (998)
Q Consensus 762 -------------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~ 828 (998)
..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~------ 248 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD------ 248 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT------
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc------
Confidence 1289999999999999999999999999999999999999999999999999965421111
Q ss_pred hhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 001902 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANIL 907 (998)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~ 907 (998)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+......+...+
T Consensus 249 -------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 309 (359)
T 3vhe_A 249 -------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309 (359)
T ss_dssp -------------------CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred -------------------chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH
Confidence 112234568999999999999999999999999999999998 999999877666555555
Q ss_pred hCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 908 HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 908 ~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
......+.....+.++.+||.+||..||.+||| +.++++|
T Consensus 310 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 349 (359)
T 3vhe_A 310 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 349 (359)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCC----HHHHHHH
Confidence 544444445567899999999999999999999 7777765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=366.14 Aligned_cols=273 Identities=21% Similarity=0.256 Sum_probs=217.4
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 739 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 739 (998)
.+..++|++.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+|+.+++.+ +||||+++++++...+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 4456789999999999999999999999999999999875422 23577899999999 99999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc-----EEEEeccCc
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-----VSLTDFDLS 814 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~-----vkL~DFG~a 814 (998)
.|+||||+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred cEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 99999999 99999999864 346999999999999999999999999999999999999998887 999999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
.......... ..+........||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 158 ~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf 217 (330)
T 2izr_A 158 KEYIDPETKK--------------------HIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 217 (330)
T ss_dssp EESBCTTTCC--------------------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred eeeecCCCCc--------------------cccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCc
Confidence 7543211100 01112335678999999999999999999999999999999999999999
Q ss_pred CCCC---hHHHHHHHHhCCCCCCC---CCCCcHHHHHHHHHccccCccCcCCChhcHHHH------HcCCCccCCChhh
Q 001902 895 RGKT---RQKTFANILHKDLKFPS---STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI------KKHPFFKGVNWAL 961 (998)
Q Consensus 895 ~~~~---~~~~~~~i~~~~~~~~~---~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el------L~Hp~f~~~~~~~ 961 (998)
.+.+ ....+..+.......+. ....+ ++.+||..||..||.+||++.++...+ +...+...++|..
T Consensus 218 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 295 (330)
T 2izr_A 218 QGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG 295 (330)
T ss_dssp TTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred cccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence 8743 33444554433222221 11233 899999999999999999955433222 2244555678863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=367.19 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=210.8
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC--e
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT--H 739 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~--~ 739 (998)
...++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 3457899999999999999999999999999999999864322 23466778999999999999999999998655 8
Q ss_pred EEEEEecCCCCchhHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----ecCCcEEEEeccCc
Q 001902 740 VCLITDYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL----QGNGHVSLTDFDLS 814 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi----~~~g~vkL~DFG~a 814 (998)
.|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 899999999999999997642 2339999999999999999999999999999999999999 77788999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc--------CCCCCChhHHHHHHHHHHH
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA--------GAGHTSAVDWWALGILLYE 886 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~~sDIwSlG~il~e 886 (998)
...... .......||+.|+|||++. +..++.++|||||||++|+
T Consensus 164 ~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~e 215 (319)
T 4euu_A 164 RELEDD----------------------------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH 215 (319)
T ss_dssp EECCTT----------------------------CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHH
T ss_pred eecCCC----------------------------CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHH
Confidence 654311 1123456999999999986 5778899999999999999
Q ss_pred HHcCCCCCCCCC----hHHHHHHHHhCCC-------------------CCCCCC----CCcHHHHHHHHHccccCccCcC
Q 001902 887 MLYGYTPFRGKT----RQKTFANILHKDL-------------------KFPSST----PTSLHAKQLMYRLLHRDPKSRL 939 (998)
Q Consensus 887 LltG~~Pf~~~~----~~~~~~~i~~~~~-------------------~~~~~~----~~s~~l~~Ll~~~L~~dP~~Rp 939 (998)
|++|..||.... ....+..+..+.. .++... ..+..+.+||.+||..||.+||
T Consensus 216 l~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~ 295 (319)
T 4euu_A 216 AATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295 (319)
T ss_dssp HHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC
T ss_pred HHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhc
Confidence 999999997433 2445555554332 111111 2345778999999999999999
Q ss_pred CChhcHHHHHcCC
Q 001902 940 GSHEGANEIKKHP 952 (998)
Q Consensus 940 t~~~~a~elL~Hp 952 (998)
| +.++|+||
T Consensus 296 s----~~ell~h~ 304 (319)
T 4euu_A 296 G----FDQFFAET 304 (319)
T ss_dssp C----HHHHHHHH
T ss_pred c----HHHhhhcc
Confidence 9 99999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=358.67 Aligned_cols=263 Identities=25% Similarity=0.349 Sum_probs=213.5
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
...+.|.....||+|+||.||+|.+..+++.||+|.+... .......+.+|+.+++.++||||+++++++...+..+
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC---CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC---chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 3455677777999999999999999999999999998754 2334567889999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec-CCcEEEEeccCccccCC
Q 001902 742 LITDYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~-~g~vkL~DFG~a~~~~~ 819 (998)
+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+|+||||+|||++. ++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999999999998652 235778999999999999999999999999999999999997 89999999999855321
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC--CCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
. ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...
T Consensus 176 ~---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 176 I---------------------------NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp --------------------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred C---------------------------CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 1 01123456999999999997643 788999999999999999999999764
Q ss_pred ChH-HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 898 TRQ-KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 898 ~~~-~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
... ...................+..+.+||.+||..||.+||+ +.++++||||+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 229 GEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRAC----ANDLLVDEFLKVSS 286 (295)
T ss_dssp SSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCC----HHHHHTSGGGCC--
T ss_pred CchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCC----HHHHhcChhhhhcc
Confidence 432 2222222212222223457889999999999999999999 99999999999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=376.25 Aligned_cols=260 Identities=23% Similarity=0.386 Sum_probs=211.1
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-----------CCCc
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-----------HPFV 727 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-----------h~nI 727 (998)
+..+..++|++++.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++++. |+||
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i 88 (373)
T 1q8y_A 13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 88 (373)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchH
Confidence 4556678999999999999999999999999999999998753 234466778999998886 8999
Q ss_pred cceeEEEeeCC----eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEec
Q 001902 728 PALYASFQTKT----HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQG 802 (998)
Q Consensus 728 v~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkP~NILi~~ 802 (998)
+++++++...+ .+++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 167 (373)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEec
Confidence 99999997654 899999999 99999999876556799999999999999999999998 9999999999999964
Q ss_pred ------CCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhH
Q 001902 803 ------NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 876 (998)
Q Consensus 803 ------~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sD 876 (998)
.+.+||+|||++..... ......||+.|+|||++.+..++.++|
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~D 217 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDE------------------------------HYTNSIQTREYRSPEVLLGAPWGCGAD 217 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTB------------------------------CCCSCCSCGGGCCHHHHHTCCCCTHHH
T ss_pred cCCCcCcceEEEcccccccccCC------------------------------CCCCCCCCccccCcHHHhCCCCCchHh
Confidence 34799999999855321 112346899999999999999999999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCh------HHHHHHHHhCCCCC-------------------------------------
Q 001902 877 WWALGILLYEMLYGYTPFRGKTR------QKTFANILHKDLKF------------------------------------- 913 (998)
Q Consensus 877 IwSlG~il~eLltG~~Pf~~~~~------~~~~~~i~~~~~~~------------------------------------- 913 (998)
||||||++|+|++|..||.+.+. ...+..+.......
T Consensus 218 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (373)
T 1q8y_A 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 297 (373)
T ss_dssp HHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh
Confidence 99999999999999999986542 22222222110000
Q ss_pred ---CCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 914 ---PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 914 ---~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
......+..+.+||.+||+.||.+||| +.++|+||||+..
T Consensus 298 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~ 340 (373)
T 1q8y_A 298 EKYKFSKDEAKEISDFLSPMLQLDPRKRAD----AGGLVNHPWLKDT 340 (373)
T ss_dssp HTTCCCHHHHHHHHHHHGGGGCSSTTTCBC----HHHHHTCGGGTTC
T ss_pred hcccCCcchHHHHHHHHHHHhccCccccCC----HHHHhhChhhhcc
Confidence 011123567889999999999999999 9999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=355.32 Aligned_cols=252 Identities=27% Similarity=0.419 Sum_probs=208.7
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccC-hhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
+..++|++.+.||+|+||.||+|.+ ++..+|+|++....... ......+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 4567999999999999999999998 48899999987643322 23356788999999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCcEEEec--------CCcEEEE
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG---IIYRDLKPENVLLQG--------NGHVSLT 809 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~---IiHrDLkP~NILi~~--------~g~vkL~ 809 (998)
|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+
T Consensus 82 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999999864 35999999999999999999999999 999999999999986 7789999
Q ss_pred eccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc
Q 001902 810 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 889 (998)
Q Consensus 810 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt 889 (998)
|||++...... ......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 159 Dfg~~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 209 (271)
T 3dtc_A 159 DFGLAREWHRT-----------------------------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT 209 (271)
T ss_dssp CCCC------------------------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHH
T ss_pred cCCcccccccc-----------------------------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 99998543211 1123468999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 890 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 890 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
|..||.+.+.......+.......+....++..+.+||.+||..||.+||| +.++++|
T Consensus 210 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~e~l~~ 267 (271)
T 3dtc_A 210 GEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPS----FTNILDQ 267 (271)
T ss_dssp CCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcC----HHHHHHH
Confidence 999999998888887777777666666778899999999999999999999 6666654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=370.13 Aligned_cols=262 Identities=21% Similarity=0.309 Sum_probs=219.4
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEc-----cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeE
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 732 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~ 732 (998)
...+..++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++++ +||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34566789999999999999999999973 467789999997542 233456788999999999 9999999999
Q ss_pred EEeeCCeEEEEEecCCCCchhHHHhhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 001902 733 SFQTKTHVCLITDYCPGGELFLLLDRQPT---------------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYR 791 (998)
Q Consensus 733 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------~~l~~~~~~~i~~qil~aL~~LH~~~IiHr 791 (998)
++...+..|+||||+++++|.+++..... ..+++..+..++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99999999999999999999999976532 237899999999999999999999999999
Q ss_pred cCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCC
Q 001902 792 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 871 (998)
Q Consensus 792 DLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 871 (998)
||||+|||++.++.+||+|||++........ ........||+.|+|||++.+..+
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~t~~y~aPE~~~~~~~ 251 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSN-------------------------YVVRGNARLPVKWMAPESLFEGIY 251 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTT-------------------------SEEETTEEECGGGCCHHHHHHCCC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCcc-------------------------ceeccCccCccCccCHHHhccCCC
Confidence 9999999999999999999999865431110 011234467889999999999999
Q ss_pred CChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 872 TSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 872 ~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
+.++|||||||++|+|++ |..||.+......+..++......+.....+..+.+||.+||..||.+||| +.++++
T Consensus 252 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~ 327 (344)
T 1rjb_A 252 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTS 327 (344)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred ChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcC----HHHHHH
Confidence 999999999999999998 999999887766677777666655556667899999999999999999999 777766
Q ss_pred C
Q 001902 951 H 951 (998)
Q Consensus 951 H 951 (998)
|
T Consensus 328 ~ 328 (344)
T 1rjb_A 328 F 328 (344)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=362.89 Aligned_cols=263 Identities=21% Similarity=0.308 Sum_probs=220.8
Q ss_pred ccccccccCCcccccccCCCCceeEEEEEEc-----cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCcccee
Q 001902 657 DSGEQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALY 731 (998)
Q Consensus 657 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 731 (998)
.+...+..++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~ 92 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLY 92 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence 3445666789999999999999999999983 456899999997542 455567888999999999999999999
Q ss_pred EEEeeCCeEEEEEecCCCCchhHHHhhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 001902 732 ASFQTKTHVCLITDYCPGGELFLLLDRQPT----------------------KVLKEDAVRFYAAEVVVALEYLHCQGII 789 (998)
Q Consensus 732 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~----------------------~~l~~~~~~~i~~qil~aL~~LH~~~Ii 789 (998)
+++...+..|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 172 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 999999999999999999999999986432 3489999999999999999999999999
Q ss_pred eccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC
Q 001902 790 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA 869 (998)
Q Consensus 790 HrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 869 (998)
||||||+|||++.++.+||+|||++........ ........+|+.|+|||++.+.
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~ 227 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDS-------------------------YVKRSQGRIPVKWMAIESLFDH 227 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSC-------------------------EECSSCCCSCGGGCCHHHHHHC
T ss_pred ccccchheEEEcCCCCEEEcccccccccccccc-------------------------ceeccCCCCcccccChhhhcCC
Confidence 999999999999999999999999865431110 0112334578899999999998
Q ss_pred CCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHH
Q 001902 870 GHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948 (998)
Q Consensus 870 ~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 948 (998)
.++.++|||||||++|+|++ |..||.+.........+.... ..+....++..+.+||.+||..||.+||+ +.++
T Consensus 228 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~l 302 (314)
T 2ivs_A 228 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPV----FADI 302 (314)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHH
T ss_pred CcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCC-cCCCCccCCHHHHHHHHHHccCChhhCcC----HHHH
Confidence 89999999999999999999 999999888777666655543 33344567899999999999999999999 6666
Q ss_pred HcC
Q 001902 949 KKH 951 (998)
Q Consensus 949 L~H 951 (998)
+++
T Consensus 303 ~~~ 305 (314)
T 2ivs_A 303 SKD 305 (314)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=370.84 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=187.6
Q ss_pred ccCCccccc-ccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee----C
Q 001902 663 NLQHFRPIK-PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----K 737 (998)
Q Consensus 663 ~~~~y~~~~-~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~----~ 737 (998)
..++|.+++ .||+|+||.||+|.+..+|+.||+|++.... .........++.++||||+++++++.. .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 357899966 5999999999999999999999999987531 112223344677799999999999976 5
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec---CCcEEEEeccCc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLS 814 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~---~g~vkL~DFG~a 814 (998)
..+++|||||++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 56899999999999999998776567999999999999999999999999999999999999986 455999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 179 ~~~~~-----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 229 (336)
T 3fhr_A 179 KETTQ-----------------------------NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229 (336)
T ss_dssp EEC---------------------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred eeccc-----------------------------cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 54321 1122446899999999998888999999999999999999999999
Q ss_pred CCCChHHHH----HHHHhC--CCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 895 RGKTRQKTF----ANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 895 ~~~~~~~~~----~~i~~~--~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
.+....... ..+... ..+.+....++..+.+||.+||..||.+||| +.++|+||||+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~ 293 (336)
T 3fhr_A 230 YSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT----ITQFMNHPWINQ 293 (336)
T ss_dssp ---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHHSHHHHT
T ss_pred CCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcC----HHHHhcCccccc
Confidence 876544332 222222 2233344567899999999999999999999 999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=358.68 Aligned_cols=272 Identities=26% Similarity=0.458 Sum_probs=211.1
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee--------
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-------- 736 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-------- 736 (998)
++|++++.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 5799999999999999999999999999999998643 3455778899999999999999999998864
Q ss_pred -----CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEec
Q 001902 737 -----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 811 (998)
Q Consensus 737 -----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DF 811 (998)
....|+||||+++++|.+++... ...++...++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 46789999999999999999864 345888999999999999999999999999999999999999999999999
Q ss_pred cCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcC
Q 001902 812 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG 890 (998)
Q Consensus 812 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG 890 (998)
|++............. ...............||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 161 g~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~- 226 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLD-------------SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY- 226 (303)
T ss_dssp CCCSCTTC--------------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS-
T ss_pred cchhhcccccchhccc-------------cccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh-
Confidence 9986543211100000 00000111223456799999999999865 68899999999999999998
Q ss_pred CCCCCCC-ChHHHHHHHHhCCCCCCCC--CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhh
Q 001902 891 YTPFRGK-TRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWAL 961 (998)
Q Consensus 891 ~~Pf~~~-~~~~~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 961 (998)
||... +.......+......++.. ...+..+.+||.+||..||.+||| +.++++||||+...+..
T Consensus 227 --p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~ 294 (303)
T 1zy4_A 227 --PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG----ARTLLNSGWLPVKHQDE 294 (303)
T ss_dssp --CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCC----HHHHHHSSCSCCCCHHH
T ss_pred --ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcC----HHHHhCCCCcCCCChHH
Confidence 56543 3334445555444444432 345678999999999999999999 99999999999876654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=355.42 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=214.8
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
.+.+..++|++++.||+|+||.||++.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 44567789999999999999999999885 678899999986532 2356788999999999999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 999999999999999999763 2459999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~ 897 (998)
... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 172 ~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 172 DDE--------------------------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp CHH--------------------------HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccc--------------------------cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 110 011223357889999999998899999999999999999998 99999998
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 898 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
+.......+..... .......+..+.+||.+||+.||.+||| +.++++|
T Consensus 226 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~ll~~ 274 (283)
T 3gen_A 226 TNSETAEHIAQGLR-LYRPHLASEKVYTIMYSCWHEKADERPT----FKILLSN 274 (283)
T ss_dssp CHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCC----HHHHHHH
T ss_pred ChhHHHHHHhcccC-CCCCCcCCHHHHHHHHHHccCChhHCcC----HHHHHHH
Confidence 88887777766532 3333456889999999999999999999 6666654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=356.88 Aligned_cols=254 Identities=22% Similarity=0.304 Sum_probs=219.3
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
.+.+..++|++.+.||+|+||.||+|.+..++..||+|++... ......+.+|+.+++.++||||+++++++...+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 3456678999999999999999999999999999999998753 334567889999999999999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
..|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999999999988666779999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~ 897 (998)
... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 163 ~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~ 216 (288)
T 3kfa_A 163 GDT--------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216 (288)
T ss_dssp SSS--------------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCc--------------------------cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 111 011223457889999999999999999999999999999999 99999988
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 898 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
+.......+... ...+....++..+.+||.+||..||.+|||+.+
T Consensus 217 ~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 261 (288)
T 3kfa_A 217 DLSQVYELLEKD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAE 261 (288)
T ss_dssp CGGGHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CHHHHHHHHhcc-CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHH
Confidence 777666655443 344444567899999999999999999999433
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=362.33 Aligned_cols=261 Identities=21% Similarity=0.314 Sum_probs=220.5
Q ss_pred cccccCCcccccccCCCCceeEEEEEE-----ccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEE
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS 733 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~ 733 (998)
..+..++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .......+.+|+.+++++ +||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 456678999999999999999999995 4568899999997542 334557788999999999 99999999999
Q ss_pred EeeCCeEEEEEecCCCCchhHHHhhCCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 001902 734 FQTKTHVCLITDYCPGGELFLLLDRQPT----------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 797 (998)
Q Consensus 734 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~N 797 (998)
+...+..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 9999999999999999999999986532 248999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHH
Q 001902 798 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 877 (998)
Q Consensus 798 ILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDI 877 (998)
||++.++.+||+|||++........ ........||+.|+|||++.+..++.++||
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 230 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSN-------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDV 230 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT-------------------------SEECSSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred EEEcCCCCEEEcccccccccccccc-------------------------ceeccCCCCcceeeChHHhcCCCCChHHHH
Confidence 9999999999999999865431111 011233457889999999999999999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 878 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 878 wSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
|||||++|+|++ |..||.+.................+.....+..+.+||.+||..||.+||| +.+++++
T Consensus 231 ~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 301 (313)
T 1t46_A 231 WSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT----FKQIVQL 301 (313)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcC----HHHHHHH
Confidence 999999999998 999999877666666666555555555667899999999999999999999 6666553
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=353.43 Aligned_cols=252 Identities=19% Similarity=0.299 Sum_probs=218.3
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC--
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-- 737 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-- 737 (998)
..+..++|++.+.||+|+||.||+|.+ +++.||+|++.... ........+.+|+.++++++||||+++++++...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 345678999999999999999999998 48899999998653 2344557788999999999999999999999876
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
+..++||||+++++|.+++.......+++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78999999999999999998765556999999999999999999999999 9999999999999999999999999874
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCC---hhHHHHHHHHHHHHHcCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS---AVDWWALGILLYEMLYGYT 892 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~---~sDIwSlG~il~eLltG~~ 892 (998)
... .....||+.|+|||++.+..++. ++|||||||++|+|++|..
T Consensus 162 ~~~--------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 209 (271)
T 3kmu_A 162 SFQ--------------------------------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV 209 (271)
T ss_dssp TTS--------------------------------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSC
T ss_pred eec--------------------------------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 321 12346899999999998765554 7999999999999999999
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 893 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 893 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
||.+.+.......+............++..+.+||.+||..||.+||| +.++++
T Consensus 210 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~ 263 (271)
T 3kmu_A 210 PFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPK----FDMIVP 263 (271)
T ss_dssp TTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 999998888888877776655555678999999999999999999999 555553
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=353.31 Aligned_cols=254 Identities=22% Similarity=0.309 Sum_probs=216.5
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+..++|++++.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 455679999999999999999999875 577899999976432 235678899999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999999999764 245999999999999999999999999999999999999999999999999998654311
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~ 899 (998)
. ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 158 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (268)
T 3sxs_A 158 Q--------------------------YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211 (268)
T ss_dssp C--------------------------EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred h--------------------------hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh
Confidence 1 011223456788999999999889999999999999999998 9999999888
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
......+...... ......+..+.+||.+||+.||.+||| +.++++|
T Consensus 212 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~ll~~ 258 (268)
T 3sxs_A 212 SEVVLKVSQGHRL-YRPHLASDTIYQIMYSCWHELPEKRPT----FQQLLSS 258 (268)
T ss_dssp HHHHHHHHTTCCC-CCCTTSCHHHHHHHHHTTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHcCCCC-CCCCcChHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 8877777665433 233446889999999999999999999 7777765
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=364.44 Aligned_cols=264 Identities=20% Similarity=0.276 Sum_probs=210.3
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+..++|++.+.||+|+||.||+|.+..+++.||+|.+... +......+.+|+.++++++||||+++++++...+..+
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 4467899999999999999999999999999999988643 4556678899999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999874 3459999999999999999999999999999999999999999999999999997653221
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
...... ..............+||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 163 ~~~~~~-------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~ 229 (310)
T 3s95_A 163 TQPEGL-------------RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229 (310)
T ss_dssp ------------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC
T ss_pred cccccc-------------ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH
Confidence 110000 0000001122235689999999999999999999999999999999999999986532211
Q ss_pred -----HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 902 -----TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 902 -----~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
......... ....++..+.+||.+||+.||.+||| +.++++
T Consensus 230 ~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps----~~~l~~ 275 (310)
T 3s95_A 230 MDFGLNVRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPS----FVKLEH 275 (310)
T ss_dssp TTSSBCHHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHhhhhhcccccc----CCCCCCHHHHHHHHHHccCChhhCcC----HHHHHH
Confidence 111111111 12345678999999999999999999 666654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=365.82 Aligned_cols=276 Identities=17% Similarity=0.224 Sum_probs=227.2
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEc-----cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEE
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS 733 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 733 (998)
...+..++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 44566789999999999999999999986 457899999987542 33445678899999999999999999999
Q ss_pred EeeCCeEEEEEecCCCCchhHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc
Q 001902 734 FQTKTHVCLITDYCPGGELFLLLDRQP--------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 805 (998)
Q Consensus 734 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~ 805 (998)
+...+..++||||+++++|.+++.... ...++...+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 999999999999999999999987521 134789999999999999999999999999999999999999999
Q ss_pred EEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHH
Q 001902 806 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 885 (998)
Q Consensus 806 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~ 885 (998)
+||+|||++....... .........||+.|+|||++.+..++.++|||||||++|
T Consensus 177 ~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 231 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 231 (322)
T ss_dssp EEECCTTCCCGGGGGG-------------------------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred EEECcCcccccccccc-------------------------ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHH
Confidence 9999999985432110 001123346789999999999989999999999999999
Q ss_pred HHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC--CCccCCChhhh
Q 001902 886 EMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH--PFFKGVNWALV 962 (998)
Q Consensus 886 eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H--p~f~~~~~~~~ 962 (998)
+|++ |..||.+.+.......+...... +....++..+.+||.+||..||.+|||+.+++..|.++ ++|+.++|...
T Consensus 232 el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~~~ 310 (322)
T 1p4o_A 232 EIATLAEQPYQGLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 310 (322)
T ss_dssp HHHHTSCCTTTTSCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTTS
T ss_pred HHHhcCCCccccCCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccccccc
Confidence 9999 89999998888777777665432 23345788999999999999999999954444444332 88877666554
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=369.11 Aligned_cols=260 Identities=22% Similarity=0.318 Sum_probs=219.8
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccC-------CeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCcccee
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGS-------GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 731 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-------~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~ 731 (998)
+.+..++|++.+.||+|+||.||+|.+..+ +..||+|++... ........+.+|+.+++++ +||||++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 346668999999999999999999998543 368999999764 2445567888999999999 999999999
Q ss_pred EEEeeCCeEEEEEecCCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 001902 732 ASFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 797 (998)
Q Consensus 732 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~N 797 (998)
+++...+.+|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999998653 2359999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHH
Q 001902 798 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 877 (998)
Q Consensus 798 ILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDI 877 (998)
||++.++.+||+|||++........ ........||+.|+|||++.+..++.++||
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~-------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 276 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDY-------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDV 276 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCT-------------------------TCCCTTCCCGGGGSCHHHHHSCCCCHHHHH
T ss_pred EEEcCCCcEEEcccCcccccccccc-------------------------cccccCCCCCcceeCHHHhcCCCCCchhHH
Confidence 9999999999999999965431110 011233467889999999999999999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 878 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 878 wSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
|||||++|+|++ |..||.+.+.......+.... .......++..+.+||.+||..||.+||| +.+++++
T Consensus 277 wslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 346 (382)
T 3tt0_A 277 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVED 346 (382)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCCSSCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCccCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 999999999999 999999988877776665543 33334567899999999999999999999 6666654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=359.07 Aligned_cols=274 Identities=19% Similarity=0.231 Sum_probs=217.9
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 739 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 739 (998)
.+..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.+ +|+|++.+++++.....
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 455678999999999999999999999999999999987542 223567799999999 89999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc-----EEEEeccCc
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-----VSLTDFDLS 814 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~-----vkL~DFG~a 814 (998)
.|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 99999999 999999998653 45999999999999999999999999999999999999987776 999999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
.......... ..+........||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 159 ~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 218 (298)
T 1csn_A 159 KFYRDPVTKQ--------------------HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218 (298)
T ss_dssp EESBCTTTCC--------------------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccccccccc--------------------cccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCc
Confidence 6643221100 01112345668999999999999999999999999999999999999999
Q ss_pred CCCC---hHHHHHHHHhCCCCCC---CCCCCcHHHHHHHHHccccCccCcCCChhcHHHH------HcCCCccCCChhh
Q 001902 895 RGKT---RQKTFANILHKDLKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI------KKHPFFKGVNWAL 961 (998)
Q Consensus 895 ~~~~---~~~~~~~i~~~~~~~~---~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el------L~Hp~f~~~~~~~ 961 (998)
.+.+ ....+..+.......+ ....++..+.+|+.+||..||.+||++.+++..+ ++......++|..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 219 QGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp SSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred chhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 8743 3444444433221111 1234688999999999999999999965543322 2344455555543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=365.39 Aligned_cols=258 Identities=20% Similarity=0.285 Sum_probs=217.7
Q ss_pred ccccCCcccccccCCCCceeEEEEEEc-----cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 735 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 735 (998)
.+..++|++++.||+|+||.||+|.+. .+++.||+|+++... .......+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 455679999999999999999999997 356899999998642 3445677889999999999999999999999
Q ss_pred eCCeEEEEEecCCCCchhHHHhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQP----------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 793 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDL 793 (998)
..+..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 9999999999999999999997642 156999999999999999999999999999999
Q ss_pred CCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCC
Q 001902 794 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 873 (998)
Q Consensus 794 kP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 873 (998)
||+|||++.++.+||+|||++....... .........||+.|+|||++.+..++.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~ 255 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSAD-------------------------YYKADGNDAIPIRWMPPESIFYNRYTT 255 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGG-------------------------CBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred CcceEEECCCCeEEEeecCCCcccccCc-------------------------cccccCCCcccceecChhhhccCCcCc
Confidence 9999999999999999999986532110 001123446899999999999989999
Q ss_pred hhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 874 AVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 874 ~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
++|||||||++|+|++ |..||.+.+.......+..+... +....++..+.+||.+||..||.+||+ +.++++
T Consensus 256 ~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~~~~ 328 (343)
T 1luf_A 256 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPS----FCSIHR 328 (343)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred ccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCC----HHHHHH
Confidence 9999999999999998 99999998888877777766542 223457889999999999999999999 555544
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=359.60 Aligned_cols=249 Identities=23% Similarity=0.307 Sum_probs=203.8
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEE
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 742 (998)
..++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+.+|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 35799999999999999999999999999999999987655556667888999999999999999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK- 188 (309)
T ss_dssp EEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc-
Confidence 99999999999999874 459999999999999999999999999999999999999999999999999985432110
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
........|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+....
T Consensus 189 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (309)
T 2h34_A 189 -------------------------LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM 243 (309)
T ss_dssp ---------------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH
T ss_pred -------------------------cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH
Confidence 0112345699999999999999999999999999999999999999988765533
Q ss_pred HHHHHhCCCCCC--CCCCCcHHHHHHHHHccccCccCcC-C
Q 001902 903 FANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRL-G 940 (998)
Q Consensus 903 ~~~i~~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rp-t 940 (998)
...+......+ ....++..+.+||.+||..||.+|| +
T Consensus 244 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s 283 (309)
T 2h34_A 244 -GAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVT 283 (309)
T ss_dssp -HHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSS
T ss_pred -HHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHh
Confidence 33344333222 2345788999999999999999999 6
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=352.15 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=210.1
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHH----HHHHHHHHHHHhCCCCCccceeEEEee
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV----HRACAEREILDMLDHPFVPALYASFQT 736 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~ 736 (998)
.+..++|++.+.||+|+||.||+|.+..+++.||+|++........... ..+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 3556899999999999999999999999999999999876533322221 678899999999999999999999876
Q ss_pred CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEecCCc-----EEEE
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGH-----VSLT 809 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkP~NILi~~~g~-----vkL~ 809 (998)
.. ++||||+++++|.+++... ...+++..+..++.||+.||.|||++| |+||||||+|||++.++. +||+
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 65 6999999999999988664 346999999999999999999999999 999999999999998776 9999
Q ss_pred eccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc--CCCCCChhHHHHHHHHHHHH
Q 001902 810 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA--GAGHTSAVDWWALGILLYEM 887 (998)
Q Consensus 810 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~sDIwSlG~il~eL 887 (998)
|||++.... .......||+.|+|||++. ...++.++|||||||++|+|
T Consensus 172 Dfg~~~~~~------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l 221 (287)
T 4f0f_A 172 DFGLSQQSV------------------------------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTI 221 (287)
T ss_dssp CCTTCBCCS------------------------------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHH
T ss_pred CCCcccccc------------------------------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHH
Confidence 999985322 1123457999999999984 45678899999999999999
Q ss_pred HcCCCCCCCCChHH--HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 888 LYGYTPFRGKTRQK--TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 888 ltG~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
++|..||....... ....+............++..+.+||.+||..||.+||| +.++++
T Consensus 222 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~ 282 (287)
T 4f0f_A 222 LTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPH----FSYIVK 282 (287)
T ss_dssp HHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcC----HHHHHH
Confidence 99999998765433 344555555555555667899999999999999999999 555543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=358.23 Aligned_cols=257 Identities=20% Similarity=0.340 Sum_probs=207.1
Q ss_pred cccccCCcccccccCCCCceeEEEEE----EccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVE----LCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 735 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~----~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 735 (998)
.++..++|++++.||+|+||.||+|. +..+++.||+|++... .......+.+|+.++++++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 45667899999999999999999998 5678999999998754 3455677889999999999999999999985
Q ss_pred e--CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccC
Q 001902 736 T--KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 813 (998)
Q Consensus 736 ~--~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~ 813 (998)
. ...+++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 4 456899999999999999998753 3599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCC
Q 001902 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 814 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~P 893 (998)
+......... ........|+..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 161 ~~~~~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 216 (295)
T 3ugc_A 161 TKVLPQDKEF------------------------FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 216 (295)
T ss_dssp CC-------------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCT
T ss_pred cccccCCcce------------------------eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccc
Confidence 9654321110 0112234578889999999999999999999999999999999999
Q ss_pred CCCCChH---------------HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 894 FRGKTRQ---------------KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 894 f~~~~~~---------------~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
|...... .............+....++..+.+||.+||..||.+|||+.++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 282 (295)
T 3ugc_A 217 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282 (295)
T ss_dssp TCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred cCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 8653211 01122233334445556688999999999999999999994443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=365.08 Aligned_cols=256 Identities=27% Similarity=0.361 Sum_probs=215.6
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccCh---hHHHHHHHHHHHHHhCC--CCCccceeEEEee
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR---NKVHRACAEREILDMLD--HPFVPALYASFQT 736 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~---~~~~~~~~E~~il~~l~--h~nIv~l~~~~~~ 736 (998)
...++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++++. |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 346789999999999999999999999999999999986543221 12234567999999996 5999999999999
Q ss_pred CCeEEEEEecCCC-CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe-cCCcEEEEeccCc
Q 001902 737 KTHVCLITDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-GNGHVSLTDFDLS 814 (998)
Q Consensus 737 ~~~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~-~~g~vkL~DFG~a 814 (998)
.+..++||||+.+ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 9999999999976 8999999764 4599999999999999999999999999999999999999 7899999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCC-CChhHHHHHHHHHHHHHcCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDIwSlG~il~eLltG~~P 893 (998)
...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..|
T Consensus 198 ~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 248 (320)
T 3a99_A 198 ALLKDT-----------------------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248 (320)
T ss_dssp EECCSS-----------------------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccc-----------------------------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCC
Confidence 553211 1123469999999999977665 6789999999999999999999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChh
Q 001902 894 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 960 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 960 (998)
|.... .+......++ ..++..+.+||.+||..||.+||| +.++++||||+.....
T Consensus 249 f~~~~------~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps----~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 249 FEHDE------EIIRGQVFFR--QRVSSECQHLIRWCLALRPSDRPT----FEEIQNHPWMQDVLLP 303 (320)
T ss_dssp CCSHH------HHHHCCCCCS--SCCCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSSCCCH
T ss_pred CCChh------hhhccccccc--ccCCHHHHHHHHHHccCChhhCcC----HHHHhcCHhhcCccCc
Confidence 97632 2334433333 346889999999999999999999 9999999999997654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=366.48 Aligned_cols=257 Identities=21% Similarity=0.301 Sum_probs=207.7
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeE----EEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY----FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 735 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~----valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 735 (998)
..+..++|++++.||+|+||.||+|.+..+++. +|+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 345678999999999999999999999888776 6666664321 1222345667999999999999999999886
Q ss_pred eCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
.+..++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred -CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence 46689999999999999999764 3468999999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPF 894 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf 894 (998)
....... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 164 ~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 218 (325)
T 3kex_A 164 LLPPDDK-------------------------QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218 (325)
T ss_dssp GSCCCTT-------------------------CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccCcccc-------------------------cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCc
Confidence 6432111 112234568889999999999999999999999999999999 99999
Q ss_pred CCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHH
Q 001902 895 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946 (998)
Q Consensus 895 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 946 (998)
.+.........+.... ..+....++..+.+||.+||..||.+||++.++++
T Consensus 219 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~ 269 (325)
T 3kex_A 219 AGLRLAEVPDLLEKGE-RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELAN 269 (325)
T ss_dssp TTSCTTHHHHHHHTTC-BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHH
T ss_pred cccCHHHHHHHHHcCC-CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9887777666665543 22333346778899999999999999999444433
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=355.76 Aligned_cols=258 Identities=28% Similarity=0.408 Sum_probs=207.5
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEE
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 742 (998)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 35689999999999999999999999999999999986555556677888999999999999999999999999999999
Q ss_pred EEecCCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 743 ITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999999864 22356899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC--
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT-- 898 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~-- 898 (998)
. .......|++.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 190 ~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 242 (310)
T 2wqm_A 190 T---------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 242 (310)
T ss_dssp ------------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC
T ss_pred C---------------------------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh
Confidence 0 11223468999999999999999999999999999999999999997643
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
.......+.....+......++.++.+||.+||..||.+||+ +.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~il~~ 291 (310)
T 2wqm_A 243 LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPD----VTYVYDV 291 (310)
T ss_dssp HHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCC----HHHHHHH
Confidence 334445555554443334567889999999999999999999 6666653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=357.87 Aligned_cols=263 Identities=24% Similarity=0.364 Sum_probs=214.4
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC--CCCccceeEEEeeC
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD--HPFVPALYASFQTK 737 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~--h~nIv~l~~~~~~~ 737 (998)
..+..++|++++.||+|+||.||+|.+. +++.||+|++.... ........+.+|+.++++++ |+||+++++++...
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 3455678999999999999999999984 58999999997643 24455678889999999997 59999999999999
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
+..|+|||+ .+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 101 ~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 101 QYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176 (313)
T ss_dssp SEEEEEECC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred CEEEEEEec-CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccc
Confidence 999999995 589999999875 4589999999999999999999999999999999999997 589999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-----------CCCCChhHHHHHHHHHHH
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----------AGHTSAVDWWALGILLYE 886 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~sDIwSlG~il~e 886 (998)
..... ........||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 177 ~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~e 231 (313)
T 3cek_A 177 QPDTT-------------------------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231 (313)
T ss_dssp --------------------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHH
T ss_pred cCccc-------------------------cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHH
Confidence 31110 011234569999999999976 467889999999999999
Q ss_pred HHcCCCCCCCCCh-HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 887 MLYGYTPFRGKTR-QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 887 LltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
|++|..||..... ...+..+.............+..+.+||.+||..||.+||+ +.++++||||+..
T Consensus 232 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~h~~~~~~ 299 (313)
T 3cek_A 232 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS----IPELLAHPYVQIQ 299 (313)
T ss_dssp HHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHCC
T ss_pred HHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcC----HHHHhcCccccCC
Confidence 9999999987543 34445555544443334445788999999999999999999 9999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=352.68 Aligned_cols=256 Identities=25% Similarity=0.359 Sum_probs=206.2
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccC---CeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 736 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 736 (998)
..+..++|++.+.||+|+||.||+|.+..+ +..+|+|.+... ........+.+|+.++++++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 345678999999999999999999998653 567999998753 23455677889999999999999999999884
Q ss_pred CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
.+..|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred cCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 56789999999999999999765 34599999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 895 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~ 895 (998)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 166 ~~~~~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~ 219 (281)
T 1mp8_A 166 MEDSTY--------------------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219 (281)
T ss_dssp ---------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCcccc--------------------------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCC
Confidence 431100 11123357889999999998899999999999999999996 999999
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 896 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 896 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
+.........+.... ..+....++..+.+||.+||..||.+||| +.++++
T Consensus 220 ~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~l~~ 269 (281)
T 1mp8_A 220 GVKNNDVIGRIENGE-RLPMPPNCPPTLYSLMTKCWAYDPSRRPR----FTELKA 269 (281)
T ss_dssp TCCGGGHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred cCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHccCChhhCcC----HHHHHH
Confidence 988877777776553 23344567899999999999999999999 555554
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=372.76 Aligned_cols=257 Identities=20% Similarity=0.281 Sum_probs=215.9
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
+.+..++|++.+.||+|+||.||+|.+..+++.||+|+++.. ........+.+|+.+++.++||||+++++++...+.
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 456678999999999999999999999989999999998754 234445678889999999999999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|+||||+++++|.+++... ...++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred cEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999999999764 24589999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~ 898 (998)
... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus 266 ~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 266 GVY-------------------------AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp SEE-------------------------ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred Cce-------------------------eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 000 001112235778999999998889999999999999999998 999999988
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcH
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 945 (998)
.......+..+ ...+....++..+.+||.+||..||.+|||+.+++
T Consensus 321 ~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 366 (377)
T 3cbl_A 321 NQQTREFVEKG-GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIY 366 (377)
T ss_dssp HHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 77766655543 33344455788999999999999999999954443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=362.74 Aligned_cols=266 Identities=18% Similarity=0.229 Sum_probs=218.0
Q ss_pred cccccCCcccccccCCCCceeEEEEE-----EccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEE
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVE-----LCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF 734 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~-----~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 734 (998)
..+..++|++++.||+|+||.||+|. +..+++.||+|++... ........+.+|+.++++++||||+++++++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVS 102 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 34667899999999999999999999 5567889999998743 2344556788999999999999999999999
Q ss_pred eeCCeEEEEEecCCCCchhHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec---CCcE
Q 001902 735 QTKTHVCLITDYCPGGELFLLLDRQPT-----KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHV 806 (998)
Q Consensus 735 ~~~~~~~lV~E~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~---~g~v 806 (998)
......|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999999986532 34899999999999999999999999999999999999994 4469
Q ss_pred EEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHH
Q 001902 807 SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 886 (998)
Q Consensus 807 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~e 886 (998)
||+|||++....... .........||+.|+|||++.+..++.++|||||||++|+
T Consensus 183 kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 237 (327)
T 2yfx_A 183 KIGDFGMARDIYRAS-------------------------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 237 (327)
T ss_dssp EECCCHHHHHHHC-------------------------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred EECcccccccccccc-------------------------ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHH
Confidence 999999985432110 0012234568999999999999899999999999999999
Q ss_pred HHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 887 MLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 887 Llt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
|++ |..||.+.........+...... .....++..+.+||.+||..||.+||+ +.++++|.|+-..
T Consensus 238 llt~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 238 IFSLGYMPYPSKSNQEVLEFVTSGGRM-DPPKNCPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYCTQ 304 (327)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHHHHH
T ss_pred HHcCCCCCCCCcCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhcCChhhCcC----HHHHHHHHHHHhc
Confidence 998 99999998887777766665432 233457889999999999999999999 9999999876543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=355.58 Aligned_cols=249 Identities=18% Similarity=0.264 Sum_probs=207.0
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCC-------eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSG-------QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS 733 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-------~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 733 (998)
.+..++|++.+.||+|+||.||+|.+..++ ..||+|++... .......+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 355678999999999999999999998776 57999998754 23445678899999999999999999999
Q ss_pred EeeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc--------
Q 001902 734 FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-------- 805 (998)
Q Consensus 734 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~-------- 805 (998)
+...+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999999998752 34999999999999999999999999999999999999998887
Q ss_pred EEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHH
Q 001902 806 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILL 884 (998)
Q Consensus 806 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il 884 (998)
+||+|||++.... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 160 ~kl~Dfg~~~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 208 (289)
T 4fvq_A 160 IKLSDPGISITVL-------------------------------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTL 208 (289)
T ss_dssp EEECCCCSCTTTS-------------------------------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHH
T ss_pred eeeccCccccccc-------------------------------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHH
Confidence 9999999984421 1122357889999999987 6789999999999999
Q ss_pred HHHHcC-CCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 885 YEMLYG-YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 885 ~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
|+|++| .+||....... ...+.......+. ..+..+.+||.+||..||.+||| +.++++|
T Consensus 209 ~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps----~~~ll~~ 269 (289)
T 4fvq_A 209 WEICSGGDKPLSALDSQR-KLQFYEDRHQLPA--PKAAELANLINNCMDYEPDHRPS----FRAIIRD 269 (289)
T ss_dssp HHHHTTTCCTTTTSCHHH-HHHHHHTTCCCCC--CSSCTTHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred HHHHcCCCCCccccchHH-HHHHhhccCCCCC--CCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 999995 45555544443 3344444333333 34677899999999999999999 7777665
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=368.16 Aligned_cols=261 Identities=21% Similarity=0.306 Sum_probs=208.8
Q ss_pred cccccccCCcccccccCCCCceeEEEEEEc---cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEE
Q 001902 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF 734 (998)
Q Consensus 658 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 734 (998)
....+..++|.+.+.||+|+||.||+|.+. .++..||+|+++... .......+.+|+.++++++||||+++++++
T Consensus 38 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 115 (373)
T 2qol_A 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVV 115 (373)
T ss_dssp TSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred HHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 344567789999999999999999999986 467789999997542 344567889999999999999999999999
Q ss_pred eeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCc
Q 001902 735 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814 (998)
Q Consensus 735 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a 814 (998)
...+.+|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 116 ~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 116 TKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred eeCCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence 9999999999999999999999765 346999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTP 893 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~P 893 (998)
......... ........+++.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 195 ~~~~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P 250 (373)
T 2qol_A 195 RVLEDDPEA------------------------AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250 (373)
T ss_dssp -------------------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CT
T ss_pred cccccCCcc------------------------ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCC
Confidence 654321110 001112346788999999999999999999999999999997 9999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHH
Q 001902 894 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 946 (998)
|.+.+.......+... ...+....++..+.+||.+||..||.+||++.++++
T Consensus 251 ~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 251 YWEMSNQDVIKAVDEG-YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp TTTCCHHHHHHHHHTT-EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcC-CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 9998887777666544 334444567889999999999999999999665433
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=363.57 Aligned_cols=260 Identities=22% Similarity=0.329 Sum_probs=219.1
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCe-----EEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEE
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ-----YFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS 733 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~-----~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~ 733 (998)
..+..++|++.+.||+|+||.||+|.+..+++ .||+|++.... .......+.+|+.+++.+ +||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34667899999999999999999999976654 89999987542 344567788999999999 89999999999
Q ss_pred EeeCCeEEEEEecCCCCchhHHHhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe
Q 001902 734 FQTKTHVCLITDYCPGGELFLLLDRQP------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ 801 (998)
Q Consensus 734 ~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~ 801 (998)
+...+.+|+||||+++++|.+++.... ...++...+..++.||+.||.|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 999999999999999999999997531 23589999999999999999999999999999999999999
Q ss_pred cCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHH
Q 001902 802 GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 881 (998)
Q Consensus 802 ~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG 881 (998)
.++.+||+|||++........ ........||+.|+|||++.+..++.++||||||
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 253 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSN-------------------------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 253 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTT-------------------------SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHH
T ss_pred CCCeEEECccccccccccccc-------------------------eeecCCCCCCccccCHHHhccCCCChHHHHHHHH
Confidence 999999999999865321110 0112334578899999999999999999999999
Q ss_pred HHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 882 ILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 882 ~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
|++|+|++ |..||.+......+..+.......+.....+..+.+||.+||..||.+||| +.++++
T Consensus 254 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~l~~ 319 (333)
T 2i1m_A 254 ILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT----FQQICS 319 (333)
T ss_dssp HHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcC----HHHHHH
Confidence 99999998 999999877666666666655555555567889999999999999999999 666655
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=362.11 Aligned_cols=257 Identities=23% Similarity=0.309 Sum_probs=205.9
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEE----EEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 736 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~v----alK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 736 (998)
.+..++|++++.||+|+||.||+|.+..+++.+ |+|.+.... .......+.+|+.++++++||||+++++++..
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 455678999999999999999999998777655 666665321 23345678899999999999999999999987
Q ss_pred CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
.. .++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred CC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 55 789999999999999998753 4599999999999999999999999999999999999999999999999999965
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 895 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~ 895 (998)
....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 167 ~~~~~~~-------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 221 (327)
T 3poz_A 167 LGAEEKE-------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp HTTTCC--------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCCccc-------------------------ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCcc
Confidence 4321110 11223457889999999999999999999999999999999 999999
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 896 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 896 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
+.........+... ...+.....+..+.+|+.+||+.||.+||+ +.++++|
T Consensus 222 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~ell~~ 272 (327)
T 3poz_A 222 GIPASEISSILEKG-ERLPQPPICTIDVYMIMVKCWMIDADSRPK----FRELIIE 272 (327)
T ss_dssp TCCGGGHHHHHHTT-CCCCCCTTBCHHHHHHHHHHTCSCGGGSCC----HHHHHHH
T ss_pred CCCHHHHHHHHHcC-CCCCCCccCCHHHHHHHHHHcCCChhhCCC----HHHHHHH
Confidence 88776665554443 344455567889999999999999999999 5555543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=357.14 Aligned_cols=262 Identities=26% Similarity=0.398 Sum_probs=203.2
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
+...++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+..+..+++.++||||+++++++...+.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 4556799999999999999999999999999999999986532 222233344455678888999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
|+||||+ ++.+..+.... ...+++..++.++.||+.||.|||++ ||+|+||||+|||++.++.+||+|||++.....
T Consensus 100 ~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 9999999 66666666543 34599999999999999999999996 999999999999999999999999999854321
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc-----CCCCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
. .......||+.|+|||++. ...++.++|||||||++|+|++|..||
T Consensus 178 ~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 229 (318)
T 2dyl_A 178 D----------------------------KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229 (318)
T ss_dssp -------------------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred C----------------------------ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCC
Confidence 1 1112346999999999994 456888999999999999999999999
Q ss_pred CCC-ChHHHHHHHHhCCC-CCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 895 RGK-TRQKTFANILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 895 ~~~-~~~~~~~~i~~~~~-~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
... .....+..+..... .++....++..+.+||.+||..||.+||+ +.++++||||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 230 KNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPK----YNKLLEHSFIKRY 290 (318)
T ss_dssp TTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC----HHHHTTSHHHHHH
T ss_pred CCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcC----HHHHhhCHHHHhc
Confidence 874 45556666665543 33444557899999999999999999999 9999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=361.84 Aligned_cols=254 Identities=29% Similarity=0.421 Sum_probs=204.5
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccCh---hHHHHHHHHHHHHHhC----CCCCccceeEEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR---NKVHRACAEREILDML----DHPFVPALYASF 734 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~---~~~~~~~~E~~il~~l----~h~nIv~l~~~~ 734 (998)
...++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.++.++ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 345789999999999999999999999999999999976533221 1223455689999998 899999999999
Q ss_pred eeCCeEEEEEec-CCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe-cCCcEEEEecc
Q 001902 735 QTKTHVCLITDY-CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-GNGHVSLTDFD 812 (998)
Q Consensus 735 ~~~~~~~lV~E~-~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~-~~g~vkL~DFG 812 (998)
...+..++|||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 999999999999 7899999999874 3599999999999999999999999999999999999999 88999999999
Q ss_pred CccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCC-ChhHHHHHHHHHHHHHcCC
Q 001902 813 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT-SAVDWWALGILLYEMLYGY 891 (998)
Q Consensus 813 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDIwSlG~il~eLltG~ 891 (998)
++...... ......||+.|+|||++.+..+. .++|||||||++|+|++|+
T Consensus 186 ~~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 236 (312)
T 2iwi_A 186 SGALLHDE-----------------------------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236 (312)
T ss_dssp SCEECCSS-----------------------------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred hhhhcccC-----------------------------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCC
Confidence 98654311 12244699999999999776664 4899999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 892 TPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 892 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
.||.... .+......++ ...+..+.+||.+||..||.+||| +.++++||||+...
T Consensus 237 ~pf~~~~------~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps----~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 237 IPFERDQ------EILEAELHFP--AHVSPDCCALIRRCLAPKPSSRPS----LEEILLDPWMQTPA 291 (312)
T ss_dssp CSCCSHH------HHHHTCCCCC--TTSCHHHHHHHHHHTCSSTTTSCC----HHHHHHSTTTCC--
T ss_pred CCCCChH------HHhhhccCCc--ccCCHHHHHHHHHHccCChhhCcC----HHHHhcChhhcCch
Confidence 9997632 2334444443 346889999999999999999999 99999999999853
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=347.39 Aligned_cols=254 Identities=22% Similarity=0.362 Sum_probs=216.1
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+..++|++.+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 455678999999999999999999985 678999999986532 235688899999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999999997653 45899999999999999999999999999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 899 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~ 899 (998)
.........|++.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 158 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (267)
T 3t9t_A 158 --------------------------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211 (267)
T ss_dssp --------------------------HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred --------------------------cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH
Confidence 0011223457889999999998889999999999999999999 9999999888
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
......+..... .......+..+.+|+.+||..||.+||+ +.+++++
T Consensus 212 ~~~~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~ll~~ 258 (267)
T 3t9t_A 212 SEVVEDISTGFR-LYKPRLASTHVYQIMNHCWRERPEDRPA----FSRLLRQ 258 (267)
T ss_dssp HHHHHHHHTTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHhcCCc-CCCCccCcHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 887777766532 2333456889999999999999999999 6666653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=362.76 Aligned_cols=266 Identities=23% Similarity=0.346 Sum_probs=196.0
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHH-HHHhCCCCCccceeEEEeeCC
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~-il~~l~h~nIv~l~~~~~~~~ 738 (998)
..+..++|++++.||+|+||.||+|.+..+|+.||+|++.... .......+..|+. +++.++||||+++++++...+
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 3466789999999999999999999999999999999997642 2333445555665 677789999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEecCCcEEEEeccCc
Q 001902 739 HVCLITDYCPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLS 814 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~---~~~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkP~NILi~~~g~vkL~DFG~a 814 (998)
..++||||++ ++|.+++.. .....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 95 DCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred ceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 9999999996 588777753 2245699999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhh----cCCCCCChhHHHHHHHHHHHHHcC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII----AGAGHTSAVDWWALGILLYEMLYG 890 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~sDIwSlG~il~eLltG 890 (998)
...... .......||+.|+|||++ .+..++.++|||||||++|+|++|
T Consensus 174 ~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g 225 (327)
T 3aln_A 174 GQLVDS----------------------------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225 (327)
T ss_dssp CC----------------------------------------------------------CCSHHHHHHHHHHHHHHHHS
T ss_pred eecccc----------------------------cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHC
Confidence 553211 011233699999999998 456789999999999999999999
Q ss_pred CCCCCCCChH-HHHHHHHhCCCC-CC--CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChh
Q 001902 891 YTPFRGKTRQ-KTFANILHKDLK-FP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 960 (998)
Q Consensus 891 ~~Pf~~~~~~-~~~~~i~~~~~~-~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 960 (998)
..||.+.... ..+..+..+..+ ++ .....+..+.+||.+||..||.+||+ +.++++||||...++.
T Consensus 226 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~hp~~~~~~~~ 295 (327)
T 3aln_A 226 RFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPK----YKELLKHPFILMYEER 295 (327)
T ss_dssp CCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCC----HHHHTTSHHHHHHHHS
T ss_pred CCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcC----HHHHHhChHHHHhHhh
Confidence 9999875432 222222222211 11 12347889999999999999999999 9999999999875543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=380.07 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=218.9
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
.+.+...+|++.+.||+|+||.||+|.+..++..||+|+++.... ....+.+|+.+|++++||||+++++++...+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 345667789999999999999999999998899999999976422 3567889999999999999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
.+|||||||++++|.+++.......++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999999999987655679999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~ 897 (998)
... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 370 ~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 370 GDT--------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp TCC--------------------------EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCc--------------------------eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 110 011223356789999999999999999999999999999998 99999998
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 898 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
+....+..+.. ....+....++..+.+||.+||+.||.+|||+.++
T Consensus 424 ~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el 469 (495)
T 1opk_A 424 DLSQVYELLEK-DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 469 (495)
T ss_dssp CGGGHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence 87766665544 33444455678999999999999999999994443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=358.98 Aligned_cols=260 Identities=24% Similarity=0.365 Sum_probs=214.9
Q ss_pred ccccCCcccccccCCCCceeEEEEEE-----ccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASF 734 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~ 734 (998)
.+..++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .......+.+|+.++.++ +||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 45567999999999999999999986 3567899999997642 344556788999999999 799999999998
Q ss_pred eeC-CeEEEEEecCCCCchhHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 001902 735 QTK-THVCLITDYCPGGELFLLLDRQPT--------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 799 (998)
Q Consensus 735 ~~~-~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NIL 799 (998)
... ..+++||||+++++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 765 458999999999999999986532 12889999999999999999999999999999999999
Q ss_pred EecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHH
Q 001902 800 LQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 879 (998)
Q Consensus 800 i~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwS 879 (998)
++.++.+||+|||++........ ........||+.|+|||++.+..++.++||||
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~-------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s 235 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPD-------------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 235 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTT-------------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred ECCCCCEEECCCccccccccCcc-------------------------ceeccCCCcceeecCchhhccccccchhHHHH
Confidence 99999999999999865431110 01123446789999999999999999999999
Q ss_pred HHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 880 LGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 880 lG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
|||++|+|++ |..||.+......+...+......+.....+..+.+||.+||..||.+||| +.++++|
T Consensus 236 lG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 304 (316)
T 2xir_A 236 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 304 (316)
T ss_dssp HHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 9999999998 999998876555544444433333444557889999999999999999999 7777765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=373.48 Aligned_cols=252 Identities=22% Similarity=0.362 Sum_probs=215.0
Q ss_pred hccccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe
Q 001902 656 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 735 (998)
Q Consensus 656 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 735 (998)
...++.+..++|++++.||+|+||.||++.+ .|+.||||+++... ....+.+|+.+|++++||||+++++++.
T Consensus 184 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~ 256 (450)
T 1k9a_A 184 YRSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIV 256 (450)
T ss_dssp HHTTCBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cccccccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence 3456778889999999999999999999998 47899999997542 3467889999999999999999999987
Q ss_pred eCC-eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCc
Q 001902 736 TKT-HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814 (998)
Q Consensus 736 ~~~-~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a 814 (998)
... .+|||||||++++|.+++.......++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 257 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336 (450)
T ss_dssp CTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence 654 7999999999999999998765555899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTP 893 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~P 893 (998)
..... ......+++.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 337 ~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P 386 (450)
T 1k9a_A 337 KEASS------------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386 (450)
T ss_dssp EECC------------------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ccccc------------------------------cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 53210 0112257889999999999999999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcH
Q 001902 894 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 945 (998)
|.+.+..+....+..+ ...+....++..+.+||.+||..||.+|||+.+++
T Consensus 387 ~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~ 437 (450)
T 1k9a_A 387 YPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLR 437 (450)
T ss_dssp STTSCTTTHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9988777777666554 33344456789999999999999999999955543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=358.08 Aligned_cols=260 Identities=20% Similarity=0.308 Sum_probs=216.5
Q ss_pred cccccCCcccccccCCCCceeEEEEEEc-------cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCcccee
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 731 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-------~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~ 731 (998)
..+..++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++++ +||||++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 3456689999999999999999999985 457889999997542 344567788999999999 999999999
Q ss_pred EEEeeCCeEEEEEecCCCCchhHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 001902 732 ASFQTKTHVCLITDYCPGGELFLLLDRQPT--------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 797 (998)
Q Consensus 732 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~N 797 (998)
+++...+.+|+||||+++++|.+++..... ..++...+..++.||+.||.|||++||+||||||+|
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 999999999999999999999999986431 248999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHH
Q 001902 798 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 877 (998)
Q Consensus 798 ILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDI 877 (998)
||++.++.+||+|||++........ ........+|+.|+|||++.+..++.++||
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 242 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDY-------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDV 242 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSS-------------------------EECCSCCCCCGGGCCHHHHHHCEECHHHHH
T ss_pred EEEcCCCCEEEcccccccccccccc-------------------------ccccCCCCcccceeChHHhcCCCcChHHHH
Confidence 9999999999999999865431110 011223457889999999998889999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 878 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 878 wSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
|||||++|+|++ |..||.+.........+.... ..+....++..+.+||.+||..||.+||+ +.+++++
T Consensus 243 ~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 312 (334)
T 2pvf_A 243 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPT----FKQLVED 312 (334)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCC-CCCCCccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 999999999999 999999988877777666553 22333457889999999999999999999 5555544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=374.49 Aligned_cols=254 Identities=22% Similarity=0.318 Sum_probs=215.1
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
.+.+..++|++.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|+.+|+.++||||+++++++. .+
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 44677789999999999999999999985 47889999998643 23567889999999999999999999886 56
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
.+|+|||||++|+|.+++.......++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 78999999999999999976433468999999999999999999999999999999999999999999999999996532
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~ 897 (998)
... ........+++.|+|||++....++.++|||||||++|+|++ |..||.+.
T Consensus 336 ~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~ 389 (454)
T 1qcf_A 336 DNE--------------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389 (454)
T ss_dssp CHH--------------------------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCc--------------------------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 100 011123346789999999998899999999999999999999 99999998
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcH
Q 001902 898 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 945 (998)
+..+....+..+ ...+....++..+.+||.+||..||.+|||+.+++
T Consensus 390 ~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~ 436 (454)
T 1qcf_A 390 SNPEVIRALERG-YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQ 436 (454)
T ss_dssp CHHHHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 888877777654 33444556789999999999999999999955443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=352.44 Aligned_cols=260 Identities=23% Similarity=0.323 Sum_probs=210.8
Q ss_pred ccccCCcccccccCCCCceeEEEEEEcc-CC--eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCG-SG--QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-~~--~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
.+..++|++++.||+|+||.||+|.+.. ++ ..||+|+++............+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 4556789999999999999999998643 33 36999999876555556678889999999999999999999999876
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
+ .++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred C-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 5 889999999999999997642 45899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~ 896 (998)
...... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 172 ~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 227 (291)
T 1u46_A 172 PQNDDH------------------------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227 (291)
T ss_dssp CC-CCE------------------------EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccccc------------------------hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 311110 011223457889999999998889999999999999999999 9999999
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
.+....+..+.......+....++..+.+||.+||..||.+||| +.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~l~~ 277 (291)
T 1u46_A 228 LNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT----FVALRD 277 (291)
T ss_dssp CCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcC----HHHHHH
Confidence 99888888888776666666778999999999999999999999 666665
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=346.98 Aligned_cols=257 Identities=21% Similarity=0.284 Sum_probs=215.0
Q ss_pred cccCCccccc-ccCCCCceeEEEEEEc--cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 662 INLQHFRPIK-PLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 662 ~~~~~y~~~~-~LG~G~~g~Vy~a~~~--~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
+..++|.++. .||+|+||.||+|.+. .++..||+|++... ........+.+|+.+++.++||||+++++++ ..+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 4456788887 9999999999999863 46889999999864 2445667888999999999999999999999 456
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
..++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 789999999999999999754 3459999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~ 897 (998)
..... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 162 ~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 217 (287)
T 1u59_A 162 ADDSY------------------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217 (287)
T ss_dssp TCSCE------------------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCcce------------------------eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 11110 011223457899999999998889999999999999999998 99999998
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 898 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
+.......+..... .+....++..+.+||.+||..||.+||+ +.++++|
T Consensus 218 ~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~l~~~ 266 (287)
T 1u59_A 218 KGPEVMAFIEQGKR-MECPPECPPELYALMSDCWIYKWEDRPD----FLTVEQR 266 (287)
T ss_dssp CTHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCC----HHHHHHH
T ss_pred CHHHHHHHHhcCCc-CCCCCCcCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 87777766665432 2233457899999999999999999999 7777766
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=358.25 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=212.9
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEE--EEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCC
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 738 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~v--alK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 738 (998)
+..++|++.+.||+|+||.||+|.+..++..+ |+|.+... ........+.+|+.+++++ +||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 55679999999999999999999999888866 99988743 2334456788899999999 9999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC
Q 001902 739 HVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 804 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g 804 (998)
.+|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997642 24699999999999999999999999999999999999999999
Q ss_pred cEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHH
Q 001902 805 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 884 (998)
Q Consensus 805 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il 884 (998)
.+||+|||++..... ........+++.|+|||++.+..++.++|||||||++
T Consensus 180 ~~kL~Dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 231 (327)
T 1fvr_A 180 VAKIADFGLSRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 231 (327)
T ss_dssp CEEECCTTCEESSCE----------------------------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred eEEEcccCcCccccc----------------------------cccccCCCCCccccChhhhccccCCchhcchHHHHHH
Confidence 999999999853210 0111233578899999999988899999999999999
Q ss_pred HHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 885 YEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 885 ~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
|+|++ |..||.+.+.......+... ...+....++..+.+||.+||..||.+||| +.++++|
T Consensus 232 ~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 294 (327)
T 1fvr_A 232 WEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 294 (327)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHGGGT-CCCCCCTTBCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHcCCCCCCCCCcHHHHHHHhhcC-CCCCCCCCCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 99998 99999998887777766554 233334457889999999999999999999 6666654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=350.32 Aligned_cols=256 Identities=21% Similarity=0.302 Sum_probs=199.6
Q ss_pred cccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 658 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
+..++..++|++.+.||+|+||.||++.+. ..+|+|+++... ........+.+|+.+++.++||||++++++. ..
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 345677889999999999999999999863 359999987543 3455667889999999999999999999955 55
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
...++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred CccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 6789999999999999999654 355999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc---CCCCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
.... .........||+.|+|||++. +..++.++|||||||++|+|++|..||
T Consensus 171 ~~~~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 225 (289)
T 3og7_A 171 SRWS-------------------------GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225 (289)
T ss_dssp --------------------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccc-------------------------ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCc
Confidence 2110 011223457999999999996 567788999999999999999999999
Q ss_pred CCCChHHHHHHHHh-CCCCCC---CCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 895 RGKTRQKTFANILH-KDLKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 895 ~~~~~~~~~~~i~~-~~~~~~---~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
.+......+...+. ...... ....++..+.+||.+||..||.+|||+.++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 279 (289)
T 3og7_A 226 SNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRI 279 (289)
T ss_dssp SSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 88766555554443 322221 123567899999999999999999994443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=357.84 Aligned_cols=254 Identities=23% Similarity=0.307 Sum_probs=205.9
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEE----EEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 736 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~v----alK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 736 (998)
.+..++|++++.||+|+||.||+|.+..+++.+ |+|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 455789999999999999999999998887765 55555432 133345778899999999999999999999987
Q ss_pred CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
.. .++||+|+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred CC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 65 789999999999999998753 4599999999999999999999999999999999999999999999999999965
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 895 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~ 895 (998)
...... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 167 ~~~~~~-------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 221 (327)
T 3lzb_A 167 LGAEEK-------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp --------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCccc-------------------------cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCC
Confidence 431111 011223457889999999999999999999999999999999 999999
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 896 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 896 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
+.........+... ...+.....+..+.+||.+||..||.+||++.++
T Consensus 222 ~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 269 (327)
T 3lzb_A 222 GIPASEISSILEKG-ERLPQPPICTIDVYMIMRKCWMIDADSRPKFREL 269 (327)
T ss_dssp TCCGGGHHHHHHTT-CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCHHHHHHHHHcC-CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 88777666555443 3444555678899999999999999999994433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=351.54 Aligned_cols=255 Identities=22% Similarity=0.312 Sum_probs=207.1
Q ss_pred cccCCcccccccCCCCceeEEEEE----EccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVE----LCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~----~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
+....|++++.||+|+||.||+|. +..+++.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 445679999999999999999999 56789999999997543 233456788999999999999999999999876
Q ss_pred --CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 738 --THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 738 --~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
+.+++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 67899999999999999996543 459999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
........ ........||..|+|||++.+..++.++|||||||++|+|++|..|+.
T Consensus 175 ~~~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 175 AIETDKEY------------------------YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp ECCTTCCE------------------------EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccCCCcc------------------------eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 54321110 012234568889999999999999999999999999999999998763
Q ss_pred C--------------CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 896 G--------------KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 896 ~--------------~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
. ......+..........+....++..+.+||.+||..||.+|||+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 292 (302)
T 4e5w_A 231 SPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQN 292 (302)
T ss_dssp SHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred chhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHH
Confidence 2 22223333334444455555668899999999999999999999443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=347.57 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=212.6
Q ss_pred cccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 658 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
..+.+..++|++++.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 79 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-
Confidence 455677789999999999999999999974 577899999875432 24678889999999999999999998864
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
+..++||||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 56899999999999999997643336999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~ 896 (998)
.... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 160 ~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 213 (279)
T 1qpc_A 160 EDNE--------------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (279)
T ss_dssp SSSC--------------------------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cCcc--------------------------cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence 3111 011223457889999999998889999999999999999999 9999999
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
.+.......+... ........++..+.+|+.+||..||.+|||+.+
T Consensus 214 ~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 259 (279)
T 1qpc_A 214 MTNPEVIQNLERG-YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDY 259 (279)
T ss_dssp CCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCHHHHHHHHhcc-cCCCCcccccHHHHHHHHHHhccChhhCCCHHH
Confidence 8887777766554 233334567889999999999999999999433
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=367.20 Aligned_cols=277 Identities=16% Similarity=0.159 Sum_probs=207.2
Q ss_pred ccCCcccccccCCCCceeEEEEEEccC-----CeEEEEEEeecccccChhH--------HHHHHHHHHHHHhCCCCCccc
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNK--------VHRACAEREILDMLDHPFVPA 729 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~valK~i~~~~~~~~~~--------~~~~~~E~~il~~l~h~nIv~ 729 (998)
..++|++++.||+|+||.||+|.+..+ ++.||+|++.......... ......|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 356899999999999999999999664 5889999987542111000 112234555667778999999
Q ss_pred eeEEEeeC----CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe--cC
Q 001902 730 LYASFQTK----THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ--GN 803 (998)
Q Consensus 730 l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~--~~ 803 (998)
+++++... .+.||||||+ |++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++ .+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 99998764 5689999999 99999999874 35699999999999999999999999999999999999999 88
Q ss_pred CcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHH
Q 001902 804 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 883 (998)
Q Consensus 804 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~i 883 (998)
+.+||+|||++.......... ...........||+.|+|||++.+..++.++|||||||+
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~ 250 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHK--------------------AYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYC 250 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCC--------------------CSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred CeEEEEECCcceecccCCccc--------------------ccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHH
Confidence 999999999996643211100 011122345679999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCChHHHHHHHHh----CCC------CCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHH-----
Q 001902 884 LYEMLYGYTPFRGKTRQKTFANILH----KDL------KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI----- 948 (998)
Q Consensus 884 l~eLltG~~Pf~~~~~~~~~~~i~~----~~~------~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el----- 948 (998)
+|+|++|..||.+......+..... ..+ .+ ....++.++.+|+..||..||.+||++.+++..+
T Consensus 251 l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 251 MIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCF-PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp HHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHS-CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhc-ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 9999999999986433222221111 000 01 1134678999999999999999999966543322
Q ss_pred -HcCCCccCCChhhh
Q 001902 949 -KKHPFFKGVNWALV 962 (998)
Q Consensus 949 -L~Hp~f~~~~~~~~ 962 (998)
+..++-..++|...
T Consensus 330 ~~~~~~~~~~dw~~~ 344 (364)
T 3op5_A 330 AIGSKDDGKLDLSVV 344 (364)
T ss_dssp HTTCCCCCCCCC---
T ss_pred HcCCCcCCccceEec
Confidence 24566677788755
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=358.06 Aligned_cols=271 Identities=20% Similarity=0.323 Sum_probs=214.7
Q ss_pred cccccCCcccccccCCCCceeEEEEE----EccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVE----LCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 735 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~----~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 735 (998)
..+..++|++++.||+|+||.||+|. +..+++.||+|++... .......+.+|+.++++++||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 94 (327)
T 3lxl_A 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSY 94 (327)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Confidence 34556899999999999999999999 4678999999998754 3445567889999999999999999999886
Q ss_pred --eCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccC
Q 001902 736 --TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 813 (998)
Q Consensus 736 --~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~ 813 (998)
....+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 95 GPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp CSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred cCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccc
Confidence 5567999999999999999997642 3599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCC
Q 001902 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 814 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~P 893 (998)
+......... ........||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 174 ~~~~~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p 229 (327)
T 3lxl_A 174 AKLLPLDKDY------------------------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK 229 (327)
T ss_dssp CEECCTTCSE------------------------EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred ceecccCCcc------------------------ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 9654311110 1122344688999999999999899999999999999999999999
Q ss_pred CCCCChH--------------HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 894 FRGKTRQ--------------KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 894 f~~~~~~--------------~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
|...... .............+....++..+.+||.+||..||.+|||+.++++ .|+..|.....+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~-~L~~~~~~~~~~ 308 (327)
T 3lxl_A 230 SCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP-QLDMLWSGSRGC 308 (327)
T ss_dssp GGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHC-------
T ss_pred CccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHHHhhhcCc
Confidence 8653321 2233333444455556678899999999999999999999433222 244444444333
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=346.92 Aligned_cols=256 Identities=23% Similarity=0.300 Sum_probs=211.5
Q ss_pred ccccCCcccccccCCCCceeEEEEEEcc---CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~---~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
.+..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 4566799999999999999999999753 34579999988642 344567888999999999999999999998754
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 5689999999999999997642 45899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~ 896 (998)
.... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 164 ~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~ 217 (281)
T 3cc6_A 164 EDED--------------------------YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217 (281)
T ss_dssp -----------------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cccc--------------------------ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence 3111 011223457889999999998899999999999999999998 9999988
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
.........+.... ..+....++..+.+||.+||..||.+||+ +.+++++
T Consensus 218 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~ell~~ 267 (281)
T 3cc6_A 218 LENKDVIGVLEKGD-RLPKPDLCPPVLYTLMTRCWDYDPSDRPR----FTELVCS 267 (281)
T ss_dssp SCGGGHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CChHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHccCCchhCcC----HHHHHHH
Confidence 77776666655543 23344457889999999999999999999 6666654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=354.06 Aligned_cols=258 Identities=21% Similarity=0.278 Sum_probs=211.1
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCC----eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEE
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSG----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF 734 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~----~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 734 (998)
...+...+|.+.+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+++.++||||+++++++
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34567789999999999999999999986543 469999987542 344556788999999999999999999999
Q ss_pred eeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCc
Q 001902 735 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814 (998)
Q Consensus 735 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a 814 (998)
...+..++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 9999999999999999999999764 345999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTP 893 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~P 893 (998)
......... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 195 ~~~~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 250 (333)
T 1mqb_A 195 RVLEDDPEA------------------------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250 (333)
T ss_dssp ----------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred hhhcccccc------------------------ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 654321110 011122346889999999999999999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 894 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 894 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
|.+.+.......+..+ ...+....++..+.+||.+||..||.+||++.++
T Consensus 251 f~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 300 (333)
T 1mqb_A 251 YWELSNHEVMKAINDG-FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 300 (333)
T ss_dssp TTTCCHHHHHHHHHTT-CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred cccCCHHHHHHHHHCC-CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9998887777766554 3344455678999999999999999999994443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=359.21 Aligned_cols=256 Identities=22% Similarity=0.244 Sum_probs=206.9
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEE
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 742 (998)
..++|++.+.||+|+||.||+|.+ .+++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE---SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 357899999999999999999997 46899999988754 23446778899999999999999999999999999999
Q ss_pred EEecCCCCchhHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 743 ITDYCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999999997543 235899999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....
T Consensus 193 ~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~ 247 (321)
T 2qkw_B 193 DQ-------------------------THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247 (321)
T ss_dssp SC-------------------------CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS
T ss_pred cc-------------------------cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH
Confidence 10 11123456899999999999999999999999999999999999999764432
Q ss_pred HHH-------HHHHhCCCC------C--CCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 901 KTF-------ANILHKDLK------F--PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 901 ~~~-------~~i~~~~~~------~--~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
... .......+. . ......+..+.+|+.+||..||.+||| +.++++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 309 (321)
T 2qkw_B 248 EMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS----MGDVLWK 309 (321)
T ss_dssp SCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcC----HHHHHHH
Confidence 111 111111111 0 011123457889999999999999999 7777765
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.39 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=205.2
Q ss_pred hhccccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEE
Q 001902 655 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF 734 (998)
Q Consensus 655 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 734 (998)
....+..+..++|++++.||+|+||.||++.+ +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++
T Consensus 11 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (278)
T 1byg_A 11 FYRSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVI 83 (278)
T ss_dssp ----CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred hhhccccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34456677888999999999999999999987 58899999987542 446788999999999999999999987
Q ss_pred ee-CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccC
Q 001902 735 QT-KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 813 (998)
Q Consensus 735 ~~-~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~ 813 (998)
.. .+.+|+||||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 163 (278)
T 1byg_A 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 163 (278)
T ss_dssp CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccc
Confidence 54 45789999999999999999765333489999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCC
Q 001902 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYT 892 (998)
Q Consensus 814 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~ 892 (998)
+..... ......+++.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 164 ~~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 213 (278)
T 1byg_A 164 TKEASS------------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 213 (278)
T ss_dssp ------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccccc------------------------------cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCC
Confidence 854321 0112357889999999999899999999999999999998 999
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 893 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 893 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
||...........+... ........++..+.+||.+||..||.+||++.++
T Consensus 214 p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 264 (278)
T 1byg_A 214 PYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQL 264 (278)
T ss_dssp SCTTSCGGGHHHHHTTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCHHHHHHHHhcC-CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 99988777766665544 2333445678999999999999999999994443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=347.23 Aligned_cols=255 Identities=21% Similarity=0.284 Sum_probs=209.5
Q ss_pred ccccCCccccc-ccCCCCceeEEEEEE--ccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 661 QINLQHFRPIK-PLGSGDTGSVHLVEL--CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 661 ~~~~~~y~~~~-~LG~G~~g~Vy~a~~--~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
.+..++|.+.+ .||+|+||.||+|.+ ..+++.||+|++.... ........+.+|+.+++.++||||+++++++ ..
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 34567899998 999999999999954 5668999999997653 2344467888999999999999999999998 56
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 7789999999999999999875 45999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~ 896 (998)
...... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 168 ~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 223 (291)
T 1xbb_A 168 RADENY------------------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223 (291)
T ss_dssp CTTCSE------------------------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccCCCc------------------------ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 321110 011123346789999999998889999999999999999999 9999999
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
.+.......+.... ..+....++..+.+||.+||..||.+||++.++
T Consensus 224 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 270 (291)
T 1xbb_A 224 MKGSEVTAMLEKGE-RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 270 (291)
T ss_dssp CCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 88877766665543 223334578899999999999999999994443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=357.19 Aligned_cols=252 Identities=22% Similarity=0.295 Sum_probs=197.8
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC--
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-- 738 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-- 738 (998)
.+..++|++++.||+|+||.||+|.+ .++.||+|++... .........|+.++++++||||+++++++....
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred ccchhhchhhheecccCceEEEEEEE--CCCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 45678999999999999999999987 4799999998753 223345566888999999999999999998643
Q ss_pred --eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCcEEEecCCcE
Q 001902 739 --HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ----------GIIYRDLKPENVLLQGNGHV 806 (998)
Q Consensus 739 --~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~----------~IiHrDLkP~NILi~~~g~v 806 (998)
.+|+||||+++++|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred CceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 479999999999999999774 399999999999999999999999 99999999999999999999
Q ss_pred EEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-----CCCChhHHHHHH
Q 001902 807 SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-----GHTSAVDWWALG 881 (998)
Q Consensus 807 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDIwSlG 881 (998)
||+|||++........ ........||+.|+|||++.+. .++.++||||||
T Consensus 171 kL~DFg~a~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG 225 (322)
T 3soc_A 171 CIADFGLALKFEAGKS-------------------------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMG 225 (322)
T ss_dssp EECCCTTCEEECTTSC-------------------------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHH
T ss_pred EEccCCcccccccccC-------------------------ccccccCccCccccCHhhcccccccCcCCCccchhHHHH
Confidence 9999999965432111 0112345799999999999874 445688999999
Q ss_pred HHHHHHHcCCCCCCCCCh---------------HHHHHHHHhCCCCCCCCC------CCcHHHHHHHHHccccCccCcCC
Q 001902 882 ILLYEMLYGYTPFRGKTR---------------QKTFANILHKDLKFPSST------PTSLHAKQLMYRLLHRDPKSRLG 940 (998)
Q Consensus 882 ~il~eLltG~~Pf~~~~~---------------~~~~~~i~~~~~~~~~~~------~~s~~l~~Ll~~~L~~dP~~Rpt 940 (998)
|++|+|++|+.||.+... ..............+... ..+..+.+||.+||+.||.+|||
T Consensus 226 ~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 305 (322)
T 3soc_A 226 LVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305 (322)
T ss_dssp HHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcC
Confidence 999999999999975421 122222222221222111 12345899999999999999999
Q ss_pred ChhcHH
Q 001902 941 SHEGAN 946 (998)
Q Consensus 941 ~~~~a~ 946 (998)
+.++++
T Consensus 306 ~~ell~ 311 (322)
T 3soc_A 306 AGCVGE 311 (322)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 444333
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=347.31 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=209.2
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee-------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------- 736 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~------- 736 (998)
..+|++++.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 357999999999999999999999899999999997542 245679999999999999999998864
Q ss_pred ---------CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEE
Q 001902 737 ---------KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 807 (998)
Q Consensus 737 ---------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vk 807 (998)
...+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 45689999999999999999865556799999999999999999999999999999999999999999999
Q ss_pred EEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHH
Q 001902 808 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 887 (998)
Q Consensus 808 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eL 887 (998)
|+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 163 l~Dfg~~~~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 214 (284)
T 2a19_B 163 IGDFGLVTSLKND----------------------------GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214 (284)
T ss_dssp ECCCTTCEESSCC----------------------------SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHH
T ss_pred ECcchhheecccc----------------------------ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHH
Confidence 9999998553311 112234699999999999999999999999999999999
Q ss_pred HcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 888 LYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 888 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
++|..||... ......+....+ ....+..+.+||.+||..||.+||| +.++++|.+.-.
T Consensus 215 ~~~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps----~~e~l~~l~~~~ 273 (284)
T 2a19_B 215 LHVCDTAFET--SKFFTDLRDGII----SDIFDKKEKTLLQKLLSKKPEDRPN----TSEILRTLTVWK 273 (284)
T ss_dssp HSCCSSHHHH--HHHHHHHHTTCC----CTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHHHT
T ss_pred HhcCCcchhH--HHHHHHhhcccc----cccCCHHHHHHHHHHccCChhhCcC----HHHHHHHHHHHh
Confidence 9999988542 223333333322 2346788999999999999999999 899998876543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=349.93 Aligned_cols=260 Identities=22% Similarity=0.302 Sum_probs=207.7
Q ss_pred ccccCCcccccccCCCCceeEEEEEEcc---CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~---~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
.+..++|.+.+.||+|+||.||+|.+.. ++..||+|++.... ........+.+|+.++++++||||+++++++...
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3556789999999999999999998865 56789999987643 2344567788999999999999999999998765
Q ss_pred C-----eEEEEEecCCCCchhHHHhh----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEE
Q 001902 738 T-----HVCLITDYCPGGELFLLLDR----QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 808 (998)
Q Consensus 738 ~-----~~~lV~E~~~ggsL~~~l~~----~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL 808 (998)
+ ..++||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence 4 45999999999999999853 22356999999999999999999999999999999999999999999999
Q ss_pred EeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHH
Q 001902 809 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 888 (998)
Q Consensus 809 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLl 888 (998)
+|||++........ ........+++.|+|||.+.+..++.++|||||||++|+|+
T Consensus 189 ~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 243 (313)
T 3brb_A 189 ADFGLSKKIYSGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243 (313)
T ss_dssp CSCSCC-----------------------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHH
T ss_pred eecCcceecccccc-------------------------cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHH
Confidence 99999865421110 01122345788999999999999999999999999999999
Q ss_pred c-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 889 Y-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 889 t-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
+ |..||.+.........+.... ..+....++..+.+||.+||..||.+||+ +.++++|
T Consensus 244 ~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~~ 302 (313)
T 3brb_A 244 TRGMTPYPGVQNHEMYDYLLHGH-RLKQPEDCLDELYEIMYSCWRTDPLDRPT----FSVLRLQ 302 (313)
T ss_dssp TTSCCSSTTCCGGGHHHHHHTTC-CCCCBTTCCHHHHHHHHHTTCSSGGGSCC----HHHHHHH
T ss_pred hcCCCCCccCCHHHHHHHHHcCC-CCCCCccccHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 9 999999988877777766653 23334457889999999999999999999 6666654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=346.30 Aligned_cols=272 Identities=18% Similarity=0.221 Sum_probs=210.3
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEE-eeCCeEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF-QTKTHVCL 742 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~-~~~~~~~l 742 (998)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+..|+.+++.++|++++..+..+ ...+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 4689999999999999999999999999999998765422 23467799999999887766665554 67888999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---ecCCcEEEEeccCccccCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi---~~~g~vkL~DFG~a~~~~~ 819 (998)
||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 99999 999999997542 459999999999999999999999999999999999999 7889999999999966432
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
.... ...+........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 161 ~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 161 ARTH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp TTTC--------------------CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccC--------------------ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 2110 00111233456899999999999999999999999999999999999999987432
Q ss_pred ---HHHHHHHHhCCCCCC---CCCCCcHHHHHHHHHccccCccCcCCChhcHHHH------HcCCCccCCChhhh
Q 001902 900 ---QKTFANILHKDLKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI------KKHPFFKGVNWALV 962 (998)
Q Consensus 900 ---~~~~~~i~~~~~~~~---~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el------L~Hp~f~~~~~~~~ 962 (998)
...+..+.......+ ....++..+.+||.+||+.||.+|||+.++++.+ ...+|-..++|..+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 221 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp SSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred hhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 223333333222222 1134678999999999999999999955443322 23566666777665
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.62 Aligned_cols=252 Identities=21% Similarity=0.246 Sum_probs=205.9
Q ss_pred CcccccccCCCCceeEEEEEEccCCe---EEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE-E
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV-C 741 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~---~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~-~ 741 (998)
.|.+.+.||+|+||.||+|.+..++. .||+|.+... ........+.+|+.+++.++||||+++++++...+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 46777999999999999999765544 8999998753 3445667888999999999999999999999766554 9
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+||||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999999764 3568999999999999999999999999999999999999999999999999996543111
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 900 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~ 900 (998)
. ..........+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||...+..
T Consensus 179 ~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~ 235 (298)
T 3pls_A 179 Y-----------------------YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235 (298)
T ss_dssp G-----------------------GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG
T ss_pred c-----------------------cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH
Confidence 0 01122334568999999999999999999999999999999999 55556665555
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
.....+... ...+.....+..+.+||.+||..||.+|||+.++
T Consensus 236 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 278 (298)
T 3pls_A 236 DLTHFLAQG-RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVL 278 (298)
T ss_dssp GHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHhhcC-CCCCCCccchHHHHHHHHHHccCChhhCcCHHHH
Confidence 555544443 3444555678899999999999999999994443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=368.35 Aligned_cols=276 Identities=18% Similarity=0.233 Sum_probs=220.1
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCC-CCccceeEEEeeCCeEE
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH-PFVPALYASFQTKTHVC 741 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~l~~~~~~~~~~~ 741 (998)
..++|++++.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+.| ++|+.+..++...+..|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 35789999999999999999999999999999998875432 1346789999999976 56666777777888999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---ecCCcEEEEeccCccccC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi---~~~g~vkL~DFG~a~~~~ 818 (998)
|||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++...
T Consensus 80 lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 999999 999999997542 459999999999999999999999999999999999999 588999999999997643
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
..... ...+........||+.|+|||++.+..++.++|||||||+||+|++|+.||.+..
T Consensus 158 ~~~~~--------------------~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~ 217 (483)
T 3sv0_A 158 DTSTH--------------------QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (483)
T ss_dssp CTTTC--------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CCccc--------------------cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 22110 0111223346789999999999999999999999999999999999999998754
Q ss_pred h---HHHHHHHHhCCCCCC---CCCCCcHHHHHHHHHccccCccCcCCChhcHH---HH---HcCCCccCCChhhhhcC
Q 001902 899 R---QKTFANILHKDLKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN---EI---KKHPFFKGVNWALVRCM 965 (998)
Q Consensus 899 ~---~~~~~~i~~~~~~~~---~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~---el---L~Hp~f~~~~~~~~~~~ 965 (998)
. ...+..+........ ....++.++.+||.+||..||.+||++.++++ ++ ..|+|+..++|..+...
T Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~ 296 (483)
T 3sv0_A 218 AGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (483)
T ss_dssp CSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-
T ss_pred chhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccc
Confidence 3 333444433221111 11346789999999999999999999765432 22 46899999999987443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=368.97 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=209.4
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
.+.+..++|++.+.||+|+||.||+|.+.. +..||+|+++.... ..+.+.+|+.+|++++||||+++++++.. +
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 345667889999999999999999999864 56799999986432 23578899999999999999999999876 6
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
.+||||||+++++|.+++.......++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 78999999999999999976444569999999999999999999999999999999999999999999999999996542
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~ 897 (998)
... ........++..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 332 ~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 332 DNE--------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp -------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CCc--------------------------eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 110 011123357889999999999999999999999999999999 99999998
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 898 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
...+....+..+ ...+....++..+.+||.+||..||.+|||+.+
T Consensus 386 ~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ 430 (452)
T 1fmk_A 386 VNREVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEERPTFEY 430 (452)
T ss_dssp CHHHHHHHHHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 888877776654 333444567889999999999999999999433
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=355.83 Aligned_cols=265 Identities=25% Similarity=0.376 Sum_probs=208.7
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe----eC
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ----TK 737 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~----~~ 737 (998)
+..++|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++++. ..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 4567899999999999999999999999999999998653 4455677889999999999999999999986 34
Q ss_pred CeEEEEEecCCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 738 THVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
...|+||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 5889999999999999998752 34569999999999999999999999999999999999999999999999999885
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC---CCChhHHHHHHHHHHHHHcCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---HTSAVDWWALGILLYEMLYGYT 892 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~sDIwSlG~il~eLltG~~ 892 (998)
........ .. ............||+.|+|||++.+.. ++.++|||||||++|+|++|..
T Consensus 183 ~~~~~~~~----~~--------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 244 (317)
T 2buj_A 183 QACIHVEG----SR--------------QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244 (317)
T ss_dssp ESCEEEES----HH--------------HHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSC
T ss_pred hccccccc----cc--------------ccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCC
Confidence 43210000 00 000001112346899999999987654 6889999999999999999999
Q ss_pred CCCCCCh-HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 893 PFRGKTR-QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 893 Pf~~~~~-~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
||..... .............++.....+..+.+||.+||..||.+||+ +.++++|
T Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~~ 300 (317)
T 2buj_A 245 PYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPH----IPLLLSQ 300 (317)
T ss_dssp TTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred ChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCC----HHHHHHH
Confidence 9954211 01122233344555666678899999999999999999999 7777765
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=360.38 Aligned_cols=259 Identities=23% Similarity=0.269 Sum_probs=204.2
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 740 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 740 (998)
.+..++|++.+.||+|+||.||+|.+ .+|+.||+|++....... ....+.+|+.+++.++||||+++++++...+..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 34567899999999999999999986 468999999987643221 123578899999999999999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 741 CLITDYCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQ---GIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~---~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
++||||+++++|.+++.... ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 99999999999999998643 23499999999999999999999999 99999999999999999999999999996
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 183 ~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 183 LMDYKD--------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp ECCSSS--------------------------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccCccc--------------------------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 543111 111234569999999999988889999999999999999999999995
Q ss_pred C----CChHHHHHHHHhCCCC---C----------CCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCC
Q 001902 896 G----KTRQKTFANILHKDLK---F----------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 952 (998)
Q Consensus 896 ~----~~~~~~~~~i~~~~~~---~----------~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp 952 (998)
. ................ . ......+..+.+|+.+||+.||.+||| +.++++|-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~~L 306 (326)
T 3uim_A 237 LARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK----MSEVVRML 306 (326)
T ss_dssp HHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCC----HHHHHHHH
T ss_pred ccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCC----HHHHHHHh
Confidence 2 1111111122221110 0 001112357899999999999999999 66666653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=344.90 Aligned_cols=245 Identities=24% Similarity=0.422 Sum_probs=197.9
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+..++|++.+.||+|+||.||++.+ .++.||+|.+... .....+.+|+.++++++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 5567899999999999999999997 4789999998643 345678899999999999999999998764 478
Q ss_pred EEEecCCCCchhHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCcEEEecCCc-EEEEeccCccc
Q 001902 742 LITDYCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVVALEYLHC---QGIIYRDLKPENVLLQGNGH-VSLTDFDLSCL 816 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~~LH~---~~IiHrDLkP~NILi~~~g~-vkL~DFG~a~~ 816 (998)
+||||+++++|.+++..... ..++...+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999999999999976432 247889999999999999999999 89999999999999998886 79999999854
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 156 ~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 205 (307)
T 2eva_A 156 IQT------------------------------HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205 (307)
T ss_dssp ---------------------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred ccc------------------------------ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence 320 01223589999999999999999999999999999999999999986
Q ss_pred CCh--HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 897 KTR--QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 897 ~~~--~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
... ......+... ...+....++..+.+||.+||..||.+||| +.++++
T Consensus 206 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~ 256 (307)
T 2eva_A 206 IGGPAFRIMWAVHNG-TRPPLIKNLPKPIESLMTRCWSKDPSQRPS----MEEIVK 256 (307)
T ss_dssp TCSSHHHHHHHHHTT-CCCCCBTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred hCccHHHHHHHHhcC-CCCCcccccCHHHHHHHHHHhcCChhhCcC----HHHHHH
Confidence 433 2223233332 233334557889999999999999999999 555544
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=358.06 Aligned_cols=252 Identities=17% Similarity=0.207 Sum_probs=202.1
Q ss_pred cCCcccccccCCCCceeEEEEEEcc--------CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccc------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCG--------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA------ 729 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~--------~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~------ 729 (998)
.++|++.+.||+|+||.||+|.+.. .++.||+|++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 4789999999999999999999987 4889999998754 35778999999999999887
Q ss_pred ---------eeEEEee-CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 001902 730 ---------LYASFQT-KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 799 (998)
Q Consensus 730 ---------l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NIL 799 (998)
+++++.. ....|+||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6777765 78899999999 999999998764467999999999999999999999999999999999999
Q ss_pred EecCC--cEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHH
Q 001902 800 LQGNG--HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 877 (998)
Q Consensus 800 i~~~g--~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDI 877 (998)
++.++ .+||+|||++.......... ...........||+.|+|||++.+..++.++||
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 251 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHV--------------------AYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDL 251 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCC--------------------CCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred EcCCCCceEEEecCcceeeccCCCccc--------------------cccccccccccCCccccCHHHHccCCCCchhhH
Confidence 99998 99999999996643211100 001112244579999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCC-hHHHHHHH----HhCCCCCCCC----CCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 878 WALGILLYEMLYGYTPFRGKT-RQKTFANI----LHKDLKFPSS----TPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 878 wSlG~il~eLltG~~Pf~~~~-~~~~~~~i----~~~~~~~~~~----~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
|||||++|+|++|..||.+.. ....+... ......++.. ..++..+.+||.+||..||.+||++.++
T Consensus 252 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 327 (352)
T 2jii_A 252 QSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAML 327 (352)
T ss_dssp HHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred HHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHH
Confidence 999999999999999998764 22222222 2222222221 2468899999999999999999995544
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=369.23 Aligned_cols=262 Identities=22% Similarity=0.325 Sum_probs=200.1
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 740 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 740 (998)
+...+|.+.+.||+|+||+||. ....+++.||||++..... ....+|+.+++.+ +||||+++++++...+..
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 3345699999999999999764 3346799999999875432 2245799999999 899999999999999999
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec---C--CcEEEEeccCcc
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---N--GHVSLTDFDLSC 815 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~---~--g~vkL~DFG~a~ 815 (998)
||||||| +++|.+++.... ..++...+..++.||+.||.|||++||+||||||+|||++. + ..+||+|||++.
T Consensus 94 ~lv~E~~-~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 94 YIAIELC-AATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEEECC-SEEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEEECC-CCCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9999999 569999997653 33555567789999999999999999999999999999953 2 358899999996
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc---CCCCCChhHHHHHHHHHHHHHc-CC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLY-GY 891 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDIwSlG~il~eLlt-G~ 891 (998)
....... ........+||+.|+|||++. ...++.++|||||||++|+|++ |.
T Consensus 172 ~~~~~~~------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~ 227 (432)
T 3p23_A 172 KLAVGRH------------------------SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS 227 (432)
T ss_dssp CC------------------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSC
T ss_pred eccCCCc------------------------ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCC
Confidence 5431110 011223467999999999997 4567789999999999999999 99
Q ss_pred CCCCCCChHHHHHHHHhCCCCCC-CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChh
Q 001902 892 TPFRGKTRQKTFANILHKDLKFP-SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 960 (998)
Q Consensus 892 ~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 960 (998)
.||...........+........ .....+..+.+||.+||+.||.+||| +.++++||||..++|.
T Consensus 228 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~evl~hp~f~~~~~~ 293 (432)
T 3p23_A 228 HPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPS----AKHVLKHPFFWSLEKQ 293 (432)
T ss_dssp BTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCC----HHHHHTSTTTCCHHHH
T ss_pred CCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCC----HHHHHhCccccChHHH
Confidence 99976544333222111111111 11223556889999999999999999 9999999999988774
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=363.39 Aligned_cols=257 Identities=25% Similarity=0.341 Sum_probs=197.2
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~l 742 (998)
.+.|.+.+.||+|+||+||.+. ..+|+.||||++.... ...+.+|+.+++.+ +||||+++++++...+.+||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 3556777899999999998764 4679999999987542 34567899999876 89999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC-------------C
Q 001902 743 ITDYCPGGELFLLLDRQPTKV-----LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-------------G 804 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~-----l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~-------------g 804 (998)
||||| +++|.+++....... .++..+..++.||+.||.|||++||+||||||+|||++.+ +
T Consensus 87 v~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 99999 569999998643211 1233456799999999999999999999999999999754 4
Q ss_pred cEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-------CCCCChhHH
Q 001902 805 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-------AGHTSAVDW 877 (998)
Q Consensus 805 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDI 877 (998)
.+||+|||++.......... .......+||+.|+|||++.+ ..++.++||
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~-----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di 222 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSF-----------------------RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI 222 (434)
T ss_dssp EEEECCCTTCEECCC-------------------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHH
T ss_pred EEEEcccccceecCCCCccc-----------------------eeeecCCCCCCCccCHHHhccccccccccCcchhhhh
Confidence 89999999996643211100 011234579999999999976 568899999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCC-----CCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 878 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSST-----PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 878 wSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-----~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
|||||++|+|++ |..||....... ..+.......+... .++.++.+||.+||+.||.+||| +.++++|
T Consensus 223 wSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~eil~h 296 (434)
T 2rio_A 223 FSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT----AMKVLRH 296 (434)
T ss_dssp HHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC----HHHHHTS
T ss_pred HhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCC----HHHHHhC
Confidence 999999999998 999997765433 34455444433321 23578999999999999999999 9999999
Q ss_pred CCccCC
Q 001902 952 PFFKGV 957 (998)
Q Consensus 952 p~f~~~ 957 (998)
|||...
T Consensus 297 p~f~~~ 302 (434)
T 2rio_A 297 PLFWPK 302 (434)
T ss_dssp GGGSCH
T ss_pred CccCCc
Confidence 999753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.12 Aligned_cols=251 Identities=27% Similarity=0.380 Sum_probs=197.1
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHh--CCCCCccceeEEEee---
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDHPFVPALYASFQT--- 736 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~--l~h~nIv~l~~~~~~--- 736 (998)
+..++|++++.||+|+||.||+|.+ +++.||+|++... ....+..|.+++.. ++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 3457899999999999999999997 7899999998653 23455667777777 799999999998654
Q ss_pred -CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCcEEEecCCcEE
Q 001902 737 -KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH--------CQGIIYRDLKPENVLLQGNGHVS 807 (998)
Q Consensus 737 -~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH--------~~~IiHrDLkP~NILi~~~g~vk 807 (998)
...+|+||||+++++|.+++.. ..+++..+..++.||+.||.||| ++||+||||||+|||++.++.+|
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred CCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 3568999999999999999965 35999999999999999999999 99999999999999999999999
Q ss_pred EEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC------CCCChhHHHHHH
Q 001902 808 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA------GHTSAVDWWALG 881 (998)
Q Consensus 808 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~sDIwSlG 881 (998)
|+|||++......... .........||+.|+|||++.+. .++.++||||||
T Consensus 154 l~Dfg~a~~~~~~~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG 210 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQ-----------------------LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG 210 (301)
T ss_dssp ECCCTTCEEEETTTTE-----------------------EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHH
T ss_pred EeeCCCeeeccccccc-----------------------ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHH
Confidence 9999998654311110 00112345799999999999876 445699999999
Q ss_pred HHHHHHHcC----------CCCCCCCC----hHHHHHHHHhCCCCCCCC------CCCcHHHHHHHHHccccCccCcCCC
Q 001902 882 ILLYEMLYG----------YTPFRGKT----RQKTFANILHKDLKFPSS------TPTSLHAKQLMYRLLHRDPKSRLGS 941 (998)
Q Consensus 882 ~il~eLltG----------~~Pf~~~~----~~~~~~~i~~~~~~~~~~------~~~s~~l~~Ll~~~L~~dP~~Rpt~ 941 (998)
|++|+|++| ..||.... ....+..........+.. ...+..+.+||.+||..||.+|||
T Consensus 211 ~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps- 289 (301)
T 3q4u_A 211 LVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT- 289 (301)
T ss_dssp HHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCC-
T ss_pred HHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCC-
Confidence 999999999 88986532 223334433322222221 123467899999999999999999
Q ss_pred hhcHHHHHc
Q 001902 942 HEGANEIKK 950 (998)
Q Consensus 942 ~~~a~elL~ 950 (998)
+.++++
T Consensus 290 ---~~~i~~ 295 (301)
T 3q4u_A 290 ---ALRIKK 295 (301)
T ss_dssp ---HHHHHH
T ss_pred ---HHHHHH
Confidence 555543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=342.73 Aligned_cols=254 Identities=19% Similarity=0.222 Sum_probs=206.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccC---CeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEE-eeCCe
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF-QTKTH 739 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~-~~~~~ 739 (998)
...|++.+.||+|+||.||+|.+..+ +..+|+|.+... ........+.+|+.++++++||||+++++++ ..++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 35799999999999999999997543 346899988753 3455667888999999999999999999985 45678
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
.|+||||+++++|.+++... ...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred eEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 89999999999999999764 35589999999999999999999999999999999999999999999999999965431
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~ 898 (998)
... ..........||+.|+|||.+.+..++.++|||||||++|+|++ |.+||.+.+
T Consensus 181 ~~~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 237 (298)
T 3f66_A 181 KEY-----------------------YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237 (298)
T ss_dssp GGG-----------------------CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred cch-----------------------hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence 110 01112234568899999999999999999999999999999999 777887777
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
.......+...... ......+..+.+|+.+||..||.+||++.++
T Consensus 238 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 282 (298)
T 3f66_A 238 TFDITVYLLQGRRL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 282 (298)
T ss_dssp TTTHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 76666666655432 2334568899999999999999999994443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=356.38 Aligned_cols=259 Identities=17% Similarity=0.138 Sum_probs=197.0
Q ss_pred cccCCcccccccCCCCceeEEEEEEcc---CCeEEEEEEeecccccChh--------HHHHHHHHHHHHHhCCCCCccce
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRN--------KVHRACAEREILDMLDHPFVPAL 730 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~---~~~~valK~i~~~~~~~~~--------~~~~~~~E~~il~~l~h~nIv~l 730 (998)
+..++|++.+.||+|+||.||+|.+.. ++..+|+|++......... ....+..|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 345789999999999999999999987 7889999998764221111 11235578888999999999999
Q ss_pred eEEEee----CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC--
Q 001902 731 YASFQT----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-- 804 (998)
Q Consensus 731 ~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g-- 804 (998)
++++.. ....|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 999987 78999999999 999999997653 699999999999999999999999999999999999999887
Q ss_pred cEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHH
Q 001902 805 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 884 (998)
Q Consensus 805 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il 884 (998)
.+||+|||++.......... ...........||+.|+|||++.+..++.++|||||||++
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 250 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHK--------------------QYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCM 250 (345)
T ss_dssp SEEECCCTTCEESSGGGCCC--------------------CCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHH
T ss_pred cEEEEeCCCceecccccccc--------------------cchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHH
Confidence 99999999996643111100 0011122456799999999999999999999999999999
Q ss_pred HHHHcCCCCCCCC--ChHHHHHHHHhCCCCCC-------CCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 885 YEMLYGYTPFRGK--TRQKTFANILHKDLKFP-------SSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 885 ~eLltG~~Pf~~~--~~~~~~~~i~~~~~~~~-------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
|+|++|..||.+. +...............+ .....+..+.+||.+||..||.+||++.+
T Consensus 251 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 318 (345)
T 2v62_A 251 LRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQA 318 (345)
T ss_dssp HHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred HHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHH
Confidence 9999999999653 22222111111111111 11257889999999999999999999444
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=346.91 Aligned_cols=233 Identities=25% Similarity=0.452 Sum_probs=192.4
Q ss_pred cCCcccc-cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHH-HhCCCCCccceeEEEee----C
Q 001902 664 LQHFRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPALYASFQT----K 737 (998)
Q Consensus 664 ~~~y~~~-~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il-~~l~h~nIv~l~~~~~~----~ 737 (998)
.++|.++ +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++.. .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4678888 7799999999999999999999999998743 3566788887 66699999999999987 7
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec---CCcEEEEeccCc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLS 814 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~---~g~vkL~DFG~a 814 (998)
..+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 78999999999999999998876567999999999999999999999999999999999999998 789999999988
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
.... +..++.++|||||||++|+|++|..||
T Consensus 168 ~~~~-------------------------------------------------~~~~~~~~DiwslG~il~el~tg~~pf 198 (299)
T 3m2w_A 168 KETT-------------------------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPF 198 (299)
T ss_dssp EECT-------------------------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccc-------------------------------------------------cccCCchhhHHHHHHHHHHHHHCCCCC
Confidence 4321 234677899999999999999999999
Q ss_pred CCCChHHHHHHHHh----CCCCCCC--CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 895 RGKTRQKTFANILH----KDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 895 ~~~~~~~~~~~i~~----~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.+.+.......+.. ....++. ...++.++.+||.+||..||.+||| +.++++||||+..
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps----~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 199 YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQS 263 (299)
T ss_dssp CC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHTG
T ss_pred CCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCC----HHHHhcChhhccc
Confidence 87654332211111 1111111 1356889999999999999999999 9999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=348.84 Aligned_cols=255 Identities=23% Similarity=0.328 Sum_probs=207.3
Q ss_pred cccCCcccccccCCCCceeEEEEEE----ccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee-
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVEL----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT- 736 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~----~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~- 736 (998)
+....|++++.||+|+||.||++.. ..+++.||+|++... ........+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 3333349999999999999988764 457899999999864 234556778999999999999999999999987
Q ss_pred -CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 737 -KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 737 -~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
...+++||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred CCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 46899999999999999999774 38999999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
....... .........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 183 ~~~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 238 (318)
T 3lxp_A 183 AVPEGHE------------------------YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238 (318)
T ss_dssp ECCTTCS------------------------EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ccccccc------------------------ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence 5432110 0012234468889999999999889999999999999999999999997
Q ss_pred CCChH--------------HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 896 GKTRQ--------------KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 896 ~~~~~--------------~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
..... ......+......+....++..+.+||.+||..||.+||| +.+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell 302 (318)
T 3lxp_A 239 SPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPT----FENLI 302 (318)
T ss_dssp SHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHH
T ss_pred ccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcC----HHHHH
Confidence 53221 1222333444455556678899999999999999999999 55555
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=351.69 Aligned_cols=264 Identities=25% Similarity=0.359 Sum_probs=191.8
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEe----
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQ---- 735 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~---- 735 (998)
.+...+|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++++. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 45556899999999999999999999999999999998643 3445667889999999995 999999999983
Q ss_pred ----eCCeEEEEEecCCCCchhHHHhh-CCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEecCCcEEE
Q 001902 736 ----TKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSL 808 (998)
Q Consensus 736 ----~~~~~~lV~E~~~ggsL~~~l~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkP~NILi~~~g~vkL 808 (998)
....+++||||+ +|+|.+++.. .....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||
T Consensus 101 ~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred ccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence 445689999999 5799888865 22356999999999999999999999999 999999999999999999999
Q ss_pred EeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhh---cCCCCCChhHHHHHHHHHH
Q 001902 809 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII---AGAGHTSAVDWWALGILLY 885 (998)
Q Consensus 809 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l---~~~~~~~~sDIwSlG~il~ 885 (998)
+|||++............. .............||+.|+|||++ .+..++.++|||||||++|
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~ 244 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSA---------------QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY 244 (337)
T ss_dssp CCCTTCBCCSSCC----------------------------------------------CCTTSCSSHHHHHHHHHHHHH
T ss_pred ecCccceeccccCcccccc---------------cccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHH
Confidence 9999997654222110000 000001122345799999999998 5667888999999999999
Q ss_pred HHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 886 EMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 886 eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
+|++|..||....... +.......+.....+..+.+||.+||+.||.+||+ +.++++|
T Consensus 245 el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~e~l~~ 302 (337)
T 3ll6_A 245 LLCFRQHPFEDGAKLR----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLS----IAEVVHQ 302 (337)
T ss_dssp HHHHSSCCC----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred HHHhCCCCCcchhHHH----hhcCcccCCcccccchHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 9999999997754433 33344445555566778999999999999999999 7777776
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=361.18 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=204.7
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC--eE
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT--HV 740 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~--~~ 740 (998)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++...+ ..
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 35689999999999999999999999999999999986432 223466778999999999999999999998655 78
Q ss_pred EEEEecCCCCchhHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----ecCCcEEEEeccCcc
Q 001902 741 CLITDYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL----QGNGHVSLTDFDLSC 815 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi----~~~g~vkL~DFG~a~ 815 (998)
|+|||||++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999999997642 2339999999999999999999999999999999999999 677789999999986
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC--------CCCCChhHHHHHHHHHHHH
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--------AGHTSAVDWWALGILLYEM 887 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~sDIwSlG~il~eL 887 (998)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 165 ~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el 216 (396)
T 4eut_A 165 ELEDD----------------------------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (396)
T ss_dssp ECCCG----------------------------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHH
T ss_pred EccCC----------------------------CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHH
Confidence 53211 11234579999999999865 4567799999999999999
Q ss_pred HcCCCCCCC----CChHHHHHHHHhCCCC-------------------CCCCCC----CcHHHHHHHHHccccCccCcCC
Q 001902 888 LYGYTPFRG----KTRQKTFANILHKDLK-------------------FPSSTP----TSLHAKQLMYRLLHRDPKSRLG 940 (998)
Q Consensus 888 ltG~~Pf~~----~~~~~~~~~i~~~~~~-------------------~~~~~~----~s~~l~~Ll~~~L~~dP~~Rpt 940 (998)
++|..||.. ......+..+..+... ++.... .+..+.+||.+||..||.+||+
T Consensus 217 ~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s 296 (396)
T 4eut_A 217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296 (396)
T ss_dssp HHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred HHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhcc
Confidence 999999964 2334555666654321 111111 3456789999999999999999
Q ss_pred Chhc
Q 001902 941 SHEG 944 (998)
Q Consensus 941 ~~~~ 944 (998)
+.++
T Consensus 297 ~~e~ 300 (396)
T 4eut_A 297 FDQF 300 (396)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=341.88 Aligned_cols=254 Identities=19% Similarity=0.218 Sum_probs=203.5
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEE-eeCCeEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF-QTKTHVCL 742 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~-~~~~~~~l 742 (998)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++..+.++ ...+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 4789999999999999999999999999999999875432 23577899999999988766555544 67788999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe---cCCcEEEEeccCccccCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~---~~g~vkL~DFG~a~~~~~ 819 (998)
||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99999 999999997542 4599999999999999999999999999999999999994 789999999999966432
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC-
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT- 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~- 898 (998)
.... ...+........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 161 ~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 3uzp_A 161 ARTH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp TTTC--------------------CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccc--------------------cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence 2110 0011123345689999999999999999999999999999999999999998743
Q ss_pred --hHHHHHHHHhCCCCCC---CCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 899 --RQKTFANILHKDLKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 899 --~~~~~~~i~~~~~~~~---~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
....+..+.......+ ....++..+.+|+.+||+.||.+||++.++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 271 (296)
T 3uzp_A 221 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL 271 (296)
T ss_dssp SSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHH
T ss_pred hhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHH
Confidence 2233333333222222 113467899999999999999999995543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=374.84 Aligned_cols=253 Identities=21% Similarity=0.283 Sum_probs=207.0
Q ss_pred ccCCccccc-ccCCCCceeEEEEEEc--cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 663 NLQHFRPIK-PLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 663 ~~~~y~~~~-~LG~G~~g~Vy~a~~~--~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
..+.|.+.. .||+|+||.||+|.+. .++..||||+++... .......+.+|+.+|++++||||+++++++.. +.
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 344555555 7999999999999875 356789999998642 33456788999999999999999999999876 56
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|||||||++++|.+++... ...+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||++.....
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred eEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 89999999999999999764 35699999999999999999999999999999999999999999999999999965431
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~ 898 (998)
.... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus 489 ~~~~------------------------~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 489 DDSY------------------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp -------------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCce------------------------eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 1110 011122346789999999999999999999999999999998 999999988
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
..+.+..+..+. ..+....++..+.+||.+||..||.+||++.++
T Consensus 545 ~~~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l 589 (613)
T 2ozo_A 545 GPEVMAFIEQGK-RMECPPECPPELYALMSDCWIYKWEDRPDFLTV 589 (613)
T ss_dssp SHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred HHHHHHHHHcCC-CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 888777776653 233334578999999999999999999995553
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=356.11 Aligned_cols=250 Identities=17% Similarity=0.209 Sum_probs=200.7
Q ss_pred ccccCCcccccccCCCCceeEEEE-----EEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC---CCCccceeE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLV-----ELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD---HPFVPALYA 732 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a-----~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~ 732 (998)
.+..++|.+.+.||+|+||.||+| .+..+++.||+|++... ....+..|+.+++.+. |+||+.+++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 455678999999999999999999 46778999999998754 2346677888888886 899999999
Q ss_pred EEeeCCeEEEEEecCCCCchhHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec-------
Q 001902 733 SFQTKTHVCLITDYCPGGELFLLLDRQ---PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG------- 802 (998)
Q Consensus 733 ~~~~~~~~~lV~E~~~ggsL~~~l~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~------- 802 (998)
++...+..|||||||++|+|.+++... ....+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 999999999999999999999999742 2456999999999999999999999999999999999999998
Q ss_pred ----CCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHH
Q 001902 803 ----NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 878 (998)
Q Consensus 803 ----~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIw 878 (998)
++.+||+|||+|..+.... ........+||+.|+|||++.+..++.++|||
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 269 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFP-------------------------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSC-------------------------TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHH
T ss_pred cccccCCEEEeeCchhhhhhccC-------------------------CCceeeeecCCCCCCChHHhcCCCCCccccHH
Confidence 8999999999996532110 11123456799999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 879 ALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 879 SlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
||||++|+|++|+.||........ .....++ ....+..+.+++..||..+|.+|++..+.+.+
T Consensus 270 slG~il~elltg~~pf~~~~~~~~-----~~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 270 GVAATVYCMLFGTYMKVKNEGGEC-----KPEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp HHHHHHHHHHHSSCCCEEEETTEE-----EECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhCCCccccCCCCce-----eechhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 999999999999999965432100 0011111 11346678899999999999999875443333
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=372.01 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=212.8
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
.+.+..++|++.+.||+|+||.||++.+.. +..||||+++.... ..+.+.+|+.+|++++|+||+++++++.. +
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 345677889999999999999999999854 56799999986432 23578899999999999999999999876 6
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
.+|||||||++++|.+++.......+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||++....
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 78999999999999999976434568999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~ 897 (998)
... ........++..|+|||++.+..++.++|||||||+||+|++ |..||.+.
T Consensus 415 ~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 415 DNE--------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp CHH--------------------------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred CCc--------------------------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 100 011123357889999999999999999999999999999999 99999998
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 898 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
...+.+..+..+ ...+....++..+.+||.+||..||.+|||+.+
T Consensus 469 ~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~ 513 (535)
T 2h8h_A 469 VNREVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEERPTFEY 513 (535)
T ss_dssp CHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 888777776654 333444567889999999999999999999443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=355.87 Aligned_cols=252 Identities=18% Similarity=0.223 Sum_probs=199.1
Q ss_pred CcccccccCCCCceeEEEEEEccC---CeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe-eCCeEE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ-TKTHVC 741 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~---~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~-~~~~~~ 741 (998)
.|++.+.||+|+||.||+|.+..+ +..||+|.+... ........+.+|+.++++++||||+++++++. ..+..|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 588889999999999999998543 346899988742 34456678899999999999999999999864 456889
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+||||+++++|.+++... ...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 168 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999999999999764 3458899999999999999999999999999999999999999999999999996542111
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 900 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~ 900 (998)
.. .........+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..
T Consensus 247 ~~-----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 247 FD-----------------------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303 (373)
T ss_dssp ----------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS
T ss_pred cc-----------------------cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH
Confidence 00 0011233457889999999999999999999999999999999 78899887766
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
.....+..+.. .+....++..+.+||.+||..||.+||++.++
T Consensus 304 ~~~~~~~~~~~-~~~p~~~~~~l~~li~~cl~~dp~~RPs~~el 346 (373)
T 3c1x_A 304 DITVYLLQGRR-LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 346 (373)
T ss_dssp CHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 66666655432 23334578899999999999999999994443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=345.96 Aligned_cols=256 Identities=20% Similarity=0.337 Sum_probs=207.3
Q ss_pred cccccCCcccccccCCCCceeEEEEE----EccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVE----LCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 735 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~----~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 735 (998)
..+..++|++++.||+|+||.||+|. +..+++.||+|++... .......+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 34556789999999999999999998 4568999999998753 3455677889999999999999999999886
Q ss_pred eCC--eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccC
Q 001902 736 TKT--HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 813 (998)
Q Consensus 736 ~~~--~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~ 813 (998)
..+ .+++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 543 7899999999999999998753 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCC
Q 001902 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 814 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~P 893 (998)
+......... ........++..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 192 ~~~~~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~ 247 (326)
T 2w1i_A 192 TKVLPQDKEY------------------------YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 247 (326)
T ss_dssp CEECCSSCSE------------------------EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCG
T ss_pred hhhccccccc------------------------cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCC
Confidence 8654321110 0112234578889999999988899999999999999999999999
Q ss_pred CCCCChH---------------HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 894 FRGKTRQ---------------KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 894 f~~~~~~---------------~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
|...... ..+...+......+....++..+.+||.+||..||.+|||+.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 312 (326)
T 2w1i_A 248 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD 312 (326)
T ss_dssp GGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHH
Confidence 8643110 1122233333344445567899999999999999999999433
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=348.06 Aligned_cols=261 Identities=22% Similarity=0.268 Sum_probs=210.8
Q ss_pred cccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 658 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
....+..++|++.+.||+|+||.||+|.+.. .+|+|++..... .......+.+|+.++++++||||+++++++...
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 3455778899999999999999999999854 499999875422 222334566799999999999999999999999
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
+.+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred CceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 9999999999999999999764 34599999999999999999999999999999999999998 789999999998553
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC---------CCCCChhHHHHHHHHHHHHH
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---------AGHTSAVDWWALGILLYEML 888 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---------~~~~~~sDIwSlG~il~eLl 888 (998)
...... ..........||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 180 ~~~~~~----------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~ 237 (319)
T 2y4i_B 180 GVLQAG----------------------RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237 (319)
T ss_dssp ------------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHH
T ss_pred cccccc----------------------ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHH
Confidence 211000 00112234468999999999975 34788999999999999999
Q ss_pred cCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 889 YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 889 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
+|..||.+.........+.....+......++..+.+||.+||..||.+||| +.++++
T Consensus 238 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~l~~ 295 (319)
T 2y4i_B 238 AREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPT----FTKLMD 295 (319)
T ss_dssp HSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCC----HHHHHH
T ss_pred hCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcC----HHHHHH
Confidence 9999999988888777777665544444467889999999999999999999 555554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=373.31 Aligned_cols=246 Identities=22% Similarity=0.305 Sum_probs=203.4
Q ss_pred cccCCCCceeEEEEEE--ccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCC
Q 001902 671 KPLGSGDTGSVHLVEL--CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 748 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~--~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 748 (998)
+.||+|+||.||+|.+ ..+++.||||+++... .+......+.+|+.+|++++||||+++++++.. +..+||||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4799999999999965 4567899999998653 344456789999999999999999999999865 55889999999
Q ss_pred CCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcc
Q 001902 749 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 828 (998)
Q Consensus 749 ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~ 828 (998)
+++|.+++... ..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||++.........
T Consensus 453 ~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~----- 525 (635)
T 4fl3_A 453 LGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY----- 525 (635)
T ss_dssp TEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc-----
Confidence 99999999764 45999999999999999999999999999999999999999999999999999654321110
Q ss_pred hhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 001902 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANIL 907 (998)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~ 907 (998)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 526 -------------------~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~ 586 (635)
T 4fl3_A 526 -------------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 586 (635)
T ss_dssp ----------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred -------------------cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 011223357889999999999999999999999999999998 999999998887777776
Q ss_pred hCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcH
Q 001902 908 HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 945 (998)
Q Consensus 908 ~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 945 (998)
.+. ..+....++.++.+||.+||..||.+||++.+++
T Consensus 587 ~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~ 623 (635)
T 4fl3_A 587 KGE-RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVE 623 (635)
T ss_dssp TTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred cCC-CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 653 2333445789999999999999999999954443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=341.87 Aligned_cols=253 Identities=21% Similarity=0.261 Sum_probs=201.1
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccc-cChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM-LNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
.|...+.||+|+||.||+|.+ +++.||+|++..... ........+.+|+.+++.++||||+++++++...+..|+||
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence 455668999999999999986 688999999875432 23445677889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 745 DYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 745 E~~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
||+++++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 188 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ- 188 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS-
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc-
Confidence 999999999998743 234699999999999999999999999999999999999999999999999999865331110
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH--
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK-- 901 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~-- 901 (998)
........||+.|+|||.+.+ .++.++|||||||++|+|++|..||.+.....
T Consensus 189 ------------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 243 (307)
T 2nru_A 189 ------------------------TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243 (307)
T ss_dssp ------------------------CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred ------------------------cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence 011234579999999999865 47889999999999999999999998754322
Q ss_pred --HHHHHHhCCC--------CCC-CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 902 --TFANILHKDL--------KFP-SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 902 --~~~~i~~~~~--------~~~-~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
....+..... ..+ .....+..+.+|+.+||+.||.+||| +.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~~l~~ 299 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD----IKKVQQ 299 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCC----HHHHHH
T ss_pred HHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 1122221111 011 11223457889999999999999999 666654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=344.07 Aligned_cols=267 Identities=22% Similarity=0.352 Sum_probs=195.4
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHH--HHhCCCCCccceeEEEe--
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFVPALYASFQ-- 735 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~i--l~~l~h~nIv~l~~~~~-- 735 (998)
..+..++|++++.||+|+||.||+|.+ +++.||+|++.... ...+..|.++ +..++||||+++++.+.
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 356788999999999999999999987 78999999987532 2334444444 44589999999998653
Q ss_pred ---eCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCcEEEecC
Q 001902 736 ---TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ---------GIIYRDLKPENVLLQGN 803 (998)
Q Consensus 736 ---~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---------~IiHrDLkP~NILi~~~ 803 (998)
....+|+|||||++++|.+++... ..++..+..++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence 234679999999999999999764 358899999999999999999999 99999999999999999
Q ss_pred CcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-------CCCCChhH
Q 001902 804 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-------AGHTSAVD 876 (998)
Q Consensus 804 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sD 876 (998)
+.+||+|||++........... ..........+||+.|+|||++.+ ..++.++|
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~-------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D 217 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRP-------------------GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVD 217 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC----------------------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHH
T ss_pred CcEEEeeccceeecccccccCc-------------------cccccccccCCCccceeCchhhcCCcccccccccccccc
Confidence 9999999999976542211100 001122335579999999999987 34567899
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCh-----------------HHHHHHHHhCC---CCCCCC----CCCcHHHHHHHHHccc
Q 001902 877 WWALGILLYEMLYGYTPFRGKTR-----------------QKTFANILHKD---LKFPSS----TPTSLHAKQLMYRLLH 932 (998)
Q Consensus 877 IwSlG~il~eLltG~~Pf~~~~~-----------------~~~~~~i~~~~---~~~~~~----~~~s~~l~~Ll~~~L~ 932 (998)
||||||++|+|++|..||..... ........... ..++.. ...+..+.+||.+||.
T Consensus 218 iwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (336)
T 3g2f_A 218 MYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297 (336)
T ss_dssp HHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSC
T ss_pred hHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhc
Confidence 99999999999999777643211 11222222221 122211 1134579999999999
Q ss_pred cCccCcCCChhcHHHH--HcCCCccC
Q 001902 933 RDPKSRLGSHEGANEI--KKHPFFKG 956 (998)
Q Consensus 933 ~dP~~Rpt~~~~a~el--L~Hp~f~~ 956 (998)
.||.+|||+.++++.| +.++|-++
T Consensus 298 ~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 298 QDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred CChhhCcchHHHHHHHHHHHHHHHhc
Confidence 9999999955443333 44666654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=375.56 Aligned_cols=261 Identities=27% Similarity=0.403 Sum_probs=209.1
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee------C
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------K 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~------~ 737 (998)
.++|++.+.||+|+||.||+|.+..+|+.||+|++... ........+.+|+.+++.++||||+++++++.. .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 36899999999999999999999999999999998754 244556778899999999999999999998765 6
Q ss_pred CeEEEEEecCCCCchhHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc---EEEEeccC
Q 001902 738 THVCLITDYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDL 813 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~---vkL~DFG~ 813 (998)
+..|+|||||+|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 78899999999999999998642 235899999999999999999999999999999999999997764 99999999
Q ss_pred ccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCC
Q 001902 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 814 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~P 893 (998)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 171 a~~~~~~----------------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~P 222 (676)
T 3qa8_A 171 AKELDQG----------------------------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222 (676)
T ss_dssp CCBTTSC----------------------------CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSS
T ss_pred ccccccc----------------------------cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 8653211 112345799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHH--------------HhCCCCCCC--------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 894 FRGKTRQKTFANI--------------LHKDLKFPS--------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 894 f~~~~~~~~~~~i--------------~~~~~~~~~--------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
|.+.......... ..+...+.. ....+..+.+||.+||..||.+||| +.++++|
T Consensus 223 f~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT----a~elL~h 298 (676)
T 3qa8_A 223 FLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT----DPQNPNV 298 (676)
T ss_dssp CCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C----CTTCCCC
T ss_pred CCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC----HHHHhcC
Confidence 9775433221100 011111111 1124678999999999999999999 8888999
Q ss_pred CCccCCC
Q 001902 952 PFFKGVN 958 (998)
Q Consensus 952 p~f~~~~ 958 (998)
|||+.++
T Consensus 299 p~F~~l~ 305 (676)
T 3qa8_A 299 GCFQALD 305 (676)
T ss_dssp TTHHHHH
T ss_pred HHHHHHH
Confidence 9999853
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=340.62 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=194.5
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC--CCCCccceeEEEeeC----
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML--DHPFVPALYASFQTK---- 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l--~h~nIv~l~~~~~~~---- 737 (998)
.++|++++.||+|+||.||+|.+ +++.||+|++... .......|.+++..+ +||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 46899999999999999999998 4899999998643 123444566666554 999999999999877
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEEEecCCcEEEE
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLT 809 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--------~IiHrDLkP~NILi~~~g~vkL~ 809 (998)
..+|+||||+++++|.+++... .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 7899999999999999999764 499999999999999999999998 99999999999999999999999
Q ss_pred eccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCCh------hHHHHHHHH
Q 001902 810 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA------VDWWALGIL 883 (998)
Q Consensus 810 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~------sDIwSlG~i 883 (998)
|||++......... .........||+.|+|||++.+..++.. +|||||||+
T Consensus 185 Dfg~a~~~~~~~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~i 241 (337)
T 3mdy_A 185 DLGLAVKFISDTNE-----------------------VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLI 241 (337)
T ss_dssp CCTTCEECC--------------------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHH
T ss_pred eCCCceeecccccc-----------------------ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHH
Confidence 99998654311110 0011234579999999999988766654 999999999
Q ss_pred HHHHHcC----------CCCCCCCC----hHHHHHHHHhC-CC--CCCC---CCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 884 LYEMLYG----------YTPFRGKT----RQKTFANILHK-DL--KFPS---STPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 884 l~eLltG----------~~Pf~~~~----~~~~~~~i~~~-~~--~~~~---~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
+|+|++| ..||.... ........... .. .++. ...++..+.+||.+||+.||.+|||
T Consensus 242 l~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps--- 318 (337)
T 3mdy_A 242 LWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT--- 318 (337)
T ss_dssp HHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC---
T ss_pred HHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCC---
Confidence 9999999 77775432 22233333322 11 1111 1134567899999999999999999
Q ss_pred cHHHHHcC
Q 001902 944 GANEIKKH 951 (998)
Q Consensus 944 ~a~elL~H 951 (998)
+.++++|
T Consensus 319 -~~ell~~ 325 (337)
T 3mdy_A 319 -ALRVKKT 325 (337)
T ss_dssp -HHHHHHH
T ss_pred -HHHHHHH
Confidence 6666655
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=355.22 Aligned_cols=247 Identities=17% Similarity=0.192 Sum_probs=194.3
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeeccccc-----ChhHHHHHHHHHHHHHhCC---------CCCc
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-----NRNKVHRACAEREILDMLD---------HPFV 727 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~-----~~~~~~~~~~E~~il~~l~---------h~nI 727 (998)
+..++|++++.||+|+||.||+|.+ +|+.||+|++...... .......+.+|+.+++.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 4457899999999999999999998 7899999999865321 2333467888999998886 7777
Q ss_pred cceeEEE-----------------ee-------------CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHH
Q 001902 728 PALYASF-----------------QT-------------KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 777 (998)
Q Consensus 728 v~l~~~~-----------------~~-------------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil 777 (998)
+++++.+ .. .+.+|||||||++|++.+.+.+ ..+++..++.++.||+
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLT 171 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHH
Confidence 7666654 22 6889999999999977666644 3489999999999999
Q ss_pred HHHHHHH-HCCceeccCCCCcEEEecCC--------------------cEEEEeccCccccCCCCCCCCCcchhhhhccc
Q 001902 778 VALEYLH-CQGIIYRDLKPENVLLQGNG--------------------HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836 (998)
Q Consensus 778 ~aL~~LH-~~~IiHrDLkP~NILi~~~g--------------------~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~ 836 (998)
.||.||| ++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~------------------ 233 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER------------------ 233 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE------------------
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC------------------
Confidence 9999999 99999999999999999887 89999999996532
Q ss_pred CCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHH-HHHHHcCCCCCCCCCh-HHHHHHHHhC-CCCC
Q 001902 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL-LYEMLYGYTPFRGKTR-QKTFANILHK-DLKF 913 (998)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~i-l~eLltG~~Pf~~~~~-~~~~~~i~~~-~~~~ 913 (998)
....+||+.|+|||++.+.. +.++||||||++ .+++++|..||.+... ......+... ....
T Consensus 234 --------------~~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 298 (336)
T 2vuw_A 234 --------------DGIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT 298 (336)
T ss_dssp --------------TTEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS
T ss_pred --------------CCcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc
Confidence 11347999999999998776 889999998777 7778889999954321 1122333322 1111
Q ss_pred CC----CCCCcHHHHHHHHHccccCccCcCCChhcHHHHH-cCCCcc
Q 001902 914 PS----STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK-KHPFFK 955 (998)
Q Consensus 914 ~~----~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL-~Hp~f~ 955 (998)
.. ...++.++.+||.+||++| | +.++| +||||+
T Consensus 299 ~~~~~~~~~~s~~~~dli~~~L~~d-----s----a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 299 KCNTPAMKQIKRKIQEFHRTMLNFS-----S----ATDLLCQHSLFK 336 (336)
T ss_dssp CCCSHHHHHHHHHHHHHHHHGGGSS-----S----HHHHHHHCGGGC
T ss_pred ccchhhhhhcCHHHHHHHHHHhccC-----C----HHHHHhcCCCcC
Confidence 11 1235778999999999977 7 99999 999996
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=360.54 Aligned_cols=254 Identities=18% Similarity=0.151 Sum_probs=199.2
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCC-CCc---------ccee--
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH-PFV---------PALY-- 731 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~nI---------v~l~-- 731 (998)
...|+..+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+.| .|. +...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3458888999999999999999999999999999885443344446778899999999977 221 1111
Q ss_pred ----------EEEee-----CCeEEEEEecCCCCchhHHHh-----hCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 001902 732 ----------ASFQT-----KTHVCLITDYCPGGELFLLLD-----RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 791 (998)
Q Consensus 732 ----------~~~~~-----~~~~~lV~E~~~ggsL~~~l~-----~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHr 791 (998)
.++.. ....+++|+++ +++|.+++. ......+++..+..++.||+.||+|||++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 11111 23467888877 889999885 2233458888999999999999999999999999
Q ss_pred cCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhh-----
Q 001902 792 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII----- 866 (998)
Q Consensus 792 DLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l----- 866 (998)
||||+|||++.++.+||+|||+++.... .....+| +.|+|||++
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~------------------------------~~~~~~g-~~y~aPE~~~~~~~ 284 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGA------------------------------SAVSPIG-RGFAPPETTAERML 284 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTE------------------------------EECCCCC-TTTCCHHHHHHHTS
T ss_pred CcccceEEEecCCeEEEEeccceeecCC------------------------------ccccCCC-CceeCchhhhcccc
Confidence 9999999999999999999999854320 1234568 999999999
Q ss_pred -----cCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCC
Q 001902 867 -----AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS 941 (998)
Q Consensus 867 -----~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~ 941 (998)
.+..++.++|||||||++|+|++|+.||.+.+.......+.. ....++..+.+||.+||..||.+||+
T Consensus 285 ~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt- 357 (413)
T 3dzo_A 285 PFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLL- 357 (413)
T ss_dssp TTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCC-
T ss_pred ccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcC-
Confidence 555688899999999999999999999988765443333322 22356789999999999999999999
Q ss_pred hhcHHHHHcCCCccCCCh
Q 001902 942 HEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 942 ~~~a~elL~Hp~f~~~~~ 959 (998)
+.++++||||+.+..
T Consensus 358 ---~~~~l~~~~~~~~~~ 372 (413)
T 3dzo_A 358 ---PLQAMETPEYEQLRT 372 (413)
T ss_dssp ---HHHHTTSHHHHHHHH
T ss_pred ---HHHHHhCHHHHHHHH
Confidence 999999999998644
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=364.65 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=209.5
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccC---CeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
.+..++|++.+.||+|+||.||+|.+..+ +..+|+|.+... ........+.+|+.++++++||||+++++++. .
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 34567899999999999999999998643 568999988753 23445577889999999999999999999985 4
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
+..|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 6689999999999999999865 345999999999999999999999999999999999999999999999999999654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~ 896 (998)
..... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 542 ~~~~~--------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 595 (656)
T 2j0j_A 542 EDSTY--------------------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595 (656)
T ss_dssp CC------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCCcc--------------------------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 31110 11123457889999999998999999999999999999997 9999999
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
.+....+..+..... .+....++..+.+||.+||..||.+||++.+
T Consensus 596 ~~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~RPs~~e 641 (656)
T 2j0j_A 596 VKNNDVIGRIENGER-LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 641 (656)
T ss_dssp CCHHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCHHHHHHHHHcCCC-CCCCccccHHHHHHHHHHcCCChhHCcCHHH
Confidence 988888877776542 2333457889999999999999999999443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=333.12 Aligned_cols=232 Identities=16% Similarity=0.137 Sum_probs=191.2
Q ss_pred hccccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEe
Q 001902 656 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 735 (998)
Q Consensus 656 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 735 (998)
+.+|..+..++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..++||||+++++++.
T Consensus 22 ~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 22 LVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp CCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 34555566688999999999999999999999999999999998776555666788899999999999999999999999
Q ss_pred eCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 736 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
..+..|+||||++|++|.+++... .....+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|.
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~-- 175 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT-- 175 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC--
T ss_pred ECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc--
Confidence 999999999999999999999542 45567888999999999999999999999999999999999999985542
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
++ .++.++|||||||++|+|++|+.||.
T Consensus 176 ---------------------------------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~ 203 (286)
T 3uqc_A 176 ---------------------------------------------MP-------DANPQDDIRGIGASLYALLVNRWPLP 203 (286)
T ss_dssp ---------------------------------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSC
T ss_pred ---------------------------------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 22 26789999999999999999999998
Q ss_pred CCChHHHHH---HHHhCCCCCC--CCCCCcHHHHHHHHHccccCccCcCCChhcHH
Q 001902 896 GKTRQKTFA---NILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946 (998)
Q Consensus 896 ~~~~~~~~~---~i~~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 946 (998)
+.+....+. .........+ ....++..+.+||.+||..||.+| |+.++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 204 EAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp CCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred cCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 865432111 1111111111 123468899999999999999999 9444433
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=339.47 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=198.8
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHh--CCCCCccceeEEEeeCC---
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDHPFVPALYASFQTKT--- 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~--l~h~nIv~l~~~~~~~~--- 738 (998)
.++|++.+.||+|+||.||+|.+ +|+.||+|++... ....+..|.+++.. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 36799999999999999999998 5899999998643 23567788999988 79999999999998775
Q ss_pred -eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCcEEEecCCcEEEE
Q 001902 739 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH--------CQGIIYRDLKPENVLLQGNGHVSLT 809 (998)
Q Consensus 739 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH--------~~~IiHrDLkP~NILi~~~g~vkL~ 809 (998)
.+|+||||+++++|.+++.+. .+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred ceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 899999999999999999763 4899999999999999999999 8999999999999999999999999
Q ss_pred eccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC------CCChhHHHHHHHH
Q 001902 810 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG------HTSAVDWWALGIL 883 (998)
Q Consensus 810 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~------~~~~sDIwSlG~i 883 (998)
|||++......... .........||+.|+|||++.+.. ++.++|||||||+
T Consensus 190 Dfg~~~~~~~~~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~i 246 (342)
T 1b6c_B 190 DLGLAVRHDSATDT-----------------------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 246 (342)
T ss_dssp CCTTCEEEETTTTE-----------------------EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHH
T ss_pred ECCCceeccccccc-----------------------cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHH
Confidence 99998654311100 001223457999999999997763 3368999999999
Q ss_pred HHHHHcC----------CCCCCCCC-----hHHHHHHHHhCCCCC--CC---CCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 884 LYEMLYG----------YTPFRGKT-----RQKTFANILHKDLKF--PS---STPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 884 l~eLltG----------~~Pf~~~~-----~~~~~~~i~~~~~~~--~~---~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
+|+|++| ..||.... .......+....... +. ....+..+.+||.+||..||.+|||
T Consensus 247 l~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps--- 323 (342)
T 1b6c_B 247 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT--- 323 (342)
T ss_dssp HHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC---
T ss_pred HHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCC---
Confidence 9999999 78987642 223333333332221 11 1123357889999999999999999
Q ss_pred cHHHHHcC
Q 001902 944 GANEIKKH 951 (998)
Q Consensus 944 ~a~elL~H 951 (998)
+.++++|
T Consensus 324 -~~~i~~~ 330 (342)
T 1b6c_B 324 -ALRIKKT 330 (342)
T ss_dssp -HHHHHHH
T ss_pred -HHHHHHH
Confidence 6666654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=366.29 Aligned_cols=243 Identities=23% Similarity=0.305 Sum_probs=197.6
Q ss_pred cccCCcccccccCCCCceeEEEEEEcc-CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe-
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCG-SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH- 739 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~-~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~- 739 (998)
+..++|++++.||+|+||.||+|.+.. +|+.||||++... ........+.+|+.++++++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 335799999999999999999999976 7999999998753 234556678899999999999999999999987655
Q ss_pred ----EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 740 ----VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 740 ----~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
.||||||++|++|.+++.. .+++..++.++.||+.||.|||++|||||||||+|||++.+ .+||+|||++.
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999988754 49999999999999999999999999999999999999975 99999999985
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
.... .....||+.|+|||++.+.. +.++|||||||++|+|++|.+||.
T Consensus 230 ~~~~-------------------------------~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~ 277 (681)
T 2pzi_A 230 RINS-------------------------------FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRN 277 (681)
T ss_dssp ETTC-------------------------------CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEET
T ss_pred hccc-------------------------------CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCc
Confidence 4320 13457999999999997654 889999999999999999999987
Q ss_pred CCChHHHHHHHHhCCCC-CCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 896 GKTRQKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 896 ~~~~~~~~~~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
+.... .++ .......+..+.+||.+||..||.+||+ ..+.+.|+|+.-
T Consensus 278 ~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~----~~~~l~~~l~~~ 326 (681)
T 2pzi_A 278 GRYVD---------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFT----TAEEMSAQLTGV 326 (681)
T ss_dssp TEECS---------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCS----SHHHHHHHHHHH
T ss_pred ccccc---------cccccccccccCHHHHHHHhhhccCChhhCCC----HHHHHHHHHHHH
Confidence 53210 010 0000113467899999999999999999 666677777643
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-30 Score=277.31 Aligned_cols=217 Identities=22% Similarity=0.448 Sum_probs=201.2
Q ss_pred cEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCCEEEEE
Q 001902 201 TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNL 280 (998)
Q Consensus 201 ~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~ 280 (998)
.|+++|. +|+|+|+|++|++++||+.+|++|+++..+.++.........++..+..+..+.++++.+++||+.+|+.
T Consensus 1 ~i~i~D~---~g~i~~~N~a~~~l~Gy~~~el~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~ 77 (227)
T 3ewk_A 1 LVSITDL---QGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNIWQGEFCNRRKDGTRYWVD 77 (227)
T ss_dssp CEEEEET---TCBEEEECHHHHHHTTCCHHHHTTSBGGGGCCSCSCHHHHHHHHHHHTTTCCEEEEEEEECSSSCEEEEE
T ss_pred CEEEECC---CCcEEehHHHHHHHHCcCHHHHcCCCHHHcCCCCCCHHHHHHHHHHHHcCCeEEEEEEEEcCCCCEEeee
Confidence 3788998 7889999999999999999999999998888777777888888999999999999999999999999999
Q ss_pred eeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhcCCCCCchhhhhHHHHHHHHhHhhHHHHHHHccCCCCccccCCCCc
Q 001902 281 LTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPP 360 (998)
Q Consensus 281 ~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~~~~~L~~~l~~~d~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 360 (998)
+++.|++|.+|.+.+++++.+|||++|++|++++.
T Consensus 78 ~~~~p~~d~~g~~~~~~~~~~DIT~~k~~e~~l~~--------------------------------------------- 112 (227)
T 3ewk_A 78 STIVPLMDNAGKPRQYISIRRDITAQKEAEAQLAR--------------------------------------------- 112 (227)
T ss_dssp EEEEEEECSSSCEEEEEEEEEECTTTTHHHHHHHH---------------------------------------------
T ss_pred eEEEEEEcCCCCEEEEEEEEEehhhHHHHHHHHHH---------------------------------------------
Confidence 99999999999999999999999999999887432
Q ss_pred ccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCCcccccccccccchhhccccCCccccccccccccCCCCCCCcccc
Q 001902 361 IIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENE 440 (998)
Q Consensus 361 ~~~~~~~~~~~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (998)
T Consensus 113 -------------------------------------------------------------------------------- 112 (227)
T 3ewk_A 113 -------------------------------------------------------------------------------- 112 (227)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccCCCCCCCCCCCCCchhhHHHHHhhhccccHHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCC
Q 001902 441 IIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNC 520 (998)
Q Consensus 441 ~~~~~~~~~~~~~~~~di~er~~~e~e~r~~~~l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~ 520 (998)
++.++++++++|+++|.+|+ |+++|++|++++||+.+|++|++.
T Consensus 113 ---------------------------------~~~~~~~~~~~i~~~d~~g~---i~~~N~~~~~~~G~~~~e~~g~~~ 156 (227)
T 3ewk_A 113 ---------------------------------LKQAMDANSEMILLTDRAGR---IIYANPALCRFSGMAEGELLGQSP 156 (227)
T ss_dssp ---------------------------------HHHHHHTCCSEEEEECTTSC---EEEECHHHHHHHTCCTHHHHSSCG
T ss_pred ---------------------------------HHHHHhcCcCeEEEEcCCCc---EEEEchHHHHHhCCCHHHHcCCCh
Confidence 46688999999999999887 999999999999999999999999
Q ss_pred ccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCc------EEEEEEEEeeeccCC----EEEEEEec
Q 001902 521 RFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGK------KFWNLFHLQPMRDQK----YFIGVQLD 581 (998)
Q Consensus 521 ~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rkdG~------~~wv~~~~spi~d~~----~~vgi~rD 581 (998)
..+.++.........+++.+..+..+.+|++.++|||+ .+|++++++|++|.+ +++++++|
T Consensus 157 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~k~G~~~~dg~~~~~~~~~~pi~d~~g~~~~~v~i~~D 227 (227)
T 3ewk_A 157 SILDSPLADQETLAAMQEALQAGQPWSGRLLNRRRTGPAPHDAEDYWAEISTTPIHTDGNGLVGYVQIQHD 227 (227)
T ss_dssp GGGBCTTSCHHHHHHHHHHHHHTCCEECCEEEEEECCSSSSCEEEEEEEEEEEEEECSSSCEEEEEEEEEC
T ss_pred hhccCCCCCHHHHHHHHHHHHcCCceeEEEEEECCCCCcCcccceEEEEEEEEEEECCCCCEEEEEEEecC
Confidence 99999999999999999999999999999999999997 899999999999876 89999987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=296.93 Aligned_cols=190 Identities=16% Similarity=0.123 Sum_probs=135.3
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccC-------hhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCCeEEE
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-------RNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~-------~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~l 742 (998)
..++.|++|.+..++....|+.|++|++.+..... ....+.+.+|+++|+++ .|+||+++++++.+++.+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 45688888888888888889999999998653221 23345688999999999 79999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
|||||+|++|.+++.+. +.++.. .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~-- 392 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD-- 392 (569)
T ss_dssp EEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred EEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--
Confidence 99999999999999875 446654 57899999999999999999999999999999999999999998654211
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCC
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 893 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~P 893 (998)
.....+.+||+.|||||++.+. +..++|+||+|+++|.|.+|..+
T Consensus 393 -------------------------~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 -------------------------CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --------------------------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -------------------------CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 1123456899999999998764 56789999999998877654433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-24 Score=258.05 Aligned_cols=194 Identities=16% Similarity=0.164 Sum_probs=146.5
Q ss_pred ccccccCCCCceeEEEEEEccCCeEEEEEEeecccccCh-----hHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEE
Q 001902 668 RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-----NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 668 ~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~-----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 742 (998)
...+.||+|+||.||++. ..++.+++|.......... ...+.+.+|+.++++++||||+++..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 345689999999999994 4678899998765333222 224567899999999999999966666667777899
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
|||||+|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+|+.......
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999999865 5688999999999999999999999999999998 999999999966431100
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC--CCCCChhHHHHHHHHHHHHHcCCCCCC
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
. ...........+||+.|||||++.. ..|+..+|+||.++-..+.+.++.+|.
T Consensus 485 --------~------------~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 --------K------------AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp --------H------------HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred --------c------------ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 0 0000011235689999999999977 567778999999999988887777664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-22 Score=222.28 Aligned_cols=134 Identities=17% Similarity=0.104 Sum_probs=109.3
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccCh---------------hHHHHHHHHHHHHHhCCCCCccce
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR---------------NKVHRACAEREILDMLDHPFVPAL 730 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~---------------~~~~~~~~E~~il~~l~h~nIv~l 730 (998)
.|.+.+.||+|+||.||+|.+ .+|+.||+|+++....... .....+.+|+.+++.++ | +.+
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 455669999999999999999 8899999999975322111 23566889999999999 4 566
Q ss_pred eEEEeeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEe
Q 001902 731 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 810 (998)
Q Consensus 731 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~D 810 (998)
++++.. +..|+|||||+|++|.+ +.. .....++.||+.||.|||++||+||||||+|||++ +|.+||+|
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 665544 45699999999999988 422 12457899999999999999999999999999999 99999999
Q ss_pred ccCc
Q 001902 811 FDLS 814 (998)
Q Consensus 811 FG~a 814 (998)
||+|
T Consensus 236 FG~a 239 (282)
T 1zar_A 236 FPQS 239 (282)
T ss_dssp CTTC
T ss_pred CCCC
Confidence 9998
|
| >4f3l_A Mclock, circadian locomoter output cycles protein kaput; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=3.6e-19 Score=202.11 Aligned_cols=103 Identities=12% Similarity=0.005 Sum_probs=94.4
Q ss_pred CceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEE
Q 001902 482 EKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFW 561 (998)
Q Consensus 482 ~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rkdG~~~w 561 (998)
.+.++..|.+|. |+|||++++.++||+++|++|+++..++||++.......++..+..|.....++++++|||+.+|
T Consensus 251 ~~f~~~~~~dg~---~~~vn~~~~~ilGY~~eEl~g~~~~~~iHpdD~~~~~~~~~~~l~~g~~~~~eyR~~~kdG~~vW 327 (361)
T 4f3l_A 251 EEFTSRHSLEWK---FLFLDHRAPPIIGYLPFEVLGTSGYDYYHVDDLENLAKCHEHLMQYGKGKSCYYRFLTKGQQWIW 327 (361)
T ss_dssp CEEEEEECTTSB---EEEECTTSHHHHCCCHHHHTTSBGGGGBCHHHHHHHHHHHHHHHHHSEEECCCEEEECTTSEEEE
T ss_pred ceeEEEEcCCce---EEEECChhhhhhCcCHHHHcCCCHHHeECHHHHHHHHHHHHHHHhCCCcceEEEEEEecCCCEEE
Confidence 467888899777 99999999999999999999999999999999888888899999888888889999999999999
Q ss_pred EEEEEeeeccC--C---EEEEEEecCCcccc
Q 001902 562 NLFHLQPMRDQ--K---YFIGVQLDGSEHLE 587 (998)
Q Consensus 562 v~~~~spi~d~--~---~~vgi~rDITerk~ 587 (998)
++.+..|+++. + +++|+.+|||+++.
T Consensus 328 v~~~~~~v~~~~~g~~~~iv~~~~dITe~~~ 358 (361)
T 4f3l_A 328 LQTHYYITYHQWNSRPEFIVCTHTVVSYAEV 358 (361)
T ss_dssp EEEEEEEEECTTTCCEEEEEEEEEECCHHHH
T ss_pred EEEEEEEEEcCCCCCeeEEEEEEEECChhHh
Confidence 99999999986 3 89999999999974
|
| >4f3l_B BMAL1B; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=4.7e-19 Score=202.76 Aligned_cols=105 Identities=10% Similarity=0.036 Sum_probs=90.3
Q ss_pred hcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCc-EEEEEEEEecCCc
Q 001902 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD-VTVQLINYTKSGK 558 (998)
Q Consensus 480 ~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~-~~~e~~~~rkdG~ 558 (998)
+..+.++..|.+|+ |+|||++++.++||+++|++|+++..++||++.......+...+..+.. ...++++++|||+
T Consensus 276 ~~~~fi~~~~~dg~---~~~vn~~~~~ilGY~~eEl~g~~~~~~iHpdD~~~~~~~~~~~l~~~~~~~~~eyR~~~kdG~ 352 (387)
T 4f3l_B 276 KSMEYVSRHAIDGK---FVFVDQRATAILAYLPQELLGTSCYEYFHQDDIGHLAECHRQVLQTREKITTNCYKFKIKDGS 352 (387)
T ss_dssp CCCEEEEEECTTSB---EEEECTHHHHHHCCCHHHHTTSBGGGTBCHHHHHHHHHHHHHHTTCSSCEECCCEEEECTTSC
T ss_pred CCceEEEEECCCCE---EEEECCCcccccCCCHHHHcCCcHHHeeCHHHHHHHHHHHHHHHhcCCCeeeEEEEEEccCCC
Confidence 45678889999777 9999999999999999999999999999999988888888888866554 5679999999999
Q ss_pred EEEEEEEEeeeccCC-----EEEEEEecCCcccc
Q 001902 559 KFWNLFHLQPMRDQK-----YFIGVQLDGSEHLE 587 (998)
Q Consensus 559 ~~wv~~~~spi~d~~-----~~vgi~rDITerk~ 587 (998)
++|++.+..++++.. +++|+.+|||+||+
T Consensus 353 ~vWv~~~~~~~~~~~~g~~~~ivg~~~dIT~Rk~ 386 (387)
T 4f3l_B 353 FITLRSRWFSFMNPWTKEVEYIVSTNTVVLANVL 386 (387)
T ss_dssp EEEEEEEEEEEEETTTTEEEEEEEEEEECC----
T ss_pred EEEEEEEEEEEECCCCCCEEEEEEEEEEcchhhc
Confidence 999999999999872 89999999999984
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} | Back alignment and structure |
|---|
Probab=99.77 E-value=3.8e-18 Score=160.66 Aligned_cols=119 Identities=26% Similarity=0.460 Sum_probs=109.8
Q ss_pred chHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEE
Q 001902 186 RVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG 265 (998)
Q Consensus 186 ~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 265 (998)
+++++|+.++++++++|+++|. +|+|+|+|++|++++||+.+|++|+++..+.++.........++..+..+..+.+
T Consensus 2 ~~~~~~~~~~~~~~~~i~~~d~---~g~i~~~N~a~~~~~G~~~~elig~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (120)
T 2gj3_A 2 LLPEIFRQTVEHAPIAISITDL---KANILYANRAFRTITGYGSEEVLGKNESILSNGTTPRLVYQALWGRLAQKKPWSG 78 (120)
T ss_dssp CCHHHHHHHHHHCSSEEEEECT---TCBEEEECHHHHHHHCCCTTGGGGCBGGGGCCTTSCHHHHHHHHHHHHTTCCEEE
T ss_pred hhHHHHHHHHHhCCCeEEEECC---CCCEEeehHHHHHHHCcCHHHHcCCCHHHcCCCCCCHHHHHHHHHHHHcCCCEEE
Confidence 4567899999999999999999 7789999999999999999999999988888777776677788888999999999
Q ss_pred EEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhh
Q 001902 266 RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHT 307 (998)
Q Consensus 266 e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk 307 (998)
+++.+++||+.+|+.++++|++|.+|.+.+++++++|||++|
T Consensus 79 e~~~~~~dG~~~~~~~~~~pi~~~~g~~~~~v~~~~DITe~k 120 (120)
T 2gj3_A 79 VLVNRRKDKTLYLAELTVAPVLNEAGETIYYLGMHRDTSELH 120 (120)
T ss_dssp EEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCSCC
T ss_pred EEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEeccCcccC
Confidence 999999999999999999999999999999999999999986
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-18 Score=188.79 Aligned_cols=139 Identities=18% Similarity=0.114 Sum_probs=108.4
Q ss_pred cccccccCCCCceeEEEEEEccCCeE--EEEEEeecccccC---------------------hhHHHHHHHHHHHHHhCC
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQY--FAMKAMDKGVMLN---------------------RNKVHRACAEREILDMLD 723 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~--valK~i~~~~~~~---------------------~~~~~~~~~E~~il~~l~ 723 (998)
|.+.+.||+|+||.||+|.+..+|+. ||||+++.....- ......+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999999788999 9999976532110 011235778999999998
Q ss_pred CCCc--cceeEEEeeCCeEEEEEecCCC-C----chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCC
Q 001902 724 HPFV--PALYASFQTKTHVCLITDYCPG-G----ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH-CQGIIYRDLKP 795 (998)
Q Consensus 724 h~nI--v~l~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~~IiHrDLkP 795 (998)
|++| +.++.+ +..+|||||+.+ | +|.++... .++..+..++.||+.+|.||| ++||+||||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8764 444432 346899999942 3 67666432 235567889999999999999 99999999999
Q ss_pred CcEEEecCCcEEEEeccCccc
Q 001902 796 ENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 796 ~NILi~~~g~vkL~DFG~a~~ 816 (998)
+|||++. .++|+|||+|..
T Consensus 200 ~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp TSEEESS--SEEECCCTTCEE
T ss_pred HHEEEcC--cEEEEECccccc
Confidence 9999997 999999999854
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1e-17 Score=160.60 Aligned_cols=126 Identities=45% Similarity=0.804 Sum_probs=104.9
Q ss_pred HHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEe
Q 001902 475 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYT 554 (998)
Q Consensus 475 ~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~r 554 (998)
+.++++++++|+++|.+|.+++|+|||++|++++||+.+|++|+++..+.+++........++..+..+..+..+.++++
T Consensus 2 ~~~~~~~~~~i~~~d~~g~~~~i~~~N~a~~~~~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 81 (132)
T 2pr5_A 2 SHMLDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNIRTALQNKEPVTVQIQNYK 81 (132)
T ss_dssp ----CCCCCEEEEECTTSTTCCEEEECHHHHHHHSCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEEC
T ss_pred hhHHhcCCCcEEEEeCCCCCCcEEEECHHHHHHhCcCHHHHcCCChhhhCCCCCCHHHHHHHHHHHHcCCCeEEEEEEEe
Confidence 35789999999999997733459999999999999999999999988888888777777888888888888999999999
Q ss_pred cCCcEEEEEEEEeeeccCC--EEEEEEecCCccccccccCcchhhhhHHHHHHH
Q 001902 555 KSGKKFWNLFHLQPMRDQK--YFIGVQLDGSEHLEPLRNSIPEATAEESEKLVK 606 (998)
Q Consensus 555 kdG~~~wv~~~~spi~d~~--~~vgi~rDITerk~~~~~~~~e~~~~~~~~~~k 606 (998)
|||+.+|++++++|+.+++ +++++++|||+||+ .++.+++.++.++
T Consensus 82 kdG~~~~~~~~~~~~~~~~~~~~~~~~~DITe~k~------~e~~l~~~~~~l~ 129 (132)
T 2pr5_A 82 KDGTMFWNELNIDPMEIEDKTYFVGIQNDITKQKE------YEKLLEDSLTEIT 129 (132)
T ss_dssp TTSCEEEEEEEEEEEEETTEEEEEEEEEECHHHHH------HHHHHHHHHHHHH
T ss_pred cCCCeeeeEEEEEeccCCCeeEEEEEEEeCcHHHH------HHHHHHHHHHHHH
Confidence 9999999999999999887 89999999999996 3444444444433
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=7.8e-18 Score=161.42 Aligned_cols=122 Identities=41% Similarity=0.722 Sum_probs=106.1
Q ss_pred HHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEe
Q 001902 192 KDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYK 271 (998)
Q Consensus 192 ~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~ 271 (998)
+.++++++++|+++|..+.+|+|+|+|++|++++||+.+|++|+++..+.+++........+...+..+..+..+++.++
T Consensus 2 ~~~~~~~~~~i~~~d~~g~~~~i~~~N~a~~~~~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 81 (132)
T 2pr5_A 2 SHMLDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNIRTALQNKEPVTVQIQNYK 81 (132)
T ss_dssp ----CCCCCEEEEECTTSTTCCEEEECHHHHHHHSCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEEC
T ss_pred hhHHhcCCCcEEEEeCCCCCCcEEEECHHHHHHhCcCHHHHcCCChhhhCCCCCCHHHHHHHHHHHHcCCCeEEEEEEEe
Confidence 35789999999999985545589999999999999999999999988887777777777788888888889999999999
Q ss_pred cCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhc
Q 001902 272 KDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 315 (998)
Q Consensus 272 kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~ 315 (998)
|||+.+|+.++++|+.+.+ +.+++++++|||++|++|++++.
T Consensus 82 kdG~~~~~~~~~~~~~~~~--~~~~~~~~~DITe~k~~e~~l~~ 123 (132)
T 2pr5_A 82 KDGTMFWNELNIDPMEIED--KTYFVGIQNDITKQKEYEKLLED 123 (132)
T ss_dssp TTSCEEEEEEEEEEEEETT--EEEEEEEEEECHHHHHHHHHHHH
T ss_pred cCCCeeeeEEEEEeccCCC--eeEEEEEEEeCcHHHHHHHHHHH
Confidence 9999999999999998765 88999999999999999998764
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=3.6e-17 Score=151.70 Aligned_cols=109 Identities=60% Similarity=1.125 Sum_probs=101.1
Q ss_pred hcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCCE
Q 001902 197 TFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTP 276 (998)
Q Consensus 197 ~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~ 276 (998)
+++++|+++|..+.+|+|+|+|++|++++||+.+|++|+++..+.++.........++.++..++.+.++++.++|||+.
T Consensus 1 ~~~~~i~i~d~~~~~g~i~~~N~a~~~l~Gy~~~e~~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~ 80 (109)
T 1n9l_A 1 GLRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTP 80 (109)
T ss_dssp CCSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCE
T ss_pred CCccEEEEEcCCCCCCeEEEEchHHHHHHCcCHHHHcCCCchhcCCCCCCHHHHHHHHHHHHcCCcEEEEEEEEcCCCCE
Confidence 36789999997656889999999999999999999999998888888777777889999999999999999999999999
Q ss_pred EEEEeeeeEEeCCCCCEEEEEEEEecchh
Q 001902 277 FWNLLTIAPIKDDEGKVLKFIGMQVEVSK 305 (998)
Q Consensus 277 ~w~~~~~spi~d~~G~v~~~v~i~~DITe 305 (998)
+|+.++++|++|++|.+.+++++.+|||+
T Consensus 81 ~~~~~~~~pi~d~~G~~~~~v~~~~DITe 109 (109)
T 1n9l_A 81 FWNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEEECCCCCEEEEEEEEEeCCC
Confidence 99999999999999999999999999995
|
| >4hia_A LOV protein; PAS, HTH, signaling protein; HET: FMN; 1.95A {Rhodobacter sphaeroides} PDB: 4hnb_A* 4hj4_A* 4hj6_A* 4hj3_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=3.3e-17 Score=164.94 Aligned_cols=142 Identities=27% Similarity=0.463 Sum_probs=125.4
Q ss_pred chHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEE
Q 001902 186 RVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG 265 (998)
Q Consensus 186 ~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 265 (998)
+..+.|+.++++++++|+++|....+|+|+|+|++|++++||+.++++|+++..+.+++........+...+..+..+..
T Consensus 4 ~~~~~~~~~~~~~~~~i~~~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (176)
T 4hia_A 4 KQFEKIRAVFDRSGVALTLVDMSLPEQPVVLANPPFLRMTGYTEGQILGFNCRFLQRGDENAQARADIRDALKLGRELQV 83 (176)
T ss_dssp HHHHHHHHHHHHCSSCCEEEETTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEE
T ss_pred HHHHHHHHHHhcCCCcEEEEecCCCCCcEEEECHHHHHHHCcCHHHHcCCCcceeeCCCCCHHHHHHHHHHHHcCCceEE
Confidence 34578899999999999999984222889999999999999999999999998888888888888889999999999999
Q ss_pred EEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhcCCCCCchhhhhHHHHHHHHhH
Q 001902 266 RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMAT 336 (998)
Q Consensus 266 e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~~~~~L~~~l~~~d~~~~~~~~ 336 (998)
+++.+++||+.+|+.++++|+.+.+|.+.+++++++|||++|++|+++ .++.+|.++...++
T Consensus 84 e~~~~~~dG~~~~~~~~~~pi~~~~g~~~~~~~~~~DITe~k~~e~~~---------~~a~~d~LtgL~NR 145 (176)
T 4hia_A 84 VLRNYRANDEPFDNLLFLHPVGGRPDAPDYFLGSQFELGRSGNSEEAA---------AAGHAGALTGELAR 145 (176)
T ss_dssp EEEEECTTCCEEEEEEEEEEESSBTTBCSEEEEEEEEESSSGGGHHHH---------HHHHHHHHHHHHHH
T ss_pred EEEEEcCCCCEEEEEEEEEEeeCCCCCeEEEEEEEEECcHhhHHHHHH---------HHhhhhHHhhhhhh
Confidence 999999999999999999999999999999999999999999999882 25667777666654
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} | Back alignment and structure |
|---|
Probab=99.73 E-value=3.1e-17 Score=154.36 Aligned_cols=110 Identities=24% Similarity=0.392 Sum_probs=101.5
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~ 553 (998)
|+.++++++++|+++|.+|+ |+|+|++|++++||+.+|++|++...+.+++........++..+..+..+..+++.+
T Consensus 7 ~~~~~~~~~~~i~~~d~~g~---i~~~N~a~~~~~G~~~~elig~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 83 (120)
T 2gj3_A 7 FRQTVEHAPIAISITDLKAN---ILYANRAFRTITGYGSEEVLGKNESILSNGTTPRLVYQALWGRLAQKKPWSGVLVNR 83 (120)
T ss_dssp HHHHHHHCSSEEEEECTTCB---EEEECHHHHHHHCCCTTGGGGCBGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEE
T ss_pred HHHHHHhCCCeEEEECCCCC---EEeehHHHHHHHCcCHHHHcCCCHHHcCCCCCCHHHHHHHHHHHHcCCCEEEEEEEE
Confidence 78899999999999999888 999999999999999999999998888888777777778888888888999999999
Q ss_pred ecCCcEEEEEEEEeeeccCC----EEEEEEecCCccc
Q 001902 554 TKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHL 586 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk 586 (998)
++||+.+|++++++|+++.+ +++++++|||++|
T Consensus 84 ~~dG~~~~~~~~~~pi~~~~g~~~~~v~~~~DITe~k 120 (120)
T 2gj3_A 84 RKDKTLYLAELTVAPVLNEAGETIYYLGMHRDTSELH 120 (120)
T ss_dssp CTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCSCC
T ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEeccCcccC
Confidence 99999999999999999765 7999999999986
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=9.7e-17 Score=159.01 Aligned_cols=140 Identities=40% Similarity=0.721 Sum_probs=119.1
Q ss_pred cccccccccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHH
Q 001902 175 SDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIR 254 (998)
Q Consensus 175 t~~~~~e~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~ 254 (998)
.++++.++++......|+.++++++++|+++|....+|+|+++|++|++++||+.++++|+++..+.+++........+.
T Consensus 21 ~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~ 100 (166)
T 3ue6_A 21 DNPSKANRILEDPDYSLVKALQMAQQNFVITDASLPDNPIVYASRGFLTLTGYSLDQILGRNCRFLQGPETDPRAVDKIR 100 (166)
T ss_dssp ----------CCCCCHHHHHHHHTTSCEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHH
T ss_pred hhhhHHHHHHHHHHHHHHHHHhcCCceEEEEEccCCCCcEEEECHHHHHHhCcCHHHHcCCCHhheeCCCCCHHHHHHHH
Confidence 35566778888899999999999999999999733347799999999999999999999999988888888888888888
Q ss_pred HHHHcCCcEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhh
Q 001902 255 ETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (998)
Q Consensus 255 ~~l~~g~~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~ 314 (998)
..+..+..+..++..++++|..+|+.+++.|+.+.+|.+.+++++++|||++|+++...+
T Consensus 101 ~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k~~~~~~e 160 (166)
T 3ue6_A 101 NAITKGVDTSVCLLNYRQDGTTFWNLFFVAGLRDSKGNIVNYVGVQSKVSEDYAKLLVNE 160 (166)
T ss_dssp HHHHHTCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEECCBCCHHHHHHHHHH
T ss_pred HHHhcCCceEEEEEEEcCCCCEEEEEEEEEeeeCCCCCEEEEEEEEEechHHHHHHHHHh
Confidence 999999999999999999999999999999999999999999999999999999876643
|
| >3rty_A Period circadian protein; PAS domain, signalling, timeless, circadian clock protein; 2.85A {Drosophila melanogaster} PDB: 1wa9_A 3gec_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.3e-16 Score=177.88 Aligned_cols=103 Identities=8% Similarity=0.001 Sum_probs=91.7
Q ss_pred CceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCc-----EEEEEEEEecC
Q 001902 482 EKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD-----VTVQLINYTKS 556 (998)
Q Consensus 482 ~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~-----~~~e~~~~rkd 556 (998)
.+.++..|.+|+ |+|+|+++..++||+++||+|+++..++||++.....+.++..+..|.. ...++++++||
T Consensus 154 ~~fi~r~~~dG~---~~yvn~~~~~lLGY~peELiG~s~~~~vHPdD~~~~~~~~~~~l~~G~~~~~~~~s~~yR~~~kd 230 (339)
T 3rty_A 154 PKFAIRHTATGI---ISHVDSAAVSALGYLPQDLIGRSIMDFYHHEDLSVMKETYETVMKKGQTAGASFCSKPYRFLIQN 230 (339)
T ss_dssp CEEEEEEETTCB---EEEECTTHHHHHCCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHHHHTTSTTCCCBCCCEEEECTT
T ss_pred ceEEEEECCCCe---EEEcChhhhcccCCCHHHHcCCcHHHEECHHHHHHHHHHHHHHHHcCCcccccccceEEEEEccC
Confidence 468888999777 9999999999999999999999999999999998888888888887764 35789999999
Q ss_pred CcEEEEEEEEeeeccCC-----EEEEEEecCCcccc
Q 001902 557 GKKFWNLFHLQPMRDQK-----YFIGVQLDGSEHLE 587 (998)
Q Consensus 557 G~~~wv~~~~spi~d~~-----~~vgi~rDITerk~ 587 (998)
|+.+|++.+.++++|.. .++|+.+.|+....
T Consensus 231 G~~vWlet~~~~~~np~s~~~~~II~~h~vi~~p~~ 266 (339)
T 3rty_A 231 GCYVLLETEWTSFVNPWSRKLEFVVGHHRVFQGPKQ 266 (339)
T ss_dssp SCEEEEEEEEEEEECTTTCSEEEEEEEEEEEECCSS
T ss_pred CCEEEEEEEEEEEECCCCCCeeEEEEEEEECCCCCC
Confidence 99999999999999764 78999998888764
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.9e-16 Score=170.64 Aligned_cols=136 Identities=38% Similarity=0.609 Sum_probs=111.0
Q ss_pred ccccccccccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHH
Q 001902 174 MSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 253 (998)
Q Consensus 174 it~~~~~e~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i 253 (998)
+......++++++++++|+.++++++++|+++|..+.+|+|+|+|++|++++||+.+|++|+++..+.+++........+
T Consensus 48 ~~~~~~~~~~l~~~~~~~~~i~~~~~~~i~~~d~~~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~~~~~~~~~~ 127 (258)
T 3p7n_A 48 APGADDTRVEVQPPAQWVLDLIEASPIASVVSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKI 127 (258)
T ss_dssp -------------CCHHHHHHHHTCSSEEEEECTTSTTCCEEEECHHHHHHHCCCGGGTTTSCGGGGCCTTCCHHHHHHH
T ss_pred CCcchhhHHHHHhHHHHHHHHHhcCCccEEEEcCCCCCCcEEEEhHHHHHHcCCCHHHHCCCChhhccCCCCchhHHHHH
Confidence 33444556778999999999999999999999985556779999999999999999999999999999988888888889
Q ss_pred HHHHHcCCcEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHH
Q 001902 254 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEG 309 (998)
Q Consensus 254 ~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~ 309 (998)
...+..+..+..+++.+++||+.+|+.+++.|++|.+|.+.+++++++|||++|+.
T Consensus 128 ~~~l~~~~~~~~e~~~~~~dG~~~~~~~~~~pi~d~~g~~~~~v~~~~DITerk~~ 183 (258)
T 3p7n_A 128 RQGVREHKPVLVEILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPN 183 (258)
T ss_dssp HHHHHHTCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCSEEEEEEEEEC------
T ss_pred HHHHHcCCCeEEEEEEEcCCCCEEEEeeEEEEEEcCCCCEEEEEEEeeecchhhhh
Confidence 99999999999999999999999999999999999999999999999999999543
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=3.5e-16 Score=144.92 Aligned_cols=104 Identities=45% Similarity=0.913 Sum_probs=93.7
Q ss_pred cCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 001902 481 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 560 (998)
Q Consensus 481 ~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rkdG~~~ 560 (998)
++++|+++|....+++|+|+|++|++++||+.+|++|+++..+.++.........+++.+..+..+..++++++|||+.+
T Consensus 2 ~~~~i~i~d~~~~~g~i~~~N~a~~~l~Gy~~~e~~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~ 81 (109)
T 1n9l_A 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred CccEEEEEcCCCCCCeEEEEchHHHHHHCcCHHHHcCCCchhcCCCCCCHHHHHHHHHHHHcCCcEEEEEEEEcCCCCEE
Confidence 57899999964223449999999999999999999999988888888888888899999999999999999999999999
Q ss_pred EEEEEEeeeccCC----EEEEEEecCCc
Q 001902 561 WNLFHLQPMRDQK----YFIGVQLDGSE 584 (998)
Q Consensus 561 wv~~~~spi~d~~----~~vgi~rDITe 584 (998)
|++++++|+++++ +++++++|||+
T Consensus 82 ~~~~~~~pi~d~~G~~~~~v~~~~DITe 109 (109)
T 1n9l_A 82 WNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEeCCC
Confidence 9999999999875 79999999996
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.4e-16 Score=168.51 Aligned_cols=155 Identities=23% Similarity=0.434 Sum_probs=130.2
Q ss_pred CCCCCCcceeEeccCCCCCCCCCCCcCCCCCCCcccccccccccccccccccchHHHHHHHHHhcCCcEEEEecCCCCCc
Q 001902 134 DTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYP 213 (998)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dit~~~~~e~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~ 213 (998)
.+..|...|+.....+..+..+. ..+.+...+|||++++++++| +.++.++++++++|+++|. +|+
T Consensus 67 ~~~dG~~~~~~~~~~p~~d~~g~-------~~~~~~~~~DIT~~k~~e~~l----~~~~~~~~~~~~~i~~~d~---~g~ 132 (227)
T 3ewk_A 67 RRKDGTRYWVDSTIVPLMDNAGK-------PRQYISIRRDITAQKEAEAQL----ARLKQAMDANSEMILLTDR---AGR 132 (227)
T ss_dssp ECSSSCEEEEEEEEEEEECSSSC-------EEEEEEEEEECTTTTHHHHHH----HHHHHHHHTCCSEEEEECT---TSC
T ss_pred EcCCCCEEeeeeEEEEEEcCCCC-------EEEEEEEEEehhhHHHHHHHH----HHHHHHHhcCcCeEEEEcC---CCc
Confidence 34566666665444333332221 123455669999999998877 4567789999999999998 788
Q ss_pred eEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCC------EEEEEeeeeEEe
Q 001902 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGT------PFWNLLTIAPIK 287 (998)
Q Consensus 214 I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~------~~w~~~~~spi~ 287 (998)
|+++|++|++++||+.+|++|+++..+.++.........++..+..+..+.++++.++|||. .+|++++++|++
T Consensus 133 i~~~N~~~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~k~G~~~~dg~~~~~~~~~~pi~ 212 (227)
T 3ewk_A 133 IIYANPALCRFSGMAEGELLGQSPSILDSPLADQETLAAMQEALQAGQPWSGRLLNRRRTGPAPHDAEDYWAEISTTPIH 212 (227)
T ss_dssp EEEECHHHHHHHTCCTHHHHSSCGGGGBCTTSCHHHHHHHHHHHHHTCCEECCEEEEEECCSSSSCEEEEEEEEEEEEEE
T ss_pred EEEEchHHHHHhCCCHHHHcCCChhhccCCCCCHHHHHHHHHHHHcCCceeEEEEEECCCCCcCcccceEEEEEEEEEEE
Confidence 99999999999999999999999999988888888999999999999999999999999997 899999999999
Q ss_pred CCCCCEEEEEEEEec
Q 001902 288 DDEGKVLKFIGMQVE 302 (998)
Q Consensus 288 d~~G~v~~~v~i~~D 302 (998)
|.+|.+.+++++++|
T Consensus 213 d~~g~~~~~v~i~~D 227 (227)
T 3ewk_A 213 TDGNGLVGYVQIQHD 227 (227)
T ss_dssp CSSSCEEEEEEEEEC
T ss_pred CCCCCEEEEEEEecC
Confidence 999999999999988
|
| >3mr0_A Sensory box histidine kinase/response regulator; PAS fold, structural genomics, PSI-2; HET: PG5; 1.49A {Burkholderia thailandensis} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.1e-16 Score=153.72 Aligned_cols=132 Identities=15% Similarity=0.193 Sum_probs=112.8
Q ss_pred ccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCC--CCCcccCCCCChHHHHHHHHHHHc
Q 001902 182 KGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR--NCRFLQGAGTDPEDVAKIRETLQN 259 (998)
Q Consensus 182 ~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~--~~~~l~~~~~~~~~~~~i~~~l~~ 259 (998)
.+|++++++|+.+++.++++++.+|. ++.++++|+++++++||+.+++.+. .+..+++|++.......+..++..
T Consensus 2 ~aL~~se~rl~~~~~~~~~g~w~~d~---~~~~~~~s~~~~~~~G~~~~~~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~ 78 (142)
T 3mr0_A 2 NALSASEERFQLAVSGASAGLWDWNP---KTGAMYLSPHFKKIMGYEDHELPDEITGHRESIHPDDRARVLAALKAHLEH 78 (142)
T ss_dssp -------CCHHHHHHHTTCEEEEECT---TTCCEEECHHHHHHTTCCGGGSCSEEC---CCBCTTTHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCcEEEEEEc---CCCeEEECHHHHHHhCCCccccCCCHHHHHhhcCHHHHHHHHHHHHHHHhC
Confidence 46888999999999999999999999 6669999999999999999998773 345678888888888888888988
Q ss_pred CCcEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhcC
Q 001902 260 GQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLR 316 (998)
Q Consensus 260 g~~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~~ 316 (998)
+..+..+++++++||..+|+.....|++|.+|.+.+++|+++|||++|++|++|+.+
T Consensus 79 ~~~~~~e~r~~~~~G~~~w~~~~~~~~~d~~g~~~~~~G~~~DITerk~~E~~L~~~ 135 (142)
T 3mr0_A 79 RDTYDVEYRVRTRSGDFRWIQSRGQALWNSAGEPYRMVGWIMDVTDRKRDEDALRVS 135 (142)
T ss_dssp CCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHHHHHHHHHH
T ss_pred CCceEEEEEEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEcCchHHHHHHHHHHH
Confidence 889999999999999999999999999999999999999999999999999997653
|
| >4hia_A LOV protein; PAS, HTH, signaling protein; HET: FMN; 1.95A {Rhodobacter sphaeroides} PDB: 4hnb_A* 4hj4_A* 4hj6_A* 4hj3_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.4e-15 Score=152.91 Aligned_cols=113 Identities=29% Similarity=0.536 Sum_probs=105.1
Q ss_pred HHHHHhhcCceEEEEcCC---CCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEE
Q 001902 474 LATTLERIEKNFVITDPR---LPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQL 550 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~---G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~ 550 (998)
|+.++++++++|+++|.+ |+ |+++|++|++++||+.+|++|+++..+.+++........+...+..+..+..++
T Consensus 9 ~~~~~~~~~~~i~~~d~~~~~g~---i~~~N~a~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 85 (176)
T 4hia_A 9 IRAVFDRSGVALTLVDMSLPEQP---VVLANPPFLRMTGYTEGQILGFNCRFLQRGDENAQARADIRDALKLGRELQVVL 85 (176)
T ss_dssp HHHHHHHCSSCCEEEETTSTTCC---EEEECHHHHHHHTCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEE
T ss_pred HHHHHhcCCCcEEEEecCCCCCc---EEEECHHHHHHHCcCHHHHcCCCcceeeCCCCCHHHHHHHHHHHHcCCceEEEE
Confidence 788999999999999997 77 999999999999999999999999889999888888888999999999999999
Q ss_pred EEEecCCcEEEEEEEEeeeccCC----EEEEEEecCCcccccc
Q 001902 551 INYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPL 589 (998)
Q Consensus 551 ~~~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~~~ 589 (998)
..+++||+.+|+.++++|+.+.+ +++++++|||++|+.+
T Consensus 86 ~~~~~dG~~~~~~~~~~pi~~~~g~~~~~~~~~~DITe~k~~e 128 (176)
T 4hia_A 86 RNYRANDEPFDNLLFLHPVGGRPDAPDYFLGSQFELGRSGNSE 128 (176)
T ss_dssp EEECTTCCEEEEEEEEEEESSBTTBCSEEEEEEEEESSSGGGH
T ss_pred EEEcCCCCEEEEEEEEEEeeCCCCCeEEEEEEEEECcHhhHHH
Confidence 99999999999999999998754 8999999999999733
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} | Back alignment and structure |
|---|
Probab=99.65 E-value=8.8e-16 Score=144.95 Aligned_cols=122 Identities=35% Similarity=0.679 Sum_probs=106.0
Q ss_pred HHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecC
Q 001902 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273 (998)
Q Consensus 194 ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kd 273 (998)
++++++++|+++|..+.+|+|+++|++|++++||+.++++|+++..+.++.........+...+..+..+..+++..+++
T Consensus 2 ~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~g~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 81 (128)
T 3t50_A 2 ASEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAIKSAIAAEKPIDIDIINYKKS 81 (128)
T ss_dssp CCCCCSSCEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEECTT
T ss_pred ccccCcccEEEecCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHhhhcCCccCHHHHHHHHHHHHcCCCceeEEEEEcCC
Confidence 46789999999997443567999999999999999999999999888888888888888889999999999999999999
Q ss_pred CCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhc
Q 001902 274 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 315 (998)
Q Consensus 274 G~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~ 315 (998)
|..+|+.+++.|+.+.+|.+.+++++++|||++|++|++...
T Consensus 82 g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k~~e~~~~~ 123 (128)
T 3t50_A 82 GEAFWNRLHISPVHNANGRLQHFVSSQLDVTLELVPRGSLEH 123 (128)
T ss_dssp CCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHC-------
T ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEEcchhhhhhhhhhh
Confidence 999999999999999999999999999999999999988543
|
| >1d06_A Nitrogen fixation regulatory protein FIXL; oxygen sensor, histidine kinase, PAS, high-resolution, two-C system, signaling protein; HET: HEM; 1.40A {Sinorhizobium meliloti} SCOP: d.110.3.2 PDB: 1ew0_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=7.8e-16 Score=146.95 Aligned_cols=122 Identities=16% Similarity=0.197 Sum_probs=97.9
Q ss_pred hhhHHHHHhhhccc-cHHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHH
Q 001902 459 VDDKVRQKEMRKGI-DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 537 (998)
Q Consensus 459 ~er~~~e~e~r~~~-~l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~ 537 (998)
+++++.|++++... .|+.++++++++|+++|.+|+ |+++|++|++||||+++|++|+++..+.+++........+.
T Consensus 2 ~~~~~~e~~l~~~~~~~~~l~~~~~d~i~~~d~~g~---i~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~ 78 (130)
T 1d06_A 2 SHMLETEDVVRARDAHLRSILDTVPDATVVSATDGT---IVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQ 78 (130)
T ss_dssp CHHHHHHHHHHHHTSCHHHHHTTCSSEEEEEETTSB---EEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHHHHHhhCcCeEEEECCCCe---EEEEcHHHHHHHCCCHHHHcCCcHHHHCCchhHHHHHHHHH
Confidence 35566666665533 489999999999999999887 99999999999999999999999888887765544444444
Q ss_pred HHHhcCCc----EEEEEEEEecCCcEEEEEEEEeeeccCC--EEEEEEecCC
Q 001902 538 AAIDNQTD----VTVQLINYTKSGKKFWNLFHLQPMRDQK--YFIGVQLDGS 583 (998)
Q Consensus 538 ~~l~~g~~----~~~e~~~~rkdG~~~wv~~~~spi~d~~--~~vgi~rDIT 583 (998)
.....+.. ...+...++|||+.+|++++++|+.+++ +++++++|||
T Consensus 79 ~~~~~~~~~~~~~~~e~~~~~kdG~~~~~~~~~~~~~~~~~~~~~~~~~DIT 130 (130)
T 1d06_A 79 RYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGERFFTGFIRDLT 130 (130)
T ss_dssp HHHHHCCCSSTTSCEEEEEECTTSCEEEEEEEEEEEEETTEEEEEEEEEECC
T ss_pred HHHhcCCccccCCeeEEEEEeCCCCEEEEEEEEEEEEECCeEEEEEEEEECc
Confidence 44444432 2457788999999999999999998766 8999999998
|
| >3f1p_B ARYL hydrocarbon receptor nuclear translocator; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.0 PDB: 3f1o_B* 3f1n_B 3h7w_B* 3h82_B* 1x0o_A 2hv1_A 4h6j_B 2b02_A* 2k7s_A 2a24_B | Back alignment and structure |
|---|
Probab=99.65 E-value=2.9e-16 Score=147.69 Aligned_cols=116 Identities=9% Similarity=0.109 Sum_probs=99.5
Q ss_pred HHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHH-cCCcEEEEEE
Q 001902 190 IVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ-NGQSYCGRLL 268 (998)
Q Consensus 190 ~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~-~g~~~~~e~~ 268 (998)
.+..+++++++.|+++|. +|+|+|+|+++++++||+++|++|+++..+++|++.......+...+. .+..+..+++
T Consensus 3 ~~~ll~e~~~d~i~~~d~---~g~i~~~n~~~~~~~G~~~~el~g~~~~~~i~p~d~~~~~~~~~~~~~~~~~~~~~e~r 79 (121)
T 3f1p_B 3 FKGLNVCQPTRFISRHNI---EGIFTFVDHRCVATVGYQPQELLGKNIVEFCHPEDQQLLRDSFQQVVKLKGQVLSVMFR 79 (121)
T ss_dssp -----CCCCCEEEEEECT---TSBEEEECTTHHHHHSCCGGGTTTSBGGGGBCTTTHHHHHHHHHHHTTSTTCCEEEEEE
T ss_pred cccceecCCCceEEEECC---CceEEEECcchhhhhCCChHHHcCCCHHHeECHHHHHHHHHHHHHHHhcCCCcccEEEE
Confidence 345688999999999998 888999999999999999999999999889999887777777777774 4557889999
Q ss_pred EEecCCCEEEEEeeeeEEeCC-CCCEEEEEEEEecchhhhH
Q 001902 269 NYKKDGTPFWNLLTIAPIKDD-EGKVLKFIGMQVEVSKHTE 308 (998)
Q Consensus 269 ~~~kdG~~~w~~~~~spi~d~-~G~v~~~v~i~~DITerk~ 308 (998)
++++||+.+|++.+..|+.|. +|.+.+++++.+|||++|+
T Consensus 80 ~~~~dG~~~w~~~~~~~~~~~~~g~~~~iv~~~~DIT~~kq 120 (121)
T 3f1p_B 80 FRSKNQEWLWMRTSSFTFQNPYSDEIEYIICTNTNVKNSSQ 120 (121)
T ss_dssp EECTTSCEEEEEEEEEEECCTTCCCCCEEEEEEEECCCC--
T ss_pred EEecCCCEEEEEEEEEEEECCCCCceeEEEEEeEEcccccC
Confidence 999999999999999999987 7889999999999999986
|
| >3f1p_B ARYL hydrocarbon receptor nuclear translocator; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.0 PDB: 3f1o_B* 3f1n_B 3h7w_B* 3h82_B* 1x0o_A 2hv1_A 4h6j_B 2b02_A* 2k7s_A 2a24_B | Back alignment and structure |
|---|
Probab=99.65 E-value=5.4e-16 Score=145.80 Aligned_cols=110 Identities=12% Similarity=0.154 Sum_probs=96.7
Q ss_pred HHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHh-cCCcEEEEEEEE
Q 001902 475 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAID-NQTDVTVQLINY 553 (998)
Q Consensus 475 ~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~-~g~~~~~e~~~~ 553 (998)
..+++++++.|+++|.+|+ |+|+|+++++++||+++|++|+++..+++|++.......+...+. .+..+..|++++
T Consensus 5 ~ll~e~~~d~i~~~d~~g~---i~~~n~~~~~~~G~~~~el~g~~~~~~i~p~d~~~~~~~~~~~~~~~~~~~~~e~r~~ 81 (121)
T 3f1p_B 5 GLNVCQPTRFISRHNIEGI---FTFVDHRCVATVGYQPQELLGKNIVEFCHPEDQQLLRDSFQQVVKLKGQVLSVMFRFR 81 (121)
T ss_dssp ---CCCCCEEEEEECTTSB---EEEECTTHHHHHSCCGGGTTTSBGGGGBCTTTHHHHHHHHHHHTTSTTCCEEEEEEEE
T ss_pred cceecCCCceEEEECCCce---EEEECcchhhhhCCChHHHcCCCHHHeECHHHHHHHHHHHHHHHhcCCCcccEEEEEE
Confidence 4578999999999999888 999999999999999999999999899999998888888888874 555789999999
Q ss_pred ecCCcEEEEEEEEeeeccC-C----EEEEEEecCCcccc
Q 001902 554 TKSGKKFWNLFHLQPMRDQ-K----YFIGVQLDGSEHLE 587 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~-~----~~vgi~rDITerk~ 587 (998)
++||+.+|++++..|+.+. + +++|+.+|||++|+
T Consensus 82 ~~dG~~~w~~~~~~~~~~~~~g~~~~iv~~~~DIT~~kq 120 (121)
T 3f1p_B 82 SKNQEWLWMRTSSFTFQNPYSDEIEYIICTNTNVKNSSQ 120 (121)
T ss_dssp CTTSCEEEEEEEEEEECCTTCCCCCEEEEEEEECCCC--
T ss_pred ecCCCEEEEEEEEEEEECCCCCceeEEEEEeEEcccccC
Confidence 9999999999999999876 2 89999999999986
|
| >1d06_A Nitrogen fixation regulatory protein FIXL; oxygen sensor, histidine kinase, PAS, high-resolution, two-C system, signaling protein; HET: HEM; 1.40A {Sinorhizobium meliloti} SCOP: d.110.3.2 PDB: 1ew0_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=5.5e-16 Score=148.02 Aligned_cols=125 Identities=22% Similarity=0.264 Sum_probs=102.0
Q ss_pred cccccccccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHH
Q 001902 175 SDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIR 254 (998)
Q Consensus 175 t~~~~~e~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~ 254 (998)
|.++++|++|++++..|+.++++++++|+++|. +|+|+++|++|++++||+.+|++|+++..++++.........+.
T Consensus 2 ~~~~~~e~~l~~~~~~~~~l~~~~~d~i~~~d~---~g~i~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~ 78 (130)
T 1d06_A 2 SHMLETEDVVRARDAHLRSILDTVPDATVVSAT---DGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQ 78 (130)
T ss_dssp CHHHHHHHHHHHHTSCHHHHHTTCSSEEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHHHHHhhCcCeEEEECC---CCeEEEEcHHHHHHHCCCHHHHcCCcHHHHCCchhHHHHHHHHH
Confidence 567788999999999999999999999999999 77899999999999999999999999888877654443334444
Q ss_pred HHHHcCCc----EEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecch
Q 001902 255 ETLQNGQS----YCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (998)
Q Consensus 255 ~~l~~g~~----~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DIT 304 (998)
.....+.. ...++..++|||+.+|++++++|+.+. ...+++++++|||
T Consensus 79 ~~~~~~~~~~~~~~~e~~~~~kdG~~~~~~~~~~~~~~~--~~~~~~~~~~DIT 130 (130)
T 1d06_A 79 RYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSG--GERFFTGFIRDLT 130 (130)
T ss_dssp HHHHHCCCSSTTSCEEEEEECTTSCEEEEEEEEEEEEET--TEEEEEEEEEECC
T ss_pred HHHhcCCccccCCeeEEEEEeCCCCEEEEEEEEEEEEEC--CeEEEEEEEEECc
Confidence 44444432 234677789999999999999999763 3456899999997
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} | Back alignment and structure |
|---|
Probab=99.62 E-value=3.2e-15 Score=161.08 Aligned_cols=112 Identities=36% Similarity=0.636 Sum_probs=100.9
Q ss_pred cHHHHHhhcCceEEEEcC---CCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEE
Q 001902 473 DLATTLERIEKNFVITDP---RLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQ 549 (998)
Q Consensus 473 ~l~~i~e~~~d~i~i~D~---~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e 549 (998)
.|+.++++++++|+++|. +|+ |++||++|++++||+++|++|+++..+.+++........+...+..+..+..+
T Consensus 64 ~~~~i~~~~~~~i~~~d~~~~~g~---i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~l~~~~~~~~e 140 (258)
T 3p7n_A 64 WVLDLIEASPIASVVSDPRLADNP---LIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREHKPVLVE 140 (258)
T ss_dssp HHHHHHHTCSSEEEEECTTSTTCC---EEEECHHHHHHHCCCGGGTTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEE
T ss_pred HHHHHHhcCCccEEEEcCCCCCCc---EEEEhHHHHHHcCCCHHHHCCCChhhccCCCCchhHHHHHHHHHHcCCCeEEE
Confidence 389999999999999999 666 99999999999999999999999999999999998888999999999999999
Q ss_pred EEEEecCCcEEEEEEEEeeeccCC----EEEEEEecCCcccc
Q 001902 550 LINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLE 587 (998)
Q Consensus 550 ~~~~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~ 587 (998)
++.+++||+.+|+.++++|+.+.+ +++++++|||++|+
T Consensus 141 ~~~~~~dG~~~~~~~~~~pi~d~~g~~~~~v~~~~DITerk~ 182 (258)
T 3p7n_A 141 ILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQP 182 (258)
T ss_dssp EEEECTTSCEEEEEEEEEEEECTTSCSEEEEEEEEEC-----
T ss_pred EEEEcCCCCEEEEeeEEEEEEcCCCCEEEEEEEeeecchhhh
Confidence 999999999999999999999765 89999999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=5.3e-16 Score=174.82 Aligned_cols=139 Identities=14% Similarity=0.132 Sum_probs=101.4
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeecccccC------------h---hHH----HHHHHHHHHHHhCCCCCc
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN------------R---NKV----HRACAEREILDMLDHPFV 727 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~------------~---~~~----~~~~~E~~il~~l~h~nI 727 (998)
|.+.+.||.|+||.||+|.+ .+|+.||||+++.....- . ... .....|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999998 569999999986432110 0 000 012346677777755544
Q ss_pred cceeEEEeeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC---
Q 001902 728 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG--- 804 (998)
Q Consensus 728 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g--- 804 (998)
....-+.... .+|||||++|++|..+... .....++.||+.+|.+||++|||||||||.|||++.+|
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 3222222222 2699999999998765421 23466789999999999999999999999999999876
Q ss_pred -------cEEEEeccCccc
Q 001902 805 -------HVSLTDFDLSCL 816 (998)
Q Consensus 805 -------~vkL~DFG~a~~ 816 (998)
.+.|+||+-+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 389999998743
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} | Back alignment and structure |
|---|
Probab=99.62 E-value=5.2e-15 Score=145.94 Aligned_cols=131 Identities=31% Similarity=0.563 Sum_probs=119.3
Q ss_pred chHHHHHHHHHhcCCcEEEEecCCCCC---ceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCc
Q 001902 186 RVSDIVKDALSTFQQTFVVSDATKPDY---PIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS 262 (998)
Q Consensus 186 ~~~~~l~~ild~~~d~i~i~D~~g~dG---~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~ 262 (998)
.++++++.+++.++++|+++|. +| +|+++|++|++++||+.++++|+++..+.++.........+...+..+..
T Consensus 22 ~~~~~~~~i~~~~~~~i~~~d~---~~~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (162)
T 3sw1_A 22 INAQLLQSMVDASNDGIVVAEK---EGDDTILIYVNAAFEYLTGYSRDEILYQDCRFLQGDDRDQLGRARIRKAMAEGRP 98 (162)
T ss_dssp CCHHHHHHHHHTCSSEEEEEEE---ETTEEEEEEECHHHHHHHTCCHHHHTTSBGGGGTTTCCCCHHHHHHHHHHHHTCC
T ss_pred chHHHHHHHHhhccCcEEEEeC---CCCccEEEEECHHHHHHHCCCHHHHcCCCcceecCCCcCHHHHHHHHHHHhcCCC
Confidence 5568899999999999999999 66 79999999999999999999999998888887777778888889999999
Q ss_pred EEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhcCCCC
Q 001902 263 YCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNG 319 (998)
Q Consensus 263 ~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~~~~~ 319 (998)
+..++...+++|..+|+.+++.|+.+.+|.+.+++++++|||++++++++++.....
T Consensus 99 ~~~~~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DiTe~k~~e~~l~~~~~~ 155 (162)
T 3sw1_A 99 CREVLRNYRKDGSAFWNELSITPVKSDFDQRTYFIGIQKDVSRQVELERELAELRAR 155 (162)
T ss_dssp EEEEEEEECTTCCEEEEEEEEEEEECSSSSCEEEEEEEEECHHHHHHHHHHHHHTC-
T ss_pred CcceEEEECCCCCEEEEEEEEEEeecCCCCEEEEEEEEEeCcHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999999999999998765444
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} | Back alignment and structure |
|---|
Probab=99.62 E-value=5.5e-15 Score=138.60 Aligned_cols=105 Identities=15% Similarity=0.144 Sum_probs=86.6
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~ 553 (998)
|+.+|++++++|+++|.+|+ |++||++|++++||+++|++|+++..+.++.... ........+..+..+..|.+++
T Consensus 13 ~~~l~e~~~d~i~~~d~~g~---i~~vN~a~~~l~Gy~~~el~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~e~~~~ 88 (117)
T 2r78_A 13 YRALFEHAIDGIFIMDAEGH---YLDVNPAICSAIGYTRDEFLALDWGVLSRGVDSG-WAAASLARIVGGEPLREERTVW 88 (117)
T ss_dssp HHHHHHHCSSEEEEECTTSB---EEEECHHHHHHHCCCHHHHTTCBTTTTTTCSTTS-HHHHHHHHHHTTCCEEEEEEEE
T ss_pred HHHHHhcCCceEEEECCCCC---EEEecHHHHHHHCcCHHHHcCCCHHHhCCccchh-HHHHHHHHHHcCCcEEEEEEEE
Confidence 78999999999999999887 9999999999999999999999877665444322 2334455666777788999999
Q ss_pred ecCCcEEEEEEEEeeeccCCEEEEEEecCC
Q 001902 554 TKSGKKFWNLFHLQPMRDQKYFIGVQLDGS 583 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~~~vgi~rDIT 583 (998)
+|||+.+|++++++|+.+. .++++++|||
T Consensus 89 ~kdG~~~~v~~~~~~~~~g-~~~~i~~DIT 117 (117)
T 2r78_A 89 TRNGDQLTVELSAHLLPDG-KILGIARDVS 117 (117)
T ss_dssp CTTSCEEEEEEEEEECTTS-CEEEEEEC--
T ss_pred ecCCCEEEEEEEEEEecCC-eEEEEEEeCC
Confidence 9999999999999999743 4889999998
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.3e-15 Score=142.93 Aligned_cols=111 Identities=14% Similarity=0.145 Sum_probs=91.6
Q ss_pred cHHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCC-HHHHHHHHHHHhcCCcEEEEEE
Q 001902 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD-PATVRKIRAAIDNQTDVTVQLI 551 (998)
Q Consensus 473 ~l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~-~~~~~~i~~~l~~g~~~~~e~~ 551 (998)
+|+.+|++++++|++ |.+|+ |++||++|++|+||+++|++|+++..+.+++.. ......+...+..+..+..|..
T Consensus 4 ~~~~~~~~~~~~i~~-~~~g~---i~~~N~a~~~l~G~~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 79 (120)
T 3mqq_A 4 DYKTAFHLAPIGLVL-SRDRV---IEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDRI 79 (120)
T ss_dssp CHHHHHHHCSSEEEE-EETTE---EEEECHHHHHHTTSCHHHHTTCBGGGGSSSHHHHHHHHHHHHHHHHHHSCEEEEEE
T ss_pred hHHHHHhcCCceEEE-ecCCE---EHHHHHHHHHHhCcCHHHhCCCchhhccCChhhHHHHHHHHHHHHhcCCcceEEEE
Confidence 489999999999975 66677 999999999999999999999998777665432 3445556667777788999999
Q ss_pred EEecCCcEEEEEEEEeeeccCC---EEEEEEecCCcccc
Q 001902 552 NYTKSGKKFWNLFHLQPMRDQK---YFIGVQLDGSEHLE 587 (998)
Q Consensus 552 ~~rkdG~~~wv~~~~spi~d~~---~~vgi~rDITerk~ 587 (998)
.+++||+.+|+.++..|+.+++ +++++++|||+||+
T Consensus 80 ~~~~dG~~~~~~~~~~~~~~~~~~~~~v~~~~DITerk~ 118 (120)
T 3mqq_A 80 MKRAGGELFWCHVTGRALDRTAPLAAGVWTFEDLSATRR 118 (120)
T ss_dssp EECTTSCEEEEEEEEEESSTTSTTSSEEEEEEESCC---
T ss_pred EEeCCCCEEEEEEEEEECCCCCCceeEEEEEEcccHhhc
Confidence 9999999999999999995544 89999999999996
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} | Back alignment and structure |
|---|
Probab=99.62 E-value=4.8e-15 Score=138.99 Aligned_cols=114 Identities=16% Similarity=0.198 Sum_probs=93.8
Q ss_pred ccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCC
Q 001902 182 KGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ 261 (998)
Q Consensus 182 ~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~ 261 (998)
+.|++++++|+.++++++++|+++|. +|+|+++|++|++++||+.+|++|+++..+.++... .........+..+.
T Consensus 4 ~~l~~se~~~~~l~e~~~d~i~~~d~---~g~i~~vN~a~~~l~Gy~~~el~g~~~~~~~~~~~~-~~~~~~~~~~~~~~ 79 (117)
T 2r78_A 4 ENLYFQSNAYRALFEHAIDGIFIMDA---EGHYLDVNPAICSAIGYTRDEFLALDWGVLSRGVDS-GWAAASLARIVGGE 79 (117)
T ss_dssp CSHHHHHHHHHHHHHHCSSEEEEECT---TSBEEEECHHHHHHHCCCHHHHTTCBTTTTTTCSTT-SHHHHHHHHHHTTC
T ss_pred hHHHHhHHHHHHHHhcCCceEEEECC---CCCEEEecHHHHHHHCcCHHHHcCCCHHHhCCccch-hHHHHHHHHHHcCC
Confidence 45788999999999999999999998 788999999999999999999999987766544332 22334556677777
Q ss_pred cEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecch
Q 001902 262 SYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (998)
Q Consensus 262 ~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DIT 304 (998)
.+..+.+.++|||+.+|+.++++|+. +|. ++++++|||
T Consensus 80 ~~~~e~~~~~kdG~~~~v~~~~~~~~--~g~---~~~i~~DIT 117 (117)
T 2r78_A 80 PLREERTVWTRNGDQLTVELSAHLLP--DGK---ILGIARDVS 117 (117)
T ss_dssp CEEEEEEEECTTSCEEEEEEEEEECT--TSC---EEEEEEC--
T ss_pred cEEEEEEEEecCCCEEEEEEEEEEec--CCe---EEEEEEeCC
Confidence 88889999999999999999999985 565 678899998
|
| >2vv6_A FIXL, sensor protein FIXL; signaling protein, transferase, phosphoprotein, nitrogen FIX PER-ARNT-SIM, metal-binding, PAS, iron, heme; HET: HEM; 1.5A {Bradyrhizobium japonicum} PDB: 1xj6_A* 1xj4_A* 2vv7_A* 2vv8_A* 1lsw_A* 1dp8_A* 1dp9_A* 1drm_A* 1lsv_A* 1dp6_A* 1lsx_A* 1lt0_A* 1y28_A* 2cmn_A* 1xj3_A* 1xj2_A* 2owh_A* 2owj_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.6e-15 Score=142.27 Aligned_cols=105 Identities=19% Similarity=0.211 Sum_probs=81.9
Q ss_pred hcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCc----EEEEEEEEec
Q 001902 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD----VTVQLINYTK 555 (998)
Q Consensus 480 ~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~----~~~e~~~~rk 555 (998)
+++++|+++|.+|+ |+++|++|++||||+++|++|+++..+.++.........+......+.. ...+...++|
T Consensus 1 ~~~d~i~~~d~~g~---i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (119)
T 2vv6_A 1 TIPDAMIVIDGHGI---IQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRR 77 (119)
T ss_dssp -CCCEEEEEETTSB---EEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECT
T ss_pred CCcceEEEECCCCe---EEEEhHHHHHHhCCCHHHHcCCCHHHhCCchHHHHHHHHHHHHhcCCCcccCCCceEEEEEeC
Confidence 36899999999887 9999999999999999999999988887766544444444444444332 3457788999
Q ss_pred CCcEEEEEEEEeeeccCC--EEEEEEecCCcccc
Q 001902 556 SGKKFWNLFHLQPMRDQK--YFIGVQLDGSEHLE 587 (998)
Q Consensus 556 dG~~~wv~~~~spi~d~~--~~vgi~rDITerk~ 587 (998)
||+.+|++++++|+.+++ +++++++|||+||+
T Consensus 78 dG~~~~~~~~~~~~~~~~~~~~~~~~~DITerk~ 111 (119)
T 2vv6_A 78 DGTTFPMHLSIGEMQSGGEPYFTGFVRDLTEHQQ 111 (119)
T ss_dssp TSCEEEEEEEEEEEEETTEEEEEEEEEECC----
T ss_pred CCCEEEEEEEEEEEEECCeEEEEEEEEEcHHHHH
Confidence 999999999999998766 89999999999997
|
| >3f1p_A Endothelial PAS domain-containing protein 1; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.7 PDB: 3f1o_A* 3f1n_A 3h7w_A* 3h82_A* 1p97_A 2a24_A 4h6j_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.4e-15 Score=141.83 Aligned_cols=105 Identities=16% Similarity=0.135 Sum_probs=96.8
Q ss_pred hcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcE
Q 001902 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKK 559 (998)
Q Consensus 480 ~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rkdG~~ 559 (998)
++++.|+++|.+|+ |+|+|+++++++||+++|++|+++..+++|++.......+...+..+..+..+++++++||+.
T Consensus 7 ~~~~~i~~~d~~g~---i~~~n~~~~~~~Gy~~~el~g~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~ 83 (117)
T 3f1p_A 7 DSKTFLSEHSMDMK---FTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGY 83 (117)
T ss_dssp GGGEEEEEECTTCB---EEEECTHHHHHHCCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHHHHSEEECCCEEEECTTSSE
T ss_pred CCccEEEEECCCce---EEEECcChhhhhCCCHHHHcCCchhheECHHHHHHHHHHHHHHHhCCCeeeeEEEEEecCCCE
Confidence 45789999999888 999999999999999999999999999999998888888888888888888899999999999
Q ss_pred EEEEEEEeeeccC-C----EEEEEEecCCcccc
Q 001902 560 FWNLFHLQPMRDQ-K----YFIGVQLDGSEHLE 587 (998)
Q Consensus 560 ~wv~~~~spi~d~-~----~~vgi~rDITerk~ 587 (998)
+|++++..|+.+. + +++++.+|||+||+
T Consensus 84 ~w~~~~~~~~~d~~~g~~~~iv~~~~DITer~~ 116 (117)
T 3f1p_A 84 VWLETQGTVIYNPRNLQPQCIMCVNYVLSEIEK 116 (117)
T ss_dssp EEEEEEEEEEEETTTTEEEEEEEEEEECSCCBC
T ss_pred EEEEEeeEEEECCCCCCceEEEEEeeecccccc
Confidence 9999999999976 3 78999999999986
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.4e-15 Score=142.71 Aligned_cols=115 Identities=15% Similarity=0.153 Sum_probs=94.0
Q ss_pred HHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCC-hHHHHHHHHHHHcCCcEEEEEE
Q 001902 190 IVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTD-PEDVAKIRETLQNGQSYCGRLL 268 (998)
Q Consensus 190 ~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~-~~~~~~i~~~l~~g~~~~~e~~ 268 (998)
.|+.+|++++++|++ |. +|+|+++|++|++++||+.+|++|+++..+++++.. ......+...+..+..+..+++
T Consensus 4 ~~~~~~~~~~~~i~~-~~---~g~i~~~N~a~~~l~G~~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 79 (120)
T 3mqq_A 4 DYKTAFHLAPIGLVL-SR---DRVIEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDRI 79 (120)
T ss_dssp CHHHHHHHCSSEEEE-EE---TTEEEEECHHHHHHTTSCHHHHTTCBGGGGSSSHHHHHHHHHHHHHHHHHHSCEEEEEE
T ss_pred hHHHHHhcCCceEEE-ec---CCEEHHHHHHHHHHhCcCHHHhCCCchhhccCChhhHHHHHHHHHHHHhcCCcceEEEE
Confidence 478899999999964 66 788999999999999999999999998877665332 3344556667777888999999
Q ss_pred EEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHH
Q 001902 269 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEG 309 (998)
Q Consensus 269 ~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~ 309 (998)
.+++||+.+|+.++..|+ +.+|...+++++++|||++|++
T Consensus 80 ~~~~dG~~~~~~~~~~~~-~~~~~~~~~v~~~~DITerk~~ 119 (120)
T 3mqq_A 80 MKRAGGELFWCHVTGRAL-DRTAPLAAGVWTFEDLSATRRV 119 (120)
T ss_dssp EECTTSCEEEEEEEEEES-STTSTTSSEEEEEEESCC----
T ss_pred EEeCCCCEEEEEEEEEEC-CCCCCceeEEEEEEcccHhhcc
Confidence 999999999999999998 5666677889999999999975
|
| >3f1p_A Endothelial PAS domain-containing protein 1; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.7 PDB: 3f1o_A* 3f1n_A 3h7w_A* 3h82_A* 1p97_A 2a24_A 4h6j_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.1e-15 Score=142.62 Aligned_cols=108 Identities=15% Similarity=0.156 Sum_probs=98.7
Q ss_pred cCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCCEE
Q 001902 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 277 (998)
Q Consensus 198 ~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 277 (998)
+++.|+++|. +|+|+|+|+++++++||+++|++|+++..+++|++.......+...+..+..+..+++++++||+.+
T Consensus 8 ~~~~i~~~d~---~g~i~~~n~~~~~~~Gy~~~el~g~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~~ 84 (117)
T 3f1p_A 8 SKTFLSEHSM---DMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYV 84 (117)
T ss_dssp GGEEEEEECT---TCBEEEECTHHHHHHCCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHHHHSEEECCCEEEECTTSSEE
T ss_pred CccEEEEECC---CceEEEECcChhhhhCCCHHHHcCCchhheECHHHHHHHHHHHHHHHhCCCeeeeEEEEEecCCCEE
Confidence 4678888888 7889999999999999999999999998899988887777888888888888888999999999999
Q ss_pred EEEeeeeEEeCC-CCCEEEEEEEEecchhhhH
Q 001902 278 WNLLTIAPIKDD-EGKVLKFIGMQVEVSKHTE 308 (998)
Q Consensus 278 w~~~~~spi~d~-~G~v~~~v~i~~DITerk~ 308 (998)
|+.++..|+.|+ +|.+.+++++.+|||++|+
T Consensus 85 w~~~~~~~~~d~~~g~~~~iv~~~~DITer~~ 116 (117)
T 3f1p_A 85 WLETQGTVIYNPRNLQPQCIMCVNYVLSEIEK 116 (117)
T ss_dssp EEEEEEEEEEETTTTEEEEEEEEEEECSCCBC
T ss_pred EEEEeeEEEECCCCCCceEEEEEeeecccccc
Confidence 999999999987 7889999999999999985
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.6e-14 Score=134.08 Aligned_cols=127 Identities=75% Similarity=1.225 Sum_probs=107.5
Q ss_pred chHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEE
Q 001902 186 RVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG 265 (998)
Q Consensus 186 ~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 265 (998)
++++.++.++++++++++++|..+.+|+|+++|+++++++||+.++++|+++..+.++.........+...+..+..+..
T Consensus 3 ~~~~~~~~~~~~~~~~i~~~d~~d~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (130)
T 2z6d_A 3 RVSQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGPDTDKNEVAKIRDCVKNGKSYCG 82 (130)
T ss_dssp ----CHHHHHHHTTCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEE
T ss_pred hHHHHHHHHHHhcccceeeeeccCCCCcEEEecHHHHHHhCcCHHHHcCCChhhccCCCCCchHHHHHHHHHHcCCccee
Confidence 45567899999999999999922227789999999999999999999999998888887777777888888899988888
Q ss_pred EEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHH
Q 001902 266 RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKD 312 (998)
Q Consensus 266 e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~ 312 (998)
++...+++|..+|+.+++.|+.+.+|.+.+++++++|||+++++|++
T Consensus 83 ~~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~~e~e 129 (130)
T 2z6d_A 83 RLLNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEVSKYTEGVND 129 (130)
T ss_dssp EEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCTTC-----
T ss_pred EEEEEcCCCcEEEEEEEEEEEECCCCCeeEEEEEEecchHHHHhhcc
Confidence 99999999999999999999999999999999999999999988764
|
| >3nja_A Probable ggdef family protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; 2.37A {Chromobacterium violaceum} | Back alignment and structure |
|---|
Probab=99.60 E-value=3.5e-15 Score=139.19 Aligned_cols=123 Identities=11% Similarity=0.015 Sum_probs=94.5
Q ss_pred cccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcC--CCCCcccCCCCChHHHHHHHHHHHcC
Q 001902 183 GLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVG--RNCRFLQGAGTDPEDVAKIRETLQNG 260 (998)
Q Consensus 183 ~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG--~~~~~l~~~~~~~~~~~~i~~~l~~g 260 (998)
+|++++++|+.+++.++++++++|. +|.++++|+++++++||+.++++| ..+..++++++.......+...+..+
T Consensus 1 al~~~~~~l~~~~~~~~~~i~~~d~---~~~~~~~n~~~~~~~G~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 77 (125)
T 3nja_A 1 SNAMAEKLLHTAESDAGIGSWVLHM---ESGRLEWSQAVHDIFGTDSATFDATEDAYFQRVHPDDRARVRRELDRHVLGD 77 (125)
T ss_dssp ----------------CCEEEEEET---TTTEEEECHHHHHHHTCCTTTCCCBHHHHHHHBCTTTHHHHHHHHHHHHHSC
T ss_pred CcHHHHHHHHHHHHhCCeeEEEEEc---CCCcEEECHHHHHHhCCCcccccccHHHHHhhcChhHHHHHHHHHHHHHhcC
Confidence 3667888999999999999999999 677999999999999999999999 44445677777777777888888888
Q ss_pred CcEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhH
Q 001902 261 QSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308 (998)
Q Consensus 261 ~~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~ 308 (998)
..+..+++.++++|..+|+.++..|+.+.+|.+.+++++++|||++|+
T Consensus 78 ~~~~~e~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~g~~~DITe~k~ 125 (125)
T 3nja_A 78 RPFDVEYRIVRPDGQVRELLERNHIQRQASGQVDHLWGTVIDMTEHKQ 125 (125)
T ss_dssp CCEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCC---
T ss_pred CCceEEEEEECCCCCEEEEEEeeEEEECCCCCEEEEEEEEEecccccC
Confidence 889999999999999999999999999999999999999999999985
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=4.5e-15 Score=146.87 Aligned_cols=123 Identities=48% Similarity=0.814 Sum_probs=105.6
Q ss_pred HHHHHhhhcc-ccHHHHHhhcCceEEEEcC---CCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHH
Q 001902 462 KVRQKEMRKG-IDLATTLERIEKNFVITDP---RLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 537 (998)
Q Consensus 462 ~~~e~e~r~~-~~l~~i~e~~~d~i~i~D~---~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~ 537 (998)
+..+++++.. ..|+.++++++++|+++|. +|+ |+++|++|++++||+.++++|+++..+.+++........+.
T Consensus 24 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~d~~~~~g~---i~~~N~~~~~l~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~ 100 (166)
T 3ue6_A 24 SKANRILEDPDYSLVKALQMAQQNFVITDASLPDNP---IVYASRGFLTLTGYSLDQILGRNCRFLQGPETDPRAVDKIR 100 (166)
T ss_dssp -------CCCCCHHHHHHHHTTSCEEEEETTSTTCC---EEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHHhcCCceEEEEEccCCCCc---EEEECHHHHHHhCcCHHHHcCCCHhheeCCCCCHHHHHHHH
Confidence 3334444332 3489999999999999999 688 99999999999999999999999888888888888888889
Q ss_pred HHHhcCCcEEEEEEEEecCCcEEEEEEEEeeeccCC----EEEEEEecCCcccc
Q 001902 538 AAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLE 587 (998)
Q Consensus 538 ~~l~~g~~~~~e~~~~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~ 587 (998)
..+..+..+..+....++||..+|+.++++|+.+.+ +++++++|||++|+
T Consensus 101 ~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k~ 154 (166)
T 3ue6_A 101 NAITKGVDTSVCLLNYRQDGTTFWNLFFVAGLRDSKGNIVNYVGVQSKVSEDYA 154 (166)
T ss_dssp HHHHHTCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEECCBCCHHHH
T ss_pred HHHhcCCceEEEEEEEcCCCCEEEEEEEEEeeeCCCCCEEEEEEEEEechHHHH
Confidence 999999999999999999999999999999998754 78999999999986
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.9e-14 Score=132.03 Aligned_cols=114 Identities=41% Similarity=0.829 Sum_probs=101.7
Q ss_pred HHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecC
Q 001902 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273 (998)
Q Consensus 194 ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kd 273 (998)
++++++++++++|....+|+|+++|++|++++||+.++++|+++..+.++.........+...+..+..+..+++.++++
T Consensus 2 ~l~~~~~~i~~~d~~~~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (115)
T 4eet_B 2 SPEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKIRDAIRDQRETTVQLINYTKS 81 (115)
T ss_dssp ---CCCCSEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEECTT
T ss_pred ccccCCCcEEEEcCCCCCCcEEEEcHHHHHHHCcCHHHHhCCCHHHhcCCCCChHHHHHHHHHHHcCCCcceEEEEecCC
Confidence 47889999999997333456999999999999999999999998888888888888888899999999999999999999
Q ss_pred CCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhh
Q 001902 274 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHT 307 (998)
Q Consensus 274 G~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk 307 (998)
|..+|+.+++.|+.+.+|.+.+++++++|||+++
T Consensus 82 g~~~~~~~~~~~~~~~~g~~~~~~~~~~DITer~ 115 (115)
T 4eet_B 82 GKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDHV 115 (115)
T ss_dssp CCEEEEEEEEEEEECTTSCEEEEEEEEEECSCCC
T ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEeecccC
Confidence 9999999999999999999999999999999874
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} | Back alignment and structure |
|---|
Probab=99.58 E-value=2e-14 Score=132.56 Aligned_cols=121 Identities=17% Similarity=0.291 Sum_probs=108.1
Q ss_pred cchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEE
Q 001902 185 PRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYC 264 (998)
Q Consensus 185 ~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~ 264 (998)
.++++.++.++++++++++++|. +|+|+++|+++++++||+.++++|+++..+.+++........+...+..+..+.
T Consensus 3 ~~~~~~~~~~~~~~~~~i~~~d~---~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (124)
T 3lyx_A 3 VDILKQRAKAFDYVFDAIVVTDL---QGFIIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSEVISAVENQGKWT 79 (124)
T ss_dssp -CHHHHHHHGGGTCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTHHHHHHHHHHHHHHTSCEE
T ss_pred hhHHHHHHHHHhhcCceEEEECC---CCcEeehhhHHHHHhCCCHHHHcCCCHHHhcCcchhhHHHHHHHHHHHcCCccc
Confidence 35668899999999999999998 777999999999999999999999998877777666666777888888999999
Q ss_pred EEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhH
Q 001902 265 GRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308 (998)
Q Consensus 265 ~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~ 308 (998)
.+....+++|..+|+.++..|+.+.+|.+.+++++++|||++|+
T Consensus 80 ~~~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~ 123 (124)
T 3lyx_A 80 GEIRMLHKDGHIGWIESMCVPIYGENYQMVGALGINRDITKRKK 123 (124)
T ss_dssp EEEEEECTTSCEEEEEEEEEEEECSTTCEEEEEEEEEECSCC--
T ss_pred ceEEEEccCCCEEEEEEEEEEEECCCCCEEEEEEEEecchhhhc
Confidence 99999999999999999999999999999999999999999986
|
| >2vv6_A FIXL, sensor protein FIXL; signaling protein, transferase, phosphoprotein, nitrogen FIX PER-ARNT-SIM, metal-binding, PAS, iron, heme; HET: HEM; 1.5A {Bradyrhizobium japonicum} PDB: 1xj6_A* 1xj4_A* 2vv7_A* 2vv8_A* 1lsw_A* 1dp8_A* 1dp9_A* 1drm_A* 1lsv_A* 1dp6_A* 1lsx_A* 1lt0_A* 1y28_A* 2cmn_A* 1xj3_A* 1xj2_A* 2owh_A* 2owj_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=6.7e-15 Score=137.92 Aligned_cols=113 Identities=18% Similarity=0.232 Sum_probs=80.5
Q ss_pred hcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCc----EEEEEEEEec
Q 001902 197 TFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS----YCGRLLNYKK 272 (998)
Q Consensus 197 ~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~~~~k 272 (998)
+++++|+++|. +|+|+++|++|++++||+.+|++|+++..+.++.........+......+.. ...++..++|
T Consensus 1 ~~~d~i~~~d~---~g~i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (119)
T 2vv6_A 1 TIPDAMIVIDG---HGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRR 77 (119)
T ss_dssp -CCCEEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECT
T ss_pred CCcceEEEECC---CCeEEEEhHHHHHHhCCCHHHHcCCCHHHhCCchHHHHHHHHHHHHhcCCCcccCCCceEEEEEeC
Confidence 36899999999 7889999999999999999999999988777665443333334444444432 2346677899
Q ss_pred CCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhh
Q 001902 273 DGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (998)
Q Consensus 273 dG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~ 314 (998)
||+.+|++++++|+.+. ...+++++++|||++|++|++++
T Consensus 78 dG~~~~~~~~~~~~~~~--~~~~~~~~~~DITerk~~e~~l~ 117 (119)
T 2vv6_A 78 DGTTFPMHLSIGEMQSG--GEPYFTGFVRDLTEHQQTQARLQ 117 (119)
T ss_dssp TSCEEEEEEEEEEEEET--TEEEEEEEEEECC----------
T ss_pred CCCEEEEEEEEEEEEEC--CeEEEEEEEEEcHHHHHHHHHHH
Confidence 99999999999999764 34578999999999999998864
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=2.8e-14 Score=130.82 Aligned_cols=107 Identities=82% Similarity=1.237 Sum_probs=97.1
Q ss_pred HHhhcCceEEEEcC---CCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001902 477 TLERIEKNFVITDP---RLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (998)
Q Consensus 477 i~e~~~d~i~i~D~---~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~ 553 (998)
++++++++|+++|. +|+ |+++|++|++++||+.+|++|+++..+.+++........+...+..+..+..+.+..
T Consensus 2 ~l~~~~~~i~~~d~~~~~g~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (115)
T 4eet_B 2 SPEFIEKNFVITDPRLPDNP---IIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKIRDAIRDQRETTVQLINY 78 (115)
T ss_dssp ---CCCCSEEEECTTSTTCC---EEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEE
T ss_pred ccccCCCcEEEEcCCCCCCc---EEEEcHHHHHHHCcCHHHHhCCCHHHhcCCCCChHHHHHHHHHHHcCCCcceEEEEe
Confidence 57899999999999 888 999999999999999999999998888888888888888899999999999999999
Q ss_pred ecCCcEEEEEEEEeeeccCC----EEEEEEecCCccc
Q 001902 554 TKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHL 586 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk 586 (998)
+++|+.+|+.++++|+.+.+ +++++++|||+|+
T Consensus 79 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DITer~ 115 (115)
T 4eet_B 79 TKSGKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDHV 115 (115)
T ss_dssp CTTCCEEEEEEEEEEEECTTSCEEEEEEEEEECSCCC
T ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeecccC
Confidence 99999999999999998765 7899999999985
|
| >3k3c_A Protein RV1364C/MT1410; sensor, PAS, signal transduction, fatty-acid binding, sigma regulator, signaling protein; HET: PLM; 1.62A {Mycobacterium tuberculosis} PDB: 3k3d_A | Back alignment and structure |
|---|
Probab=99.57 E-value=3.7e-15 Score=146.81 Aligned_cols=126 Identities=10% Similarity=0.095 Sum_probs=106.3
Q ss_pred cchHHHHHHHHHhcCCcEEEEe-cCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcE
Q 001902 185 PRVSDIVKDALSTFQQTFVVSD-ATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSY 263 (998)
Q Consensus 185 ~~~~~~l~~ild~~~d~i~i~D-~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~ 263 (998)
..+++.|+.++++++++|+++| . +|+|+++|++|++++||+ +++|+++..++++.........+..++..|...
T Consensus 13 ~~~~~~~~~~~~~~~~~i~~~d~~---~~~i~~~N~~~~~~~g~~--~~~G~~~~~~~~~~~~~~~~~~~~~~~~~g~~~ 87 (158)
T 3k3c_A 13 VGAAEDVRRIFEHIPAILVGLEGP---DHRFVAVNAAYRGFSPLL--DTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQ 87 (158)
T ss_dssp TCCHHHHHHHHHHCSSEEEEEETT---TTEEEEECHHHHHHCTTC--CSTTSBHHHHSGGGGGTTHHHHHHHHHHHCCCE
T ss_pred HHHHHHHHHHHhcCCceEEEEECC---CcEeHHHHHHHHHHcCCc--hhcCCcHHHhCCchhHHHHHHHHHHHHHhCCcc
Confidence 4556789999999999999999 8 888999999999999999 999999888877766555677788888888875
Q ss_pred EEEEE-E--Ee-cC-CCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhc
Q 001902 264 CGRLL-N--YK-KD-GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 315 (998)
Q Consensus 264 ~~e~~-~--~~-kd-G~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~ 315 (998)
..+.. . .+ .+ |..+|+.++++|+++.+|.+.|++++++|||++|++|++++.
T Consensus 88 ~~~~~~~~~~~~~~~g~~~~~~~~~~pi~~~~g~~~g~~~~~~DITe~k~~e~~l~~ 144 (158)
T 3k3c_A 88 SGSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRARQAAEA 144 (158)
T ss_dssp EEEEEEEEEESSSSCEEEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHHHHHHHHH
T ss_pred cccceeEEeccCCCCcceEEEEEEEEEeECCCCCEEEEEEEEEehhHHHHHHHHHHH
Confidence 54322 2 22 22 777899999999999999999999999999999999998753
|
| >3mr0_A Sensory box histidine kinase/response regulator; PAS fold, structural genomics, PSI-2; HET: PG5; 1.49A {Burkholderia thailandensis} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.6e-14 Score=140.25 Aligned_cols=123 Identities=15% Similarity=0.222 Sum_probs=106.2
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCC--CCccccCCCCCHHHHHHHHHHHhcCCcEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGR--NCRFLQGPETDPATVRKIRAAIDNQTDVTVQLI 551 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~--~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~ 551 (998)
|+.+++.+++++|.+|..+. ++++|+++++++||+.+++.+. .+..++||++...+...+...+..+..+..|++
T Consensus 11 l~~~~~~~~~g~w~~d~~~~---~~~~s~~~~~~~G~~~~~~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~~e~r 87 (142)
T 3mr0_A 11 FQLAVSGASAGLWDWNPKTG---AMYLSPHFKKIMGYEDHELPDEITGHRESIHPDDRARVLAALKAHLEHRDTYDVEYR 87 (142)
T ss_dssp HHHHHHHTTCEEEEECTTTC---CEEECHHHHHHTTCCGGGSCSEEC---CCBCTTTHHHHHHHHHHHHHHCCCEEEEEE
T ss_pred HHHHHHhCCcEEEEEEcCCC---eEEECHHHHHHhCCCccccCCCHHHHHhhcCHHHHHHHHHHHHHHHhCCCceEEEEE
Confidence 89999999999999999877 9999999999999999998873 356688999988888889999988888999999
Q ss_pred EEecCCcEEEEEEEEeeeccCC----EEEEEEecCCccccccccCcchhhhhHHHHHH
Q 001902 552 NYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPLRNSIPEATAEESEKLV 605 (998)
Q Consensus 552 ~~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~~~~~~~~e~~~~~~~~~~ 605 (998)
++++||+.+|+..+..|++|.+ .++|+++|||+||+ .+++++++++.+
T Consensus 88 ~~~~~G~~~w~~~~~~~~~d~~g~~~~~~G~~~DITerk~------~E~~L~~~~~~l 139 (142)
T 3mr0_A 88 VRTRSGDFRWIQSRGQALWNSAGEPYRMVGWIMDVTDRKR------DEDALRVSREEL 139 (142)
T ss_dssp EECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHH------HHHHHHHHHHHH
T ss_pred EECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEcCchHHH------HHHHHHHHHHHH
Confidence 9999999999999999998875 79999999999996 445555555544
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.1e-14 Score=137.29 Aligned_cols=109 Identities=45% Similarity=0.827 Sum_probs=99.9
Q ss_pred HHhhcCceEEEEcC---CCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001902 477 TLERIEKNFVITDP---RLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (998)
Q Consensus 477 i~e~~~d~i~i~D~---~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~ 553 (998)
++++++++|+++|. +|+ |+++|++|++++||+.++++|+++..+.+++........+...+..+..+..+....
T Consensus 2 ~~~~~~~~i~~~d~~~~~g~---i~~~N~~~~~l~g~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 78 (128)
T 3t50_A 2 ASEFTLMPMLITNPHLPDNP---IVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAIKSAIAAEKPIDIDIINY 78 (128)
T ss_dssp CCCCCSSCEEEECTTSTTCC---EEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEE
T ss_pred ccccCcccEEEecCCCCCCc---EEEEcHHHHHHhCcCHHHHcCCCHhhhcCCccCHHHHHHHHHHHHcCCCceeEEEEE
Confidence 46889999999999 677 999999999999999999999998888888888888888999999999999999999
Q ss_pred ecCCcEEEEEEEEeeeccCC----EEEEEEecCCccccc
Q 001902 554 TKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEP 588 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~~ 588 (998)
+++|..+|+.+++.|+.+.+ +++++++|||++|+.
T Consensus 79 ~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k~~ 117 (128)
T 3t50_A 79 KKSGEAFWNRLHISPVHNANGRLQHFVSSQLDVTLELVP 117 (128)
T ss_dssp CTTCCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHC-
T ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEEcchhhhh
Confidence 99999999999999998764 889999999999973
|
| >3mxq_A Sensor protein; PSI2, MCSG, structural genomics, protein structure initiativ midwest center for structural genomics; 2.78A {Vibrio cholerae o1 biovar el tor} | Back alignment and structure |
|---|
Probab=99.56 E-value=4.1e-15 Score=146.76 Aligned_cols=125 Identities=14% Similarity=0.177 Sum_probs=100.2
Q ss_pred ccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCC
Q 001902 182 KGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ 261 (998)
Q Consensus 182 ~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~ 261 (998)
+++++++.+|+.+++++++||+++|. +|+|++||+++++++|++.+|++|+++.+++++ ....+...+..++..|.
T Consensus 15 ~~~~~~~~~l~~il~~~~~gi~v~D~---~g~I~~~N~a~~~~~G~~~~eviG~~~~~~~p~-~~~~~~~~l~~vl~~G~ 90 (152)
T 3mxq_A 15 NAMAKSRLLLSELLDQLSFALCIVRN---DYVIVKVNEYFESRVIFDGETMQGKNILELFPE-SADYLKRKIDTALVIES 90 (152)
T ss_dssp HHHHHHHHHHHHHHHHHCCEEEEEET---TSBEEEECHHHHHTSSSCHHHHTTSBHHHHSGG-GHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHHHHHhcCCCCEEEEcC---CCEEEEECHHHHHHHCcCHHHHCCCCHHHhcCC-hHHHHHHHHHHHHhcCC
Confidence 35778888999999999999999999 888999999999999999999999999988887 55556667888898887
Q ss_pred cEEEE---------EE---EEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHH
Q 001902 262 SYCGR---------LL---NYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGA 310 (998)
Q Consensus 262 ~~~~e---------~~---~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E 310 (998)
+.... +. ...++|..+|..++++|+.|++|++.|++++++|||+++.+.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ti~Pl~d~~G~v~gv~~ii~DVTe~~~a~ 151 (152)
T 3mxq_A 91 SSFSSWEQKPHLLPFKSSRPVSGEEEQMYQNLEVIPIHSEDGTIEHVCLCVYDVTIQASQQ 151 (152)
T ss_dssp CEEEECCSSSCSSCC----------CCEEEEEEEEEEECTTSCEEEEEEEEEEEECC----
T ss_pred ceeeecccccccccccccCCCCCCCcEEEEEEEEEEEECCCCCEEEEEEEEEECCHHHhcc
Confidence 63221 11 124677888999999999999999999999999999998753
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.2e-14 Score=137.07 Aligned_cols=124 Identities=17% Similarity=0.159 Sum_probs=95.3
Q ss_pred cccccccccccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhc--CCCCCcccCCCCChHHH
Q 001902 173 EMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVV--GRNCRFLQGAGTDPEDV 250 (998)
Q Consensus 173 dit~~~~~e~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEli--G~~~~~l~~~~~~~~~~ 250 (998)
++|++++++++|+++++.|+.++++++++|+++|. +|+|+++|++|++++||+.+|++ |+++..+.+ ......
T Consensus 1 ~~t~r~~~e~~L~~~~~~~~~l~e~~~~~i~~~d~---~g~i~~~N~a~~~~~G~~~~el~g~g~~~~~~~~--~~~~~~ 75 (126)
T 3bwl_A 1 SNAERKRREKRLEETSSRLEALFENSPDMIDVLDA---DGTICEVNQRFCAELGYDESEVLGRSIWEFDLMF--DAEDVQ 75 (126)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHCSSEEEEECT---TCBEEEECHHHHHHHTCCGGGTTTSBGGGTBTTC--CHHHHH
T ss_pred CchhHHHHHHHHHHHHHHHHHHHhhCCcEEEEEcC---CCCEEEEcHHHHHHhCCCHHHHhhCCCchhhccC--CHHHHH
Confidence 47899999999999999999999999999999998 78899999999999999999994 676665655 212121
Q ss_pred HHHHHHHHcCCcEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecch
Q 001902 251 AKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (998)
Q Consensus 251 ~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DIT 304 (998)
..+ .....+.....+.+++++||+.+|+.++..++.+ +|. .+++++++|||
T Consensus 76 ~~~-~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~-~~~-~~~~~~~~DIT 126 (126)
T 3bwl_A 76 TQL-SGFSVDERRKFEGLYERRDGSTMSVEVHLLRFNL-EGE-DRFLAISRDIT 126 (126)
T ss_dssp HHH-HTCCTTCEEEEEEEEECTTSCEEEEEEEEEEEEE-TTE-EEEEEEEEEC-
T ss_pred HHH-HHHhcCCCcceEEEEEeCCCCEEEEEEEeEEEec-CCc-EEEEEEEEeCC
Confidence 111 1112334455667778999999999988888743 343 46789999998
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} | Back alignment and structure |
|---|
Probab=99.55 E-value=3.1e-14 Score=134.26 Aligned_cols=121 Identities=13% Similarity=0.097 Sum_probs=92.4
Q ss_pred CchhhHHHHHhhhccc-cHHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhh--cCCCCccccCCCCCHHHH
Q 001902 457 DSVDDKVRQKEMRKGI-DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEI--LGRNCRFLQGPETDPATV 533 (998)
Q Consensus 457 di~er~~~e~e~r~~~-~l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEl--iG~~~~~l~~p~~~~~~~ 533 (998)
++++|++.|++++... .|+.++++++++|+++|.+|+ |++||++|++++||+.+|+ +|++...+.+ +.....
T Consensus 1 ~~t~r~~~e~~L~~~~~~~~~l~e~~~~~i~~~d~~g~---i~~~N~a~~~~~G~~~~el~g~g~~~~~~~~--~~~~~~ 75 (126)
T 3bwl_A 1 SNAERKRREKRLEETSSRLEALFENSPDMIDVLDADGT---ICEVNQRFCAELGYDESEVLGRSIWEFDLMF--DAEDVQ 75 (126)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHCSSEEEEECTTCB---EEEECHHHHHHHTCCGGGTTTSBGGGTBTTC--CHHHHH
T ss_pred CchhHHHHHHHHHHHHHHHHHHHhhCCcEEEEEcCCCC---EEEEcHHHHHHhCCCHHHHhhCCCchhhccC--CHHHHH
Confidence 4678888888887643 489999999999999999777 9999999999999999999 4666665655 222222
Q ss_pred HHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEeeeccCC--EEEEEEecCC
Q 001902 534 RKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK--YFIGVQLDGS 583 (998)
Q Consensus 534 ~~i~~~l~~g~~~~~e~~~~rkdG~~~wv~~~~spi~d~~--~~vgi~rDIT 583 (998)
..+. ....+.....+..+.++||+.+|++++..++.+++ .++++++|||
T Consensus 76 ~~~~-~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~~~~~~~~~~~~DIT 126 (126)
T 3bwl_A 76 TQLS-GFSVDERRKFEGLYERRDGSTMSVEVHLLRFNLEGEDRFLAISRDIT 126 (126)
T ss_dssp HHHH-TCCTTCEEEEEEEEECTTSCEEEEEEEEEEEEETTEEEEEEEEEEC-
T ss_pred HHHH-HHhcCCCcceEEEEEeCCCCEEEEEEEeEEEecCCcEEEEEEEEeCC
Confidence 2211 12234445677788899999999999998886665 7899999998
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=7.8e-14 Score=132.76 Aligned_cols=136 Identities=85% Similarity=1.246 Sum_probs=117.1
Q ss_pred HHHHHhhcCceEEEEcC---CCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEE
Q 001902 474 LATTLERIEKNFVITDP---RLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQL 550 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~---~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~ 550 (998)
|+.++++++++++++|. +|. |+++|+++++++||+.++++|+++..+.+++........+...+..+..+..+.
T Consensus 4 l~~~~~~~~~~i~~~d~~~~~~~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (146)
T 2v0u_A 4 LATTLERIEKNFVITDPRLPDNP---IIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATVRKIRDAIDNQTEVTVQL 80 (146)
T ss_dssp CCCTGGGSSSCEEEECTTSTTCC---EEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEE
T ss_pred HHHHHhcCCCcEEEEcCCCCCce---EEEEcHHHHHHHCcCHHHHcCCCHHHhcCCcCChHHHHHHHHHHhcCCCcceEE
Confidence 45689999999999999 888 999999999999999999999998888888888888888888899998899999
Q ss_pred EEEecCCcEEEEEEEEeeeccCC----EEEEEEecCCccccccccCcchhhhhHHHHHHHHhhhhhhhhhccC
Q 001902 551 INYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKEL 619 (998)
Q Consensus 551 ~~~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~~~~~~~~e~~~~~~~~~~k~~~~~v~e~~~el 619 (998)
...+++|..+|+.++..|+.+.+ +++++++|||++|+ ++.+.+.++.++....++.+++++|
T Consensus 81 ~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l 146 (146)
T 2v0u_A 81 INYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVR-------DAAEREGVMLIKKTAENIDEAAKEL 146 (146)
T ss_dssp EEECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEEESSCCC-------HHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCCcEEEEEEEEEEeECCCCCEEEEEEEEeechHHHH-------HHHHHHHHHHHHHHHhccHhhHhcC
Confidence 99999999999999999998765 78999999999985 3344455666677777777776654
|
| >3kx0_X Uncharacterized protein RV1364C/MT1410; PAS domain, sensory domain, mycobacteium tuberculos molecule binding domain; 2.30A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.7e-14 Score=147.20 Aligned_cols=123 Identities=11% Similarity=0.127 Sum_probs=103.2
Q ss_pred cchHHHHHHHHHhcCCcEEEEe-cCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcE
Q 001902 185 PRVSDIVKDALSTFQQTFVVSD-ATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSY 263 (998)
Q Consensus 185 ~~~~~~l~~ild~~~d~i~i~D-~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~ 263 (998)
..++++|+.++++++++|+++| . +|+|+++|++|++++||+ +++|+++..++++.........+..++..|...
T Consensus 33 ~~~~~~l~~l~~~~~~~i~~~d~~---~g~i~~~N~a~~~l~G~~--~~~G~~~~~~~~~~~~~~~~~~~~~~~~~g~~~ 107 (185)
T 3kx0_X 33 VGAAEDVRRIFEHIPAILVGLEGP---DHRFVAVNAAYRGFSPLL--DTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQ 107 (185)
T ss_dssp TCCHHHHHHHHHHCSSEEEEEETT---TTEEEEECHHHHHHCCCC--SCTTSBHHHHCTTSCSSSSHHHHHHHHHHCCCE
T ss_pred hhhHHHHHHHHhcCCceEEEEECC---CcEEEEEcHHHHHHcCCc--cccCCcHHHHCCchhhhhHHHHHHHHHHcCCcc
Confidence 5677899999999999999999 8 888999999999999999 999999988888776655667778888888876
Q ss_pred EEEEEEE---ecC--CCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHH
Q 001902 264 CGRLLNY---KKD--GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKD 312 (998)
Q Consensus 264 ~~e~~~~---~kd--G~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~ 312 (998)
..+.... +++ |..+|+.+++.|+.+.+|.+.|++++++|||++|++|++
T Consensus 108 ~~~~~~~~~~~~~~gg~~~~~~~~~~pi~~~~g~~~g~~~~~~DITerk~~e~~ 161 (185)
T 3kx0_X 108 SGSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRARQA 161 (185)
T ss_dssp EEEEEEEC--------CCEEEEEEEEEEECTTSCEEEEEEEEEECHHHHTTCC-
T ss_pred cccceeEEeeccCCCCccEEEEEEEEEEECCCCCEEEEEEEEEeCCHHHHHHHH
Confidence 6542222 222 778899999999999999999999999999999999988
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=5.5e-14 Score=157.35 Aligned_cols=121 Identities=40% Similarity=0.796 Sum_probs=111.0
Q ss_pred HHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecC
Q 001902 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273 (998)
Q Consensus 194 ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kd 273 (998)
++++++++|+++|....+|+|+|+|++|++++||+.+|++|+++..+.+++........+...+..+..+..+++.+++|
T Consensus 16 ~~~~~~~~i~~~D~~~~~g~i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~d 95 (332)
T 2wkq_A 16 TLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARFLQGPETDRATVRKIRDAIDNQTEVTVQLINYTKS 95 (332)
T ss_dssp CGGGCCSEEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTT
T ss_pred HhhcCCCcEEEecCCCCCCCEEEeehHHHHHhCCCHHHHcCCCchhhcCCCCCHHHHHHHHHHHHcCCeeEEEEEEEcCC
Confidence 46899999999998444666999999999999999999999999988888888888888999999999999999999999
Q ss_pred CCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhh
Q 001902 274 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (998)
Q Consensus 274 G~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~ 314 (998)
|+.+|+.++++|++|.+|.+.+++++++|||++++++++++
T Consensus 96 G~~~~~~~~~~pi~d~~g~~~~~v~~~~DITe~k~~e~~~~ 136 (332)
T 2wkq_A 96 GKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRDAAERE 136 (332)
T ss_dssp CCEEEEEEEEEEEECTTSCEEEEEEEEEEESSCCCHHHHHH
T ss_pred CCEEEEeeEEEEeEcCCCCEEEEEEEeccCchhhhhhhhcc
Confidence 99999999999999999999999999999999998887743
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} | Back alignment and structure |
|---|
Probab=99.52 E-value=7.9e-14 Score=127.78 Aligned_cols=112 Identities=13% Similarity=0.142 Sum_probs=92.6
Q ss_pred HHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEE-E
Q 001902 188 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG-R 266 (998)
Q Consensus 188 ~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~-e 266 (998)
+++|+.++++++++++++|. +|+|+++|+++++++||+.++++|+++..++ ++........+..++. +..... +
T Consensus 2 e~~~~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 76 (114)
T 3luq_A 2 DERLRLFTEHAPAALAMFDR---EMRYLAVSRRWREDYGLGDGDILGMSHYDIF-PEIGEEWKSVHRRGLA-GEVIRVEE 76 (114)
T ss_dssp CHHHHHHHHTCSSEEEEEET---TCBEEEECHHHHHHTTCCSSCCTTCBHHHHC-TTCCHHHHHHHHHHHT-TCCEEEEE
T ss_pred hHHHHHHHhcCCceEEEEcC---CcEEEEECHHHHHHHCCCHHHHcCCcHHHHC-CccHHHHHHHHHHHhc-CCcceeee
Confidence 46889999999999999998 7889999999999999999999999988777 4444544445555554 554444 4
Q ss_pred EEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecch
Q 001902 267 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (998)
Q Consensus 267 ~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DIT 304 (998)
....+++|..+|+.++..|+.+.+|.+.|++++++|||
T Consensus 77 ~~~~~~~g~~~~~~~~~~p~~~~~g~~~~~~~~~~DIT 114 (114)
T 3luq_A 77 DCFVRADGRTQWLRWEVRPWYEGEGRVGGVVIFTEDIT 114 (114)
T ss_dssp EEEEC--CCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred eEEEcCCCcEEEEEEEEEEeECCCCCEEEEEEEEeeCC
Confidence 47789999999999999999999999999999999997
|
| >3nja_A Probable ggdef family protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; 2.37A {Chromobacterium violaceum} | Back alignment and structure |
|---|
Probab=99.51 E-value=4.3e-14 Score=131.74 Aligned_cols=111 Identities=12% Similarity=0.003 Sum_probs=90.9
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcC--CCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILG--RNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLI 551 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG--~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~ 551 (998)
|+.++++++++++++|.+|. ++++|+++++++||+.++++| ..+..+.+|++.......+...+..+..+..+++
T Consensus 9 l~~~~~~~~~~i~~~d~~~~---~~~~n~~~~~~~G~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~e~~ 85 (125)
T 3nja_A 9 LHTAESDAGIGSWVLHMESG---RLEWSQAVHDIFGTDSATFDATEDAYFQRVHPDDRARVRRELDRHVLGDRPFDVEYR 85 (125)
T ss_dssp --------CCEEEEEETTTT---EEEECHHHHHHHTCCTTTCCCBHHHHHHHBCTTTHHHHHHHHHHHHHSCCCEEEEEE
T ss_pred HHHHHHhCCeeEEEEEcCCC---cEEECHHHHHHhCCCcccccccHHHHHhhcChhHHHHHHHHHHHHHhcCCCceEEEE
Confidence 68899999999999999887 999999999999999999999 4455677888888888888888888888999999
Q ss_pred EEecCCcEEEEEEEEeeeccCC----EEEEEEecCCcccc
Q 001902 552 NYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLE 587 (998)
Q Consensus 552 ~~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~ 587 (998)
..++||+.+|+.++..|+.+.+ +++|+++|||+||+
T Consensus 86 ~~~~~g~~~~~~~~~~~~~~~~g~~~~~~g~~~DITe~k~ 125 (125)
T 3nja_A 86 IVRPDGQVRELLERNHIQRQASGQVDHLWGTVIDMTEHKQ 125 (125)
T ss_dssp EECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCC---
T ss_pred EECCCCCEEEEEEeeEEEECCCCCEEEEEEEEEecccccC
Confidence 9999999999999999998865 79999999999984
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} | Back alignment and structure |
|---|
Probab=99.50 E-value=8e-14 Score=128.98 Aligned_cols=102 Identities=18% Similarity=0.185 Sum_probs=86.4
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~ 553 (998)
++.++++++++|+++|.+|+ |+++|++|++++||+++|++|+++..+.++..... +..+..+..+..+..++
T Consensus 15 ~~~~~~~~~~~i~~~d~~g~---i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~~~~~-----~~~~~~~~~~~~e~~~~ 86 (118)
T 3olo_A 15 AHYLINNAVEASFCLGDNWQ---FLYVNDATCRMTEYSREQLLSMNLQDIDVDFALHD-----WEEIRQKNNYTFKTRYR 86 (118)
T ss_dssp HHHHHHHCSSEEEEECTTSB---EEEECHHHHHHHCCCHHHHTTCBGGGTBTTGGGSC-----HHHHHHHSEEEEEEEEE
T ss_pred HHHHHhcCCceEEEECCCCc---EEEEHHHHHHHHCCCHHHHhCCChhhcccccCHHH-----HHHHHhcCcEEEEEEEE
Confidence 68899999999999999877 99999999999999999999999877775433222 23344456788899999
Q ss_pred ecCCcEEEEEEEEeeeccCC--EEEEEEecCC
Q 001902 554 TKSGKKFWNLFHLQPMRDQK--YFIGVQLDGS 583 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~--~~vgi~rDIT 583 (998)
++||+.+|++++..|+.+++ +++++++|||
T Consensus 87 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~DIT 118 (118)
T 3olo_A 87 SQSGRIFLVEMSLTFLEDQERRFSCVFVREKS 118 (118)
T ss_dssp CTTCCEEEEEEEEEEEEETTEEEEEEEEEEC-
T ss_pred ccCCCEEEEEEEEEEEEECCccEEEEEEEeCC
Confidence 99999999999999998777 7889999998
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.1e-13 Score=154.76 Aligned_cols=109 Identities=91% Similarity=1.339 Sum_probs=102.2
Q ss_pred HHHhhcCceEEEEcC---CCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEE
Q 001902 476 TTLERIEKNFVITDP---RLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552 (998)
Q Consensus 476 ~i~e~~~d~i~i~D~---~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~ 552 (998)
.++++++++|+++|. +|+ |++||++|++++||+++|++|+++..+.+++........++..+..+..+..+.+.
T Consensus 15 ~~~~~~~~~i~~~D~~~~~g~---i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 91 (332)
T 2wkq_A 15 TTLERIEKNFVITDPRLPDNP---IIFASDSFLQLTEYSREEILGRNARFLQGPETDRATVRKIRDAIDNQTEVTVQLIN 91 (332)
T ss_dssp CCGGGCCSEEEEECTTSTTCC---EEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEE
T ss_pred hHhhcCCCcEEEecCCCCCCC---EEEeehHHHHHhCCCHHHHcCCCchhhcCCCCCHHHHHHHHHHHHcCCeeEEEEEE
Confidence 468999999999999 888 99999999999999999999999998999888888888899999999999999999
Q ss_pred EecCCcEEEEEEEEeeeccCC----EEEEEEecCCcccc
Q 001902 553 YTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLE 587 (998)
Q Consensus 553 ~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~ 587 (998)
+++||+.+|++++++|+++.+ +++++++|||++|+
T Consensus 92 ~~~dG~~~~~~~~~~pi~d~~g~~~~~v~~~~DITe~k~ 130 (332)
T 2wkq_A 92 YTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVR 130 (332)
T ss_dssp ECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEEESSCCC
T ss_pred EcCCCCEEEEeeEEEEeEcCCCCEEEEEEEeccCchhhh
Confidence 999999999999999999764 89999999999986
|
| >3h9w_A Diguanylate cyclase with PAS/PAC sensor; alpha-beta protein., structural genomics, PSI-2, protein STR initiative; 1.90A {Marinobacter aquaeolei} | Back alignment and structure |
|---|
Probab=99.49 E-value=5e-14 Score=130.91 Aligned_cols=112 Identities=13% Similarity=0.100 Sum_probs=96.2
Q ss_pred cCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCC-CCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCCE
Q 001902 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRN-CRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTP 276 (998)
Q Consensus 198 ~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~-~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~ 276 (998)
++++++.+|.. +|+++|+|+++++++||+.++++|.. +..+++|++.......+...+..+..+..+++++++||+.
T Consensus 2 a~~giw~~d~~--~~~~~~~n~~~~~l~G~~~~e~~~~~~~~~~ihpdd~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~ 79 (115)
T 3h9w_A 2 TKAIPWKINWQ--TMAFEYIGPQIEALLGWPQGSWKSVEDWATRMHPEDQEWVVNFCVKQSECGVDHEADYRALHRDGHY 79 (115)
T ss_dssp -CCEEEEEETT--TTEEEEECTHHHHHHCSCGGGCCBHHHHHHSBCHHHHHHHHHHHHHHHHTTCCEEEEEEEECTTSCE
T ss_pred cceEEEEEEcC--CCcEEEEChhHHHHhCCChHHccCHHHHHHhcCHHHHHHHHHHHHHHHhcCCcccEEEEEEcCCCCE
Confidence 46889999943 67799999999999999999999832 2356788777777788888888888899999999999999
Q ss_pred EEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHH
Q 001902 277 FWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAK 311 (998)
Q Consensus 277 ~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~ 311 (998)
+|+..+..|++|++|++.+++|+..|||++|++|+
T Consensus 80 ~w~~~~~~~~~d~~G~~~~~~G~~~Dit~~k~~~~ 114 (115)
T 3h9w_A 80 VWIRDVVHVVRDDSGEVEALIGFMFDISLEHHHHH 114 (115)
T ss_dssp EEEEEEEEEEECTTSCEEEEEEEEEECGGGGC---
T ss_pred EEEEEEEEEEECCCCCEEEEEEEEeccCccccccc
Confidence 99999999999999999999999999999998875
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} | Back alignment and structure |
|---|
Probab=99.49 E-value=2.1e-13 Score=125.50 Aligned_cols=111 Identities=21% Similarity=0.237 Sum_probs=99.0
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~ 553 (998)
++.++++++++++++|.+|. |+++|+++++++||+.++++|++...+.+++........+...+..+..+..+....
T Consensus 9 ~~~~~~~~~~~i~~~d~~~~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (124)
T 3lyx_A 9 RAKAFDYVFDAIVVTDLQGF---IIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSEVISAVENQGKWTGEIRML 85 (124)
T ss_dssp HHHGGGTCSSEEEEEETTCB---EEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTHHHHHHHHHHHHHHTSCEEEEEEEE
T ss_pred HHHHHhhcCceEEEECCCCc---EeehhhHHHHHhCCCHHHHcCCCHHHhcCcchhhHHHHHHHHHHHcCCcccceEEEE
Confidence 68899999999999999777 999999999999999999999998877777766667777888888898899999999
Q ss_pred ecCCcEEEEEEEEeeeccCC----EEEEEEecCCcccc
Q 001902 554 TKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLE 587 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~ 587 (998)
+++|..+|+.+++.|+.+.+ +++++++|||++|+
T Consensus 86 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~ 123 (124)
T 3lyx_A 86 HKDGHIGWIESMCVPIYGENYQMVGALGINRDITKRKK 123 (124)
T ss_dssp CTTSCEEEEEEEEEEEECSTTCEEEEEEEEEECSCC--
T ss_pred ccCCCEEEEEEEEEEEECCCCCEEEEEEEEecchhhhc
Confidence 99999999999999998665 78999999999985
|
| >3eeh_A Putative light and redox sensing histidine kinase; structural genomic MCSG, protein structure initiative, midwest center for STRU genomics; HET: PG5; 1.95A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.48 E-value=8.3e-14 Score=128.93 Aligned_cols=121 Identities=11% Similarity=0.133 Sum_probs=97.8
Q ss_pred ccccccchHHHHHHHHHhcCCcEEEEecCCCC-CceEEccHHHHHHcCCChhhhcCCC--CCcccCCCCChHHHHHHHHH
Q 001902 180 KEKGLPRVSDIVKDALSTFQQTFVVSDATKPD-YPIMYASAGFFKMTGYTSKEVVGRN--CRFLQGAGTDPEDVAKIRET 256 (998)
Q Consensus 180 ~e~~l~~~~~~l~~ild~~~d~i~i~D~~g~d-G~I~~vN~a~~~l~Gys~eEliG~~--~~~l~~~~~~~~~~~~i~~~ 256 (998)
++++|++++++|+.++++++++++++|. + |+|+++|+++++++||+.++++|.. +..+.++++.......+..
T Consensus 2 ~e~~l~~~~~~~~~~~~~~~~~i~~~d~---~~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 77 (125)
T 3eeh_A 2 AKQQAAKSERRVRELTEATNDILWEFTA---DLSEVLVINSAYEDIWGRSVAKLRENPHDFLNGIHPEDRELMKDTMQS- 77 (125)
T ss_dssp --------CHHHHHHHSCCCCEEEEEET---TSSCEEEECTHHHHHHSSCHHHHHHCGGGGGGGBCHHHHHHHHHHHHH-
T ss_pred hHHHHHHHHHHHHHHHhcCCceEEEEEc---CCCcEEEecHHHHHHHCCCHHHHccCcHHHHHhcCHHHHHHHHHHHHH-
Confidence 5677888999999999999999999998 6 7799999999999999999999987 3445555544444444444
Q ss_pred HHcCCcEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecch
Q 001902 257 LQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (998)
Q Consensus 257 l~~g~~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DIT 304 (998)
+..+..+..+++..+++|..+|+.++..|+.+.+|.+.+++++++|||
T Consensus 78 ~~~~~~~~~e~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIT 125 (125)
T 3eeh_A 78 LMDGESADVECRVNATEEYQRWVWIQGEPITNDAGETVRVAGFARDIT 125 (125)
T ss_dssp HHTTCCEEEEEEECGGGTTCEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred HHcCCCccEEEEEEcCCCCEEEEEEecEEEECCCCCEEEEEEEEEecC
Confidence 677888889999999999999999999999999999999999999997
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=6.1e-13 Score=123.28 Aligned_cols=112 Identities=46% Similarity=0.871 Sum_probs=101.3
Q ss_pred HHHHHhhcCceEEEEc---CCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEE
Q 001902 474 LATTLERIEKNFVITD---PRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQL 550 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D---~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~ 550 (998)
++.++++++++++++| .+|. |+++|+++++++||+.++++|+++..+.++.........+...+..+..+..+.
T Consensus 8 ~~~~~~~~~~~i~~~d~~d~~~~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (130)
T 2z6d_A 8 LKTALSTLQQTFVVSDATQPHCP---IVYASSGFFTMTGYSSKEIVGRNCRFLQGPDTDKNEVAKIRDCVKNGKSYCGRL 84 (130)
T ss_dssp HHHHHHHTTCEEEEEETTSTTCC---EEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEE
T ss_pred HHHHHHhcccceeeeeccCCCCc---EEEecHHHHHHhCcCHHHHcCCChhhccCCCCCchHHHHHHHHHHcCCcceeEE
Confidence 7889999999999999 8777 999999999999999999999998888888888887888888888888888899
Q ss_pred EEEecCCcEEEEEEEEeeeccCC----EEEEEEecCCccccc
Q 001902 551 INYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEP 588 (998)
Q Consensus 551 ~~~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~~ 588 (998)
...+++|+.+|+.+++.|+.+.+ +++++++|||++|+.
T Consensus 85 ~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~~ 126 (130)
T 2z6d_A 85 LNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEVSKYTEG 126 (130)
T ss_dssp EEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCTTC--
T ss_pred EEEcCCCcEEEEEEEEEEEECCCCCeeEEEEEEecchHHHHh
Confidence 99999999999999999998754 789999999999973
|
| >2kdk_A ARYL hydrocarbon receptor nuclear translocator-LI 2; circadian clock, PAS domain, transcription, activator, biolo rhythms, DNA-binding, nucleus; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.5e-13 Score=128.43 Aligned_cols=110 Identities=13% Similarity=0.095 Sum_probs=96.0
Q ss_pred HHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcC-CcEEEEEEEE
Q 001902 475 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ-TDVTVQLINY 553 (998)
Q Consensus 475 ~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g-~~~~~e~~~~ 553 (998)
..++++++++|+++|.+|+ |+|+|+++++++||+.+|++|+++..+.+|++.......+...+..+ .....+++++
T Consensus 6 ~~~~~~~~~~i~~~d~~g~---i~~~N~~~~~~~G~~~~el~g~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~e~r~~ 82 (121)
T 2kdk_A 6 GEINVKPTEFITRFAVNGK---FVYVDQRATAILGYLPQELLGTSCYEYFHQDDHNNLTDKHKAVLQSKEKILTDSYKFR 82 (121)
T ss_dssp TCCCCCSSEEEEEECTTSB---EEEECTHHHHHTCCCTTTSBTSBTTTTBCSSSHHHHHHHHHHHHTSSSCEEEEEEEEE
T ss_pred cccccCCccEEEEECCCee---EEEEChhHHHHHCCCHHHHcCCcHHHeeCHHHHHHHHHHHHHHHhCCCCCccEEEEEE
Confidence 3467899999999999887 99999999999999999999999888889988777777777777654 4468899999
Q ss_pred ecCCcEEEEEEEEeeeccCC-----EEEEEEecCCcccc
Q 001902 554 TKSGKKFWNLFHLQPMRDQK-----YFIGVQLDGSEHLE 587 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~-----~~vgi~rDITerk~ 587 (998)
++||+.+|++++.+|+++.. +++++.+|||+.++
T Consensus 83 ~~dG~~~~~~~~~~~~~d~~~~~~~~~v~~~~~i~~~~~ 121 (121)
T 2kdk_A 83 AKDGSFVTLKSQWFSFTNPDTKELEYIVSVNTLVLGHSE 121 (121)
T ss_dssp CSSSCEEEEEEEEEEEECCSSSCEEEEEEEEECCSSCCC
T ss_pred EcCCCEEEEEEEEEEEECCCCCeeeEEEEEEEeccccCC
Confidence 99999999999999998763 78999999999863
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.3e-13 Score=125.88 Aligned_cols=114 Identities=11% Similarity=0.098 Sum_probs=92.1
Q ss_pred cccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcC
Q 001902 181 EKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNG 260 (998)
Q Consensus 181 e~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g 260 (998)
++++++..+.++.++++++++|+++|. +|+|+++|+++++++||+.+|++|+++..+.++..... +..+..+
T Consensus 5 ~~~~e~~~~~~~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~~~~~-----~~~~~~~ 76 (118)
T 3olo_A 5 NIQSELEFKFAHYLINNAVEASFCLGD---NWQFLYVNDATCRMTEYSREQLLSMNLQDIDVDFALHD-----WEEIRQK 76 (118)
T ss_dssp --CHHHHHHHHHHHHHHCSSEEEEECT---TSBEEEECHHHHHHHCCCHHHHTTCBGGGTBTTGGGSC-----HHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCceEEEECC---CCcEEEEHHHHHHHHCCCHHHHhCCChhhcccccCHHH-----HHHHHhc
Confidence 445566778889999999999999998 78899999999999999999999999887775443222 3344456
Q ss_pred CcEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecch
Q 001902 261 QSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (998)
Q Consensus 261 ~~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DIT 304 (998)
..+..+.+.++++|+.+|+.++..|+.+.+ ..+++++++|||
T Consensus 77 ~~~~~e~~~~~~~g~~~~~~~~~~~~~~~~--~~~~~~~~~DIT 118 (118)
T 3olo_A 77 NNYTFKTRYRSQSGRIFLVEMSLTFLEDQE--RRFSCVFVREKS 118 (118)
T ss_dssp SEEEEEEEEECTTCCEEEEEEEEEEEEETT--EEEEEEEEEEC-
T ss_pred CcEEEEEEEEccCCCEEEEEEEEEEEEECC--ccEEEEEEEeCC
Confidence 677889999999999999999999997643 356789999997
|
| >3mfx_A Sensory BOX/ggdef family protein; alpha-beta protein, structural genomics, PSI-2, protein structure initiative; 2.40A {Shewanella oneidensis} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.6e-13 Score=131.56 Aligned_cols=109 Identities=12% Similarity=0.109 Sum_probs=86.1
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCC-------cE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT-------DV 546 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~-------~~ 546 (998)
|+.+++++++||+++|.+|+ |+++|++|++||||+++|++|+++..+.+++........+......+. ..
T Consensus 9 l~~i~~~~~d~i~~~D~~g~---I~~~N~aa~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (129)
T 3mfx_A 9 IELFIQHLTEAMILVNANGF---IRSCNQRSAELLDCPQVSLKGQDWRNFLTEHHQARYDNLLSHDVQLGTNCGQPVQHP 85 (129)
T ss_dssp HHHHHTTCSSEEEEEETTSB---EEEECHHHHHHTTSCHHHHTTSBGGGGBCTTCCGGGGCTTC----------CCSCEE
T ss_pred HHHHHhcCCceEEEECCCCE---EEeEhHHHHHHHCcCHHHHcCCcHHHHcChHhHHHHHHHHHHHHhcCcccccccCCC
Confidence 78899999999999999888 999999999999999999999998888887765542222222222221 24
Q ss_pred EEEEEEEecCCcEEEEEEEEeeeccCC-EEEEEEecCCcc
Q 001902 547 TVQLINYTKSGKKFWNLFHLQPMRDQK-YFIGVQLDGSEH 585 (998)
Q Consensus 547 ~~e~~~~rkdG~~~wv~~~~spi~d~~-~~vgi~rDITer 585 (998)
..|+..+++||+.+|++++++|+.+++ .|+++++|+...
T Consensus 86 ~~E~~~~rkdG~~~~velsis~i~~~~~~~v~~~~~~~~~ 125 (129)
T 3mfx_A 86 AQETTLICASGKAKDVELSISYIPGHEPMFVMVMHDLEHH 125 (129)
T ss_dssp EEEEEEECTTSCEEEEEEEEEEECSSSCEEEEEEEEC---
T ss_pred ceEEEEEcCCCCEEEEEEEEEEecCCCcEEEEEEechhhh
Confidence 678999999999999999999999666 899999998654
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 | Back alignment and structure |
|---|
Probab=99.45 E-value=1.3e-12 Score=117.44 Aligned_cols=107 Identities=29% Similarity=0.579 Sum_probs=94.6
Q ss_pred CcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCC--CCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCCEE
Q 001902 200 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRN--CRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 277 (998)
Q Consensus 200 d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~--~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 277 (998)
.+|+++|....+|+|+++|++|++++||+.++++|++ ...+.++.........+...+..+..+..++..++++|..+
T Consensus 2 ~~i~i~d~~~~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~ 81 (110)
T 1byw_A 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCF 81 (110)
T ss_dssp CEEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEE
T ss_pred CCEEEEeccCCCCcEEEECHHHHHHhCCCHHHHccCCCccccccCCcCCHHHHHHHHHHHhcCCCceEEEEEEcCCCCEE
Confidence 5899999865678999999999999999999999998 45566666666667778888888888889998899999999
Q ss_pred EEEeeeeEEeCCCCCEEEEEEEEecchhh
Q 001902 278 WNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306 (998)
Q Consensus 278 w~~~~~spi~d~~G~v~~~v~i~~DITer 306 (998)
|+.+++.|+.+.+|.+.+++++++|||++
T Consensus 82 ~~~~~~~~~~~~~g~~~~~~~~~~DiTe~ 110 (110)
T 1byw_A 82 LCLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred EEEEEEEEeecCCCCEEEEEEEEEeccCC
Confidence 99999999999999999999999999975
|
| >4dj3_A Period circadian protein homolog 3; PAS domain, circadian rhythm, protein binding; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.4e-12 Score=140.81 Aligned_cols=101 Identities=13% Similarity=0.113 Sum_probs=86.9
Q ss_pred ceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCc---EEEEEEEEecCCcE
Q 001902 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD---VTVQLINYTKSGKK 559 (998)
Q Consensus 483 d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~---~~~e~~~~rkdG~~ 559 (998)
+-+...+.+|+ |+|||+++..++||.++||+|+++..++||++.....+.+.+.+..+.. ...++++++|||+.
T Consensus 175 ~Fitrh~~dG~---~~yvs~~~~~lLGY~peELig~s~~~~vHPdD~~~~~~~~~~~l~~~~~~~f~s~~yR~~~kdG~~ 251 (317)
T 4dj3_A 175 IFTTTHTPGCV---FLEVDERAVPLLGYLPQDLIGTSILTYLHPEDRPLMVAIHQKVLKYAGHPPFEHSPVRFCTQNGEY 251 (317)
T ss_dssp EEEEEECTTSB---EEEECTTHHHHHSCCHHHHTTSBGGGGBCTTTTTHHHHHHHHHHHTTTSCCEECCCEEEECTTSCE
T ss_pred ceEEEecCCCe---EEEEChHHhhhcCcChHHHcCCCHHHeECHHHHHHHHHHHHHHHHcCCCccccceEEEEEccCCCE
Confidence 56777888777 9999999999999999999999999999999999988888888887654 46789999999999
Q ss_pred EEEEEEEeeeccCC-----EEEEEEecCCccc
Q 001902 560 FWNLFHLQPMRDQK-----YFIGVQLDGSEHL 586 (998)
Q Consensus 560 ~wv~~~~spi~d~~-----~~vgi~rDITerk 586 (998)
+|++.+.+++++.. .++++-+-|+...
T Consensus 252 vwvet~~~~~~np~s~~~e~II~~h~v~~~p~ 283 (317)
T 4dj3_A 252 VILDSSWSSFVNPWSRKVSFIIGRHKVRTSPL 283 (317)
T ss_dssp EEEEEEEEEEECSSSCCEEEEEEEEEECCCCS
T ss_pred EEEEEEEEEEECCCCCcccEEEEEEEeccCCC
Confidence 99999999998753 7777777555554
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} | Back alignment and structure |
|---|
Probab=99.45 E-value=4.6e-13 Score=131.84 Aligned_cols=111 Identities=35% Similarity=0.632 Sum_probs=102.7
Q ss_pred HHHHHhhcCceEEEEcCCC---CCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEE
Q 001902 474 LATTLERIEKNFVITDPRL---PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQL 550 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G---~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~ 550 (998)
|+.++++++++|+++|.+| + |+++|++|++++||+.++++|+++..+.++.........+...+..+..+..+.
T Consensus 27 ~~~i~~~~~~~i~~~d~~~~~~~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 103 (162)
T 3sw1_A 27 LQSMVDASNDGIVVAEKEGDDTI---LIYVNAAFEYLTGYSRDEILYQDCRFLQGDDRDQLGRARIRKAMAEGRPCREVL 103 (162)
T ss_dssp HHHHHHTCSSEEEEEEEETTEEE---EEEECHHHHHHHTCCHHHHTTSBGGGGTTTCCCCHHHHHHHHHHHHTCCEEEEE
T ss_pred HHHHHhhccCcEEEEeCCCCccE---EEEECHHHHHHHCCCHHHHcCCCcceecCCCcCHHHHHHHHHHHhcCCCCcceE
Confidence 6889999999999999977 7 999999999999999999999998888888888888888888898999999999
Q ss_pred EEEecCCcEEEEEEEEeeeccCC----EEEEEEecCCcccc
Q 001902 551 INYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLE 587 (998)
Q Consensus 551 ~~~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~ 587 (998)
...+++|..+|+.+++.|+.+.+ +++++++|||++|+
T Consensus 104 ~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DiTe~k~ 144 (162)
T 3sw1_A 104 RNYRKDGSAFWNELSITPVKSDFDQRTYFIGIQKDVSRQVE 144 (162)
T ss_dssp EEECTTCCEEEEEEEEEEEECSSSSCEEEEEEEEECHHHHH
T ss_pred EEECCCCCEEEEEEEEEEeecCCCCEEEEEEEEEeCcHHHH
Confidence 99999999999999999998764 89999999999996
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.3e-13 Score=127.64 Aligned_cols=115 Identities=9% Similarity=-0.035 Sum_probs=104.5
Q ss_pred hHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCC--CcccCCCCChHHHHHHHHHHHcCCcEE
Q 001902 187 VSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNC--RFLQGAGTDPEDVAKIRETLQNGQSYC 264 (998)
Q Consensus 187 ~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~--~~l~~~~~~~~~~~~i~~~l~~g~~~~ 264 (998)
++++|+.++++++++++.+|. +|.++++|+++++++||+.++++|... ..+++|++.......+...+..+..+.
T Consensus 2 s~~~~~~l~~~~~~~i~~~d~---~~~~~~~n~~~~~~~G~~~~~~~~~~~~~~~~i~p~d~~~~~~~~~~~~~~~~~~~ 78 (118)
T 3icy_A 2 NAEELQALVDNIPAAIYHLDV---SGQATIRFRPPAFLKTLVSEHAGTTRLNTLSMIHHDDRHMLSNAYSKLREAKHSLT 78 (118)
T ss_dssp HHHHHHHHHTTCCCCCEEECT---TSCEEECCCCCGGGGGGEEEETTEEEEGGGGGBCGGGHHHHHHHHHHHHHSCCEEE
T ss_pred cHHHHHHHHhcCCceEEEEEc---CCCceEEechhHhhcCCCHHHccCChhHHHHHcCHHHHHHHHHHHHHHHhcCCCce
Confidence 568899999999999999998 777999999999999999999988764 457788777777788888888888899
Q ss_pred EEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecch
Q 001902 265 GRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (998)
Q Consensus 265 ~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DIT 304 (998)
.+++.++++|..+|+.....|+.+++|.+.+++|+++|||
T Consensus 79 ~e~r~~~~~g~~~w~~~~~~~~~~~~g~~~~~~g~~~DIT 118 (118)
T 3icy_A 79 LVYRIVTPEGKLHWIEDHMRSSFSDDGLFSGIDGILCEVT 118 (118)
T ss_dssp EEEEEECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEEEEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 9999999999999999999999999999999999999998
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* | Back alignment and structure |
|---|
Probab=99.44 E-value=4.8e-13 Score=130.05 Aligned_cols=126 Identities=32% Similarity=0.590 Sum_probs=104.7
Q ss_pred ccccccccccccccccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCC--
Q 001902 168 VRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGT-- 245 (998)
Q Consensus 168 ~~~~~dit~~~~~e~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~-- 245 (998)
+....|++.++..+..+ .++++. ++|+++|..+.+|+|+|+|+++++++||+.+|++|+++..+.+++.
T Consensus 13 ~~~~~~~~~r~~~~~~~--------~~~~~~-~~i~~~d~~d~~g~i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~~~~ 83 (149)
T 3d72_A 13 MGYLIQIMNRPNPQVEL--------GPVDTS-VALILCDLKQKDTPIVYASEAFLYMTGYSNAEVLGRNCRFLQSPDGMV 83 (149)
T ss_dssp HHHHHHHHHCSSCSSCC--------CSCCTT-SCEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGGSTTSCC
T ss_pred eeeeehhhhCcchhHHH--------HhhcCC-ccEEEEeccCCCCcEEEECHHHHHHHCcCHHHHcCCChhHhCCccccc
Confidence 34446777665544322 345664 9999999443488899999999999999999999999988877764
Q ss_pred ---------ChHHHHHHHHHHHcCCcEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEec
Q 001902 246 ---------DPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVE 302 (998)
Q Consensus 246 ---------~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~D 302 (998)
.......+...+..+..+..++..+++||+.+|+.++++|+.+.+|.+.+++++++|
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~i~~~~g~~~~~v~~~~D 149 (149)
T 3d72_A 84 KPKSTRKYVDSNTINTMRKAIDRNAEVQVEVVNFKKNGQRFVNFLTMIPVRDETGEYRYSMGFQCE 149 (149)
T ss_dssp CTTCCCSSSCHHHHHHHHHHHHHTCCEEEEEEEECTTCCEEEEEEEEEEEECTTSSEEEEEEECCC
T ss_pred cccccccccChHHHHHHHHHHHCCCceEEEEEEECCCCCEEEEEEEEEEEEcCCCCEEEEEEEEeC
Confidence 666777888888889999999999999999999999999999999999999999887
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=6.5e-13 Score=126.26 Aligned_cols=121 Identities=40% Similarity=0.821 Sum_probs=107.1
Q ss_pred HHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEE
Q 001902 191 VKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNY 270 (998)
Q Consensus 191 l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 270 (998)
|+.++++++++++++|..+.+|+|+++|+++++++||+.++++|+++..+.++.........+...+..+..+..++...
T Consensus 4 l~~~~~~~~~~i~~~d~~~~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (146)
T 2v0u_A 4 LATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATVRKIRDAIDNQTEVTVQLINY 83 (146)
T ss_dssp CCCTGGGSSSCEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEE
T ss_pred HHHHHhcCCCcEEEEcCCCCCceEEEEcHHHHHHHCcCHHHHcCCCHHHhcCCcCChHHHHHHHHHHhcCCCcceEEEEE
Confidence 34578999999999987222455999999999999999999999999888888887777888888999999999999999
Q ss_pred ecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHH
Q 001902 271 KKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAK 311 (998)
Q Consensus 271 ~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~ 311 (998)
+++|..+|+.++..|+.+.+|.+.+++++++|||++++.++
T Consensus 84 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~~~~ 124 (146)
T 2v0u_A 84 TKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRDAA 124 (146)
T ss_dssp CTTCCEEEEEEEEEEEECTTSCEEEEEEEEEEESSCCCHHH
T ss_pred ecCCcEEEEEEEEEEeECCCCCEEEEEEEEeechHHHHHHH
Confidence 99999999999999999999999999999999999998433
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} | Back alignment and structure |
|---|
Probab=99.44 E-value=2e-13 Score=127.63 Aligned_cols=110 Identities=13% Similarity=0.144 Sum_probs=91.4
Q ss_pred HHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEe
Q 001902 475 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYT 554 (998)
Q Consensus 475 ~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~r 554 (998)
+.++++++++|+++|.+|+ |+++|+++++++||+.++++|+++..+.+++........+...+.++.. ..+....+
T Consensus 2 ~~l~~~~~~~i~~~d~~g~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 77 (126)
T 3mjq_A 2 KNFLETIEDMILIINREGR---LLYANTAVPKKLGYTHEELMSMHILTITSAGKMAEGEKILAELFAGKKE-SLPLSLEK 77 (126)
T ss_dssp CTTGGGCSSEEEEEETTSB---EEEECTHHHHHHSCCHHHHHHSBHHHHHCTTCHHHHHHHHHHHHHTCCS-EEEEEEEC
T ss_pred hhHHhhCCceEEEEeCCCc---EEEEcHHHHHHHCCCHHHHcCCCHHHHcCchhHHHHHHHHHHHHhCCCc-eeEEEEEc
Confidence 4578999999999999877 9999999999999999999999988888887777666667776666655 77888899
Q ss_pred cCCcEEEEEEEEeeeccCC--EEEEEEecCCccccc
Q 001902 555 KSGKKFWNLFHLQPMRDQK--YFIGVQLDGSEHLEP 588 (998)
Q Consensus 555 kdG~~~wv~~~~spi~d~~--~~vgi~rDITerk~~ 588 (998)
++|..+|+.++..|+..++ +++++++|||++|+.
T Consensus 78 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~DITe~k~a 113 (126)
T 3mjq_A 78 KEGTSIPAKARIWQGKWHNEPCLFAIIKDLSKEERA 113 (126)
T ss_dssp TTSCEEEEEEEEEEEESSSSEEEEEEEEECC-----
T ss_pred cCCCEEEEEEEEEeeeECCceEEEEEEEechHHHHh
Confidence 9999999999998776655 899999999999973
|
| >1v9y_A Heme PAS sensor protein; signaling protein; HET: HEM; 1.32A {Escherichia coli} SCOP: d.110.3.2 PDB: 1v9z_A* 1vb6_A* 1s67_L* 1s66_L* | Back alignment and structure |
|---|
Probab=99.43 E-value=2.3e-13 Score=134.13 Aligned_cols=141 Identities=20% Similarity=0.267 Sum_probs=87.2
Q ss_pred ccccccccccccccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHH
Q 001902 170 SSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPED 249 (998)
Q Consensus 170 ~~~dit~~~~~e~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~ 249 (998)
+..+++...+..+++..+++.|+.+++.++++++++|. +|+|+++|+++++++||+.++++|+++..++++......
T Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~i~~~d~---~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~~~~ 97 (167)
T 1v9y_A 21 MRQDAEVIMKLTDADNAADGIFFPALEQNMMGAVLINE---NDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAH 97 (167)
T ss_dssp -------------------CCHHHHHHTCSSEEEEECT---TSBEEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTH
T ss_pred HHhhHHHHHHHHHHHhhhhHHHHHHHHhCCCCEEEECC---CCcEEEECHHHHHHhCCCHHHHcCCChhhccCccccchH
Confidence 34677777888888889999999999999999999998 778999999999999999999999998887776655444
Q ss_pred HHHHHHHHHcCCc----EEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhc
Q 001902 250 VAKIRETLQNGQS----YCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 315 (998)
Q Consensus 250 ~~~i~~~l~~g~~----~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~ 315 (998)
...+......+.. +..++...+++|..+|+.+++.|+ +.+|.+ +++++++|||++++++++++.
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~-~~~g~~-~~~~~~~DiT~~~~~e~~l~~ 165 (167)
T 1v9y_A 98 PEYIRHNREGGKARVEGMSRELQLEKKDGSKIWTRFALSKV-SAEGKV-YYLALVRDASVEMAQKEQTRQ 165 (167)
T ss_dssp HHHHHHHHC----------CEEEEECTTSCEEEEEEEEEEE-EETTEE-EEEEEEEC-------------
T ss_pred HHHHHHHhhcCCCcccccceEEEEEcCCCcEEEEEEEEEEE-ecCCCE-EEEEEEecCcHHHHHHHHHHh
Confidence 4455444444433 455778889999999999999999 445655 589999999999999887653
|
| >2kdk_A ARYL hydrocarbon receptor nuclear translocator-LI 2; circadian clock, PAS domain, transcription, activator, biolo rhythms, DNA-binding, nucleus; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.8e-13 Score=125.71 Aligned_cols=111 Identities=13% Similarity=0.098 Sum_probs=94.9
Q ss_pred HHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCC-cEEEEEEEEec
Q 001902 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ-SYCGRLLNYKK 272 (998)
Q Consensus 194 ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~-~~~~e~~~~~k 272 (998)
++++++++|+++|. +|+|+|+|+++++++||+.+|++|+++..+++|++.......+...+..+. ....+++++++
T Consensus 8 ~~~~~~~~i~~~d~---~g~i~~~N~~~~~~~G~~~~el~g~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~e~r~~~~ 84 (121)
T 2kdk_A 8 INVKPTEFITRFAV---NGKFVYVDQRATAILGYLPQELLGTSCYEYFHQDDHNNLTDKHKAVLQSKEKILTDSYKFRAK 84 (121)
T ss_dssp CCCCSSEEEEEECT---TSBEEEECTHHHHHTCCCTTTSBTSBTTTTBCSSSHHHHHHHHHHHHTSSSCEEEEEEEEECS
T ss_pred cccCCccEEEEECC---CeeEEEEChhHHHHHCCCHHHHcCCcHHHeeCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Confidence 56788999999998 788999999999999999999999998888888776666666666666544 46788999999
Q ss_pred CCCEEEEEeeeeEEeCCC-CCEEEEEEEEecchhhh
Q 001902 273 DGTPFWNLLTIAPIKDDE-GKVLKFIGMQVEVSKHT 307 (998)
Q Consensus 273 dG~~~w~~~~~spi~d~~-G~v~~~v~i~~DITerk 307 (998)
||+.+|+.++..|++|.. |.+.+++++.+||++.+
T Consensus 85 dG~~~~~~~~~~~~~d~~~~~~~~~v~~~~~i~~~~ 120 (121)
T 2kdk_A 85 DGSFVTLKSQWFSFTNPDTKELEYIVSVNTLVLGHS 120 (121)
T ss_dssp SSCEEEEEEEEEEEECCSSSCEEEEEEEEECCSSCC
T ss_pred CCCEEEEEEEEEEEECCCCCeeeEEEEEEEeccccC
Confidence 999999999999999876 56778899999999864
|
| >3k3c_A Protein RV1364C/MT1410; sensor, PAS, signal transduction, fatty-acid binding, sigma regulator, signaling protein; HET: PLM; 1.62A {Mycobacterium tuberculosis} PDB: 3k3d_A | Back alignment and structure |
|---|
Probab=99.43 E-value=2.8e-13 Score=133.24 Aligned_cols=109 Identities=10% Similarity=0.063 Sum_probs=91.4
Q ss_pred HHHHHhhcCceEEEEc-CCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEE
Q 001902 474 LATTLERIEKNFVITD-PRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D-~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~ 552 (998)
|+.++++++++|+++| .+|+ |+++|++|++++||+ +++|+++..+.++.........+.+.+..|.....+...
T Consensus 19 ~~~~~~~~~~~i~~~d~~~~~---i~~~N~~~~~~~g~~--~~~G~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~ 93 (158)
T 3k3c_A 19 VRRIFEHIPAILVGLEGPDHR---FVAVNAAYRGFSPLL--DTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQSGSEWR 93 (158)
T ss_dssp HHHHHHHCSSEEEEEETTTTE---EEEECHHHHHHCTTC--CSTTSBHHHHSGGGGGTTHHHHHHHHHHHCCCEEEEEEE
T ss_pred HHHHHhcCCceEEEEECCCcE---eHHHHHHHHHHcCCc--hhcCCcHHHhCCchhHHHHHHHHHHHHHhCCccccccee
Confidence 7899999999999999 9777 999999999999999 999999888887766666677788888888775544332
Q ss_pred ---Eec-C-CcEEEEEEEEeeeccCC----EEEEEEecCCcccc
Q 001902 553 ---YTK-S-GKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLE 587 (998)
Q Consensus 553 ---~rk-d-G~~~wv~~~~spi~d~~----~~vgi~rDITerk~ 587 (998)
.+. + |..+|+.++++|+.+.+ +++++++|||++|+
T Consensus 94 ~~~~~~~~~g~~~~~~~~~~pi~~~~g~~~g~~~~~~DITe~k~ 137 (158)
T 3k3c_A 94 LQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVR 137 (158)
T ss_dssp EEEESSSSCEEEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHH
T ss_pred EEeccCCCCcceEEEEEEEEEeECCCCCEEEEEEEEEehhHHHH
Confidence 222 2 77899999999999765 89999999999996
|
| >3h9w_A Diguanylate cyclase with PAS/PAC sensor; alpha-beta protein., structural genomics, PSI-2, protein STR initiative; 1.90A {Marinobacter aquaeolei} | Back alignment and structure |
|---|
Probab=99.41 E-value=2.8e-13 Score=125.83 Aligned_cols=105 Identities=12% Similarity=0.081 Sum_probs=91.9
Q ss_pred cCceEEEEc-CCCCCCCEEEcCHHHHHHcCCChhhhcCCC-CccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCc
Q 001902 481 IEKNFVITD-PRLPDNPIIFASDSFLELTEYSREEILGRN-CRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGK 558 (998)
Q Consensus 481 ~~d~i~i~D-~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~-~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rkdG~ 558 (998)
+++++|.+| .+|. ++|+|+++++++||+.+|++|.. +..+++|++.......+...+..+..+..|++++++||+
T Consensus 2 a~~giw~~d~~~~~---~~~~n~~~~~l~G~~~~e~~~~~~~~~~ihpdd~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~ 78 (115)
T 3h9w_A 2 TKAIPWKINWQTMA---FEYIGPQIEALLGWPQGSWKSVEDWATRMHPEDQEWVVNFCVKQSECGVDHEADYRALHRDGH 78 (115)
T ss_dssp -CCEEEEEETTTTE---EEEECTHHHHHHCSCGGGCCBHHHHHHSBCHHHHHHHHHHHHHHHHTTCCEEEEEEEECTTSC
T ss_pred cceEEEEEEcCCCc---EEEEChhHHHHhCCChHHccCHHHHHHhcCHHHHHHHHHHHHHHHhcCCcccEEEEEEcCCCC
Confidence 568999999 5455 99999999999999999999932 345788998888888889999888889999999999999
Q ss_pred EEEEEEEEeeeccCC----EEEEEEecCCccccc
Q 001902 559 KFWNLFHLQPMRDQK----YFIGVQLDGSEHLEP 588 (998)
Q Consensus 559 ~~wv~~~~spi~d~~----~~vgi~rDITerk~~ 588 (998)
.+|+..+..|++|.+ +++|+..|||++|+.
T Consensus 79 ~~w~~~~~~~~~d~~G~~~~~~G~~~Dit~~k~~ 112 (115)
T 3h9w_A 79 YVWIRDVVHVVRDDSGEVEALIGFMFDISLEHHH 112 (115)
T ss_dssp EEEEEEEEEEEECTTSCEEEEEEEEEECGGGGC-
T ss_pred EEEEEEEEEEEECCCCCEEEEEEEEeccCccccc
Confidence 999999999998865 899999999999973
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} | Back alignment and structure |
|---|
Probab=99.41 E-value=4.3e-13 Score=125.42 Aligned_cols=118 Identities=20% Similarity=0.209 Sum_probs=90.1
Q ss_pred HHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEe
Q 001902 192 KDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYK 271 (998)
Q Consensus 192 ~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~ 271 (998)
+.++++++++|+++|. +|+|+++|+++++++||+.++++|+++..+++++........+...+..+.. ..++...+
T Consensus 2 ~~l~~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 77 (126)
T 3mjq_A 2 KNFLETIEDMILIINR---EGRLLYANTAVPKKLGYTHEELMSMHILTITSAGKMAEGEKILAELFAGKKE-SLPLSLEK 77 (126)
T ss_dssp CTTGGGCSSEEEEEET---TSBEEEECTHHHHHHSCCHHHHHHSBHHHHHCTTCHHHHHHHHHHHHHTCCS-EEEEEEEC
T ss_pred hhHHhhCCceEEEEeC---CCcEEEEcHHHHHHHCCCHHHHcCCCHHHHcCchhHHHHHHHHHHHHhCCCc-eeEEEEEc
Confidence 4578999999999998 7789999999999999999999999988887776665555666666666555 77888889
Q ss_pred cCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhc
Q 001902 272 KDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 315 (998)
Q Consensus 272 kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~ 315 (998)
++|..+|+.++..|+.+ +...+++++++|||++|++++++..
T Consensus 78 ~~g~~~~~~~~~~~~~~--~~~~~~~~~~~DITe~k~a~~~~~~ 119 (126)
T 3mjq_A 78 KEGTSIPAKARIWQGKW--HNEPCLFAIIKDLSKEERASSPPFL 119 (126)
T ss_dssp TTSCEEEEEEEEEEEES--SSSEEEEEEEEECC-----------
T ss_pred cCCCEEEEEEEEEeeeE--CCceEEEEEEEechHHHHhhcccch
Confidence 99999999999988765 3457889999999999999988554
|
| >3gdi_A Period circadian protein homolog 2; tandem PAS domains, biological rhythms, cytoplasm, nucleus, phosphoprotein, transcription; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.3e-12 Score=143.59 Aligned_cols=101 Identities=10% Similarity=0.062 Sum_probs=86.3
Q ss_pred ceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCC-cEE-EEEEEEecCCcEE
Q 001902 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT-DVT-VQLINYTKSGKKF 560 (998)
Q Consensus 483 d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~-~~~-~e~~~~rkdG~~~ 560 (998)
.-+...+.+|+ |+|+|+++..++||.++||+|++...++||++.....+.+.+.+..++ ... .++++++|||+.+
T Consensus 166 ~Fitrh~~dG~---~~yvd~~~~~lLGY~peELig~s~~~~iHpdD~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~v 242 (309)
T 3gdi_A 166 IFTTTHTPNCL---FQAVDERAVPLLGYLPQDLIETPVLVQLHPSDRPLMLAIHKKILQAGGQPFDYSPIRFRTRNGEYI 242 (309)
T ss_dssp EEEEEECTTCB---EEEECTTHHHHHSCCHHHHTTSBHHHHBCTTSHHHHHHHHHHHHHTTTCCEEEEEEEEECTTSCEE
T ss_pred eEEEEecCCCe---EEEECcccccccCcCHHHHcCCCHHHhCCHHHHHHHHHHHHHHHhcCCceeeceEEEEEccCCCEE
Confidence 46777888777 999999999999999999999999999999998888888888887554 455 6899999999999
Q ss_pred EEEEEEeeeccCC-----EEEEEEecCCccc
Q 001902 561 WNLFHLQPMRDQK-----YFIGVQLDGSEHL 586 (998)
Q Consensus 561 wv~~~~spi~d~~-----~~vgi~rDITerk 586 (998)
|++.+.+++.+.. .++|+-+-|+...
T Consensus 243 wvet~~~~~~np~s~~~e~ii~~h~v~~gp~ 273 (309)
T 3gdi_A 243 TLDTSWSSFINPWSRKISFIIGRHKVRVGPL 273 (309)
T ss_dssp EEEEEEEEEECTTTCCEEEEEEEEEEEECCS
T ss_pred EEEEEEEEEECCCCCcccEEEEEEEEccCCC
Confidence 9999988887653 7888877777654
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.9e-12 Score=118.36 Aligned_cols=106 Identities=14% Similarity=0.118 Sum_probs=86.8
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~ 553 (998)
|+.++++++++|+++|.+|+ |+++|++|++++||+.++++|+++..+. |+........+...+.++.....+....
T Consensus 5 ~~~~~~~~~~~i~~~d~~g~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (114)
T 3luq_A 5 LRLFTEHAPAALAMFDREMR---YLAVSRRWREDYGLGDGDILGMSHYDIF-PEIGEEWKSVHRRGLAGEVIRVEEDCFV 80 (114)
T ss_dssp HHHHHHTCSSEEEEEETTCB---EEEECHHHHHHTTCCSSCCTTCBHHHHC-TTCCHHHHHHHHHHHTTCCEEEEEEEEE
T ss_pred HHHHHhcCCceEEEEcCCcE---EEEECHHHHHHHCCCHHHHcCCcHHHHC-CccHHHHHHHHHHHhcCCcceeeeeEEE
Confidence 78899999999999999777 9999999999999999999999987776 5555665555666665444344444788
Q ss_pred ecCCcEEEEEEEEeeeccCC----EEEEEEecCC
Q 001902 554 TKSGKKFWNLFHLQPMRDQK----YFIGVQLDGS 583 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~----~~vgi~rDIT 583 (998)
+++|..+|+.++..|+.+.+ +++++++|||
T Consensus 81 ~~~g~~~~~~~~~~p~~~~~g~~~~~~~~~~DIT 114 (114)
T 3luq_A 81 RADGRTQWLRWEVRPWYEGEGRVGGVVIFTEDIT 114 (114)
T ss_dssp C--CCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred cCCCcEEEEEEEEEEeECCCCCEEEEEEEEeeCC
Confidence 99999999999999998765 7999999998
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A | Back alignment and structure |
|---|
Probab=99.40 E-value=4.8e-12 Score=119.13 Aligned_cols=118 Identities=27% Similarity=0.537 Sum_probs=101.0
Q ss_pred HHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCC--CCcccCCCCChHHHHHHHHHHHcCCcEEEE
Q 001902 189 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRN--CRFLQGAGTDPEDVAKIRETLQNGQSYCGR 266 (998)
Q Consensus 189 ~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~--~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e 266 (998)
+.+...++.++++++++|....+|+|+++|+++++++||+.++++|++ +..+.+++........+...+..+..+..+
T Consensus 19 ~~~~~~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (138)
T 2l0w_A 19 DTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVE 98 (138)
T ss_dssp HHHHHHHTTTTSEEEEEESSSTTCBEEEECSHHHHHHSCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHTTCSSCEEEE
T ss_pred HHHHHHHhcCCCCEEEEecCCCCCEEEEeCHHHHHHhCCCHHHHcCCCCcccccCCcccchhHHHHHHHHHhhcCCceeE
Confidence 445566777999999999732245699999999999999999999998 456667666666677788888888888888
Q ss_pred EEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhh
Q 001902 267 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306 (998)
Q Consensus 267 ~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITer 306 (998)
...++++|..+|+.+++.|+.+.+|.+.+++++++|||++
T Consensus 99 ~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~ 138 (138)
T 2l0w_A 99 IAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEK 138 (138)
T ss_dssp EEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEEEEEC
T ss_pred EEEECCCCCEEEEEEEEEEEeCCCCCEEEEEEEEEeccCC
Confidence 8889999999999999999999999999999999999975
|
| >3kx0_X Uncharacterized protein RV1364C/MT1410; PAS domain, sensory domain, mycobacteium tuberculos molecule binding domain; 2.30A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.39 E-value=3.9e-13 Score=136.94 Aligned_cols=132 Identities=11% Similarity=0.093 Sum_probs=91.3
Q ss_pred HHHHHhhcCceEEEEc-CCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEE
Q 001902 474 LATTLERIEKNFVITD-PRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D-~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~ 552 (998)
|+.++++++++|+++| .+|+ |+++|++|++++||+ +++|+++..+.++.........+...+..|.....+...
T Consensus 39 l~~l~~~~~~~i~~~d~~~g~---i~~~N~a~~~l~G~~--~~~G~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~ 113 (185)
T 3kx0_X 39 VRRIFEHIPAILVGLEGPDHR---FVAVNAAYRGFSPLL--DTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQSGSEWR 113 (185)
T ss_dssp HHHHHHHCSSEEEEEETTTTE---EEEECHHHHHHCCCC--SCTTSBHHHHCTTSCSSSSHHHHHHHHHHCCCEEEEEEE
T ss_pred HHHHHhcCCceEEEEECCCcE---EEEEcHHHHHHcCCc--cccCCcHHHHCCchhhhhHHHHHHHHHHcCCccccccee
Confidence 7899999999999999 9777 999999999999999 999999888888776666667788888788876555333
Q ss_pred E---ecC--CcEEEEEEEEeeeccCC----EEEEEEecCCccccccccCcchhhhhHHHHHHHHhhhhh
Q 001902 553 Y---TKS--GKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENV 612 (998)
Q Consensus 553 ~---rkd--G~~~wv~~~~spi~d~~----~~vgi~rDITerk~~~~~~~~e~~~~~~~~~~k~~~~~v 612 (998)
. +++ |..+|+.++++|+.+.+ +++++++|||++|+.+++ ....+++.++.++....++
T Consensus 114 ~~~~~~~~gg~~~~~~~~~~pi~~~~g~~~g~~~~~~DITerk~~e~~--~~~ll~~~~~~l~~~~~~~ 180 (185)
T 3kx0_X 114 LQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRARQA--AEARVEELSERYRNVRDSA 180 (185)
T ss_dssp EC--------CCEEEEEEEEEEECTTSCEEEEEEEEEECHHHHTTCC----------------------
T ss_pred EEeeccCCCCccEEEEEEEEEEECCCCCEEEEEEEEEeCCHHHHHHHH--HHHHHHHHHHHHHHHHhhh
Confidence 2 223 78899999999998765 799999999999973322 1222445555554444433
|
| >4dj2_A Period circadian protein homolog 1; PAS domains, circadian clock protein, protein binding; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.38 E-value=2e-12 Score=142.76 Aligned_cols=103 Identities=11% Similarity=0.079 Sum_probs=88.2
Q ss_pred CceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhc-CCcE-EEEEEEEecCCcE
Q 001902 482 EKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDN-QTDV-TVQLINYTKSGKK 559 (998)
Q Consensus 482 ~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~-g~~~-~~e~~~~rkdG~~ 559 (998)
.+-+...+.+|+ |+|+|+++..++||.++||+|+++..++||++.....+.+.+.+.. |... ..++++++|||++
T Consensus 176 ~~Fitrh~~dG~---~~yvd~~~~~lLGY~peELig~s~~~~vHPdD~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~ 252 (320)
T 4dj2_A 176 RIFTTRHTPSCL---FQDVDERAAPLLGYLPQDLLGAPVLLFLHPEDRPLMLAIHKKILQLAGQPFDHSPIRFCARNGEY 252 (320)
T ss_dssp CEEEEEECTTCB---EEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHTTSSSCCEECCCEEEECSSSCE
T ss_pred ceEEEEecCCce---EEEcCcceeccCCcChHHHcCCcHHHhCCHHHHHHHHHHHHHHHhcCCCcccceEEEEEccCCCE
Confidence 456777888777 9999999999999999999999999999999988888888888874 4445 4699999999999
Q ss_pred EEEEEEEeeeccCC-----EEEEEEecCCcccc
Q 001902 560 FWNLFHLQPMRDQK-----YFIGVQLDGSEHLE 587 (998)
Q Consensus 560 ~wv~~~~spi~d~~-----~~vgi~rDITerk~ 587 (998)
+|++.+.+++.+.. ++||.-+-|+....
T Consensus 253 vwvet~~~~~~np~s~~~e~II~~h~v~~gp~~ 285 (320)
T 4dj2_A 253 VTMDTSWAGFVHPWSRKVAFVLGRHKVRTAPLN 285 (320)
T ss_dssp EEEECEEEEEECTTTCSEEEEEEEEEESSCCSS
T ss_pred EEEEEEEEEEECCCCCCccEEEEEEEEccCCCC
Confidence 99999998888753 88898888887653
|
| >3mxq_A Sensor protein; PSI2, MCSG, structural genomics, protein structure initiativ midwest center for structural genomics; 2.78A {Vibrio cholerae o1 biovar el tor} | Back alignment and structure |
|---|
Probab=99.37 E-value=7.9e-13 Score=130.36 Aligned_cols=110 Identities=14% Similarity=0.161 Sum_probs=87.4
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEE----
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQ---- 549 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e---- 549 (998)
|+.+++++++||+++|.+|+ |++||+++++++|++++|++|+++.++.+. ........+..++..|.+....
T Consensus 24 l~~il~~~~~gi~v~D~~g~---I~~~N~a~~~~~G~~~~eviG~~~~~~~p~-~~~~~~~~l~~vl~~G~~~~~~~~~~ 99 (152)
T 3mxq_A 24 LSELLDQLSFALCIVRNDYV---IVKVNEYFESRVIFDGETMQGKNILELFPE-SADYLKRKIDTALVIESSSFSSWEQK 99 (152)
T ss_dssp HHHHHHHHCCEEEEEETTSB---EEEECHHHHHTSSSCHHHHTTSBHHHHSGG-GHHHHHHHHHHHHHHTSCEEEECCSS
T ss_pred HHHHHhcCCCCEEEEcCCCE---EEEECHHHHHHHCcCHHHHCCCCHHHhcCC-hHHHHHHHHHHHHhcCCceeeecccc
Confidence 78999999999999999888 999999999999999999999998888877 5555667788888888653221
Q ss_pred -----EEE---EecCCcEEEEEEEEeeeccCC----EEEEEEecCCcccc
Q 001902 550 -----LIN---YTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLE 587 (998)
Q Consensus 550 -----~~~---~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~ 587 (998)
+.. ..++|+.+|..++++|++|.+ +++++++|||+++.
T Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~ti~Pl~d~~G~v~gv~~ii~DVTe~~~ 149 (152)
T 3mxq_A 100 PHLLPFKSSRPVSGEEEQMYQNLEVIPIHSEDGTIEHVCLCVYDVTIQAS 149 (152)
T ss_dssp SCSSCC----------CCEEEEEEEEEEECTTSCEEEEEEEEEEEECC--
T ss_pred cccccccccCCCCCCCcEEEEEEEEEEEECCCCCEEEEEEEEEECCHHHh
Confidence 111 236778889999999999865 89999999999985
|
| >3mfx_A Sensory BOX/ggdef family protein; alpha-beta protein, structural genomics, PSI-2, protein structure initiative; 2.40A {Shewanella oneidensis} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.2e-12 Score=123.57 Aligned_cols=112 Identities=11% Similarity=0.065 Sum_probs=85.2
Q ss_pred HHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcC-------
Q 001902 188 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNG------- 260 (998)
Q Consensus 188 ~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g------- 260 (998)
.+.++.+++++++||+++|. +|+|+++|+++++++||+.+|++|+++..++++.........+......+
T Consensus 6 ~~~l~~i~~~~~d~i~~~D~---~g~I~~~N~aa~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (129)
T 3mfx_A 6 LETIELFIQHLTEAMILVNA---NGFIRSCNQRSAELLDCPQVSLKGQDWRNFLTEHHQARYDNLLSHDVQLGTNCGQPV 82 (129)
T ss_dssp HHHHHHHHTTCSSEEEEEET---TSBEEEECHHHHHHTTSCHHHHTTSBGGGGBCTTCCGGGGCTTC----------CCS
T ss_pred HHHHHHHHhcCCceEEEECC---CCEEEeEhHHHHHHHCcCHHHHcCCcHHHHcChHhHHHHHHHHHHHHhcCccccccc
Confidence 46789999999999999999 78899999999999999999999999998887766443222222111211
Q ss_pred CcEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchh
Q 001902 261 QSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 305 (998)
Q Consensus 261 ~~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITe 305 (998)
..+..++..+++||+.+|++++++|+.+ ++. .++++++|+..
T Consensus 83 ~~~~~E~~~~rkdG~~~~velsis~i~~--~~~-~~v~~~~~~~~ 124 (129)
T 3mfx_A 83 QHPAQETTLICASGKAKDVELSISYIPG--HEP-MFVMVMHDLEH 124 (129)
T ss_dssp CEEEEEEEEECTTSCEEEEEEEEEEECS--SSC-EEEEEEEEC--
T ss_pred CCCceEEEEEcCCCCEEEEEEEEEEecC--CCc-EEEEEEechhh
Confidence 1245788999999999999999999973 332 47889999753
|
| >3vol_A Aerotaxis transducer AER2; heme, oxygen sensor protein, PAS, HAMP, cyanoMet, CN-bound, protein; HET: HEM; 2.40A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.36 E-value=5.1e-12 Score=134.17 Aligned_cols=119 Identities=15% Similarity=0.209 Sum_probs=94.0
Q ss_pred ccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHc------------CCChhhhcCCCCCcccCCCCChHHHH
Q 001902 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMT------------GYTSKEVVGRNCRFLQGAGTDPEDVA 251 (998)
Q Consensus 184 l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~------------Gys~eEliG~~~~~l~~~~~~~~~~~ 251 (998)
+.....+++.++++++++|+++|. +|+|+|+|++|++++ ||+.++++|+++..+++. .....
T Consensus 17 ~~~e~~~l~~iLd~~~~~vii~D~---~g~I~~~N~a~~~ll~~~~~~~~~~l~G~~~~eliG~~~~~~~~~---~~~~~ 90 (233)
T 3vol_A 17 RGSHMARIKSALDNVSANVMIADN---DLNIIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFHKN---PAHQR 90 (233)
T ss_dssp -CTHHHHHHHHHTTSSSEEEEEET---TSBEEEECHHHHHHHHHTHHHHHTTCTTCCTTSCTTCBGGGGSSS---HHHHH
T ss_pred hHHHHHHHHHHHhcCCCcEEEECC---CCcEEEecHHHHHHHHHHHHHHHhhcCCCCHHHHcCCCHHHHcCC---HHHHH
Confidence 344557889999999999999999 888999999999999 899999999999877653 23333
Q ss_pred HHHHHHHcCCcEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhc
Q 001902 252 KIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 315 (998)
Q Consensus 252 ~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~ 315 (998)
.++..+. ..+..++. .+|. |+.++++|++|++|++.|++++++|||+++++|++++.
T Consensus 91 ~~~~~~~--~~~~~~~~---~~g~--~~~~~~~Pi~d~~G~~~g~v~~~~DITe~~~~e~ei~~ 147 (233)
T 3vol_A 91 HLLANLT--GVHKAELN---LGGR--RFSLDVVPVFNDANERLGSAVQWTDRTEEHRAEQEVSQ 147 (233)
T ss_dssp HHHHTCC--SCEEEEEE---ETTE--EEEEEEEEEECTTCCEEEEEEEEEECHHHHHHHHHHHH
T ss_pred HHHHhcc--cceeEEEE---ECCE--EEEEEEEEEECCCCCEEEEEEEEehhhHHHHHHHHHHH
Confidence 3433322 23444443 3563 77899999999999999999999999999999988543
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.3e-12 Score=120.80 Aligned_cols=107 Identities=11% Similarity=0.013 Sum_probs=97.5
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCC--ccccCCCCCHHHHHHHHHHHhcCCcEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNC--RFLQGPETDPATVRKIRAAIDNQTDVTVQLI 551 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~--~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~ 551 (998)
|+.++++++++|+.+|.+|. ++++|+++++++||+.++++|... ..+++|++.......+...+..+..+..|++
T Consensus 6 ~~~l~~~~~~~i~~~d~~~~---~~~~n~~~~~~~G~~~~~~~~~~~~~~~~i~p~d~~~~~~~~~~~~~~~~~~~~e~r 82 (118)
T 3icy_A 6 LQALVDNIPAAIYHLDVSGQ---ATIRFRPPAFLKTLVSEHAGTTRLNTLSMIHHDDRHMLSNAYSKLREAKHSLTLVYR 82 (118)
T ss_dssp HHHHHTTCCCCCEEECTTSC---EEECCCCCGGGGGGEEEETTEEEEGGGGGBCGGGHHHHHHHHHHHHHSCCEEEEEEE
T ss_pred HHHHHhcCCceEEEEEcCCC---ceEEechhHhhcCCCHHHccCChhHHHHHcCHHHHHHHHHHHHHHHhcCCCceEEEE
Confidence 78899999999999999887 999999999999999999988763 5678899888888888888888889999999
Q ss_pred EEecCCcEEEEEEEEeeeccCC----EEEEEEecCC
Q 001902 552 NYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGS 583 (998)
Q Consensus 552 ~~rkdG~~~wv~~~~spi~d~~----~~vgi~rDIT 583 (998)
.+++||+.+|+..+..|+.+++ +++|+++|||
T Consensus 83 ~~~~~g~~~w~~~~~~~~~~~~g~~~~~~g~~~DIT 118 (118)
T 3icy_A 83 IVTPEGKLHWIEDHMRSSFSDDGLFSGIDGILCEVT 118 (118)
T ss_dssp EECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 9999999999999999999875 6899999998
|
| >1v9y_A Heme PAS sensor protein; signaling protein; HET: HEM; 1.32A {Escherichia coli} SCOP: d.110.3.2 PDB: 1v9z_A* 1vb6_A* 1s67_L* 1s66_L* | Back alignment and structure |
|---|
Probab=99.32 E-value=5.9e-12 Score=123.85 Aligned_cols=112 Identities=23% Similarity=0.357 Sum_probs=86.5
Q ss_pred cHHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCc----EEE
Q 001902 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD----VTV 548 (998)
Q Consensus 473 ~l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~----~~~ 548 (998)
.|+.++++++++|+++|.+|. |+++|++|++++||+.++++|+++..+.++.........+......+.. +..
T Consensus 41 ~~~~~l~~~~~~i~~~d~~g~---i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 117 (167)
T 1v9y_A 41 IFFPALEQNMMGAVLINENDE---VMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSR 117 (167)
T ss_dssp CHHHHHHTCSSEEEEECTTSB---EEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------C
T ss_pred HHHHHHHhCCCCEEEECCCCc---EEEECHHHHHHhCCCHHHHcCCChhhccCccccchHHHHHHHHhhcCCCcccccce
Confidence 489999999999999999777 9999999999999999999999988887776655555555555555433 456
Q ss_pred EEEEEecCCcEEEEEEEEeeeccCC--EEEEEEecCCcccc
Q 001902 549 QLINYTKSGKKFWNLFHLQPMRDQK--YFIGVQLDGSEHLE 587 (998)
Q Consensus 549 e~~~~rkdG~~~wv~~~~spi~d~~--~~vgi~rDITerk~ 587 (998)
+....+++|..+|+.+++.|+.+++ +++++++|||++|+
T Consensus 118 ~~~~~~~~g~~~~~~~~~~~~~~~g~~~~~~~~~DiT~~~~ 158 (167)
T 1v9y_A 118 ELQLEKKDGSKIWTRFALSKVSAEGKVYYLALVRDASVEMA 158 (167)
T ss_dssp EEEEECTTSCEEEEEEEEEEEEETTEEEEEEEEEC------
T ss_pred EEEEEcCCCcEEEEEEEEEEEecCCCEEEEEEEecCcHHHH
Confidence 7888999999999999999996555 78999999999996
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 | Back alignment and structure |
|---|
Probab=99.32 E-value=1.7e-11 Score=110.01 Aligned_cols=103 Identities=30% Similarity=0.546 Sum_probs=87.4
Q ss_pred ceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCC--CccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 001902 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRN--CRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 560 (998)
Q Consensus 483 d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~--~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rkdG~~~ 560 (998)
++|+++|....++.|+++|++|++++||+.++++|++ ...+.+++........+...+..+..+..+....+++|+.+
T Consensus 2 ~~i~i~d~~~~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~ 81 (110)
T 1byw_A 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCF 81 (110)
T ss_dssp CEEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEE
T ss_pred CCEEEEeccCCCCcEEEECHHHHHHhCCCHHHHccCCCccccccCCcCCHHHHHHHHHHHhcCCCceEEEEEEcCCCCEE
Confidence 6899999752223399999999999999999999998 55566666666667778888888888899999999999999
Q ss_pred EEEEEEeeeccCC----EEEEEEecCCcc
Q 001902 561 WNLFHLQPMRDQK----YFIGVQLDGSEH 585 (998)
Q Consensus 561 wv~~~~spi~d~~----~~vgi~rDITer 585 (998)
|+.+++.|+.+.+ +++++++|||+|
T Consensus 82 ~~~~~~~~~~~~~g~~~~~~~~~~DiTe~ 110 (110)
T 1byw_A 82 LCLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred EEEEEEEEeecCCCCEEEEEEEEEeccCC
Confidence 9999999998765 789999999986
|
| >3eeh_A Putative light and redox sensing histidine kinase; structural genomic MCSG, protein structure initiative, midwest center for STRU genomics; HET: PG5; 1.95A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.32 E-value=3.2e-12 Score=118.06 Aligned_cols=106 Identities=8% Similarity=0.071 Sum_probs=91.4
Q ss_pred HHHHHhhcCceEEEEcCC-CCCCCEEEcCHHHHHHcCCChhhhcCCC--CccccCCCCCHHHHHHHHHHHhcCCcEEEEE
Q 001902 474 LATTLERIEKNFVITDPR-LPDNPIIFASDSFLELTEYSREEILGRN--CRFLQGPETDPATVRKIRAAIDNQTDVTVQL 550 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~-G~d~~I~~vN~a~~~l~Gy~~eEliG~~--~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~ 550 (998)
|+.++++++++++++|.+ |. |+++|+++++++||+.++++|++ +..+.+|++.......+.. +..+..+..++
T Consensus 13 ~~~~~~~~~~~i~~~d~~~~~---i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~e~ 88 (125)
T 3eeh_A 13 VRELTEATNDILWEFTADLSE---VLVINSAYEDIWGRSVAKLRENPHDFLNGIHPEDRELMKDTMQS-LMDGESADVEC 88 (125)
T ss_dssp HHHHHSCCCCEEEEEETTSSC---EEEECTHHHHHHSSCHHHHHHCGGGGGGGBCHHHHHHHHHHHHH-HHTTCCEEEEE
T ss_pred HHHHHhcCCceEEEEEcCCCc---EEEecHHHHHHHCCCHHHHccCcHHHHHhcCHHHHHHHHHHHHH-HHcCCCccEEE
Confidence 789999999999999997 77 99999999999999999999987 4556677666555555555 56777788999
Q ss_pred EEEecCCcEEEEEEEEeeeccCC----EEEEEEecCC
Q 001902 551 INYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGS 583 (998)
Q Consensus 551 ~~~rkdG~~~wv~~~~spi~d~~----~~vgi~rDIT 583 (998)
+..+++|+.+|+.++..|+.+.+ +++++++|||
T Consensus 89 ~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIT 125 (125)
T 3eeh_A 89 RVNATEEYQRWVWIQGEPITNDAGETVRVAGFARDIT 125 (125)
T ss_dssp EECGGGTTCEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEEcCCCCEEEEEEecEEEECCCCCEEEEEEEEEecC
Confidence 99999999999999999999854 7999999998
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A | Back alignment and structure |
|---|
Probab=99.30 E-value=1.9e-11 Score=114.98 Aligned_cols=109 Identities=28% Similarity=0.518 Sum_probs=95.6
Q ss_pred HHHHHhhcCceEEEEcC---CCCCCCEEEcCHHHHHHcCCChhhhcCCC--CccccCCCCCHHHHHHHHHHHhcCCcEEE
Q 001902 474 LATTLERIEKNFVITDP---RLPDNPIIFASDSFLELTEYSREEILGRN--CRFLQGPETDPATVRKIRAAIDNQTDVTV 548 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~---~G~d~~I~~vN~a~~~l~Gy~~eEliG~~--~~~l~~p~~~~~~~~~i~~~l~~g~~~~~ 548 (998)
+...+++++++|+++|. +|+ |+++|++|++++||+.++++|++ ...+.+++........+...+..+..+..
T Consensus 21 ~~~~~~~~~~~i~~~d~~~~~g~---i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (138)
T 2l0w_A 21 IIRKFEGQSRKFIIANARVENCA---VIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKV 97 (138)
T ss_dssp HHHHHTTTTSEEEEEESSSTTCB---EEEECSHHHHHHSCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHTTCSSCEEE
T ss_pred HHHHHhcCCCCEEEEecCCCCCE---EEEeCHHHHHHhCCCHHHHcCCCCcccccCCcccchhHHHHHHHHHhhcCCcee
Confidence 34567779999999999 888 99999999999999999999998 56677777777777788888888888889
Q ss_pred EEEEEecCCcEEEEEEEEeeeccCC----EEEEEEecCCcc
Q 001902 549 QLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEH 585 (998)
Q Consensus 549 e~~~~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITer 585 (998)
+....+++|+.+|+.+++.|+.+.+ +++++++|||+|
T Consensus 98 ~~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~ 138 (138)
T 2l0w_A 98 EIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEK 138 (138)
T ss_dssp EEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEEEEEC
T ss_pred EEEEECCCCCEEEEEEEEEEEeCCCCCEEEEEEEEEeccCC
Confidence 9999999999999999999998764 789999999986
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.5e-11 Score=119.41 Aligned_cols=103 Identities=39% Similarity=0.797 Sum_probs=89.9
Q ss_pred HHHHhhcCceEEEEc---CCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCC-----------CHHHHHHHHHHH
Q 001902 475 ATTLERIEKNFVITD---PRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPET-----------DPATVRKIRAAI 540 (998)
Q Consensus 475 ~~i~e~~~d~i~i~D---~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~-----------~~~~~~~i~~~l 540 (998)
..++++. ++|+++| .+|+ |+++|++|++++||+.+|++|+++..+.+++. .......+...+
T Consensus 29 ~~~~~~~-~~i~~~d~~d~~g~---i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 104 (149)
T 3d72_A 29 LGPVDTS-VALILCDLKQKDTP---IVYASEAFLYMTGYSNAEVLGRNCRFLQSPDGMVKPKSTRKYVDSNTINTMRKAI 104 (149)
T ss_dssp CCSCCTT-SCEEEEETTSTTCC---EEEECHHHHHHHCCCHHHHTTSCGGGGGSTTSCCCTTCCCSSSCHHHHHHHHHHH
T ss_pred HHhhcCC-ccEEEEeccCCCCc---EEEECHHHHHHHCcCHHHHcCCChhHhCCccccccccccccccChHHHHHHHHHH
Confidence 3466675 9999999 6777 99999999999999999999999888888774 667777888888
Q ss_pred hcCCcEEEEEEEEecCCcEEEEEEEEeeeccCC----EEEEEEec
Q 001902 541 DNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLD 581 (998)
Q Consensus 541 ~~g~~~~~e~~~~rkdG~~~wv~~~~spi~d~~----~~vgi~rD 581 (998)
..+..+..+...+++||+.+|+.++++|+++.+ +++++++|
T Consensus 105 ~~~~~~~~e~~~~~~dG~~~~~~~~~~~i~~~~g~~~~~v~~~~D 149 (149)
T 3d72_A 105 DRNAEVQVEVVNFKKNGQRFVNFLTMIPVRDETGEYRYSMGFQCE 149 (149)
T ss_dssp HHTCCEEEEEEEECTTCCEEEEEEEEEEEECTTSSEEEEEEECCC
T ss_pred HCCCceEEEEEEECCCCCEEEEEEEEEEEEcCCCCEEEEEEEEeC
Confidence 888889999999999999999999999999765 78888776
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=2.2e-11 Score=131.45 Aligned_cols=139 Identities=13% Similarity=0.074 Sum_probs=112.2
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEeeCCeEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lV 743 (998)
+.|++...++.|+++.||++.. .+..+++|+........ ...+..|+.+++.+. +..++++++++...+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 4799999999999999999975 46899999987532111 235778999999984 67788999999998999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-------------------------------------- 785 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-------------------------------------- 785 (998)
|||++|.+|.+.+.. ......++.+++.+|..||+
T Consensus 89 ~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 89 MSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 999999999876421 12234678899999999998
Q ss_pred ---------------------CCceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 786 ---------------------QGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 786 ---------------------~~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876566799999874
|
| >4hi4_A Aerotaxis transducer AER2; PAS domain, diatomic GAS sensor, signaling protein; HET: HEM GOL; 2.30A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.24 E-value=4.6e-11 Score=112.41 Aligned_cols=106 Identities=17% Similarity=0.256 Sum_probs=80.8
Q ss_pred HHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcC------------CChhhhcCCCCCcccCCCCChHHHHHHHH
Q 001902 188 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTG------------YTSKEVVGRNCRFLQGAGTDPEDVAKIRE 255 (998)
Q Consensus 188 ~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~G------------ys~eEliG~~~~~l~~~~~~~~~~~~i~~ 255 (998)
..+++++++++++||+++|. +|+|+|+|++|++++| |+.++++|+++..+.+. ......+..
T Consensus 4 ~~rl~~il~~~~~gviv~D~---~g~I~~~N~a~~~llg~~~~~i~~~~~g~~~~~~~G~~~~~~~~~---~~~~~~~~~ 77 (121)
T 4hi4_A 4 MARIASALDNVSANVMIADN---DLNIIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFHKN---PAHQRHLLA 77 (121)
T ss_dssp HHHHHHHHTTSSSEEEEEET---TCBEEEECHHHHHHHHHTHHHHHHHCTTCCGGGCTTCBGGGGCSS---HHHHHHHHH
T ss_pred HHHHHHHHhcCCccEEEEcC---CCeEEEecHHHHHHHHHHHHHHHHhcCCCChHHhcCCCHHHhcCC---HHHHHHHHh
Confidence 36789999999999999999 7789999999999995 89999999998877643 222223332
Q ss_pred HHHcCCcEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhh
Q 001902 256 TLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306 (998)
Q Consensus 256 ~l~~g~~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITer 306 (998)
.+. ..+..++. .+|. ++.++++|++|.+|++.|++++++|||++
T Consensus 78 ~~~--~~~~~~~~---~~~~--~~~~~~~pi~~~~g~~~g~v~~~~DiTee 121 (121)
T 4hi4_A 78 NLT--GVHKAELN---LGGR--RFSLDVVPVFNDANARLGSAVQWTDRTEE 121 (121)
T ss_dssp HCS--SCEEEEEE---ETTE--EEEEEEEEEECTTSCEEEEEEEEEECC--
T ss_pred CcC--CCcEEEEE---ECCE--EEEEEEEEEECCCCCEEEEEEEEEEecCC
Confidence 222 33444433 3554 55789999999999999999999999974
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=99.24 E-value=1e-11 Score=115.56 Aligned_cols=92 Identities=11% Similarity=0.065 Sum_probs=70.5
Q ss_pred HHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEec
Q 001902 476 TTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTK 555 (998)
Q Consensus 476 ~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rk 555 (998)
.++++++++|+++|.+|+ |+|+|+++++++||+++|++|+++..+.||++.......+. ..+.....++++++|
T Consensus 3 ~lle~~~d~i~v~d~~G~---i~yvn~~~~~~lGy~~~el~G~~~~~~ihp~D~~~~~~~~~---~~~~~~~~e~r~~~k 76 (111)
T 2vlg_A 3 FPLQTKTDIHAVLASNGR---IIYISANSKLHLGYLQGEMIGSFLKTFLHEEDQFLVESYFY---NEHHLMPCTFRFIKK 76 (111)
T ss_dssp ------CCEEEEECTTSB---EEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHHHHHHH---CSCCSSCEEEEEECT
T ss_pred chhhcCCCEEEEEcCCCe---EEEEChHHHHHhCCCHHHHcCCcHHHeECHhHHHHHHHHHh---ccCCCccEEEEEEcC
Confidence 478999999999999887 99999999999999999999999988999998776554432 223334568889999
Q ss_pred CCcEEEEEEEEeeeccCC
Q 001902 556 SGKKFWNLFHLQPMRDQK 573 (998)
Q Consensus 556 dG~~~wv~~~~spi~d~~ 573 (998)
||+.+|++++++++++..
T Consensus 77 dG~~~wve~~~~~v~~~~ 94 (111)
T 2vlg_A 77 DHTIVWVEAAVEIVTTRA 94 (111)
T ss_dssp TSCEEEEEEEEEEC----
T ss_pred CCCEEEEEEEEEEEeccc
Confidence 999999999999998765
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.23 E-value=5.5e-12 Score=117.90 Aligned_cols=108 Identities=11% Similarity=0.125 Sum_probs=76.4
Q ss_pred hHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEE
Q 001902 187 VSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGR 266 (998)
Q Consensus 187 ~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e 266 (998)
+++.|+.++++++++|+++|. +|+|+++|+++++++||+.++++|+++..+++++...............+...
T Consensus 17 ~~~~~~~i~~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 90 (125)
T 3fc7_A 17 TRKKFESLVSDSPDGIVHLTT---NGTILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLEAGKSAVENGTAT--- 90 (125)
T ss_dssp ---------CCSCCEEEEEET---TSBEEEECHHHHHHHTSCHHHHTTSBGGGSSCHHHHHHHHHHHHHHHHHTSCE---
T ss_pred HHHHHHHHHhcCCCeEEEEcC---CCeEEEECHHHHHHhCCCHHHHcCccHHHhCCHHHHHHHHHHHHHHhcCCCeE---
Confidence 778999999999999999999 77899999999999999999999999887774332222222234555666543
Q ss_pred EEEEecCCC-EEEEEeeeeEEeCCCCCEEEEEEEEecch
Q 001902 267 LLNYKKDGT-PFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (998)
Q Consensus 267 ~~~~~kdG~-~~w~~~~~spi~d~~G~v~~~v~i~~DIT 304 (998)
..++|. .+|+.+++.|+.+. |...+++++++|||
T Consensus 91 ---~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~~DIT 125 (125)
T 3fc7_A 91 ---RSEDAVGGRHYHNQYIPVDSH-RKSDTFQLVSRDIT 125 (125)
T ss_dssp ---EEEEEETTEEEEEEEEESSTT-TTTTEEEEEEEECC
T ss_pred ---EeEcCCCcEEEEEEEEeEecC-CCeEEEEEEEecCC
Confidence 234454 67999999998765 66678999999997
|
| >2qkp_A Uncharacterized protein; structural genomics, unknown function, PSI-2, protein struct initiative; 1.75A {Streptococcus mutans} | Back alignment and structure |
|---|
Probab=99.22 E-value=2.4e-11 Score=119.69 Aligned_cols=118 Identities=17% Similarity=0.176 Sum_probs=95.6
Q ss_pred HHHHHHHHHhcCCcEEEEecCCCCCceEEccHH---HHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEE
Q 001902 188 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAG---FFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYC 264 (998)
Q Consensus 188 ~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a---~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~ 264 (998)
.+.+.++|++++++|+++|. +|+|+|+|++ +++++| ..++++|+++..+.++. .......+...+++|....
T Consensus 18 ~~~l~~IL~~~~~gI~~vD~---~g~I~~~N~a~~~~~~i~g-~~~~~iGr~v~~~~~~~-~~~~v~~i~~~l~~g~~~~ 92 (151)
T 2qkp_A 18 VEQANLILNHLPLEITFVNK---DDIFQYYNDSVPAAEMVFK-RTPSQVGRNVELCHPPK-VLDKVKKVFELLRNGQRDK 92 (151)
T ss_dssp HHHHHHHHHHSSSEEEEEET---TSBEEEECCCSCGGGCSSC-CCGGGTTSBGGGSSCHH-HHHHHHHHHHHHHTTSBSE
T ss_pred HHHHHHHHHhCCCceEEEcC---CCeEEEEeCCCchhhhhcC-CCHHHcCCCHHHhCCHH-HHHHHHHHHHHHHcCCccE
Confidence 46789999999999999999 7779999999 999999 56789999998776532 2233456777788888766
Q ss_pred EEEEEEecC-CCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHH
Q 001902 265 GRLLNYKKD-GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKD 312 (998)
Q Consensus 265 ~e~~~~~kd-G~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~ 312 (998)
.+++....+ | .++.++..|++|++|++.|++.+++|||+.++++++
T Consensus 93 ~~~~~~~~~~~--~~v~v~~~Pi~d~~G~~~G~vev~~Dit~l~~le~~ 139 (151)
T 2qkp_A 93 VNMWFQSERLG--KFVYVTYAAVRDQAGDFQGVLEYVQDIKPFFELDSE 139 (151)
T ss_dssp EEEEEEETTTT--EEEEEEEEEEECTTCCEEEEEEEEEECGGGGGGGGC
T ss_pred EEEEEecCCCC--eEEEEEEEEEECCCCCEEEEEEEEEECHHHHhhhhh
Confidence 666653332 4 456788999999999999999999999999988776
|
| >3fg8_A Uncharacterized protein RHA05790; PAS domain, structural genomics, PS protein structure initiative, midwest center for structural genomics, MCSG; HET: 3PB; 1.80A {Rhodococcus SP} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.4e-11 Score=115.33 Aligned_cols=105 Identities=14% Similarity=0.085 Sum_probs=86.9
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~ 553 (998)
++.++++++++|+++|.+|+ |+++|+++++++||+.++++|+++..+.++.........+.+.+..+.....++...
T Consensus 14 ~~~il~~~~~~i~~~D~~g~---i~~~N~a~~~l~g~~~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (118)
T 3fg8_A 14 RENLYFQGGLGFMALDEDLR---IIYVNSGCLRHVRRSRDELLGRVVTEVLPETQGSYFDALCRKVLATGREQQTRVDSL 90 (118)
T ss_dssp CCCSSSCTTCEEEEECTTCB---EEEECHHHHHHHTCCHHHHTTSBHHHHCGGGTTSHHHHHHHHHHHHCCCEEEEEECS
T ss_pred HHHHHhhCCceEEEECCCCe---EEEECHHHHHHhCCCHHHHcCCcHHHHcCccchHHHHHHHHHHHHcCCceEEEEEEE
Confidence 45689999999999999777 999999999999999999999998888877666667778888888888877644333
Q ss_pred ecCCcEEEEEEEEeeeccCCEEEEEEecCCcc
Q 001902 554 TKSGKKFWNLFHLQPMRDQKYFIGVQLDGSEH 585 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~~~vgi~rDITer 585 (998)
..+| .|+.+++.|+.+ +++++++|||+|
T Consensus 91 ~~~g--~~~~~~~~p~~~--g~v~~~~DITer 118 (118)
T 3fg8_A 91 YSPG--MTIEVTAAADSG--ALVVHFRDVTAE 118 (118)
T ss_dssp SSTT--CEEEEEEEEETT--EEEEEEEECSCC
T ss_pred cCCC--eEEEEEEEEcCC--cEEEEEEeccCC
Confidence 3466 477888888754 589999999987
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.19 E-value=1.8e-11 Score=114.39 Aligned_cols=101 Identities=12% Similarity=0.108 Sum_probs=75.5
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~ 553 (998)
|+.++++++++|+++|.+|+ |+++|++|++++||+.++++|+++..+.+++...............+... .
T Consensus 21 ~~~i~~~~~~~i~~~d~~g~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 91 (125)
T 3fc7_A 21 FESLVSDSPDGIVHLTTNGT---ILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLEAGKSAVENGTAT------R 91 (125)
T ss_dssp -----CCSCCEEEEEETTSB---EEEECHHHHHHHTSCHHHHTTSBGGGSSCHHHHHHHHHHHHHHHHHTSCE------E
T ss_pred HHHHHhcCCCeEEEEcCCCe---EEEECHHHHHHhCCCHHHHcCccHHHhCCHHHHHHHHHHHHHHhcCCCeE------E
Confidence 78999999999999999887 99999999999999999999999887774332222323334555556543 3
Q ss_pred ecCCc-EEEEEEEEeeeccCC---EEEEEEecCC
Q 001902 554 TKSGK-KFWNLFHLQPMRDQK---YFIGVQLDGS 583 (998)
Q Consensus 554 rkdG~-~~wv~~~~spi~d~~---~~vgi~rDIT 583 (998)
.++|. .+|+.++++|+.+++ +++++++|||
T Consensus 92 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~DIT 125 (125)
T 3fc7_A 92 SEDAVGGRHYHNQYIPVDSHRKSDTFQLVSRDIT 125 (125)
T ss_dssp EEEEETTEEEEEEEEESSTTTTTTEEEEEEEECC
T ss_pred eEcCCCcEEEEEEEEeEecCCCeEEEEEEEecCC
Confidence 44566 789999999997765 8999999998
|
| >1ll8_A PAS kinase; PAS domain, ligand binding, ligand screening, kinase regulation, transferase; NMR {Homo sapiens} SCOP: d.110.3.5 | Back alignment and structure |
|---|
Probab=99.18 E-value=7.9e-12 Score=115.79 Aligned_cols=100 Identities=16% Similarity=0.214 Sum_probs=77.8
Q ss_pred hcCceEEEEcCC-CCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHH-Hhc-CCc---EEEEEEEE
Q 001902 480 RIEKNFVITDPR-LPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA-IDN-QTD---VTVQLINY 553 (998)
Q Consensus 480 ~~~d~i~i~D~~-G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~-l~~-g~~---~~~e~~~~ 553 (998)
+.+++|+++|.+ |+ |+++|++|++||||+++|++|+++..+.++..... ...+... +.. +.. ...+...+
T Consensus 6 ~~~~~i~~~d~~~g~---I~~~N~aa~~l~G~~~~el~g~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (114)
T 1ll8_A 6 EFNKAIFTVDAKTTE---ILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDV-VEALSEEHMEADGHAAVVFGTVVDII 81 (114)
T ss_dssp TTTCEEEEEETTTCB---EEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTHH-HHHTTSSTTSSSSCSSCCCSSSEEEC
T ss_pred CCCceEEEEECCCCe---EEEehHHHHHHhCCCHHHHcCCCHHHhcCcchhHH-HHHHHHHhhccCCcceeccCcEEEEE
Confidence 456899999997 77 99999999999999999999999888888764432 2222221 111 211 13456778
Q ss_pred ecCCcEEEEEEEEeeeccCC--EEEEEEecCC
Q 001902 554 TKSGKKFWNLFHLQPMRDQK--YFIGVQLDGS 583 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~--~~vgi~rDIT 583 (998)
+|||+.+|++++++|+.+++ +++++++|++
T Consensus 82 ~~dG~~~~v~~~~~~~~~~~~~~~v~~~~~~~ 113 (114)
T 1ll8_A 82 SRSGEKIPVSVWMKRMRQERRLCCVVVLEPVE 113 (114)
T ss_dssp CTTCCCEEEECCEECCBSSSSBEEEEEEEECC
T ss_pred ecCCCEEEEEEEEEeeccCCccEEEEEEeecC
Confidence 99999999999999998875 8999999986
|
| >4f3l_A Mclock, circadian locomoter output cycles protein kaput; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.18 E-value=2.3e-11 Score=137.80 Aligned_cols=108 Identities=11% Similarity=0.011 Sum_probs=96.9
Q ss_pred CcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCCEEEE
Q 001902 200 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWN 279 (998)
Q Consensus 200 d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~ 279 (998)
..++..|. ||+|+|+|++++.++||+++|++|+++..++||++.......++..+..|.....++++++|||..+|+
T Consensus 252 ~f~~~~~~---dg~~~~vn~~~~~ilGY~~eEl~g~~~~~~iHpdD~~~~~~~~~~~l~~g~~~~~eyR~~~kdG~~vWv 328 (361)
T 4f3l_A 252 EFTSRHSL---EWKFLFLDHRAPPIIGYLPFEVLGTSGYDYYHVDDLENLAKCHEHLMQYGKGKSCYYRFLTKGQQWIWL 328 (361)
T ss_dssp EEEEEECT---TSBEEEECTTSHHHHCCCHHHHTTSBGGGGBCHHHHHHHHHHHHHHHHHSEEECCCEEEECTTSEEEEE
T ss_pred eeEEEEcC---CceEEEECChhhhhhCcCHHHHcCCCHHHeECHHHHHHHHHHHHHHHhCCCcceEEEEEEecCCCEEEE
Confidence 44555555 888999999999999999999999999999999887777778888888888777889999999999999
Q ss_pred EeeeeEEeCC-CCCEEEEEEEEecchhhhHHH
Q 001902 280 LLTIAPIKDD-EGKVLKFIGMQVEVSKHTEGA 310 (998)
Q Consensus 280 ~~~~spi~d~-~G~v~~~v~i~~DITerk~~E 310 (998)
+.+..|++|. .|++.+++++.+|||+++..+
T Consensus 329 ~~~~~~v~~~~~g~~~~iv~~~~dITe~~~~~ 360 (361)
T 4f3l_A 329 QTHYYITYHQWNSRPEFIVCTHTVVSYAEVRA 360 (361)
T ss_dssp EEEEEEEECTTTCCEEEEEEEEEECCHHHHHH
T ss_pred EEEEEEEEcCCCCCeeEEEEEEEECChhHhhc
Confidence 9999999998 799999999999999998765
|
| >3fg8_A Uncharacterized protein RHA05790; PAS domain, structural genomics, PS protein structure initiative, midwest center for structural genomics, MCSG; HET: 3PB; 1.80A {Rhodococcus SP} | Back alignment and structure |
|---|
Probab=99.17 E-value=9.5e-12 Score=116.50 Aligned_cols=110 Identities=17% Similarity=0.133 Sum_probs=87.1
Q ss_pred chHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEE
Q 001902 186 RVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG 265 (998)
Q Consensus 186 ~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 265 (998)
...+.+++++++++++|+++|. +|+|+++|+++++++||+.++++|+++..++++.........+..++..+.....
T Consensus 9 ~~~~~~~~il~~~~~~i~~~D~---~g~i~~~N~a~~~l~g~~~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (118)
T 3fg8_A 9 HHSSGRENLYFQGGLGFMALDE---DLRIIYVNSGCLRHVRRSRDELLGRVVTEVLPETQGSYFDALCRKVLATGREQQT 85 (118)
T ss_dssp ----CCCCSSSCTTCEEEEECT---TCBEEEECHHHHHHHTCCHHHHTTSBHHHHCGGGTTSHHHHHHHHHHHHCCCEEE
T ss_pred cccchHHHHHhhCCceEEEECC---CCeEEEECHHHHHHhCCCHHHHcCCcHHHHcCccchHHHHHHHHHHHHcCCceEE
Confidence 4445566789999999999998 7889999999999999999999999988887766666677788888898888777
Q ss_pred EEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhh
Q 001902 266 RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306 (998)
Q Consensus 266 e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITer 306 (998)
++.....+| .|+.+++.|+.+ |++++++|||++
T Consensus 86 ~~~~~~~~g--~~~~~~~~p~~~------g~v~~~~DITer 118 (118)
T 3fg8_A 86 RVDSLYSPG--MTIEVTAAADSG------ALVVHFRDVTAE 118 (118)
T ss_dssp EEECSSSTT--CEEEEEEEEETT------EEEEEEEECSCC
T ss_pred EEEEEcCCC--eEEEEEEEEcCC------cEEEEEEeccCC
Confidence 443333466 478888889743 378899999985
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=99.16 E-value=3.3e-11 Score=112.15 Aligned_cols=94 Identities=17% Similarity=0.104 Sum_probs=68.4
Q ss_pred HHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEec
Q 001902 193 DALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKK 272 (998)
Q Consensus 193 ~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~k 272 (998)
.++++++++|+++|. +|+|+|+|+++++++||+.+|++|+++..+++|++.......+. ..+.....++++++|
T Consensus 3 ~lle~~~d~i~v~d~---~G~i~yvn~~~~~~lGy~~~el~G~~~~~~ihp~D~~~~~~~~~---~~~~~~~~e~r~~~k 76 (111)
T 2vlg_A 3 FPLQTKTDIHAVLAS---NGRIIYISANSKLHLGYLQGEMIGSFLKTFLHEEDQFLVESYFY---NEHHLMPCTFRFIKK 76 (111)
T ss_dssp ------CCEEEEECT---TSBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHHHHHHH---CSCCSSCEEEEEECT
T ss_pred chhhcCCCEEEEEcC---CCeEEEEChHHHHHhCCCHHHHcCCcHHHeECHhHHHHHHHHHh---ccCCCccEEEEEEcC
Confidence 478999999999998 78899999999999999999999999988888877554433321 223334567888999
Q ss_pred CCCEEEEEeeeeEEeCCCCC
Q 001902 273 DGTPFWNLLTIAPIKDDEGK 292 (998)
Q Consensus 273 dG~~~w~~~~~spi~d~~G~ 292 (998)
||+.+|++++++++.+..+.
T Consensus 77 dG~~~wve~~~~~v~~~~~~ 96 (111)
T 2vlg_A 77 DHTIVWVEAAVEIVTTRAER 96 (111)
T ss_dssp TSCEEEEEEEEEEC------
T ss_pred CCCEEEEEEEEEEEecccCC
Confidence 99999999999999887553
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.1e-10 Score=107.93 Aligned_cols=107 Identities=21% Similarity=0.254 Sum_probs=84.5
Q ss_pred HHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcE-EEEEE
Q 001902 190 IVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSY-CGRLL 268 (998)
Q Consensus 190 ~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~-~~e~~ 268 (998)
+...+++++++||+++|. +|+|+++|+++++++||+.++++|+++..++++... ....+..++..+... ..+..
T Consensus 8 l~~~il~~~~~~i~~~D~---~g~I~~~N~aa~~l~g~~~~~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 82 (115)
T 3b33_A 8 LPSAILNNMVTATLILDD---GLAIRYANPAAELLFSQSAKRIVEQSLSQLIQHASL--DLALLTQPLQSGQSITDSDVT 82 (115)
T ss_dssp HHHHHHHHCSSEEEEECT---TCBEEEECHHHHHHTTSCHHHHTTCBHHHHCSEEEC--CTHHHHHHHHHCCCEEEEEEE
T ss_pred cHHHHHhhcCceEEEECC---CCcEEEECHHHHHHhCCCHHHHhCCCHHHHhCccch--hhHHHHHHHHcCCcccCCceE
Confidence 455699999999999999 777999999999999999999999998766553221 123445566666653 35566
Q ss_pred EEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecch
Q 001902 269 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (998)
Q Consensus 269 ~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DIT 304 (998)
.. ++|..+|+.++++|+.+ +|. .+++.+++||+
T Consensus 83 ~~-~~g~~~~~~~~~~pi~~-~g~-~~~l~~~~Di~ 115 (115)
T 3b33_A 83 FV-VDGRPLMLEVTVSPITW-QRQ-LMLLVEMRKID 115 (115)
T ss_dssp EE-ETTEEEEEEEEEEEEEE-TTE-EEEEEEEEEC-
T ss_pred Ee-cCCCEEEEEEEEEEeec-CCc-eEEEEEEEeCC
Confidence 55 88999999999999998 775 68899999985
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} | Back alignment and structure |
|---|
Probab=99.10 E-value=2.8e-10 Score=105.06 Aligned_cols=104 Identities=13% Similarity=0.101 Sum_probs=82.2
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCc-EEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD-VTVQLIN 552 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~-~~~e~~~ 552 (998)
...+++++++||+++|.+|+ |+++|+++++++||+.++++|+++..+.++... ....+.+.+..+.. ...+...
T Consensus 9 ~~~il~~~~~~i~~~D~~g~---I~~~N~aa~~l~g~~~~~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 83 (115)
T 3b33_A 9 PSAILNNMVTATLILDDGLA---IRYANPAAELLFSQSAKRIVEQSLSQLIQHASL--DLALLTQPLQSGQSITDSDVTF 83 (115)
T ss_dssp HHHHHHHCSSEEEEECTTCB---EEEECHHHHHHTTSCHHHHTTCBHHHHCSEEEC--CTHHHHHHHHHCCCEEEEEEEE
T ss_pred HHHHHhhcCceEEEECCCCc---EEEECHHHHHHhCCCHHHHhCCCHHHHhCccch--hhHHHHHHHHcCCcccCCceEE
Confidence 46699999999999999888 999999999999999999999997766554321 12334555666655 3456666
Q ss_pred EecCCcEEEEEEEEeeeccCC--EEEEEEecCC
Q 001902 553 YTKSGKKFWNLFHLQPMRDQK--YFIGVQLDGS 583 (998)
Q Consensus 553 ~rkdG~~~wv~~~~spi~d~~--~~vgi~rDIT 583 (998)
. ++|+.+|+.++++|+.+++ +++.+++||+
T Consensus 84 ~-~~g~~~~~~~~~~pi~~~g~~~~l~~~~Di~ 115 (115)
T 3b33_A 84 V-VDGRPLMLEVTVSPITWQRQLMLLVEMRKID 115 (115)
T ss_dssp E-ETTEEEEEEEEEEEEEETTEEEEEEEEEEC-
T ss_pred e-cCCCEEEEEEEEEEeecCCceEEEEEEEeCC
Confidence 5 8999999999999998854 7999999985
|
| >4f3l_B BMAL1B; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.09 E-value=9.6e-11 Score=133.83 Aligned_cols=108 Identities=12% Similarity=0.025 Sum_probs=90.7
Q ss_pred cCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCc-EEEEEEEEecCCCE
Q 001902 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS-YCGRLLNYKKDGTP 276 (998)
Q Consensus 198 ~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~-~~~e~~~~~kdG~~ 276 (998)
..+.++..|. ||+|+|+|++++.++||+++|++|+++..++||++.......+...+..++. ...++++++|||..
T Consensus 277 ~~~fi~~~~~---dg~~~~vn~~~~~ilGY~~eEl~g~~~~~~iHpdD~~~~~~~~~~~l~~~~~~~~~eyR~~~kdG~~ 353 (387)
T 4f3l_B 277 SMEYVSRHAI---DGKFVFVDQRATAILAYLPQELLGTSCYEYFHQDDIGHLAECHRQVLQTREKITTNCYKFKIKDGSF 353 (387)
T ss_dssp CCEEEEEECT---TSBEEEECTHHHHHHCCCHHHHTTSBGGGTBCHHHHHHHHHHHHHHTTCSSCEECCCEEEECTTSCE
T ss_pred CceEEEEECC---CCEEEEECCCcccccCCCHHHHcCCcHHHeeCHHHHHHHHHHHHHHHhcCCCeeeEEEEEEccCCCE
Confidence 4556666776 8889999999999999999999999999999988877777777777766554 55799999999999
Q ss_pred EEEEeeeeEEeCC-CCCEEEEEEEEecchhhhH
Q 001902 277 FWNLLTIAPIKDD-EGKVLKFIGMQVEVSKHTE 308 (998)
Q Consensus 277 ~w~~~~~spi~d~-~G~v~~~v~i~~DITerk~ 308 (998)
+|++.+..+++|. .|++.+++|+.+|||+||+
T Consensus 354 vWv~~~~~~~~~~~~g~~~~ivg~~~dIT~Rk~ 386 (387)
T 4f3l_B 354 ITLRSRWFSFMNPWTKEVEYIVSTNTVVLANVL 386 (387)
T ss_dssp EEEEEEEEEEEETTTTEEEEEEEEEEECC----
T ss_pred EEEEEEEEEEECCCCCCEEEEEEEEEEcchhhc
Confidence 9999999999987 7889999999999999984
|
| >1ll8_A PAS kinase; PAS domain, ligand binding, ligand screening, kinase regulation, transferase; NMR {Homo sapiens} SCOP: d.110.3.5 | Back alignment and structure |
|---|
Probab=99.06 E-value=5.6e-11 Score=109.99 Aligned_cols=102 Identities=15% Similarity=0.233 Sum_probs=75.8
Q ss_pred hcCCcEEEEecCCCC-CceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHH-HHc-CCc---EEEEEEEE
Q 001902 197 TFQQTFVVSDATKPD-YPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRET-LQN-GQS---YCGRLLNY 270 (998)
Q Consensus 197 ~~~d~i~i~D~~g~d-G~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~-l~~-g~~---~~~e~~~~ 270 (998)
+.+++|+++|. + |+|+++|+++++++||+.+|++|+++..++++..... ...+... +.. +.. ...++..+
T Consensus 6 ~~~~~i~~~d~---~~g~I~~~N~aa~~l~G~~~~el~g~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (114)
T 1ll8_A 6 EFNKAIFTVDA---KTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDV-VEALSEEHMEADGHAAVVFGTVVDII 81 (114)
T ss_dssp TTTCEEEEEET---TTCBEEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTHH-HHHTTSSTTSSSSCSSCCCSSSEEEC
T ss_pred CCCceEEEEEC---CCCeEEEehHHHHHHhCCCHHHHcCCCHHHhcCcchhHH-HHHHHHHhhccCCcceeccCcEEEEE
Confidence 34579999998 6 7799999999999999999999999998887754332 2222221 111 111 12346678
Q ss_pred ecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecch
Q 001902 271 KKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (998)
Q Consensus 271 ~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DIT 304 (998)
++||+.+|+.++++|+.+.++ .+++++++|++
T Consensus 82 ~~dG~~~~v~~~~~~~~~~~~--~~~v~~~~~~~ 113 (114)
T 1ll8_A 82 SRSGEKIPVSVWMKRMRQERR--LCCVVVLEPVE 113 (114)
T ss_dssp CTTCCCEEEECCEECCBSSSS--BEEEEEEEECC
T ss_pred ecCCCEEEEEEEEEeeccCCc--cEEEEEEeecC
Confidence 999999999999999987554 36789999986
|
| >4hi4_A Aerotaxis transducer AER2; PAS domain, diatomic GAS sensor, signaling protein; HET: HEM GOL; 2.30A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.06 E-value=7.6e-10 Score=103.96 Aligned_cols=99 Identities=20% Similarity=0.310 Sum_probs=73.2
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcC------------CChhhhcCCCCccccCCCCCHHHHHHHHHHHh
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTE------------YSREEILGRNCRFLQGPETDPATVRKIRAAID 541 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~G------------y~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~ 541 (998)
|+++++++++||+++|.+|+ |+++|++|++|+| |+.++++|++...+.+. ......+...+.
T Consensus 7 l~~il~~~~~gviv~D~~g~---I~~~N~a~~~llg~~~~~i~~~~~g~~~~~~~G~~~~~~~~~---~~~~~~~~~~~~ 80 (121)
T 4hi4_A 7 IASALDNVSANVMIADNDLN---IIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFHKN---PAHQRHLLANLT 80 (121)
T ss_dssp HHHHHTTSSSEEEEEETTCB---EEEECHHHHHHHHHTHHHHHHHCTTCCGGGCTTCBGGGGCSS---HHHHHHHHHHCS
T ss_pred HHHHHhcCCccEEEEcCCCe---EEEecHHHHHHHHHHHHHHHHhcCCCChHHhcCCCHHHhcCC---HHHHHHHHhCcC
Confidence 78999999999999999888 9999999999995 99999999998776642 222333333332
Q ss_pred cCCcEEEEEEEEecCCcEEEEEEEEeeeccCC----EEEEEEecCCcc
Q 001902 542 NQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEH 585 (998)
Q Consensus 542 ~g~~~~~e~~~~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITer 585 (998)
..+..++. .+|. ++.++++|+.+.+ +++++++|||++
T Consensus 81 --~~~~~~~~---~~~~--~~~~~~~pi~~~~g~~~g~v~~~~DiTee 121 (121)
T 4hi4_A 81 --GVHKAELN---LGGR--RFSLDVVPVFNDANARLGSAVQWTDRTEE 121 (121)
T ss_dssp --SCEEEEEE---ETTE--EEEEEEEEEECTTSCEEEEEEEEEECC--
T ss_pred --CCcEEEEE---ECCE--EEEEEEEEEECCCCCEEEEEEEEEEecCC
Confidence 23443332 3555 4577899999754 899999999985
|
| >3vol_A Aerotaxis transducer AER2; heme, oxygen sensor protein, PAS, HAMP, cyanoMet, CN-bound, protein; HET: HEM; 2.40A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.05 E-value=4.8e-10 Score=118.85 Aligned_cols=101 Identities=19% Similarity=0.311 Sum_probs=79.6
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHc------------CCChhhhcCCCCccccCCCCCHHHHHHHHHHHh
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELT------------EYSREEILGRNCRFLQGPETDPATVRKIRAAID 541 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~------------Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~ 541 (998)
++.++++++++|+++|.+|+ |+|+|++|++++ ||++++++|+++..+.+. ......++..+.
T Consensus 24 l~~iLd~~~~~vii~D~~g~---I~~~N~a~~~ll~~~~~~~~~~l~G~~~~eliG~~~~~~~~~---~~~~~~~~~~~~ 97 (233)
T 3vol_A 24 IKSALDNVSANVMIADNDLN---IIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFHKN---PAHQRHLLANLT 97 (233)
T ss_dssp HHHHHTTSSSEEEEEETTSB---EEEECHHHHHHHHHTHHHHHTTCTTCCTTSCTTCBGGGGSSS---HHHHHHHHHTCC
T ss_pred HHHHHhcCCCcEEEECCCCc---EEEecHHHHHHHHHHHHHHHhhcCCCCHHHHcCCCHHHHcCC---HHHHHHHHHhcc
Confidence 68899999999999999888 999999999998 899999999998877642 333444444433
Q ss_pred cCCcEEEEEEEEecCCcEEEEEEEEeeeccCC----EEEEEEecCCcccc
Q 001902 542 NQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLE 587 (998)
Q Consensus 542 ~g~~~~~e~~~~rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~ 587 (998)
. .+..++ +.+|. |+.++++|+.|++ +++++++|||++++
T Consensus 98 ~--~~~~~~---~~~g~--~~~~~~~Pi~d~~G~~~g~v~~~~DITe~~~ 140 (233)
T 3vol_A 98 G--VHKAEL---NLGGR--RFSLDVVPVFNDANERLGSAVQWTDRTEEHR 140 (233)
T ss_dssp S--CEEEEE---EETTE--EEEEEEEEEECTTCCEEEEEEEEEECHHHHH
T ss_pred c--ceeEEE---EECCE--EEEEEEEEEECCCCCEEEEEEEEehhhHHHH
Confidence 2 344443 34664 6788999999864 89999999999986
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.04 E-value=4.4e-10 Score=120.52 Aligned_cols=135 Identities=13% Similarity=0.084 Sum_probs=100.0
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCC--ccceeEEEeeCCeEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF--VPALYASFQTKTHVCL 742 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~l~~~~~~~~~~~l 742 (998)
.+|.+....+.|..+.||++.. .+|..+++|+.... ....+..|..+++.+.+.+ +++++.+....+..++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 3555544444666799999964 56778999987643 1134667899998885434 5678888888888999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------------------
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG----------------------------------- 787 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~----------------------------------- 787 (998)
||||++|.+|. ... .. ...++.+++..|..||+..
T Consensus 93 v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 93 LLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 99999998884 211 12 2356677888888888643
Q ss_pred -----------------------ceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 788 -----------------------IIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 788 -----------------------IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
++|+|++|+|||++.++.+.|+|||.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998743
|
| >3a0r_A Sensor protein; four helix bundle, PAS fold, kinase, phosphoprotein, transfe two-component regulatory system; 3.80A {Thermotoga maritima} | Back alignment and structure |
|---|
Probab=99.00 E-value=3.1e-10 Score=127.41 Aligned_cols=130 Identities=15% Similarity=0.102 Sum_probs=91.2
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~ 553 (998)
++.++++++++|+++|.+|+ |+++|++|+++|||+++|++|+++..+.+++ .....+...+..+.....+
T Consensus 10 ~~~i~~~~~~~i~~~d~~g~---i~~~N~a~~~l~G~~~~e~~G~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~---- 79 (349)
T 3a0r_A 10 SESILESLETAIITLSKDGR---ITEWNKKAEQLFGLKKENVLGRRLKDLPDFE---EIGSVAESVFENKEPVFLN---- 79 (349)
T ss_dssp CCSSGGGSSSEEEEEESSSB---CSCBCHHHHHHHSCCSTTTTTCBSTTSTTTT---HHHHHHHHHHHHCCCCEEE----
T ss_pred HHHHHhhhcCeEEEECCCCC---EEeeHHHHHHHhCCCHHHHcCcCHHHCcChh---HHHHHHHHHHhcCCceeec----
Confidence 56799999999999999887 9999999999999999999999987773322 3334455555556543322
Q ss_pred ecCCcEEEEEEEEeeeccCC-----EEEEEEecCCccccccccCcchhhhhHHHHHHHHhhhhhh
Q 001902 554 TKSGKKFWNLFHLQPMRDQK-----YFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVN 613 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~-----~~vgi~rDITerk~~~~~~~~e~~~~~~~~~~k~~~~~v~ 613 (998)
...+..+|+.++++|+.+.+ +++++++|||++|+.+++....+.++....++....|.+.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~DiTe~~~~e~~~~~~~~~~~~~~~~~~i~Helr 144 (349)
T 3a0r_A 80 FYKFGERYFNIRFSPFRNAKTQLLEGVIITIDDVTELYKYEEERKRRERLSILGEMTARVAHEIR 144 (349)
T ss_dssp CCCBTTBCCEEEEEEECCTTTTSSCEEEEEEECCSTTTTTTTTTTHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccCceEEEEEEEEEEcCCCceeeEEEEEEEechHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc
Confidence 12223357888899998764 7999999999999855554444444444444444444433
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=1e-09 Score=124.15 Aligned_cols=142 Identities=18% Similarity=0.277 Sum_probs=106.9
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEee--cccccChhHHHHHHHHHHHHHhCC--CCCccceeEEEeeC---Ce
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD--KGVMLNRNKVHRACAEREILDMLD--HPFVPALYASFQTK---TH 739 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~--~~~~~~~~~~~~~~~E~~il~~l~--h~nIv~l~~~~~~~---~~ 739 (998)
...++.|+.|.++.||++.. .+..+++|+.. ..... .....+.+|..+++.+. +..+++++.++.+. +.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 34567899999999999986 34688899775 33211 12346778999999996 45578888888765 45
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC---------------------------------- 785 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~---------------------------------- 785 (998)
.|+||||++|.++.+... ..++......++.+++..|+.||+
T Consensus 116 ~~~vme~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp CEEEEECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred eEEEEEecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 899999999988854221 237788889999999999999997
Q ss_pred ------------------------CCceeccCCCCcEEEecCCc--EEEEeccCccc
Q 001902 786 ------------------------QGIIYRDLKPENVLLQGNGH--VSLTDFDLSCL 816 (998)
Q Consensus 786 ------------------------~~IiHrDLkP~NILi~~~g~--vkL~DFG~a~~ 816 (998)
..++|+|++|+|||++.++. +.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997753 68999998854
|
| >2w0n_A Sensor protein DCUS; signal transduction, two-component regulatory system, PAS, kinase, membrane, transferase, solid state cell inner membrane; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.7e-10 Score=106.11 Aligned_cols=109 Identities=11% Similarity=0.153 Sum_probs=85.8
Q ss_pred cccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCC---ChhhhcCCCCCcccCCCCChHHHHHHHHHH
Q 001902 181 EKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGY---TSKEVVGRNCRFLQGAGTDPEDVAKIRETL 257 (998)
Q Consensus 181 e~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gy---s~eEliG~~~~~l~~~~~~~~~~~~i~~~l 257 (998)
.+++...++.++.++++++++|+++|. +|+|+++|+++++++|| +.++++|+++..+.++.. +...+
T Consensus 7 ~~~l~~~~~~~~~il~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~~~~g~~~~~~~~~~~-------~~~~~ 76 (118)
T 2w0n_A 7 PYEISTLFEQRQAMLQSIKEGVVAVDD---RGEVTLINDAAQELLNYRKSQDDEKLSTLSHSWSQVVD-------VSEVL 76 (118)
T ss_dssp HHHHCTTHHHHHHHHHCCCCCCEEEBT---TTBCCCBCHHHHHHHCSCTTTTTSSCCCTTCCCSCTHH-------HHHHH
T ss_pred HHHHHHHHHHHHHHHhhccccEEEECC---CCcEeehhHHHHHHhCCCccChhhhhccCcccccCchh-------HHHHh
Confidence 445777888999999999999999998 77799999999999998 889999999887765421 44555
Q ss_pred HcCCcEEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecch
Q 001902 258 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (998)
Q Consensus 258 ~~g~~~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DIT 304 (998)
..+....... ...+| .|+.++..|+.+ +|++.|++++++|||
T Consensus 77 ~~~~~~~~~~--~~~~~--~~~~~~~~p~~~-~g~~~g~v~~~~DiT 118 (118)
T 2w0n_A 77 RDGTPRRDEE--ITIKD--RLLLINTVPVRS-NGVIIGAISTFRDKT 118 (118)
T ss_dssp HTTCCCCCCC--EESSS--CEECCCEECCCC-SSCCCCEEECCCCCC
T ss_pred ccCceeccEE--EEECC--EEEEEeeceeee-CCEEEEEEEEEEeCC
Confidence 5555432211 23456 477888999987 788889999999997
|
| >3a0r_A Sensor protein; four helix bundle, PAS fold, kinase, phosphoprotein, transfe two-component regulatory system; 3.80A {Thermotoga maritima} | Back alignment and structure |
|---|
Probab=98.97 E-value=4.1e-10 Score=126.38 Aligned_cols=121 Identities=11% Similarity=0.112 Sum_probs=89.7
Q ss_pred ccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcE
Q 001902 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSY 263 (998)
Q Consensus 184 l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~ 263 (998)
+++++++++.++++++++|+++|. +|+|+++|++|++++||+.++++|+++..+.++ ......+...+..+...
T Consensus 3 l~~~~~~~~~i~~~~~~~i~~~d~---~g~i~~~N~a~~~l~G~~~~e~~G~~~~~~~~~---~~~~~~~~~~~~~~~~~ 76 (349)
T 3a0r_A 3 VEHLRNFSESILESLETAIITLSK---DGRITEWNKKAEQLFGLKKENVLGRRLKDLPDF---EEIGSVAESVFENKEPV 76 (349)
T ss_dssp ------CCCSSGGGSSSEEEEEES---SSBCSCBCHHHHHHHSCCSTTTTTCBSTTSTTT---THHHHHHHHHHHHCCCC
T ss_pred hHHHHHHHHHHHhhhcCeEEEECC---CCCEEeeHHHHHHHhCCCHHHHcCcCHHHCcCh---hHHHHHHHHHHhcCCce
Confidence 455667788899999999999999 788999999999999999999999998877332 23344455566666554
Q ss_pred EEEEEEEecCCCEEEEEeeeeEEeCCCCCE-EEEEEEEecchhhhHHHHHhh
Q 001902 264 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKV-LKFIGMQVEVSKHTEGAKDKM 314 (998)
Q Consensus 264 ~~e~~~~~kdG~~~w~~~~~spi~d~~G~v-~~~v~i~~DITerk~~E~~l~ 314 (998)
.... ..+...|+.++++|+.+.+|.. .|++++++|||+++++|++++
T Consensus 77 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~DiTe~~~~e~~~~ 124 (349)
T 3a0r_A 77 FLNF----YKFGERYFNIRFSPFRNAKTQLLEGVIITIDDVTELYKYEEERK 124 (349)
T ss_dssp EEEC----CCBTTBCCEEEEEEECCTTTTSSCEEEEEEECCSTTTTTTTTTT
T ss_pred eecc----cccCceEEEEEEEEEEcCCCceeeEEEEEEEechHHHHHHHHHH
Confidence 3321 2223347888999999888775 589999999999999887654
|
| >3cax_A Uncharacterized protein PF0695; structural genomics, unknown function, PSI-2, protein struct initiative; 2.43A {Pyrococcus furiosus dsm 3638} | Back alignment and structure |
|---|
Probab=98.96 E-value=8.3e-10 Score=125.19 Aligned_cols=120 Identities=13% Similarity=0.180 Sum_probs=97.7
Q ss_pred ccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcE
Q 001902 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSY 263 (998)
Q Consensus 184 l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~ 263 (998)
.....+.++++|+++++||+++|. +|+|+|+|++ ++++ ++.++++|+++..++++. .......+..++.+|...
T Consensus 234 g~~~~~~l~~IL~~l~dgIivvD~---~g~I~~~N~a-e~i~-~~~~e~iGr~v~~~~p~~-~~~~~~~l~~~l~~g~~~ 307 (369)
T 3cax_A 234 GYLNIEELKAIFEALPVDVTFIDK---DDRVRFFSPG-ERIF-TRTPSVLGRPVQLCHPPK-SVYVVNKILKAFKEGRKK 307 (369)
T ss_dssp CEECHHHHHHHHHHSSSEEEEECT---TSBEEEECCS-SCSS-CCCGGGTTCBTTTSSCGG-GHHHHHHHHHHHHHTSCS
T ss_pred chhhHHHHHHHHHhCCCcEEEECC---CCcEEEEcCH-HHcc-CChHHHcCCcHHHHCChh-hHHHHHHHHHHHHcCCce
Confidence 345557889999999999999999 7779999999 9999 999999999998877643 233445567778888765
Q ss_pred EEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHH
Q 001902 264 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKD 312 (998)
Q Consensus 264 ~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~ 312 (998)
..+... .++| .++.++.+||+|.+|++.|++.+++|||+.++++++
T Consensus 308 ~~~~~~-~~~g--~~v~v~~~PI~d~~G~~~G~v~v~~DITe~~~le~~ 353 (369)
T 3cax_A 308 EATFWL-RLRE--KYVYIKYVPLFNEKGEYIGTLEMTMDIAPYKKIEGE 353 (369)
T ss_dssp CEEEEE-EETT--EEEEEEEEEEECTTSCEEEEEEEEEECHHHHTCCSC
T ss_pred EEEEEE-eeCC--EEEEEEEEEEECCCCCEEEEEEEEEcCHHHHHHHHH
Confidence 555544 3456 477889999999999999999999999999987765
|
| >2qkp_A Uncharacterized protein; structural genomics, unknown function, PSI-2, protein struct initiative; 1.75A {Streptococcus mutans} | Back alignment and structure |
|---|
Probab=98.94 E-value=1.5e-09 Score=106.80 Aligned_cols=109 Identities=15% Similarity=0.121 Sum_probs=84.5
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHH---HHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDS---FLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQL 550 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a---~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~ 550 (998)
|..++++++++|+++|.+|+ |+|+|++ ++++|| ..++++|+++..+.++. .....+.+.+.+..|+....+.
T Consensus 21 l~~IL~~~~~gI~~vD~~g~---I~~~N~a~~~~~~i~g-~~~~~iGr~v~~~~~~~-~~~~v~~i~~~l~~g~~~~~~~ 95 (151)
T 2qkp_A 21 ANLILNHLPLEITFVNKDDI---FQYYNDSVPAAEMVFK-RTPSQVGRNVELCHPPK-VLDKVKKVFELLRNGQRDKVNM 95 (151)
T ss_dssp HHHHHHHSSSEEEEEETTSB---EEEECCCSCGGGCSSC-CCGGGTTSBGGGSSCHH-HHHHHHHHHHHHHTTSBSEEEE
T ss_pred HHHHHHhCCCceEEEcCCCe---EEEEeCCCchhhhhcC-CCHHHcCCCHHHhCCHH-HHHHHHHHHHHHHcCCccEEEE
Confidence 68899999999999999888 9999999 999999 56899999988765533 2333455677777787766666
Q ss_pred EEEecCCcEEEEEEEEeeeccC-C---EEEEEEecCCccccc
Q 001902 551 INYTKSGKKFWNLFHLQPMRDQ-K---YFIGVQLDGSEHLEP 588 (998)
Q Consensus 551 ~~~rkdG~~~wv~~~~spi~d~-~---~~vgi~rDITerk~~ 588 (998)
+....+ ...++.++..|++|+ + |++.+++|||+.++-
T Consensus 96 ~~~~~~-~~~~v~v~~~Pi~d~~G~~~G~vev~~Dit~l~~l 136 (151)
T 2qkp_A 96 WFQSER-LGKFVYVTYAAVRDQAGDFQGVLEYVQDIKPFFEL 136 (151)
T ss_dssp EEEETT-TTEEEEEEEEEEECTTCCEEEEEEEEEECGGGGGG
T ss_pred EEecCC-CCeEEEEEEEEEECCCCCEEEEEEEEEECHHHHhh
Confidence 653332 124578889999985 3 888899999998863
|
| >3a0s_A Sensor protein; PAS-fold, kinase, phosphoprotein, transferase, two-component regulatory system; HET: PG4 PGE; 1.47A {Thermotoga maritima} PDB: 3a0v_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=9.5e-09 Score=89.42 Aligned_cols=95 Identities=12% Similarity=0.051 Sum_probs=73.2
Q ss_pred cCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCCEE
Q 001902 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 277 (998)
Q Consensus 198 ~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 277 (998)
++++|+++|. +|+|+++|+++++++||+.++++|+++..+ + ........+...+..+..+... . ++|...
T Consensus 1 ~~~~i~~~d~---~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~--~--~~~~~~ 70 (96)
T 3a0s_A 1 METAIITLSK---DGRITEWNKKAEQLFGLKKENVLGRRLKDL-P--DFEEIGSVAESVFENKEPVFLN--F--YKFGER 70 (96)
T ss_dssp CCCEEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGS-T--TCHHHHHHHHHHHHHTCCEEEE--E--EEETTE
T ss_pred CCceEEEEcC---CCCEeehhHHHHHHhCCCHHHhcCCCHHHC-c--chHHHHHHHHHHhccCCeEEEE--E--EcCCcE
Confidence 4789999998 777999999999999999999999998877 2 2234455566666666665432 2 234446
Q ss_pred EEEeeeeEEeCCCCC-EEEEEEEEec
Q 001902 278 WNLLTIAPIKDDEGK-VLKFIGMQVE 302 (998)
Q Consensus 278 w~~~~~spi~d~~G~-v~~~v~i~~D 302 (998)
|+.+++.|+.+.+|+ +.|++++++|
T Consensus 71 ~~~~~~~p~~~~~~~~~~g~v~~~~D 96 (96)
T 3a0s_A 71 YFNIRFSPFRNAKTQLLEGVIITIDD 96 (96)
T ss_dssp EEEEEEEEEECTTTCCEEEEEEEEEC
T ss_pred EEEEEEEEeEcCCCCeeeEEEEEecC
Confidence 899999999988665 6799999887
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.89 E-value=1.7e-09 Score=119.40 Aligned_cols=133 Identities=18% Similarity=0.175 Sum_probs=100.0
Q ss_pred ccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCC--ccceeEEEeeCC---eEEEE
Q 001902 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPF--VPALYASFQTKT---HVCLI 743 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~n--Iv~l~~~~~~~~---~~~lV 743 (998)
++.++.|.++.||++. ..+++|+.... .....+..|..+++.+ .+.. +++++......+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999874 45889986532 3456788899999888 4433 445555443333 35899
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-------------------------------------- 785 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-------------------------------------- 785 (998)
|+|++|.+|...... .++......++.+++..|+.||+
T Consensus 95 m~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999999998764332 27788888889999999999996
Q ss_pred --------------------CCceeccCCCCcEEEec--CCcEEEEeccCccc
Q 001902 786 --------------------QGIIYRDLKPENVLLQG--NGHVSLTDFDLSCL 816 (998)
Q Consensus 786 --------------------~~IiHrDLkP~NILi~~--~g~vkL~DFG~a~~ 816 (998)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 13699999999999998 45688999998854
|
| >2ykf_A Pdtas, probable sensor histidine kinase pdtas; transferase, two-component system, GAF domain, PAS domain; 2.00A {Mycobacterium tuberculosis} PDB: 2ykh_A | Back alignment and structure |
|---|
Probab=98.37 E-value=2.6e-10 Score=125.66 Aligned_cols=104 Identities=14% Similarity=0.070 Sum_probs=72.1
Q ss_pred HHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcC---CChhhhcCCCCccccCCC---CCH--HHHHHHHHHHhc-CCc
Q 001902 475 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTE---YSREEILGRNCRFLQGPE---TDP--ATVRKIRAAIDN-QTD 545 (998)
Q Consensus 475 ~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~G---y~~eEliG~~~~~l~~p~---~~~--~~~~~i~~~l~~-g~~ 545 (998)
+.+++++++||+++|.+|+ |+++|++++++|| ++ ++++|+++..+.+.. ... .....+...+.+ +..
T Consensus 173 ~~~~~~~~dGIivvD~~G~---Ii~~N~aA~~ll~~lG~~-~~~iGk~l~el~~~~~~~~~~~~~~~~~l~~vl~~~~~~ 248 (305)
T 2ykf_A 173 SRSSPRAGDGFIRLDVDGV---VSYASPNALSAYHRMGLT-TELEGVNLIDATRPLISDPFEAHEVDEHVQDLLAGDGKG 248 (305)
Confidence 4478999999999999888 9999999999984 55 789999987776543 100 122222224443 333
Q ss_pred EEEEEEEEecCCcEEEEEEEEeeeccCC---EEEEEEecCCcccc
Q 001902 546 VTVQLINYTKSGKKFWNLFHLQPMRDQK---YFIGVQLDGSEHLE 587 (998)
Q Consensus 546 ~~~e~~~~rkdG~~~wv~~~~spi~d~~---~~vgi~rDITerk~ 587 (998)
...+.. .+| .++.++..|+.+++ +++.+++|||++++
T Consensus 249 ~~~ei~---~~~--~~l~v~~~Pi~~~g~~~G~Vvv~rDITE~~~ 288 (305)
T 2ykf_A 249 MRMEVD---AGG--ATVLLRTLPLVVAGRNVGAAILIRDVTEVKR 288 (305)
Confidence 322221 123 46677889998766 78899999999996
|
| >1nwz_A PYP, photoactive yellow protein; PAS, LOV, GAF, domains fold, signaling protein; HET: HC4; 0.82A {Halorhodospira halophila} SCOP: d.110.3.1 PDB: 1kou_A* 1ot9_A* 1otb_A* 1s4r_A* 1s4s_A* 1ts0_A* 1ts6_A* 1ts7_A* 1ts8_A* 1uwn_X* 1uwp_X* 2d01_A* 2phy_A* 2pyp_A* 2pyr_A* 2qj5_A* 2qj7_A* 2qws_A* 2zoh_A* 2zoi_A* ... | Back alignment and structure |
|---|
Probab=98.84 E-value=2.2e-08 Score=93.84 Aligned_cols=100 Identities=20% Similarity=0.188 Sum_probs=79.0
Q ss_pred HHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCc-ccCCCCChHHHHHHHHHHHcCCcEEEEEEE-
Q 001902 192 KDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRF-LQGAGTDPEDVAKIRETLQNGQSYCGRLLN- 269 (998)
Q Consensus 192 ~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~-l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~- 269 (998)
..++++++.|++++|. +|+|++||+++++++||++++++|+++.. +.+......+...+.+.+..|. ...++.+
T Consensus 20 ~~~ld~l~~Gii~lD~---~g~I~~~N~~~e~~sG~~~~eviGk~~f~~~~~~~~~~~f~~rf~~~~~~g~-l~~~~~~v 95 (125)
T 1nwz_A 20 DGQLDGLAFGAIQLDG---DGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGN-LNTMFEYT 95 (125)
T ss_dssp HHHHTTCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTC-CEEEEEEE
T ss_pred HHHHhccCceEEEECC---CCEEEEEHHHHHHHhCCCHHHHcCCchhhhccchhcccHHHHHHHHHHhcCc-eeEEEEEE
Confidence 4579999999999999 88899999999999999999999999975 4444556677788888888776 4444444
Q ss_pred EecCCCEEEEEeeeeEEeCCCCCEEEEE
Q 001902 270 YKKDGTPFWNLLTIAPIKDDEGKVLKFI 297 (998)
Q Consensus 270 ~~kdG~~~w~~~~~spi~d~~G~v~~~v 297 (998)
.+++|..++ ++++...+.+|+..++.
T Consensus 96 ~~~~~~p~~--v~i~l~~~~~~~~~~i~ 121 (125)
T 1nwz_A 96 FDYQMTPTK--VKVHMKKALSGDSYWVF 121 (125)
T ss_dssp ECTTSCCEE--EEEEEEECSSSSEEEEE
T ss_pred EcCCCCEEE--EEEEEEEcCCCCEEEEE
Confidence 499999554 55666677888776543
|
| >1mzu_A PPR; photoactive yellow protein, PAS, PYP, signaling protein; HET: HC4; 2.00A {Rhodospirillum centenum} SCOP: d.110.3.1 | Back alignment and structure |
|---|
Probab=98.81 E-value=2.7e-08 Score=93.39 Aligned_cols=99 Identities=12% Similarity=0.101 Sum_probs=78.2
Q ss_pred HHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCc-ccCCCCChHHHHHHHHHHHcCCcEEEEEEE-E
Q 001902 193 DALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRF-LQGAGTDPEDVAKIRETLQNGQSYCGRLLN-Y 270 (998)
Q Consensus 193 ~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~-l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~-~ 270 (998)
+++++++.|++++|. +|+|++||+++++++||++++++|+++.. +.+......+...+.+.+..|. ...++.+ .
T Consensus 26 ~~ld~l~~GiivlD~---dg~I~~~N~~~e~isG~s~eeviGk~~f~~~~p~~~~~~f~grf~~~~~~G~-l~~~~~yv~ 101 (129)
T 1mzu_A 26 AEFDALPVGAIQVDG---SGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGT-LDARFDFVF 101 (129)
T ss_dssp TTGGGCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSC-CEEEEEEEE
T ss_pred HHHhccCceEEEECC---CCeEEEEHHHHHHHhCCCHHHHcCCchhhhccchhcccHHHHHHHHHHhcCc-eeEEEEEEE
Confidence 369999999999999 78899999999999999999999999975 4444556677888888888766 4444444 4
Q ss_pred ecCCCEEEEEeeeeEEeCCCCCEEEEE
Q 001902 271 KKDGTPFWNLLTIAPIKDDEGKVLKFI 297 (998)
Q Consensus 271 ~kdG~~~w~~~~~spi~d~~G~v~~~v 297 (998)
+++|..+ .++++...+.+|+..++.
T Consensus 102 ~~~~~p~--~v~i~l~~~~~~~~~~i~ 126 (129)
T 1mzu_A 102 DFQMAPV--RVQIRMQNAGVPDRYWIF 126 (129)
T ss_dssp ECSSCEE--EEEEEEEECSSTTEEEEE
T ss_pred cCCCCEE--EEEEEEEEcCCCCEEEEE
Confidence 9999955 455666677888876543
|
| >1nwz_A PYP, photoactive yellow protein; PAS, LOV, GAF, domains fold, signaling protein; HET: HC4; 0.82A {Halorhodospira halophila} SCOP: d.110.3.1 PDB: 1kou_A* 1ot9_A* 1otb_A* 1s4r_A* 1s4s_A* 1ts0_A* 1ts6_A* 1ts7_A* 1ts8_A* 1uwn_X* 1uwp_X* 2d01_A* 2phy_A* 2pyp_A* 2pyr_A* 2qj5_A* 2qj7_A* 2qws_A* 2zoh_A* 2zoi_A* ... | Back alignment and structure |
|---|
Probab=98.81 E-value=2.8e-08 Score=93.09 Aligned_cols=95 Identities=9% Similarity=0.050 Sum_probs=75.7
Q ss_pred HHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCcccc-CCCCCHHHHHHHHHHHhcCCcEEEEEEE-
Q 001902 475 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQ-GPETDPATVRKIRAAIDNQTDVTVQLIN- 552 (998)
Q Consensus 475 ~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~-~p~~~~~~~~~i~~~l~~g~~~~~e~~~- 552 (998)
..+++++++||+++|.+|+ |++||.++++++||+++|++|+++.... +......+...+.+.+..|. ...+..+
T Consensus 20 ~~~ld~l~~Gii~lD~~g~---I~~~N~~~e~~sG~~~~eviGk~~f~~~~~~~~~~~f~~rf~~~~~~g~-l~~~~~~v 95 (125)
T 1nwz_A 20 DGQLDGLAFGAIQLDGDGN---ILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGN-LNTMFEYT 95 (125)
T ss_dssp HHHHTTCSSEEEEEETTCB---EEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTC-CEEEEEEE
T ss_pred HHHHhccCceEEEECCCCE---EEEEHHHHHHHhCCCHHHHcCCchhhhccchhcccHHHHHHHHHHhcCc-eeEEEEEE
Confidence 5689999999999999888 9999999999999999999999986644 44566667788888888776 5555555
Q ss_pred EecCCcEEEEEEEEeeeccCC
Q 001902 553 YTKSGKKFWNLFHLQPMRDQK 573 (998)
Q Consensus 553 ~rkdG~~~wv~~~~spi~d~~ 573 (998)
.+++|+.+++.+++....+.+
T Consensus 96 ~~~~~~p~~v~i~l~~~~~~~ 116 (125)
T 1nwz_A 96 FDYQMTPTKVKVHMKKALSGD 116 (125)
T ss_dssp ECTTSCCEEEEEEEEECSSSS
T ss_pred EcCCCCEEEEEEEEEEcCCCC
Confidence 499999777766655554443
|
| >2jhe_A Transcription regulator TYRR; aromatic hydrocarbons catabolism, TYRR protei nucleotide-binding, transcription regulation, activator; HET: PG4; 2.30A {Escherichia coli} | Back alignment and structure |
|---|
Probab=98.78 E-value=5.8e-09 Score=106.14 Aligned_cols=108 Identities=12% Similarity=0.092 Sum_probs=82.3
Q ss_pred cchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCC--c
Q 001902 185 PRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ--S 262 (998)
Q Consensus 185 ~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~--~ 262 (998)
++....++.+++++++||+++|. +|+|+++|+++++++|++.++++|+++..+.++.. +...+..+. .
T Consensus 76 ~~~~~~l~~il~~~~~gvi~~D~---~g~I~~~N~aa~~llg~~~~~~~g~~~~~~~~~~~-------~~~~~~~~~~~~ 145 (190)
T 2jhe_A 76 EREHLALSALLEALPEPVLSVDM---KSKVDMANPASCQLFGQKLDRLRNHTAAQLINGFN-------FLRWLESEPQDS 145 (190)
T ss_dssp THHHHHHHHHHHHCSSCEEEECT---TCBEEEECHHHHHHHTSCHHHHTTSBGGGTSTTCC-------HHHHHHTCCCSC
T ss_pred HHHHHHHHHHHHhCCCcEEEEcC---CCCEEEEcHHHHHHhCCCHHHhcCccHHHHhCCCC-------HHHHHhcCCCCC
Confidence 45567899999999999999999 77799999999999999999999999987776542 123344443 2
Q ss_pred EEEEEEEEecCCCEEEEEeeeeEEeCCCCC----EEEEEEEEecchhhh
Q 001902 263 YCGRLLNYKKDGTPFWNLLTIAPIKDDEGK----VLKFIGMQVEVSKHT 307 (998)
Q Consensus 263 ~~~e~~~~~kdG~~~w~~~~~spi~d~~G~----v~~~v~i~~DITerk 307 (998)
...++.. +|. ++.++++|+.+.+|+ +.|++++++|||+++
T Consensus 146 ~~~~~~~---~g~--~~~~~~~pi~~~~~~~~~~~~g~v~~~~DiTe~~ 189 (190)
T 2jhe_A 146 HNEHVVI---NGQ--NFLMEITPVYLQDENDQHVLTGAVVMLRSTIRMG 189 (190)
T ss_dssp EEEEEEE---TTE--EEEEEEEEETTTTEEEEEEEE-HHHHHHHHTTTC
T ss_pred cceEEEE---CCe--EEEEEEEEEEecCCCCcceEEeEEEEEeccchhc
Confidence 3333332 775 456778999875555 788889999999876
|
| >1mzu_A PPR; photoactive yellow protein, PAS, PYP, signaling protein; HET: HC4; 2.00A {Rhodospirillum centenum} SCOP: d.110.3.1 | Back alignment and structure |
|---|
Probab=98.77 E-value=4e-08 Score=92.23 Aligned_cols=94 Identities=12% Similarity=0.027 Sum_probs=74.5
Q ss_pred HHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCcccc-CCCCCHHHHHHHHHHHhcCCcEEEEEEE-E
Q 001902 476 TTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQ-GPETDPATVRKIRAAIDNQTDVTVQLIN-Y 553 (998)
Q Consensus 476 ~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~-~p~~~~~~~~~i~~~l~~g~~~~~e~~~-~ 553 (998)
.+++++++||+++|.+|+ |++||.++++++||+++|++|+++.... +......+...+.+.+..|. ...+..+ .
T Consensus 26 ~~ld~l~~GiivlD~dg~---I~~~N~~~e~isG~s~eeviGk~~f~~~~p~~~~~~f~grf~~~~~~G~-l~~~~~yv~ 101 (129)
T 1mzu_A 26 AEFDALPVGAIQVDGSGV---IHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGT-LDARFDFVF 101 (129)
T ss_dssp TTGGGCSSEEEEEETTCB---EEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSC-CEEEEEEEE
T ss_pred HHHhccCceEEEECCCCe---EEEEHHHHHHHhCCCHHHHcCCchhhhccchhcccHHHHHHHHHHhcCc-eeEEEEEEE
Confidence 369999999999999888 9999999999999999999999986644 44556667888888888776 5555555 4
Q ss_pred ecCCcEEEEEEEEeeeccCC
Q 001902 554 TKSGKKFWNLFHLQPMRDQK 573 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~ 573 (998)
+++|+.+++.+++....+.+
T Consensus 102 ~~~~~p~~v~i~l~~~~~~~ 121 (129)
T 1mzu_A 102 DFQMAPVRVQIRMQNAGVPD 121 (129)
T ss_dssp ECSSCEEEEEEEEEECSSTT
T ss_pred cCCCCEEEEEEEEEEcCCCC
Confidence 99999777766655554443
|
| >2ykf_A Pdtas, probable sensor histidine kinase pdtas; transferase, two-component system, GAF domain, PAS domain; 2.00A {Mycobacterium tuberculosis} PDB: 2ykh_A | Back alignment and structure |
|---|
Probab=98.24 E-value=8.8e-10 Score=121.45 Aligned_cols=161 Identities=16% Similarity=0.111 Sum_probs=107.6
Q ss_pred ccCCCCCCCCCCCcCCCCCCCcccccc-ccccc---ccccccccchHHHHHHHH-----------------HhcCCcEEE
Q 001902 146 RTSGGDDPNGKPGTSRRNSNNSVRSSG-EMSDE---GGKEKGLPRVSDIVKDAL-----------------STFQQTFVV 204 (998)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-dit~~---~~~e~~l~~~~~~l~~il-----------------d~~~d~i~i 204 (998)
|..+ ......|+.......+.+.... |+++. +..|.+..+....|..++ +++++||++
T Consensus 107 ~~~~-v~~~~~Pi~~~g~vigvl~~~~~di~~~~~~~~~e~~~~~~~~~L~~mi~~~~~~~~~~~~~~~~~~~~~dGIiv 185 (305)
T 2ykf_A 107 QHDG-HSVEVSPVRFGDQVVAVLTRHQPELAARRRSGHLETAYRLCATDLLRMLAEGTFPDAGDVAMSRSSPRAGDGFIR 185 (305)
Confidence 3444 5556666665444445555558 99976 344555555556566555 489999999
Q ss_pred EecCCCCCceEEccHHHHHHcC---CChhhhcCCCCCcccCCC---CCh--HHHHHHHHHHHc-CCcEEEEEEEEecCCC
Q 001902 205 SDATKPDYPIMYASAGFFKMTG---YTSKEVVGRNCRFLQGAG---TDP--EDVAKIRETLQN-GQSYCGRLLNYKKDGT 275 (998)
Q Consensus 205 ~D~~g~dG~I~~vN~a~~~l~G---ys~eEliG~~~~~l~~~~---~~~--~~~~~i~~~l~~-g~~~~~e~~~~~kdG~ 275 (998)
+|. +|+|+++|+++++++| ++ ++++|+++..+.+.. ... .....+...+.+ +.....+.. .+|
T Consensus 186 vD~---~G~Ii~~N~aA~~ll~~lG~~-~~~iGk~l~el~~~~~~~~~~~~~~~~~l~~vl~~~~~~~~~ei~---~~~- 257 (305)
T 2ykf_A 186 LDV---DGVVSYASPNALSAYHRMGLT-TELEGVNLIDATRPLISDPFEAHEVDEHVQDLLAGDGKGMRMEVD---AGG- 257 (305)
Confidence 999 7779999999999985 55 789999988776543 100 112222223433 333322221 223
Q ss_pred EEEEEeeeeEEeCCCCCEEEEEEEEecchhhhHHHHHhhcCC
Q 001902 276 PFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRP 317 (998)
Q Consensus 276 ~~w~~~~~spi~d~~G~v~~~v~i~~DITerk~~E~~l~~~~ 317 (998)
.++.++..|+.+ +|++.|++.+++|||+.+++|++|+.+.
T Consensus 258 -~~l~v~~~Pi~~-~g~~~G~Vvv~rDITE~~~lE~eL~~K~ 297 (305)
T 2ykf_A 258 -ATVLLRTLPLVV-AGRNVGAAILIRDVTEVKRRDRALISKD 297 (305)
Confidence 466788899986 5788899999999999999999987643
|
| >2w0n_A Sensor protein DCUS; signal transduction, two-component regulatory system, PAS, kinase, membrane, transferase, solid state cell inner membrane; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=98.75 E-value=2.3e-09 Score=98.37 Aligned_cols=96 Identities=19% Similarity=0.165 Sum_probs=74.0
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCC---ChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEY---SREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQL 550 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy---~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~ 550 (998)
++.++++++++|+++|.+|+ |+++|++|++++|| +.++++|+++..+.++.. +...+..+.....+.
T Consensus 17 ~~~il~~~~~~i~~~d~~g~---i~~~N~~~~~~~g~~~~~~~~~~g~~~~~~~~~~~-------~~~~~~~~~~~~~~~ 86 (118)
T 2w0n_A 17 RQAMLQSIKEGVVAVDDRGE---VTLINDAAQELLNYRKSQDDEKLSTLSHSWSQVVD-------VSEVLRDGTPRRDEE 86 (118)
T ss_dssp HHHHHHCCCCCCEEEBTTTB---CCCBCHHHHHHHCSCTTTTTSSCCCTTCCCSCTHH-------HHHHHHTTCCCCCCC
T ss_pred HHHHHhhccccEEEECCCCc---EeehhHHHHHHhCCCccChhhhhccCcccccCchh-------HHHHhccCceeccEE
Confidence 68899999999999999887 99999999999998 889999999877765431 344555554322111
Q ss_pred EEEecCCcEEEEEEEEeeeccCC---EEEEEEecCC
Q 001902 551 INYTKSGKKFWNLFHLQPMRDQK---YFIGVQLDGS 583 (998)
Q Consensus 551 ~~~rkdG~~~wv~~~~spi~d~~---~~vgi~rDIT 583 (998)
...+| .|+.++..|+.+++ +++++++|||
T Consensus 87 --~~~~~--~~~~~~~~p~~~~g~~~g~v~~~~DiT 118 (118)
T 2w0n_A 87 --ITIKD--RLLLINTVPVRSNGVIIGAISTFRDKT 118 (118)
T ss_dssp --EESSS--CEECCCEECCCCSSCCCCEEECCCCCC
T ss_pred --EEECC--EEEEEeeceeeeCCEEEEEEEEEEeCC
Confidence 23466 46777888998755 7899999998
|
| >3rty_A Period circadian protein; PAS domain, signalling, timeless, circadian clock protein; 2.85A {Drosophila melanogaster} PDB: 1wa9_A 3gec_A | Back alignment and structure |
|---|
Probab=98.75 E-value=1.8e-08 Score=112.18 Aligned_cols=106 Identities=10% Similarity=0.030 Sum_probs=91.0
Q ss_pred CCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCc-----EEEEEEEEecC
Q 001902 199 QQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS-----YCGRLLNYKKD 273 (998)
Q Consensus 199 ~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~-----~~~e~~~~~kd 273 (998)
.+.++..+. ||+|+|+|+++..++||+++|++|+++..++||++.......++..+..|.. ...+++++++|
T Consensus 154 ~~fi~r~~~---dG~~~yvn~~~~~lLGY~peELiG~s~~~~vHPdD~~~~~~~~~~~l~~G~~~~~~~~s~~yR~~~kd 230 (339)
T 3rty_A 154 PKFAIRHTA---TGIISHVDSAAVSALGYLPQDLIGRSIMDFYHHEDLSVMKETYETVMKKGQTAGASFCSKPYRFLIQN 230 (339)
T ss_dssp CEEEEEEET---TCBEEEECTTHHHHHCCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHHHHTTSTTCCCBCCCEEEECTT
T ss_pred ceEEEEECC---CCeEEEcChhhhcccCCCHHHHcCCcHHHEECHHHHHHHHHHHHHHHHcCCcccccccceEEEEEccC
Confidence 456677777 8889999999999999999999999999999999887777778888877764 35789999999
Q ss_pred CCEEEEEeeeeEEeCCC-CCEEEEEEEEecchhhh
Q 001902 274 GTPFWNLLTIAPIKDDE-GKVLKFIGMQVEVSKHT 307 (998)
Q Consensus 274 G~~~w~~~~~spi~d~~-G~v~~~v~i~~DITerk 307 (998)
|..+|++.+.++++|.. +.+.++|++.+.|+...
T Consensus 231 G~~vWlet~~~~~~np~s~~~~~II~~h~vi~~p~ 265 (339)
T 3rty_A 231 GCYVLLETEWTSFVNPWSRKLEFVVGHHRVFQGPK 265 (339)
T ss_dssp SCEEEEEEEEEEEECTTTCSEEEEEEEEEEEECCS
T ss_pred CCEEEEEEEEEEEECCCCCCeeEEEEEEEECCCCC
Confidence 99999999999999865 56778889988887764
|
| >3a0s_A Sensor protein; PAS-fold, kinase, phosphoprotein, transferase, two-component regulatory system; HET: PG4 PGE; 1.47A {Thermotoga maritima} PDB: 3a0v_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=4.6e-08 Score=84.97 Aligned_cols=91 Identities=18% Similarity=0.132 Sum_probs=68.6
Q ss_pred cCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 001902 481 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 560 (998)
Q Consensus 481 ~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rkdG~~~ 560 (998)
++++|+++|.+|+ |+++|+++++++||+.++++|++...+ +. .......+...+..+..+.. . .++|..+
T Consensus 1 ~~~~i~~~d~~g~---i~~~N~~~~~l~g~~~~~~~g~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~--~--~~~~~~~ 70 (96)
T 3a0s_A 1 METAIITLSKDGR---ITEWNKKAEQLFGLKKENVLGRRLKDL--PD-FEEIGSVAESVFENKEPVFL--N--FYKFGER 70 (96)
T ss_dssp CCCEEEEEETTSB---EEEECHHHHHHHCCCHHHHTTSBGGGS--TT-CHHHHHHHHHHHHHTCCEEE--E--EEEETTE
T ss_pred CCceEEEEcCCCC---EeehhHHHHHHhCCCHHHhcCCCHHHC--cc-hHHHHHHHHHHhccCCeEEE--E--EEcCCcE
Confidence 4689999999887 999999999999999999999998777 33 33444556666666665432 2 2244556
Q ss_pred EEEEEEeeeccCC-----EEEEEEec
Q 001902 561 WNLFHLQPMRDQK-----YFIGVQLD 581 (998)
Q Consensus 561 wv~~~~spi~d~~-----~~vgi~rD 581 (998)
|+.++++|+.+.+ +++++++|
T Consensus 71 ~~~~~~~p~~~~~~~~~~g~v~~~~D 96 (96)
T 3a0s_A 71 YFNIRFSPFRNAKTQLLEGVIITIDD 96 (96)
T ss_dssp EEEEEEEEEECTTTCCEEEEEEEEEC
T ss_pred EEEEEEEEeEcCCCCeeeEEEEEecC
Confidence 8999999998752 67777776
|
| >3cax_A Uncharacterized protein PF0695; structural genomics, unknown function, PSI-2, protein struct initiative; 2.43A {Pyrococcus furiosus dsm 3638} | Back alignment and structure |
|---|
Probab=98.65 E-value=3.7e-08 Score=111.61 Aligned_cols=107 Identities=15% Similarity=0.147 Sum_probs=85.3
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~ 553 (998)
|..+++++++||+++|.+|+ |+++|++ +++| ++.++++|+++..+.++. .......+...+.+|.....+.+..
T Consensus 241 l~~IL~~l~dgIivvD~~g~---I~~~N~a-e~i~-~~~~e~iGr~v~~~~p~~-~~~~~~~l~~~l~~g~~~~~~~~~~ 314 (369)
T 3cax_A 241 LKAIFEALPVDVTFIDKDDR---VRFFSPG-ERIF-TRTPSVLGRPVQLCHPPK-SVYVVNKILKAFKEGRKKEATFWLR 314 (369)
T ss_dssp HHHHHHHSSSEEEEECTTSB---EEEECCS-SCSS-CCCGGGTTCBTTTSSCGG-GHHHHHHHHHHHHHTSCSCEEEEEE
T ss_pred HHHHHHhCCCcEEEECCCCc---EEEEcCH-HHcc-CChHHHcCCcHHHHCChh-hHHHHHHHHHHHHcCCceEEEEEEe
Confidence 68899999999999999888 9999999 9999 999999999988776643 3333455667777776654555443
Q ss_pred ecCCcEEEEEEEEeeeccCC----EEEEEEecCCcccccc
Q 001902 554 TKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSEHLEPL 589 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~----~~vgi~rDITerk~~~ 589 (998)
++| .++.++.+|++|.+ |++.+++|||+.++.+
T Consensus 315 -~~g--~~v~v~~~PI~d~~G~~~G~v~v~~DITe~~~le 351 (369)
T 3cax_A 315 -LRE--KYVYIKYVPLFNEKGEYIGTLEMTMDIAPYKKIE 351 (369)
T ss_dssp -ETT--EEEEEEEEEEECTTSCEEEEEEEEEECHHHHTCC
T ss_pred -eCC--EEEEEEEEEEECCCCCEEEEEEEEEcCHHHHHHH
Confidence 466 47888999999754 8899999999998643
|
| >4dj3_A Period circadian protein homolog 3; PAS domain, circadian rhythm, protein binding; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.57 E-value=1.9e-07 Score=102.83 Aligned_cols=97 Identities=13% Similarity=0.109 Sum_probs=82.7
Q ss_pred CCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCc---EEEEEEEEecCCCEEEEEeeeeEE
Q 001902 210 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS---YCGRLLNYKKDGTPFWNLLTIAPI 286 (998)
Q Consensus 210 ~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~---~~~e~~~~~kdG~~~w~~~~~spi 286 (998)
.||+|+|+|+++..++||+++|++|+++..++||++.....+.+...+..++. ...++++++|||..+|++...+++
T Consensus 182 ~dG~~~yvs~~~~~lLGY~peELig~s~~~~vHPdD~~~~~~~~~~~l~~~~~~~f~s~~yR~~~kdG~~vwvet~~~~~ 261 (317)
T 4dj3_A 182 PGCVFLEVDERAVPLLGYLPQDLIGTSILTYLHPEDRPLMVAIHQKVLKYAGHPPFEHSPVRFCTQNGEYVILDSSWSSF 261 (317)
T ss_dssp TTSBEEEECTTHHHHHSCCHHHHTTSBGGGGBCTTTTTHHHHHHHHHHHTTTSCCEECCCEEEECTTSCEEEEEEEEEEE
T ss_pred CCCeEEEEChHHhhhcCcChHHHcCCCHHHeECHHHHHHHHHHHHHHHHcCCCccccceEEEEEccCCCEEEEEEEEEEE
Confidence 38999999999999999999999999999999999988888888888887664 357899999999999999999999
Q ss_pred eCC-CCCEEEEEEEEecchhh
Q 001902 287 KDD-EGKVLKFIGMQVEVSKH 306 (998)
Q Consensus 287 ~d~-~G~v~~~v~i~~DITer 306 (998)
+|. .+++.++|+..+-++..
T Consensus 262 ~np~s~~~e~II~~h~v~~~p 282 (317)
T 4dj3_A 262 VNPWSRKVSFIIGRHKVRTSP 282 (317)
T ss_dssp ECSSSCCEEEEEEEEEECCCC
T ss_pred ECCCCCcccEEEEEEEeccCC
Confidence 986 45667777777744443
|
| >2jhe_A Transcription regulator TYRR; aromatic hydrocarbons catabolism, TYRR protei nucleotide-binding, transcription regulation, activator; HET: PG4; 2.30A {Escherichia coli} | Back alignment and structure |
|---|
Probab=98.54 E-value=6.9e-08 Score=98.04 Aligned_cols=99 Identities=11% Similarity=0.068 Sum_probs=73.3
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCC--cEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT--DVTVQLI 551 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~--~~~~e~~ 551 (998)
++.+++++++||+++|.+|+ |+++|++|+++||++.++++|+++..+.++... ...+..+. ....++.
T Consensus 82 l~~il~~~~~gvi~~D~~g~---I~~~N~aa~~llg~~~~~~~g~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 151 (190)
T 2jhe_A 82 LSALLEALPEPVLSVDMKSK---VDMANPASCQLFGQKLDRLRNHTAAQLINGFNF-------LRWLESEPQDSHNEHVV 151 (190)
T ss_dssp HHHHHHHCSSCEEEECTTCB---EEEECHHHHHHHTSCHHHHTTSBGGGTSTTCCH-------HHHHHTCCCSCEEEEEE
T ss_pred HHHHHHhCCCcEEEEcCCCC---EEEEcHHHHHHhCCCHHHhcCccHHHHhCCCCH-------HHHHhcCCCCCcceEEE
Confidence 68899999999999999888 999999999999999999999998877765431 22334343 2333332
Q ss_pred EEecCCcEEEEEEEEeeeccCC--------EEEEEEecCCcccc
Q 001902 552 NYTKSGKKFWNLFHLQPMRDQK--------YFIGVQLDGSEHLE 587 (998)
Q Consensus 552 ~~rkdG~~~wv~~~~spi~d~~--------~~vgi~rDITerk~ 587 (998)
. +|.. +.++++|+.+.+ +++.+++|||++++
T Consensus 152 ~---~g~~--~~~~~~pi~~~~~~~~~~~~g~v~~~~DiTe~~~ 190 (190)
T 2jhe_A 152 I---NGQN--FLMEITPVYLQDENDQHVLTGAVVMLRSTIRMGR 190 (190)
T ss_dssp E---TTEE--EEEEEEEETTTTEEEEEEEE-HHHHHHHHTTTCC
T ss_pred E---CCeE--EEEEEEEEEecCCCCcceEEeEEEEEeccchhcC
Confidence 2 7754 556788997622 34556899999873
|
| >3gdi_A Period circadian protein homolog 2; tandem PAS domains, biological rhythms, cytoplasm, nucleus, phosphoprotein, transcription; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.53 E-value=3.4e-07 Score=100.51 Aligned_cols=98 Identities=12% Similarity=0.111 Sum_probs=83.9
Q ss_pred CCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCc-EE-EEEEEEecCCCEEEEEeeeeEEe
Q 001902 210 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS-YC-GRLLNYKKDGTPFWNLLTIAPIK 287 (998)
Q Consensus 210 ~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~-~~-~e~~~~~kdG~~~w~~~~~spi~ 287 (998)
.||+|+|+|+++..++||.++|++|+++..++||++.....+.+...+..++. .. .++++++|||..+|++...+++.
T Consensus 173 ~dG~~~yvd~~~~~lLGY~peELig~s~~~~iHpdD~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~vwvet~~~~~~ 252 (309)
T 3gdi_A 173 PNCLFQAVDERAVPLLGYLPQDLIETPVLVQLHPSDRPLMLAIHKKILQAGGQPFDYSPIRFRTRNGEYITLDTSWSSFI 252 (309)
T ss_dssp TTCBEEEECTTHHHHHSCCHHHHTTSBHHHHBCTTSHHHHHHHHHHHHHTTTCCEEEEEEEEECTTSCEEEEEEEEEEEE
T ss_pred CCCeEEEECcccccccCcCHHHHcCCCHHHhCCHHHHHHHHHHHHHHHhcCCceeeceEEEEEccCCCEEEEEEEEEEEE
Confidence 38899999999999999999999999999999998877777777777776544 55 68999999999999999999998
Q ss_pred CC-CCCEEEEEEEEecchhhh
Q 001902 288 DD-EGKVLKFIGMQVEVSKHT 307 (998)
Q Consensus 288 d~-~G~v~~~v~i~~DITerk 307 (998)
|. .+++.++|++.+-|+...
T Consensus 253 np~s~~~e~ii~~h~v~~gp~ 273 (309)
T 3gdi_A 253 NPWSRKISFIIGRHKVRVGPL 273 (309)
T ss_dssp CTTTCCEEEEEEEEEEEECCS
T ss_pred CCCCCcccEEEEEEEEccCCC
Confidence 85 567888899888877643
|
| >4dj2_A Period circadian protein homolog 1; PAS domains, circadian clock protein, protein binding; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.48 E-value=2.6e-07 Score=101.90 Aligned_cols=104 Identities=13% Similarity=0.071 Sum_probs=85.6
Q ss_pred cEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcC-CcE-EEEEEEEecCCCEEE
Q 001902 201 TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNG-QSY-CGRLLNYKKDGTPFW 278 (998)
Q Consensus 201 ~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g-~~~-~~e~~~~~kdG~~~w 278 (998)
-+...+. ||+|+|+|+++..++||.++|++|+++..++||++.....+.+...+..+ ... ..++++++|||..+|
T Consensus 178 Fitrh~~---dG~~~yvd~~~~~lLGY~peELig~s~~~~vHPdD~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~vw 254 (320)
T 4dj2_A 178 FTTRHTP---SCLFQDVDERAAPLLGYLPQDLLGAPVLLFLHPEDRPLMLAIHKKILQLAGQPFDHSPIRFCARNGEYVT 254 (320)
T ss_dssp EEEEECT---TCBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHTTSSSCCEECCCEEEECSSSCEEE
T ss_pred EEEEecC---CceEEEcCcceeccCCcChHHHcCCcHHHhCCHHHHHHHHHHHHHHHhcCCCcccceEEEEEccCCCEEE
Confidence 3444444 88999999999999999999999999999999988777666677777644 445 368999999999999
Q ss_pred EEeeeeEEeCC-CCCEEEEEEEEecchhhh
Q 001902 279 NLLTIAPIKDD-EGKVLKFIGMQVEVSKHT 307 (998)
Q Consensus 279 ~~~~~spi~d~-~G~v~~~v~i~~DITerk 307 (998)
++...+++.|. .+++.++|+..+-|+...
T Consensus 255 vet~~~~~~np~s~~~e~II~~h~v~~gp~ 284 (320)
T 4dj2_A 255 MDTSWAGFVHPWSRKVAFVLGRHKVRTAPL 284 (320)
T ss_dssp EECEEEEEECTTTCSEEEEEEEEEESSCCS
T ss_pred EEEEEEEEECCCCCCccEEEEEEEEccCCC
Confidence 99999999885 577888899888777653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.6e-06 Score=93.50 Aligned_cols=133 Identities=17% Similarity=0.172 Sum_probs=100.1
Q ss_pred ccCCCCce-eEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEeeCCeEEEEEecCCC
Q 001902 672 PLGSGDTG-SVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLITDYCPG 749 (998)
Q Consensus 672 ~LG~G~~g-~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~g 749 (998)
.+..|..| .||+......+..+++|+-... ....+..|..+|+.+. +--|++++.++.+.+..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34556655 6999887777788999986643 3456778999998884 33477889999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------------
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ------------------------------------------- 786 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~------------------------------------------- 786 (998)
.++.+..... ......++.++...|..||..
T Consensus 105 ~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 105 KTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp EEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 9888765432 122344566777777777741
Q ss_pred ---------------CceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 787 ---------------GIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 787 ---------------~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
.++|+|++|.|||++.++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 158999999999999877777999998843
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.1e-06 Score=96.78 Aligned_cols=133 Identities=18% Similarity=0.144 Sum_probs=97.4
Q ss_pred ccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCC---CccceeEEEe-eCCeEEEEEe
Q 001902 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP---FVPALYASFQ-TKTHVCLITD 745 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~---nIv~l~~~~~-~~~~~~lV~E 745 (998)
++.++.|....||++ +..+++|+... ......+..|..+|+.+.+. .|++++.+.. ..+..++|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456788999999998 46788997532 23456788999999999642 3667777664 4566889999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ--------------------------------------- 786 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--------------------------------------- 786 (998)
|++|.+|....-. .++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9999888764221 145666666667777777766642
Q ss_pred ---------------------CceeccCCCCcEEEec---CCc-EEEEeccCccc
Q 001902 787 ---------------------GIIYRDLKPENVLLQG---NGH-VSLTDFDLSCL 816 (998)
Q Consensus 787 ---------------------~IiHrDLkP~NILi~~---~g~-vkL~DFG~a~~ 816 (998)
.++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2499999999999997 355 58999998854
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=7.8e-06 Score=93.43 Aligned_cols=81 Identities=14% Similarity=0.107 Sum_probs=51.2
Q ss_pred cccccCCCCceeEEEEEEccCCeEEEEEEeecccc-cC---hhHHHHHHHHHHHHHhCCC---CCccceeEEEeeCCeEE
Q 001902 669 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM-LN---RNKVHRACAEREILDMLDH---PFVPALYASFQTKTHVC 741 (998)
Q Consensus 669 ~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~-~~---~~~~~~~~~E~~il~~l~h---~nIv~l~~~~~~~~~~~ 741 (998)
.++.||.|.++.||++....+++.+++|....... .. .....+...|..+++.+.. ..+++++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 45789999999999997655678899998654321 00 0123455678888887732 345566643 344568
Q ss_pred EEEecCCCCc
Q 001902 742 LITDYCPGGE 751 (998)
Q Consensus 742 lV~E~~~ggs 751 (998)
+||||++|..
T Consensus 112 lvmE~l~g~~ 121 (397)
T 2olc_A 112 TVMEDLSHLK 121 (397)
T ss_dssp EEECCCTTSE
T ss_pred EEEEeCCCcc
Confidence 9999997743
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=2.4e-05 Score=87.81 Aligned_cols=86 Identities=12% Similarity=0.028 Sum_probs=56.8
Q ss_pred cccccc-CCCCceeEEEEEEc--c----CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCC---CCccceeEEEeeC
Q 001902 668 RPIKPL-GSGDTGSVHLVELC--G----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH---PFVPALYASFQTK 737 (998)
Q Consensus 668 ~~~~~L-G~G~~g~Vy~a~~~--~----~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h---~nIv~l~~~~~~~ 737 (998)
..++.| +.|..+.+|++... . ++..+++|+..............+..|..+++.+.. -.+++++.+....
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345677 88999999998753 1 267899998764320000001345678888887742 3577888877654
Q ss_pred ---CeEEEEEecCCCCchh
Q 001902 738 ---THVCLITDYCPGGELF 753 (998)
Q Consensus 738 ---~~~~lV~E~~~ggsL~ 753 (998)
+..|+||||++|.++.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3568999999887654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.89 E-value=0.0001 Score=81.90 Aligned_cols=137 Identities=14% Similarity=0.116 Sum_probs=79.0
Q ss_pred ccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC--CCCccceeE------EEeeCCeEE
Q 001902 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD--HPFVPALYA------SFQTKTHVC 741 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~--h~nIv~l~~------~~~~~~~~~ 741 (998)
++.|+.|..+.||++.. .+..+++|+.... . ..+..|..+++.|. .-.|++++. +....+..+
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 45677778899999986 3345999988752 1 23334555555552 113444443 123467789
Q ss_pred EEEecCCCCchh-----------H---HHhh--CCCC-C---------CCHH--------H-------------------
Q 001902 742 LITDYCPGGELF-----------L---LLDR--QPTK-V---------LKED--------A------------------- 768 (998)
Q Consensus 742 lV~E~~~ggsL~-----------~---~l~~--~~~~-~---------l~~~--------~------------------- 768 (998)
+||+|++|.++. . .++. .... + ..+. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986542 1 1111 1000 0 0110 0
Q ss_pred ----HHHHHHHHHHHHHHHHH-------------CCceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 769 ----VRFYAAEVVVALEYLHC-------------QGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 769 ----~~~i~~qil~aL~~LH~-------------~~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
+..+..++..++.+|+. ..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11112233445666652 479999999999999888899999999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00037 Score=76.63 Aligned_cols=77 Identities=19% Similarity=0.183 Sum_probs=61.1
Q ss_pred ccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC---CCCccceeEEEeeCCeEEEEE
Q 001902 668 RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD---HPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 668 ~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~lV~ 744 (998)
.-++.|+.|.+..+|++.. ++..+++|+.... ....+..|...|+.|. ...|++++.+....+..++||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 3457789999999999985 4678899987643 2456778888888873 367889999888888999999
Q ss_pred ecCCCCch
Q 001902 745 DYCPGGEL 752 (998)
Q Consensus 745 E~~~ggsL 752 (998)
||++|..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00042 Score=79.63 Aligned_cols=77 Identities=25% Similarity=0.266 Sum_probs=46.3
Q ss_pred cccccCCCCceeEEEEEEccCCeEEEEEEeecccc-cChh---HHHHHHHHHHHHHh---CCCCCccceeEEEeeCCeEE
Q 001902 669 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM-LNRN---KVHRACAEREILDM---LDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 669 ~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~-~~~~---~~~~~~~E~~il~~---l~h~nIv~l~~~~~~~~~~~ 741 (998)
.++.||.|..+.||++.. +++.++||....... .... .......|.+++.. .....+++++.+. .+..+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 357789999999999964 567899995432111 0000 00112223333332 2345677887665 46678
Q ss_pred EEEecC-CC
Q 001902 742 LITDYC-PG 749 (998)
Q Consensus 742 lV~E~~-~g 749 (998)
+||||+ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 77
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00033 Score=76.52 Aligned_cols=71 Identities=14% Similarity=0.027 Sum_probs=45.3
Q ss_pred ccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCc-cceeEEEeeCCeEEEEEecC-
Q 001902 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV-PALYASFQTKTHVCLITDYC- 747 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~lV~E~~- 747 (998)
++.|+.|....+|++ ..+++|+....... ......|..+++.+....+ ++++.+. .+.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 688999999999999 45889987653111 1122457777777643223 5666543 33346899999
Q ss_pred CCCch
Q 001902 748 PGGEL 752 (998)
Q Consensus 748 ~ggsL 752 (998)
+|.+|
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 76555
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.001 Score=75.12 Aligned_cols=139 Identities=19% Similarity=0.270 Sum_probs=83.5
Q ss_pred ccccCCCCceeEEEEEEcc-------CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEeeCCeEE
Q 001902 670 IKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVC 741 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~~-------~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~ 741 (998)
++.|..|-...+|++.... .++.|++|+.... . .....+.+|..+++.|. +.-.+++++.+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 3567788889999998642 3578999986432 1 12345567999988884 3334677766543 2
Q ss_pred EEEecCCCCchhH--------------HHh---hC--C-CCCC--CHHHHHHHHHHHHH-------------------HH
Q 001902 742 LITDYCPGGELFL--------------LLD---RQ--P-TKVL--KEDAVRFYAAEVVV-------------------AL 780 (998)
Q Consensus 742 lV~E~~~ggsL~~--------------~l~---~~--~-~~~l--~~~~~~~i~~qil~-------------------aL 780 (998)
+||||++|.+|.. .|. .. . .... -..++..+..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999998866531 111 11 0 1111 13455656544422 23
Q ss_pred HHHH----H----CCceeccCCCCcEEEecC----CcEEEEeccCccc
Q 001902 781 EYLH----C----QGIIYRDLKPENVLLQGN----GHVSLTDFDLSCL 816 (998)
Q Consensus 781 ~~LH----~----~~IiHrDLkP~NILi~~~----g~vkL~DFG~a~~ 816 (998)
..|. . ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3333 2 249999999999999976 7899999998843
|
| >1oj5_A Steroid receptor coactivator 1A; transcriptional coactivator, complex, LXXLL motif, transcriptional regulation; 2.2A {Mus musculus} SCOP: d.110.3.8 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00047 Score=64.22 Aligned_cols=99 Identities=13% Similarity=0.113 Sum_probs=79.4
Q ss_pred ceEEEEcCCCCCCCEEEcCHHHHHHcCCCh--hhhcCCCCccccCCCCCH--HHHHHHHHHHhcCCcEEEEEEEEecCCc
Q 001902 483 KNFVITDPRLPDNPIIFASDSFLELTEYSR--EEILGRNCRFLQGPETDP--ATVRKIRAAIDNQTDVTVQLINYTKSGK 558 (998)
Q Consensus 483 d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~--eEliG~~~~~l~~p~~~~--~~~~~i~~~l~~g~~~~~e~~~~rkdG~ 558 (998)
.-+.-.|.+|+ |++|.....+ .+|.. +||||+++.++.|+++.. ...+.+.+++..|.....-++++.|||.
T Consensus 8 ~F~sRh~~dGK---f~~vDq~~~r-~~~~~g~qdLlGrsiy~f~H~~D~~~s~l~~h~~~vl~~Gq~~S~~YRfr~k~g~ 83 (132)
T 1oj5_A 8 SFMTKQDTTGK---IISIDTSSLR-AAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGT 83 (132)
T ss_dssp EEEEEECTTCC---EEEEECHHHH-TTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSC
T ss_pred eeEEeecCCCc---EEEEeccccc-ccccccHHHHHHHHHHHHhCcccchHHHHHHHHHHHHHcCCccccceEEEecCCc
Confidence 34566788888 9999998874 77777 999999999999999865 7778888889888888888999999999
Q ss_pred EEEEEEEEeeeccCC-----EEEEEEecCCcc
Q 001902 559 KFWNLFHLQPMRDQK-----YFIGVQLDGSEH 585 (998)
Q Consensus 559 ~~wv~~~~spi~d~~-----~~vgi~rDITer 585 (998)
.+|+......+++.. +++++-.=|.+.
T Consensus 84 ~V~~qT~sk~f~np~t~e~e~Ivs~n~v~r~~ 115 (132)
T 1oj5_A 84 MLSAHTRCKLCYPQSPDMQPFIMGIHIIDREH 115 (132)
T ss_dssp EEEEEEEEEEECC----CCCEEEEEEEEECC-
T ss_pred EEEEEEEEEEecCCCCCCCCEEEEEEEEEcCC
Confidence 999998887777652 777775544444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0012 Score=73.04 Aligned_cols=137 Identities=13% Similarity=0.163 Sum_probs=71.9
Q ss_pred cccCCCCcee-EEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCC--CCccceeEEEeeCCeEEEEEecC
Q 001902 671 KPLGSGDTGS-VHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTKTHVCLITDYC 747 (998)
Q Consensus 671 ~~LG~G~~g~-Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h--~nIv~l~~~~~~~~~~~lV~E~~ 747 (998)
+.|+.|+... +|++.. .++..+++|....... ..+..|..+++.+.. -.+++++.+....+ +++||++
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 4566665554 667653 2366788886543210 223446666666632 34567776533333 6899999
Q ss_pred CCCchhHHHhhC---------------------C---CCCCCHHHHH-------H-HH------------HHHHHHHHHH
Q 001902 748 PGGELFLLLDRQ---------------------P---TKVLKEDAVR-------F-YA------------AEVVVALEYL 783 (998)
Q Consensus 748 ~ggsL~~~l~~~---------------------~---~~~l~~~~~~-------~-i~------------~qil~aL~~L 783 (998)
++.++.+.+... . ...+...... . +. ..+...+..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 776665433211 0 0112221110 0 00 0111222333
Q ss_pred H------HCCceeccCCCCcEEEecC----CcEEEEeccCccc
Q 001902 784 H------CQGIIYRDLKPENVLLQGN----GHVSLTDFDLSCL 816 (998)
Q Consensus 784 H------~~~IiHrDLkP~NILi~~~----g~vkL~DFG~a~~ 816 (998)
. ...++|+|+.|.|||++.+ +.+.|+||+.+..
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1 2369999999999999874 6899999998854
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0016 Score=71.57 Aligned_cols=144 Identities=19% Similarity=0.232 Sum_probs=80.4
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCC--CccceeEE------EeeC
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP--FVPALYAS------FQTK 737 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~--nIv~l~~~------~~~~ 737 (998)
...-++.|+.|....+|++... +| .+++|+..... ....+..|..+++.+... .+++++.. ....
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~ 95 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 95 (322)
T ss_dssp CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred cceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence 3344577888999999999863 33 68899887521 112344577777666321 13444321 1234
Q ss_pred CeEEEEEecCCCCchhH-----------H---HhhC--C--CC---CCCHHHHHH---------------HHHHHHHHHH
Q 001902 738 THVCLITDYCPGGELFL-----------L---LDRQ--P--TK---VLKEDAVRF---------------YAAEVVVALE 781 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~-----------~---l~~~--~--~~---~l~~~~~~~---------------i~~qil~aL~ 781 (998)
+..+++|+|++|..+.. . ++.. . .. ......-.. +...+...+.
T Consensus 96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~ 175 (322)
T 2ppq_A 96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 175 (322)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence 66799999998865421 0 1110 0 00 011000000 0011344555
Q ss_pred HHHH-------CCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 782 YLHC-------QGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 782 ~LH~-------~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
.++. .+++|+|++|.|||++.++.+.|+||+.+..
T Consensus 176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 5553 3699999999999999776668999998743
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0013 Score=75.70 Aligned_cols=75 Identities=20% Similarity=0.289 Sum_probs=50.7
Q ss_pred cccccCCCCceeEEEEEEcc-------CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCC-ccceeEEEeeCCeE
Q 001902 669 PIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF-VPALYASFQTKTHV 740 (998)
Q Consensus 669 ~~~~LG~G~~g~Vy~a~~~~-------~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~~~~~ 740 (998)
-++.|+.|....||++.... .+..+++|+.... .. ...+..|..+++.+...+ .+++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 34678899999999998742 2578999988431 01 134446888888884333 4677765542
Q ss_pred EEEEecCCCCch
Q 001902 741 CLITDYCPGGEL 752 (998)
Q Consensus 741 ~lV~E~~~ggsL 752 (998)
.+||||++|.+|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 389999987444
|
| >1oj5_A Steroid receptor coactivator 1A; transcriptional coactivator, complex, LXXLL motif, transcriptional regulation; 2.2A {Mus musculus} SCOP: d.110.3.8 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00046 Score=64.30 Aligned_cols=95 Identities=8% Similarity=-0.004 Sum_probs=75.1
Q ss_pred CCCCceEEccHHHHHHcCCCh--hhhcCCCCCcccCCCCCh--HHHHHHHHHHHcCCcEEEEEEEEecCCCEEEEEeeee
Q 001902 209 KPDYPIMYASAGFFKMTGYTS--KEVVGRNCRFLQGAGTDP--EDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIA 284 (998)
Q Consensus 209 g~dG~I~~vN~a~~~l~Gys~--eEliG~~~~~l~~~~~~~--~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~s 284 (998)
+.||+|+++..... ..+|.. +||+|+.+.+++++++.. ...+....++..|...+.-++++.|+|..+|++....
T Consensus 14 ~~dGKf~~vDq~~~-r~~~~~g~qdLlGrsiy~f~H~~D~~~s~l~~h~~~vl~~Gq~~S~~YRfr~k~g~~V~~qT~sk 92 (132)
T 1oj5_A 14 DTTGKIISIDTSSL-RAAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSAHTRCK 92 (132)
T ss_dssp CTTCCEEEEECHHH-HTTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEEEEEEEE
T ss_pred cCCCcEEEEecccc-cccccccHHHHHHHHHHHHhCcccchHHHHHHHHHHHHHcCCccccceEEEecCCcEEEEEEEEE
Confidence 34888999999887 478888 999999999999988854 7778888888888888888999999999999999888
Q ss_pred EEeCCC-CCEEEEEEEEecch
Q 001902 285 PIKDDE-GKVLKFIGMQVEVS 304 (998)
Q Consensus 285 pi~d~~-G~v~~~v~i~~DIT 304 (998)
.+++.- .++.+++++-.=+.
T Consensus 93 ~f~np~t~e~e~Ivs~n~v~r 113 (132)
T 1oj5_A 93 LCYPQSPDMQPFIMGIHIIDR 113 (132)
T ss_dssp EECC----CCCEEEEEEEEEC
T ss_pred EecCCCCCCCCEEEEEEEEEc
Confidence 887752 34556666554443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.97 E-value=0.005 Score=62.82 Aligned_cols=122 Identities=16% Similarity=0.103 Sum_probs=80.7
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcc
Q 001902 750 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH-CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 828 (998)
Q Consensus 750 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~ 828 (998)
-+|.++|... +.+++++++|.++.|.+.+|.-+- .+.-..+=+.|..|++..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence 4789999875 467999999999999999988772 22222444567999999999987664 2110
Q ss_pred hhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 001902 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANIL 907 (998)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~ 907 (998)
.....+.|||.+. ...+.+.=|||||+++|..+- |-++
T Consensus 98 --------------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e-------------- 136 (229)
T 2yle_A 98 --------------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE-------------- 136 (229)
T ss_dssp -----------------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT--------------
T ss_pred --------------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc--------------
Confidence 0123456777653 344568899999999999983 3222
Q ss_pred hCCCCCCCCCCCcHHHHHHHHHcccc
Q 001902 908 HKDLKFPSSTPTSLHAKQLMYRLLHR 933 (998)
Q Consensus 908 ~~~~~~~~~~~~s~~l~~Ll~~~L~~ 933 (998)
.....+|..+.+||..|..-
T Consensus 137 ------~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 137 ------NEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ------TEEECCCHHHHHHHHHHTTC
T ss_pred ------ccchhhCHHHHHHHHHHHhc
Confidence 12234688889999988755
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0022 Score=72.17 Aligned_cols=75 Identities=21% Similarity=0.232 Sum_probs=45.5
Q ss_pred ccccCCCCceeEEEEEEcc--------CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCC-ccceeEEEeeCCeE
Q 001902 670 IKPLGSGDTGSVHLVELCG--------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF-VPALYASFQTKTHV 740 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~~--------~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~~~~~ 740 (998)
+..|+.|....+|++.... .+..+++|+...... .......|..+++.+...+ +++++..+ .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 4678888899999998743 136899998764311 1112356788887774333 55776544 22
Q ss_pred EEEEecCCCCch
Q 001902 741 CLITDYCPGGEL 752 (998)
Q Consensus 741 ~lV~E~~~ggsL 752 (998)
++||||++|.++
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999988554
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0027 Score=68.73 Aligned_cols=80 Identities=19% Similarity=0.115 Sum_probs=55.8
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCC---CCccceeEEEeeCCeEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH---PFVPALYASFQTKTHVC 741 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h---~nIv~l~~~~~~~~~~~ 741 (998)
....-+..+|.|..+.||++.. .+|+.|++|+....... ....+..|...|+.|.. --+++++.+ .. -+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TE
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ce
Confidence 4566678899999999999986 57899999986543221 12346679999988843 234555543 22 36
Q ss_pred EEEecCCCCch
Q 001902 742 LITDYCPGGEL 752 (998)
Q Consensus 742 lV~E~~~ggsL 752 (998)
+||||++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999977543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0048 Score=67.91 Aligned_cols=138 Identities=14% Similarity=0.054 Sum_probs=78.8
Q ss_pred cccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCC--CCccceeEE-----EeeCCeEEEE
Q 001902 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYAS-----FQTKTHVCLI 743 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h--~nIv~l~~~-----~~~~~~~~lV 743 (998)
..|+ |....||++.. .+|+.+++|+...... ....+..|..+++.+.. -.+++++.. ....+..++|
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88889998865 3466899999864311 12355567777777632 124444432 2235567899
Q ss_pred EecCCCCchh-----------HH---Hhh----CCC---CCCCHHHH----------------------HHHHHHHHHHH
Q 001902 744 TDYCPGGELF-----------LL---LDR----QPT---KVLKEDAV----------------------RFYAAEVVVAL 780 (998)
Q Consensus 744 ~E~~~ggsL~-----------~~---l~~----~~~---~~l~~~~~----------------------~~i~~qil~aL 780 (998)
|+|++|.++. .. ++. ... ..++.... ...+..++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999875542 01 111 000 11121110 11111222222
Q ss_pred HHH----HHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 781 EYL----HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 781 ~~L----H~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
.-+ +...++|+|++|.|||++ + .+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 221 123589999999999999 5 899999998743
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0053 Score=71.09 Aligned_cols=75 Identities=15% Similarity=0.158 Sum_probs=49.5
Q ss_pred ccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCc-cceeEEEeeCCeEEEEEecCC
Q 001902 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV-PALYASFQTKTHVCLITDYCP 748 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~lV~E~~~ 748 (998)
++.|+.|-...+|++.....+..|++|+...... . . -....|..+++.|...++ +++++.+. + .+||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~--~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-E--I-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-S--C-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-h--h-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 4678889999999998754458899998754321 1 0 112468889998865444 57777663 2 25999998
Q ss_pred CCch
Q 001902 749 GGEL 752 (998)
Q Consensus 749 ggsL 752 (998)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 8555
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0057 Score=67.96 Aligned_cols=30 Identities=23% Similarity=0.368 Sum_probs=27.1
Q ss_pred CceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 787 GIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 787 ~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
.++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 599999999999999888899999998754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.90 E-value=0.015 Score=66.35 Aligned_cols=75 Identities=21% Similarity=0.304 Sum_probs=49.0
Q ss_pred ccccCCCCceeEEEEEEccC-------CeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEeeCCeEE
Q 001902 670 IKPLGSGDTGSVHLVELCGS-------GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVC 741 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~~~-------~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~ 741 (998)
++.|..|-...+|++..... +..|++|+...... ......+|..+++.+. +.-.+++++.+. + +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~----~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG----KFYDSKVELDVFRYLSNINIAPNIIADFP--E--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc----hhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--C
Confidence 46677888899999987421 57899998754321 1112345788887774 333566665332 2 6
Q ss_pred EEEecCCCCch
Q 001902 742 LITDYCPGGEL 752 (998)
Q Consensus 742 lV~E~~~ggsL 752 (998)
+||||++|.+|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.11 E-value=0.17 Score=57.44 Aligned_cols=29 Identities=28% Similarity=0.401 Sum_probs=24.9
Q ss_pred ceeccCCCCcEEEe------cCCcEEEEeccCccc
Q 001902 788 IIYRDLKPENVLLQ------GNGHVSLTDFDLSCL 816 (998)
Q Consensus 788 IiHrDLkP~NILi~------~~g~vkL~DFG~a~~ 816 (998)
++|+|+.+.|||+. .++.+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 68999999999994 467899999999843
|
| >2ool_A Sensor protein; bacteriophytochrome, photoconversion, photoreceptor, biliver signaling protein; HET: LBV; 2.20A {Rhodopseudomonas palustris} SCOP: d.110.2.1 d.110.3.9 | Back alignment and structure |
|---|
Probab=86.76 E-value=0.88 Score=49.86 Aligned_cols=77 Identities=13% Similarity=0.151 Sum_probs=50.7
Q ss_pred eEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCc---EEEEEEEEec-CCcE
Q 001902 484 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD---VTVQLINYTK-SGKK 559 (998)
Q Consensus 484 ~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~---~~~e~~~~rk-dG~~ 559 (998)
.++++|.. +++|+.+|..+++++|++.++++|++...+.+++. ...+...+..+.. ..++++.... +|..
T Consensus 44 ~Ll~~~~~--~~~i~~~S~N~~~~lg~~~~~llG~~l~~ll~~~~----~~~l~~~l~~~~~~~~~p~~~~~~~~~~~~~ 117 (337)
T 2ool_A 44 YLFVVSET--DLRIASVSANVEDLLRQPPASLLNVPIAHYLTAAS----AARLTHALHGGDPAAINPIRLDVVTPDGERA 117 (337)
T ss_dssp EEEEECTT--TCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCHHH----HHHHHHHHCC----CCCSEEEEEEETTEEEE
T ss_pred EEEEEECC--CCEEEEEehhHHHHHCcCHHHHcCCCHHHHcCHHH----HHHHHHHHhcCCccccCcEEEEEeccCCCeE
Confidence 44556654 34599999999999999999999999888887643 3345555543321 2234444443 4667
Q ss_pred EEEEEEE
Q 001902 560 FWNLFHL 566 (998)
Q Consensus 560 ~wv~~~~ 566 (998)
||+.++.
T Consensus 118 f~~~~Hr 124 (337)
T 2ool_A 118 FNGILHR 124 (337)
T ss_dssp EEEEEEE
T ss_pred EEEEEEE
Confidence 7877664
|
| >2ool_A Sensor protein; bacteriophytochrome, photoconversion, photoreceptor, biliver signaling protein; HET: LBV; 2.20A {Rhodopseudomonas palustris} SCOP: d.110.2.1 d.110.3.9 | Back alignment and structure |
|---|
Probab=84.31 E-value=1.2 Score=48.73 Aligned_cols=74 Identities=18% Similarity=0.151 Sum_probs=47.6
Q ss_pred EEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCc---EEEEEEEEec-CCCEEE
Q 001902 203 VVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS---YCGRLLNYKK-DGTPFW 278 (998)
Q Consensus 203 ~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~---~~~e~~~~~k-dG~~~w 278 (998)
+++|. .+++|+.+|..+++++|++.++++|+++..+++++ ....+...+..+.. ...+++.... +|..+|
T Consensus 46 l~~~~--~~~~i~~~S~N~~~~lg~~~~~llG~~l~~ll~~~----~~~~l~~~l~~~~~~~~~p~~~~~~~~~~~~~f~ 119 (337)
T 2ool_A 46 FVVSE--TDLRIASVSANVEDLLRQPPASLLNVPIAHYLTAA----SAARLTHALHGGDPAAINPIRLDVVTPDGERAFN 119 (337)
T ss_dssp EEECT--TTCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCHH----HHHHHHHHHCC----CCCSEEEEEEETTEEEEEE
T ss_pred EEEEC--CCCEEEEEehhHHHHHCcCHHHHcCCCHHHHcCHH----HHHHHHHHHhcCCccccCcEEEEEeccCCCeEEE
Confidence 44553 26889999999999999999999999998887753 33445555543321 1123443333 456666
Q ss_pred EEee
Q 001902 279 NLLT 282 (998)
Q Consensus 279 ~~~~ 282 (998)
+.+.
T Consensus 120 ~~~H 123 (337)
T 2ool_A 120 GILH 123 (337)
T ss_dssp EEEE
T ss_pred EEEE
Confidence 6544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 998 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-79 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-71 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-69 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-68 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-68 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-67 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-66 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-65 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-65 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-64 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-63 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-63 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-62 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-62 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-62 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-61 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-58 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-56 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-53 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-52 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-51 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-51 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-49 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-48 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-48 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-47 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-45 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-44 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-43 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-42 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-40 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-39 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-39 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-36 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-30 | |
| d1n9la_ | 109 | d.110.3.6 (A:) Putative blue light receptor, phot- | 1e-24 | |
| d1n9la_ | 109 | d.110.3.6 (A:) Putative blue light receptor, phot- | 1e-20 | |
| d1jnua_ | 104 | d.110.3.6 (A:) Photoreceptor phy3 flavin-binding d | 5e-21 | |
| d1jnua_ | 104 | d.110.3.6 (A:) Photoreceptor phy3 flavin-binding d | 4e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-13 | |
| d1bywa_ | 110 | d.110.3.6 (A:) Erg potassium channel, N-terminal d | 9e-13 | |
| d1bywa_ | 110 | d.110.3.6 (A:) Erg potassium channel, N-terminal d | 4e-12 | |
| d1xj3a1 | 106 | d.110.3.2 (A:154-259) Histidine kinase FixL heme d | 3e-06 | |
| d1xj3a1 | 106 | d.110.3.2 (A:154-259) Histidine kinase FixL heme d | 1e-05 | |
| d1ew0a_ | 130 | d.110.3.2 (A:) Histidine kinase FixL heme domain { | 8e-06 | |
| d1ew0a_ | 130 | d.110.3.2 (A:) Histidine kinase FixL heme domain { | 7e-05 | |
| d1ll8a_ | 114 | d.110.3.5 (A:) N-terminal PAS domain of Pas kinase | 2e-04 | |
| d1p97a_ | 114 | d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-t | 0.001 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 258 bits (659), Expect = 3e-79
Identities = 102/309 (33%), Positives = 150/309 (48%), Gaps = 31/309 (10%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 725
F+ K LG G +V L + + +A+K ++K ++ NKV ER+++ LDHP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 726 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
F LY +FQ + Y GEL + + E RFY AE+V ALEYLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 126
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
+GII+RDLKPEN+LL + H+ +TDF + + S +
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------------------------- 161
Query: 846 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905
+NSFVGT +Y++PE++ + D WALG ++Y+++ G PFR F
Sbjct: 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK 221
Query: 906 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFFKGVNWALVR 963
I+ + FP A+ L+ +LL D RLG E G +K HPFF+ V W +
Sbjct: 222 IIKLEYDFPEK--FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 279
Query: 964 CMNPPELDA 972
PP+L A
Sbjct: 280 QQTPPKLTA 288
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 2e-71
Identities = 88/293 (30%), Positives = 124/293 (42%), Gaps = 37/293 (12%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
L+ F +PLG G G+V+L S A+K + K + H+ E EI L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 783
HP + LY F T V LI +Y P G ++ L + E Y E+ AL Y
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYC 122
Query: 784 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 843
H + +I+RD+KPEN+LL G + + DF S
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA-------------------------- 156
Query: 844 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903
P + GT +Y+ PE+I G H VD W+LG+L YE L G PF T Q+T+
Sbjct: 157 ---PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 213
Query: 904 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
I + FP A+ L+ RLL +P R E+ +HP+
Sbjct: 214 KRISRVEFTFPDFVTEG--ARDLISRLLKHNPSQRP----MLREVLEHPWITA 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 3e-69
Identities = 105/349 (30%), Positives = 173/349 (49%), Gaps = 48/349 (13%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-L 722
++ F K LG G G V L E + Q+FA+KA+ K V+L + V E+ +L +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 723 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 782
+HPF+ ++ +FQTK ++ + +Y GG+L + FYAAE+++ L++
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQF 118
Query: 783 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
LH +GI+YRDLK +N+LL +GH+ + DF +
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--------------------------- 151
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
+N+F GT +YIAPEI+ G + +VDWW+ G+LLYEML G +PF G+ ++
Sbjct: 152 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 211
Query: 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962
F +I + +P AK L+ +L R+P+ RLG +I++HP F+ +NW +
Sbjct: 212 FHSIRMDNPFYPRWLEKE--AKDLLVKLFVREPEKRLGV---RGDIRQHPLFREINWEEL 266
Query: 963 --RCMNPP-------ELDAPLFATDTEKEYKVVDPG----MQDLQQNVF 998
+ ++PP D F + E + + + QN+F
Sbjct: 267 ERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMF 315
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 229 bits (584), Expect = 2e-68
Identities = 120/346 (34%), Positives = 176/346 (50%), Gaps = 46/346 (13%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
LQ F+ ++ LG+G G VHL+ +G+Y+AMK + K +++ +V ER +L ++
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 783
HPF+ ++ +FQ + +I DY GGELF LL + +FYAAEV +ALEYL
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLALEYL 120
Query: 784 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 843
H + IIYRDLKPEN+LL NGH+ +TDF +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---------------------- 158
Query: 844 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903
+ GT +YIAPE+++ + ++DWW+ GIL+YEML GYTPF KT+
Sbjct: 159 --------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210
Query: 904 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWA-- 960
IL+ +L+FP K L+ RL+ RD RLG+ G ++K HP+FK V W
Sbjct: 211 EKILNAELRFPPFFNED--VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268
Query: 961 LVRCMNPP--------ELDAPLFATDTEKEYKVVDPGMQDLQQNVF 998
L R + P + D F E++ G D ++F
Sbjct: 269 LSRNIETPYEPPIQQGQGDTSQFDKYPEEDINYGVQGE-DPYADLF 313
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 7e-68
Identities = 113/347 (32%), Positives = 173/347 (49%), Gaps = 41/347 (11%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 721
+ + F +K LG G G V LV +G+Y+AMK + K V++ +++V E +L
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 722 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 781
HPF+ AL +FQT +C + +Y GGELF L R+ E+ RFY AE+V ALE
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALE 119
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
YLH + ++YRD+K EN++L +GH+ +TDF L
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-------------------------- 153
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + ++
Sbjct: 154 -EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
Query: 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWA 960
F IL ++++FP + AK L+ LL +DPK RLG A E+ +H FF +NW
Sbjct: 213 LFELILMEEIRFPRTLSPE--AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270
Query: 961 LV--RCMNPP-------ELDAPLFATDTEKEYKVVDPGMQDLQQNVF 998
V + + PP E+D F + + + P + +
Sbjct: 271 DVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLL 317
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 226 bits (578), Expect = 4e-67
Identities = 76/322 (23%), Positives = 134/322 (41%), Gaps = 40/322 (12%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
L H+ + LG+G G VH V +G FA K + ++ V + E + + +L
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLR 81
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 783
HP + L+ +F+ + +I ++ GGELF + + K + ED Y +V L ++
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHM 140
Query: 784 HCQGIIYRDLKPENVLL--QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
H ++ DLKPEN++ + + + L DF L+
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-------------------------- 174
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901
+P ++ GT E+ APE+ G D W++G+L Y +L G +PF G+ +
Sbjct: 175 --HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232
Query: 902 TFANILHKDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959
T N+ D S + + K + +LL DP +R+ ++ +HP+ N
Sbjct: 233 TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM----TIHQALEHPWLTPGNA 288
Query: 960 ALVRCMNPPELDAPLFATDTEK 981
P + + K
Sbjct: 289 PGRDSQIPSSRYTKIRDSIKTK 310
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 225 bits (575), Expect = 1e-66
Identities = 78/312 (25%), Positives = 136/312 (43%), Gaps = 40/312 (12%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
++ ++ LGSG G VH +G+ F K ++ L++ V E I++ L
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLH 84
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 783
HP + L+ +F+ K + LI ++ GGELF + + K + E V Y + L+++
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHM 143
Query: 784 HCQGIIYRDLKPENVLL--QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
H I++ D+KPEN++ + V + DF L+ +
Sbjct: 144 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN----------------------- 180
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901
P T E+ APEI+ D WA+G+L Y +L G +PF G+ +
Sbjct: 181 -----PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 235
Query: 902 TFANILHKDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959
T N+ D +F +S+ AK + LL ++P+ RL ++ +HP+ KG +
Sbjct: 236 TLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL----TVHDALEHPWLKGDHS 291
Query: 960 ALVRCMNPPELD 971
L + +
Sbjct: 292 NLTSRIPSSRYN 303
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 2e-65
Identities = 64/297 (21%), Positives = 118/297 (39%), Gaps = 41/297 (13%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 725
+ I LG G G V+ + + A K +D + ++ E +IL DHP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHP 69
Query: 726 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
+ L +F + ++ ++ ++C GG + ++ + L E ++ + + AL YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD 128
Query: 786 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 845
II+RDLK N+L +G + L DF +S
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSA---------------------------KNT 161
Query: 846 EPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
++ +SF+GT ++APE++ + D W+LGI L EM P
Sbjct: 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221
Query: 901 KTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
+ I + + S + K + + L ++ +R +++ +HPF
Sbjct: 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW----TTSQLLQHPFVTV 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 221 bits (563), Expect = 7e-65
Identities = 103/356 (28%), Positives = 167/356 (46%), Gaps = 54/356 (15%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 721
+ + F + +G G G V+ +G+ +AMK +DK + + A ER +L +
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 722 L---DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 778
+ D PF+ + +F T + I D GG+L L + E +RFYAAE+++
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIIL 118
Query: 779 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 838
LE++H + ++YRDLKP N+LL +GHV ++D L+C S K
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----------------- 161
Query: 839 QNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGK 897
++ VGT Y+APE++ G + S+ DW++LG +L+++L G++PFR
Sbjct: 162 ------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209
Query: 898 TRQKTFANILHKDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFF 954
+ I L P S + L+ LL RD RLG GA E+K+ PFF
Sbjct: 210 KTKDKH-EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
Query: 955 KGVNWALV--RCMNPP------------ELDAPLFATDTEKEYKVVDPGMQDLQQN 996
+ ++W +V + PP D F + K K++D Q+L +N
Sbjct: 269 RSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDS-DQELYRN 323
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 217 bits (554), Expect = 3e-64
Identities = 67/294 (22%), Positives = 106/294 (36%), Gaps = 40/294 (13%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
+ F ++ +G G G+V+ + + A+K M + K E L L H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
P + + L+ +YC G LL + K L+E + + L YLH
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH 132
Query: 785 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 844
+I+RD+K N+LL G V L DF + +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI---------------------------- 164
Query: 845 AEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYEMLYGYTPFRGKTRQK 901
M +NSFVGT ++APE+I VD W+LGI E+ P
Sbjct: 165 ---MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221
Query: 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+I + S S + + + L + P+ R + + KH F
Sbjct: 222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP----TSEVLLKHRFVL 271
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 213 bits (542), Expect = 4e-63
Identities = 79/306 (25%), Positives = 125/306 (40%), Gaps = 49/306 (16%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK------VHRACAEREI 718
+++ P + LG G + V + + +A+K +D + + E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 719 LDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 777
L + HP + L +++T T L+ D GELF L + T L E R ++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALL 120
Query: 778 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
+ LH I++RDLKPEN+LL + ++ LTDF SC
Sbjct: 121 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--------------------- 159
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA------GHTSAVDWWALGILLYEMLYGY 891
+P GT Y+APEII + G+ VD W+ G+++Y +L G
Sbjct: 160 -------LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
Query: 892 TPFRGKTRQKTFANILHKDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGSHEGANEIK 949
PF + + I+ + +F S K L+ R L P+ R A E
Sbjct: 213 PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY----TAEEAL 268
Query: 950 KHPFFK 955
HPFF+
Sbjct: 269 AHPFFQ 274
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 5e-63
Identities = 122/325 (37%), Positives = 176/325 (54%), Gaps = 38/325 (11%)
Query: 654 KILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNK-V 709
+ E++ +++F +K LG+G G V LV +G+ +AMK + K ++ + K
Sbjct: 13 NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 72
Query: 710 HRACAEREILDMLDH-PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 768
ER++L+ + PF+ L+ +FQT+T + LI DY GGELF L ++ E
Sbjct: 73 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHE 130
Query: 769 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 828
V+ Y E+V+ALE+LH GIIYRD+K EN+LL NGHV LTDF LS
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK------------- 177
Query: 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYE 886
F+A+ + F GT EY+AP+I+ G +GH AVDWW+LG+L+YE
Sbjct: 178 -------------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 224
Query: 887 MLYGYTPFRGKTRQKTFANILHKDLKFPSSTPT--SLHAKQLMYRLLHRDPKSRLGS-HE 943
+L G +PF + + A I + LK P S AK L+ RLL +DPK RLG
Sbjct: 225 LLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPR 284
Query: 944 GANEIKKHPFFKGVNWALVRCMNPP 968
A+EIK+H FF+ +NW + P
Sbjct: 285 DADEIKEHLFFQKINWDDLAAKKVP 309
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 213 bits (544), Expect = 6e-63
Identities = 82/316 (25%), Positives = 134/316 (42%), Gaps = 49/316 (15%)
Query: 649 WKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK 708
WK + I D + LG+G V L E + + A+K + K + K
Sbjct: 1 WKQAEDIRD--------IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGK 50
Query: 709 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 768
E +L + HP + AL +++ H+ LI GGELF + + E
Sbjct: 51 EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERD 108
Query: 769 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSCKPQLLL 825
+V+ A++YLH GI++RDLKPEN+L + + ++DF LS +
Sbjct: 109 ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED------- 161
Query: 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 885
P ++ GT Y+APE++A ++ AVD W++G++ Y
Sbjct: 162 ---------------------PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAY 200
Query: 886 EMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGSHE 943
+L GY PF + K F IL + +F S + AK + L+ +DP+ R
Sbjct: 201 ILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---- 256
Query: 944 GANEIKKHPFFKGVNW 959
+ +HP+ G
Sbjct: 257 TCEQALQHPWIAGDTA 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 1e-62
Identities = 67/345 (19%), Positives = 120/345 (34%), Gaps = 80/345 (23%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 720
++ F I LG+G+ G V V SG A K + + ++ E ++L
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLH 59
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
+ P++ Y +F + + + ++ GG L +L + + E + + V+ L
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 117
Query: 781 EYLH-CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
YL I++RD+KP N+L+ G + L DF +S
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---------------------- 155
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899
+NSFVGT Y++PE + G ++ D W++G+ L EM G P
Sbjct: 156 -------IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208
Query: 900 QKTFANILHKDLKFPSSTPT---------------------------------------- 919
++ + + TP
Sbjct: 209 KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSG 268
Query: 920 --SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962
SL + + + L ++P R ++ H F K + V
Sbjct: 269 VFSLEFQDFVNKCLIKNPAERA----DLKQLMVHAFIKRSDAEEV 309
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 2e-62
Identities = 68/294 (23%), Positives = 123/294 (41%), Gaps = 35/294 (11%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
++ + ++ LG G G V L + + A+K +D ++ + E I ML+
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLN 61
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 783
H V Y + L +YC GGELF ++ + E + + +++ + YL
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYL 119
Query: 784 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 843
H GI +RD+KPEN+LL ++ ++DF L+ + +
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--------------------- 158
Query: 844 MAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQ-K 901
R N GT Y+APE++ H VD W+ GI+L ML G P+ + +
Sbjct: 159 ----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214
Query: 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+++ K L++++L +P +R+ +IKK ++
Sbjct: 215 EYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI----TIPDIKKDRWYN 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 2e-62
Identities = 63/294 (21%), Positives = 117/294 (39%), Gaps = 42/294 (14%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
+ + + +G G +G+V+ +GQ A++ M+ + + E ++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKN 76
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
P + S+ + ++ +Y GG L ++ E + E + ALE+LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLH 133
Query: 785 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 844
+I+RD+K +N+LL +G V LTDF +
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA---------------------------QI 166
Query: 845 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904
++ VGT ++APE++ + VD W+LGI+ EM+ G P+ + +
Sbjct: 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
Query: 905 NILHK---DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
I +L+ P + + R L D + R A E+ +H F K
Sbjct: 227 LIATNGTPELQNPEKLSAI--FRDFLNRCLDMDVEKRG----SAKELLQHQFLK 274
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (542), Expect = 3e-62
Identities = 107/334 (32%), Positives = 159/334 (47%), Gaps = 44/334 (13%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 720
L F IK LG+G G V LV+ SG ++AMK +DK ++ ++ E+ IL
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
++ PF+ L SF+ +++ ++ +Y GGE+F L R E RFYAA++V+
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTF 154
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
EYLH +IYRDLKPEN+L+ G++ +TDF +
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------------- 189
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
+ + GT E +APEII G+ AVDWWALG+L+YEM GY PF
Sbjct: 190 -----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNW 959
+ + I+ ++FPS + K L+ LL D R G+ G N+IK H +F +W
Sbjct: 245 QIYEKIVSGKVRFPSHFSSD--LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302
Query: 960 ALV--RCMNPP-------ELDAPLFATDTEKEYK 984
+ R + P D F E+E +
Sbjct: 303 IAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 4e-61
Identities = 87/317 (27%), Positives = 139/317 (43%), Gaps = 45/317 (14%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-NRNKVHRACAERE--ILDML 722
++ + LGSG V +G +A K + K +R V R ERE IL +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 723 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 782
HP V L+ ++ KT V LI + GGELF L + + L E+ + +++ + Y
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYY 128
Query: 783 LHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 838
LH I + DLKPEN++L + + DF L+
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------------------- 165
Query: 839 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 898
+ + GT E++APEI+ D W++G++ Y +L G +PF G T
Sbjct: 166 -----KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220
Query: 899 RQKTFANILHKDLKFPSSTP--TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956
+Q+T AN+ + +F TS AK + RLL +DPK R+ + +HP+ K
Sbjct: 221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM----TIQDSLQHPWIKP 276
Query: 957 VNW--ALVRCMNPPELD 971
+ AL + P+ +
Sbjct: 277 KDTQQALSSAWSHPQFE 293
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 9e-61
Identities = 66/296 (22%), Positives = 120/296 (40%), Gaps = 42/296 (14%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
+ + +G+G G + G+ K +D G M + +E +L L HP
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPN 64
Query: 727 VPALYASF--QTKTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEY 782
+ Y +T T + ++ +YC GG+L ++ + + + L E+ V ++ +AL+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 783 LHCQG-----IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
H + +++RDLKP NV L G +V L DF L+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR---------------------- 162
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897
+ + +FVGT Y++PE + + D W+LG LLYE+ PF
Sbjct: 163 -----ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217
Query: 898 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 953
++++ I + S +++ R+L+ R EI ++P
Sbjct: 218 SQKELAGKIREGKFRRIPYR-YSDELNEIITRMLNLKDYHRP----SVEEILENPL 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-60
Identities = 67/294 (22%), Positives = 121/294 (41%), Gaps = 41/294 (13%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 725
+ + LG G+ G VH S + + K + E IL++ H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHR 61
Query: 726 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
+ L+ SF++ + +I ++ G ++F ++ + L E + Y +V AL++LH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS 120
Query: 786 QGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 843
I + D++PEN++ Q + + + +F +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-------------------- 160
Query: 844 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903
EY APE+ ++A D W+LG L+Y +L G PF +T Q+
Sbjct: 161 --------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
Query: 904 ANILHKDLKFPSSTPT--SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
NI++ + F S+ A + RLL ++ KSR+ A+E +HP+ K
Sbjct: 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM----TASEALQHPWLK 262
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-58
Identities = 60/305 (19%), Positives = 119/305 (39%), Gaps = 45/305 (14%)
Query: 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 718
G + + + +G G +V+ + A + L +++ R E E+
Sbjct: 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR-KLTKSERQRFKEEAEM 61
Query: 719 LDMLDHPFVPALYASFQT----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 774
L L HP + Y S+++ K + L+T+ G L L R KV+K +R +
Sbjct: 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCR 119
Query: 775 EVVVALEYLHCQG--IIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEK 831
+++ L++LH + II+RDLK +N+ + G G V + D L+ L
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--------------- 164
Query: 832 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 891
+ + + +GT E++APE+ + +VD +A G+ + EM
Sbjct: 165 --------------KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE 209
Query: 892 TPFRGK-TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950
P+ + + + K+++ + ++ R ++
Sbjct: 210 YPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY----SIKDLLN 265
Query: 951 HPFFK 955
H FF+
Sbjct: 266 HAFFQ 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 193 bits (490), Expect = 5e-56
Identities = 58/282 (20%), Positives = 115/282 (40%), Gaps = 32/282 (11%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 725
+ + LG G VHL + A+K + + + + R E + L+HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 726 FVPALYASFQTKTH----VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 781
+ A+Y + + +T ++ +Y G L ++ + + A+ AL
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALN 125
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
+ H GII+RD+KP N+++ V + DF ++ +
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN------------------- 166
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901
+ + + +GT +Y++PE G + D ++LG +LYE+L G PF G +
Sbjct: 167 -----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221
Query: 902 TFANILHKDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGS 941
+ +D PS+ L ++ + L ++P++R +
Sbjct: 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 263
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 5e-53
Identities = 57/284 (20%), Positives = 106/284 (37%), Gaps = 38/284 (13%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 721
I + +GSG G+V+ + G A+K ++ ++ E +L
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLRK 60
Query: 722 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 781
H + + T + ++T +C G L+ L TK + + A + ++
Sbjct: 61 TRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMD 118
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
YLH + II+RDLK N+ L + V + DF L+ + S
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS----------------------- 155
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAG---HTSAVDWWALGILLYEMLYGYTPFRGKT 898
G+ ++APE+I ++ D +A GI+LYE++ G P+
Sbjct: 156 --RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213
Query: 899 RQKTFANILHKDLKFPSSTPTSLH----AKQLMYRLLHRDPKSR 938
+ ++ + P + + K+LM L + R
Sbjct: 214 NRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-52
Identities = 66/299 (22%), Positives = 109/299 (36%), Gaps = 49/299 (16%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH---RACAEREILDML 722
++ LGSG GSV+ A+K ++K + + ++ R E +L +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 723 D--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
V L F+ LI + + + L+E+ R + +V+ A+
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 123
Query: 781 EYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
+ H G+++RD+K EN+L+ N G + L DF L
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----------------- 166
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEMLYGYTPFRGKT 898
F GT Y PE I + + W+LGILLY+M+ G PF
Sbjct: 167 ------------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214
Query: 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957
I+ + F + + L+ L P R EI+ HP+ + V
Sbjct: 215 ------EIIRGQVFFRQRVSSE--CQHLIRWCLALRPSDRP----TFEEIQNHPWMQDV 261
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-52
Identities = 61/299 (20%), Positives = 109/299 (36%), Gaps = 54/299 (18%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 729
+ LG G G V + + + FA+K + R E E+ P +
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVR 69
Query: 730 LYASFQT----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 785
+ ++ + + ++ + GGELF + + + E + A++YLH
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 786 QGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
I +RD+KPEN+L + N + LTDF +
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--------------------------- 162
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
+ + T Y+APE++ + + D W+LG+++Y +L GY PF
Sbjct: 163 -ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221
Query: 903 FANILHK------DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+ + + P + S K L+ LL +P R+ E HP+
Sbjct: 222 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM----TITEFMNHPWIM 276
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 1e-51
Identities = 59/293 (20%), Positives = 110/293 (37%), Gaps = 35/293 (11%)
Query: 671 KPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 728
K LGSG+ G+V + A+K + + AE ++ LD+P++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIV 71
Query: 729 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 788
+ + ++ L+ + G L L + +K+ + +V + ++YL
Sbjct: 72 RMIGICEAESW-MLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNF 128
Query: 789 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 848
++RDL NVLL + ++DF LS
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN------------------------YY 164
Query: 849 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANIL 907
+A ++ APE I +S D W+ G+L++E YG P+RG + A +
Sbjct: 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224
Query: 908 H-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959
+ + P+ P + LM D ++R G ++ ++ VN
Sbjct: 225 KGERMGCPAGCPREM--YDLMNLCWTYDVENRPGFAA-VELRLRNYYYDVVNE 274
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-51
Identities = 59/281 (20%), Positives = 93/281 (33%), Gaps = 30/281 (10%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREI 718
I + R ++ LG G G V E G A+K + V+ + E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 719 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 778
+ LDH + LY T + ++T+ P G L L + + YA +V
Sbjct: 65 MHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAE 122
Query: 779 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 838
+ YL + I+RDL N+LL V + DF L
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN------------------ 164
Query: 839 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGK 897
+ + APE + + A D W G+ L+EM YG P+ G
Sbjct: 165 ------DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218
Query: 898 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ I + + P +M + P+ R
Sbjct: 219 NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-51
Identities = 60/298 (20%), Positives = 110/298 (36%), Gaps = 43/298 (14%)
Query: 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 718
G +N++ + ++ +G G+ G V L + G A+K + AE +
Sbjct: 1 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN-----DATAQAFLAEASV 53
Query: 719 LDMLDHPFVPALYASF-QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 777
+ L H + L + K + ++T+Y G L L + VL D + ++ +V
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 778 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
A+EYL ++RDL NVL+ + ++DF L+ S
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----------------- 156
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRG 896
++ ++ APE + ++ D W+ GILL+E+ +G P+
Sbjct: 157 -------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203
Query: 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN---EIKKH 951
+ + K K + ++M H D R + IK H
Sbjct: 204 IPLKDVVPRVE-KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 6e-51
Identities = 74/327 (22%), Positives = 111/327 (33%), Gaps = 62/327 (18%)
Query: 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLDHPFV 727
+ LG G +V+ + Q A+K + G A RE +L L HP +
Sbjct: 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 728 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 787
L +F K+++ L+ D+ ++ D VL ++ Y + LEYLH
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 788 IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEP 847
I++RDLKP N+LL NG + L DF L+ P
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK---------------------------SFGSP 153
Query: 848 MRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 906
RA V T Y APE++ GA + VD WA+G +L E+L G + I
Sbjct: 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213
Query: 907 LHKDLKFPSST--------------------------PTSLHAKQLMYRLLHRDPKSRLG 940
L+ L +P +R+
Sbjct: 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI- 272
Query: 941 SHEGANEIKKHPFFKGVNWALVRCMNP 967
A + K +F C P
Sbjct: 273 ---TATQALKMKYFSNRPGPTPGCQLP 296
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 3e-50
Identities = 60/278 (21%), Positives = 105/278 (37%), Gaps = 34/278 (12%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 721
I+ + +K LG+G G V + G A+K + +G M E +++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED----EFIEEAKVMMN 55
Query: 722 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 781
L H + LY + + +IT+Y G L L + + + +V A+E
Sbjct: 56 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAME 114
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
YL + ++RDL N L+ G V ++DF LS
Sbjct: 115 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY------------------------- 149
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQ 900
+ + +S + PE++ + +S D WA G+L++E+ G P+ T
Sbjct: 150 -VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208
Query: 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+T +I + L+ S +MY H R
Sbjct: 209 ETAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADER 245
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-49
Identities = 58/287 (20%), Positives = 103/287 (35%), Gaps = 35/287 (12%)
Query: 673 LGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 730
LG G+ GSV A+K + +G + E +I+ LD+P++ L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 731 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 790
Q + + L+ + GG L L + + V +V + ++YL + ++
Sbjct: 75 IGVCQAE-ALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 132
Query: 791 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 850
RDL NVLL + ++DF LS +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS---------------------- 170
Query: 851 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH- 908
+ ++ APE I +S D W+ G+ ++E L YG P++ + A I
Sbjct: 171 --AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 228
Query: 909 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
K ++ P P L LM + R + + ++
Sbjct: 229 KRMECPPECPPEL--YALMSDCWIYKWEDRPDFLT-VEQRMRACYYS 272
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-48
Identities = 69/323 (21%), Positives = 118/323 (36%), Gaps = 61/323 (18%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
+++F+ ++ +G G G V+ +G+ A+K + A E +L L+
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN 59
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 783
HP + L T+ + L+ ++ L +D + ++ Y +++ L +
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 784 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 843
H +++RDLKP+N+L+ G + L DF L+
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---------------------------A 151
Query: 844 MAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEMLYGYTPFRGKTRQKT 902
P+R V T Y APEI+ G + S AVD W+LG + EM+ F G +
Sbjct: 152 FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211
Query: 903 FANILHKDLKFPSST---------------------------PTSLHAKQLMYRLLHRDP 935
I P + L+ ++LH DP
Sbjct: 212 LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 271
Query: 936 KSRLGSHEGANEIKKHPFFKGVN 958
R+ A HPFF+ V
Sbjct: 272 NKRI----SAKAALAHPFFQDVT 290
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (434), Expect = 3e-48
Identities = 64/300 (21%), Positives = 111/300 (37%), Gaps = 33/300 (11%)
Query: 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAER 716
++I++ + + +G+G+ G V L G+ + A+K + G + +E
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEA 78
Query: 717 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 776
I+ DHP V L T V +IT++ G L RQ + +
Sbjct: 79 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-LRQNDGQFTVIQLVGMLRGI 137
Query: 777 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
++YL ++RDL N+L+ N ++DF LS
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD------------- 184
Query: 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFR 895
++ + APE I TSA D W+ GI+++E++ YG P+
Sbjct: 185 ---------PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235
Query: 896 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN---EIKKHP 952
T Q I +D + P QLM +D R + N ++ ++P
Sbjct: 236 DMTNQDVINAIE-QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 9e-48
Identities = 57/305 (18%), Positives = 104/305 (34%), Gaps = 55/305 (18%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ-----YFAMKAMDKGVMLNRNKVHRACAER 716
++ K LGSG G V G + A+K + + + ++ +E
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSEL 91
Query: 717 EILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK------------- 762
+++ L H + L + + LI +YC G+L L + K
Sbjct: 92 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 763 --------VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814
VL + + +A +V +E+L + ++RDL NVL+ V + DF L+
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 874
++ +++APE + +T
Sbjct: 212 RDIMSDSNYVVRGN-------------------------ARLPVKWMAPESLFEGIYTIK 246
Query: 875 VDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHR 933
D W+ GILL+E+ G P+ G F ++ K + +M
Sbjct: 247 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 306
Query: 934 DPKSR 938
D + R
Sbjct: 307 DSRKR 311
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 9e-48
Identities = 79/351 (22%), Positives = 130/351 (37%), Gaps = 76/351 (21%)
Query: 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 726
+ K +G+G G V+ +LC SG+ A+K + + E +I+ LDH
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 74
Query: 727 VPALYASFQT------KTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVA 779
+ L F + + ++ L+ DY P + + + L V+ Y ++ +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 780 LEYLHCQGIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 838
L Y+H GI +RD+KP+N+LL + V L DF +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-------------------- 174
Query: 839 QNPVFMAEPMRASNSFVGTEEYIAP-EIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897
+ S++ + Y AP I +TS++D W+ G +L E+L G F G
Sbjct: 175 --------RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226
Query: 898 TRQKTFANIL-----------------HKDLKFPSSTP----------TSLHAKQLMYRL 930
+ I+ + + KFP T A L RL
Sbjct: 227 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRL 286
Query: 931 LHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEK 981
L P +RL E H FF + V+ N + LF T++
Sbjct: 287 LEYTPTARL----TPLEACAHSFFDELRDPNVKLPNGRDTP-ALFNFTTQE 332
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 9e-48
Identities = 69/319 (21%), Positives = 118/319 (36%), Gaps = 55/319 (17%)
Query: 640 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 699
KP +D W ++ + + ++ LG+G G V + G A+K++
Sbjct: 1 KPWWEDE--W-----------EVPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLK 46
Query: 700 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 759
+G M AE ++ L H + LYA T+ + +IT+Y G L L
Sbjct: 47 QGSM----SPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTP 101
Query: 760 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819
L + + AA++ + ++ + I+RDL+ N+L+ + DF L+ L
Sbjct: 102 SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL--- 158
Query: 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 879
A ++ APE I T D W+
Sbjct: 159 -----------------------IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 880 LGILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKS 937
GILL E++ +G P+ G T + N+ + P + P L QLM P+
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL--YQLMRLCWKERPED 253
Query: 938 RLGSHEGANEIKK--HPFF 954
R + ++ FF
Sbjct: 254 RP----TFDYLRSVLEDFF 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-47
Identities = 68/329 (20%), Positives = 122/329 (37%), Gaps = 68/329 (20%)
Query: 665 QHFRPIKPLGSGDTGSVHLV-ELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML- 722
Q + + +G G G V +L G++ A+K + E +L L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLE 65
Query: 723 --DHPFVPALYASFQT-----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 775
+HP V L+ +T + L+ ++ L D+ P + + ++ +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL-DKVPEPGVPTETIKDMMFQ 124
Query: 776 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 835
++ L++LH +++RDLKP+N+L+ +G + L DF L+ + S
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS----------------- 167
Query: 836 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895
A S V T Y APE++ + + + VD W++G + EM FR
Sbjct: 168 -----------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216
Query: 896 GKTRQKTFANILH-----------KDLKFPSS--------------TPTSLHAKQLMYRL 930
G + IL +D+ P T K L+ +
Sbjct: 217 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 276
Query: 931 LHRDPKSRLGSHEGANEIKKHPFFKGVNW 959
L +P R+ A HP+F+ +
Sbjct: 277 LTFNPAKRI----SAYSALSHPYFQDLER 301
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (428), Expect = 2e-47
Identities = 54/278 (19%), Positives = 93/278 (33%), Gaps = 30/278 (10%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 720
++ LG G G V+ A+K + + + +V E ++
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMK 68
Query: 721 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
+ HP + L + +IT++ G L L + + + + A ++ A+
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
EYL + I+RDL N L+ N V + DF LS L
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------------------------ 164
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
+ A ++ APE +A + D WA G+LL+E+
Sbjct: 165 --MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222
Query: 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+L KD + +LM +P R
Sbjct: 223 SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 260
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 4e-47
Identities = 51/277 (18%), Positives = 102/277 (36%), Gaps = 32/277 (11%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 721
I+ ++ +GSG G VHL + A+K + +G M + + E E++
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIE----EAEVMMK 56
Query: 722 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 781
L HP + LY + +CL+ ++ G L R + + + +V +
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
YL +I+RDL N L+ N + ++DF ++
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF------------------------- 150
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901
+ + +S ++ +PE+ + + ++S D W+ G+L++E+
Sbjct: 151 -VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209
Query: 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ + S H Q+M P+ R
Sbjct: 210 EVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDR 246
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-47
Identities = 65/329 (19%), Positives = 105/329 (31%), Gaps = 69/329 (20%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 725
+ + +G G G V +GQ A+K + A E +IL +L H
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME-NEKEGFPITALREIKILQLLKHE 69
Query: 726 FVPALYASFQTKT--------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 777
V L +TK + L+ D+C LL + ++ ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLL 127
Query: 778 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
L Y+H I++RD+K NVL+ +G + L DF L+ S
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN--------------- 172
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRG 896
+ V T Y PE++ G + +D W G ++ EM +G
Sbjct: 173 --------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224
Query: 897 KTRQKTFANILHKDLKFPSSTP------------------------------TSLHAKQL 926
T Q A I +A L
Sbjct: 225 NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL 284
Query: 927 MYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
+ +LL DP R+ +++ H FF
Sbjct: 285 IDKLLVLDPAQRI----DSDDALNHDFFW 309
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 9e-47
Identities = 59/297 (19%), Positives = 106/297 (35%), Gaps = 40/297 (13%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 721
I + R LG G G V + G+ + A+K + G M E +++
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE----AFLQEAQVMKK 68
Query: 722 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 781
L H + LYA ++ + ++T+Y G L L + K L+ + AA++ +
Sbjct: 69 LRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
Y+ ++RDL+ N+L+ N + DF L+ L
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARL------------------------- 162
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQ 900
A ++ APE T D W+ GILL E+ G P+ G +
Sbjct: 163 -IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221
Query: 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK--HPFFK 955
+ + + + P LM + ++P+ R ++ +F
Sbjct: 222 EVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERP----TFEYLQAFLEDYFT 273
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 162 bits (411), Expect = 3e-45
Identities = 60/320 (18%), Positives = 117/320 (36%), Gaps = 63/320 (19%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
++ + ++ +G G G V+ + G+ FA+K + + E IL L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLE-KEDEGIPSTTIREISILKELK 58
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 783
H + LY TK + L+ ++ LL + L+ + + +++ + Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYC 116
Query: 784 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 843
H + +++RDLKP+N+L+ G + + DF L+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLAR---------------------------A 149
Query: 844 MAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902
P+R + T Y AP+++ G+ +++ +D W++G + EM+ G F G +
Sbjct: 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ 209
Query: 903 FANILHKDLKFPSSTP---------------------------TSLHAKQLMYRLLHRDP 935
I S L+ ++L DP
Sbjct: 210 LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269
Query: 936 KSRLGSHEGANEIKKHPFFK 955
R+ A + +H +FK
Sbjct: 270 NQRI----TAKQALEHAYFK 285
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 9e-45
Identities = 66/351 (18%), Positives = 120/351 (34%), Gaps = 67/351 (19%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 725
+ + +G G G V + A+K + ++ R E +IL H
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHE 66
Query: 726 FVPALYASFQTKTHV----CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 781
+ + + T + + G +L+ LL Q L D + ++ +++ L+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLK 123
Query: 782 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
Y+H +++RDLKP N+LL + + DF L+ +
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-------------------- 163
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900
+ +V T Y APEI+ G+T ++D W++G +L EML F GK
Sbjct: 164 ----DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 219
Query: 901 KTFANIL--------------------HKDLKFPSSTPTSLH---------AKQLMYRLL 931
+IL + L P + A L+ ++L
Sbjct: 220 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKML 279
Query: 932 HRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKE 982
+P R+ + HP+ + + + D KE
Sbjct: 280 TFNPHKRI----EVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKE 326
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 161 bits (409), Expect = 2e-44
Identities = 69/367 (18%), Positives = 125/367 (34%), Gaps = 87/367 (23%)
Query: 634 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 693
++V + W +++ G N ++ ++ LG G V + +
Sbjct: 7 ARVYTDVNTHRPREYWDYESHVVEWG---NQDDYQLVRKLGRGKYSEVFEAINITNNEKV 63
Query: 694 AMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH--VCLITDYCPGG 750
+K + K + E +IL+ L P + L + L+ ++
Sbjct: 64 VVKILKP------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117
Query: 751 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLT 809
+ L L + +RFY E++ AL+Y H GI++RD+KP NV++ + + L
Sbjct: 118 DFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 172
Query: 810 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA 869
D+ L+ P + N V + + PE++
Sbjct: 173 DWGLAE----------------------------FYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 870 -GHTSAVDWWALGILLYEMLYGYTPFR-GKTRQKTFANI-----------------LHKD 910
+ ++D W+LG +L M++ PF G I + D
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 911 LKFPSSTPT------------------SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 952
+F S A + +LL D +SRL A E +HP
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHP 320
Query: 953 FFKGVNW 959
+F V
Sbjct: 321 YFYTVVK 327
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-44
Identities = 58/321 (18%), Positives = 116/321 (36%), Gaps = 63/321 (19%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
+Q + ++ +G G G+V + + + A+K + + A E +L L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK 59
Query: 724 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 783
H + L+ + + L+ ++C L + V+ + +++ L +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY--FDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 784 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 843
H + +++RDLKP+N+L+ NG + L +F L+
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARA--------------------------- 150
Query: 844 MAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTP-FRGKTRQK 901
P+R ++ V T Y P+++ GA +++++D W+ G + E+ P F G
Sbjct: 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
Query: 902 TFANILHKDLKFPSSTPTSLH---------------------------AKQLMYRLLHRD 934
I S+ + L+ LL +
Sbjct: 211 QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCN 270
Query: 935 PKSRLGSHEGANEIKKHPFFK 955
P R+ A E +HP+F
Sbjct: 271 PVQRI----SAEEALQHPYFS 287
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 5e-44
Identities = 54/294 (18%), Positives = 99/294 (33%), Gaps = 45/294 (15%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 720
++ + +G G+ G V + G +++ E E+L
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65
Query: 721 ML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLL--------------DRQPTKVLK 765
L HP + L + + + ++ L +Y P G L L L
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 766 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825
+ +AA+V ++YL + I+RDL N+L+ N + DF LS
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS----------- 174
Query: 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 885
E ++A E + + +T+ D W+ G+LL+
Sbjct: 175 -----------------RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217
Query: 886 EML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
E++ G TP+ G T + + + + + LM + P R
Sbjct: 218 EIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYER 270
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 1e-43
Identities = 57/307 (18%), Positives = 102/307 (33%), Gaps = 58/307 (18%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAE 715
+ + ++ +G G G V G A+K + + + + E
Sbjct: 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQRE 66
Query: 716 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ---------------- 759
++ D+P + L +CL+ +Y G+L L
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 760 ------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 813
L A +V + YL + ++RDL N L+ N V + DF L
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 814 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 873
S ++ A+ +A + ++ PE I +T+
Sbjct: 187 SRN-------------------------IYSADYYKADGNDAIPIRWMPPESIFYNRYTT 221
Query: 874 AVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLL 931
D WA G++L+E+ YG P+ G ++ + + L P + P L LM
Sbjct: 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLEL--YNLMRLCW 279
Query: 932 HRDPKSR 938
+ P R
Sbjct: 280 SKLPADR 286
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (399), Expect = 2e-43
Identities = 49/300 (16%), Positives = 100/300 (33%), Gaps = 38/300 (12%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 725
+R + +GSG G ++L +G+ A+K + + K + E +I M+
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQGG 62
Query: 726 -FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
+P + + ++ + L ++ V A +++ +EY+H
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDL--FNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 785 CQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 841
+ I+RD+KP+N L+ V + DF L+ K +
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK--------------------KYRDAR 160
Query: 842 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901
P R + + GT Y + G + D +LG +L G P++G
Sbjct: 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220
Query: 902 TFANILHKDLKFPSSTPTSLH------AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955
K S+ L + + + ++ ++ F +
Sbjct: 221 KRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP-DYSYLRQLFRNLFHR 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-43
Identities = 57/309 (18%), Positives = 101/309 (32%), Gaps = 50/309 (16%)
Query: 653 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRN 707
Q D + K LG+G G V G + A+K + +
Sbjct: 11 QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLT 68
Query: 708 KVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ------- 759
+ +E ++L L +H + L + +IT+YC G+L L R+
Sbjct: 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 760 ---------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 810
L + + ++ +V + +L + I+RDL N+LL + D
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 811 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 870
F L+ + +++APE I
Sbjct: 189 FGLARDIKND-------------------------SNYVVKGNARLPVKWMAPESIFNCV 223
Query: 871 HTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYR 929
+T D W+ GI L+E+ G +P+ G F ++ + + S +M
Sbjct: 224 YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT 283
Query: 930 LLHRDPKSR 938
DP R
Sbjct: 284 CWDADPLKR 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-43
Identities = 75/345 (21%), Positives = 128/345 (37%), Gaps = 42/345 (12%)
Query: 651 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-- 708
A+ +IL E F+ IK LGSG G+V+ G+ + K + +
Sbjct: 1 ALLRILKETE------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 54
Query: 709 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 768
E ++ +D+P V L T T LIT P G L + +
Sbjct: 55 NKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI-GSQY 112
Query: 769 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 828
+ + ++ + YL + +++RDL NVL++ HV +TDF L+ L +
Sbjct: 113 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------- 164
Query: 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 888
E + +++A E I +T D W+ G+ ++E++
Sbjct: 165 -----------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 207
Query: 889 -YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947
+G P+ G + +IL K + P ++ +M + D SR E E
Sbjct: 208 TFGSKPYDGIPASEIS-SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
Query: 948 ---IKKHPFFKGVNWALVRCMNPPELDAPLFA--TDTEKEYKVVD 987
+ + P V R P D+ + D E VVD
Sbjct: 267 FSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVD 311
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-43
Identities = 68/295 (23%), Positives = 107/295 (36%), Gaps = 41/295 (13%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREI 718
I + + +G G G VH A+K + + + E
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--CTSDSVREKFLQEALT 61
Query: 719 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 778
+ DHP + L T+ V +I + C GEL L + L ++ YA ++
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLST 119
Query: 779 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 838
AL YL + ++RD+ NVL+ N V L DF LS
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-------------------- 159
Query: 839 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGK 897
++ +++APE I TSA D W G+ ++E+L +G PF+G
Sbjct: 160 ------DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213
Query: 898 TRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951
I + + L P + P +L LM + DP R E+K
Sbjct: 214 KNNDVIGRIENGERLPMPPNCPPTL--YSLMTKCWAYDPSRRP----RFTELKAQ 262
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-42
Identities = 71/328 (21%), Positives = 120/328 (36%), Gaps = 67/328 (20%)
Query: 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 724
+R ++P+GSG G+V +G A+K + + + RA E +L + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRH 76
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEY 782
V L F + TD+ L + L ED ++F +++ L Y
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 783 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 842
+H GII+RDLKP N+ + + + + DF L+ +
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---------------------- 174
Query: 843 FMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901
+V T Y APE+I +T VD W++G ++ EM+ G T F+G
Sbjct: 175 --------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226
Query: 902 TFANILHKDLKFPSSTP-----------------------------TSLHAKQLMYRLLH 932
I+ P+ S A L+ ++L
Sbjct: 227 QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLV 286
Query: 933 RDPKSRLGSHEGANEIKKHPFFKGVNWA 960
D + R+ A E HP+F+ ++
Sbjct: 287 LDAEQRV----TAGEALAHPYFESLHDT 310
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (391), Expect = 2e-42
Identities = 49/285 (17%), Positives = 92/285 (32%), Gaps = 39/285 (13%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 724
H++ + +G G G + + Q A+K + R+ + E +L
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGC 60
Query: 725 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
+P +Y Q H L+ D LL + V A +++ ++ +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 785 CQGIIYRDLKPENVLL-----QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 839
+ ++YRD+KP+N L+ + + + DF +
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR--------------------D 158
Query: 840 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899
P R + GT Y++ G + D ALG + L G P++G
Sbjct: 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218
Query: 900 QKTFANILHKDLKFPSSTPTSLHA------KQLMYRLLHRDPKSR 938
K S+ L A + M+ + +
Sbjct: 219 ATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 3e-42
Identities = 69/369 (18%), Positives = 135/369 (36%), Gaps = 86/369 (23%)
Query: 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 723
L+ ++ +KP+GSG G V + A+K + + N+ RA E ++ ++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN 74
Query: 724 HPFVPALYASFQTK------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 777
H + +L F + V L+ + ++ + + + +++
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQML 129
Query: 778 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 837
+++LH GII+RDLKP N++++ + + + DF L+ +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-------------- 175
Query: 838 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897
+V T Y APE+I G G+ VD W++G ++ EM+ F G+
Sbjct: 176 --------------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 898 TRQKTFANIL---------------------------HKDLKFPSSTPTSLH-------- 922
+ ++ + L FP P SL
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281
Query: 923 -----AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLF-- 975
A+ L+ ++L DP R+ ++ +HP+ PP++
Sbjct: 282 LKASQARDLLSKMLVIDPAKRI----SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDE 337
Query: 976 ATDTEKEYK 984
T +E+K
Sbjct: 338 REHTIEEWK 346
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-40
Identities = 60/301 (19%), Positives = 105/301 (34%), Gaps = 53/301 (17%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACA 714
+ KPLG G G V L E G A+K + + +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLIS 67
Query: 715 EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLL--------------DRQ 759
E E++ M+ H + L + + +I +Y G L L
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 760 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819
P + L + A +V +EYL + I+RDL NVL+ + + + DF L+
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH- 186
Query: 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 879
+ + + + +++APE + +T D W+
Sbjct: 187 ------------------------HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 222
Query: 880 LGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKS 937
G+LL+E+ G +P+ G ++ F + + PS+ L +M H P
Sbjct: 223 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNEL--YMMMRDCWHAVPSQ 280
Query: 938 R 938
R
Sbjct: 281 R 281
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-40
Identities = 51/314 (16%), Positives = 105/314 (33%), Gaps = 46/314 (14%)
Query: 662 INLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAER 716
+ + + LG G G V+ G A+K +++ + E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEA 74
Query: 717 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL--------DRQPTKVLKEDA 768
++ + V L +I + G+L L +
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 769 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 828
+ A E+ + YL+ ++RDL N ++ + V +
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG------------------- 175
Query: 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 888
G ++ + R + +++PE + T+ D W+ G++L+E+
Sbjct: 176 ------DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229
Query: 889 -YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 946
P++G + ++ ++ L P + P L +LM +PK R E +
Sbjct: 230 TLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIIS 287
Query: 947 EIKK--HPFFKGVN 958
IK+ P F+ V+
Sbjct: 288 SIKEEMEPGFREVS 301
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-40
Identities = 51/282 (18%), Positives = 95/282 (33%), Gaps = 31/282 (10%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAER 716
+I+ K +G+G+ G V+ L S A+K + G + E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEA 60
Query: 717 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 776
I+ H + L + +IT+Y G R+ + +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENG-ALDKFLREKDGEFSVLQLVGMLRGI 119
Query: 777 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
++YL ++RDL N+L+ N ++DF LS + P+ T+
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-------- 171
Query: 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 896
+ APE I+ TSA D W+ GI+++E++
Sbjct: 172 ----------------GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215
Query: 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
+ ++ + P+ QLM + ++ R
Sbjct: 216 ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARR 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 8e-40
Identities = 62/313 (19%), Positives = 114/313 (36%), Gaps = 53/313 (16%)
Query: 661 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAE 715
+ + KPLG G G V + G + + A+K + +G + ++ + E
Sbjct: 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS--E 66
Query: 716 REILDMLDHPF--VPALYASFQTKTHVCLITDYCPGGELFLLLDRQ-------------- 759
+IL + H V L A + + +I ++C G L L +
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 760 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819
L + + Y+ +V +E+L + I+RDL N+LL V + DF L+
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD--- 183
Query: 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 879
++ +++APE I +T D W+
Sbjct: 184 ----------------------IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 221
Query: 880 LGILLYEMLYGY-TPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938
G+LL+E+ +P+ G + F L + + + T+ Q M H +P R
Sbjct: 222 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 281
Query: 939 LGSHEGANEIKKH 951
+E+ +H
Sbjct: 282 P----TFSELVEH 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-39
Identities = 57/308 (18%), Positives = 118/308 (38%), Gaps = 37/308 (12%)
Query: 637 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYF 693
VH + +A+Q ++ + + HF + +G G G V+ L G +
Sbjct: 2 VHIDLSALNPELVQAVQHVVIGPSSLIV-HFNEV--IGRGHFGCVYHGTLLDNDGKKIHC 58
Query: 694 AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALY-ASFQTKTHVCLITDYCPGGEL 752
A+K++++ + + +V + E I+ HP V +L +++ ++ Y G+L
Sbjct: 59 AVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 116
Query: 753 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 812
+ + +D + F +V +++L + ++RDL N +L V + DF
Sbjct: 117 RNFIRNETHNPTVKDLIGF-GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 175
Query: 813 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT 872
L+ K + + +++A E + T
Sbjct: 176 LARDMYDK-----------------------EFDSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 873 SAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRL 930
+ D W+ G+LL+E++ G P+ +L + L P P L ++M +
Sbjct: 213 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL--YEVMLKC 270
Query: 931 LHRDPKSR 938
H + R
Sbjct: 271 WHPKAEMR 278
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 8e-39
Identities = 70/354 (19%), Positives = 122/354 (34%), Gaps = 73/354 (20%)
Query: 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 725
++ + P+GSG GSV +G A+K + + + R E +L + H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHE 77
Query: 726 FVPALYASFQTKTHVC-----LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 780
V L F + + + G +L ++ Q L +D V+F +++ L
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGL 134
Query: 781 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 840
+Y+H II+RDLKP N+ + + + + DF L+ T +
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM------------------- 175
Query: 841 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEMLYGYTPFRGKTR 899
+V T Y APEI+ H + VD W++G ++ E+L G T F G
Sbjct: 176 -----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224
Query: 900 QKTFANILHKDLKFPSSTP-----------------------------TSLHAKQLMYRL 930
IL + + A L+ ++
Sbjct: 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM 284
Query: 931 LHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYK 984
L D R+ A + H +F + + P + E+K
Sbjct: 285 LVLDSDKRI----TAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWK 334
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 8e-36
Identities = 57/309 (18%), Positives = 103/309 (33%), Gaps = 74/309 (23%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDHPFVP 728
+ +G G G V + G+ A+K + + + E EI L H +
Sbjct: 9 ESIGKGRFGEVWRGKW--RGEEVAVK------IFSSREERSWFREAEIYQTVMLRHENIL 60
Query: 729 ALYASFQ----TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 784
A+ T T + L++DY G LF L+R + + + A L +LH
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLH 117
Query: 785 CQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 836
+ I +RDLK +N+L++ NG + D L+ +
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI------------ 165
Query: 837 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH------TSAVDWWALGILLYEMLYG 890
A N VGT+ Y+APE++ + + D +A+G++ +E+
Sbjct: 166 -----------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214
Query: 891 YTPFRGKTRQKTFANILHK-----------------DLKFP---SSTPTSLHAKQLMYRL 930
+ + L P S ++M
Sbjct: 215 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC 274
Query: 931 LHRDPKSRL 939
+ + +RL
Sbjct: 275 WYANGAARL 283
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (306), Expect = 1e-30
Identities = 57/357 (15%), Positives = 110/357 (30%), Gaps = 87/357 (24%)
Query: 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 718
GE + ++ LG G +V L + + + AMK + + + +
Sbjct: 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 66
Query: 719 -------LDMLDHPFVPALYASFQTKT---HVCLITDYCPGGELFLLLDRQPTKVLKEDA 768
D + + L F K ++ G L L+ + + +
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 769 VRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLP 826
V+ + ++++ L+Y+H + GII+ D+KPENVL++ L ++ L +
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC------ 180
Query: 827 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 886
+ + T EY +PE++ GA D W+ L++E
Sbjct: 181 -------------------WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 221
Query: 887 MLYGYTPFRGKTRQKTFANILH-------------------------------------- 908
++ G F + H
Sbjct: 222 LITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKL 281
Query: 909 --------KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957
K+ S + + +L DP+ R A + HP+ K
Sbjct: 282 KFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA----DAGGLVNHPWLKDT 334
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 109 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 96.9 bits (240), Expect = 1e-24
Identities = 65/107 (60%), Positives = 86/107 (80%)
Query: 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETL 257
+ TFVV+DAT PD P++YAS GF+ MTGY EV+G NCRFLQG GTDP++V KIR+ +
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 258 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+ G++ RLLNY+KDGTPFWNLLT+ PIK +G+V KF+G+QV+V+
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVDVT 108
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 109 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 85.7 bits (211), Expect = 1e-20
Identities = 47/105 (44%), Positives = 65/105 (61%), Gaps = 4/105 (3%)
Query: 481 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAI 540
+ FV+ D LPD P+++AS+ F +T Y +E+LG NCRFLQG TDP V+KIR AI
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 541 DNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLD 581
+V+L+NY K G FWNL + P++ F+GVQ+D
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVD 106
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Score = 86.9 bits (214), Expect = 5e-21
Identities = 46/104 (44%), Positives = 69/104 (66%)
Query: 200 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQN 259
++FV++D PD PI++AS F ++T YT +EV+G NCRFLQG GTD + V IR+ ++
Sbjct: 1 KSFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKE 60
Query: 260 GQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
+ ++LNY K G FWNL + ++D+ G V FIG+Q E+
Sbjct: 61 QRDVTVQVLNYTKGGRAFWNLFHLQVMRDENGDVQYFIGVQQEM 104
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Score = 81.5 bits (200), Expect = 4e-19
Identities = 72/103 (69%), Positives = 82/103 (79%), Gaps = 4/103 (3%)
Query: 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDN 542
K+FVITDPRLPDNPIIFASD FLELTEY+REE+LG NCRFLQG TD V+ IR A+
Sbjct: 1 KSFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKE 60
Query: 543 QTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLD 581
Q DVTVQ++NYTK G+ FWNLFHLQ MRD+ YFIGVQ +
Sbjct: 61 QRDVTVQVLNYTKGGRAFWNLFHLQVMRDENGDVQYFIGVQQE 103
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.5 bits (164), Expect = 2e-13
Identities = 25/159 (15%), Positives = 46/159 (28%), Gaps = 30/159 (18%)
Query: 671 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN-KVHRACAERE------------ 717
K +G G +V +K G + K R +
Sbjct: 6 KLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 718 --ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 775
L L VP +YA ++ + ++ +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGN----AVLMELIDAK---------ELYRVRVENPDEVLDM 111
Query: 776 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814
++ + + +GI++ DL NVL+ G + DF S
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEGIW-IIDFPQS 149
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.6 bits (153), Expect = 9e-13
Identities = 31/107 (28%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 200 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNC--RFLQGAGTDPEDVAKIRETL 257
+ F++++A + ++Y + GF ++ GY+ EV+ R C FL G T A+I + L
Sbjct: 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQAL 61
Query: 258 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+ + Y+KDG+ F L+ + P+K+++G V+ FI V
Sbjct: 62 LGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVM 108
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.6 bits (148), Expect = 4e-12
Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 6/108 (5%)
Query: 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNC--RFLQGPETDPATVRKIRAAI 540
+ F+I + R+ + +I+ +D F EL YSR E++ R C FL GP T +I A+
Sbjct: 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQAL 61
Query: 541 DNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQK----YFIGVQLDGSE 584
+ V++ Y K G F L + P++++ FI E
Sbjct: 62 LGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVME 109
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} Length = 106 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Score = 44.7 bits (104), Expect = 3e-06
Identities = 19/106 (17%), Positives = 34/106 (32%), Gaps = 9/106 (8%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKI----RAAID 541
++ D I S + L +S E +G+N L I +
Sbjct: 4 IVIDG---HGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDP 60
Query: 542 NQTDVTVQLINYTKSGKKFWNLFHLQPMRD--QKYFIGVQLDGSEH 585
+ + + + G F + M+ + YF G D +EH
Sbjct: 61 HIIGIGRIVTGKRRDGTTFPMHLSIGEMQSGGEPYFTGFVRDLTEH 106
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} Length = 106 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Score = 43.2 bits (100), Expect = 1e-05
Identities = 17/103 (16%), Positives = 36/103 (34%), Gaps = 6/103 (5%)
Query: 208 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI----RETLQNGQSY 263
I S ++ G++ E +G+N L + I + +
Sbjct: 6 IDGHGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGI 65
Query: 264 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306
+ ++DGT F L+I ++ F G ++++H
Sbjct: 66 GRIVTGKRRDGTTFPMHLSIGEMQSGGEPY--FTGFVRDLTEH 106
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Score = 44.3 bits (103), Expect = 8e-06
Identities = 20/101 (19%), Positives = 41/101 (40%), Gaps = 6/101 (5%)
Query: 208 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ----SY 263
+ D I+ +A + GY +EV+G+N R L E ++ + G+
Sbjct: 32 SATDGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQRYMATGEKRIIGI 91
Query: 264 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+ +KDG+ F L + ++ + F G +++
Sbjct: 92 DRVVSGQRKDGSTFPMKLAVGEMRSGGERF--FTGFIRDLT 130
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Score = 41.6 bits (96), Expect = 7e-05
Identities = 26/127 (20%), Positives = 48/127 (37%), Gaps = 13/127 (10%)
Query: 461 DKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNC 520
D VR ++ L + L+ + V++ D I+ + + + Y+ EE++G+N
Sbjct: 9 DVVRARDAH----LRSILDTVPDATVVSAT---DGTIVSFNAAAVRQFGYAEEEVIGQNL 61
Query: 521 RFLQG----PETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRD--QKY 574
R L E D R + + + K G F + MR +++
Sbjct: 62 RILMPEPYRHEHDGYLQRYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGERF 121
Query: 575 FIGVQLD 581
F G D
Sbjct: 122 FTGFIRD 128
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (92), Expect = 2e-04
Identities = 15/99 (15%), Positives = 33/99 (33%), Gaps = 8/99 (8%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 545
D + I+ A+D L YS ++++G+ ++
Sbjct: 12 FTVDAK--TTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGH 69
Query: 546 VTV----QLINYTKSGKKFWNLFHLQPMR--DQKYFIGV 578
V + ++SG+K ++ MR + + V
Sbjct: 70 AAVVFGTVVDIISRSGEKIPVSVWMKRMRQERRLCCVVV 108
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.3 bits (85), Expect = 0.001
Identities = 18/107 (16%), Positives = 33/107 (30%), Gaps = 3/107 (2%)
Query: 199 QQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ 258
+TF+ D Y ++ GY +E++GR+ A +
Sbjct: 5 SKTFLSR--HSMDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCT 62
Query: 259 NGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDE-GKVLKFIGMQVEVS 304
GQ G+ K G W I + + + + +S
Sbjct: 63 KGQVVSGQYRMLAKHGGYVWLETQGTVIYNPRNLQPQCIMCVNYVLS 109
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 998 | |||
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1n9la_ | 109 | Putative blue light receptor, phot-lov1 domain {Gr | 99.79 | |
| d1n9la_ | 109 | Putative blue light receptor, phot-lov1 domain {Gr | 99.75 | |
| d1bywa_ | 110 | Erg potassium channel, N-terminal domain {Human (H | 99.73 | |
| d1jnua_ | 104 | Photoreceptor phy3 flavin-binding domain, lov2 {Ma | 99.71 | |
| d1ew0a_ | 130 | Histidine kinase FixL heme domain {Rhizobium melil | 99.67 | |
| d1ew0a_ | 130 | Histidine kinase FixL heme domain {Rhizobium melil | 99.67 | |
| d1bywa_ | 110 | Erg potassium channel, N-terminal domain {Human (H | 99.67 | |
| d1jnua_ | 104 | Photoreceptor phy3 flavin-binding domain, lov2 {Ma | 99.64 | |
| d1xj3a1 | 106 | Histidine kinase FixL heme domain {Bradyrhizobium | 99.58 | |
| d1v9ya_ | 113 | Direct oxygen sensor protein, DOS {Escherichia col | 99.57 | |
| d1p97a_ | 114 | Hypoxia-inducible factor Hif2a, C-terminal domain | 99.54 | |
| d1p97a_ | 114 | Hypoxia-inducible factor Hif2a, C-terminal domain | 99.52 | |
| d1xj3a1 | 106 | Histidine kinase FixL heme domain {Bradyrhizobium | 99.5 | |
| d1v9ya_ | 113 | Direct oxygen sensor protein, DOS {Escherichia col | 99.5 | |
| d1nwza_ | 125 | Photoactive yellow protein, PYP {Ectothiorhodospir | 99.38 | |
| d1mzua_ | 110 | PYP domain of sensor histidine kinase Ppr {Rhodosp | 99.37 | |
| d1ll8a_ | 114 | N-terminal PAS domain of Pas kinase {Human (Homo s | 99.31 | |
| d1nwza_ | 125 | Photoactive yellow protein, PYP {Ectothiorhodospir | 99.28 | |
| d1mzua_ | 110 | PYP domain of sensor histidine kinase Ppr {Rhodosp | 99.26 | |
| d1ll8a_ | 114 | N-terminal PAS domain of Pas kinase {Human (Homo s | 99.16 | |
| d1oj5a_ | 109 | PAS domain of steroid receptor coactivator 1A, NCo | 98.85 | |
| d1oj5a_ | 109 | PAS domain of steroid receptor coactivator 1A, NCo | 98.82 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.39 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.92 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.82 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.95 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.48 | |
| d2oola2 | 114 | Sensor protein PhyB2 {Rhodopseudomonas palustris [ | 96.25 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.2 | |
| d2oola2 | 114 | Sensor protein PhyB2 {Rhodopseudomonas palustris [ | 95.9 | |
| d2o9ca2 | 127 | Bacteriophytochrome BphP {Deinococcus radiodurans | 89.59 | |
| d2veaa3 | 127 | Phytochrome-like protein Cph1 {Synechocystis sp. p | 89.5 | |
| d2o9ca2 | 127 | Bacteriophytochrome BphP {Deinococcus radiodurans | 88.23 | |
| d2veaa3 | 127 | Phytochrome-like protein Cph1 {Synechocystis sp. p | 87.94 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=481.33 Aligned_cols=279 Identities=36% Similarity=0.640 Sum_probs=247.1
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++++.||+|+||+||+|.++.+|+.||||++.+....+......+.+|+.+|++++||||++++++|.+++.+|||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999876554555667889999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.......
T Consensus 87 mEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~- 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK- 163 (288)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc-
Confidence 9999999999998765 4599999999999999999999999999999999999999999999999999976431111
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
.......+||+.|||||++.+..++.++|||||||++|+|++|..||.+.+....+
T Consensus 164 ------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~ 219 (288)
T d1uu3a_ 164 ------------------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 219 (288)
T ss_dssp ------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ------------------------ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH
Confidence 11234567999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc--HHHHHcCCCccCCChhhhhcCCCCCCC
Q 001902 904 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG--ANEIKKHPFFKGVNWALVRCMNPPELD 971 (998)
Q Consensus 904 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~--a~elL~Hp~f~~~~~~~~~~~~~~~~~ 971 (998)
.++.+..+.+|. .++.++++||.+||+.||.+|||+.++ ...+++||||++++|..+....||.++
T Consensus 220 ~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 220 QKIIKLEYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp HHHHTTCCCCCT--TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred HHHHcCCCCCCc--cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence 999988877764 478999999999999999999996653 446899999999999999999999763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=477.09 Aligned_cols=278 Identities=40% Similarity=0.767 Sum_probs=248.6
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+.+++|++++.||+|+||.||+|+++.+|+.||+|++++...........+.+|+.+|++++||||++++++|.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 45678999999999999999999999999999999998776555566788899999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 82 iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~- 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred cceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC-
Confidence 999999999999999875 45999999999999999999999999999999999999999999999999999653211
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
.......+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+...
T Consensus 159 --------------------------~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 212 (337)
T d1o6la_ 159 --------------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212 (337)
T ss_dssp --------------------------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred --------------------------CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH
Confidence 112345689999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh-cHHHHHcCCCccCCChhhh--hcCCCCCC
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALV--RCMNPPEL 970 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~--~~~~~~~~ 970 (998)
.+..+....+.+|. .+|.++++||.+||++||.+|++... .+.++++||||++++|..+ +.+.||..
T Consensus 213 ~~~~i~~~~~~~p~--~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~ 282 (337)
T d1o6la_ 213 LFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFK 282 (337)
T ss_dssp HHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred HHHHHhcCCCCCCc--cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCC
Confidence 99999998887775 47899999999999999999996543 3899999999999999887 44555544
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-54 Score=462.69 Aligned_cols=257 Identities=34% Similarity=0.569 Sum_probs=233.3
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEE
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 742 (998)
.+++|++++.||+|+||.||+|.++.+|+.||+|++.+....+......+.+|+.+++.++||||+++++++.+++.+||
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 35689999999999999999999999999999999987655555556788899999999999999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
|||||++|+|.+++.+. ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|.....
T Consensus 84 vmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--- 158 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 158 (263)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---
T ss_pred EEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC---
Confidence 99999999999999874 4599999999999999999999999999999999999999999999999999954321
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
......+||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+....
T Consensus 159 --------------------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 212 (263)
T d2j4za1 159 --------------------------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 212 (263)
T ss_dssp --------------------------CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred --------------------------CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH
Confidence 112345799999999999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
+..+.+....+|. .+|.++++||.+||+.||.+||| +.++|+||||++
T Consensus 213 ~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dp~~R~t----~~eil~hp~~~~ 260 (263)
T d2j4za1 213 YKRISRVEFTFPD--FVTEGARDLISRLLKHNPSQRPM----LREVLEHPWITA 260 (263)
T ss_dssp HHHHHTTCCCCCT--TSCHHHHHHHHHHTCSSGGGSCC----HHHHHTCHHHHH
T ss_pred HHHHHcCCCCCCc--cCCHHHHHHHHHHccCCHhHCcC----HHHHHcCcCcCC
Confidence 9999888777665 46899999999999999999999 999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9e-53 Score=467.35 Aligned_cols=273 Identities=41% Similarity=0.809 Sum_probs=243.6
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46899999999999999999999999999999999876555555677889999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
||||+||+|..++... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 83 mE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---- 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 156 (316)
T ss_dssp ECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred eeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc----
Confidence 9999999999999875 4589999999999999999999999999999999999999999999999999965321
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
.....+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+....+
T Consensus 157 --------------------------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 210 (316)
T d1fota_ 157 --------------------------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210 (316)
T ss_dssp --------------------------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred --------------------------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH
Confidence 123468999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhh--hcCCCCCC
Q 001902 904 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV--RCMNPPEL 970 (998)
Q Consensus 904 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~--~~~~~~~~ 970 (998)
..+......+|. .++.++.++|.+||..||.+|++.. +.++++|+||||++++|..+ +.+.||..
T Consensus 211 ~~i~~~~~~~p~--~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~ 278 (316)
T d1fota_ 211 EKILNAELRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYE 278 (316)
T ss_dssp HHHHHCCCCCCT--TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCC
T ss_pred HHHHcCCCCCCC--CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCC
Confidence 999998776664 4688999999999999999997332 24999999999999999977 45555543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-52 Score=471.08 Aligned_cols=273 Identities=37% Similarity=0.685 Sum_probs=243.8
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
+++|++++.||+|+||.||+|+++.+|+.||||++.+....+......+.+|+.+|+.++||||+++++++.....+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 56899999999999999999999999999999999876555555667889999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+.||+|..++.+. +.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 120 ~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---- 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred cccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc----
Confidence 9999999999999775 3599999999999999999999999999999999999999999999999999965421
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 903 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 903 (998)
.....+||+.|||||++.+..++.++|||||||++|+|++|++||.+.+....+
T Consensus 194 --------------------------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 247 (350)
T d1rdqe_ 194 --------------------------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247 (350)
T ss_dssp --------------------------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred --------------------------ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH
Confidence 123457999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcC-CChhcHHHHHcCCCccCCChhhhh--cCCCCCC
Q 001902 904 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRL-GSHEGANEIKKHPFFKGVNWALVR--CMNPPEL 970 (998)
Q Consensus 904 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rp-t~~~~a~elL~Hp~f~~~~~~~~~--~~~~~~~ 970 (998)
..+....+.+|. .++.++.+||.+||..||.+|+ +.++.+++|++||||++++|..+. .+.||..
T Consensus 248 ~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~ 315 (350)
T d1rdqe_ 248 EKIVSGKVRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFI 315 (350)
T ss_dssp HHHHHCCCCCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred HHHhcCCCCCCc--cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCcc
Confidence 999988776654 5789999999999999999995 333449999999999999998773 4555544
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=457.05 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=226.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
++|++++.||+|+||.||+|.+..+|+.||+|++...... ..+.+.+|+.+|++++||||++++++|.+.+.+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 5799999999999999999999999999999999865332 3467889999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
|||+||+|.+++.+. .+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 97 Ey~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~---- 169 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 169 (293)
T ss_dssp ECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST----
T ss_pred EecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc----
Confidence 999999999988763 4999999999999999999999999999999999999999999999999999654311
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 904 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~ 904 (998)
.......+||+.|||||++.+..++.++|||||||++|+|++|.+||.+.+....+.
T Consensus 170 -----------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 226 (293)
T d1yhwa1 170 -----------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (293)
T ss_dssp -----------------------TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred -----------------------cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH
Confidence 112235579999999999999999999999999999999999999999988887777
Q ss_pred HHHhCC-CCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 905 NILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 905 ~i~~~~-~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
.+.... ..++....+|.++++||.+||..||.+||| +.++|+||||+.
T Consensus 227 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s----~~eil~Hp~~~~ 275 (293)
T d1yhwa1 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS----AKELLQHQFLKI 275 (293)
T ss_dssp HHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCC----HHHHTTCGGGGG
T ss_pred HHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhCC
Confidence 776543 334444567899999999999999999999 999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=456.01 Aligned_cols=260 Identities=26% Similarity=0.425 Sum_probs=220.5
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++++.||+|+||+||+|.++.+|+.||+|++..... ....+.+.+|+.+|++++||||+++++++.+.+.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 4689999999999999999999999999999999976432 22345688999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
||||+||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 82 mEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~-- 157 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 157 (271)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred EeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC--
Confidence 9999999999999764 469999999999999999999999999999999999999999999999999996543111
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCC-CChhHHHHHHHHHHHHHcCCCCCCCCChH-H
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQ-K 901 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDIwSlG~il~eLltG~~Pf~~~~~~-~ 901 (998)
........+||+.|||||++.+..+ +.++|||||||++|+|++|++||.+.... .
T Consensus 158 -----------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~ 214 (271)
T d1nvra_ 158 -----------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214 (271)
T ss_dssp -----------------------EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH
T ss_pred -----------------------ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH
Confidence 0112345689999999999988776 56899999999999999999999876543 3
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
.+..+.......+....+|.++.+||.+||+.||.+||| +.++|+||||+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----~~eil~hpwf~~ 265 (271)
T d1nvra_ 215 EYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT----IPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC----HHHHTTCTTTTC
T ss_pred HHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcC----HHHHhcCHhhCc
Confidence 344444444444444567899999999999999999999 999999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=459.62 Aligned_cols=271 Identities=37% Similarity=0.745 Sum_probs=236.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHH-hCCCCCccceeEEEeeCCeEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD-MLDHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~-~l~h~nIv~l~~~~~~~~~~~l 742 (998)
+++|++++.||+|+||+||+|.++.+|+.||||++++...........+..|..++. .++||||+++++++.+++.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 368999999999999999999999999999999998765444445566677777665 6899999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
|||||++|+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++.....
T Consensus 81 vmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-- 156 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-- 156 (320)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--
T ss_pred EEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc--
Confidence 99999999999999875 45899999999999999999999999999999999999999999999999999653211
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....
T Consensus 157 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~ 211 (320)
T d1xjda_ 157 -------------------------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 211 (320)
T ss_dssp -------------------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -------------------------cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence 1122345799999999999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHH-HHHcCCCccCCChhhhh--cCCCCC
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN-EIKKHPFFKGVNWALVR--CMNPPE 969 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~-elL~Hp~f~~~~~~~~~--~~~~~~ 969 (998)
+..+......+|. .+|.++.+||.+||..||.+||+ +. ++++||||++++|..++ .+.||.
T Consensus 212 ~~~i~~~~~~~p~--~~s~~~~dli~~~L~~dP~~R~s----~~~~l~~hpff~~~~~~~l~~~~~~pp~ 275 (320)
T d1xjda_ 212 FHSIRMDNPFYPR--WLEKEAKDLLVKLFVREPEKRLG----VRGDIRQHPLFREINWEELERKEIDPPF 275 (320)
T ss_dssp HHHHHHCCCCCCT--TSCHHHHHHHHHHSCSSGGGSBT----TBSCGGGSGGGTTCCHHHHHTTCSCC--
T ss_pred HHHHHcCCCCCCc--cCCHHHHHHHHHhcccCCCCCcC----HHHHHHhCchhccCCHHHHHhcCCCCCC
Confidence 9999888776664 46899999999999999999999 64 78999999999998774 344443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-51 Score=456.33 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=230.0
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 745 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 745 (998)
.|++++.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+|++++|||||++++++.+.+.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999987665566667789999999999999999999999999999999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
||++|+|..++... ..+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|....
T Consensus 96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~------- 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 166 (309)
T ss_dssp CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-------
T ss_pred ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC-------
Confidence 99999998776654 459999999999999999999999999999999999999999999999999985432
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC---CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
.....+||+.|||||++.+ ..|+.++|||||||++|+|++|..||.+.+....
T Consensus 167 ------------------------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~ 222 (309)
T d1u5ra_ 167 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (309)
T ss_dssp ------------------------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ------------------------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 1124579999999999964 4588899999999999999999999999999888
Q ss_pred HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 903 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 903 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
+..+.....+.+....+|..+.+||.+||+.||.+||| +.++|+||||+.
T Consensus 223 ~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT----SEVLLKHRFVLR 272 (309)
T ss_dssp HHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHTTCHHHHS
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcC----HHHHHhCHHhcC
Confidence 88888887766666678999999999999999999999 999999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=452.74 Aligned_cols=264 Identities=30% Similarity=0.470 Sum_probs=230.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccC---hhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN---RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57999999999999999999999999999999998654322 223577889999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC----cEEEEeccCcccc
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCLT 817 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g----~vkL~DFG~a~~~ 817 (998)
||||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+| .+||+|||+|...
T Consensus 90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999999775 4599999999999999999999999999999999999999776 5999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 168 ~~~----------------------------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 219 (293)
T d1jksa_ 168 DFG----------------------------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219 (293)
T ss_dssp TTS----------------------------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCC----------------------------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence 311 1223457999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHhCCCCCCCC--CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhhh
Q 001902 898 TRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 962 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 962 (998)
+..+.+..+......++.. ..+|..+++||.+||+.||.+||| +.++|+||||+..+|...
T Consensus 220 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s----~~eil~hp~~~~~~~~~~ 282 (293)
T d1jksa_ 220 TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT----IQDSLQHPWIKPKDTQQA 282 (293)
T ss_dssp SHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC----HHHHHHSTTTCC------
T ss_pred CHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccCCCChhHh
Confidence 9999999998887665532 457889999999999999999999 999999999999888654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-52 Score=464.04 Aligned_cols=262 Identities=25% Similarity=0.407 Sum_probs=221.1
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
+..++|++++.||+|+||+||+|.++.+|+.||+|+++... .......+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45678999999999999999999999999999999998642 3445578889999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEecCCcEEEEeccCccccCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 820 (998)
||||||+||+|.+++.+. +.+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+|+....
T Consensus 81 iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 999999999999999875 4599999999999999999999974 999999999999999999999999999964320
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
....+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..
T Consensus 158 ----------------------------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 158 ----------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp ----------------------------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred ----------------------------CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 1123568999999999999999999999999999999999999999876543
Q ss_pred HHH------------------------------------------HHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCc
Q 001902 901 KTF------------------------------------------ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 938 (998)
Q Consensus 901 ~~~------------------------------------------~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~R 938 (998)
... ..+.....+.......|.++++||.+||+.||.+|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R 289 (322)
T d1s9ja_ 210 ELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 289 (322)
T ss_dssp HHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHC
Confidence 211 11111111111122357899999999999999999
Q ss_pred CCChhcHHHHHcCCCccCCChh
Q 001902 939 LGSHEGANEIKKHPFFKGVNWA 960 (998)
Q Consensus 939 pt~~~~a~elL~Hp~f~~~~~~ 960 (998)
|| ++++|+||||+..++.
T Consensus 290 ~t----a~e~L~Hpf~~~~~~~ 307 (322)
T d1s9ja_ 290 AD----LKQLMVHAFIKRSDAE 307 (322)
T ss_dssp CC----HHHHHTSHHHHHHHHS
T ss_pred cC----HHHHhhCHhhCcCCcc
Confidence 99 9999999999986654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-51 Score=453.94 Aligned_cols=256 Identities=30% Similarity=0.497 Sum_probs=214.6
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
+.|++++.||+|+||+||+|.++.+|+.||||++.+..... ....+.+|+.+|++++||||+++++++.+++.+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999998654322 2356778999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe---cCCcEEEEeccCccccCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~---~~g~vkL~DFG~a~~~~~~~ 821 (998)
|||+||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||+. .+|.+||+|||+|+.....
T Consensus 87 E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~- 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 163 (307)
T ss_dssp CCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred eccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence 999999999999764 4599999999999999999999999999999999999995 4789999999999643211
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
......+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+...
T Consensus 164 ---------------------------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 216 (307)
T d1a06a_ 164 ---------------------------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK 216 (307)
T ss_dssp ------------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ---------------------------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 11234679999999999999999999999999999999999999999999989
Q ss_pred HHHHHHhCCCCCC--CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 902 TFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 902 ~~~~i~~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
....+......++ ....+|.++.+||.+||..||.+||| +.++|+||||++
T Consensus 217 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s----~~eil~hp~~~~ 269 (307)
T d1a06a_ 217 LFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT----CEQALQHPWIAG 269 (307)
T ss_dssp HHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHHSTTTTS
T ss_pred HHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcC----HHHHhcCHhhCC
Confidence 9899988766554 33568899999999999999999999 999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=452.51 Aligned_cols=258 Identities=25% Similarity=0.412 Sum_probs=226.7
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 744 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 744 (998)
+.|++++.||+|+||.||+|+++.+|+.||+|++... .....+.+.+|+++|++++|||||++++++.+.+.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 4699999999999999999999999999999999764 2334567888999999999999999999999999999999
Q ss_pred ecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCC
Q 001902 745 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 824 (998)
Q Consensus 745 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 824 (998)
|||+||+|.+++.+. ...+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 89 Ey~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~----- 162 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR----- 162 (288)
T ss_dssp ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH-----
T ss_pred ecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC-----
Confidence 999999999998654 24599999999999999999999999999999999999999999999999999854320
Q ss_pred CCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhc-----CCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 825 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
........+||+.|||||++. +..|+.++|||||||++|+|++|++||.+.+.
T Consensus 163 ----------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~ 220 (288)
T d2jfla1 163 ----------------------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220 (288)
T ss_dssp ----------------------HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred ----------------------CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH
Confidence 001223567999999999984 45678999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCC-CCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 900 QKTFANILHKDLKF-PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 900 ~~~~~~i~~~~~~~-~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.+.+..+.....+. +....+|.++.+||.+||+.||.+||| +.++|+||||+.-
T Consensus 221 ~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t----~~ell~hp~~~~~ 275 (288)
T d2jfla1 221 MRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWT----TSQLLQHPFVTVD 275 (288)
T ss_dssp GGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCC----HHHHTTSGGGCCC
T ss_pred HHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccCCC
Confidence 88888888876433 334567899999999999999999999 9999999999863
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.4e-51 Score=463.35 Aligned_cols=275 Identities=33% Similarity=0.600 Sum_probs=227.2
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHH---HHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC---AEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~---~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
.+++|++++.||+|+||.||+|.+..+|+.||||++.+...........+. .++.+++.++|||||+++++|.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 467999999999999999999999999999999999765443332233333 44667777789999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|||||||+||+|.+++.+. ..+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999999875 4589999999999999999999999999999999999999999999999999965431
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
. .....+||+.|||||++.. ..|+.++|||||||++|+|++|+.||.+.+
T Consensus 160 ~-----------------------------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 160 K-----------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp S-----------------------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred C-----------------------------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 1 1234579999999999965 568999999999999999999999998765
Q ss_pred hHHHH---HHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhh--hcCCCCCC
Q 001902 899 RQKTF---ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV--RCMNPPEL 970 (998)
Q Consensus 899 ~~~~~---~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~--~~~~~~~~ 970 (998)
..... ..+.... .+....+|.++.+||.+||..||.+|||.. ..|+++++||||++++|..+ ..+.||..
T Consensus 211 ~~~~~~~~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~ 286 (364)
T d1omwa3 211 TKDKHEIDRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI 286 (364)
T ss_dssp SSCHHHHHHHSSSCC--CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred HHHHHHHHHhcccCC--CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcC
Confidence 43222 2222222 233345799999999999999999999954 45899999999999999877 34445443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5e-51 Score=459.19 Aligned_cols=262 Identities=28% Similarity=0.466 Sum_probs=233.2
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
+++|++++.||+|+||.||+|.++.+|+.||+|++... .....+.+.+|+.+|++++|||||+++++|.+.+.+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999754 234456788999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec--CCcEEEEeccCccccCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG--NGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~--~g~vkL~DFG~a~~~~~~~ 821 (998)
||||+||+|.+++... ...+++..++.|+.||+.||.|||++|||||||||+|||++. +|.+||+|||+|......
T Consensus 102 mE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 102 YEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp ECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred EEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 9999999999998654 345999999999999999999999999999999999999964 678999999999654311
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
.......||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 180 ---------------------------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 232 (350)
T d1koaa2 180 ---------------------------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232 (350)
T ss_dssp ---------------------------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ---------------------------cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 12234679999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCC--CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCChhh
Q 001902 902 TFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWAL 961 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 961 (998)
.+..+......++.. ..+|.++++||.+||+.||.+||| +.++|+||||+...+..
T Consensus 233 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 233 TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT----IHQALEHPWLTPGNAPG 290 (350)
T ss_dssp HHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCC----HHHHHHSTTTSCTTCCS
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccCCCCCCC
Confidence 999998887665543 457899999999999999999999 99999999999876643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=445.78 Aligned_cols=257 Identities=25% Similarity=0.455 Sum_probs=216.2
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee--CCeEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVCL 742 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~~l 742 (998)
++|++++.||+|+||.||+|+++.+|+.||+|++..... +......+.+|+.++++++|||||++++++.+ .+.+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 579999999999999999999999999999999987643 44556778899999999999999999999864 567899
Q ss_pred EEecCCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 743 ITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQG-----IIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~~-----IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
|||||+||+|.+++.+. ....+++..++.++.||+.||.|||++| ||||||||+|||++.+|.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998642 2356999999999999999999999976 9999999999999999999999999996
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 895 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~ 895 (998)
..... .......+||+.|||||++.+..++.++|||||||++|+|++|..||.
T Consensus 163 ~~~~~---------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~ 215 (269)
T d2java1 163 ILNHD---------------------------TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215 (269)
T ss_dssp HC--------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ecccC---------------------------CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCC
Confidence 54311 112235689999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 896 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 896 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
+.+..+.+..+..+.... ....+|.++.+||.+||..||.+||| +.+||+|||+
T Consensus 216 ~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~li~~~L~~dp~~Rps----~~ell~hp~i 269 (269)
T d2java1 216 AFSQKELAGKIREGKFRR-IPYRYSDELNEIITRMLNLKDYHRPS----VEEILENPLI 269 (269)
T ss_dssp CSSHHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSTTC
T ss_pred CCCHHHHHHHHHcCCCCC-CCcccCHHHHHHHHHHcCCChhHCcC----HHHHHhCCcC
Confidence 999888888888776542 23457899999999999999999999 9999999995
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-50 Score=456.28 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=230.9
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.+.|++++.||+|+||.||+|.+..+|+.||+|+++... ......+.+|+.+|++++|||||+++++|.+++.+|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999999999999999998643 33456778899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe--cCCcEEEEeccCccccCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~--~~g~vkL~DFG~a~~~~~~~ 821 (998)
||||+||+|.+++... ...+++..++.++.||+.||.|||++|||||||||+|||++ .+|.+||+|||+|......
T Consensus 105 mE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 105 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 9999999999987654 34599999999999999999999999999999999999998 5789999999999654311
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
.......||+.|||||++.+..++.++|||||||++|+|++|.+||.+.+...
T Consensus 183 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 235 (352)
T d1koba_ 183 ---------------------------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 235 (352)
T ss_dssp ---------------------------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred ---------------------------CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 12234579999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCC--CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 902 TFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
.+..+......++.. ..+|.++.+||.+||+.||.+||| +.++|+||||++.
T Consensus 236 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s----~~eil~Hp~~~~~ 289 (352)
T d1koba_ 236 TLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT----VHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC----HHHHHTSTTTSSC
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhCCC
Confidence 999999887766543 468999999999999999999999 9999999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=438.40 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=214.9
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee----CCeEEE
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----KTHVCL 742 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~----~~~~~l 742 (998)
|++.++||+|+||+||+|.+..+++.||+|.+..... .......+.+|+++|++++|||||++++++.. ...+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4777889999999999999999999999999986543 44556788999999999999999999999864 457899
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEe-cCCcEEEEeccCccccCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQ-GNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkP~NILi~-~~g~vkL~DFG~a~~~~~ 819 (998)
|||||++|+|.+++.+. ..+++..++.++.||+.||+|||++| ||||||||+|||++ .++.+||+|||+|+....
T Consensus 90 vmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999999775 45999999999999999999999998 99999999999997 478999999999854220
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
......+||+.|||||++.+ .++.++|||||||++|+|++|+.||.+...
T Consensus 168 -----------------------------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~ 217 (270)
T d1t4ha_ 168 -----------------------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN 217 (270)
T ss_dssp -----------------------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred -----------------------------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc
Confidence 11235689999999999876 599999999999999999999999987655
Q ss_pred HHH-HHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 900 QKT-FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 900 ~~~-~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
... +..+..+..+.......++++.+||.+||..||++||| +.++|+||||+
T Consensus 218 ~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s----~~ell~Hp~fk 270 (270)
T d1t4ha_ 218 AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS----IKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGC
T ss_pred HHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcC----HHHHhCCcccC
Confidence 444 44444443333333456889999999999999999999 99999999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-49 Score=431.96 Aligned_cols=260 Identities=30% Similarity=0.452 Sum_probs=229.1
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccC------hhHHHHHHHHHHHHHhCC-CCCccceeEEEee
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN------RNKVHRACAEREILDMLD-HPFVPALYASFQT 736 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~------~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~ 736 (998)
.++|++.+.||+|+||+||+|++..+|+.||||++.+..... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999999999999999998754332 223456789999999996 9999999999999
Q ss_pred CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
++.+|||||||+||+|.+++..+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999999999775 4599999999999999999999999999999999999999999999999999965
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC------CCCCChhHHHHHHHHHHHHHcC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG------AGHTSAVDWWALGILLYEMLYG 890 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~sDIwSlG~il~eLltG 890 (998)
.+.. ......+||+.|+|||.+.+ ..++.++||||+||++|+|++|
T Consensus 160 ~~~~----------------------------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g 211 (277)
T d1phka_ 160 LDPG----------------------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211 (277)
T ss_dssp CCTT----------------------------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred ccCC----------------------------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccC
Confidence 4311 11234579999999999853 3568899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhCCCCCC--CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 891 YTPFRGKTRQKTFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 891 ~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
+.||.+.+.......+..+...++ ....+|+++++||.+||+.||.+||| +.++|+||||+..
T Consensus 212 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s----~~eil~h~~~~~~ 276 (277)
T d1phka_ 212 SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT----AEEALAHPFFQQY 276 (277)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC----HHHHTTSGGGCTT
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC----HHHHHcCHHHHHh
Confidence 999999999998888988766544 33468999999999999999999999 9999999999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=440.29 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=228.4
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
.++|++++.||+|+||+||+|.++.+|+.||+|+++... .....+.+|+.+|+.++||||++++++|.+.+.+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999997642 2335677899999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC--CcEEEEeccCccccCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN--GHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~--g~vkL~DFG~a~~~~~~~ 821 (998)
||||+|++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 80 mE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp ECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 9999999999999765 2459999999999999999999999999999999999999854 48999999998653211
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 901 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 901 (998)
.......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 158 ---------------------------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~ 210 (321)
T d1tkia_ 158 ---------------------------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp ---------------------------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ---------------------------CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH
Confidence 12234578999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCC--CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 902 TFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
.+..|......++.. ..+|.++++||.+||..||.+||| +.++|+||||++
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s----~~eil~hp~~~~ 263 (321)
T d1tkia_ 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT----ASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC----HHHHHHSHHHHS
T ss_pred HHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhcc
Confidence 999999887766543 357899999999999999999999 999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=432.26 Aligned_cols=256 Identities=28% Similarity=0.385 Sum_probs=211.9
Q ss_pred cccccCCCCceeEEEEEEccCCeEEEEEEeecccccCh--hHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEec
Q 001902 669 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR--NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 746 (998)
Q Consensus 669 ~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 746 (998)
.++.||+|+||+||+|+++.+|+.||||+++....... .....+.+|+.+|++++|||||++++++..++++||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46789999999999999999999999999976533221 1235678999999999999999999999999999999999
Q ss_pred CCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCC
Q 001902 747 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 826 (998)
Q Consensus 747 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 826 (998)
|.++++..+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~------ 153 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP------ 153 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC------
T ss_pred hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC------
Confidence 988877766644 356999999999999999999999999999999999999999999999999998654311
Q ss_pred cchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001902 827 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 905 (998)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 905 (998)
.......+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..
T Consensus 154 ---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~ 212 (299)
T d1ua2a_ 154 ---------------------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 212 (299)
T ss_dssp ---------------------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ---------------------cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHH
Confidence 1122345799999999998754 578999999999999999999999999998888877
Q ss_pred HHhCCC-----CC---------------CC------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCC
Q 001902 906 ILHKDL-----KF---------------PS------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 957 (998)
Q Consensus 906 i~~~~~-----~~---------------~~------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 957 (998)
+.+... .+ +. ....+.++.+||.+||+.||++||| +.++|+||||+..
T Consensus 213 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s----a~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 213 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT----ATQALKMKYFSNR 286 (299)
T ss_dssp HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSS
T ss_pred HHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcC----HHHHhCCHhhCCC
Confidence 764210 00 00 1235788999999999999999999 9999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=428.67 Aligned_cols=261 Identities=26% Similarity=0.452 Sum_probs=217.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
+++|++++.||+|+||+||+|.+..+|+.||||+++.... .......+.+|+++|++++||||+++++++.+.+.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 3689999999999999999999999999999999976532 233456788999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
||||. +++.+++.......+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 80 ~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--- 155 (298)
T d1gz8a_ 80 FEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--- 155 (298)
T ss_dssp EECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC---
T ss_pred EeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC---
Confidence 99995 55555555544567999999999999999999999999999999999999999999999999998654311
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC-CCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
........||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+....
T Consensus 156 ------------------------~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~ 211 (298)
T d1gz8a_ 156 ------------------------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211 (298)
T ss_dssp ------------------------SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH
Confidence 12233457999999999987765 47899999999999999999999999888777
Q ss_pred HHHHHhCCCC------------------CCC---------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 903 FANILHKDLK------------------FPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 903 ~~~i~~~~~~------------------~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
+..+...... ++. ....|.++++||.+||..||.+||| +.+||+||||+
T Consensus 212 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t----~~ell~H~ff~ 287 (298)
T d1gz8a_ 212 LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS----AKAALAHPFFQ 287 (298)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGT
T ss_pred HHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcC----HHHHhCCHhhc
Confidence 7766542100 000 1245788999999999999999999 99999999998
Q ss_pred CC
Q 001902 956 GV 957 (998)
Q Consensus 956 ~~ 957 (998)
.+
T Consensus 288 ~~ 289 (298)
T d1gz8a_ 288 DV 289 (298)
T ss_dssp TC
T ss_pred cC
Confidence 76
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-48 Score=424.27 Aligned_cols=257 Identities=22% Similarity=0.268 Sum_probs=219.8
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
+++..++|++.+.||+|+||+||+|.+..+|+.||||+++.+. ...+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 4566778999999999999999999999999999999987643 234678899999999999999999999999999
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|||||||++|+|.+++.......+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999999999876667899999999999999999999999999999999999999999999999999965432
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 168 ~~~--------------------------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~ 221 (287)
T d1opja_ 168 DTY--------------------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 221 (287)
T ss_dssp SSS--------------------------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCc--------------------------eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch
Confidence 111 112234589999999999999999999999999999999997666555444
Q ss_pred HHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 900 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
...+..++......+....++..+.+||.+||..||.+||| +.++++
T Consensus 222 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ei~~ 268 (287)
T d1opja_ 222 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS----FAEIHQ 268 (287)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcC----HHHHHH
Confidence 44455555555555555678999999999999999999999 666654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=437.15 Aligned_cols=253 Identities=25% Similarity=0.435 Sum_probs=211.9
Q ss_pred cCCccccc-ccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHh-CCCCCccceeEEEee----C
Q 001902 664 LQHFRPIK-PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPALYASFQT----K 737 (998)
Q Consensus 664 ~~~y~~~~-~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~-l~h~nIv~l~~~~~~----~ 737 (998)
.++|+++. .||+|+||+||+|.+..+++.||||+++.. ..+.+|+.++.+ ++|||||+++++|.+ .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 56899886 599999999999999999999999998753 456779988755 589999999999875 4
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec---CCcEEEEeccCc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLS 814 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~---~g~vkL~DFG~a 814 (998)
.++|||||||+||+|.+++.......+++..++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 67999999999999999998765567999999999999999999999999999999999999985 567999999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
+..... ......+||+.|||||++.+..|+.++|||||||++|+|+||++||
T Consensus 162 ~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf 213 (335)
T d2ozaa1 162 KETTSH----------------------------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213 (335)
T ss_dssp EECCCC----------------------------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSC
T ss_pred eeccCC----------------------------CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCC
Confidence 654311 1223457999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHh----CCCCCCCC--CCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 895 RGKTRQKTFANILH----KDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 895 ~~~~~~~~~~~i~~----~~~~~~~~--~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
.+.+.......+.. ....+|.. ..+|.++.+||.+||+.||.+||| +.++|+||||+.
T Consensus 214 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s----~~eil~hp~~~~ 277 (335)
T d2ozaa1 214 YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 277 (335)
T ss_dssp EETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCC----HHHHHHSHHHHT
T ss_pred CCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC----HHHHHcCHHhhC
Confidence 88765554443332 33333332 347889999999999999999999 999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-48 Score=418.39 Aligned_cols=252 Identities=27% Similarity=0.377 Sum_probs=214.3
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChh---HHHHHHHHHHHHHhCC--CCCccceeEEEeeCCe
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN---KVHRACAEREILDMLD--HPFVPALYASFQTKTH 739 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~---~~~~~~~E~~il~~l~--h~nIv~l~~~~~~~~~ 739 (998)
++|++.+.||+|+||.||+|.+..+|+.||||++.+....+.. ...++.+|+.++++++ ||||++++++|.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5899999999999999999999999999999999865443321 1234567999999996 8999999999999999
Q ss_pred EEEEEecCCC-CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecC-CcEEEEeccCcccc
Q 001902 740 VCLITDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLT 817 (998)
Q Consensus 740 ~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~-g~vkL~DFG~a~~~ 817 (998)
+|+||||+.+ +++.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999999976 5788888764 459999999999999999999999999999999999999954 79999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCC-CChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+
T Consensus 162 ~~-----------------------------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 162 KD-----------------------------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp CS-----------------------------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred cc-----------------------------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 21 11234679999999999987665 5679999999999999999999976
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCCh
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 959 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 959 (998)
. ..+......++. .+|.++++||.+||..||.+||| ++++|+||||+.+..
T Consensus 213 ~------~~i~~~~~~~~~--~~s~~~~~li~~~L~~dp~~R~s----~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 213 D------EEIIRGQVFFRQ--RVSSECQHLIRWCLALRPSDRPT----FEEIQNHPWMQDVLL 263 (273)
T ss_dssp H------HHHHHCCCCCSS--CCCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSSCCC
T ss_pred c------hHHhhcccCCCC--CCCHHHHHHHHHHccCCHhHCcC----HHHHhcCHhhCCCCC
Confidence 3 245566555544 47899999999999999999999 999999999998643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=414.27 Aligned_cols=257 Identities=21% Similarity=0.287 Sum_probs=210.3
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
+.+..++|++.+.||+|+||.||+|... ..||||+++.... +....+.+.+|+.+|++++|||||++++++. .+.
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence 4567789999999999999999999753 3699999976533 4456778899999999999999999999765 456
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|||||||++|+|.+++.... ..+++..+..++.||++||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 899999999999999997653 4599999999999999999999999999999999999999999999999999965431
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC---CCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
.. .........||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+
T Consensus 157 ~~-------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~ 211 (276)
T d1uwha_ 157 WS-------------------------GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211 (276)
T ss_dssp ----------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cC-------------------------CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC
Confidence 11 0112245679999999999965 3578899999999999999999999998
Q ss_pred CChHHHHHHHHhCCCCCC----CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 897 KTRQKTFANILHKDLKFP----SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~----~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
.+....+..++......| ....++.++.+||.+||..||.+||| +.+|++|
T Consensus 212 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt----~~~il~~ 266 (276)
T d1uwha_ 212 INNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL----FPQILAS 266 (276)
T ss_dssp CCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcC----HHHHHHH
Confidence 777666655554433322 23456889999999999999999999 7777665
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=420.70 Aligned_cols=262 Identities=24% Similarity=0.385 Sum_probs=215.0
Q ss_pred cCCcccccccCCCCceeEEEEEEccC-CeEEEEEEeecccccChhHHHHHHHHHHHHHhC---CCCCccceeEEEee---
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGS-GQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQT--- 736 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l---~h~nIv~l~~~~~~--- 736 (998)
.++|++++.||+|+||+||+|++..+ ++.||||+++...... .....+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 46899999999999999999999765 6789999997653322 2223445677776665 89999999999853
Q ss_pred --CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCc
Q 001902 737 --KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 814 (998)
Q Consensus 737 --~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a 814 (998)
...+|++|||+.++.+...... ....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred ccCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 3578999999987776554433 3456999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 815 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
..... .......+||+.|+|||++.+..|+.++|||||||++|+|++|++||
T Consensus 164 ~~~~~----------------------------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf 215 (305)
T d1blxa_ 164 RIYSF----------------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 215 (305)
T ss_dssp CCCCG----------------------------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred hhhcc----------------------------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCC
Confidence 54321 11234567999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHhCCC-----CC--------------------CCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 895 RGKTRQKTFANILHKDL-----KF--------------------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 895 ~~~~~~~~~~~i~~~~~-----~~--------------------~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
.+.+..+.+..+..... .+ ......+..+.+||.+||++||.+||| +.++|
T Consensus 216 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s----a~e~L 291 (305)
T d1blxa_ 216 RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSAL 291 (305)
T ss_dssp CCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHHH
T ss_pred CCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcC----HHHHh
Confidence 99988888777754200 00 012346788999999999999999999 99999
Q ss_pred cCCCccCCCh
Q 001902 950 KHPFFKGVNW 959 (998)
Q Consensus 950 ~Hp~f~~~~~ 959 (998)
+||||+.+++
T Consensus 292 ~Hpff~~i~~ 301 (305)
T d1blxa_ 292 SHPYFQDLER 301 (305)
T ss_dssp TSGGGTTCCC
T ss_pred cChhhcCchh
Confidence 9999998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.7e-47 Score=416.14 Aligned_cols=251 Identities=23% Similarity=0.357 Sum_probs=213.9
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC----e
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----H 739 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----~ 739 (998)
.++|++.+.||+|+||.||+|.+..+|+.||||++++....+......+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367999999999999999999999999999999999876667777788999999999999999999999997643 4
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|||||||+|++|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.++.++|+|||.+.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 89999999999999998775 4599999999999999999999999999999999999999999999999998855331
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 899 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 899 (998)
... ........+||+.|||||++.+..++.++|||||||++|+|+||.+||.+.+.
T Consensus 164 ~~~------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 219 (277)
T d1o6ya_ 164 SGN------------------------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 219 (277)
T ss_dssp ---------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccc------------------------cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH
Confidence 111 11223456899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCC--CCCCCcHHHHHHHHHccccCccCcCC
Q 001902 900 QKTFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLG 940 (998)
Q Consensus 900 ~~~~~~i~~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt 940 (998)
.+.+..++......+ ....+|.++.+||.+||..||.+||+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~ 262 (277)
T d1o6ya_ 220 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262 (277)
T ss_dssp HHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCS
T ss_pred HHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHh
Confidence 888888887765543 23567899999999999999999995
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=416.40 Aligned_cols=263 Identities=23% Similarity=0.346 Sum_probs=220.1
Q ss_pred ccccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee
Q 001902 657 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 736 (998)
Q Consensus 657 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 736 (998)
...+.+..++|++++.||+|+||.||+|.+. +++.||||+++.... ..+.+.+|+.++++++|||||++++++..
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 79 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence 3455677789999999999999999999984 678999999975432 24578899999999999999999998754
Q ss_pred CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
+.+|||||||++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus 80 -~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEE
Confidence 5679999999999999988765445699999999999999999999999999999999999999999999999999966
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 895 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~ 895 (998)
..... ........||+.|||||++.+..++.++|||||||++|||+| |.+||.
T Consensus 159 ~~~~~--------------------------~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~ 212 (272)
T d1qpca_ 159 IEDNE--------------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212 (272)
T ss_dssp CSSSC--------------------------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccCCc--------------------------cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 43111 112234579999999999999999999999999999999999 556666
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc--CCCccC
Q 001902 896 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK--HPFFKG 956 (998)
Q Consensus 896 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~--Hp~f~~ 956 (998)
..+....+..+..+ ...+....++.++.+|+.+||+.||.+||| +.++++ |+||+.
T Consensus 213 ~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt----~~ei~~~L~~~fts 270 (272)
T d1qpca_ 213 GMTNPEVIQNLERG-YRMVRPDNCPEELYQLMRLCWKERPEDRPT----FDYLRSVLEDFFTA 270 (272)
T ss_dssp TCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhc-CCCCCcccChHHHHHHHHHHcCCCHhHCcC----HHHHHHHhhhhhhc
Confidence 66666666666554 333444567899999999999999999999 788877 788864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=425.18 Aligned_cols=261 Identities=21% Similarity=0.311 Sum_probs=220.3
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCC-----eEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEE
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS 733 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-----~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~ 733 (998)
+++..++|++.+.||+|+||+||+|.+..++ ..||+|.+.... .......+.+|+.++.++ +|||||+++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 3466678999999999999999999987654 379999886542 233456788999999998 89999999999
Q ss_pred EeeCCeEEEEEecCCCCchhHHHhhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 001902 734 FQTKTHVCLITDYCPGGELFLLLDRQPT---------------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 792 (998)
Q Consensus 734 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrD 792 (998)
+...+.+|||||||++|+|.+++..+.. ..+++..++.++.||+.||+|||++||||||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 9999999999999999999999976432 3589999999999999999999999999999
Q ss_pred CCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCC
Q 001902 793 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT 872 (998)
Q Consensus 793 LkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 872 (998)
|||+|||++.++.+||+|||+|+....... ........||+.|||||++.+..++
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~l~~~~~~ 244 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSN-------------------------YVVRGNARLPVKWMAPESLFEGIYT 244 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT-------------------------SEEETTEEECGGGCCHHHHHHCCCC
T ss_pred CchhccccccCCeEEEeeccccccccCCCc-------------------------eeeeccccCCCccCChHHHcCCCCC
Confidence 999999999999999999999965431110 1122345689999999999999999
Q ss_pred ChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 873 SAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 873 ~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
.++|||||||++|||++ |.+||.+.+....+..++.....++....++.++.+||.+||+.||++||| +.+|++|
T Consensus 245 ~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt----~~ei~~~ 320 (325)
T d1rjba_ 245 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 320 (325)
T ss_dssp HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred cceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 99999999999999997 999999988777778888877766666678999999999999999999999 7777765
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=423.73 Aligned_cols=285 Identities=41% Similarity=0.732 Sum_probs=232.5
Q ss_pred cccCCcccccccCCCCceeEEEEEE---ccCCeEEEEEEeeccccc-ChhHHHHHHHHHHHHHhCCC-CCccceeEEEee
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVEL---CGSGQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDH-PFVPALYASFQT 736 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~---~~~~~~valK~i~~~~~~-~~~~~~~~~~E~~il~~l~h-~nIv~l~~~~~~ 736 (998)
+.+++|++++.||+|+||.||+|.+ ..+|+.||||++++.... +....+.+.+|+.++++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 4568899999999999999999998 346899999999765432 22334567889999999976 899999999999
Q ss_pred CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
...+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|..
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999999875 4488999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC--CCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
+.... ........|++.|+|||.+.+. .++.++|||||||+||+|++|+.||
T Consensus 179 ~~~~~--------------------------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF 232 (322)
T d1vzoa_ 179 FVADE--------------------------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 232 (322)
T ss_dssp CCGGG--------------------------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred hcccc--------------------------cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 43111 1122345799999999999764 4677999999999999999999999
Q ss_pred CCCChHHHHHH----HHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCCh-hcHHHHHcCCCccCCChhhhhcCCCCC
Q 001902 895 RGKTRQKTFAN----ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPPE 969 (998)
Q Consensus 895 ~~~~~~~~~~~----i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~~~~~ 969 (998)
.+.+....... ......++| ..+|.++.+||.+||..||.+|||+. ..++|+|+||||++++|..+.....|.
T Consensus 233 ~~~~~~~~~~~i~~~~~~~~~~~~--~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~ 310 (322)
T d1vzoa_ 233 TVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPA 310 (322)
T ss_dssp SCTTSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred CCCCHHHHHHHHHHhcccCCCCCc--ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCc
Confidence 87654433333 333444433 35799999999999999999999654 248999999999999999886655554
Q ss_pred CCCCCCC
Q 001902 970 LDAPLFA 976 (998)
Q Consensus 970 ~~~p~~~ 976 (998)
.-.|.+.
T Consensus 311 p~~p~~~ 317 (322)
T d1vzoa_ 311 PFKPVIR 317 (322)
T ss_dssp SCCCCCC
T ss_pred CCCCCCC
Confidence 4446554
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=423.70 Aligned_cols=258 Identities=28% Similarity=0.429 Sum_probs=213.3
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC-----
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----- 738 (998)
.++|++++.||+|+||+||+|.++.+|+.||||++++.. ......+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 478999999999999999999999999999999998653 34556678899999999999999999999997654
Q ss_pred -eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 739 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 739 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
++|+||||| +.+|..+++. ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 579999999 7788888765 34999999999999999999999999999999999999999999999999999553
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
. ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+
T Consensus 172 ~------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 172 D------------------------------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp C------------------------------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred C------------------------------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence 2 112345799999999999764 568899999999999999999999999
Q ss_pred CChHHHHHHHHhCCCCC-----------------------C------CCCCCcHHHHHHHHHccccCccCcCCChhcHHH
Q 001902 897 KTRQKTFANILHKDLKF-----------------------P------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 947 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~-----------------------~------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 947 (998)
.+....+..+....... . .....++.+.+||.+||..||.+||| +.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~e 297 (346)
T d1cm8a_ 222 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT----AGE 297 (346)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHH
T ss_pred CChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcC----HHH
Confidence 88776665544311110 0 11346889999999999999999999 999
Q ss_pred HHcCCCccCCChh
Q 001902 948 IKKHPFFKGVNWA 960 (998)
Q Consensus 948 lL~Hp~f~~~~~~ 960 (998)
+|+||||+.+...
T Consensus 298 iL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 298 ALAHPYFESLHDT 310 (346)
T ss_dssp HHHSGGGTTTC--
T ss_pred HhcChhhCcCCCc
Confidence 9999999987543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=411.06 Aligned_cols=263 Identities=21% Similarity=0.277 Sum_probs=218.2
Q ss_pred ccCCcccccc-cCCCCceeEEEEEEcc--CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 663 NLQHFRPIKP-LGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 663 ~~~~y~~~~~-LG~G~~g~Vy~a~~~~--~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
..++|.+... ||+|+||.||+|.++. ++..||||+++... .......+.+|+++|++++|||||++++++.. +.
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 3456777774 9999999999998753 45689999997542 44556788999999999999999999999865 46
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|||||||++|+|.+++... ...+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 89999999999999998654 34699999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~ 898 (998)
.... ........||+.|||||++.+..++.++|||||||++|||+| |..||.+.+
T Consensus 162 ~~~~------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 162 DDSY------------------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp CSCE------------------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccc------------------------cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 2111 112234568999999999999999999999999999999997 999999988
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
..+.+..+..+.. .+....++.++.+||.+||..||++|||+.+ +.+.|+|+|+.
T Consensus 218 ~~~~~~~i~~~~~-~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~-i~~~L~~~~~~ 272 (285)
T d1u59a_ 218 GPEVMAFIEQGKR-MECPPECPPELYALMSDCWIYKWEDRPDFLT-VEQRMRACYYS 272 (285)
T ss_dssp THHHHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred HHHHHHHHHcCCC-CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHH-HHHHHHHHHHH
Confidence 8777777766532 2333567899999999999999999999655 34557888764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=406.30 Aligned_cols=253 Identities=22% Similarity=0.364 Sum_probs=207.8
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEE
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 741 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 741 (998)
|+.++|++++.||+|+||.||+|.+. ++..||||+++.... ..+.+.+|+.++++++||||+++++++...+.+|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence 34568999999999999999999985 578899999976432 2356889999999999999999999999999999
Q ss_pred EEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCC
Q 001902 742 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 821 (998)
Q Consensus 742 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 821 (998)
+|||||++|+|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+......
T Consensus 77 lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred EEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 999999999999998765 3458999999999999999999999999999999999999999999999999996543111
Q ss_pred CCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 001902 822 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 900 (998)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~ 900 (998)
. .......||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..
T Consensus 156 ~--------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~ 209 (263)
T d1sm2a_ 156 Y--------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209 (263)
T ss_dssp -----------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH
T ss_pred c--------------------------eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH
Confidence 0 11223568999999999999999999999999999999998 67777777777
Q ss_pred HHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 901 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 901 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
..+..+..+. ..+....++.++.+|+.+||+.||.+||| +++|++|
T Consensus 210 ~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~p~~Rps----~~~il~~ 255 (263)
T d1sm2a_ 210 EVVEDISTGF-RLYKPRLASTHVYQIMNHCWKERPEDRPA----FSRLLRQ 255 (263)
T ss_dssp HHHHHHHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHhcC-CCCCccccCHHHHHHHHHHccCCHhHCcC----HHHHHHH
Confidence 7777776653 23334456889999999999999999999 7777765
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-46 Score=413.59 Aligned_cols=258 Identities=23% Similarity=0.317 Sum_probs=207.3
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCCe---EEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
.+..+.|++.+.||+|+||+||+|.++.+++ .||+|.+.... .....+.+.+|+.+|++++|||||++++++...
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4556789999999999999999999976654 58888876532 344567889999999999999999999999999
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
+.+|+|||||++|+|.+++... ...+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+..
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999999999988765 345999999999999999999999999999999999999999999999999999664
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~ 896 (998)
...... ..........||+.|||||++.+..++.++|||||||++|||+| |.+||.+
T Consensus 179 ~~~~~~----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 179 EDDTSD----------------------PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp ---------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCCCCc----------------------ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence 321110 00011223468999999999999999999999999999999997 8999999
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
.+..+.+..+..+ ...+....++..+.+||.+||+.||.+|||+.++
T Consensus 237 ~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei 283 (299)
T d1jpaa_ 237 MTNQDVINAIEQD-YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283 (299)
T ss_dssp CCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCHHHHHHHHHcC-CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 9888877777654 3344455688999999999999999999995544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=401.46 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=217.9
Q ss_pred ccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEE
Q 001902 663 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 742 (998)
Q Consensus 663 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 742 (998)
+.++|++++.||+|+||.||+|++ .+++.||||.+++... ..+.+.+|+.++++++||||+++++++.+.+.+++
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 457899999999999999999998 4788999999986533 23568899999999999999999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCC
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 822 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 822 (998)
||||+++|+|..++.... ..+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 77 v~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~- 154 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 154 (258)
T ss_dssp EEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-
T ss_pred EEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC-
Confidence 999999999999876542 458999999999999999999999999999999999999999999999999996543111
Q ss_pred CCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHH
Q 001902 823 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK 901 (998)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~ 901 (998)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+
T Consensus 155 -------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~ 209 (258)
T d1k2pa_ 155 -------------------------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209 (258)
T ss_dssp -------------------------CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred -------------------------ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence 111233579999999999999999999999999999999998 899999999888
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 902 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 902 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
....+..+. ..+.....+.++.+||.+||+.||++||| +.+|++|
T Consensus 210 ~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPt----~~eil~~ 254 (258)
T d1k2pa_ 210 TAEHIAQGL-RLYRPHLASEKVYTIMYSCWHEKADERPT----FKILLSN 254 (258)
T ss_dssp HHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHhCC-CCCCcccccHHHHHHHHHHccCCHhHCcC----HHHHHHH
Confidence 888777653 33444567889999999999999999999 6666665
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.2e-46 Score=410.95 Aligned_cols=258 Identities=23% Similarity=0.372 Sum_probs=214.6
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
+++|+++++||+|+||+||+|+++ +|+.||||++..... .......+.+|+.+|++++||||+++++++...+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 368999999999999999999985 789999999976533 333457788999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|||+.++.+..+.... +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||.|......
T Consensus 79 ~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--- 153 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--- 153 (286)
T ss_dssp EECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC---
Confidence 9999777776666543 56999999999999999999999999999999999999999999999999998654311
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 902 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 902 (998)
........|++.|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+....
T Consensus 154 ------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~ 209 (286)
T d1ob3a_ 154 ------------------------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ 209 (286)
T ss_dssp --------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH
Confidence 112234468999999999976 4568999999999999999999999999888777
Q ss_pred HHHHHhCCCC------------------CC---------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 903 FANILHKDLK------------------FP---------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 903 ~~~i~~~~~~------------------~~---------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
+.++...... +. .....+..+.+||.+||..||++||| +.|+|+||||+
T Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s----~~ell~Hp~f~ 285 (286)
T d1ob3a_ 210 LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT----AKQALEHAYFK 285 (286)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGG
T ss_pred HHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccC
Confidence 7766531000 00 11345788999999999999999999 99999999998
Q ss_pred C
Q 001902 956 G 956 (998)
Q Consensus 956 ~ 956 (998)
.
T Consensus 286 ~ 286 (286)
T d1ob3a_ 286 E 286 (286)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=406.92 Aligned_cols=256 Identities=21% Similarity=0.292 Sum_probs=209.1
Q ss_pred cccCCCCceeEEEEEEc--cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEEEecCC
Q 001902 671 KPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 748 (998)
Q Consensus 671 ~~LG~G~~g~Vy~a~~~--~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 748 (998)
++||+|+||.||+|.+. .+++.||||+++... .+....+.+.+|+.+|++++|||||++++++.. +..|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 46999999999999864 456889999997653 344556789999999999999999999999865 45789999999
Q ss_pred CCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCCCcc
Q 001902 749 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 828 (998)
Q Consensus 749 ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~ 828 (998)
+|+|.+++... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.......
T Consensus 91 ~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~------ 162 (277)
T d1xbba_ 91 LGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN------ 162 (277)
T ss_dssp TEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS------
T ss_pred CCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccc------
Confidence 99999999875 4599999999999999999999999999999999999999999999999999965431111
Q ss_pred hhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 001902 829 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANIL 907 (998)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~ 907 (998)
.........||+.|||||++.+..++.++|||||||++|||++ |.+||.+.+..+....+.
T Consensus 163 ------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~ 224 (277)
T d1xbba_ 163 ------------------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224 (277)
T ss_dssp ------------------EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred ------------------ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH
Confidence 0112234579999999999999999999999999999999997 999999988887777666
Q ss_pred hCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccC
Q 001902 908 HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 956 (998)
Q Consensus 908 ~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 956 (998)
.+. ..+....++.++.+||.+||+.||.+|||+.++ .+.|+|+|+.-
T Consensus 225 ~~~-~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i-~~~L~~~~~~~ 271 (277)
T d1xbba_ 225 KGE-RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV-ELRLRNYYYDV 271 (277)
T ss_dssp TTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH-HHHHHHHHHHH
T ss_pred cCC-CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHH-HHHhhCHHhhc
Confidence 543 233345678999999999999999999994442 33467777653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-46 Score=405.32 Aligned_cols=261 Identities=22% Similarity=0.342 Sum_probs=214.0
Q ss_pred cccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
+.+..++|++.+.||+|+||.||+|.+.. ++.||||+++.... ..+.+.+|+.++++++|||||++++++.+ +.
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~ 85 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 85 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-CC
Confidence 44666899999999999999999999865 46799999975432 23578899999999999999999999855 55
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+++|||||++|+|..++.......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 78999999999999998765445699999999999999999999999999999999999999999999999999965431
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcC-CCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG-YTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG-~~Pf~~~~ 898 (998)
.. ........||+.|+|||++....++.++|||||||++|||++| .+||.+..
T Consensus 166 ~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~ 219 (285)
T d1fmka3 166 NE--------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 219 (285)
T ss_dssp ------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CC--------------------------ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC
Confidence 11 0112345699999999999999999999999999999999995 55556666
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc--CCCccCC
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK--HPFFKGV 957 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~--Hp~f~~~ 957 (998)
..+.+..+..+ ...+....++.++++||.+||+.||++||+ +.+|++ |+||+..
T Consensus 220 ~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 220 NREVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEERPT----FEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHHHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHTTTSCS
T ss_pred HHHHHHHHHhc-CCCCCCcccCHHHHHHHHHHcccCHhHCcC----HHHHHHHHhhhhcCC
Confidence 66666655543 344555668899999999999999999999 888877 8888764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-45 Score=411.39 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=209.9
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEee--CCeE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQT--KTHV 740 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~--~~~~ 740 (998)
.++|++++.||+|+||+||+|+++.+|+.||||++++. ....+.+|+.+|+.+. ||||++++++|.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 46899999999999999999999999999999998754 2356788999999995 9999999999974 4679
Q ss_pred EEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC-cEEEEeccCccccCC
Q 001902 741 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSC 819 (998)
Q Consensus 741 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g-~vkL~DFG~a~~~~~ 819 (998)
|+|||||.+++|..+. ..+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|.....
T Consensus 108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999999998764 3499999999999999999999999999999999999999655 699999999865321
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
. ......+||+.|+|||.+.+. .++.++|||||||++|+|++|..||....
T Consensus 183 ~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 183 G----------------------------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp T----------------------------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred C----------------------------CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 1 122345799999999998775 47899999999999999999999997654
Q ss_pred hH-HHHHHHHh-------------CCC----------------------CCCCCCCCcHHHHHHHHHccccCccCcCCCh
Q 001902 899 RQ-KTFANILH-------------KDL----------------------KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH 942 (998)
Q Consensus 899 ~~-~~~~~i~~-------------~~~----------------------~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~ 942 (998)
.. .....+.. ... ..+....++.++.+||.+||+.||.+|||
T Consensus 235 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t-- 312 (328)
T d3bqca1 235 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT-- 312 (328)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC--
T ss_pred hhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC--
Confidence 32 22222211 000 01112336788999999999999999999
Q ss_pred hcHHHHHcCCCccCCChh
Q 001902 943 EGANEIKKHPFFKGVNWA 960 (998)
Q Consensus 943 ~~a~elL~Hp~f~~~~~~ 960 (998)
++++|+||||+.+.|.
T Consensus 313 --a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 313 --AREAMEHPYFYTVVKD 328 (328)
T ss_dssp --HHHHHTSGGGTTSCCC
T ss_pred --HHHHhcCcccCCCCCC
Confidence 9999999999998873
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=398.77 Aligned_cols=256 Identities=21% Similarity=0.270 Sum_probs=205.7
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccCC----eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGSG----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 736 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~----~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 736 (998)
++..+.|++.+.||+|+||.||+|.+..++ ..||||.+.... .......+.+|+.++++++|||||++++++..
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 355678999999999999999999987654 479999987542 33445678899999999999999999999999
Q ss_pred CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
.+..++|||||.++++.+++... ...+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999999999988765 35699999999999999999999999999999999999999999999999999966
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcC-CCCCC
Q 001902 817 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG-YTPFR 895 (998)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG-~~Pf~ 895 (998)
....... ........||+.|||||++.+..++.++|||||||++|||++| .+||.
T Consensus 160 ~~~~~~~------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 160 LEDDPEA------------------------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp --------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCCCcc------------------------ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 4321110 1122344689999999999999999999999999999999985 55555
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 896 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 896 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
+.+....+..+.. ....+....++..+.+||.+||..||++|||+.++
T Consensus 216 ~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ei 263 (283)
T d1mqba_ 216 ELSNHEVMKAIND-GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 263 (283)
T ss_dssp TCCHHHHHHHHHT-TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred cCCHHHHHHHHhc-cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHH
Confidence 5565555555544 34445555688999999999999999999994443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=411.78 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=210.6
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC-----e
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-----H 739 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-----~ 739 (998)
++|++++.||+|+||+||+|.+..+|+.||||++.+.. .....+.+.+|+.+|++++||||+++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 57999999999999999999999999999999997532 3445677889999999999999999999987543 3
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
+|++| |+.+++|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|.....
T Consensus 86 ~~l~~-~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 86 VYLVT-HLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEE-ECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEE-eecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 55554 55699999999764 499999999999999999999999999999999999999999999999999965431
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 898 (998)
... ........+||+.|+|||++.. ..++.++||||+||++|+|++|..||.+.+
T Consensus 162 ~~~------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 162 DHD------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp GGC------------------------BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCc------------------------cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 110 0112345679999999999844 567889999999999999999999999887
Q ss_pred hHHHHHHHHhCC----------------------CCCC-------CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 899 RQKTFANILHKD----------------------LKFP-------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 899 ~~~~~~~i~~~~----------------------~~~~-------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
............ .+.. .....|.++++||.+||..||.+||| +.++|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----a~e~L 293 (345)
T d1pmea_ 218 YLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE----VEQAL 293 (345)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC----HHHHH
T ss_pred HHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC----HHHHh
Confidence 765555443210 0000 11345778999999999999999999 99999
Q ss_pred cCCCccCC
Q 001902 950 KHPFFKGV 957 (998)
Q Consensus 950 ~Hp~f~~~ 957 (998)
+||||+..
T Consensus 294 ~hpf~~~~ 301 (345)
T d1pmea_ 294 AHPYLEQY 301 (345)
T ss_dssp TSGGGTTT
T ss_pred cCHhhccC
Confidence 99999965
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=409.04 Aligned_cols=263 Identities=25% Similarity=0.320 Sum_probs=211.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee-------
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------- 736 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~------- 736 (998)
.++|++++.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 4699999999999999999999999999999999876533 23345677899999999999999999998854
Q ss_pred -CCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 737 -KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 737 -~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
.+.+|+|||||.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 4568999999977666554433 3569999999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCC-CCCChhHHHHHHHHHHHHHcCCCCC
Q 001902 816 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF 894 (998)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf 894 (998)
....... .........+||+.|+|||++.+. .+++++|||||||++|+|++|++||
T Consensus 166 ~~~~~~~-----------------------~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf 222 (318)
T d3blha1 166 AFSLAKN-----------------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222 (318)
T ss_dssp ECCC----------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ecccccc-----------------------cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC
Confidence 5432111 011223346799999999999765 6899999999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCCCCCC------------------------------CCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 895 RGKTRQKTFANILHKDLKFPSS------------------------------TPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 895 ~~~~~~~~~~~i~~~~~~~~~~------------------------------~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
.+.+.......+......++.. ...+..+.+||.+||..||++|||
T Consensus 223 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s---- 298 (318)
T d3blha1 223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID---- 298 (318)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC----
T ss_pred CCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcC----
Confidence 9988877766655421111100 012567789999999999999999
Q ss_pred HHHHHcCCCccC
Q 001902 945 ANEIKKHPFFKG 956 (998)
Q Consensus 945 a~elL~Hp~f~~ 956 (998)
+.++|+||||+.
T Consensus 299 a~elL~Hpff~~ 310 (318)
T d3blha1 299 SDDALNHDFFWS 310 (318)
T ss_dssp HHHHHHSGGGSS
T ss_pred HHHHHcChhhcc
Confidence 999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=412.45 Aligned_cols=255 Identities=29% Similarity=0.444 Sum_probs=210.2
Q ss_pred CcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee------CCe
Q 001902 666 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------KTH 739 (998)
Q Consensus 666 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~------~~~ 739 (998)
+|+.++.||+|+||+||+|++..+|+.||||++..... ...+|+.+|++++||||++++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 69999999999999999999999999999999976532 22369999999999999999999853 346
Q ss_pred EEEEEecCCCCchhHHHhh-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC-cEEEEeccCcccc
Q 001902 740 VCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLT 817 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g-~vkL~DFG~a~~~ 817 (998)
+|||||||+++.+..+... .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 8999999976544443321 2345699999999999999999999999999999999999999775 8999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcC-CCCCChhHHHHHHHHHHHHHcCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~ 896 (998)
... ......+||+.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+
T Consensus 174 ~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 174 VRG----------------------------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp CTT----------------------------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cCC----------------------------cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence 211 12234579999999999875 5689999999999999999999999999
Q ss_pred CChHHHHHHHHhC-----------------CCCCCC----------CCCCcHHHHHHHHHccccCccCcCCChhcHHHHH
Q 001902 897 KTRQKTFANILHK-----------------DLKFPS----------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 949 (998)
Q Consensus 897 ~~~~~~~~~i~~~-----------------~~~~~~----------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 949 (998)
.+....+..+... ...++. ....++++.+||.+||..||.+||| +.|+|
T Consensus 226 ~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L 301 (350)
T d1q5ka_ 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEAC 301 (350)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHH
T ss_pred CCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC----HHHHh
Confidence 8887777766531 111111 2346789999999999999999999 99999
Q ss_pred cCCCccCCCh
Q 001902 950 KHPFFKGVNW 959 (998)
Q Consensus 950 ~Hp~f~~~~~ 959 (998)
+||||+.+..
T Consensus 302 ~Hp~f~~~~~ 311 (350)
T d1q5ka_ 302 AHSFFDELRD 311 (350)
T ss_dssp TSGGGGGGGC
T ss_pred cCHhhccccC
Confidence 9999987643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=399.14 Aligned_cols=256 Identities=25% Similarity=0.359 Sum_probs=209.3
Q ss_pred ccccCCcccccccCCCCceeEEEEEEccC---CeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 737 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 737 (998)
++..++|++.+.||+|+||.||+|.+..+ +..||+|.++.. ........+.+|+.++++++||||+++++++. +
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 45667899999999999999999998654 457888887643 34555678899999999999999999999986 4
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
+.+|+|||||++|+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+..
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred CeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 67899999999999999887653 46999999999999999999999999999999999999999999999999999654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~ 896 (998)
.... ........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+
T Consensus 159 ~~~~--------------------------~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~ 212 (273)
T d1mp8a_ 159 EDST--------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212 (273)
T ss_dssp --------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCCc--------------------------ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC
Confidence 3111 112234568999999999999999999999999999999997 9999999
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
.+..+.+..+..+.. .+....++..+.+||.+||..||.+||| +.+|++|
T Consensus 213 ~~~~~~~~~i~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps----~~ei~~~ 262 (273)
T d1mp8a_ 213 VKNNDVIGRIENGER-LPMPPNCPPTLYSLMTKCWAYDPSRRPR----FTELKAQ 262 (273)
T ss_dssp CCGGGHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCCHhHCcC----HHHHHHH
Confidence 988888888776542 3444568899999999999999999999 7777765
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=415.17 Aligned_cols=263 Identities=23% Similarity=0.411 Sum_probs=209.3
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee------C
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------K 737 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~------~ 737 (998)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.++++++||||++++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 3689999999999999999999999999999999987543 45566778899999999999999999999963 4
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
.++|+|||||.++ +.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++...
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp CEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred ceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 7899999999655 444443 24899999999999999999999999999999999999999999999999988543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
.. .......+||+.|+|||++.+..+++++||||+||++|+|++|++||.+.
T Consensus 170 ~~----------------------------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 170 GT----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp ---------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cc----------------------------ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 21 11223557999999999999999999999999999999999999999988
Q ss_pred ChHHHHHHHHhC----------------------CCCCCCC------------------CCCcHHHHHHHHHccccCccC
Q 001902 898 TRQKTFANILHK----------------------DLKFPSS------------------TPTSLHAKQLMYRLLHRDPKS 937 (998)
Q Consensus 898 ~~~~~~~~i~~~----------------------~~~~~~~------------------~~~s~~l~~Ll~~~L~~dP~~ 937 (998)
+.......++.. ....... ...|.++.+||.+||..||++
T Consensus 222 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~ 301 (355)
T d2b1pa1 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred CHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhH
Confidence 877666655431 1110000 012557899999999999999
Q ss_pred cCCChhcHHHHHcCCCccCCChhhhhc
Q 001902 938 RLGSHEGANEIKKHPFFKGVNWALVRC 964 (998)
Q Consensus 938 Rpt~~~~a~elL~Hp~f~~~~~~~~~~ 964 (998)
||| |+++|+||||+..-+.....
T Consensus 302 R~t----a~elL~Hpw~~~~~~~~~~~ 324 (355)
T d2b1pa1 302 RIS----VDDALQHPYINVWYDPAEVE 324 (355)
T ss_dssp SCC----HHHHHTSTTTGGGCCHHHHT
T ss_pred CcC----HHHHhcCcccCCCCCccccc
Confidence 999 99999999999854444433
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-45 Score=398.95 Aligned_cols=260 Identities=21% Similarity=0.364 Sum_probs=218.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCeEEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 743 (998)
+++|++++.||+|+||+||+|.+..+|+.||||+++... ........+.+|+.+|+.++||||+++++++......++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 368999999999999999999999999999999997653 3445677889999999999999999999999999999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 823 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 823 (998)
|+++.+++|..++... +.+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||.|......
T Consensus 80 ~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--- 154 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--- 154 (292)
T ss_dssp EECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC---
T ss_pred eeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC---
Confidence 9999999998887654 56899999999999999999999999999999999999999999999999999654311
Q ss_pred CCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC-CCChhHHHHHHHHHHHHHcCCCCCC-CCChHH
Q 001902 824 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFR-GKTRQK 901 (998)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDIwSlG~il~eLltG~~Pf~-~~~~~~ 901 (998)
........+++.|+|||.+.... ++.++|||||||++|+|++|..||. +.+...
T Consensus 155 ------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 210 (292)
T d1unla_ 155 ------------------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210 (292)
T ss_dssp ------------------------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH
T ss_pred ------------------------CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH
Confidence 11223446788999999987765 6889999999999999999998864 445555
Q ss_pred HHHHHHhCCCC---------------------------CCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCc
Q 001902 902 TFANILHKDLK---------------------------FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 954 (998)
Q Consensus 902 ~~~~i~~~~~~---------------------------~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 954 (998)
.+..+...... .......+..+.+||.+||+.||.+||| ++|+|+||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s----a~e~L~Hp~f 286 (292)
T d1unla_ 211 QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS----AEEALQHPYF 286 (292)
T ss_dssp HHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGG
T ss_pred HHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcC----HHHHhcChhh
Confidence 55554321000 0011345778999999999999999999 9999999999
Q ss_pred cCC
Q 001902 955 KGV 957 (998)
Q Consensus 955 ~~~ 957 (998)
+.+
T Consensus 287 ~~~ 289 (292)
T d1unla_ 287 SDF 289 (292)
T ss_dssp SSC
T ss_pred cCC
Confidence 874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=398.59 Aligned_cols=256 Identities=22% Similarity=0.310 Sum_probs=209.1
Q ss_pred cccCCcccccccCCCCceeEEEEEEccC---CeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCC
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 738 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 738 (998)
|..++|++++.||+|+||.||+|++..+ ...||||++.+.........+.+.+|+.+|++++||||+++++++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 4456899999999999999999987433 34789999987766666777889999999999999999999999965 4
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
..++|||||++++|.+++..+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 6789999999999998887643 459999999999999999999999999999999999999999999999999996643
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~ 897 (998)
.... .........|+..|+|||++.+..++.++|||||||++|||+| |..||.+.
T Consensus 163 ~~~~------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 163 QNDD------------------------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp C-CC------------------------EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCCC------------------------cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence 2111 0112234568889999999999999999999999999999998 89999999
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChh
Q 001902 898 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
+..+.+..+......++....++..+.+||.+||..||.+|||+.+
T Consensus 219 ~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e 264 (273)
T d1u46a_ 219 NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA 264 (273)
T ss_dssp CHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999998887777777778999999999999999999999443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=412.11 Aligned_cols=256 Identities=26% Similarity=0.382 Sum_probs=213.5
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeC-----C
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----T 738 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~ 738 (998)
.++|++++.||+|+||+||+|++..+|+.||||++++.. .+......+.+|+.+|++++||||+++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 368999999999999999999999999999999998653 3445566788999999999999999999998643 3
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccC
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 818 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 818 (998)
..++||+|+.|++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred ceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 34566677779999999965 349999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC-CCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 819 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
.......||+.|+|||.+.+.. ++.++|||||||++|+|++|.+||.+.
T Consensus 173 ------------------------------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 173 ------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp ------------------------------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ------------------------------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 1123457999999999987754 578999999999999999999999998
Q ss_pred ChHHHHHHHHhCCCCC-----------------------CC------CCCCcHHHHHHHHHccccCccCcCCChhcHHHH
Q 001902 898 TRQKTFANILHKDLKF-----------------------PS------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 948 (998)
Q Consensus 898 ~~~~~~~~i~~~~~~~-----------------------~~------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 948 (998)
+.......+....... +. ....+..+++||.+||+.||.+||| +.++
T Consensus 223 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~el 298 (348)
T d2gfsa1 223 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQA 298 (348)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC----HHHH
T ss_pred CHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC----HHHH
Confidence 8877777665421111 10 1346788999999999999999999 9999
Q ss_pred HcCCCccCC
Q 001902 949 KKHPFFKGV 957 (998)
Q Consensus 949 L~Hp~f~~~ 957 (998)
|+||||+..
T Consensus 299 L~Hp~f~~~ 307 (348)
T d2gfsa1 299 LAHAYFAQY 307 (348)
T ss_dssp HTSGGGTTT
T ss_pred hcCHhhCCC
Confidence 999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=396.69 Aligned_cols=250 Identities=22% Similarity=0.376 Sum_probs=208.4
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee-C
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-K 737 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-~ 737 (998)
|+.+..++|++++.||+|+||.||+|.+ +|..||||+++.. ...+.+.+|+.++++++||||+++++++.+ .
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 5678888999999999999999999998 5789999999754 234678899999999999999999998854 5
Q ss_pred CeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCcccc
Q 001902 738 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 817 (998)
Q Consensus 738 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~ 817 (998)
+.+|+||||+++|+|.+++..+....+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++..
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceec
Confidence 67899999999999999997654445899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 896 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~ 896 (998)
.. ......+|+.|+|||++.+..++.++|||||||++|||+| |.+||..
T Consensus 154 ~~------------------------------~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~ 203 (262)
T d1byga_ 154 SS------------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203 (262)
T ss_dssp --------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred CC------------------------------CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC
Confidence 21 1223468899999999999999999999999999999998 8999998
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 897 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 897 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
.+....+..+..+ ...+.....+.++.+||.+||..||.+||| +.+|++
T Consensus 204 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~Rps----~~~l~~ 252 (262)
T d1byga_ 204 IPLKDVVPRVEKG-YKMDAPDGCPPAVYEVMKNCWHLDAAMRPS----FLQLRE 252 (262)
T ss_dssp SCGGGHHHHHTTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCHHHHHHHHHcC-CCCCCCccCCHHHHHHHHHHcccCHhHCcC----HHHHHH
Confidence 8887777776553 333344557899999999999999999999 555544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=399.39 Aligned_cols=260 Identities=24% Similarity=0.357 Sum_probs=206.6
Q ss_pred ccccCCcccccccCCCCceeEEEEEEcc-----CCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEE
Q 001902 661 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASF 734 (998)
Q Consensus 661 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~ 734 (998)
.+..++|++++.||+|+||.||+|.+.. +++.||+|+++... .......+..|..++.++ +|+||+.+++++
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 3556789999999999999999999754 35789999987542 334456677788877776 689999999987
Q ss_pred ee-CCeEEEEEecCCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 001902 735 QT-KTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 799 (998)
Q Consensus 735 ~~-~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NIL 799 (998)
.. ++.+++|||||++|+|.+++.... ...+++..+..++.||+.||.|||++|||||||||+|||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 65 457899999999999999997532 234899999999999999999999999999999999999
Q ss_pred EecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHH
Q 001902 800 LQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 879 (998)
Q Consensus 800 i~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwS 879 (998)
++.++.+||+|||+|+....... ........||+.|||||++.+..++.++||||
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~-------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS 221 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPD-------------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 221 (299)
T ss_dssp ECGGGCEEECC------CCSCTT-------------------------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHH
T ss_pred ECCCCcEEEccCcchhhcccccc-------------------------ccccCceeeCccccchhHhhcCCCCcccceee
Confidence 99999999999999965431111 11234567999999999999999999999999
Q ss_pred HHHHHHHHHcC-CCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 880 LGILLYEMLYG-YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 880 lG~il~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
|||++|||++| .+||.+......+..++.....++....++.++.+||.+||+.||.+||| +.++++|
T Consensus 222 ~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt----~~eil~~ 290 (299)
T d1ywna1 222 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 290 (299)
T ss_dssp HHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred hHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 99999999986 57888876666666655554444555567899999999999999999999 7777776
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=399.94 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=207.3
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCe----EEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEeeCCe
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 739 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 739 (998)
..+|++++.||+|+||+||+|.+..+|+ .||+|.++... .....+.+.+|+.++++++|||||++++++.++ .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 4579999999999999999999988876 57777776432 333456789999999999999999999999865 5
Q ss_pred EEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCC
Q 001902 740 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 819 (998)
Q Consensus 740 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 819 (998)
.+++|||+.+++|.+++... ...+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 67888999999999988765 35699999999999999999999999999999999999999999999999999966432
Q ss_pred CCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHc-CCCCCCCCC
Q 001902 820 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 898 (998)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~ 898 (998)
... ........||+.|||||++.+..++.++|||||||++|||+| |.+||.+.+
T Consensus 164 ~~~-------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 164 EEK-------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp TCC---------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred ccc-------------------------cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence 111 011233468999999999999999999999999999999998 899999888
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 899 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 899 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
..+....+..+. ..+....++..+.+|+.+||..||.+||| +.+|++|
T Consensus 219 ~~~~~~~i~~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs----~~eil~~ 266 (317)
T d1xkka_ 219 ASEISSILEKGE-RLPQPPICTIDVYMIMVKCWMIDADSRPK----FRELIIE 266 (317)
T ss_dssp GGGHHHHHHHTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHcCC-CCCCCcccCHHHHHHHHHhCCCChhhCcC----HHHHHHH
Confidence 777666665543 33444567899999999999999999999 7777766
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=389.98 Aligned_cols=260 Identities=22% Similarity=0.320 Sum_probs=214.0
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEccCC-------eEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccce
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSG-------QYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPAL 730 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-------~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l 730 (998)
.+.+..++|++.+.||+|+||.||+|++..++ ..||||++++.. .......+.+|..++.++ +|||||++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 34567789999999999999999999986554 479999997653 334556788888888888 89999999
Q ss_pred eEEEeeCCeEEEEEecCCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 001902 731 YASFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPE 796 (998)
Q Consensus 731 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~ 796 (998)
++++.+++.+++|||||++|+|.+++.... ...+++..+..++.||+.||+|||++|||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 999999999999999999999999997542 235899999999999999999999999999999999
Q ss_pred cEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhH
Q 001902 797 NVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 876 (998)
Q Consensus 797 NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sD 876 (998)
|||++.++.+||+|||+++....... ........||+.|+|||++.+..|+.++|
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~l~~~~y~~k~D 219 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDY-------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSD 219 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCT-------------------------TCCCTTSCCGGGGSCHHHHHHCCCCHHHH
T ss_pred ceeecCCCCeEeccchhhcccccccc-------------------------ccccccCCCChhhhhhhHhcCCCCCchhh
Confidence 99999999999999999965431110 11234567899999999999999999999
Q ss_pred HHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 877 WWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 877 IwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
||||||++|+|++ |.+||.+.+....+..+..+ ..++....++..+.+||.+||+.||.+||| +.+|++
T Consensus 220 iwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~dP~~Rps----~~eil~ 289 (299)
T d1fgka_ 220 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVE 289 (299)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred hHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcC-CCCCCCccchHHHHHHHHHHccCCHhHCcC----HHHHHH
Confidence 9999999999997 79999988887776665543 444555668899999999999999999999 555554
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-43 Score=391.01 Aligned_cols=255 Identities=20% Similarity=0.266 Sum_probs=214.6
Q ss_pred cccCCcccccccCCCCceeEEEEEEcc-----CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 736 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 736 (998)
+..++|++++.||+|+||+||+|++.. +++.||||+++... .......+.+|+.+|++++||||+++++++..
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 345689999999999999999999753 56899999987542 34456788999999999999999999999999
Q ss_pred CCeEEEEEecCCCCchhHHHhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 001902 737 KTHVCLITDYCPGGELFLLLDRQP----------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLK 794 (998)
Q Consensus 737 ~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLk 794 (998)
.+..++||||+++|+|.+++.... ...++...+..++.||+.||+|||+++|||||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 999999999999999999986421 2248889999999999999999999999999999
Q ss_pred CCcEEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCCh
Q 001902 795 PENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 874 (998)
Q Consensus 795 P~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~ 874 (998)
|+|||++.++.+||+|||+|+...... .........||+.|+|||.+.+..++.+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~t~k 222 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSAD-------------------------YYKADGNDAIPIRWMPPESIFYNRYTTE 222 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGG-------------------------CBC----CCBCGGGCCHHHHHHCCCCHH
T ss_pred ccceEECCCCcEEEccchhheeccCCc-------------------------cccccCCCCcCcCcCCHHHHccCCCChh
Confidence 999999999999999999986543111 1112345678999999999999999999
Q ss_pred hHHHHHHHHHHHHHcCC-CCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhc
Q 001902 875 VDWWALGILLYEMLYGY-TPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 944 (998)
Q Consensus 875 sDIwSlG~il~eLltG~-~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 944 (998)
+|||||||++|||++|. +||.+.+..+.+..+..+.. .+....++.++.+||.+||+.||.+|||+.++
T Consensus 223 sDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~-~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev 292 (301)
T d1lufa_ 223 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSI 292 (301)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCC-CCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 99999999999999985 78999888888888776653 23344678999999999999999999994443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-44 Score=394.74 Aligned_cols=255 Identities=22% Similarity=0.315 Sum_probs=212.5
Q ss_pred cccCCcccccccCCCCceeEEEEEEccCCeE--EEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEEEeeCC
Q 001902 662 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 738 (998)
Q Consensus 662 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~--valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 738 (998)
++.++|++.+.||+|+||.||+|.++.+|.. ||||.+... ......+.+.+|+.+|.++ +||||+++++++..++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 5667999999999999999999999888875 566766532 2334556789999999998 7999999999999999
Q ss_pred eEEEEEecCCCCchhHHHhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCC
Q 001902 739 HVCLITDYCPGGELFLLLDRQ--------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 804 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g 804 (998)
.+|+||||+++|+|.+++.+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999753 235699999999999999999999999999999999999999999
Q ss_pred cEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHH
Q 001902 805 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 884 (998)
Q Consensus 805 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il 884 (998)
.+||+|||+|..... ........||+.|+|||.+.+..++.++|||||||++
T Consensus 165 ~~kl~DfG~a~~~~~----------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil 216 (309)
T d1fvra_ 165 VAKIADFGLSRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 216 (309)
T ss_dssp CEEECCTTCEESSCE----------------------------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred ceEEccccccccccc----------------------------cccccceecCCcccchHHhccCCCCccceeehhHHHH
Confidence 999999999854321 1112345689999999999999999999999999999
Q ss_pred HHHHcC-CCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 885 YEMLYG-YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 885 ~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
|+|++| .+||.+.+..+.+..+..+. .++....++.++.+||.+||..||++||| +.++++|
T Consensus 217 ~ell~~~~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPs----~~eil~~ 279 (309)
T d1fvra_ 217 WEIVSLGGTPYCGMTCAELYEKLPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 279 (309)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHGGGTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhcC-CCCCCccCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 999996 56788888888877776642 33444567899999999999999999999 7777766
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=392.71 Aligned_cols=271 Identities=18% Similarity=0.233 Sum_probs=225.5
Q ss_pred ccccccCCcccccccCCCCceeEEEEEEcc-----CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEE
Q 001902 659 GEQINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS 733 (998)
Q Consensus 659 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 733 (998)
.+.+..++|++.+.||+|+||.||+|.+.. ++..||||+++... .......+.+|+.++++++||||++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 345667899999999999999999999853 35789999997542 44455678899999999999999999999
Q ss_pred EeeCCeEEEEEecCCCCchhHHHhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCc
Q 001902 734 FQTKTHVCLITDYCPGGELFLLLDRQ--------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 805 (998)
Q Consensus 734 ~~~~~~~~lV~E~~~ggsL~~~l~~~--------~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~ 805 (998)
+...+..++|||||++|+|.+++... ....++...+..++.||+.||.|||+++|+||||||+|||++.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 99999999999999999999988642 1234788999999999999999999999999999999999999999
Q ss_pred EEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHH
Q 001902 806 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 885 (998)
Q Consensus 806 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~ 885 (998)
+||+|||+|....... .........||+.|+|||.+.+..++.++|||||||++|
T Consensus 172 ~Kl~DFGla~~~~~~~-------------------------~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~ 226 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 226 (308)
T ss_dssp EEECCTTCCCGGGGGG-------------------------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred EEEeecccceeccCCc-------------------------ceeeccceecccccCCHHHHccCCCCcccccccHHHHHH
Confidence 9999999996543111 011223456899999999999999999999999999999
Q ss_pred HHHcC-CCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc--CCCccCC
Q 001902 886 EMLYG-YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK--HPFFKGV 957 (998)
Q Consensus 886 eLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~--Hp~f~~~ 957 (998)
||+|| .+||.+.+..+.+..+..+.. .+....++..+.+||.+||+.||.+|||+.++++.|.+ +|+|+.+
T Consensus 227 El~t~~~~p~~~~~~~~~~~~i~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 227 EIATLAEQPYQGLSNEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp HHHHTSCCTTTTSCHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence 99997 588999888888888776543 33344578899999999999999999995554444433 7777654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=390.33 Aligned_cols=260 Identities=21% Similarity=0.316 Sum_probs=220.5
Q ss_pred cccccCCcccccccCCCCceeEEEEEEc-----cCCeEEEEEEeecccccChhHHHHHHHHHHHHHhC-CCCCccceeEE
Q 001902 660 EQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS 733 (998)
Q Consensus 660 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~ 733 (998)
+.+..++|++.+.||+|+||.||+|.+. .+++.||||+++... .......+.+|+.+++.+ +|||||+++++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3455679999999999999999999863 467899999998643 344566788999999999 79999999999
Q ss_pred EeeCCeEEEEEecCCCCchhHHHhhCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 001902 734 FQTKTHVCLITDYCPGGELFLLLDRQP----------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 797 (998)
Q Consensus 734 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~N 797 (998)
+...+.+|+|||||++|+|.+++.+.. ...+++..+..++.||+.||+|||++|||||||||+|
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 999999999999999999999997642 2258999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHH
Q 001902 798 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 877 (998)
Q Consensus 798 ILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDI 877 (998)
||++.++.+||+|||+++....... .......+||+.|+|||++.+..++.++||
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DI 230 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSN-------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDV 230 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT-------------------------SEECSSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred ccccccCcccccccchheeccCCCc-------------------------ceEeeecccChHHcCHHHhcCCCCCCcccc
Confidence 9999999999999999965431111 112334679999999999999999999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHc
Q 001902 878 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 950 (998)
Q Consensus 878 wSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 950 (998)
|||||++|+|+| |.+||.+.+....+..++......+.....+.++.+||.+||+.||.+||| +.+|++
T Consensus 231 wS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs----~~~il~ 300 (311)
T d1t46a_ 231 WSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT----FKQIVQ 300 (311)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred cchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 999999999998 777787777777777777766666666668899999999999999999999 555543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-42 Score=379.50 Aligned_cols=263 Identities=18% Similarity=0.229 Sum_probs=204.1
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCC-ccceeEEEeeCCeEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF-VPALYASFQTKTHVCLI 743 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~~~~~~lV 743 (998)
++|++++.||+|+||.||+|.+..+|+.||||++..... ...+..|+++++.++|++ |+.+..++...+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 579999999999999999999999999999999876432 134678999999997765 55566667888999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec---CCcEEEEeccCccccCCC
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCK 820 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~---~g~vkL~DFG~a~~~~~~ 820 (998)
|||+ +++|.+.+... ...+++..+..++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+.....
T Consensus 82 me~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9999 66776666543 356999999999999999999999999999999999999874 457999999999765422
Q ss_pred CCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCChH
Q 001902 821 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 900 (998)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 900 (998)
... ...........+||+.|||||++.+..++.++|||||||++|+|++|..||......
T Consensus 160 ~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~ 219 (299)
T d1ckia_ 160 RTH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219 (299)
T ss_dssp TTC--------------------CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred ccc--------------------cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchH
Confidence 111 011123345678999999999999999999999999999999999999999876554
Q ss_pred HHHHHHH---hCCCCCC---CCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCcc
Q 001902 901 KTFANIL---HKDLKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 955 (998)
Q Consensus 901 ~~~~~i~---~~~~~~~---~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 955 (998)
.....+. ......+ ....++.++.+||.+||..||.+||++.+ +.++|+|+|.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~-i~~~l~~~~~~ 279 (299)
T d1ckia_ 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSY-LRQLFRNLFHR 279 (299)
T ss_dssp -----HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHH-HHHHHHHHHHH
T ss_pred HHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHH-HHHHHHHHHHH
Confidence 4333222 1111111 12356889999999999999999999544 45677877654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=376.61 Aligned_cols=251 Identities=18% Similarity=0.223 Sum_probs=202.2
Q ss_pred ccccCCCCceeEEEEEEccCC---eEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCccceeEEEee-CCeEEEEEe
Q 001902 670 IKPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KTHVCLITD 745 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~~~~---~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-~~~~~lV~E 745 (998)
.+.||+|+||+||+|.+..++ ..||||.+++. .+......+.+|+++|++++||||+++++++.. ++..++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 467999999999999986543 46899998742 355667889999999999999999999998765 568999999
Q ss_pred cCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEeccCccccCCCCCCCC
Q 001902 746 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 825 (998)
Q Consensus 746 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 825 (998)
||++++|.+++... ...++...+..++.|++.||.|||+++|+||||||+|||+++++.+||+|||++.........
T Consensus 110 ~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~-- 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD-- 186 (311)
T ss_dssp CCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC--
T ss_pred EeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc--
Confidence 99999999998765 345788889999999999999999999999999999999999999999999999664322110
Q ss_pred CcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHH
Q 001902 826 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT-RQKTFA 904 (998)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~-~~~~~~ 904 (998)
.........||+.|+|||.+....++.++|||||||++|||++|..||.... ......
T Consensus 187 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~ 245 (311)
T d1r0pa_ 187 ---------------------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 245 (311)
T ss_dssp ---------------------CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH
T ss_pred ---------------------cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 0112234579999999999999999999999999999999999777776543 334444
Q ss_pred HHHhCCCCCCCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcC
Q 001902 905 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 951 (998)
Q Consensus 905 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 951 (998)
.+..+. ..+....++..+.+||.+||..||.+||+ +.++++|
T Consensus 246 ~i~~g~-~~~~p~~~~~~l~~li~~cl~~dP~~RPs----~~ei~~~ 287 (311)
T d1r0pa_ 246 YLLQGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPS----FSELVSR 287 (311)
T ss_dssp HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHcCC-CCCCcccCcHHHHHHHHHHcCCCHhHCcC----HHHHHHH
Confidence 555443 33344557889999999999999999999 6666665
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1e-40 Score=366.53 Aligned_cols=252 Identities=20% Similarity=0.238 Sum_probs=205.0
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCC-CCccceeEEEeeCCeEEE
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH-PFVPALYASFQTKTHVCL 742 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~l~~~~~~~~~~~l 742 (998)
.++|++++.||+|+||+||+|++..+|+.||||++..... ...+..|+++++.+.| +||+.+++++......|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 4689999999999999999999999999999999865421 2345678899999965 899999999999999999
Q ss_pred EEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec-----CCcEEEEeccCcccc
Q 001902 743 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-----NGHVSLTDFDLSCLT 817 (998)
Q Consensus 743 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~-----~g~vkL~DFG~a~~~ 817 (998)
||||+ +++|.+++... ...++...+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+|+..
T Consensus 79 vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99999 89999998765 346999999999999999999999999999999999999974 578999999999765
Q ss_pred CCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhHHHHHHHHHHHHHcCCCCCCCC
Q 001902 818 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 897 (998)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 897 (998)
....... ..+.......+||+.|||||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 157 ~~~~~~~--------------------~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~ 216 (293)
T d1csna_ 157 RDPVTKQ--------------------HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216 (293)
T ss_dssp BCTTTCC--------------------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccCcccc--------------------ceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence 4221110 11122345678999999999999999999999999999999999999999764
Q ss_pred Ch---HHHHHHHHhCCCCCC---CCCCCcHHHHHHHHHccccCccCcCCCh
Q 001902 898 TR---QKTFANILHKDLKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSH 942 (998)
Q Consensus 898 ~~---~~~~~~i~~~~~~~~---~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~ 942 (998)
.. ...+..+.......+ ....++.++.+|+..|+..+|++||++.
T Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~ 267 (293)
T d1csna_ 217 KAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYD 267 (293)
T ss_dssp CSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred cchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence 33 333333332211111 1134678999999999999999999843
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-40 Score=363.38 Aligned_cols=245 Identities=22% Similarity=0.295 Sum_probs=186.0
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHH--HHHHHHhCCCCCccceeEEEeeCC----
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA--EREILDMLDHPFVPALYASFQTKT---- 738 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~--E~~il~~l~h~nIv~l~~~~~~~~---- 738 (998)
.+|.+.+.||+|+||.||+|++ +|+.||||+++... ...... |+..+..++||||+++++++...+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 4688899999999999999997 68999999986432 223333 444556789999999999997543
Q ss_pred eEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCcEEEecCCcEEEEe
Q 001902 739 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC--------QGIIYRDLKPENVLLQGNGHVSLTD 810 (998)
Q Consensus 739 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~--------~~IiHrDLkP~NILi~~~g~vkL~D 810 (998)
.+|+|||||++|+|.+++++. .+++..+..++.|++.||.|||+ +|||||||||+||||+.++.+||+|
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 689999999999999999874 48999999999999999999996 5999999999999999999999999
Q ss_pred ccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCC------CCChhHHHHHHHHH
Q 001902 811 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG------HTSAVDWWALGILL 884 (998)
Q Consensus 811 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~------~~~~sDIwSlG~il 884 (998)
||++......... ........+||+.|+|||++.+.. ++.++|||||||+|
T Consensus 152 FGl~~~~~~~~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl 208 (303)
T d1vjya_ 152 LGLAVRHDSATDT-----------------------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208 (303)
T ss_dssp CTTCEEEETTTTE-----------------------ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHH
T ss_pred cCccccccCCCcc-----------------------eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHH
Confidence 9999664322110 011233567999999999987653 46689999999999
Q ss_pred HHHHcCCCCCCCCC--------------hHHHHHHHH-hCCCC--CCCC---CCCcHHHHHHHHHccccCccCcCCChh
Q 001902 885 YEMLYGYTPFRGKT--------------RQKTFANIL-HKDLK--FPSS---TPTSLHAKQLMYRLLHRDPKSRLGSHE 943 (998)
Q Consensus 885 ~eLltG~~Pf~~~~--------------~~~~~~~i~-~~~~~--~~~~---~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 943 (998)
|||+||.+||.... ......... ..... ++.. ......+.+|+.+||..||.+|||+.+
T Consensus 209 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 287 (303)
T d1vjya_ 209 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287 (303)
T ss_dssp HHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred HHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence 99999988773211 112222332 22221 1111 112235889999999999999999443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-39 Score=368.24 Aligned_cols=263 Identities=23% Similarity=0.372 Sum_probs=202.5
Q ss_pred cccccccCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-----------CCC
Q 001902 658 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-----------HPF 726 (998)
Q Consensus 658 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-----------h~n 726 (998)
.|+.+..++|++++.||+|+||+||+|++..+|+.||||++++.. ...+...+|+.+++.++ |+|
T Consensus 6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence 466666678999999999999999999999999999999997542 23456678888888775 578
Q ss_pred ccceeEEEee--CCeEEEEEecCCCCc-hhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEec
Q 001902 727 VPALYASFQT--KTHVCLITDYCPGGE-LFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQG 802 (998)
Q Consensus 727 Iv~l~~~~~~--~~~~~lV~E~~~ggs-L~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkP~NILi~~ 802 (998)
|+++++++.. ....+++|+++..+. ............+++..++.++.||+.||.|||+ .||+||||||+|||++.
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeec
Confidence 9999988754 456777777765544 3444444555679999999999999999999998 89999999999999987
Q ss_pred CC------cEEEEeccCccccCCCCCCCCCcchhhhhcccCCCCcccccccccccccccCCCCcccchhhcCCCCCChhH
Q 001902 803 NG------HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 876 (998)
Q Consensus 803 ~g------~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sD 876 (998)
++ .++|+|||.|.... ......+||+.|+|||++.+..++.++|
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D 211 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYD------------------------------EHYTNSIQTREYRSPEVLLGAPWGCGAD 211 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETT------------------------------BCCCSCCSCGGGCCHHHHHTCCCCTHHH
T ss_pred cCcccccceeeEeecccccccc------------------------------cccccccccccccChhhccccCCCcccc
Confidence 65 39999999985432 1123457999999999999999999999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCChH------HHHHHHHh--CC------------------------CCC-----------
Q 001902 877 WWALGILLYEMLYGYTPFRGKTRQ------KTFANILH--KD------------------------LKF----------- 913 (998)
Q Consensus 877 IwSlG~il~eLltG~~Pf~~~~~~------~~~~~i~~--~~------------------------~~~----------- 913 (998)
||||||++++|++|+.||...... ..+...+. +. +..
T Consensus 212 iwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (362)
T d1q8ya_ 212 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 291 (362)
T ss_dssp HHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH
T ss_pred ccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcc
Confidence 999999999999999999754321 11111110 00 000
Q ss_pred ---CCCCCCcHHHHHHHHHccccCccCcCCChhcHHHHHcCCCccCCC
Q 001902 914 ---PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 958 (998)
Q Consensus 914 ---~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 958 (998)
......+.++.+||.+||..||.+||| ++|+|+||||+.+-
T Consensus 292 ~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt----a~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 292 EKYKFSKDEAKEISDFLSPMLQLDPRKRAD----AGGLVNHPWLKDTL 335 (362)
T ss_dssp HTTCCCHHHHHHHHHHHGGGGCSSTTTCBC----HHHHHTCGGGTTCT
T ss_pred cccccCcccCHHHHHHHHHHCCCChhHCcC----HHHHhcCcccCCCC
Confidence 001123567899999999999999999 99999999999653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=3e-22 Score=204.24 Aligned_cols=136 Identities=19% Similarity=0.146 Sum_probs=106.2
Q ss_pred cccccccCCCCceeEEEEEEccCCeEEEEEEeeccccc---------------ChhHHHHHHHHHHHHHhCCCCCcccee
Q 001902 667 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML---------------NRNKVHRACAEREILDMLDHPFVPALY 731 (998)
Q Consensus 667 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~---------------~~~~~~~~~~E~~il~~l~h~nIv~l~ 731 (998)
+.+.++||+|+||.||+|.+ .+|+.||||+++..... ..........|..++.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 35678999999999999998 57999999987643211 011123445688899999999999887
Q ss_pred EEEeeCCeEEEEEecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecCCcEEEEec
Q 001902 732 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 811 (998)
Q Consensus 732 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkP~NILi~~~g~vkL~DF 811 (998)
++.. .+++|||+++..+.. ++...+..++.||+.+|+|||++||+||||||+|||++.+ .++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred EecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 6532 279999998776543 3444567889999999999999999999999999999965 5899999
Q ss_pred cCcccc
Q 001902 812 DLSCLT 817 (998)
Q Consensus 812 G~a~~~ 817 (998)
|.|...
T Consensus 147 G~a~~~ 152 (191)
T d1zara2 147 PQSVEV 152 (191)
T ss_dssp TTCEET
T ss_pred CCcccC
Confidence 998543
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.79 E-value=4.1e-19 Score=163.25 Aligned_cols=108 Identities=60% Similarity=1.139 Sum_probs=102.0
Q ss_pred cCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCCEE
Q 001902 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 277 (998)
Q Consensus 198 ~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 277 (998)
+.++++|+|+..+||+|+|||++|++++||+.+|++|+++..+.+++........++.++..+..+++|+++++|||+.+
T Consensus 2 i~~~~vi~Da~~pdg~Ii~vN~a~~~~~Gy~~~El~G~~~~~l~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~kdG~~~ 81 (109)
T d1n9la_ 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred ccceEEEEeCCCCCCeEEEEcHHHHHHHCcCHHHHcCCcceeeecccCCHHHhhhhhhHhhcCCceeeeEEEEecCCeEE
Confidence 56899999976668999999999999999999999999999888888888889999999999999999999999999999
Q ss_pred EEEeeeeEEeCCCCCEEEEEEEEecchh
Q 001902 278 WNLLTIAPIKDDEGKVLKFIGMQVEVSK 305 (998)
Q Consensus 278 w~~~~~spi~d~~G~v~~~v~i~~DITe 305 (998)
|++++++|++|++|++.+++++++|||.
T Consensus 82 w~~~~~~pi~d~~G~v~~~v~~~~DITa 109 (109)
T d1n9la_ 82 WNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECCC
Confidence 9999999999999999999999999984
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.75 E-value=6.7e-18 Score=154.99 Aligned_cols=104 Identities=45% Similarity=0.913 Sum_probs=94.8
Q ss_pred cCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 001902 481 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 560 (998)
Q Consensus 481 ~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rkdG~~~ 560 (998)
+.++++++|+.-.|++|+|||++|++|+||+++|++|+++..+.+++......+.+++.+..+..+.+|+++++|||+.+
T Consensus 2 i~~~~vi~Da~~pdg~Ii~vN~a~~~~~Gy~~~El~G~~~~~l~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~kdG~~~ 81 (109)
T d1n9la_ 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred ccceEEEEeCCCCCCeEEEEcHHHHHHHCcCHHHHcCCcceeeecccCCHHHhhhhhhHhhcCCceeeeEEEEecCCeEE
Confidence 46899999964224459999999999999999999999999999999888899999999999999999999999999999
Q ss_pred EEEEEEeeeccCC----EEEEEEecCCc
Q 001902 561 WNLFHLQPMRDQK----YFIGVQLDGSE 584 (998)
Q Consensus 561 wv~~~~spi~d~~----~~vgi~rDITe 584 (998)
|++++++|++|++ +++++++|||.
T Consensus 82 w~~~~~~pi~d~~G~v~~~v~~~~DITa 109 (109)
T d1n9la_ 82 WNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECCC
Confidence 9999999999876 89999999994
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=2.3e-17 Score=151.53 Aligned_cols=106 Identities=28% Similarity=0.555 Sum_probs=98.0
Q ss_pred cEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCc--ccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCCEEE
Q 001902 201 TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRF--LQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFW 278 (998)
Q Consensus 201 ~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~--l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w 278 (998)
.++|+|+...|++|+|||++|++++||+.+|++|+++.. +.+++........+..++..+..+..+++.++++|+.+|
T Consensus 3 ~f~i~~~~~~d~~I~~~N~a~~~l~G~~~~eiiG~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~~~g~~~w 82 (110)
T d1bywa_ 3 KFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFL 82 (110)
T ss_dssp EEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEEE
T ss_pred eEEEEcCCCCCCEEEEEcHHHHHHhCCCHHHhcccCcccccceeeheecccccccchhhcccccccceeeeeecccceee
Confidence 478899888899999999999999999999999998763 446777788889999999999999999999999999999
Q ss_pred EEeeeeEEeCCCCCEEEEEEEEecchhh
Q 001902 279 NLLTIAPIKDDEGKVLKFIGMQVEVSKH 306 (998)
Q Consensus 279 ~~~~~spi~d~~G~v~~~v~i~~DITer 306 (998)
+.++++|++|++|++++++++++|||||
T Consensus 83 ~~~~~~pi~d~~G~v~~~i~~~~DITer 110 (110)
T d1bywa_ 83 CLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred eeeeEEEEECCCCCEEEEEEEEEECCCC
Confidence 9999999999999999999999999986
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Probab=99.71 E-value=3.3e-17 Score=148.74 Aligned_cols=103 Identities=45% Similarity=0.866 Sum_probs=98.6
Q ss_pred cEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCCEEEEE
Q 001902 201 TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNL 280 (998)
Q Consensus 201 ~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~ 280 (998)
.++|+|+..+||+|+|+|++|++++||+.+|++|+++..+.+++........+...+..+..+.++++.+++||+.+|+.
T Consensus 2 ~fvi~d~~~pd~~I~y~N~a~~~~~G~s~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~~~ 81 (104)
T d1jnua_ 2 SFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTKGGRAFWNL 81 (104)
T ss_dssp EEEEECTTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEcCCCCCCEEEEEcHHHHHHHCcCHHHHCCccceeccccccchHHHhhhhhhhhcCceeEeEEEEEecccceEEEE
Confidence 47899987779999999999999999999999999999899999999999999999999999999999999999999999
Q ss_pred eeeeEEeCCCCCEEEEEEEEecc
Q 001902 281 LTIAPIKDDEGKVLKFIGMQVEV 303 (998)
Q Consensus 281 ~~~spi~d~~G~v~~~v~i~~DI 303 (998)
++++|++|++|++.+++++++||
T Consensus 82 ~~~~pi~d~~G~v~~~i~i~~DI 104 (104)
T d1jnua_ 82 FHLQVMRDENGDVQYFIGVQQEM 104 (104)
T ss_dssp EEEEEECTTTSSCCEEEEEEEEC
T ss_pred EEEEEEECCCCCEEEEEEEEEcC
Confidence 99999999999999999999998
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Probab=99.67 E-value=3.6e-17 Score=154.60 Aligned_cols=125 Identities=22% Similarity=0.267 Sum_probs=108.2
Q ss_pred cccccccccccchHHHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHH
Q 001902 175 SDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIR 254 (998)
Q Consensus 175 t~~~~~e~~l~~~~~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~ 254 (998)
|+..+++++|++++++|+.+++++++||+++|. +|+|++||+++++++||+.+|++|+++..+.++.........+.
T Consensus 2 s~l~~~e~~l~~~e~~~~~i~~~~~~~i~~~d~---~g~i~~~N~~~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~ 78 (130)
T d1ew0a_ 2 SHMLETEDVVRARDAHLRSILDTVPDATVVSAT---DGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQ 78 (130)
T ss_dssp CHHHHHHHHHHHHTSCHHHHHTTCSSEEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTGGGHHHHHH
T ss_pred ChHHHHHHHHHHHHHHHHHHHHcCCCeEEEEeC---CccEEEEHHHHHHhhcCCHHHhcCCccccccccchhHHHHHHHH
Confidence 456788999999999999999999999999999 78899999999999999999999999988888777766666666
Q ss_pred HHHHcCCc----EEEEEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecch
Q 001902 255 ETLQNGQS----YCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (998)
Q Consensus 255 ~~l~~g~~----~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DIT 304 (998)
..+..+.. ...++...++||+.+|+.++++|+.+.++ .+++++++|||
T Consensus 79 ~~~~~~~~~~~~~~~e~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~i~rDIT 130 (130)
T d1ew0a_ 79 RYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGE--RFFTGFIRDLT 130 (130)
T ss_dssp HHHHHCCCSSTTSCEEEEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEECC
T ss_pred HHHHhCCCccccceeeEEEEcCCCCEEEEEEEEEEEEECCe--EEEEEEEEECC
Confidence 66665543 46788889999999999999999987543 45889999998
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Probab=99.67 E-value=1.5e-16 Score=150.33 Aligned_cols=108 Identities=18% Similarity=0.242 Sum_probs=95.8
Q ss_pred cHHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCc----EEE
Q 001902 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD----VTV 548 (998)
Q Consensus 473 ~l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~----~~~ 548 (998)
.|+.+++++++||+++|.+|+ |++||++|++|+||+++|++|+++..+.++.........+...+..+.. ...
T Consensus 17 ~~~~i~~~~~~~i~~~d~~g~---i~~~N~~~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (130)
T d1ew0a_ 17 HLRSILDTVPDATVVSATDGT---IVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQRYMATGEKRIIGIDR 93 (130)
T ss_dssp CHHHHHTTCSSEEEEEETTSB---EEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTGGGHHHHHHHHHHHCCCSSTTSCE
T ss_pred HHHHHHHcCCCeEEEEeCCcc---EEEEHHHHHHhhcCCHHHhcCCccccccccchhHHHHHHHHHHHHhCCCcccccee
Confidence 489999999999999999888 9999999999999999999999988888887777766666666655543 567
Q ss_pred EEEEEecCCcEEEEEEEEeeeccCC--EEEEEEecCC
Q 001902 549 QLINYTKSGKKFWNLFHLQPMRDQK--YFIGVQLDGS 583 (998)
Q Consensus 549 e~~~~rkdG~~~wv~~~~spi~d~~--~~vgi~rDIT 583 (998)
++...++||+.+|++++++|+.+++ .++++++|||
T Consensus 94 e~~~~~~dG~~~~v~~~~~~i~~~~~~~~~~i~rDIT 130 (130)
T d1ew0a_ 94 VVSGQRKDGSTFPMKLAVGEMRSGGERFFTGFIRDLT 130 (130)
T ss_dssp EEEEECTTSCEEEEEEEEEEEEETTEEEEEEEEEECC
T ss_pred eEEEEcCCCCEEEEEEEEEEEEECCeEEEEEEEEECC
Confidence 8899999999999999999999887 8999999998
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=2e-16 Score=145.04 Aligned_cols=103 Identities=29% Similarity=0.521 Sum_probs=93.6
Q ss_pred ceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCcc--ccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 001902 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF--LQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 560 (998)
Q Consensus 483 d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~--l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rkdG~~~ 560 (998)
..++++|+++.|.+|+|||++|++|+||+++|++|+++.. +.+|+........+...+.++..+..++++++++|+.+
T Consensus 2 ~~f~i~~~~~~d~~I~~~N~a~~~l~G~~~~eiiG~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~~~g~~~ 81 (110)
T d1bywa_ 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCF 81 (110)
T ss_dssp CEEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEE
T ss_pred ceEEEEcCCCCCCEEEEEcHHHHHHhCCCHHHhcccCcccccceeeheecccccccchhhcccccccceeeeeeccccee
Confidence 3578899887788899999999999999999999998643 45678888889999999999999999999999999999
Q ss_pred EEEEEEeeeccCC----EEEEEEecCCcc
Q 001902 561 WNLFHLQPMRDQK----YFIGVQLDGSEH 585 (998)
Q Consensus 561 wv~~~~spi~d~~----~~vgi~rDITer 585 (998)
|++++++|++|++ +++++++|||||
T Consensus 82 w~~~~~~pi~d~~G~v~~~i~~~~DITer 110 (110)
T d1bywa_ 82 LCLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred eeeeeEEEEECCCCCEEEEEEEEEECCCC
Confidence 9999999999887 899999999997
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Probab=99.64 E-value=1.2e-15 Score=138.26 Aligned_cols=99 Identities=72% Similarity=1.185 Sum_probs=92.0
Q ss_pred eEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEE
Q 001902 484 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNL 563 (998)
Q Consensus 484 ~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rkdG~~~wv~ 563 (998)
.++++|+...|++|+|||+|||+++||+.+|++|+++..+.+++......+.+...+..+..+.+|.+++++||+.+|++
T Consensus 2 ~fvi~d~~~pd~~I~y~N~a~~~~~G~s~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~~~ 81 (104)
T d1jnua_ 2 SFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTKGGRAFWNL 81 (104)
T ss_dssp EEEEECTTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEcCCCCCCEEEEEcHHHHHHHCcCHHHHCCccceeccccccchHHHhhhhhhhhcCceeEeEEEEEecccceEEEE
Confidence 57899965445569999999999999999999999999899999999999999999999999999999999999999999
Q ss_pred EEEeeeccCC----EEEEEEecC
Q 001902 564 FHLQPMRDQK----YFIGVQLDG 582 (998)
Q Consensus 564 ~~~spi~d~~----~~vgi~rDI 582 (998)
++++|++|++ +++++++||
T Consensus 82 ~~~~pi~d~~G~v~~~i~i~~DI 104 (104)
T d1jnua_ 82 FHLQVMRDENGDVQYFIGVQQEM 104 (104)
T ss_dssp EEEEEECTTTSSCCEEEEEEEEC
T ss_pred EEEEEEECCCCCEEEEEEEEEcC
Confidence 9999999886 999999998
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Probab=99.58 E-value=1.4e-15 Score=137.48 Aligned_cols=100 Identities=19% Similarity=0.212 Sum_probs=86.1
Q ss_pred ceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCC----cEEEEEEEEecCCc
Q 001902 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT----DVTVQLINYTKSGK 558 (998)
Q Consensus 483 d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~----~~~~e~~~~rkdG~ 558 (998)
|||+++|.+|+ |+++|++|++|+||+++|++|++...+.++.........+...+.... ....+...++|||+
T Consensus 1 dgi~~~D~~G~---I~~~N~a~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~ 77 (106)
T d1xj3a1 1 DAMIVIDGHGI---IQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGT 77 (106)
T ss_dssp CCEEEEETTSB---EEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSC
T ss_pred CEEEEECCCCc---EEEEcHHHHHHhhhchHhhcCCCcccccccccccchhhhhhhhhhhcccccccccceeeeeeccce
Confidence 69999999888 999999999999999999999998888888776666665555554333 25678999999999
Q ss_pred EEEEEEEEeeeccCC--EEEEEEecCCcc
Q 001902 559 KFWNLFHLQPMRDQK--YFIGVQLDGSEH 585 (998)
Q Consensus 559 ~~wv~~~~spi~d~~--~~vgi~rDITer 585 (998)
.+|++++++|+.+++ +++++++||||+
T Consensus 78 ~~~v~~~~~~~~~~~~~~~~~~~~DITE~ 106 (106)
T d1xj3a1 78 TFPMHLSIGEMQSGGEPYFTGFVRDLTEH 106 (106)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEEEECHHH
T ss_pred EEEEEEEEEEEEECCeEEEEEEEEeCCCC
Confidence 999999999999887 899999999974
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Probab=99.57 E-value=4.9e-15 Score=135.61 Aligned_cols=105 Identities=24% Similarity=0.382 Sum_probs=87.4
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCC----cEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT----DVTVQ 549 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~----~~~~e 549 (998)
|.++++++++||+++|.+|+ |+++|++|++|+||+++|++|++...+.++.........+...+..+. ....|
T Consensus 3 ~~~~~e~~~d~i~~~d~~g~---i~~~N~~~~~l~Gy~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 79 (113)
T d1v9ya_ 3 FFPALEQNMMGAVLINENDE---VMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSRE 79 (113)
T ss_dssp HHHHHHTCSSEEEEECTTSB---EEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------CE
T ss_pred HHHHHHcCcCcEEEEeCCCC---EEEEchhHhhhhccchhhhcCcceeccccccccccccccccccccccccccccccee
Confidence 78999999999999999888 999999999999999999999998888776666555555555554333 35678
Q ss_pred EEEEecCCcEEEEEEEEeeeccCC--EEEEEEec
Q 001902 550 LINYTKSGKKFWNLFHLQPMRDQK--YFIGVQLD 581 (998)
Q Consensus 550 ~~~~rkdG~~~wv~~~~spi~d~~--~~vgi~rD 581 (998)
...++|||+.+|++++++|+.+++ .+++++||
T Consensus 80 ~~~~~~dG~~~~v~~~~~~i~~~~~~~~~~v~rD 113 (113)
T d1v9ya_ 80 LQLEKKDGSKIWTRFALSKVSAEGKVYYLALVRD 113 (113)
T ss_dssp EEEECTTSCEEEEEEEEEEEEETTEEEEEEEEEC
T ss_pred eeeccccceeEEEEEEEEEEEECCeEEEEEEEEC
Confidence 889999999999999999999877 88999988
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=3.5e-15 Score=137.47 Aligned_cols=106 Identities=15% Similarity=0.173 Sum_probs=93.1
Q ss_pred CcEEE--EecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCCEE
Q 001902 200 QTFVV--SDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 277 (998)
Q Consensus 200 d~i~i--~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 277 (998)
...+| .|. ||+|+|+|+++++++||+.+|++|+++..++++++.....+.+...+..+..+..+++++++||+.+
T Consensus 5 ~~~fi~r~~~---dG~i~~~N~~~~~~~G~~~~el~g~~~~~~~~~ed~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~ 81 (114)
T d1p97a_ 5 SKTFLSRHSM---DMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYV 81 (114)
T ss_dssp CEEEEEEECT---TTSCSEECTTHHHHTSSCHHHHTTSCHHHHSCSSSHHHHHHHHHHHTTTSEEEEEEEEEECTTSCEE
T ss_pred cCEEEEEECC---CCcEEEECHHHHHHcCCCccccccccccccccccccccceeeeeecccccceeecceeeeeecCcce
Confidence 34444 466 8889999999999999999999999998888888777777777777777777889999999999999
Q ss_pred EEEeeeeEEeCC-CCCEEEEEEEEecchhhhH
Q 001902 278 WNLLTIAPIKDD-EGKVLKFIGMQVEVSKHTE 308 (998)
Q Consensus 278 w~~~~~spi~d~-~G~v~~~v~i~~DITerk~ 308 (998)
|++++.+|++|+ +|++.+++++.+||||+|+
T Consensus 82 wv~~~~~~~~~~~~~~~~~ii~~~~dite~k~ 113 (114)
T d1p97a_ 82 WLETQGTVIYNPRNLQPQCIMCVNYVLSEIEK 113 (114)
T ss_dssp EEEEEEEEEECTTTCSEEEEEEEEEEEEEEEC
T ss_pred EEEEEEEEEEeCCCCCEEEEEEEEEECChhhc
Confidence 999999999997 6899999999999999985
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=8.6e-15 Score=134.76 Aligned_cols=102 Identities=17% Similarity=0.143 Sum_probs=91.2
Q ss_pred ceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEE
Q 001902 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWN 562 (998)
Q Consensus 483 d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~~~~e~~~~rkdG~~~wv 562 (998)
+.|+..|.+|+ |+|||+++++++||+.+|++|+++..+.+|++.....+.+...+.++..+..+++++++||+.+|+
T Consensus 7 ~fi~r~~~dG~---i~~~N~~~~~~~G~~~~el~g~~~~~~~~~ed~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~wv 83 (114)
T d1p97a_ 7 TFLSRHSMDMK---FTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYVWL 83 (114)
T ss_dssp EEEEEECTTTS---CSEECTTHHHHTSSCHHHHTTSCHHHHSCSSSHHHHHHHHHHHTTTSEEEEEEEEEECTTSCEEEE
T ss_pred EEEEEECCCCc---EEEECHHHHHHcCCCccccccccccccccccccccceeeeeecccccceeecceeeeeecCcceEE
Confidence 44555699777 999999999999999999999998888999988888888888888777889999999999999999
Q ss_pred EEEEeeeccC-C----EEEEEEecCCcccc
Q 001902 563 LFHLQPMRDQ-K----YFIGVQLDGSEHLE 587 (998)
Q Consensus 563 ~~~~spi~d~-~----~~vgi~rDITerk~ 587 (998)
+++.+|+++. + +++++.+||||+||
T Consensus 84 ~~~~~~~~~~~~~~~~~ii~~~~dite~k~ 113 (114)
T d1p97a_ 84 ETQGTVIYNPRNLQPQCIMCVNYVLSEIEK 113 (114)
T ss_dssp EEEEEEEECTTTCSEEEEEEEEEEEEEEEC
T ss_pred EEEEEEEEeCCCCCEEEEEEEEEECChhhc
Confidence 9999999975 3 89999999999996
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Probab=99.50 E-value=4.2e-14 Score=127.52 Aligned_cols=102 Identities=19% Similarity=0.262 Sum_probs=84.5
Q ss_pred CcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCc----EEEEEEEEecCCC
Q 001902 200 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS----YCGRLLNYKKDGT 275 (998)
Q Consensus 200 d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~~~~kdG~ 275 (998)
|||+++|. +|+|+++|++|++++||+.+|++|+++..++++.........+...+..... ...++..++|||+
T Consensus 1 dgi~~~D~---~G~I~~~N~a~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~ 77 (106)
T d1xj3a1 1 DAMIVIDG---HGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGT 77 (106)
T ss_dssp CCEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSC
T ss_pred CEEEEECC---CCcEEEEcHHHHHHhhhchHhhcCCCcccccccccccchhhhhhhhhhhcccccccccceeeeeeccce
Confidence 68999999 7779999999999999999999999998888877666655555555544432 4567888999999
Q ss_pred EEEEEeeeeEEeCCCCCEEEEEEEEecchhh
Q 001902 276 PFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306 (998)
Q Consensus 276 ~~w~~~~~spi~d~~G~v~~~v~i~~DITer 306 (998)
.+|++++++|+.+.++ .+++++++||||.
T Consensus 78 ~~~v~~~~~~~~~~~~--~~~~~~~~DITE~ 106 (106)
T d1xj3a1 78 TFPMHLSIGEMQSGGE--PYFTGFVRDLTEH 106 (106)
T ss_dssp EEEEEEEEEEEEETTE--EEEEEEEEECHHH
T ss_pred EEEEEEEEEEEEECCe--EEEEEEEEeCCCC
Confidence 9999999999987544 5689999999974
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Probab=99.50 E-value=3.5e-14 Score=129.78 Aligned_cols=108 Identities=21% Similarity=0.358 Sum_probs=86.0
Q ss_pred HHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCC----cEEE
Q 001902 190 IVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ----SYCG 265 (998)
Q Consensus 190 ~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~----~~~~ 265 (998)
+|.++|+++++||+++|. +|+|+++|++|++++||+.+|++|+++..+.+..........+...+..+. ....
T Consensus 2 ~~~~~~e~~~d~i~~~d~---~g~i~~~N~~~~~l~Gy~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (113)
T d1v9ya_ 2 IFFPALEQNMMGAVLINE---NDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSR 78 (113)
T ss_dssp CHHHHHHTCSSEEEEECT---TSBEEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------C
T ss_pred HHHHHHHcCcCcEEEEeC---CCCEEEEchhHhhhhccchhhhcCcceecccccccccccccccccccccccccccccce
Confidence 478999999999999998 788999999999999999999999998877776655555455444443332 3456
Q ss_pred EEEEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEec
Q 001902 266 RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVE 302 (998)
Q Consensus 266 e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~D 302 (998)
+...++|||+.+|++++++|+.+++| ..++++++|
T Consensus 79 e~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~v~rD 113 (113)
T d1v9ya_ 79 ELQLEKKDGSKIWTRFALSKVSAEGK--VYYLALVRD 113 (113)
T ss_dssp EEEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEC
T ss_pred eeeeccccceeEEEEEEEEEEEECCe--EEEEEEEEC
Confidence 78889999999999999999998654 457888887
|
| >d1nwza_ d.110.3.1 (A:) Photoactive yellow protein, PYP {Ectothiorhodospira halophila [TaxId: 1053]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: Photoactive yellow protein, PYP species: Ectothiorhodospira halophila [TaxId: 1053]
Probab=99.38 E-value=9.4e-13 Score=123.18 Aligned_cols=106 Identities=10% Similarity=0.023 Sum_probs=91.3
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCC-CCCHHHHHHHHHHHhcCCcEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGP-ETDPATVRKIRAAIDNQTDVTVQLIN 552 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p-~~~~~~~~~i~~~l~~g~~~~~e~~~ 552 (998)
+..+++++++||+++|.+|+ |+++|++++++|||+++|++|+++..+..| +........+.+.+..|.....+...
T Consensus 19 ~d~~ld~~p~gi~~lD~~G~---i~~~N~a~~~l~G~~~~e~iG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~ 95 (125)
T d1nwza_ 19 DDGQLDGLAFGAIQLDGDGN---ILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGNLNTMFEYT 95 (125)
T ss_dssp CHHHHTTCSSEEEEEETTCB---EEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTCCEEEEEEE
T ss_pred HHHHHhCCCccEEEEeCCCC---EEEEcHHHHHhhccchHhhcCCCHHHccCchhhhhheeeeceeeeecCCcceEEEEE
Confidence 68899999999999999888 999999999999999999999997655544 45556677788888889887777778
Q ss_pred EecCCcEEEEEEEEeeeccCCEEEEEEecC
Q 001902 553 YTKSGKKFWNLFHLQPMRDQKYFIGVQLDG 582 (998)
Q Consensus 553 ~rkdG~~~wv~~~~spi~d~~~~vgi~rDI 582 (998)
.++||+.+|+++++.++.+++.+..+++||
T Consensus 96 ~~~~G~~~~v~v~l~~~~~g~~~~v~V~di 125 (125)
T d1nwza_ 96 FDYQMTPTKVKVHMKKALSGDSYWVFVKRV 125 (125)
T ss_dssp ECTTSCCEEEEEEEEECSSSSEEEEEEEEC
T ss_pred eccCCcEEEEEEEEEEecCCCEEEEEEEEC
Confidence 899999999999999998888555677876
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Probab=99.37 E-value=8.7e-13 Score=120.42 Aligned_cols=101 Identities=13% Similarity=-0.002 Sum_probs=82.9
Q ss_pred HHHHHhhcCceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCcccc-CCCCCHHHHHHHHHHHhcCCcEEEEEEE
Q 001902 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQ-GPETDPATVRKIRAAIDNQTDVTVQLIN 552 (998)
Q Consensus 474 l~~i~e~~~d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~-~p~~~~~~~~~i~~~l~~g~~~~~e~~~ 552 (998)
++++++++|+||+++|.+|+ |++||+++++||||+++|++|+++..+. ++.....+...+.+.+..|.........
T Consensus 5 ~~A~ld~~p~gvi~~D~~G~---I~~~N~aa~~~~G~~~eellG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~ 81 (110)
T d1mzua_ 5 GTAEFDALPVGAIQVDGSGV---IHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGTLDARFDFV 81 (110)
T ss_dssp -CTTGGGCSSEEEEEETTCB---EEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSCCEEEEEEE
T ss_pred HHHHHhCCCcEEEEEcCCCC---EEEeHHHHHHHHcCCHHHHcCCCHHHhcCChhhhHHHHHHHHHHHhccccCcceEEE
Confidence 56789999999999999887 9999999999999999999999975544 4455666778888989888764443444
Q ss_pred EecCCcEEEEEEEEeeeccCC-EEEE
Q 001902 553 YTKSGKKFWNLFHLQPMRDQK-YFIG 577 (998)
Q Consensus 553 ~rkdG~~~wv~~~~spi~d~~-~~vg 577 (998)
.++||+.+++++++++..+.+ .++-
T Consensus 82 l~~~G~~~~v~v~~~~~~~~~~~~i~ 107 (110)
T d1mzua_ 82 FDFQMAPVRVQIRMQNAGVPDRYWIF 107 (110)
T ss_dssp EECSSCEEEEEEEEEECSSTTEEEEE
T ss_pred EecCCceEEEEEEEEEecCCCEEEEE
Confidence 689999999999999988777 4443
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=3.1e-13 Score=124.24 Aligned_cols=102 Identities=15% Similarity=0.163 Sum_probs=86.0
Q ss_pred hhcCceEEEEcC-CCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCc----EEEEEEEE
Q 001902 479 ERIEKNFVITDP-RLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD----VTVQLINY 553 (998)
Q Consensus 479 e~~~d~i~i~D~-~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~----~~~e~~~~ 553 (998)
+.+.+||+++|. +|+ |++||++++++|||+++|++|+++.++.++++.......+...+.++.. +..+...+
T Consensus 5 ~~~n~AI~~id~~~G~---I~~~N~a~~~l~Gy~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 81 (114)
T d1ll8a_ 5 PEFNKAIFTVDAKTTE---ILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGHAAVVFGTVVDII 81 (114)
T ss_dssp TTTTCEEEEEETTTCB---EEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTHHHHHTTSSTTSSSSCSSCCCSSSEEEC
T ss_pred hhcCcEEEEEECCCCE---EEEECHHHHHhhcCCHHHHcCCCeeeecCcccHHHHHHHHHHHHhcCCCccceeeEEEEEE
Confidence 456789999995 477 9999999999999999999999999999888877766555555555532 33478889
Q ss_pred ecCCcEEEEEEEEeeeccCC--EEEEEEecCC
Q 001902 554 TKSGKKFWNLFHLQPMRDQK--YFIGVQLDGS 583 (998)
Q Consensus 554 rkdG~~~wv~~~~spi~d~~--~~vgi~rDIT 583 (998)
++||+.+||+++++++..++ .++++++||+
T Consensus 82 ~~~G~~~pvevs~~~i~~~~~~~~l~vi~dV~ 113 (114)
T d1ll8a_ 82 SRSGEKIPVSVWMKRMRQERRLCCVVVLEPVE 113 (114)
T ss_dssp CTTCCCEEEECCEECCBSSSSBEEEEEEEECC
T ss_pred ccCCcEEEEEEEEEEEEECCeEEEEEEEEECc
Confidence 99999999999999998777 8999999993
|
| >d1nwza_ d.110.3.1 (A:) Photoactive yellow protein, PYP {Ectothiorhodospira halophila [TaxId: 1053]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: Photoactive yellow protein, PYP species: Ectothiorhodospira halophila [TaxId: 1053]
Probab=99.28 E-value=5e-12 Score=118.12 Aligned_cols=108 Identities=19% Similarity=0.140 Sum_probs=88.3
Q ss_pred HHHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCccc-CCCCChHHHHHHHHHHHcCCcEEEEE
Q 001902 189 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQ-GAGTDPEDVAKIRETLQNGQSYCGRL 267 (998)
Q Consensus 189 ~~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~-~~~~~~~~~~~i~~~l~~g~~~~~e~ 267 (998)
.++..++|++++||+++|. +|+|+++|+++++++||+++|++|+++..++ |+.........+.+++.+|.....+.
T Consensus 17 ~~~d~~ld~~p~gi~~lD~---~G~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~ 93 (125)
T d1nwza_ 17 KMDDGQLDGLAFGAIQLDG---DGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGNLNTMFE 93 (125)
T ss_dssp TCCHHHHTTCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTCCEEEEE
T ss_pred HHHHHHHhCCCccEEEEeC---CCCEEEEcHHHHHhhccchHhhcCCCHHHccCchhhhhheeeeceeeeecCCcceEEE
Confidence 4567899999999999999 7889999999999999999999999986555 44455566778888898998877777
Q ss_pred EEEecCCCEEEEEeeeeEEeCCCCCEEEEEEEEecc
Q 001902 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303 (998)
Q Consensus 268 ~~~~kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DI 303 (998)
..++++|..+|+++++.++.+ |+- +..+++||
T Consensus 94 ~~~~~~G~~~~v~v~l~~~~~--g~~--~~v~V~di 125 (125)
T d1nwza_ 94 YTFDYQMTPTKVKVHMKKALS--GDS--YWVFVKRV 125 (125)
T ss_dssp EEECTTSCCEEEEEEEEECSS--SSE--EEEEEEEC
T ss_pred EEeccCCcEEEEEEEEEEecC--CCE--EEEEEEEC
Confidence 778999999999999888744 442 23566775
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Probab=99.26 E-value=1e-11 Score=113.15 Aligned_cols=96 Identities=10% Similarity=0.071 Sum_probs=78.2
Q ss_pred HHHHHHHhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCc-ccCCCCChHHHHHHHHHHHcCCcEEEEEE
Q 001902 190 IVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRF-LQGAGTDPEDVAKIRETLQNGQSYCGRLL 268 (998)
Q Consensus 190 ~l~~ild~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~-l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 268 (998)
.+.++||++|+||+++|. +|+|++||+++++|+||+++|++|+++.. +.|+.....+...+.+.+.+|........
T Consensus 4 ~~~A~ld~~p~gvi~~D~---~G~I~~~N~aa~~~~G~~~eellG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~ 80 (110)
T d1mzua_ 4 MGTAEFDALPVGAIQVDG---SGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGTLDARFDF 80 (110)
T ss_dssp --CTTGGGCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSCCEEEEEE
T ss_pred HHHHHHhCCCcEEEEEcC---CCCEEEeHHHHHHHHcCCHHHHcCCCHHHhcCChhhhHHHHHHHHHHHhccccCcceEE
Confidence 456789999999999998 88899999999999999999999999864 44455566677888888999886444334
Q ss_pred EEecCCCEEEEEeeeeEEeC
Q 001902 269 NYKKDGTPFWNLLTIAPIKD 288 (998)
Q Consensus 269 ~~~kdG~~~w~~~~~spi~d 288 (998)
..+++|..+++++++.+..+
T Consensus 81 ~l~~~G~~~~v~v~~~~~~~ 100 (110)
T d1mzua_ 81 VFDFQMAPVRVQIRMQNAGV 100 (110)
T ss_dssp EEECSSCEEEEEEEEEECSS
T ss_pred EEecCCceEEEEEEEEEecC
Confidence 46899999999999888743
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.16 E-value=5.1e-12 Score=115.93 Aligned_cols=105 Identities=12% Similarity=0.163 Sum_probs=84.0
Q ss_pred HhcCCcEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCc----EEEEEEEEe
Q 001902 196 STFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS----YCGRLLNYK 271 (998)
Q Consensus 196 d~~~d~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~~~~ 271 (998)
+.+.++|+++|.. +|+|+++|++++++|||+.+|++|+++.++.++.........+...+..+.. +..++..++
T Consensus 5 ~~~n~AI~~id~~--~G~I~~~N~a~~~l~Gy~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 82 (114)
T d1ll8a_ 5 PEFNKAIFTVDAK--TTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGHAAVVFGTVVDIIS 82 (114)
T ss_dssp TTTTCEEEEEETT--TCBEEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTHHHHHTTSSTTSSSSCSSCCCSSSEEECC
T ss_pred hhcCcEEEEEECC--CCEEEEECHHHHHhhcCCHHHHcCCCeeeecCcccHHHHHHHHHHHHhcCCCccceeeEEEEEEc
Confidence 4577899999953 5779999999999999999999999999999887776655555555554432 233677889
Q ss_pred cCCCEEEEEeeeeEEeCCCCCEEEEEEEEecch
Q 001902 272 KDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (998)
Q Consensus 272 kdG~~~w~~~~~spi~d~~G~v~~~v~i~~DIT 304 (998)
++|+.+|++++++++..++ +. .++++++||+
T Consensus 83 ~~G~~~pvevs~~~i~~~~-~~-~~l~vi~dV~ 113 (114)
T d1ll8a_ 83 RSGEKIPVSVWMKRMRQER-RL-CCVVVLEPVE 113 (114)
T ss_dssp TTCCCEEEECCEECCBSSS-SB-EEEEEEEECC
T ss_pred cCCcEEEEEEEEEEEEECC-eE-EEEEEEEECc
Confidence 9999999999999997654 43 4789999994
|
| >d1oj5a_ d.110.3.8 (A:) PAS domain of steroid receptor coactivator 1A, NCo-A1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PAS domain of steroid receptor coactivator 1A, NCo-A1 domain: PAS domain of steroid receptor coactivator 1A, NCo-A1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.85 E-value=8.6e-10 Score=99.83 Aligned_cols=91 Identities=12% Similarity=0.109 Sum_probs=75.5
Q ss_pred EEEEcCCCCCCCEEEcCHHHHHHcCCC-hhhhcCCCCccccCCCCCHH--HHHHHHHHHhcCCcEEEEEEEEecCCcEEE
Q 001902 485 FVITDPRLPDNPIIFASDSFLELTEYS-REEILGRNCRFLQGPETDPA--TVRKIRAAIDNQTDVTVQLINYTKSGKKFW 561 (998)
Q Consensus 485 i~i~D~~G~d~~I~~vN~a~~~l~Gy~-~eEliG~~~~~l~~p~~~~~--~~~~i~~~l~~g~~~~~e~~~~rkdG~~~w 561 (998)
+.-.|.+|+ |+++|+++++++||. .+||+|+++.+++||++.+. ....+...+..|.....++++++|||+.+|
T Consensus 5 ~trh~~~g~---~~~vd~~~~~~~gy~~~eelig~s~~~f~HPeD~~~~~~~~~~~~~~~~g~~~~~~yR~~~kdG~~vW 81 (109)
T d1oj5a_ 5 MTKQDTTGK---IISIDTSSLRAAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLS 81 (109)
T ss_dssp EEEECTTCC---EEEEECHHHHTTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEE
T ss_pred EEEECCCce---EEEECHHHhhHhhcCCHHHHcCCcHHHeECcccchHHHhhHHHHHHHhhcccchhhhhhhhccCcEEE
Confidence 445688777 999999999999998 59999999999999988653 334456777888889999999999999999
Q ss_pred EEEEEeeeccCC-----EEEEE
Q 001902 562 NLFHLQPMRDQK-----YFIGV 578 (998)
Q Consensus 562 v~~~~spi~d~~-----~~vgi 578 (998)
++.+..++++.. .++|+
T Consensus 82 v~t~~~~~~~~~~~~~~~Ii~~ 103 (109)
T d1oj5a_ 82 AHTRCKLCYPQSPDMQPFIMGI 103 (109)
T ss_dssp EEEEEEEECC----CCCEEEEE
T ss_pred EEEEEEEEECCCCCcccEEEEE
Confidence 999999999764 55554
|
| >d1oj5a_ d.110.3.8 (A:) PAS domain of steroid receptor coactivator 1A, NCo-A1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PAS domain of steroid receptor coactivator 1A, NCo-A1 domain: PAS domain of steroid receptor coactivator 1A, NCo-A1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.82 E-value=9.6e-10 Score=99.51 Aligned_cols=89 Identities=11% Similarity=0.061 Sum_probs=71.0
Q ss_pred CCceEEccHHHHHHcCCCh-hhhcCCCCCcccCCCCCh--HHHHHHHHHHHcCCcEEEEEEEEecCCCEEEEEeeeeEEe
Q 001902 211 DYPIMYASAGFFKMTGYTS-KEVVGRNCRFLQGAGTDP--EDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIK 287 (998)
Q Consensus 211 dG~I~~vN~a~~~l~Gys~-eEliG~~~~~l~~~~~~~--~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~spi~ 287 (998)
+|+|+++|+++++++||.. +|++|+++..++||++.. .........+..|.....++++++|||+.+|++.+..+++
T Consensus 11 ~g~~~~vd~~~~~~~gy~~~eelig~s~~~f~HPeD~~~~~~~~~~~~~~~~g~~~~~~yR~~~kdG~~vWv~t~~~~~~ 90 (109)
T d1oj5a_ 11 TGKIISIDTSSLRAAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSAHTRCKLCY 90 (109)
T ss_dssp TCCEEEEECHHHHTTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEEEEEEEEEEC
T ss_pred CceEEEECHHHhhHhhcCCHHHHcCCcHHHeECcccchHHHhhHHHHHHHhhcccchhhhhhhhccCcEEEEEEEEEEEE
Confidence 8889999999999999985 999999999999988754 2333456677888888899999999999999999999999
Q ss_pred CCCCCE-EEEEEE
Q 001902 288 DDEGKV-LKFIGM 299 (998)
Q Consensus 288 d~~G~v-~~~v~i 299 (998)
|+.|+. ..++|+
T Consensus 91 ~~~~~~~~~Ii~~ 103 (109)
T d1oj5a_ 91 PQSPDMQPFIMGI 103 (109)
T ss_dssp C----CCCEEEEE
T ss_pred CCCCCcccEEEEE
Confidence 875543 344443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.39 E-value=1.1e-06 Score=91.70 Aligned_cols=139 Identities=13% Similarity=0.095 Sum_probs=96.6
Q ss_pred CCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEeeCCeEEEE
Q 001902 665 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLI 743 (998)
Q Consensus 665 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lV 743 (998)
..|+.++..+.++.+.||++. ..+..+++|......... ...+..|..+++.+. +--+++++.+...++..++|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 467777766556667899886 356678899876543222 234566888887773 44467888888888999999
Q ss_pred EecCCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------
Q 001902 744 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ------------------------------------- 786 (998)
Q Consensus 744 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~------------------------------------- 786 (998)
|++++|.++.+..... .....++.++...+..||+.
T Consensus 89 ~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 9999998886554221 11223345555555555531
Q ss_pred ----------------------CceeccCCCCcEEEecCCcEEEEeccCcc
Q 001902 787 ----------------------GIIYRDLKPENVLLQGNGHVSLTDFDLSC 815 (998)
Q Consensus 787 ----------------------~IiHrDLkP~NILi~~~g~vkL~DFG~a~ 815 (998)
.++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 15899999999999977666799999884
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.92 E-value=1.7e-05 Score=81.84 Aligned_cols=75 Identities=16% Similarity=0.141 Sum_probs=53.0
Q ss_pred ccCCCCc-eeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCC--CCccceeEEEeeCCeEEEEEecCC
Q 001902 672 PLGSGDT-GSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTKTHVCLITDYCP 748 (998)
Q Consensus 672 ~LG~G~~-g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h--~nIv~l~~~~~~~~~~~lV~E~~~ 748 (998)
.+..|.. +.||++.. ..+..+++|....... ..+..|...++.+.. -.+++++.+..+.+..++||+|++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 4455554 67899886 4577789998765422 235667777777633 336788888888889999999998
Q ss_pred CCchh
Q 001902 749 GGELF 753 (998)
Q Consensus 749 ggsL~ 753 (998)
|.++.
T Consensus 90 G~~~~ 94 (255)
T d1nd4a_ 90 GQDLL 94 (255)
T ss_dssp SEETT
T ss_pred ccccc
Confidence 87663
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.82 E-value=1.9e-05 Score=87.26 Aligned_cols=81 Identities=15% Similarity=0.130 Sum_probs=51.0
Q ss_pred ccccCCCCceeEEEEEEccCCeEEEEEEeecccccC----hhHHHHHHHHHHHHHhCC-C--CCccceeEEEeeCCeEEE
Q 001902 670 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN----RNKVHRACAEREILDMLD-H--PFVPALYASFQTKTHVCL 742 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~----~~~~~~~~~E~~il~~l~-h--~nIv~l~~~~~~~~~~~l 742 (998)
.+.||.|....||++.+..+++.+++|.-....... +....+...|...|+.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457899999999999987778899999755321111 112344556888887662 2 456666643 3445578
Q ss_pred EEecCCCCch
Q 001902 743 ITDYCPGGEL 752 (998)
Q Consensus 743 V~E~~~ggsL 752 (998)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977553
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.95 E-value=0.001 Score=72.91 Aligned_cols=74 Identities=20% Similarity=0.304 Sum_probs=51.2
Q ss_pred ccccCCCCceeEEEEEEcc-------CCeEEEEEEeecccccChhHHHHHHHHHHHHHhCC-CCCccceeEEEeeCCeEE
Q 001902 670 IKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVC 741 (998)
Q Consensus 670 ~~~LG~G~~g~Vy~a~~~~-------~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~ 741 (998)
+++|+.|-.-.+|++.... ..+.|++++.... . ......+|..+++.+. +.-.+++++++.+ +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~---~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E---TESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--c---hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 3678999999999998743 2456888876521 1 1234567888988884 4334677776643 5
Q ss_pred EEEecCCCCch
Q 001902 742 LITDYCPGGEL 752 (998)
Q Consensus 742 lV~E~~~ggsL 752 (998)
+||||++|.+|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 89999987655
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.48 E-value=0.0031 Score=67.06 Aligned_cols=70 Identities=11% Similarity=0.029 Sum_probs=45.5
Q ss_pred ceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCCc--ccee-----EEEeeCCeEEEEEecCCCC
Q 001902 678 TGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV--PALY-----ASFQTKTHVCLITDYCPGG 750 (998)
Q Consensus 678 ~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nI--v~l~-----~~~~~~~~~~lV~E~~~gg 750 (998)
-..||++.. .+|..|++|+..++.. ...++..|...+..|....| +... ..+...+..+.++++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 468999987 6788999999876422 23456668888777742222 1111 1234567789999999774
Q ss_pred ch
Q 001902 751 EL 752 (998)
Q Consensus 751 sL 752 (998)
.+
T Consensus 110 ~~ 111 (325)
T d1zyla1 110 QF 111 (325)
T ss_dssp EC
T ss_pred CC
Confidence 43
|
| >d2oola2 d.110.3.9 (A:26-139) Sensor protein PhyB2 {Rhodopseudomonas palustris [TaxId: 1076]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Sensor protein PhyB2 species: Rhodopseudomonas palustris [TaxId: 1076]
Probab=96.25 E-value=0.0012 Score=58.76 Aligned_cols=76 Identities=13% Similarity=0.166 Sum_probs=49.6
Q ss_pred ceEEEEcC-CCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCc---EEEEEEEEecC-C
Q 001902 483 KNFVITDP-RLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD---VTVQLINYTKS-G 557 (998)
Q Consensus 483 d~i~i~D~-~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~---~~~e~~~~rkd-G 557 (998)
-.++++|. +|+ |++|+++...++|++.++++|++..++.++++. ..+++.+..... ..........+ |
T Consensus 18 G~Llvld~~d~~---I~~vS~N~~~lLG~~~~~llG~~l~dll~~~~~----~~i~~~l~~~~~~~~~~~~~~~~~~~~~ 90 (114)
T d2oola2 18 GYLFVVSETDLR---IASVSANVEDLLRQPPASLLNVPIAHYLTAASA----ARLTHALHGGDPAAINPIRLDVVTPDGE 90 (114)
T ss_dssp SEEEEECTTTCB---EEEEETTHHHHHSSCGGGGTTCBGGGGBCHHHH----HHHHHHHCC----CCCSEEEEEEETTEE
T ss_pred cEEEEEECCCCE---EEEEcCCHHHHhCCChHHHcCCCHHHhCCHHHH----HHHHHHHhcCCcccCCCEEEEEecCCCC
Confidence 45677775 355 999999999999999999999999888877543 445555543322 12233444433 4
Q ss_pred cEEEEEEE
Q 001902 558 KKFWNLFH 565 (998)
Q Consensus 558 ~~~wv~~~ 565 (998)
..|++-++
T Consensus 91 ~~~~~~~H 98 (114)
T d2oola2 91 RAFNGILH 98 (114)
T ss_dssp EEEEEEEE
T ss_pred eEEEEEEE
Confidence 45555444
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.20 E-value=0.0057 Score=64.35 Aligned_cols=146 Identities=17% Similarity=0.148 Sum_probs=77.7
Q ss_pred cCCcccccccCCCCceeEEEEEEccCCeEEEEEEeecccccChhHHHHHHHHHHHHHhCCCCC--ccceeE------EEe
Q 001902 664 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF--VPALYA------SFQ 735 (998)
Q Consensus 664 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~i~~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~l~~------~~~ 735 (998)
++...-++.|..|--.+.|++... +..|++|++.... + ...+..|..++..|...+ ++.+.. +..
T Consensus 17 lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~--~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~ 89 (316)
T d2ppqa1 17 VGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE 89 (316)
T ss_dssp CCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred CCCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCC--C---HHHHHHHHHHHHhhhhccccccccceecCCCccee
Confidence 445555677888888999999863 3458999986531 1 233444666666663222 211111 122
Q ss_pred eCCeEEEEEecCCCCchhH--------------HHhh---C-C---CCCC------------------CHHHHHHHHHHH
Q 001902 736 TKTHVCLITDYCPGGELFL--------------LLDR---Q-P---TKVL------------------KEDAVRFYAAEV 776 (998)
Q Consensus 736 ~~~~~~lV~E~~~ggsL~~--------------~l~~---~-~---~~~l------------------~~~~~~~i~~qi 776 (998)
.....+.++.++.|..... .++. . . .... ........+..+
T Consensus 90 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 169 (316)
T d2ppqa1 90 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 169 (316)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred eecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHH
Confidence 3456677787776643311 0000 0 0 0000 001111222223
Q ss_pred HHHHHHHHH----CCceeccCCCCcEEEecCCcEEEEeccCccc
Q 001902 777 VVALEYLHC----QGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 816 (998)
Q Consensus 777 l~aL~~LH~----~~IiHrDLkP~NILi~~~g~vkL~DFG~a~~ 816 (998)
...+...+. .|+||+|+.++||+++.+...-|+||+.++.
T Consensus 170 ~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 170 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 333333332 3799999999999999887778999999854
|
| >d2oola2 d.110.3.9 (A:26-139) Sensor protein PhyB2 {Rhodopseudomonas palustris [TaxId: 1076]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Sensor protein PhyB2 species: Rhodopseudomonas palustris [TaxId: 1076]
Probab=95.90 E-value=0.0023 Score=56.82 Aligned_cols=54 Identities=17% Similarity=0.195 Sum_probs=40.8
Q ss_pred cEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcC
Q 001902 201 TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNG 260 (998)
Q Consensus 201 ~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g 260 (998)
.++++|. .+|+|+|++++...++|++.++++|+++.++++++. ...+++.+...
T Consensus 19 ~Llvld~--~d~~I~~vS~N~~~lLG~~~~~llG~~l~dll~~~~----~~~i~~~l~~~ 72 (114)
T d2oola2 19 YLFVVSE--TDLRIASVSANVEDLLRQPPASLLNVPIAHYLTAAS----AARLTHALHGG 72 (114)
T ss_dssp EEEEECT--TTCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCHHH----HHHHHHHHCC-
T ss_pred EEEEEEC--CCCEEEEEcCCHHHHhCCChHHHcCCCHHHhCCHHH----HHHHHHHHhcC
Confidence 3455553 278899999999999999999999999998887643 44555555443
|
| >d2o9ca2 d.110.3.9 (A:4-130) Bacteriophytochrome BphP {Deinococcus radiodurans [TaxId: 1299]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Deinococcus radiodurans [TaxId: 1299]
Probab=89.59 E-value=0.24 Score=43.98 Aligned_cols=78 Identities=9% Similarity=0.000 Sum_probs=51.0
Q ss_pred ceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHHHHHHHHHHHhcCCc--EEEEEEEEecCCcEE
Q 001902 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD--VTVQLINYTKSGKKF 560 (998)
Q Consensus 483 d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~~~~~i~~~l~~g~~--~~~e~~~~rkdG~~~ 560 (998)
-.++++|.. ++.|+.++.....++|++.++++|++...+.+.. ...+...+..... ..........+|..+
T Consensus 36 G~LLald~~--~~~I~~~S~N~~~~lG~~~~~llG~~l~~ll~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f 108 (127)
T d2o9ca2 36 GALLTADGH--SGEVLQMSLNAATFLGQEPTVLRGQTLAALLPEQ-----WPALQAALPPGCPDALQYRATLDWPAAGHL 108 (127)
T ss_dssp SEEEEEETT--TCBEEEEETTHHHHHSSCHHHHTTCBHHHHCTTT-----HHHHHHHSCTTCCTTCCEEEEECCSSSSEE
T ss_pred eEEEEEECC--CCEEEEECCCHHHHhCCChHHHcCCCHHHHCCHH-----HHHHHHHhhhcCcccccceeeeecCCCceE
Confidence 355666753 4459999999999999999999999988877532 1223333333222 233334445677788
Q ss_pred EEEEEEe
Q 001902 561 WNLFHLQ 567 (998)
Q Consensus 561 wv~~~~s 567 (998)
|+.++.+
T Consensus 109 ~~~~Hrs 115 (127)
T d2o9ca2 109 SLTVHRV 115 (127)
T ss_dssp EEEEEEE
T ss_pred EEEEEEE
Confidence 8877643
|
| >d2veaa3 d.110.3.9 (A:4-130) Phytochrome-like protein Cph1 {Synechocystis sp. pcc 6803 [TaxId: 1148]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Phytochrome-like protein Cph1 species: Synechocystis sp. pcc 6803 [TaxId: 1148]
Probab=89.50 E-value=0.081 Score=47.26 Aligned_cols=47 Identities=19% Similarity=0.084 Sum_probs=35.5
Q ss_pred ceEEEEcCCCCCCCEEEcCHHHHHHcCCChhhhcCCCCccccCCCCCHH
Q 001902 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPA 531 (998)
Q Consensus 483 d~i~i~D~~G~d~~I~~vN~a~~~l~Gy~~eEliG~~~~~l~~p~~~~~ 531 (998)
-.++++|.. +++|+.++.....++|+++++++|++...+.+++....
T Consensus 27 G~LLald~~--~~~I~~aS~N~~~~lG~~~~~lLG~~l~~ll~~~~~~~ 73 (127)
T d2veaa3 27 GLVVVLQEP--DLTISQISANCTGILGRSPEDLLGRTLGEVFDSFQIDP 73 (127)
T ss_dssp SEEEEEETT--TTEEEEEETTHHHHTSCCTTTSSTTTTTTTSBCC----
T ss_pred eEEEEEECC--CCEEEEEcCCHHHHhCcChHHHcCCCHHHHCCHHHHHH
Confidence 355666643 44599999999999999999999999888887765443
|
| >d2o9ca2 d.110.3.9 (A:4-130) Bacteriophytochrome BphP {Deinococcus radiodurans [TaxId: 1299]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Deinococcus radiodurans [TaxId: 1299]
Probab=88.23 E-value=0.35 Score=42.88 Aligned_cols=75 Identities=11% Similarity=0.019 Sum_probs=48.5
Q ss_pred cEEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCCChHHHHHHHHHHHcCCc--EEEEEEEEecCCCEEE
Q 001902 201 TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS--YCGRLLNYKKDGTPFW 278 (998)
Q Consensus 201 ~i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~--~~~e~~~~~kdG~~~w 278 (998)
.++++|.. +++|+.++....+++|++.++++|+++..+++.. ...+...+..... ..........+|..+|
T Consensus 37 ~LLald~~--~~~I~~~S~N~~~~lG~~~~~llG~~l~~ll~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~ 109 (127)
T d2o9ca2 37 ALLTADGH--SGEVLQMSLNAATFLGQEPTVLRGQTLAALLPEQ-----WPALQAALPPGCPDALQYRATLDWPAAGHLS 109 (127)
T ss_dssp EEEEEETT--TCBEEEEETTHHHHHSSCHHHHTTCBHHHHCTTT-----HHHHHHHSCTTCCTTCCEEEEECCSSSSEEE
T ss_pred EEEEEECC--CCEEEEECCCHHHHhCCChHHHcCCCHHHHCCHH-----HHHHHHHhhhcCcccccceeeeecCCCceEE
Confidence 34555642 6889999999999999999999999999877542 1223333333222 2333444455667666
Q ss_pred EEee
Q 001902 279 NLLT 282 (998)
Q Consensus 279 ~~~~ 282 (998)
+.+.
T Consensus 110 ~~~H 113 (127)
T d2o9ca2 110 LTVH 113 (127)
T ss_dssp EEEE
T ss_pred EEEE
Confidence 6554
|
| >d2veaa3 d.110.3.9 (A:4-130) Phytochrome-like protein Cph1 {Synechocystis sp. pcc 6803 [TaxId: 1148]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Phytochrome-like protein Cph1 species: Synechocystis sp. pcc 6803 [TaxId: 1148]
Probab=87.94 E-value=0.16 Score=45.28 Aligned_cols=42 Identities=24% Similarity=0.280 Sum_probs=34.8
Q ss_pred EEEEecCCCCCceEEccHHHHHHcCCChhhhcCCCCCcccCCCC
Q 001902 202 FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGT 245 (998)
Q Consensus 202 i~i~D~~g~dG~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~ 245 (998)
++++|. .+++|+.+......++|++.++++|+++..++++..
T Consensus 29 LLald~--~~~~I~~aS~N~~~~lG~~~~~lLG~~l~~ll~~~~ 70 (127)
T d2veaa3 29 VVVLQE--PDLTISQISANCTGILGRSPEDLLGRTLGEVFDSFQ 70 (127)
T ss_dssp EEEEET--TTTEEEEEETTHHHHTSCCTTTSSTTTTTTTSBCC-
T ss_pred EEEEEC--CCCEEEEEcCCHHHHhCcChHHHcCCCHHHHCCHHH
Confidence 455563 278899999999999999999999999998877654
|